Citrus Sinensis ID: 042766

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910----
Protein Sequence
MPNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEEEccccEEccccccccccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHcccccccEEccccccEEccccccccccccccEEEcccccccccccHHHHHHccccEEcccccccEEcccccccccccccEEEcccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEEcccEEEEcccccccccccccEEEccccccEEcccccccccccccEEEccccEEEEcccHHHHcccccccEEccccccccccccccccccccccEEcccccccccccHHHHcccccccHHccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEccccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEEcccccEEEEEEccccEEEEEEEEEcccccccHHHHHHHHHHccccccccccEEEEEcccccccccEEEEEEEccccccHHHHccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccEEEEcccEEEEc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccccccccccccEEEEcccccEEEEEEcccccccccccHHHcccHHHEEEEcccccccccccHHHHccHHcEEEEcccccccccccccHHcccccEEEEcccccccccccHHHccccccEEEEEccccccccccccHccHHHHHEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEcccccccccccHHHHcccccccEEEEEccccccccccHHHcccccEEEEcccccccccccHHHcccccccEEEEcccccccccccccHHHHHHccccccEEEEEccccccccccHHHHHcccccEEEEEEEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHcccccEEEcccccccccccccHccccEEEEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccHHHHHEEccccccccccccccEEEccccEEEcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEEccccEEEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHEEEEccccccccccEEEEEEEcccccHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHEEccccccccccccccEEEEEccEcEcccHccccccEcEEEcccccEEcc
Coil and Loop (DISEMBL)
MPNISISISCLAILIRCFSLflinspsfsagqtnETDRLALLAIKSqlhdpsgvtsswnntmnfcqwtgvtcghrhqrltelnlssqriggvlspyvgnlSFLRYINladngfrgdipqEIGNLFRLEKlalsnnsfsgtiptnlsrcsnLIHFCasnnklegqipKEIGNLLKLQRLSVDINyltgqlpdsvgnlSAIEVIRITenslggkipttLGLLRRLVNLNVaenqfsgmfprsicnissvELIFLtenrfsgifpfdillnlpnlkklgiggnnfvgsipdslsnasnlelldlpsnqfkgkvsidfssLKNLWLLNLeqnnlgtgtandLDFVIFLSNcsslkvlslsdnqfggelpHSIANLSLKMIELSvgrnqisgtippgirNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFlrggipsglgnltklgsldlgsnslqgnipsslgncQNLILFIASYnkltgdlpqqlLSITTLSLVLDLSnnllngslplqvgnlKNLVMLDissnqfsgvipvtlstcvsleyldisinsfygvipLSFRFLKSIKALNVssnnlsgkipefleNLSFLEFLNLSYnyfegevpvkgvfsnktkislhgnvklcggidelhlpscpskgsrkpkitLLKVLIPVVVSCLLLSSCLTIVYARkrrsthksvdtspmeklfpMVSYAELSkatsefsssnmigqgrfgtvykgilgdDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIcsstdfegvDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLhhhcqppmvhgdlkpsnvlldydmVAHVGDFGLakflsnhhldiasktpsssigikgtvgyvapgKFFMLYthipsfsctnvhhf
Flexible Loop (DISEMBL)
MPNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRItenslggkipTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIvyarkrrsthksvdtspmekLFPMVSYAELSKATsefsssnmigqGRFGTVYKGILGDDEMVVAVKVINlkqkgasksfVSECEALRNIRHRNLIKIITicsstdfeGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIasktpsssigikGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Low Complexity Region (SEG)
MPNisisisCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPttlgllrrlvnlnvAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSlknlwllnleqnnlGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTlslvldlsnnllngslplQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPeflenlsfleflnlsYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKvlipvvvsclllsscltivYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Disordered region (IsUnstruct)
****SISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSC******KPKITLLKVLIPVVVSCLLLSSCLTIVYAR*****************************************GRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNV***
Disordered Region (DISOPRED)
********SCLAILIRCFSLFLINSPSFSA**TNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGID********************KVLIPVVVSCLLLSSCLTIVYA********************MVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK*ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL****************GIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Disordered Region (DISEMBL)
MPNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARK**********SPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Disordered Region (DISPRO)
*PNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRST********MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH********PSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	914	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.939	0.850	0.451	0.0
C0LGT6	1031	LRR receptor-like serine/	no	no	0.936	0.830	0.453	0.0
Q9SD62	1025	Putative receptor-like pr	no	no	0.936	0.835	0.473	0.0
Q9FL28	1173	LRR receptor-like serine/	no	no	0.867	0.676	0.360	1e-121
O49318	1124	Probable leucine-rich rep	no	no	0.910	0.740	0.322	1e-114
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.907	0.752	0.330	1e-113
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.904	0.825	0.335	1e-112
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.875	0.640	0.342	1e-111
O49545	1003	Leucine-rich repeat recep	no	no	0.900	0.820	0.340	1e-110
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.799	0.745	0.365	1e-109

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  729 bits (1882), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/880 (45%), Positives = 580/880 (65%), Gaps = 21/880 (2%)

Query: 29  SAGQTNETDRLALLAIKSQL-HDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQ 87
           + G T+ETDR ALL  KSQ+  D   V SSWN++   C W GVTCG +++R+T L L   
Sbjct: 17  THGFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVTCGRKNKRVTHLELGRL 76

Query: 88  RIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSR 147
           ++GGV+SP +GNLSFL  ++L +N F G IPQE+G L RLE L +  N   G IP  L  
Sbjct: 77  QLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYN 136

Query: 148 CSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN 207
           CS L++    +N+L G +P E+G+L  L +L++  N + G+LP S+GNL+ +E + ++ N
Sbjct: 137 CSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHN 196

Query: 208 SLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILL 267
           +L G+IP+ +  L ++ +L +  N FSG+FP ++ N+SS++L+ +  N FSG    D+ +
Sbjct: 197 NLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGI 256

Query: 268 NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQ 327
            LPNL    +GGN F GSIP +LSN S LE L +  N   G +   F ++ NL LL L  
Sbjct: 257 LLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIPT-FGNVPNLKLLFLHT 315

Query: 328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISG 387
           N+LG+ ++ DL+F+  L+NC+ L+ L +  N+ GG+LP SIANLS K++ L +G   ISG
Sbjct: 316 NSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLISG 375

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKL 447
           +IP  I NL+NL    L+ N   G +P  + +L NL+ LS+F+N L GGIP+ +GN+T L
Sbjct: 376 SIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTML 435

Query: 448 GSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLN 507
            +LDL +N  +G +P+SLGNC +L+      NKL G +P +++ I  L L LD+S N L 
Sbjct: 436 ETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLI 494

Query: 508 GSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS 567
           GSLP  +G L+NL  L +  N+ SG +P TL  C+++E L +  N FYG IP   + L  
Sbjct: 495 GSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVG 553

Query: 568 IKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLC 627
           +K +++S+N+LSG IPE+  + S LE+LNLS+N  EG+VPVKG+F N T +S+ GN  LC
Sbjct: 554 VKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLC 613

Query: 628 GGIDELHL-------PSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTH 680
           GGI    L       PS   K S + K  ++ V + + +  LL  + +T+++ RKR+   
Sbjct: 614 GGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNK 673

Query: 681 KSVDTSP--MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI 738
           ++ + +P  +E L   +SY +L  AT+ FSSSNM+G G FGTVYK +L  ++ VVAVKV+
Sbjct: 674 ETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVL 733

Query: 739 NLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL 798
           N++++GA KSF++ECE+L++IRHRNL+K++T CSS DF+G +F+AL++E+M NGSL+ WL
Sbjct: 734 NMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWL 793

Query: 799 HQSNDQVE-----VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
           H   ++VE      R L+L++R+NIAIDVAS ++YLH HC  P+ H DLKPSNVLLD D+
Sbjct: 794 HP--EEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDL 851

Query: 854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            AHV DFGLA+ L     + +     SS G++GT+GY AP
Sbjct: 852 TAHVSDFGLARLLLKFD-EESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 399/879 (45%), Positives = 558/879 (63%), Gaps = 23/879 (2%)

Query: 33  TNETDRLALLAIKSQL--HDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIG 90
           +NETD  ALL  KSQ+  ++   V +SWN++  FC W GVTCG R +R+  LNL   ++ 
Sbjct: 27  SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86

Query: 91  GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSN 150
           GV+SP +GNLSFLR +NLADN F   IPQ++G LFRL+ L +S N   G IP++LS CS 
Sbjct: 87  GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146

Query: 151 LIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLG 210
           L     S+N L   +P E+G+L KL  L +  N LTG  P S+GNL++++ +    N + 
Sbjct: 147 LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMR 206

Query: 211 GKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLP 270
           G+IP  +  L ++V   +A N FSG FP ++ NISS+E + L +N FSG    D    LP
Sbjct: 207 GEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLP 266

Query: 271 NLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL 330
           NL++L +G N F G+IP +L+N S+LE  D+ SN   G + + F  L+NLW L +  N+L
Sbjct: 267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326

Query: 331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP 390
           G  +++ L+F+  ++NC+ L+ L +  N+ GGELP SIANLS  +  L +G+N ISGTIP
Sbjct: 327 GNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIP 386

Query: 391 PGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSL 450
             I NLV+L   +LE N   G +P    +L NLQ + +++N + G IPS  GN+T+L  L
Sbjct: 387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446

Query: 451 DLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSL 510
            L SNS  G IP SLG C+ L+      N+L G +PQ++L I +L+ + DLSNN L G  
Sbjct: 447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYI-DLSNNFLTGHF 505

Query: 511 PLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKA 570
           P +VG L+ LV L  S N+ SG +P  +  C+S+E+L +  NSF G IP   R L S+K 
Sbjct: 506 PEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISR-LVSLKN 564

Query: 571 LNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGI 630
           ++ S+NNLSG+IP +L +L  L  LNLS N FEG VP  GVF N T +S+ GN  +CGG+
Sbjct: 565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624

Query: 631 DELHLPSCPSKGS---RKPKITLLKVLIPV---VVSCLLLSSCLTIVYARKRRSTHKSVD 684
            E+ L  C  + S   RKP     KV+  +   + S LL+    ++ +  KR+  + + D
Sbjct: 625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684

Query: 685 TSPMEK-----LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN 739
            +P +          VSY EL  ATS FSS+N+IG G FG V+KG+LG +  +VAVKV+N
Sbjct: 685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744

Query: 740 LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
           L + GA+KSF++ECE  + IRHRNL+K+IT+CSS D EG DF+ALV+E+M  GSL+ WL 
Sbjct: 745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQ 804

Query: 800 -----QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV 854
                + ND    R L+  +++NIAIDVASA+EYLH HC  P+ H D+KPSN+LLD D+ 
Sbjct: 805 LEDLERVNDH--SRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862

Query: 855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           AHV DFGLA+ L  +  + +     SS G++GT+GY AP
Sbjct: 863 AHVSDFGLAQLLYKYDRE-SFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  691 bits (1784), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/877 (47%), Positives = 576/877 (65%), Gaps = 21/877 (2%)

Query: 33  TNETDRLALLAIKSQLHDPSGVT-SSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGG 91
           T ETD+ ALL  KSQ+ + S V   SWN+++  C WTGV CG +H+R+T ++L   ++ G
Sbjct: 36  TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95

Query: 92  VLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNL 151
           V+SP+VGNLSFLR +NLADN F G IP E+GNLFRL+ L +SNN F G IP  LS CS+L
Sbjct: 96  VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155

Query: 152 IHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG 211
                S+N LE  +P E G+L KL  LS+  N LTG+ P S+GNL++++++    N + G
Sbjct: 156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEG 215

Query: 212 KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPN 271
           +IP  +  L++++   +A N+F+G+FP  I N+SS+  + +T N FSG    D    LPN
Sbjct: 216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query: 272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLG 331
           L+ L +G N+F G+IP++LSN S+L  LD+PSN   GK+ + F  L+NL LL L  N+LG
Sbjct: 276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query: 332 TGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPP 391
             ++ DLDF+  L+NCS L+ L++  N+ GG+LP  IANLS ++ ELS+G N ISG+IP 
Sbjct: 336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395

Query: 392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
           GI NLV+L T  L  N   G +P  + EL  L+++ +++N L G IPS LGN++ L  L 
Sbjct: 396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP 511
           L +NS +G+IPSSLG+C  L+      NKL G +P +L+ + +L +VL++S NLL G L 
Sbjct: 456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLR 514

Query: 512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL 571
             +G LK L+ LD+S N+ SG IP TL+ C+SLE+L +  NSF G IP   R L  ++ L
Sbjct: 515 QDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFL 573

Query: 572 NVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGID 631
           ++S NNLSG IPE++ N S L+ LNLS N F+G VP +GVF N + +S+ GN+ LCGGI 
Sbjct: 574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633

Query: 632 ELHLPSC----PSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKR----RSTHKSV 683
            L L  C    P + S   KI  + V   +    LL    + + + + R    R+ +   
Sbjct: 634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693

Query: 684 DT--SPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
           D   SP++  +  +SY EL K T  FSSSN+IG G FG V+KG LG     VA+KV+NL 
Sbjct: 694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753

Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
           ++GA+KSF++ECEAL  IRHRNL+K++TICSS+DFEG DF+ALV+E+M NG+L+ WLH  
Sbjct: 754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP- 812

Query: 802 NDQVE-----VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH 856
            D++E      R L L  R+NIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ AH
Sbjct: 813 -DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAH 871

Query: 857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           V DFGLA+ L     D       SS G++GT+GY AP
Sbjct: 872 VSDFGLAQLLLKFDRD-TFHIQFSSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  436 bits (1121), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 315/873 (36%), Positives = 463/873 (53%), Gaps = 80/873 (9%)

Query: 85   SSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTN 144
            +   + G +   +G L+ L  ++L+ N   G IP++ GNL  L+ L L+ N   G IP  
Sbjct: 200  AGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAE 259

Query: 145  LSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRI 204
            +  CS+L+     +N+L G+IP E+GNL++LQ L +  N LT  +P S+  L+ +  + +
Sbjct: 260  IGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGL 319

Query: 205  TENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD 264
            +EN L G I   +G L  L  L +  N F+G FP+SI N+ ++ ++ +  N  SG  P D
Sbjct: 320  SENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPAD 379

Query: 265  ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLN 324
            + L L NL+ L    N   G IP S+SN + L+LLDL  NQ  G++   F  + NL  ++
Sbjct: 380  LGL-LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFIS 437

Query: 325  LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQ 384
            + +N+  TG   D  F     NCS+L+ LS++DN   G L   I  L  K+  L V  N 
Sbjct: 438  IGRNHF-TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQ-KLRILQVSYNS 490

Query: 385  ISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL 444
            ++G IP  I NL +L    L  N F G IP  +S L  LQ L +++N L G IP  + ++
Sbjct: 491  LTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDM 550

Query: 445  TKLGSLDLGSN-------------------SLQGN-----IPSSLGNCQNLILFIASYNK 480
              L  LDL +N                   SLQGN     IP+SL +   L  F  S N 
Sbjct: 551  KLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNL 610

Query: 481  LTGDLPQQLL-SITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLS 539
            LTG +P +LL S+  + L L+ SNNLL G++P ++G L+ +  +D+S+N FSG IP +L 
Sbjct: 611  LTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQ 670

Query: 540  TCVSLEYLD-------------------------ISINSFYGVIPLSFRFLKSIKALNVS 574
             C ++  LD                         +S NSF G IP SF  +  + +L++S
Sbjct: 671  ACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLS 730

Query: 575  SNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELH 634
            SNNL+G+IPE L NLS L+ L L+ N  +G VP  GVF N     L GN  LCG    L 
Sbjct: 731  SNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK 790

Query: 635  LPSCPSKGSRKPKITLLKVLI-------PVVVSCLLLSSCLTIVYARKRRSTHKSVDTSP 687
              +   K S   K T + ++I        +V+  +L+ +C      +   S+  S+    
Sbjct: 791  PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLD 850

Query: 688  MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS- 746
                       EL +AT  F+S+N+IG     TVYKG L +D  V+AVKV+NLK+  A  
Sbjct: 851  SALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAES 909

Query: 747  -KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
             K F +E + L  ++HRNL+KI+       +E    KALV  +MENG+LED +H S   +
Sbjct: 910  DKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPI 965

Query: 806  EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
                 SL++++++ + +AS I+YLH     P+VH DLKP+N+LLD D VAHV DFG A+ 
Sbjct: 966  G----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARI 1021

Query: 866  LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM 898
            L          T +S+   +GT+GY+AP   +M
Sbjct: 1022 LGFRE---DGSTTASTSAFEGTIGYLAPEFAYM 1051

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  412 bits (1060), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 319/989 (32%), Positives = 467/989 (47%), Gaps = 157/989 (15%)

Query: 36  TDRLALLAIKSQ-LHDPSGVTSSWNNTMNF-CQWTGVTCGHRHQR-------LTELNLSS 86
           +D   LL +K++   D      +WN      C W GV C  +          +T L+LSS
Sbjct: 35  SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSS 94

Query: 87  QRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLS 146
             + G++SP +G L  L Y+NLA N   GDIP+EIGN  +LE + L+NN F G+IP  ++
Sbjct: 95  MNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEIN 154

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
           + S L  F   NNKL G +P+EIG+L  L+ L    N LTG LP S+GNL+ +   R  +
Sbjct: 155 KLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQ 214

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDIL 266
           N   G IPT +G    L  L +A+N  SG  P+ I  +  ++ + L +N+FSG  P DI 
Sbjct: 215 NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIG 274

Query: 267 LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF-------------------- 306
            NL +L+ L + GN+ VG IP  + N  +L+ L L  NQ                     
Sbjct: 275 -NLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFS 333

Query: 307 ----KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC--------------- 347
                G++ ++ S +  L LL L QN L     N+L  +  L+                 
Sbjct: 334 ENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGF 393

Query: 348 ---------------------------SSLKVLSLSDNQFGGELPHSIANLSLKMIELSV 380
                                      S L V+  S+NQ  G++P  I   S  +I L++
Sbjct: 394 QNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQS-NLILLNL 452

Query: 381 GRNQISGTIPPGIR------------------------NLVNLITFTLEVNQFHGTIPDV 416
           G N+I G IPPG+                          LVNL    L+ N+F G +P  
Sbjct: 453 GSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPE 512

Query: 417 ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIA 476
           I   + LQ+L +  N     +P+ +  L+ L + ++ SNSL G IPS + NC+ L     
Sbjct: 513 IGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDL 572

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
           S N   G LP +L S+  L  +L LS N  +G++P  +GNL +L  L +  N FSG IP 
Sbjct: 573 SRNSFIGSLPPELGSLHQLE-ILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPP 631

Query: 537 TLSTCVSLEY-LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFL 595
            L    SL+  +++S N F G IP     L  +  L++++N+LSG+IP   ENLS L   
Sbjct: 632 QLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGC 691

Query: 596 NLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLK--- 652
           N SYN   G++P   +F N T  S  GN  LCGG    HL SC    S  P I+ LK   
Sbjct: 692 NFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG----HLRSCDPSHSSWPHISSLKAGS 747

Query: 653 -------------------VLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTS--PMEKL 691
                              +LI +VV  L      T  Y   +    +  D    P E+ 
Sbjct: 748 ARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERF 807

Query: 692 FPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKV------INLKQKGA 745
               +  ++ +AT  F  S ++G+G  GTVYK ++   + +   K+       N      
Sbjct: 808 ----TVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNT 863

Query: 746 SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
             SF +E   L  IRHRN++++ + C     +G +   L++EYM  GSL + LH      
Sbjct: 864 DNSFRAEILTLGKIRHRNIVRLYSFCYH---QGSNSNLLLYEYMSRGSLGELLHGGKSH- 919

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
               +    R  IA+  A  + YLHH C+P ++H D+K +N+L+D +  AHVGDFGLAK 
Sbjct: 920 ---SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKV 976

Query: 866 LSNHHLDIA-SKTPSSSIGIKGTVGYVAP 893
                +D+  SK+ S+   + G+ GY+AP
Sbjct: 977 -----IDMPLSKSVSA---VAGSYGYIAP 997

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  409 bits (1050), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 320/968 (33%), Positives = 458/968 (47%), Gaps = 139/968 (14%)

Query: 41  LLAIKSQLHDPSGVTSSWNNTMNF-CQWTGVTCGHRHQ--RLTELNLSSQRIGGVLSPYV 97
           LL IKS+  D      +WN+  +  C WTGV C +      +  LNLSS  + G LSP +
Sbjct: 34  LLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSI 93

Query: 98  GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS 157
           G L  L+ ++L+ NG  G IP+EIGN   LE L L+NN F G IP  + +  +L +    
Sbjct: 94  GGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIY 153

Query: 158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIR-------------- 203
           NN++ G +P EIGNLL L +L    N ++GQLP S+GNL  +   R              
Sbjct: 154 NNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEI 213

Query: 204 ----------ITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT 253
                     + +N L G++P  +G+L++L  + + EN+FSG  PR I N +S+E + L 
Sbjct: 214 GGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALY 273

Query: 254 ENRFSGIFPFDI-----------------------LLNLPNLKKLGIGGNNFVGSIPDSL 290
           +N+  G  P ++                       + NL    ++    N   G IP  L
Sbjct: 274 KNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLEL 333

Query: 291 SNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGT---------------- 334
            N   LELL L  NQ  G + ++ S+LKNL  L+L  N L TG                 
Sbjct: 334 GNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINAL-TGPIPLGFQYLRGLFMLQL 392

Query: 335 -ANDLDFVI--FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPP 391
             N L   I   L   S L VL +SDN   G +P  +  L   MI L++G N +SG IP 
Sbjct: 393 FQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLC-LHSNMIILNLGTNNLSGNIPT 451

Query: 392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
           GI     L+   L  N   G  P  + +  N+  + +  N  RG IP  +GN + L  L 
Sbjct: 452 GITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQ 511

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP 511
           L  N   G +P  +G    L     S NKLTG++P ++ +   L   LD+  N  +G+LP
Sbjct: 512 LADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQ-RLDMCCNNFSGTLP 570

Query: 512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIK-A 570
            +VG+L  L +L +S+N  SG IPV L     L  L +  N F G IP     L  ++ A
Sbjct: 571 SEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIA 630

Query: 571 LNVSSNNLSGKIPEFLENLSFLEF------------------------LNLSYNYFEGEV 606
           LN+S N L+G+IP  L NL  LEF                         N SYN   G +
Sbjct: 631 LNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPI 690

Query: 607 PVKGVFSNKTKISLHGNVKLCGGIDELHL---PSCPSKGSRKP------KITLLKVLIPV 657
           P+     N +  S  GN  LCG      +   P  PS+ + KP      KI  +   +  
Sbjct: 691 PL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIG 747

Query: 658 VVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEK----LFPM---VSYAELSKATSEFSSS 710
            VS +L++  + ++    R     + D  P E      FP     ++ +L  AT  F  S
Sbjct: 748 GVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDES 807

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-----SFVSECEALRNIRHRNLI 765
            ++G+G  GTVYK +L      +AVK +    +G +      SF +E   L NIRHRN++
Sbjct: 808 FVVGRGACGTVYKAVL-PAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIV 866

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+   C   + +G +   L++EYM  GSL + LH  +  ++  K     R  IA+  A  
Sbjct: 867 KLHGFC---NHQGSNL--LLYEYMPKGSLGEILHDPSCNLDWSK-----RFKIALGAAQG 916

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           + YLHH C+P + H D+K +N+LLD    AHVGDFGLAK +   H    SK+ S+   I 
Sbjct: 917 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH----SKSMSA---IA 969

Query: 886 GTVGYVAP 893
           G+ GY+AP
Sbjct: 970 GSYGYIAP 977

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  405 bits (1040), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 295/880 (33%), Positives = 450/880 (51%), Gaps = 53/880 (6%)

Query: 36  TDRLALLAIKSQ--LHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVL 93
           T+  ALL++KS   + + S + +SWN +  FC WTGVTC    + +T L+LS   + G L
Sbjct: 26  TELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLNLSGTL 85

Query: 94  SPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSR-CSNLI 152
           S  V +L  L+ ++LA N   G IP +I NL+ L  L LSNN F+G+ P  LS    NL 
Sbjct: 86  SSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLR 145

Query: 153 HFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK 212
                NN L G +P  + NL +L+ L +  NY +G++P + G    +E + ++ N L GK
Sbjct: 146 VLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGK 205

Query: 213 IPTTLGLLRRLVNLNVA-ENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPN 271
           IP  +G L  L  L +   N F    P  I N+S +          +G  P +I   L  
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEI-GKLQK 264

Query: 272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLG 331
           L  L +  N F G+I   L   S+L+ +DL +N F G++   FS LKNL LLNL +N L 
Sbjct: 265 LDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLY 324

Query: 332 TGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPP 391
                      F+     L+VL L +N F G +P  +   + +++ L +  N+++GT+PP
Sbjct: 325 GAIPE------FIGEMPELEVLQLWENNFTGSIPQKLGE-NGRLVILDLSSNKLTGTLPP 377

Query: 392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
            + +   L+T     N   G+IPD + + ++L ++ +  NFL G IP  L  L KL  ++
Sbjct: 378 NMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVE 437

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIA-SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSL 510
           L  N L G +P S G     +  I+ S N+L+G LP  + +++ +  +L L  N  +GS+
Sbjct: 438 LQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLL-LDGNKFSGSI 496

Query: 511 PLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKA 570
           P ++G L+ L  LD S N FSG I   +S C  L ++D+S N   G IP     +K +  
Sbjct: 497 PPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNY 556

Query: 571 LNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGI 630
           LN+S N+L G IP  + ++  L  ++ SYN   G VP  G FS     S  GN  LCG  
Sbjct: 557 LNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGP- 615

Query: 631 DELHLPSCPSKGSRKPKITLLKVLIPVVVS-----CLLLSSCLTIVYARKRRSTHKSVDT 685
              +L  C  KG+ +  +  L     +++      C ++ + + I+ AR  R+  ++   
Sbjct: 616 ---YLGPC-GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA--- 668

Query: 686 SPMEKLFPMVSYAELSKATSE----FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
               K + + ++  L     +        N+IG+G  G VYKG +   ++ VAVK +   
Sbjct: 669 ----KAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDL-VAVKRLATM 723

Query: 742 QKGASKS--FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
             G+S    F +E + L  IRHR++++++  CS+      +   LV+EYM NGSL + LH
Sbjct: 724 SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-----ETNLLVYEYMPNGSLGEVLH 778

Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
                     L    R  IA++ A  + YLHH C P +VH D+K +N+LLD +  AHV D
Sbjct: 779 GKKGG----HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVAD 834

Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFML 899
           FGLAKFL +      S T      I G+ GY+AP   + L
Sbjct: 835 FGLAKFLQD------SGTSECMSAIAGSYGYIAPEYAYTL 868

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  405 bits (1040), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 298/871 (34%), Positives = 445/871 (51%), Gaps = 71/871 (8%)

Query: 79   LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNSF 137
            L  L+LS+  + G +     N+S L  + LA+N   G +P+ I  N   LE+L LS    
Sbjct: 289  LQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQL 348

Query: 138  SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLS 197
            SG IP  LS+C +L     SNN L G IP+ +  L++L  L +  N L G L  S+ NL+
Sbjct: 349  SGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLT 408

Query: 198  AIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
             ++ + +  N+L GK+P  +  LR+L  L + EN+FSG  P+ I N +S+++I +  N F
Sbjct: 409  NLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHF 468

Query: 258  SGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSL 317
             G  P  I   L  L  L +  N  VG +P SL N   L +LDL  NQ  G +   F  L
Sbjct: 469  EGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFL 527

Query: 318  KNLWLLNLEQNNLGTGTANDLDFVIFLSN------------------CSSLKVLS--LSD 357
            K L  L L  N+L     N  D +I L N                  C S   LS  +++
Sbjct: 528  KGLEQLMLYNNSL---QGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN 584

Query: 358  NQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVI 417
            N F  E+P  + N S  +  L +G+NQ++G IP  +  +  L    +  N   GTIP  +
Sbjct: 585  NGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQL 643

Query: 418  SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
               K L  + + NNFL G IP  LG L++LG L L SN    ++P+ L NC  L++    
Sbjct: 644  VLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLD 703

Query: 478  YNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVT 537
             N L G +PQ++ ++  L+ VL+L  N  +GSLP  +G L  L  L +S N  +G IPV 
Sbjct: 704  GNSLNGSIPQEIGNLGALN-VLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVE 762

Query: 538  LSTCVSLE-YLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
            +     L+  LD+S N+F G IP +   L  ++ L++S N L+G++P  + ++  L +LN
Sbjct: 763  IGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLN 822

Query: 597  LSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGS--RKPKITLLKVL 654
            +S+N   G++  K  FS     S  GN  LCG      L  C    S  ++  ++   V+
Sbjct: 823  VSFNNLGGKL--KKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVV 876

Query: 655  IPVVVSCLLLSSCLTIVYA---RKR---------------------RSTHKSVDTSPMEK 690
            I   +S L     + +V A   ++R                     ++THK +  +   K
Sbjct: 877  IISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASK 936

Query: 691  LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV 750
                + + ++ +AT   S   MIG G  G VYK  L + E V   K++      ++KSF 
Sbjct: 937  --SDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFS 994

Query: 751  SECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK- 809
             E + L  IRHR+L+K++  CSS   EG++   L++EYM+NGS+ DWLH+    +E +K 
Sbjct: 995  REVKTLGRIRHRHLVKLMGYCSSKS-EGLNL--LIYEYMKNGSIWDWLHEDKPVLEKKKK 1051

Query: 810  -LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             L    R+ IA+ +A  +EYLHH C PP+VH D+K SNVLLD +M AH+GDFGLAK L+ 
Sbjct: 1052 LLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE 1111

Query: 869  HHLDIASKTPSSSIGIKGTVGYVAPGKFFML 899
            +          S+     + GY+AP   + L
Sbjct: 1112 N----CDTNTDSNTWFACSYGYIAPEYAYSL 1138

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 300/882 (34%), Positives = 450/882 (51%), Gaps = 59/882 (6%)

Query: 40  ALLAIKSQL----HDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSP 95
           ALL++K+ L     D +   SSW  + +FC W GVTC    + +T L+LS   + G LSP
Sbjct: 28  ALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGLNLSGTLSP 87

Query: 96  YVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSR-CSNLIHF 154
            V +L  L+ ++LA+N   G IP EI +L  L  L LSNN F+G+ P  +S    NL   
Sbjct: 88  DVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLRVL 147

Query: 155 CASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIP 214
              NN L G +P  + NL +L+ L +  NY  G++P S G+   IE + ++ N L GKIP
Sbjct: 148 DVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGKIP 207

Query: 215 TTLGLLRRLVNLNVAE-NQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLK 273
             +G L  L  L +   N F    P  I N+S +          +G  P +I   L  L 
Sbjct: 208 PEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIG-KLQKLD 266

Query: 274 KLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG 333
            L +  N F G +   L   S+L+ +DL +N F G++   F+ LKNL LLNL +N L   
Sbjct: 267 TLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHG- 325

Query: 334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA-NLSLKMIELSVGRNQISGTIPPG 392
                +   F+ +   L+VL L +N F G +P  +  N  L +++LS   N+++GT+PP 
Sbjct: 326 -----EIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLS--SNKLTGTLPPN 378

Query: 393 IRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDL 452
           + +   L T     N   G+IPD + + ++L ++ +  NFL G IP GL  L KL  ++L
Sbjct: 379 MCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVEL 438

Query: 453 GSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL 512
             N L G +P + G   NL     S N+L+G LP  + + T +  +L L  N   G +P 
Sbjct: 439 QDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLL-LDGNKFQGPIPS 497

Query: 513 QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN 572
           +VG L+ L  +D S N FSG I   +S C  L ++D+S N   G IP     +K +  LN
Sbjct: 498 EVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLN 557

Query: 573 VSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDE 632
           +S N+L G IP  + ++  L  L+ SYN   G VP  G FS     S  GN  LCG    
Sbjct: 558 LSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGP--- 614

Query: 633 LHLPSCP---SKG-----SRKPKITLLK-VLIPVVVSCLLLSSCLTIVYARKRRSTHKSV 683
            +L  C    +KG     S+ P    +K +L+  ++ C +  + + I+ AR  +   +S 
Sbjct: 615 -YLGPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKASES- 672

Query: 684 DTSPMEKLFPMVSYAELSKATSE----FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN 739
                 + + + ++  L     +        N+IG+G  G VYKG++ + ++ VAVK + 
Sbjct: 673 ------RAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDL-VAVKRLA 725

Query: 740 LKQKGASKS--FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDW 797
              +G+S    F +E + L  IRHR++++++  CS+      +   LV+EYM NGSL + 
Sbjct: 726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNH-----ETNLLVYEYMPNGSLGEV 780

Query: 798 LHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV 857
           LH          L    R  IA++ A  + YLHH C P +VH D+K +N+LLD +  AHV
Sbjct: 781 LHGKKGG----HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHV 836

Query: 858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFML 899
            DFGLAKFL +      S T      I G+ GY+AP   + L
Sbjct: 837 ADFGLAKFLQD------SGTSECMSAIAGSYGYIAPEYAYTL 872

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  398 bits (1023), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 290/793 (36%), Positives = 429/793 (54%), Gaps = 62/793 (7%)

Query: 149 SNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL-SAIEVIRITEN 207
           + +I    S   L G+I   I NL  L  L +  N+  G++P  +G+L   ++ + ++EN
Sbjct: 66  TQVIELDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSEN 125

Query: 208 SLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI-CN--ISSVELIFLTENRFSGIFPFD 264
            L G IP  LGLL RLV L++  N+ +G  P  + CN   SS++ I L+ N  +G  P +
Sbjct: 126 LLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLN 185

Query: 265 ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV-SIDFSSLKNLWLL 323
              +L  L+ L +  N   G++P SLSN++NL+ +DL SN   G++ S   S +  L  L
Sbjct: 186 YHCHLKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFL 245

Query: 324 NLEQNNLGTGTAN-DLD-FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVG 381
            L  N+  +   N +L+ F   L+N S L+ L L+ N  GGE+  S+ +LS+ ++++ + 
Sbjct: 246 YLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLD 305

Query: 382 RNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL 441
           +N+I G+IPP I NL+NL    L  N   G IP  + +L  L+++ + NN L G IP  L
Sbjct: 306 QNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMEL 365

Query: 442 GNLTKLGSLDLGSNSLQGNIPSSLGN------------------------CQNLILFIAS 477
           G++ +LG LD+  N+L G+IP S GN                        C NL +   S
Sbjct: 366 GDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLS 425

Query: 478 YNKLTGDLPQQLLS-ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
           +N LTG +P +++S +  L L L+LS+N L+G +PL++  +  ++ +D+SSN+ SG IP 
Sbjct: 426 HNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPP 485

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
            L +C++LE+L++S N F   +P S   L  +K L+VS N L+G IP   +  S L+ LN
Sbjct: 486 QLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLN 545

Query: 597 LSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGS-RKPKITLLKVLI 655
            S+N   G V  KG FS  T  S  G+  LCG I  +   +C  K       + +L  LI
Sbjct: 546 FSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLI 603

Query: 656 PVVVSCLL---------LSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSE 706
              V C+              LT+    +     K     P    +P +SY +L  AT  
Sbjct: 604 ATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPK---YPRISYQQLIAATGG 660

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLI 765
           F++S++IG GRFG VYKG+L ++   VAVKV++ K     S SF  EC+ L+  RHRNLI
Sbjct: 661 FNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLI 719

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +IIT CS        F ALV   M NGSLE  L+    +   + L LIQ +NI  DVA  
Sbjct: 720 RIITTCSKP-----GFNALVLPLMPNGSLERHLYPG--EYSSKNLDLIQLVNICSDVAEG 772

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG-- 883
           I YLHH+    +VH DLKPSN+LLD +M A V DFG+++ +     +  S   S S G  
Sbjct: 773 IAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ETVSTDDSVSFGST 831

Query: 884 ---IKGTVGYVAP 893
              + G+VGY+AP
Sbjct: 832 DGLLCGSVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	914
359482058	1040	PREDICTED: probable LRR receptor-like se	0.968	0.850	0.525	0.0
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.954	0.457	0.528	0.0
224081190	1011	predicted protein [Populus trichocarpa]	0.964	0.872	0.499	0.0
255577438	1028	receptor-kinase, putative [Ricinus commu	0.964	0.857	0.491	0.0
224127492	1022	predicted protein [Populus trichocarpa]	0.949	0.849	0.498	0.0
224097748	1032	predicted protein [Populus trichocarpa]	0.932	0.825	0.515	0.0
224090977	1034	predicted protein [Populus trichocarpa]	0.969	0.856	0.482	0.0
224119022	1021	predicted protein [Populus trichocarpa]	0.959	0.858	0.489	0.0
224097752	1025	predicted protein [Populus trichocarpa]	0.934	0.833	0.497	0.0
224097750	1023	predicted protein [Populus trichocarpa]	0.934	0.834	0.489	0.0

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  857 bits (2213), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 472/899 (52%), Positives = 610/899 (67%), Gaps = 14/899 (1%)

Query: 5   SISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQL-HDPSGVTSSWNNTMN 63
           ++++S    L    SL  +  P       NETDRLALLAIK+Q+  DP G+T+SWN++++
Sbjct: 8   AVNLSSSGFLRPKKSLVRVQHPVVLPSHRNETDRLALLAIKAQITQDPLGITTSWNDSVH 67

Query: 64  FCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGN 123
           FC WTGVTCGHRHQR+  LNL+S  + G LSP +GNL+FL  +NL  N F G IPQE+G 
Sbjct: 68  FCNWTGVTCGHRHQRVNTLNLNSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGR 127

Query: 124 LFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN 183
           L RL  L L+NNSFSG IP NLSRCSNL++F    N L G+IP  +G+  K+ R+ +  N
Sbjct: 128 LSRLRALNLTNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYN 187

Query: 184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICN 243
            LTG +PDS+GNL++I+ +    N L G IP  LG L+ L  + +  N FSG+ P S+ N
Sbjct: 188 NLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYN 247

Query: 244 ISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPS 303
           +SS+E+  L  N+  G  P+D+   LPNL+ L IG N+F GS+P SLSNASNL   D+  
Sbjct: 248 MSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDITM 307

Query: 304 NQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE 363
           + F GKVSIDF  + NLW L L  N LG G A+DL F+  L  C +LKVL LS +QFGG 
Sbjct: 308 SNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGV 367

Query: 364 LPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNL 423
           LP+SIANLS ++++L +  NQ+SGTIPPGI NLVNL    L  N F G+IP +I  L+ L
Sbjct: 368 LPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQML 427

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG 483
            ++ +  N L G IPS LGN+T+L SL L +N L G IPSS GN   L     SYN L G
Sbjct: 428 GRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNG 487

Query: 484 DLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVS 543
            +P++++ + +L++ L+L+ N L G LP +V  LKNL  LD+S N+ SG IP  L +C++
Sbjct: 488 TIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLT 547

Query: 544 LEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE 603
           LE+L +  N F G IP SF  L+ +  L++S NNLSG+IPEFL+ LS L  LNLS+N FE
Sbjct: 548 LEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFE 606

Query: 604 GEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSC----PSKGSRKPKITLLKVLIPVVV 659
           G++P KGVF+N T  S+ GN KLCGGI ELHLP+C    P  G  K  + L+  L+   +
Sbjct: 607 GQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFL 666

Query: 660 SCLLLSSCLTIVYARKRRSTHKSVDTSPMEK-LFPMVSYAELSKATSEFSSSNMIGQGRF 718
             +L+ S L I   R RR   +   TS   K L   VSY  L KAT  FSS+N+IG G F
Sbjct: 667 GLVLIMSLLVI--NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGF 724

Query: 719 GTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG 778
           G+VYKGILG DE VVAVKVI L Q+GA KSF +ECEALRNIRHRNL+K++T CSS D++G
Sbjct: 725 GSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQG 784

Query: 779 VDFKALVFEYMENGSLEDWLH--QSNDQVE--VRKLSLIQRMNIAIDVASAIEYLHHHCQ 834
            DFKALV+E+M NGSLE+WLH   + D++   +R LSL QR+NIAIDVASA++YLHHHC 
Sbjct: 785 NDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCH 844

Query: 835 PPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            P+VH DLKPSN+LLD DM AHVGDFGLA+F+       +  + SSSIG+KGT+GY AP
Sbjct: 845 KPIVHCDLKPSNILLDNDMTAHVGDFGLARFIP-EAAGRSHPSQSSSIGLKGTIGYAAP 902

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  855 bits (2209), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/890 (52%), Positives = 608/890 (68%), Gaps = 18/890 (2%)

Query: 18  FSLFLINSPSFSAGQT----NETDRLALLAIKSQL-HDPSGVTSSWNNTMNFCQWTGVTC 72
           +++  ++SPS +   T    NETDRLALLAIK+Q+  DP G+T+SWN++++FC WTGVTC
Sbjct: 48  YTIIFLHSPSPTTSSTILYGNETDRLALLAIKAQITQDPLGITTSWNDSVHFCNWTGVTC 107

Query: 73  GHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLAL 132
           GHRHQR+  LNLSS  + G LSP +GNL+FL  +NL  N F G IPQE+G L RL  L L
Sbjct: 108 GHRHQRVNTLNLSSLHLVGSLSPSIGNLTFLTGLNLELNNFHGQIPQELGRLSRLRALNL 167

Query: 133 SNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
           +NNSFSG IP NLSRCSNL++F    N L G+IP  +G+  K+ R+ +  N LTG +PDS
Sbjct: 168 TNNSFSGEIPANLSRCSNLVYFRLGFNNLIGRIPSWLGSYPKVVRMQLHYNNLTGPVPDS 227

Query: 193 VGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFL 252
           +GNL++I+ +    N L G IP  LG L+ L  + +  N FSG+ P S+ N+SS+E+  L
Sbjct: 228 LGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVYNMSSLEVFSL 287

Query: 253 TENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI 312
             N+  G  P+D+   LPNL+ L IG N+F G +P SLSNASNL   D+  + F GKVSI
Sbjct: 288 PYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDITMSNFTGKVSI 347

Query: 313 DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS 372
           DF  + NLW L L  N LG G A+DL F+  L  C +LKVL LS +QFGG LP+SIANLS
Sbjct: 348 DFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGGVLPNSIANLS 407

Query: 373 LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF 432
            ++++L +  NQ+SGTIPPGI NLVNL    L  N F G+IP +I  L+ L ++ +  N 
Sbjct: 408 TQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQMLGRIDLSRNQ 467

Query: 433 LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSI 492
           L G IPS LGN+T+L SL L +N L G IPSS GN   L     SYN L G +P++++ +
Sbjct: 468 LSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLNGTIPEKVMDL 527

Query: 493 TTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISIN 552
            +L++ L+L+ N L G LP +V  LKNL  LD+S N+ SG IP  L +C++LE+L +  N
Sbjct: 528 VSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCLTLEHLHMEGN 587

Query: 553 SFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVF 612
            F G IP SF  L+ +  L++S NNLSG+IPEFL+ LS L  LNLS+N FEG++P KGVF
Sbjct: 588 FFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPTKGVF 646

Query: 613 SNKTKISLHGNVKLCGGIDELHLPSC----PSKGSRKPKITLLKVLIPVVVSCLLLSSCL 668
           +N T  S+ GN KLCGGI ELHLP+C    P  G  K  + L+  L+   +  +L+ S L
Sbjct: 647 NNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLIMSLL 706

Query: 669 TIVYARKRRSTHKSVDTSPMEK-LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILG 727
            I   R RR   +   TS   K L   VSY  L KAT  FSS+N+IG G FG+VYKG LG
Sbjct: 707 VI--NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLG 764

Query: 728 DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE 787
            DE VVAVKVI L Q+GA KSF +ECEALRNIRHRNL+K++T CSS D++G DFKALV+E
Sbjct: 765 QDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYE 824

Query: 788 YMENGSLEDWLH--QSNDQVE--VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK 843
           +M NGSLE+WLH   + D++   +R LSL QR+NIAIDVASA++YLHHHC  P+VH DLK
Sbjct: 825 FMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHCHKPIVHCDLK 884

Query: 844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           PSN+LLD DM AHVGDFGLA+F+       +  + SSSIG+KGT+GY AP
Sbjct: 885 PSNILLDNDMTAHVGDFGLARFIP-EAAGRSHPSQSSSIGLKGTIGYAAP 933

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 448/897 (49%), Positives = 603/897 (67%), Gaps = 15/897 (1%)

Query: 6   ISISCLAILIRCFSLFLIN--SPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMN 63
           + +S ++  I C  L LI   S SFS  + NETDRL+LLA K+Q+ DP    SSWN + +
Sbjct: 1   MELSGMSSCIFCPLLLLIIQLSFSFSLHEGNETDRLSLLAFKAQITDPLDALSSWNASTH 60

Query: 64  FCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGN 123
           FC+W+GV CGHRHQR+ ELNL S ++ G LSP++GNLSFLR +NL  N F  DIPQE+G 
Sbjct: 61  FCKWSGVICGHRHQRIVELNLQSSQLTGNLSPHIGNLSFLRVLNLEGNYFSRDIPQELGR 120

Query: 124 LFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN 183
           LFRL++L L NN+FSG IP N+S CSNL+     +N L G+IP ++G+L KL    +  N
Sbjct: 121 LFRLQRLVLGNNTFSGEIPVNISSCSNLLVLHLGSNNLTGKIPAQLGSLSKLGAFVLQGN 180

Query: 184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICN 243
            L G +P S GNLS+++    T+N L G IP +LG L+RL    VAEN  SG  P SICN
Sbjct: 181 NLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLSGTIPSSICN 240

Query: 244 ISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPS 303
           ISS+  + L +N+  G  P D+ LNLPNL  L I  N+  G IP +LSNAS + L+DL  
Sbjct: 241 ISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNASKIFLVDLSY 300

Query: 304 NQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE 363
           N   GK+  D +SL +L  L +  N+LG G  +DL F+  L+N ++L+ L ++DN FGG 
Sbjct: 301 NNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLGINDNNFGGV 359

Query: 364 LPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNL 423
           LP  ++N S  +  ++ GRNQI G+IP  I NL++L T +LE NQ HG IP  I +L+NL
Sbjct: 360 LPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIPSSIGKLQNL 419

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG 483
             L +  N + G IPS LGN+T L  +    N+LQG IP+SLGN   L++   S N L+G
Sbjct: 420 AALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLILDLSQNNLSG 479

Query: 484 DLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVS 543
            +P+++L I++LS++L L +N L GSLP +VG L NL  L +S N+ SG IP +L +C S
Sbjct: 480 PIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKSLDSCKS 539

Query: 544 LEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE 603
           LE LD+  N F G +P     L++++ L +S NNLSG+IP+FL++   LE L+LSYN FE
Sbjct: 540 LEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDLSYNDFE 598

Query: 604 GEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSC-- 661
           GEVP +GVF N ++IS+ GN KLCGGI +L LP C S    +PK +  K+++ + + C  
Sbjct: 599 GEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPK-SHTKLILIIAIPCGF 657

Query: 662 --LLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFG 719
             ++L +   + Y+RK +    S  +   E  F  ++Y +L +AT  FSSSN++G G FG
Sbjct: 658 LGIVLMTSFLLFYSRKTKDEPASGPS--WESSFQRLTYQDLLQATDGFSSSNLVGAGAFG 715

Query: 720 TVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV 779
           +VY+G L  D  VVAVKV+NL +KGASKSF++EC AL NIRHRNL+K+IT CSS DF+G 
Sbjct: 716 SVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSNDFQGN 775

Query: 780 DFKALVFEYMENGSLEDWLHQ---SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP 836
           DFKALV+E+M NGSLE+WLH    S+   E R L L+QR+NIAIDVASA++YLH+HCQ P
Sbjct: 776 DFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDYLHNHCQVP 835

Query: 837 MVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           +VH DLKPSNVLL  DM A VGDFGLA+FL      + +   SSS+G+KGT+GY AP
Sbjct: 836 VVHCDLKPSNVLLGDDMTACVGDFGLARFLPEASNQLPADE-SSSVGLKGTIGYAAP 891

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis]

 Score =  808 bits (2087), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/900 (49%), Positives = 609/900 (67%), Gaps = 18/900 (2%)

Query: 6   ISISCLAILIRCFSLFLIN---SPSFSAGQTNETDRLALLAIKSQL-HDPSGVTSSWNNT 61
           + +S ++I I  + LFL     S S  +G+ NETDRL+LLA K+ +  DP  + SSWN +
Sbjct: 1   MKLSGISIFILLWVLFLKMIQLSCSSLSGRGNETDRLSLLAFKAHITDDPLHILSSWNES 60

Query: 62  MNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI 121
           ++FC+W+G+TCG RHQR+ E++L S R+ G L+ ++GNLSFLR +NL +N     IPQEI
Sbjct: 61  LHFCKWSGITCGSRHQRVIEIDLESSRLSGSLTAFIGNLSFLRVLNLQNNSLSHYIPQEI 120

Query: 122 GNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD 181
           G LFRL  L L  NSFSG IP N+S CSNL+      N L G++P E+ +L KLQ    +
Sbjct: 121 GRLFRLRTLILRRNSFSGEIPVNISYCSNLLTLRLGRNNLTGKLPAELKSLSKLQMFEFE 180

Query: 182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI 241
           INYLTG++  S  NLS++E+I  T N+  G+IP ++G L+ L   ++  + FSG+ P SI
Sbjct: 181 INYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFSGVIPPSI 240

Query: 242 CNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
            N+SS+ ++ +  N+  G  P D+  +LP L+ L +  N F GSIP ++SNASNL  LD+
Sbjct: 241 FNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNASNLVALDV 300

Query: 302 PSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
             N F GKV    + L NL  + + +NNLG G  +DL F+  L+N ++L++L++++N  G
Sbjct: 301 SQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILAITENNLG 359

Query: 362 GELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK 421
           G LP  ++N S K++ ++ GRN+I G IP  I NL+ L     E N+  G+IP  + +LK
Sbjct: 360 GVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIPSSLGKLK 419

Query: 422 NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKL 481
           NL +L + +N + G IPS LGN+T L ++ L  N+L+G+IPSSLGNCQ ++L   S N L
Sbjct: 420 NLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLMDLSRNNL 479

Query: 482 TGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTC 541
           +G +P++L+SI +LS+ LDLS N   GSLP++VG L NL  LD+S N+ SG IP +L +C
Sbjct: 480 SGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKSLGSC 539

Query: 542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNY 601
             LE L +  N+F G IP+S   L+ I  LN+S NNL+G+IP F      LE L+LSYN 
Sbjct: 540 TRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDLSYND 599

Query: 602 FEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKIT-LLKVLI----P 656
           FEGEVP +GVF N +  S+ GN  LCGGI E++LP C    S KPK +  L+++I     
Sbjct: 600 FEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIVVACC 659

Query: 657 VVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQG 716
            VV  LLL+S L     + R+  +K    S ++  F  VSY  L KAT  FSS+N+IG G
Sbjct: 660 GVVGVLLLTSALLFCCLKMRK--NKEASGSSLDIFFQKVSYQNLLKATDGFSSANLIGAG 717

Query: 717 RFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF 776
            FG+VYKGIL  DE ++AVKV+NL+ KGAS+SF++EC+AL N+RHRNL+K++T CSS+DF
Sbjct: 718 SFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSSSDF 777

Query: 777 EGVDFKALVFEYMENGSLEDWLH--QSNDQVE-VRKLSLIQRMNIAIDVASAIEYLHHHC 833
           E  DFKALV+EYM NGSLE+WLH  Q+ DQ +  R LSLI+R++I+IDVASA++YLH+ C
Sbjct: 778 EENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASALDYLHNQC 837

Query: 834 QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           Q P+VH DLKPSN+LLD DM AHVGDFGLA+FL          +PSSSIGI+GTVGY AP
Sbjct: 838 QVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAA---PHHSSPSSSIGIRGTVGYAAP 894

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa]

 Score =  806 bits (2083), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/885 (49%), Positives = 596/885 (67%), Gaps = 17/885 (1%)

Query: 18  FSLFLINSPSFSAGQTNETDRLALLAIKSQLH-DPSGVTSSWNNTMNFCQWTGVTCGHRH 76
             ++L+ S SFS    NETD+L+LL  K+Q+  DP G  SSWN +  FCQW+GVTCG RH
Sbjct: 16  LQIYLLVSFSFSIYGGNETDKLSLLTFKAQITGDPLGKLSSWNESSQFCQWSGVTCGRRH 75

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
           QR+ EL+L S ++ G LSP++GNLSFLR +NLA+N     IPQE+G LFRLE+L L NN+
Sbjct: 76  QRVVELDLHSYQLVGSLSPHIGNLSFLRILNLANNSLSLYIPQELGRLFRLEELVLRNNT 135

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
           F G IP N+SRC+NL     S   L G++P E+G L KLQ L++++N   G++P S GNL
Sbjct: 136 FDGGIPANISRCANLRILDFSRGNLTGKLPAELGLLSKLQVLTIELNNFVGEIPYSFGNL 195

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           SAI  I  + N+L G IP   G L+RL  L++  N  SGM P SI N+SS+ L+    N+
Sbjct: 196 SAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLSGMIPPSIFNLSSLTLLSFPVNQ 255

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS 316
             G  P  + L LPNL+   I  N F G IP + SNASNL    + SN F GKV    SS
Sbjct: 256 LYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNASNLLSFQIGSNNFNGKVP-PLSS 314

Query: 317 LKNLWLLNLEQNNLGTGTANDLDFVIFLSN-CSSLKVLSLSDNQFGGELPHSIANLSLKM 375
             +L +L +  NNLG G  NDL+FV  L+N  +SL+ L  SDN FGG LP  ++N S K+
Sbjct: 315 SHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEALDTSDNNFGGVLPEIVSNFSTKL 374

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
           ++++  RNQI G+IP  I NL+NL    LE NQ  G IP  + +L+ L  L +  N + G
Sbjct: 375 MKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMIPSSMGKLQKLSDLFLNGNKISG 434

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL 495
            IPS +GN+T LG +++  N+L+G+IP SLGN Q L+    S N L+G +P++L+SI +L
Sbjct: 435 MIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLSLALSQNNLSGPIPKELVSIPSL 494

Query: 496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY 555
           S+ L LS N L GSLP+++  L NL  LD+S N+FSG IP +L +CVSLE L +  N   
Sbjct: 495 SMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGEIPKSLGSCVSLESLHLEENFLQ 554

Query: 556 GVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNK 615
           G IP++   L++I+ LN+S NNL+G+IPEFLE+   LE LNLS+N FEGEVPV+G F N 
Sbjct: 555 GPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLESLNLSFNDFEGEVPVQGAFQNT 614

Query: 616 TKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTI----V 671
           + IS+ GN KLCGGI +L+L  CPS      K +  K++  +   C  L   L I     
Sbjct: 615 SAISIFGNKKLCGGIPQLNLTRCPSSEPTNSK-SPTKLIWIIGSVCGFLGVILIISFLLF 673

Query: 672 YARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEM 731
           Y  +++    +     +E  FP V+Y +L  AT  FSS+N+IG+G FG+V+KGILG D++
Sbjct: 674 YCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSANLIGEGSFGSVFKGILGPDKI 733

Query: 732 VVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN 791
           VVAVKV+NL +KGASKSF++ECEAL++IRHRNL+K++T CSS DF+G DFKALV+E+M N
Sbjct: 734 VVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTTCSSIDFQGNDFKALVYEFMVN 793

Query: 792 GSLEDWLH--QSNDQVEVRK-LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848
           G+LE+WLH  Q++D+    K L L+ R+NIAI +ASA+ YLHH CQ P++H DLKPSN+L
Sbjct: 794 GNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALNYLHHDCQMPIIHCDLKPSNIL 853

Query: 849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           LD +M AHVGDFGLA+F    H + +++T  SS+G+KGT+GY AP
Sbjct: 854 LDTNMTAHVGDFGLARF----HSEASNQT--SSVGLKGTIGYAAP 892

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097748|ref|XP_002311065.1| predicted protein [Populus trichocarpa] gi|222850885|gb|EEE88432.1| predicted protein [Populus trichocarpa]

 Score =  794 bits (2050), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/873 (51%), Positives = 603/873 (69%), Gaps = 21/873 (2%)

Query: 34  NETDRLALLAIKSQLH-DPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGV 92
           NETDRL+LLA K Q+  DP G  SSWN++ +FC+W+GVTCG RHQR+ EL+L+S ++ G 
Sbjct: 31  NETDRLSLLAFKDQIEADPLGTLSSWNDSSHFCEWSGVTCGRRHQRVVELDLNSCKLVGS 90

Query: 93  LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLI 152
           LSP++GNLSFLR +NL +N F   IPQEIG LFRL+KL L NN+F+G IP N+SRCSNL+
Sbjct: 91  LSPHIGNLSFLRILNLNNNSFSHTIPQEIGRLFRLQKLLLRNNTFTGEIPVNISRCSNLL 150

Query: 153 HFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK 212
           H     N+L G +P E+G+L K+Q    +IN L G++P S GNLS++E I    N+L G 
Sbjct: 151 HLYLGGNELTGGLPGELGSLSKMQWFVFEINNLVGEIPISFGNLSSVEAIFGGANNLRGG 210

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           IP   G L+RL NL    N  SG  P SI N+SS+  + L+ N+  G  P D+ L LPNL
Sbjct: 211 IPKNFGQLKRLKNLVFNINNLSGTIPPSIYNLSSLTTLSLSSNQLHGSLPSDLGLTLPNL 270

Query: 273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT 332
           + LG+  N+F G IP SL NASN+ ++DL SN+F GKV  D   +  L  L ++ N+LG 
Sbjct: 271 ETLGLHTNHFSGLIPASLFNASNITVIDLSSNKFTGKVP-DLGHMPKLRRLVIQTNDLGN 329

Query: 333 GTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPG 392
              +DL F+  L+N ++L+VL ++DN  GG LP  I+N S+K+I ++ GRNQI G IP  
Sbjct: 330 NEDDDLGFLYPLANNTNLQVLGINDNNLGGALPEKISNFSIKLIHMTFGRNQIRGIIPTD 389

Query: 393 IRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDL 452
           I NLVNL T  LE+NQ  GTIP  I +L+NL+ LS+ +N + G IPS LGN T L +L+L
Sbjct: 390 IGNLVNLQTLGLEMNQLTGTIPSSIGKLRNLRVLSLRSNKISGSIPSSLGNCTSLINLEL 449

Query: 453 GSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL 512
            +N+L G+IPSSL NCQNL+  + S N L+G +P++L+ I++LS  LDLS N L GSLP+
Sbjct: 450 HANNLNGSIPSSLENCQNLLSLLLSRNNLSGPIPKELMRISSLSRYLDLSENQLTGSLPM 509

Query: 513 QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN 572
           +V  L NL  L +S N+ SG IP TL +CVSLEYL ++ NSF+G IP S   L++++ L 
Sbjct: 510 EVDKLVNLGYLTVSYNRLSGEIPRTLGSCVSLEYLYLADNSFHGSIPESLSSLRALQVLY 569

Query: 573 VSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDE 632
           +S NNL+GKIP+ L     L  L+LS+N  EGEVPV+GVF+N +  S+ GN +LCGGI +
Sbjct: 570 LSRNNLTGKIPKSLGEFKLLTILDLSFNDLEGEVPVQGVFANASGFSVLGNEELCGGIPQ 629

Query: 633 LHLPSCPSKGSRK-PKITLLKVLIPVVVSCL-LLSSCLTIVYARKRRSTHKSVDTSPMEK 690
           L+L  C SK S++    T LK +I +    + ++   L   + R+++S  +    SP E 
Sbjct: 630 LNLSRCTSKKSKQLTSSTRLKFIIAIPCGFVGIILLLLLFFFLREKKS--RPASGSPWES 687

Query: 691 LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQKGASK 747
            F  V+Y +L +AT+ FS++N+IG G FG+VYKGIL  D      VAVKV NL ++GASK
Sbjct: 688 TFQRVAYEDLLQATNGFSAANLIGSGSFGSVYKGILKTDGAAVATVAVKVFNLLREGASK 747

Query: 748 SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ---SNDQ 804
           SF++EC AL NIRHRNL+K++T CS  DF+G DFKALV+E+M NGSLE+WLH    S++ 
Sbjct: 748 SFMAECAALVNIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVRISDEA 807

Query: 805 VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              R LSL+QR+NIAIDVASA++YLH+HCQ  +VH DLKPSNVLLD D+ AHVGDFGLA+
Sbjct: 808 HRRRDLSLLQRLNIAIDVASALDYLHNHCQIAVVHCDLKPSNVLLDGDLTAHVGDFGLAR 867

Query: 865 FLSNHHLDIASKTP----SSSIGIKGTVGYVAP 893
            L+      AS  P    +SSIG+KGT+GY AP
Sbjct: 868 LLTQ-----ASHQPGLDQTSSIGLKGTIGYAAP 895

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2041), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/905 (48%), Positives = 606/905 (66%), Gaps = 19/905 (2%)

Query: 4   ISISISCLAILIRCFSLFLINSPSFSAGQT----NETDRLALLAIKSQLH-DPSGVTSSW 58
           +S S+    IL  CF +  +++PSF+   T    NETD LALLAIK+Q+  DP G+ SSW
Sbjct: 1   MSCSLFLKVILQSCFVVIFLHAPSFTQAATTLSGNETDHLALLAIKAQIKLDPLGLMSSW 60

Query: 59  NNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIP 118
           N++++FC W G+ CG+ HQR+  LNLS   + G LSP +GN+SFLR I+L  N F G+IP
Sbjct: 61  NDSLHFCNWGGIICGNLHQRVITLNLSHYGLVGSLSPQIGNMSFLRGISLEQNYFHGEIP 120

Query: 119 QEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL 178
           QEIG L RL+ +  SNNSFSG IP NLS CS+L+      NKL GQIP ++G+L KL+R+
Sbjct: 121 QEIGRLDRLKYINFSNNSFSGEIPANLSGCSSLLMLRLGFNKLTGQIPYQLGSLQKLERV 180

Query: 179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFP 238
            +  N L G +PDS+GN+S++  + ++ N+  G IP  LG L+ L  L +  N  SGM P
Sbjct: 181 QLHYNNLNGSVPDSLGNISSVRSLSLSVNNFEGSIPDALGRLKTLNFLGLGLNNLSGMIP 240

Query: 239 RSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLEL 298
            +I N+SS+ +  L  N+  G  P D+ L LPNL+ L IG N F G +P S+SNASNL  
Sbjct: 241 PTIFNLSSLIVFTLPYNQLHGTLPSDLGLTLPNLQVLNIGHNFFSGPLPVSISNASNLLE 300

Query: 299 LDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
           LD+ ++ F  KV+IDF  L NLW L L  N LG G A+DL F+  L+ C +L++L LS++
Sbjct: 301 LDIDTSNFT-KVTIDFGGLPNLWSLALSSNPLGKGEADDLSFIDSLTKCRNLRLLDLSNS 359

Query: 359 QFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVIS 418
            FGG +P SI NLS ++  L +  NQ+SG+IP  I NL+NL   T+E N   G+IP V+ 
Sbjct: 360 HFGGVIPDSIGNLSTQLFLLKLRGNQLSGSIPTVIENLLNLAELTVEKNYLSGSIPSVLG 419

Query: 419 ELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASY 478
            LK LQ+L +  N L G IPS LGN+T+L    L  N + G+IPSS GN + L     S 
Sbjct: 420 NLKMLQRLDLSENKLSGLIPSSLGNITQLFEFHLQKNQIMGSIPSSFGNLKYLQNLDLSQ 479

Query: 479 NKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTL 538
           N L+G +P++++ +++L++ L+L+ N L G LP +  NL NL  LD+S N+  G IP +L
Sbjct: 480 NLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSSL 539

Query: 539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLS 598
            +CV+LE L +  N F G IP SF  L+ ++ +++S NNLSG+IP+FL+ L+ +  LNLS
Sbjct: 540 GSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLALIS-LNLS 598

Query: 599 YNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCP------SKGSRKPKITLLK 652
           +N+FEGEVP +G F N T ISL GN +LCGGI +L LP C        K SR+ K+ ++ 
Sbjct: 599 FNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKL-MIA 657

Query: 653 VLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNM 712
           +L P++V   ++S  +     +K R +  +   S  ++L   VSY  L KAT+ FSS+N+
Sbjct: 658 ILTPLLVLVFVMSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATAGFSSANL 717

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG G FG+VY+GIL  +E VVAVKV+ ++Q+   KSF++ECE L+NIRHRNL+KI+T CS
Sbjct: 718 IGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLVKILTACS 777

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLH---QSND-QVEVRKLSLIQRMNIAIDVASAIEY 828
           S DF+G DFKALV+E+M NG+LE WLH   ++N    +++ LS  QR+NIAIDVA+A+ Y
Sbjct: 778 SVDFQGNDFKALVYEFMPNGTLESWLHSFPRTNGINEDLKILSFHQRLNIAIDVAAALNY 837

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           LH+ C  P+VH DLKPSNVLLD DM AHVGDFGLA+F+    ++ + +  SSS+G+KGTV
Sbjct: 838 LHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFIE-EAINPSHRNESSSVGLKGTV 896

Query: 889 GYVAP 893
           GY AP
Sbjct: 897 GYAAP 901

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa]

 Score =  790 bits (2039), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/890 (48%), Positives = 598/890 (67%), Gaps = 13/890 (1%)

Query: 10  CLAILIRCFSLFLINSPSFSAGQ-TNETDRLALLAIKSQL-HDPSGVTSSWNNTMNFCQW 67
           C A   R F +FL++  S +    TNETD LAL+  K+++  DP G+ SSWN+T++FCQW
Sbjct: 3   CSAFCFRSF-VFLLSLISVTCSDYTNETDLLALIQFKNKIVDDPLGIMSSWNSTIHFCQW 61

Query: 68  TGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRL 127
            GV+CG RHQR+  L L S ++ G +SP++GNLSFLR ++L +N F  +IP ++G L  L
Sbjct: 62  HGVSCGRRHQRVRVLALQSLKLSGTISPHIGNLSFLRELHLQNNSFFHEIPPQVGRLRSL 121

Query: 128 EKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTG 187
           +  +L NNS SG IP ++S CSNLI      N L G+IP E+G+LLKL+ L++++N LTG
Sbjct: 122 QIFSLHNNSISGQIPPSISDCSNLISIKIEFNNLTGEIPMELGSLLKLKNLTLEVNGLTG 181

Query: 188 QLPDSVGNLSAIEVIRITENS-LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISS 246
            +P S+GNLS++E++R+ +N  L G +P+TLG L+ L  LN+ +N+ SG+ P SI N+SS
Sbjct: 182 TIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRLSGVIPPSIFNLSS 241

Query: 247 VELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
           +  + +  N F G  P DI ++LPNL+   I  N F GSIP S+SNASN+ELL +  N  
Sbjct: 242 LTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNASNIELLQVSLNNL 301

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
            G+V      L  L    L  N+LG+G ANDL F+  L+N ++L+ LS+  N FGGELP 
Sbjct: 302 TGEVPT-LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYLSIKRNNFGGELPK 360

Query: 367 SIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQL 426
            I+NLS  +  +S+  N I G+IP GI  LVNL  F +  N+  G IP  I EL+NL+ L
Sbjct: 361 QISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGIIPSSIGELQNLEGL 420

Query: 427 SVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP 486
            +  N L G IPS +GNLTKL +L LG NSL+G+IPSSLGNC+ L++     N L+GD+P
Sbjct: 421 VLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLVLTLCGNNLSGDIP 480

Query: 487 QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEY 546
             L  I +L L +  S N  +GSLP+++G L NL  LD+S N  SG IP +L  C+SLE 
Sbjct: 481 PGLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGEIPSSLGGCISLED 539

Query: 547 LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEV 606
           L ++ N F+G IP +   L+ +   N S NNLSGKIPEF +  + LE L+LSYN FEG +
Sbjct: 540 LYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLEMLDLSYNNFEGMI 599

Query: 607 PVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVL--IPVVVSCLLL 664
           P +G+F N T +S+ GN +LCGG  EL LP C     ++ K+ L   +  I V+++  L+
Sbjct: 600 PDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIAIFAITVLLALALV 659

Query: 665 SSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKG 724
            +CL +  +R++R   + +  S M      VSY  L KAT+ FSSSN++G G FG+VYKG
Sbjct: 660 VTCLFLCSSRRKR---REIKLSSMRNELLEVSYQILLKATNGFSSSNLVGIGSFGSVYKG 716

Query: 725 ILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL 784
           +L  + MV+AVKV+NL ++GAS+SF++ECEALRNIRHRNL+K++T CSS D+ G DFKA+
Sbjct: 717 MLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLTACSSIDYHGNDFKAI 776

Query: 785 VFEYMENGSLEDWLH-QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK 843
           V+E+M NGSLEDWLH           L+L+QR+NIAIDVA A+EYLHHHC+ P+ H DLK
Sbjct: 777 VYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEYLHHHCEMPIAHCDLK 836

Query: 844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           PSNVLLD ++  HVGDFGLAKFLS   LD  +   S+SIG++GT+GY  P
Sbjct: 837 PSNVLLDDELTGHVGDFGLAKFLSGASLDYPTNE-STSIGVRGTIGYAPP 885

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa]

 Score =  785 bits (2028), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 433/870 (49%), Positives = 593/870 (68%), Gaps = 16/870 (1%)

Query: 34  NETDRLALLAIKSQL-HDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGV 92
           NETDRL+LLA+KSQ+ +DP G+ SSWN +++FC W+GV CG RH+R+ E++L S ++ G 
Sbjct: 32  NETDRLSLLALKSQITNDPFGMLSSWNESLHFCDWSGVICGKRHRRVVEIDLHSAQLVGS 91

Query: 93  LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLI 152
           LSP++GNLSFLR + L +N F  +IPQE+G+LFRL  L+L NN+F G IP N+S CSNL+
Sbjct: 92  LSPHIGNLSFLRILKLENNRFSHNIPQELGHLFRLRMLSLENNTFDGKIPVNISHCSNLL 151

Query: 153 HFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK 212
               S N L G++P E+G+L KLQ      NYL G +P S GNLSAI  I    N L G 
Sbjct: 152 ILSLSGNNLTGKLPIELGSLSKLQVFFFQFNYLVGGIPSSFGNLSAIIQIFGAGNYLQGG 211

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           IP ++G L+ L + +   N  +GM P SI N+SS+    +  N+  G  P D+ L LPNL
Sbjct: 212 IPNSIGQLKSLKSFSFGRNNMTGMIPPSIYNLSSLMRFAVPVNQLHGNLPPDLGLTLPNL 271

Query: 273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT 332
           + L +  N F GSIP + SNAS + +++L +N   G+V  D SSL  L  L ++ N LG 
Sbjct: 272 EILLMSFNRFSGSIPPTFSNASTIAVIELSNNNLTGRVP-DLSSLSKLRWLIVDVNYLGN 330

Query: 333 GTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPG 392
           G  +DL F+  L+N +SL+ LS++DN FGG LP  I+N S  +  ++ GRNQI G+IP G
Sbjct: 331 GNDDDLSFLPPLANKTSLEELSINDNNFGGLLPKIISNFSENLKRMTFGRNQIRGSIPSG 390

Query: 393 IRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDL 452
           I NL+ L T  LE+NQ  G IP+ I +L+NL  L++  N + G IPS +GN+T L  + L
Sbjct: 391 IGNLIGLDTLGLEMNQLTGVIPNSIGKLQNLGVLALGGNKISGNIPSSMGNITSLLEVYL 450

Query: 453 GSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL 512
            +N+LQG IPSSLGNCQNL++     N L+G +P++++SI + S +L LS N L GSLPL
Sbjct: 451 SANNLQGRIPSSLGNCQNLLILHLDQNNLSGSIPKEVISIPSSSRILVLSENQLTGSLPL 510

Query: 513 QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN 572
           +VG L NL   ++S N+ SG IP TL +CVSLE+L +  N F G IP S   L++++ LN
Sbjct: 511 EVGKLANLGYFNLSHNRLSGEIPRTLGSCVSLEFLYMEGNLFQGPIPESLSSLRALQILN 570

Query: 573 VSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDE 632
           +S NNLSG+IP+FL  L  L  L+LS+N  EGEVPV+G+F+  +  S+ GN KLCGG+ +
Sbjct: 571 LSHNNLSGEIPKFLAELKLLTSLDLSFNNLEGEVPVQGIFARASGFSMLGNKKLCGGMPQ 630

Query: 633 LHLPSC-PSKGSRKPKITLLKVLIPV---VVSCLLLSSCLTIVYARKRRSTHKSVDTSPM 688
           L+L  C   K  +    T LK++I +    V  +L+ S +   + ++++S  +    SP 
Sbjct: 631 LNLSRCTSKKSRKLKSSTKLKLIIAIPCGFVGIILVVSYMLFFFLKEKKS--RPASGSPW 688

Query: 689 EKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS 748
           E  F  V+Y +L +AT+ FS +N+IG G FG+VYKGIL  D   VAVKV NL ++GASKS
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748

Query: 749 FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH--QSNDQVE 806
           F++EC AL NIRHRNL+K++T CS  DF+G DFKALV+E+M NGSLE+WLH  Q +D+  
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808

Query: 807 VRK-LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
            R+ LSL+QR+NIAIDVASA++YLH+HCQ  +VH DLKPSNVLLD D+ AHVGDFGLA+ 
Sbjct: 809 RRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARL 868

Query: 866 L--SNHHLDIASKTPSSSIGIKGTVGYVAP 893
           L  ++H L +     +SSIG+KGT+GY AP
Sbjct: 869 LPQASHQLCLDQ---TSSIGLKGTIGYAAP 895

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa]

 Score =  779 bits (2011), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/869 (48%), Positives = 582/869 (66%), Gaps = 15/869 (1%)

Query: 34  NETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVL 93
           NETDRL+LLA K+Q+ DP G  SSWN +++FC+W+GV CG +H+R+ EL+L S ++ G L
Sbjct: 31  NETDRLSLLAFKTQISDPLGKLSSWNESLHFCEWSGVICGRKHRRVVELDLHSSQLAGSL 90

Query: 94  SPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIH 153
           SP++GNLSFLR +NL  N F   IPQE+G LFR+++L+L NN+FSG IP N+SRC+NL+ 
Sbjct: 91  SPHIGNLSFLRILNLEKNSFSYLIPQELGRLFRIQELSLGNNTFSGEIPVNISRCTNLLS 150

Query: 154 FCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKI 213
              ++N L G++P E G+L KLQ L+   N+L G++P S GNLS +++IR   N+L G I
Sbjct: 151 IGLASNNLTGKLPAEFGSLSKLQVLNFQRNHLFGEIPPSYGNLSELQIIRGVRNNLQGGI 210

Query: 214 PTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLK 273
           P ++G L+RL +     N  SG  P SI N+SS+       N+  GI P ++ L LPNL 
Sbjct: 211 PDSIGQLKRLADFTFGVNSLSGTIPSSIYNMSSLVRFSAPLNQLYGILPPELGLTLPNLD 270

Query: 274 KLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG 333
              I  N F G IP +LSNAS +  L L +N F GKV    + L NL  L L  NNLG  
Sbjct: 271 TFNILSNQFRGLIPSTLSNASKISDLQLRNNSFTGKVP-SLAGLHNLQRLVLNFNNLGNN 329

Query: 334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI 393
             +DL F+  L+N +SL++L+++ N FGG LP  + N S K+  + +G N + G+IP  I
Sbjct: 330 EDDDLGFLYPLANTTSLEILAINHNNFGGVLPEIVCNFSTKLRIMIIGENNLRGSIPTEI 389

Query: 394 RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG 453
             L+ L T  LE+NQ  G IP  I +L+ L   ++  N + G IPS LGN+T L  +   
Sbjct: 390 GKLIGLDTLGLELNQLTGIIPSSIGKLQRLGVFNINGNKISGNIPSSLGNITSLLEVYFF 449

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQ 513
           +N+LQG IPSSLGNCQNL++     N L+G +P+++L I++LS+ LDL+ N L G LP +
Sbjct: 450 ANNLQGRIPSSLGNCQNLLMLRLDQNNLSGSIPKEVLGISSLSMYLDLAENQLIGPLPSE 509

Query: 514 VGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNV 573
           VG L +L  L++  N+ SG IP  LS+CVSLE+L++  N F G IP S   L++++ LN+
Sbjct: 510 VGKLVHLGGLNVYKNRLSGEIPGILSSCVSLEHLNLGPNFFQGSIPESLSSLRALQILNL 569

Query: 574 SSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDEL 633
           S NNLSGKIP+FL     L  L+LS+N  EGEVPV+GVF+  +  S+ GN KLCGG  +L
Sbjct: 570 SHNNLSGKIPKFLAEFKLLTSLDLSFNNLEGEVPVQGVFARASGFSMLGNKKLCGGRPQL 629

Query: 634 HLPSC-PSKGSRKPKITLLKVLIPV---VVSCLLLSSCLTIVYARKRRSTHKSVDTSPME 689
           +L  C   K  +    T +K++I +    V  +LL S +     ++++S  +    SP E
Sbjct: 630 NLSRCTSKKSRKLKSSTKMKLIIAIPCGFVGIILLVSYMLFFLLKEKKS--RPASGSPWE 687

Query: 690 KLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF 749
             F  V+Y +L +AT  FS +N+IG G FG+VYKGIL  D   VAVKV NL ++GASKSF
Sbjct: 688 STFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKSF 747

Query: 750 VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH--QSNDQVEV 807
           ++EC AL NIRHRNL+K++T CS  DF+G DFKALV+E+M NGSLE+WLH  Q +D+  V
Sbjct: 748 MAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAHV 807

Query: 808 RK-LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           R+ LSL+QR+NIAIDVASA++YLH+HCQ  + H DLKPSNVLLD DM AHVGDFGLA+ L
Sbjct: 808 RRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARLL 867

Query: 867 --SNHHLDIASKTPSSSIGIKGTVGYVAP 893
             ++H L +     +SSIG+KGT+GY AP
Sbjct: 868 PQASHQLCLDQ---TSSIGLKGTIGYAAP 893

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	914
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.936	0.835	0.440	1.8e-183
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.956	0.865	0.413	2.4e-179
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.937	0.831	0.422	9.6e-176
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.939	0.849	0.401	4.6e-174
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.956	0.866	0.398	1e-169
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.968	0.863	0.406	3.3e-166
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.776	0.873	0.388	1.1e-126
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.658	0.481	0.303	4.6e-103
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.873	0.680	0.326	4.2e-102
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.670	0.605	0.292	1.5e-97

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1780 (631.7 bits), Expect = 1.8e-183, P = 1.8e-183
 Identities = 386/877 (44%), Positives = 530/877 (60%)

Query:    33 TNETDRLALLAIKSQLHDPSGVT-SSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGG 91
             T ETD+ ALL  KSQ+ + S V   SWN+++  C WTGV CG +H+R+T ++L   ++ G
Sbjct:    36 TEETDKQALLEFKSQVSETSRVVLGSWNDSLPLCSWTGVKCGLKHRRVTGVDLGGLKLTG 95

Query:    92 VLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNL 151
             V+SP+VGNLSFLR +NLADN F G IP E+GNLFRL+ L +SNN F G IP  LS CS+L
Sbjct:    96 VVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSL 155

Query:   152 IHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG 211
                  S+N LE  +P E G+L KL  LS+  N LTG+ P S+GNL++++++    N + G
Sbjct:   156 STLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEG 215

Query:   212 KIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPN 271
             +IP              A N+F+G+FP  I N+SS+  + +T N FSG    D    LPN
Sbjct:   216 EIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPN 275

Query:   272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSXXXXXXXXXXXXXXG 331
             L+ L +G N+F G+IP++LSN S+L  LD+PSN   GK+ + F                G
Sbjct:   276 LQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLG 335

Query:   332 TGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPP 391
               ++ DLDF+  L+NCS L+ L++  N+ GG+LP  IANLS ++ ELS+G N ISG+IP 
Sbjct:   336 NYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPH 395

Query:   392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
             GI NLV+L T  L  N   G +P  + EL  L+++ +++N L G IPS LGN++ L  L 
Sbjct:   396 GIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLY 455

Query:   452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXX 511
             L +NS +G+IPSSLG+C  L+      NKL G +P +L+ + +                 
Sbjct:   456 LLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ 515

Query:   512 XQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL 571
               +G LK L+ LD+S N+ SG IP TL+ C+SLE+L +  NSF G IP   R L  ++ L
Sbjct:   516 -DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFL 573

Query:   572 NVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGID 631
             ++S NNLSG IP                N F+G VP +GVF N + +S+ GN+ LCGGI 
Sbjct:   574 DLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIP 633

Query:   632 ELHLPSC----PSKGSRKPKITLLKXXXXXXXXXXXXXXXXXXXYARKR----RSTHKSV 683
              L L  C    P + S   KI  +                    + + R    R+ +   
Sbjct:   634 SLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEN 693

Query:   684 DTS--PMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
             D S  P++  +  +SY EL K T  FSSSN+IG G FG V+KG LG     VA+KV+NL 
Sbjct:   694 DRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLC 753

Query:   742 QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
             ++GA+KSF++ECEAL  IRHRNL+K++TICSS+DFEG DF+ALV+E+M NG+L+ WLH  
Sbjct:   754 KRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP- 812

Query:   802 NDQVEV-----RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH 856
              D++E      R L L  R+NIAIDVASA+ YLH +C  P+ H D+KPSN+LLD D+ AH
Sbjct:   813 -DEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAH 871

Query:   857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             V DFGLA+ L     D       SS G++GT+GY AP
Sbjct:   872 VSDFGLAQLLLKFDRD-TFHIQFSSAGVRGTIGYAAP 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1741 (617.9 bits), Expect = 2.4e-179, P = 2.4e-179
 Identities = 370/895 (41%), Positives = 538/895 (60%)

Query:    15 IRCFSLFLINSPSF--SAGQTNETDRLALLAIKSQL-HDPSGVTSSWNNTMNFCQWTGVT 71
             +R F L   N+     + G T+ETDR ALL  KSQ+  D   V SSWN++   C W GVT
Sbjct:     1 MRLFLLLAFNALMLLETHGFTDETDRQALLQFKSQVSEDKRVVLSSWNHSFPLCNWKGVT 60

Query:    72 CGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLA 131
             CG +++R+T L L   ++GGV+SP +GNLSFL  ++L +N F G IPQE+G L RLE L 
Sbjct:    61 CGRKNKRVTHLELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLD 120

Query:   132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
             +  N   G IP  L  CS L++    +N+L G +P E+G+L  L +L++  N + G+LP 
Sbjct:   121 MGINYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPT 180

Query:   192 SVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIF 251
             S+GNL+ +E + ++ N+L G+IP                N FSG+FP ++ N+SS++L+ 
Sbjct:   181 SLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLG 240

Query:   252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
             +  N FSG    D+ + LPNL    +GGN F GSIP +LSN S LE L +  N   G + 
Sbjct:   241 IGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP 300

Query:   312 IDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL 371
               F +              G+ ++ DL+F+  L+NC+ L+ L +  N+ GG+LP SIANL
Sbjct:   301 T-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANL 359

Query:   372 SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN 431
             S K++ L +G   ISG+IP  I NL+NL    L+ N   G +P  + +L NL+ LS+F+N
Sbjct:   360 SAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSN 419

Query:   432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLI-LFIASYNKLTGDLPQQLL 490
              L GGIP+ +GN+T L +LDL +N  +G +P+SLGNC +L+ L+I   NKL G +P +++
Sbjct:   420 RLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGD-NKLNGTIPLEIM 478

Query:   491 SITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
              I                     +G L+NL  L +  N+ SG +P TL  C+++E L + 
Sbjct:   479 KIQQLLRLDMSGNSLIGSLPQ-DIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLE 537

Query:   551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKG 610
              N FYG IP   + L  +K +++S+N+LSG IP               +N  EG+VPVKG
Sbjct:   538 GNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKG 596

Query:   611 VFSNKTKISLHGNVKLCGGIDELHLPSC----PS---KGSRKPKITLLKXXXXXXXXXXX 663
             +F N T +S+ GN  LCGGI    L  C    PS   K S + K  ++            
Sbjct:   597 IFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLL 656

Query:   664 XXXXXXXXYARKRRSTHKSVDTSP--MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTV 721
                     + RKR+   ++ + +P  +E L   +SY +L  AT+ FSSSNM+G G FGTV
Sbjct:   657 FMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTV 716

Query:   722 YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF 781
             YK +L  ++ VVAVKV+N++++GA KSF++ECE+L++IRHRNL+K++T CSS DF+G +F
Sbjct:   717 YKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEF 776

Query:   782 KALVFEYMENGSLEDWLHQSN-DQVE--VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV 838
             +AL++E+M NGSL+ WLH    +++    R L+L++R+NIAIDVAS ++YLH HC  P+ 
Sbjct:   777 RALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIA 836

Query:   839 HGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             H DLKPSNVLLD D+ AHV DFGLA+ L     + +     SS G++GT+GY AP
Sbjct:   837 HCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE-SFFNQLSSAGVRGTIGYAAP 890

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1707 (606.0 bits), Expect = 9.6e-176, P = 9.6e-176
 Identities = 371/878 (42%), Positives = 516/878 (58%)

Query:    33 TNETDRLALLAIKSQLHDPSG--VTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIG 90
             +NETD  ALL  KSQ+ + +   V +SWN++  FC W GVTCG R +R+  LNL   ++ 
Sbjct:    27 SNETDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVISLNLGGFKLT 86

Query:    91 GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSN 150
             GV+SP +GNLSFLR +NLADN F   IPQ++G LFRL+ L +S N   G IP++LS CS 
Sbjct:    87 GVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNCSR 146

Query:   151 LIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLG 210
             L     S+N L   +P E+G+L KL  L +  N LTG  P S+GNL++++ +    N + 
Sbjct:   147 LSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMR 206

Query:   211 GKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLP 270
             G+IP              A N FSG FP ++ NISS+E + L +N FSG    D    LP
Sbjct:   207 GEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLP 266

Query:   271 NLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSXXXXXXXXXXXXXX 330
             NL++L +G N F G+IP +L+N S+LE  D+ SN   G + + F                
Sbjct:   267 NLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSL 326

Query:   331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP 390
             G  +++ L+F+  ++NC+ L+ L +  N+ GGELP SIANLS  +  L +G+N ISGTIP
Sbjct:   327 GNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIP 386

Query:   391 PGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSL 450
               I NLV+L   +LE N   G +P    +L NLQ + +++N + G IPS  GN+T+L  L
Sbjct:   387 HDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKL 446

Query:   451 DLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTXXXXXXXXXXXXXXXX 510
              L SNS  G IP SLG C+ L+      N+L G +PQ++L I +                
Sbjct:   447 HLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFP 506

Query:   511 XXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKA 570
               +VG L+ LV L  S N+ SG +P  +  C+S+E+L +  NSF G IP   R L S+K 
Sbjct:   507 E-EVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISR-LVSLKN 564

Query:   571 LNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGI 630
             ++ S+NNLSG+IP                N FEG VP  GVF N T +S+ GN  +CGG+
Sbjct:   565 VDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGV 624

Query:   631 DELHLPSCPSKGS---RKP---KITLLKXXXXXXXXXXXXXXXXXXXYARKRRSTHKSVD 684
              E+ L  C  + S   RKP   +  ++                    +  KR+  + + D
Sbjct:   625 REMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684

Query:   685 TSPMEK----LF-PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN 739
              +P +     +F   VSY EL  ATS FSS+N+IG G FG V+KG+LG +  +VAVKV+N
Sbjct:   685 GNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLN 744

Query:   740 LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
             L + GA+KSF++ECE  + IRHRNL+K+IT+CSS D EG DF+ALV+E+M  GSL+ WL 
Sbjct:   745 LLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWL- 803

Query:   800 QSNDQVEV----RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA 855
             Q  D   V    R L+  +++NIAIDVASA+EYLH HC  P+ H D+KPSN+LLD D+ A
Sbjct:   804 QLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTA 863

Query:   856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             HV DFGLA+ L  +  + +     SS G++GT+GY AP
Sbjct:   864 HVSDFGLAQLLYKYDRE-SFLNQFSSAGVRGTIGYAAP 900

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1676 (595.0 bits), Expect = 4.6e-174, Sum P(2) = 4.6e-174
 Identities = 352/877 (40%), Positives = 525/877 (59%)

Query:    31 GQTNETDRLALLAIKSQLHDPS-GVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRI 89
             G T+ETDR ALL  KSQ+ +    V SSWNN+   C W  VTCG +H+R+T LNL   ++
Sbjct:    19 GFTDETDRQALLEFKSQVSEGKRDVLSSWNNSFPLCNWKWVTCGRKHKRVTHLNLGGLQL 78

Query:    90 GGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCS 149
             GG++SP +GN+SFL  ++L+DN F G IP+E+GNLFRLE L ++ NS  G IP  LS CS
Sbjct:    79 GGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEGGIPATLSNCS 138

Query:   150 NLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSL 209
              L++    +N L   +P E+G+L KL  L +  N L G+LP S+GNL++++ +  T+N++
Sbjct:   139 RLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNI 198

Query:   210 GGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNL 269
              G++P              + N+F G+FP +I N+S++E +FL  + FSG    D    L
Sbjct:   199 EGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLL 258

Query:   270 PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSXXXXXXXXXXXXX 329
             PN+++L +G N+ VG+IP +LSN S L+   +  N   G +  +F               
Sbjct:   259 PNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENP 318

Query:   330 XGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTI 389
              G+ T  DL+F+  L+NC+ L++LS+   + GG LP SIAN+S ++I L++  N   G+I
Sbjct:   319 LGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSI 378

Query:   390 PPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGS 449
             P  I NL+ L    L  N   G +P  + +L  L  LS+++N + G IPS +GNLT+L  
Sbjct:   379 PQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEI 438

Query:   450 LDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTXXXXXXXXXXXXXXX 509
             L L +NS +G +P SLG C +++     YNKL G +P++++ I T               
Sbjct:   439 LYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSL 498

Query:   510 XXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIK 569
                 +G+L+NLV L + +N+FSG +P TL  C+++E L +  NSF G IP + R L  ++
Sbjct:   499 PN-DIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVR 556

Query:   570 ALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKGVFSNKTKISLHGNVKLCGG 629
              +++S+N+LSG IP                N F G+VP KG F N T + + GN  LCGG
Sbjct:   557 RVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGG 616

Query:   630 IDELHLPSC-----P--SKGSRKPKITLLKXXXXXXXXXXXXXXXXXXXYARKRRSTHKS 682
             I +L L  C     P  +K S   K   +                    + RKRR   ++
Sbjct:   617 IKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQT 676

Query:   683 VDTSP--MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL 740
              +  P  +E     +SY +L  AT+ FSSSNM+G G FGTV+K +L  +  +VAVKV+N+
Sbjct:   677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736

Query:   741 KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ 800
             +++GA KSF++ECE+L++ RHRNL+K++T C+STDF+G +F+AL++EY+ NGS++ WLH 
Sbjct:   737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796

Query:   801 SNDQVEVRK----LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH 856
                + E+R+    L+L++R+NI IDVAS ++YLH HC  P+ H DLKPSNVLL+ D+ AH
Sbjct:   797 EEVE-EIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAH 855

Query:   857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             V DFGLA+ L     + +     SS G++GT+GY AP
Sbjct:   856 VSDFGLARLLLKFDKE-SFLNQLSSAGVRGTIGYAAP 891

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1650 (585.9 bits), Expect = 1.0e-169, P = 1.0e-169
 Identities = 356/894 (39%), Positives = 522/894 (58%)

Query:    15 IRCFSLFLINS-PSFSA-GQTNETDRLALLAIKSQLHDPS-GVTSSWNNTMNFCQWTGVT 71
             +R F L   N+     A G T+E+DR ALL IKSQ+ +      S+WNN+   C W  V 
Sbjct:     1 MRLFLLLAFNALMQLEAYGFTDESDRQALLEIKSQVSESKRDALSAWNNSFPLCSWKWVR 60

Query:    72 CGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLA 131
             CG +H+R+T L+L   ++GGV+SP +GNLSFL Y++L++N F G IPQE+GNLFRL+ LA
Sbjct:    61 CGRKHKRVTRLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLA 120

Query:   132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
             +  N   G IP +LS CS L++    +N L   +P E+G+L KL  L + +N L G+ P 
Sbjct:   121 VGFNYLEGEIPASLSNCSRLLYLDLFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPV 180

Query:   192 SVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIF 251
              + NL+++ V+ +  N L G+IP                N FSG+FP +  N+SS+E ++
Sbjct:   181 FIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLY 240

Query:   252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
             L  N FSG    D    LPN+ +L + GN   G+IP +L+N S LE+  +  N+  G +S
Sbjct:   241 LLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSIS 300

Query:   312 IDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL 371
              +F                G+ +  DL F+  L+NCS L  LS+S N+ GG LP SI N+
Sbjct:   301 PNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNM 360

Query:   372 SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN 431
             S ++  L++  N I G+IP  I NL+ L +  L  N   G +P  +  L  L +L +F+N
Sbjct:   361 STELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSN 420

Query:   432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
                G IPS +GNLT+L  L L +NS +G +P SLG+C +++     YNKL G +P++++ 
Sbjct:   421 RFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQ 480

Query:   492 ITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISI 551
             I T                   +G L+NLV L + +N  SG +P TL  C+S+E + +  
Sbjct:   481 IPTLVHLNMESNSLSGSLPN-DIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQE 539

Query:   552 NSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKGV 611
             N F G IP   + L  +K +++S+NNLSG I                 N FEG VP +G+
Sbjct:   540 NHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGI 598

Query:   612 FSNKTKISLHGNVKLCGGIDELHLPSC----PSKGSRKPKITLLKXXXXXXXXXXXXXXX 667
             F N T +S+ GN  LCG I EL L  C    P   +R P  +LLK               
Sbjct:   599 FQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHP--SLLKKVAIGVSVGIALLLL 656

Query:   668 X---XXXYARKRRSTHKSVDTSP--MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVY 722
                    + +KR++  K  +++P  +E     +SY +L  AT  FSSSN++G G FGTV+
Sbjct:   657 LFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVF 716

Query:   723 KGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK 782
             K +L  +  +VAVKV+N++++GA KSF++ECE+L++IRHRNL+K++T C+S DF+G +F+
Sbjct:   717 KALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFR 776

Query:   783 ALVFEYMENGSLEDWLHQSN-DQVE--VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH 839
             AL++E+M NGSL+ WLH    +++    R L+L++R+NIAIDVAS ++YLH HC  P+ H
Sbjct:   777 ALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAH 836

Query:   840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
              DLKPSN+LLD D+ AHV DFGLA+ L     + +     SS G++GT+GY AP
Sbjct:   837 CDLKPSNILLDDDLTAHVSDFGLARLLLKFDQE-SFFNQLSSAGVRGTIGYAAP 889

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1617 (574.3 bits), Expect = 3.3e-166, P = 3.3e-166
 Identities = 368/905 (40%), Positives = 509/905 (56%)

Query:    11 LAILIRCFSLFLINSPSFSAGQTNET-DRLALLAIKSQLHDPSGVT-SSWNNTMN--FCQ 66
             L + +  FS  L+  PS S    +   D LALL+ KS L    G + +SWN + +   C 
Sbjct:     6 LLLFVLLFSALLL-CPSSSDDDGDAAGDELALLSFKSSLLYQGGQSLASWNTSGHGQHCT 64

Query:    67 WTGVTCGHRHQR----LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIG 122
             W GV CG R +R    + +L L S  + G++SP +GNLSFLR ++L DN   G+IP E+ 
Sbjct:    65 WVGVVCGRRRRRHPHRVVKLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELS 124

Query:   123 NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK-LQRLSVD 181
              L RL+ L LS+NS  G+IP  +  C+ L     S+N+L G IP+EIG  LK L  L + 
Sbjct:   125 RLSRLQLLELSDNSIQGSIPAAIGACTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLY 184

Query:   182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSI 241
              N L+G++P ++GNL++++   ++ N L G IP               +N  SGM P SI
Sbjct:   185 KNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSI 244

Query:   242 CNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
              N+SS+    + EN+  G+ P +    L  L+ + +G N F G IP S++NAS+L ++ +
Sbjct:   245 WNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQI 304

Query:   302 PSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
               N F G ++  F                 T   +D  F+  L+NCS L+ L+L +N  G
Sbjct:   305 YGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLG 364

Query:   362 GELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK 421
             G LP+S +NLS  +  L++  N+I+G+IP  I NL+ L    L  N F G++P  +  LK
Sbjct:   365 GVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLK 424

Query:   422 NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKL 481
             NL  L  + N L G IP  +GNLT+L  L LG+N   G IP +L N  NL+    S N L
Sbjct:   425 NLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNL 484

Query:   482 TGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTC 541
             +G +P +L +I T                  ++G+LKNLV     SN+ SG IP TL  C
Sbjct:   485 SGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDC 544

Query:   542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNY 601
               L YL +  N   G IP +   LK ++ L++SSNNLSG+IP               +N 
Sbjct:   545 QLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNS 604

Query:   602 FEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSC-PSKGSRKPKITLLKXXXXXXXX 660
             F GEVP  G F+  + IS+ GN KLCGGI +LHLP C P   +RK    +L         
Sbjct:   605 FVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRK-HFPVLPISVSLAAA 663

Query:   661 XXXXXXXXXXXYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGT 720
                           KR  T K   +    K  P+VSY++L KAT  F+ +N++G G FG+
Sbjct:   664 LAILSSLYLLITWHKR--TKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGS 721

Query:   721 VYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD 780
             VYKG L   + V AVKV+ L+   A KSF +ECEALRN+RHRNL+KI+TICSS D  G D
Sbjct:   722 VYKGKLNIQDHV-AVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGND 780

Query:   781 FKALVFEYMENGSLEDWLH-QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH 839
             FKA+V+++M NGSLEDW+H ++NDQ + R L+L +R+ I +DVA A++YLH H   P+VH
Sbjct:   781 FKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVH 840

Query:   840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP--GKFF 897
              D+K SNVLLD DMVAHVGDFGLA+ L +    I   T  SS+G  GT+GY AP  G   
Sbjct:   841 CDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQST--SSMGFIGTIGYAAPEYGVGL 898

Query:   898 MLYTH 902
             +  TH
Sbjct:   899 IASTH 903

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1244 (443.0 bits), Expect = 1.1e-126, P = 1.1e-126
 Identities = 279/719 (38%), Positives = 391/719 (54%)

Query:   106 INLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQI 165
             + L  +   G I   +GNL  L  L LS+N  SG IP  LSR S L     + N L G+I
Sbjct:    83 LRLRSSNLAGIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEI 142

Query:   166 PKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXX 225
             P  +GNL  L  L +  N L+G +P S+G L+ +  + + EN+L G IP           
Sbjct:   143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202

Query:   226 XXXAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS 285
                A N  SG  P  I NISS+ +  +  N+ SG  P +   NLP+L+++ +  N F G 
Sbjct:   203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGR 262

Query:   286 IPDSLSNASNLELLDLPSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLS 345
             IP S+ NASN+ +  +  N F G V  +                      ND  F+  L+
Sbjct:   263 IPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALT 322

Query:   346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE 405
             NCS+L+ + L   +FGG LP S++NLS  ++ LS+  N+ISG++P  I NLVNL   +L 
Sbjct:   323 NCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLA 382

Query:   406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSL 465
              N   G++P   S+LKNL++L+V NN L G +P  +GNLT+L ++++  N+  G IPS+L
Sbjct:   383 NNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTL 442

Query:   466 GNCQNLILFIASYNKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDI 525
             GN   L      +N   G +P ++ SI                    ++G LKN+V    
Sbjct:   443 GNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHA 502

Query:   526 SSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXX 585
              SN+ SG  P T+  C  L++L +  N   G IP++   LK +  L++S NNLSG+IP  
Sbjct:   503 DSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMS 562

Query:   586 XXXXXXXXXXXXXYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRK 645
                          +N F GEVP  GVF+N ++I + GN  +CGGI ELHLP+C  K  +K
Sbjct:   563 LGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKK 622

Query:   646 PK--ITLLKXXXXXXXXXXXXXXXXXXXYARKRRSTHKSVDTSPMEKLFPMVSYAELSKA 703
              K  I LL                       KRR       TS M+   PM++Y +L KA
Sbjct:   623 KKHQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTS-MQG-HPMITYKQLVKA 680

Query:   704 TSEFSSSNMIGQGRFGTVYKGILG--DDEM--VVAVKVINLKQKGASKSFVSECEALRNI 759
             T  FSSS+++G G FG+VYKG     D E+  +VAV+V+ L+   A KSF +ECE LRN 
Sbjct:   681 TDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNT 740

Query:   760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH-QSNDQVEVRKLSLIQRMN 817
             RHRNL+KI+TICSS D  G DFKA+V+++M NGSLEDWLH ++NDQ E R L+L QR++
Sbjct:   741 RHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 672 (241.6 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
 Identities = 190/627 (30%), Positives = 290/627 (46%)

Query:    11 LAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQL-HDPS--GVTSSWNN-TMNFCQ 66
             L + I CFS   +  P    G  N  D   LL +K  L  +P        WN+  +N+C 
Sbjct:     7 LLLFILCFSG--LGQP----GIINN-DLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCS 59

Query:    67 WTGVTCGHRHQ-RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLF 125
             WTGVTC +    R+  LNL+   + G +SP+ G    L +++L+ N   G IP  + NL 
Sbjct:    60 WTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLT 119

Query:   126 RLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYL 185
              LE L L +N  +G IP+ L    N+      +N+L G IP+ +GNL+ LQ L++    L
Sbjct:   120 SLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRL 179

Query:   186 TGQLPDSVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNIS 245
             TG +P  +G L  ++ + + +N L G IP              AEN  +G  P  +  + 
Sbjct:   180 TGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLE 239

Query:   246 SVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQ 305
             ++E++ L  N  +G  P   L  +  L+ L +  N   G IP SL++  NL+ LDL +N 
Sbjct:   240 NLEILNLANNSLTGEIPSQ-LGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANN 298

Query:   306 FKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP 365
               G++  +F +                     +      SN ++L+ L LS  Q  GE+P
Sbjct:   299 LTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSI-----CSNNTNLEQLVLSGTQLSGEIP 353

Query:   366 HSIANL-SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ 424
               ++   SLK ++LS   N ++G+IP  +  LV L    L  N   GT+   IS L NLQ
Sbjct:   354 VELSKCQSLKQLDLS--NNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQ 411

Query:   425 QLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD 484
              L +++N L G +P  +  L KL  L L  N   G IP  +GNC +L +     N   G+
Sbjct:   412 WLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGE 471

Query:   485 LPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSL 544
             +P  +  +                     +GN   L +LD++ NQ SG IP +      L
Sbjct:   472 IPPSIGRLKELNLLHLRQNELVGGLPAS-LGNCHQLNILDLADNQLSGSIPSSFGFLKGL 530

Query:   545 EYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEG 604
             E L +  NS  G +P S   L+++  +N+S N L+G I                 N FE 
Sbjct:   531 EQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTN-NGFED 589

Query:   605 EVPVK-GVFSNKTKISLHGNVKLCGGI 630
             E+P++ G   N  ++ L G  +L G I
Sbjct:   590 EIPLELGNSQNLDRLRL-GKNQLTGKI 615

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 272/832 (32%), Positives = 411/832 (49%)

Query:    79 LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
             L  L L+   + G +   +GN S L  + L DN   G IP E+GNL +L+ L +  N  +
Sbjct:   242 LQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLT 301

Query:   139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
              +IP++L R + L H   S N L G I +EIG L  L+ L++  N  TG+ P S+ NL  
Sbjct:   302 SSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRN 361

Query:   199 IEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELIFLTENRFS 258
             + V+ +  N++ G++P               +N  +G  P SI N + ++L+ L+ N+ +
Sbjct:   362 LTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMT 421

Query:   259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSXX 318
             G  P        NL  + IG N+F G IPD + N SNLE L +  N   G +        
Sbjct:   422 GEIPRGF--GRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQ 479

Query:   319 XXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
                          TG          + N   L +L L  N F G +P  ++NL+L +  L
Sbjct:   480 KLRILQVSYNSL-TGPIPRE-----IGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGL 532

Query:   379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
              +  N + G IP  + ++  L    L  N+F G IP + S+L++L  LS+  N   G IP
Sbjct:   533 RMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIP 592

Query:   439 SGLGNLTKLGSLDLGSNSLQGNIPSSL-GNCQNLILFIA-SYNKLTGDLPQQLLSITTXX 496
             + L +L+ L + D+  N L G IP  L  + +N+ L++  S N LTG +P++L  +    
Sbjct:   593 ASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQ 652

Query:   497 XXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEY-LDISINSFY 555
                              +   KN+  LD S N  SG IP  +   + +   L++S NSF 
Sbjct:   653 EIDLSNNLFSGSIPRS-LQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFS 711

Query:   556 GVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVKGVFSNK 615
             G IP SF  +  + +L++SSNNL+G+IP                N  +G VP  GVF N 
Sbjct:   712 GEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNI 771

Query:   616 TKISLHGNVKLCGGIDELHLPSCPSKGS---RKPKITLLKXXXXXXXXXXXXXXXXXXXY 672
                 L GN  LCG    L   +   K S   ++ ++ L+                     
Sbjct:   772 NASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCC 831

Query:   673 ARKRRSTHKSVDTS-P-MEKLFPMVSYA--ELSKATSEFSSSNMIGQGRFGTVYKGILGD 728
              +K +    S ++S P ++    +  +   EL +AT  F+S+N+IG     TVYKG L +
Sbjct:   832 KKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-E 890

Query:   729 DEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF 786
             D  V+AVKV+NLK+  A   K F +E + L  ++HRNL+KI+       +E    KALV 
Sbjct:   891 DGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFA----WESGKTKALVL 946

Query:   787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
              +MENG+LED +H S   +     SL++++++ + +AS I+YLH     P+VH DLKP+N
Sbjct:   947 PFMENGNLEDTIHGSAAPIG----SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPAN 1002

Query:   847 VLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM 898
             +LLD D VAHV DFG A+ L     D  S T S+S   +GT+GY+AP   +M
Sbjct:  1003 ILLDSDRVAHVSDFGTARILGFRE-D-GSTTASTS-AFEGTIGYLAPEFAYM 1051

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 710 (255.0 bits), Expect = 1.5e-97, Sum P(2) = 1.5e-97
 Identities = 186/635 (29%), Positives = 303/635 (47%)

Query:    13 ILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSW--NNTMNFCQWTGV 70
             I++  +  ++ ++ S  A   N  +   LL++KS L DP      W  ++T + C WTGV
Sbjct:     6 IVLFLYYCYIGSTSSVLASIDNVNELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGV 65

Query:    71 TCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKL 130
              C + +  + +L+L+   + G +S  +  LS L   N++ NGF   +P+ I  L   + +
Sbjct:    66 RC-NSNGNVEKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPL---KSI 121

Query:   131 ALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP 190
              +S NSFSG++    +    L+H  AS N L G + +++GNL+ L+ L +  N+  G LP
Sbjct:   122 DISQNSFSGSLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLP 181

Query:   191 DSVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSICNISSVELI 250
              S  NL  +  + ++ N+L G++P                N+F G  P    NI+S++ +
Sbjct:   182 SSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYL 241

Query:   251 FLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV 310
              L   + SG  P + L  L +L+ L +  NNF G+IP  + + + L++LD   N   G++
Sbjct:   242 DLAIGKLSGEIPSE-LGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEI 300

Query:   311 SIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA- 369
              ++ +                +G+         +S+ + L+VL L +N   GELP  +  
Sbjct:   301 PMEITKLKNLQLLNLMRNKL-SGSIPPA-----ISSLAQLQVLELWNNTLSGELPSDLGK 354

Query:   370 NLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVF 429
             N  L+ +++S   N  SG IP  + N  NL    L  N F G IP  +S  ++L ++ + 
Sbjct:   355 NSPLQWLDVS--SNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQ 412

Query:   430 NNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQL 489
             NN L G IP G G L KL  L+L  N L G IP  + +  +L     S N++   LP  +
Sbjct:   413 NNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTI 472

Query:   490 LSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDI 549
             LSI                    Q  +  +L  LD+SSN  +G IP ++++C  L  L++
Sbjct:   473 LSIHNLQAFLVADNFISGEVPD-QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNL 531

Query:   550 SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXXXXYNYFEGEVPVK 609
               N+  G IP     + ++  L++S+N+L+G +P               YN   G VP+ 
Sbjct:   532 RNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPIN 591

Query:   610 GVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSR 644
             G         L GN  LCGG+    LP C SK  R
Sbjct:   592 GFLKTINPDDLRGNSGLCGGV----LPPC-SKFQR 621

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGP4	Y3475_ARATH	2, ., 7, ., 1, 1, ., 1	0.4511	0.9398	0.8504	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00050192 hypothetical protein (1011 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	914
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-115
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-37
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-33
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-21
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-18
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-14
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-13
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	7e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-06
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	5e-06
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-06
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-04
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-04
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.002
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.002
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.002
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.004
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.004
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	0.004
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.004
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.004
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.004
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  375 bits (965), Expect = e-115
 Identities = 273/872 (31%), Positives = 426/872 (48%), Gaps = 94/872 (10%)

Query: 10  CLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTG 69
           C  ++   F LFL    +FS     E +   LL+ KS ++DP    S+WN++ + C W G
Sbjct: 9   CPYLIFMLFFLFL----NFSMLHAEELE--LLLSFKSSINDPLKYLSNWNSSADVCLWQG 62

Query: 70  VTCGHRHQRLTELNLSSQRIGGVLS------PYV-------GNLSF------------LR 104
           +TC +   R+  ++LS + I G +S      PY+         LS             LR
Sbjct: 63  ITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLR 121

Query: 105 YINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQ 164
           Y+NL++N F G IP+  G++  LE L LSNN  SG IP ++   S+L       N L G+
Sbjct: 122 YLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 165 IPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV 224
           IP  + NL  L+ L++  N L GQ+P  +G + +++ I +  N+L G+IP  +G L  L 
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Query: 225 NLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG 284
           +L++  N  +G  P S+ N+ +++ +FL +N+ SG  P  I  +L  L  L +  N+  G
Sbjct: 240 HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLDLSDNSLSG 298

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
            IP+ +    NLE+L L SN F GK+ +  +SL  L +L L  N        +L      
Sbjct: 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL------ 352

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTL 404
              ++L VL LS N   GE+P  + +               SG       NL  LI F+ 
Sbjct: 353 GKHNNLTVLDLSTNNLTGEIPEGLCS---------------SG-------NLFKLILFS- 389

Query: 405 EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSS 464
             N   G IP  +   ++L+++ + +N   G +PS    L  +  LD+ +N+LQG I S 
Sbjct: 390 --NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD 524
             +  +L +   + NK  G LP    S    +L  DLS N  +G++P ++G+L  L+ L 
Sbjct: 448 KWDMPSLQMLSLARNKFFGGLPDSFGSKRLENL--DLSRNQFSGAVPRKLGSLSELMQLK 505

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE 584
           +S N+ SG IP  LS+C  L  LD+S N   G IP SF  +  +  L++S N LSG+IP+
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565

Query: 585 FLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSR 644
            L N+  L  +N+S+N+  G +P  G F      ++ GN+ LCGG     LP C  K  R
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC--KRVR 623

Query: 645 KPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTH-KSVDTSP-MEKLFPMVSYAELSK 702
           K       +   +    +L       V+ R R +   K V+      +L    S    S 
Sbjct: 624 KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI 683

Query: 703 ATSEFSSS----NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN 758
             ++  SS    N+I +G+ G  YKG    + M   VK IN        S +++   +  
Sbjct: 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGK 739

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N++K+I +C S   E   +  L+ EY+E  +L + L         R LS  +R  I
Sbjct: 740 LQHPNIVKLIGLCRS---EKGAY--LIHEYIEGKNLSEVL---------RNLSWERRRKI 785

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
           AI +A A+ +LH  C P +V G+L P  +++D
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  137 bits (347), Expect = 8e-37
 Identities = 58/183 (31%), Positives = 89/183 (48%), Gaps = 23/183 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G+G FGTVY          VA+K+I  +   +     + E E L+ + H N++K+  + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                   +   LV EY E GSL+D L ++       KLS  + + I + +   +EYLH 
Sbjct: 61  EDE-----NHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110

Query: 832 HCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
           +    ++H DLKP N+LLD D     + DFGL+K L++          S    I GT  Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--------SLLKTIVGTPAY 159

Query: 891 VAP 893
           +AP
Sbjct: 160 MAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (326), Expect = 2e-33
 Identities = 59/182 (32%), Positives = 84/182 (46%), Gaps = 24/182 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G FG VY         +VA+KVI   K K   +  + E + L+ ++H N++++  + 
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
               FE  D   LV EY E G L D L +        +LS  +       + SA+EYLH 
Sbjct: 66  ----FEDEDKLYLVMEYCEGGDLFDLLKKR------GRLSEDEARFYLRQILSALEYLHS 115

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                +VH DLKP N+LLD D    + DFGLA+ L                   GT  Y+
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---------LTTFVGTPEYM 163

Query: 892 AP 893
           AP
Sbjct: 164 AP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  126 bits (320), Expect = 1e-32
 Identities = 62/183 (33%), Positives = 87/183 (47%), Gaps = 24/183 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           +G G FGTVYK        +VAVK++  +       ++   E   LR + H N++++I  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                FE  D   LV EY E G L D+L +         LS  +   IA+ +   +EYLH
Sbjct: 67  -----FEDKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEYLH 115

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
            +    ++H DLKP N+LLD + V  + DFGLAK L            SS     GT  Y
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--------SSLTTFVGTPWY 164

Query: 891 VAP 893
           +AP
Sbjct: 165 MAP 167

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (319), Expect = 2e-32
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 18/161 (11%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG VYKG L       E  VAVK +     +   + F+ E   ++ + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           + +C  T  E +    +V EYM  G L D+L +        KL+L   + +A+ +A  +E
Sbjct: 67  LGVC--TQGEPL---YIVTEYMPGGDLLDFLRKHG-----EKLTLKDLLQMALQIAKGME 116

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           YL        VH DL   N L+  ++V  + DFGL++ +  
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYE 154

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (315), Expect = 5e-32
 Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 18/163 (11%)

Query: 712 MIGQGRFGTVYKGIL----GDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIK 766
            +G+G FG VYKG L    G  ++ VAVK +     +   + F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ +C+    E +    +V EYME G L  +L ++       KLSL   ++ A+ +A  +
Sbjct: 66  LLGVCTEE--EPL---YIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGM 115

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           EYL        +H DL   N L+  ++V  + DFGL++ L + 
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  124 bits (315), Expect = 6e-32
 Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 21/169 (12%)

Query: 711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
             +G+G FG VYKG L         VAVK +   ++ AS+     F+ E   ++ + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV---EVRKLSLIQRMNIAI 820
           +++++ +C  T+ E +    LV EYME G L D+L +S       E   LSL   ++ AI
Sbjct: 58  VVRLLGVC--TEEEPL---YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            +A  +EYL        VH DL   N L+  D+V  + DFGL++ + + 
Sbjct: 113 QIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  123 bits (310), Expect = 3e-31
 Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 17/163 (10%)

Query: 712 MIGQGRFGTVYKGIL----GDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIK 766
            +G+G FG VYKG L       E+ VAVK +     +   + F+ E   +R + H N++K
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ +C+    E +    +V EYM  G L D+L ++  +     LSL   ++ A+ +A  +
Sbjct: 66  LLGVCTEE--EPL---MIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGM 116

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           EYL        +H DL   N L+  ++V  + DFGL++ L + 
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  100 bits (251), Expect = 2e-23
 Identities = 48/192 (25%), Positives = 91/192 (47%), Gaps = 24/192 (12%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRHRN 763
           E++   ++G+G FG+VY  +  D   ++AVK + L        ++   E   L +++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL--SLIQRMNIAID 821
           +++        +   ++   +  EY+  GSL   L +        KL   +I++      
Sbjct: 61  IVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKK------FGKLPEPVIRKY--TRQ 109

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +   + YLH +    +VH D+K +N+L+D D V  + DFG AK L +       +T   +
Sbjct: 110 ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IETGEGT 160

Query: 882 IGIKGTVGYVAP 893
             ++GT  ++AP
Sbjct: 161 GSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 17/166 (10%)

Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN 758
            ++    +  ++  IG+G FG V  G     +  VAVK +      A ++F++E   +  
Sbjct: 2   AINSKELKLGAT--IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAA-QAFLAEASVMTT 56

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           +RH NL++++ +      +G     +V EYM  GSL D+L      V        Q++  
Sbjct: 57  LRHPNLVQLLGVV----LQGNPL-YIVTEYMAKGSLVDYLRSRGRAVITLA----QQLGF 107

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A+DV   +EYL    +   VH DL   NVL+  D+VA V DFGLAK
Sbjct: 108 ALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 58/191 (30%), Positives = 88/191 (46%), Gaps = 30/191 (15%)

Query: 710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKI 767
            N IG G FG VY  +  D   ++AVK I ++       K    E + L  ++H NL+K 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK- 63

Query: 768 ITICSSTDFEGVDF---KALVF-EYMENGSLEDWL-HQSNDQVEVRKLSLIQRMNIAIDV 822
                   + GV+    K  +F EY   G+LE+ L H       V ++  +Q       +
Sbjct: 64  --------YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ-------L 108

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              + YLH H    +VH D+KP+N+ LD++ V  +GDFG A  L N+     +       
Sbjct: 109 LEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN----TTTMGEEVQ 161

Query: 883 GIKGTVGYVAP 893
            + GT  Y+AP
Sbjct: 162 SLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 61/171 (35%), Positives = 90/171 (52%), Gaps = 32/171 (18%)

Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNL 764
           +G+G FG V+ G        +D+ +VAVK   LK+     A K F  E E L N +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH---------QSNDQVEVRKLSLIQR 815
           +K   +C+    EG D   +VFEYME+G L  +L          +S D   + +L+L Q 
Sbjct: 71  VKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS-PMGELTLSQL 124

Query: 816 MNIAIDVASAIEYL--HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + IA+ +AS + YL   H      VH DL   N L+ YD+V  +GDFG+++
Sbjct: 125 LQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 18/167 (10%)

Query: 710 SNMIGQGRFGTVYKG---ILGDDE-MVVAVKVINLKQKGASKS-FVSECEALRNIRHRNL 764
              +G+G FG V       LGD+    VAVK +N   +   +S F  E E LR + H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K   +C       +    L+ EY+ +GSL D+L +  DQ     ++L + +  +  +  
Sbjct: 69  VKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQICK 120

Query: 825 AIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            ++YL         +H DL   N+L++ + +  + DFGLAK L    
Sbjct: 121 GMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 93.0 bits (232), Expect = 6e-21
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 22/188 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
            F     IG+G FG VYK         VA+KVI L+ K   +  ++E + L+  +H N++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K     S    + +    +V E+   GSL+D L  +N     + L+  Q   +  ++   
Sbjct: 61  KYY--GSYLKKDEL---WIVMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKG 110

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +EYLH +    ++H D+K +N+LL  D    + DFGL+  LS+      +K  ++ +   
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARNTMV--- 158

Query: 886 GTVGYVAP 893
           GT  ++AP
Sbjct: 159 GTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 56/169 (33%), Positives = 88/169 (52%), Gaps = 31/169 (18%)

Query: 711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
            +IG G FG V +G L   G  E+ VA+K   LK  G+S      F++E   +    H N
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT--LKA-GSSDKQRLDFLTEASIMGQFDHPN 66

Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +I++         EGV  K+    ++ EYMENGSL+ +L + ND     K ++ Q + + 
Sbjct: 67  IIRL---------EGVVTKSRPVMIITEYMENGSLDKFLRE-NDG----KFTVGQLVGML 112

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L +
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 13/162 (8%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
            EF+    +G G FG V++G L  + + VA+K++        + F  E +AL+ +RH++L
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           I +  +CS    E V    ++ E ME GSL  +L     QV    L +   +++A  VA 
Sbjct: 65  ISLFAVCSVG--EPV---YIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAE 115

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            + YL        +H DL   N+L+  D+V  V DFGLA+ +
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 89.1 bits (222), Expect = 1e-19
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 22/186 (11%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
             IG+G FG VY      D  +  +K I+L        +  ++E + L+ + H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  FE      +V EY + G L   + +     E +     Q ++  + +  A++Y
Sbjct: 66  E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKY 118

Query: 829 LH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           LH       ++H D+KP N+ L  + +  +GDFG++K L +  +D+A     + +   GT
Sbjct: 119 LHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLA----KTVV---GT 166

Query: 888 VGYVAP 893
             Y++P
Sbjct: 167 PYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 3e-19
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 20/163 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G VYK        +VA+K I ++ +  G   + + E + L+ +RH N++++  I
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 771 CSSTDFEGVDFKALVFEYME---NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
            +S     +    +VFEYM+    G L        D  EV K +  Q       +   ++
Sbjct: 67  VTSKGKGSI---YMVFEYMDHDLTGLL--------DSPEV-KFTESQIKCYMKQLLEGLQ 114

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           YLH +    ++H D+K SN+L++ D V  + DFGLA+  +  +
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 26/163 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +GQG  G VYK        + A+K I++       K  + E + LR+     ++K     
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----- 63

Query: 772 SSTDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                 G  +K    ++V EYM+ GSL D L       +V K+       IA  +   ++
Sbjct: 64  ----CYGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLD 113

Query: 828 YLH--HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           YLH   H    ++H D+KPSN+L++      + DFG++K L N
Sbjct: 114 YLHTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 57/190 (30%), Positives = 95/190 (50%), Gaps = 28/190 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK   LK    S ++F+ E + ++ +RH  L+++  +C
Sbjct: 14  LGAGQFGEVWMG-TWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
             ++ E +    +V EYM  GSL D+L       E +KL L Q +++A  +A  + YL  
Sbjct: 71  --SEEEPI---YIVTEYMSKGSLLDFLKSG----EGKKLRLPQLVDMAAQIAEGMAYLE- 120

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N+L+  ++V  + DFGLA+ + +   D  +    +   IK T    
Sbjct: 121 --SRNYIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWT---- 171

Query: 892 AP-----GKF 896
           AP     G+F
Sbjct: 172 APEAANYGRF 181

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 34/193 (17%)

Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEALRNIRHRNL 764
           +IG G FG V +G L   G  E+ VA+K +      KQ+   + F+SE   +    H N+
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 765 IKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           I +         EGV  K+    ++ E+MENG+L+ +L Q++ Q  V     IQ + +  
Sbjct: 68  IHL---------EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-----IQLVGMLR 113

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +A+ ++YL    +   VH DL   N+L++ ++V  V DFGL++FL +   D +  T +S
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTS 167

Query: 881 SIGIKGTVGYVAP 893
           S+G K  + + AP
Sbjct: 168 SLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 19/176 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V++G L ++   VAVK   LK      K F++E + ++ +RH  LI++  +C
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
             T  E +    +V E M+ GSL ++L         R L L Q +++A  VAS + YL  
Sbjct: 71  --TLEEPI---YIVTELMKYGSLLEYLQGG----AGRALKLPQLIDMAAQVASGMAYLEA 121

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
                 +H DL   NVL+  + +  V DFGLA+ +     DI      +   IK T
Sbjct: 122 Q---NYIHRDLAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWT 171

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 30/193 (15%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRN 763
            +   ++IG+G FG VYKG+  +    VA+K I+L   ++ A KS + E + L+N++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++K I        E  D   ++ EY ENGSL   + +                 +A+ V 
Sbjct: 61  IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGP---------FPESLVAVYVY 106

Query: 824 ---SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
                + YLH   +  ++H D+K +N+L   D V  + DFG+A  L++   D AS     
Sbjct: 107 QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----- 158

Query: 881 SIGIKGTVGYVAP 893
              + GT  ++AP
Sbjct: 159 ---VVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.8 bits (211), Expect = 6e-18
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 16/157 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G +G VYK        +VA+K I L  +  G   + + E   L+ ++H N++K++ +
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             +          LVFEY +   L+ +L +         LS     +I   +   + Y H
Sbjct: 67  IHT-----ERKLYLVFEYCDM-DLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCH 115

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
            H    ++H DLKP N+L++ D V  + DFGLA+   
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 25/158 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVK------VINLKQKGASKSFVSECEALRNIRHRNLIK 766
           IG+G FG VYKG+L      VAVK        +LK+K     F+ E E L+   H N++K
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I +C     + +    +V E +  GSL  +L +  +++ V+KL     + +++D A+ +
Sbjct: 57  LIGVC--VQKQPI---YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           EYL        +H DL   N L+  + V  + DFG+++
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 9/164 (5%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLKQKGAS--KSFVSECEALRNIRH 761
                ++G+G FG+V +G L  D+     VAVK + L     S  + F+SE   +++  H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 762 RNLIKIITIC-SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
            N++K+I +C  ++  + +    ++  +M++G L  +L  S       KL L   +   +
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           D+A  +EYL +      +H DL   N +L  DM   V DFGL+K
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 24/191 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRN 763
           ++ +  + +G G++G VY+G+     + VAVK   LK+     + F+ E   ++ I+H N
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 63

Query: 764 LIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           L++++ +C+    F       ++ E+M  G+L D+L +  ++ EV  + L+    +A  +
Sbjct: 64  LVQLLGVCTREPPF------YIITEFMTYGNLLDYL-RECNRQEVNAVVLLY---MATQI 113

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           +SA+EYL        +H DL   N L+  + +  V DFGL++ ++         T ++  
Sbjct: 114 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHA 163

Query: 883 GIKGTVGYVAP 893
           G K  + + AP
Sbjct: 164 GAKFPIKWTAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 22/182 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMV---VAVKVINLKQ-KGASKSFVSECEALRNI 759
           +E     ++G G FGTVYKG+ + + E V   VA+KV+  +    A+K  + E   + ++
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H ++++++ IC S+         L+ + M  G L D++    D +  + L     +N  
Sbjct: 67  DHPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWC 115

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL---SNHHLDIASK 876
           + +A  + YL       +VH DL   NVL+       + DFGLAK L      +     K
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172

Query: 877 TP 878
            P
Sbjct: 173 VP 174

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 83.6 bits (205), Expect = 6e-17
 Identities = 60/185 (32%), Positives = 90/185 (48%), Gaps = 19/185 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G FG VY      D  +VA+KV+  K   +    + F+ E + L ++ H   I  + 
Sbjct: 8   LGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                +        LV EY++ GSLED L +   +     LS  + + I   + SA+EYL
Sbjct: 65  DFFQDE----GSLYLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYL 117

Query: 830 HHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           H      ++H D+KP N+LLD D  V  + DFGLAK L +     +     S+    GT 
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST--SVGTP 172

Query: 889 GYVAP 893
           GY+AP
Sbjct: 173 GYMAP 177

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 30/197 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEAL-RNIRHRNLIKII 768
           IG+G F TV      +     A+K+++   L ++   K    E E L R   H  +IK+ 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
              +  D E + F   V EY  NG L  ++ +         L        A ++  A+EY
Sbjct: 69  --YTFQDEENLYF---VLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILLALEY 117

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK--- 885
           LH      ++H DLKP N+LLD DM   + DFG AK L  +    ++K  +++I  +   
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 886 ---------GTVGYVAP 893
                    GT  YV+P
Sbjct: 175 NRRRFASFVGTAEYVSP 191

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 28/195 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L   +  VA+K I   ++GA   + F+ E + +  + H
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK--VAIKTI---REGAMSEEDFIEEAQVMMKLSH 58

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LVFE+ME+G L D+L     +     L     + + +D
Sbjct: 59  PKLVQLYGVC----TERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLD 108

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL       ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 109 VCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-------TSS 158

Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 159 TGTKFPVKWSSPEVF 173

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 18/159 (11%)

Query: 713 IGQGRFGTVYK-GILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIIT 769
           IG+G  G V+K       E  VA+K + L++   G     + E +AL+  +H  ++K++ 
Sbjct: 8   IGEGAHGIVFKAKDRETGE-TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +       G     LV EYM    L + L       E R L   Q  +    +   + Y+
Sbjct: 67  V--FPHGSGF---VLVMEYMP-SDLSEVLRD-----EERPLPEAQVKSYMRMLLKGVAYM 115

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           H      ++H DLKP+N+L+  D V  + DFGLA+  S 
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.1 bits (192), Expect = 9e-16
 Identities = 57/159 (35%), Positives = 80/159 (50%), Gaps = 23/159 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMV-VAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V   +LGD     VAVK I  K    +++F++E   +  +RH NL++++ + 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 772 SSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  V+ K    +V EYM  GSL D+L      V    L     +  ++DV  A+EY
Sbjct: 69  -------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 117

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           L  +     VH DL   NVL+  D VA V DFGL K  S
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 18/170 (10%)

Query: 712 MIGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLIKI 767
            IG+G+FG VY+G+     ++++ VAVK        + +  F+ E   +R   H +++K+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           I + +       +   +V E    G L  +L  +   +++  L L      +  +++A+ 
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY-----SYQLSTALA 121

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           YL        VH D+   NVL+       +GDFGL+++L +     ASK 
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 23/170 (13%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGIL---GDD-EMVVAVKVINLKQKGASKSFVSECE---AL 756
            +E     ++G G FGTV+KGI    GD  ++ VA+K I  + +   ++F    +   A+
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAM 63

Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
            ++ H  +++++ IC     +      LV +    GSL D + Q  D ++ ++L     +
Sbjct: 64  GSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRL-----L 112

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           N  + +A  + YL  H    MVH +L   N+LL  D +  + DFG+A  L
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 22/166 (13%)

Query: 713 IGQGRFGTVY----KGILGD-DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V+      +L + D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLH---------QSNDQVEVRKLSLIQRMNI 818
             +C+    EG     +VFEYM +G L  +L             + V   +L+L Q + I
Sbjct: 73  YGVCT----EG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  +AS + YL        VH DL   N L+   +V  +GDFG+++
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 19/153 (12%)

Query: 713 IGQGRFGTVYKG-ILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V +G   G     VAVK  N+K    +++F+ E   +  + H+NL++++ + 
Sbjct: 14  IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                       +V E M  G+L ++L      +    +S+IQ +  ++DVA  +EYL  
Sbjct: 69  LHNGLY------IVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE- 117

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                +VH DL   N+L+  D VA V DFGLA+
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 48/183 (26%), Positives = 84/183 (45%), Gaps = 28/183 (15%)

Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASK---SFVSE 752
           E+  +   F     +G+G FG VYKG L    +     +V +  LK+    K    F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRK- 809
            E + +++H N++ ++ +C+           ++FEY+ +G L ++L  +  +  V     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQP-----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 810 -------LSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
                  L     ++IAI +A+ +EYL  HH     VH DL   N L+   +   + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 862 LAK 864
           L++
Sbjct: 170 LSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 28/192 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    +G G+FG V+ G   G  +  VA+K+I    +GA     F+ E + +  + H
Sbjct: 4   SELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIR---EGAMSEDDFIEEAKVMMKLSH 58

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            NL+++  +C+    +   F  +V EYM NG L ++L +        KL     +++  D
Sbjct: 59  PNLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSD 108

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V  A+EYL  +     +H DL   N L+  D V  V DFGLA+++    LD      +SS
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV----LD---DQYTSS 158

Query: 882 IGIKGTVGYVAP 893
            G K  V +  P
Sbjct: 159 QGTKFPVKWAPP 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 53/185 (28%), Positives = 77/185 (41%), Gaps = 46/185 (24%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIK--- 766
           IG+G FGTV K     D  ++  K I   N+ +K   +  VSE   LR ++H N+++   
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNIVRYYD 66

Query: 767 -IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR---------- 815
            II   + T +       +V EY E G L                 LIQ+          
Sbjct: 67  RIIDRSNQTLY-------IVMEYCEGGDLA---------------QLIQKCKKERKYIEE 104

Query: 816 ---MNIAIDVASAIEYLHH--HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
                I   +  A+   H+       ++H DLKP+N+ LD +    +GDFGLAK L  H 
Sbjct: 105 EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHD 163

Query: 871 LDIAS 875
              A 
Sbjct: 164 SSFAK 168

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 53/175 (30%), Positives = 88/175 (50%), Gaps = 31/175 (17%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEALR 757
           S  +   +IG G FG V++GIL   G  E+ VA+K +      KQ+   + F+SE   + 
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR---QDFLSEASIMG 61

Query: 758 NIRHRNLIKIITICSSTDFEGV--DFK--ALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
              H N+I++         EGV   FK   ++ EYMENG+L+ +L   + +      S  
Sbjct: 62  QFSHHNIIRL---------EGVVTKFKPAMIITEYMENGALDKYLRDHDGE-----FSSY 107

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           Q + +   +A+ ++YL        VH DL   N+L++ ++   V DFGL++ L +
Sbjct: 108 QLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 5e-15
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 29/161 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-------HRNLI 765
           +G G FG+VY     +   +VA+K   +K+K  S     EC  LR ++       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK--MKKKFYS---WEECMNLREVKSLRKLNEHPNIV 61

Query: 766 KIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           K+  +    D  +        VFEYME       L+Q     + +  S     +I   + 
Sbjct: 62  KLKEVFRENDELY-------FVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             + ++H H      H DLKP N+L+    V  + DFGLA+
Sbjct: 110 QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.7 bits (186), Expect = 7e-15
 Identities = 53/168 (31%), Positives = 79/168 (47%), Gaps = 26/168 (15%)

Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLI 765
           +G+G FG V    Y         +VAVK   LK++   +    +  E   L+ + H N++
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K    CS    +G+    L+ EY+  GSL D+L +         L+L Q +  A  +   
Sbjct: 70  KYKGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKHK-------LNLAQLLLFAQQICEG 119

Query: 826 IEYLH--HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
           + YLH  H+     +H DL   NVLLD D +  +GDFGLAK +   H 
Sbjct: 120 MAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 27/189 (14%)

Query: 713 IGQGRFGTVY---KGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           I +G +G V+   K   GD   + A+KVI    + +K      ++E + L   +   ++K
Sbjct: 1   ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN--DQVEVRKLSLIQRMNIAIDVAS 824
           +    S   F+G     LV EY+  G L   L      D+   R            ++  
Sbjct: 58  LY--YS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR--------IYIAEIVL 104

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A+EYLH +    ++H DLKP N+L+D +    + DFGL+K          +        I
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 162 VGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 39/168 (23%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-----SFVSECEALRNIRHRNLIKI 767
           +G+G +  VYK    +   +VA+K I L ++  +K     + + E + L+ ++H N+I +
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI---DVAS 824
           + +             LVFE+ME   LE                +I+  +I +   D+ S
Sbjct: 68  LDVFGHKSN-----INLVFEFME-TDLE---------------KVIKDKSIVLTPADIKS 106

Query: 825 -------AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
                   +EYLH +    ++H DLKP+N+L+  D V  + DFGLA+ 
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 23/167 (13%)

Query: 713 IGQGRFGTV-----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V     Y      D+M+VAVK +      A K F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVR--------KLSLIQRMN 817
             +C        D   +VFEYM++G L  +L  H  +  + V         +L L Q ++
Sbjct: 73  YGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           IA  +AS + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 26/170 (15%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           + +   IG+G  G VYK         VA+K + L+++   +  ++E   +++ +H N++ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVD 79

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN------IAI 820
                 S       +  +V EYM+ GSL D + Q+             RMN      +  
Sbjct: 80  YY---DSYLVGDELW--VVMEYMDGGSLTDIITQNF-----------VRMNEPQIAYVCR 123

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           +V   +EYLH      ++H D+K  N+LL  D    + DFG A  L+   
Sbjct: 124 EVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 36/211 (17%)

Query: 712 MIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS---FVSECEALRNI-RHR 762
            +G+G FG V K         ++   VAVK+  LK     K     VSE E ++ I +H+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ----------SNDQVEVRKLSL 812
           N+I ++ +C+    EG  +  +V EY  +G+L D+L             + +     L+ 
Sbjct: 77  NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
              ++ A  VA  +E+L        +H DL   NVL+  D V  + DFGLA+ +  HH+D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHID 186

Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRVYTH 213

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 16/157 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G VYK        +VA+K I L+   +G  K+ + E + L+ + H N+IK++ +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                    D   LVFE+M+     D      D+      SLI   +    +   + + H
Sbjct: 67  F----RHKGDL-YLVFEFMD----TDLYKLIKDRQRGLPESLI--KSYLYQLLQGLAFCH 115

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
            H    ++H DLKP N+L++ + V  + DFGLA+   
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFG 149

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 23/168 (13%)

Query: 711 NMIGQGRFGTVYKG----ILGDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHR 762
           N +G G FG VY+G    ILG     + V V  L+ KGA+    K F+ E   + N  H 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHP 59

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ-VEVRKLSLIQRMNIAID 821
           N++K++ +C   + +      ++ E ME G L  +L  +  +      L+L + ++I +D
Sbjct: 60  NIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAK 864
           VA    YL    Q   +H DL   N L+     D D V  +GDFGLA+
Sbjct: 115 VAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 28/187 (14%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIIT 769
           ++G+G FG V+      D+ +V +K I ++Q  K    +  +EC+ L+ + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 770 ICSSTDFEGVDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                +F  ++ KAL  V EY   G+L +++ +       R  SL+    I       + 
Sbjct: 67  -----NF--LEDKALMIVMEYAPGGTLAEYIQK-------RCNSLLDEDTILHFFVQILL 112

Query: 828 YLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            LHH     ++H DLK  N+LLD + MV  +GDFG++K LS         + S +  + G
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---------SKSKAYTVVG 163

Query: 887 TVGYVAP 893
           T  Y++P
Sbjct: 164 TPCYISP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 72.9 bits (180), Expect = 3e-14
 Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 43/193 (22%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V      D   + A+KV+    + ++   +  ++E   L  I H  ++K   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN---------IAI 820
             +   F+  +   LV EY   G L                S + +            A 
Sbjct: 59  HYA---FQTEEKLYLVLEYAPGGEL---------------FSHLSKEGRFSEERARFYAA 100

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
           ++  A+EYLH      +++ DLKP N+LLD D    + DFGLAK LS+      + T   
Sbjct: 101 EIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFC- 154

Query: 881 SIGIKGTVGYVAP 893
                GT  Y+AP
Sbjct: 155 -----GTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 8/161 (4%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRNLIKII 768
           +G+G FG+V +G L  D+ ++ V V  +K    ++S    F+SE   ++   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 769 TIC-SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
            +C  + + EG     ++  +M++G L  +L  S      + L     +    D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           YL        +H DL   N +L+ +M   V DFGL+K + N
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 61/187 (32%), Positives = 92/187 (49%), Gaps = 32/187 (17%)

Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEALRNIRHRNL 764
           +IG G FG V  G L   G  E+ VA+K +      KQ+   + F+SE   +    H N+
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPNI 67

Query: 765 IKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           I +         EGV  K+    +V EYMENGSL+ +L + + Q  V     IQ + +  
Sbjct: 68  IHL---------EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLR 113

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L +   + A  T   
Sbjct: 114 GIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGG 169

Query: 881 SIGIKGT 887
            I I+ T
Sbjct: 170 KIPIRWT 176

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 18/169 (10%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHR 762
           +EF   N IG+G +G VY+        +VA+K + +  +  G   S + E   L N+RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMEN--GSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           N++++  +      + + F  LV EY E    SL D +     + +V+ L L        
Sbjct: 67  NIVELKEVVVGKHLDSI-F--LVMEYCEQDLASLLDNMPTPFSESQVKCLML-------- 115

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            +   ++YLH +    ++H DLK SN+LL       + DFGLA+     
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 18/159 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNIRHRNLIKIITIC 771
           IG G    VY  I   +   VA+K I+L++   S   +  E +A+    H N++K     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK----- 63

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI---DVASAIEY 828
             T F   D   LV  Y+  GSL D +  S           +    IA    +V   +EY
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEY 117

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           LH + Q   +H D+K  N+LL  D    + DFG++  L+
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLA 153

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 41/171 (23%), Positives = 77/171 (45%), Gaps = 26/171 (15%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +GQG FG VY+G+      G+ E  VA+K +N   + AS      F++E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 764 LIKIITICSSTDFEGVDFKALV-FEYMENGSLEDWLHQ---SNDQVEVRK-LSLIQRMNI 818
           +++++ + S+          LV  E M  G L+ +L       +        +L + + +
Sbjct: 71  VVRLLGVVSTGQ------PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           A ++A  + YL        VH DL   N ++  D+   +GDFG+ + +   
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 24/182 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +GQG FG V+ G   +    VA+K   LK    S ++F+ E + ++ +RH  L+++  + 
Sbjct: 14  LGQGCFGEVWMGTW-NGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           S           +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+  
Sbjct: 71  SEEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE- 119

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
             +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + 
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWT 170

Query: 892 AP 893
           AP
Sbjct: 171 AP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 13/165 (7%)

Query: 710 SNMIGQGRFGTVYKGILGDDEMVVAVK--VINLKQKGASKSFVSECEALRNIR---HRNL 764
              IG+G +GTVYK    +    VA+K   + L ++G   S + E   L+ +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++++ +C     +      LVFE+++    +D L     +     L      ++   +  
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            +++LH H    +VH DLKP N+L+  D    + DFGLA+  S  
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.3 bits (180), Expect = 3e-13
 Identities = 34/79 (43%), Positives = 50/79 (63%)

Query: 411 GTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN 470
           G IP+ IS+L++LQ +++  N +RG IP  LG++T L  LDL  NS  G+IP SLG   +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 471 LILFIASYNKLTGDLPQQL 489
           L +   + N L+G +P  L
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 20/164 (12%)

Query: 713 IGQGRFGTV-----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V     Y      D+++VAVK +      A K F  E E L N++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLH-QSNDQVEV------RKLSLIQRMNIAI 820
             +C     EG D   +VFEYM++G L  +L     D V +       +L+  Q ++IA 
Sbjct: 73  YGVC----VEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +A+ + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.1 bits (174), Expect = 4e-13
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 45/225 (20%)

Query: 706 EFSSSNMI-----GQGRFGTVYK----GILGD--DEMV-VAVKVINLKQKGASKSF---V 750
           EF    ++     G+G FG V +    GI     D+ V VAVK+  LK     K     +
Sbjct: 8   EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLI 65

Query: 751 SECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--------S 801
           SE E ++ I +H+N+I ++ +C+    EG  +  ++ EY   G+L ++L          +
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQ---EGPLY--VIVEYAAKGNLREFLRARRPPGPDYT 120

Query: 802 NDQVEVRK--LSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
            D  +V +  LS    ++ A  VA  +EYL    C    +H DL   NVL+  D V  + 
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIA 176

Query: 859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           DFGLA+ +  H +D   KT +  + +K    ++AP   F  +YTH
Sbjct: 177 DFGLARGV--HDIDYYKKTSNGRLPVK----WMAPEALFDRVYTH 215

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 13/153 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           IG G FG V    +  D  V  V V  LK   +SK    F+ + +  R ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
            C     E + +  LVFEY E G L+ +L Q        +L L+QRM  A ++A+ + ++
Sbjct: 63  QC----VEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHM 115

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           H H     +H DL   N  L  D+   VGD+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 34/210 (16%)

Query: 713 IGQGRFGTVYKG-ILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V     +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L               QV   +LS  
Sbjct: 86  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDI 873
             ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  HH+D 
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 195

Query: 874 ASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
             KT +  + +K    ++AP   F  +YTH
Sbjct: 196 YKKTTNGRLPVK----WMAPEALFDRIYTH 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 29/190 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK   LK    S +SF+ E + ++ +RH  L+++  + 
Sbjct: 14  LGNGQFGEVWMGTW-NGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           S           +V EYM  GSL D+L       E R L L   +++A  VA+ + Y+  
Sbjct: 71  SEEPI------YIVTEYMSKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIE- 119

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
             +   +H DL+ +N+L+   +V  + DFGLA+ + ++         ++  G K  + + 
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWT 170

Query: 892 AP-----GKF 896
           AP     G+F
Sbjct: 171 APEAALYGRF 180

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 6e-13
 Identities = 36/85 (42%), Positives = 53/85 (62%)

Query: 499 LDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVI 558
           L L N  L G +P  +  L++L  +++S N   G IP +L +  SLE LD+S NSF G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 559 PLSFRFLKSIKALNVSSNNLSGKIP 583
           P S   L S++ LN++ N+LSG++P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 17/157 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G       V A+K  +LKQ   S   F++E   ++ ++H  L+++  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKV-AIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L       E  KL++ + +++A  +A  + ++  
Sbjct: 71  TQEPI------YIITEYMENGSLVDFLKTP----EGIKLTINKLIDMAAQIAEGMAFIE- 119

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             +   +H DL+ +N+L+   +   + DFGLA+ + +
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 28/191 (14%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK----GASKSFVSECEALRNIRHR 762
           F    +IG+G FG V      D + + A+K +N KQK    G+ ++ ++E   L+ + H 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            L+ +     S  F+  +   LV + +  G L   L Q        K S  Q      ++
Sbjct: 61  FLVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEI 109

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+EYLH      ++H D+KP N+LLD     H+ DF +A  +            + + 
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---------TPDTLTT 157

Query: 883 GIKGTVGYVAP 893
              GT GY+AP
Sbjct: 158 STSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.5 bits (172), Expect = 6e-13
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 19/167 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMV---VAVKVIN-LKQKGASKSFVSECEALRNI 759
           +E     ++G G FGTVYKGI + + E V   VA+K++N      A+  F+ E   + ++
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H +L++++ +C S   +      LV + M +G L D++H+  D +  + L     +N  
Sbjct: 67  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWC 115

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL    +  +VH DL   NVL+       + DFGLA+ L
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 47/160 (29%), Positives = 69/160 (43%), Gaps = 23/160 (14%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIK 766
           +G G FG+V KG+       E+ VAVK   LKQ       K F+ E   +  + H  +++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKT--LKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I +C            LV E    G L  +L +   ++ V  L       +A  VA  +
Sbjct: 61  LIGVCKGEPL------MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGM 108

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        VH DL   NVLL     A + DFG+++ L
Sbjct: 109 AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 43/174 (24%), Positives = 87/174 (50%), Gaps = 18/174 (10%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVV--AVKVINLKQKGASKS----FVSECEALRNIR 760
            + S+++ +G FG ++ GIL D++      V V  +K   AS+      + E   L  + 
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLS 66

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN--DQVEVRKLSLIQRMNI 818
           H+N++ I+ +C     E  +   +++ YM  G+L+ +L Q    +    + LS  Q +++
Sbjct: 67  HQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK--FLSNHH 870
           AI +A  + YLH      ++H D+   N ++D ++   + D  L++  F  ++H
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.5 bits (171), Expect = 1e-12
 Identities = 47/165 (28%), Positives = 68/165 (41%), Gaps = 27/165 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVK------VINLKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V            A+K      ++ LKQ    +  ++E   L++IRH  L+ 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---VEHVLNEKRILQSIRHPFLVN 65

Query: 767 IITICSSTDFEGVDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +      +     D   L  V EY+  G L   L +S       +         A  V  
Sbjct: 66  LY----GSFQ---DDSNLYLVMEYVPGGELFSHLRKS------GRFPEPVARFYAAQVVL 112

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           A+EYLH      +V+ DLKP N+LLD D    + DFG AK +   
Sbjct: 113 ALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 2e-12
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 33/162 (20%)

Query: 40  ALLAIKSQLHDPSGVTSSWNNTMNFCQ---WTGVTCG----HRHQRLTELNLSSQRIGGV 92
           AL  +KS L  P      WN      Q   W+G  C          +  L L +Q + G 
Sbjct: 376 ALQTLKSSLGLPLRF--GWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGF 433

Query: 93  LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLI 152
           +   +  L  L+ INL+ N  RG+IP  +G++  LE L LS NSF+G+IP +L       
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL------- 486

Query: 153 HFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
                            G L  L+ L+++ N L+G++P ++G
Sbjct: 487 -----------------GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 36/177 (20%)

Query: 713 IGQGRFGTVYK----GIL-GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHRN 763
           IGQG FG V++    G+L  +   +VAVK++   ++ AS      F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLED--------WLHQ-SNDQVEVRK----- 809
           ++K++ +C+     G     L+FEYM  G L +             S+     RK     
Sbjct: 70  IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 810 --LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             LS  +++ IA  VA+ + YL    +   VH DL   N L+  +MV  + DFGL++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 32/186 (17%)

Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKI 767
           +G G+FG V    ++G     +  VA+K+I  K+   S+  F+ E + +  + H  L+++
Sbjct: 12  LGTGQFGVVKYGKWRG-----QYDVAIKMI--KEGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             +C+    +   +  +V EYM NG L ++L +       ++    Q + +  DV   + 
Sbjct: 65  YGVCTK---QRPIY--IVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMA 114

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           YL        +H DL   N L+D      V DFGL++++    LD      +SS+G K  
Sbjct: 115 YLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LD---DEYTSSVGSKFP 164

Query: 888 VGYVAP 893
           V +  P
Sbjct: 165 VRWSPP 170

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 15/159 (9%)

Query: 712 MIGQGRFGTVYK---GILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
            +G+G FG+V       L D+   VVAVK +        + F  E E L++++H N++K 
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             +C S     +    LV EY+  GSL D+L +  ++++ RKL L      A  +   +E
Sbjct: 71  KGVCYSAGRRNL---RLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-----ASQICKGME 122

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           YL        VH DL   N+L++ +    +GDFGL K L
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 21/184 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           IG+G+F  VYK I   D  VVA+K +    +    A +  + E + L+ + H N+IK + 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                 F   +   +V E  + G L   +     Q   R +         + + SA+E++
Sbjct: 70  -----SFIENNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTIWKYFVQLCSALEHM 122

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H      ++H D+KP+NV +    V  +GD GL +F S       SKT +++  + GT  
Sbjct: 123 HSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKT-TAAHSLVGTPY 171

Query: 890 YVAP 893
           Y++P
Sbjct: 172 YMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 26/168 (15%)

Query: 711 NMIGQGRFGTVYKGIL----GDD-EMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNL 764
             +G G FG VY+G+     GD  E+ VAVK +        +S F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 765 IKIITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQS-NDQVEVRKLSLIQRMNIA 819
           +++I         GV F+ L    + E M  G L+ +L ++         L++   +  A
Sbjct: 72  VRLI---------GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAK 864
            DVA   +YL    +   +H D+   N LL       VA + DFG+A+
Sbjct: 123 RDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 26/192 (13%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIKI 767
           IG+G +G VYK     G D    A+K       +  G S+S   E   LR ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM--NIAIDVASA 825
           + +      + V    L+F+Y E+    D         + +++S+   M  ++   + + 
Sbjct: 68  VEVFLEHADKSV---YLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           + YLH +    ++H DLKP+N+L+        V  +GD GLA+  +        K  +  
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA-----PLKPLADL 172

Query: 882 IGIKGTVGYVAP 893
             +  T+ Y AP
Sbjct: 173 DPVVVTIWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 32/166 (19%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS------KSFVSECEALRNIRHRNLI 765
           ++G+G +G V K        +VA+K    K K +       K+ + E + LR +RH N++
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN--DQVEVRKLS--LIQRMNIAID 821
            +         +G  +  LVFEY+E   LE             VR     L+Q       
Sbjct: 64  NLKEAFRR---KGRLY--LVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ------- 111

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              AI Y H H    ++H D+KP N+L+    V  + DFG A+ L 
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 19/168 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMV---VAVKVI-NLKQKGASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+ + + E V   VA+K +       A+K  + E   + ++
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 67  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 115

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + +A  + YL       +VH DL   NVL+       + DFGLAK L 
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 48/168 (28%), Positives = 89/168 (52%), Gaps = 14/168 (8%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHR 762
           S++     IGQG FG V+K      + +VA+K + ++   +G   + + E + L+ ++H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 763 NLIKIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           N++ +I IC +       +K    LVFE+ E+  L   L  SN  V+   LS I+++   
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKF-TLSEIKKV--M 125

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
             + + + Y+H +    ++H D+K +N+L+  D +  + DFGLA+  S
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 16/157 (10%)

Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y     +    VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             IC+     G+    L+ E++ +GSL+++L ++       K++L Q++  A+ +   ++
Sbjct: 72  KGICTEDGGNGIK---LIMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMD 123

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           YL        VH DL   NVL++ +    +GDFGL K
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 9e-12
 Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 3/104 (2%)

Query: 130 LALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQL 189
           L L N    G IP ++S+  +L     S N + G IP  +G++  L+ L +  N   G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 190 PDSVGNLSAIEVIRITENSLGGKIPTTLG--LLRRLVNLNVAEN 231
           P+S+G L+++ ++ +  NSL G++P  LG  LL R  + N  +N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR-ASFNFTDN 525

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 36/90 (40%), Positives = 56/90 (62%), Gaps = 1/90 (1%)

Query: 426 LSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDL 485
           L + N  LRG IP+ +  L  L S++L  NS++GNIP SLG+  +L +   SYN   G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 486 PQQLLSITTLSLVLDLSNNLLNGSLPLQVG 515
           P+ L  +T+L  +L+L+ N L+G +P  +G
Sbjct: 483 PESLGQLTSLR-ILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.8 bits (164), Expect = 1e-11
 Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNLIKIITI 770
           IG G +G V   +       VA+K I+        +K  + E + LR++RH N+I ++ I
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67

Query: 771 C---SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
               S  DF  V    +V E ME   L   +         + L+          +   ++
Sbjct: 68  LRPPSPEDFNDV---YIVTELMET-DLHKVIKSP------QPLTDDHIQYFLYQILRGLK 117

Query: 828 YLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           YLH  +     +H DLKPSN+L++ +    + DFGLA+ +    
Sbjct: 118 YLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 29/194 (14%)

Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIR 760
           K+ SE    N IG G  GTVYK I      + A+KVI    +    +    E E LR++ 
Sbjct: 71  KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN 130

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K    C        + + L+ E+M+ GSLE       D+   + L+     ++A 
Sbjct: 131 HPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG--THIADE---QFLA-----DVAR 175

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP-S 879
            + S I YLH      +VH D+KPSN+L++      + DFG+++ L    +D     P +
Sbjct: 176 QILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-AQTMD-----PCN 226

Query: 880 SSIGIKGTVGYVAP 893
           SS+   GT+ Y++P
Sbjct: 227 SSV---GTIAYMSP 237

Length = 353

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 9/164 (5%)

Query: 707 FSSSNMIGQGRFGTVYKGILG--DDEMV-VAVKVINLKQKGAS--KSFVSECEALRNIRH 761
           F+   M+G+G FG+V +  L   D     VAVK++      +S  + F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 762 RNLIKIITICSSTDFEG-VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
            N+IK+I +   +  +G +    ++  +M++G L  +L  S    E   L L   +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           D+AS +EYL        +H DL   N +L+ +M   V DFGL+K
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 26/177 (14%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRN 758
            +   +F     IG+G +G VYK    D   +VA+K + L  +++G   + + E + LR 
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 759 IRHRNLIKIITICSSTDFEGVDFKA------LVFEYMEN---GSLEDWL-HQSNDQVEVR 808
           + HRN++ +  I +    + +DFK       LVFEYM++   G LE  L H S D ++  
Sbjct: 63  LNHRNIVNLKEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-- 119

Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
             S ++++         + Y H   +   +H D+K SN+LL+      + DFGLA+ 
Sbjct: 120 --SFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 16/158 (10%)

Query: 711 NMIGQGRFGTVYKGILGDD---EMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D    ++  AVK +N +      + F+ E   +++  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 61  LLGICLPS--EGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           EYL        VH DL   N +LD      V DFGLA+
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 45/181 (24%), Positives = 89/181 (49%), Gaps = 22/181 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +        ++F+ E + ++ +RH  L+ +  + S
Sbjct: 14  LGQGCFGEVWMGTW-NGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V E+M  GSL D+L + +     + L L Q +++A  +A  + Y+   
Sbjct: 72  EEPI------YIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIE-- 119

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   +H DL+ +N+L+  ++V  + DFGLA+ + ++         ++  G K  + + A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWTA 171

Query: 893 P 893
           P
Sbjct: 172 P 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 31/84 (36%), Positives = 50/84 (59%)

Query: 158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTL 217
           N  L G IP +I  L  LQ +++  N + G +P S+G+++++EV+ ++ NS  G IP +L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 218 GLLRRLVNLNVAENQFSGMFPRSI 241
           G L  L  LN+  N  SG  P ++
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 24/162 (14%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           ++G+G +G V K    +   +VA+K    +   K   K  + E   L+ +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 770 ICSSTDFEGVDFKA--LVFEYMENGSLEDWLHQSN--DQVEVRKLSLIQRMNIAIDVASA 825
           +           K   LVFE++++  L+D     N  D+  VRK  L Q       +   
Sbjct: 68  VFRRK-------KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKY-LFQ-------ILRG 112

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           IE+ H H    ++H D+KP N+L+    V  + DFG A+ L+
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 54/185 (29%), Positives = 79/185 (42%), Gaps = 34/185 (18%)

Query: 696 SYAEL-SKATSE--FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF--- 749
             AEL SK   E  F+    IG G FG VY         VVA+K ++   K +++ +   
Sbjct: 3   EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62

Query: 750 VSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQV 805
           + E   L+ +RH N I         +++G   +     LV EY         L  ++D +
Sbjct: 63  IKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYC--------LGSASDIL 105

Query: 806 EVRKLSLIQRMNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           EV K  L Q + IA         + YLH H     +H D+K  N+LL       + DFG 
Sbjct: 106 EVHKKPL-QEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161

Query: 863 AKFLS 867
           A  +S
Sbjct: 162 ASLVS 166

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.5 bits (162), Expect = 2e-11
 Identities = 77/272 (28%), Positives = 110/272 (40%), Gaps = 16/272 (5%)

Query: 249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG 308
           L  L  N          LL L NL  L +  NN     P      SNL+ LDL  N+ + 
Sbjct: 95  LPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE- 153

Query: 309 KVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSI 368
            +     +L NL  L+L  N+L     +DL  ++  SN S+L  L LS N+         
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDL-----SDLPKLL--SNLSNLNNLDLSGNKI--SDLPPE 204

Query: 369 ANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSV 428
             L   + EL +  N I   +   + NL NL    L  N+    +P+ I  L NL+ L +
Sbjct: 205 IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDL 262

Query: 429 FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ 488
            NN +     S LG+LT L  LDL  NSL   +P        L L       LT    + 
Sbjct: 263 SNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL--LLNLLLTLKALEL 318

Query: 489 LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNL 520
            L+   L+  +  +    +      + +L NL
Sbjct: 319 KLNSILLNNNILSNGETSSPEALSILESLNNL 350

Length = 394

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 22/168 (13%)

Query: 711 NMIGQGRFGTVYKGILGDD--EMVVAVKVIN-LKQKGASKSFVSECEALRNI-RHRNLIK 766
           ++IG+G FG V + ++  D  +M  A+K++     +   + F  E E L  +  H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS----NDQVEVRK------LSLIQRM 816
           ++  C     E   +  +  EY   G+L D+L +S     D    ++      L+  Q +
Sbjct: 68  LLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             A DVA+ ++YL    +   +H DL   NVL+  ++ + + DFGL++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 29/163 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G+G +G+VYK I  +   VVA+KV+ +  +   +  + E   L+      ++K      
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62

Query: 773 STDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI---DVASA 825
              + G  FK     +V EY   GS+       +D +++   +L +   IA         
Sbjct: 63  ---YYGSYFKNTDLWIVMEYCGAGSV-------SDIMKITNKTLTEE-EIAAILYQTLKG 111

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           +EYLH +     +H D+K  N+LL+ +  A + DFG++  L++
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  I       VA+K +NL+Q+
Sbjct: 1   DEEILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  +H N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 58  PKKELIINEILVMRENKHPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTET-- 110

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 111 CMDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 19/156 (12%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           ++G+G FG V+KG L  D+  VAVK    +L Q+   K F+SE   L+   H N++K+I 
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIG 59

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +C  T  + +    +V E +  G    +L +  D+++ ++L     +  A+D A+ + YL
Sbjct: 60  VC--TQRQPI---YIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYL 109

Query: 830 H-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              +C    +H DL   N L+  + V  + DFG+++
Sbjct: 110 ESKNC----IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 13/162 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR---HRNLIKI 767
           IG G +GTVYK         VA+K + ++  + G   S V E   L+ +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           + +C+++  +      LVFE+++   L  +L    D+V    L      ++       ++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           +LH +C   +VH DLKP N+L+       + DFGLA+  S  
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 17/162 (10%)

Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G G FG V +G     G   + VAVK + + K       F+ E   + ++ H NLI++ 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +          +V E    GSL D L +      +    +    + A+ +A+ + Y
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLRKD----ALGHFLISTLCDYAVQIANGMRY 112

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           L        +H DL   N+LL  D    +GDFGL + L  + 
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.3 bits (160), Expect = 4e-11
 Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 43/173 (24%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVI-----NLKQKGASKSF--VSECEALRNIRHRNLI 765
           +G+G +G V+K I    + VVA+K I     N     A ++F  +   + L +  H N++
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGD--HPNIV 70

Query: 766 KIITICSSTDFEGVDFKA-------LVFEYMENGSLEDWLHQSNDQVEVRK--LSLIQRM 816
           K++ +           KA       LVFEYME     D LH       +R   L  + + 
Sbjct: 71  KLLNV----------IKAENDKDIYLVFEYMET----D-LHAV-----IRANILEDVHKR 110

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            I   +  A++Y+H      ++H DLKPSN+LL+ D    + DFGLA+ LS  
Sbjct: 111 YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 15/154 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TVYKG       +VA+K I+L  ++G   + + E   ++ ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63

Query: 772 SSTDFEGVDFK-ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
              D    + K  LVFEYM+   L+ ++     +     L      +    +   I + H
Sbjct: 64  --HDVIHTENKLMLVFEYMDK-DLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCH 117

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +    ++H DLKP N+L++      + DFGLA+
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG G +G VYK        +VA+KVI L+     +    E   L+  RH N++       
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF---- 66

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V EY   GSL+D    +   +   +++ + R     +    + YLH  
Sbjct: 67  -GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET 120

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            +   +H D+K +N+LL  D    + DFG++  L+ 
Sbjct: 121 GK---IHRDIKGANILLTEDGDVKLADFGVSAQLTA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 26/184 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVI--NLKQKGASKSFVSECEALRN 758
           +E     ++G G FGTVYKGI   D    ++ VA+KV+  N   K A+K  + E   +  
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 65

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           +    + +++ IC ++  +      LV + M  G L D++ ++ D++  + L     +N 
Sbjct: 66  VGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL----SNHHLDIA 874
            + +A  + YL    +  +VH DL   NVL+       + DFGLA+ L    + +H D  
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-G 170

Query: 875 SKTP 878
            K P
Sbjct: 171 GKVP 174

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 6e-11
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 40/177 (22%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
             F+    IG+G FG VYK I      VVA+KVI+L+            EA   I   ++
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEI--EDI 46

Query: 765 IKIITICSS------TDFEG---VDFK-ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
            + I   S       T + G      K  ++ EY   GS  D L          K   + 
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----------KPGKLD 96

Query: 815 RMNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
              IA    +V   +EYLH   +   +H D+K +N+LL  +    + DFG++  L++
Sbjct: 97  ETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.7 bits (157), Expect = 6e-11
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 43/224 (19%)

Query: 706 EFSSSNM-----IGQGRFGTVYKG-ILGDDE------MVVAVKVINLKQKGASKSF---V 750
           E S + +     +G+G FG V     +G D+      + VAVK+  LK     K     V
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLV 65

Query: 751 SECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--------S 801
           SE E ++ I +H+N+I ++  C+    +      LV EY   G+L ++L          S
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYS 120

Query: 802 NDQVEV--RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
            D  ++   +L+    ++ A  VA  +EYL        +H DL   NVL+  D V  + D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIAD 177

Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           FGLA+ +  H++D   KT +  + +K    ++AP   F  +YTH
Sbjct: 178 FGLARDV--HNIDYYKKTTNGRLPVK----WMAPEALFDRVYTH 215

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 28/193 (14%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRN 763
           +F   N IG+G FG V+K +   D+ V A+K I+L +      +  + E   L  +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 764 LIKIITICSSTDFEG-VDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +I+         +E  +D   L  V EY ENG L   L         R L   Q     I
Sbjct: 61  IIRY--------YESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFI 108

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +   + +LH      ++H D+K  N+ LD      +GD G+AK LS++     + T   
Sbjct: 109 QILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANT--- 160

Query: 881 SIGIKGTVGYVAP 893
              I GT  Y++P
Sbjct: 161 ---IVGTPYYLSP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.1 bits (154), Expect = 9e-11
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 41/191 (21%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIKI---- 767
           +G G  G V K +      ++AVK I L+   A  K  + E + L       ++      
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 768 -----ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
                I+IC               EYM+ GSL+  L +   ++  R L       IA+ V
Sbjct: 69  YNNGDISIC--------------MEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              + YLH   +  ++H D+KPSN+L++      + DFG++  L N    +A KT     
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---SLA-KT----- 158

Query: 883 GIKGTVGYVAP 893
              GT  Y+AP
Sbjct: 159 -FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 22/174 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-R 760
           ++    ++IG+G FG V K  +  D + +   +  +K+   K   + F  E E L  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKL 810
           H N+I ++  C     E   +  L  EY  +G+L D+L +S                  L
Sbjct: 67  HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           S  Q ++ A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 20/181 (11%)

Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRH 761
           A + + +   +G+G + TVYKGI   +  +VA+KVI++K ++G   + + E   L+ ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++ +  I  +   E + F   VFEYM    L  ++ Q    +    + L         
Sbjct: 63  ANIVLLHDIIHTK--ETLTF---VFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQ 111

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +   + Y+H      ++H DLKP N+L+ Y     + DFGLA+  S     I S+T SS 
Sbjct: 112 LLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS-----IPSQTYSSE 163

Query: 882 I 882
           +
Sbjct: 164 V 164

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 32/189 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEA----LRNIRHRNLIK 766
           ++G G FG+VY+G+  DD    AVK ++L   G   +  V + E     L  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVAS 824
            +     T+ E  D   +  E +  GSL   L  + S  +  +R             +  
Sbjct: 67  YL----GTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIR--------LYTRQILL 113

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            +EYLH       VH D+K +N+L+D + V  + DFG+AK              S +   
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSF 161

Query: 885 KGTVGYVAP 893
           KG+  ++AP
Sbjct: 162 KGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 45/176 (25%), Positives = 88/176 (50%), Gaps = 30/176 (17%)

Query: 713 IGQGRFGTVY----KGIL------------GDDEMVVAVKVINLK-QKGASKSFVSECEA 755
           +G+G+FG V+    +G+             G+  ++VAVK++     K A   F+ E + 
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQ---SNDQVEVRKL 810
           +  ++  N+I+++ +C ++     D   ++ EYMENG L  +L  H+   + ++ +V  +
Sbjct: 73  MSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           S    + +A  +AS ++YL        VH DL   N L+  +    + DFG+++ L
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 24/160 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS------FVSECEALRNIRHRNLIK 766
           IG G FG V   +LG+    ++   + +K+  AS +      F+ E +  R + H N+++
Sbjct: 3   IGNGWFGKV---LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLS---LIQRMNIAIDVA 823
            +  C     E + +  LV E+   G L+++L    ++  V +++   ++QRM  A +VA
Sbjct: 60  CLGQCI----ESIPY-LLVLEFCPLGDLKNYLRS--NRGMVAQMAQKDVLQRM--ACEVA 110

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
           S + +LH   Q   +H DL   N  L  D+   +GD+GLA
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 34/198 (17%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGD--DEMVVAVKVINLKQKGA--SKSFVSECEALRNIR 760
           SE +    +G G+FG V+   LG    ++ VA+K IN   +GA   + F+ E + +  + 
Sbjct: 4   SELTFMKELGSGQFGVVH---LGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLS 57

Query: 761 HRNLIKIITICSSTDFEGVDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           H  L+++  +C+         K L  V E+MENG L ++L Q   ++    L     +++
Sbjct: 58  HPKLVQLYGVCTQQ-------KPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSM 105

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
             DV   +EYL    +   +H DL   N L+    V  V DFG+ +++    LD      
Sbjct: 106 CQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LD---DEY 155

Query: 879 SSSIGIKGTVGYVAPGKF 896
           +SS G K  V +  P  F
Sbjct: 156 TSSSGAKFPVKWSPPEVF 173

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 16/156 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA---SKSFVSECEALRNIRHRNLIKIIT 769
           IG G FG V  G +        V V  L+   +      F+ E +  R+++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR--KLSLIQRMNIAIDVASAIE 827
            C+    E   +  LV E+   G L+ +L +S  + E+     + +QRM  A ++A  + 
Sbjct: 63  QCT----EVTPY-LLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRM--ACEIALGLL 114

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
           +LH +     +H DL   N LL  D+   +GD+GL+
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 34/195 (17%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVK------VINLKQKGASKSFVSECEALRN 758
            +      +G G FG V+       E   A+K      VI LKQ+    +   E   L+ 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKE 57

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + H  +I++    +  D     F  ++ EY+  G L  +L  S       + S    +  
Sbjct: 58  VSHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNS------GRFSNSTGLFY 106

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++  A+EYLH      +V+ DLKP N+LLD +    + DFG AK L +    +     
Sbjct: 107 ASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---- 159

Query: 879 SSSIGIKGTVGYVAP 893
                  GT  Y+AP
Sbjct: 160 -------GTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 36/195 (18%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINL----------KQKGASKSFVSECEALRNIRH 761
           +IG+G +G VY  +      ++AVK + L          +QK   K+  SE E L+++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 762 RNLIKIITICSSTDFE-GVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNI 818
            N+++ +       FE   ++ ++  EY+  GS+   L  +   ++  VR  +       
Sbjct: 68  LNIVQYL------GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE------ 115

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
              V   + YLH      ++H DLK  N+L+D D +  + DFG++K       DI     
Sbjct: 116 --QVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDN-- 164

Query: 879 SSSIGIKGTVGYVAP 893
             ++ ++G+V ++AP
Sbjct: 165 DQNMSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 42/158 (26%), Positives = 83/158 (52%), Gaps = 16/158 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   ++   VAVK   LK    S ++F+ E   ++ ++H  L+++  + 
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    E +    ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+  
Sbjct: 71  TKE--EPI---YIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE- 120

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +NVL+   ++  + DFGLA+ + ++
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 60.9 bits (147), Expect = 5e-10
 Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 22/168 (13%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS---KSFVSECEALRNI-RHRNLIK 766
           ++IG+G FG V K  +  D + +   +  +K+  +    + F  E E L  +  H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS----NDQVEVRK------LSLIQRM 816
           ++  C     E   +  L  EY  +G+L D+L +S     D            LS  Q +
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + A DVA  ++YL    Q   +H DL   N+L+  + VA + DFGL++
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 26/159 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVI------NLKQKGASKSFVSECEALRNIRHRNLIK 766
           IG+G FG V+ G L  D   VAVK        +LK K     F+ E   L+   H N+++
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I +C+           +V E ++ G    +L     +++V+   LIQ +    + A+ +
Sbjct: 58  LIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVE---NAAAGM 107

Query: 827 EYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           EYL   HC    +H DL   N L+    V  + DFG+++
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 706 EFSSSN---MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR 762
           E+  +    ++G+G +G VY       ++ +A+K I  +     +    E      ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N+++ +   S   F    FK +  E +  GSL   L      ++  + ++I        +
Sbjct: 66  NIVQYLGSDSENGF----FK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QI 117

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
              ++YLH +    +VH D+K  NVL++ Y  V  + DFG +K L       A   P + 
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-------AGINPCTE 167

Query: 882 IGIKGTVGYVAPG------KFFMLYTHIPSFSCTNV 911
               GT+ Y+AP       + +     I S  CT V
Sbjct: 168 T-FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIV 202

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 60.7 bits (148), Expect = 8e-10
 Identities = 44/163 (26%), Positives = 85/163 (52%), Gaps = 18/163 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRN 763
           E+   N I +G +G VY+        +VA+K + ++++  G   + + E   L  ++H N
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           ++ +  +   ++   +D   +V EY+E+   SL + + Q   Q EV+ L ++Q +     
Sbjct: 66  IVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL-MLQLL----- 116

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             S + +LH +    ++H DLK SN+LL+   +  + DFGLA+
Sbjct: 117 --SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 45/225 (20%)

Query: 706 EFSSSNM-----IGQGRFGTVYKG-ILGDDE------MVVAVKVINLKQKGASKSF---V 750
           EFS   +     +G+G FG V     LG D+      + VAVK+  LK     K     V
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLV 68

Query: 751 SECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN------- 802
           SE E ++ I +H+N+I ++  C+    +G  +  ++ EY   G+L ++L           
Sbjct: 69  SEMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYS 123

Query: 803 ---DQVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
               +V   +++    ++    VA  +EYL    C    +H DL   NVL+  + V  + 
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIA 179

Query: 859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           DFGLA+ ++N  +D   KT +  + +K    ++AP   F  +YTH
Sbjct: 180 DFGLARDVNN--IDYYKKTTNGRLPVK----WMAPEALFDRVYTH 218

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 40/172 (23%), Positives = 74/172 (43%), Gaps = 22/172 (12%)

Query: 707 FSSSNM-----IGQGRFGTVYKG-----ILGDDEMVVAVKVIN-LKQKGASKSFVSECEA 755
           F  SN+     +G+G FG V+            E +V VK +   K +     F  E + 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK---LSL 812
            R + H+N+++++ +C   +        ++ EY + G L+ +L  +  + E  K   LS 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            Q++ +   +A  +++L +      VH DL   N L+       V    L+K
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G  G V+  +  D +  VAVK I L    + K  + E + +R + H N++K+  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 773 ST---------DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
            +             ++   +V EYME   L + L Q     E  +L + Q +       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLR------ 125

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAKFLSNHH 870
             ++Y+H      ++H DLKP+NV ++  D+V  +GDFGLA+ +  H+
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 47/191 (24%), Positives = 77/191 (40%), Gaps = 32/191 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-----KSFVSECEALRNIRHRNLIK 766
           ++GQG FG VY     D    +AVK +              +   E + L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 767 IITICSSTDFEGVDFKALVF-EYMENGSLEDWLHQS---NDQVEVRKLSLIQRMNIAIDV 822
                        D    +F EYM  GS++D L       + V  RK +          +
Sbjct: 69  YYGC------LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV-TRKYTR--------QI 113

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              +EYLH +    +VH D+K +N+L D      +GDFG +K L                
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS---- 166

Query: 883 GIKGTVGYVAP 893
            + GT  +++P
Sbjct: 167 -VTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 42/161 (26%), Positives = 78/161 (48%), Gaps = 17/161 (10%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 765 IKIITICSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           +K++ +  +      + K  LVFE++ +  L+ ++    D   +  + L    +    + 
Sbjct: 62  VKLLDVIHT------ENKLYLVFEFL-HQDLKKFM----DASPLSGIPLPLIKSYLFQLL 110

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 53.9 bits (130), Expect = 2e-09
 Identities = 24/41 (58%), Positives = 27/41 (65%), Gaps = 2/41 (4%)

Query: 34 NETDRLALLAIKSQL-HDPSGVTSSWN-NTMNFCQWTGVTC 72
             DR ALLA KS L  DPSG  SSWN ++ + C WTGVTC
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 25/159 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G VYK        +VA+K I L+   +G   + + E   L+ + H N+++++ +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 771 CSSTDFEGVDFKA-LVFEYMENGSLEDWL----HQSNDQVEVRKLSLIQRMNIAIDVASA 825
             S      + K  LVFE++ +  L+ ++        D   ++   L Q       +   
Sbjct: 67  VHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSY-LYQ-------LLQG 111

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           I Y H H    ++H DLKP N+L+D +    + DFGLA+
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 49/192 (25%), Positives = 87/192 (45%), Gaps = 21/192 (10%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVK---VINLKQKGASKSFVSECEALRNIRH 761
           + F     IG+G+F  VY+     D + VA+K   + +L    A    + E + L+ + H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N+IK         F   +   +V E  + G L   +     Q  +     + +    + 
Sbjct: 62  PNVIKY-----YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQ 114

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           + SA+E++H      ++H D+KP+NV +    V  +GD GL +F S       SKT +++
Sbjct: 115 LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKT-TAA 163

Query: 882 IGIKGTVGYVAP 893
             + GT  Y++P
Sbjct: 164 HSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 50/184 (27%), Positives = 75/184 (40%), Gaps = 24/184 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V    +     + A K ++   LK++   +  ++E + L  +  R       
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  +  FE  D   LV   M  G L+   H  N  V        + +  A  +   +E+L
Sbjct: 56  VSLAYAFETKDDLCLVMTLMNGGDLK--YHIYN--VGEPGFPEARAIFYAAQIICGLEHL 111

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H   Q  +V+ DLKP NVLLD      + D GLA  L         K         GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELK------GGKKIKGRA---GTPG 159

Query: 890 YVAP 893
           Y+AP
Sbjct: 160 YMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 55/185 (29%), Positives = 78/185 (42%), Gaps = 26/185 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G FG V       D    AVKV+     LK+K            L+N++H  L+ + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  F+  D    V +Y+  G L   L +     E R      R   A ++ASA+ Y
Sbjct: 62  ----HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-----RF-YAAEIASALGY 111

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           LH      +++ DLKP N+LLD      + DFGL K        I     +S+    GT 
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK------EGIEHSKTTSTFC--GTP 160

Query: 889 GYVAP 893
            Y+AP
Sbjct: 161 EYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 38/173 (21%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITIC 771
           IG+G +G VYK        +VA+K++++  +   +    E   LR    H N+       
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIA------ 66

Query: 772 SSTDFEGVDFKA----------LVFEYMENGSLEDW---LHQSNDQVEVRKLSLIQRMNI 818
               F G   K           LV E    GS+ D    L +   +++   ++ I R   
Sbjct: 67  ---TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR--- 120

Query: 819 AIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVG--DFGLAKFLSN 868
             +    + YLH +      +H D+K  N+LL  +  A V   DFG++  L +
Sbjct: 121 --ETLRGLAYLHENKV----IHRDIKGQNILLTKN--AEVKLVDFGVSAQLDS 165

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 46/171 (26%), Positives = 87/171 (50%), Gaps = 20/171 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TV+KG     E +VA+K I L+ ++GA  + + E   L+N++H N++ +  I 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
             T+        LVFEY+++  L+ +L    + + +  + +         +   + Y H 
Sbjct: 73  H-TERC----LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM-----FQLLRGLSYCHK 121

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
                ++H DLKP N+L++      + DFGLA+  S     + +KT S+ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKS-----VPTKTYSNEV 164

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 29/175 (16%)

Query: 713 IGQGRFGTVY----KGIL----------GDDEMVVAVKVINLK-QKGASKSFVSECEALR 757
           +G+G+FG V+    +G+               ++VAVK++     K A   F+ E + + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK------LS 811
            +++ N+I+++ +C S D        ++ EYMENG L  +L Q   +           +S
Sbjct: 73  RLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           +   + +A+ +AS ++YL        VH DL   N L+       + DFG+++ L
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 4/98 (4%)

Query: 383 NQ-ISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL 441
           NQ + G IP  I  L +L +  L  N   G IP  +  + +L+ L +  N   G IP  L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 442 GNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN 479
           G LT L  L+L  NSL G +P++LG     +L  AS+N
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG---GRLLHRASFN 521

Length = 623

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 28/172 (16%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG VYKGI    + VVA+K+I+L++           + + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L      +E   ++ I R    
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 108

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 109 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 37/157 (23%), Positives = 76/157 (48%), Gaps = 15/157 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G+FG V+     +    VAVK +         +F++E   ++ ++H  L+K+  + +
Sbjct: 14  LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 72  KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 119

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            Q   +H DL+ +N+L+   +V  + DFGLA+ + ++
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 49/173 (28%), Positives = 87/173 (50%), Gaps = 24/173 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TVYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR--KLSLIQRMNIAIDVASAIEYL 829
            +          LVFEY++   L+ +L    + + +   KL L Q +         + Y 
Sbjct: 74  HTEKS-----LTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYC 120

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           H      ++H DLKP N+L++      + DFGLA+  S     I +KT S+ +
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYSNEV 165

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 24/162 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVK-VINLKQK-GASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G FG VYK        VVA+K ++   +K G   + + E + L+ ++H N++ +I +
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 771 C-----SSTDFEGVDFKALVFEYME---NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
                  S    G  +  +V  YM+   +G LE      N  V   KL+  Q     + +
Sbjct: 76  AVERPDKSKRKRGSVY--MVTPYMDHDLSGLLE------NPSV---KLTESQIKCYMLQL 124

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              I YLH   +  ++H D+K +N+L+D   +  + DFGLA+
Sbjct: 125 LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 28/172 (16%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++           + + +I+    I 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---------DEIEDIQQE--IT 54

Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L       E   L   Q   I 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 107

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 19/159 (11%)

Query: 713 IGQGRFGTVYKGILG--DDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           +G G FGTV KG+      E  VAVK++       +     + E   ++ + +  ++++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q N  V  + ++      +   V+  ++Y
Sbjct: 63  GICEAESW------MLVMELAELGPLNKFL-QKNKHVTEKNIT-----ELVHQVSMGMKY 110

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           L        VH DL   NVLL     A + DFGL+K L 
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 22/157 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +GTV+K    +   +VA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 771 CSSTDFEGVDFK-ALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAIDVASAIE 827
             S      D K  LVFEY +   L+ +    N  ++  + K  + Q +         + 
Sbjct: 68  LHS------DKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLK-------GLA 113

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.8 bits (139), Expect = 9e-09
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 31/171 (18%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---VSECEALRNIRHRN 763
           FS    IG G FG VY      +  VVA+K ++   K +++ +   + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            I          + G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 77  TI---------QYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118

Query: 820 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
                A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 69/264 (26%), Positives = 114/264 (43%), Gaps = 15/264 (5%)

Query: 101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK 160
           S L+ ++L+DN     +P  + NL  L+ L LS N  S  +P  LS  SNL +   S NK
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197

Query: 161 LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLL 220
           +   +P EI  L  L+ L +  N +  +L  S+ NL  +  + ++ N L   +P ++G L
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNL 254

Query: 221 RRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGN 280
             L  L+++ NQ       S+ +++++  + L+ N  S   P   LL L     L +   
Sbjct: 255 SNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312

Query: 281 NFVGSIPDSLSNASNLELLDLPSNQFKGKVS--IDFSSLKNLWLL--NLEQNNLGTGTAN 336
                    L   S L   ++ SN             SL NLW L   L+++NL      
Sbjct: 313 L----KALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVK 368

Query: 337 DLDFVIFLSNCSSLKVLSLSDNQF 360
           + + +  L +     V  L +   
Sbjct: 369 NPNAIGSLLDLVKKHVNQLLEKVN 392

Length = 394

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 18/156 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G VYK         +A+K I L+Q+  G   + + E   L+ ++H N++++  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 771 CSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
             S      + +  LVFEY++   L+   H  +     +   LI+       +   I Y 
Sbjct: 70  VHS------EKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIK--TYLYQILRGIAYC 118

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVA-HVGDFGLAK 864
           H H    ++H DLKP N+L+D    A  + DFGLA+
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 37/178 (20%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---------VSECEA 755
           S +     IG G +G V   I       VA+K I         +F         + E + 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKI 57

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ---SNDQVEVRKLS- 811
           LR+ +H N+I I  I      +  D   +V + ME+      LH    S+  +    +  
Sbjct: 58  LRHFKHDNIIAIRDILRPPGADFKDV-YVVMDLMESD-----LHHIIHSDQPLTEEHIRY 111

Query: 812 -LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L Q       +   ++Y+H      ++H DLKPSN+L++ D    +GDFG+A+ LS+
Sbjct: 112 FLYQ-------LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 112

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 113 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 25/191 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-----KSFVS----ECEALRNIRHR 762
           +IG G FG+VY G+      ++AVK + L    AS     +S +     E   L+ ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N+++ +   SS D + ++      EY+  GS+   L+      E    +L++  N    +
Sbjct: 67  NIVQYLG--SSLDADHLNI---FLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              + YLH+     ++H D+K +N+L+D      + DFG++K L  + L   +     S 
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171

Query: 883 GIKGTVGYVAP 893
            ++G+V ++AP
Sbjct: 172 -LQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 27/195 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVK---VINLKQKGASKSFVSECEALRNIRH 761
           + F     IG+G+F  VY+     D   VA+K   +  +    A +  V E + L+ + H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI--- 818
            N+IK +       F   +   +V E  + G L   +         ++  LI    +   
Sbjct: 62  PNVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFK-----KQKRLIPERTVWKY 111

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
            + + SA+E++H      ++H D+KP+NV +    V  +GD GL +F S       SKT 
Sbjct: 112 FVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-------SKT- 160

Query: 879 SSSIGIKGTVGYVAP 893
           +++  + GT  Y++P
Sbjct: 161 TAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 31/161 (19%)

Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHRNL 764
           ++G GRFG + +G L      E+ VA+  +   + G S    + F++E   L    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 765 IKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +++         EGV  +     +V EYM NG+L+ +L +   Q     L   Q M +  
Sbjct: 69  VRL---------EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLP 114

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            +AS ++YL    +   VH  L    VL++ D+V  +  F 
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 24/173 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TVYKG       +VA+K I L+  +GA  + + E   L++++H N++ +  I 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR--KLSLIQRMNIAIDVASAIEYL 829
            +          LVFEY++   L+ ++      + +   +L L Q +         + Y 
Sbjct: 73  HTK-----KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYC 119

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           H      ++H DLKP N+L+       + DFGLA+  S     + SKT S+ +
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS-----VPSKTYSNEV 164

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA--LRNIRHRNLIKIITI 770
           +G+G +G V       D     +K +NL+     +   +E EA  L  ++H N++     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64

Query: 771 CSSTDFEGVD-FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                +EG D    +V  + E G L   L +   ++    L   Q +   + +A A++YL
Sbjct: 65  --RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H   +  ++H DLK  NV L    +  VGD G+A+ L N   D+AS        + GT  
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMAST-------LIGTPY 167

Query: 890 YVAPGKF 896
           Y++P  F
Sbjct: 168 YMSPELF 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  I       VA+K +NL+Q+
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 58  PKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC- 111

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+++LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 112 -MDEGQIAAVCR-----ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 17/157 (10%)

Query: 713 IGQGRFGTVYKGI--LGDDEMVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G G FG V KG+  +   ++ VA+KV+ N  +K      + E E +  + +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +C +          LV E    G L  +L    D++ V  +  +        V+  ++YL
Sbjct: 63  VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-----QVSMGMKYL 111

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
                   VH DL   NVLL     A + DFGL+K L
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 28/172 (16%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++        +E E + +I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54

Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L               Q   + 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATML 107

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 108 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 56.9 bits (137), Expect = 3e-08
 Identities = 74/271 (27%), Positives = 111/271 (40%), Gaps = 11/271 (4%)

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
            + L     + LD    L N   L  L L+ N+    +   +   +L    L +  N I+
Sbjct: 72  LDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTS--LDLDNNNIT 129

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTK 446
              P       NL    L  N+   ++P  +  L NL+ L +  N L   +P  L NL+ 
Sbjct: 130 DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSN 187

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
           L +LDL  N +  ++P  +     L     S N +   L    LS       L+LSNN L
Sbjct: 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELL--SSLSNLKNLSGLELSNNKL 244

Query: 507 NGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR-FL 565
              LP  +GNL NL  LD+S+NQ S +    L +  +L  LD+S NS    +PL     L
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 566 KSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
                LN+     + ++      L+     N
Sbjct: 302 LLELLLNLLLTLKALELKLNSILLNNNILSN 332

Length = 394

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 50/174 (28%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV-SECE------ALRNIR----- 760
           IG+G +G V+K    +   +VA+K            FV SE +      ALR IR     
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIK-----------KFVESEDDPVIKKIALREIRMLKQL 57

Query: 761 -HRNLIKIITICSSTDFEGVDFKA-----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
            H NL+ +I +          F+      LVFEY ++  L + L ++      R +    
Sbjct: 58  KHPNLVNLIEV----------FRRKRKLHLVFEYCDHTVLNE-LEKN-----PRGVPEHL 101

Query: 815 RMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              I      A+ + H H+C    +H D+KP N+L+       + DFG A+ L+
Sbjct: 102 IKKIIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 31/165 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---VSECEALRNIRHRNLIKIIT 769
           IG G FG VY         VVAVK ++   K  ++ +   + E + L+ ++H N I    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI---- 84

Query: 770 ICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
                +++G   K     LV EY         L  ++D +EV K  L Q + IA     A
Sbjct: 85  -----EYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIAAITHGA 130

Query: 826 IE---YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           ++   YLH H    M+H D+K  N+LL       + DFG A   S
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 30/188 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G FG VY+    D   + A+KV+      + K  V++ E    I  RN++    +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 773 STDFEGVDFK-------ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           S    G+ F         LV +YM  G L  W  Q   +    +     +  IA ++  A
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDR----AKFYIA-ELVLA 108

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +E+LH +    +V+ DLKP N+LLD      + DFGL+K  +N   +  + T        
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNT------FC 157

Query: 886 GTVGYVAP 893
           GT  Y+AP
Sbjct: 158 GTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 55.3 bits (134), Expect = 3e-08
 Identities = 48/184 (26%), Positives = 72/184 (39%), Gaps = 26/184 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G G FG V    +       A+K +  +   + G  +   SE E L    H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
             +  D + +     + EY   G L   L       +               V  A EYL
Sbjct: 60  -RTFKDKKYIYM---LMEYCLGGELWTILR------DRGLFDEYTARFYIACVVLAFEYL 109

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H+     +++ DLKP N+LLD +    + DFG AK L +       KT +      GT  
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-----GQKTWT----FCGTPE 157

Query: 890 YVAP 893
           YVAP
Sbjct: 158 YVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 4e-08
 Identities = 27/85 (31%), Positives = 48/85 (56%)

Query: 178 LSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMF 237
           L +D   L G +P+ +  L  ++ I ++ NS+ G IP +LG +  L  L+++ N F+G  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 238 PRSICNISSVELIFLTENRFSGIFP 262
           P S+  ++S+ ++ L  N  SG  P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 26/183 (14%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGI---LGDDEMVVAVKVINL 740
           D   MEKL  +VS  +  K  + +     IGQG  GTV+  I    G +   VA+K INL
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQE---VAIKQINL 54

Query: 741 KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ 800
           +++   +  ++E   ++ +++ N++  +       F   D   +V EY+  GSL D + +
Sbjct: 55  QKQPKKELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVVTE 109

Query: 801 S-NDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           +  D+ ++          +  +   A+E+LH +    ++H D+K  NVLL  D    + D
Sbjct: 110 TCMDEAQIAA--------VCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTD 158

Query: 860 FGL 862
           FG 
Sbjct: 159 FGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 20/164 (12%)

Query: 713 IGQGRFGTVYKGI-LGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR---HRNLIK 766
           IG+G +G V+K   L +    VA+K + ++  ++G   S + E   LR++    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ---VEVRKLSLIQRMNIAIDVA 823
           +  +C+ +  +      LVFE+++   L  +L +  +     E  K  + Q +       
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR------ 121

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
             +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 122 -GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 27/170 (15%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNIRH-- 761
           S +    +IG+G +G VY+G       VVA+K+INL       S +  E   L  +R   
Sbjct: 1   SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60

Query: 762 -RNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
             N+ K         + G   K     ++ EY E GS+   +      +  + +S+I R 
Sbjct: 61  PPNITK---------YYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIR- 108

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
               +V  A++Y+H      ++H D+K +N+L+       + DFG+A  L
Sbjct: 109 ----EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 38/173 (21%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRN 763
           +++    IG+G +G VYKG       +VA+K I L+  ++G   + + E   L+ ++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 764 LIKIITICSST-------DFEGVDFKALV-----FEYMENGSLEDWLHQSNDQVEVRKLS 811
           ++ +  +           +F  +D K  +      +YM+   ++ +L+Q           
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----------- 109

Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                     +   I + H      ++H DLKP N+L+D   V  + DFGLA+
Sbjct: 110 ----------ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 30/171 (17%)

Query: 713 IGQGRFGTVY----KGILGDDEM------------VVAVKVINL-KQKGASKSFVSECEA 755
           +G+G+FG V+     G+    E             +VAVKV+       A + F+ E + 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ-----SNDQVEVRKL 810
           L  +   N+ +++ +C+           ++ EYMENG L  +L +     S      + L
Sbjct: 73  LSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
           S    + +A  +AS + YL        VH DL   N L+  +    + DFG
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 38/179 (21%)

Query: 713 IGQGRFGTVYKGILGDDE-----MVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G+G FG V K      +       VAVK++   ++ AS S     +SE   L+ + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN------------------DQV 805
           +IK+   CS           L+ EY + GSL  +L +S                   D  
Sbjct: 65  VIKLYGACSQDGP-----LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + R L++   ++ A  ++  ++YL    +  +VH DL   NVL+       + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 24/165 (14%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHRN 763
           +GQG FG VY+G       G+ E  VAVK +N    L+++     F++E   ++     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 70

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV---RKLSLIQRM-NIA 819
           +++++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A
Sbjct: 71  VVRLLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 24/173 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TV+KG     E +VA+K I L+ ++GA  + + E   L++++H N++ +  I 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR--KLSLIQRMNIAIDVASAIEYL 829
             TD        LVFEY++   L+ ++    + + +   K+ L Q       +   + Y 
Sbjct: 74  H-TD----KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ-------ILRGLAYC 120

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           H      ++H DLKP N+L++      + DFGLA+  S     + +KT S+ +
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----VPTKTYSNEV 165

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 50/157 (31%), Positives = 73/157 (46%), Gaps = 18/157 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEAL-RNIRHRNLIKI 767
           +IG+G FG V       +E   AVKV+  K   +K   K  +SE   L +N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                   F+  D    V +Y+  G L   L +    +E R          A ++ASA+ 
Sbjct: 62  -----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY------AAEIASALG 110

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           YLH      +V+ DLKP N+LLD      + DFGL K
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 19/155 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G + TVYKG    +  +VA+KVI L+ ++G   + + E   L+ ++H N++ +  I 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
            +      +   LVFEY+    L  ++  H      E  KL L Q +         + Y+
Sbjct: 73  HTK-----ETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYI 119

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           H   Q  ++H DLKP N+L+       + DFGLA+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 703 ATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSECEAL 756
           A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E   +
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE---VRKLSLI 813
           +     ++++++ + S      V     + E M  G L+ +L     ++E   V+    +
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 814 QRM-NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           ++M  +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 18/157 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHRNLIKI 767
           +IG+G FG V       D    AVKV+     LK+K  +         L+N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                   F+  +    V +Y+  G L  + H   +    R     +    A +VASAI 
Sbjct: 62  -----HYSFQTAEKLYFVLDYVNGGEL--FFHLQRE----RCFLEPRARFYAAEVASAIG 110

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           YLH      +++ DLKP N+LLD      + DFGL K
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 36/144 (25%), Positives = 72/144 (50%), Gaps = 20/144 (13%)

Query: 713 IGQGRFGTVYKGI---LGDD----EMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +GQG F  ++KGI   +GD     +  V +KV++   +  S+SF      +  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
               +C        D   +V EY++ GSL+ +L ++ +      +++  ++ +A  +A A
Sbjct: 63  LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLL 849
           + +L       + HG++   NVLL
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 42/215 (19%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            +F    +IG+G FG V+     D   V A+KV+    + ++       +E + L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             ++K+    S   F+  +   LV EYM  G L + L + +   E        R  IA +
Sbjct: 61  PWIVKLY--YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIA-E 109

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAK----------FLSNH 869
           +  A++ +H   +   +H D+KP N+L+D D   H+   DFGL K          +L++ 
Sbjct: 110 LVLALDSVH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDS 164

Query: 870 HLDIASKTPSSSIGIK-----------GTVGYVAP 893
           H  +                       GT  Y+AP
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 40/205 (19%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS--FVSECEALRNIRHRNLIKIIT 769
           +IG+G +G V   I       VA+K IN   +  S +   + E + LR +RH ++++I  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 770 IC---SSTDFEGVDFKALVFEYMENGSLEDWLHQ---SNDQV--EVRKLSLIQRMNIAID 821
           I    S  +F+ +    +VFE ME+      LHQ   +ND +  E  +  L Q +     
Sbjct: 67  IMLPPSRREFKDI---YVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQLLR---- 114

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
              A++Y+H      + H DLKP N+L + D    + DFGLA+   N        TP++ 
Sbjct: 115 ---ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN-------DTPTAI 161

Query: 882 IGIK--GTVGYVAP---GKFFMLYT 901
                  T  Y AP   G FF  YT
Sbjct: 162 FWTDYVATRWYRAPELCGSFFSKYT 186

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 40/193 (20%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
           +IG+G FG VY     D   + A+K ++   +K K      ++E         R ++ ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE---------RIMLSLV 51

Query: 769 T-------ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI-AI 820
           +       +C S  F   D  + + + M  G L   L Q     E         M   A 
Sbjct: 52  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-------AEMRFYAA 104

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
           ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P +
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHA 154

Query: 881 SIGIKGTVGYVAP 893
           S+   GT GY+AP
Sbjct: 155 SV---GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 53.2 bits (127), Expect = 3e-07
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 31/171 (18%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---VSECEALRNIRHRN 763
           F+    IG G FG VY         VVA+K ++   K +++ +   + E + L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
                    S +++G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 128

Query: 820 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
                A++   YLH H    M+H D+K  N+LL       + DFG A   S
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 36/191 (18%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIIT-- 769
           +IG+G FG VY     D   + A+K ++ K+    +    E  AL     R ++ +++  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALN---ERIMLSLVSTG 54

Query: 770 -----ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN--DQVEVRKLSLIQRMNIAIDV 822
                +C +  F   D    + + M  G L   L Q     + E+R          A ++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY--------ATEI 106

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P +S+
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV 156

Query: 883 GIKGTVGYVAP 893
              GT GY+AP
Sbjct: 157 ---GTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 32/194 (16%)

Query: 713 IGQGRFGTVYKGILGDD-EMVVAVKVINLK-------QKGASKSF---VSECEALR-NIR 760
           +G G FG VYK    ++ + ++A+K IN+        ++   KS    VSE   ++  +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+++         F   D   +V + +E   L +  H ++ + + ++ +  +  NI +
Sbjct: 68  HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +  A+ YLH   +  +VH DL P+N++L  D    + DFGLAK           K P S
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK----------QKQPES 168

Query: 881 SI-GIKGTVGYVAP 893
            +  + GT+ Y  P
Sbjct: 169 KLTSVVGTILYSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 49.3 bits (118), Expect = 7e-07
 Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 25/165 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI--KIITI 770
           +  G    VY   LG  +    +K+   ++KGA      E   L+ +  + L   K++  
Sbjct: 6   LKGGLTNRVYL--LGTKDEDYVLKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS 61

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             S  +       L+ E++E  +L++   +  +              IA  +A  +  LH
Sbjct: 62  GESDGWS-----YLLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLH 103

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS 875
                 + HGDL P N+L+D   +  + D+  A +      D+A+
Sbjct: 104 QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY-GPPAFDLAA 147

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 51.3 bits (123), Expect = 8e-07
 Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 14/169 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G +G+VYK     D    A+K ++L    QK    + V+E   L ++ H N+I    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-VNEIRILASVNHPNII---- 62

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                 F   +   +V EY   G L   + +   + ++     I R  I I +   ++ L
Sbjct: 63  -SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQAL 119

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           H      ++H DLK +N+LL  + +  +GD G++K L  +       TP
Sbjct: 120 HEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 24/168 (14%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+  FG +YKG L     D   +VA+K + ++        F  E   +  + H N++ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWL-----HQ----SNDQVEVRKLSLIQR--M 816
           + +   T  + V    ++FEY+  G L ++L     H     S+D+    K SL     +
Sbjct: 73  LGVV--TQEQPV---CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +IAI +A+ +EYL  H     VH DL   N+L+   +   + D GL++
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 9e-07
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 25/192 (13%)

Query: 706 EFSSSNMIGQGRFGTVY---KGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR 762
           +F   +++G+G FG V    +   GD   + A+KV+      A ++ VS  E  R+I   
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGD---IYAMKVMKKSVLLAQET-VSFFEEERDILSI 57

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           +    I       F+  D   LV EY   G L   L++  DQ +     + Q       +
Sbjct: 58  SNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYL 108

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG-LAKFLSNHHLDIASKTPSSS 881
           A  +  +H   Q   VH D+KP NVL+D      + DFG  A+  +N    + SK P   
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPV-- 164

Query: 882 IGIKGTVGYVAP 893
               GT  Y+AP
Sbjct: 165 ----GTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.1 bits (122), Expect = 9e-07
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 21/162 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL-----KQKGASKSFVSECEALRNIRHRNLIKI 767
           IG+G FG +Y      D     +K I+L     K+K ASK    E   L  ++H N   I
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           +T  +S    G  F  +V EY + G   D + + N Q  V   S  Q ++  + ++  ++
Sbjct: 62  VTFFASFQENGRLF--IVMEYCDGG---DLMKRINRQRGVL-FSEDQILSWFVQISLGLK 115

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSN 868
           ++H      ++H D+K  N+ L  + MVA +GDFG+A+ L++
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 40/168 (23%), Positives = 84/168 (50%), Gaps = 21/168 (12%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL---KQKGASKSFV---SECEALRNI 759
           E++   ++G+G +GTVY G+    ++ +AVK + L       A K +     E + L+++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +H N+++ +  C        +  ++  E++  GS+   L++     E       ++    
Sbjct: 60  KHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ---- 110

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
             +   + YLH++C   +VH D+K +NV+L  + +  + DFG A+ L+
Sbjct: 111 --ILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 1e-06
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           EF     I +G FG VY G   ++  + AVKV+  K    +K+ V + +A R+     L 
Sbjct: 5   EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDAL--ALS 61

Query: 766 K---IITICSSTDFEGVDFKALVFEYMENGSLEDWLH---QSNDQVEVRKLSLIQRMNIA 819
           K   I+ +  S   +  +   LV EY+  G ++  LH     ++++ V+ +S        
Sbjct: 62  KSPFIVHLYYS--LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-------- 111

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            +VA A++YLH H    ++H DLKP N+L+  +    + DFGL+K   N  L++     +
Sbjct: 112 -EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167

Query: 880 SSIGIKGTVGYVAPGKFFMLYTHI 903
            S+          PG+   L + +
Sbjct: 168 PSMAKPKNDYSRTPGQVLSLISSL 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 41/214 (19%)

Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     L   + V+ V V  LK    S   ++ +SE +
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
            + ++  H N++ ++  C+     G     ++ EY   G L ++L +  +      L+L 
Sbjct: 91  IMSHLGNHENIVNLLGACTIG---GPIL--VITEYCCYGDLLNFLRRKRESF----LTLE 141

Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++ +  VA  + +L   +C    +H DL   NVLL +  +  + DFGLA+       D
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR-------D 190

Query: 873 IASKTPSSSIGIKGT----VGYVAPGKFF-MLYT 901
           I +    S+  +KG     V ++AP   F  +YT
Sbjct: 191 IMN---DSNYVVKGNARLPVKWMAPESIFNCVYT 221

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 15/163 (9%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           S   +   IG+G  G V           VAVK ++L+++   +   +E   +R+ +H N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++     S+   G D   +V E++E G+L D +  +    E       Q   + + V  
Sbjct: 79  VEMY----SSYLVG-DELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLAVLK 126

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           A+ +LH      ++H D+K  ++LL  D    + DFG    +S
Sbjct: 127 ALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 26/180 (14%)

Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGA-SKSFVSE 752
           E++ +T  F     +G+ RFG VYKG L     G+    VA+K +  K +G   + F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL----------HQSN 802
                 ++H N++ ++ + +          +++F Y  +  L ++L             +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           D+     L     ++I   +A+ +E+L  H    +VH DL   NVL+   +   + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 25/102 (24%)

Query: 209 LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLN 268
           L G IP  +  LR L ++N++ N   G  P S+ +I+S+E++ L+ N F+G         
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG--------- 480

Query: 269 LPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV 310
                           SIP+SL   ++L +L+L  N   G+V
Sbjct: 481 ----------------SIPESLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 34/168 (20%), Positives = 70/168 (41%), Gaps = 29/168 (17%)

Query: 711 NMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKG---ASKSFVSEC----------EAL 756
             +G+G +G V K       ++V   KV  ++        +  V  C          + +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
             I+H N++ ++ +     +   DF  LV + M +    D     + ++   +L+  Q  
Sbjct: 75  NEIKHENIMGLVDV-----YVEGDFINLVMDIMAS----DLKKVVDRKI---RLTESQVK 122

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            I + + + +  LH       +H DL P+N+ ++   +  + DFGLA+
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 31/195 (15%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNL 764
           +    + +G+G  G+V K  L +  M+ A+K I         K  + E E  ++ +   +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN------I 818
           +K          E      +  EY E GSL+          +V+K     R+       I
Sbjct: 62  VKYYGAFLD---ESSSSIGIAMEYCEGGSLDSIYK------KVKKRG--GRIGEKVLGKI 110

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A  V   + YLH      ++H D+KPSN+LL       + DFG++  L N          
Sbjct: 111 AESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN---------- 157

Query: 879 SSSIGIKGTVGYVAP 893
           S +    GT  Y+AP
Sbjct: 158 SLAGTFTGTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 22/150 (14%)

Query: 731 MVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM 789
           ++VAVK++     K A   F+ E + L  ++  N+I+++ +C        D   ++ EYM
Sbjct: 47  LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYM 101

Query: 790 ENGSLEDWL--HQSNDQVE-----------VRKLSLIQRMNIAIDVASAIEYLHHHCQPP 836
           ENG L  +L  H  +D+ E           +  +S    +++A+ +AS ++YL       
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158

Query: 837 MVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            VH DL   N L+  ++   + DFG+++ L
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 40/168 (23%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G V      +    VA+K I      +  +K  + E + LR++ H N+I I  I
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQ--------SNDQVE------VRKLSLIQRM 816
                 E  +   +V+E M+       LHQ        S+D  +      +R L  I   
Sbjct: 73  MPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           N+                   +H DLKPSN+LL+ +    + DFGLA+
Sbjct: 128 NV-------------------LHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 38/154 (24%), Positives = 75/154 (48%), Gaps = 19/154 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  +  A K+I ++ +   + F+ E + L   +H N++ +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL----- 67

Query: 773 STDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
              +E   ++    ++ E+ + G+L+  +     ++E R L+  Q   +   +  A+ +L
Sbjct: 68  ---YEAYFYENKLWILIEFCDGGALDSIM----LELE-RGLTEPQIRYVCRQMLEALNFL 119

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
           H H    ++H DLK  N+LL  D    + DFG++
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 4e-06
 Identities = 47/181 (25%), Positives = 76/181 (41%), Gaps = 40/181 (22%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHR 762
             + + + IG+G +G V         + VA+K I+    Q    ++ + E + LR  +H 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ-------SNDQVE------VRK 809
           N+I I+ I     FE  +   +V E ME       L++       SND ++      +R 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRG 118

Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           L  I   N+                   +H DLKPSN+LL+ +    + DFGLA+     
Sbjct: 119 LKYIHSANV-------------------LHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159

Query: 870 H 870
           H
Sbjct: 160 H 160

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 22/161 (13%)

Query: 713 IGQGRFG--TVYKGILGDDEMVVAVKVINLKQKGASKSF--VSECEALRNIRHRNLIKII 768
           +G+G FG  T+Y+    +D+ +V  K +NL +    +    ++E   L  ++H N   II
Sbjct: 8   LGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---II 62

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA--IDVASAI 826
              +    +      +  EY   G+L D + +   Q+        + M +     + SA+
Sbjct: 63  AYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQL------FEEEMVLWYLFQIVSAV 114

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
            Y+H   +  ++H D+K  N+ L    +  +GDFG++K L 
Sbjct: 115 SYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 13/151 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +   + A KVI  K +   + ++ E E L    H  ++K++    
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL---G 76

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
           +  ++G  +  ++ E+   G+++  + + +     R L+  Q   I   +  A++YLH  
Sbjct: 77  AFYWDGKLW--IMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH-- 127

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               ++H DLK  NVLL  D    + DFG++
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 25/149 (16%)

Query: 713 IGQGRFGTVYKGILGD------------DEMVVAVKVINLKQKGASKSFVSECEALRNIR 760
           +G+G    +Y GIL               E+ V +KV++   +  S +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H++++ +  +C   D E +    +V E++E G L+ ++H+ +D      L+   +  +A 
Sbjct: 63  HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
            +ASA+ YL       +VHG++   N+LL
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 25/192 (13%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHR 762
           +F    +IG+G FG V    +   E + A+K++N   + ++  +  F  E    RN+   
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLVN 57

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
              + IT      F+  ++  LV +Y   G L   L +  D++ E      I  M +AI 
Sbjct: 58  GDCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
              +I  LH+      VH D+KP NVLLD +    + DFG    ++         T  SS
Sbjct: 117 ---SIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ------DGTVQSS 161

Query: 882 IGIKGTVGYVAP 893
           + + GT  Y++P
Sbjct: 162 VAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 44/164 (26%), Positives = 67/164 (40%), Gaps = 34/164 (20%)

Query: 713 IGQGRFGTVY---KGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           I +G FG+VY   K   GD     A+KV+  K    +K+ V+  +A R I          
Sbjct: 4   ISKGAFGSVYLAKKRSTGD---YFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM---------NIAI 820
                 F+  D+  LV EY+  G                  SLI+ +             
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +V   +E LH   Q  ++H D+KP N+L+D      + DFGL++
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  ++ A KVI+ K +   + ++ E + L +  H N++K++    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              F   +   ++ E+   G+++  + +       R L+  Q   +      A+ YLH  
Sbjct: 71  ---FYYENNLWILIEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLH-- 120

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            +  ++H DLK  N+L   D    + DFG++
Sbjct: 121 -ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 25/192 (13%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHR 762
           +F    +IG+G FG V    L + + V A+K++N   + ++  +  F  E + L N  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN- 60

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
              + IT      F+  +   LV +Y   G L   L +  D++ E      +  M IAID
Sbjct: 61  ---QWITTLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
              ++  LH+      VH D+KP N+L+D +    + DFG    L      +   T  SS
Sbjct: 117 ---SVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKL------MEDGTVQSS 161

Query: 882 IGIKGTVGYVAP 893
           + + GT  Y++P
Sbjct: 162 VAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 16/165 (9%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--ASKSFVSECEALRNIRHR 762
           ++F    ++G+G +G V K    + + +VA+K     ++     ++ + E + LR ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++++        F       LVFEY+E   LE      N     +  S I ++      
Sbjct: 61  NIVEL-----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------ 109

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
             AI + H +    +VH D+KP N+L+ ++ V  + DFG A+ LS
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 53/186 (28%), Positives = 81/186 (43%), Gaps = 26/186 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEAL-RNIRHRNLIKI 767
           +IG+G FG V       D    AVKV+  K    +   K  ++E   L +N++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                   F+  +    V +++  G L   L +     E R      R   A ++ASA+ 
Sbjct: 62  -----HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-----RFYAA-EIASALG 110

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           YLH      +V+ DLKP N+LLD      + DFGL K      +  +  T +      GT
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTT----FCGT 159

Query: 888 VGYVAP 893
             Y+AP
Sbjct: 160 PEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.0 bits (117), Expect = 1e-05
 Identities = 55/206 (26%), Positives = 85/206 (41%), Gaps = 38/206 (18%)

Query: 712 MIGQGRFGTVYKGILGDDEMV---VAVKVIN---LKQKGASKSFVSECEALRNIRHRNLI 765
           +IG+G  G VY   L  D +    VA+K I     +     K F+ E +   ++ H  ++
Sbjct: 9   LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 766 KIITICSSTD--------FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + +ICS  D         EG   K+L+    +  SL   L +        K S+   ++
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE--------KTSVGAFLS 117

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS---NHHLDIA 874
           I   + + IEY+H      ++H DLKP N+LL       + D+G A F        LDI 
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 875 SKTPSSSIG-------IKGTVGYVAP 893
               +           I GT  Y+AP
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 23/159 (14%)

Query: 712 MIGQGRFGTVYKGILGDDE---MVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLI 765
           ++G+G FG V   IL  ++      A+K++    +  K      V+E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            +        F+  D    V EY   G L  + H S ++V   + +         ++ SA
Sbjct: 59  AL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YGAEIVSA 107

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.0 bits (114), Expect = 2e-05
 Identities = 74/248 (29%), Positives = 104/248 (41%), Gaps = 11/248 (4%)

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
              S+  N     +     N + L       +     +P  +S L +L  LS  +     
Sbjct: 29  TPQSINLNFPDSNLESVAVNRLALNLS----SNTLLLLPSSLSRLLSLDLLS-PSGISSL 83

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL 495
                L NL  L SLDL  N L+ NI   L    NL       N +T   P   L  + L
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNITDIPPLIGLLKSNL 142

Query: 496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY 555
              LDLS+N +  SLP  + NL NL  LD+S N  S  +P  LS   +L  LD+S N   
Sbjct: 143 K-ELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI- 198

Query: 556 GVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNK 615
             +P     L +++ L++S+N++  ++   L NL  L  L LS N  E      G  SN 
Sbjct: 199 SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNL 257

Query: 616 TKISLHGN 623
             + L  N
Sbjct: 258 ETLDLSNN 265

Length = 394

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 36/214 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS---FVSECEA--LRNIRHRNLIK 766
           ++GQG FG VY     D    +AVK +    +    S      ECE   L+N+ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAIDVAS 824
                       +   ++  E+M  GS++D L       E   RK +          +  
Sbjct: 69  YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--------QILE 117

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            + YLH +    +VH D+K +N+L D      +GDFG +K L    L        S  G+
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL--------SGTGM 166

Query: 885 KGTVG---YVAP----GKFFMLYTHIPSFSCTNV 911
           K   G   +++P    G+ +     I S  CT V
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 27/193 (13%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHR 762
           +F    +IG+G FG V    + +   V A+K++N   + ++  +  F  E + L N   R
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAI 820
            +  +        F+  +   LV +Y   G L   L +  D++  ++ +  L + M +AI
Sbjct: 62  WITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE-MVLAI 115

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
           D    + Y         VH D+KP NVLL  D   H+    LA F S   L  A  T  S
Sbjct: 116 DSVHQLGY---------VHRDIKPDNVLL--DKNGHI---RLADFGSCLRLL-ADGTVQS 160

Query: 881 SIGIKGTVGYVAP 893
           ++ + GT  Y++P
Sbjct: 161 NVAV-GTPDYISP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 36/214 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEA--LRNIRHRNLIK 766
           ++G+G FG VY     D    +AVK +      Q+ + +    ECE   L+N+RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAIDVAS 824
                   + + +   ++  EYM  GS++D L       E   R+ +          +  
Sbjct: 69  YYGCLRDPEEKKL---SIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--------QILQ 117

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            + YLH +    +VH D+K +N+L D      +GDFG +K +    +        S  GI
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM--------SGTGI 166

Query: 885 KGTVG---YVAP----GKFFMLYTHIPSFSCTNV 911
           K   G   +++P    G+ +     + S +CT V
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVV 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 53/199 (26%), Positives = 79/199 (39%), Gaps = 42/199 (21%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVK------VINLKQKGASKSFVSECEALRN 758
           S+F     +G G FG V            A+K      ++ +KQ    +    E   L  
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV---QHVAQEKSILME 74

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS----NDQVEVRKLSLIQ 814
           + H  ++ ++  CS  D   V F   + E++  G L   L ++    ND   V K     
Sbjct: 75  LSHPFIVNMM--CSFQDENRVYF---LLEFVVGGELFTHLRKAGRFPND---VAKF---- 122

Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                 ++  A EYLH      +++ DLKP N+LLD      V DFG AK          
Sbjct: 123 ---YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------- 166

Query: 875 SKTPSSSIGIKGTVGYVAP 893
            K P  +  + GT  Y+AP
Sbjct: 167 -KVPDRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.5 bits (113), Expect = 3e-05
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 1/72 (1%)

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
           G  P DI   L +L+ + + GN+  G+IP SL + ++LE+LDL  N F G +      L 
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 319 NLWLLNLEQNNL 330
           +L +LNL  N+L
Sbjct: 491 SLRILNLNGNSL 502

Length = 623

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 42/171 (24%), Positives = 67/171 (39%), Gaps = 33/171 (19%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNIRH 761
           T+ +     +G G FG V           VA+K I         +K    E + L+++RH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 762 RNLIKIITICSS--------TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
            N+I +  I  S        T+  G D   L    + +  LE    Q             
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQY------------ 112

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                   +   ++Y+H      +VH DLKPSN+L++ +    + DFGLA+
Sbjct: 113 ----FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 23/146 (15%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVIN-----LKQKG-ASKSFVSECEALRNIRHRN 763
           +GQG F  +YKG+L    D ++V   + ++     L      S +F      +  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           L+K+  +C        D   +V EY++ G L+ +LH+  + V     SL  ++++A  +A
Sbjct: 63  LVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNV-----SLHWKLDVAKQLA 111

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL 849
           SA+ YL       +VHG++   N+L+
Sbjct: 112 SALHYLEDK---KLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 36/150 (24%), Positives = 70/150 (46%), Gaps = 15/150 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 84  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLKALSVLHAQ 135

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
               ++H D+K  ++LL +D    + DFG 
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 17/156 (10%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G+G FG V            A+K++    +  K      ++E   L+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  F+  D    V EY+  G L  + H S ++V     S  +      ++ SA++Y
Sbjct: 61  ----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGAEIVSALDY 110

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           LH      +V+ DLK  N++LD D    + DFGL K
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 21/162 (12%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF-VS--ECEA--LRNIRHRNLIK 766
           ++GQG FG VY     D    +A K +    +    S  VS  ECE   L+N++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAIDVAS 824
                            +  EYM  GS++D L       E   RK +          +  
Sbjct: 69  YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR--------QILE 117

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            + YLH +    +VH D+K +N+L D      +GDFG +K L
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 32/194 (16%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----KGASKSFVSECEALRNIRHR 762
           F    ++G+G FG V    +     + A K +  K+    KG S + ++E + L  +  +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA-LNEKQILEKVNSQ 60

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ-SNDQVEVRKLSLIQRMNIAID 821
            ++ +     +  +E  D   LV   M  G L+  ++   N   E  +      +  A +
Sbjct: 61  FVVNL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAE 110

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +   +E LH   +   V+ DLKP N+LLD      + D GL           A K P   
Sbjct: 111 ILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL-----------AVKIPEGE 156

Query: 882 I--GIKGTVGYVAP 893
              G  GTVGY+AP
Sbjct: 157 SIRGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 29/72 (40%), Positives = 38/72 (52%), Gaps = 11/72 (15%)

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           + S +E+LH      +++ DLKP NVLLD D    + D GLA  L     D  SKT    
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL----KDGQSKTK--- 155

Query: 882 IGIKGTVGYVAP 893
            G  GT G++AP
Sbjct: 156 -GYAGTPGFMAP 166

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 22/159 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMV---VAVKVIN---LKQKGASKSFVSECEALRNIRHRNLI 765
           ++G+G FG V   IL  ++      A+K++    +  K      ++E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            +        F+  D    V EY   G L  + H S ++V     S  +      ++ SA
Sbjct: 59  AL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVSA 107

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           ++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 13/161 (8%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLI-KIIT 769
           IG+G +G VYK    +   +VA+K   L+  ++G   + + E   L+ +     I +++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL--SLIQRMNIAIDVASAIE 827
           +    +  G     LVFEY+++  L+ ++  SN +   R L    I+     +    A  
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDS-DLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGVA-- 124

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLS 867
           + H H    ++H DLKP N+L+D    +  + D GL +  S
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 15/155 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V           VAVK ++L+++   +   +E   +R+  H N++ +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
           ++   G D   +V E++E G+L D +  +    E       Q   + + V  A+ YLH+ 
Sbjct: 86  NSYLVG-DELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 137

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL  D    + DFG    +S
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.8 bits (109), Expect = 6e-05
 Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 24/173 (13%)

Query: 707 FSSSNM-----IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIR 760
           F++ ++     IG+G FGTV K +      ++AVK I         K  + + + +  +R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDW---LHQSNDQVEVRKLSLIQRM- 816
             +   I+    +   EG  +  +  E M+  SL+ +   ++      EV K  + + + 
Sbjct: 59  SSDCPYIVKFYGALFREGDCW--ICMELMDI-SLDKFYKYVY------EVLKSVIPEEIL 109

Query: 817 -NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             IA+    A+ YL    +  ++H D+KPSN+LLD +    + DFG++  L +
Sbjct: 110 GKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 53/193 (27%), Positives = 78/193 (40%), Gaps = 47/193 (24%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKI-- 767
            ++G G  GTVYK        ++AVKVI L       K  +SE E L       +I    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 768 -------ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
                  I+IC+              E+M+ GSL D   +  + V  R         IA+
Sbjct: 67  AFFVENRISICT--------------EFMDGGSL-DVYRKIPEHVLGR---------IAV 102

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            V   + YL       ++H D+KPSN+L++      + DFG++  L N          S 
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----------SI 149

Query: 881 SIGIKGTVGYVAP 893
           +    GT  Y+AP
Sbjct: 150 AKTYVGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH--R 762
            +F +  +I  G +G VY     +     A+K IN KQ    ++ + +    R+I     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL-HQSNDQVEVRKLSLIQRMNIAID 821
           N   +   CS   FE      +V EY+E G     L +     V+      + RM  A  
Sbjct: 60  NPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKNIGALPVD------MARMYFAET 110

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG--DFGLAKF--------LSNHHL 871
           V  A+EYLH++    +VH DLKP N+L+    + H+   DFGL+K         L   H+
Sbjct: 111 VL-ALEYLHNY---GIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 872 DIASKTPSSSIGIKGTVGYVAP 893
           +  ++       + GT  Y+AP
Sbjct: 165 EKDTREFLDK-QVCGTPEYIAP 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)

Query: 288 DSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC 347
           DS      ++ L L +   +G +  D S L++L  +NL  N++             L + 
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP------PSLGSI 465

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP 390
           +SL+VL LS N F G +P S+  L+   I L++  N +SG +P
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRI-LNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 15/155 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V           VAVK+++L+++   +   +E   +R+ +H+N++++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY---- 84

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
            +   G +   L+ E+++ G+L D + Q+       +L+  Q   +   V  A+ YLH  
Sbjct: 85  KSYLVGEELWVLM-EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL  D    + DFG    +S
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 12/141 (8%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G +G VYK     G DE   A+K I  +  G S S   E   LR ++H N+I +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM--NIAIDVASAIEY 828
             S     V    L+F+Y E+            +   + + L + M  ++   +   I Y
Sbjct: 67  FLSHSDRKV---WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 829 LHHHCQPPMVHGDLKPSNVLL 849
           LH +    ++H DLKP+N+L+
Sbjct: 124 LHANW---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 20/60 (33%), Positives = 36/60 (60%)

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           NL  LD+S+N+ + +         +L+ LD+S N+   + P +F  L S+++L++S NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 21/60 (35%), Positives = 33/60 (55%)

Query: 543 SLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF 602
           +L+ LD+S N    +   +F+ L ++K L++S NNL+   PE    L  L  L+LS N  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 14/162 (8%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F     IG G +G VYK    +   + A+KVI L+          E   +++ +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
                     +   D   +  E+   GSL+D  H +        LS  Q   ++ +    
Sbjct: 70  AYF-----GSYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQG 118

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + YLH   +   +H D+K +N+LL  +    + DFG++  ++
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 1e-04
 Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 17/163 (10%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            +F     +GQG +G V+     D   +VA+K +    L +    +  ++E + L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+K++       F+  ++  L  EY+  G     L+      E      +  M  A+D
Sbjct: 61  EWLVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
               + Y         +H DLKP N L+D      + DFGL+K
Sbjct: 116 ALHELGY---------IHRDLKPENFLIDASGHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.0 bits (107), Expect = 1e-04
 Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 46/178 (25%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA---------L 756
            + + + +G G +G V           VA+K +       S+ F S   A         L
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-------SRPFQSAIHAKRTYRELRLL 68

Query: 757 RNIRHRNLIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSL 812
           +++ H N+I ++ +     S  DF+ V    LV   M                ++  +  
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDV---YLVTHLM--------------GADLNNIVK 111

Query: 813 IQRMN------IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            Q+++      +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 27/161 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEM---VVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLI 765
           ++G+G FG V   IL  ++      A+K++    +  K      ++E   L+N RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVA 823
            +        F+  D    V EY   G L  + H S ++V  E R      R   A ++ 
Sbjct: 59  AL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRA-----RFYGA-EIV 105

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           SA+ YLH      +V+ DLK  N++LD D    + DFGL K
Sbjct: 106 SALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 26/191 (13%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----KGASKSFVSECEALRNIRHR 762
           F    ++G+G FG V    +     + A K +  K+    KG S + ++E + L  +  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSR 60

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            ++ +     +  +E  D   LV   M  G L+  ++   +       ++      A ++
Sbjct: 61  FVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF----YAAEI 111

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              +E LH   Q  +V+ DLKP N+LLD      + D GLA         +      +  
Sbjct: 112 CCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA---------VHVPEGQTIK 159

Query: 883 GIKGTVGYVAP 893
           G  GTVGY+AP
Sbjct: 160 GRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 2e-04
 Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 422 NLQQLSVFNNFLRGGIPSGLGNLTK---LGSLDLGSNSLQGN----IPSSLGNCQ-NLIL 473
            LQ+L + +N L       L +L +   L  L L +N L       +   L +    L  
Sbjct: 82  GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141

Query: 474 FIASYNKLTG----DLPQQLLSITTLSLVLDLSNNLLNG----SLPLQVGNLKNLVMLDI 525
            +   N+L G     L + L +   L   L+L+NN +      +L   +    NL +LD+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLK-ELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 526 SSNQF----SGVIPVTLSTCVSLEYLDISINSF-----YGVIPLSFRFLKSIKALNVSSN 576
           ++N      +  +  TL++  SLE L++  N+        +         S+  L++S N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260

Query: 577 NL----SGKIPEFLENLSFLEFLNLSYNYF 602
           ++    +  + E L     L  L+L  N F
Sbjct: 261 DITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 24/184 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V    + +   + A K ++   LK+K   K  + E E L  +   N   I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  +  FE      LV   M  G L+   H  N  V  R L + + ++ +  +   I +L
Sbjct: 58  LAYA--FESKTHLCLVMSLMNGGDLK--YHIYN--VGERGLEMERVIHYSAQITCGILHL 111

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H      +V+ D+KP NVLLD      + D GLA         +  K   +     GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---------VELKDGKTITQRAGTNG 159

Query: 890 YVAP 893
           Y+AP
Sbjct: 160 YMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 53/201 (26%), Positives = 80/201 (39%), Gaps = 40/201 (19%)

Query: 710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKI 767
           S ++G G  GTV       D    AVKV++++   +       +E   L N    +++K 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK- 95

Query: 768 ITICSSTDF--------EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN-- 817
              C   DF        E V   ALV +Y   G L           E++  +   R    
Sbjct: 96  ---CHE-DFAKKDPRNPENVLMIALVLDYANAGDLRQ---------EIKSRAKTNRTFRE 142

Query: 818 -----IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
                + I V  A+   HH     M+H D+K +N+LL  + +  +GDFG +K  +    D
Sbjct: 143 HEAGLLFIQVLLAV---HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199

Query: 873 IASKTPSSSIGIKGTVGYVAP 893
              +T        GT  YVAP
Sbjct: 200 DVGRT------FCGTPYYVAP 214

Length = 496

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 20/158 (12%)

Query: 712 MIGQGRFGTVYKGIL-GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK---- 766
           ++G+G FG V    L G DE V A+KV  LK+    +    +C  +   R   L      
Sbjct: 2   VLGKGSFGKVMLAELKGTDE-VYAIKV--LKKDVILQDDDVDC-TMTEKRILALAAKHPF 57

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     F+  D    V EY+  G L   + +S      RK    +    A +V  A+
Sbjct: 58  LTALHCC--FQTKDRLFFVMEYVNGGDLMFQIQRS------RKFDEPRSRFYAAEVTLAL 109

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +LH H    +++ DLK  N+LLD +    + DFG+ K
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 44.3 bits (104), Expect = 2e-04
 Identities = 38/155 (24%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           +G G +G+V         + VAVK ++   +    +K    E   L++++H N+I ++ +
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 771 CS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
            + +   E  +   LV   M  G+        N+ V+ +KL+      +   +   ++Y+
Sbjct: 85  FTPARSLEEFNDVYLVTHLM--GA------DLNNIVKCQKLTDDHVQFLIYQILRGLKYI 136

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           H      ++H DLKPSN+ ++ D    + DFGLA+
Sbjct: 137 H---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 36/147 (24%), Positives = 57/147 (38%), Gaps = 26/147 (17%)

Query: 753 CEALRNIRHRNLIKIITICSSTDFEGV---DFKALVFEYMENGSLEDWLHQSNDQVEVRK 809
           C  L    H N++ ++         G         VFEY+   +L + L  + D      
Sbjct: 32  CARLY---HPNIVALLD-------SGEAPPGLLFAVFEYVPGRTLREVL--AADGA---- 75

Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFL 866
           L   +   + + V  A+   H+     +VH DLKP N+++        A V DFG+   L
Sbjct: 76  LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132

Query: 867 SNHHLDIASKTPSSSIGIKGTVGYVAP 893
                D    T + +  + GT  Y AP
Sbjct: 133 PGVR-DADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 3e-04
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 9/87 (10%)

Query: 807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           +R L L Q   +A  + SAI+Y+  H +  ++H D+K  NVL++      +GDFG A F 
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYI--HGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFA 310

Query: 867 SNHHLDIASKTPSSSIGIKGTVGYVAP 893
                   S +     GI GTV   AP
Sbjct: 311 R------GSWSTPFHYGIAGTVDTNAP 331

Length = 461

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 23/159 (14%)

Query: 713 IGQGRFGTV---YKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKI 767
           IG G  G V   +  +LG   + VAVK ++   + +  +K    E   L+ + H+N+I +
Sbjct: 29  IGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85

Query: 768 ITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI-DVASA 825
           + + +     E      LV E M+  +L   +H   D          +RM+  +  +   
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDH---------ERMSYLLYQMLCG 135

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           I++LH      ++H DLKPSN+++  D    + DFGLA+
Sbjct: 136 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 12/160 (7%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLI 765
           F    ++G G +G VYKG       + A+KV+++      +    E   L+    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66

Query: 766 KIITICSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSN-DQVEVRKLSLIQRMNIAIDVA 823
                    +  G+D +  LV E+   GS+ D +  +  + ++   ++ I R     ++ 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-----EIL 121

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             + +LH H    ++H D+K  NVLL  +    + DFG++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 26/164 (15%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINL-----KQKGASKSFVSECEALRNIRHRNL 764
           IG+G FG   K IL    +D     +K IN+     K++  S+    E   L N++H N+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPNI 61

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++         FE      +V +Y E G   D   + N Q  V      Q ++  + +  
Sbjct: 62  VQY-----QESFEENGNLYIVMDYCEGG---DLYKKINAQRGV-LFPEDQILDWFVQICL 112

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           A++++H      ++H D+K  N+ L  D    +GDFG+A+ L++
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 21/176 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLKQKGASKSFVSECEALRNIRHR 762
           E+    +IG G FG VY+     D  +      K+ NL+    +++ V E     NI   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDI 68

Query: 763 NLIKIITICSSTDFEGV-------DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           + I +     + D  G+        FK     Y     L + L ++  ++  R     ++
Sbjct: 69  DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYY--RFILLEKLVENTKEIFKRIKCKNKK 126

Query: 816 M--NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           +  NI  D+ + +EY+H H    + HGD+KP N+++D +   ++ D+G+A     H
Sbjct: 127 LIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179

Length = 294

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G+G FG V    L +   + AVKV+    + Q    +  ++E   L   R+   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
             C    F+  D    V E++  G L   + +S      R+    +    A ++ SA+ +
Sbjct: 62  YCC----FQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEITSALMF 111

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           LH      +++ DLK  NVLLD++    + DFG+ K
Sbjct: 112 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 24/191 (12%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL--RNIRHRN 763
           +F+   ++G+G FG V        + + A+K+  LK+    +    EC  +  R +  ++
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
               +T   S  F+ VD    V EY+  G L   + Q      V K    Q +  A +++
Sbjct: 59  KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD-IASKTPSSSI 882
             + +LH   +  +++ DLK  NV+LD +    + DFG+ K    H +D + ++T     
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT----- 160

Query: 883 GIKGTVGYVAP 893
              GT  Y+AP
Sbjct: 161 -FCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 29/120 (24%), Positives = 53/120 (44%), Gaps = 7/120 (5%)

Query: 275 LGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGT 334
           LG+      G IP+ +S   +L+ ++L  N  +G +     S+ +L +L+L  N+     
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 335 ANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIR 394
                    L   +SL++L+L+ N   G +P ++    L     +   N     I PG+R
Sbjct: 483 PES------LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGI-PGLR 535

Length = 623

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 33/170 (19%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA---------LR 757
           ++S   +G G +G+V   I       VA+K +       S+ F SE  A         L+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLK 69

Query: 758 NIRHRNLIKIITI-CSSTDFEGVDFKALVFEYMENGSLED--WLHQSNDQVEVRKLSLIQ 814
           +++H N+I ++ +  S+   +      LV  YM+   L+       S D+V+     L+ 
Sbjct: 70  HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY----LVY 124

Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +M         ++Y+H      ++H DLKP N+ ++ D    + DFGLA+
Sbjct: 125 QM------LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 43.1 bits (102), Expect = 5e-04
 Identities = 21/80 (26%), Positives = 37/80 (46%), Gaps = 9/80 (11%)

Query: 785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP 844
           V EY+  G L   + +S       +    +    A ++   +++LH      +++ DLK 
Sbjct: 74  VMEYVNGGDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKL 124

Query: 845 SNVLLDYDMVAHVGDFGLAK 864
            NVLLD +    + DFG+ K
Sbjct: 125 DNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 6e-04
 Identities = 20/60 (33%), Positives = 26/60 (43%)

Query: 271 NLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL 330
           NLK L +  N        +     NL++LDL  N         FS L +L  L+L  NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 14/142 (9%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G +G VYK     G D+   A+K I  +  G S S   E   LR ++H N+I +  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 771 CSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM--NIAIDVASAIE 827
             S      D K  L+F+Y E+            +   + + L + M  ++   +   I 
Sbjct: 67  FLSH----ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 828 YLHHHCQPPMVHGDLKPSNVLL 849
           YLH +    ++H DLKP+N+L+
Sbjct: 123 YLHANW---VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.3 bits (100), Expect = 7e-04
 Identities = 53/209 (25%), Positives = 82/209 (39%), Gaps = 24/209 (11%)

Query: 169 IGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRR---LVN 225
             +L +  R    I      L   +     ++ + +++N+LG      L  L R   L  
Sbjct: 57  CLSLNETGR----IPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQE 112

Query: 226 LNVAENQFSGMFPRSIC-----NISSVELIFLTENRFSGIFPFDILLNLP---NLKKLGI 277
           L +  N       R +         ++E + L  NR  G     +   L    +LK+L +
Sbjct: 113 LKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNL 172

Query: 278 GGNNFVG----SIPDSLSNASNLELLDLPSNQFK----GKVSIDFSSLKNLWLLNLEQNN 329
             N        ++ + L    NLE+LDL +N         ++   +SLK+L +LNL  NN
Sbjct: 173 ANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232

Query: 330 LGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
           L    A  L     LS   SL  LSLS N
Sbjct: 233 LTDAGAAALA-SALLSPNISLLTLSLSCN 260

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 14/151 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G +G VYK        + AVK+I L+          E   ++  +H N++       
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG--- 73

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   +   +  EY   GSL+D  H +        LS +Q   +  +    + YLH  
Sbjct: 74  --SYLSREKLWICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK 125

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            +   +H D+K +N+LL  +    + DFG+A
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 17/168 (10%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F S  +IG+G FG V      D   V A+K++  K     K  V    A R+I    L+
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDI----LV 56

Query: 766 KIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           +  ++     F     K    L+ E++  G +   L + +   E      I    +AID 
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              + ++H          D+KP N+LLD      + DFGL   L   H
Sbjct: 117 IHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 42.0 bits (99), Expect = 8e-04
 Identities = 26/76 (34%), Positives = 43/76 (56%), Gaps = 11/76 (14%)

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           IA+ +  A+EYLH   +  ++H D+KPSNVL++ +    + DFG    +S + +D  +KT
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKT 161

Query: 878 PSSSIGIKGTVGYVAP 893
             +     G   Y+AP
Sbjct: 162 IDA-----GCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           +G G +G+V           VAVK ++   +    ++    E   L++++H N+I ++ +
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 771 CS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
            + +T  E  +   LV   M  G+        N+ V+ +KLS      +   +   ++Y+
Sbjct: 83  FTPATSIENFNEVYLVTNLM--GA------DLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           H      ++H DLKPSNV ++ D    + DFGLA+
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 34/160 (21%), Positives = 64/160 (40%), Gaps = 32/160 (20%)

Query: 737 VINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV---DFKALVFEYMENGS 793
           V+ + QKG +   + E   L+N+ H ++I++     S     +    + + ++ Y+   S
Sbjct: 95  VLKIGQKGTT---LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS 151

Query: 794 LEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
                         R L + Q + I   +   + YLH      ++H D+K  N+ ++   
Sbjct: 152 --------------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVD 194

Query: 854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
              +GD G A+F                +G+ GTV   AP
Sbjct: 195 QVCIGDLGAAQFPVVAPAF---------LGLAGTVETNAP 225

Length = 357

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 55/260 (21%), Positives = 92/260 (35%), Gaps = 46/260 (17%)

Query: 115 GDIPQEIGNLFRLEKLALSNNSFSGTIPT---NLSRCSNLIHFCASNNKLEGQIPKEIGN 171
             + Q +     L++L LS+N+          +L R S+L     +NN L  +  + +  
Sbjct: 71  QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130

Query: 172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAEN 231
            LK    +++   L     + +   S               +   L   R L  LN+A N
Sbjct: 131 GLKDLPPALEKLVLGR---NRLEGASCEA------------LAKALRANRDLKELNLANN 175

Query: 232 QFSGMFPRSICNI----SSVELIFLTENRFS---GIFPFDILLNLPNLKKLGIGGNNFVG 284
                  R++        ++E++ L  N  +        + L +L +L+ L +G NN   
Sbjct: 176 GIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN--- 232

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
                L++A    L                 SL  L L     N++    A DL  V+  
Sbjct: 233 -----LTDAGAAALAS----ALLSPN----ISLLTLSLSC---NDITDDGAKDLAEVLA- 275

Query: 345 SNCSSLKVLSLSDNQFGGEL 364
               SL  L L  N+FG E 
Sbjct: 276 -EKESLLELDLRGNKFGEEG 294

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 21/182 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR-NLIKIITIC 771
           IG+G FG V +    D + + A+K I  K    S+S V+   A R +  + N   I+ + 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
            S  F+  +   LV  ++  G L   L +       R      R   A ++  A+E LH 
Sbjct: 60  FS--FQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA-----RFYTA-ELLCALENLH- 110

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
             +  +++ DLKP N+LLDY     + DFGL K      L++     +++    GT  Y+
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCK------LNMKDDDKTNTFC--GTPEYL 160

Query: 892 AP 893
           AP
Sbjct: 161 AP 162

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 11/73 (15%)

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
           ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K      +D   K  S 
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS- 157

Query: 881 SIGIKGTVGYVAP 893
                GTV Y+AP
Sbjct: 158 ---FCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 21/167 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-----RHRNLIKI 767
           IG+G +G V+K +   +    AVK+++            E EA  NI      H N++K 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN---IAIDVAS 824
             +    D +  D   LV E    GS+ D +           L   +RM    IA  +  
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF--------LKRGERMEEPIIAYILHE 132

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
           A+  L H      +H D+K +N+LL  +    + DFG++  L++  L
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 12/172 (6%)

Query: 695 VSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE 754
           +  + L      F    ++G G +G VYKG       + A+KV+++ +    +    E  
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEIN 64

Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSN-DQVEVRKLS 811
            L+    HRN+             G D +  LV E+   GS+ D +  +  + ++   ++
Sbjct: 65  MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124

Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            I R     ++   + +LH H    ++H D+K  NVLL  +    + DFG++
Sbjct: 125 YICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 21/170 (12%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F S  +IG+G FG V      D   + A+K++  K     K  V+   A R+I    L+
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDI----LV 56

Query: 766 K-----IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +     ++ +  S  F+      L+ E++  G +   L + +   E      I    +AI
Sbjct: 57  EADGAWVVKMFYS--FQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           D    + ++H          D+KP N+LLD      + DFGL   L   H
Sbjct: 115 DAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 0.003
 Identities = 41/174 (23%), Positives = 68/174 (39%), Gaps = 38/174 (21%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF-VSEC-EALRNIRHRNLIKII 768
           ++IG+G    + KG     + V+  +V         K +   E  E LR  R R   +++
Sbjct: 339 HLIGKGAEADIKKGEYLGRDAVIKERV--------PKGYRHPELDERLRTERTRAEARLL 390

Query: 769 TICSST--------DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +             D +  +   +V EY+    L+D L  + + V               
Sbjct: 391 SEARRAGVPTPVIYDVDPEEKT-IVMEYIGGKDLKDVLEGNPELVR-------------- 435

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            V   +  LH      +VHGDL  SN ++  D +  + DFGL K+ S+   D A
Sbjct: 436 KVGEIVAKLHKA---GIVHGDLTTSNFIVRDDRLYLI-DFGLGKY-SDLIEDKA 484

Length = 535

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.003
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 25/160 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G  G V+   L     + A+KV++ K   ++   K  ++E E L  + H     + T
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP---FLPT 65

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND---QVEVRKLSLIQRMNIAIDVASAI 826
           + +S  F+   +  LV +Y   G L   L +        EV +         A +V  A+
Sbjct: 66  LYAS--FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-------YAAEVLLAL 116

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAK 864
           EYLH      +V+ DLKP N+LL      H+   DF L+K
Sbjct: 117 EYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSK 151

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 40.2 bits (94), Expect = 0.003
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 19/156 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G+VYK +     + +A+K I L+   +     + E + L    H+ +   I   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIV-- 62

Query: 772 SSTDFEGVDF-KALVF---EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
              DF G  F +  V+   EYM+ GSL D L+      E     +++R  I   V   ++
Sbjct: 63  ---DFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
           +L       ++H D+KP+NVL++ +    + DFG++
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 40/200 (20%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F   + +G G  G V K       +++A K+I+L+ K           A+RN   R L 
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK----------PAIRNQIIREL- 54

Query: 766 KIITICSS---TDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRM 816
           +++  C+S     F G  +     ++  E+M+ GSL        DQV  E +++      
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL--------DQVLKEAKRIPEEILG 106

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
            ++I V   + YL    Q  ++H D+KPSN+L++      + DFG++  L +        
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------- 156

Query: 877 TPSSSIGIKGTVGYVAPGKF 896
             S +    GT  Y++P + 
Sbjct: 157 --SMANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 20/112 (17%)

Query: 784 LVFEYMENGSLEDWLHQSN--DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD 841
           L+ +Y+  G L   L+Q     + EVR       + IA ++  A+++LH   Q  +++ D
Sbjct: 82  LILDYVNGGELFTHLYQREHFTESEVR-------VYIA-EIVLALDHLH---QLGIIYRD 130

Query: 842 LKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           +K  N+LLD +    + DFGL+K       + A           GT+ Y+AP
Sbjct: 131 IKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-------FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 40.0 bits (94), Expect = 0.004
 Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 16/96 (16%)

Query: 793 SLEDW-LHQSNDQVEVRKLS-LIQRMNIAIDVASAIEYLHHH---CQPPMVHGDLKPSNV 847
              +W + +    + +  +     R  +   +   +  L  H       ++HGDL P NV
Sbjct: 150 RRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNV 209

Query: 848 LLD-YDMVAHVGDFG----------LAKFLSNHHLD 872
           L D    V+   DF           LA  L+  + D
Sbjct: 210 LFDDDTDVSGFIDFDDAGYGWFIYDLAIALNAWNGD 245

Length = 331

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 29/195 (14%)

Query: 707 FSSSNMIGQGRFGTVY--KGILGDDE-----MVVAVKVINLKQKGASKSFVSECEALRNI 759
           F    ++G G +G V+  + + G D      M V  K   +++   ++   +E + L +I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           R    +  +     TD +      L+ +Y+  G L   L Q     E       Q + I 
Sbjct: 62  RQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQIY 110

Query: 820 I-DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
             ++  A+E+LH   +  +++ D+K  N+LLD +    + DFGL+K     H D   +  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAY 164

Query: 879 SSSIGIKGTVGYVAP 893
           S      GT+ Y+AP
Sbjct: 165 S----FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 49/170 (28%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 730 EMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM 789
           E VVA K + L  +  +    SE   L    H  ++K        DF+  D   L+ EY 
Sbjct: 94  EKVVA-KFVMLNDERQAAYARSELHCLAACDHFGIVK-----HFDDFKSDDKLLLIMEYG 147

Query: 790 ENGSLEDWLHQSNDQVEVR-KLSL-IQRMNIAI---DVASAIEYLHHHCQPPMVHGDLKP 844
             G L       N Q++ R K  L  Q   + +    +  A++ +H      M+H DLK 
Sbjct: 148 SGGDL-------NKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKS 197

Query: 845 SNVLLDYDMVAHVGDFGLAKFLSNH-HLDIASKTPSSSIGIKGTVGYVAP 893
           +N+ L    +  +GDFG +K  S+   LD+AS          GT  Y+AP
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS-------FCGTPYYLAP 240

Length = 478

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.9 bits (94), Expect = 0.004
 Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 34/174 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV---SECEALRNIR-HRNLIKII 768
           IG+G F  V K          A+K   +K+   S   V    E +ALR +  H N++++I
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 769 TICSSTDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
            +         D K    ALVFE M+  +L + +     +   R L   +  +    +  
Sbjct: 65  EVL-------FDRKTGRLALVFELMD-MNLYELI-----KGRKRPLPEKRVKSYMYQLLK 111

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           +++++H +    + H D+KP N+L+  D++  + DFG  +        I SK P
Sbjct: 112 SLDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCR-------GIYSKPP 154

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 23/76 (30%), Positives = 37/76 (48%), Gaps = 11/76 (14%)

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           + + +  A+ YL       ++H D+KPSN+LLD      + DFG++  L      + SK 
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL------VDSKA 170

Query: 878 PSSSIGIKGTVGYVAP 893
            + S    G   Y+AP
Sbjct: 171 KTRS---AGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	914
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.98
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
PHA03207	392	serine/threonine kinase US3; Provisional	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.95
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.95
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.95
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.95
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.94
PHA02882	294	putative serine/threonine kinase; Provisional	99.94
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.94
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.94
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.9
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.89
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.89
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
PLN00181	793	protein SPA1-RELATED; Provisional	99.76
smart00090	237	RIO RIO-like kinase.	99.75
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.74
PLN03150	623	hypothetical protein; Provisional	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.58
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.53
PLN03150	623	hypothetical protein; Provisional	99.52
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.52
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.47
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.45
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.18
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.12
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.08
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.04
KOG3087	229	consensus Serine/threonine protein kinase [General	99.04
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.02
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.01
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.0
KOG1243	690	consensus Protein kinase [General function predict	98.94
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.84
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.68
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.67
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.46
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.45
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
PRK09902	216	hypothetical protein; Provisional	98.43
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.34
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.33

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-112  Score=1071.40  Aligned_cols=833  Identities=32%  Similarity=0.505  Sum_probs=725.8

Q ss_pred             CCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCC
Q 042766           33 TNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNG  112 (914)
Q Consensus        33 ~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~  112 (914)
                      ..++|+.||++||+++.+|...+.+|+.+.|||.|.||+|++ .++|+.|||+++.++|.+++.+..+++|++|+|++|+
T Consensus        26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~  104 (968)
T PLN00113         26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ  104 (968)
T ss_pred             CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence            477899999999999988888889998888999999999975 5689999999999999999999999999999999999


Q ss_pred             CcccCCcccC-CCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCc
Q 042766          113 FRGDIPQEIG-NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD  191 (914)
Q Consensus       113 l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  191 (914)
                      ++|.+|..+. ++++|++|+|++|+++|.+|.  +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+++.+|.
T Consensus       105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~  182 (968)
T PLN00113        105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN  182 (968)
T ss_pred             cCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence            9999998765 999999999999999998886  5689999999999999999999999999999999999999999999


Q ss_pred             ccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcc
Q 042766          192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPN  271 (914)
Q Consensus       192 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~  271 (914)
                      .++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..+.++++|++|++++|++++.+|.. +.++++
T Consensus       183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~  261 (968)
T PLN00113        183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKN  261 (968)
T ss_pred             hhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999988865 458999


Q ss_pred             cceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCc
Q 042766          272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK  351 (914)
Q Consensus       272 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  351 (914)
                      |++|+|++|++.+.+|..+.++++|++|+|++|++++.+|..+.++++|+.|++++|.+.+.      .|..+..+++|+
T Consensus       262 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~------~~~~~~~l~~L~  335 (968)
T PLN00113        262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK------IPVALTSLPRLQ  335 (968)
T ss_pred             CCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCc------CChhHhcCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999876      566788999999


Q ss_pred             EEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccc
Q 042766          352 VLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN  431 (914)
Q Consensus       352 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  431 (914)
                      .|+|++|++++.+|..+..+. +|+.|++++|++++.+|..+..+.+|+.|++++|++.+.+|..+..+++|+.|++++|
T Consensus       336 ~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n  414 (968)
T PLN00113        336 VLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN  414 (968)
T ss_pred             EEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCC
Confidence            999999999999999998876 7999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcc
Q 042766          432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP  511 (914)
Q Consensus       432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p  511 (914)
                      ++++.+|..|..++.|+.|+|++|.+++.+|..+..+++|+.|++++|++.|.+|..+. ...+ +.|++++|++++.+|
T Consensus       415 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L-~~L~ls~n~l~~~~~  492 (968)
T PLN00113        415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRL-ENLDLSRNQFSGAVP  492 (968)
T ss_pred             EeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccc-eEEECcCCccCCccC
Confidence            99999999999999999999999999999999999999999999999999999887653 4555 899999999999999


Q ss_pred             ccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCC
Q 042766          512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSF  591 (914)
Q Consensus       512 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  591 (914)
                      ..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+.++++
T Consensus       493 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  572 (968)
T PLN00113        493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES  572 (968)
T ss_pred             hhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCCccCCCCCCCCCCCCCCCccceeEEEehhHHHHhHhhhhheee
Q 042766          592 LEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIV  671 (914)
Q Consensus       592 L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~l~~~~c~~~~s~~~~~~~~~v~i~~v~~~~~~~~~~~~~  671 (914)
                      |+.|++++|+++|.+|..+++.++...++.||+.+||+.+....+.|.....  .....+.+++.++++++++.+++.++
T Consensus       573 L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  650 (968)
T PLN00113        573 LVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFV  650 (968)
T ss_pred             cCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999765545567753221  11122222222222122222222222


Q ss_pred             heeecccc-ccccCCCc--ccc------ccCccCHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC
Q 042766          672 YARKRRST-HKSVDTSP--MEK------LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ  742 (914)
Q Consensus       672 ~~~rrr~~-~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~  742 (914)
                      ++++|+.. .+......  .+.      ....+++++   ....|...+.||+|+||.||+|++..+++.||||+++...
T Consensus       651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~  727 (968)
T PLN00113        651 FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN  727 (968)
T ss_pred             HHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc
Confidence            22222211 11111100  000      001122222   3346777889999999999999998899999999886332


Q ss_pred             CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHH
Q 042766          743 KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV  822 (914)
Q Consensus       743 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i  822 (914)
                      .    ...+|++.+++++|||||+++++|...     +..++||||+++|+|.++++         .++|.++.+|+.|+
T Consensus       728 ~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~i  789 (968)
T PLN00113        728 S----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGI  789 (968)
T ss_pred             c----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHH
Confidence            2    123568899999999999999997543     36799999999999999985         36888999999999


Q ss_pred             HHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----h
Q 042766          823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----M  898 (914)
Q Consensus       823 ~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~  898 (914)
                      ++|++|||+.+.++|+|||+||+||+++.++.+++. ||.+......            ....||++|||||++.    +
T Consensus       790 a~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~  856 (968)
T PLN00113        790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------------TKCFISSAYVAPETRETKDIT  856 (968)
T ss_pred             HHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------------CCccccccccCcccccCCCCC
Confidence            999999997766799999999999999999988875 6665432110            1236899999999984    5


Q ss_pred             hhcccCcccccccccC
Q 042766          899 LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       899 ~~~Di~s~g~~~~~~f  914 (914)
                      .++|||||||++|||+
T Consensus       857 ~~sDv~S~Gvvl~el~  872 (968)
T PLN00113        857 EKSDIYGFGLILIELL  872 (968)
T ss_pred             cccchhhHHHHHHHHH
Confidence            8999999999999984

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.6e-65  Score=642.51  Aligned_cols=515  Identities=33%  Similarity=0.521  Sum_probs=489.0

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCcc-ccCCcchhccCCCcccCCCChhccccccccccc
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLS-RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLS  179 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  179 (914)
                      .+++.|+|++|+++|.+|..+..+++|++|+|++|+++|.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4689999999999999999999999999999999999999998876 999999999999999998886  5689999999


Q ss_pred             cccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccC
Q 042766          180 VDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG  259 (914)
Q Consensus       180 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  259 (914)
                      |++|.+++.+|..++++++|++|+|++|.+.+.+|.+++++++|++|+|++|++++.+|..++++++|++|+|++|++++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcc
Q 042766          260 IFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD  339 (914)
Q Consensus       260 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  339 (914)
                      .+|..+ .++++|++|+|++|++.+.+|..++++++|++|+|++|++++..|..+.++++|++|++++|.+.+.      
T Consensus       227 ~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~------  299 (968)
T PLN00113        227 EIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGE------  299 (968)
T ss_pred             cCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccC------
Confidence            888665 5899999999999999999999999999999999999999999999999999999999999999876      


Q ss_pred             hhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhc
Q 042766          340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE  419 (914)
Q Consensus       340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  419 (914)
                      +|..+.++++|+.|++++|.+.+.+|..+..++ +|+.|++++|.+.+.+|..++.+.+|+.|++++|++++.+|..+..
T Consensus       300 ~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~  378 (968)
T PLN00113        300 IPELVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS  378 (968)
T ss_pred             CChhHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhC
Confidence            667788999999999999999999999998887 6999999999999999999999999999999999999999999999


Q ss_pred             ccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhh
Q 042766          420 LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVL  499 (914)
Q Consensus       420 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L  499 (914)
                      +++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+..+..+ +.|
T Consensus       379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L  457 (968)
T PLN00113        379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QML  457 (968)
T ss_pred             cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cEE
Confidence            9999999999999999999999999999999999999999999999999999999999999999999988888888 899


Q ss_pred             cccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccc
Q 042766          500 DLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLS  579 (914)
Q Consensus       500 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  579 (914)
                      ++++|++.+.+|..++ .++|+.|||++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++
T Consensus       458 ~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        458 SLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             ECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            9999999999987764 589999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCCCeEeCCCCccccccCCC-CcCCCCCccCccCCCCCC
Q 042766          580 GKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVFSNKTKISLHGNVKLC  627 (914)
Q Consensus       580 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc  627 (914)
                      +.+|..+..+++|+.|||++|+++|.+|.. ..+..+..+++++|+..+
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            999999999999999999999999999965 445677888899987544

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.8e-47  Score=386.69  Aligned_cols=473  Identities=27%  Similarity=0.390  Sum_probs=295.8

Q ss_pred             CCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccc
Q 042766          103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI  182 (914)
Q Consensus       103 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  182 (914)
                      |+.|++++|.++ .+-+.+.+|..|.+|++.+|+++ +.|++++.+..++.|+.|+|+++ .+|++++++.+|+.|+.+.
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            344455555555 34444556666666666666665 56666666666666666666665 5666666666666666666


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCccc
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFP  262 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  262 (914)
                      |.+. .+|++++.+..|+.++..+|+++ ..|..++++.+|..|++.+|++....|..+. ++.|++||+..|-++ .+|
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP  199 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP  199 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence            6666 56666666666666666666666 5566666666666666666666644333333 555555555555554 334


Q ss_pred             ccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhh
Q 042766          263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI  342 (914)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  342 (914)
                      +++. .+.+|..|+|.+|+|. .+| .|..++.|.+|+++.|+|+-.+.+....+.++.+|||..|+++..+       +
T Consensus       200 ~~lg-~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~P-------d  269 (565)
T KOG0472|consen  200 PELG-GLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVP-------D  269 (565)
T ss_pred             hhhc-chhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCc-------h
Confidence            4443 5556666666666665 455 6777777888888888777555455557777777777777777643       3


Q ss_pred             cccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCC--CCcEE-------EcccCc-----
Q 042766          343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLV--NLITF-------TLEVNQ-----  408 (914)
Q Consensus       343 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L-------~L~~N~-----  408 (914)
                      .+.-+++|++||+|+|.|+ .+|.+++++  +|+.|-+.+|-+..+-.+.+.+=+  =|++|       -++.-+     
T Consensus       270 e~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~  346 (565)
T KOG0472|consen  270 EICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET  346 (565)
T ss_pred             HHHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence            3556677777777777777 566677766  467777777766532111111100  01111       011000     


Q ss_pred             ----ccccCChhhhcccCCceeeecccccccccCccccCCC---CCCeEEeeCCcCCCCCCCccCCCCCcccc-ccCCCc
Q 042766          409 ----FHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLT---KLGSLDLGSNSLQGNIPSSLGNCQNLILF-IASYNK  480 (914)
Q Consensus       409 ----l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~l~~N~  480 (914)
                          ..+..| ....+.+.+.|+++.-+++ .+|+......   -.+..+++.|++. ++|..+..++.+... .+++|.
T Consensus       347 ~~t~~~~~~~-~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~  423 (565)
T KOG0472|consen  347 AMTLPSESFP-DIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK  423 (565)
T ss_pred             cCCCCCCccc-chhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence                001111 1233456777777777777 4554432222   2667777777776 677766666655543 344444


Q ss_pred             cCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCc
Q 042766          481 LTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPL  560 (914)
Q Consensus       481 l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  560 (914)
                      + +.+|..+..++.+ ..|+|+||.+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++..+.|.
T Consensus       424 i-sfv~~~l~~l~kL-t~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~  499 (565)
T KOG0472|consen  424 I-SFVPLELSQLQKL-TFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS  499 (565)
T ss_pred             c-ccchHHHHhhhcc-eeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence            4 4777777777777 67777777777 67777777777777777777776 6677777777777777777777766666


Q ss_pred             chhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccc
Q 042766          561 SFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE  603 (914)
Q Consensus       561 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  603 (914)
                      .+.+|.+|..|||.+|.|. .+|..++++.+|++|++++|+|.
T Consensus       500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            6777778888888877776 67777778888888888888776

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.9e-47  Score=387.37  Aligned_cols=474  Identities=27%  Similarity=0.410  Sum_probs=350.8

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      ..++.+++++|.+. .+.+.+.+|..|+.|++++|+++ ++|++++.+..++.|+.|+|+++ .+|+.++.+.+|+.|+.
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            34567788888875 46677888888888888888888 78888888888888888888888 88888888888888888


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCC
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM  236 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  236 (914)
                      ++|.+. .+|+.++.+..|..|+..+|+++ ..|+.++++.+|..|++.+|+++...|..+. +++|++||...|-+. .
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t  197 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T  197 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence            888887 77888888888888888888888 7788888888888888888888854444444 888888888888887 6


Q ss_pred             CCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccc-cccccccccccCccCCcccccccc
Q 042766          237 FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLS-NASNLELLDLPSNQFKGKVSIDFS  315 (914)
Q Consensus       237 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~  315 (914)
                      +|..++.+.+|+.|||.+|++. .+|  -|.++..|++|+++.|+|. .+|.... +++++.+|||..|+++ ..|..+.
T Consensus       198 lP~~lg~l~~L~~LyL~~Nki~-~lP--ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c  272 (565)
T KOG0472|consen  198 LPPELGGLESLELLYLRRNKIR-FLP--EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC  272 (565)
T ss_pred             CChhhcchhhhHHHHhhhcccc-cCC--CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence            7778888888888888888887 345  2457888888888888888 5555544 7888888888888888 4666777


Q ss_pred             ccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhcccc--ccEEE-------Eeeccc--
Q 042766          316 SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL--KMIEL-------SVGRNQ--  384 (914)
Q Consensus       316 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~--~L~~L-------~L~~N~--  384 (914)
                      -+++|.+||+++|.|++.       |..++++ .|+.|.+.+|.+. .+-..+-....  -|++|       -++.-+  
T Consensus       273 lLrsL~rLDlSNN~is~L-------p~sLgnl-hL~~L~leGNPlr-TiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~  343 (565)
T KOG0472|consen  273 LLRSLERLDLSNNDISSL-------PYSLGNL-HLKFLALEGNPLR-TIRREIISKGTQEVLKYLRSKIKDDGLSQSEGG  343 (565)
T ss_pred             HhhhhhhhcccCCccccC-------Ccccccc-eeeehhhcCCchH-HHHHHHHcccHHHHHHHHHHhhccCCCCCCccc
Confidence            888888888888888875       4457888 8888888888876 22222211100  01111       000000  


Q ss_pred             -------ccccCCccccCCCCCcEEEcccCcccccCChhhhcccC---CceeeecccccccccCccccCCCCCC-eEEee
Q 042766          385 -------ISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKN---LQQLSVFNNFLRGGIPSGLGNLTKLG-SLDLG  453 (914)
Q Consensus       385 -------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls  453 (914)
                             ..+ .......+.+.+.|+++.-+++ .+|+....-.+   ....+++.|++. ++|..+..+..+. .++++
T Consensus       344 ~e~~~t~~~~-~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls  420 (565)
T KOG0472|consen  344 TETAMTLPSE-SFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS  420 (565)
T ss_pred             ccccCCCCCC-cccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence                   000 1112344557778888888887 44544433333   677888888887 6777666665544 34555


Q ss_pred             CCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccc
Q 042766          454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV  533 (914)
Q Consensus       454 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  533 (914)
                      +|.++ .+|..+..+++|..|++++|-+. .+|..++.+..+ +.||+|+|+|. .+|.....+..++.+-.++|++..+
T Consensus       421 nn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~L-q~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~v  496 (565)
T KOG0472|consen  421 NNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRL-QTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSV  496 (565)
T ss_pred             cCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhh-heecccccccc-cchHHHhhHHHHHHHHhcccccccc
Confidence            55554 77778888888888888888776 788888888776 78888888887 6777777777777777777888877


Q ss_pred             cCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccc
Q 042766          534 IPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLS  579 (914)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  579 (914)
                      .|..+.+|.+|..|||.+|.+. .+|..++++++|++|++++|.+.
T Consensus       497 d~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  497 DPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            7777888888888888888886 67778888888888888888887

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=372.93  Aligned_cols=369  Identities=21%  Similarity=0.240  Sum_probs=335.2

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      .-+.||+++|.++..-+..|.++++|+.+++..|.++ .||...+...+|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            3478999999999888889999999999999999999 899988888899999999999997777789999999999999


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                      .|.|+..--.+|..-.++++|+|++|+++..--..|.++.+|..|.|++|+++...+.+|.++++|+.|+|..|+|. ++
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-iv  236 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IV  236 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-ee
Confidence            99999555567877789999999999999888999999999999999999999888889999999999999999997 44


Q ss_pred             cccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchh
Q 042766          262 PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV  341 (914)
Q Consensus       262 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  341 (914)
                      ..-.|.++++|+.|.|..|.+...-...|-.+.++++|+|+.|+++..-.+++.+|+.|+.|+|++|.|..+....    
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~----  312 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS----  312 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch----
Confidence            4567889999999999999999888899999999999999999999999999999999999999999999985554    


Q ss_pred             hcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCCh---hhh
Q 042766          342 IFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD---VIS  418 (914)
Q Consensus       342 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~---~~~  418 (914)
                        .+.+++|++|+|++|+|+..-+.++..+. .|++|+|++|+|+..-..+|..+.+|++|||++|.++..+.+   .|.
T Consensus       313 --WsftqkL~~LdLs~N~i~~l~~~sf~~L~-~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~  389 (873)
T KOG4194|consen  313 --WSFTQKLKELDLSSNRITRLDEGSFRVLS-QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN  389 (873)
T ss_pred             --hhhcccceeEeccccccccCChhHHHHHH-HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence              45688999999999999966666777766 799999999999999999999999999999999999977754   588


Q ss_pred             cccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCc
Q 042766          419 ELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK  480 (914)
Q Consensus       419 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  480 (914)
                      +|++|+.|+|.+|+|+.+.-.+|.++..|++|||.+|.|..+-|++|..+ +|+.|.+..-.
T Consensus       390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss  450 (873)
T KOG4194|consen  390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS  450 (873)
T ss_pred             cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence            99999999999999997666789999999999999999999999999999 89888776433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-43  Score=370.51  Aligned_cols=378  Identities=23%  Similarity=0.222  Sum_probs=315.7

Q ss_pred             ccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccccccccc
Q 042766          223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP  302 (914)
Q Consensus       223 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  302 (914)
                      -+.||+++|+++.+-+..|.++++|+.+++.+|.++. +|.. .....+|+.|+|.+|.|+.+-.+.++.++.|++||||
T Consensus        80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f-~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRF-GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccc-cccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4457777777777767777777777777777777763 4432 2244568888888888887777778888888888888


Q ss_pred             CccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeec
Q 042766          303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGR  382 (914)
Q Consensus       303 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~  382 (914)
                      .|.|+.+....|..-.++++|+|++|.|+.+....      |.++.+|..|.|+.|+++ .+|...+...++|+.|+|.+
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~------F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnr  230 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGH------FDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNR  230 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeecccccccccccc------ccccchheeeecccCccc-ccCHHHhhhcchhhhhhccc
Confidence            88888877778888788888888888888876553      567778888888888888 56655555334788888888


Q ss_pred             ccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCC
Q 042766          383 NQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP  462 (914)
Q Consensus       383 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  462 (914)
                      |+|.-.---.|.+|.+|+.|.|..|.++..-...|..+.++++|+|+.|+++..-..++.+++.|+.||||+|.|+.+.+
T Consensus       231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~  310 (873)
T KOG4194|consen  231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI  310 (873)
T ss_pred             cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence            88885556789999999999999999998888999999999999999999998888889999999999999999998888


Q ss_pred             CccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCc---ccc
Q 042766          463 SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV---TLS  539 (914)
Q Consensus       463 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~  539 (914)
                      ++...+++|+.|+|++|+++.--+..+..+..+ ++|.|++|+++..--.+|..+++|+.|||++|.|++.+.+   .|.
T Consensus       311 d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L-e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~  389 (873)
T KOG4194|consen  311 DSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL-EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN  389 (873)
T ss_pred             chhhhcccceeEeccccccccCChhHHHHHHHh-hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence            989999999999999999994444455555555 8999999999977778899999999999999999988765   488


Q ss_pred             ccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCCc
Q 042766          540 TCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGV  611 (914)
Q Consensus       540 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  611 (914)
                      +|++|+.|+|.+|+|..+...+|..+..|+.|||.+|.|..+.|++|..+ .|+.|-+..-.|-|+|...|.
T Consensus       390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl  460 (873)
T KOG4194|consen  390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWL  460 (873)
T ss_pred             cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHH
Confidence            89999999999999998888999999999999999999999999999999 899999999999999987653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=349.37  Aligned_cols=188  Identities=29%  Similarity=0.497  Sum_probs=166.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ...+|...+.||+|+||+||+|+++.++..||||.+.+.  ..+..+-+..|+++|+.++|||||++++++..     .+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----DD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----CC
Confidence            346888899999999999999999999999999999766  44556778999999999999999999999544     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC------Cc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD------MV  854 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~------~~  854 (914)
                      +.|+|||||.||||.+|+++++      .+++..+..++.|+|.|+++||++   +||||||||+|||++..      -.
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence            8999999999999999999764      689999999999999999999999   99999999999999865      46


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      +||+|||+||.+....         .....||+|.|||||++    |+-++|+||+|+++|+|
T Consensus       154 LKIADFGfAR~L~~~~---------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~  207 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGS---------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC  207 (429)
T ss_pred             EEecccchhhhCCchh---------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence            8999999999886433         22357999999999999    46999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-41  Score=329.75  Aligned_cols=197  Identities=25%  Similarity=0.414  Sum_probs=168.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ...+|++.++||+|.||+||++.+..+|+.||.|.+...  +....++...|+.+|++++|||||++++...   .+...
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~e   93 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNE   93 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccch
Confidence            345799999999999999999999999999999999743  4556678999999999999999999987422   23344


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeecCCCcEEEe
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ..+||||||++|+|.++++..+.  +.+.+++..+++++.|++.||.++|... ++  |+||||||.||+++.+|.||++
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeec
Confidence            58999999999999999986543  3468999999999999999999999942 24  9999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |||+++++.....        .....+|||+||+||.+.    +.++||||+||.+|||
T Consensus       171 DfGL~r~l~s~~t--------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEM  221 (375)
T KOG0591|consen  171 DFGLGRFLSSKTT--------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEM  221 (375)
T ss_pred             cchhHhHhcchhH--------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence            9999999865332        223578999999999994    5999999999999998

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-39  Score=331.59  Aligned_cols=188  Identities=30%  Similarity=0.430  Sum_probs=159.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-------cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-------GASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      .+.|.+.+.+|+|+||.|-+|..+.+++.||||++.....       .......+|+++|++++|||||+++++     |
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence            4578889999999999999999999999999999974321       122345799999999999999999999     5


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---C
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---M  853 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~  853 (914)
                      +.+++.|+||||++||+|.+++-.++      .+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   .
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence            55568899999999999999998764      455556678999999999999999   99999999999999766   7


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+|+.....         ......||||.|.|||++.       ..++|+||+||++|-++
T Consensus       317 llKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL  375 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL  375 (475)
T ss_pred             EEEecccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEe
Confidence            8999999999976421         2234589999999999994       35889999999998653

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=377.90  Aligned_cols=484  Identities=28%  Similarity=0.336  Sum_probs=320.1

Q ss_pred             EEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCC-CccccCCcchhccCCCcccCCCChhcccccccccccccccc
Q 042766          106 INLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT-NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINY  184 (914)
Q Consensus       106 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (914)
                      +|.++.+++ .||..+..-..++.|+++.|.+- ..|- .+.+.-+|+.||+|+|+++ ..|..+..+.+|+.|+++.|.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            344444444 45554444444555555555544 2222 2223333666666666655 556666666666666666666


Q ss_pred             ccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCccccc
Q 042766          185 LTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD  264 (914)
Q Consensus       185 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  264 (914)
                      +. ..|.+..++.+|++|.|.+|.+. ..|..+..+++|++|++|.|++. .+|..+..++.++.+..++|.....++  
T Consensus        80 i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg--  154 (1081)
T KOG0618|consen   80 IR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLG--  154 (1081)
T ss_pred             Hh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhc--
Confidence            65 55555666666666666666655 55666666666666666666665 556666666666666666662211111  


Q ss_pred             ccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcc
Q 042766          265 ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL  344 (914)
Q Consensus       265 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l  344 (914)
                         . ..++.++|..|.+.+.++..+.+++.  .|||++|.+.   -..+..+.+|+.+....|++.....         
T Consensus       155 ---~-~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~~---------  216 (1081)
T KOG0618|consen  155 ---Q-TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELEI---------  216 (1081)
T ss_pred             ---c-ccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEEe---------
Confidence               1 12667777777777777766666665  6777777766   2335666777777777777766532         


Q ss_pred             cCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCc
Q 042766          345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ  424 (914)
Q Consensus       345 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  424 (914)
                       .-++|+.|+.++|.++...+.   ..+.+++++++++|++++ +|++++.+.+|+.++..+|+++ .+|..+....+|+
T Consensus       217 -~g~~l~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~  290 (1081)
T KOG0618|consen  217 -SGPSLTALYADHNPLTTLDVH---PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLV  290 (1081)
T ss_pred             -cCcchheeeeccCcceeeccc---cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHH
Confidence             236778888888877732222   223467888888888884 4588888888888888888885 6777778888888


Q ss_pred             eeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCC-ccccccCCCccCCCCchhhhcccchhhhhcccC
Q 042766          425 QLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN-LILFIASYNKLTGDLPQQLLSITTLSLVLDLSN  503 (914)
Q Consensus       425 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~  503 (914)
                      .|+..+|.+. .+|.....++.|++|||..|+|....+..+..... |..|+.+.|++. ..|..-......++.|++.+
T Consensus       291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lylan  368 (1081)
T KOG0618|consen  291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLAN  368 (1081)
T ss_pred             HHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhc
Confidence            8888888888 66777777888888888888887444444444443 677777777776 44432222233337888888


Q ss_pred             CccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccC
Q 042766          504 NLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP  583 (914)
Q Consensus       504 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  583 (914)
                      |.++...-+.+.+.+.|+.|+|++|+|...+...+.++..|++|+||+|+|+ .+|.+...++.|++|...+|+|. ..|
T Consensus       369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP  446 (1081)
T KOG0618|consen  369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP  446 (1081)
T ss_pred             CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence            8888777677778888888888888887555566778888888888888887 67788888888888888888887 556


Q ss_pred             ccccccCCCCeEeCCCCcccc-ccCCCCcCCCCCccCccCCCCC
Q 042766          584 EFLENLSFLEFLNLSYNYFEG-EVPVKGVFSNKTKISLHGNVKL  626 (914)
Q Consensus       584 ~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~~~~~~~~~~~n~~l  626 (914)
                       .+..+++|+.+|+|.|+|+- .+|..-...++..+++.||.++
T Consensus       447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  447 -ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             -hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence             77778888888888888863 3444333356777788888764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=326.97  Aligned_cols=190  Identities=26%  Similarity=0.362  Sum_probs=168.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|++.++||+|+||+||.++.+++++.+|+|++++..   ....+....|..++.+++||.||+++..     |++.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccC
Confidence            3568999999999999999999999999999999997542   3456788999999999999999999866     7788


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..|+|+||+.||+|...+.+.      ..+++..+..++.+|+.||.|||+.   +|||||+||||||+|.+|+++|+|
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence            8999999999999999999876      3688889999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......        ..+..+|||+.|||||++.    +.++|.||+|+++|||.
T Consensus       169 FgL~k~~~~~~--------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML  219 (357)
T KOG0598|consen  169 FGLCKEDLKDG--------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML  219 (357)
T ss_pred             cccchhcccCC--------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence            99998543211        1223489999999999994    69999999999999984

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-40  Score=368.96  Aligned_cols=488  Identities=27%  Similarity=0.321  Sum_probs=367.5

Q ss_pred             ceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccC
Q 042766           78 RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS  157 (914)
Q Consensus        78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  157 (914)
                      +++.|++..|.+-...-+++..--.|+.|||++|.+. ..|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|.|.
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~   99 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK   99 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence            3677778777653322233434444888999888887 78888888888999999998888 788888888999999998


Q ss_pred             CCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCC
Q 042766          158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMF  237 (914)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  237 (914)
                      +|.+. ..|..+..+.+|++||+|.|.+. .+|..+..++.++++..++|......+..    . ++.++|..|.+.+.+
T Consensus       100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~----~-ik~~~l~~n~l~~~~  172 (1081)
T KOG0618|consen  100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQT----S-IKKLDLRLNVLGGSF  172 (1081)
T ss_pred             cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccc----c-chhhhhhhhhcccch
Confidence            88887 78888888899999999999887 88888888888888888888333233332    2 888888888888888


Q ss_pred             CCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccccccccc
Q 042766          238 PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSL  317 (914)
Q Consensus       238 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  317 (914)
                      +..+..++.  .|+|.+|++. ..  + ..++++|+.|....|++....    -.-++|+.|+.++|.++...+  -..-
T Consensus       173 ~~~i~~l~~--~ldLr~N~~~-~~--d-ls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p  240 (1081)
T KOG0618|consen  173 LIDIYNLTH--QLDLRYNEME-VL--D-LSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVP  240 (1081)
T ss_pred             hcchhhhhe--eeecccchhh-hh--h-hhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--cccc
Confidence            888877776  7889998886 22  2 237788888888888887332    234678888899998883332  2234


Q ss_pred             ccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCC
Q 042766          318 KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLV  397 (914)
Q Consensus       318 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~  397 (914)
                      .+|+++++++|+++..       |+|++.+.+|+.++..+|+++ .+|..+.... +|+.|....|.+. .+|....+++
T Consensus       241 ~nl~~~dis~n~l~~l-------p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~L~~l~~~~nel~-yip~~le~~~  310 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLSNL-------PEWIGACANLEALNANHNRLV-ALPLRISRIT-SLVSLSAAYNELE-YIPPFLEGLK  310 (1081)
T ss_pred             ccceeeecchhhhhcc-------hHHHHhcccceEecccchhHH-hhHHHHhhhh-hHHHHHhhhhhhh-hCCCcccccc
Confidence            6888999999988874       567888899999999999996 7888888776 5888888888888 5666777888


Q ss_pred             CCcEEEcccCcccccCChhhhcccC-CceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCcccccc
Q 042766          398 NLITFTLEVNQFHGTIPDVISELKN-LQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIA  476 (914)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  476 (914)
                      .|++|+|..|+|...++..+..+.. |+.|+.+.|++.......=.....|+.|+|.+|.++...-..+.+.++|+.|+|
T Consensus       311 sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhL  390 (1081)
T KOG0618|consen  311 SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHL  390 (1081)
T ss_pred             eeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeee
Confidence            8999999999988555555555544 788888888887433222234567888888888888776677888888888888


Q ss_pred             CCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccc
Q 042766          477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYG  556 (914)
Q Consensus       477 ~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  556 (914)
                      ++|+|. .+|+....-...++.|+||+|+++ .+|..+..++.|++|...+|++. ..| .+..++.|+.+|+|.|+|+.
T Consensus       391 syNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  391 SYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             cccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            888887 677665444444478888888888 67788888888888888888887 556 78888888888888888864


Q ss_pred             cCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCC
Q 042766          557 VIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN  600 (914)
Q Consensus       557 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  600 (914)
                      ..-..-..-++|++|||++|.=.-..-..|..++++...+++-|
T Consensus       467 ~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  467 VTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             hhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            43222222278888888888732244456666777777777766

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=322.52  Aligned_cols=187  Identities=27%  Similarity=0.400  Sum_probs=163.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++.+..+.||+|..|+||+|+|+.+++.+|+|++... +....+++.+|++++++++||+||++||.+....    ....
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceEE
Confidence            3556678999999999999999999999999999644 3445678999999999999999999999965433    1589


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      |+||||++|+|+++++..      ..+++....+|+.+|++||.|||+.  .+||||||||+|||+...|.|||+|||.+
T Consensus       155 I~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS  226 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVS  226 (364)
T ss_pred             eehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccccc
Confidence            999999999999999865      3689999999999999999999963  19999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +.+...          ....++||..|||||.+.    +.++||||||.++.|+
T Consensus       227 ~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~  270 (364)
T KOG0581|consen  227 GILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL  270 (364)
T ss_pred             HHhhhh----------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence            876542          123578999999999994    5899999999999886

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-38  Score=331.00  Aligned_cols=192  Identities=28%  Similarity=0.418  Sum_probs=168.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .+.|+..++||+|+||.||+|++..+|+.||+|+++...  ++...-..+||.+|++++||||+++.+...+..   ...
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---Cce
Confidence            356888899999999999999999999999999998664  555677889999999999999999999976542   357


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+|+|||+. ||.-++...+     ..+++.++..++.|++.||.|||++   +|+|||||.+|||||.+|.+||+|||
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence            8999999976 9998887654     5799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      +|+++......       .-+..+-|.+|+|||.+     |+.++|+||.||++.|||
T Consensus       264 LAr~y~~~~~~-------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~  314 (560)
T KOG0600|consen  264 LARFYTPSGSA-------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF  314 (560)
T ss_pred             ceeeccCCCCc-------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence            99987653321       12345789999999999     579999999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=314.01  Aligned_cols=188  Identities=24%  Similarity=0.362  Sum_probs=160.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +.|+...++|+|+||+||+|++++||+.||||++....  +...+...+|+++|++++|||+|.++++     |+.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence            35777889999999999999999999999999996332  3345678999999999999999999998     4555689


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++|+|||+. ++.+-+.+..     ..++...+.++++|++.|+.|+|++   ++|||||||||||++.+|.+|++|||+
T Consensus        77 hLVFE~~dh-TvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   77 HLVFEYCDH-TVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             EEEeeecch-HHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence            999999976 5555555443     4688889999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+.+..+.        ..-+..+.|.+|+|||.+     +|.++|||++||++.||+
T Consensus       148 AR~L~~pg--------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~  196 (396)
T KOG0593|consen  148 ARTLSAPG--------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL  196 (396)
T ss_pred             hHhhcCCc--------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh
Confidence            99886321        111236789999999998     579999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-37  Score=336.05  Aligned_cols=187  Identities=27%  Similarity=0.439  Sum_probs=169.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .+|...+.||+|||+.||++++..+|+.||+|++...   .....+...+||++.+.++|||||+++++     |++...
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            5799999999999999999999999999999999753   45567889999999999999999999999     777789


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+|.|+|+.++|.+++++.      .++++.++..+.+||+.|+.|||+.   +|||||||..|++++++.+|||+|||
T Consensus        93 VYivLELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence            99999999999999999855      5799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +|..+..++        .+....||||.|+|||++.    +..+||||+||++|.+
T Consensus       164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtL  211 (592)
T KOG0575|consen  164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTL  211 (592)
T ss_pred             eeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhh
Confidence            999876432        2344689999999999995    5899999999999865

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=337.74  Aligned_cols=205  Identities=42%  Similarity=0.694  Sum_probs=175.0

Q ss_pred             cCccCHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEe
Q 042766          692 FPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC  771 (914)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  771 (914)
                      ...++++++..++++|...+.||+|+||.||+|...++ +.||||++........++|..|++++.+++|||+|+++|||
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45689999999999999999999999999999999754 88999988644332145699999999999999999999999


Q ss_pred             ecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC
Q 042766          772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY  851 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~  851 (914)
                      ...+    ...++|+|||++|+|++++......    .++|.++++||.++|+||+|||+.+.|+||||||||+|||+|+
T Consensus       141 ~e~~----~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  141 LEGG----EHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             ecCC----ceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            7544    2589999999999999999876421    7899999999999999999999998889999999999999999


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccc-cCcccccccchhh----hhhcccCccccccccc
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI-KGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~-~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ++++||+|||+|+......     .   ..... .||.+|+|||++.    +.++||||||+.+.|+
T Consensus       213 ~~~aKlsDFGLa~~~~~~~-----~---~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl  271 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGD-----T---SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL  271 (361)
T ss_pred             CCCEEccCccCcccCCccc-----c---ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence            9999999999997543200     0   00011 7999999999995    4899999999988765

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=329.48  Aligned_cols=200  Identities=27%  Similarity=0.407  Sum_probs=172.8

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .+...+|.+.+.||+|+|++|++|+.+.+++.||||++.++   .+...+...+|-++|.++ .||.|++++.-     |
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----F  143 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----F  143 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----e
Confidence            44567899999999999999999999999999999999643   344556788899999999 89999999977     6


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      ++....|+|+||+++|+|.++|++.+      .+++..+..++.||+.|++|||++   |||||||||||||+|.||++|
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence            66678999999999999999999874      688999999999999999999999   999999999999999999999


Q ss_pred             Eecccccccccccccc-----cccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLD-----IASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~-----~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||.|+.+.+....     ...........++||..|.+||++.    +..+|+|+|||++|+|.
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml  281 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML  281 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh
Confidence            9999999998764332     1111111235689999999999995    69999999999999983

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6.8e-37  Score=297.78  Aligned_cols=188  Identities=27%  Similarity=0.410  Sum_probs=163.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|...+.+|+|+||.||+|++..+|+.||||+++...  ++......+|++.|+.++|+||+.+++++     ...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            46888899999999999999999999999999998553  33456789999999999999999999984     444578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      .+|+|||+. +|+..++...     ..++..+...++.++.+|++|||++   .|+|||+||.|+|++.+|.+||+|||+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEEEEeccc-cHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence            999999975 9999998764     6789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.+.....        .....+-|.+|+|||.++     +..+|+||.||++.|++
T Consensus       148 Ar~f~~p~~--------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl  196 (318)
T KOG0659|consen  148 ARFFGSPNR--------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL  196 (318)
T ss_pred             hhccCCCCc--------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence            998764331        112236899999999985     58999999999999873

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.3e-38  Score=339.98  Aligned_cols=367  Identities=26%  Similarity=0.411  Sum_probs=194.6

Q ss_pred             CCCCCCEEEcCCCCCc-ccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccc
Q 042766           99 NLSFLRYINLADNGFR-GDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQR  177 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  177 (914)
                      =|+..|-.|+++|.|+ +..|.....+++++-|.|...++. .+|+.++++.+|++|.+++|++. .+-..++.|+.|+.
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs   82 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS   82 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence            3555666677777776 356666666666777766666665 66666666666666666666665 44455666666666


Q ss_pred             cccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCc
Q 042766          178 LSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR  256 (914)
Q Consensus       178 L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  256 (914)
                      +++..|++.. -+|..+..|..|..||||+|+++ ..|..+..-+++.+|+||+|+|.                      
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie----------------------  139 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE----------------------  139 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc----------------------
Confidence            6666666542 24444555555555555555555 44555555555555555555554                      


Q ss_pred             ccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCC
Q 042766          257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTAN  336 (914)
Q Consensus       257 l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  336 (914)
                         .+|..+|.+++.|-.||||+|++. .+|..+..+..|++|+||+|.+....-..+..+++|++|.+++.+=+-.   
T Consensus       140 ---tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~---  212 (1255)
T KOG0444|consen  140 ---TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLD---  212 (1255)
T ss_pred             ---cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhh---
Confidence               234455556666666666666665 4555566666666666666665543333444555566666655443221   


Q ss_pred             CcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChh
Q 042766          337 DLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV  416 (914)
Q Consensus       337 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  416 (914)
                        .+|..+..+.+|..+|||.|.+. .+|+++..+. +|+.|+|++|+|+ .+....+.+.+|++|+||.|+++ .    
T Consensus       213 --N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~-~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~----  282 (1255)
T KOG0444|consen  213 --NIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLR-NLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-V----  282 (1255)
T ss_pred             --cCCCchhhhhhhhhccccccCCC-cchHHHhhhh-hhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-c----
Confidence              14444555555666666666555 4444444333 2333333333333 12222333344444444444444 3    


Q ss_pred             hhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCC-CCCCccCCCCCccccccCCCccCCCCchhhhcccch
Q 042766          417 ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-NIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL  495 (914)
Q Consensus       417 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  495 (914)
                                          +|++++++++|+.|++.+|+++- -+|+.++++.+|+.+..++|++. .+|.+++.+..+
T Consensus       283 --------------------LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL  341 (1255)
T KOG0444|consen  283 --------------------LPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKL  341 (1255)
T ss_pred             --------------------chHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHH
Confidence                                44444444444444444444431 24444444444444444444444 444444444444


Q ss_pred             hhhhcccCCccCCCccccccccccceeecccCCcc
Q 042766          496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF  530 (914)
Q Consensus       496 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  530 (914)
                       +.|.|+.|++- .+|.++.-|+.|+.|||.+|.=
T Consensus       342 -~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  342 -QKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             -HHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence             44444444444 4455555555555666655543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.2e-37  Score=305.52  Aligned_cols=191  Identities=23%  Similarity=0.382  Sum_probs=167.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|+..+.|++|+||.||||+++.+++.||+|+++++.  .+..-...+||.++.+++|||||.+.++.....   .+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MD  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cc
Confidence            4568999999999999999999999999999999998654  334456789999999999999999999976554   34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..|+|||||+. ||...+...+     +++...++..++.|+++|++|||++   .|+||||||+|+|+...|.+||+||
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEeccc
Confidence            68999999976 9999998754     6899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh-----hhhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~  913 (914)
                      |+||.+..+.        ..-+..+-|.+|+|||.+     ++.++|+||+||++.||
T Consensus       222 GLAR~ygsp~--------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~  271 (419)
T KOG0663|consen  222 GLAREYGSPL--------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAEL  271 (419)
T ss_pred             chhhhhcCCc--------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHH
Confidence            9999886542        122346789999999999     46999999999999886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=312.99  Aligned_cols=195  Identities=30%  Similarity=0.473  Sum_probs=165.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+|...+.||+|+||.||.+.+.++|+..|||.+...+....+.+.+|+.+|++++|||||+++|......  . ...+
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence            346778899999999999999999889999999997654333677899999999999999999999643322  1 3688


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFGl  862 (914)
                      +.|||+++|+|.+++.+.++     .+++..+.++++||++||+|||++   +||||||||+|||++. ++.+||+|||+
T Consensus        93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence            99999999999999997642     589999999999999999999999   9999999999999999 79999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-h----hhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-M----LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-~----~~~Di~s~g~~~~~~f  914 (914)
                      |+.....     .........+.||+.|||||++. +    .++||||+|||++|||
T Consensus       165 a~~~~~~-----~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~  216 (313)
T KOG0198|consen  165 AKKLESK-----GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML  216 (313)
T ss_pred             ccccccc-----cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence            9876531     01112233578999999999997 3    3899999999999997

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=299.94  Aligned_cols=185  Identities=25%  Similarity=0.327  Sum_probs=165.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|+..+.+|.|+||.|..++++.+|..+|+|++++.+   ....+...+|..+|+.+.||.++++++-+     .+..
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence            357889999999999999999999999999999997554   23445678899999999999999999874     4455


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||.|..++++.      .++++..+..+|.||+.|++|||+.   +|++||+||||||+|.+|.+||+||
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            899999999999999999876      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+|+.+.+.           ....||||.|+|||+++    +.++|-|+||+.+|||
T Consensus       189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEM  234 (355)
T KOG0616|consen  189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEM  234 (355)
T ss_pred             cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHH
Confidence            999976432           34579999999999995    6999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.7e-36  Score=317.99  Aligned_cols=198  Identities=23%  Similarity=0.340  Sum_probs=168.4

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ...++|+....||+|+||.||.|+.+.||+.+|+|++++..   ....+....|-.+|...++|.||++|..     |++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQD  212 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQD  212 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ecC
Confidence            35678999999999999999999999999999999997543   4556778889999999999999999976     777


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      .++.|+||||++|||+..++.+.      ..+++..+..++.+++-|+.-+|..   |+|||||||+|+|||..|++|++
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLMRK------DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeec
Confidence            78999999999999999999876      4789999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccc-----------------cccCC----CC------------------ccccccCcccccccchhh--
Q 042766          859 DFGLAKFLSNHHLD-----------------IASKT----PS------------------SSIGIKGTVGYVAPGKFF--  897 (914)
Q Consensus       859 DFGla~~~~~~~~~-----------------~~~~~----~~------------------~~~~~~GT~~y~APE~~~--  897 (914)
                      |||+++-+...+..                 .....    +.                  .....+|||.|||||++.  
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            99999654321100                 00000    00                  013578999999999995  


Q ss_pred             --hhhcccCccccccccc
Q 042766          898 --MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       898 --~~~~Di~s~g~~~~~~  913 (914)
                        +..+|.||+||++|||
T Consensus       364 gY~~~cDwWSLG~ImyEm  381 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEM  381 (550)
T ss_pred             CCCccccHHHHHHHHHHH
Confidence              5889999999999998

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.2e-37  Score=332.53  Aligned_cols=384  Identities=24%  Similarity=0.380  Sum_probs=223.9

Q ss_pred             cccccccccccccc-CcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceee
Q 042766          173 LKLQRLSVDINYLT-GQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF  251 (914)
Q Consensus       173 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  251 (914)
                      +-.+-.|+++|.++ +..|.....++++++|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.++
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            33444555555555 345555666666666666666665 55666666666666666666665 3334455566666666


Q ss_pred             ccCCccc-CcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcC
Q 042766          252 LTENRFS-GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL  330 (914)
Q Consensus       252 L~~N~l~-~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  330 (914)
                      +..|++. .-+|.++| .+..|+.||||+|++. ..|..+...+++-+|+||+|+|..++...|.+++.|-.|||++|++
T Consensus        85 ~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            6666653 23455666 6667777777777776 5666677777777777777777766666666777777777777776


Q ss_pred             CCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccc
Q 042766          331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH  410 (914)
Q Consensus       331 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  410 (914)
                      ...       |.....+..|++|+|++|.+...--.                         .+-.+++|++|.+++.+=+
T Consensus       163 e~L-------PPQ~RRL~~LqtL~Ls~NPL~hfQLr-------------------------QLPsmtsL~vLhms~TqRT  210 (1255)
T KOG0444|consen  163 EML-------PPQIRRLSMLQTLKLSNNPLNHFQLR-------------------------QLPSMTSLSVLHMSNTQRT  210 (1255)
T ss_pred             hhc-------CHHHHHHhhhhhhhcCCChhhHHHHh-------------------------cCccchhhhhhhcccccch
Confidence            654       33355666667777777665411000                         0112333444444433221


Q ss_pred             -ccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhh
Q 042766          411 -GTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQL  489 (914)
Q Consensus       411 -~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  489 (914)
                       ..+|.++..+.+|..+|||.|.+. .+|+.+.++.+|+.|+||+|+|+ .+.-..+...+|+.|++|.|+++ .+|..+
T Consensus       211 l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~av  287 (1255)
T KOG0444|consen  211 LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAV  287 (1255)
T ss_pred             hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHH
Confidence             234444444444444444444444 44444444444444444444444 33333344444555555555554 445555


Q ss_pred             hcccchhhhhcccCCccC-CCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCC
Q 042766          490 LSITTLSLVLDLSNNLLN-GSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSI  568 (914)
Q Consensus       490 ~~~~~l~~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  568 (914)
                      ..++.+ +.|++.+|+++ .-+|..++.|.+|+.+..++|.+. ..|..+..|..|+.|.|++|++. ..|.++.-|+.|
T Consensus       288 cKL~kL-~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l  364 (1255)
T KOG0444|consen  288 CKLTKL-TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDL  364 (1255)
T ss_pred             hhhHHH-HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCc
Confidence            555544 44555555443 236777788888888888888887 67888888888888888888886 678888888888


Q ss_pred             CEEEccCCccccccCccccccCCCCeEeCC
Q 042766          569 KALNVSSNNLSGKIPEFLENLSFLEFLNLS  598 (914)
Q Consensus       569 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  598 (914)
                      +.|||..|.=--..|.--..-+.|+.-++.
T Consensus       365 ~vLDlreNpnLVMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  365 KVLDLRENPNLVMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             ceeeccCCcCccCCCCcchhhhcceeeecc
Confidence            888888886443444322222455554443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-36  Score=320.74  Aligned_cols=187  Identities=33%  Similarity=0.481  Sum_probs=166.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+..  +++.+.+.+|++++++++|||||.++++     |+...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            46888899999999999999999999999999997543  3445678999999999999999999988     6777799


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+|.||+.| +|..++...      ..+++..+..|+.|++.||.|||+.   +|+|||+||.|||++..|++|++|||+
T Consensus        77 ~vVte~a~g-~L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQD------GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             EEEehhhhh-hHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence            999999976 999999876      4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+.......        ....+.|||.|||||++    ++..+|.||+||++||||
T Consensus       147 Ar~m~~~t~--------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~  194 (808)
T KOG0597|consen  147 ARAMSTNTS--------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELY  194 (808)
T ss_pred             hhhcccCce--------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHh
Confidence            997654321        22346799999999999    468999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=320.20  Aligned_cols=188  Identities=25%  Similarity=0.398  Sum_probs=168.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ...|...++||+|+.|.||.|+...+++.||||++....+...+-+.+|+.+|+..+|+|||.+++-|...     +..|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeE
Confidence            34677788999999999999999999999999999988888888899999999999999999999875433     5899


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|||||+||+|.+.+...       .+++.+...|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++
T Consensus       347 VVMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc  416 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC  416 (550)
T ss_pred             EEEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence            999999999999998753       589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      ..+.....        .....+|||+|||||++    +|.++||||+|+..+||+
T Consensus       417 aqi~~~~~--------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv  463 (550)
T KOG0578|consen  417 AQISEEQS--------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV  463 (550)
T ss_pred             eccccccC--------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHh
Confidence            87654321        23457899999999999    589999999999999996

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=315.80  Aligned_cols=190  Identities=26%  Similarity=0.419  Sum_probs=163.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchH-HHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIR-HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|...++||.|+||.||+|+...+++.||||+++.+-....+ .-.||+..|++++ |||||++.+++.+.+    .
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence            346899999999999999999999999999999999755444333 3468999999998 999999999854332    3


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++|||||+ .+|++.+++++     +.+++..++.|+.||++||+|+|.+   |+.|||+||||||+.....+||+||
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence            8999999995 59999998764     6899999999999999999999999   9999999999999998889999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+||.+....       +.  +..+.|.+|+|||++     |+.+.|+|++||+.+|.+
T Consensus       155 GLARev~Skp-------PY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~  204 (538)
T KOG0661|consen  155 GLAREVRSKP-------PY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY  204 (538)
T ss_pred             ccccccccCC-------Cc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH
Confidence            9999765321       11  246799999999998     469999999999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=316.20  Aligned_cols=188  Identities=35%  Similarity=0.532  Sum_probs=157.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc--hHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++...+.+|+|+||+||+|.++++ ..||||++...+...  .++|.+|+.+|++++|||||+++|+|....    ...+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~  116 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC  116 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence            344456699999999999999743 239999997543222  569999999999999999999999986543    2578


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCCCCCeeecCCC-cEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP-MVHGDLKPSNVLLDYDM-VAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~ki~DFG  861 (914)
                      +||||+++|+|.+++....    ...+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||
T Consensus       117 iVtEy~~~GsL~~~l~~~~----~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKR----KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence            9999999999999998741    26899999999999999999999999   6 99999999999999997 99999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh------hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~  913 (914)
                      +++......        .......||+.|||||++.      +.++||||||+++.|+
T Consensus       190 lsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl  239 (362)
T KOG0192|consen  190 LSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL  239 (362)
T ss_pred             cceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence            998754321        1122357999999999996      3899999999999886

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-34  Score=298.11  Aligned_cols=197  Identities=24%  Similarity=0.420  Sum_probs=165.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCC-cceEEeEeecCC-CCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRN-LIKIITICSSTD-FEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-~~~~  779 (914)
                      ...|+..++||+|+||+||+|+.+.+|+.||+|+++...  ++......+|+.+++.++|+| |+.+++++.... ++..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456777888999999999999999999999999998653  346677899999999999999 999999976543 2334


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||++ -+|.+++.......  ..++...+..+++|++.||+|||++   +|+||||||+|||++++|.+||+|
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence            47889999995 59999998754211  3566688999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.+.-+.        ..-+..++|..|.|||++.     +...||||+||+++|||
T Consensus       164 FGlAra~~ip~--------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~  215 (323)
T KOG0594|consen  164 FGLARAFSIPM--------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMF  215 (323)
T ss_pred             cchHHHhcCCc--------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHH
Confidence            99999654221        1123457999999999995     58999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=300.20  Aligned_cols=194  Identities=25%  Similarity=0.323  Sum_probs=167.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|+..++||.|..++||+|++..+++.||||++..++- ...+.+.+|+..|+.++||||++++..+.     .....
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----eccee
Confidence            4689999999999999999999999999999999986643 33588999999999999999999988744     34589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+||.||.+|++.++++..-.    ..+++..+..|.+++++||.|||.+   |.||||+|+.||||+.+|.|||+|||.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYP----DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCcee
Confidence            999999999999999987643    4688999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh------hhhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~------~~~~~Di~s~g~~~~~~  913 (914)
                      +..+.+.... .   ..+...++||+.|||||++      |+.++||||||+|..|+
T Consensus       173 sa~l~~~G~R-~---~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~EL  225 (516)
T KOG0582|consen  173 SASLFDSGDR-Q---VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACEL  225 (516)
T ss_pred             eeeecccCce-e---eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHH
Confidence            7766553311 1   1111567999999999995      56999999999998875

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-35  Score=299.73  Aligned_cols=191  Identities=27%  Similarity=0.423  Sum_probs=158.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      -.|...+++|+|+||.||+|+...+++.||||++-.+.+.    -.+|+++|++++|||||++..++....-.+.-+..+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3577789999999999999999999999999988544332    246999999999999999998877654332346678


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki~DFGla  863 (914)
                      ||||||. +|.++++....  ....++...+.-+++|+.+|++|||+.   +|+||||||+|+|+|.+ |.+||+|||.|
T Consensus       100 VleymP~-tL~~~~r~~~~--~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTR--ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHhchH-HHHHHHHHHhh--cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            9999975 99999985311  125678888889999999999999998   99999999999999977 99999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+...+.         .....-|..|+|||.++     +.+.||||.||++.||+
T Consensus       174 K~L~~~ep---------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl  220 (364)
T KOG0658|consen  174 KVLVKGEP---------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL  220 (364)
T ss_pred             eeeccCCC---------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh
Confidence            98754331         23456789999999995     58999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=307.71  Aligned_cols=189  Identities=30%  Similarity=0.515  Sum_probs=160.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.++..+.||+|.||+||.|++.. ...||+|.++.. ....++|.+|+++|++++|++||+++|+|....     ..+|
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyI  278 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYI  278 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEE
Confidence            455667889999999999999974 347999999744 345578999999999999999999999986533     6899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      |||||+.|+|.+|++...    ...+...+.+.++.|||+||+||.++   ++|||||.++||||+++..+||+|||+||
T Consensus       279 VtE~m~~GsLl~yLr~~~----~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTRE----GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEecccCcHHHHhhhcC----CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999998733    25788899999999999999999999   99999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      ...++.+....       +..-...|.|||.+    ++.++||||||++++|||
T Consensus       352 ~~~d~~Y~~~~-------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~f  398 (468)
T KOG0197|consen  352 LIGDDEYTASE-------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELF  398 (468)
T ss_pred             ccCCCceeecC-------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHh
Confidence            65554432211       12234579999999    579999999999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=298.15  Aligned_cols=197  Identities=25%  Similarity=0.334  Sum_probs=160.6

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------------CcchHHHHHHHHHHHhcCCCCcceE
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------------KGASKSFVSECEALRNIRHRNLIKI  767 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l  767 (914)
                      +...+|++.+.||+|.||+|-+|++..+++.||||++.+..              ....+...+||.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45578999999999999999999999999999999996432              1123578999999999999999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV  847 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NI  847 (914)
                      +++-.+..   .+..|||+|||..|.+...-...      ..+++.++++|+++++.||+|||.+   +||||||||+|+
T Consensus       174 iEvLDDP~---s~~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  174 IEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             EEeecCcc---cCceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            99854433   35789999999988876532221      2288999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCccccccccc
Q 042766          848 LLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       848 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~  913 (914)
                      |++++|+|||+|||.+..+.... +.  .....-...+|||.|||||...        +.+.||||+|+|+|-|
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~-~~--~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl  312 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGS-DE--GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL  312 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCC-cc--ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence            99999999999999998764321 10  1111222368999999999974        5899999999999854

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=293.38  Aligned_cols=194  Identities=26%  Similarity=0.368  Sum_probs=169.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEee--ccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..|...+.||+|+||.|+.|+++.+|+.||||++.  .+.....++..+|+++++.++|+||+.++++......+.-...
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            45666789999999999999999999999999996  5666677899999999999999999999999876555555678


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+|+|+| +-+|.+.++..      ..++...+..+.+|+++|++|+|+.   +|+|||+||.|++++.+...||+|||+
T Consensus       102 YiV~elM-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             EEehhHH-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence            9999999 56999999875      3588999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+.....      ......+..+.|.+|.|||+.     ++.+.||||.||++.||.
T Consensus       172 AR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL  222 (359)
T KOG0660|consen  172 ARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML  222 (359)
T ss_pred             eeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence            9987532      112233567899999999999     468999999999999983

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-34  Score=310.88  Aligned_cols=190  Identities=25%  Similarity=0.338  Sum_probs=163.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc----CC-cchHHHHHHHHHHHhcC-CCCcceEEeEeecCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK----QK-GASKSFVSECEALRNIR-HRNLIKIITICSSTD  775 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  775 (914)
                      ...+.|...+.||+|+||+|+.|++..+++.||+|+++.+    .. ...+.+.+|+.++++++ ||||++++++..   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            3456899999999999999999999999999999977643    12 23456778999999999 999999999954   


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-Cc
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MV  854 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~  854 (914)
                        .....++||||+.||+|.+++...      .++.+.++.+++.|++.|++|||++   +|+||||||||||++.+ ++
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence              444799999999999999999874      4678899999999999999999999   99999999999999999 99


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCccccccccc
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~  913 (914)
                      +||+|||++.....        ........+||+.|+|||++.      +.++||||+|+++|.|
T Consensus       160 ~Kl~DFG~s~~~~~--------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~m  216 (370)
T KOG0583|consen  160 LKLSDFGLSAISPG--------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVL  216 (370)
T ss_pred             EEEeccccccccCC--------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHH
Confidence            99999999987621        111223578999999999994      4789999999999876

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=308.28  Aligned_cols=182  Identities=28%  Similarity=0.377  Sum_probs=158.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      -|+..+.||+|+||.||.|++..+.+.||||++......   ...++.+|+..|++++|||+|.+.|+|...     ...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chH
Confidence            466678899999999999999999999999999754332   335889999999999999999999986543     367


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+||||| -|+-.|++.-++     +++.+.++..|+.+.++||+|||+.   +.||||||+.|||+++.|.||++|||.
T Consensus       102 WLVMEYC-lGSAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS  172 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS  172 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence            9999999 568888887654     5788889999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh-------hhhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-------~~~~~Di~s~g~~~~~~  913 (914)
                      |.....            ...++|||+|||||++       |+.++||||+|+||+|+
T Consensus       173 Asi~~P------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL  218 (948)
T KOG0577|consen  173 ASIMAP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  218 (948)
T ss_pred             hhhcCc------------hhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence            976532            1247999999999999       56999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-34  Score=294.01  Aligned_cols=186  Identities=24%  Similarity=0.349  Sum_probs=167.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      -+|++.+.+|+|+||+|-+|+.+..|+.||||.+++.   ++++.-.+.+|+++|+.++||||+++|++     |+..+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence            3788889999999999999999999999999999744   44555678999999999999999999998     788889


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      ..|||||..+|.|++|+.+.      ..+++.++.++++||..|+.|+|.+   +++|||||.+|||+|.++++||+|||
T Consensus       128 IvivMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            99999999999999999876      4799999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      ++-.+.+..         .-..+||+|-|.+||++.     |..+|-||+|+.+|.+
T Consensus       199 LSNly~~~k---------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtL  246 (668)
T KOG0611|consen  199 LSNLYADKK---------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTL  246 (668)
T ss_pred             hhhhhcccc---------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHH
Confidence            998776432         233689999999999984     5889999999988753

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-34  Score=306.83  Aligned_cols=194  Identities=28%  Similarity=0.478  Sum_probs=164.9

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      .+++....+++.+.+.||+|.||+||||+|.++   ||||++.....  ...+.|.+|+.++++-+|.||+-+.|||...
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            355556667788889999999999999999754   99999986653  3457999999999999999999999998655


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                      .      ..||+.+|+|.+|+.+++..+     ..++..+.++||.|||+|+.|||.+   +|||||||..||++.++++
T Consensus       461 ~------~AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k  526 (678)
T KOG0193|consen  461 P------LAIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK  526 (678)
T ss_pred             c------eeeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence            4      389999999999999998764     5789999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCccccccccc
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~  913 (914)
                      |||+|||+|..-.-....      ..-....|..-|||||+++       +.++|||||||+.|||
T Consensus       527 VkIgDFGLatvk~~w~g~------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YEL  586 (678)
T KOG0193|consen  527 VKIGDFGLATVKTRWSGE------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYEL  586 (678)
T ss_pred             EEEecccceeeeeeeccc------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHH
Confidence            999999999764332111      1112345888999999994       6999999999999997

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-33  Score=302.82  Aligned_cols=189  Identities=25%  Similarity=0.412  Sum_probs=166.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce-
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF-  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~-  781 (914)
                      ++|...+++|+|+||.++.++++.+++.||+|.+....  ....+...+|+.++++++|||||.+.+.+     ...+. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~-----~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF-----EEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccch-----hcCCce
Confidence            57888999999999999999999999999999998654  33445789999999999999999999884     33334 


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .+|||+||+||++.+.+++.++    ..+++.+..+++.|++.|+.|||++   +|+|||||+.||+++.++.|||+|||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence            9999999999999999987653    5789999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      +|+.+....        ......+|||.||.||++    ++.++||||+||.+|||
T Consensus       152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm  199 (426)
T KOG0589|consen  152 LAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM  199 (426)
T ss_pred             hhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence            999876533        122346899999999999    57999999999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=307.40  Aligned_cols=189  Identities=23%  Similarity=0.336  Sum_probs=165.2

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFE  777 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  777 (914)
                      ...++|...++||+|.||+|+.|..+.+++.+|||++++..   ..+.+..+.|.+|++.. +||.++.++..     |+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQ  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQ  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----cc
Confidence            34568999999999999999999999999999999998653   45677888999988877 49999999987     77


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      +.++.++||||+.||++..+.+.       ..+++..+..|+..|+.||+|||++   +|||||||.+|||+|.+|++||
T Consensus       440 T~~~l~fvmey~~Ggdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             cCCeEEEEEEecCCCcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence            77899999999999995554442       4799999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      +|||+++.-..        .......+||||.|||||++    |+.++|.|+||+.+|||
T Consensus       510 ADFGlcKe~m~--------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeM  561 (694)
T KOG0694|consen  510 ADFGLCKEGMG--------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEM  561 (694)
T ss_pred             cccccccccCC--------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHH
Confidence            99999985321        12234568999999999999    57999999999999998

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=282.71  Aligned_cols=185  Identities=24%  Similarity=0.360  Sum_probs=163.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      -|.+.+++|+|+||.||+|.++.+|..||||.+..+  .+.+++.+|+.++++++.|++|++||.|....     ..|+|
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIV  106 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIV  106 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEee
Confidence            477888999999999999999999999999998644  45678899999999999999999999864333     68999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ||||..|+..++++.++     +++++.+...+.+..++||+|||..   .-||||||+.|||+..+|.+|++|||.|..
T Consensus       107 MEYCGAGSiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             hhhcCCCcHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccch
Confidence            99999999999998654     6899999999999999999999998   889999999999999999999999999987


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +.+..        .......|||.|||||++.    ...+||||+|+|.+||
T Consensus       179 LTDTM--------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEM  222 (502)
T KOG0574|consen  179 LTDTM--------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEM  222 (502)
T ss_pred             hhhhH--------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhh
Confidence            65432        2233578999999999994    6999999999999998

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.9e-34  Score=295.84  Aligned_cols=187  Identities=27%  Similarity=0.385  Sum_probs=162.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..|+..+.||+|.||.||+|.+..+++.||+|+++.+. ....+++.+|+.++.+++++||.++|+.+...     ...|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHH
Confidence            45777799999999999999999999999999998664 44567899999999999999999999986543     3789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ++||||.||++.+.++...      .+.+.+..-|++++..|+.|+|.+   +.+|||||+.||++..+|.||++|||.+
T Consensus        88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa  158 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA  158 (467)
T ss_pred             HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence            9999999999999997643      346667777899999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      ..+....        .....++|||.|||||++    |+.++||||+|+|.|||
T Consensus       159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEl  204 (467)
T KOG0201|consen  159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIEL  204 (467)
T ss_pred             eeeechh--------hccccccccccccchhhhccccccchhhhhhhhHHHHHH
Confidence            7664322        222468999999999999    46999999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-33  Score=290.40  Aligned_cols=191  Identities=29%  Similarity=0.400  Sum_probs=156.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ...+..+.||+|.||.||+|+..  ++.||||++...   ..+.|..|-++.+.  ++|+||++++++-...+-. ....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence            34556689999999999999985  588999999643   33567777777654  6899999999875443322 3467


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC------CCCCcEecCCCCCCeeecCCCcEE
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH------CQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~------~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      ++|+||.+.|+|.+|++.+       ..+|....+|+.-+++||+|||+.      .+|+|+|||||++|||+..|+++.
T Consensus       284 wLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            9999999999999999875       689999999999999999999986      368999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhhh----------hhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM----------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~----------~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+|..+...      .+.....+.+||.+|||||++.|          .+.|+||+|.++-||+
T Consensus       357 IaDFGLAl~~~p~------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~  418 (534)
T KOG3653|consen  357 IADFGLALRLEPG------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA  418 (534)
T ss_pred             eeccceeEEecCC------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999877532      12223345789999999999953          7899999998877763

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.8e-32  Score=307.09  Aligned_cols=196  Identities=22%  Similarity=0.306  Sum_probs=161.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...   ......+.+|+++++.++||||+++++++.     ....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence            36889999999999999999999999999999997432   233456788999999999999999999854     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence            99999999999999998754      3588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccC------------------------------CCCccccccCcccccccchhh----hhhcccCccc
Q 042766          862 LAKFLSNHHLDIASK------------------------------TPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFS  907 (914)
Q Consensus       862 la~~~~~~~~~~~~~------------------------------~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g  907 (914)
                      +++.+..........                              ........+||+.|||||++.    +.++|+||+|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            997653221100000                              000111347999999999984    5789999999


Q ss_pred             ccccccC
Q 042766          908 CTNVHHF  914 (914)
Q Consensus       908 ~~~~~~f  914 (914)
                      |++|||+
T Consensus       227 ~il~el~  233 (364)
T cd05599         227 VIMYEML  233 (364)
T ss_pred             hHHHHhh
Confidence            9999985

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.98  E-value=1.9e-32  Score=306.37  Aligned_cols=196  Identities=23%  Similarity=0.295  Sum_probs=162.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|+..+.||+|+||+||+|++..+++.||+|+++...   ......+.+|++++++++||+|+++++.+.     ....
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence            36889999999999999999999999999999997432   233457788999999999999999998854     4457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.+.      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence            89999999999999999764      3688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccc---------------------------cCCCCccccccCcccccccchhh----hhhcccCcccccc
Q 042766          862 LAKFLSNHHLDIA---------------------------SKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTN  910 (914)
Q Consensus       862 la~~~~~~~~~~~---------------------------~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~  910 (914)
                      +|+.+........                           ..........+||+.|||||++.    +.++|+||+||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            9986532110000                           00000112457999999999984    5789999999999


Q ss_pred             cccC
Q 042766          911 VHHF  914 (914)
Q Consensus       911 ~~~f  914 (914)
                      |||+
T Consensus       227 ~ell  230 (363)
T cd05628         227 YEML  230 (363)
T ss_pred             HHHH
Confidence            9984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=3.8e-33  Score=268.96  Aligned_cols=207  Identities=22%  Similarity=0.254  Sum_probs=173.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|.+.+.+|+|||+.||.++...+++.||+|++.....++.+..++|++..++++|||++++++++....-++....|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            46899999999999999999999889999999999877777788999999999999999999999987765555667799


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ++++|...|+|.+.+...+.  +...+++.+.++|+.+|++|+++||+. .|+++||||||.||++.+++.+++.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            99999999999999976542  345799999999999999999999998 557999999999999999999999999988


Q ss_pred             ccccccccc-cccCCCCccccccCcccccccchh-------hhhhcccCccccccccc
Q 042766          864 KFLSNHHLD-IASKTPSSSIGIKGTVGYVAPGKF-------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       864 ~~~~~~~~~-~~~~~~~~~~~~~GT~~y~APE~~-------~~~~~Di~s~g~~~~~~  913 (914)
                      +...-.... .....-+.+.....|..|+|||.|       -+.++||||+|||+|+|
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~  234 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM  234 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence            754321100 000011123344578899999999       36999999999999986

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-32  Score=305.24  Aligned_cols=196  Identities=22%  Similarity=0.296  Sum_probs=160.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++.     ...+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence            36888999999999999999999999999999986432   233457889999999999999999999854     4458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999754      3578888999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccc---------ccCC------------------------------CCccccccCcccccccchhh----h
Q 042766          862 LAKFLSNHHLDI---------ASKT------------------------------PSSSIGIKGTVGYVAPGKFF----M  898 (914)
Q Consensus       862 la~~~~~~~~~~---------~~~~------------------------------~~~~~~~~GT~~y~APE~~~----~  898 (914)
                      +|+.+.......         ....                              .......+||+.|||||++.    +
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            997432211000         0000                              00001257999999999984    5


Q ss_pred             hhcccCcccccccccC
Q 042766          899 LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       899 ~~~Di~s~g~~~~~~f  914 (914)
                      .++|+||+||++|||+
T Consensus       227 ~~~DiwSlGvil~ell  242 (377)
T cd05629         227 QECDWWSLGAIMFECL  242 (377)
T ss_pred             CceeeEecchhhhhhh
Confidence            8899999999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=3.5e-32  Score=306.16  Aligned_cols=195  Identities=21%  Similarity=0.288  Sum_probs=160.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .|+..+.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|++++++++||||+++++++.     ..+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            6888999999999999999999999999999997542   234467889999999999999999999854     34589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            9999999999999999764      3578888999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccc---------------------------------------cCCCCccccccCcccccccchhh----hh
Q 042766          863 AKFLSNHHLDIA---------------------------------------SKTPSSSIGIKGTVGYVAPGKFF----ML  899 (914)
Q Consensus       863 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~GT~~y~APE~~~----~~  899 (914)
                      ++.+........                                       ..........+||+.|||||++.    +.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            865421100000                                       00000012357999999999984    57


Q ss_pred             hcccCcccccccccC
Q 042766          900 YTHIPSFSCTNVHHF  914 (914)
Q Consensus       900 ~~Di~s~g~~~~~~f  914 (914)
                      ++||||+||++|||+
T Consensus       228 ~~DiwSlG~il~ell  242 (381)
T cd05626         228 LCDWWSVGVILFEML  242 (381)
T ss_pred             ccceeehhhHHHHHH
Confidence            899999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.2e-33  Score=268.38  Aligned_cols=190  Identities=22%  Similarity=0.348  Sum_probs=166.2

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      .+.++|++.+.||+|.||.||.|+.+.++-.||+|++.+..   .+..+++.+|+++-+.++||||+++|+|+.     +
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d   93 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----D   93 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----c
Confidence            34578999999999999999999999999999999996442   345578999999999999999999999954     4


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....|+++||.++|++...+...+.    ..+++.....+..|+|.|+.|+|..   +||||||||+|+|++.++..||+
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            4589999999999999999985443    5688889999999999999999998   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |||.+-.-.          .......|||..|.|||+..    +..+|+|++|+.+||+
T Consensus       167 dfGwsV~~p----------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yef  215 (281)
T KOG0580|consen  167 DFGWSVHAP----------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEF  215 (281)
T ss_pred             CCCceeecC----------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHH
Confidence            999886421          22344689999999999996    4899999999999986

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=7.7e-32  Score=296.46  Aligned_cols=182  Identities=25%  Similarity=0.273  Sum_probs=155.3

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++++++||||+++++++.     ..+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence            46999999999999999999999999997432   233456788999999999999999998854     3458899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+...
T Consensus        76 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          76 YANGGELFFHLSRE------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            99999999998754      3678999999999999999999999   99999999999999999999999999997532


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  189 (323)
T cd05571         147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  189 (323)
T ss_pred             cCC--------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhh
Confidence            111        1122457999999999984    57899999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=295.38  Aligned_cols=181  Identities=28%  Similarity=0.442  Sum_probs=159.0

Q ss_pred             cccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccC
Q 042766          712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN  791 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  791 (914)
                      ++|+|+||+||.|++.++...+|||.+..++....+-+.+||...++++|.|||+++|.|..     .++.-|.||-+||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCCC
Confidence            79999999999999999999999999987777777889999999999999999999998543     3478899999999


Q ss_pred             CCHHHHHhccCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CCCcEEEecccccccccc
Q 042766          792 GSLEDWLHQSNDQVEVRKL--SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSN  868 (914)
Q Consensus       792 gsL~~~l~~~~~~~~~~~~--~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~~~~ki~DFGla~~~~~  868 (914)
                      |+|.+.++..=     .++  .+...-.+.+||++||.|||++   .|||||||-+||||. ..|.+||+|||.++.+..
T Consensus       657 GSLSsLLrskW-----GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  657 GSLSSLLRSKW-----GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             CcHHHHHHhcc-----CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            99999997542     334  6777888999999999999999   999999999999996 679999999999987643


Q ss_pred             cccccccCCCCccccccCcccccccchh------hhhhcccCccccccccc
Q 042766          869 HHLDIASKTPSSSIGIKGTVGYVAPGKF------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       869 ~~~~~~~~~~~~~~~~~GT~~y~APE~~------~~~~~Di~s~g~~~~~~  913 (914)
                      -        ..+...+.||..|||||++      +|.++||||||||.+||
T Consensus       729 i--------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM  771 (1226)
T KOG4279|consen  729 I--------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM  771 (1226)
T ss_pred             C--------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence            1        1233457899999999999      67999999999999998

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=4.5e-32  Score=302.99  Aligned_cols=191  Identities=19%  Similarity=0.264  Sum_probs=161.9

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.     .
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-----~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-----D  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----c
Confidence            3456899999999999999999999999999999998642   2233456889999999999999999999854     4


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||+++|+|.+++...       .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEE
Confidence            45899999999999999998643       478888999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.......       ......+||+.|||||++.        +.++|+||+||++|||+
T Consensus       185 DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell  241 (370)
T cd05621         185 DFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML  241 (370)
T ss_pred             ecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence            9999986532211       1112457999999999984        36899999999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=9.9e-32  Score=302.36  Aligned_cols=196  Identities=21%  Similarity=0.266  Sum_probs=160.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ......+.+|++++++++||||+++++.+.     ..+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCE
Confidence            36899999999999999999999999999999986432   233467889999999999999999998854     4458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRL------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            99999999999999999764      3578888899999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccc-----------------------------------ccCCCCccccccCcccccccchhh----hhhcc
Q 042766          862 LAKFLSNHHLDI-----------------------------------ASKTPSSSIGIKGTVGYVAPGKFF----MLYTH  902 (914)
Q Consensus       862 la~~~~~~~~~~-----------------------------------~~~~~~~~~~~~GT~~y~APE~~~----~~~~D  902 (914)
                      +|+.+.......                                   ...........+||+.|||||++.    +.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            986432100000                                   000000112457999999999984    57899


Q ss_pred             cCcccccccccC
Q 042766          903 IPSFSCTNVHHF  914 (914)
Q Consensus       903 i~s~g~~~~~~f  914 (914)
                      |||+||++|||.
T Consensus       227 iwSlGvilyell  238 (376)
T cd05598         227 WWSVGVILYEML  238 (376)
T ss_pred             eeeccceeeehh
Confidence            999999999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=5.3e-32  Score=298.40  Aligned_cols=186  Identities=22%  Similarity=0.303  Sum_probs=161.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|++++++++||||+++++++.     ..+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence            357999999999999999999999999999999997432   234467889999999999999999999854     345


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence            789999999999999999764      3578888899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.....           .....||+.|||||++.    +.++|+||+||++|||+
T Consensus       163 g~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  209 (329)
T PTZ00263        163 GFAKKVPDR-----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI  209 (329)
T ss_pred             cCceEcCCC-----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence            999865321           11357999999999984    57899999999999874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=5.8e-32  Score=304.77  Aligned_cols=195  Identities=20%  Similarity=0.270  Sum_probs=159.9

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++.+.     ..+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5888999999999999999999999999999996432   233457889999999999999999999854     34589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        77 ~lv~E~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence            9999999999999998754      3578888999999999999999999   999999999999999999999999999


Q ss_pred             ccccccccccc---------------------------------------ccCCCCccccccCcccccccchhh----hh
Q 042766          863 AKFLSNHHLDI---------------------------------------ASKTPSSSIGIKGTVGYVAPGKFF----ML  899 (914)
Q Consensus       863 a~~~~~~~~~~---------------------------------------~~~~~~~~~~~~GT~~y~APE~~~----~~  899 (914)
                      |+.+.......                                       ...........+||+.|||||++.    +.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            86432100000                                       000000112357999999999984    58


Q ss_pred             hcccCcccccccccC
Q 042766          900 YTHIPSFSCTNVHHF  914 (914)
Q Consensus       900 ~~Di~s~g~~~~~~f  914 (914)
                      ++|+||+||++|||+
T Consensus       228 ~~DiwSlGvil~ell  242 (382)
T cd05625         228 LCDWWSVGVILYEML  242 (382)
T ss_pred             eeeEEechHHHHHHH
Confidence            899999999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-32  Score=294.78  Aligned_cols=185  Identities=25%  Similarity=0.356  Sum_probs=160.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            36888999999999999999999899999999996432   23345788999999999999999999874     44458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence            89999999999999999764      3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.....           .....||+.|+|||++.    +.++||||+||++|+|+
T Consensus       147 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~  192 (291)
T cd05612         147 FAKKLRDR-----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML  192 (291)
T ss_pred             cchhccCC-----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            99865321           11346999999999985    57899999999999874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-33  Score=299.38  Aligned_cols=187  Identities=24%  Similarity=0.374  Sum_probs=165.0

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .|.++..||.|+||+||+|+.+.++...|.|++..+.....+++.-||+||+.++||+||++++.|+.     .+..||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----enkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----ENKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCceEEE
Confidence            46677789999999999999999998899999988888888999999999999999999999987542     2468999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      .|||.||-.+.++-.-+     +.+++.++..+++|++.||.|||++   .|||||||+.|||++-+|.++++|||.+..
T Consensus       108 iEFC~GGAVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             EeecCCchHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence            99999999999887654     5789999999999999999999999   999999999999999999999999998754


Q ss_pred             ccccccccccCCCCccccccCcccccccchh---------hhhhcccCccccccccc
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKF---------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~---------~~~~~Di~s~g~~~~~~  913 (914)
                      ...        +......+.|||+|||||+.         |++++||||||+|++||
T Consensus       180 n~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM  228 (1187)
T KOG0579|consen  180 NKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM  228 (1187)
T ss_pred             chh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence            321        12234468999999999998         57999999999999998

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=1e-31  Score=296.64  Aligned_cols=186  Identities=23%  Similarity=0.335  Sum_probs=159.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc-EEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|++..++ ..||+|++...   .....+.+.+|+++++.++||||+++++++..     .
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-----E  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----C
Confidence            357999999999999999999976554 78999998643   23345678899999999999999999998543     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~D  174 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTD  174 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEec
Confidence            5789999999999999999764      3588899999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.....           .....||+.|||||++.    +.++|+||+||++|||+
T Consensus       175 FG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  222 (340)
T PTZ00426        175 FGFAKVVDTR-----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL  222 (340)
T ss_pred             CCCCeecCCC-----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHh
Confidence            9999865321           12357999999999984    57899999999999984

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=296.43  Aligned_cols=185  Identities=23%  Similarity=0.354  Sum_probs=160.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+++++.++||||+++++++.     ..+.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence            36889999999999999999999999999999997432   234467889999999999999999998854     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence            89999999999999999754      3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+....           ......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  192 (333)
T cd05600         147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL  192 (333)
T ss_pred             CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhh
Confidence            9976432           112357999999999984    57899999999999984

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=309.78  Aligned_cols=203  Identities=23%  Similarity=0.274  Sum_probs=165.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeE-eecCCCCC-CceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITI-CSSTDFEG-VDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~-~~~~  782 (914)
                      ++++.++|.+|||+.||.|++...+..||+|++-..++...+...+||++|++++ |+|||.+++. .....-.+ ..+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5677889999999999999999887999999998778888899999999999997 9999999983 22221222 3467


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      .|.||||+||.|-+++..+..    ..+++.++++|++|+++|+++||.. +|+|||||||.||||++.+|..||||||-
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            899999999999999986532    4599999999999999999999987 78899999999999999999999999998


Q ss_pred             cccccccc-cccccCCCCccccccCcccccccchhh-------hhhcccCccccccccc
Q 042766          863 AKFLSNHH-LDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~-~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~  913 (914)
                      |....... .......-........|+-|+|||++-       ++++|||++||.+|.+
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL  251 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL  251 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence            86432211 000001111233456899999999982       6999999999999853

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=2e-31  Score=297.88  Aligned_cols=196  Identities=23%  Similarity=0.300  Sum_probs=162.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++...   ......+.+|+.++.+++||+|+++++.+     +....
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            36888999999999999999999999999999997432   33446788899999999999999999884     34458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence            89999999999999999764      3588899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccc---------------------------cCCCCccccccCcccccccchhh----hhhcccCcccccc
Q 042766          862 LAKFLSNHHLDIA---------------------------SKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTN  910 (914)
Q Consensus       862 la~~~~~~~~~~~---------------------------~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~  910 (914)
                      +++.+........                           ..........+||+.|||||++.    +.++|+||+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            9975532110000                           00001112457999999999984    5789999999999


Q ss_pred             cccC
Q 042766          911 VHHF  914 (914)
Q Consensus       911 ~~~f  914 (914)
                      |||+
T Consensus       227 yel~  230 (360)
T cd05627         227 YEML  230 (360)
T ss_pred             eecc
Confidence            9985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=1.1e-31  Score=300.32  Aligned_cols=195  Identities=19%  Similarity=0.259  Sum_probs=164.1

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      .++....++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++.+.  
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--  113 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--  113 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--
Confidence            34445567999999999999999999999999999999998642   2233456789999999999999999998854  


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                         .....++||||+++|+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus       114 ---~~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~  180 (371)
T cd05622         114 ---DDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             ---cCCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence               345899999999999999998643       477888899999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.......       ......+||+.|||||++.        +.++|+||+||++|||+
T Consensus       181 ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell  241 (371)
T cd05622         181 LKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  241 (371)
T ss_pred             EEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH
Confidence            99999999986543211       1112457999999999984        36899999999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=297.32  Aligned_cols=193  Identities=27%  Similarity=0.411  Sum_probs=160.8

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~  783 (914)
                      .|...+.||+||||.||+|+++.+|+.||||.++.. .....++..+|++++++++|||||+++++-.... .-......
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            345567899999999999999999999999999754 3455678899999999999999999998732211 00123568


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec--CCC--cEEEec
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--YDM--VAHVGD  859 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~ki~D  859 (914)
                      +|||||.||||...+.+...   ...+++.+.+.+..+++.||.|||++   +||||||||.||++-  .+|  ..||+|
T Consensus        94 lvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             EEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence            99999999999999987543   46799999999999999999999999   999999999999984  334  589999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      ||.||.+.++.         .....+||+.|.|||++.     +..+|-||||||+||.
T Consensus       168 fG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c  217 (732)
T KOG4250|consen  168 FGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC  217 (732)
T ss_pred             ccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence            99999876543         234578999999999984     5889999999999974

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.5e-32  Score=292.72  Aligned_cols=187  Identities=22%  Similarity=0.321  Sum_probs=163.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+.|+.++.||.|+.|.|..|++..||+.+|||++....   ......+.+|+.+|+-+.||||+++|++     ++...
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~   85 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQ   85 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCc
Confidence            356888999999999999999999999999999997552   2334578899999999999999999999     56666


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      +.|+|.||++||.|.+++-+++      ++++.++.++++||+.|+.|+|+.   +|+|||+||+|+|+|..+.+||+||
T Consensus        86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence            9999999999999999998764      688899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      |+|..-..+.         .-...||+|.|.|||+++     |.++||||-|+++|.+
T Consensus       157 GMAsLe~~gk---------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfAL  205 (786)
T KOG0588|consen  157 GMASLEVPGK---------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFAL  205 (786)
T ss_pred             ceeecccCCc---------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHH
Confidence            9998643322         223468999999999995     5899999999988753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=2.1e-31  Score=287.72  Aligned_cols=187  Identities=23%  Similarity=0.331  Sum_probs=158.2

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      |+..+.||+|+||.||+|++..+++.||+|.+....   ......+.+|++++++++|++|+++++++.     ..+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeEE
Confidence            677889999999999999999999999999986432   223346789999999999999999998854     344789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++.....    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999988864321    3688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......         ......||+.|||||++.    +.++|+||+||++++|+
T Consensus       150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~  195 (285)
T cd05631         150 VQIPEGE---------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI  195 (285)
T ss_pred             EEcCCCC---------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHH
Confidence            8653211         112346999999999984    58899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=1.2e-31  Score=299.88  Aligned_cols=190  Identities=20%  Similarity=0.271  Sum_probs=160.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|+++++.++||||+++++++.     ..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            456899999999999999999999999999999999643   2233456789999999999999999998843     44


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...       .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence            5899999999999999998643       467888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.......       ......+||+.|||||++.        +.++|+||+||++|||+
T Consensus       186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell  241 (370)
T cd05596         186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  241 (370)
T ss_pred             ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence            999986532211       0112357999999999974        46899999999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=5e-31  Score=290.38  Aligned_cols=182  Identities=25%  Similarity=0.277  Sum_probs=154.0

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|++..+++.||+|+++...   ......+.+|+++++.++||||+++++++.     ..+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence            46899999999999999999999999997432   233456788999999999999999998853     3458899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      |+++|+|.+++...      ..+++.++..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          76 YANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            99999999988754      368899999999999999999997 6   8999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        .......||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  190 (325)
T cd05594         147 IKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  190 (325)
T ss_pred             CCCC--------cccccccCCcccCCHHHHccCCCCCccccccccceeeeec
Confidence            2211        1112356999999999984    58899999999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=292.44  Aligned_cols=187  Identities=28%  Similarity=0.458  Sum_probs=155.5

Q ss_pred             ccccCcccCCccEEEEEEEECCCc----EEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDE----MVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      -...++||+|+||.||+|+.+..+    ..||||..+...   .....++.+|+++|++++|||||++||++....    
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~----  234 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE----  234 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----
Confidence            344589999999999999986432    238999987422   445678999999999999999999999976544    


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                       ..++|||+|+||+|.+++++.+     ..++..+...++.+.|.||+|||++   ++|||||.++|+|++.++.+||+|
T Consensus       235 -Pl~ivmEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  235 -PLMLVMELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             -ccEEEEEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence             6899999999999999999865     3689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.-........        ...-...|+|||.+    ++.++||||||++++|.|
T Consensus       306 FGLs~~~~~~~~~~~--------~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif  356 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKF--------LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF  356 (474)
T ss_pred             cccccCCcceeeccc--------cccCcceecChhhhccCccccccchhheeeeEEeee
Confidence            999875431111100        01234689999998    579999999999999987

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-31  Score=292.98  Aligned_cols=190  Identities=24%  Similarity=0.271  Sum_probs=160.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.     ..+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence            3688999999999999999999999999999999642   2334456889999999999999999998854     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.+..     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999997533     3688889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +++.+.....       .......||+.|||||++.         +.++|+||+||++|+|+
T Consensus       148 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~  202 (331)
T cd05597         148 SCLRLLADGT-------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML  202 (331)
T ss_pred             ceeecCCCCC-------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh
Confidence            9976543211       1112246999999999985         35799999999999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=3e-32  Score=289.02  Aligned_cols=173  Identities=29%  Similarity=0.485  Sum_probs=151.3

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEec
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEY  788 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  788 (914)
                      ..+-+|.|+.|.||+|+.+  ++.||||+++.-       -..+|+-|++++||||+.+.|+|....     ..+|||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEf  193 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEF  193 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeec
Confidence            3567999999999999996  578999987522       134788899999999999999987654     78999999


Q ss_pred             ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccc
Q 042766          789 MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN  868 (914)
Q Consensus       789 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~  868 (914)
                      |+.|.|+++++..      ..++....+.+..+||.|+.|||.+   .|||||||.-||||+.+..|||+|||.++...+
T Consensus       194 Ca~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             cccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            9999999999865      4688889999999999999999999   999999999999999999999999999987654


Q ss_pred             cccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       869 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      .         .....++||..|||||++.    ..++||||||+++.||
T Consensus       265 ~---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEm  304 (904)
T KOG4721|consen  265 K---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEM  304 (904)
T ss_pred             h---------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHH
Confidence            2         1233589999999999996    5999999999999887

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=274.84  Aligned_cols=189  Identities=28%  Similarity=0.438  Sum_probs=153.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+....+.||+|.||+||+|+|+  |+.||||++...   +.+.+.+|.++.+.  ++|+||+.+++.-.... ..-...
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEE
Confidence            35667789999999999999997  678999999643   33667788888776  59999999987532211 112358


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEecCCCCCCeeecCCCcEEE
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      |+|.||.|.|+|+||+.+.       .++....++++.-+|.||++||..     .+|.|.|||||+.|||+..++...|
T Consensus       285 wLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            9999999999999999863       688899999999999999999975     4799999999999999999999999


Q ss_pred             ecccccccccccc--cccccCCCCccccccCcccccccchhh----------hhhcccCcccccccc
Q 042766          858 GDFGLAKFLSNHH--LDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVH  912 (914)
Q Consensus       858 ~DFGla~~~~~~~--~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~  912 (914)
                      +|+|+|-......  .+.+      ....+||.+|||||++-          -..+||||||.++-|
T Consensus       358 ADLGLAv~h~~~t~~idi~------~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE  418 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIP------PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE  418 (513)
T ss_pred             eeceeeEEecccCCcccCC------CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence            9999997665432  2222      23468999999999982          288999999987655

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.6e-31  Score=276.04  Aligned_cols=199  Identities=27%  Similarity=0.293  Sum_probs=169.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|+..+.||+|.-|+||.|+.++++..+|+|++++..   +....+...|-+||+.++||.++.+|+.     |+...
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~  150 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDK  150 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccc
Confidence            457888899999999999999999999999999997543   4445678889999999999999999998     66677


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      +.++|||||+||+|....++...    ..+++..+..++.+|+-||+|||-.   |||.||||||||||.++|++.++||
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF  223 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF  223 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence            99999999999999999887654    6899999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccc-------------------------------ccc-----------------ccCCCCccccccCcccccc
Q 042766          861 GLAKFLSNHH-------------------------------LDI-----------------ASKTPSSSIGIKGTVGYVA  892 (914)
Q Consensus       861 Gla~~~~~~~-------------------------------~~~-----------------~~~~~~~~~~~~GT~~y~A  892 (914)
                      .++.......                               ...                 +.....++..++||-.|.|
T Consensus       224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA  303 (459)
T KOG0610|consen  224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA  303 (459)
T ss_pred             cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence            9875432100                               000                 0112233557899999999


Q ss_pred             cchhhh----hhcccCcccccccccC
Q 042766          893 PGKFFM----LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       893 PE~~~~----~~~Di~s~g~~~~~~f  914 (914)
                      ||++.|    -++|.|+||+.+|||.
T Consensus       304 PEvI~G~GHgsAVDWWtfGIflYEmL  329 (459)
T KOG0610|consen  304 PEVIRGEGHGSAVDWWTFGIFLYEML  329 (459)
T ss_pred             ceeeecCCCCchhhHHHHHHHHHHHH
Confidence            999974    8999999999999984

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=293.20  Aligned_cols=185  Identities=26%  Similarity=0.353  Sum_probs=159.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-C-----CCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-H-----RNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~  778 (914)
                      .+|.+.+.||+|+||.|.+|.+..|++.||||+++.+ .....+...|+.+|..++ |     -|+|++++++     ..
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~f  259 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YF  259 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cc
Confidence            3899999999999999999999999999999999633 334567788999999996 3     4799999994     44


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC--CcEE
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD--MVAH  856 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~--~~~k  856 (914)
                      .++.|||+|.+ ..+|+++++..+-    ..++...+..|+.||+.||.+||+.   +|||+||||||||+..-  ..+|
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence            45899999999 5699999998754    5799999999999999999999999   99999999999999654  3799


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||.|+...+...           ..+-+..|+|||++    ++.+.|+|||||+++|||
T Consensus       332 VIDFGSSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~  382 (586)
T KOG0667|consen  332 VIDFGSSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELF  382 (586)
T ss_pred             EEecccccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHh
Confidence            999999987543221           34677899999999    469999999999999997

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=4.2e-31  Score=291.03  Aligned_cols=182  Identities=25%  Similarity=0.291  Sum_probs=155.1

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|+++++.++||||+++++++.     ..+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence            46899999999999999999999999997432   234467889999999999999999998853     4458899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        76 y~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          76 YVNGGELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            99999999988754      3688999999999999999999999   99999999999999999999999999987532


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...        ......+||+.|||||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell  189 (328)
T cd05593         147 TDA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  189 (328)
T ss_pred             Ccc--------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHh
Confidence            211        1112357999999999984    58899999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.3e-31  Score=301.84  Aligned_cols=196  Identities=29%  Similarity=0.497  Sum_probs=163.4

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++....+.||+|+||+||+|+..     ++...||||.++..... ...+|++|+++++.++|||||+++|+|...+   
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~---  562 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD---  562 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC---
Confidence            44556789999999999999874     34578999999866554 6789999999999999999999999986554   


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCccc--------ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVE--------VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                        ..++|+|||..|||.+|+........        ..+++..+.+.||.|||.||+||-++   .+|||||..+|+||.
T Consensus       563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence              78999999999999999985433211        23488999999999999999999999   899999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      ++..|||+|||++|.+-..++.....      ...=..+|||||.+    |+..+||||||+++-|.|
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccC------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence            99999999999998765444332221      11235689999999    469999999999999887

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=3.1e-32  Score=270.01  Aligned_cols=197  Identities=25%  Similarity=0.361  Sum_probs=165.2

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCc----EEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDE----MVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ....|+....||+|+||.||+|+.+++.    +.+|+|.++.+.  .+......+|+..++.++|||++.+..++...  
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence            3457899999999999999999765443    378999997442  34567889999999999999999998886442  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC----
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD----  852 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~----  852 (914)
                        ....++++||.+. +|.++|+-++.... +.++...+..|..||+.|+.|||++   =|+||||||.|||+..+    
T Consensus       100 --d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper  172 (438)
T KOG0666|consen  100 --DKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER  172 (438)
T ss_pred             --CceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence              3578999999986 99999987665443 6899999999999999999999999   79999999999999887    


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      |.|||+|||+||.+...-.     +.......+-|.+|+|||.+.     +.+.|+|+.||++.|+
T Consensus       173 G~VKIaDlGlaR~~~~plk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl  233 (438)
T KOG0666|consen  173 GRVKIADLGLARLFNNPLK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL  233 (438)
T ss_pred             CeeEeecccHHHHhhcccc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence            8999999999999875432     222334578899999999994     5999999999999886

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.6e-31  Score=289.75  Aligned_cols=180  Identities=23%  Similarity=0.332  Sum_probs=153.9

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||.||+|++..+++.||+|+++..   .......+.+|++++++++||||+++++++.     ..+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            69999999999999999999999999643   2334467889999999999999999998854     345789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          76 NGGELFHHLQRE------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            999999999764      3588899999999999999999999   9999999999999999999999999999753221


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~  187 (312)
T cd05585         147 D--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML  187 (312)
T ss_pred             C--------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHH
Confidence            1        1122357999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=2.9e-31  Score=291.78  Aligned_cols=182  Identities=25%  Similarity=0.289  Sum_probs=154.4

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|++..+++.||+|+++..   .......+.+|++++++++||||+++++++.     ..+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            4689999999999999999999999999743   2233456788999999999999999998854     3457899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          76 YANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            99999999988754      3688999999999999999999999   99999999999999999999999999987532


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...        .......||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  189 (323)
T cd05595         147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  189 (323)
T ss_pred             CCC--------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHH
Confidence            211        1112357999999999984    58899999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=5.2e-31  Score=291.14  Aligned_cols=190  Identities=23%  Similarity=0.258  Sum_probs=161.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.     ....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence            36888999999999999999999999999999997432   234467889999999999999999998853     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.+..     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence            899999999999999997653     3688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+......       ......||+.|+|||++.          +.++||||+||++|||+
T Consensus       148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~  203 (330)
T cd05601         148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI  203 (330)
T ss_pred             CCeECCCCCce-------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence            99865432211       112346999999999985          37899999999999984

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=4.4e-31  Score=291.36  Aligned_cols=190  Identities=23%  Similarity=0.285  Sum_probs=160.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+|+.+++.++|++|+++++++.     ..+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence            3688999999999999999999999999999998642   2233456788999999999999999999854     4458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++||+|.+++.+..     ..+++..+..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence            899999999999999997642     3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.......       .......||+.|||||++.         +.++|+||+||++|||+
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell  202 (331)
T cd05624         148 SCLKMNQDGT-------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML  202 (331)
T ss_pred             ceeeccCCCc-------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh
Confidence            9976543211       1112356999999999874         36799999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=2.1e-31  Score=295.31  Aligned_cols=198  Identities=22%  Similarity=0.356  Sum_probs=157.9

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|+++++++ +||||++++++|...  
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP--   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence            467999999999999999999852     345689999986432 23346789999999999 899999999987432  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcc---------------------------------------------------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQV---------------------------------------------------  805 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  805 (914)
                        ....++||||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence              245789999999999999997532100                                                   


Q ss_pred             -----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCc
Q 042766          806 -----EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS  880 (914)
Q Consensus       806 -----~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~  880 (914)
                           ....+++.++..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+|+.........      .
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------~  232 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------R  232 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchh------c
Confidence                 013578888999999999999999999   99999999999999999999999999998653321110      1


Q ss_pred             cccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          881 SIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       881 ~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....+|+.|||||++.    +.++|||||||++|||+
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~  270 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF  270 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHH
Confidence            11234678899999984    57899999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=281.63  Aligned_cols=191  Identities=24%  Similarity=0.361  Sum_probs=166.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ....|..-++||+|+||.||-|+.+.||+.||+|.+.++   .+........|-.+++++..+.||.+-..     |+..
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk  257 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK  257 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence            345678889999999999999999999999999988643   34455677899999999999999987655     6777


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||..|.||+|.-+|.+.+.    ..+++..+..++.+|+.||++||..   +||.||+||+|||+|+.|+++|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence            799999999999999988887653    5799999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      .|+|..+.+..         ...+.+||.+|||||++    ++...|-||+||.+|||+
T Consensus       331 LGLAvei~~g~---------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi  380 (591)
T KOG0986|consen  331 LGLAVEIPEGK---------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI  380 (591)
T ss_pred             cceEEecCCCC---------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence            99998775432         12245899999999999    568899999999999984

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-33  Score=265.28  Aligned_cols=187  Identities=24%  Similarity=0.376  Sum_probs=159.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|++.+.||+|+|+.||++.++.+|+.+|+|++...  .....+.+.+|+.+.+.++||||+++.+.     +....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            346788889999999999999999999999999999643  33466789999999999999999999876     44456


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~ki  857 (914)
                      +.|+|+|+|+|++|..-+-.+      ..+++..+-.++.||++|+.|+|.+   +|||||+||+|+++...   ..+|+
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceee
Confidence            899999999999997644332      4678889999999999999999999   99999999999999643   46999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVH  912 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~  912 (914)
                      +|||+|..+.+.         ....+++|||+|||||++    ++..+|||+-|+++|.
T Consensus       155 ~~FGvAi~l~~g---------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfi  204 (355)
T KOG0033|consen  155 ADFGLAIEVNDG---------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI  204 (355)
T ss_pred             cccceEEEeCCc---------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHH
Confidence            999999876532         234467999999999999    5799999999988764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=5.2e-31  Score=285.19  Aligned_cols=188  Identities=25%  Similarity=0.408  Sum_probs=158.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++.     .....+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            57899999999999999999999999999999997443 233457789999999999999999999853     344789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++ +|.+++...+     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          80 LVFEYLDS-DLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             EEEeCCCc-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999974 9999887543     3578889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......||+.|||||++.     +.++|+||+||++|+|+
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~  198 (288)
T cd07871         151 RAKSVPT--------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA  198 (288)
T ss_pred             eeccCCC--------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHH
Confidence            7543211        1112346899999999884     47899999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.5e-31  Score=293.09  Aligned_cols=196  Identities=23%  Similarity=0.303  Sum_probs=163.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|.+.+.||+|+||+||+|++..+++.||||+++...   ......+.+|+++++.++||||+++++++     +..+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            36889999999999999999999999999999997432   24456788999999999999999999874     34458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence            99999999999999999764      3688899999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccccc---------------------cccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLD---------------------IASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~---------------------~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++........                     .............||+.|+|||++.    +.++||||+||++|||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  224 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML  224 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence            99865432200                     0000011123457999999999985    47999999999999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.2e-31  Score=291.84  Aligned_cols=194  Identities=25%  Similarity=0.322  Sum_probs=160.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|++..+++.||||+++..  ......++.+|++++++++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999999999999998632  223345788999999999999999999987655444445689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++...      ..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        81 lv~e~~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          81 VVFELME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEecCC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence            9999995 6999988754      3588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      +........     ........||+.|+|||++.      +.++||||+||++|||+
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~  202 (338)
T cd07859         151 RVAFNDTPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL  202 (338)
T ss_pred             cccccccCc-----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH
Confidence            864321110     11122457999999999873      46899999999999874

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.4e-31  Score=260.46  Aligned_cols=189  Identities=28%  Similarity=0.401  Sum_probs=162.6

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----c---chHHHHHHHHHHHhc-CCCCcceEEeEe
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----G---ASKSFVSECEALRNI-RHRNLIKIITIC  771 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~---~~~~~~~E~~~l~~l-~h~niv~l~~~~  771 (914)
                      +.....|...+.+|+|..++|.+|.++.++..+|+|++.....     .   -.++..+|+.+++++ .||+|+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678888999999999999999999999999999974321     1   134667899999998 699999999984


Q ss_pred             ecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC
Q 042766          772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY  851 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~  851 (914)
                           +...+.++|+|.|+.|.|.+++...      ..+++.+..+|++|+.+|+.|||.+   .|||||+||+|||+|+
T Consensus        93 -----es~sF~FlVFdl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd  158 (411)
T KOG0599|consen   93 -----ESDAFVFLVFDLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD  158 (411)
T ss_pred             -----cCcchhhhhhhhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence                 4555889999999999999999764      6799999999999999999999999   9999999999999999


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccccCcccccccchh----------hhhhcccCcccccccc
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----------FMLYTHIPSFSCTNVH  912 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----------~~~~~Di~s~g~~~~~  912 (914)
                      +.++||+|||+|+.+...+         .-...||||+|.|||.+          ++..+|+|+.|++.|.
T Consensus       159 n~~i~isDFGFa~~l~~Ge---------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyT  220 (411)
T KOG0599|consen  159 NMNIKISDFGFACQLEPGE---------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYT  220 (411)
T ss_pred             ccceEEeccceeeccCCch---------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHH
Confidence            9999999999998765432         23357999999999998          4689999999988764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=1.5e-30  Score=287.70  Aligned_cols=188  Identities=22%  Similarity=0.257  Sum_probs=157.0

Q ss_pred             cccccCcccCCccEEEEEEEEC---CCcEEEEEEEeecc----CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLK----QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFE  777 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  777 (914)
                      +|++.+.||+|+||.||+|+..   .+++.||+|+++..    .....+.+.+|++++++++ ||+|+++++++     +
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4788899999999999999874   46889999999642    2233456788999999994 99999999874     4


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      ..+..++||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl  146 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL  146 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence            445789999999999999998754      3588899999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++.+.....       .......||+.|||||++.     +.++||||+||++|||+
T Consensus       147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  201 (332)
T cd05614         147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL  201 (332)
T ss_pred             eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh
Confidence            99999986532211       1122457999999999984     35799999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=1e-30  Score=288.76  Aligned_cols=190  Identities=23%  Similarity=0.281  Sum_probs=159.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...   .......+.+|+.++..++|++|+++++++.     ....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence            3688899999999999999999999999999998632   2233456888999999999999999998854     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.+..     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999997643     3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......       ......+||+.|||||++.         +.++|+|||||++|||+
T Consensus       148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell  202 (332)
T cd05623         148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML  202 (332)
T ss_pred             hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh
Confidence            9975432111       1112357999999999984         46899999999999874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=264.75  Aligned_cols=197  Identities=22%  Similarity=0.353  Sum_probs=165.5

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCC
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTD  775 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  775 (914)
                      +++.-+.++     +.||+|+|+.|--|+...++..||||++++.......+..+|++++.+++ |+||++++++     
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----  144 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----  144 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence            445444443     68999999999999999999999999998776666788999999999995 9999999999     


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC--
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--  853 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~--  853 (914)
                      |++....|+|||-|.||+|.+.|.++      ..+++.++.+++.+|+.||.|||.+   ||.|||+||+|||.....  
T Consensus       145 FEdd~~FYLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  145 FEDDTRFYLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             hcccceEEEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence            77777999999999999999999876      4689999999999999999999999   999999999999997654  


Q ss_pred             -cEEEecccccccccccccccccCCCCccccccCcccccccchh---------hhhhcccCccccccccc
Q 042766          854 -VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF---------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       854 -~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~---------~~~~~Di~s~g~~~~~~  913 (914)
                       -|||+||.++.-+.-...-.+.. ...-...+|+..|||||+.         |+.+.|.||+|+++|.|
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spas-tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm  284 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPAS-TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM  284 (463)
T ss_pred             CceeeeccccccccccCCCCCCCC-CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence             58999999986544322111111 2233457899999999997         57999999999999977

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=9.1e-31  Score=285.55  Aligned_cols=189  Identities=24%  Similarity=0.396  Sum_probs=157.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++.     .....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            367999999999999999999999899999999997443 233456789999999999999999999854     34578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ +++.+++....     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999995 68888876543     3578888999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......        .......||+.|||||++.     +.++|+||+||++|||+
T Consensus       150 ~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  198 (303)
T cd07869         150 ARAKSVPS--------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI  198 (303)
T ss_pred             ceeccCCC--------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence            97543211        1112346899999999974     46789999999999873

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=1.5e-30  Score=286.15  Aligned_cols=182  Identities=25%  Similarity=0.308  Sum_probs=153.4

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..+++.||+|+++..   .....+.+..|.++++.+ +||+|+++++++.     ..+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            4699999999999999999999999999743   233445677899998876 7999999999854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          76 EYVNGGDLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999999999988754      3578889999999999999999999   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        .......||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  190 (321)
T cd05591         147 ILNG--------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM  190 (321)
T ss_pred             ccCC--------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHh
Confidence            2211        1122357999999999984    57899999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=285.68  Aligned_cols=186  Identities=30%  Similarity=0.364  Sum_probs=162.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  779 (914)
                      ...|++.+.||+|.||+||+|+.+.+|+.+|+|++.+...   ...+.+.+|+.+|+++. |||||++++.     ++..
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FEDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEcC
Confidence            3578888999999999999999999999999999975543   23468999999999998 9999999999     4555


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC----CcE
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD----MVA  855 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~----~~~  855 (914)
                      ...++|||+++||.|.+.+...       .+++..+..++.|++.|++|||+.   +|+|||+||+|+|+...    +.+
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence            5899999999999999998754       289999999999999999999998   99999999999999643    579


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |++|||+|.....         .......+||++|+|||+..    +..+|+||.|++.|.|
T Consensus       179 k~~DFGla~~~~~---------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiL  231 (382)
T KOG0032|consen  179 KLIDFGLAKFIKP---------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYIL  231 (382)
T ss_pred             EEeeCCCceEccC---------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHH
Confidence            9999999987653         12334679999999999994    6999999999998875

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=2.1e-30  Score=285.39  Aligned_cols=182  Identities=27%  Similarity=0.332  Sum_probs=151.2

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++.     ..+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            46999999999999999999999999996432   223345556655 467799999999998854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          76 DFVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            999999999988654      4688999999999999999999999   9999999999999999999999999998743


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  190 (325)
T cd05604         147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML  190 (325)
T ss_pred             CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhh
Confidence            2111        1122457999999999984    47899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=1.3e-30  Score=285.60  Aligned_cols=182  Identities=23%  Similarity=0.310  Sum_probs=151.8

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|.+++... +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999997432   23345566777777654 8999999998853     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~gg~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          76 EYLNGGDLMFHIQSS------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             cCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            999999999998754      3588889999999999999999999   9999999999999999999999999999754


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||+++||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  190 (316)
T cd05592         147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML  190 (316)
T ss_pred             CCCC--------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHH
Confidence            3211        1122457999999999984    57899999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1.4e-30  Score=286.51  Aligned_cols=187  Identities=21%  Similarity=0.263  Sum_probs=156.3

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCce
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +|.+.+.||+|+||.||+|++..+++.||+|+++...   ....+.+..|..++..+ .|++|+++++++.     ..+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence            5788899999999999999999999999999997432   22334667788888877 5788999988853     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence            89999999999999998754      3578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  195 (323)
T cd05616         147 MCKENMWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML  195 (323)
T ss_pred             CceecCCCC--------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHH
Confidence            997532111        1122357999999999985    57899999999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=242.30  Aligned_cols=186  Identities=24%  Similarity=0.407  Sum_probs=159.0

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|...++||+|+||+||+|+.+++++.||+|+++..+  ++......+|+.+++.++|.|||+++++.     ......-
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence            5677789999999999999999999999999998553  45567889999999999999999999873     3345788


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+|||. .+|..+...-.     ..++...+..++.|+++|+.|+|++   ++.|||+||+|.+|..+|+.|++|||+|
T Consensus        78 lvfe~cd-qdlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             EeHHHhh-HHHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence            9999994 58998887643     4678888999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhhh-----hhcccCccccccccc
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-----LYTHIPSFSCTNVHH  913 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~Di~s~g~~~~~~  913 (914)
                      +.+.-+.        .+-...+-|.+|.+|.+++|     ...|+||-||++.|+
T Consensus       149 rafgipv--------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifael  195 (292)
T KOG0662|consen  149 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL  195 (292)
T ss_pred             hhcCCce--------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHH
Confidence            9765321        12234568999999999964     889999999998774

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=1.7e-30  Score=286.27  Aligned_cols=182  Identities=22%  Similarity=0.284  Sum_probs=153.5

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++..     ....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence            46999999999999999999999999997542   23345677899988876 79999999998543     45789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          76 EYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            999999999988654      3688999999999999999999999   9999999999999999999999999999753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        .......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  190 (329)
T cd05618         147 LRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM  190 (329)
T ss_pred             cCCC--------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh
Confidence            2111        1122357999999999985    47899999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.3e-30  Score=286.97  Aligned_cols=187  Identities=22%  Similarity=0.268  Sum_probs=156.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCC-CcceEEeEeecCCCCCCce
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHR-NLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~  781 (914)
                      +|++.+.||+|+||.||+|++..+++.||+|+++..   .....+.+..|+++++.++|+ +|+++++++.     ..+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            478889999999999999999999999999999743   233456788899999999875 5777877743     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence            89999999999999998754      3578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......        ......+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell  195 (324)
T cd05587         147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML  195 (324)
T ss_pred             cceecCCCC--------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH
Confidence            987432111        1122457999999999985    47899999999999874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=1.4e-30  Score=285.93  Aligned_cols=182  Identities=24%  Similarity=0.306  Sum_probs=153.4

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|+++.+++.||||+++..   .....+.+.+|.++++.. +||||+++++++.     ..+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            4689999999999999999999999999743   233456778888888876 6999999999853     445789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 Ey~~~g~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          76 EFVNGGDLMFHIQKS------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             cCCCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999999999988764      3588899999999999999999999   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        .......||+.|||||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  190 (320)
T cd05590         147 IFNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML  190 (320)
T ss_pred             CcCC--------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHh
Confidence            2111        1122357999999999985    57899999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=1.5e-30  Score=284.06  Aligned_cols=196  Identities=23%  Similarity=0.383  Sum_probs=157.5

Q ss_pred             hcccccCcccCCccEEEEEEEECC----------------CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD----------------DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKI  767 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  767 (914)
                      ++|.+.+.||+|+||.||+|++..                ++..||+|++.... .....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998642                34579999987543 2234578999999999999999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ-------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQ  834 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~  834 (914)
                      ++++...     +..++||||+++|+|.+++......             .....+++.++.+++.|++.|++|||+.  
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            9996543     3689999999999999998653211             1113578888999999999999999999  


Q ss_pred             CCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccc
Q 042766          835 PPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTN  910 (914)
Q Consensus       835 ~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~  910 (914)
                       +|+||||||+||+++.++.+||+|||+++.........      ......++..|||||++.    +.++|+|||||++
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence             99999999999999999999999999998654322110      111234688999999974    5889999999999


Q ss_pred             cccC
Q 042766          911 VHHF  914 (914)
Q Consensus       911 ~~~f  914 (914)
                      |||+
T Consensus       231 ~el~  234 (304)
T cd05096         231 WEIL  234 (304)
T ss_pred             HHHH
Confidence            9863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=2.7e-30  Score=284.31  Aligned_cols=182  Identities=29%  Similarity=0.363  Sum_probs=150.6

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||+|++....   ....+.+.+|.. +++.++||||+++++++.     ..+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999996432   222344555555 467899999999998854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          76 DYVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             cCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            999999999998754      3678889999999999999999999   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  190 (323)
T cd05575         147 IEHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML  190 (323)
T ss_pred             ccCC--------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhh
Confidence            2211        1122457999999999984    47899999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=2.5e-30  Score=284.37  Aligned_cols=182  Identities=28%  Similarity=0.339  Sum_probs=150.2

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++.     ..+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999999999999999996432   223344555554 578899999999998854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          76 DYVNGGELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            999999999888654      3578888999999999999999998   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  190 (321)
T cd05603         147 VEPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML  190 (321)
T ss_pred             CCCC--------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhh
Confidence            2211        1122457999999999984    47899999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1.9e-30  Score=286.07  Aligned_cols=182  Identities=21%  Similarity=0.263  Sum_probs=153.9

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..+++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence            46899999999999999999999999997432   23345678899999998 7999999999854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          76 EFVSGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            999999999988654      3689999999999999999999999   9999999999999999999999999998742


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  190 (329)
T cd05588         147 IRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM  190 (329)
T ss_pred             ccCC--------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH
Confidence            2111        1122457999999999985    47899999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=3.2e-30  Score=279.49  Aligned_cols=193  Identities=24%  Similarity=0.440  Sum_probs=158.1

Q ss_pred             hcccccCcccCCccEEEEEEEEC-CCcEEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-DDEMVVAVKVINLKQ--KGASKSFVSECEALRNI---RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||+||+|++. .+++.||+|+++...  ......+.+|+++++++   +||||++++++|.....+.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999985 457889999987443  22335667788887766   6999999999986544444


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||++ ++|.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence            557899999996 699999875432    4588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++......         ......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       153 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  203 (290)
T cd07862         153 DFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF  203 (290)
T ss_pred             cccceEeccCCc---------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHH
Confidence            999998654221         112356999999999984    57899999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.5e-30  Score=286.42  Aligned_cols=185  Identities=23%  Similarity=0.319  Sum_probs=154.1

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHH---HhcCCCCcceEEeEeecCCCCCCc
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEAL---RNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      |++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|++++   +.++||||+++++++.     ...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            567889999999999999999999999999997432   23345667776665   5668999999999854     345


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|..++..       ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence            88999999999999988754       3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  195 (324)
T cd05589         146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML  195 (324)
T ss_pred             cCCccCCCCC--------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence            9987432111        1122467999999999984    57899999999999974

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=3e-30  Score=284.21  Aligned_cols=182  Identities=30%  Similarity=0.374  Sum_probs=149.4

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||+|++....   ......+.+|.. +++.++||||+++++++.     ..+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            46999999999999999999999999997432   122234444444 567899999999998854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+|+..
T Consensus        76 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          76 DYINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             eCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            999999999998764      3577888889999999999999999   9999999999999999999999999999753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  190 (325)
T cd05602         147 IEHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML  190 (325)
T ss_pred             ccCC--------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHh
Confidence            2211        1122457999999999984    47899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=2.7e-30  Score=284.17  Aligned_cols=182  Identities=23%  Similarity=0.310  Sum_probs=152.2

Q ss_pred             CcccCCccEEEEEEEEC---CCcEEEEEEEeecc----CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          711 NMIGQGRFGTVYKGILG---DDEMVVAVKVINLK----QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.||+|+||.||+|+..   .+++.||+|+++..    .......+.+|++++++++||||+++++++..     .+..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeEE
Confidence            67999999999999874   46889999999743    22334567889999999999999999988543     44789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          77 LILEYLSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             EEEeCCCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            999999999999998764      3577888889999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......||+.|+|||++.    +.++||||+||++|||+
T Consensus       148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  194 (323)
T cd05584         148 KESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML  194 (323)
T ss_pred             eecccCC--------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHh
Confidence            7532211        1112357999999999984    47899999999999974

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=300.48  Aligned_cols=194  Identities=21%  Similarity=0.254  Sum_probs=162.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCC-cEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD-EMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+++++.++||||+++++++..     .+..+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEE
Confidence            3488999999999999999998777 78899998765555555678889999999999999999999644     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.++++....  ....+++.++..++.|++.||+|+|++   +|+||||||+|||++.++.+||+|||+|
T Consensus       142 lv~E~~~gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            99999999999998864321  124688899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+.....      .......+||+.|||||++.    +.++||||+||++|||+
T Consensus       217 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  265 (478)
T PTZ00267        217 KQYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL  265 (478)
T ss_pred             eecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH
Confidence            87643211      11122457999999999984    57899999999999985

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=2.8e-30  Score=285.08  Aligned_cols=188  Identities=22%  Similarity=0.339  Sum_probs=161.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..++..||+|+++.... ...+.+.+|++++++++||||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence            3589999999999999999999999999999999975432 3346789999999999999999999986543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...      ..+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            9999999999999999764      35788899999999999999999852  699999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......          .....||+.|+|||++.    +.++|+||+||++|||+
T Consensus       151 ~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  196 (331)
T cd06649         151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA  196 (331)
T ss_pred             cccccccc----------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence            97653211          12346999999999985    47899999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.5e-30  Score=292.26  Aligned_cols=182  Identities=23%  Similarity=0.297  Sum_probs=155.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|++.+.||+|+||.||+|++..+++.||+|...      ...+.+|++++++++||||+++++++..     ....++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEE
Confidence            57999999999999999999999999999999653      2356789999999999999999998543     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+. ++|.+++...      ..+++.+++.++.|++.||+|||++   +||||||||+||+++.++.+||+|||+|+
T Consensus       161 v~e~~~-~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~  230 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAK------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC  230 (391)
T ss_pred             EEecCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence            999994 7899888654      3578899999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......       ........||+.|+|||++.    +.++|+||+||++|||+
T Consensus       231 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  277 (391)
T PHA03212        231 FPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA  277 (391)
T ss_pred             cccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            543211       11122457999999999984    57899999999999873

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.7e-31  Score=286.61  Aligned_cols=186  Identities=23%  Similarity=0.451  Sum_probs=160.9

Q ss_pred             cccCcccCCccEEEEEEEECCCcEEEEEEEeec----cCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL----KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       708 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +..++||+|+|-+||+|.+..+|..||.-.++.    +.....++|..|+.+|+.++|||||++|.++.+..   .....
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence            556799999999999999999999998655542    23445589999999999999999999999976554   24678


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki~DFGl  862 (914)
                      +|+|.+..|+|..|+++++      .++......|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|.|+
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             eeeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            9999999999999999874      578889999999999999999998 7899999999999999865 8999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh---hhhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF---FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~---~~~~~Di~s~g~~~~~~  913 (914)
                      |+.......          ...+|||.|||||++   |...+||||||..+.||
T Consensus       193 Atl~r~s~a----------ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEM  236 (632)
T KOG0584|consen  193 ATLLRKSHA----------KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEM  236 (632)
T ss_pred             HHHhhcccc----------ceeccCccccChHHHhhhcchhhhhhhhhHHHHHH
Confidence            997654321          236899999999999   57999999999998887

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=304.23  Aligned_cols=196  Identities=24%  Similarity=0.305  Sum_probs=170.7

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeec---cCCcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL---KQKGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      .++.-..++|.+.++||+|+||.|..++++.++++||+|++.+   -.+.....|..|-.+|...+.+-|+.++..    
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA----  143 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA----  143 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH----
Confidence            3444556799999999999999999999999999999999975   345566789999999999999999998765    


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                       |++..+.|+|||||+||+|-..+.+.+      .+++..+..|+..|+-|+.-+|+.   |+|||||||+|||+|..|+
T Consensus       144 -FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  144 -FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             -hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCc
Confidence             788889999999999999999998763      688999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchh---------hhhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF---------FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~---------~~~~~Di~s~g~~~~~~f  914 (914)
                      +|++|||.+-.+..++.       ..+...+|||.|++||++         ||.-+|.||+|+.+|||+
T Consensus       214 ikLADFGsClkm~~dG~-------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl  275 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADGT-------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML  275 (1317)
T ss_pred             EeeccchhHHhcCCCCc-------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence            99999998865543221       123346899999999998         468899999999999995

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=2.7e-30  Score=283.08  Aligned_cols=182  Identities=21%  Similarity=0.301  Sum_probs=152.3

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|+++.+++.||+|+++...   ....+....|.+++... +||+|+++++++.     ..+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999997432   23445667788888764 8999999999854     345899999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          76 EFLNGGDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            999999999998754      3578889999999999999999999   9999999999999999999999999998743


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~  190 (316)
T cd05620         147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML  190 (316)
T ss_pred             ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHH
Confidence            2111        1122457999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=307.18  Aligned_cols=192  Identities=29%  Similarity=0.441  Sum_probs=164.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +-+++...+||.|.||.||-|...++|+..|+|.++..+  ....+...+|..++..++|||+|++||+-.+.+     .
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-----k 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-----K 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-----H
Confidence            345677789999999999999999999999999997543  344567889999999999999999999855443     6


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .+|.||||++|+|.+.+...+      ..++.....+..|++.|++|||++   |||||||||+||+++.+|.+|.+|||
T Consensus      1309 v~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccc
Confidence            889999999999999987642      456666677889999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhhh-------hhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-------LYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~Di~s~g~~~~~~  913 (914)
                      .|..+..+..    +.+..-...+||+.|||||++.+       .+.||||+||+++||
T Consensus      1380 sa~ki~~~~~----~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1380 SAVKIKNNAQ----TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred             ceeEecCchh----cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence            9988765532    22344557899999999999963       789999999999998

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=3.2e-30  Score=282.37  Aligned_cols=182  Identities=24%  Similarity=0.335  Sum_probs=152.2

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||||+++...   ....+.+..|..+++.. +||||+++++++..     .+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence            46899999999999999999999999997532   23345667788888764 89999999998543     45789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ey~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          76 EYLNGGDLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            999999999998754      3578889999999999999999999   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        .......||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  190 (316)
T cd05619         147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML  190 (316)
T ss_pred             CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHH
Confidence            2111        1112357999999999984    57899999999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=5.5e-30  Score=281.29  Aligned_cols=182  Identities=24%  Similarity=0.306  Sum_probs=153.7

Q ss_pred             CcccCCccEEEEEEEE---CCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      +.||+|+||.||++++   ..+++.||+|+++...  ......+.+|++++++++||||+++++++.     ..+..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999986   3578999999997432  223456778999999999999999999854     34578999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||+++|+|.+++.+.      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        77 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          77 LDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            9999999999998654      3688999999999999999999999   999999999999999999999999999976


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....        .......||+.|||||++.    +.++|+||+||++|||+
T Consensus       148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  192 (318)
T cd05582         148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML  192 (318)
T ss_pred             cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeec
Confidence            43221        1122457999999999984    47899999999999985

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=2.5e-30  Score=279.87  Aligned_cols=188  Identities=23%  Similarity=0.324  Sum_probs=157.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|+++.+++.||+|+++...  ....+.+.+|++++++++||||+++++++.     ..+..+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEEE
Confidence            6889999999999999999999999999999997442  233467889999999999999999998853     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++++.+..+....      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~  147 (287)
T cd07848          77 LVFEYVEKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA  147 (287)
T ss_pred             EEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence            999999987776554322      3588889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......       .......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       148 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~  195 (287)
T cd07848         148 RNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS  195 (287)
T ss_pred             cccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHH
Confidence            86543211       1112356999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=274.08  Aligned_cols=187  Identities=21%  Similarity=0.285  Sum_probs=161.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .-|...+.||+|.|++|-.|++.-+|+.||||++++..  ......+.+|++.|+-++|||||++|++     ++.....
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence            45777889999999999999999999999999997553  3344678899999999999999999998     4555589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFG  861 (914)
                      |+|.|.-++|+|++||.++.     ..+.+..+.+++.||+.|+.|+|..   .+|||||||+||.+-+ -|-||++|||
T Consensus        93 yLiLELGD~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EEEEEecCCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence            99999999999999998775     5788999999999999999999998   8999999999998754 5899999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhhh-----hhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-----LYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~Di~s~g~~~~~~  913 (914)
                      ++-.+...         ..-...||+..|.|||++.|     +++||||+|+++|.+
T Consensus       165 FSNkf~PG---------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyML  212 (864)
T KOG4717|consen  165 FSNKFQPG---------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYML  212 (864)
T ss_pred             ccccCCCc---------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHH
Confidence            99765432         22335799999999999965     899999999998753

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=3e-30  Score=283.68  Aligned_cols=187  Identities=22%  Similarity=0.279  Sum_probs=155.8

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCce
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +|+..+.||+|+||.||+|+++.+++.||+|+++..   .....+.+..|.++++.+. |++|+++++++     +..+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            467788999999999999999999999999999743   2234456788999998886 46777888774     33457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence            89999999999999998754      3588999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......        .......||+.|||||++.    +.++|+||+||+++||+
T Consensus       147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell  195 (323)
T cd05615         147 MCKEHMVDG--------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML  195 (323)
T ss_pred             cccccCCCC--------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHH
Confidence            987532211        1122356999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=5.1e-30  Score=282.35  Aligned_cols=182  Identities=22%  Similarity=0.280  Sum_probs=153.9

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence            46999999999999999999999999997432   23345688999999888 6999999999853     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          76 EYVNGGDLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            999999999988654      3689999999999999999999999   9999999999999999999999999998743


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell  190 (327)
T cd05617         147 LGPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM  190 (327)
T ss_pred             cCCC--------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHH
Confidence            2111        1122457999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.1e-30  Score=275.84  Aligned_cols=188  Identities=23%  Similarity=0.330  Sum_probs=158.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .|+..+.||+|+||.||+|++..+++.||+|++....   ......+.+|++++++++||||+++++++.     ..+..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence            3778899999999999999999899999999986432   222346778999999999999999998853     34578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||+
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999988865321    4688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......         ......||+.|||||++.    +.++|+||+||++|||+
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~  195 (285)
T cd05605         149 AVEIPEGE---------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI  195 (285)
T ss_pred             ceecCCCC---------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHH
Confidence            98653221         111346999999999984    57899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=5.3e-30  Score=302.39  Aligned_cols=202  Identities=25%  Similarity=0.320  Sum_probs=161.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...   ....+++.+|++++++++||||+++++++..     .+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence            57899999999999999999999999999999996432   2234678999999999999999999998644     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQ-----VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      .++||||++||+|.+++......     ......++..+++++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998642110     1123466778899999999999999999   999999999999999999999


Q ss_pred             Eecccccccccccccccc----------cCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIA----------SKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~----------~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+|+..........          ..........+||+.|||||++.    +.++|+||+||+++||+
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL  225 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML  225 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence            999999987632110000          00001112357999999999985    47899999999999873

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=5.7e-30  Score=275.84  Aligned_cols=184  Identities=24%  Similarity=0.319  Sum_probs=153.3

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||+||+|++..+++.||+|.+....   ....+.+..|++++++++||||+++.+++.     .....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence            699999999999999999999999986432   223356788999999999999999988743     345789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++|+|.+++.....  ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        76 ~~g~L~~~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          76 NGGDLRYHIYNVDE--ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            99999988754321  124689999999999999999999999   9999999999999999999999999999765432


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ..        ......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       151 ~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  191 (280)
T cd05608         151 QS--------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI  191 (280)
T ss_pred             Cc--------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence            11        112357999999999985    47899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-31  Score=261.78  Aligned_cols=190  Identities=26%  Similarity=0.315  Sum_probs=163.8

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|...+++|+|.||+|..|+.+.+++.||+|+++++-   +.....-..|-++++..+||.+..+...     |+..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccC
Confidence            3467888999999999999999999999999999997543   2333456778999999999999877644     7777


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||..||.|.-.+.+.      +.+++.....+..+|+.||.|||++   +||.||+|.+|.|+|.||++||+|
T Consensus       241 drlCFVMeyanGGeLf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhh------hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence            8999999999999999888764      4688888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.-..        .......+||||.|.|||++    +|.++|.|.+|++.|||.
T Consensus       312 FGLCKE~I~--------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm  362 (516)
T KOG0690|consen  312 FGLCKEEIK--------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM  362 (516)
T ss_pred             cccchhccc--------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence            999985221        12234468999999999999    689999999999999983

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-29  Score=280.46  Aligned_cols=180  Identities=26%  Similarity=0.295  Sum_probs=148.9

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc---CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI---RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ||+|+||+||+|++..+++.||||++....   .........|..++.+.   +||+|+++++++.     .....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence            799999999999999999999999996432   22233455677777665   6999999998853     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        76 e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          76 DYMSGGELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             cCCCCChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            999999999988754      3588999999999999999999999   9999999999999999999999999998753


Q ss_pred             cccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.     +.++|+||+||++|+|.
T Consensus       147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell  191 (330)
T cd05586         147 LTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC  191 (330)
T ss_pred             CCCC--------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec
Confidence            2211        1122457999999999984     47799999999999984

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=3.8e-30  Score=286.73  Aligned_cols=184  Identities=29%  Similarity=0.421  Sum_probs=153.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++|+||+++++++     +..+..+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeEE
Confidence            46777889999999999999999899999999986443 23346789999999999999999999985     3445789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+..          ...+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999986532          345667788999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +.+.....        ......||..|+|||++.         +.++|||||||++|||+
T Consensus       216 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~  267 (353)
T PLN00034        216 RILAQTMD--------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY  267 (353)
T ss_pred             eecccccc--------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH
Confidence            86542210        112347999999999873         24799999999999874

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=8.9e-30  Score=281.07  Aligned_cols=188  Identities=22%  Similarity=0.341  Sum_probs=160.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...     +..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence            368999999999999999999999999999999987542 23346789999999999999999999996543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...      ..+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            9999999999999999754      35788889999999999999999742  699999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+....          .....||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~  196 (333)
T cd06650         151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA  196 (333)
T ss_pred             chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            97653211          11346999999999985    47899999999999873

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4e-30  Score=296.89  Aligned_cols=201  Identities=24%  Similarity=0.296  Sum_probs=164.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC---C
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF---E  777 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~  777 (914)
                      ...+|.+.+.||+|+||+||+|++..+++.||||+++...  ......+.+|+.++..++|+||+++++.+...+.   .
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3468999999999999999999999999999999997543  3344578899999999999999998876543221   1


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      .....++||||+++|+|.++++....  ....+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence            11246899999999999999975432  224688999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++.+......      ......+||+.|||||++.    +.++|||||||++|||+
T Consensus       185 ~DFGls~~~~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl  239 (496)
T PTZ00283        185 GDFGFSKMYAATVSD------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL  239 (496)
T ss_pred             EecccCeeccccccc------cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999876432111      1122457999999999984    57899999999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=286.57  Aligned_cols=202  Identities=28%  Similarity=0.503  Sum_probs=165.3

Q ss_pred             CccCHHHHHHHhhcc---------cccCcccCCccEEEEEEEECCCc---EEEEEEEeecc-CCcchHHHHHHHHHHHhc
Q 042766          693 PMVSYAELSKATSEF---------SSSNMIGQGRFGTVYKGILGDDE---MVVAVKVINLK-QKGASKSFVSECEALRNI  759 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l  759 (914)
                      ...+++|.-.+..+|         .+.++||.|.||+||+|+.+..+   ..||||.++.. .++...+|..|+.||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            345566655544443         46789999999999999997544   57999999754 345667999999999999


Q ss_pred             CCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042766          760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH  839 (914)
Q Consensus       760 ~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivH  839 (914)
                      +||||+++.|+....     ...+||.|||++|+|+.|++.+.     ..+++.+...+.++||.|++||-+.   ++||
T Consensus       688 dHPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVH  754 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVH  754 (996)
T ss_pred             CCCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---Cchh
Confidence            999999999996543     37899999999999999999876     3588899999999999999999998   9999


Q ss_pred             cCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccc
Q 042766          840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVH  912 (914)
Q Consensus       840 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~  912 (914)
                      |||.++|||++.+..+||+|||++|.+.++. ....    ...+-.=..+|.|||.+    ++.++|+||||+++-|
T Consensus       755 RDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~y----tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE  826 (996)
T KOG0196|consen  755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAY----TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  826 (996)
T ss_pred             hhhhhhheeeccceEEEeccccceeecccCC-Cccc----cccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence            9999999999999999999999999886543 1111    11111224679999999    5799999999998765

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=5.6e-30  Score=292.29  Aligned_cols=192  Identities=24%  Similarity=0.364  Sum_probs=155.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC---CCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFE---GVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~  780 (914)
                      ..+|++.+.||+|+||.||+|++..+++.||||++....    ....+|+.++++++||||+++++++....+.   ...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999999899999999885322    2345799999999999999999886543322   223


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEec
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGD  859 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~D  859 (914)
                      +.++||||++ +++.+++.....  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence            5779999997 478777754211  125688999999999999999999999   999999999999999664 799999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.+....         ......||+.|||||++.     +.++||||+||++|||+
T Consensus       215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  265 (440)
T PTZ00036        215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI  265 (440)
T ss_pred             cccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            99998654221         112357899999999974     46799999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=276.10  Aligned_cols=191  Identities=25%  Similarity=0.414  Sum_probs=161.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +...+.++||+|-||+|..|... .+..||||.++..... ...+|.+|+++|.+++|||||+++|+|...+     ..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence            45677899999999999999886 4689999999866543 4589999999999999999999999997655     689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+|||++|+|.+|+.++..    .........+|+.||+.|++||.+.   ++||||+.+.|+|+|.++++||+|||++
T Consensus       612 mI~EYmEnGDLnqFl~ahea----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence            99999999999999987743    2234556778999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |.+-..++.....      ..+=..+|||||.+    ++.++|+|+||.|++|||
T Consensus       685 R~lysg~yy~vqg------r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~  733 (807)
T KOG1094|consen  685 RNLYSGDYYRVQG------RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVF  733 (807)
T ss_pred             cccccCCceeeec------ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHH
Confidence            9665443322111      23456789999999    579999999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=267.34  Aligned_cols=181  Identities=27%  Similarity=0.394  Sum_probs=152.8

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      .+++|+|.||+||-|+++.+|+.||||++++..  ......+..|+.+|+++.||.||.+..+     ++..+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            478999999999999999999999999997432  3445788999999999999999999888     666779999999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEEEecccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK  864 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~ki~DFGla~  864 (914)
                      -+.| +..++|-..    +..++++.....++.||+.||.|||.+   +|||.||||||||+...   -.+||+|||.||
T Consensus       644 Kl~G-DMLEMILSs----EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  644 KLHG-DMLEMILSS----EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             hhcc-hHHHHHHHh----hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence            9954 655555432    225788888889999999999999999   99999999999999643   479999999999


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccc
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVH  912 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~  912 (914)
                      ++.+..         .....+|||.|.|||+++    ...-|+||.|+++|-
T Consensus       716 iIgEks---------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYV  758 (888)
T KOG4236|consen  716 IIGEKS---------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYV  758 (888)
T ss_pred             ecchhh---------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEE
Confidence            886532         223578999999999995    488899999999873

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=8.6e-30  Score=272.34  Aligned_cols=190  Identities=23%  Similarity=0.376  Sum_probs=156.9

Q ss_pred             hhcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..+|++.+.||+|+||.||+|++.   ..+..||+|.++... ....+.+.+|+.++++++||||+++++++..     .
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~   78 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G   78 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence            357889999999999999999875   456789999987543 2334678999999999999999999998643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++|+|.+++....     ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+|++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence            47899999999999999997643     3688999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||.+........       .......+|..|+|||++.    +.++|||||||+++|+
T Consensus       151 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  201 (266)
T cd05064         151 FRRLQEDKSEAI-------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV  201 (266)
T ss_pred             Ccccccccccch-------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence            998765322110       0111234678899999884    5889999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=9.8e-30  Score=285.12  Aligned_cols=197  Identities=23%  Similarity=0.385  Sum_probs=157.9

Q ss_pred             hhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++     .+++..||||+++... ....+.+.+|+++++.+ +||||++++++|..   
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~---  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV---  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc---
Confidence            35789999999999999999975     3456789999986432 33446788999999999 89999999998644   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc----------------------------------------------------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ----------------------------------------------------  804 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  804 (914)
                        .+..++||||+++|+|.+++......                                                    
T Consensus       111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence              34789999999999999999753210                                                    


Q ss_pred             -----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          805 -----------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       805 -----------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                                       .....+++..+.+++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                             0112578889999999999999999998   99999999999999999999999999998654


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......      ......++..|||||++.    +.++|+|||||+++||+
T Consensus       266 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ell  310 (375)
T cd05104         266 NDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF  310 (375)
T ss_pred             Cccccc------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHH
Confidence            322110      011234567899999984    58899999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=1.7e-29  Score=273.61  Aligned_cols=192  Identities=26%  Similarity=0.427  Sum_probs=158.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNI---RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +|++.+.||+|+||+||+|++..+++.||+|.++...  ......+.+|+++++.+   +||||+++++++.....+...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999999999999999987432  22334566788877665   799999999987654444455


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++ +++.+++.....    ..+++.++..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence            7899999997 589998875432    3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       153 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~  201 (288)
T cd07863         153 GLARIYSCQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF  201 (288)
T ss_pred             CccccccCcc---------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHH
Confidence            9998654221         111346899999999984    47899999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1.1e-29  Score=278.70  Aligned_cols=182  Identities=23%  Similarity=0.293  Sum_probs=153.5

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||+||+|++..+++.||||+++..   .......+.+|.++++.+ +||||+++++++.     ..+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            4699999999999999999999999999743   233445677899999888 6999999999854     345789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        76 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          76 EYVNGGDLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            999999999988754      3688999999999999999999999   9999999999999999999999999998743


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....        ......+||+.|||||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~  190 (318)
T cd05570         147 ILGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML  190 (318)
T ss_pred             CcCC--------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh
Confidence            2111        1112357999999999984    47899999999999874

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=7e-30  Score=285.96  Aligned_cols=198  Identities=23%  Similarity=0.376  Sum_probs=157.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ..++|++.+.||+|+||.||+|++..     +++.||+|+++... ....+.+.+|+++++++ +||||++++++|..  
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence            34579999999999999999998643     33579999997443 23345788999999999 89999999998643  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCc---------------------------------------------------
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQ---------------------------------------------------  804 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  804 (914)
                         .+..++||||+++|+|.+++......                                                   
T Consensus       114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence               34789999999999999998643210                                                   


Q ss_pred             -------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccc
Q 042766          805 -------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL  871 (914)
Q Consensus       805 -------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  871 (914)
                                   ....++++.++++++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                         0113578889999999999999999999   999999999999999999999999999986533211


Q ss_pred             ccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          872 DIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       872 ~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .      .......+++.|||||++.    +.++|+|||||++|||+
T Consensus       268 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  308 (374)
T cd05106         268 Y------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF  308 (374)
T ss_pred             e------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHH
Confidence            0      0111223567899999884    58999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.3e-29  Score=275.34  Aligned_cols=188  Identities=26%  Similarity=0.359  Sum_probs=163.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ....|.+...||+|.|++|..|++..++..||||.++...-  .....+.+|+++|..++|||||+++++.     +...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence            34678999999999999999999999999999999975542  2334588999999999999999999984     4445


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..|+||||+.+|.+++++.+++      ...+..+..++.|+.+|++|||++   .|||||||++|||++.+.++||+||
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecc
Confidence            8999999999999999998875      344577888999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      |++.++....         .....+|++.|.|||+++     +..+|+||+|+++|.+
T Consensus       200 gfS~~~~~~~---------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L  248 (596)
T KOG0586|consen  200 GFSTFFDYGL---------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL  248 (596)
T ss_pred             ccceeecccc---------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence            9999875332         123578999999999996     4899999999998864

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=2.1e-29  Score=270.92  Aligned_cols=181  Identities=24%  Similarity=0.343  Sum_probs=152.2

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||.||+|+.+.+++.||+|.+....   ....+.+..|++++++++||||+++++++.     .....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence            699999999999999999999999986432   223345677999999999999999998853     345789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      +|++|.+++.....    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        76 ~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          76 NGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             CCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999998865432    4588899999999999999999998   9999999999999999999999999999765432


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .         ......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       149 ~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~  188 (277)
T cd05607         149 K---------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV  188 (277)
T ss_pred             c---------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHH
Confidence            1         111246899999999984    57899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=1.7e-29  Score=277.23  Aligned_cols=189  Identities=25%  Similarity=0.422  Sum_probs=156.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|+..+.||+|+||.||+|++..+++    .||+|+++... ....+++.+|+.+++.++||||++++++|...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            579999999999999999999865554    48999986432 33456888999999999999999999997532     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                       ..++|+||+++|+|.+++....     ..+++..+++++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence             3578999999999999998653     3578889999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++.........      ......++..|||||++.    +.++|+|||||++||+
T Consensus       153 fG~a~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el  204 (316)
T cd05108         153 FGLAKLLGADEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL  204 (316)
T ss_pred             ccccccccCCCcce------eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence            99998764322110      111233577899999984    4789999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.8e-30  Score=298.68  Aligned_cols=196  Identities=28%  Similarity=0.462  Sum_probs=161.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCC-----cEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD-----EMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ..-+..+.||+|+||.||+|...+-     ...||||.++.. +.+...+|.+|..+|++++|||||+++|+|...    
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~----  767 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS----  767 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC----
Confidence            3455678999999999999998642     345999998644 455678999999999999999999999998653    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQ-VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                       ...+|++|||+||+|..|+++.+.. .....++..+.+.++.|||+|+.||+++   ++|||||..+|+|++....|||
T Consensus       768 -~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  768 -GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             -CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence             3678999999999999999876332 2246788999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+.+.+.++......      ..=...|||||.+    ++.++||||||+++.|.|
T Consensus       844 aDFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif  898 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF  898 (1025)
T ss_pred             cccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence            99999995544433222211      1223579999999    469999999999999976

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=1.7e-29  Score=283.66  Aligned_cols=192  Identities=23%  Similarity=0.293  Sum_probs=158.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..+++.||||++...  +....+++.+|+++++.++||||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999889999999998643  223446788999999999999999999987554332333689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        81 lv~e~~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEeeccc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence            9999996 6888887653      4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......       .......||+.|+|||++.     +.++|+||+||+++||+
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  199 (372)
T cd07853         151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL  199 (372)
T ss_pred             eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH
Confidence            86432211       1112346899999999984     46789999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=3e-29  Score=270.31  Aligned_cols=183  Identities=21%  Similarity=0.275  Sum_probs=153.2

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc---hHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA---SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ...||+|++|.||+|++  +++.||||+++......   .+.+.+|++++++++||||++++|++.... +.....++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEE
Confidence            36799999999999998  57899999997543332   467889999999999999999999875421 2234678999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..+.+++.|++.|++|+|+..  +++||||||+||+++.++.+||+|||+++..
T Consensus       102 Ey~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        102 EYCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EeCCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            999999999999764      35788899999999999999999732  7889999999999999999999999999865


Q ss_pred             cccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ....           ....||+.|+|||++.      +.++|||||||++|||+
T Consensus       174 ~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~  216 (283)
T PHA02988        174 SSPP-----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF  216 (283)
T ss_pred             cccc-----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence            3211           1246899999999984      46999999999999874

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=2.5e-29  Score=269.00  Aligned_cols=188  Identities=23%  Similarity=0.313  Sum_probs=161.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.+++.++||||+++++++..     .+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            478888999999999999999998999999999976655555678899999999999999999998543     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++...      ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence            99999999999998754      3588999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      ......        .......||+.|+|||++.       +.++|+||+||++++|+
T Consensus       155 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~  203 (267)
T cd06645         155 QITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA  203 (267)
T ss_pred             EccCcc--------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence            653211        1112356999999999973       36899999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=4.1e-29  Score=267.36  Aligned_cols=188  Identities=23%  Similarity=0.312  Sum_probs=161.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|+.++++++||||+++++++..     ....++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            579999999999999999999998999999999976555555678899999999999999999998643     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++...      ..+++.++..++.|++.|++|||+.   +|+|||+||+||+++.++.+||+|||+++
T Consensus        84 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          84 CMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999998754      3578899999999999999999998   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      ......        .......|++.|+|||.+.       +.++|+||+||+++||+
T Consensus       155 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~  203 (267)
T cd06646         155 KITATI--------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA  203 (267)
T ss_pred             eecccc--------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence            653211        1112346899999999873       36799999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=4.4e-29  Score=274.25  Aligned_cols=191  Identities=24%  Similarity=0.313  Sum_probs=150.8

Q ss_pred             cCcccCCccEEEEEEEEC--CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          710 SNMIGQGRFGTVYKGILG--DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      .++||+|+||+||+|++.  .+++.||+|.+...  .....+.+|++++++++||||+++++++...   .....++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence            468999999999999975  36689999998533  2345678999999999999999999986532   2346899999


Q ss_pred             cccCCCHHHHHhccCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee----cCCCcEEEecc
Q 042766          788 YMENGSLEDWLHQSNDQ---VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGDF  860 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl----~~~~~~ki~DF  860 (914)
                      |++ +++.+++......   .....+++..+..++.|++.||+|||++   +|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            995 5898887643211   1123588999999999999999999999   99999999999999    45679999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+......     ........||+.|||||++.     +.++|+||+||++++|+
T Consensus       157 G~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (317)
T cd07868         157 GFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (317)
T ss_pred             CceeccCCCCcc-----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence            999876432211     11122457999999999984     46799999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=3.3e-29  Score=279.95  Aligned_cols=191  Identities=24%  Similarity=0.297  Sum_probs=157.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .......+.+|+.+++.++||||+++++++.... .+..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999999999999998643  2334567889999999999999999999875332 1223


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++ ++.+.+.        ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEec
Confidence            457999999965 6766664        2467788899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       167 fg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  216 (359)
T cd07876         167 FGLARTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV  216 (359)
T ss_pred             CCCccccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH
Confidence            99997543211         112356899999999984    47899999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3e-29  Score=284.81  Aligned_cols=184  Identities=27%  Similarity=0.305  Sum_probs=155.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ...|.+.+.||+|+||.||+|++..+++.||||...      ...+.+|++++++++|+|||++++++...     +..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEE
Confidence            346899999999999999999999999999999642      23457899999999999999999986543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+. ++|.+++....     ..+++.+++.|+.|++.||.|||++   +||||||||+|||++.++.+||+|||++
T Consensus       237 lv~e~~~-~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        237 LVLPKYR-SDLYTYLGARL-----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEccC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999994 79998886543     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +.......      ........||+.|||||++.    +.++|||||||++|||
T Consensus       308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El  355 (461)
T PHA03211        308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA  355 (461)
T ss_pred             eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHH
Confidence            86543211      01122457999999999984    5789999999999986

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=3e-29  Score=274.37  Aligned_cols=188  Identities=24%  Similarity=0.398  Sum_probs=157.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|...+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++||||+++++++..     .+..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            56889999999999999999999899999999997443 3334567899999999999999999998643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++ ++.+++...+     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence            99999974 8988886543     3578889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......||+.|+|||++.     +.++|+||+||++++|+
T Consensus       152 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  199 (309)
T cd07872         152 RAKSVPTK--------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA  199 (309)
T ss_pred             eecCCCcc--------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            75432111        111246899999999884     46899999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=297.51  Aligned_cols=199  Identities=22%  Similarity=0.361  Sum_probs=161.8

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ....+|.+.+.||+|+||+||+|++..++..||+|++....  ......+.+|+.++++++|||||++++++...   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            34568999999999999999999999999999999987442  23456789999999999999999999986532   23


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEecCCCCCCeeecCC---
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQ----PPMVHGDLKPSNVLLDYD---  852 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~----~~ivHrDlkp~NILl~~~---  852 (914)
                      ...|+||||+++|+|.+++.....  ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+   
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~--~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            468999999999999999875321  12468999999999999999999998521    259999999999999642   


Q ss_pred             --------------CcEEEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccc
Q 042766          853 --------------MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVH  912 (914)
Q Consensus       853 --------------~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~  912 (914)
                                    +.+||+|||+++.+....         ......||+.|||||++.      +.++|||||||++||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc---------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence                          358999999998653221         112357999999999983      468999999999998


Q ss_pred             cC
Q 042766          913 HF  914 (914)
Q Consensus       913 ~f  914 (914)
                      |+
T Consensus       236 LL  237 (1021)
T PTZ00266        236 LC  237 (1021)
T ss_pred             HH
Confidence            74

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=5.5e-29  Score=268.93  Aligned_cols=194  Identities=27%  Similarity=0.411  Sum_probs=159.5

Q ss_pred             hcccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+|++.+.||+|+||.||+|+.    ..+++.||+|++........+.+.+|++++++++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4788899999999999999984    356789999998765555567889999999999999999999986532   234


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...+     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence            5789999999999999997543     3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++..........     ......++..|+|||+..    +.++|+||+||+++|||
T Consensus       153 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  205 (284)
T cd05081         153 GLTKVLPQDKEYYK-----VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF  205 (284)
T ss_pred             cccccccCCCccee-----ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh
Confidence            99987643221100     011123455699999984    58899999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.96  E-value=5.9e-29  Score=268.56  Aligned_cols=187  Identities=24%  Similarity=0.351  Sum_probs=157.4

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      |+..+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.++++++|++|+++++.+..     .+..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEEE
Confidence            667789999999999999999999999999986432   2223467789999999999999999988543     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++...+.    ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999998865331    4688999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......         ......||+.|||||++.    +.++|+||+||++|+|+
T Consensus       150 ~~~~~~~---------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~  195 (285)
T cd05630         150 VHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI  195 (285)
T ss_pred             eecCCCc---------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHH
Confidence            7543211         111346999999999984    57899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=3.7e-29  Score=281.06  Aligned_cols=198  Identities=24%  Similarity=0.390  Sum_probs=158.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCC-cchHHHHHHHHHHHhcC-CCCcceEEeEeecCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQK-GASKSFVSECEALRNIR-HRNLIKIITICSSTD  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  775 (914)
                      ..++|.+.+.||+|+||.||+|++..     ++..||||+++.... ...+.+.+|++++++++ ||||++++++|..  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            34688899999999999999998743     245799999964432 33467899999999996 9999999999643  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCc---------------------------------------------------
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQ---------------------------------------------------  804 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  804 (914)
                         ....++||||+++|+|.+++...+..                                                   
T Consensus       113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence               34789999999999999998653210                                                   


Q ss_pred             ---------------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          805 ---------------------------------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       805 ---------------------------------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                                                             .....+++.++..++.|+++|++|||+.   +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence                                                   0012478888899999999999999998   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.++.+||+|||+++........      .......|++.|||||++.    +.++|||||||+++||+
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  333 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF  333 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999865432111      1112345788999999984    57899999999999873

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.5e-29  Score=279.03  Aligned_cols=184  Identities=21%  Similarity=0.293  Sum_probs=155.0

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ....+|++.+.||+|+||.||+|++..+++.||+|+...      .....|+.++++++||||+++++++..     ...
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAI  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe-----CCe
Confidence            344579999999999999999999998999999997532      123569999999999999999998654     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+. ++|.+++....     ..+++.+++.|+.||+.||+|||++   +||||||||+||+++.++.+||+|||
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence            899999994 68999886543     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.....         .......||+.|+|||++.    +.++|+|||||++|||+
T Consensus       203 ~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell  250 (357)
T PHA03209        203 AAQFPVVA---------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML  250 (357)
T ss_pred             cccccccC---------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence            99753211         1122457999999999984    58899999999999873

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.3e-29  Score=277.43  Aligned_cols=191  Identities=24%  Similarity=0.327  Sum_probs=158.9

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~  778 (914)
                      ...++|+..+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999999899999999986432  2234567899999999999999999987643221 22


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....+++||++ +++|.++++.       ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence            23578999998 7899988753       3588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++.....           .....||+.|+|||++.     +.++||||+||++|+|+
T Consensus       161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  210 (343)
T cd07878         161 DFGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             CCccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH
Confidence            99999864321           12357999999999984     46899999999999873

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=3.9e-29  Score=276.18  Aligned_cols=198  Identities=23%  Similarity=0.362  Sum_probs=157.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++.+     +++.||+|+++... ....+.+.+|+++++++ +||||++++++|...  
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence            3579999999999999999997543     45789999986432 22345678899999999 799999999987543  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc----------------------------------------------------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ----------------------------------------------------  804 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  804 (914)
                        ....++||||+++++|.+++......                                                    
T Consensus        84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence              24678999999999999998643210                                                    


Q ss_pred             ---ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCcc
Q 042766          805 ---VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS  881 (914)
Q Consensus       805 ---~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~  881 (914)
                         .....+++..+.+++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+++.+.......      ..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~  232 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RK  232 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hc
Confidence               0013688999999999999999999999   99999999999999999999999999998754322111      11


Q ss_pred             ccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          882 IGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       882 ~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....++..|||||++.    +.++|+||+||+++||+
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~  269 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF  269 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHH
Confidence            1235677899999884    47899999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=3.9e-29  Score=279.02  Aligned_cols=192  Identities=22%  Similarity=0.284  Sum_probs=158.6

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~  778 (914)
                      ...++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... .+.
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999999989999999998643  2334467889999999999999999999875432 223


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||+++ ++.+.+.        ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence            3457999999965 6777664        2477888899999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       162 Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  212 (355)
T cd07874         162 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  212 (355)
T ss_pred             eCcccccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            999998643211         112357999999999984    47899999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-29  Score=277.54  Aligned_cols=201  Identities=23%  Similarity=0.333  Sum_probs=173.4

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ++.....++-|++.++||.|.+|.||+++.+.+++.+|+|+...... ..+++..|.++++.. .|||++.++|++.-.+
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            33344455678999999999999999999999999999999875543 446778889998887 6999999999988766


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                      --.++.+|+|||||.||+..|.++...    ...+.|.....|++.++.|+.+||.+   .++|||+|-.|||++.++.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence            667788999999999999999998765    36789999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchh---------hhhhcccCccccccccc
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF---------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~---------~~~~~Di~s~g~~~~~~  913 (914)
                      |+.|||.+..+..        +.......+|||.|||||++         ++.++|+||+|+|.+||
T Consensus       163 KLvDFGvSaQlds--------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEl  221 (953)
T KOG0587|consen  163 KLVDFGVSAQLDS--------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEM  221 (953)
T ss_pred             EEeeeeeeeeeec--------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehh
Confidence            9999999875532        23344567899999999998         46999999999999987

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=5.3e-29  Score=278.87  Aligned_cols=191  Identities=23%  Similarity=0.284  Sum_probs=158.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  779 (914)
                      ..++|+..+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.+++.++||||+++++++.... ++..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            356899999999999999999999989999999998643  2334467889999999999999999998865332 2333


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++ ++.+++..        .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence            467999999964 78777742        467888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       170 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  219 (364)
T cd07875         170 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  219 (364)
T ss_pred             CCCccccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH
Confidence            99998643211         112356999999999985    47899999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=4e-29  Score=288.74  Aligned_cols=191  Identities=22%  Similarity=0.346  Sum_probs=154.1

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCC------CcceEEeEe
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR------NLIKIITIC  771 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~  771 (914)
                      +++....++|++.+.||+|+||+||+|++..+++.||||+++... ...+....|++++++++|.      +++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344455678999999999999999999999899999999996322 2334566788888777554      578888876


Q ss_pred             ecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeec
Q 042766          772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~  850 (914)
                      ...    ..+.++|||++ +++|.+++.+.      ..+++.++..|+.||+.||+|||+ .   +||||||||+|||++
T Consensus       201 ~~~----~~~~~iv~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~  266 (467)
T PTZ00284        201 QNE----TGHMCIVMPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME  266 (467)
T ss_pred             EcC----CceEEEEEecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence            432    24689999998 78999988754      368899999999999999999997 5   899999999999998


Q ss_pred             CCC----------------cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccc
Q 042766          851 YDM----------------VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTN  910 (914)
Q Consensus       851 ~~~----------------~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~  910 (914)
                      .++                .+||+|||.+.....           .....+||+.|||||++.    +.++|||||||++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  335 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII  335 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence            765                499999998763211           112467999999999985    5789999999999


Q ss_pred             cccC
Q 042766          911 VHHF  914 (914)
Q Consensus       911 ~~~f  914 (914)
                      |||+
T Consensus       336 ~ell  339 (467)
T PTZ00284        336 YELY  339 (467)
T ss_pred             HHHH
Confidence            9985

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=6.2e-29  Score=267.97  Aligned_cols=197  Identities=29%  Similarity=0.491  Sum_probs=160.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|.+.+.||+|+||.||+|++..     +++.||||.++..... ..+.+.+|++++++++||||+++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence            3568889999999999999998753     3578999998754433 45789999999999999999999998644    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCC--------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSND--------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                       ....++||||+++++|.+++...+.        ......+++.++..++.|++.|++|+|+.   +++||||||+||++
T Consensus        80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili  155 (280)
T cd05049          80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV  155 (280)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence             3478999999999999999976532        11234578899999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+||+|||+++.........      ......+++.|+|||++.    +.++|+||+||+++||+
T Consensus       156 ~~~~~~kl~d~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~  218 (280)
T cd05049         156 GYDLVVKIGDFGMSRDVYTTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF  218 (280)
T ss_pred             cCCCeEEECCcccceecccCccee------cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH
Confidence            999999999999997643221110      111234678999999884    58899999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=9.5e-29  Score=263.85  Aligned_cols=190  Identities=24%  Similarity=0.493  Sum_probs=159.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|++++++++||||+++++++...     ...++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEE
Confidence            4688889999999999999999988999999998643 33456789999999999999999999986433     36789


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++.....    ..+++..++.++.|+++|++|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        80 v~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999975432    4688999999999999999999998   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........       ......++..|+|||.+.    +.++|+|||||++|||+
T Consensus       153 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  199 (263)
T cd05052         153 LMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA  199 (263)
T ss_pred             ccccceee-------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            76432211       111223567899999885    46899999999999984

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.1e-28  Score=264.75  Aligned_cols=199  Identities=26%  Similarity=0.425  Sum_probs=158.9

Q ss_pred             ccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCc
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVD  780 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  780 (914)
                      |++.+.||+|+||.||+|++..+   +..||+|+++....  ...+.+.+|++.+++++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56778999999999999998643   47899999874432  234578999999999999999999998765432 2334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...........+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence            5789999999999999986543222234689999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.........      ......++..|+|||+..    +.++|+|||||++|||+
T Consensus       158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~  209 (273)
T cd05035         158 GLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA  209 (273)
T ss_pred             cceeecccccccc------ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHH
Confidence            9998764332110      111234577899999874    57899999999999873

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=8.4e-29  Score=267.35  Aligned_cols=196  Identities=26%  Similarity=0.452  Sum_probs=159.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCc-----EEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDE-----MVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||.||+|.+...+     ..||+|.++.... ....++.+|++++++++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-----   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-----
Confidence            47889999999999999999986544     7899999864332 234578999999999999999999998643     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQV----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                      ....+++|||+++|+|.+++.......          ....+++.+++.++.|++.|++|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            346899999999999999997542211          114578889999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.++.+||+|||+++........      .......+|+.|||||++.    +.++|+|||||++|||+
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~  220 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF  220 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence            999999999999999865322110      1112345788999999874    58899999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=1.1e-28  Score=266.48  Aligned_cols=187  Identities=24%  Similarity=0.332  Sum_probs=157.3

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      |+..+.||+|+||+||+|++..+++.||+|.+....   ......+.+|++++++++|++|+++.+++.     ..+..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            666788999999999999999999999999986432   223356788999999999999999988854     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++...+.    ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEeccCccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999998865421    4689999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       150 ~~~~~~~---------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~  195 (285)
T cd05632         150 VKIPEGE---------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI  195 (285)
T ss_pred             eecCCCC---------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHH
Confidence            7543211         112346999999999984    57899999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=1.9e-28  Score=264.39  Aligned_cols=188  Identities=22%  Similarity=0.340  Sum_probs=160.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .|++.+.||+|+||.||+|++..++..+|+|.+........+.+.+|+++++.++||||+++++++..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            46788899999999999999999999999999876555556788999999999999999999998643     3478999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||++++++.+++....     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~  152 (282)
T cd06643          81 IEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAK  152 (282)
T ss_pred             EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccc
Confidence            99999999999876532     4688999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      .....        .......||+.|+|||++.         +.++|+||+||++++|+
T Consensus       153 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~  202 (282)
T cd06643         153 NTRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA  202 (282)
T ss_pred             ccccc--------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence            43211        1112356899999999973         35899999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=2.1e-28  Score=264.43  Aligned_cols=194  Identities=26%  Similarity=0.432  Sum_probs=159.2

Q ss_pred             hcccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..|++.+.||+|+||.||+|++    ..+++.||+|.++... ....+.+.+|++++++++||||+++++++...   +.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            3568889999999999999985    3567899999986443 33446889999999999999999999987543   23


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++.+..     ..+++.++..++.|++.|++|+|++   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECC
Confidence            46789999999999999986542     3578999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.+.......     .......|+..|+|||++.    +.++|+|||||+++||+
T Consensus       153 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell  206 (284)
T cd05079         153 FGLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL  206 (284)
T ss_pred             CccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh
Confidence            99998764322110     0111345778899999874    47899999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=8.5e-29  Score=267.77  Aligned_cols=205  Identities=20%  Similarity=0.277  Sum_probs=168.0

Q ss_pred             CHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       696 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++.+..+.++|++.+.||+|+||.||+|++..+++.||+|+++.. ......+.+|+.+++++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3445556778999999999999999999999989999999987543 22346788899999999 699999999987655


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                      ..+.....++||||+++++|.+++.....  ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence            44555678999999999999998864221  124578888999999999999999998   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +|++|||+++.......        ......||+.|+|||++.         +.++|+||+||+++||+
T Consensus       163 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~  223 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG  223 (286)
T ss_pred             EEEccCCceeecccCCC--------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence            99999999986532211        112346999999999873         46899999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=9.9e-29  Score=265.14  Aligned_cols=199  Identities=27%  Similarity=0.408  Sum_probs=157.2

Q ss_pred             ccccCcccCCccEEEEEEEECCCcE--EEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEM--VVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  781 (914)
                      |.+.+.||+|+||.||+|++..++.  .||+|.++..  .....+.+.+|++++++++||||+++++++..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467899999999999999876664  6999988643  23345678899999999999999999998753321 12235


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...+.......+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885432212234588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.........      ......+++.|+|||+..    +.++|+|||||+++||+
T Consensus       158 ~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~  208 (272)
T cd05075         158 LSKKIYNGDYYR------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIA  208 (272)
T ss_pred             cccccCccccee------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHH
Confidence            998764322110      111234677899999984    58899999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=9.4e-29  Score=265.30  Aligned_cols=196  Identities=23%  Similarity=0.347  Sum_probs=163.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC-Cc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG-VD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~-~~  780 (914)
                      +.+.|+..+.||+|+||.||+|++..+++.||+|++.... .....+.+|+++++++ +||||+++++++.....+. ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888999999999999999999999999999987543 3446788999999998 6999999999976543222 24


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++.....    ..+++..+..++.|++.|++|||++   +|+|||+||+||++++++.+||+||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence            68899999999999999876432    4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......        .......|++.|+|||++.         +.++|+||+||+++||+
T Consensus       156 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~  210 (272)
T cd06637         156 GVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA  210 (272)
T ss_pred             CCceeccccc--------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH
Confidence            9997653211        1122457999999999984         35799999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=1.1e-28  Score=262.10  Aligned_cols=188  Identities=29%  Similarity=0.471  Sum_probs=156.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|+++. +..+|+|.+... ....+.+.+|++++++++||||+++++++..     ....++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCEEE
Confidence            578889999999999999999864 567999987533 3345678999999999999999999998643     346899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|+|.+++....     ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence            999999999999987543     3578899999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........       ......++..|+|||++.    +.++|+|||||+++|||
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~  195 (256)
T cd05114         149 YVLDDEYT-------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF  195 (256)
T ss_pred             ccCCCcee-------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHH
Confidence            65332110       111234667899999984    58899999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=1.3e-28  Score=265.10  Aligned_cols=190  Identities=25%  Similarity=0.388  Sum_probs=154.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|+..+.||+|+||+||+|++..+++    .||+|.+.... .....++..|+..+++++||||+++++++..      
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence            478888999999999999999976665    46777764322 2233567788889999999999999998632      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++++||+++|+|.+++....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D  152 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD  152 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence            24678999999999999997643     4688999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........      .......|+..|+|||++.    +.++|+|||||+++|++
T Consensus       153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~  205 (279)
T cd05111         153 FGVADLLYPDDKK------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM  205 (279)
T ss_pred             CccceeccCCCcc------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence            9999865432111      1112345778999999984    57899999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=236.17  Aligned_cols=190  Identities=21%  Similarity=0.318  Sum_probs=154.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++....+.||+|+||.|-+.++..+|+..|+|.++.. ..+..++..+|+.+..+. ..|.+|++||...     .....
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regdv  120 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGDV  120 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----ccccE
Confidence            4455567899999999999999999999999999744 334556788899876554 7999999999743     23468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+.||.|+ -+|..+.++.-  .....+++.-.-+||..+++|+.|||++.  .|||||+||+|||++.+|+|||+|||.
T Consensus       121 wIcME~M~-tSldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence            99999995 58887765421  12257888889999999999999999985  899999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh--------hhhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF--------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~--------~~~~~Di~s~g~~~~~~  913 (914)
                      +..+.+....         +--.|-..|||||.+        ++.++||||+|+|++||
T Consensus       196 sG~L~dSiAk---------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiEl  245 (282)
T KOG0984|consen  196 SGYLVDSIAK---------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEM  245 (282)
T ss_pred             ceeehhhhHH---------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhh
Confidence            9877643211         113588899999998        46899999999999987

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.96  E-value=1.5e-28  Score=266.11  Aligned_cols=196  Identities=25%  Similarity=0.425  Sum_probs=160.1

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|.+.+.||+|+||.||+|+..     .++..||+|.+........+.+.+|++++++++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence            57889999999999999999862     3557799999875555556789999999999999999999998653     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc-------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ-------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                      ...++||||+++++|.+++...+..       .....+++.+++.++.|++.|++|||++   +++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            4789999999999999999754310       1123589999999999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+++........      .......+++.|+|||++.    +.++|+|||||++++|+
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~  216 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF  216 (288)
T ss_pred             CcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999865322110      1111234678899999985    47899999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=8.2e-29  Score=266.55  Aligned_cols=198  Identities=23%  Similarity=0.382  Sum_probs=158.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ..++|+..+.||+|+||.||+|++.     .+++.||+|++.... .....++.+|+.++++++||||+++++++.    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4568999999999999999999874     245789999885332 223457889999999999999999999854    


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQV----EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                       .....++||||+++|+|.+++...+...    .....++..+..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence             3347899999999999999987533211    123467888999999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+|++|||+++..........      .....+++.|||||++.    +.++|+|||||++|||+
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  215 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA  215 (277)
T ss_pred             CCEEECCCCCccccCCcceeec------CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence            9999999999976543221111      11234678899999984    57899999999999873

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.6e-29  Score=266.82  Aligned_cols=189  Identities=23%  Similarity=0.348  Sum_probs=162.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++..     ....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence            568999999999999999999988899999999976655566789999999999999999999998643     447899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++...+     ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus        80 v~e~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          80 LIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             EeeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence            999999999999987643     4688999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      ......        .......||+.|+|||++.         +.++|+||+||++++|+
T Consensus       152 ~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~  202 (280)
T cd06611         152 KNKSTL--------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA  202 (280)
T ss_pred             hhcccc--------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence            543211        1122356899999999974         35799999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.95  E-value=1.7e-28  Score=262.28  Aligned_cols=193  Identities=24%  Similarity=0.348  Sum_probs=159.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+.....     ...+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            478889999999999999999999999999999864321     22357888999999999999999999754321   2


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++...      ..+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence            4678999999999999998754      2477888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........     ........||..|+|||++.    +.++|+|||||++++|+
T Consensus       150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  203 (265)
T cd06652         150 FGASKRLQTICLS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML  203 (265)
T ss_pred             Ccccccccccccc-----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence            9999865432111     11122346899999999985    47899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=3.5e-28  Score=258.20  Aligned_cols=189  Identities=20%  Similarity=0.306  Sum_probs=160.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|++.+.||+|+||.||++++..+++.||+|.++.. .....+.+.+|+.++++++||||+++++.+.     .....++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence            477889999999999999999999999999998643 2334567889999999999999999999854     3458899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++++++.+++.....    ..+++..++.++.|++.|+.|||++   +|+|+||||+||++++++.++++|||.++
T Consensus        76 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEeeCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999998865432    4578889999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......|++.|+|||++.    +.++|+||+||++++|+
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~  194 (255)
T cd08219         149 LLTSPGA--------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC  194 (255)
T ss_pred             eeccccc--------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehh
Confidence            6543211        112356899999999984    47899999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.5e-28  Score=264.74  Aligned_cols=190  Identities=26%  Similarity=0.420  Sum_probs=156.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcE----EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ..+|+..+.||+|+||+||+|++..+++    .||+|+++... ....+.+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS----   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence            3578899999999999999999866655    48999986443 23456788999999999999999999987532    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                        ..+++|||+++|+|.+++....     ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence              3578999999999999997643     3688999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |||+++.........      ......+++.|||||+..    +.++|+|||||++|||
T Consensus       152 dfG~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el  204 (279)
T cd05109         152 DFGLARLLDIDETEY------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL  204 (279)
T ss_pred             CCCceeeccccccee------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence            999998764321110      011224577899999984    4789999999999986

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.3e-30  Score=251.17  Aligned_cols=197  Identities=24%  Similarity=0.400  Sum_probs=165.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC---C
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG---V  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~---~  779 (914)
                      +.|....+||+|.||+||+|+.+.+++.||+|++-.+  .++......+|+.++..++|+|++.++++|....-..   .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4566678999999999999999999999999877543  3455677889999999999999999999987644222   2


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...|+||++|+. +|.-.+....     ..++..+..+++.++..||.|+|+.   .|+|||+||+|+||+.+|.+||+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence            347999999976 8998887653     5789999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.+...+...+.    .-+..+-|.+|.+||.+     ++.+.|+|.-||+..|||
T Consensus       168 FGlar~fs~~~n~~kp----rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw  223 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKP----RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW  223 (376)
T ss_pred             cccccceecccccCCC----CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence            9999887654322111    12345679999999999     468999999999999996

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=1.9e-28  Score=265.92  Aligned_cols=189  Identities=24%  Similarity=0.324  Sum_probs=161.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|++++++++||||+++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            568899999999999999999999999999999976665566788999999999999999999998643     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++++++..++.+..     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        87 v~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEecCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence            999999999998876543     3588999999999999999999998   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      ......        .......|++.|+|||++.         +.++|+||+||++|||+
T Consensus       159 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~  209 (292)
T cd06644         159 KNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA  209 (292)
T ss_pred             eccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence            532211        1112346899999999974         45799999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=1.4e-28  Score=265.63  Aligned_cols=196  Identities=23%  Similarity=0.370  Sum_probs=157.8

Q ss_pred             hcccccCcccCCccEEEEEEEEC----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|++.+.||+|+||.||+|++.    .++..||+|.+.... ......+.+|++++++++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            56888899999999999999863    456789999986433 2334678899999999999999999998543     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ-----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                      ...++||||+++++|.+++......           .....+++.++..++.|++.|++|||++   +|+||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            4689999999999999998633210           0123578889999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.++.+||+|||+++.........      ......++..|+|||++.    +.++|+|||||+++||+
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  220 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF  220 (283)
T ss_pred             EcCCCcEEeccccccccccCCccee------cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence            9999999999999998654322111      112234678899999984    57899999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.9e-29  Score=243.16  Aligned_cols=187  Identities=20%  Similarity=0.305  Sum_probs=155.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+.+....||+|+.|.|++++++.++...|||.+.... ....+++...+.++.+.. .|.||+.+||+...     ...
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV  166 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV  166 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence            34455677999999999999999999999999997543 445567888888776664 89999999996543     367


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++.||.| +...+..+++-+     .++++.-+-++...+++||.||.+++  +|||||+||+|||+|+.|++|++|||+
T Consensus       167 ~IcMelM-s~C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  167 FICMELM-STCAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             HHHHHHH-HHHHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            8899998 457777776654     57888888899999999999999876  999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh-------hhhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-------~~~~~Di~s~g~~~~~~  913 (914)
                      +..+.+...         ....+|-+.|||||.+       ++.++|+||||+|+||+
T Consensus       239 sGrlvdSkA---------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveL  287 (391)
T KOG0983|consen  239 SGRLVDSKA---------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVEL  287 (391)
T ss_pred             cceeecccc---------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhh
Confidence            987765321         1234799999999998       57999999999999985

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=1.7e-28  Score=260.07  Aligned_cols=185  Identities=24%  Similarity=0.387  Sum_probs=151.9

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      +.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46999999999999999899999999876332 2334678999999999999999999998643     34689999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++....     ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        76 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          76 QGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             cCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence            9999999997543     3578899999999999999999999   9999999999999999999999999998754321


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....      ......++..|+|||.+.    +.++|+||+||++|||+
T Consensus       148 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~  190 (252)
T cd05084         148 VYAS------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF  190 (252)
T ss_pred             cccc------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence            1100      001112356799999984    47899999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=2.4e-28  Score=260.48  Aligned_cols=190  Identities=23%  Similarity=0.454  Sum_probs=157.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++..     ....+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcE
Confidence            467999999999999999999976 55679999876432 245788999999999999999999988543     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.++++....    ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        78 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999975421    4678889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......++..|+|||++.    +.++|+||+||++|+|+
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  198 (261)
T cd05072         151 RVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV  198 (261)
T ss_pred             eecCCCcee-------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHH
Confidence            875432211       111234677899999985    46899999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=1.7e-28  Score=262.84  Aligned_cols=189  Identities=24%  Similarity=0.312  Sum_probs=148.6

Q ss_pred             CcccCCccEEEEEEEECC--CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGD--DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||+||+|+...  ....+|+|.+.... ......+.+|+++++.++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence            358999999999997532  44578888875432 2334578899999999999999999998643     346899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++...... .....++.....++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence            99999999999765321 113356778889999999999999999   99999999999999999999999999987543


Q ss_pred             ccccccccCCCCccccccCcccccccchhh-----------hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di~s~g~~~~~~f  914 (914)
                      .....      .......+++.|+|||++.           +.++|+||+||+++||+
T Consensus       152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~  203 (269)
T cd05042         152 PEDYY------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF  203 (269)
T ss_pred             cchhe------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence            22110      0112235678899999863           46899999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.95  E-value=2.1e-28  Score=268.85  Aligned_cols=191  Identities=25%  Similarity=0.329  Sum_probs=150.6

Q ss_pred             cCcccCCccEEEEEEEECC--CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          710 SNMIGQGRFGTVYKGILGD--DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      ..+||+|+||.||+|++..  ++..||+|.+...  .....+.+|++++++++||||+++++++...   .....++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence            3579999999999999754  5678999988533  2345678999999999999999999987532   2346899999


Q ss_pred             cccCCCHHHHHhccCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee----cCCCcEEEecc
Q 042766          788 YMENGSLEDWLHQSNDQ---VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGDF  860 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl----~~~~~~ki~DF  860 (914)
                      |++ +++.+++......   .....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            996 5888887533211   1123588899999999999999999999   99999999999999    56679999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+........     ........||+.|+|||++.     +.++|+||+||+++||+
T Consensus       157 G~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~  210 (317)
T cd07867         157 GFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (317)
T ss_pred             cceeccCCCccc-----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH
Confidence            999876432211     11122457899999999884     46799999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=2.1e-28  Score=265.85  Aligned_cols=187  Identities=24%  Similarity=0.351  Sum_probs=161.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+........+.+.+|++++++++||||+++++++..     ....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence            478889999999999999999988999999999986665566788999999999999999999998643     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++..       ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        95 v~e~~~~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             eecccCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence            9999999999999864       2478889999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......|++.|+|||.+.    +.++|+|||||++++|+
T Consensus       165 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~  210 (296)
T cd06654         165 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI  210 (296)
T ss_pred             hcccccc--------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence            6432211        112346899999999984    47899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=2.3e-28  Score=259.64  Aligned_cols=188  Identities=24%  Similarity=0.461  Sum_probs=157.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||.|++.+ +..||+|.++.. ....+.+.+|+.++++++||||+++++++...     ...++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEE
Confidence            578889999999999999998864 456999988633 23456789999999999999999999986433     36799


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|+|.+++....     ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        77 v~e~~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          77 VTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence            999999999999997543     3588999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......       .......++..|+|||++.    +.++|+|||||++++||
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~  195 (256)
T cd05113         149 YVLDDEY-------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY  195 (256)
T ss_pred             ecCCCce-------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHh
Confidence            6543211       0111234677899999985    58899999999999985

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-29  Score=247.12  Aligned_cols=189  Identities=25%  Similarity=0.328  Sum_probs=158.9

Q ss_pred             Hhhccccc-CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSS-NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+++|++. ++||-|-.|.|..|.++.+++.+|+|++.     +.....+|++..-.. .|||||.++++|... +++..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            34566543 68999999999999999999999999984     335567899986665 699999999987544 56777


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki  857 (914)
                      ...+|||+|+||.|.+.+..++.    ..+++.++..|++||+.|++|||+.   +|.|||+||||+|...   +..+|+
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eeEeeeecccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence            88999999999999999988764    6799999999999999999999999   9999999999999974   458999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      +|||+|+.-..+         ......+-||+|.|||++    ++...|+||+|+++|.|
T Consensus       206 tDfGFAK~t~~~---------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl  256 (400)
T KOG0604|consen  206 TDFGFAKETQEP---------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_pred             cccccccccCCC---------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence            999999864321         122245789999999999    57889999999988865

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=2.9e-28  Score=258.92  Aligned_cols=189  Identities=26%  Similarity=0.361  Sum_probs=161.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|++|.||+|++..+++.||+|.+...  .....+.+.+|++++++++||||+++++++.     ..+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            477889999999999999999999999999998743  2345568899999999999999999999854     335789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999976421    4688899999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+.....        ......|++.|+|||++.    +.++|+|||||++++|+
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  195 (256)
T cd08529         149 KLLSDNTN--------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC  195 (256)
T ss_pred             eeccCccc--------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence            86643211        112346899999999985    47899999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=2.4e-28  Score=266.99  Aligned_cols=186  Identities=23%  Similarity=0.340  Sum_probs=158.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|++.+.||+|+||.||+|++..++..||+|.++.... ....++.+|++++++++||||+++++++..     .+..++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            68899999999999999999999999999999864422 234568899999999999999999998643     348899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.++++..      ..+++..+..++.|+++|+.|||+.+  +++||||||+||+++.++.+||+|||+++
T Consensus        77 v~ey~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          77 CMEHMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             EeeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcc
Confidence            99999999999999764      35788899999999999999999732  89999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......          .....|++.|+|||++.    +.++|+||+||++++|+
T Consensus       149 ~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~  192 (308)
T cd06615         149 QLIDSM----------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA  192 (308)
T ss_pred             cccccc----------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHH
Confidence            543211          12357899999999984    46799999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.95  E-value=2.1e-28  Score=265.31  Aligned_cols=206  Identities=22%  Similarity=0.264  Sum_probs=168.6

Q ss_pred             cCHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeec
Q 042766          695 VSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSS  773 (914)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  773 (914)
                      +...++..+.++|++.+.||+|+||.||+|+...+++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555566789999999999999999999999899999999986432 2346778899999999 89999999999865


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                      .+.......++||||+++++|.++++....  ....+++..++.++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            443334568999999999999998864211  124688999999999999999999998   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++.......        ......|+..|+|||++.         +.++|+||+||+++||+
T Consensus       166 ~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~  227 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG  227 (291)
T ss_pred             CEEEeecccchhcccccc--------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence            999999999986543211        111346899999999873         47899999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=2.3e-28  Score=266.43  Aligned_cols=188  Identities=24%  Similarity=0.400  Sum_probs=158.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|.++... ......+.+|++++++++||||+++++++.     .....+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            57899999999999999999999899999999987443 333457789999999999999999999954     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++....     ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             EEEeccc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            9999996 59999887543     3578889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......+++.|+|||++.     +.++|+||+||++++|+
T Consensus       152 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  199 (301)
T cd07873         152 RAKSIPT--------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS  199 (301)
T ss_pred             hccCCCC--------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH
Confidence            7543211        1112245789999999984     36799999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=2.9e-28  Score=265.62  Aligned_cols=194  Identities=26%  Similarity=0.390  Sum_probs=155.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcE--EEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEM--VVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|+++.++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++..     .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-----~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----R   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----C
Confidence            3578889999999999999999877665  45777765322 23446788999999999 89999999998643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQV----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      +..++||||+++++|.+++...+...          ....+++.+++.++.|++.|++|||++   +|+||||||+||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili  157 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  157 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence            47899999999999999997543211          123578999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+||+|||+++......         ......++..|+|||++.    +.++|+|||||+++||+
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  217 (303)
T cd05088         158 GENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  217 (303)
T ss_pred             cCCCcEEeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHH
Confidence            999999999999986422110         011123567899999874    57899999999999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=3.2e-28  Score=260.67  Aligned_cols=189  Identities=23%  Similarity=0.360  Sum_probs=150.5

Q ss_pred             CcccCCccEEEEEEEEC--CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILG--DDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|++.  .++..+|+|.++.... .....+.+|+.++++++||||+++++++...     ...++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence            36899999999999864  3457899998865432 2335788999999999999999999986443     36789999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++..... ......++..+..++.|++.|++|||+.   +++||||||+||+++.++++|++|||+++...
T Consensus        76 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          76 FCPLGDLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CCCCCcHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999999975432 1123456777889999999999999999   99999999999999999999999999997543


Q ss_pred             ccccccccCCCCccccccCcccccccchhh-----------hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di~s~g~~~~~~f  914 (914)
                      .....      .......|++.|+|||++.           +.++|+|||||+++||+
T Consensus       152 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~  203 (269)
T cd05087         152 KEDYY------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF  203 (269)
T ss_pred             Cccee------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence            22110      1112346788999999874           46899999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.5e-28  Score=259.48  Aligned_cols=191  Identities=25%  Similarity=0.375  Sum_probs=159.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|+..+.||+|++|.||+|++..+++.||+|.+.....     ...+.+.+|++++++++||||+++++++.     ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence            468889999999999999999998999999999864321     12357889999999999999999999954     34


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++++|.+++...      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            4899999999999999998764      3578888999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........     ........|+..|+|||+..    +.++|+||+||++++|+
T Consensus       148 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  201 (263)
T cd06625         148 FGASKRLQTICSS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML  201 (263)
T ss_pred             cccceeccccccc-----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHH
Confidence            9999765322110     00112346889999999985    47899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=3.2e-28  Score=260.30  Aligned_cols=191  Identities=27%  Similarity=0.437  Sum_probs=157.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||+||+|++..+   ...||||+++... ......+.+|+.++++++||||+++++++..     .
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence            35789999999999999999998643   4689999986443 3344678899999999999999999998543     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++....     ..+++.++++++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d  149 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD  149 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence            46899999999999999997643     3688999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++........      .......+++.|+|||.+.    +.++|+|||||++|+|
T Consensus       150 fg~~~~~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l  201 (266)
T cd05033         150 FGLSRRLEDSEAT------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV  201 (266)
T ss_pred             cchhhcccccccc------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence            9999876421110      0111234567899999985    4789999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.2e-28  Score=265.75  Aligned_cols=196  Identities=24%  Similarity=0.396  Sum_probs=156.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCC--------------cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD--------------EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIIT  769 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  769 (914)
                      .+|++.+.||+|+||.||+|++.++              ...||+|.++... ......+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5789999999999999999987543              3458999986442 233457899999999999999999999


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCc------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK  843 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlk  843 (914)
                      ++..     ....++||||+++++|.+++......      .....+++.+++.++.|++.|++|||+.   +++|||||
T Consensus        85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            9643     34789999999999999998653210      0112468889999999999999999999   99999999


Q ss_pred             CCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       844 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+||+++.++.+||+|||+++........      .......++..|+|||++.    +.++|+|||||++++|+
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~  225 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF  225 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcce------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence            99999999999999999999765332110      1111234678899999874    58999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=2.3e-28  Score=271.10  Aligned_cols=198  Identities=22%  Similarity=0.362  Sum_probs=156.6

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||+||+|++.     .+++.||||+++... ......+.+|++++.++ +||||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            357999999999999999999853     457889999997433 22345788999999999 689999999987432  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcc---------------------------------------------------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQV---------------------------------------------------  805 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  805 (914)
                        ....++||||+++|+|.+++.......                                                   
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              246789999999999999986532100                                                   


Q ss_pred             ----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccccccc
Q 042766          806 ----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS  875 (914)
Q Consensus       806 ----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~  875 (914)
                                ....+++.++.+++.|+++|++|||++   +|+||||||+||+++.++.+||+|||+++.........  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--  236 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--  236 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh--
Confidence                      012468888999999999999999999   99999999999999999999999999998653221100  


Q ss_pred             CCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          876 KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       876 ~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                          ......+++.|+|||++.    +.++|+|||||++++|+
T Consensus       237 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  275 (343)
T cd05103         237 ----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  275 (343)
T ss_pred             ----hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence                011234677899999984    47899999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.95  E-value=3.2e-28  Score=264.26  Aligned_cols=198  Identities=26%  Similarity=0.401  Sum_probs=159.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCC-----cEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDD-----EMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ..++|+..+.||+|+||.||+|++...     ...||+|.+.... ......+.+|+++++++ +||||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            346789999999999999999998643     3789999986432 23345688999999999 89999999998643  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCC----------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSND----------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                         ....++||||+++|+|.+++.....          ......+++..+++++.|++.|++|||+.   +|+||||||+
T Consensus        88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence               3468999999999999999975321          01235688999999999999999999998   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.++.+|++|||+++.+........      .....++..|+|||++.    +.++|+|||||+++|++
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  228 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF  228 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHh
Confidence            99999999999999999987643221111      11123567899999874    47899999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=5.1e-29  Score=287.44  Aligned_cols=206  Identities=24%  Similarity=0.336  Sum_probs=163.2

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCC----
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTD----  775 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  775 (914)
                      .+-..+|+..+.||+||||.||+|+.+-+|+.||||+|.... ......+.+|+..+++++|||||+++..+...+    
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345568889999999999999999999999999999997553 334467889999999999999999976433210    


Q ss_pred             --------------------------------------------------------------------------------
Q 042766          776 --------------------------------------------------------------------------------  775 (914)
Q Consensus       776 --------------------------------------------------------------------------------  775 (914)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -CC-----------------------------CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHH
Q 042766          776 -FE-----------------------------GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA  825 (914)
Q Consensus       776 -~~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~g  825 (914)
                       .+                             .....||-||||+..++.+++++...     .-.....+++++||++|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-----~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-----NSQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-----chhhHHHHHHHHHHHHH
Confidence             00                             01346899999999888888876532     11355788999999999


Q ss_pred             HHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc----ccc------cccccCCCCccccccCcccccccch
Q 042766          826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS----NHH------LDIASKTPSSSIGIKGTVGYVAPGK  895 (914)
Q Consensus       826 l~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~----~~~------~~~~~~~~~~~~~~~GT~~y~APE~  895 (914)
                      |+|+|++   |||||||||.||++|+++.|||+|||+|+...    ...      ...........++.+||.-|+|||+
T Consensus       710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            9999999   99999999999999999999999999998732    111      1112222234567899999999999


Q ss_pred             h-------hhhhcccCcccccccccC
Q 042766          896 F-------FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       896 ~-------~~~~~Di~s~g~~~~~~f  914 (914)
                      +       +..++|+||+|++++|||
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~  812 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEML  812 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHh
Confidence            9       357899999999999996

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=3.1e-28  Score=262.22  Aligned_cols=181  Identities=27%  Similarity=0.345  Sum_probs=154.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...     ...++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence            6788899999999999999999899999999986442 23346788999999999999999999986543     47889


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++++++..+.          .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||++.
T Consensus        77 v~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~  143 (279)
T cd06619          77 CTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST  143 (279)
T ss_pred             EEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence            99999999997642          357778889999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......          .....||+.|+|||++.    +.++|+||+||++++|+
T Consensus       144 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~  187 (279)
T cd06619         144 QLVNSI----------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELA  187 (279)
T ss_pred             eccccc----------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHH
Confidence            653211          12357999999999984    57899999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=2.6e-28  Score=260.09  Aligned_cols=178  Identities=23%  Similarity=0.400  Sum_probs=147.6

Q ss_pred             CcccCCccEEEEEEEECC------------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          711 NMIGQGRFGTVYKGILGD------------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      +.||+|+||.||+|+...            ....||+|.+..........+.+|+.++++++||||+++++++...    
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~----   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD----   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence            468999999999998642            2346899988765555566888999999999999999999996543    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc----
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV----  854 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~----  854 (914)
                       ...++||||+++|+|..++....     ..+++..+++++.|+++|++|||+.   +|+||||||+||+++.++.    
T Consensus        77 -~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          77 -VENIMVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             -CCCEEEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence             36789999999999999887543     3588999999999999999999998   9999999999999987664    


Q ss_pred             ---EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          855 ---AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       855 ---~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                         +|++|||++......            ....||..|||||++.     +.++|||||||++|||
T Consensus       148 ~~~~~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el  202 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI  202 (262)
T ss_pred             CceeEeCCCCCCccccCc------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence               899999998754211            1245888999999874     4679999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=3.2e-28  Score=263.89  Aligned_cols=196  Identities=27%  Similarity=0.447  Sum_probs=159.8

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|...+.||+|+||.||+|++.     .++..||+|.++.......+.+.+|++++++++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-----G   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-----C
Confidence            56888899999999999999864     3456799999865555455788999999999999999999998643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      ...++||||+++++|.+++......          .....+++..++.++.|++.|++|||++   +|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            4689999999999999999754310          1123588999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+||+|||+++........      .......|+..|+|||++.    +.++|+|||||+++||+
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  219 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF  219 (291)
T ss_pred             ccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999765432111      1112345788999999885    47899999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=2.9e-28  Score=264.84  Aligned_cols=188  Identities=24%  Similarity=0.347  Sum_probs=162.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+|+..+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++..     .+..+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEE
Confidence            3689999999999999999999988999999999976655566788999999999999999999998643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.+       ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        93 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~  162 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (297)
T ss_pred             EeecccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccc
Confidence            99999999999999864       3478889999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........        ......|++.|+|||.+.    +.++|+||+||++|+|+
T Consensus       163 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~  209 (297)
T cd06656         163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV  209 (297)
T ss_pred             eEccCCcc--------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence            76532211        112346899999999984    47899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.6e-28  Score=277.19  Aligned_cols=185  Identities=25%  Similarity=0.288  Sum_probs=153.9

Q ss_pred             hhcccccCcccCCccEEEEEEEEC--CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG--DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..+|.+.+.||+|+||.||+|...  .+++.||+|.+...     +...+|++++++++||||+++++++.     ....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence            357999999999999999999864  35678999987532     34568999999999999999998854     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+. +++.+++...      ..+++.+++.++.|++.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG  230 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG  230 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence            899999995 6899988543      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.......      ........||+.|+|||++.    +.++|+||+||++|||+
T Consensus       231 ~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~  281 (392)
T PHA03207        231 AACKLDAHPD------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS  281 (392)
T ss_pred             cccccCcccc------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence            9976543221      11123467999999999984    47899999999999973

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=3.3e-28  Score=273.24  Aligned_cols=199  Identities=24%  Similarity=0.380  Sum_probs=159.0

Q ss_pred             HHhhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCCcceEEeEeecC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR-HRNLIKIITICSST  774 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  774 (914)
                      ...++|.+.+.||+|+||.||+|+++     .+++.||+|+++... ....+.+.+|++++.++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34457888999999999999999964     345789999997443 223457889999999997 99999999986543


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc--------------------------------------------------
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ--------------------------------------------------  804 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------  804 (914)
                           ...++||||+++|+|.+++++.+..                                                  
T Consensus       114 -----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         114 -----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             -----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence                 3689999999999999999754210                                                  


Q ss_pred             ------------------------------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 042766          805 ------------------------------------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDL  842 (914)
Q Consensus       805 ------------------------------------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDl  842 (914)
                                                                .....+++..+.+++.|++.|++|||+.   +|+||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl  265 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL  265 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence                                                      0113467788899999999999999998   9999999


Q ss_pred             CCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          843 KPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       843 kp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+||+++.++.+|++|||+++........      .......|++.|||||++.    +.++|+|||||+++||+
T Consensus       266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l  335 (401)
T cd05107         266 AARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF  335 (401)
T ss_pred             CcceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence            999999999999999999999865332110      0111235788999999985    57899999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=5e-28  Score=257.25  Aligned_cols=184  Identities=24%  Similarity=0.415  Sum_probs=149.4

Q ss_pred             cccCCccEEEEEEEEC--CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEec
Q 042766          712 MIGQGRFGTVYKGILG--DDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEY  788 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  788 (914)
                      .||+|+||.||+|+++  .++..||+|++..... ...+.+.+|++++++++||||+++++++..      ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence            3899999999999875  4566799999865432 334678999999999999999999998632      257899999


Q ss_pred             ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccc
Q 042766          789 MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN  868 (914)
Q Consensus       789 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~  868 (914)
                      +++++|.+++....     ..+++.++++++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++....
T Consensus        76 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          76 ASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            99999999987543     4688999999999999999999998   999999999999999999999999999986543


Q ss_pred             cccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       869 ~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......     ......+++.|+|||++.    +.++|+|||||++||++
T Consensus       148 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  192 (257)
T cd05115         148 DDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF  192 (257)
T ss_pred             Ccccee-----ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence            221100     111223467899999874    46899999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=1.7e-28  Score=261.62  Aligned_cols=191  Identities=28%  Similarity=0.477  Sum_probs=162.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ...+|+..+.||+|+||.||+|++.. ++.||+|++..........+.+|+.+++.++||||+++++++..     ....
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCCe
Confidence            34679999999999999999999986 88999999976655556788999999999999999999998643     3468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++.....    ..+++.++++++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence            999999999999999976432    4678999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.........        .....++..|+|||++.    +.++|+||+||++++|+
T Consensus       151 ~~~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~  198 (261)
T cd05148         151 ARLIKEDVYL--------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF  198 (261)
T ss_pred             hhhcCCcccc--------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            9865432111        11234678899999984    47899999999998873

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=2.5e-28  Score=263.64  Aligned_cols=196  Identities=22%  Similarity=0.351  Sum_probs=157.0

Q ss_pred             hcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      .+|.+.+.||+|+||.||+|++..     .++.||+|+++..... ..+.+.+|+.++++++||||+++++++...    
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~----   80 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE----   80 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence            457788999999999999998753     3578999999744332 345788999999999999999999986433    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCC----------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSND----------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                       ...++++||+++++|.+++.....          ......+++..+++++.|++.|++|+|+.   +|+||||||+||+
T Consensus        81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil  156 (283)
T cd05091          81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL  156 (283)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence             468899999999999999853211          01123578888999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++++.+||+|||+++........      .......+++.|||||++.    +.++|+||+||+++||+
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  220 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYY------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF  220 (283)
T ss_pred             ecCCCceEecccccccccccchhe------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence            999999999999999865432211      1111234678999999985    47899999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=2.8e-28  Score=260.80  Aligned_cols=192  Identities=25%  Similarity=0.412  Sum_probs=160.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||.++...   ......+.+|++++++++||||+++++++..     .+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            57899999999999999999999899999999886432   2334578899999999999999999998543     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++.....  ....+++..++.++.|++.|++|||++   +++||||||+||+++.++.++|+|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence            8999999999999998864321  124578889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......        ......|++.|+|||.+.    +.++|+||+||+++||+
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~  200 (267)
T cd08228         152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             cceeccchhH--------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence            9987543221        111346889999999984    47899999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.2e-28  Score=262.50  Aligned_cols=188  Identities=22%  Similarity=0.300  Sum_probs=154.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  780 (914)
                      ...|++.+.||+||.+.||+++..+ ...||+|++...  +......+..|++.|.+++ |.+||++++|-..     ++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~  433 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG  433 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence            4578999999999999999998864 456777766533  3445678999999999995 9999999999443     56


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      +.|+||||- ..+|.+++++...     ..+...++.+..|++.|+.++|.+   ||||.||||.|+|+ -+|.+||+||
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDF  503 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDF  503 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeee
Confidence            899999987 4699999987653     333337788999999999999999   99999999999998 4679999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---------------hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------------~~~~Di~s~g~~~~~~  913 (914)
                      |+|..+..+.....      ....+||+.|||||.+.               +.++||||+||++|+|
T Consensus       504 GIA~aI~~DTTsI~------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM  565 (677)
T KOG0596|consen  504 GIANAIQPDTTSIV------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM  565 (677)
T ss_pred             chhcccCcccccee------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence            99998765443322      22468999999999992               4889999999999998

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=3.6e-28  Score=267.98  Aligned_cols=193  Identities=19%  Similarity=0.177  Sum_probs=154.7

Q ss_pred             ccCcccCC--ccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          709 SSNMIGQG--RFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       709 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.++||+|  +||+||+|+++.+++.||+|+++...  ....+.+.+|+++++.++||||+++++++...     +..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence            45789999  67899999999999999999997542  23345678899999999999999999996543     47899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|+|.+++.....    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        77 v~e~~~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEeccCCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence            9999999999999975421    3588999999999999999999998   99999999999999999999999998765


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ............ ........++..|||||++.      +.++|+||+||+++||+
T Consensus       150 ~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~  204 (327)
T cd08227         150 SMINHGQRLRVV-HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA  204 (327)
T ss_pred             cccccccccccc-ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence            433211111000 00112245788899999984      37899999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.1e-28  Score=257.83  Aligned_cols=188  Identities=30%  Similarity=0.474  Sum_probs=155.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|++.+.||+|+||.||+|+++ ++..+|+|++... ......+.+|++++++++||||+++++++.     ..+..++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFI   76 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEE
Confidence            46888999999999999999986 4668999988533 223457889999999999999999999854     3347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++....     ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        77 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          77 VTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             EEecCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence            999999999999997543     3678999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...+....       ......++..|+|||.+.    +.++|+|||||++++|+
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~  195 (256)
T cd05059         149 YVLDDQYT-------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF  195 (256)
T ss_pred             eccccccc-------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHh
Confidence            65432111       111223456899999984    47899999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.8e-28  Score=260.56  Aligned_cols=197  Identities=21%  Similarity=0.366  Sum_probs=159.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC-----cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD-----EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+.... ......+.+|+.+++.++||||+++++++..    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST----   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence            35788999999999999999998643     4789999986432 2334578899999999999999999998543    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQV----EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                       ....++||||+++|+|.+++.......    ....+++..++.++.|++.|+.|||+.   +|+||||||+||+++.++
T Consensus        81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~  156 (277)
T cd05032          81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence             357899999999999999997543211    123478889999999999999999998   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++.........      ......+|..|+|||++.    +.++|+||+||+++|++
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  215 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA  215 (277)
T ss_pred             CEEECCcccchhhccCcccc------cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence            99999999998654322111      111235788999999884    48899999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.95  E-value=3.1e-28  Score=262.05  Aligned_cols=197  Identities=23%  Similarity=0.380  Sum_probs=158.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|++..     ++..||+|.+.... ......+.+|+.++++++|+||+++++++...   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER---   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence            4678999999999999999999976     77899999886433 23345789999999999999999999986433   


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC---
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM---  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~---  853 (914)
                        ...++||||+++++|.+++...+... ....+++.++++++.||+.|++|||+.   +++||||||+||+++.++   
T Consensus        82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCc
Confidence              35789999999999999997653211 123589999999999999999999999   999999999999998764   


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+|++|||+++..........      .....++..|||||++.    +.++|||||||+++||+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~  215 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRK------GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF  215 (277)
T ss_pred             ceEeccCccccccCCccceec------CCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence            699999999986532211110      11123457899999984    58999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=2.3e-28  Score=260.29  Aligned_cols=186  Identities=31%  Similarity=0.473  Sum_probs=158.2

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcch--HHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|+||+||+|++..+++.||+|++........  ....+|+.++++++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            6778899999999999999999999999999976543322  234569999999999999999999654     347889


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++...      ..+++.++..++.|+++||+|||+.   +|+||||||+||+++.++.++|+|||.+.
T Consensus        76 v~~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKN------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEETTEBHHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             ccccccccccccccccc------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            99999999999999833      4689999999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .....        ........||+.|+|||++.     +.++|+||+||++++|+
T Consensus       147 ~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  193 (260)
T PF00069_consen  147 KLSEN--------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELL  193 (260)
T ss_dssp             ESTST--------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHH
T ss_pred             ccccc--------cccccccccccccccccccccccccccccccccccccccccc
Confidence            54111        11122357899999999985     49999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=2.7e-28  Score=259.46  Aligned_cols=188  Identities=33%  Similarity=0.544  Sum_probs=152.3

Q ss_pred             ccCcccCCccEEEEEEEEC----CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          709 SSNMIGQGRFGTVYKGILG----DDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+.||+|+||.||+|.+.    ..+..||||.++.... ...+.+.+|++.+++++||||++++|+|....     ..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----ccc
Confidence            4578999999999999997    4568899999964332 34678999999999999999999999987332     489


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++....    ...+++.+++.|+.|+++||+|||++   +|+|+||+++||+++.++.+||+|||++
T Consensus        78 lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             ccccccccccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            9999999999999998762    15689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........      .......+...|+|||.+.    +.++||||||++++|+|
T Consensus       151 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~  199 (259)
T PF07714_consen  151 RPISEKSKY------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEIL  199 (259)
T ss_dssp             EETTTSSSE------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHH
T ss_pred             ccccccccc------cccccccccccccccccccccccccccccccccccccccc
Confidence            876321111      1111234778899999984    58999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=5e-28  Score=258.07  Aligned_cols=188  Identities=27%  Similarity=0.479  Sum_probs=155.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|++.++ ..||+|+++... ...+.+.+|++++++++||||+++++++..      ...++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l   77 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI   77 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEE
Confidence            5799999999999999999998755 469999986433 234678999999999999999999987421      34689


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|+|.+++.....    ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             EEEcCCCCcHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence            9999999999999975421    3578899999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+......       ......++..|+|||+..    +.++|+||+||++|||+
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ell  197 (262)
T cd05071         151 LIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT  197 (262)
T ss_pred             eccccccc-------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence            65432211       111234678899999884    57999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.95  E-value=4.1e-28  Score=263.74  Aligned_cols=196  Identities=23%  Similarity=0.398  Sum_probs=156.9

Q ss_pred             hcccccCcccCCccEEEEEEEECC----------------CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD----------------DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKI  767 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  767 (914)
                      ++|++.+.||+|+||.||+|++..                ++..||+|++.... .....++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468999999999999999986532                34579999986442 3345688999999999999999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ-----VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDL  842 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDl  842 (914)
                      ++++...     +..++||||+++|+|.+++......     .....+++.++..++.|++.|++|||+.   +|+||||
T Consensus        85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            9986443     3689999999999999999764321     1123578889999999999999999999   9999999


Q ss_pred             CCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          843 KPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       843 kp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+||+++.++.+|++|||+++.+......      .......+++.|+|||+..    +.++|+|||||++|||+
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~  226 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL  226 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcce------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHH
Confidence            999999999999999999999865332110      0111234567899999874    57899999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=5.4e-28  Score=262.89  Aligned_cols=197  Identities=22%  Similarity=0.377  Sum_probs=159.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc----------------EEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE----------------MVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIK  766 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  766 (914)
                      .++|++.+.||+|+||.||+|++...+                ..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357899999999999999999876433                568999986443 234567889999999999999999


Q ss_pred             EEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCc-----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ-----VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       767 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                      +++++...     ...++||||+++++|.+++......     .....+++..++.++.|++.|++|||+.   +|+|||
T Consensus        84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            99986443     4789999999999999999764311     0113689999999999999999999998   999999


Q ss_pred             CCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+||+++.++.++++|||+++.........      ......+|+.|||||++.    +.++|+|||||++|||+
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  226 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL  226 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHH
Confidence            99999999999999999999997654322111      111235778999999974    58899999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.95  E-value=5.6e-28  Score=258.84  Aligned_cols=193  Identities=27%  Similarity=0.461  Sum_probs=156.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE---EEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM---VVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||.||+|++..+++   .||||.++.. .....+++..|+.++++++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCC
Confidence            468889999999999999999876553   6999998644 2334568999999999999999999999853     344


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++....     ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+|++||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df  150 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF  150 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence            6899999999999999987643     3578999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+++...........   .......++..|+|||++.    +.++|+||+||+++||
T Consensus       151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~  204 (269)
T cd05065         151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV  204 (269)
T ss_pred             ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence            999865432211100   0011112346799999985    4789999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=3.2e-28  Score=263.41  Aligned_cols=198  Identities=22%  Similarity=0.360  Sum_probs=156.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ..++|++.+.||+|+||.||+|++++     .+..||+|.++.... .....+.+|+.++++++||||+++++++..   
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK---   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence            45789999999999999999997652     356899998864332 233467889999999999999999998543   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQV----EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                        ....++||||+++|+|.+++...+...    .....++..+.+++.|++.|++|||++   +|+||||||+||+++.+
T Consensus        81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~  155 (288)
T cd05061          81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD  155 (288)
T ss_pred             --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence              346799999999999999997533211    123456778889999999999999998   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+|++|||+++.........      ......++..|+|||++.    +.++|+|||||+++||+
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~  215 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT  215 (288)
T ss_pred             CcEEECcCCcccccccccccc------ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHH
Confidence            999999999998654322111      111234677899999984    58899999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=4.4e-28  Score=259.32  Aligned_cols=191  Identities=28%  Similarity=0.443  Sum_probs=156.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+|++.+.||+|+||.||+|++..+   +..||+|.++... ....+.+.+|+.++++++||||+++++++..     .+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CC
Confidence            5788999999999999999988533   3479999886432 2234678999999999999999999998643     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++....     ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++||
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~df  150 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDF  150 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCC
Confidence            7899999999999999997643     3578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+++.+.......     .......++..|+|||++.    +.++|+|||||++||+
T Consensus       151 g~~~~~~~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el  202 (267)
T cd05066         151 GLSRVLEDDPEAA-----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV  202 (267)
T ss_pred             Cccccccccccee-----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence            9998764322110     0111223467899999985    4789999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=254.44  Aligned_cols=197  Identities=25%  Similarity=0.386  Sum_probs=163.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-------CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-------KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      .++|-....||+|+|+.||+|.+....+.||||+-....       +.-.+...+|.++.+.++||-||++|+|+.... 
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-  540 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-  540 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc-
Confidence            346778889999999999999999888999999875321       122356789999999999999999999975332 


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DM  853 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~  853 (914)
                         +..+-|.|||+|.+|+-|++.+      +.+++.++..|+.||+.||.||.+. +|+|||-||||.|||+..   -|
T Consensus       541 ---dsFCTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  541 ---DSFCTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             ---ccceeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence               4678899999999999999987      4689999999999999999999987 789999999999999953   47


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccc
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVH  912 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~  912 (914)
                      .+||+|||+++.+.++..+.... ..-....+||.+|.+||.|-        +.++|+||+|+++|.
T Consensus       611 eIKITDFGLSKIMdddSy~~vdG-meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ  676 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDG-MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ  676 (775)
T ss_pred             eeEeeecchhhhccCCccCcccc-eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence            89999999999987655432211 22234578999999999993        589999999999875

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=5.4e-28  Score=261.99  Aligned_cols=185  Identities=26%  Similarity=0.330  Sum_probs=160.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++.     ....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence            36888999999999999999999899999999986432   234467889999999999999999999854     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...      ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence            89999999999999998764      3688899999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.....           .....|++.|+|||.+.    +.++|+||+|+++++|+
T Consensus       147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  192 (290)
T cd05580         147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML  192 (290)
T ss_pred             CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHH
Confidence            99865432           12346899999999985    47899999999999874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=3e-28  Score=261.40  Aligned_cols=177  Identities=22%  Similarity=0.340  Sum_probs=145.3

Q ss_pred             cccCCccEEEEEEEECC------------------------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceE
Q 042766          712 MIGQGRFGTVYKGILGD------------------------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI  767 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  767 (914)
                      .||+|+||.||+|+...                        ....||+|+++.........+.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999998532                        124688998865544445678899999999999999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV  847 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NI  847 (914)
                      +++|...     ...++||||+++|+|..++....     ..+++..++.++.|+++||+|||++   +|+||||||+||
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI  148 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence            9997543     36789999999999999987543     3678899999999999999999998   999999999999


Q ss_pred             eecCCC-------cEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          848 LLDYDM-------VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       848 Ll~~~~-------~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      +++.++       .+|++|||.+......            ....|+..|+|||++.     +.++|+|||||+++|+
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            997654       4899999988643211            1135788899999884     4789999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.95  E-value=9.3e-28  Score=256.65  Aligned_cols=193  Identities=23%  Similarity=0.364  Sum_probs=159.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|+..+.||+|+||.||+|.+..++..||+|++.....     ...+.+.+|++++++++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            368889999999999999999998999999999864321     2335688999999999999999999986432   13


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...+++|||+++++|.+++...      ..+++...+.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            4678999999999999999754      3578888999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.......     .........|+..|+|||++.    +.++|+||+||++++++
T Consensus       150 fg~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~  203 (266)
T cd06651         150 FGASKRLQTICM-----SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML  203 (266)
T ss_pred             CCCccccccccc-----cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence            999976532110     001112346899999999985    46899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=5e-28  Score=261.57  Aligned_cols=189  Identities=24%  Similarity=0.355  Sum_probs=157.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|++|.||+|++..+++.||+|+++...  ....+.+.+|+.++++++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            4788899999999999999999899999999986442  2334678899999999999999999999643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ +++.+++.....   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence            9999997 689888865321   24688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......|++.|+|||++.     +.++|+||+||++++|+
T Consensus       149 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~  196 (285)
T cd07861         149 RAFGIPV--------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA  196 (285)
T ss_pred             eecCCCc--------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHH
Confidence            7543211        0111235789999999874     46799999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.6e-28  Score=256.65  Aligned_cols=189  Identities=26%  Similarity=0.341  Sum_probs=162.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|++..+++.+|+|++........+.+.+|++++++++||||+++++++..     ....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            578899999999999999999988889999999986655566789999999999999999999998543     447899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      +|||+++++|.+++....     ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.
T Consensus        78 ~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence            999999999999987642     3688899999999999999999998   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhhh-------hhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~Di~s~g~~~~~~f  914 (914)
                      ......        .......|+..|+|||.+.+       .++|+||+||++++|+
T Consensus       150 ~~~~~~--------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~  198 (262)
T cd06613         150 QLTATI--------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA  198 (262)
T ss_pred             hhhhhh--------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence            654211        01123468999999999743       4789999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=6e-28  Score=258.44  Aligned_cols=191  Identities=25%  Similarity=0.344  Sum_probs=158.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||+++++++..     .+..
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~   80 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFF   80 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEE
Confidence            44555566789999999999999998999999999876655566789999999999999999999998643     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCC--CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKL--SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~--~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~D  859 (914)
                      ++||||+++++|.+++....     ..+  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEec
Confidence            99999999999999997542     233  7788889999999999999998   9999999999999986 67999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ||.+........        ......|++.|+|||++.      +.++|+||+|+++++|+
T Consensus       153 fg~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~  205 (268)
T cd06624         153 FGTSKRLAGINP--------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA  205 (268)
T ss_pred             chhheecccCCC--------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHH
Confidence            999876532111        111245899999999873      47899999999998874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.95  E-value=5.8e-28  Score=262.64  Aligned_cols=193  Identities=24%  Similarity=0.396  Sum_probs=154.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE--EEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM--VVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||+||+|+...++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++..     ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----RG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----CC
Confidence            578899999999999999999876664  4688887632 233446789999999999 79999999998543     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQV----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ..++||||+++++|.+++.......          ....+++.++..++.|++.|++|||++   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            6899999999999999997543111          113588899999999999999999998   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++.+||+|||++.......         .......+..|+|||++.    +.++|+|||||++|||+
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~  212 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV---------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV  212 (297)
T ss_pred             CCCeEEECCcCCCcccccee---------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999986432110         001112356799999984    57899999999999985

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=6.7e-28  Score=261.76  Aligned_cols=187  Identities=25%  Similarity=0.367  Sum_probs=161.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|+..+.||+|+||.||+|++..+++.||+|.+........+.+.+|++++++++||||+++++++..     ....++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence            468999999999999999999998999999999976655566788999999999999999999998543     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++..       ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        94 v~e~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEecCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence            9999999999998864       3578999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......|++.|+|||.+.    +.++|+|||||++++|+
T Consensus       164 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~ll  209 (296)
T cd06655         164 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV  209 (296)
T ss_pred             hcccccc--------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence            6543211        112346899999999984    47899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.2e-28  Score=264.05  Aligned_cols=197  Identities=25%  Similarity=0.285  Sum_probs=161.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|.+......   ..+.+.+|++++++++||||+++++++.     .....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCEE
Confidence            688899999999999999999988999999999754322   4467889999999999999999998853     34578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++.....    ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence            999999999999999875432    4688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccc---------------------cCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIA---------------------SKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~---------------------~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +...........                     ...........||..|+|||+..    +.++||||+||++|+|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence            876432110000                     00001122457899999999985    46899999999999874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=8.3e-28  Score=259.57  Aligned_cols=190  Identities=29%  Similarity=0.406  Sum_probs=155.2

Q ss_pred             ccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      |+..+.||+|+||+||+++.    ..++..||+|.++.... ...+.+.+|++++++++||||+++++++...   ....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence            38889999999999988653    35678899999875432 3456788999999999999999999987532   2346


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...       .+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence            78999999999999998653       589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++..........     ......++..|+|||+..    +.++|+|||||+++||+
T Consensus       153 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~  204 (283)
T cd05080         153 LAKAVPEGHEYYR-----VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL  204 (283)
T ss_pred             cccccCCcchhhc-----cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence            9986643221100     011234677899999884    57899999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=1.1e-27  Score=254.80  Aligned_cols=190  Identities=24%  Similarity=0.383  Sum_probs=159.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|++|.||+|++..+++.||+|.+....  ....+.+.+|++++++++|||++++++.+..    .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4788899999999999999999889999999986443  2344578899999999999999999887432    224678


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|+|+.   +|+||||||+||+++.++.++|+|||++
T Consensus        77 lv~e~~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEecccCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence            99999999999999976422    4589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......|++.|+|||+..    +.++|+||+||++++|+
T Consensus       150 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~  196 (257)
T cd08223         150 RVLENQC--------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA  196 (257)
T ss_pred             EEecccC--------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence            8654321        1122356899999999985    46899999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=6.8e-28  Score=263.07  Aligned_cols=198  Identities=24%  Similarity=0.397  Sum_probs=158.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-------CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeec
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-------DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSS  773 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  773 (914)
                      ...+|.+.+.||+|+||.||+|++.       .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3467889999999999999999853       234579999886432 23446789999999999 89999999998644


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQV----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK  843 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlk  843 (914)
                           ....++||||+++|+|.+++.......          ....+++.+++.++.|+++|++|||++   +|+|||||
T Consensus        93 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk  164 (304)
T cd05101          93 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA  164 (304)
T ss_pred             -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence                 347899999999999999997643210          124578889999999999999999999   99999999


Q ss_pred             CCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       844 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+||+++.++.+||+|||+++.........      ......+++.|+|||++.    +.++|+|||||++++|+
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  233 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF  233 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999998664322111      111234678899999985    46899999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.95  E-value=7.5e-28  Score=262.22  Aligned_cols=193  Identities=24%  Similarity=0.396  Sum_probs=157.8

Q ss_pred             hhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|.+.+.||+|+||.||+|++     ..++..||+|.++... ....+.+.+|+++++++ +||||+++++++...  
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG--  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence            35799999999999999999985     3356689999986443 23346789999999999 799999999986443  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                         +..++||||+++|+|.+++.....    ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+|
T Consensus       112 ---~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~  181 (302)
T cd05055         112 ---GPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK  181 (302)
T ss_pred             ---CceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence               468999999999999999975431    3489999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++|||+++........      .......+++.|+|||++.    +.++|+||+||+++||+
T Consensus       182 l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~  237 (302)
T cd05055         182 ICDFGLARDIMNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF  237 (302)
T ss_pred             ECCCcccccccCCCce------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence            9999999865432110      0111234678899999885    47899999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=9.1e-28  Score=255.16  Aligned_cols=184  Identities=32%  Similarity=0.421  Sum_probs=154.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|++.+.||+|+||.||+|...  +..||+|.++..  ...+.+.+|+.++++++|++++++++++..    .....++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEE
Confidence            57888999999999999999875  667999988532  335678999999999999999999987532    2346799


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++.....    ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+|++|||+++
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             EEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence            9999999999999976432    3578899999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......           ....++..|||||++.    +.++|+||+||++|+|+
T Consensus       151 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~  193 (256)
T cd05082         151 EASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY  193 (256)
T ss_pred             eccccC-----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHH
Confidence            543211           1123567899999985    46899999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=7.7e-28  Score=256.55  Aligned_cols=190  Identities=28%  Similarity=0.474  Sum_probs=157.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++..     ....+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCee
Confidence            356889999999999999999976 45689999986443 345678999999999999999999998543     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....    ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        78 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence            9999999999999997643    14688999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ...+..++..|+|||++.    +.++|+|||||+++||+
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  198 (261)
T cd05068         151 RVIKEDIYE-------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV  198 (261)
T ss_pred             EEccCCccc-------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHH
Confidence            876432111       111223456899999874    57899999999999873

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=8.8e-28  Score=255.30  Aligned_cols=189  Identities=21%  Similarity=0.338  Sum_probs=161.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||.++...+++.||+|.+....  ....+.+.+|++++++++|+||+++++++..     .+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            4788999999999999999999999999999987543  3445678899999999999999999999643     45789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEecCCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999976421    4678999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......||+.|+|||+..    +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~  195 (256)
T cd08221         149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL  195 (256)
T ss_pred             EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence            86543221        112356899999999984    46799999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=7.5e-28  Score=259.41  Aligned_cols=196  Identities=27%  Similarity=0.436  Sum_probs=159.0

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|...+.||+|+||.||+|+..     .++..||+|.+........+.+.+|++++++++|+||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            46788899999999999999753     3567899999876555566789999999999999999999998644     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ---------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ...++||||+++++|.+++...+..         .....+++..++.++.|++.|++|||+.   +|+||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            4689999999999999999764321         0113578899999999999999999998   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.+||+|||+++........      .......+++.|+|||++.    +.++|+|||||+++||+
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  218 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF  218 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence            9999999999999755322110      0111234678899999884    47899999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.95  E-value=8.3e-28  Score=256.44  Aligned_cols=188  Identities=26%  Similarity=0.447  Sum_probs=150.0

Q ss_pred             CcccCCccEEEEEEEECC---CcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGD---DEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..   .+..||+|.+... .....+.+.+|+.+++.++||||+++++++...    ....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998743   3467999988533 233456888999999999999999999976432    23578999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++....     ...++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        77 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          77 PYMKHGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             ecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence            9999999999997543     2456778889999999999999998   9999999999999999999999999999865


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+.....    ........++..|+|||.+.    +.++|+|||||+++||+
T Consensus       149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  196 (262)
T cd05058         149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM  196 (262)
T ss_pred             cCCccee----ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHH
Confidence            4321100    01112335678899999884    47899999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=9.7e-28  Score=256.68  Aligned_cols=193  Identities=24%  Similarity=0.432  Sum_probs=159.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---------chHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---------ASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      +|.+...||+|+||.||+|.+..+++.||+|.+......         ..+.+.+|++++++++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            367788999999999999999888999999988643321         12568899999999999999999998543   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                        ....++||||+++++|.+++...      ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence              34788999999999999999764      3578888999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||.++..........  .........|+..|+|||.+.    +.++|+||+||++++|+
T Consensus       147 l~dfg~~~~~~~~~~~~~--~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~  206 (267)
T cd06628         147 ISDFGISKKLEANSLSTK--TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML  206 (267)
T ss_pred             ecccCCCcccccccccCC--ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh
Confidence            999999987653221111  111122356899999999984    46899999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=4.2e-28  Score=262.01  Aligned_cols=187  Identities=24%  Similarity=0.411  Sum_probs=156.3

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..+|+.||+|+++...  ......+.+|++++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            4778899999999999999999999999999997432  22345678899999999999999999884     4445789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+||++ +++.+++....     ..+++..++.++.||++|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        76 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence            9999996 58888876543     3588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......+++.|+|||++.     +.++|+||+||++++|+
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  194 (284)
T cd07839         147 RAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA  194 (284)
T ss_pred             hccCCCC--------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHH
Confidence            7653211        1112245789999999874     46799999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.95  E-value=5.7e-28  Score=267.51  Aligned_cols=195  Identities=26%  Similarity=0.361  Sum_probs=162.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++... ......++.+|+.++++++||||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            36899999999999999999999999999999998643 23345678899999999999999999998776665556678


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ +++.+++..       ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          84 YIVQELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             EEEehhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            99999996 588887754       3588899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++........     ........||+.|||||.+.     +.++|+||+||++++|+
T Consensus       153 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~  204 (336)
T cd07849         153 ARIADPEHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML  204 (336)
T ss_pred             eeeccccccc-----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9865432211     11122357899999999863     46899999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-29  Score=256.07  Aligned_cols=188  Identities=22%  Similarity=0.299  Sum_probs=160.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  779 (914)
                      ..+|....+||+|+||+|..|..+++.+.||||++++.   ...+.+.-+.|-++|+--. -|.+++++.+     |+..
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhh
Confidence            35788999999999999999999999999999999744   2334455667778887764 6678888776     7777


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..|+||||+.||+|.-.+.+.+      .+-+..++.+|.+||-||-|||++   +||.||||.+|||+|.+|++||+|
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence            89999999999999999988764      466778899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      ||+++.-.-        .......++|||.|+|||++    ++..+|.||||+.+|||
T Consensus       494 FGmcKEni~--------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm  543 (683)
T KOG0696|consen  494 FGMCKENIF--------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM  543 (683)
T ss_pred             ccccccccc--------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence            999985321        12234468999999999998    68999999999999998

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=9.9e-28  Score=260.12  Aligned_cols=188  Identities=24%  Similarity=0.395  Sum_probs=156.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|+..+.||+|+||.||+|+++.+++.||+|.+..... .....+.+|++++++++||||+++++++.     ..+..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            578999999999999999999998899999999875432 23356778999999999999999999854     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++....     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             EEEecCC-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence            9999997 49999887643     3678889999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......++..|+|||++.     +.++|+||+||++++|+
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~  198 (291)
T cd07844         151 RAKSVPS--------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA  198 (291)
T ss_pred             cccCCCC--------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHH
Confidence            7542211        0111234788999999884     36789999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=2.5e-28  Score=259.77  Aligned_cols=179  Identities=24%  Similarity=0.381  Sum_probs=148.7

Q ss_pred             CcccCCccEEEEEEEECCCcE-------EEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEM-------VVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.||+|+||.||+|+++..+.       .||+|.+........+.+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            469999999999999865443       4888888655445557888999999999999999999996543     3678


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc--------E
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV--------A  855 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~  855 (914)
                      +||||+++|+|.+++...+     ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.        +
T Consensus        76 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence            9999999999999997653     3578889999999999999999999   9999999999999987765        6


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |++|||.+......            ....|++.|||||++.     +.++|+||+||++|||+
T Consensus       148 ~l~d~g~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~  199 (258)
T cd05078         148 KLSDPGISITVLPK------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF  199 (258)
T ss_pred             EecccccccccCCc------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH
Confidence            89999988654221            1245888999999985     35799999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=255.15  Aligned_cols=193  Identities=23%  Similarity=0.369  Sum_probs=159.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|++.+.||+|+||.||+|++..+++.||+|.+....     ....+.+.+|++++++++||||+++++++....   .
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence            47889999999999999999999899999999885331     223457889999999999999999999864322   2


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++...      ..+++..+.+++.|++.|+.|||++   +++||||||+||+++.++.++|+|
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence            4578999999999999998754      3478888999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........     ........|+..|+|||++.    +.++|+|||||++++++
T Consensus       150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  203 (264)
T cd06653         150 FGASKRIQTICMS-----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML  203 (264)
T ss_pred             ccccccccccccc-----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence            9999865321110     11112356899999999985    47899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=6.8e-28  Score=260.69  Aligned_cols=190  Identities=20%  Similarity=0.312  Sum_probs=158.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|.++.. .......+.+|++++++++||||+++++++..     ....+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence            3688899999999999999999989999999998654 22334678899999999999999999998543     45789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||++
T Consensus        76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999999999999875321   136899999999999999999999632  8999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      +.+....          .....|++.|+|||++.          +.++|+||+||++++|+
T Consensus       151 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~  201 (286)
T cd06622         151 GNLVASL----------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA  201 (286)
T ss_pred             ccccCCc----------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence            7653211          11245889999999984          45789999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=8.8e-28  Score=257.19  Aligned_cols=192  Identities=26%  Similarity=0.460  Sum_probs=156.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc---EEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE---MVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|+..+.||+|+||.||+|+...++   ..||+|.++... ....+.+.+|++++++++||||+++.+++..     .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-----F   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----C
Confidence            357888999999999999999986544   379999986442 3345678899999999999999999998643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++++|.+++....     ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  150 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD  150 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence            46899999999999999997543     3588999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++.........     ........++.|+|||++.    +.++|+|||||++|||
T Consensus       151 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el  203 (268)
T cd05063         151 FGLSRVLEDDPEGT-----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV  203 (268)
T ss_pred             Cccceecccccccc-----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence            99997654321110     0111123456799999885    4789999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=1.3e-27  Score=254.64  Aligned_cols=189  Identities=26%  Similarity=0.499  Sum_probs=156.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. ++..||+|.++.... ..+++.+|+.++++++|++++++++++..      ...+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence            357889999999999999999876 456799999864433 45678999999999999999999987522      2468


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|++|||+.   +|+||||||+||++++++.+||+|||.+
T Consensus        77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence            99999999999999975421    4578999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......++..|+|||+..    +.++|+|||||++++|+
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  197 (260)
T cd05070         150 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV  197 (260)
T ss_pred             eeccCcccc-------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHH
Confidence            865432211       111234667899999985    46899999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=8.4e-28  Score=262.69  Aligned_cols=197  Identities=26%  Similarity=0.400  Sum_probs=157.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECC-------CcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD-------DEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++|.+.+.||+|+||.||+|++..       +...||+|.++... ......+.+|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3679999999999999999998743       23579999987442 23345788899999999 799999999986543


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                           +..++||||+++|+|.+++...+..          .....+++.++++++.|++.|++|||+.   +++||||||
T Consensus        97 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          97 -----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             -----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence                 4689999999999999999764321          1123588999999999999999999998   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+++.++.+||+|||.++.........      ......+++.|||||++.    +.++|+||+||++|||+
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~  236 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  236 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhh------ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999997654221110      011123557899999884    47899999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=1.2e-27  Score=258.17  Aligned_cols=203  Identities=23%  Similarity=0.318  Sum_probs=165.8

Q ss_pred             CHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       696 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      +..++....+.|++.+.||+|+||.||+|++..+++.||+|++.... ....++..|+.+++++ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44455556789999999999999999999999899999999986443 2345788899999998 699999999987533


Q ss_pred             CC-CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          775 DF-EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       775 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                      .. ......++||||+++|+|.+++...+.    ..+++..++.++.|++.|++|||+.   +|+|||+||+||+++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            21 234578999999999999999876432    3577888899999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      .++|+|||+++......        .......|++.|+|||++.         +.++|+||+||+++||+
T Consensus       159 ~~~l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~  220 (282)
T cd06636         159 EVKLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA  220 (282)
T ss_pred             CEEEeeCcchhhhhccc--------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH
Confidence            99999999987543211        1112356999999999873         35799999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=1.2e-27  Score=256.00  Aligned_cols=188  Identities=24%  Similarity=0.359  Sum_probs=147.8

Q ss_pred             CcccCCccEEEEEEEECCC--cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDD--EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.||+|+||.||+|+...+  ...+++|.+.... ....+.+.+|+.+++.++||||+++++++..     ....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence            3699999999999976433  3456677765433 3345789999999999999999999998653     346899999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++.+....  ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~  150 (268)
T cd05086          76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY  150 (268)
T ss_pred             cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence            99999999999764321  23466777889999999999999998   99999999999999999999999999986432


Q ss_pred             ccccccccCCCCccccccCcccccccchhh-----------hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di~s~g~~~~~~f  914 (914)
                      ....      ........|+..|+|||++.           +.++|+|||||+++||+
T Consensus       151 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~  202 (268)
T cd05086         151 KEDY------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF  202 (268)
T ss_pred             cchh------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence            1110      01112356889999999873           36799999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=1.4e-27  Score=253.87  Aligned_cols=183  Identities=27%  Similarity=0.417  Sum_probs=149.9

Q ss_pred             cccCCccEEEEEEEE--CCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEe
Q 042766          712 MIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      .||+|+||.||+|++  ..++..||+|+++....  ...+.+.+|+.++++++||||+++++++..      +..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            589999999999975  45678999999864432  234678999999999999999999998532      24689999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+++|+|.+++...      ..+++..+.+++.|++.|++|+|++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        76 ~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          76 LAELGPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            99999999999754      3588899999999999999999998   99999999999999999999999999998654


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......     .......+++.|||||.+.    +.++|+|||||++|||+
T Consensus       147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  192 (257)
T cd05116         147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF  192 (257)
T ss_pred             CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence            322110     0111234568999999874    46899999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=9.8e-28  Score=261.59  Aligned_cols=191  Identities=27%  Similarity=0.444  Sum_probs=155.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcE----EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ..+|+..+.||+|+||.||+|++..+++    .||+|.+..... .....+.+|+.++++++||||++++++|...    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----   81 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----   81 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence            3578888999999999999999876665    578888764332 2234788999999999999999999987432    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                        ..++|+||+++|+|.+++....     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+
T Consensus        82 --~~~~v~e~~~~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          82 --TIQLVTQLMPHGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             --CceeeehhcCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence              3568999999999999987643     3578889999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++........      .......++..|||||++.    +.++|+|||||++|||+
T Consensus       152 Dfg~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~  205 (303)
T cd05110         152 DFGLARLLEGDEKE------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM  205 (303)
T ss_pred             cccccccccCcccc------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHH
Confidence            99999866432211      0111234678899999884    47899999999999863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=1.1e-27  Score=259.06  Aligned_cols=188  Identities=26%  Similarity=0.382  Sum_probs=160.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence            4788899999999999999999889999999997544  3345688999999999999999999998543     45789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+ +++|.+++....     ..+++.+++.++.|++.|++|||+.   +|+|+||||+||+++.++.++++|||++
T Consensus        76 ~v~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            999999 999999987543     4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......       .......||..|+|||++.     +.++|+||+||+++||+
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~  195 (286)
T cd07832         147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL  195 (286)
T ss_pred             ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH
Confidence            86543221       1112346899999999974     47899999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=9.9e-28  Score=255.32  Aligned_cols=176  Identities=26%  Similarity=0.450  Sum_probs=148.3

Q ss_pred             CcccCCccEEEEEEEECCCc----------EEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          711 NMIGQGRFGTVYKGILGDDE----------MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +.||+|+||.||+|++..++          ..||+|.+...... ...+.+|+.++++++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999998666          45788877544333 6788999999999999999999998754      2


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-------
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-------  853 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-------  853 (914)
                      ..++||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++       
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~  145 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP  145 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence            4689999999999999998653     2688899999999999999999998   999999999999999887       


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCccccccccc
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~  913 (914)
                      .+|++|||+++.....            ....++..|+|||++.      +.++|+||+||+++|+
T Consensus       146 ~~kl~Dfg~a~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l  199 (259)
T cd05037         146 FIKLSDPGIPITVLSR------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI  199 (259)
T ss_pred             eEEeCCCCcccccccc------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHH
Confidence            7999999999864321            1235777899999974      3589999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=1.1e-27  Score=260.65  Aligned_cols=187  Identities=26%  Similarity=0.402  Sum_probs=157.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-----chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-----ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +|+..+.||+|+||.||+|++..+++.||||.++.....     ....+.+|++++++++|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence            477788999999999999999988999999999754322     23467789999999999999999998644     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +|+|.+++....     ..+++..++.++.|+++||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            789999999 899999997642     2688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.......        ......+++.|+|||.+.     +.++|+|||||+++||+
T Consensus       147 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~  197 (298)
T cd07841         147 GLARSFGSPNR--------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL  197 (298)
T ss_pred             eeeeeccCCCc--------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            99986543211        111235788999999884     36799999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=5.2e-28  Score=262.09  Aligned_cols=186  Identities=24%  Similarity=0.339  Sum_probs=157.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .|.....||+|+||.||+|.+..++..||||.+........+.+.+|+.++++++||||+++++.+..     .+..++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence            34445679999999999999988899999999876555556788999999999999999999988543     4578999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||+++++|.+++..       ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        98 ~e~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~  167 (292)
T cd06658          98 MEFLEGGALTDIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQ  167 (292)
T ss_pred             EeCCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence            999999999998854       2478889999999999999999999   999999999999999999999999999875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....        .......||+.|+|||++.    +.++|+||+||+++||+
T Consensus       168 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~  212 (292)
T cd06658         168 VSKEV--------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI  212 (292)
T ss_pred             ccccc--------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            43221        1112346899999999984    58899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.95  E-value=1.6e-27  Score=257.69  Aligned_cols=188  Identities=23%  Similarity=0.350  Sum_probs=158.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|+..+.||+|+||.||+|+++.+++.||+|++....  ....+.+.+|++++++++||||+++++++..     ....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence            36888899999999999999999899999999986432  2234568899999999999999999998543     4478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++++.+..++...      ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEeccCccHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence            9999999998888877543      3588999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +........        ......|+..|+|||++.     +.++|+||+||++++|+
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~  195 (286)
T cd07847         147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL  195 (286)
T ss_pred             ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHH
Confidence            986543211        111245889999999975     36799999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=1.2e-27  Score=259.41  Aligned_cols=189  Identities=26%  Similarity=0.414  Sum_probs=156.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..+|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++|+||+++++++.     .....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence            468999999999999999999999899999999986543 233456789999999999999999999854     33478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ +++.+++....     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence            99999995 68887775432     3467788889999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.......        ......+++.|+|||++.     +.++|+||+||++++|+
T Consensus       150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  198 (291)
T cd07870         150 ARAKSIPSQ--------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML  198 (291)
T ss_pred             ccccCCCCC--------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence            975432110        112245789999999874     35789999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2e-27  Score=255.98  Aligned_cols=190  Identities=26%  Similarity=0.436  Sum_probs=156.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE----EEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|++.+.||+|+||+||+|.+..+++    .||+|....... .....+.+|++++++++||||+++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            578889999999999999999865553    689998764432 334678899999999999999999998754      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++....     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d  152 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD  152 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence            36789999999999999997653     3588999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||.++.........      ......++..|+|||.+.    +.++|+||+||+++|++
T Consensus       153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~  205 (279)
T cd05057         153 FGLAKLLDVDEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM  205 (279)
T ss_pred             CcccccccCcccce------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence            99998764321110      011223467899999884    47899999999998863

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=6.6e-28  Score=261.96  Aligned_cols=186  Identities=23%  Similarity=0.327  Sum_probs=158.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .|+....||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++..     .+..++|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            34455689999999999999988899999999976555556788899999999999999999998543     4578999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||+++++|.+++..       ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~  166 (297)
T cd06659          97 MEFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ  166 (297)
T ss_pred             EecCCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhh
Confidence            999999999998754       3578899999999999999999999   999999999999999999999999999875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....        .......|+..|+|||++.    +.++|+||+||+++||+
T Consensus       167 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  211 (297)
T cd06659         167 ISKDV--------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV  211 (297)
T ss_pred             ccccc--------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            43221        1112356899999999985    47899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=9.2e-28  Score=256.84  Aligned_cols=192  Identities=24%  Similarity=0.408  Sum_probs=160.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...+   .....++.+|+++++.++||||+++++++..     .+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            46888899999999999999998899999999886432   2334578899999999999999999998643     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++.....  ....+++.+++.++.|++.|++|||++   +++|+||||+||+++.++.++++|||
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence            8999999999999999874321  124688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......        ......|+..|+|||++.    +.++|+||+||++++|+
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~  200 (267)
T cd08229         152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             hhhccccCCc--------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence            9886543221        112346899999999984    46899999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=1.7e-27  Score=254.70  Aligned_cols=192  Identities=26%  Similarity=0.428  Sum_probs=161.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++...   ....+.+.+|++++++++|++|+++++++..     .+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            47889999999999999999999899999999886432   2335688999999999999999999998543     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++.....  ....+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence            8999999999999999865321  124578999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......        ......|++.|+|||.+.    +.++|+||+||++++|+
T Consensus       152 ~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~  200 (267)
T cd08224         152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  200 (267)
T ss_pred             eeeeccCCCc--------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence            9876543211        112346899999999985    46799999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.95  E-value=2.1e-27  Score=252.96  Aligned_cols=190  Identities=31%  Similarity=0.515  Sum_probs=157.8

Q ss_pred             CcccCCccEEEEEEEECCC---cEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++...   +..||+|++...... ..+.+.+|++.++.++|+||+++++++..     ....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4699999999999999865   889999999754433 36788999999999999999999998644     45789999


Q ss_pred             ecccCCCHHHHHhccCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          787 EYMENGSLEDWLHQSNDQ---VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ||+++++|.+++......   .....+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999864210   0025689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......      ........+++.|+|||.+.    +.++|+||+||++|+|+
T Consensus       153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  201 (262)
T cd00192         153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF  201 (262)
T ss_pred             cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHH
Confidence            87654321      01122356889999999984    58899999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.95  E-value=1.8e-27  Score=260.97  Aligned_cols=197  Identities=26%  Similarity=0.421  Sum_probs=156.5

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-------CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-------DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++|.+.+.||+|+||.||+|++.       .....||+|.++... ......+.+|+++++++ +||||+++++++.. 
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-   89 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-   89 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence            368889999999999999999863       234679999986432 23345788999999999 69999999998643 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                          ....++||||+++|+|.+++......          .....+++.++.+++.|++.|++|||++   +|+||||||
T Consensus        90 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          90 ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             ----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence                34689999999999999999764311          1124588999999999999999999998   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+++.++.+||+|||+++.........      ......++..|||||++.    +.++|+|||||++++|+
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  230 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYK------KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF  230 (314)
T ss_pred             eeEEEcCCCcEEEcccccccccccccccc------ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHH
Confidence            99999999999999999998654321110      011123456899999984    46899999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.95  E-value=1.3e-27  Score=255.90  Aligned_cols=191  Identities=20%  Similarity=0.323  Sum_probs=158.9

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|++.....      ...+.+.+|++++++++||||+++++++.     ..
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence            47788999999999999999988999999999974331      13467889999999999999999999854     34


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEe
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVG  858 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~  858 (914)
                      +..++||||+++++|.+++.+.      ..+++..+..++.|++.|+.|||++   +++||||||+||+++.++ .+||+
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence            5789999999999999999754      3578889999999999999999999   999999999999998776 69999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||.+..........    ........||..|+|||++.    +.++|+||+||++++++
T Consensus       147 dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~  202 (268)
T cd06630         147 DFGAAARLAAKGTGA----GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA  202 (268)
T ss_pred             ccccccccccccccC----CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence            999998765432111    11122356899999999874    47899999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-29  Score=242.91  Aligned_cols=187  Identities=24%  Similarity=0.314  Sum_probs=150.8

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ....||.|+||+|++..++.+|+..|||+++... ....+++..|.+...+- +.||||++||.+...     +..|+.|
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCM  142 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICM  142 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeH
Confidence            3467999999999999999999999999998554 45677899999875554 689999999986432     2579999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      |.|+ -++..+.+.-. ......+++.-.-+|+.-.+.||.||.+..  .|||||+||+|||++..|.+|++|||.+..+
T Consensus       143 ELMd-~SlDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  143 ELMD-ISLDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHh-hhHHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9994 57776654321 122356788888888888999999998774  8999999999999999999999999999766


Q ss_pred             cccccccccCCCCccccccCcccccccchh------hhhhcccCccccccccc
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKF------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~------~~~~~Di~s~g~~~~~~  913 (914)
                      .+...         .+.-+|-..|||||.+      ++.++|+||+|+|+||.
T Consensus       219 v~SiA---------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~Ev  262 (361)
T KOG1006|consen  219 VDSIA---------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEV  262 (361)
T ss_pred             HHHHH---------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeee
Confidence            44221         1124688999999999      46899999999999984

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.95  E-value=1.5e-27  Score=258.45  Aligned_cols=195  Identities=24%  Similarity=0.361  Sum_probs=155.2

Q ss_pred             cccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      +|++.+.||+|+||.||+|+...     ....+|+|.+..... ...+++.+|+.++++++||||+++++.+...     
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence            47788999999999999998743     335789998864332 2346788999999999999999999986433     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ------------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                      +..++||||+++|+|.+++......                  .....+++..++.++.|++.|++|||+.   +|+|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            4678999999999999998753211                  1123588999999999999999999998   999999


Q ss_pred             CCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+||++++++.+||+|||+++........      .......++..|+|||++.    +.++|+|||||+++||+
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~  223 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV  223 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHH
Confidence            9999999999999999999999865322111      0111234677899999874    58899999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.8e-27  Score=255.59  Aligned_cols=198  Identities=23%  Similarity=0.318  Sum_probs=164.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC-CCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDF-EGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-~~~~  780 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+++++++ +|+||+++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            45789999999999999999999988899999999875433 446789999999999 69999999999765442 3345


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++.....  ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++||
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence            68999999999999998865321  124688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      |++.......        .......|++.|+|||++.         +.++|+||+||++++|+
T Consensus       158 ~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~  212 (275)
T cd06608         158 GVSAQLDSTL--------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA  212 (275)
T ss_pred             ccceecccch--------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence            9987653221        1112346899999999873         35799999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.95  E-value=1.4e-27  Score=256.56  Aligned_cols=195  Identities=21%  Similarity=0.359  Sum_probs=158.2

Q ss_pred             hcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|+..+.||+|+||.||+|+.+.     +.+.||+|.+...... ..+.+.+|++++++++||||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-----   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-----
Confidence            578889999999999999999753     3467999988654433 45689999999999999999999998643     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcc---cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQV---EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                      ....++||||+++|+|.+++.......   ....+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence            346799999999999999997653211   012589999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++|||+++.......       .......++..|+|||...    +.++|+||+||++++||
T Consensus       157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  212 (275)
T cd05046         157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF  212 (275)
T ss_pred             EEcccccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence            9999999875432111       1112335778899999874    47799999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=1.9e-27  Score=252.83  Aligned_cols=186  Identities=25%  Similarity=0.374  Sum_probs=154.1

Q ss_pred             CcccCCccEEEEEEEECC-C--cEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGD-D--EMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|++|.||+|++.. .  ...||||.+..... ...+.+.+|++++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999854 2  34699999976554 456789999999999999999999998543      4789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++++|.+++.....    ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.+
T Consensus        75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence            99999999999976531    3688999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......     ........++..|+|||++.    +.++|+|||||+++||+
T Consensus       148 ~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~  194 (257)
T cd05040         148 PQNEDH-----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF  194 (257)
T ss_pred             cccccc-----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence            432211     00111345788999999874    47899999999999884

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=1.9e-27  Score=259.67  Aligned_cols=195  Identities=22%  Similarity=0.266  Sum_probs=158.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|.+....   ....+.+.+|+++++.++||||+++++.+.     ..++.
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCEE
Confidence            6888999999999999999999999999999987443   233457889999999999999999998854     34578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++|++|.+++...      ..+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.+|++|||+
T Consensus        77 ~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          77 CMVMEYVEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence            9999999999999999754      3578889999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccc-------cccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLD-------IASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~-------~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++........       .............|+..|+|||++.    +.++|+|||||+++||+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~  210 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL  210 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH
Confidence            8742111000       0000001112346889999999874    58899999999999873

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=6.3e-28  Score=257.58  Aligned_cols=187  Identities=26%  Similarity=0.352  Sum_probs=160.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------CcchHHHHHHHHHHHhcC---CCCcceEEeE
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------KGASKSFVSECEALRNIR---HRNLIKIITI  770 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~  770 (914)
                      ...++|+..+.+|+|+||.|+.|.++.....|+||.+.+++        ....-..--||.+|+.++   |+||++++.+
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34567999999999999999999999889999999996432        111123456999999997   9999999999


Q ss_pred             eecCCCCCCceEeEEEecc-cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          771 CSSTDFEGVDFKALVFEYM-ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       771 ~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                           |++.++.|++||-. +|-+|.++|..+      ..+++.++.-|++||+.|+++||++   +|||||||-||+.+
T Consensus       638 -----FEddd~yyl~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenviv  703 (772)
T KOG1152|consen  638 -----FEDDDYYYLETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIV  703 (772)
T ss_pred             -----eecCCeeEEEecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhcccccccc---CceecccccccEEE
Confidence                 77778999999975 567999999876      4688999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccc
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVH  912 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~  912 (914)
                      +.+|-+|++|||.|...+....+          .++||..|.|||++.     |...|||++|+.+|.
T Consensus       704 d~~g~~klidfgsaa~~ksgpfd----------~f~gtv~~aapevl~g~~y~gk~qdiwalgillyt  761 (772)
T KOG1152|consen  704 DSNGFVKLIDFGSAAYTKSGPFD----------VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYT  761 (772)
T ss_pred             ecCCeEEEeeccchhhhcCCCcc----------eeeeeccccchhhhCCCccCCCcchhhhhhheeeE
Confidence            99999999999999876543322          478999999999995     588999999999885

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.6e-27  Score=251.80  Aligned_cols=184  Identities=26%  Similarity=0.402  Sum_probs=150.6

Q ss_pred             CcccCCccEEEEEEEECCCc---EEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDE---MVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..++   ..||+|.+..... ...+++.+|++++++++||||+++++++..      ...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence            46999999999999886544   7899999874433 245678999999999999999999998532      2468999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        75 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          75 ELAPLGPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EeCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence            999999999999764      2578999999999999999999999   9999999999999999999999999999866


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......     ........++..|+|||.+.    +.++|+|||||++++|+
T Consensus       146 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~  192 (257)
T cd05060         146 GAGSDY-----YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF  192 (257)
T ss_pred             ecCCcc-----cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHH
Confidence            432211     01111223457899999984    47899999999999873

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=1.9e-27  Score=256.41  Aligned_cols=199  Identities=22%  Similarity=0.341  Sum_probs=160.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD----DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      ..++|++.+.||+|+||.||+|.+..    ++..||+|++.... ....+.+.+|+.++++++||||+++++++...   
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            34688999999999999999999875    36889999886332 33456788999999999999999999987532   


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCc--ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQ--VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                       ....++++||+++++|.+++...+..  .....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence             34678999999999999998764321  1124688999999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+++.+........      .....++..|+|||++.    +.++||||+||+++|++
T Consensus       157 kl~d~g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~  213 (280)
T cd05043         157 KITDNALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM  213 (280)
T ss_pred             EECCCCCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHh
Confidence            9999999986543221100      01234677899999984    47899999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=1.6e-27  Score=258.14  Aligned_cols=197  Identities=25%  Similarity=0.430  Sum_probs=157.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      ..+|++.+.||+|+||.||+|++..     ++..||+|++..... ...+.+.+|++++++++||||+++++++..    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence            3578999999999999999999743     578899999864432 234678899999999999999999998643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCc----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQ----------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                       ....++||||+++|+|.+++......                .....+++.+++.++.|++.|++|+|++   +++|||
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          80 -GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             -CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence             34679999999999999999753211                1123578889999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+||+++.++.+||+|||+++........      .......++..|+|||++.    +.++|+|||||+++||+
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  226 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYY------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  226 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccc------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence            9999999999999999999998754322110      0111223567899999875    47899999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.95  E-value=5e-27  Score=253.61  Aligned_cols=194  Identities=25%  Similarity=0.394  Sum_probs=159.4

Q ss_pred             hcccccCcccCCccEEEEEEEECC----CcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD----DEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|+..+.||+|+||.||+|++..    +++.||||++...... ..+.+.+|++++++++||||+++++++...   ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence            467788999999999999999753    4789999999755443 457899999999999999999999986432   24


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++....     ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence            46899999999999999997653     3588999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||.+...........     ......++..|+|||...    +.++|+|||||+++||+
T Consensus       153 fg~~~~~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~  206 (284)
T cd05038         153 FGLAKVLPEDKDYYY-----VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF  206 (284)
T ss_pred             cccccccccCCccee-----ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheee
Confidence            999987653211100     111234566799999884    47899999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=7.8e-28  Score=246.59  Aligned_cols=186  Identities=26%  Similarity=0.383  Sum_probs=156.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC--CCC----cceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR--HRN----LIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~~~~~~~  777 (914)
                      ..+|.+...+|+|+||.|.+|.++.++..||+|+++.- ....++..-|+++++++.  -|+    +|++.++     |+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            67899999999999999999999999999999999632 234567788999999994  232    6677666     66


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC------
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY------  851 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~------  851 (914)
                      -.++.++|+|.+ |-++.++++....    .+++..++..+++|++++++|||+.   +++|-||||||||+.+      
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            667899999998 7799999987643    6899999999999999999999999   9999999999999832      


Q ss_pred             --------------CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          852 --------------DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       852 --------------~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                                    +..+||+|||-|++-.+.+           ...+.|..|.|||++.    +.++|+||+||+++|+
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                          2358999999998754332           2467899999999995    5999999999999997


Q ss_pred             C
Q 042766          914 F  914 (914)
Q Consensus       914 f  914 (914)
                      |
T Consensus       303 y  303 (415)
T KOG0671|consen  303 Y  303 (415)
T ss_pred             e
Confidence            5

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.95  E-value=2.4e-27  Score=262.25  Aligned_cols=196  Identities=26%  Similarity=0.411  Sum_probs=156.6

Q ss_pred             hcccccCcccCCccEEEEEEEECC-------CcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD-------DEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      .+|++.+.||+|+||.||+|++..       .+..||+|.++... ....+.+.+|+++++++ +||||+++++++..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            478999999999999999998642       23478999886432 23346789999999999 79999999998643  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                         ....++||||+++|+|.+++......          .....+++.+++.++.|++.|++|||++   +|+||||||+
T Consensus        90 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          90 ---DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence               34689999999999999999754311          1224588899999999999999999998   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.++.+||+|||+++........      .......++..|||||++.    +.++|+|||||+++||+
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  230 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF  230 (334)
T ss_pred             eEEEcCCCcEEECCcccceeccccccc------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHH
Confidence            999999999999999999865432111      0111234567899999984    47899999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1e-27  Score=259.23  Aligned_cols=187  Identities=24%  Similarity=0.374  Sum_probs=158.0

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|++.....  ...+.+.+|++++++++||||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            68889999999999999999998899999998864322  2346788999999999999999999985     4455889


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++++++.++....      ..+++.+++.++.|++.|++|||+.   +|+|||+||+||++++++.+||+|||++
T Consensus        77 lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~  147 (286)
T cd07846          77 LVFEFVDHTVLDDLEKYP------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA  147 (286)
T ss_pred             EEEecCCccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence            999999999998877543      3578999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......|+..|+|||++.     +.++|+|||||+++||+
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  195 (286)
T cd07846         148 RTLAAPGE--------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML  195 (286)
T ss_pred             eeccCCcc--------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHH
Confidence            86533211        112346889999999874     36799999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.95  E-value=2.4e-27  Score=257.31  Aligned_cols=190  Identities=23%  Similarity=0.365  Sum_probs=159.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|.++...  ......+.+|++++++++||||+++++++....   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            57889999999999999999999899999999997443  223346778999999999999999999865432   2578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ ++|.+++....     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence            99999997 59999887643     3689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.......        ......+++.|+|||.+.     +.++|+||+||++++|+
T Consensus       153 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~  201 (293)
T cd07843         153 AREYGSPLK--------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL  201 (293)
T ss_pred             eeeccCCcc--------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHH
Confidence            986643211        111245789999999984     46799999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=3.4e-27  Score=251.43  Aligned_cols=188  Identities=25%  Similarity=0.475  Sum_probs=154.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|.+.+.||+|+||.||+|++..+ ..||+|.+.... ...+.+.+|++++++++|||++++++++.      ....++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            4688889999999999999998755 458999876433 34567889999999999999999998752      134689


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.++++....    ..+++..++.++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++
T Consensus        78 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999999999976431    4578899999999999999999998   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........       ......++..|+|||+..    +.++|+||+||++|||+
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~  197 (260)
T cd05069         151 LIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELV  197 (260)
T ss_pred             EccCCccc-------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHH
Confidence            65432211       111234678899999874    57899999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=2.6e-27  Score=254.93  Aligned_cols=179  Identities=25%  Similarity=0.303  Sum_probs=145.5

Q ss_pred             cccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHh---cCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRN---IRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .||+|+||.||+|++..+++.||+|.+.....   .....+.+|..+++.   .+||+|+++++++..     .+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            48999999999999998999999999864321   222334455544443   479999999888543     3478999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||+++|+|.+++...      ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++..
T Consensus        76 ~e~~~~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          76 LDLMNGGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            9999999999998754      3589999999999999999999999   999999999999999999999999999875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .....          .....||+.|||||++.     +.++|+||+||++|+|+
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~  190 (279)
T cd05633         147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL  190 (279)
T ss_pred             ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHH
Confidence            43211          11246999999999874     46789999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=2e-27  Score=256.77  Aligned_cols=188  Identities=21%  Similarity=0.311  Sum_probs=159.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|+++++.++||||+++++++...     ...
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~   78 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNI   78 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEE
Confidence            357888999999999999999999899999999986543 33457889999999999999999999996543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++...      ..+++..+..++.|++.|+.|||+..  +++||||||+||+++.++.++|+|||+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCc
Confidence            9999999999999998754      35789999999999999999999732  899999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......          .....||..|+|||++.    +.++|+|||||++++++
T Consensus       151 ~~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~  196 (284)
T cd06620         151 SGELINSI----------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA  196 (284)
T ss_pred             ccchhhhc----------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH
Confidence            87542211          11346899999999984    47899999999998863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.6e-27  Score=254.42  Aligned_cols=187  Identities=28%  Similarity=0.338  Sum_probs=161.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|+..+.||.|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEE
Confidence            36888899999999999999999999999999987543 3345678899999999999999999998543     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+||+++++|.+++...       .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999998743       578899999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......|++.|+|||++.    +.++|+|||||++++|+
T Consensus       146 ~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~  192 (274)
T cd06609         146 GQLTSTM--------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA  192 (274)
T ss_pred             eeecccc--------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence            8764321        1122356899999999985    47899999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=2.8e-27  Score=251.35  Aligned_cols=187  Identities=25%  Similarity=0.369  Sum_probs=161.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|.+.....  .+++.+|++++++++||||+++++++..     ....++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEE
Confidence            578999999999999999999998889999999864432  6789999999999999999999998643     357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ++||+++++|.+++...+     ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||++.
T Consensus        76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence            999999999999987543     4689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhhh----hhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM----LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~----~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......|+..|+|||++.+    .++|+|||||++++|+
T Consensus       148 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~  193 (256)
T cd06612         148 QLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMA  193 (256)
T ss_pred             hcccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHH
Confidence            6543211        1123458899999999853    6899999999998874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=1.3e-27  Score=257.10  Aligned_cols=187  Identities=26%  Similarity=0.363  Sum_probs=158.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++.     .....+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence            35677788999999999999998889999999986443 334467889999999999999999999853     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++..       ..+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.+|++|||++
T Consensus        79 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06642          79 IIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence            99999999999998864       3578889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+.....        ......|+..|+|||++.    +.++|+|||||+++||+
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  195 (277)
T cd06642         149 GQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA  195 (277)
T ss_pred             ccccCcch--------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHH
Confidence            86543211        112346899999999985    46899999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=3.6e-27  Score=251.25  Aligned_cols=189  Identities=23%  Similarity=0.475  Sum_probs=156.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.++||+|+||.||+|... +++.||+|.+.... ...+++.+|++++++++||||+++++++.      .+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcE
Confidence            357889999999999999999876 56789999986433 34568899999999999999999998742      23578


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||++
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence            99999999999999875432    4688899999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......++..|+|||++.    +.++|+|||||++||++
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~  197 (260)
T cd05067         150 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV  197 (260)
T ss_pred             eecCCCCcc-------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHH
Confidence            765422111       111234678899999884    57899999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=7.5e-28  Score=258.56  Aligned_cols=196  Identities=22%  Similarity=0.297  Sum_probs=161.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+-|..++.||-|+||+|..++..+|...||+|.+++.+   +........|-.||+.-+.+-||++|..     |++.+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkd  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKD  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCC
Confidence            355788899999999999999999999999999997554   3334466789999999999999999866     67778


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      .+|+||||++||++...+-+.+      .+++..+..++.++..|+++.|..   |+|||||||+|||||.||++|++||
T Consensus       703 nLYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             ceEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeec
Confidence            9999999999999999987653      578888899999999999999998   9999999999999999999999999


Q ss_pred             ccccccc---cccc---------ccccCCC----------------------CccccccCcccccccchhh----hhhcc
Q 042766          861 GLAKFLS---NHHL---------DIASKTP----------------------SSSIGIKGTVGYVAPGKFF----MLYTH  902 (914)
Q Consensus       861 Gla~~~~---~~~~---------~~~~~~~----------------------~~~~~~~GT~~y~APE~~~----~~~~D  902 (914)
                      |+++-+.   +..+         +......                      ......+||+.|+|||++.    ..-+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            9986432   1000         0000000                      0012457999999999993    58899


Q ss_pred             cCccccccccc
Q 042766          903 IPSFSCTNVHH  913 (914)
Q Consensus       903 i~s~g~~~~~~  913 (914)
                      .||.|+++|||
T Consensus       854 wws~gvil~em  864 (1034)
T KOG0608|consen  854 WWSVGVILYEM  864 (1034)
T ss_pred             hhHhhHHHHHH
Confidence            99999999998

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=2.5e-27  Score=254.01  Aligned_cols=189  Identities=23%  Similarity=0.407  Sum_probs=155.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+|.+.+.||+|+||.||+|++...   ...||||...... ....+.+.+|+.++++++||||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4688889999999999999997543   4578999886544 3445688999999999999999999998643      2


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++....     ..+++..++.++.|++.|++|+|+.   +++||||||+||+++.++.+|++||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~  151 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF  151 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence            4679999999999999997643     3588999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++........       ......++..|+|||++.    +.++|+||+||+++|++
T Consensus       152 g~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  202 (270)
T cd05056         152 GLSRYLEDESYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL  202 (270)
T ss_pred             ceeeecccccce-------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence            999865432211       011223567899999874    47899999999998863

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=4.5e-27  Score=252.39  Aligned_cols=199  Identities=26%  Similarity=0.406  Sum_probs=155.9

Q ss_pred             ccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC-Cc
Q 042766          707 FSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG-VD  780 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~-~~  780 (914)
                      |.+.+.||+|+||.||+|+++   .+++.||||++..+.  ....+++.+|++++++++||||+++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   357899999986432  234567889999999999999999999875432111 12


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++++||+++|+|.+++...........+++..+++++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            3578999999999998875432212224578889999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.........      ......+++.|+|||.+.    +.++|+||+||++++|+
T Consensus       158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~  209 (273)
T cd05074         158 GLSKKIYSGDYYR------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM  209 (273)
T ss_pred             cccccccCCccee------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHh
Confidence            9998654322110      111234677899999984    57899999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.94  E-value=3.4e-27  Score=252.89  Aligned_cols=187  Identities=27%  Similarity=0.412  Sum_probs=149.1

Q ss_pred             CcccCCccEEEEEEEECCCcE--EEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEM--VVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++.+++.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...     ...++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence            468999999999999987765  4688887632 233456788999999999 799999999986543     4679999


Q ss_pred             ecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          787 EYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      ||+++|+|.+++...+..          .....+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            999999999999754311          1123578999999999999999999998   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++|||+++......         .......+..|+|||++.    +.++|+|||||+++||+
T Consensus       153 l~dfgl~~~~~~~~---------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~  205 (270)
T cd05047         153 IADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  205 (270)
T ss_pred             ECCCCCccccchhh---------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99999986322110         001123466799999984    47899999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=4.7e-27  Score=248.72  Aligned_cols=183  Identities=26%  Similarity=0.426  Sum_probs=149.8

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      +.||+|+||.||+|... ++..||+|+++.... .....+.+|++++++++||||+++++++...     ...++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECC
Confidence            46899999999999875 678899998864432 2335788999999999999999999986543     3679999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++....     ..+++.+++.++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++......
T Consensus        75 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          75 PGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            9999999987543     3578899999999999999999998   9999999999999999999999999998754322


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...       ......++..|+|||++.    +.++|+|||||++++++
T Consensus       147 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~  188 (250)
T cd05085         147 IYS-------SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF  188 (250)
T ss_pred             ccc-------cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHh
Confidence            110       011123567899999985    46899999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=2.2e-27  Score=252.61  Aligned_cols=186  Identities=28%  Similarity=0.410  Sum_probs=160.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||++++++     ++.....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            4788899999999999999999899999999997443   2345788999999999999999999987     4455689


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++...      ..+++.++..++.|+++|+.|||+.   +++|+||||+||+++.++.++|+|||.
T Consensus        76 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            9999999999999999754      3688899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......         ......|+..|+|||++.    +.++|+||+||++|+|+
T Consensus       147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  193 (258)
T cd05578         147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL  193 (258)
T ss_pred             ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHH
Confidence            87654321         112346889999999985    58899999999999874

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=3.8e-27  Score=254.43  Aligned_cols=191  Identities=21%  Similarity=0.303  Sum_probs=154.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHH-HHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEA-LRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++... ......+..|++. ++..+||||+++++++..     ....
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence            36888999999999999999999999999999987543 2233456667665 566789999999998643     3468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ |+|.+++.....  ....+++..++.++.|++.|++|||+++  +++||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~  150 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYD--KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI  150 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999996 689888765321  1246899999999999999999999853  799999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~f  914 (914)
                      ++......         ......|+..|+|||++.        +.++|+||+||++++|+
T Consensus       151 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~  201 (283)
T cd06617         151 SGYLVDSV---------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA  201 (283)
T ss_pred             cccccccc---------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence            98653211         111246889999999873        47799999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=4e-27  Score=250.24  Aligned_cols=189  Identities=22%  Similarity=0.317  Sum_probs=159.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+++...+++.||+|.+....  ....+++.+|++++++++||||+++++++     +..+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            4788899999999999999999899999999986432  23446789999999999999999999984     4455889


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.++++++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||++
T Consensus        76 lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999875431    3578889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........        ......|++.|+|||+..    +.++|+|||||++++|+
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~  195 (256)
T cd08218         149 RVLNSTVE--------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC  195 (256)
T ss_pred             eecCcchh--------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHH
Confidence            86543211        111245899999999985    36799999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.1e-27  Score=250.90  Aligned_cols=190  Identities=27%  Similarity=0.497  Sum_probs=158.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|.+.+.||+|+||.||+|++. +++.||||.+.... ...+++.+|++++++++||||+++++++..     ....+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence            468999999999999999999986 45779999986433 345678999999999999999999998543     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.+|++|||.+
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             EEEeccCCCCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence            99999999999999976432    4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......++..|+|||.+.    +.++|+||+||++++++
T Consensus       151 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~  198 (261)
T cd05034         151 RLIEDDEYT-------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV  198 (261)
T ss_pred             eeccchhhh-------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHH
Confidence            866432111       111223567899999884    57899999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=5.9e-27  Score=256.52  Aligned_cols=198  Identities=25%  Similarity=0.395  Sum_probs=160.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC---C
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE---G  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~  778 (914)
                      .++|+..+.||+|+||.||+|++..+++.||||.+....  ......+.+|++++++++||||+++++++......   .
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999999999999999986443  22334667899999999999999999987654321   2


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||++ +++.+++....     ..+++.+++.++.|++.|++|||++   +++||||||+||+++.++.+||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence            245699999996 58888876542     3688999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||++..........    ........++..|+|||++.     +.++|+||+||++|+|+
T Consensus       162 dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~  218 (310)
T cd07865         162 DFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW  218 (310)
T ss_pred             cCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence            999998764432111    11122346889999999874     46799999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=8e-28  Score=278.74  Aligned_cols=195  Identities=22%  Similarity=0.253  Sum_probs=148.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCc-EEEEEEEe--------------ec---cCCcchHHHHHHHHHHHhcCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVI--------------NL---KQKGASKSFVSECEALRNIRHRNL  764 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~ni  764 (914)
                      ..++|++.+.||+|+||+||+|+.+... +.+++|.+              ..   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999999875322 22222211              00   112234568899999999999999


Q ss_pred             ceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       765 v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                      +++++++..     .+..++|||++ ++++.+++....... .......++..|+.|++.||+|||++   +||||||||
T Consensus       226 v~l~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP  295 (501)
T PHA03210        226 LKIEEILRS-----EANTYMITQKY-DFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL  295 (501)
T ss_pred             CcEeEEEEE-----CCeeEEEEecc-ccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            999999654     34789999999 468888775432111 12234566788999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||++.++.+||+|||+|+.+.....       .......||+.|+|||++.    +.++|||||||++|||+
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  362 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML  362 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999999999987643211       1122457999999999984    57899999999999974

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.94  E-value=4.5e-27  Score=257.26  Aligned_cols=191  Identities=27%  Similarity=0.386  Sum_probs=158.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....  .....+.+|++++++++|+||+++++++....   .+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence            4689999999999999999999999999999999975432  22345678999999999999999999865322   245


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ ++|.+++....     ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence            799999996 58988887543     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......        ......+++.|+|||++.     +.++|+||+||+++||+
T Consensus       154 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  203 (309)
T cd07845         154 LARTYGLPAK--------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL  203 (309)
T ss_pred             eeeecCCccC--------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH
Confidence            9986643210        111234688999999984     47899999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.2e-27  Score=250.10  Aligned_cols=185  Identities=32%  Similarity=0.475  Sum_probs=156.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+|++.+.||+|+||.||+|+..  ++.||+|.++.... ..+++.+|+.++++++|+||+++++++..     ....+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeE
Confidence            357888999999999999999875  67899999965433 46788999999999999999999998643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.++++....    ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999976432    3689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......           ...++..|+|||++.    +.++|+||+||++++|+
T Consensus       150 ~~~~~~~~-----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~  193 (256)
T cd05039         150 KEASQGQD-----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY  193 (256)
T ss_pred             cccccccc-----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHH
Confidence            86532110           123566799999884    46899999999998863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=5.8e-27  Score=252.10  Aligned_cols=187  Identities=26%  Similarity=0.362  Sum_probs=159.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..|+..+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++..     ....+
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEE
Confidence            45778889999999999999999889999999987543 3345678899999999999999999998644     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++..       ..+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++
T Consensus        79 lv~e~~~~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~  148 (277)
T cd06640          79 IIMEYLGGGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA  148 (277)
T ss_pred             EEEecCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence            99999999999999864       2478888999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........        ......|+..|+|||++.    +.++|+|||||+++||+
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~  195 (277)
T cd06640         149 GQLTDTQI--------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA  195 (277)
T ss_pred             eeccCCcc--------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHH
Confidence            76543211        112346889999999974    47899999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.94  E-value=5.7e-27  Score=250.44  Aligned_cols=192  Identities=24%  Similarity=0.391  Sum_probs=157.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      +|+..+.||+|+||.||+|+.. +++.+|+|.++....      ...+.+.+|++++++++|+||+++++++..     .
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence            4778899999999999999875 778999999864321      123568899999999999999999999643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++++|.+++.+.      ..+++..+..++.|++.|++|+|+.   +|+|+||||+||+++.++.+||+|
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence            5789999999999999999754      3578889999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.........  ..........||..|+|||++.    +.++|+||+||++++|+
T Consensus       146 fg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  202 (265)
T cd06631         146 FGCARRLAWVGLHG--THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA  202 (265)
T ss_pred             chhhHhhhhccccc--cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH
Confidence            99998653211110  0111122356999999999985    47899999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=4e-27  Score=255.35  Aligned_cols=188  Identities=26%  Similarity=0.362  Sum_probs=160.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|+...++..||+|.+........+.+.+|+.++++++||||+++++++..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            3689999999999999999999988889999999875555556788999999999999999999998543     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+||+++++|.+++.+.       .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~  162 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  162 (293)
T ss_pred             EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence            999999999999998653       467888999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........        ......|++.|+|||.+.    +.++|+|||||++++++
T Consensus       163 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll  209 (293)
T cd06647         163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV  209 (293)
T ss_pred             eccccccc--------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHH
Confidence            75543211        112346899999999984    47899999999998874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=5.3e-27  Score=249.47  Aligned_cols=186  Identities=27%  Similarity=0.413  Sum_probs=157.9

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +|+..+.||+|+||+||+|....+++.||+|.+....     ....+.+.+|++++++++||||+++++++..     ..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence            4677889999999999999998889999999986543     2244678899999999999999999998543     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            789999999999999999754      3578889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |++.......         ......|++.|+|||.+.     +.++|+||+||++++|+
T Consensus       147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~  196 (258)
T cd06632         147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA  196 (258)
T ss_pred             ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHH
Confidence            9987653321         112356899999999984     45799999999998874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=7.6e-27  Score=253.75  Aligned_cols=197  Identities=23%  Similarity=0.343  Sum_probs=159.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|+..+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|++++++++ ||||+++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999999999999999986443  223467889999999995 699999999876554333345


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEecc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDF  860 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DF  860 (914)
                      .++||||+++ ++.+++...... ....+++..++.++.||+.||+|||+.   +|+||||||+||+++. ++.+||+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence            7999999985 899988654321 124689999999999999999999999   9999999999999998 889999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.+....        .......+++.|+|||++.     +.++|+||+||++|+|+
T Consensus       156 g~~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~  206 (295)
T cd07837         156 GLGRAFSIPV--------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS  206 (295)
T ss_pred             ccceecCCCc--------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence            9997653211        0111235788999999874     46899999999999873

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.94  E-value=5.3e-27  Score=261.56  Aligned_cols=191  Identities=23%  Similarity=0.278  Sum_probs=158.2

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~  779 (914)
                      ...+|+..+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|++++++++||||+++++++.... ++..
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346899999999999999999999999999999998632  2334457788999999999999999999865332 2333


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||++ +++.+.+..        .++..++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence            46799999995 588887753        377888899999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       162 fg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         162 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             CccceeCCCCC---------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence            99998653221         112346899999999985    47899999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=7e-27  Score=250.77  Aligned_cols=189  Identities=24%  Similarity=0.445  Sum_probs=156.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC----------cchHHHHHHHHHHHhcCCCCcceEEeEeecCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK----------GASKSFVSECEALRNIRHRNLIKIITICSSTD  775 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  775 (914)
                      +|...+.||+|+||.||+|+...+++.||+|.++....          ...+.+.+|++++++++||||+++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            46778899999999999999988899999998863211          112467889999999999999999998543  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                         ....++||||+++++|.+++...      ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+
T Consensus        80 ---~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          80 ---EEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             ---CCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence               34789999999999999999764      3578888999999999999999998   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      |++|||+++.......      ........|+..|+|||++.      +.++|+||+||++++++
T Consensus       148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~  206 (272)
T cd06629         148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF  206 (272)
T ss_pred             EEeecccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence            9999999975432110      11122356899999999874      35699999999998874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=6.5e-27  Score=248.76  Aligned_cols=189  Identities=29%  Similarity=0.525  Sum_probs=157.9

Q ss_pred             ccccCcccCCccEEEEEEEECCCc----EEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDE----MVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +++.+.||+|+||.||+|++...+    ..||+|+++..... ..+.+.+|++.++.++|+||+++++++...     +.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence            356789999999999999998766    89999999654433 567899999999999999999999986443     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .+++|||+++++|.+++.....    ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg  148 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG  148 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence            8999999999999999976431    2289999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++...........       ...+++.|+|||...    +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~~~~~~~-------~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~  198 (258)
T smart00219      149 LSRDLYDDDYYKKK-------GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF  198 (258)
T ss_pred             Cceecccccccccc-------cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence            99876543211110       123788999999883    58999999999998874

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=6.3e-27  Score=248.64  Aligned_cols=188  Identities=26%  Similarity=0.422  Sum_probs=158.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|....+++.+|+|.+....  ....+.+.+|++++++++||||+++++++     ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            4788899999999999999999899999999987542  23456888999999999999999999874     3345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki~DFGl  862 (914)
                      +||||+++++|.+++.....    ..+++..++.++.|++.|++|||++   +|+||||||+||+++.+ +.+|++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999976432    4588999999999999999999999   99999999999999865 4689999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......         ......|++.|+|||.+.    +.++|+|||||++++|+
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~  195 (256)
T cd08220         149 SKILSSKS---------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA  195 (256)
T ss_pred             ceecCCCc---------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH
Confidence            98654321         112346899999999985    46899999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=8.4e-27  Score=248.37  Aligned_cols=189  Identities=22%  Similarity=0.451  Sum_probs=155.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. .+..||+|.+... ....+.+.+|++++++++|+||+++++++..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            357889999999999999999875 4557999988643 2345678899999999999999999988543      3578


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....    ...++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence            99999999999999976432    4578889999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......++..|+|||++.    +.++|+||+||++|+++
T Consensus       150 ~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~  197 (260)
T cd05073         150 RVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV  197 (260)
T ss_pred             eeccCCCcc-------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHH
Confidence            865432211       111234667899999984    46899999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=7.2e-27  Score=251.37  Aligned_cols=179  Identities=25%  Similarity=0.302  Sum_probs=145.6

Q ss_pred             cccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHH---HHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEA---LRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .||+|+||.||+|++..+++.||+|.+.....   .....+..|..+   ++...||+|+++++++.     ..+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence            48999999999999988999999999864421   112233444443   44457999999988843     44578999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      |||++||+|.+++...      ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        76 ~e~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          76 LDLMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            9999999999988654      3689999999999999999999998   999999999999999999999999999875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +....          .....||..|+|||++.     +.++|+||+||++|||+
T Consensus       147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~  190 (278)
T cd05606         147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL  190 (278)
T ss_pred             cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH
Confidence            43211          11346999999999984     46799999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.9e-27  Score=252.09  Aligned_cols=186  Identities=25%  Similarity=0.337  Sum_probs=158.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC---CCCcceEEeEeecCCCCCCce
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR---HRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .|+..+.||+|+||.||+|++..+++.||+|.++... ....+++.+|++++++++   |||++++++++..     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence            4777889999999999999998899999999986542 334567889999999996   9999999998543     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...       .+++..++.++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence            89999999999999988642       578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++........        ......|+..|+|||++.     +.++|+||+||++++|+
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll  196 (277)
T cd06917         147 VAALLNQNSS--------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA  196 (277)
T ss_pred             ceeecCCCcc--------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence            9987643221        112346899999999874     46899999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=8.6e-27  Score=248.83  Aligned_cols=191  Identities=29%  Similarity=0.458  Sum_probs=160.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|.++.....  ..+.+.+|++++++++|+||+++++++.     ..+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            478889999999999999999888999999999755443  5678999999999999999999999853     334789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +|+||+++++|.+++...      ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        76 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEecCCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence            999999999999998754      3478888999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhhh-------hhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~Di~s~g~~~~~~f  914 (914)
                      ...........    .......|++.|+|||++.+       .++|+|||||++++++
T Consensus       147 ~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~  200 (264)
T cd06626         147 VKLKNNTTTMG----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA  200 (264)
T ss_pred             cccCCCCCccc----ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH
Confidence            87644321110    00123568899999999853       5699999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=4.5e-27  Score=260.08  Aligned_cols=195  Identities=26%  Similarity=0.355  Sum_probs=160.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++.... ......
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            68999999999999999999999999999999986432  234467788999999999999999998765433 234578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ ++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~  153 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM  153 (334)
T ss_pred             EEEEehhh-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence            99999995 6899988654      3588999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++........    .........|+..|+|||++.     +.++|+||+||++++|+
T Consensus       154 ~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~  206 (334)
T cd07855         154 ARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML  206 (334)
T ss_pred             ceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence            9765432211    111122357899999999873     47899999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=258.66  Aligned_cols=190  Identities=25%  Similarity=0.394  Sum_probs=158.2

Q ss_pred             ccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ....+.||+|.||+|++|.|..   +...||||.++..... ...+|.+|+.+|.+++|||++++||++...      ..
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p~  185 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PA  185 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------hh
Confidence            3445789999999999999964   3467999999765544 668999999999999999999999996542      46


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      .+|||.++.|+|.+.+++..    ...+.......++.|||.|++||.++   +.||||+..+|+++.....|||+|||+
T Consensus       186 mMV~ELaplGSLldrLrka~----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAK----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             hHHhhhcccchHHHHHhhcc----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccc
Confidence            89999999999999998732    25677888899999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      .+.+...+..... .+    ...-...|.|||.+    |+.++|+|+||+|+.|||
T Consensus       259 mRaLg~ned~Yvm-~p----~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF  309 (1039)
T KOG0199|consen  259 MRALGENEDMYVM-AP----QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF  309 (1039)
T ss_pred             eeccCCCCcceEe-cC----CCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence            9988764321111 11    11234579999999    579999999999999998

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=6.2e-27  Score=257.12  Aligned_cols=196  Identities=23%  Similarity=0.362  Sum_probs=158.6

Q ss_pred             cccccCcccCCccEEEEEEEECC--CcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGD--DEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .|++.+.||+|+||.||+|++..  +++.||+|.+....   ....+.+.+|++++++++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            37788899999999999999987  78999999997532   44456788999999999999999999997543   125


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC----CCcEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY----DMVAH  856 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~----~~~~k  856 (914)
                      ..++||||+++ ++.+++...... ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccC-CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence            78999999964 777776543221 113688899999999999999999999   9999999999999999    89999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+++........     ........||+.|+|||++.     +.++|+||+||++++|+
T Consensus       153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  210 (316)
T cd07842         153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (316)
T ss_pred             ECCCccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999876432211     11223457899999999874     36799999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=264.69  Aligned_cols=188  Identities=28%  Similarity=0.447  Sum_probs=156.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCc----EEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDE----MVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +....++||+|+||+||+|.+-..+    .+||||++... ..+...++.+|+-+|.+++|||+++++|+|....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            4455689999999999999985444    46899988633 3456789999999999999999999999987654     


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                       ..||++||++|+|.++++.++     ..+-....+.|..|||+||.|||.+   ++|||||..+|||+.+...+||.||
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEec
Confidence             678999999999999999876     4677778899999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      |+|+...........      ....-.+.|||=|.+    ++.++||||||+|+-|.
T Consensus       843 gla~ll~~d~~ey~~------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWEl  893 (1177)
T KOG1025|consen  843 GLAKLLAPDEKEYSA------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWEL  893 (1177)
T ss_pred             chhhccCcccccccc------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHH
Confidence            999987654322111      112345679999988    47999999999998774

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.94  E-value=7.1e-27  Score=253.47  Aligned_cols=197  Identities=21%  Similarity=0.300  Sum_probs=145.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccCCcch-----------HHHHHHHHHHHhcCCCCcceEEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQKGAS-----------KSFVSECEALRNIRHRNLIKIITI  770 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~  770 (914)
                      .+|++.+.||+|+||.||+|++..+   +..+|+|+.........           .....+...+..++|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999999877   66778886543332111           112233445566789999999987


Q ss_pred             eecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      +.... ....+.+++||++. .++.+.+...      ...++..+..++.|++.|++|||+.   +|+||||||+|||++
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLV-ENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             eeEec-CCceEEEEEEehhc-cCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            54332 22235678888874 4777766543      2356778899999999999999998   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      .++.+||+|||+|+.+......... .........||+.|||||+..    +.++|||||||+++||
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el  226 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW  226 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCccccc-ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999876432211110 111122356999999999984    5899999999999987

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.2e-27  Score=247.47  Aligned_cols=184  Identities=27%  Similarity=0.444  Sum_probs=151.8

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ++||+|+||.||+|.+.. ++.||+|.+...... ..+.+.+|++++++++||||+++++++..     ....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence            469999999999999987 899999998754433 45688999999999999999999998643     34789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++....     ..+++..++.++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++.....
T Consensus        75 ~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          75 PGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             CCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            9999999997543     3578889999999999999999999   9999999999999999999999999999865321


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ....      ......++..|+|||++.    +.++|+||+||++|||+
T Consensus       147 ~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~  189 (251)
T cd05041         147 IYTV------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETF  189 (251)
T ss_pred             ccee------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHH
Confidence            1110      001123467799999874    47899999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-29  Score=241.93  Aligned_cols=188  Identities=22%  Similarity=0.295  Sum_probs=152.3

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeec--cCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ..+.||-|+||+||.+++..+|+.||.|++..  ..-...+++.+|++++..++|.|++..+++-.-...+--.+.|++.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            34789999999999999999999999998852  2334567899999999999999999888764332222223467889


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      |.|. .+|..++-..      ..++...+.-+.+||++|++|||+.   +|.||||||.|.|+..+...||+|||+|+..
T Consensus       137 ELmQ-SDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHH-hhhhheeccC------CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence            9885 4888877543      5678888888999999999999999   9999999999999999999999999999965


Q ss_pred             cccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      ...+       ....+..+-|-+|.|||.++     +.++||||.||++.|+
T Consensus       207 e~d~-------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaEL  251 (449)
T KOG0664|consen  207 DQRD-------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAEL  251 (449)
T ss_pred             chhh-------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHH
Confidence            4322       11223456788999999995     4889999999998775

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=9.5e-27  Score=247.34  Aligned_cols=188  Identities=29%  Similarity=0.508  Sum_probs=155.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|++.+.||+|+||.||+|.+. .+..+|+|.++.. ......+.+|++++++++||+|+++++++..     ....++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCceEE
Confidence            57888999999999999999886 4668999988633 2334678999999999999999999998543     346899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence            999999999999987543     3578889999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......       .......++.+|+|||++.    +.++|+||+||+++||+
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~  195 (256)
T cd05112         149 FVLDDQY-------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVF  195 (256)
T ss_pred             ecccCcc-------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHH
Confidence            6533211       1111234567899999885    47899999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=4.7e-27  Score=253.88  Aligned_cols=188  Identities=26%  Similarity=0.405  Sum_probs=156.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|++|.||+|++..+++.||||+++...  ......+.+|++++++++||||+++++++.     ..+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4788899999999999999999899999999986443  223357889999999999999999999853     445789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++.....    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence            9999995 689998865432    4688999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......+++.|+|||++.     +.++|+|||||++|+|+
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~  195 (284)
T cd07860         148 RAFGVPVR--------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV  195 (284)
T ss_pred             hhcccCcc--------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH
Confidence            76532110        111235788999999874     46799999999999873

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=7.5e-27  Score=249.30  Aligned_cols=193  Identities=26%  Similarity=0.381  Sum_probs=160.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  ....+++.+|++++++++||||+++++++...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            4778899999999999999999899999999986432  23345788999999999999999999876432   234679


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH-----HHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH-----~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ++|||+++++|.+++.....  ....+++.+++.++.|++.|++|+|     +.   +++||||||+||+++.++.+|++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence            99999999999999975421  2256889999999999999999999     66   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++.......        ......|++.|+|||++.    +.++|+||+||++++|+
T Consensus       153 d~g~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~  204 (265)
T cd08217         153 DFGLAKILGHDSS--------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC  204 (265)
T ss_pred             cccccccccCCcc--------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHH
Confidence            9999986543221        012346899999999985    46799999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.94  E-value=4.6e-27  Score=251.76  Aligned_cols=190  Identities=27%  Similarity=0.427  Sum_probs=151.8

Q ss_pred             CcccCCccEEEEEEEECCCc------EEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          711 NMIGQGRFGTVYKGILGDDE------MVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.||+|+||.||+|++.+..      +.||+|.+.... ......+.+|++++++++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            36899999999999986433      789999885432 2345678899999999999999999998643     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-----cEEE
Q 042766          784 LVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-----VAHV  857 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~ki  857 (914)
                      +||||+++++|.+++....... ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .+|+
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997542211 123578899999999999999999998   999999999999999877     8999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++..........      .....++..|+|||++.    +.++|+|||||++++|+
T Consensus       153 ~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell  207 (269)
T cd05044         153 GDFGLARDIYKSDYYRK------EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL  207 (269)
T ss_pred             CCccccccccccccccc------CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence            99999986543221111      11234678899999884    58899999999999873

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1e-26  Score=251.48  Aligned_cols=191  Identities=24%  Similarity=0.320  Sum_probs=159.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|...+.||+|++|.||+|++..+++.||+|.+..... ....++.+|++++++++||||+++++++...   .....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            67888999999999999999998999999999874432 3456789999999999999999999987543   2346899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++.....  ....+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        79 v~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~  153 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG  153 (287)
T ss_pred             EEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccc
Confidence            9999999999998764221  124578889999999999999999999   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......          ....++..|+|||.+.    +.++|+||+||++|+|+
T Consensus       154 ~~~~~~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~  197 (287)
T cd06621         154 ELVNSLA----------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA  197 (287)
T ss_pred             ccccccc----------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence            5432110          1245788999999885    46899999999999875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=9.3e-27  Score=251.55  Aligned_cols=189  Identities=24%  Similarity=0.410  Sum_probs=157.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|+..+.||+|++|.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...     +..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence            47888999999999999999998999999999975432 3346778899999999999999999986543     47899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++ ++.+++.....   ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++
T Consensus        76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            9999975 89998875432   24689999999999999999999998   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......+|+.|+|||++.     +.++|+||+||++++|+
T Consensus       149 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~  195 (284)
T cd07836         149 AFGIPVN--------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI  195 (284)
T ss_pred             hhcCCcc--------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            6532110        111245789999999873     46899999999998874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=1.1e-26  Score=248.02  Aligned_cols=187  Identities=27%  Similarity=0.396  Sum_probs=161.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++.+++++||||+++++++..     ....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence            68888999999999999999999999999999875543 445789999999999999999999998543     357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ||||+++++|.+++...      ..+++..+..++.|+++|++|+|+ .   +++||||+|+||+++.++.++++|||.+
T Consensus        77 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          77 VLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             EEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999999764      468899999999999999999999 8   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......|+..|+|||.+.    +.++|+|||||++++|+
T Consensus       148 ~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~  194 (264)
T cd06623         148 KVLENTLD--------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA  194 (264)
T ss_pred             eecccCCC--------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH
Confidence            86543221        111346889999999985    46899999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=1.3e-26  Score=250.40  Aligned_cols=186  Identities=23%  Similarity=0.329  Sum_probs=158.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      +|...+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|+.++++++||||+++++++..     .+..++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            45556799999999999999988899999999876555556678899999999999999999998543     3478999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      +||+++++|.+++..       ..+++.++..++.|++.|++|+|+.   +|+||||||+||+++.++.++++|||.+..
T Consensus        95 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          95 MEFLEGGALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EeccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence            999999999999875       2478889999999999999999999   999999999999999999999999998875


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....        .......|++.|+|||+..    +.++|+||+||++++|+
T Consensus       165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell  209 (285)
T cd06648         165 VSKEV--------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV  209 (285)
T ss_pred             hccCC--------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence            43211        0112346899999999984    47899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=5e-27  Score=250.83  Aligned_cols=186  Identities=25%  Similarity=0.370  Sum_probs=159.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +|+..+.||+|+||.||+|+++.+++.||+|++.... ....+++.+|++++++++||||+++++++...     ...++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEE
Confidence            6778899999999999999999899999999987543 33456788999999999999999999986443     57899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ||||+++++|.+++....     ..+++.....++.|++.|++|+|+ .   +++||||||+||+++.++.+||+|||.+
T Consensus        77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999997643     468888999999999999999999 7   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........          ....|+..|+|||.+.    +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~----------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~  193 (265)
T cd06605         149 GQLVNSLA----------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA  193 (265)
T ss_pred             hhhHHHHh----------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            76532211          0156889999999985    47899999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=7.2e-27  Score=258.71  Aligned_cols=193  Identities=25%  Similarity=0.345  Sum_probs=160.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..+|.+.+.||+|+||.||+|++..+++.||||.++..  .......+.+|+.++++++||||+++++++.....+....
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35789999999999999999999999999999998643  2333457788999999999999999999865443333346


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+. ++|.+++...      ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence            899999995 7899988754      3688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......        .......||..|+|||++.     +.++|+||+||++++|+
T Consensus       154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  203 (337)
T cd07858         154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL  203 (337)
T ss_pred             cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence            998653321        1112346889999999874     37899999999998873

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=1.2e-26  Score=249.61  Aligned_cols=181  Identities=25%  Similarity=0.348  Sum_probs=152.3

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||+||+|++..+++.||+|.+....   ....+.+.+|++++++++||||+++++++.     ..+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence            699999999999999899999999986432   223456778999999999999999998853     345789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++.....    ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.++.....
T Consensus        76 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          76 NGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             CCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999876532    3689999999999999999999999   9999999999999999999999999998765321


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .         ......|+..|+|||++.    +.++|+||+||++++|.
T Consensus       149 ~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~  188 (277)
T cd05577         149 K---------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI  188 (277)
T ss_pred             C---------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHh
Confidence            1         111245888999999984    46799999999998873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.94  E-value=1.7e-26  Score=246.88  Aligned_cols=187  Identities=24%  Similarity=0.311  Sum_probs=152.1

Q ss_pred             HHHHHHHhhcccccCcc--cCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeec
Q 042766          697 YAELSKATSEFSSSNMI--GQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSS  773 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  773 (914)
                      ..+.....++|++.+.+  |+|+||.||+++.+.+++.+|+|.+........     |+.....+ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            44555556677877777  999999999999999999999999864432211     23222222 79999999998644


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                           .+..++||||+++++|.+++...      ..+++.++..++.|+++|++|||+.   +++||||||+||+++.++
T Consensus        81 -----~~~~~iv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         81 -----LKGHVLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             -----CCeeEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence                 34789999999999999999754      3689999999999999999999999   999999999999999998


Q ss_pred             -cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 -VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 -~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                       .++|+|||+++.....            ....||..|+|||++.    +.++|+||+||++++|+
T Consensus       147 ~~~~l~dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~  200 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTP------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL  200 (267)
T ss_pred             CeEEEecCccceecCCC------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence             9999999998754321            1235899999999984    47799999999999873

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=1.2e-26  Score=251.47  Aligned_cols=188  Identities=21%  Similarity=0.286  Sum_probs=155.7

Q ss_pred             cccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ----KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFE  777 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  777 (914)
                      +|++.+.||+|+||.||+|+..   .+|+.||+|+++...    ....+.+.+|+++++++ +|++|+++++++     +
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4778899999999999999884   478899999986432    22346788999999999 599999998874     3


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      .....++||||+++++|.+++...      ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence            345789999999999999998754      3578888999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++........       ......|+..|+|||.+.      +.++|+||+||++++|+
T Consensus       147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll  202 (290)
T cd05613         147 TDFGLSKEFHEDEVE-------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL  202 (290)
T ss_pred             eeCccceeccccccc-------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh
Confidence            999999865432211       112356899999999984      36799999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=1.2e-26  Score=246.19  Aligned_cols=182  Identities=30%  Similarity=0.459  Sum_probs=152.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||.||+|+.  +++.||+|.++..  ...+.+.+|+.++++++||||+++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            5789999999999999999875  5678999998533  234678899999999999999999998643      23689


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++.....    ..+++..++.++.|++.|+.|+|+.   +++||||||+||+++.++.+||+|||.++
T Consensus        76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence            9999999999999976432    4578889999999999999999998   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......           .....+..|+|||++.    +.++|+||+||+++||+
T Consensus       149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~  191 (254)
T cd05083         149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF  191 (254)
T ss_pred             eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence            542210           0123456899999874    47899999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=7e-27  Score=253.01  Aligned_cols=188  Identities=25%  Similarity=0.349  Sum_probs=157.8

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|++++++++|+||+++++++..     .+..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            6888999999999999999999899999999986432  3345788999999999999999999998644     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++++.+..+....      ..+++.++..++.|++.|++|||+.   +++|||+||+||+++.++.+||+|||++
T Consensus        77 iv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          77 LVFEYVERTLLELLEASP------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             EEEecCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence            999999987776655432      3578899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......       .......|+..|+|||++.     +.++|+||+||++++|+
T Consensus       148 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~  196 (288)
T cd07833         148 RALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL  196 (288)
T ss_pred             cccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH
Confidence            87543221       0112356889999999974     36799999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.94  E-value=7.6e-27  Score=258.96  Aligned_cols=194  Identities=26%  Similarity=0.379  Sum_probs=157.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC---------
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTD---------  775 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  775 (914)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            68999999999999999999999999999999997666666678899999999999999999987754322         


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCc
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMV  854 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~  854 (914)
                      +......++||||++ ++|.+++..       ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++. ++.
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~  153 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence            111235789999996 589888754       2578899999999999999999998   9999999999999974 567


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|++|||.++........     ........||..|+|||++.     +.++|+||+||++++|+
T Consensus       154 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  213 (342)
T cd07854         154 LKIGDFGLARIVDPHYSH-----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  213 (342)
T ss_pred             EEECCcccceecCCcccc-----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence            899999999765322110     01111235889999999873     36899999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=1.3e-26  Score=249.50  Aligned_cols=186  Identities=27%  Similarity=0.367  Sum_probs=157.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      -|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++..     ....++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeEEE
Confidence            4777889999999999999998889999999986433 2334678899999999999999999998643     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++++|.+++..       ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        80 v~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          80 IMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             EEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence            9999999999999864       3578899999999999999999998   99999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......|+..|+|||.+.    +.++|+||+||++++|+
T Consensus       150 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~  195 (277)
T cd06641         150 QLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA  195 (277)
T ss_pred             ecccchh--------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence            6543211        112246889999999884    46899999999998874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=1.9e-26  Score=252.01  Aligned_cols=183  Identities=27%  Similarity=0.356  Sum_probs=154.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..|+..+.||+|+||.||+|++..+++.||+|++.....   ...+++.+|++++++++||||+++++++...     +.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            458888999999999999999988899999999864332   2335688999999999999999999997543     46


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ |++.+++....     ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.+||+|||
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence            899999996 57877775432     3588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~  913 (914)
                      +++.....            ....|++.|+|||++.       +.++|+|||||+++||
T Consensus       161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el  207 (307)
T cd06607         161 SASLVSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL  207 (307)
T ss_pred             cceecCCC------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence            98754211            1246889999999873       4689999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.94  E-value=1.3e-26  Score=256.88  Aligned_cols=195  Identities=27%  Similarity=0.375  Sum_probs=158.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++...  .......+.+|+.+++++ +||||+++++++...   ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence            356899999999999999999999888999999988532  223345677899999999 999999999986432   23


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||++ ++|.+++...       .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence            46799999997 5999988642       567888899999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.........   .........||+.|+|||++.     +.++|+|||||++++|+
T Consensus       151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~  207 (337)
T cd07852         151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML  207 (337)
T ss_pred             ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH
Confidence            99998664322110   011223457999999999873     47899999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=1.9e-26  Score=250.50  Aligned_cols=189  Identities=26%  Similarity=0.393  Sum_probs=154.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|+..+.||+|++|.||+|++..+++.||+|.+....  ....+.+.+|++++++++||||+++++++..     ....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence            47889999999999999999999899999999986432  2334678899999999999999999999643     3578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFG  861 (914)
                      ++||||++ +++.+++.....    ...++..+..++.|++.|++|||++   +|+||||||+||+++. ++.+||+|||
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence            99999995 588888765432    3467788889999999999999999   9999999999999985 5679999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......        .......|++.|+|||++.     +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~  198 (294)
T PLN00009        149 LARAFGIPV--------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV  198 (294)
T ss_pred             cccccCCCc--------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            997543211        0111235789999999885     36799999999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=252.63  Aligned_cols=186  Identities=27%  Similarity=0.496  Sum_probs=158.2

Q ss_pred             ccccCcccCCccEEEEEEEECC----CcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGILGD----DEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ....+.||+|-||.||+|.+..    ....||||..+.+ .....+.|.+|+.+|++++|||||+++|+|...      .
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------P  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------c
Confidence            3456789999999999999853    2356899988753 345578999999999999999999999998654      4


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|||||.++.|.|.+|++..+     ..++......++.||+.|++|||+.   ..|||||..+|||+....-||++|||
T Consensus       465 ~WivmEL~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence            899999999999999999876     5788889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      ++|.+.+..+..+..       ..=...|||||-+    ++.++|+|=||+.+-|.
T Consensus       537 LSR~~ed~~yYkaS~-------~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI  585 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASR-------GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI  585 (974)
T ss_pred             hhhhccccchhhccc-------cccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence            999988766543331       1234579999998    57999999999877654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=2.1e-26  Score=246.19  Aligned_cols=195  Identities=26%  Similarity=0.336  Sum_probs=162.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||+||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..     ....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence            36889999999999999999998889999999986433 2345788999999999999999999988543     45789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....   ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|++|||++
T Consensus        76 iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            99999999999999975321   13578999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ..+.......    ........|+..|+|||++.     +.++|+||+||++++|+
T Consensus       150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~  201 (267)
T cd06610         150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA  201 (267)
T ss_pred             HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence            8765432110    01123456999999999974     46899999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.94  E-value=1.9e-26  Score=251.60  Aligned_cols=197  Identities=25%  Similarity=0.379  Sum_probs=160.3

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCC----
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTD----  775 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  775 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||+|+++...  ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35578999999999999999999999899999999997543  233456788999999999999999999875432    


Q ss_pred             -CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          776 -FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       776 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                       .+.....++||||+++ ++.+.+....     ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence             1123378999999975 7777776432     4689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||.++.......       .......++..|+|||++.     +.++|+||+||++++|+
T Consensus       155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~  212 (302)
T cd07864         155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF  212 (302)
T ss_pred             EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH
Confidence            99999999986543221       0111234688899999874     47899999999998874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=1.1e-26  Score=247.97  Aligned_cols=188  Identities=24%  Similarity=0.345  Sum_probs=154.3

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++||||+++++.+     +.....++||||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999998899999999864432   3456788999999999999999998874     3445789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++...      ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        76 ~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          76 PGGDLASLLENV------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            999999999764      3688999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ................++..|+|||...    +.++|+||+||++++++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~  195 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL  195 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence            1110000011223456889999999985    46899999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.94  E-value=1.7e-26  Score=252.99  Aligned_cols=202  Identities=23%  Similarity=0.359  Sum_probs=160.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC---CC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDF---EG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  778 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.....  .....+.+|++++++++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999998999999999864432  223467889999999999999999987644321   12


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||+++ ++.+.+....     ..+++.++..++.|+++||+|||+.   +|+||||||+||++++++.+||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence            3457999999964 7777776432     4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccC---CCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASK---TPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~---~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++............   .........||+.|+|||++.     +.++|+||+||++++|+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~  221 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF  221 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH
Confidence            999998654322111100   111223456899999999874     46799999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=3e-26  Score=251.57  Aligned_cols=183  Identities=28%  Similarity=0.352  Sum_probs=154.0

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .|+..+.||+|+||.||+|++..++..||+|++.....   .....+.+|++++++++|||++++++++...     ...
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence            36778899999999999999998999999999864322   2335788999999999999999999986543     468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ |++.+.+....     ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       101 ~lv~e~~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635         101 WLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             EEEEeCCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence            99999996 58888776443     4688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +......            ....|++.|+|||++.       +.++|+||+||++++|+
T Consensus       172 ~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~  218 (317)
T cd06635         172 ASIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  218 (317)
T ss_pred             ccccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence            8754321            1246899999999973       47899999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=2.4e-26  Score=245.18  Aligned_cols=179  Identities=26%  Similarity=0.333  Sum_probs=153.2

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++.     .....++||||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999889999999997433   234467899999999999999999999854     344789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++.+.      ..+++..+..++.|++.|++|+|++   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        76 ~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          76 LGGELWTILRDR------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             CCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999999999764      3478889999999999999999998   9999999999999999999999999999865432


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .         ......|++.|+|||.+.    +.++|+||+||++|+|+
T Consensus       147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~  186 (262)
T cd05572         147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL  186 (262)
T ss_pred             c---------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHH
Confidence            1         112346899999999984    47799999999999874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.94  E-value=1.4e-26  Score=250.73  Aligned_cols=182  Identities=23%  Similarity=0.335  Sum_probs=155.1

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ...||+|+||.||+|+...+++.||||++........+.+.+|+.++++++|+||+++++++..     .+..++||||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEEecC
Confidence            4679999999999999998999999999865555556678999999999999999999998543     45789999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++..       ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus       100 ~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657         100 EGGALTDIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             CCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            99999998754       2478889999999999999999999   9999999999999999999999999998755322


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .        .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       170 ~--------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~  210 (292)
T cd06657         170 V--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV  210 (292)
T ss_pred             c--------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence            1        1112346899999999884    57899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.94  E-value=1.5e-26  Score=255.17  Aligned_cols=191  Identities=18%  Similarity=0.213  Sum_probs=151.2

Q ss_pred             CcccCC--ccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQG--RFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ..||+|  +||+||+|++..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..     .+..++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence            456776  99999999999999999999987543  2234678899999999999999999999643     44789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||++++++.+++.+...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+...
T Consensus        79 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          79 PFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             ecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999999999876532    3588899999999999999999998   9999999999999999999999999866433


Q ss_pred             cccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      .......... ........++..|||||++.      +.++|+||+||++|+|+
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~  204 (328)
T cd08226         152 VRNGQKAKVV-YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA  204 (328)
T ss_pred             hccCcccccc-ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence            2211110000 00011224667899999984      36789999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-28  Score=251.95  Aligned_cols=396  Identities=19%  Similarity=0.244  Sum_probs=202.5

Q ss_pred             CCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccc-ccccCCCCCccc
Q 042766          164 QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE-NQFSGMFPRSIC  242 (914)
Q Consensus       164 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~  242 (914)
                      .+|..+..  .-.+++|..|+|+...|.+|+.+.+|+.||||+|+|+.+-|.+|.++++|..|-+-+ |+|+......|.
T Consensus        60 eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            45554432  455667777777755556677777777777777777766677777777666655554 667655556666


Q ss_pred             cccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccC------------Cccc
Q 042766          243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF------------KGKV  310 (914)
Q Consensus       243 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l------------~~~~  310 (914)
                      +|.+|+.|.+.-|++.- ++.+.+..+++|..|.|-.|.++.+--.+|..+.+++.+.+..|.+            ....
T Consensus       138 gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~  216 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN  216 (498)
T ss_pred             hHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence            66666666666666653 3445556666666666666666633333666666666666666652            1122


Q ss_pred             cccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCC
Q 042766          311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP  390 (914)
Q Consensus       311 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p  390 (914)
                      |..+++.+...-..+.++++....+..+     ...+.++..=..+.....+..|..                       
T Consensus       217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf-----~c~~esl~s~~~~~d~~d~~cP~~-----------------------  268 (498)
T KOG4237|consen  217 PIETSGARCVSPYRLYYKRINQEDARKF-----LCSLESLPSRLSSEDFPDSICPAK-----------------------  268 (498)
T ss_pred             hhhcccceecchHHHHHHHhcccchhhh-----hhhHHhHHHhhccccCcCCcChHH-----------------------
Confidence            3333344444444444444443332221     111111111111111122233332                       


Q ss_pred             ccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCC
Q 042766          391 PGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN  470 (914)
Q Consensus       391 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  470 (914)
                       +|.++++|++|+|++|+++++-+.+|.++.++++|.|..|+|.......|.++..|+.|+|.+|+|+..-|.+|..+..
T Consensus       269 -cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~  347 (498)
T KOG4237|consen  269 -CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS  347 (498)
T ss_pred             -HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence             3444555555555555555444455555555555555555544444444444555555555555554444444544444


Q ss_pred             ccccccCCCccCC-----------------CCchhhhcccchhhhhcccCCccCC---Ccccccc---------ccccce
Q 042766          471 LILFIASYNKLTG-----------------DLPQQLLSITTLSLVLDLSNNLLNG---SLPLQVG---------NLKNLV  521 (914)
Q Consensus       471 L~~L~l~~N~l~~-----------------~~p~~~~~~~~l~~~L~Ls~N~l~~---~~p~~~~---------~l~~L~  521 (914)
                      |..|++-.|.+.-                 ..|..  .-+.....++++.+.+..   ..|.+.+         ..+-+.
T Consensus       348 l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~  425 (498)
T KOG4237|consen  348 LSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLD  425 (498)
T ss_pred             eeeeehccCcccCccchHHHHHHHhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhh
Confidence            4444444444321                 11110  000111233333333321   0111111         111111


Q ss_pred             -eecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCC
Q 042766          522 -MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN  600 (914)
Q Consensus       522 -~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  600 (914)
                       +..-|++.+. .+|..+-  ..-.+|++.+|.++ .+|.+  .+.+| .+|+|+|+++...-..|.++++|.+|-||+|
T Consensus       426 tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  426 TVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence             1223333333 3333322  23456788888887 55655  56677 7888888888777778888888888888876

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.94  E-value=2.6e-26  Score=254.90  Aligned_cols=196  Identities=22%  Similarity=0.336  Sum_probs=161.6

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      ..++....++|+..+.||+|+||.||+|++..+++.||+|+++...  ....+.+.+|++++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3456667789999999999999999999998899999999986432  22345788899999999999999999986533


Q ss_pred             C-CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          775 D-FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       775 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                      . ++.....+++++++ +++|.+++..       ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            2 22334568888887 7899988764       3578899999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++.....           .....||+.|+|||.+.     +.++|+||+||++++|+
T Consensus       158 ~~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  212 (345)
T cd07877         158 ELKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  212 (345)
T ss_pred             CEEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH
Confidence            9999999998754221           12346899999999874     46899999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.94  E-value=2.4e-26  Score=254.06  Aligned_cols=194  Identities=23%  Similarity=0.306  Sum_probs=156.7

Q ss_pred             cccccCcccCCccEEEEEEEECCC--cEEEEEEEeecc--CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDD--EMVVAVKVINLK--QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +|++.+.||+|+||.||+|++..+  +..||+|++...  .....+.+.+|+++++++ +||||+++++++.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            477889999999999999999877  889999998632  222346788999999999 5999999998754321 2334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..+++|||++ ++|.+++...      ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence            5789999985 6999988654      4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.+......    .........||+.|+|||+..     +.++|+||+||++++|+
T Consensus       150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~  204 (332)
T cd07857         150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL  204 (332)
T ss_pred             CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            999866432211    111122457999999999874     46899999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1e-27  Score=260.33  Aligned_cols=187  Identities=25%  Similarity=0.371  Sum_probs=165.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|+..+.+|.|+||.||+|++..+++..|+|+++........-..+|+-+++.++|||||.++|-+...     +..|+
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh-----cCcEE
Confidence            5788899999999999999999999999999999988777778888999999999999999999985433     47899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      .||||.||+|++..+..      .++++.+...+++...+|++|+|+.   +-+|||||-.||++++.|.+|++|||.+.
T Consensus        90 cMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             EEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence            99999999999988755      4788889999999999999999999   89999999999999999999999999987


Q ss_pred             cccccccccccCCCCccccccCcccccccchh-------hhhhcccCccccccccc
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-------~~~~~Di~s~g~~~~~~  913 (914)
                      .+....        ..+..+.|||+|||||+.       ++..+|+|+.|+|.+|+
T Consensus       161 qitati--------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel  208 (829)
T KOG0576|consen  161 QITATI--------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL  208 (829)
T ss_pred             hhhhhh--------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence            654321        223457899999999998       56999999999998874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=2.7e-26  Score=248.29  Aligned_cols=189  Identities=26%  Similarity=0.419  Sum_probs=158.0

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |++.+.||+|+||.||+|++..+++.||+|++....  ......+.+|++++++++|||++++++++....   .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            567789999999999999999889999999997653  334567889999999999999999999975431   257899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++ +|.+++....     ..+++.+++.++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.++
T Consensus        78 v~e~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             Eeccccc-cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9999974 8998887542     3688999999999999999999998   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .......       .......++..|+|||.+.     +.++|+|||||+++||+
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~  196 (287)
T cd07840         149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF  196 (287)
T ss_pred             eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence            6643221       0112245788999999763     47899999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=3.5e-26  Score=247.33  Aligned_cols=190  Identities=25%  Similarity=0.363  Sum_probs=162.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ....|+..+.||+|+||.||+|++..++..||+|+++.... ..+.+.+|++++++++|+||+++++++...     ...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEE
Confidence            45568888999999999999999988899999999975544 456788999999999999999999986543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++|+||+++++|.+++....     ..+++.++..++.|++.|++|||+.   +|+|+|+||+||+++.++.+||+|||.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999999998653     3689999999999999999999998   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........        ......|++.|+|||++.    +.++|+|||||++|+|+
T Consensus       163 ~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~  210 (286)
T cd06614         163 AAQLTKEKS--------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA  210 (286)
T ss_pred             hhhhccchh--------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHH
Confidence            875533211        112345889999999884    57899999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.93  E-value=2.8e-26  Score=247.54  Aligned_cols=186  Identities=22%  Similarity=0.311  Sum_probs=152.4

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |++.+.||+|+||.||+|++..+++.||+|+++... ........+|+.+++++. ||||+++++++....   .+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            567789999999999999999899999999986432 222334567999999885 999999999975431   246899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++ +++.+++....     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++. +.+||+|||+++
T Consensus        78 v~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          78 VFELMD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEecCC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence            999996 58888886542     3689999999999999999999999   9999999999999999 999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ......         ......+|+.|+|||++.     +.++|+||+||+++||+
T Consensus       148 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~  193 (282)
T cd07831         148 GIYSKP---------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL  193 (282)
T ss_pred             ccccCC---------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH
Confidence            653221         111245889999999863     57899999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4e-27  Score=252.05  Aligned_cols=188  Identities=24%  Similarity=0.522  Sum_probs=161.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+....++||-|.||.||.|.|+.-...||||.++ ++....++|.+|+.+|+.++|||+|+++|+|....     ..||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-----PFYI  340 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-----PFYI  340 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-----CeEE
Confidence            45667789999999999999999888999999986 55667889999999999999999999999987544     6799


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      |.|||.+|+|.+|+++..+    ..++....+.++.||+.|++||..+   ++|||||..+|+|+.++..|||+|||+++
T Consensus       341 iTEfM~yGNLLdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  341 ITEFMCYGNLLDYLRECNR----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEecccCccHHHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999987643    4566777889999999999999998   99999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccc
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVH  912 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~  912 (914)
                      ++..+.+....       +..-...|.|||-+    ++.++|+|+||+.+.|
T Consensus       414 lMtgDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWE  458 (1157)
T KOG4278|consen  414 LMTGDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWE  458 (1157)
T ss_pred             hhcCCceeccc-------CccCcccccCcccccccccccchhhHHHHHHHHH
Confidence            98765432211       12234579999998    5799999999998755

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=2.4e-26  Score=248.13  Aligned_cols=187  Identities=26%  Similarity=0.400  Sum_probs=155.8

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|++++++++|||++++++++.     .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            567789999999999999999899999999987543  233467889999999999999999999854     3357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++ ++|.+++.....    ..+++..++.++.|+++|++|||+.   +++||||+|+||+++.++.+||+|||+++
T Consensus        76 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEeccC-cCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999995 699999876432    3689999999999999999999998   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......+++.|+|||++.     +.++|+||+||++++|+
T Consensus       148 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~  194 (283)
T cd07835         148 AFGVPVR--------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV  194 (283)
T ss_pred             ccCCCcc--------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHH
Confidence            5432110        111235788999999873     46799999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.93  E-value=2.3e-26  Score=244.42  Aligned_cols=189  Identities=23%  Similarity=0.350  Sum_probs=158.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|++..++..||+|.+....  ....+.+.+|++++++++|+||+++++++.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            4778899999999999999999999999999986542  234467889999999999999999999853     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFGl  862 (914)
                      +|+||+++++|.+++.....    ..+++..+..++.|+++|++|||+.   +++|+||||+||++++++ .+|++|||.
T Consensus        76 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999975432    3578999999999999999999999   999999999999999885 579999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........        ......|++.|+|||++.    +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~  196 (257)
T cd08225         149 ARQLNDSME--------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC  196 (257)
T ss_pred             chhccCCcc--------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            976543211        111245899999999884    47899999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=9.2e-28  Score=246.01  Aligned_cols=277  Identities=22%  Similarity=0.213  Sum_probs=148.7

Q ss_pred             eEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecC-CCCCCCcCCCCccccCCcchhccC
Q 042766           79 LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALS-NNSFSGTIPTNLSRCSNLIHFCAS  157 (914)
Q Consensus        79 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L~Ls  157 (914)
                      .++++|..|+++...+.+|..+..||+||||+|+|+..-|++|..|.+|..|-+- +|+|+...-..|+.|..|+.|.+.
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence            3455555555554444445555555555555555555555555555554333332 255553222345555555555555


Q ss_pred             CCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCC------------CCCCCCccchhhhcccc
Q 042766          158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENS------------LGGKIPTTLGLLRRLVN  225 (914)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~------------l~~~~p~~~~~l~~L~~  225 (914)
                      -|++.-...++|..+++|..|.+.+|.+...--.+|..+.+++.+.+..|.            .....|..++..+...-
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p  228 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP  228 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence            555554444555555555555555555552222255555555555555555            22233444444444444


Q ss_pred             cccccccccCCCCCccc-cccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCc
Q 042766          226 LNVAENQFSGMFPRSIC-NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN  304 (914)
Q Consensus       226 L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  304 (914)
                      ..+.++++....+..|. .+.++..-..+.....++.|...|..+++|++|+|++|+|+++-+.+|..+..++.|.|..|
T Consensus       229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N  308 (498)
T KOG4237|consen  229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN  308 (498)
T ss_pred             HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence            44555544433333332 12222222233333445566666666677777777777776666666666666777777777


Q ss_pred             cCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          305 QFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       305 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      +|..+....|.++..|++|+|.+|+|+.+      .|.+|..+.+|.+|.|-.|.+.
T Consensus       309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~------~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  309 KLEFVSSGMFQGLSGLKTLSLYDNQITTV------APGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hHHHHHHHhhhccccceeeeecCCeeEEE------ecccccccceeeeeehccCccc
Confidence            66666666666666666666666666665      3334555556666666665553

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.7e-26  Score=253.48  Aligned_cols=190  Identities=23%  Similarity=0.324  Sum_probs=157.2

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4568999999999999999999999899999999985432  2234568899999999999999999998653321 112


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+ +++|.+++..       ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            3468999999 7799988864       3578899999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.....           .....|++.|+|||++.     +.++|+||+||++++++
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~  210 (343)
T cd07880         162 FGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML  210 (343)
T ss_pred             cccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            9999754321           11346889999999874     36899999999998864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.1e-26  Score=254.59  Aligned_cols=194  Identities=25%  Similarity=0.314  Sum_probs=161.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|+++++.++||||+++++++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999999889999999987543  34456889999999999999999999986554323334689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ ++|.+++...      ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        81 lv~e~~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          81 IVTELME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             EEecchh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            9999997 5899988754      3688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhhh-----hhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-----LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~Di~s~g~~~~~~f  914 (914)
                      .........     ........||+.|+|||++.+     .++|+||+||++++|+
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~  201 (330)
T cd07834         151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL  201 (330)
T ss_pred             Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH
Confidence            876543211     011223468999999999853     5899999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=3.1e-26  Score=266.59  Aligned_cols=198  Identities=20%  Similarity=0.184  Sum_probs=136.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCC----cEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeec-CCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSS-TDFE  777 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  777 (914)
                      ..++|+..+.||+|+||.||+|++..+    +..||+|++....  ..+....|  .++...+.+++.+...+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    8999999875322  11111111  1122222233222211111 1113


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQV--------------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK  843 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlk  843 (914)
                      .....++||||+++++|.+++.......              .........+..++.|++.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            3457899999999999999987542100              001112334567999999999999998   99999999


Q ss_pred             CCCeeecC-CCcEEEecccccccccccccccccCCCCccccccCcccccccchhhh------------------------
Q 042766          844 PSNVLLDY-DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM------------------------  898 (914)
Q Consensus       844 p~NILl~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~------------------------  898 (914)
                      |+|||++. ++.+||+|||+|+.+.....       .......||+.|||||++..                        
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            99999986 58999999999986543211       11124679999999997631                        


Q ss_pred             --hhcccCcccccccccC
Q 042766          899 --LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       899 --~~~Di~s~g~~~~~~f  914 (914)
                        .++||||+||++|||.
T Consensus       356 ~~~k~DVwSlGviL~el~  373 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMA  373 (566)
T ss_pred             CCCCcccHHHHHHHHHHH
Confidence              2359999999999973

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=8.3e-26  Score=244.44  Aligned_cols=191  Identities=26%  Similarity=0.425  Sum_probs=156.2

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhc---CCCCcceEEeEeecCCCCCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNI---RHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      |++.+.||+|+||.||+|+++.+++.||+|+++....  .....+.+|+++++++   +||||+++++++...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5677899999999999999988899999999974322  2234667788877666   5999999999987655333345


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .+++|||++ +++.+++.....    ..+++.+++.++.|++.|++|||+.   +++|+|+||+||+++.++.+||+|||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence            899999996 589998875432    3589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++.+.....         .....++..|+|||++.    +.++|+|||||++++|+
T Consensus       153 ~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~  200 (287)
T cd07838         153 LARIYSFEMA---------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF  200 (287)
T ss_pred             cceeccCCcc---------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHH
Confidence            9976543211         11235789999999985    47899999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.4e-26  Score=252.89  Aligned_cols=188  Identities=24%  Similarity=0.341  Sum_probs=154.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  780 (914)
                      ..+|...+.||+|+||.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368999999999999999999998899999999986432  2234568899999999999999999998754321 1223


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++ .++.++..        ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        94 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             eEEEEecccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence            5689999996 47776652        3578889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.....           .....||+.|+|||++.     +.++|+||+||+++||+
T Consensus       162 g~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~  209 (342)
T cd07879         162 GLARHADAE-----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML  209 (342)
T ss_pred             CCCcCCCCC-----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence            998754211           11346889999999874     36899999999999874

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=6.6e-26  Score=239.89  Aligned_cols=187  Identities=30%  Similarity=0.420  Sum_probs=161.8

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      +|+..+.||+|++|.||+|++..+++.||+|++........+.+.+|++++++++||+++++++++...     ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence            477889999999999999999888999999999765554667899999999999999999999985433     478999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      +||+++++|.+++....     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            99999999999987643     4689999999999999999999998   999999999999999999999999999976


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......         .....|+..|+|||++.    +.++|+|||||++++|+
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~  191 (253)
T cd05122         148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA  191 (253)
T ss_pred             cccccc---------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHH
Confidence            543211         12356899999999985    47899999999999874

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.93  E-value=2.8e-26  Score=248.32  Aligned_cols=192  Identities=22%  Similarity=0.273  Sum_probs=151.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|+..+.||+|+||.||++++..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++..     ....
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~   78 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDC   78 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcE
Confidence            35666789999999999999999999999999986443 234567889999999996 9999999998543     3467


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      +++|||++ +++.++...... .....+++..+.+++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecch
Confidence            89999985 466554321100 01146889999999999999999999742  899999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+....         ......||+.|+|||++.       +.++|+||+||++++|+
T Consensus       155 ~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  204 (288)
T cd06616         155 SGQLVDSI---------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA  204 (288)
T ss_pred             hHHhccCC---------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHH
Confidence            97654321         111235899999999874       35799999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=7e-26  Score=240.18  Aligned_cols=187  Identities=30%  Similarity=0.479  Sum_probs=160.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|++|.||+|++..+++.||+|.+.....  ...+.+.+|++++++++|||++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            47788999999999999999998899999999975543  345688999999999999999999998643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++...      ..+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus        76 ~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          76 IILEYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence            999999999999998754      3688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........        .....|+..|+|||...    +.++|+|++|+++++|+
T Consensus       147 ~~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~  193 (254)
T cd06627         147 TKLNDVSKD--------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL  193 (254)
T ss_pred             eecCCCccc--------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHH
Confidence            876432211        12346899999999874    47899999999998874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.93  E-value=4.2e-26  Score=252.56  Aligned_cols=195  Identities=20%  Similarity=0.339  Sum_probs=155.0

Q ss_pred             hccc-ccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc--------------hHHHHHHHHHHHhcCCCCcceEEe
Q 042766          705 SEFS-SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--------------SKSFVSECEALRNIRHRNLIKIIT  769 (914)
Q Consensus       705 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  769 (914)
                      ++|. +.+.||+|+||+||+|++..+++.||||+++......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3554 4577999999999999999899999999986432211              125789999999999999999999


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      ++..     .+..++||||++ |+|.+++...      ..+++.....++.|++.|++|||+.   +|+||||||+||++
T Consensus        88 ~~~~-----~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill  152 (335)
T PTZ00024         88 VYVE-----GDFINLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI  152 (335)
T ss_pred             EEec-----CCcEEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence            8643     347899999996 6999998654      3588899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeccccccccccccccc------ccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDI------ASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~------~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+|++|||+++.........      ............+++.|+|||++.     +.++|+||+||++++|+
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~  228 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL  228 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999998664211100      000011112345788999999884     46799999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=5.5e-26  Score=257.31  Aligned_cols=202  Identities=18%  Similarity=0.240  Sum_probs=148.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC----------------CCcEEEEEEEeeccCCcchH--------------HHHHH
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG----------------DDEMVVAVKVINLKQKGASK--------------SFVSE  752 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  752 (914)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                23467999998654332222              33457


Q ss_pred             HHHHHhcCCCCc-----ceEEeEeecCCC---CCCceEeEEEecccCCCHHHHHhccCCc------------------cc
Q 042766          753 CEALRNIRHRNL-----IKIITICSSTDF---EGVDFKALVFEYMENGSLEDWLHQSNDQ------------------VE  806 (914)
Q Consensus       753 ~~~l~~l~h~ni-----v~l~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~  806 (914)
                      +.++.+++|.++     ++++++|.....   ...+..++||||+++++|.++++.....                  ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677777654211   1234579999999999999998753210                  01


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccC
Q 042766          807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG  886 (914)
Q Consensus       807 ~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~G  886 (914)
                      ....++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||+++.......       .......+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~g~~  372 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------FNPLYGML  372 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------cCccccCC
Confidence            12356778889999999999999998   999999999999999999999999999975432110       01112345


Q ss_pred             cccccccchhhh--------------------------hhcccCcccccccccC
Q 042766          887 TVGYVAPGKFFM--------------------------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       887 T~~y~APE~~~~--------------------------~~~Di~s~g~~~~~~f  914 (914)
                      |+.|+|||++..                          .+.|+||+||++++|+
T Consensus       373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~  426 (507)
T PLN03224        373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMC  426 (507)
T ss_pred             CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHH
Confidence            899999998732                          2369999999999984

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=3.1e-26  Score=246.80  Aligned_cols=196  Identities=27%  Similarity=0.402  Sum_probs=162.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|...+.||+|+||.||+|+...+++.||+|++...   .....+.+.+|++++++++ ||||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            3688899999999999999999989999999998643   2233467889999999998 99999999874     4455


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++||
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence            789999999999999999764      3689999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccccccccc------------CCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIAS------------KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~------------~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |++............            ..........|+..|+|||++.    +.++|+||+||++++++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~  216 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML  216 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence            999876543211000            0012233457899999999884    47899999999988763

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=7.6e-26  Score=247.23  Aligned_cols=184  Identities=27%  Similarity=0.369  Sum_probs=154.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..|+..+.||+|+||.||+|++..+++.||+|.+....   ....+++.+|+++++.++|+|++++++++...     ..
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Ce
Confidence            34777789999999999999999899999999986432   22345678999999999999999999986543     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+. |++.+++....     ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence            899999996 68888775432     3578899999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      ++......            ....||+.|+|||++.       +.++|+||+||++++|+
T Consensus       161 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  208 (308)
T cd06634         161 SASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  208 (308)
T ss_pred             cceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH
Confidence            98754321            1246889999999974       35799999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=5.3e-26  Score=249.49  Aligned_cols=185  Identities=22%  Similarity=0.181  Sum_probs=146.6

Q ss_pred             ccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCH
Q 042766          717 RFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSL  794 (914)
Q Consensus       717 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL  794 (914)
                      ++|.||.++...+++.||||++...  .....+.+.+|++++++++||||+++++++.     ..+..+++|||+++|++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence            3455566666668999999999754  3344568999999999999999999999854     34578999999999999


Q ss_pred             HHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccc
Q 042766          795 EDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA  874 (914)
Q Consensus       795 ~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~  874 (914)
                      .+++.....    ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||.+.......... 
T Consensus        87 ~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-  158 (314)
T cd08216          87 EDLLKTHFP----EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-  158 (314)
T ss_pred             HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc-
Confidence            999976432    3578889999999999999999999   99999999999999999999999999887654322110 


Q ss_pred             cCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          875 SKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       875 ~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ...........++..|+|||++.      +.++|+||+||+++||+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~  204 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA  204 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH
Confidence            00111123456888999999973      46899999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=1.1e-25  Score=246.43  Aligned_cols=182  Identities=28%  Similarity=0.364  Sum_probs=152.7

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      |...+.||+|+||+||+|++..+++.||+|++.....   ...+.+.+|++++++++|||++++++++...     ...+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence            6667789999999999999998999999999864332   2335678899999999999999999996543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+. |++.+++....     ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        98 lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEecCC-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence            9999995 58888776543     4688999999999999999999999   9999999999999999999999999988


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      .....            .....|+..|+|||++.       +.++|+||+||++++|+
T Consensus       169 ~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~  214 (313)
T cd06633         169 SKSSP------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  214 (313)
T ss_pred             cccCC------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHH
Confidence            64211            11346899999999973       46789999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8e-26  Score=240.84  Aligned_cols=178  Identities=23%  Similarity=0.318  Sum_probs=146.7

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHH-HhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEAL-RNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|++..+++.||+|+++....   .....+..|..++ ...+|+|++++++++..     .+..++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence            568999999999999998999999999864321   1223344555544 45589999999998543     34789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++++|.+++...      ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        77 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          77 EYLNGGDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             eccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            999999999999754      3578889999999999999999998   9999999999999999999999999998754


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ..            .....|++.|+|||.+.    +.++|+||+|+++|+|+
T Consensus       148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~  187 (260)
T cd05611         148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL  187 (260)
T ss_pred             cc------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHH
Confidence            32            11246889999999985    46799999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=9.8e-26  Score=239.53  Aligned_cols=191  Identities=25%  Similarity=0.418  Sum_probs=161.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|++++++++|||++++++.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            47888999999999999999998899999999975433  455678899999999999999999988543     35789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.....  ....+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence            99999999999999976421  125789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        .......|++.|+|||...    +.++|+||+|+++++|+
T Consensus       151 ~~~~~~~--------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~  197 (258)
T cd08215         151 KVLSSTV--------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC  197 (258)
T ss_pred             eecccCc--------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH
Confidence            8654321        0112346899999999874    47899999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.93  E-value=7.5e-26  Score=244.98  Aligned_cols=188  Identities=21%  Similarity=0.270  Sum_probs=155.0

Q ss_pred             cccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCC
Q 042766          706 EFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ----KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFE  777 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  777 (914)
                      +|++.+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|+++++++ +||+|+++++.+     +
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4778899999999999999864   356889999986432    23345788999999999 599999998874     3


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      .....++||||+++|+|.+++...      ..+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence            445789999999999999998753      3578889999999999999999998   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++.......       .......|+..|+|||.+.      +.++|+||+||++++|+
T Consensus       147 ~dfg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~  202 (288)
T cd05583         147 TDFGLSKEFLAEEE-------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL  202 (288)
T ss_pred             EECccccccccccc-------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence            99999876543211       1112356899999999984      36899999999999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=231.44  Aligned_cols=189  Identities=21%  Similarity=0.280  Sum_probs=161.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|...++||+|+|++|..++++.+.+.||+|+++++   +..+..-...|-.+..+. +||.+|.++.+     |+.
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt  322 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT  322 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence            346799999999999999999999999999999999754   333444556677777665 79999999877     677


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++|.||++||+|.-.+.+.      +.++++.+..+..+|+-||.|||++   |||.||+|.+|+|+|..|++|++
T Consensus       323 esrlffvieyv~ggdlmfhmqrq------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghiklt  393 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLT  393 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeec
Confidence            77999999999999998877765      4789999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+|+++.--        .+......++|||.|+|||+++    |..+|.|++|+..+||
T Consensus       394 dygmcke~l--------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfem  444 (593)
T KOG0695|consen  394 DYGMCKEGL--------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM  444 (593)
T ss_pred             ccchhhcCC--------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHH
Confidence            999997421        1222344689999999999995    6889999999998887

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=9.6e-26  Score=241.53  Aligned_cols=190  Identities=25%  Similarity=0.416  Sum_probs=155.0

Q ss_pred             cccccCcccCCccEEEEEEEECC-CcEEEEEEEeeccC----------CcchHHHHHHHHHHHh-cCCCCcceEEeEeec
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGD-DEMVVAVKVINLKQ----------KGASKSFVSECEALRN-IRHRNLIKIITICSS  773 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  773 (914)
                      +|++.+.||+|+||.||+|++.. +++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 67899999886322          1223457788888865 799999999998543


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~  852 (914)
                           .+..++||||+++++|.+++.....  ....+++..+++++.|++.|+.|||+ .   +++||||||+||+++.+
T Consensus        81 -----~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~  150 (269)
T cd08528          81 -----NDRLYIVMDLIEGAPLGEHFNSLKE--KKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED  150 (269)
T ss_pred             -----CCeEEEEEecCCCCcHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence                 4578999999999999998854211  12468889999999999999999996 5   89999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||.+.......         ......|+..|+|||++.    +.++|+||+||++++|+
T Consensus       151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~  207 (269)
T cd08528         151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC  207 (269)
T ss_pred             CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence            999999999998654321         112356899999999985    47899999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.93  E-value=7.5e-26  Score=249.25  Aligned_cols=188  Identities=26%  Similarity=0.315  Sum_probs=156.8

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++...  .....+.+.+|++++++++||||+++++++...    
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----
Confidence            34567899999999999999999999999999999988532  223456788999999999999999999986432    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||+ +++|.++++..       .+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeC
Confidence            24678999999 56999888642       467778888999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||.++.....           .....+++.|+|||++.     +.++|+||+||++++|+
T Consensus       151 dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~  200 (328)
T cd07856         151 DFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML  200 (328)
T ss_pred             ccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence            99998753211           11246788999999863     47899999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=1.6e-25  Score=237.98  Aligned_cols=191  Identities=26%  Similarity=0.417  Sum_probs=162.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|+..+.||+|++|.||+|++..+++.|++|++.....  ...+.+.+|++++++++||||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            47778899999999999999998999999999875542  44678899999999999999999999865431   24789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++...      ..+++.+++.++.|++.|++|||+.   +++|+|++|+||+++.++.+||+|||.+
T Consensus        78 lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence            999999999999999764      2689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .........      .......++..|+|||.+.    ..++|+||+||++++|+
T Consensus       149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~  197 (260)
T cd06606         149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA  197 (260)
T ss_pred             Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            876543210      0122356899999999984    57899999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=1.1e-25  Score=238.91  Aligned_cols=189  Identities=24%  Similarity=0.374  Sum_probs=159.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +|++.+.||+|+||.||+|++..+++.+|+|.+....  ......+.+|++++++++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            4788899999999999999999899999999987543  233457789999999999999999998853     335789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++.+...  ....+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence            99999999999999876321  124688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......          .....|++.|+|||.+.    +.++|+||+|+++++|+
T Consensus       151 ~~~~~~~----------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~  195 (256)
T cd08530         151 KVLKKNM----------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA  195 (256)
T ss_pred             hhhccCC----------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence            8764321          11235889999999985    46899999999998874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-25  Score=241.98  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=154.9

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |++.+.||+|++|+||+|+...+++.||||++..... .......+|+..+++++ ||||+++++++..     .+..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            5677899999999999999998899999999864432 22234567999999999 9999999998543     457899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+ +|++.+++....    ...+++.+++.++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||.++
T Consensus        76 v~e~~-~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEecC-CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence            99999 789999887643    14679999999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ......         ......|+..|+|||++.     +.++|+|||||++++|+
T Consensus       148 ~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~  193 (283)
T cd07830         148 EIRSRP---------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY  193 (283)
T ss_pred             eccCCC---------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH
Confidence            653221         111246889999999873     47899999999998874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=1.7e-25  Score=241.34  Aligned_cols=186  Identities=27%  Similarity=0.429  Sum_probs=156.3

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|+||.||+|+...+++.||+|++....  ....+.+.+|++++++++|+|++++++++..     .+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence            556788999999999999999899999999997553  3345678899999999999999999998543     357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++ ++|.+++....     ..+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.+||+|||.++
T Consensus        76 v~e~~~-~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence            999997 59999998643     3688999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......++..|+|||.+.     +.++|+||+||+++|++
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  193 (282)
T cd07829         147 AFGIPLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI  193 (282)
T ss_pred             ccCCCcc--------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHH
Confidence            6543211        111234678899999974     35899999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=2.1e-25  Score=242.52  Aligned_cols=189  Identities=21%  Similarity=0.295  Sum_probs=153.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++.+.. ||||+++++++..     ...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CCe
Confidence            357888999999999999999999889999999997543 233456677887776664 9999999999644     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ +++.+++....     ..+++..+..++.|++.|++|||+..  +|+||||||+||+++.++.+||+|||
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence            899999985 57887776532     36888999999999999999999731  89999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhhh--------hhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM--------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~Di~s~g~~~~~~f  914 (914)
                      ++..+.....         .....|++.|+|||++.+        .++|+|||||++++|+
T Consensus       161 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~  212 (296)
T cd06618         161 ISGRLVDSKA---------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA  212 (296)
T ss_pred             cchhccCCCc---------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH
Confidence            9876532211         112358889999999853        4799999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.6e-27  Score=247.14  Aligned_cols=188  Identities=22%  Similarity=0.287  Sum_probs=162.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++++....||-|+||.|-.++.......+|+|++++.   +....+....|-.+|.+++.|.||++|.-     |.+.
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~  492 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDS  492 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccc
Confidence            345666778899999999999998766666899988644   34455678889999999999999999976     5666


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      .+.|+.||-|-||.+...++.++      .++...+..++..+.+|.+|||++   +||.|||||+|.++|.+|-+|+.|
T Consensus       493 kyvYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEee
Confidence            78999999999999999998764      577788889999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+|+.+...         ..+..+||||.|.|||++.    +.++|.|++|+.+||+
T Consensus       564 FGFAKki~~g---------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~EL  612 (732)
T KOG0614|consen  564 FGFAKKIGSG---------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYEL  612 (732)
T ss_pred             hhhHHHhccC---------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHH
Confidence            9999987543         2345689999999999996    4899999999999885

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=2.2e-25  Score=240.65  Aligned_cols=186  Identities=27%  Similarity=0.406  Sum_probs=156.1

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|++|.||+|++..+++.+|+|.++....  .....+.+|++++++++|++|+++++++..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            5667899999999999999988999999999864432  345678899999999999999999998543     357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++ ++.+++....     ..+++.+++.++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||.+.
T Consensus        76 v~e~~~~-~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEeccCC-CHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999975 8888887542     4688999999999999999999999   99999999999999999999999999997


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......++..|+|||.+.     +.++|+||+||++++|+
T Consensus       147 ~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~  193 (283)
T cd05118         147 SFGSPVR--------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL  193 (283)
T ss_pred             ecCCCcc--------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence            6643220        111245888999999974     46899999999999874

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN03210 Resistant to P

Probab=99.92  E-value=2e-24  Score=272.53  Aligned_cols=345  Identities=22%  Similarity=0.284  Sum_probs=237.2

Q ss_pred             CCCCCCCCCCEEEcCCCC------CcccCCcccCCCC-CCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCCh
Q 042766           95 PYVGNLSFLRYINLADNG------FRGDIPQEIGNLF-RLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPK  167 (914)
Q Consensus        95 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~  167 (914)
                      .++..+++|+.|.+..+.      +...+|..+..++ +|+.|++.+|.+. .+|..+ ...+|+.|++++|++. .+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            447788999999886653      3446777777765 5899999988887 788777 5788999999999887 6777


Q ss_pred             hccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcccccccc
Q 042766          168 EIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV  247 (914)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  247 (914)
                      .+..+++|++|+|++|...+.+|+ +..+++|+.|+|++|.....+|..++++++|+.|++++|.....+|..+ ++++|
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL  706 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL  706 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence            888888899999988765556774 7788888888888887666888888888888888888875545666655 67888


Q ss_pred             ceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccC
Q 042766          248 ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQ  327 (914)
Q Consensus       248 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  327 (914)
                      +.|++++|...+.+|.    ..++|++|+|++|.+. .+|..+ .+++|+.|++.++...... ..+..+          
T Consensus       707 ~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~-~~~~~l----------  769 (1153)
T PLN03210        707 YRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLW-ERVQPL----------  769 (1153)
T ss_pred             CEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccc-cccccccccccccchhhcc-cccccc----------
Confidence            8888888765555552    2457777777777776 455544 4667777776654322110 000000          


Q ss_pred             CcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccC
Q 042766          328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVN  407 (914)
Q Consensus       328 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  407 (914)
                                  .+......++|+.|+|++|...+.+|.++..+. +|+.|++++|...+.+|..+ ++++|+.|+|++|
T Consensus       770 ------------~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~-~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c  835 (1153)
T PLN03210        770 ------------TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH-KLEHLEIENCINLETLPTGI-NLESLESLDLSGC  835 (1153)
T ss_pred             ------------chhhhhccccchheeCCCCCCccccChhhhCCC-CCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence                        000112235666666666666556666666655 56677776665444566555 5777777887776


Q ss_pred             cccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeC-CcCCCCCCCccCCCCCccccccCCCc
Q 042766          408 QFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS-NSLQGNIPSSLGNCQNLILFIASYNK  480 (914)
Q Consensus       408 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~  480 (914)
                      .....+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.++++++.
T Consensus       836 ~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        836 SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            544455543   356778888888877 5677777788888888877 4454 466677777788887777664

syringae 6; Provisional

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.6e-25  Score=234.25  Aligned_cols=180  Identities=29%  Similarity=0.354  Sum_probs=153.2

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      ||+|+||.||+|++..+++.||+|+++....   .....+..|++++++++||||+++++.+     +.....++||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            6999999999999988899999999874432   2445788999999999999999999874     4456889999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccc
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH  869 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~  869 (914)
                      ++++|.+++...      ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          76 PGGELFSHLSKE------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            999999999764      3578999999999999999999998   9999999999999999999999999999765432


Q ss_pred             ccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          870 HLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       870 ~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .        .......|+..|+|||...    +.++|+||+||++++++
T Consensus       147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~  187 (250)
T cd05123         147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML  187 (250)
T ss_pred             C--------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence            1        1122356899999999985    47899999999998864

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.92  E-value=1.8e-25  Score=234.43  Aligned_cols=169  Identities=17%  Similarity=0.095  Sum_probs=140.9

Q ss_pred             CccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHH
Q 042766          716 GRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLE  795 (914)
Q Consensus       716 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  795 (914)
                      |.||.||+|++..+++.||+|+++...     .+.+|...+....||||+++++++.     ..+..++||||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence            899999999999999999999986432     2334555556667999999999854     345789999999999999


Q ss_pred             HHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccccccc
Q 042766          796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS  875 (914)
Q Consensus       796 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~  875 (914)
                      +++.+.      ..+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.++++|||.+......      
T Consensus        74 ~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------  138 (237)
T cd05576          74 SHISKF------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------  138 (237)
T ss_pred             HHHHHh------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc------
Confidence            998754      3588999999999999999999998   9999999999999999999999999988654321      


Q ss_pred             CCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          876 KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       876 ~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                           .....++..|||||+..    +.++|+||+||++|||+
T Consensus       139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  176 (237)
T cd05576         139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL  176 (237)
T ss_pred             -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHH
Confidence                 11234677899999873    47899999999999873

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.3e-25  Score=249.35  Aligned_cols=190  Identities=23%  Similarity=0.337  Sum_probs=157.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||++...  .....+.+.+|+.++++++||||+++++++...+. ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            356899999999999999999999989999999998643  22334567889999999999999999887543321 222


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++|+||+ +++|.+++..       ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d  161 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD  161 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence            3479999999 6799998864       3588999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||++......           .....+|..|+|||...     +.++|+||+||++++|+
T Consensus       162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell  210 (343)
T cd07851         162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  210 (343)
T ss_pred             cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH
Confidence            9999764321           11346889999999874     47899999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=3.3e-26  Score=217.87  Aligned_cols=184  Identities=21%  Similarity=0.384  Sum_probs=153.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCce
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..++|++.+++|+|.|++||.|....+.+.++||++++-   ..+.+.+|+.+++.+. ||||++++++..++.   ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence            346899999999999999999999888899999999643   3367889999999997 999999999876544   234


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEEecc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDF  860 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki~DF  860 (914)
                      ..+|+||+.+.+......         .++......++.++++||.|+|+.   ||+|||+||.|++||.. ...+++|+
T Consensus       110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence            679999999888777653         466678888999999999999999   99999999999999965 57999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh-----hhhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~  913 (914)
                      |+|.++....         .-...+.+.+|.-||.+     +++.-|+|||||.++.|
T Consensus       178 GLAEFYHp~~---------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~m  226 (338)
T KOG0668|consen  178 GLAEFYHPGK---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM  226 (338)
T ss_pred             chHhhcCCCc---------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHH
Confidence            9999875422         11124567889999998     46889999999998876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=1.2e-24  Score=260.07  Aligned_cols=185  Identities=28%  Similarity=0.405  Sum_probs=154.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++...   ......+.+|+.+++.++||||+++++++..     ..
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence            357999999999999999999999999999999996433   2234678899999999999999999987543     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++..++.|+.||+.||+|||++   +||||||||+|||++.++.+||+||
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence            789999999999999999754      3578888999999999999999998   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTN  910 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~  910 (914)
                      |+++.......        ......||+.|+|||..+     ....++|++|+..
T Consensus       149 Gls~~~~~~~~--------~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~  195 (669)
T cd05610         149 GLSKVTLNREL--------NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT  195 (669)
T ss_pred             CCCccccCCcc--------cccccccCccccCccccccCCCCceeeeeeecCcCC
Confidence            99986543221        122457999999999874     2567777777643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.6e-24  Score=235.07  Aligned_cols=171  Identities=20%  Similarity=0.192  Sum_probs=130.7

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECC-CcEEEEEEEeecc-----CCcchHHHHHHHHHHHhcCCCCcce-EEeEeec
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGD-DEMVVAVKVINLK-----QKGASKSFVSECEALRNIRHRNLIK-IITICSS  773 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~  773 (914)
                      .....+|...+.||+|+||+||+|+++. +++.||||++...     .....+.+.+|++++++++|+|++. ++++   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3445689999999999999999999875 6788899987532     1223457899999999999999985 4331   


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCeeecCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDYD  852 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDl-kp~NILl~~~  852 (914)
                            +..++||||++|++|... ...         .   ...++.|+++||+|||+.   +|+|||| ||+|||++.+
T Consensus        91 ------~~~~LVmE~~~G~~L~~~-~~~---------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~  148 (365)
T PRK09188         91 ------GKDGLVRGWTEGVPLHLA-RPH---------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD  148 (365)
T ss_pred             ------CCcEEEEEccCCCCHHHh-Ccc---------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC
Confidence                  246899999999999732 110         0   135788999999999999   9999999 9999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchh
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF  896 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~  896 (914)
                      +.+||+|||+|+.+..............-....|++.|+|||.+
T Consensus       149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            99999999999977543211111111112357899999999998

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=5e-25  Score=234.67  Aligned_cols=190  Identities=23%  Similarity=0.312  Sum_probs=152.2

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-----CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-----QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      +|.+.+.||+|+||.||+|++..++..+++|+++..     ......++.+|+.++++++||||+++++++.     ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            478889999999999999999877666767766421     1223446778999999999999999998853     334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++.....  ....+++.+++.++.|++.|+.|||+.   +++|+|+||+||+++. +.+|++||
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKH--TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence            68999999999999998865321  124689999999999999999999998   9999999999999975 56999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |.++.......        ......|++.|+|||.+.    +.++|+||+|+++++|+
T Consensus       150 g~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~  199 (260)
T cd08222         150 GVSRLLMGSCD--------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC  199 (260)
T ss_pred             CceeecCCCcc--------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            99976543211        112345889999999884    35799999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PLN03210 Resistant to P

Probab=99.91  E-value=5.5e-24  Score=268.65  Aligned_cols=344  Identities=21%  Similarity=0.240  Sum_probs=237.0

Q ss_pred             cccCCCCCCCeeecCCCC------CCCcCCCCccccC-CcchhccCCCcccCCCChhccccccccccccccccccCcCCc
Q 042766          119 QEIGNLFRLEKLALSNNS------FSGTIPTNLSRCS-NLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD  191 (914)
Q Consensus       119 ~~~~~l~~L~~L~Ls~N~------l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  191 (914)
                      .+|.++++|+.|.+..+.      +...+|..+..++ +|+.|++.+|.++ .+|..| ...+|++|+|++|++. .+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            456778888888886553      3334666666654 5777777777776 667666 4577777888777776 5666


Q ss_pred             ccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcc
Q 042766          192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPN  271 (914)
Q Consensus       192 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~  271 (914)
                      .+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|...  ++++
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~s  705 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLKS  705 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCCC
Confidence            777777777777777654446664 6677777777777776555677777777777777777765444555443  5667


Q ss_pred             cceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCc
Q 042766          272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK  351 (914)
Q Consensus       272 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  351 (914)
                      |+.|+|++|...+.+|..   .++|++|+|++|.++.. |..+ .+++|++|++.++......                 
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~~~~~~l~-----------------  763 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL-RLENLDELILCEMKSEKLW-----------------  763 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc-cccccccccccccchhhcc-----------------
Confidence            777777776544444432   34566666666666532 2222 3455555555443221110                 


Q ss_pred             EEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccc
Q 042766          352 VLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN  431 (914)
Q Consensus       352 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  431 (914)
                            +.+. .++........+|+.|++++|...+.+|..++++++|+.|++++|..-+.+|..+ .+++|+.|++++|
T Consensus       764 ------~~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c  835 (1153)
T PLN03210        764 ------ERVQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC  835 (1153)
T ss_pred             ------cccc-ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence                  1111 1222223334579999999999888999999999999999999986555777765 7899999999998


Q ss_pred             ccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCC-CccCCCCchhhhcccchhhhhcccCC
Q 042766          432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASY-NKLTGDLPQQLLSITTLSLVLDLSNN  504 (914)
Q Consensus       432 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~~~l~~~L~Ls~N  504 (914)
                      .....+|..   .++|+.|+|++|.++ .+|.++..+++|+.|++++ |++. .+|..+..+..+ +.++++++
T Consensus       836 ~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L-~~L~l~~C  903 (1153)
T PLN03210        836 SRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHL-ETVDFSDC  903 (1153)
T ss_pred             Ccccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCC-CeeecCCC
Confidence            755556643   368999999999998 6899999999999999998 4555 688777777776 67777665

syringae 6; Provisional

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=5.9e-25  Score=245.42  Aligned_cols=186  Identities=30%  Similarity=0.403  Sum_probs=145.7

Q ss_pred             ccccCcccCCccE-EEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFG-TVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |...+++|.|+.| .||+|...  ++.||||++-.+   ......+||..++.- +|||||++|+.     .++..+.||
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YI  580 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYI  580 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEE
Confidence            3445678999887 57999984  779999988532   335668999999998 59999999876     344568999


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---C--CcEEEec
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---D--MVAHVGD  859 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~ki~D  859 (914)
                      +.|.| ..+|.+++.....  +.........+.+..|+++||++||+.   +||||||||.||||+.   +  .+++|+|
T Consensus       581 alELC-~~sL~dlie~~~~--d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  581 ALELC-ACSLQDLIESSGL--DVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EehHh-hhhHHHHHhcccc--chhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence            99999 5699999987511  111122145577889999999999998   9999999999999976   3  4799999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++.+.......     ....+..||-+|+|||++.    ..++||+|+||++|+.
T Consensus       655 fglsKkl~~~~sS~-----~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYv  707 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSF-----SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYV  707 (903)
T ss_pred             cccccccCCCcchh-----hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEE
Confidence            99999876543222     2234568999999999996    3889999999999863

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=4.7e-24  Score=249.33  Aligned_cols=265  Identities=25%  Similarity=0.317  Sum_probs=143.0

Q ss_pred             CCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccc
Q 042766          103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI  182 (914)
Q Consensus       103 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  182 (914)
                      -..|+|++|+++ .+|..+..  +|+.|++++|+|+ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+|++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence            346666666666 56665542  5666677666666 45532   356666666666666 34432   24555666666


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCccc
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFP  262 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  262 (914)
                      |.++ .+|..+   ++|+.|++++|+++ .+|..   +++|+.|+|++|+|++ +|..   ..                 
T Consensus       272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~-----------------  322 (788)
T PRK15387        272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PS-----------------  322 (788)
T ss_pred             Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cc-----------------
Confidence            6655 334322   34555555555555 23331   2345555555555553 2221   12                 


Q ss_pred             ccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhh
Q 042766          263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI  342 (914)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  342 (914)
                              +|+.|++++|+|++ +|..   ..+|++|+|++|+|+++++ .   ..+|+.|++++|+|+.++.       
T Consensus       323 --------~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~-l---p~~L~~L~Ls~N~L~~LP~-------  379 (788)
T PRK15387        323 --------ELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLPT-L---PSELYKLWAYNNRLTSLPA-------  379 (788)
T ss_pred             --------cccccccccCcccc-cccc---ccccceEecCCCccCCCCC-C---CcccceehhhccccccCcc-------
Confidence                    34444444444442 2321   1245555555555553221 1   1344455555555554321       


Q ss_pred             cccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccC
Q 042766          343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKN  422 (914)
Q Consensus       343 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  422 (914)
                         ...+|+.|+|++|+|+ .+|...    .+|+.|++++|+|++ +|...   .+|+.|++++|+|+ .+|..+..+++
T Consensus       380 ---l~~~L~~LdLs~N~Lt-~LP~l~----s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~  446 (788)
T PRK15387        380 ---LPSGLKELIVSGNRLT-SLPVLP----SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSS  446 (788)
T ss_pred             ---cccccceEEecCCccc-CCCCcc----cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccC
Confidence               1134566666666665 344321    246666666666664 44432   35677888888887 56777888888


Q ss_pred             CceeeecccccccccCccccC
Q 042766          423 LQQLSVFNNFLRGGIPSGLGN  443 (914)
Q Consensus       423 L~~L~L~~N~l~~~~p~~~~~  443 (914)
                      |+.|+|++|.|++..+..+..
T Consensus       447 L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        447 ETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             CCeEECCCCCCCchHHHHHHH
Confidence            888888888888777665533

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=5e-24  Score=250.66  Aligned_cols=195  Identities=27%  Similarity=0.443  Sum_probs=157.0

Q ss_pred             hcccccCcccCCccEEEEEEEEC----C---CcEEEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG----D---DEMVVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~----~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ++..+.+.+|+|+||.|++|...    .   ....||||..+.. ...+.+.+..|+++|+.+ +||||+.+.|+|..  
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence            34456679999999999999753    1   2567999998743 334567899999999998 59999999999865  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccC---Ccc-----cc--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSN---DQV-----EV--RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~-----~~--~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                         ....++|+||++.|+|.++++..+   ...     ..  ..++..+.+.++.|||.|++||++.   ++||||+..+
T Consensus       374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence               347899999999999999998776   100     01  2488999999999999999999999   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccC--cccccccchh----hhhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG--TVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~G--T~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |||+.++..+||+|||+|+...........       ...|  ...|||||.+    +..++|+||||+.++|+|
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif  515 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF  515 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEec-------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence            999999999999999999965443322111       1122  2349999998    469999999999999987

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=5.7e-24  Score=248.58  Aligned_cols=246  Identities=23%  Similarity=0.322  Sum_probs=175.6

Q ss_pred             cccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeecc
Q 042766          174 KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT  253 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  253 (914)
                      +|+.|++++|+++ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+|++|+++. +|..+   .+|+.|+++
T Consensus       223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls  290 (788)
T PRK15387        223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLTH-LPALP---SGLCKLWIF  290 (788)
T ss_pred             CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchhh-hhhch---hhcCEEECc
Confidence            3444444444444 23321   245555555555555 23432   2456666666666663 33322   456677777


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCC
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      +|+++. +|.    ..++|+.|+|++|+|++ +|..   ..+|+.|++++|+|+++++  +  ..+|+.|+|++|+|+.+
T Consensus       291 ~N~Lt~-LP~----~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~LP~--l--p~~Lq~LdLS~N~Ls~L  357 (788)
T PRK15387        291 GNQLTS-LPV----LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSLPT--L--PSGLQELSVSDNQLASL  357 (788)
T ss_pred             CCcccc-ccc----cccccceeECCCCcccc-CCCC---cccccccccccCccccccc--c--ccccceEecCCCccCCC
Confidence            887774 343    24689999999999985 4543   2468899999999986442  1  25899999999999986


Q ss_pred             CCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccC
Q 042766          334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTI  413 (914)
Q Consensus       334 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  413 (914)
                      +..          .++|+.|++++|+|+ .+|...    .+|+.|++++|+|++ +|..   ..+|+.|++++|++++ +
T Consensus       358 P~l----------p~~L~~L~Ls~N~L~-~LP~l~----~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-I  417 (788)
T PRK15387        358 PTL----------PSELYKLWAYNNRLT-SLPALP----SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-L  417 (788)
T ss_pred             CCC----------Ccccceehhhccccc-cCcccc----cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-C
Confidence            431          257889999999999 577532    468999999999995 5543   3679999999999995 5


Q ss_pred             ChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCC
Q 042766          414 PDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNC  468 (914)
Q Consensus       414 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  468 (914)
                      |..+   .+|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++..|..+..+
T Consensus       418 P~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        418 PMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             Ccch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            6543   46889999999999 789999999999999999999999888766444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.90  E-value=9.3e-24  Score=248.79  Aligned_cols=333  Identities=17%  Similarity=0.307  Sum_probs=189.2

Q ss_pred             CCCCHhHHHHHHHHHHhcCCCCCCCCC----CCCCCCCCCccc----------------eeecCCCCceEEEecCCCCCc
Q 042766           31 GQTNETDRLALLAIKSQLHDPSGVTSS----WNNTMNFCQWTG----------------VTCGHRHQRLTELNLSSQRIG   90 (914)
Q Consensus        31 ~~~~~~~~~aLl~~k~~~~~~~~~~~~----w~~~~~~c~w~g----------------v~C~~~~~~v~~l~l~~~~l~   90 (914)
                      +.+.++|.+.+++..+.+.-| ++..+    |.+++|+|.-..                |.|.  +..||.+..-+....
T Consensus        58 ~~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~  134 (754)
T PRK15370         58 ETASPEEIKSKFECLRMLAFP-AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQA  134 (754)
T ss_pred             CCCCHHHHHHHHHHHHHhcCC-chhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccc
Confidence            345888999999999999644 34444    998899996543                5663  455666665543221


Q ss_pred             cccCCCCCCCCCCCEEEc----CCCCCccc----------CCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           91 GVLSPYVGNLSFLRYINL----ADNGFRGD----------IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        91 ~~~~~~l~~l~~L~~L~L----~~n~l~~~----------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      ....   +.-..-.+-..    ..+.-.+.          +..+  -..+.+.|+++++.++ .+|..+.  ++|+.|+|
T Consensus       135 ~~~~---~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~C--l~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~L  206 (754)
T PRK15370        135 SSAS---GSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDC--LKNNKTELRLKILGLT-TIPACIP--EQITTLIL  206 (754)
T ss_pred             ccCC---CCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhh--cccCceEEEeCCCCcC-cCCcccc--cCCcEEEe
Confidence            1110   00000000000    00000000          0011  1124566666666666 4565543  35666666


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCC
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM  236 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  236 (914)
                      ++|+++ .+|..+.  ++|++|+|++|+++ .+|..+.  .+|+.|+|++|.++ .+|..+.  ++|+.|+|++|+|+ .
T Consensus       207 s~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~  276 (754)
T PRK15370        207 DNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-C  276 (754)
T ss_pred             cCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-c
Confidence            666666 4555443  36667777777666 4555443  35677777777766 5555543  46777777777776 3


Q ss_pred             CCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccc
Q 042766          237 FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS  316 (914)
Q Consensus       237 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  316 (914)
                      +|..+.  .+|+.|++++|+|++ +|..+.   ++|+.|++++|+++. +|..+.  ++|+.|++++|.++++ |..+. 
T Consensus       277 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp---~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~-  345 (754)
T PRK15370        277 LPENLP--EELRYLSVYDNSIRT-LPAHLP---SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP-  345 (754)
T ss_pred             cccccC--CCCcEEECCCCcccc-Ccccch---hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccccC-Chhhc-
Confidence            455443  467777777777764 343322   467777888887773 454432  5788888888888763 44342 


Q ss_pred             cccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCcc----
Q 042766          317 LKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPG----  392 (914)
Q Consensus       317 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~----  392 (914)
                       ++|+.|++++|+|+.++..       +  .++|+.|+|++|+++ .+|..+..   .|+.|++++|++. .+|..    
T Consensus       346 -~sL~~L~Ls~N~L~~LP~~-------l--p~~L~~LdLs~N~Lt-~LP~~l~~---sL~~LdLs~N~L~-~LP~sl~~~  410 (754)
T PRK15370        346 -PELQVLDVSKNQITVLPET-------L--PPTITTLDVSRNALT-NLPENLPA---ALQIMQASRNNLV-RLPESLPHF  410 (754)
T ss_pred             -CcccEEECCCCCCCcCChh-------h--cCCcCEEECCCCcCC-CCCHhHHH---HHHHHhhccCCcc-cCchhHHHH
Confidence             5788888888887754321       1  257888888888877 45654432   3555566666555 22322    


Q ss_pred             ccCCCCCcEEEcccCccc
Q 042766          393 IRNLVNLITFTLEVNQFH  410 (914)
Q Consensus       393 ~~~l~~L~~L~L~~N~l~  410 (914)
                      ++.++++..|++.+|.++
T Consensus       411 ~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        411 RGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hhcCCCccEEEeeCCCcc
Confidence            222344455555555544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=218.26  Aligned_cols=187  Identities=23%  Similarity=0.266  Sum_probs=152.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeec--cCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  781 (914)
                      .+|.....+|.|+- .|..|-+.-.++.||+|+...  ......++..+|..++..++|+||++++.++.-... +....
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999988 777788888889999998742  234456788999999999999999999998653322 22235


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+||||| .+++.+.+..        .++-.....|..|++.|++|+|+.   +|+||||||+||++..++.+||.|||
T Consensus        96 ~y~v~e~m-~~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence            78999999 4699998873        355567888999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +|+.-...         -..+..+.|..|.|||++.    ...+||||.||+..||
T Consensus       164 ~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEl  210 (369)
T KOG0665|consen  164 LARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL  210 (369)
T ss_pred             hhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHH
Confidence            99853221         1223468999999999995    4899999999999887

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=4.1e-24  Score=233.99  Aligned_cols=180  Identities=24%  Similarity=0.282  Sum_probs=149.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+.|.....+|.|+|+.|-++.+..+++..|+|++....    .+..+|+.++... +||||+++.+.+     .+....
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee-----cCCcee
Confidence            456777788999999999999999999999999996442    2334677766655 699999999984     455689


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee-cCCCcEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-DYDMVAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl-~~~~~~ki~DFG  861 (914)
                      |+|||++.|+-+.+.+...+      ... .++..|+++|+.|+.|||++   ||||||+||+|||+ +..++++|+|||
T Consensus       392 ~~v~e~l~g~ell~ri~~~~------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             eeeehhccccHHHHHHHhcc------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence            99999999998888776542      222 67788999999999999998   99999999999999 588999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      .++.....           ....+=|..|.|||+.    ++.++|+||+|+++|+|
T Consensus       462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~M  506 (612)
T KOG0603|consen  462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEM  506 (612)
T ss_pred             hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHH
Confidence            99876532           1123568899999999    56999999999999998

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=7.2e-24  Score=223.80  Aligned_cols=191  Identities=23%  Similarity=0.295  Sum_probs=157.3

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC------CCCcceEEeEeecC
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR------HRNLIKIITICSST  774 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  774 (914)
                      .....+|.+....|+|-|+.|.+|++...|..||||+|... +...+.=.+|+++|++++      ..++++++..    
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~----  502 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH----  502 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence            34457899999999999999999999988899999999733 333455678999999994      3467777765    


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-C
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-M  853 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~  853 (914)
                       |....++|+|+|-+ .-+|.++++..+.   ...+....+..++.|+.-||..|..+   +|+|.||||+|||+.+. .
T Consensus       503 -F~hknHLClVFE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  503 -FKHKNHLCLVFEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN  574 (752)
T ss_pred             -hhhcceeEEEehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence             55566999999988 5699999998764   34677788899999999999999988   99999999999999876 5


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||||||.|....+.+..          .+.-+..|.|||++.    .+..|+||+||++||+|
T Consensus       575 iLKLCDfGSA~~~~eneit----------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY  629 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEIT----------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY  629 (752)
T ss_pred             eeeeccCcccccccccccc----------HHHHHHhccCcceeecCcccCCccceeeceeeEEee
Confidence            7899999999877654431          233556799999994    58999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.89  E-value=4.8e-23  Score=213.93  Aligned_cols=188  Identities=31%  Similarity=0.470  Sum_probs=158.9

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      |...+.||+|++|.||+|++.++++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...     ...+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence            45678899999999999999988899999999765544 567899999999999999999999986433     468899


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      +||+++++|.+++....     ..+++.....++.+++.++.|+|+.   +++|+|++|+||+++.++.++|+|||.+..
T Consensus        76 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG-----GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EeccCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            99999999999997643     1178889999999999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .....       ........++..|+|||.+.     +.++|+|++||++++|+
T Consensus       148 ~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~  194 (225)
T smart00221      148 IHRDL-------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL  194 (225)
T ss_pred             ecCcc-------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence            64321       00122356888999999872     36899999999998875

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=204.18  Aligned_cols=182  Identities=22%  Similarity=0.322  Sum_probs=148.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.|.+.+.+|+|.||.+-.|+++++.+.+|+|.++. .....++|.+|..---.+ .|.||+.-|++.    |+..+..+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence            478999999999999999999999999999999863 334567899998764445 489999887653    67778889


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CC-CcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YD-MVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~-~~~ki~DFG  861 (914)
                      ++|||+|.|+|.+-+...       .+-+....+++.|+++|+.|||++   .+||||||.+||||- .| .+||++|||
T Consensus        99 F~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             EeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence            999999999999977653       466778889999999999999999   999999999999994 33 489999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVH  912 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~  912 (914)
                      ..+....-.           ....-+..|-|||...         .+.+|+|.||++++.
T Consensus       169 ~t~k~g~tV-----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~  217 (378)
T KOG1345|consen  169 LTRKVGTTV-----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFY  217 (378)
T ss_pred             cccccCcee-----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeee
Confidence            987543211           0123456789999873         488999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=1.7e-22  Score=212.18  Aligned_cols=175  Identities=30%  Similarity=0.433  Sum_probs=150.1

Q ss_pred             ccEEEEEEEECCCcEEEEEEEeeccCCcc-hHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHH
Q 042766          717 RFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLE  795 (914)
Q Consensus       717 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  795 (914)
                      +||.||+|++..+++.||+|++....... .+.+.+|++.+++++|+||+++++++...     ...+++|||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence            58999999999889999999997554444 68899999999999999999999986543     4789999999999999


Q ss_pred             HHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccccccc
Q 042766          796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS  875 (914)
Q Consensus       796 ~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~  875 (914)
                      +++....      .+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++++|||.+.......     
T Consensus        76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----  141 (244)
T smart00220       76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----  141 (244)
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence            9987542      378899999999999999999999   99999999999999999999999999998654321     


Q ss_pred             CCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          876 KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       876 ~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                          ......|+..|+|||...    +.++|+|++|+++++++
T Consensus       142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~  180 (244)
T smart00220      142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELL  180 (244)
T ss_pred             ----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence                112346889999999884    58999999999988764

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-22  Score=213.00  Aligned_cols=136  Identities=26%  Similarity=0.461  Sum_probs=119.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-----C---CCcceEEeEeecCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-----H---RNLIKIITICSSTDF  776 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~~~  776 (914)
                      .+|.+.++||=|.|++||.|++.+..+.||+|+.+.. +.-.+....||++|++++     |   ..||++++.+.... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence            6899999999999999999999999999999998633 334567889999999983     3   35999999987765 


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      ..+.+.++|+|++ |.+|..+|+....    +.++...+.+|++||+.||.|||+.|  +|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            4456899999999 8899999987654    67999999999999999999999987  99999999999998

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=2e-22  Score=237.61  Aligned_cols=259  Identities=19%  Similarity=0.359  Sum_probs=179.3

Q ss_pred             ccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCcc
Q 042766           67 WTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLS  146 (914)
Q Consensus        67 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  146 (914)
                      |.-..|-.  ...+.|++++++++. +|..+.  +.|+.|+|++|+++ .+|..+.  ++|++|+|++|+|+ .+|..+.
T Consensus       170 ~r~~~Cl~--~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~  240 (754)
T PRK15370        170 QRMRDCLK--NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP  240 (754)
T ss_pred             HHHHhhcc--cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh
Confidence            33345633  346789999888874 565553  57899999999998 6776654  58999999999998 6777654


Q ss_pred             ccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccc
Q 042766          147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNL  226 (914)
Q Consensus       147 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  226 (914)
                        .+|+.|+|++|++. .+|..+.  ++|++|+|++|+++ .+|..+.  ++|+.|++++|+|++ +|..+.  ++|+.|
T Consensus       241 --~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L  309 (754)
T PRK15370        241 --DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHL  309 (754)
T ss_pred             --ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHH
Confidence              47889999999988 7787765  47889999999888 5677654  478888888888884 565443  468888


Q ss_pred             ccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccC
Q 042766          227 NVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF  306 (914)
Q Consensus       227 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  306 (914)
                      ++++|+++. +|..+.  ++|+.|++++|.+++ +|..+   .++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|
T Consensus       310 ~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l---~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~L  379 (754)
T PRK15370        310 NVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASL---PPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNAL  379 (754)
T ss_pred             HhcCCcccc-CCcccc--ccceeccccCCcccc-CChhh---cCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcC
Confidence            888888884 454432  577888888888775 45433   257777888887776 4565543  5677777777777


Q ss_pred             CccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       307 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      +.+++ .+.  ..|+.|++++|+++.++..   +|.+++.++++..|++.+|.++
T Consensus       380 t~LP~-~l~--~sL~~LdLs~N~L~~LP~s---l~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        380 TNLPE-NLP--AALQIMQASRNNLVRLPES---LPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCCCH-hHH--HHHHHHhhccCCcccCchh---HHHHhhcCCCccEEEeeCCCcc
Confidence            75433 232  3566777777777655432   3444445555666666666554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.87  E-value=1.1e-21  Score=201.16  Aligned_cols=180  Identities=32%  Similarity=0.505  Sum_probs=152.0

Q ss_pred             ccCCccEEEEEEEECCCcEEEEEEEeeccCCc-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccC
Q 042766          713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN  791 (914)
Q Consensus       713 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  791 (914)
                      ||+|++|.||+|+...+++.+++|++...... ..+.+.+|++.++.++|++|+++++++...     ...+++|||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence            68999999999999888999999999754332 346899999999999999999999986443     478999999999


Q ss_pred             CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEecccccccccccc
Q 042766          792 GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAKFLSNHH  870 (914)
Q Consensus       792 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFGla~~~~~~~  870 (914)
                      ++|.+++....     ..+++..+..++.+++++++|||+.   +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            99999987542     3578899999999999999999999   9999999999999999 8999999999998654321


Q ss_pred             cccccCCCCccccccCcccccccchhhh-----hhcccCccccccccc
Q 042766          871 LDIASKTPSSSIGIKGTVGYVAPGKFFM-----LYTHIPSFSCTNVHH  913 (914)
Q Consensus       871 ~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~Di~s~g~~~~~~  913 (914)
                      .        ......+...|++||.+..     .+.|+|++|++++++
T Consensus       148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             c--------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            1        1122457889999999753     889999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.87  E-value=3.2e-22  Score=208.63  Aligned_cols=192  Identities=28%  Similarity=0.373  Sum_probs=153.5

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCC
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTD  775 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  775 (914)
                      +......|...++||+|+|++||+|.+..   ..+.||+|.+....  ...++..|+++|..+. +.||+++.++     
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~-----  103 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC-----  103 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----
Confidence            34445678899999999999999999876   77899999986443  3467899999999985 9999999988     


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCc
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMV  854 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~  854 (914)
                      +...+...+||||++..+..++..         .++..++..+.+.+..||+++|.+   ||||||+||.|++.+. .+.
T Consensus       104 ~rnnd~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r  171 (418)
T KOG1167|consen  104 FRNNDQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR  171 (418)
T ss_pred             hccCCeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence            566678999999999999988875         456778889999999999999999   9999999999999985 467


Q ss_pred             EEEecccccccccccc------------ccc------------------------ccCCCCccccccCcccccccchhh-
Q 042766          855 AHVGDFGLAKFLSNHH------------LDI------------------------ASKTPSSSIGIKGTVGYVAPGKFF-  897 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~------------~~~------------------------~~~~~~~~~~~~GT~~y~APE~~~-  897 (914)
                      -.|.|||+|.......            ...                        ....+......+||++|.|||+++ 
T Consensus       172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k  251 (418)
T KOG1167|consen  172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR  251 (418)
T ss_pred             ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence            8899999997311100            000                        011112234668999999999995 


Q ss_pred             ----hhhcccCcccccc
Q 042766          898 ----MLYTHIPSFSCTN  910 (914)
Q Consensus       898 ----~~~~Di~s~g~~~  910 (914)
                          +.++||||.|+++
T Consensus       252 ~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  252 CPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             ccCcCCccceeecccee
Confidence                5889999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=9.8e-21  Score=189.35  Aligned_cols=139  Identities=17%  Similarity=0.151  Sum_probs=107.7

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--c-------h-----------------HHHHHHHHHHHhcCCCC
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--A-------S-----------------KSFVSECEALRNIRHRN  763 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~n  763 (914)
                      .+.||+|+||.||+|++. +|+.||||+++.....  .       .                 ....+|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754211  1       1                 12245999999998887


Q ss_pred             cceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCC
Q 042766          764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDL  842 (914)
Q Consensus       764 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~L-H~~~~~~ivHrDl  842 (914)
                      +.....+..       ...++||||++|+++.......      ..++..++..++.|++.++.|+ |+.   +|+||||
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl  144 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQDC---RLVHADL  144 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence            644332211       1237999999988776543222      3578889999999999999999 677   9999999


Q ss_pred             CCCCeeecCCCcEEEecccccccc
Q 042766          843 KPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       843 kp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+||+++ ++.++++|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-20  Score=203.03  Aligned_cols=196  Identities=21%  Similarity=0.283  Sum_probs=154.7

Q ss_pred             cccccCcccCCccEEEEEEEECCCc-EEEEEEEeeccCCcchHHHHHHHHHHHhcCC----CCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRH----RNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~  780 (914)
                      +|.+.+.||+|+||.||.|.+..++ +.+|+|............+..|+.++..+..    +++.++++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987664 6889998865433333378889999998873    57888887742    3445


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-----CcE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-----MVA  855 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~  855 (914)
                      +.++||+.+ |.+|.++.+...    ...++...+.+|+.|++.+|+++|+.   |++||||||+|+.+...     ..+
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence            789999988 889999886554    25799999999999999999999999   99999999999999865     469


Q ss_pred             EEeccccccccc--ccccccccCCCCc-cccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLS--NHHLDIASKTPSS-SIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~--~~~~~~~~~~~~~-~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      .+.|||+|+.+.  ...... ...+.. ...+.||..|++++..    .+.+.|+||++.++++++
T Consensus       167 ~llDfGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~  231 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL  231 (322)
T ss_pred             EEEecCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh
Confidence            999999999333  222111 111112 3456799999999987    469999999998888764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.83  E-value=7.4e-21  Score=194.85  Aligned_cols=204  Identities=19%  Similarity=0.300  Sum_probs=159.3

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCc-----EEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeE
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDE-----MVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITI  770 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~  770 (914)
                      .+++.....+++....+.+|.||.||+|.+++.+     +.|-+|.++.. ++-....+..|.-.+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455566667888889999999999999887433     33555655422 23344678899999999999999999999


Q ss_pred             eecCCCCCCceEeEEEecccCCCHHHHHhccCC--cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSND--QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                      +..    .....++++.++.-|+|..|+...+.  ....+.++..+...++.|++.|++|||++   +|||.||..+|.+
T Consensus       356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV  428 (563)
T ss_pred             Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence            854    34567889999999999999983322  22356788889999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      ||+.-.|||+|=.++|.+-..++..-..      .......|||||.+    ++.++|+||||+++-|+
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGD------nEnRPvkWMslEal~n~~yssasDvWsfGVllWEL  491 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGD------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWEL  491 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCC------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHH
Confidence            9999999999999998654433322221      12345689999999    56999999999988765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=7.9e-20  Score=183.80  Aligned_cols=139  Identities=22%  Similarity=0.202  Sum_probs=110.2

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc--------------------------hHHHHHHHHHHHhcCCCC
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--------------------------SKSFVSECEALRNIRHRN  763 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n  763 (914)
                      ...||+|+||.||+|++. +|+.||||+++......                          ...+.+|++.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999997542110                          123467899999999998


Q ss_pred             cceEEeEeecCCCCCCceEeEEEecccCCCHHHH-HhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecC
Q 042766          764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDW-LHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGD  841 (914)
Q Consensus       764 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrD  841 (914)
                      +.....+...       ..++||||++|+++... +..       ..++..++..++.|++.++.|+|+ .   +|+|||
T Consensus        81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD  143 (190)
T cd05145          81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD  143 (190)
T ss_pred             CCCceEEEec-------CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            7544433211       23799999998865443 322       346778889999999999999999 8   999999


Q ss_pred             CCCCCeeecCCCcEEEeccccccccc
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |||+||+++ ++.++|+|||+|+...
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecC
Confidence            999999999 8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=4.8e-20  Score=185.72  Aligned_cols=174  Identities=16%  Similarity=0.153  Sum_probs=130.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHH---------HHHHHHHHHhcCCCCcceEEeEeec
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS---------FVSECEALRNIRHRNLIKIITICSS  773 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~  773 (914)
                      ...+|...+.+|+|+||.||.+..  ++..+|+|+++.......+.         +.+|+..++++.||+|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            457899999999999999999655  35579999997543333222         6899999999999999999887543


Q ss_pred             CCC---CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          774 TDF---EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       774 ~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ...   ......++||||++|.+|.++..          .+.    ....+++.++..+|+.   +++|||+||+||+++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            321   11235789999999999988732          122    2456899999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhhhhhcccCcccccccc
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVH  912 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~Di~s~g~~~~~  912 (914)
                      .+| ++++|||..+......   +.             ...-=|.-++.+.|+|++|+|++.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~---a~-------------d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRK---AK-------------DRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             CCC-EEEEECCCcccccchh---hH-------------HHHHHHhHhcccccccceeEeehH
Confidence            998 9999999887543211   00             001122234578999999999764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=9.1e-20  Score=183.56  Aligned_cols=189  Identities=21%  Similarity=0.335  Sum_probs=155.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .|.+.++||+|.||+++.|+.--+++.||||.-..+++  ..++..|.+..+.+. .+.|...|.|.     +.+.+-.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL  101 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL  101 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence            79999999999999999999998999999998754433  356778888888875 68888887662     33446789


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-----cEEEec
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-----VAHVGD  859 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~ki~D  859 (914)
                      |||.+ |.+|+|.+.-.+     +.++...+.-+|.|++.-++|+|++   ..|.|||||+|+||...+     .+.|+|
T Consensus       102 VidLL-GPSLEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             hhhhh-CcCHHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence            99998 889999988654     6899999999999999999999999   999999999999997543     588999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNV  911 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~  911 (914)
                      ||+|+.+.++.... ..+..+.....||.+||+=..-.    +.+.|.-|+|=++.
T Consensus       173 FGmAK~YrDp~Tkq-HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFm  227 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQ-HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFM  227 (449)
T ss_pred             ccchhhhcCccccc-cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhh
Confidence            99999998876432 23344556778999999987764    47888888887644

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=8.1e-20  Score=175.95  Aligned_cols=192  Identities=23%  Similarity=0.327  Sum_probs=152.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCC-CCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH-RNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ...|...++||.|+||.+|.|.....|+.||||+-..  .....++..|..+.+.+++ ..|..+..|.     ....+-
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccc
Confidence            4679999999999999999999999999999998642  2334567889999999875 4566666553     334577


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~ki~D  859 (914)
                      .+|||.. |.+|++.+.-.     .+.++...++-.|-|++.-++|+|.+   +.|||||||+|+|+.-+   ..+.++|
T Consensus        87 vlVMdLL-GPsLEdLfnfC-----~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID  157 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFC-----SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID  157 (341)
T ss_pred             eeeeecc-CccHHHHHHHH-----hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence            8999998 88999988643     25788899999999999999999999   99999999999999644   4688999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVH  912 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~  912 (914)
                      ||+|+.+.+...... -+..+.....||.+|.+=...    ++.+.|.-|+|.++.+
T Consensus       158 FGLaKky~d~~t~~H-Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmY  213 (341)
T KOG1163|consen  158 FGLAKKYRDIRTRQH-IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMY  213 (341)
T ss_pred             ccchhhhcccccccc-CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeee
Confidence            999998876543222 223345567899999887655    4688999999987654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=5.7e-21  Score=174.38  Aligned_cols=165  Identities=30%  Similarity=0.559  Sum_probs=124.0

Q ss_pred             cCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccc
Q 042766          121 IGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIE  200 (914)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  200 (914)
                      +.++.+.+.|-||+|+++ .+|+.++.+.+|+.|++++|+++ .+|.+++++++|+.|+++.|++. .+|..||.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            445666777777777777 77777888888888888888887 77888888888888888888887 7888888888888


Q ss_pred             eeecccCCCC-CCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccC
Q 042766          201 VIRITENSLG-GKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG  279 (914)
Q Consensus       201 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~  279 (914)
                      +|||+.|++. ..+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.++. .+++|++|++.+
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig-~lt~lrelhiqg  182 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIG-DLTRLRELHIQG  182 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHH-HHHHHHHHhccc
Confidence            8888888876 457888888888888999888887 67777788888877777777765 2454443 566666666666


Q ss_pred             ccCCCCCCCcccc
Q 042766          280 NNFVGSIPDSLSN  292 (914)
Q Consensus       280 N~l~~~~p~~~~~  292 (914)
                      |+++ .+|..+++
T Consensus       183 nrl~-vlppel~~  194 (264)
T KOG0617|consen  183 NRLT-VLPPELAN  194 (264)
T ss_pred             ceee-ecChhhhh
Confidence            6666 44544443

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.3e-18  Score=175.33  Aligned_cols=142  Identities=18%  Similarity=0.337  Sum_probs=109.3

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-----CCCCcceEEeEeecCCCCCCce
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-----RHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +...+.||+|+||.||.  +..++.. +||++........+.+.+|+.+++++     +||||++++|++.+..  +.+.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            34567899999999995  6666555 69988765555667899999999999     6799999999975432  2234


Q ss_pred             -EeEEEec--ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEecCCCCCCeeecC----CC
Q 042766          782 -KALVFEY--MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI-EYLHHHCQPPMVHGDLKPSNVLLDY----DM  853 (914)
Q Consensus       782 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl-~~LH~~~~~~ivHrDlkp~NILl~~----~~  853 (914)
                       ..+||||  +++|+|.+++++.       .+++.  ..++.|++.++ +|||++   +||||||||+|||++.    ++
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence             3479999  5579999999753       23443  35677888777 999999   9999999999999974    34


Q ss_pred             cEEEec-cccccc
Q 042766          854 VAHVGD-FGLAKF  865 (914)
Q Consensus       854 ~~ki~D-FGla~~  865 (914)
                      .++|+| ||.+..
T Consensus       147 ~~~LiDg~G~~~~  159 (210)
T PRK10345        147 IPVVCDNIGESTF  159 (210)
T ss_pred             cEEEEECCCCcce
Confidence            899999 555443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=2.6e-21  Score=212.80  Aligned_cols=258  Identities=22%  Similarity=0.269  Sum_probs=128.1

Q ss_pred             EecCCCCCc-cccCCCCCCCCCCCEEEcCCCCCcc----cCCcccCCCCCCCeeecCCCCCCC------cCCCCccccCC
Q 042766           82 LNLSSQRIG-GVLSPYVGNLSFLRYINLADNGFRG----DIPQEIGNLFRLEKLALSNNSFSG------TIPTNLSRCSN  150 (914)
Q Consensus        82 l~l~~~~l~-~~~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~  150 (914)
                      |+|..+.++ ......+..++.|++|+++++.++.    .++..+...+.|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            566666665 2334445566667777777777643    245555666667777777766652      12233445555


Q ss_pred             cchhccCCCcccCCCChhcccccc---ccccccccccccC----cCCcccccc-cccceeecccCCCCCCCCccchhhhc
Q 042766          151 LIHFCASNNKLEGQIPKEIGNLLK---LQRLSVDINYLTG----QLPDSVGNL-SAIEVIRITENSLGGKIPTTLGLLRR  222 (914)
Q Consensus       151 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~  222 (914)
                      |++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++..+.       
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-------  155 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE-------  155 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH-------
Confidence            555555555555444444444443   5555555555542    111223333 4444444444444421111       


Q ss_pred             ccccccccccccCCCCCccccccccceeeccCCcccCccccc---ccccCcccceeeccCccCCCC----CCCccccccc
Q 042766          223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD---ILLNLPNLKKLGIGGNNFVGS----IPDSLSNASN  295 (914)
Q Consensus       223 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~  295 (914)
                                   .++..+..+.+|++|++++|.+++.....   .+..+++|++|+|++|.+.+.    ++..+..+++
T Consensus       156 -------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~  222 (319)
T cd00116         156 -------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS  222 (319)
T ss_pred             -------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence                         11222333444555555555554211111   111334566666666655422    2233445566


Q ss_pred             cccccccCccCCcccccccc-----ccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          296 LELLDLPSNQFKGKVSIDFS-----SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       296 L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      |++|++++|++++.....+.     ..+.|+.|++++|.++.....  .+...+..+++|+++++++|.++
T Consensus       223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~--~l~~~~~~~~~L~~l~l~~N~l~  291 (319)
T cd00116         223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAK--DLAEVLAEKESLLELDLRGNKFG  291 (319)
T ss_pred             CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHH--HHHHHHhcCCCccEEECCCCCCc
Confidence            77777777766643222221     125666666666666532111  12333445566677777777666

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=1.3e-20  Score=172.01  Aligned_cols=152  Identities=26%  Similarity=0.471  Sum_probs=85.1

Q ss_pred             ceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccC
Q 042766           78 RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS  157 (914)
Q Consensus        78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  157 (914)
                      .+|.|-|++|.++ .+||.+++|.+|+.|++++|+++ .+|.+++.+++|++|+++-|++. ..|..|+.++.|+.|||+
T Consensus        34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence            3455555555553 34555555555555555555555 55555555555555555555555 555555555555555555


Q ss_pred             CCcccC-CCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          158 NNKLEG-QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       158 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      +|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+.+|++|.+.+|+++
T Consensus       111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            555542 34555555555555555555555 55555555555555555555554 45555555555555555555555

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=1.5e-20  Score=206.71  Aligned_cols=286  Identities=22%  Similarity=0.252  Sum_probs=142.7

Q ss_pred             eeeccCccCC-CCCCCccccccccccccccCccCCcc----ccccccccccccceeccCCcCCCCCCCCcchhhcccCCC
Q 042766          274 KLGIGGNNFV-GSIPDSLSNASNLELLDLPSNQFKGK----VSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCS  348 (914)
Q Consensus       274 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~  348 (914)
                      .|+|+++.++ ...+..+..+++|+.|+++++.++..    ++..+...++|++|+++++.+...+.....++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4566666665 33344455566677777777766432    223334445566666666555421111111223344455


Q ss_pred             CCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccc----cCChhhhcc-cCC
Q 042766          349 SLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG----TIPDVISEL-KNL  423 (914)
Q Consensus       349 ~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l-~~L  423 (914)
                      +|+.|++++|.+.+..+..+..+..                     . ++|++|++++|++++    .+...+..+ ++|
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~---------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L  139 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLR---------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL  139 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhc---------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCc
Confidence            5555555555554333333322221                     0 124444444444441    112223333 455


Q ss_pred             ceeeecccccccc----cCccccCCCCCCeEEeeCCcCCCC----CCCccCCCCCccccccCCCccCCCCchhhhcccch
Q 042766          424 QQLSVFNNFLRGG----IPSGLGNLTKLGSLDLGSNSLQGN----IPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL  495 (914)
Q Consensus       424 ~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  495 (914)
                      +.|++++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+++....        
T Consensus       140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------  211 (319)
T cd00116         140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------  211 (319)
T ss_pred             eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH--------
Confidence            5555555555421    122334444555555555555421    122223334444444444444311110        


Q ss_pred             hhhhcccCCccCCCccccccccccceeecccCCccccccCccccc-----cccccEEEeeccccc----ccCCcchhccC
Q 042766          496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLST-----CVSLEYLDISINSFY----GVIPLSFRFLK  566 (914)
Q Consensus       496 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~----~~~p~~~~~l~  566 (914)
                                   .++..+..+++|++|++++|++++.....+..     .+.|+.|++++|.++    ..+...+..++
T Consensus       212 -------------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~  278 (319)
T cd00116         212 -------------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKE  278 (319)
T ss_pred             -------------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCC
Confidence                         11223445667777777777776533333222     367788888887775    22334455667


Q ss_pred             CCCEEEccCCccccc----cCcccccc-CCCCeEeCCCCcc
Q 042766          567 SIKALNVSSNNLSGK----IPEFLENL-SFLEFLNLSYNYF  602 (914)
Q Consensus       567 ~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~ls~N~l  602 (914)
                      +|+.+++++|.++..    ....+... +.|+.+|+.+|+|
T Consensus       279 ~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         279 SLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            788888888888744    44444444 6778888877764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.76  E-value=1.8e-19  Score=221.19  Aligned_cols=147  Identities=12%  Similarity=0.162  Sum_probs=102.4

Q ss_pred             cCC-CCcceEEeEeecCCCC--CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042766          759 IRH-RNLIKIITICSSTDFE--GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQP  835 (914)
Q Consensus       759 l~h-~niv~l~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~  835 (914)
                      .+| +||.++++++......  .....+.+|||+ +++|.+++....     ..+++.+++.++.||++||+|||++   
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---   99 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ---   99 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            345 4777777765222211  123467788988 669999997532     4689999999999999999999999   


Q ss_pred             CcEecCCCCCCeeecCC-------------------CcEEEecccccccccccccc------c-c-cCCCCccccccCcc
Q 042766          836 PMVHGDLKPSNVLLDYD-------------------MVAHVGDFGLAKFLSNHHLD------I-A-SKTPSSSIGIKGTV  888 (914)
Q Consensus       836 ~ivHrDlkp~NILl~~~-------------------~~~ki~DFGla~~~~~~~~~------~-~-~~~~~~~~~~~GT~  888 (914)
                      +||||||||+|||++..                   +.+|++|||+++........      . . ...+......+||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            99999999999999654                   44556666666532110000      0 0 00001112346899


Q ss_pred             cccccchhh----hhhcccCcccccccccC
Q 042766          889 GYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       889 ~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .|||||++.    +.++|||||||++|||+
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl  209 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELF  209 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHh
Confidence            999999984    68999999999999985

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=6.3e-18  Score=174.95  Aligned_cols=144  Identities=19%  Similarity=0.181  Sum_probs=112.6

Q ss_pred             hcccccCcccCCccEEEEEEE-ECCCcEEEEEEEeeccCCc------------------------chHHHHHHHHHHHhc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKG------------------------ASKSFVSECEALRNI  759 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  759 (914)
                      .-|++.+.||+|+||.||+|+ +..+|+.||+|+++.....                        ....+.+|++.++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999999 6668999999999743210                        012356899999999


Q ss_pred             CCCC--cceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-
Q 042766          760 RHRN--LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP-  836 (914)
Q Consensus       760 ~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~-  836 (914)
                      .+..  +.+++++         ...++||||++|+++..+....      ......++..++.|++.+++|+|+.   + 
T Consensus       108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---g~  169 (237)
T smart00090      108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYKE---GE  169 (237)
T ss_pred             HhcCCCCCeeeEe---------cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence            7633  4444443         1247999999998887654322      2345556788999999999999999   8 


Q ss_pred             cEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          837 MVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       837 ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      |+|||+||+||+++ ++.++++|||.|+...
T Consensus       170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99999999999999 8899999999998654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.74  E-value=1.2e-17  Score=184.32  Aligned_cols=190  Identities=33%  Similarity=0.476  Sum_probs=151.8

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---chHHHHHHHHHHHhcCCC-CcceEEeEeecCCCCCCceE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---ASKSFVSECEALRNIRHR-NLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  782 (914)
                      |...+.+|.|+||.||++.+.   ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++++++.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            667788999999999999987   67899998754332   367899999999999988 7999999862     22347


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFG  861 (914)
                      +++++|+.++++.+++......   ..++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence            9999999999999777654211   2688889999999999999999999   899999999999999988 79999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVH  912 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~  912 (914)
                      .++............  .......||..|+|||...       ....|+|++|+++++
T Consensus       148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~  203 (384)
T COG0515         148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE  203 (384)
T ss_pred             cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence            998554322111000  1223568999999999774       368999999987765

>PLN03150 hypothetical protein; Provisional

Probab=99.72  E-value=1.6e-17  Score=195.99  Aligned_cols=151  Identities=31%  Similarity=0.498  Sum_probs=114.8

Q ss_pred             CCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCC----CccceeecCC--C--CceEEEecCCCCCccccCCCCCCCCCC
Q 042766           32 QTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFC----QWTGVTCGHR--H--QRLTELNLSSQRIGGVLSPYVGNLSFL  103 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~~c----~w~gv~C~~~--~--~~v~~l~l~~~~l~~~~~~~l~~l~~L  103 (914)
                      .+.++|..||+++|+++.++..  .+|. +..||    .|.||.|+..  .  .+|+.|+|+++++.|.+|+.++.+++|
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~-g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L  444 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLR--FGWN-GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL  444 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCccc--CCCC-CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence            4578899999999999975542  4897 43443    7999999532  2  257888888888888888888888888


Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccc-cccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNL-LKLQRLSVDI  182 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~  182 (914)
                      ++|+|++|.++|.+|..++++++|+.|||++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++++
T Consensus       445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~  524 (623)
T PLN03150        445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD  524 (623)
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence            888888888888888888888888888888888888888878888888888888888877777777653 3555666666


Q ss_pred             ccc
Q 042766          183 NYL  185 (914)
Q Consensus       183 N~l  185 (914)
                      |..
T Consensus       525 N~~  527 (623)
T PLN03150        525 NAG  527 (623)
T ss_pred             Ccc
Confidence            653

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1e-16  Score=157.77  Aligned_cols=178  Identities=15%  Similarity=0.037  Sum_probs=123.1

Q ss_pred             cccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC----cchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceE
Q 042766          708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK----GASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       708 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+...|++|+||+||.+..  .+..++.+.+.....    .....+.+|+++|+++. |++|++++++         ...
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            4567899999999997665  566777776653321    11236889999999995 5789999875         235


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCeeecCCCcEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDL-KPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDl-kp~NILl~~~~~~ki~DFG  861 (914)
                      +++|||++|.+|.+....             ....++.|++.+++++|++   ||+|||| ||+|||++.++.++|+|||
T Consensus        74 ~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             EEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence            899999999998764321             1134678999999999999   9999999 7999999999999999999


Q ss_pred             ccccccccccc---cccCCCC--ccccccCcccccccchhhh------hhcccCcccccccc
Q 042766          862 LAKFLSNHHLD---IASKTPS--SSIGIKGTVGYVAPGKFFM------LYTHIPSFSCTNVH  912 (914)
Q Consensus       862 la~~~~~~~~~---~~~~~~~--~~~~~~GT~~y~APE~~~~------~~~Di~s~g~~~~~  912 (914)
                      +|.........   .....-.  ...-...++.|++|+....      .+.+-.+-|+-+|.
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~  199 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYR  199 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHH
Confidence            99854321100   0000000  0112237889999987632      33344455655554

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.3e-16  Score=161.85  Aligned_cols=143  Identities=24%  Similarity=0.231  Sum_probs=110.3

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc----------------------chHHHHHHHHHHH
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG----------------------ASKSFVSECEALR  757 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  757 (914)
                      +.....-|...+.||+|+||.||+|... +++.||||+++.....                      ....+.+|+.++.
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3333334778899999999999999885 7899999987643210                      1123678899999


Q ss_pred             hcCCCC--cceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042766          758 NIRHRN--LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQP  835 (914)
Q Consensus       758 ~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~  835 (914)
                      ++.|++  +++.++.         ...++||||++|+++.+....            .....++.+++.++.++|+.   
T Consensus        89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~---  144 (198)
T cd05144          89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH---  144 (198)
T ss_pred             HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---
Confidence            998874  4444332         235899999999998765321            23456889999999999998   


Q ss_pred             CcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          836 PMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       836 ~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      +|+||||||+||++++++.++|+|||+|....
T Consensus       145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.4e-16  Score=162.06  Aligned_cols=135  Identities=21%  Similarity=0.339  Sum_probs=109.6

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--------ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +.||+|++|.||+|++  .+..|++|+.......        ....+.+|++++..+.|++|.....++...     ...
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence            5799999999999988  4567889976533211        124678899999999999887666654322     356


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++|++|.+++....         + .+..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence            89999999999999986431         1 7788999999999999999   999999999999999 78999999999


Q ss_pred             cccc
Q 042766          863 AKFL  866 (914)
Q Consensus       863 a~~~  866 (914)
                      ++..
T Consensus       141 a~~~  144 (211)
T PRK14879        141 AEFS  144 (211)
T ss_pred             ccCC
Confidence            9753

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=4.3e-16  Score=182.27  Aligned_cols=138  Identities=24%  Similarity=0.317  Sum_probs=108.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CC------cchHHHHHHHHHHHhcCCCCcceEEeEeecCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QK------GASKSFVSECEALRNIRHRNLIKIITICSSTD  775 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  775 (914)
                      ...|...+.||+|+||+||+|++....  +++|+...+  ..      ...+++.+|++++++++|++++....++... 
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence            344566789999999999999986443  334432211  11      1235688999999999999998877665432 


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                          ...++||||++|++|.+++.              ....++.|+++++.|+|+.   +|+|||+||+||++ .++.+
T Consensus       409 ----~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        409 ----EEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             ----CCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence                24679999999999999875              2456899999999999999   99999999999999 57799


Q ss_pred             EEecccccccc
Q 042766          856 HVGDFGLAKFL  866 (914)
Q Consensus       856 ki~DFGla~~~  866 (914)
                      +|+|||+|+..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=3.8e-17  Score=189.68  Aligned_cols=187  Identities=21%  Similarity=0.263  Sum_probs=141.8

Q ss_pred             cccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcc----hHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGA----SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       708 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ...+.+|.|++|.|+.+......+..+.|.++..  ....    ...+..|+.+-..+.|||++.....+...     ..
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence            3457899999998888887766666666655321  1111    12255677778888999988766653322     12


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      ..-+||||++ +|..++...      ..+...++-.+..|++.|++|+|+.   ||.|||+|++|++++.+|.+||+|||
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            2334999999 999998764      2577788889999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      .+..+.-...    .......+++|+..|+|||++.     ....||||-|++.+.|
T Consensus       466 ~~~vf~~~~e----~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m  518 (601)
T KOG0590|consen  466 AASVFRYPWE----KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM  518 (601)
T ss_pred             cceeeccCcc----hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence            9987653221    1112345789999999999994     3899999999988766

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=6.1e-16  Score=157.38  Aligned_cols=131  Identities=25%  Similarity=0.375  Sum_probs=102.9

Q ss_pred             cccCCccEEEEEEEECCCcEEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--------ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .||+|+||.||+|.+  ++..|++|+.......        ..+++.+|+++++.++|+++.....++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            489999999999986  4567889986432211        125677899999999988755444333221     2458


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++|++|.+++....      .       .++.|++.++.++|+.   +++|||+||+||+++ ++.++++|||++
T Consensus        74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            9999999999999875421      0       6889999999999999   999999999999999 889999999998


Q ss_pred             ccc
Q 042766          864 KFL  866 (914)
Q Consensus       864 ~~~  866 (914)
                      +..
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.63  E-value=2.4e-17  Score=181.21  Aligned_cols=176  Identities=23%  Similarity=0.245  Sum_probs=144.9

Q ss_pred             cccCCccEEEEEEEE---CCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEeEE
Q 042766          712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQK--GASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      ++|+|+||.|+.++-   .+.+..+|+|+.++...  +.......|..++..++ ||.+|++...     ++.....+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            379999999987643   34677899998875432  11225566888888887 9999998766     5566688999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ++|..||++...+...      ..+++.....+...++-|++++|+.   +|+|||+|++||+++.+|++|+.|||+++.
T Consensus        76 ld~~rgg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             hhhcccchhhhccccC------CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence            9999999999888765      4567777888888999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccCCCCccccccCcccccccchhhh--hhcccCccccccccc
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM--LYTHIPSFSCTNVHH  913 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~--~~~Di~s~g~~~~~~  913 (914)
                      ..+...            .|||..|||||++.+  .+.|.||||.+.+||
T Consensus       147 ~v~~~~------------~cgt~eymApEI~~gh~~a~D~ws~gvl~fel  184 (612)
T KOG0603|consen  147 AVKEKI------------ACGTYEYRAPEIINGHLSAADWWSFGVLAFEL  184 (612)
T ss_pred             hHhhhh------------cccchhhhhhHhhhccCCcccchhhhhhHHHH
Confidence            654321            289999999999984  899999999998886

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=5.2e-15  Score=148.87  Aligned_cols=136  Identities=24%  Similarity=0.298  Sum_probs=97.5

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc--hH----------------------HHHHHHHHHHhcCCCC--
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--SK----------------------SFVSECEALRNIRHRN--  763 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~----------------------~~~~E~~~l~~l~h~n--  763 (914)
                      .+.||+|+||.||+|++. +++.||||+++......  ..                      ....|.+.+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 78899999986432111  11                      1135666666665443  


Q ss_pred             cceEEeEeecCCCCCCceEeEEEecccCCCHHH-HHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecC
Q 042766          764 LIKIITICSSTDFEGVDFKALVFEYMENGSLED-WLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGD  841 (914)
Q Consensus       764 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrD  841 (914)
                      +.+.+++         ...++||||++++++.. .+...       ... .++..++.+++.++.++|. .   +|+|||
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D  140 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGD  140 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence            4444432         13589999999854321 11111       001 4567899999999999999 7   999999


Q ss_pred             CCCCCeeecCCCcEEEeccccccccc
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      +||+||+++ ++.++++|||.|....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CChhhEEEE-CCcEEEEECccccccc
Confidence            999999999 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.58  E-value=9.1e-16  Score=152.77  Aligned_cols=94  Identities=22%  Similarity=0.241  Sum_probs=80.7

Q ss_pred             CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccc
Q 042766          792 GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL  871 (914)
Q Consensus       792 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  871 (914)
                      |+|.+++...+     ..+++.+++.|+.|++.||+|||++   +      ||+||+++.++.+|+  ||.++.....  
T Consensus         1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~--   62 (176)
T smart00750        1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE--   62 (176)
T ss_pred             CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc--
Confidence            68999997643     4689999999999999999999998   5      999999999999999  9999865321  


Q ss_pred             ccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          872 DIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       872 ~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                                 ...||+.|||||++.    +.++|||||||++|||.
T Consensus        63 -----------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell   98 (176)
T smart00750       63 -----------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL   98 (176)
T ss_pred             -----------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence                       125899999999994    58899999999999973

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=2.6e-15  Score=154.91  Aligned_cols=142  Identities=23%  Similarity=0.280  Sum_probs=104.0

Q ss_pred             CCCCcceEEeEeecCC----------------------CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHH
Q 042766          760 RHRNLIKIITICSSTD----------------------FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN  817 (914)
Q Consensus       760 ~h~niv~l~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~  817 (914)
                      +|||||++.+++.+.-                      .-.+...|+||.-++ .+|.+++...       ..+.....-
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-------~~s~r~~~~  345 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-------HRSYRTGRV  345 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-------CCchHHHHH
Confidence            6999999988765431                      112335789998884 5999998754       345566777


Q ss_pred             HHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec--CCC--cEEEecccccccccccccccccCCCCccccccCccccccc
Q 042766          818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--YDM--VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP  893 (914)
Q Consensus       818 i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~--~~~--~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~AP  893 (914)
                      +..|+++|+.|||.+   +|.|||+|++|||+.  +|+  ...|+|||++-.-..+....+...  .....-|-..-|||
T Consensus       346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S--~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYES--DEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccccc--ccccCCCcceecch
Confidence            899999999999999   999999999999994  444  577899998754332222221111  11233477778999


Q ss_pred             chhh----------hhhcccCcccccccccC
Q 042766          894 GKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       894 E~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      |++.          -.++|.|+.|...||.|
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIf  451 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIF  451 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHh
Confidence            9984          27899999999999987

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=2.7e-14  Score=138.13  Aligned_cols=135  Identities=22%  Similarity=0.289  Sum_probs=109.6

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCC--CCcceEEeEeecCCCCCCceEeEEE
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH--RNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.+.||+|.++.||+++..+  ..+++|.......  ...+.+|+.+++.++|  ..+++++++..     ..+..+++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEE
Confidence            34679999999999999854  6789998854332  4678899999999976  48888887743     335689999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ||++++.+..+             +......++.+++++++++|....++++|+|+||+||+++.++.++++|||.++.
T Consensus        73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99988776543             3345667889999999999986445799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.56  E-value=4.8e-16  Score=152.29  Aligned_cols=180  Identities=22%  Similarity=0.365  Sum_probs=139.5

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ...+|.+...|+.|+|++.+.  .+++|++...+  ....++|..|.-.++-+.||||+.++|.|.++.     ...++.
T Consensus       194 l~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~is  266 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVIIS  266 (448)
T ss_pred             hhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEee
Confidence            345688899999999999754  35667776443  345578999999999999999999999986654     678999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      .||+.|+|+..+++...    ..++..++++++.++++|++|||+. +|-|-.--+.+..++||++.+++|+ .+-+++-
T Consensus       267 q~mp~gslynvlhe~t~----vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs  340 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTS----VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS  340 (448)
T ss_pred             eeccchHHHHHHhcCcc----EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee
Confidence            99999999999987643    4577789999999999999999997 4445555788999999999988874 1111110


Q ss_pred             cccccccccCCCCccccccCcccccccchhhh-------hhcccCccccccccc
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-------LYTHIPSFSCTNVHH  913 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~Di~s~g~~~~~~  913 (914)
                      -            ...+..-.|.||+||.++.       .++|+|||.+.+.|+
T Consensus       341 f------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel  382 (448)
T KOG0195|consen  341 F------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL  382 (448)
T ss_pred             e------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence            0            0112345789999999963       789999999887664

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=4.8e-14  Score=146.40  Aligned_cols=140  Identities=18%  Similarity=0.137  Sum_probs=105.4

Q ss_pred             Cccc-CCccEEEEEEEECCCcEEEEEEEeeccC-------------CcchHHHHHHHHHHHhcCCCCc--ceEEeEeecC
Q 042766          711 NMIG-QGRFGTVYKGILGDDEMVVAVKVINLKQ-------------KGASKSFVSECEALRNIRHRNL--IKIITICSST  774 (914)
Q Consensus       711 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  774 (914)
                      ..|| .|+.|+||+++..  +..+|+|.+....             .....++.+|++++++++|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            5677 8888999998874  5678999885311             1223568899999999998875  6666654322


Q ss_pred             CCCCCceEeEEEecccC-CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          775 DFEGVDFKALVFEYMEN-GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                      . ......++||||++| .+|.+++...       .++..    .+.+++.++.++|+.   ||+||||||+|||++.++
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG  179 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence            1 111234699999997 6999988642       23333    356899999999999   999999999999999999


Q ss_pred             cEEEeccccccccc
Q 042766          854 VAHVGDFGLAKFLS  867 (914)
Q Consensus       854 ~~ki~DFGla~~~~  867 (914)
                      .++|+|||.++...
T Consensus       180 ~v~LIDfg~~~~~~  193 (239)
T PRK01723        180 KFWLIDFDRGELRT  193 (239)
T ss_pred             CEEEEECCCcccCC
Confidence            99999999987643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.53  E-value=6.6e-15  Score=153.14  Aligned_cols=191  Identities=21%  Similarity=0.270  Sum_probs=120.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCC----------CCcceEEeEee
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRH----------RNLIKIITICS  772 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  772 (914)
                      .+...+.||.|+++.||++++.++++.+|+|++.....   ...+++.+|.-....+.+          -.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45567899999999999999999999999999964432   233556666544443222          11222222211


Q ss_pred             cCC----CCCC---c-----eEeEEEecccCCCHHHHHhc---cCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042766          773 STD----FEGV---D-----FKALVFEYMENGSLEDWLHQ---SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPM  837 (914)
Q Consensus       773 ~~~----~~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~i  837 (914)
                      ...    ++..   .     ..+++|+-+ -+||.+++..   ....  ........++.+..|+++.++++|+.   |+
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence            100    0000   1     125677777 4688887652   2110  12344555677789999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchh------------hhhhcccCc
Q 042766          838 VHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF------------FMLYTHIPS  905 (914)
Q Consensus       838 vHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~------------~~~~~Di~s  905 (914)
                      ||+||||+|++++.+|.++++||+......+...           ....+..|.+||..            ++.+.|.|+
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceee-----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence            9999999999999999999999997765432111           02345779999877            357889999


Q ss_pred             cccccccc
Q 042766          906 FSCTNVHH  913 (914)
Q Consensus       906 ~g~~~~~~  913 (914)
                      +|+++|.+
T Consensus       236 LG~~ly~l  243 (288)
T PF14531_consen  236 LGITLYSL  243 (288)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999875

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=2.1e-14  Score=169.63  Aligned_cols=118  Identities=32%  Similarity=0.509  Sum_probs=99.0

Q ss_pred             cceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCC
Q 042766          519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLS  598 (914)
Q Consensus       519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls  598 (914)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|||++|+++|.+|+.+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCC--CcCCCCCccCccCCCCCCCCccCCCCCCCC
Q 042766          599 YNYFEGEVPVK--GVFSNKTKISLHGNVKLCGGIDELHLPSCP  639 (914)
Q Consensus       599 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~lc~~~~~l~~~~c~  639 (914)
                      +|+++|.+|..  .....+..+.+.+|+.+|+.+ .  .+.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~--l~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-G--LRACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC-C--CCCCc
Confidence            99999998864  122344567889999999852 3  24675

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.2e-14  Score=171.66  Aligned_cols=188  Identities=21%  Similarity=0.244  Sum_probs=134.9

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC---CCCcceEEeEeecCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR---HRNLIKIITICSSTDFEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  778 (914)
                      .....|.+.+.||+|+||+||+|...+ |+.||+|+-+....   .+|.-=.+++.+++   -+.|+++...+.   +. 
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~---~~-  766 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHV---FQ-  766 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHc---cC-
Confidence            344578899999999999999999986 99999998754332   22222223344444   122333322211   22 


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-------
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-------  851 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-------  851 (914)
                       +..++|+||.+.|+|.+++...      ..+++..++.++.|++..++.||..   +|||+||||+|.|+..       
T Consensus       767 -~~S~lv~ey~~~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  767 -NASVLVSEYSPYGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             -CcceeeeeccccccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence             3457999999999999999844      5689999999999999999999999   9999999999999942       


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ...++|+|||.+--+.--      .....-.+.++|-.+-.+|+..    .+.+|-+.++-|++-|
T Consensus       837 ~~~l~lIDfG~siDm~lf------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~m  896 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLF------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVM  896 (974)
T ss_pred             ccceEEEecccceeeeEc------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHH
Confidence            246899999988543210      0111234567888999999985    4777777766665543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.51  E-value=2.5e-15  Score=173.10  Aligned_cols=187  Identities=23%  Similarity=0.262  Sum_probs=136.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHH--HHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEA--LRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++...+.+|++.|=+|.+|+++ .|. |+||++-..+ .-..+.+.++++-  ..-++|||.+.+..+     .......
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence            6777789999999999999997 454 8899986554 3333444444333  555689999987654     3334456


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+|=+|.. -+|+|.+..+      .-+...+.+-|+.|++.|+.-+|..   +|+|+|||.|||||+.=.-+.|+||.-
T Consensus        97 ylvRqyvk-hnLyDRlSTR------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   97 YLVRQYVK-HNLYDRLSTR------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHHHHHHh-hhhhhhhccc------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence            77888884 4899988765      3567778888999999999999999   999999999999999888899999974


Q ss_pred             cccccccccccccCCCCcccccc----Ccccccccchhh---------------hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIK----GTVGYVAPGKFF---------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~----GT~~y~APE~~~---------------~~~~Di~s~g~~~~~~f  914 (914)
                      -+..     ..+...+..-..+.    .-.-|+|||.|.               .++-||+|.||++.|+|
T Consensus       167 FKPt-----YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf  232 (1431)
T KOG1240|consen  167 FKPT-----YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF  232 (1431)
T ss_pred             cCCc-----cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence            4321     11122222211111    223499999994               26789999999999986

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=3.3e-15  Score=161.04  Aligned_cols=177  Identities=26%  Similarity=0.438  Sum_probs=141.1

Q ss_pred             CCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccce
Q 042766          122 GNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEV  201 (914)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  201 (914)
                      ..|+.-...||+.|++. ++|..+..+-.|+.+.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |+.
T Consensus        72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv  147 (722)
T KOG0532|consen   72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV  147 (722)
T ss_pred             ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence            45666678888888888 88888888888888888888887 78888888888888888888888 7888787776 888


Q ss_pred             eecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc
Q 042766          202 IRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN  281 (914)
Q Consensus       202 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~  281 (914)
                      |-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++.. +|.++. .| .|..||+|.|+
T Consensus       148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~-~L-pLi~lDfScNk  222 (722)
T KOG0532|consen  148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELC-SL-PLIRLDFSCNK  222 (722)
T ss_pred             EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHh-CC-ceeeeecccCc
Confidence            888888888 77888888888888888888888 677788888888888888888874 455543 23 46777777777


Q ss_pred             CCCCCCCccccccccccccccCccCCc
Q 042766          282 FVGSIPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       282 l~~~~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                      +. .+|-.|.+|+.|++|-|.+|.+..
T Consensus       223 is-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  223 IS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             ee-ecchhhhhhhhheeeeeccCCCCC
Confidence            77 677777777777777777777763

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.47  E-value=3.9e-15  Score=160.50  Aligned_cols=172  Identities=34%  Similarity=0.551  Sum_probs=96.3

Q ss_pred             CCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccC
Q 042766          398 NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS  477 (914)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  477 (914)
                      .-...||+.|++. .+|..+..+..|+.+.|+.|.+. .+|..++++..|++|||+.|+++ .+|..++.|+ |+.|.++
T Consensus        76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            3344555555555 55555555555555556555555 45555555555666666666555 4455454443 4555555


Q ss_pred             CCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeeccccccc
Q 042766          478 YNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV  557 (914)
Q Consensus       478 ~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  557 (914)
                      +|+++ .+|..++...++ ..||.+.|.+. .+|..++++.+|+.|++..|++.. .|..+. .-.|..||+|+|+++ .
T Consensus       152 NNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~-~LpLi~lDfScNkis-~  225 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELC-SLPLIRLDFSCNKIS-Y  225 (722)
T ss_pred             cCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHh-CCceeeeecccCcee-e
Confidence            55555 555555533333 45555555555 455556666666666666666653 344444 334556666666665 5


Q ss_pred             CCcchhccCCCCEEEccCCccc
Q 042766          558 IPLSFRFLKSIKALNVSSNNLS  579 (914)
Q Consensus       558 ~p~~~~~l~~L~~L~Ls~N~l~  579 (914)
                      +|..|..|+.|++|-|.+|.|.
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCC
Confidence            5666666666666666666665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.46  E-value=1.3e-14  Score=167.46  Aligned_cols=159  Identities=26%  Similarity=0.364  Sum_probs=110.8

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|..++.|..|+||.||.++|+.+.+.+|+|+=+ +..           +++     ||..+-+           ..
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~l-----------ilR-----nilt~a~-----------np  132 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNL-----------ILR-----NILTFAG-----------NP  132 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccc-cch-----------hhh-----ccccccC-----------Cc
Confidence            3468889999999999999999999999999995421 110           111     2333221           12


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      +.|      ||=...++..+      +++.        +++.+++|+|+.   +|+|||+||+|.+|+.=|++|++|||+
T Consensus       133 fvv------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  133 FVV------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             cee------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhh
Confidence            223      34344444322      1221        237889999999   999999999999999999999999999


Q ss_pred             cccccc--------cccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          863 AKFLSN--------HHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~--------~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      .+.--.        .+.. .....-...+.+|||.|+|||++    ||..+|.|++|++.||+
T Consensus       190 sk~GLms~atnl~eg~I~-k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeF  251 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIE-KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF  251 (1205)
T ss_pred             hhhhhhhccchhhhcchH-HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHH
Confidence            875211        1111 11111123467999999999999    57999999999999985

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.45  E-value=9.4e-14  Score=157.26  Aligned_cols=198  Identities=28%  Similarity=0.461  Sum_probs=107.6

Q ss_pred             EEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccC-CcchhccCCCcccCCCChhccccccccccccccc
Q 042766          105 YINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCS-NLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      .++++.|.+... +..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            355555555322 223344455555666655555 5555555553 5666666666555 44455555566666666666


Q ss_pred             cccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccc
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPF  263 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  263 (914)
                      +++ .+|...+.++.|+.|++++|+++ .+|...+.+..|++|++++|++. ..+..+.++.++..+.+.+|++...  .
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~--~  248 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL--P  248 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec--c
Confidence            655 44544445555666666666655 44544444555666666666433 3444555555666666666655431  1


Q ss_pred             cccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccc
Q 042766          264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI  312 (914)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  312 (914)
                      ....++++++.|++++|+++. ++. ++.+.+++.||+++|.+....+.
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             chhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence            233355566666666666653 222 66666666666666666655443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.43  E-value=1.5e-14  Score=156.40  Aligned_cols=122  Identities=26%  Similarity=0.425  Sum_probs=100.3

Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      +.||.|++|+-.+|.+|+.+.+.   ...-++.....++.|++.|+.|   +   +.+|||+||.||+...+..+||.||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~---~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT---GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc---ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence            57899999999999999975543   2456778889999999999999   5   8999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      |+..........  .......+...||..||+||++    ++.++||||+|.+++|+
T Consensus       401 gl~ts~~~~~~~--~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL  455 (516)
T KOG1033|consen  401 GLVTSQDKDETV--APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAEL  455 (516)
T ss_pred             hheeecccCCcc--cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHH
Confidence            999866543311  1112234456899999999999    46999999999998875

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=1.7e-13  Score=155.11  Aligned_cols=196  Identities=33%  Similarity=0.452  Sum_probs=136.2

Q ss_pred             CeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccc-cccccccccccccCcCCcccccccccceeeccc
Q 042766          128 EKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLL-KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE  206 (914)
Q Consensus       128 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  206 (914)
                      ..|+++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.+. +|++|++++|++. .+|..++.+++|+.|++++
T Consensus        96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             ceeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            35777777764 23344555677777788877777 6677676664 7888888888777 6666677777888888888


Q ss_pred             CCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCC
Q 042766          207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI  286 (914)
Q Consensus       207 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~  286 (914)
                      |+++ .+|...+.++.|+.|++++|+++ .+|........|++|.+++|.+... + ....++.++..|.+++|++. ..
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~-~-~~~~~~~~l~~l~l~~n~~~-~~  247 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIEL-L-SSLSNLKNLSGLELSNNKLE-DL  247 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceec-c-hhhhhcccccccccCCceee-ec
Confidence            8777 55665557777777888888777 5565555666677777777743211 2 22346677777777777776 33


Q ss_pred             CCccccccccccccccCccCCccccccccccccccceeccCCcCCCC
Q 042766          287 PDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       287 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      +..++.+++++.|++++|+++.+..  +..+.+++.|++++|.+...
T Consensus       248 ~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~  292 (394)
T COG4886         248 PESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA  292 (394)
T ss_pred             cchhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence            6677777778888888887775554  77777778888877777655

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.39  E-value=1.3e-12  Score=147.46  Aligned_cols=143  Identities=20%  Similarity=0.236  Sum_probs=99.0

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc----------------------------------------hHHH
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA----------------------------------------SKSF  749 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~  749 (914)
                      .+.||.|++|.||+|+.+ +|+.||||+.++.-...                                        .-++
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            367999999999999986 68899999986431000                                        0124


Q ss_pred             HHHHHHHHhcC----CCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHH-
Q 042766          750 VSECEALRNIR----HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS-  824 (914)
Q Consensus       750 ~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~-  824 (914)
                      .+|++.+.+++    |.+-+.+-.++...    ....++||||++|+++.++.....     ...   ...+++.+++. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~-----~~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDE-----AGL---DRKALAENLARS  268 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHh-----cCC---CHHHHHHHHHHH
Confidence            55666665552    32223322232211    124689999999999988765321     112   23446666665 


Q ss_pred             HHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccc
Q 042766          825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN  868 (914)
Q Consensus       825 gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~  868 (914)
                      .+..+|..   |++|+|+||.||+++.++.++++|||++..+..
T Consensus       269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            46778888   999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=2.6e-12  Score=146.38  Aligned_cols=148  Identities=18%  Similarity=0.243  Sum_probs=95.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc----------------------------------chH--
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG----------------------------------ASK--  747 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~--  747 (914)
                      ..+|+. +.||+|++|+||+|+.+++|+.||||+.++.-..                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            445666 7899999999999999987999999999743100                                  011  


Q ss_pred             ----HHHHHHHHHHhcC----CCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHH--hccCCcccccCCCHHHHHH
Q 042766          748 ----SFVSECEALRNIR----HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMN  817 (914)
Q Consensus       748 ----~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~  817 (914)
                          ++.+|+..+.+++    +...+.+-.++.+.    ....++||||++|+.+.++-  ...+.  ....+....+..
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~--d~~~la~~~v~~  271 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGT--DMKLLAERGVEV  271 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCC--CHHHHHHHHHHH
Confidence                2445555555542    33333333332211    13467999999999998753  22110  011222222333


Q ss_pred             HHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----cEEEecccccccccc
Q 042766          818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----VAHVGDFGLAKFLSN  868 (914)
Q Consensus       818 i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----~~ki~DFGla~~~~~  868 (914)
                      ++.|+       +..   |++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       272 ~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33333       345   999999999999999988    999999999987754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.3e-13  Score=160.25  Aligned_cols=191  Identities=25%  Similarity=0.309  Sum_probs=148.9

Q ss_pred             hcccccCcccCCccEEEEEEEEC-CCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-DDEMVVAVKVINLKQ--KGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..|...+.||+|+|+.|-.+... .....+|+|.+....  ....+....|..+-..+. |+|++++++..     ....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            46777788999999999887763 445667778775433  333455566888877776 99999999873     4455


Q ss_pred             eEeEEEecccCCCHHHHH-hccCCcccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEecCCCCCCeeecCCC-cEEE
Q 042766          781 FKALVFEYMENGSLEDWL-HQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDM-VAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~ki  857 (914)
                      ..++++||.+|+++.+.+ ....     ...+...+..+..|+..++.|+| ..   ++.|||+||+|.+++..+ ..|+
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             ccccccCcccccccccccccCCc-----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccC
Confidence            789999999999999888 3321     24555667789999999999999 77   999999999999999999 9999


Q ss_pred             ecccccccccccccccccCCCCccccccC-cccccccchhh-----hhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKG-TVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~G-T~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      +|||+|..+...     ..........+| ++.|+|||...     +...|+||.|++..-|
T Consensus       167 ~df~~At~~~~~-----~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~  223 (601)
T KOG0590|consen  167 ADFGLATAYRNK-----NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAM  223 (601)
T ss_pred             CCchhhcccccc-----CCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccc
Confidence            999999876541     112223345678 99999999984     5899999999998755

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=3.4e-11  Score=118.94  Aligned_cols=131  Identities=18%  Similarity=0.161  Sum_probs=95.5

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcc-eEEeEeecCCCCCCceEeEEEec
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI-KIITICSSTDFEGVDFKALVFEY  788 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~  788 (914)
                      .+.++.|.++.||+++..  +..|++|+...... ....+.+|+++++.+.+.+++ +++.+..       ...++||||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-------~~~~lv~e~   72 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP-------ETGVLITEF   72 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC-------CCCeEEEEe
Confidence            356899999999999875  67899998753322 233567899999998765544 4544321       124799999


Q ss_pred             ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          789 MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       789 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~--~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ++|.++.+. .          .   ....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.|..
T Consensus        73 i~G~~l~~~-~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE-D----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc-c----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999887643 0          0   11235678999999999982  12359999999999999 66899999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.21  E-value=7.8e-12  Score=138.60  Aligned_cols=140  Identities=29%  Similarity=0.427  Sum_probs=112.4

Q ss_pred             HHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 042766          756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQP  835 (914)
Q Consensus       756 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~  835 (914)
                      |+.+.|.|+.+++|.+...     ...++|.+||+.|+|.+.+....     ..+++.-...+++++++|++|+|..   
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~s---   67 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHNS---   67 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhcC---
Confidence            3578899999999998654     36789999999999999998743     6788999999999999999999987   


Q ss_pred             Cc-EecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----------hhhccc
Q 042766          836 PM-VHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHI  903 (914)
Q Consensus       836 ~i-vHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di  903 (914)
                      +| .|+.+++.|.++|..+.+|++|||+.....+.. ....     .....-..-|.|||.+.           +.+.|+
T Consensus        68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~-----~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi  141 (484)
T KOG1023|consen   68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEA-----HHPIRKALLWTAPELLRGALSQSLESALTQKGDI  141 (484)
T ss_pred             cceeeeeeccccceeeeeEEEEechhhhcccccccc-cccc-----cchhHHHHhccCHHHhcccccccccccccccCCe
Confidence            45 999999999999999999999999988764300 0000     01112334599999984           356899


Q ss_pred             CcccccccccC
Q 042766          904 PSFSCTNVHHF  914 (914)
Q Consensus       904 ~s~g~~~~~~f  914 (914)
                      ||||++++|++
T Consensus       142 Ys~~ii~~ei~  152 (484)
T KOG1023|consen  142 YSFGIIMYEIL  152 (484)
T ss_pred             ehHHHHHHHHH
Confidence            99999998863

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=2.2e-10  Score=113.40  Aligned_cols=136  Identities=20%  Similarity=0.204  Sum_probs=97.7

Q ss_pred             CcccCCccEEEEEEEECC------CcEEEEEEEeeccC-------------C---------cchHHH----HHHHHHHHh
Q 042766          711 NMIGQGRFGTVYKGILGD------DEMVVAVKVINLKQ-------------K---------GASKSF----VSECEALRN  758 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~-------------~---------~~~~~~----~~E~~~l~~  758 (914)
                      ..||.|--+.||.|...+      .+..+|||+.+...             .         ...+.+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998653      35789999986311             0         012233    389999999


Q ss_pred             cCC--CCcceEEeEeecCCCCCCceEeEEEecccCCCHHH-HHhccCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCC
Q 042766          759 IRH--RNLIKIITICSSTDFEGVDFKALVFEYMENGSLED-WLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQ  834 (914)
Q Consensus       759 l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~L-H~~~~  834 (914)
                      +..  -++.+.+++         ...++||||+.+..+.. .+++       ..++..+...+..+++.++.++ |..  
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            864  456666654         23579999997654321 2221       1234455667889999999999 777  


Q ss_pred             CCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          835 PPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       835 ~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                       +|||+|+++.||+++ ++.+.|+|||.|-..
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             999999999999997 468999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.18  E-value=3e-12  Score=134.63  Aligned_cols=210  Identities=20%  Similarity=0.199  Sum_probs=120.4

Q ss_pred             CCCCCCCeeecCCCCCCCcCC--CCccccCCcchhccCCCcccCCCC--hhccccccccccccccccccCcCCcc-cccc
Q 042766          122 GNLFRLEKLALSNNSFSGTIP--TNLSRCSNLIHFCASNNKLEGQIP--KEIGNLLKLQRLSVDINYLTGQLPDS-VGNL  196 (914)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l  196 (914)
                      .++.+|+...|.+.... ..+  .....+++++.||||+|-|....|  .-...|++|+.|+|+.|++.-..... -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            46777888888777765 333  356678888888888887764322  22446788888888888876322221 2356


Q ss_pred             cccceeecccCCCCCCC-CccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCccccee
Q 042766          197 SAIEVIRITENSLGGKI-PTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKL  275 (914)
Q Consensus       197 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L  275 (914)
                      ++|+.|.|+.|.|+... -......++|+.|+|+.|...+........+..|+.|||++|++-..-.......++.|..|
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence            67777788877776322 22234567777777777754434444555566677777777766533212233356666666


Q ss_pred             eccCccCCCC-CCCc-----cccccccccccccCccCCcccc-ccccccccccceeccCCcCCC
Q 042766          276 GIGGNNFVGS-IPDS-----LSNASNLELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGT  332 (914)
Q Consensus       276 ~Ls~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  332 (914)
                      +++.+.+..+ .|+.     ...+++|++|+++.|+|..... ..+..+++|+.|....|.++.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            6666665532 1222     2344556666666665532111 122334444444444454443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.17  E-value=5.7e-12  Score=142.78  Aligned_cols=248  Identities=25%  Similarity=0.304  Sum_probs=155.7

Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .+..+..+++..|.+. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+||+|+|+..  ..+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence            4566667777777777 34445777778888888888887 4444477788888888888888743  234556668888


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCC-ccchhhhcccccccccccccCCCCCccccccccceeeccCCcc
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF  257 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  257 (914)
                      ++++|.++ .++ .+..+..|+.+++++|.+...-+ . ...+.+++.+++++|.+..  ...+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence            88888877 322 34457778888888887774433 2 4667778888888887763  23344455555567777777


Q ss_pred             cCcccccccccCcc--cceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCC
Q 042766          258 SGIFPFDILLNLPN--LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTA  335 (914)
Q Consensus       258 ~~~~p~~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  335 (914)
                      +..-+..   .+..  |+.+++++|.+. ..+..+..+..+..||+++|++.....  +.....+..+.+..|.+.....
T Consensus       221 ~~~~~l~---~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  294 (414)
T KOG0531|consen  221 SKLEGLN---ELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG--LERLPKLSELWLNDNKLALSEA  294 (414)
T ss_pred             eeccCcc---cchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc--ccccchHHHhccCcchhcchhh
Confidence            6442211   2233  777788888776 334566677777888888887764332  4455666666677766653321


Q ss_pred             CCcchhhcccCCCCCcEEeccccccCCC
Q 042766          336 NDLDFVIFLSNCSSLKVLSLSDNQFGGE  363 (914)
Q Consensus       336 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  363 (914)
                      ..  ........+.++...+..|.+...
T Consensus       295 ~~--~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
T KOG0531|consen  295 IS--QEYITSAAPTLVTLTLELNPIRKI  320 (414)
T ss_pred             hh--ccccccccccccccccccCccccc
Confidence            11  001134455666666666665543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=5.5e-12  Score=125.93  Aligned_cols=206  Identities=20%  Similarity=0.227  Sum_probs=123.3

Q ss_pred             CcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccc-ccccCcCCcccccc
Q 042766          118 PQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI-NYLTGQLPDSVGNL  196 (914)
Q Consensus       118 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l  196 (914)
                      |-.+.-+++|..+.+|++.-. .|-.-...-+.|+++...+..++ ..|. +-....+..+.-+. .-.+|..-..+...
T Consensus       207 ~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTW  283 (490)
T KOG1259|consen  207 SFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPS-LLPETILADPSGSEPSTSNGSALVSADTW  283 (490)
T ss_pred             ccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-cccc-ccchhhhcCccCCCCCccCCceEEecchH
Confidence            333444555666666654322 11111122345666665554443 2221 11112222222111 12234444445556


Q ss_pred             cccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceee
Q 042766          197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG  276 (914)
Q Consensus       197 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  276 (914)
                      ..|+.+|||+|.++ .+.++..-+++++.|++|+|.|...  ..+..+++|+.||||+|.++...  ++-.++-|++.|.
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~--Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECV--GWHLKLGNIKTLK  358 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhh--hhHhhhcCEeeee
Confidence            67888888888887 6677777788888888888888733  33777888888888888887542  3334778888888


Q ss_pred             ccCccCCCCCCCccccccccccccccCccCCcccc-ccccccccccceeccCCcCCCC
Q 042766          277 IGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       277 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      |+.|.|...  ..+..+-+|..||+++|+|..... ..+++++.|+++.|.+|.+...
T Consensus       359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            888888632  456777888888888888875432 3456666666666666666554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.12  E-value=1.3e-11  Score=139.78  Aligned_cols=151  Identities=26%  Similarity=0.349  Sum_probs=67.7

Q ss_pred             cccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceee
Q 042766          172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF  251 (914)
Q Consensus       172 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  251 (914)
                      +..++.+++..|.+. .+-..+..+.+|+.|++.+|++.. +...+..+++|++|+|++|+|+...  .+..+..|+.|+
T Consensus        71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence            334444444444444 222234444555555555555542 2222445555555555555555332  233334455555


Q ss_pred             ccCCcccCcccccccccCcccceeeccCccCCCCCC-CccccccccccccccCccCCccccccccccccccceeccCCcC
Q 042766          252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL  330 (914)
Q Consensus       252 L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  330 (914)
                      +++|.++..   .-+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+..+.  .+..+..+..+++..|.+
T Consensus       147 l~~N~i~~~---~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  147 LSGNLISDI---SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eccCcchhc---cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccc
Confidence            555555432   112234555555555555553322 1 344555555555555554222  222333333344444444


Q ss_pred             CC
Q 042766          331 GT  332 (914)
Q Consensus       331 ~~  332 (914)
                      +.
T Consensus       221 ~~  222 (414)
T KOG0531|consen  221 SK  222 (414)
T ss_pred             ee
Confidence            43

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.3e-11  Score=116.00  Aligned_cols=109  Identities=28%  Similarity=0.384  Sum_probs=32.0

Q ss_pred             CCCCCCCCEEEcCCCCCcccCCcccC-CCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhc-ccccc
Q 042766           97 VGNLSFLRYINLADNGFRGDIPQEIG-NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLK  174 (914)
Q Consensus        97 l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~  174 (914)
                      +.+...+++|+|++|+|+ .|. .++ .+++|+.||||+|.++ .++ .+..+++|++|++++|+++ .+++.+ ..+++
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            344456777777777777 343 354 4677777888877777 343 4666777777777777777 444444 35677


Q ss_pred             ccccccccccccCcC-CcccccccccceeecccCCCC
Q 042766          175 LQRLSVDINYLTGQL-PDSVGNLSAIEVIRITENSLG  210 (914)
Q Consensus       175 L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~  210 (914)
                      |++|+|++|+|...- -..+..+++|++|+|.+|.++
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            777777777776321 123445566666666666655

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=6e-11  Score=131.53  Aligned_cols=190  Identities=25%  Similarity=0.275  Sum_probs=147.5

Q ss_pred             cccccCcccC--CccEEEEEEEE--CCCcEEEEEEEee--ccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCC
Q 042766          706 EFSSSNMIGQ--GRFGTVYKGIL--GDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEG  778 (914)
Q Consensus       706 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  778 (914)
                      .|...+.+|+  |.+|.||.++.  +.++..+|+|.-+  ........+-.+|+...++++ |++.++.+..     +++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence            4566788999  99999999999  8889999999843  333344445567888777775 9999985554     666


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEecCCCCCCeeecCC-C
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS----AIEYLHHHCQPPMVHGDLKPSNVLLDYD-M  853 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~----gl~~LH~~~~~~ivHrDlkp~NILl~~~-~  853 (914)
                      .+..++-.|++ +.++.++.....     ..++....+.+..+...    |+.++|+.   +++|-|+||+||+...+ .
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence            77889999998 578888876542     34677777888888888    99999999   99999999999999999 8


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccc
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVH  912 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~  912 (914)
                      ..+.+|||+...+.+.....   .........|...|+|||...   +...|++++|-++.+
T Consensus       261 s~~~~df~~v~~i~~~~~~~---~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~  319 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSS---VFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILE  319 (524)
T ss_pred             eeecCCcceeEEccCCcccc---ceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHh
Confidence            89999999998877654211   111122335778899999985   589999999987654

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.08  E-value=4.6e-12  Score=129.92  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=145.9

Q ss_pred             CceEEEecCCCCCcc----ccCCCCCCCCCCCEEEcCCC---CCcccCCcc-------cCCCCCCCeeecCCCCCCCcCC
Q 042766           77 QRLTELNLSSQRIGG----VLSPYVGNLSFLRYINLADN---GFRGDIPQE-------IGNLFRLEKLALSNNSFSGTIP  142 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~L~~n---~l~~~~p~~-------~~~l~~L~~L~Ls~N~l~~~~p  142 (914)
                      ..++.|+|++|.+..    .+.+.+.+.++|+..++|+-   ++...+|+.       +...++|++||||+|-|.-.-+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            357889999988743    24455778888888888873   233355554       3456688889999988864444


Q ss_pred             CC----ccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCC----CC
Q 042766          143 TN----LSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK----IP  214 (914)
Q Consensus       143 ~~----l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p  214 (914)
                      +.    +.++.+|++|.|.+|.+.-.--..++.  .|+.|.  .|+.       .+.-++|+++...+|++..-    +-
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~A  178 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATALA  178 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHHH
Confidence            43    346788888888888775221112221  233333  1221       11224566666666666522    12


Q ss_pred             ccchhhhcccccccccccccC----CCCCccccccccceeeccCCcccCccc---ccccccCcccceeeccCccCCCCCC
Q 042766          215 TTLGLLRRLVNLNVAENQFSG----MFPRSICNISSVELIFLTENRFSGIFP---FDILLNLPNLKKLGIGGNNFVGSIP  287 (914)
Q Consensus       215 ~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~~l~~L~~L~Ls~N~l~~~~p  287 (914)
                      ..|...+.|+.+.++.|.|..    .+...|..+++|+.|||.+|-++..-.   ...+..+++|++|++++|.+...-.
T Consensus       179 ~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga  258 (382)
T KOG1909|consen  179 EAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGA  258 (382)
T ss_pred             HHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccH
Confidence            234445566666666666541    112345667777777777776653211   2233455677788888877764322


Q ss_pred             Ccc-----ccccccccccccCccCCccc----cccccccccccceeccCCcCC
Q 042766          288 DSL-----SNASNLELLDLPSNQFKGKV----SIDFSSLKNLWLLNLEQNNLG  331 (914)
Q Consensus       288 ~~~-----~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  331 (914)
                      .+|     ...++|++|.|.+|.|+...    .......+.|..|+|++|.+.
T Consensus       259 ~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  259 IAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            222     13578888888888886422    233455788888888888885

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.08  E-value=1.3e-12  Score=133.88  Aligned_cols=255  Identities=19%  Similarity=0.237  Sum_probs=120.6

Q ss_pred             cCCCCCCCCCCCEEEcCCCCCcc----cCCcccCCCCCCCeeecCCC---CCCCcCCCCc-------cccCCcchhccCC
Q 042766           93 LSPYVGNLSFLRYINLADNGFRG----DIPQEIGNLFRLEKLALSNN---SFSGTIPTNL-------SRCSNLIHFCASN  158 (914)
Q Consensus        93 ~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~Ls~  158 (914)
                      +-+.+..+..+++|+||+|.|.-    .+...+.+.++|+..++|+=   ++...+|+.+       ...++|++||||.
T Consensus        22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD  101 (382)
T KOG1909|consen   22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD  101 (382)
T ss_pred             HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence            33456677888999999998863    34556777888888888752   2222344433       2344555555555


Q ss_pred             CcccCCCChhc----cccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          159 NKLEGQIPKEI----GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       159 N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      |.|.-..+..|    .++..|++|+|.+|.+.-.--..++.  .|..|.  .|..       .+.-++|+++..++|++.
T Consensus       102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~~~~~Lrv~i~~rNrle  170 (382)
T KOG1909|consen  102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AASKPKLRVFICGRNRLE  170 (382)
T ss_pred             cccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cCCCcceEEEEeeccccc
Confidence            55543333322    23344555555544443100001110  122221  1111       112245666666776665


Q ss_pred             CCC----CCccccccccceeeccCCcccCc---ccccccccCcccceeeccCccCCCC----CCCccccccccccccccC
Q 042766          235 GMF----PRSICNISSVELIFLTENRFSGI---FPFDILLNLPNLKKLGIGGNNFVGS----IPDSLSNASNLELLDLPS  303 (914)
Q Consensus       235 ~~~----p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~  303 (914)
                      ...    ...|...+.|+.+.++.|.|...   .-...+..+++|++|||..|-++..    +...++.+++|+.|++++
T Consensus       171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d  250 (382)
T KOG1909|consen  171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD  250 (382)
T ss_pred             cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence            221    12344455666666666655311   1112233555555555555555421    223344455555555555


Q ss_pred             ccCCccccccc-----cccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecccccc
Q 042766          304 NQFKGKVSIDF-----SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF  360 (914)
Q Consensus       304 N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  360 (914)
                      +.++.....+|     ...++|++|.|.+|.|+......  +.......+.|..|+|++|.+
T Consensus       251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~--la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  251 CLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALA--LAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             cccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHH--HHHHHhcchhhHHhcCCcccc
Confidence            55554333222     12345555555555554332221  111223344444444444444

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.07  E-value=2.5e-11  Score=127.78  Aligned_cols=143  Identities=23%  Similarity=0.242  Sum_probs=69.0

Q ss_pred             hhhhcccccccccccccCCCCCc-cccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccc
Q 042766          218 GLLRRLVNLNVAENQFSGMFPRS-ICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL  296 (914)
Q Consensus       218 ~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  296 (914)
                      ..|++|+.|+|+.|++.....+. -..++.|+.|.|+.|.++..--.++...+|+|+.|+|..|...+........+..|
T Consensus       169 eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L  248 (505)
T KOG3207|consen  169 EQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL  248 (505)
T ss_pred             HhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH
Confidence            34555555555555554222211 12345555555665555532222333455666666666664333334444455566


Q ss_pred             ccccccCccCCcccc-ccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecccccc
Q 042766          297 ELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF  360 (914)
Q Consensus       297 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  360 (914)
                      +.|||++|++-.... ...+.++.|..|+++.+.+..+..-+.+...-....++|++|+++.|++
T Consensus       249 ~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I  313 (505)
T KOG3207|consen  249 QELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI  313 (505)
T ss_pred             hhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence            666666666553321 2334556666666666655544322211111123344555555555544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=2.4e-09  Score=101.72  Aligned_cols=130  Identities=27%  Similarity=0.338  Sum_probs=95.1

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCC--------cchHHHHHHHHHHHhcCCCCcc--eEEeEeecCCCCCCc
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--------GASKSFVSECEALRNIRHRNLI--KIITICSSTDFEGVD  780 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~~~~~~~~  780 (914)
                      ..+++|+-+.+|.+.+.  |..+++|.-.++.-        -..++..+|+.++++++-..|.  .++.+       +++
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------DPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------cCC
Confidence            46889999999999774  33455664332211        1234678899999998755443  33333       123


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ...|+|||++|..|.+.+...             ...++..+-.-+.-||..   +|||+|+.++||++..++ +.++||
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence            467999999999999888643             134666777788899999   999999999999997775 889999


Q ss_pred             cccccc
Q 042766          861 GLAKFL  866 (914)
Q Consensus       861 Gla~~~  866 (914)
                      |++.+-
T Consensus       136 GLg~~s  141 (204)
T COG3642         136 GLGEFS  141 (204)
T ss_pred             Cccccc
Confidence            999853

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.04  E-value=7.9e-11  Score=114.14  Aligned_cols=57  Identities=28%  Similarity=0.463  Sum_probs=8.4

Q ss_pred             cccccccccccccCcCCcccc-cccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          174 KLQRLSVDINYLTGQLPDSVG-NLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      ++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.++.. + .+..+++|++|++++|+|+
T Consensus        20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCC
Confidence            4455555555554 222 122 244444444444444421 1 2333444444444444444

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.04  E-value=2.4e-09  Score=100.86  Aligned_cols=143  Identities=23%  Similarity=0.271  Sum_probs=101.5

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ....+-||+-+.|+++.+.  |+.+.||.-..+.        .-..++..+|++.+.++.--.|....-++.+     ..
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TY   83 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cC
Confidence            5678899999999999984  6666676442221        1123577899999999875554332222221     22


Q ss_pred             eEeEEEecccC-CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC---cEE
Q 042766          781 FKALVFEYMEN-GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM---VAH  856 (914)
Q Consensus       781 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~---~~k  856 (914)
                      .-.++|||++| .++.+++.....    ..........++.+|-+.+.-||.+   +|||+||..+||++..++   .+.
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence            35689999977 478888765432    1222223367888899999999999   999999999999997765   468


Q ss_pred             Eeccccccc
Q 042766          857 VGDFGLAKF  865 (914)
Q Consensus       857 i~DFGla~~  865 (914)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.02  E-value=4.6e-11  Score=119.41  Aligned_cols=207  Identities=21%  Similarity=0.233  Sum_probs=132.7

Q ss_pred             CCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeeccc-CCCCCCCCccchh
Q 042766          141 IPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE-NSLGGKIPTTLGL  219 (914)
Q Consensus       141 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~  219 (914)
                      +|-.+.-..+|..+.+|++.-. .+-+-...-+.|+++.+.+..++. .|. +--...+....-+. .-.+|..-..+..
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dT  282 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADT  282 (490)
T ss_pred             cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecch
Confidence            3445556677788888777644 222222334678888887766552 221 11112222221111 2233444445556


Q ss_pred             hhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccc
Q 042766          220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELL  299 (914)
Q Consensus       220 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  299 (914)
                      ...|++||||+|.|+ .+.++..-++.++.|++|+|.+..+   +-...+++|+.||||+|.++ .+..+-..+.+.+.|
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v---~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV---QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee---hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            678999999999988 5667777788888888888888743   22446788888888888877 455555667788888


Q ss_pred             cccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCC
Q 042766          300 DLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG  362 (914)
Q Consensus       300 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  362 (914)
                      .|+.|.|...  ..+..+-+|..||+++|+|....     -...+++++-|+.+.|.+|.+.+
T Consensus       358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ld-----eV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELD-----EVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             ehhhhhHhhh--hhhHhhhhheeccccccchhhHH-----HhcccccccHHHHHhhcCCCccc
Confidence            8888877632  23455667778888888876652     23356778888888888888774

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=3e-11  Score=122.54  Aligned_cols=153  Identities=20%  Similarity=0.331  Sum_probs=114.9

Q ss_pred             HHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC
Q 042766          754 EALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC  833 (914)
Q Consensus       754 ~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~  833 (914)
                      .-+-++.|.|+|+++.|+.+..+++.....++.|||+.|++.+++++.+.  ....+......+|+-||..||.|||+. 
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            34556689999999999888777677788899999999999999987542  335677788889999999999999996 


Q ss_pred             CCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccc
Q 042766          834 QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCT  909 (914)
Q Consensus       834 ~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~  909 (914)
                      .|+|+|+++..+-|++..+|-+||.- +.......   ..............|-++|.|||.-.    ..++|||+||..
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~---s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmc  271 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHP---SVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMC  271 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecc-cCccccch---hhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHH
Confidence            88999999999999999999999742 21111110   00001111122235778999999873    589999999977


Q ss_pred             cccc
Q 042766          910 NVHH  913 (914)
Q Consensus       910 ~~~~  913 (914)
                      .++|
T Consensus       272 Alem  275 (458)
T KOG1266|consen  272 ALEM  275 (458)
T ss_pred             HHHH
Confidence            6665

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.00  E-value=3e-09  Score=110.12  Aligned_cols=145  Identities=23%  Similarity=0.303  Sum_probs=106.6

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCC--CcceEEeEeecCCCCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHR--NLIKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      +.++.|.++.||+++..+ |+.+++|+...... .....+.+|+++++.+.+.  .+.+++.+.....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            568999999999998753 57899998754332 2345788999999999763  4567777643221  1124589999


Q ss_pred             cccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 042766          788 YMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC----------------------------------  833 (914)
Q Consensus       788 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~----------------------------------  833 (914)
                      |++|.++.+.+..       ..++..+...++.++++++.++|+..                                  
T Consensus        81 ~i~G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          81 RVDGRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EeCCEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            9999888765421       13566667777888888888888521                                  


Q ss_pred             -------------------CCCcEecCCCCCCeeecC--CCcEEEeccccccc
Q 042766          834 -------------------QPPMVHGDLKPSNVLLDY--DMVAHVGDFGLAKF  865 (914)
Q Consensus       834 -------------------~~~ivHrDlkp~NILl~~--~~~~ki~DFGla~~  865 (914)
                                         ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               246899999999999998  67789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.94  E-value=2e-09  Score=120.48  Aligned_cols=166  Identities=18%  Similarity=0.215  Sum_probs=124.4

Q ss_pred             EEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccC
Q 042766          723 KGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN  802 (914)
Q Consensus       723 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  802 (914)
                      .|..+.++.+|.|...+...........+-++.++.++||+|++++..     ++..+..|+|+|-+.  .|..++++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKELG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHHhH
Confidence            466667888999998876655445567778889999999999999976     455568999999884  6888887532


Q ss_pred             CcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccc
Q 042766          803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI  882 (914)
Q Consensus       803 ~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~  882 (914)
                               .....--+.||+.||.|||+.|  +++|+++.-..|+++..|.-||++|.++....+...      +..  
T Consensus       103 ---------~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~--  163 (690)
T KOG1243|consen  103 ---------KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAK--  163 (690)
T ss_pred             ---------HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccc--
Confidence                     4455667889999999999765  999999999999999999999999998865432111      000  


Q ss_pred             cccCcccccccchhh--hhhcccCcccccccccC
Q 042766          883 GIKGTVGYVAPGKFF--MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       883 ~~~GT~~y~APE~~~--~~~~Di~s~g~~~~~~f  914 (914)
                      ...---.|..||...  +...|.|-|||.+.+.|
T Consensus       164 ~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~  197 (690)
T KOG1243|consen  164 SLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELF  197 (690)
T ss_pred             cchhhhcccChhhcCccccchhhhhHHHHHHHHh
Confidence            011122366676653  35789999999988765

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.92  E-value=1.3e-09  Score=79.41  Aligned_cols=39  Identities=59%  Similarity=1.075  Sum_probs=31.2

Q ss_pred             HhHHHHHHHHHHhcC-CCCCCCCCCCCC--CCCCCccceeec
Q 042766           35 ETDRLALLAIKSQLH-DPSGVTSSWNNT--MNFCQWTGVTCG   73 (914)
Q Consensus        35 ~~~~~aLl~~k~~~~-~~~~~~~~w~~~--~~~c~w~gv~C~   73 (914)
                      ++|++||++||+++. +|.+.+.+|+..  .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            679999999999998 577899999976  799999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.3e-09  Score=86.92  Aligned_cols=60  Identities=37%  Similarity=0.540  Sum_probs=33.9

Q ss_pred             cceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCcc
Q 042766          519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL  578 (914)
Q Consensus       519 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  578 (914)
                      +|++|++++|+++.+.+..|.++++|++|++++|+++...|.+|..+++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555555555555555555555555555555555555555555555555543

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.89  E-value=1.2e-09  Score=131.96  Aligned_cols=131  Identities=24%  Similarity=0.300  Sum_probs=82.5

Q ss_pred             CCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCC--CCCcCC-CCccccCCcchhccCCCcccCCCChhcccccc
Q 042766           98 GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS--FSGTIP-TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK  174 (914)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  174 (914)
                      .+....|...+.+|.+. .++....+ ++|+.|-+..|.  +. .++ ..|..++.|+.||||+|.=-+.+|+.++.|-+
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~  596 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH  596 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence            34456677777777665 44443332 357777777765  33 333 33556777777777766555567777777777


Q ss_pred             ccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccc
Q 042766          175 LQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQ  232 (914)
Q Consensus       175 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  232 (914)
                      ||+|+|++..++ .+|..+++|..|.+|++..+.-...+|.....|++|++|.+-.-.
T Consensus       597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            777777777776 667777777777777777665544556666666777776665543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.85  E-value=2.1e-09  Score=85.63  Aligned_cols=61  Identities=38%  Similarity=0.536  Sum_probs=58.2

Q ss_pred             ccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCcc
Q 042766          542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF  602 (914)
Q Consensus       542 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  602 (914)
                      ++|++|++++|+++...+.+|..+++|++|++++|+++...|+.|.++++|++|++++|++
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999988889999999999999999999999999999999999999999985

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.84  E-value=2.3e-08  Score=98.73  Aligned_cols=125  Identities=25%  Similarity=0.252  Sum_probs=81.1

Q ss_pred             EEEEEEECCCcEEEEEEEeeccC-------------Cc-------------chHHHHHHHHHHHhcCCC--CcceEEeEe
Q 042766          720 TVYKGILGDDEMVVAVKVINLKQ-------------KG-------------ASKSFVSECEALRNIRHR--NLIKIITIC  771 (914)
Q Consensus       720 ~Vy~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~  771 (914)
                      .||.|... ++..+|+|+.+...             ..             ......+|++.|.++...  ++.+.+.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999885 67799999986311             00             013567899999999766  466766551


Q ss_pred             ecCCCCCCceEeEEEeccc--CCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCCee
Q 042766          772 SSTDFEGVDFKALVFEYME--NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~L-H~~~~~~ivHrDlkp~NIL  848 (914)
                               ...+||||++  |..+..+....        ++......++.+++..+..+ |..   ||||+|+.+.||+
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl  139 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL  139 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred             ---------CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence                     2469999998  55554433321        11223455677788866664 677   9999999999999


Q ss_pred             ecCCCcEEEecccccccc
Q 042766          849 LDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~  866 (914)
                      ++++ .+.|+|||.|...
T Consensus       140 v~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EETT-CEEE--GTTEEET
T ss_pred             eecc-eEEEEecCcceec
Confidence            9988 8999999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=3.4e-09  Score=128.11  Aligned_cols=132  Identities=20%  Similarity=0.304  Sum_probs=107.7

Q ss_pred             CCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc--ccCCCChhccccccccccccccccccCcCCccccccccc
Q 042766          122 GNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK--LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAI  199 (914)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  199 (914)
                      .+....+...+-+|++. .++.... .++|++|-+..|.  +....++.|..++.|++|||++|.=-+.+|+++++|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            34467888888888886 5555544 3379999999986  542333457789999999999987777999999999999


Q ss_pred             ceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCc
Q 042766          200 EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR  256 (914)
Q Consensus       200 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  256 (914)
                      ++|+|++..++ .+|..+++|++|.+||+..+.-...+|.....+++|++|.+..-.
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            99999999998 899999999999999999988766678888889999999886554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=9.2e-08  Score=100.45  Aligned_cols=146  Identities=14%  Similarity=0.044  Sum_probs=99.4

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----------cchHHHHHHHHHHHhcCCCCc--ceEEeEeecCCCC
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----------GASKSFVSECEALRNIRHRNL--IKIITICSSTDFE  777 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~  777 (914)
                      +.+-+.....|+++..  .|+.|.||.......           .....+.+|...+.++...+|  ++..++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444455777665  467899997642220           111247899999888854333  3444443221111


Q ss_pred             CCceEeEEEecccCC-CHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-----
Q 042766          778 GVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-----  851 (914)
Q Consensus       778 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-----  851 (914)
                      .....++|||++++. +|.+++.....    ...+...+..++.+++..+.-||..   ||+|+|+++.|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence            123568999999876 89998853211    2345566778999999999999999   9999999999999985     


Q ss_pred             --CCcEEEeccccccc
Q 042766          852 --DMVAHVGDFGLAKF  865 (914)
Q Consensus       852 --~~~~ki~DFGla~~  865 (914)
                        ++.+.++||+.++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46899999998864

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.70  E-value=1e-07  Score=96.30  Aligned_cols=136  Identities=26%  Similarity=0.227  Sum_probs=98.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC----------------C------cchHHHHHHHHHHHhcCCC-
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----------------K------GASKSFVSECEALRNIRHR-  762 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~------~~~~~~~~E~~~l~~l~h~-  762 (914)
                      -..+...||-|--+.||.|... .|.++|||.-+...                .      .......+|+++|.++.-. 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3456789999999999999987 67889999764210                0      0123578999999999755 


Q ss_pred             -CcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          763 -NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       763 -niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                       .|.+.+++         +...+||||++|-.|...-           ++....-.++..|++-+.-.-..   ||||+|
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGD  227 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGD  227 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence             66766654         3568999999986665532           11223334455555555555566   999999


Q ss_pred             CCCCCeeecCCCcEEEeccccccc
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      +.+=||++++||.+.++||--+..
T Consensus       228 lSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         228 LSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             CchheEEEecCCCEEEEeCccccc
Confidence            999999999999999999976653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.68  E-value=1e-08  Score=113.97  Aligned_cols=188  Identities=19%  Similarity=0.194  Sum_probs=134.5

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEEC-CCcEEEEEEEeeccCCcch--HHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILG-DDEMVVAVKVINLKQKGAS--KSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .....+|..+..||.|.|+.|+.+..+ .++..||+|.....-....  ..-..|+.+...+ -|.+++.++..     +
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W  335 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----W  335 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----c
Confidence            344567888999999999999998766 6788999997753322221  2234566666666 48888776544     2


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVA  855 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~  855 (914)
                      ......++--|||++++........      ..+++...+++..|++.++.++|+.   .++|+|+||+||++..+ +..
T Consensus       336 ~~~r~~~ip~e~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  336 SQLRQGYIPLEFCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             cccccccCchhhhcCcchhhhhHHH------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhh
Confidence            3333567889999999888766322      4567778889999999999999988   99999999999999886 788


Q ss_pred             EEecccccccccccccccccCCCCccccccCccccc-ccchh-----hhhhcccCccccccccc
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV-APGKF-----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~-APE~~-----~~~~~Di~s~g~~~~~~  913 (914)
                      +++|||+++.+.-..           ....++-+++ ++|..     ...+.|++|||.++++.
T Consensus       407 ~~~~~~~~t~~~~~~-----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~  459 (524)
T KOG0601|consen  407 KLGDFGCWTRLAFSS-----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA  459 (524)
T ss_pred             hccccccccccceec-----------ccccccccccccchhhcccccccccccccccccccccc
Confidence            999999986432111           0122333444 24444     35899999999887764

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.67  E-value=8.2e-10  Score=122.86  Aligned_cols=181  Identities=29%  Similarity=0.286  Sum_probs=89.3

Q ss_pred             ChhhhcccCCceeeecccccccccCccccCC-CCCCeEEeeCCcCCC---CCCCccCC------CCCccccccCCCccCC
Q 042766          414 PDVISELKNLQQLSVFNNFLRGGIPSGLGNL-TKLGSLDLGSNSLQG---NIPSSLGN------CQNLILFIASYNKLTG  483 (914)
Q Consensus       414 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~---~~p~~~~~------l~~L~~L~l~~N~l~~  483 (914)
                      |-.+..+.+|+.|.|.++.|..  ...+..+ .+|+.|-.. |.++.   .+....+.      .-.|...+.++|.|. 
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence            3345566777777777777653  1112211 234444322 22221   11111111      123445556666665 


Q ss_pred             CCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchh
Q 042766          484 DLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR  563 (914)
Q Consensus       484 ~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  563 (914)
                      .+..++.-++.+ +.||||+|+++..-  .+..++.|++|||+.|++..++--...++. |+.|+|++|.++...  .+.
T Consensus       178 ~mD~SLqll~al-e~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~--gie  251 (1096)
T KOG1859|consen  178 LMDESLQLLPAL-ESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR--GIE  251 (1096)
T ss_pred             hHHHHHHHHHHh-hhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh--hHH
Confidence            333333333333 56666666665321  455566666666666666643333333443 666666666665322  345


Q ss_pred             ccCCCCEEEccCCccccccC-ccccccCCCCeEeCCCCcccc
Q 042766          564 FLKSIKALNVSSNNLSGKIP-EFLENLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       564 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~  604 (914)
                      +|++|+.||||+|-|++.-. ..+..|..|..|+|.+|++.|
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c  293 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC  293 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence            66666666666666654211 123445556666666666654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.66  E-value=1.9e-07  Score=101.38  Aligned_cols=145  Identities=17%  Similarity=0.184  Sum_probs=115.2

Q ss_pred             EEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEEecccC-CCHHHH
Q 042766          719 GTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN-GSLEDW  797 (914)
Q Consensus       719 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~  797 (914)
                      .+.|+|....+|..|++|+++............-+++++++.|+|||++.+++....|.+ ...++|++|.|+ ++|.+.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D-~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGD-LSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCc-ceEEEEEecCCCCchHHHH
Confidence            578999999999999999996444333334455688999999999999999877555433 357899999986 688876


Q ss_pred             HhccCC---------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          798 LHQSND---------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       798 l~~~~~---------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                      ......         ..+....++...|.++.|+..||.++|+.   |..-+-+.|.+|+++.+.+++|+..|....+.
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            543221         12345678899999999999999999999   99999999999999999999998888776554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=1.5e-06  Score=88.29  Aligned_cols=111  Identities=26%  Similarity=0.295  Sum_probs=84.6

Q ss_pred             hHHHHHHHHHHHhcCCCC--cceEEeEeecCCCCCCceEeEEEecccCC-CHHHHHhccCCcccccCCCHHHHHHHHHHH
Q 042766          746 SKSFVSECEALRNIRHRN--LIKIITICSSTDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDV  822 (914)
Q Consensus       746 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i  822 (914)
                      .....+|...+..+....  +.+.+++..... ......++|+|++++. +|.+++....      ..+......++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l  127 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRAL  127 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHH
Confidence            356788999888875333  445555544322 1123568999999884 8999987532      24555677899999


Q ss_pred             HHHHHHHHhCCCCCcEecCCCCCCeeecCCC---cEEEecccccccc
Q 042766          823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM---VAHVGDFGLAKFL  866 (914)
Q Consensus       823 ~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~---~~ki~DFGla~~~  866 (914)
                      +..++-||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   999999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.46  E-value=4.3e-09  Score=117.26  Aligned_cols=125  Identities=24%  Similarity=0.292  Sum_probs=51.3

Q ss_pred             ccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCC-ccccccccceeecc
Q 042766          175 LQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPR-SICNISSVELIFLT  253 (914)
Q Consensus       175 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~  253 (914)
                      |...+.+.|.++ .+..++.-++.|+.|+|++|+++..  +.+..+++|++|||+.|++.. +|. ....+. |+.|.++
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeeeec
Confidence            444444444444 3333444444444444444444422  134444444444444444442 221 111222 4444444


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCCC-CCccccccccccccccCccCC
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI-PDSLSNASNLELLDLPSNQFK  307 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  307 (914)
                      +|.++...  + ..+|.+|+.|||++|-|.+.- -..+..+..|+.|.|.+|.+-
T Consensus       241 nN~l~tL~--g-ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTTLR--G-IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHhhh--h-HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            44444221  1 124445555555555443211 011333445555555555443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.45  E-value=1.5e-08  Score=90.44  Aligned_cols=103  Identities=28%  Similarity=0.357  Sum_probs=44.3

Q ss_pred             EEEecCCCCCccccCCC---CCCCCCCCEEEcCCCCCcccCCcccC-CCCCCCeeecCCCCCCCcCCCCccccCCcchhc
Q 042766           80 TELNLSSQRIGGVLSPY---VGNLSFLRYINLADNGFRGDIPQEIG-NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFC  155 (914)
Q Consensus        80 ~~l~l~~~~l~~~~~~~---l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  155 (914)
                      -.+||+++.+ +.++..   +....+|+..+|++|.|. ..|..|. ..+.++.|+|++|+++ .+|.++..++.|+.|+
T Consensus        30 h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   30 HFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            3455555554 223322   223334444455555554 3333332 2234444444444444 4444444444444444


Q ss_pred             cCCCcccCCCChhcccccccccccccccccc
Q 042766          156 ASNNKLEGQIPKEIGNLLKLQRLSVDINYLT  186 (914)
Q Consensus       156 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  186 (914)
                      ++.|.+. ..|..|..|.+|-.||..+|.+.
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            4444444 33444444444444444444433

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=3.3e-08  Score=99.39  Aligned_cols=189  Identities=24%  Similarity=0.264  Sum_probs=103.2

Q ss_pred             CCCCCCEEEcCCCCCcc--cCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccC-CCChhccccccc
Q 042766           99 NLSFLRYINLADNGFRG--DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEG-QIPKEIGNLLKL  175 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L  175 (914)
                      ..++++.|||.+|.|+.  +|-.-+.+|+.|++|+||.|++...|-..=..+++|++|-|.+..+.- .....+..++.+
T Consensus        69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v  148 (418)
T KOG2982|consen   69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV  148 (418)
T ss_pred             HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence            34677788888888773  233445677788888888888774332211455677777776666542 223345566777


Q ss_pred             cccccccccccCcCCcccccccccceeecccCCCCCCCCc--cchhhhcccccccccccccCCCCCccccccccceeecc
Q 042766          176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPT--TLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT  253 (914)
Q Consensus       176 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  253 (914)
                      ++|++|.|.+.              .+.+..|-.+...|+  .+..++.+..+.++-|++...+|       ++..+.+-
T Consensus       149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~  207 (418)
T KOG2982|consen  149 TELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVC  207 (418)
T ss_pred             hhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeee
Confidence            77777766433              222333333322221  12233445556666666664443       44555555


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCC-CCCccccccccccccccCccCCc
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS-IPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                      .|.+...-...-+..++.+-.|+|+.|+|..- --+.+..++.|..|.+++|.+..
T Consensus       208 e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  208 EGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            66554333333333455555666666666421 12345556666666666666553

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=5.4e-06  Score=82.29  Aligned_cols=145  Identities=19%  Similarity=0.120  Sum_probs=103.1

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc-C-----CcchHHHHHHHHHHHhcCCCC--cceEEeEeecCCCCCCceE
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK-Q-----KGASKSFVSECEALRNIRHRN--LIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~-----~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~  782 (914)
                      ---|+||-+.|++....+  +.+=+|+-... .     +-....|.+|+..+.++...+  +.+.. ++...........
T Consensus        24 pN~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA  100 (216)
T PRK09902         24 PNYRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA  100 (216)
T ss_pred             CCcCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence            345778888999977643  35677766411 0     234578999999999985332  44444 2221111223346


Q ss_pred             eEEEecccC-CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc--EEEec
Q 042766          783 ALVFEYMEN-GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV--AHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~--~ki~D  859 (914)
                      +||+|-++| .+|.+++.+...    .+.+..++..+..++++.++-||+.   ++.|+|+.+.||+++.++.  ++++|
T Consensus       101 ~LVTe~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902        101 LLVTEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             EEEEEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEE
Confidence            899997753 589998865321    3456777788999999999999999   9999999999999987666  99999


Q ss_pred             cccccc
Q 042766          860 FGLAKF  865 (914)
Q Consensus       860 FGla~~  865 (914)
                      |.-++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            987764

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=1.9e-08  Score=89.76  Aligned_cols=134  Identities=18%  Similarity=0.365  Sum_probs=100.8

Q ss_pred             CCEEEcCCCCCcccCCccc---CCCCCCCeeecCCCCCCCcCCCCcc-ccCCcchhccCCCcccCCCChhcccccccccc
Q 042766          103 LRYINLADNGFRGDIPQEI---GNLFRLEKLALSNNSFSGTIPTNLS-RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus       103 L~~L~L~~n~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      +..+||+++.+- .+++..   ....+|+..+||+|.|. .+|+.|. ..+-++.|+|++|+++ .+|.++..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            456788888775 566554   45556777799999998 6666665 4468999999999998 889999999999999


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcc
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI  241 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  241 (914)
                      +++.|.+. ..|.-+..|.+|..|+..+|.+. .+|..+-.-+..-..++.++.+.+.-+.-+
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl  166 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL  166 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence            99999998 77888888999999999999887 666654333444445566667766555433

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=1.8e-06  Score=98.24  Aligned_cols=141  Identities=20%  Similarity=0.263  Sum_probs=91.9

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccC----------------------Cc----c--------------hHHHH
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----------------------KG----A--------------SKSFV  750 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~----~--------------~~~~~  750 (914)
                      +.|+.++-|.||+|+.+ +|+.||||+.++.-                      ..    .              .-++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67999999999999998 58999999986421                      00    0              01345


Q ss_pred             HHHHHHHhcC-----CCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHH
Q 042766          751 SECEALRNIR-----HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA  825 (914)
Q Consensus       751 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~g  825 (914)
                      +|+..+.+++     .+.+. +=.+|    ++-.....++|||++|-.+.++.....     ...+..   .++..++++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~-VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k---~ia~~~~~~  276 (517)
T COG0661         210 REAANAERFRENFKDDPDVY-VPKVY----WEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRK---ELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeE-eceee----hhccCCcEEEEEeeCCEecccHHHHHh-----cCCCHH---HHHHHHHHH
Confidence            6666666652     34432 21222    222235689999999988888743221     223322   233333332


Q ss_pred             -HHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccccc
Q 042766          826 -IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN  868 (914)
Q Consensus       826 -l~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~  868 (914)
                       +.-+-..   |+.|.|..|.||+++.+|++.+.|||+...+.+
T Consensus       277 f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         277 FLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             1222223   899999999999999999999999999887654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.33  E-value=8.3e-08  Score=112.21  Aligned_cols=196  Identities=21%  Similarity=0.225  Sum_probs=132.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..+.+.+.+-+.+|+++.++.++-..++...++|+.....   ..+.+....+-.+.-...||-++....-     +...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence            4456777888999999999998887777666666553221   1122233333333333445665544322     3344


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||+|..++++...++..+.      .+..-+......+..+.+|||..   .++|||+||.|+++..+++.+++|
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            567899999999999999887652      22223334455678899999998   799999999999999999999999


Q ss_pred             cccccccccc----------------cccc-------ccCCCCccccccCcccccccchhh----hhhcccCcccccccc
Q 042766          860 FGLAKFLSNH----------------HLDI-------ASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVH  912 (914)
Q Consensus       860 FGla~~~~~~----------------~~~~-------~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~  912 (914)
                      ||.......-                ....       ............||+.|.|||...    +..+|.|+.|...+|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9854332110                0000       000112244678999999999996    489999999988776

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	914
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-42
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-20
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-42
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-20
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-26
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-18
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-15
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-14
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-14
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-10
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-06
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-05
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  170 bits (431), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 184/584 (31%), Positives = 259/584 (44%), Gaps = 70/584 (11%)
Query: 41  LLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPY---- 96
           L++ K  L D + +   W++  N C + GVTC  R  ++T ++LSS+ +    S      
Sbjct: 14  LISFKDVLPDKN-LLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSL 70
Query: 97  ----VGNLSFL--RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSG--TIPTNLSRC 148
                    FL   +IN + +GF+            L  L LS NS SG  T  T+L  C
Sbjct: 71  LSLTGLESLFLSNSHINGSVSGFKCSA--------SLTSLDLSRNSLSGPVTTLTSLGSC 122
Query: 149 SNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV---DINYLTGQ------LPDSVGNLSA- 198
           S L     S+N L+   P ++   LKL  L V     N ++G       L D  G L   
Sbjct: 123 SGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 180
Query: 199 ------------------IEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRS 240
                             +E + ++ N+    IP                N+ SG F R+
Sbjct: 181 AISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISG-NKLSGDFSRA 239
Query: 241 ICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN-LELL 299
           I   + ++L+ ++ N+F G  P    L L +L+ L +  N F G IPD LS A + L  L
Sbjct: 240 ISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 296
Query: 300 DLPSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
           DL  N F G V   F S                    D      L     LKVL LS N+
Sbjct: 297 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT-----LLKMRGLKVLDLSFNE 351
Query: 360 FGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVN-LITFTLEVNQFHGTIPDVI 417
           F GELP S+ NLS  ++ L +  N  SG I P + +N  N L    L+ N F G IP  +
Sbjct: 352 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 411
Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
           S    L  L +  N+L G IPS LG+L+KL  L L  N L+G IP  L   + L   I  
Sbjct: 412 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 471
Query: 478 YNKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVT 537
           +N LTG++P   LS  T                   +G L+NL +L +S+N FSG IP  
Sbjct: 472 FNDLTGEIPSG-LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 530
Query: 538 LSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
           L  C SL +LD++ N F G IP +  F +S K   +++N ++GK
Sbjct: 531 LGDCRSLIWLDLNTNLFNGTIPAAM-FKQSGK---IAANFIAGK 570

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 109/371 (29%), Positives = 165/371 (44%), Gaps = 44/371 (11%)
Query: 244 ISSVELIFLTENRFSGIFPFDILLN--LPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
           ++S+E++ L+ N  SG      +L+     LK L I GN   G +   +S   NLE LD+
Sbjct: 147 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDV 204
Query: 302 PSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
            SN F                         TG       + FL +CS+L+ L +S N+  
Sbjct: 205 SSNNFS------------------------TG-------IPFLGDCSALQHLDISGNKLS 233
Query: 362 GELPHSIANLS-LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVIS-E 419
           G+   +I+  + LK++ +S   NQ  G IPP    L +L   +L  N+F G IPD +S  
Sbjct: 234 GDFSRAISTCTELKLLNIS--SNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 420 LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIASY 478
              L  L +  N   G +P   G+ + L SL L SN+  G +P  +L   + L +   S+
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 479 NKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQV-GNLKN-LVMLDISSNQFSGVIPV 536
           N+ +G+LP+ L +++                    +  N KN L  L + +N F+G IP 
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 409
Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXX 596
           TLS C  L  L +S N   G IP S   L  ++ L +  N L G+IP             
Sbjct: 410 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 469
Query: 597 XXYNYFEGEVP 607
             +N   GE+P
Sbjct: 470 LDFNDLTGEIP 480

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  169 bits (429), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 184/584 (31%), Positives = 258/584 (44%), Gaps = 70/584 (11%)
Query: 41  LLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPY---- 96
           L++ K  L D   +   W++  N C + GVTC  R  ++T ++LSS+ +    S      
Sbjct: 17  LISFKDVLPD-KNLLPDWSSNKNPCTFDGVTC--RDDKVTSIDLSSKPLNVGFSAVSSSL 73
Query: 97  ----VGNLSFL--RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSG--TIPTNLSRC 148
                    FL   +IN + +GF+            L  L LS NS SG  T  T+L  C
Sbjct: 74  LSLTGLESLFLSNSHINGSVSGFKCSA--------SLTSLDLSRNSLSGPVTTLTSLGSC 125
Query: 149 SNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV---DINYLTGQ------LPDSVGNLSA- 198
           S L     S+N L+   P ++   LKL  L V     N ++G       L D  G L   
Sbjct: 126 SGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 199 ------------------IEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRS 240
                             +E + ++ N+    IP                N+ SG F R+
Sbjct: 184 AISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISG-NKLSGDFSRA 242
Query: 241 ICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN-LELL 299
           I   + ++L+ ++ N+F G  P    L L +L+ L +  N F G IPD LS A + L  L
Sbjct: 243 ISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 300 DLPSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
           DL  N F G V   F S                    D      L     LKVL LS N+
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT-----LLKMRGLKVLDLSFNE 354
Query: 360 FGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVN-LITFTLEVNQFHGTIPDVI 417
           F GELP S+ NLS  ++ L +  N  SG I P + +N  N L    L+ N F G IP  +
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
           S    L  L +  N+L G IPS LG+L+KL  L L  N L+G IP  L   + L   I  
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 478 YNKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFSGVIPVT 537
           +N LTG++P   LS  T                   +G L+NL +L +S+N FSG IP  
Sbjct: 475 FNDLTGEIPSG-LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 538 LSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
           L  C SL +LD++ N F G IP +  F +S K   +++N ++GK
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAM-FKQSGK---IAANFIAGK 573

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 109/371 (29%), Positives = 165/371 (44%), Gaps = 44/371 (11%)
Query: 244 ISSVELIFLTENRFSGIFPFDILLN--LPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
           ++S+E++ L+ N  SG      +L+     LK L I GN   G +   +S   NLE LD+
Sbjct: 150 LNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDV 207
Query: 302 PSNQFKGKVSIDFSSXXXXXXXXXXXXXXGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
            SN F                         TG       + FL +CS+L+ L +S N+  
Sbjct: 208 SSNNFS------------------------TG-------IPFLGDCSALQHLDISGNKLS 236
Query: 362 GELPHSIANLS-LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVIS-E 419
           G+   +I+  + LK++ +S   NQ  G IPP    L +L   +L  N+F G IPD +S  
Sbjct: 237 GDFSRAISTCTELKLLNIS--SNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 420 LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIASY 478
              L  L +  N   G +P   G+ + L SL L SN+  G +P  +L   + L +   S+
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 479 NKLTGDLPQQLLSITTXXXXXXXXXXXXXXXXXXQV-GNLKN-LVMLDISSNQFSGVIPV 536
           N+ +G+LP+ L +++                    +  N KN L  L + +N F+G IP 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPXXXXXXXXXXXXX 596
           TLS C  L  L +S N   G IP S   L  ++ L +  N L G+IP             
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472
Query: 597 XXYNYFEGEVP 607
             +N   GE+P
Sbjct: 473 LDFNDLTGEIP 483

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  120 bits (302), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           S  EL  A+  FS+ N++G+G FG VYKG L D  +V   ++   + +G    F +E E 
Sbjct: 29  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEM 88
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           +    HRNL+++   C +        + LV+ YM NGS+   L +  +      L   +R
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQP--PLDWPKR 141
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS 875
             IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +         
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------Y 194
Query: 876 KTPSSSIGIKGTVGYVAP 893
           K       ++GT+G++AP
Sbjct: 195 KDXHVXXAVRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           S  EL  A+  F + N++G+G FG VYKG L D  +V   ++   + +G    F +E E 
Sbjct: 21  SLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           +    HRNL+++   C +        + LV+ YM NGS+   L +  +      L   +R
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTE-----RLLVYPYMANGSVASCLRERPESQP--PLDWPKR 133
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS 875
             IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +         
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-------Y 186
Query: 876 KTPSSSIGIKGTVGYVAP 893
           K       ++G +G++AP
Sbjct: 187 KDXHVXXAVRGXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 691 LFPMVSY----AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS 746
           L P  SY     +L +AT+ F    +IG G FG VYKG+L D    VA+K    +     
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGI 79
Query: 747 KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE 806
           + F +E E L   RH +L+ +I  C   + E +    L+++YMENG+L+  L+ S+  + 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERN-EMI----LIYKYMENGNLKRHLYGSD--LP 132
Query: 807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-- 864
              +S  QR+ I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 865 -FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF 896
             L   HL            +KGT+GY+ P  F
Sbjct: 190 TELDQTHLXXV---------VKGTLGYIDPEYF 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 108/213 (50%), Gaps = 27/213 (12%)
Query: 691 LFPMVSY----AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS 746
           L P  SY     +L +AT+ F    +IG G FG VYKG+L D    VA+K    +     
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGI 79
Query: 747 KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE 806
           + F +E E L   RH +L+ +I  C   + E +    L+++YMENG+L+  L+ S+  + 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERN-EMI----LIYKYMENGNLKRHLYGSD--LP 132
Query: 807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-- 864
              +S  QR+ I I  A  + YLH      ++H D+K  N+LLD + V  + DFG++K  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 865 -FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF 896
             L   HL            +KGT+GY+ P  F
Sbjct: 190 TELGQTHLXXV---------VKGTLGYIDPEYF 213

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 41/228 (17%)
Query: 681 KSVDTSPMEKLFPMVSYAELSKATSEFSSS------NMIGQGRFGTVYKGILGDDEMVVA 734
           KS++ S  +  F   S+ EL   T+ F         N +G+G FG VYKG + +    VA
Sbjct: 3   KSLEVS--DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 735 VK----VINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYME 790
           VK    ++++  +   + F  E + +   +H NL++++   S    +G D   LV+ YM 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMP 113
Query: 791 NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVL 848
           NGSL D L   +       LS   R  IA   A+ I +LH  HH     +H D+K +N+L
Sbjct: 114 NGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI---GIKGTVGYVAP 893
           LD    A + DFGLA+         AS+  + ++    I GT  Y+AP
Sbjct: 166 LDEAFTAKISDFGLAR---------ASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 110/228 (48%), Gaps = 41/228 (17%)
Query: 681 KSVDTSPMEKLFPMVSYAELSKATSEFSSS------NMIGQGRFGTVYKGILGDDEMVVA 734
           KS++ S  +  F   S+ EL   T+ F         N +G+G FG VYKG + +    VA
Sbjct: 3   KSLEVS--DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVA 58
Query: 735 VK----VINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYME 790
           VK    ++++  +   + F  E + +   +H NL++++   S    +G D   LV+ YM 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMP 113
Query: 791 NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVL 848
           NGSL D L   +       LS   R  IA   A+ I +LH  HH     +H D+K +N+L
Sbjct: 114 NGSLLDRLSCLDG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI---GIKGTVGYVAP 893
           LD    A + DFGLA+         AS+  + ++    I GT  Y+AP
Sbjct: 166 LDEAFTAKISDFGLAR---------ASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 692 FPMVSYAELSKATSEFSSS------NMIGQGRFGTVYKGILGDDEMVVAVK----VINLK 741
           F   S+ EL   T+ F         N +G+G FG VYKG + +    VAVK    ++++ 
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDIT 63
Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
            +   + F  E + +   +H NL++++   S    +G D   LV+ YM NGSL D L   
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLSCL 118
Query: 802 NDQVEVRKLSLIQRMNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A + D
Sbjct: 119 DG---TPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISD 170
Query: 860 FGLAKFLSNHHLDIASKTPSSSI---GIKGTVGYVAP 893
           FGLA+         AS+  +  +    I GT  Y+AP
Sbjct: 171 FGLAR---------ASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 125/301 (41%), Gaps = 42/301 (13%)
Query: 34  NETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQ--WTGVTCGHRHQ--RLTELNLSSQR- 88
           N  D+ ALL IK  L +P+ + SSW  T + C   W GV C    Q  R+  L+LS    
Sbjct: 4   NPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 89  --------------------IGGV------LSPYVGNLSFLRYINLADNGFRGDIPQEIG 122
                               IGG+      + P +  L+ L Y+ +      G IP  + 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 123 NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL-QRLSVD 181
            +  L  L  S N+ SGT+P ++S   NL+      N++ G IP   G+  KL   +++ 
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPXXXXXXXXXXXXXXAENQFSGMFPRSI 241
            N LTG++P +  NL+ +  + ++ N L G                 A+N  +  F    
Sbjct: 183 RNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA--FDLGK 239
Query: 242 CNIS-SVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLD 300
             +S ++  + L  NR  G  P   L  L  L  L +  NN  G IP       NL+  D
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQ----GGNLQRFD 294
Query: 301 L 301
           +
Sbjct: 295 V 295

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 6/222 (2%)
Query: 364 LPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNL 423
           +P S+ANL         G N + G IPP I  L  L    +      G IPD +S++K L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIA-SYNKLT 482
             L    N L G +P  + +L  L  +    N + G IP S G+   L   +  S N+LT
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 483 GDLPQQLLSITTXXXXXXXXXXXXXXXXXXQVGNLKNLVMLDISSNQFS-GVIPVTLSTC 541
           G +P    ++                      G+ KN   + ++ N  +  +  V LS  
Sbjct: 188 GKIPPTFANLNLAFVDLSRNMLEGDASVL--FGSDKNTQKIHLAKNSLAFDLGKVGLSK- 244
Query: 542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP 583
            +L  LD+  N  YG +P     LK + +LNVS NNL G+IP
Sbjct: 245 -NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKII 768
            +IG+GR+G VYKG L  DE  VAVKV +   +   ++F++E    R   + H N+ + I
Sbjct: 19  ELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFI 73
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                   +G     LV EY  NGSL  +L  H S+          +    +A  V   +
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---------WVSSCRLAHSVTRGL 124
Query: 827 EYLH------HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            YLH       H +P + H DL   NVL+  D    + DFGL+  L+ + L    +  ++
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 881 SIGIKGTVGYVAP 893
           +I   GT+ Y+AP
Sbjct: 185 AISEVGTIRYMAP 197

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSE 752
           P  +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E
Sbjct: 2   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 60
Query: 753 CEALRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLS 811
              ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + 
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ-EVNAVV 113
Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
           L+    +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++    
Sbjct: 114 LLY---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---- 163
Query: 872 DIASKTPSSSIGIKGTVGYVAP 893
                T ++  G K  + + AP
Sbjct: 164 ---GDTXTAHAGAKFPIKWTAP 182

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 96/187 (51%), Gaps = 29/187 (15%)
Query: 713 IGQGRFGTVYKGIL-GDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLIKII- 768
           IG G FGTV++    G D   VAVK++  +   A +   F+ E   ++ +RH N++  + 
Sbjct: 45  IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQS--NDQVEVRKLSLIQRMNIAIDVASAI 826
            +    +       ++V EY+  GSL   LH+S   +Q++ R+     R+++A DVA  +
Sbjct: 102 AVTQPPNL------SIVTEYLSRGSLYRLLHKSGAREQLDERR-----RLSMAYDVAKGM 150
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            YLH+   PP+VH DLK  N+L+D      V DFGL++  ++  L         S    G
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL--------XSKXAAG 201
Query: 887 TVGYVAP 893
           T  ++AP
Sbjct: 202 TPEWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 97/187 (51%), Gaps = 29/187 (15%)
Query: 713 IGQGRFGTVYKGIL-GDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLIKII- 768
           IG G FGTV++    G D   VAVK++  +   A +   F+ E   ++ +RH N++  + 
Sbjct: 45  IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQS--NDQVEVRKLSLIQRMNIAIDVASAI 826
            +    +       ++V EY+  GSL   LH+S   +Q++ R+     R+++A DVA  +
Sbjct: 102 AVTQPPNL------SIVTEYLSRGSLYRLLHKSGAREQLDERR-----RLSMAYDVAKGM 150
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            YLH+   PP+VH +LK  N+L+D      V DFGL++  ++  L        SS    G
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--------SSKSAAG 201
Query: 887 TVGYVAP 893
           T  ++AP
Sbjct: 202 TPEWMAP 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLIKIITI 770
           IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +          A+V ++ E  SL   LH S  + E++KL     ++IA   A  ++YLH
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA----KFLSNHHLDIASKTPSSSIGIKG 886
                 ++H DLK +N+ L  D    +GDFGLA    ++  +H  +  S          G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----------G 184
Query: 887 TVGYVAPGKFFMLYTHIPSFSCTNVHHF 914
           ++ ++AP    M  ++  SF  ++V+ F
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQ-SDVYAF 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 34/208 (16%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLIKIITI 770
           IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            ++         A+V ++ E  SL   LH S  + E++KL     ++IA   A  ++YLH
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 137
Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA----KFLSNHHLDIASKTPSSSIGIKG 886
                 ++H DLK +N+ L  D    +GDFGLA    ++  +H  +  S          G
Sbjct: 138 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----------G 184
Query: 887 TVGYVAPGKFFMLYTHIPSFSCTNVHHF 914
           ++ ++AP    M  ++  SF  ++V+ F
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQ-SDVYAF 211

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLIKIITI 770
           IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +          A+V ++ E  SL   LH S  + E++KL     ++IA   A  ++YLH
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH 125
Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA----KFLSNHHLDIASKTPSSSIGIKG 886
                 ++H DLK +N+ L  D    +GDFGLA    ++  +H  +  S          G
Sbjct: 126 AKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS----------G 172
Query: 887 TVGYVAPGKFFMLYTHIPSFSCTNVHHF 914
           ++ ++AP    M  ++  SF  ++V+ F
Sbjct: 173 SILWMAPEVIRMQDSNPYSFQ-SDVYAF 199

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 49/190 (25%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           ++ +  + +G G+FG VY+G+     + VAVK +  +     + F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 765 IKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S +  + +A  ++
Sbjct: 70  VQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQIS 119
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++         T ++  G
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAG 169
Query: 884 IKGTVGYVAP 893
            K  + + AP
Sbjct: 170 AKFPIKWTAP 179

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 36/194 (18%)
Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGA-----SKSFVSECEALRNIRHRN 763
           +IG G FG V +G L   G  E  VA+K +    KG       + F+SE   +    H N
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPN 78
Query: 764 LIKIITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +I++         EGV   ++    + E+MENG+L+ +L  ++ Q      ++IQ + + 
Sbjct: 79  IIRL---------EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGML 124
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             +AS + YL    +   VH DL   N+L++ ++V  V DFGL++FL  +  D    T +
Sbjct: 125 RGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD---PTET 178
Query: 880 SSIGIKGTVGYVAP 893
           SS+G K  + + AP
Sbjct: 179 SSLGGKIPIRWTAP 192

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 43/218 (19%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVIN---- 739
           ++ + ++A  EF+            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 740 LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLE 795
            KQ+   + F+SE   +    H N+I +         EGV  K+    ++ E+MENGSL+
Sbjct: 75  EKQR---RDFLSEASIMGQFDHPNVIHL---------EGVVTKSTPVMIITEFMENGSLD 122
Query: 796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA 855
            +L Q++ Q      ++IQ + +   +A+ ++YL        VH DL   N+L++ ++V 
Sbjct: 123 SFLRQNDGQ-----FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVC 174
Query: 856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            V DFGL++FL +   D +  T +S++G K  + + AP
Sbjct: 175 KVSDFGLSRFLED---DTSDPTYTSALGGKIPIRWTAP 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 48/190 (25%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 765 IKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S +  + +A  ++
Sbjct: 70  VQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQIS 119
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++         T ++  G
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAG 169
Query: 884 IKGTVGYVAP 893
            K  + + AP
Sbjct: 170 AKFPIKWTAP 179

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 59/168 (35%), Positives = 92/168 (54%), Gaps = 31/168 (18%)
Query: 711 NMIGQGRFGTVYKGILGDDEMV---VAVKVINLKQKGASKSFVS----ECEALRNIRHRN 763
           + +G G FG V    +G+ ++    VAVK++N +QK  S   V     E + L+  RH +
Sbjct: 17  DTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 764 LIKIITICSS-TDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAI 820
           +IK+  + S+ TDF       +V EY+  G L D++  H   +++E R+L   Q+     
Sbjct: 73  IIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEMEARRL--FQQ----- 119
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            + SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S+
Sbjct: 120 -ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 59/168 (35%), Positives = 92/168 (54%), Gaps = 31/168 (18%)
Query: 711 NMIGQGRFGTVYKGILGDDEMV---VAVKVINLKQKGASKSFVS----ECEALRNIRHRN 763
           + +G G FG V    +G+ ++    VAVK++N +QK  S   V     E + L+  RH +
Sbjct: 17  DTLGVGTFGKVK---IGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 764 LIKIITICSS-TDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAI 820
           +IK+  + S+ TDF       +V EY+  G L D++  H   +++E R+L   Q+     
Sbjct: 73  IIKLYQVISTPTDF------FMVMEYVSGGELFDYICKHGRVEEMEARRL--FQQ----- 119
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            + SA++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S+
Sbjct: 120 -ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSAVV 112
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ----EVSAVV 112
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 52/202 (25%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSE 752
           P  +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E
Sbjct: 5   PSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKE 63
Query: 753 CEALRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLS 811
              ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + 
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVV 116
Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
           L+    +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++    
Sbjct: 117 LLY---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---- 166
Query: 872 DIASKTPSSSIGIKGTVGYVAP 893
                T ++  G K  + + AP
Sbjct: 167 ---GDTYTAHAGAKFPIKWTAP 185

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL 756
           Y E+    SE   S  IG G FGTVYKG    D  V  +KV++   +   ++F +E   L
Sbjct: 30  YWEIE--ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAVL 86
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
           R  RH N++  +   +  +       A+V ++ E  SL   LH     V+  K  + Q +
Sbjct: 87  RKTRHVNILLFMGYMTKDNL------AIVTQWCEGSSLYKHLH-----VQETKFQMFQLI 135
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           +IA   A  ++YLH      ++H D+K +N+ L   +   +GDFGLA   S        +
Sbjct: 136 DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 877 TPSSSIGIKGTVGYVAP 893
            P+      G+V ++AP
Sbjct: 193 QPT------GSVLWMAP 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 36/194 (18%)
Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGA-----SKSFVSECEALRNIRHRN 763
           +IG G FG V +G L   G  E  VA+K +    KG       + F+SE   +    H N
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTL----KGGYTERQRREFLSEASIMGQFEHPN 76
Query: 764 LIKIITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +I++         EGV   ++    + E+MENG+L+ +L  ++ Q      ++IQ + + 
Sbjct: 77  IIRL---------EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-----FTVIQLVGML 122
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             +AS + YL    +   VH DL   N+L++ ++V  V DFGL++FL  +  D    T +
Sbjct: 123 RGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD---PTYT 176
Query: 880 SSIGIKGTVGYVAP 893
           SS+G K  + + AP
Sbjct: 177 SSLGGKIPIRWTAP 190

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLY 120
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 121 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 167
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 168 GDTYTAHAGAKFPIKWTAP 186

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSAVV 112
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSAVV 112
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 113 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSAVV 117
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 167
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 168 GDTYTAHAGAKFPIKWTAP 186

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 120
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 121 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 167
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 168 GDTXTAHAGAKFPIKWTAP 186

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 63
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 116
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 117 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 163
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 164 GDTYTAPAGAKFPIKWTAP 182

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 117
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 118 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 164
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 165 GDTYTAPAGAKFPIKWTAP 183

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 120
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 121 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 167
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 168 GDTYTAHAGAKFPIKWTAP 186

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 75
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 128
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 129 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 175
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 176 GDTYTAHAGAKFPIKWTAP 194

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 67
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 120
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 121 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 167
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 168 GDTYTAHAGAKFPIKWTAP 186

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 115
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 116 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 62
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 115
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 116 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 163 GDTYTAHAGAKFPIKWTAP 181

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 117
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 118 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 164
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 165 GDTYTAHAGAKFPIKWTAP 183

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 64
Query: 756 LRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           ++ I+H NL++++ +C+    F       ++ E+M  G+L D+L + N Q EV  + L+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY 117
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
              +A  ++SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++       
Sbjct: 118 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT------- 164
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T ++  G K  + + AP
Sbjct: 165 GDTYTAHAGAKFPIKWTAP 183

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           ++ +  + +G G++G VY G+     + VAVK +  +     + F+ E   ++ I+H NL
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++++ +C+    E   +  +V EYM  G+L D+L + N + EV  + L+    +A  ++S
Sbjct: 91  VQLLGVCT---LEPPFY--IVTEYMPYGNLLDYLRECNRE-EVTAVVLLY---MATQISS 141
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A+EYL    +   +H DL   N L+  + V  V DFGL++ ++         T ++  G 
Sbjct: 142 AMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-------GDTYTAHAGA 191
Query: 885 KGTVGYVAP 893
           K  + + AP
Sbjct: 192 KFPIKWTAP 200

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 48/190 (25%), Positives = 98/190 (51%), Gaps = 22/190 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   ++ I+H NL
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 765 IKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++++ +C+    F       ++ E+M  G+L D+L + N Q    ++S +  + +A  ++
Sbjct: 70  VQLLGVCTREPPF------YIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQIS 119
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           SA+EYL    +   +H DL   N L+  + +  V DFGL++ ++         T ++  G
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTFTAHAG 169
Query: 884 IKGTVGYVAP 893
            K  + + AP
Sbjct: 170 AKFPIKWTAP 179

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL 756
           Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 270
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
           + I+H NL++++ +C+        F  ++ E+M  G+L D+L + N Q    ++S +  +
Sbjct: 271 KEIKHPNLVQLLGVCTREP----PF-YIITEFMTYGNLLDYLRECNRQ----EVSAVVLL 321
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
            +A  ++SA+EYL    +   +H +L   N L+  + +  V DFGL++ ++         
Sbjct: 322 YMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------D 371
Query: 877 TPSSSIGIKGTVGYVAP 893
           T ++  G K  + + AP
Sbjct: 372 TYTAHAGAKFPIKWTAP 388

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 19/184 (10%)
Query: 682 SVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
           S D + M+ L    S  +      + +    IG G FGTVYKG    D   VAVK++N+ 
Sbjct: 13  SEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVT 69
Query: 742 QKGASK--SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
                +  +F +E   LR  RH N++  +   +          A+V ++ E  SL   LH
Sbjct: 70  APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH 123
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
                +   K  +I+ ++IA   A  ++YLH      ++H DLK +N+ L  D+   +GD
Sbjct: 124 -----IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 175
Query: 860 FGLA 863
           FGLA
Sbjct: 176 FGLA 179

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 19/184 (10%)
Query: 682 SVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
           S D + M+ L    S  +      + +    IG G FGTVYKG    D   VAVK++N+ 
Sbjct: 13  SEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVT 69
Query: 742 QKGASK--SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
                +  +F +E   LR  RH N++  +   +          A+V ++ E  SL   LH
Sbjct: 70  APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH 123
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
                +   K  +I+ ++IA   A  ++YLH      ++H DLK +N+ L  D+   +GD
Sbjct: 124 -----IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 175
Query: 860 FGLA 863
           FGLA
Sbjct: 176 FGLA 179

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   ++         A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 66  ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 114
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 19/184 (10%)
Query: 682 SVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK 741
           S D + M+ L    S  +      + +    IG G FGTVYKG    D   VAVK++N+ 
Sbjct: 12  SEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVT 68
Query: 742 QKGASK--SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH 799
                +  +F +E   LR  RH N++  +   +          A+V ++ E  SL   LH
Sbjct: 69  APTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH 122
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
                +   K  +I+ ++IA   A  ++YLH      ++H DLK +N+ L  D+   +GD
Sbjct: 123 -----IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD 174
Query: 860 FGLA 863
           FGLA
Sbjct: 175 FGLA 178

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 20/197 (10%)
Query: 697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL 756
           Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   +
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 309
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
           + I+H NL++++ +C+        F  ++ E+M  G+L D+L + N Q EV  + L+   
Sbjct: 310 KEIKHPNLVQLLGVCTREP----PF-YIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY-- 361
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
            +A  ++SA+EYL    +   +H +L   N L+  + +  V DFGL++ ++         
Sbjct: 362 -MATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-------GD 410
Query: 877 TPSSSIGIKGTVGYVAP 893
           T ++  G K  + + AP
Sbjct: 411 TYTAHAGAKFPIKWTAP 427

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   +          A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 119
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 28/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L  D+  VA+K I   ++GA   + F+ E E +  + H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 59
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LVFE+ME+G L D+L           L     + + +D
Sbjct: 60  PKLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 109
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 110 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSS 159
Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 160 TGTKFPVKWASPEVF 174

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 28/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L  D+  VA+K I   ++GA   + F+ E E +  + H
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 64
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LVFE+ME+G L D+L           L     + + +D
Sbjct: 65  PKLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 114
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 115 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSS 164
Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 165 TGTKFPVKWASPEVF 179

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 28/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L  D+  VA+K I   ++GA   + F+ E E +  + H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 61
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LVFE+ME+G L D+L           L     + + +D
Sbjct: 62  PKLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 111
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 112 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSS 161
Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 162 TGTKFPVKWASPEVF 176

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   +          A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 114
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 67
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   +          A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 68  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 116
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 117 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 153

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 70
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   +          A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 71  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 119
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 120 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 156

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 692 FPMVSYAELSKATSEFSSS------NMIGQGRFGTVYKGILGDDEMVVAVK----VINLK 741
           F   S+ EL   T+ F         N  G+G FG VYKG + +    VAVK    ++++ 
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN--TTVAVKKLAAMVDIT 60
Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
            +   + F  E +     +H NL++++   S    +G D   LV+ Y  NGSL D L   
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSS----DGDDL-CLVYVYXPNGSLLDRLSCL 115
Query: 802 NDQVEVRKLSLIQRMNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           +       LS   R  IA   A+ I +LH  HH     +H D+K +N+LLD    A + D
Sbjct: 116 DG---TPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISD 167
Query: 860 FGLAKFLSNHHLDIASKTPSSSIG---IKGTVGYVAP 893
           FGLA+         AS+  +  +    I GT  Y AP
Sbjct: 168 FGLAR---------ASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 19/160 (11%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK--SFVSECEALRNIRHRN 763
           + +    IG G FGTVYKG    D   VAVK++N+      +  +F +E   LR  RH N
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++  +   +          A+V ++ E  SL   LH     +   K  +I+ ++IA   A
Sbjct: 66  ILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-----IIETKFEMIKLIDIARQTA 114
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             ++YLH      ++H DLK +N+ L  D+   +GDFGLA
Sbjct: 115 QGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D + M+ L    S  +      + +    IG G FGTVYKG    D   VAVK++N+   
Sbjct: 7   DRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP 63
Query: 744 GASK--SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
              +  +F +E   LR  RH N++  +   +          A+V ++ E  SL   LH  
Sbjct: 64  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQL------AIVTQWCEGSSLYHHLH-- 115
Query: 802 NDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
              +   K  +I+ ++IA   A  ++YLH      ++H DLK +N+ L  D+   +GDFG
Sbjct: 116 ---IIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG 169
Query: 862 LA 863
           LA
Sbjct: 170 LA 171

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 34/195 (17%)
Query: 710 SNMIGQGRFGTVYKGIL---GDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHR 762
             +IG G FG V  G L   G  E+ VA+K +      KQ+   + F+SE   +    H 
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHP 68
Query: 763 NLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           N+I +         EGV  K+    ++ E+MENGSL+ +L Q++ Q      ++IQ + +
Sbjct: 69  NVIHL---------EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-----FTVIQLVGM 114
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
              +A+ ++YL        VH  L   N+L++ ++V  V DFGL++FL +   D +  T 
Sbjct: 115 LRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTY 168
Query: 879 SSSIGIKGTVGYVAP 893
           +S++G K  + + AP
Sbjct: 169 TSALGGKIPIRWTAP 183

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 275 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 333 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 382
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
                VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 383 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 432
Query: 893 P 893
           P
Sbjct: 433 P 433

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 26/194 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHR 762
           SE +    IG G+FG V+ G  L  D+  VA+K I  K+   S+  F+ E E +  + H 
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI--KEGSMSEDDFIEEAEVMMKLSHP 82
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            L+++  +C     E      LVFE+ME+G L D+L           L     + + +DV
Sbjct: 83  KLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 132
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              + YL   C   ++H DL   N L+  + V  V DFG+ +F+ +          +SS 
Sbjct: 133 CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSST 182
Query: 883 GIKGTVGYVAPGKF 896
           G K  V + +P  F
Sbjct: 183 GTKFPVKWASPEVF 196

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 11/193 (5%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVINLKQKGASK--SFVSECEALRNIRHRNLI 765
            ++G+G FG+V +G L  ++   + VAVK + L      +   F+SE   +++  H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +++ +C     +G+    ++  +M+ G L  +L  S  +   + + L   +   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN---HHLDIASKTPSSSI 882
           +EYL +      +H DL   N +L  DM   V DFGL+K + +   +     +K P   I
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 883 GIKGTVGYVAPGK 895
            I+     V   K
Sbjct: 217 AIESLADRVYTSK 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 52/167 (31%), Positives = 82/167 (49%), Gaps = 23/167 (13%)
Query: 713 IGQGRFGTV-----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V     Y      D+M+VAVK +      A K F  E E L N++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVR--------KLSLIQRMN 817
             +C        D   +VFEYM++G L  +L  H  +  + V         +L L Q ++
Sbjct: 83  YGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           IA  +AS + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
                VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 893 P 893
           P
Sbjct: 350 P 350

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
                VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 893 P 893
           P
Sbjct: 350 P 350

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 250 EEPI------YIVGEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
                VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 300 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 349
Query: 893 P 893
           P
Sbjct: 350 P 350

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 87/168 (51%), Gaps = 22/168 (13%)
Query: 708 SSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHR 762
           +   +IG G FG VYKG+L    G  E+ VA+K +        +  F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 763 NLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           N+I++  + S        +K ++   EYMENG+L+ +L + + +      S++Q + +  
Sbjct: 107 NIIRLEGVISK-------YKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLR 154
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            +A+ ++YL +      VH DL   N+L++ ++V  V DFGL++ L +
Sbjct: 155 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 28/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L  D+  VA+K I   ++GA   + F+ E E +  + H
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 61
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LVFE+ME+G L D+L           L     + + +D
Sbjct: 62  PKLVQLYGVC----LEQAPI-CLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 111
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL    +  ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 112 VCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSS 161
Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 162 TGTKFPVKWASPEVF 176

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 28/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRH 761
           SE +    IG G+FG V+ G  L  D+  VA+K I   ++GA   + F+ E E +  + H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSH 62
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L+++  +C     E      LV E+ME+G L D+L           L     + + +D
Sbjct: 63  PKLVQLYGVC----LEQAPI-CLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLD 112
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           V   + YL   C   ++H DL   N L+  + V  V DFG+ +F+ +          +SS
Sbjct: 113 VCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSS 162
Query: 882 IGIKGTVGYVAPGKF 896
            G K  V + +P  F
Sbjct: 163 TGTKFPVKWASPEVF 177

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 56/156 (35%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 713 IGQGRFGTVYKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V   +LGD     VAVK I  K    +++F++E   +  +RH NL++++ + 
Sbjct: 14  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 772 SSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  V+ K    +V EYM  GSL D+L      V    L     +  ++DV  A+EY
Sbjct: 69  -------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 117
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           L  +     VH DL   NVL+  D VA V DFGL K
Sbjct: 118 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 56/156 (35%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 713 IGQGRFGTVYKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V   +LGD     VAVK I  K    +++F++E   +  +RH NL++++ + 
Sbjct: 20  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 772 SSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  V+ K    +V EYM  GSL D+L      V    L     +  ++DV  A+EY
Sbjct: 75  -------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 123
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           L  +     VH DL   NVL+  D VA V DFGL K
Sbjct: 124 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 156

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 56/156 (35%), Positives = 79/156 (50%), Gaps = 23/156 (14%)
Query: 713 IGQGRFGTVYKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V   +LGD     VAVK I  K    +++F++E   +  +RH NL++++ + 
Sbjct: 29  IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 772 SSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  V+ K    +V EYM  GSL D+L      V    L     +  ++DV  A+EY
Sbjct: 84  -------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 132
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           L  +     VH DL   NVL+  D VA V DFGL K
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 165

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 711 NMIGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
             +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +C S    G     L+ EY+  GSL D+L +  ++++  KL     +     +   +
Sbjct: 76  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           EYL        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 711 NMIGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
             +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +C S    G     L+ EY+  GSL D+L +  ++++  KL     +     +   +
Sbjct: 83  YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 134
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           EYL        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 135 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 96  GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 147
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 148 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 711 NMIGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
             +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +C S    G     L+ EY+  GSL D+L +  ++++  KL     +     +   +
Sbjct: 107 YKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 158
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           EYL        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 88/181 (48%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 193 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L     +     L L Q +++A  +AS + Y+   
Sbjct: 251 EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVERM 300
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
                VH DL+ +N+L+  ++V  V DFGL + + ++         ++  G K  + + A
Sbjct: 301 N---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEY-------TARQGAKFPIKWTA 350
Query: 893 P 893
           P
Sbjct: 351 P 351

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 51/164 (31%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 713 IGQGRFGTV-----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V     Y      D+++VAVK +      A K F  E E L N++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLH-QSNDQVEV------RKLSLIQRMNIAI 820
             +C     EG D   +VFEYM++G L  +L     D V +       +L+  Q ++IA 
Sbjct: 81  YGVC----VEG-DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +A+ + YL        VH DL   N L+  +++  +GDFG+++
Sbjct: 136 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 40/193 (20%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINL--- 740
           +Y + ++A  EF+            +IG G FG V  G L   G  E+ VA+K + +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 741 -KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLE 795
            KQ+   + F+ E   +    H N+I +         EGV  K+    +V EYMENGSL+
Sbjct: 64  EKQR---RDFLGEASIMGQFDHPNIIHL---------EGVVTKSKPVMIVTEYMENGSLD 111
Query: 796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA 855
            +L +++ Q      ++IQ + +   +++ ++YL        VH DL   N+L++ ++V 
Sbjct: 112 TFLKKNDGQ-----FTVIQLVGMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVC 163
Query: 856 HVGDFGLAKFLSN 868
            V DFGL++ L +
Sbjct: 164 KVSDFGLSRVLED 176

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGLA+ L +   + A  T    I I+ T
Sbjct: 191 FGLARVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S    G     L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 130 L---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 16  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 74  EEPI------XIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE-- 121
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 122 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-------TARQGAKFPIKWTA 173
Query: 893 P 893
           P
Sbjct: 174 P 174

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 133 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 76  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 127
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 128 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 83  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 134
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 135 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 84  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 135
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 136 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 82  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 133
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 134 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 78  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 129
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 130 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 77  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 129 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 691 LFPMVSYAELSKATSEFSSSNM-----IGQGRFGTVYKGIL---GDDEMVVAVKVINL-- 740
           L P  S   + +   E  ++N+     +G G FG V  G L      E+ VA+K + +  
Sbjct: 14  LVPRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 741 --KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSL 794
             KQ+   + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL
Sbjct: 74  TEKQR---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSL 121
Query: 795 EDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV 854
           + +L + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V
Sbjct: 122 DSFLRKHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLV 173
Query: 855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
             V DFGL++ L +   + A  T    I I+ T
Sbjct: 174 CKVSDFGLSRVLEDDP-EAAYTTRGGKIPIRWT 205

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ IRH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L     Q    ++  I+ +     +   +EY
Sbjct: 81  GVCYSAGRRNLK---LIMEYLPYGSLRDYL-----QAHAERIDHIKLLQYTSQICKGMEY 132
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 133 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 19  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 77  EEPI------YIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE-- 124
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 125 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 176
Query: 893 P 893
           P
Sbjct: 177 P 177

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEX-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 30/198 (15%)
Query: 713 IGQGRFGTVYKGILGDDEM-VVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           IG+G FG V   +LGD     VAVK I  K    +++F++E   +  +RH NL++++ + 
Sbjct: 201 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 772 SSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                  V+ K    +V EYM  GSL D+L      V    L     +  ++DV  A+EY
Sbjct: 256 -------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 304
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           L  +     VH DL   NVL+  D VA V DFGL K       + +S   +  + +K T 
Sbjct: 305 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA 354
Query: 889 GYVAPGKFFMLYTHIPSF 906
                 K F   + + SF
Sbjct: 355 PEALREKKFSTKSDVWSF 372

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 32/195 (16%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEAL 756
            +  S   ++G G FG V  G L      E+ VA+K + +    KQ+   + F+ E   +
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIM 71
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSL 812
               H N+I++         EGV  K+    +V EYMENGSL+ +L + + Q      ++
Sbjct: 72  GQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTV 117
Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
           IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L +   +
Sbjct: 118 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-E 173
Query: 873 IASKTPSSSIGIKGT 887
            A  T    I I+ T
Sbjct: 174 AAYTTRGGKIPIRWT 188

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMV---VAVKVINLKQ-KGASKSFVSECEALRNI 759
           +E     ++G G FGTVYKGI + + E V   VA+K++N      A+  F+ E   + ++
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H +L++++ +C S   +      LV + M +G L +++H+  D +  + L     +N  
Sbjct: 98  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWC 146
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L 
Sbjct: 147 VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 191

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 29  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 88
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 89  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 136
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 137 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 188
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 189 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V EYMENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL + L +   + A  T    I I+ T
Sbjct: 191 FGLGRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 15  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 73  EEPI------YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 120
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 121 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 172
Query: 893 P 893
           P
Sbjct: 173 P 173

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 17  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 75  EEPI------YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 122
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 123 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 174
Query: 893 P 893
           P
Sbjct: 175 P 175

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVCEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q ++++  +AS + Y+   
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETG----KYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 180
Query: 893 P 893
           P
Sbjct: 181 P 181

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 23  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q ++++  +AS + Y+   
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETG----KYLRLPQLVDMSAQIASGMAYVE-- 128
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++
Sbjct: 129 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 164

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 84/168 (50%), Gaps = 19/168 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINLKQ-KGASKSFVSECEALRNI 759
           +E     ++G G FGTVYKGI   +    ++ VA+K++N      A+  F+ E   + ++
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H +L++++ +C S   +      LV + M +G L +++H+  D +  + L     +N  
Sbjct: 75  DHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + +A  + YL       +VH DL   NVL+       + DFGLA+ L 
Sbjct: 124 VQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 168

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 48/166 (28%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V+       +   D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ---------SNDQVEVRKLSLIQRMNI 818
             +C+    EG     +VFEYM +G L  +L             + V    L L Q + +
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 19/171 (11%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSEC 753
           ++      +   + +G+G+F TVYK    +   +VA+K I L  +     G +++ + E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 754 EALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           + L+ + H N+I ++       F      +LVF++ME   LE  +  ++  +    +   
Sbjct: 64  KLLQELSHPNIIGLLDA-----FGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY 117
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             M +       +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK
Sbjct: 118 MLMTL-----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 29/167 (17%)
Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEALRNIRHRNL 764
           +IG G FG V  G L   G  E+ VA+K +      KQ+   + F+SE   +    H N+
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDFLSEASIMGQFDHPNI 71
Query: 765 IK---IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           I    ++T C            ++ EYMENGSL+ +L +++      + ++IQ + +   
Sbjct: 72  IHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG-----RFTVIQLVGMLRG 118
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           + S ++YL        VH DL   N+L++ ++V  V DFG+++ L +
Sbjct: 119 IGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED 162

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 29/167 (17%)
Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEALRNIRHRNL 764
           +IG G FG V  G L   G  E+ VA+K +      KQ+   + F+SE   +    H N+
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR---RDFLSEASIMGQFDHPNI 77
Query: 765 IK---IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           I    ++T C            ++ EYMENGSL+ +L +++      + ++IQ + +   
Sbjct: 78  IHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG-----RFTVIQLVGMLRG 124
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           + S ++YL        VH DL   N+L++ ++V  V DFG+++ L +
Sbjct: 125 IGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLED 168

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 106/230 (46%), Gaps = 39/230 (16%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINL--- 740
           ++ + ++A  EF+            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 741 -KQKGASKSFVSECEALRNIRHRNLIK---IITICSSTDFEGVDFKALVFEYMENGSLED 796
            KQ+   + F+SE   +    H N+I    ++T C            ++ EYMENGSL+ 
Sbjct: 71  DKQR---RDFLSEASIMGQFDHPNIIHLEGVVTKCKPV--------MIITEYMENGSLDA 119
Query: 797 WLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH 856
           +L +++      + ++IQ + +   + S ++YL        VH DL   N+L++ ++V  
Sbjct: 120 FLRKNDG-----RFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCK 171
Query: 857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSF 906
           V DFG+++ L +   + A  T    I I+ T       + F   + + S+
Sbjct: 172 VSDFGMSRVLEDDP-EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY 220

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  G L D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVMEYMSKGCLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V+       +   D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLH---------QSNDQVEVRKLSLIQRMNI 818
             +C+    EG     +VFEYM +G L  +L             + V    L L Q + +
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKT 877
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++   S  +  +  +T
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL  +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 21/163 (12%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV----SECEALRNIRHRNLIK 766
           + +G G FG V  G        VAVK++N +QK  S   V     E + L+  RH ++IK
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 767 IITICSS-TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +  + S+ +D        +V EY+  G L D++ ++    E     L Q+      + S 
Sbjct: 81  LYQVISTPSDI------FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ------ILSG 128
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           ++Y H H    +VH DLKP NVLLD  M A + DFGL+  +S+
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 79  GVCYSAGRRNLK---LIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 130
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H +L   N+L++ +    +GDFGL K L         K P  S
Sbjct: 131 LG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y     +    VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             IC+     G+    L+ E++ +GSL+++L ++ +     K++L Q++  A+ +   ++
Sbjct: 89  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 140
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           YL        VH DL   NVL++ +    +GDFGL K + 
Sbjct: 141 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 46/181 (25%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G+FG V+ G    +  V A+K +      + +SF+ E + ++ ++H  L+++  + S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKV-AIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  GSL D+L       E R L L   +++A  VA+ + Y+   
Sbjct: 75  EEPI------YIVTEYMNKGSLLDFLKDG----EGRALKLPNLVDMAAQVAAGMAYIE-- 122
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   +H DL+ +N+L+   ++  + DFGLA+ + ++         ++  G K  + + A
Sbjct: 123 -RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEX-------TARQGAKFPIKWTA 174
Query: 893 P 893
           P
Sbjct: 175 P 175

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 155 LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 205
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           ++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y     +    VAVK +  +  G        E E LRN+ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             IC+     G+    L+ E++ +GSL+++L ++ +     K++L Q++  A+ +   ++
Sbjct: 77  KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMD 128
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           YL        VH DL   NVL++ +    +GDFGL K + 
Sbjct: 129 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 165

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 37  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 143
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 144 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 202
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 203 ---RYMAP 207

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 95  SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 156
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 215
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 216 ---RYMAP 220

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V    Y  +  +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ E++  GSL ++L +  ++++  KL     +     +   +EY
Sbjct: 81  GVCYSAGRRNLK---LIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEY 132
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           L        +H DL   N+L++ +    +GDFGL K L         K P  S
Sbjct: 133 LG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 100 SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 150
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 151 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 96  SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 203

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 95  SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 145
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 146 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 202

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L+++  + S
Sbjct: 26  LGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      +V EYM  G L D+L         + L L Q +++A  +AS + Y+   
Sbjct: 84  EEPI------YIVTEYMSKGCLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVE-- 131
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            +   VH DL+ +N+L+  ++V  V DFGLA+ + ++         ++  G K  + + A
Sbjct: 132 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 183
Query: 893 P 893
           P
Sbjct: 184 P 184

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 84/174 (48%), Gaps = 25/174 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-------KSFVSECEA 755
           A +E      IG+G FG V+KG L  D+ VVA+K + L             + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           + N+ H N++K+  +  +          +V E++  G   D  H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSV--K 124
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAK 864
           + + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFGL++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V           VA+K+IN K    S        E   LR +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  S D E +    +V EY  N  L D++ Q +   E       Q+      + SA+EY 
Sbjct: 81  VIKSKD-EII----MVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 128
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           H H    +VH DLKP N+LLD  +   + DFGL+  +++
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 126
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 126
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 30  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 87  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 135
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 136 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 171

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 29  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 86  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 134
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 135 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 170

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 84  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 132
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 133 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 84  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 132
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 133 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 168

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 22  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 79  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 127
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 128 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 163

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 31  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 87
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 88  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 136
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 137 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 172

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 126
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 16  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 73  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 122 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 157

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 23  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 80  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 128
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 129 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 164

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 26  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 83  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 131
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +N+L+   +   + DFGLA+ + ++
Sbjct: 132 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 167

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 93  SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 143
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 144 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 200

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V           VA+K+IN K    S        E   LR +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  S D E +    +V EY  N  L D++ Q +   E       Q+      + SA+EY 
Sbjct: 82  VIKSKD-EII----MVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 129
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           H H    +VH DLKP N+LLD  +   + DFGL+  +++
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 165

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 137 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 192 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 241
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 242 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 272

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 151 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 201 HHIDXXKKTTNGRLPVK----WMAPEALFDRIYTH 231

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE     +I+   +A+  AS + +LH
Sbjct: 72  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE----GMIK---LALSTASGLAHLH 123
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 124 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 182
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 183 ---RYMAP 187

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V           VA+K+IN K    S        E   LR +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  S D E +    +V EY  N  L D++ Q +   E       Q+      + SA+EY 
Sbjct: 72  VIKSKD-EII----MVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 119
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           H H    +VH DLKP N+LLD  +   + DFGL+  +++
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 155

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 710 SNMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  
Sbjct: 96  SLLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKG 146
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +++L        VH DL   N +LD      V DFGLA+ + +   D       + + +K
Sbjct: 147 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK 203

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 115 LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 165
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V           VA+K+IN K    S        E   LR +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +  S D E +    +V EY  N  L D++ Q +   E       Q+      + SA+EY 
Sbjct: 76  VIKSKD-EII----MVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQ------IISAVEYC 123
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           H H    +VH DLKP N+LLD  +   + DFGL+  +++
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 159

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V+       +   D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLH---------QSNDQVEVRKLSLIQRMNI 818
             +C+    EG     +VFEYM +G L  +L             + V    L L Q + +
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKT 877
           A  VA+ + YL        VH DL   N L+   +V  +GDFG+++   S  +  +  +T
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 114 LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 164
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 69  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 120
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 121 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 179
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 180 ---RYMAP 184

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 95  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 145
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 88  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 138
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 95  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 145
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 96  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 91  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 141
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 81  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 136 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 185
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 186 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 216

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 94  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 144
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 93  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 143
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 711 NMIGQGRFGTVYKGILGDDE---MVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIK 766
            +IG+G FG VY G L D++   +  AVK +N +   G    F++E   +++  H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           ++ IC  +  EG     +V  YM++G L +++        V+ L     +   + VA  +
Sbjct: 96  LLGICLRS--EGSPL--VVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGM 146
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +YL        VH DL   N +LD      V DFGLA+
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V E MENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---AVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR 760
           ATS +     IG G +GTVYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 761 ---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
              H N+++++ +C+++  +      LVFE+++   L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 88  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 143 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 192
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 193 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 223

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 151 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 201 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 231

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 85  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 140 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 189
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 190 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 220

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 151 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 201 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 231

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR 760
           ATS +     IG G +GTVYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 761 ---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
              H N+++++ +C+++  +      LVFE+++   L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 13/170 (7%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR 760
           ATS +     IG G +GTVYK         VA+K + +   ++G   S V E   LR + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 761 ---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
              H N+++++ +C+++  +      LVFE+++   L  +L    D+     L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKD 116
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           +       +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 163

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINL-KQ 742
           +Y E  +A   F+            +IG G  G V  G L   G  ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 743 KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
           +   + F+SE   +    H N+I++  + +           +V EYMENGSL+ +L   +
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-----AMIVTEYMENGSLDTFLRTHD 145
Query: 803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            Q      +++Q + +   V + + YL        VH DL   NVL+D ++V  V DFGL
Sbjct: 146 GQ-----FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSF 906
           ++ L +   D A  T    I I+ T       + F   + + SF
Sbjct: 198 SRVLEDDP-DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 89  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 144 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 193
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 194 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 18/163 (11%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y         +VAVK +        +S +  E + LR + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
              C      G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 148
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           YLH       +H DL   NVLLD D +  +GDFGLAK +   H
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 34/208 (16%)
Query: 693 PMVSYAELSKA--TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQK 743
           P  +  E +K    +  S   ++G G FG V  G L      E+ VA+K + +    KQ+
Sbjct: 31  PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 90
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              + F+ E   +    H N+I++         EGV  K+    +V E MENGSL+ +L 
Sbjct: 91  ---RDFLGEASIMGQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           + + Q      ++IQ + +   +AS ++YL        VH DL   N+L++ ++V  V D
Sbjct: 139 KHDAQ-----FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSD 190
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           FGL++ L +   + A  T    I I+ T
Sbjct: 191 FGLSRVLEDDP-EAAYTTRGGKIPIRWT 217

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINL----KQKGASKSFVSECEAL 756
            +  S   ++G G FG V  G L      E+ VA+K + +    KQ+   + F+ E   +
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIM 71
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSL 812
               H N+I++         EGV  K+    +V E MENGSL+ +L + + Q      ++
Sbjct: 72  GQFDHPNIIRL---------EGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-----FTV 117
Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
           IQ + +   +AS ++YL        VH DL   N+L++ ++V  V DFGL++ L +   +
Sbjct: 118 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP-E 173
Query: 873 IASKTPSSSIGIKGT 887
            A  T    I I+ T
Sbjct: 174 AAYTTRGGKIPIRWT 188

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH 761
           +  S+F    ++GQG FG V K     D    A+K I   ++  S + +SE   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNH 61
Query: 762 RNLIKIITICSSTD-----FEGVDFKALVF---EYMENGSLEDWLHQSN-DQVEVRKLSL 812
           + +++                 V  K+ +F   EY ENG+L D +H  N +Q       L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
            ++      +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK + +  LD
Sbjct: 122 FRQ------ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV-HRSLD 171
Query: 873 I----ASKTPSSSIGIKGTVG---YVA 892
           I    +   P SS  +   +G   YVA
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVA 198

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 44/215 (20%)
Query: 713 IGQGRFG-TVYKGILGDDE----MVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG  V    +G D+     V  V V  LK     K     +SE E ++ I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL---------------HQSNDQVEVR 808
           +I ++  C+    +G  +  ++ EY   G+L ++L               H   +Q+  +
Sbjct: 96  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L     ++ A  VA  +EYL        +H DL   NVL+  D V  + DFGLA+ +  
Sbjct: 151 DL-----VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-- 200
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
           HH+D   KT +  + +K    ++AP   F  +YTH
Sbjct: 201 HHIDYYKKTTNGRLPVK----WMAPEALFDRIYTH 231

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINL-KQ 742
           +Y E  +A   F+            +IG G  G V  G L   G  ++ VA+K +     
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 743 KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
           +   + F+SE   +    H N+I++  + +           +V EYMENGSL+ +L   +
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-----AMIVTEYMENGSLDTFLRTHD 145
Query: 803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            Q      +++Q + +   V + + YL        VH DL   NVL+D ++V  V DFGL
Sbjct: 146 GQ-----FTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSF 906
           ++ L +   D A  T    I I+ T       + F   + + SF
Sbjct: 198 SRVLEDDP-DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNIRHRN 763
           ++F     +G+G FG V++     D+   A+K I L  +  A +  + E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 764 LIKIITIC----SSTDFEGVDFKALVFEYME---NGSLEDWLHQSNDQVEVRKLSLIQRM 816
           +++         ++   +    K  ++  M+     +L+DW++     +E R+ S+   +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVC--L 121
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           +I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +     +    
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 877 TP----SSSIGIKGTVGYVAP 893
           TP    +   G  GT  Y++P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 67  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 118
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 177
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 178 ---RYMAP 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 24/188 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E  + +  RH N++  I  
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
            +  +        LV +Y E+GSL D+L++    VE         + +A+  AS + +LH
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTVTVE-------GMIKLALSTASGLAHLH 117
Query: 831 HHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
                   +P + H DLK  N+L+  +    + D GLA    +   D     P+  +G K
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTK 176
Query: 886 GTVGYVAP 893
               Y+AP
Sbjct: 177 ---RYMAP 181

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 41/158 (25%), Positives = 86/158 (54%), Gaps = 17/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 17  LGAGQFGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 74  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H +L+ +N+L+   +   + DFGLA+ + ++
Sbjct: 123 --ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDN 158

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVIN---LKQKGASKSFVSECEALR 757
           +  +    ++G+G FG V   IL  D++     AVKVI+   +KQK   +S + E + L+
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N++K+        FE   +  LV E    G L D      + +  ++ S +    
Sbjct: 88  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFD------EIISRKRFSEVDAAR 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL+      H + A
Sbjct: 137 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST-----HFE-A 187
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK     I   GT  Y+AP
Sbjct: 188 SKKMKDKI---GTAYYIAP 203

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-------KSFVSECEA 755
           A +E      IG+G FG V+KG L  D+ VVA+K + L             + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           + N+ H N++K+  +  +          +V E++  G   D  H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSV--K 124
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAK 864
           + + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DFG ++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRH 761
           ++S+F     +G G + TVYKG+     + VA+K + L  ++G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++++  +  +      +   LVFE+M+N  L+ ++         R L L         
Sbjct: 63  ENIVRLYDVIHTE-----NKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +   + + H +    ++H DLKP N+L++      +GDFGLA+
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 26/186 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VAVK+I  K+   S+  F  E + +  + H  L+K   +C
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 772 SSTDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
           S       ++   +V EY+ NG L ++L      +E  +L     + +  DV   + +L 
Sbjct: 73  SK------EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLE 121
Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
            H     +H DL   N L+D D+   V DFG+ +++ +           SS+G K  V +
Sbjct: 122 SH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-------VSSVGTKFPVKW 171
Query: 891 VAPGKF 896
            AP  F
Sbjct: 172 SAPEVF 177

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-------KSFVSECEA 755
           A +E      IG+G FG V+KG L  D+ VVA+K + L             + F  E   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           + N+ H N++K+  +  +          +V E++  G   D  H+  D+    K S+  +
Sbjct: 77  MSNLNHPNIVKLYGLMHNP-------PRMVMEFVPCG---DLYHRLLDKAHPIKWSV--K 124
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAK 864
           + + +D+A  IEY+ +   PP+VH DL+  N+ L     +  + A V DF L++
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V ++ L++     A+K  + E   + ++
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 109 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 157
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 158 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 201

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 30/190 (15%)
Query: 714 GQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE--ALRNIRHRNLIKIITIC 771
            +GRFG V+K  L ++   VAVK+  ++ K   +S+ +E E  +L  ++H N+++ I   
Sbjct: 33  ARGRFGCVWKAQLLNE--YVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                  VD   L+  + E GSL D+L       +   +S  +  +IA  +A  + YLH 
Sbjct: 88  KRGTSVDVDL-WLITAFHEKGSLSDFL-------KANVVSWNELCHIAETMARGLAYLHE 139
Query: 832 HC-------QPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTPSSSIG 883
                    +P + H D+K  NVLL  ++ A + DFGLA KF        A K+   + G
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE-------AGKSAGDTHG 192
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 193 QVGTRRYMAP 202

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 26/192 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           E     ++G+G FG V K      +  VA+K   ++ +   K+F+ E   L  + H N++
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIV 65
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+   C       ++   LV EY E GSL + LH +     +   +    M+  +  +  
Sbjct: 66  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 115
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           + YLH      ++H DLKP N+LL     V  + DFG A  +  H  +            
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN-----------N 164
Query: 885 KGTVGYVAPGKF 896
           KG+  ++AP  F
Sbjct: 165 KGSAAWMAPEVF 176

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVI---NLKQKGASKSFVSECEALR 757
           +  +    ++G+G FG V   IL  D++     AVKVI    +KQK   +S + E + L+
Sbjct: 48  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N++K+        FE   +  LV E    G L D +      +  ++ S +    
Sbjct: 105 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 153
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL+          A
Sbjct: 154 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------A 204
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK     I   GT  Y+AP
Sbjct: 205 SKKMKDKI---GTAYYIAP 220

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVI---NLKQKGASKSFVSECEALR 757
           +  +    ++G+G FG V   IL  D++     AVKVI    +KQK   +S + E + L+
Sbjct: 49  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N++K+        FE   +  LV E    G L D +      +  ++ S +    
Sbjct: 106 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 154
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL+          A
Sbjct: 155 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------A 205
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK     I   GT  Y+AP
Sbjct: 206 SKKMKDKI---GTAYYIAP 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 686 SPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--- 742
           +P   ++P++ +       ++    ++IG+G FG V K  +  D + +   +  +K+   
Sbjct: 3   NPDPTIYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 55
Query: 743 KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
           K   + F  E E L  +  H N+I ++  C     E   +  L  EY  +G+L D+L +S
Sbjct: 56  KDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKS 110
Query: 802 N----------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY 851
                             LS  Q ++ A DVA  ++YL    Q   +H DL   N+L+  
Sbjct: 111 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 167
Query: 852 DMVAHVGDFGLAK 864
           + VA + DFGL++
Sbjct: 168 NYVAKIADFGLSR 180

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 29/198 (14%)
Query: 681 KSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL 740
           + V  +P   ++P++ +       ++    ++IG+G FG V K  +  D + +   +  +
Sbjct: 5   RKVKNNPDPTIYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 57
Query: 741 KQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLED 796
           K+   K   + F  E E L  +  H N+I ++  C     E   +  L  EY  +G+L D
Sbjct: 58  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLD 112
Query: 797 WLHQSN----------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSN 846
           +L +S                  LS  Q ++ A DVA  ++YL    Q   +H +L   N
Sbjct: 113 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARN 169
Query: 847 VLLDYDMVAHVGDFGLAK 864
           +L+  + VA + DFGL++
Sbjct: 170 ILVGENYVAKIADFGLSR 187

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVIN---LKQKGASKSFVSECEALR 757
           +  +    ++G+G FG V   IL  D++     AVKVI+   +KQK   +S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N++K+        FE   +  LV E    G L D +      +  ++ S +    
Sbjct: 82  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 130
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S I Y+H +    +VH DLKP N+LL+    D    + DFGL+          A
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------A 181
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK     I   GT  Y+AP
Sbjct: 182 SKKMKDKI---GTAYYIAP 197

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 26/192 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           E     ++G+G FG V K      +  VA+K   ++ +   K+F+ E   L  + H N++
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+   C       ++   LV EY E GSL + LH +     +   +    M+  +  +  
Sbjct: 65  KLYGAC-------LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQG 114
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           + YLH      ++H DLKP N+LL     V  + DFG A  +  H  +            
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN-----------N 163
Query: 885 KGTVGYVAPGKF 896
           KG+  ++AP  F
Sbjct: 164 KGSAAWMAPEVF 175

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 171

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 124
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 29/193 (15%)
Query: 686 SPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--- 742
           +P   ++P++ +       ++    ++IG+G FG V K  +  D + +   +  +K+   
Sbjct: 13  NPDPTIYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 743 KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
           K   + F  E E L  +  H N+I ++  C     E   +  L  EY  +G+L D+L +S
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKS 120
Query: 802 N----------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY 851
                             LS  Q ++ A DVA  ++YL    Q   +H DL   N+L+  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 177
Query: 852 DMVAHVGDFGLAK 864
           + VA + DFGL++
Sbjct: 178 NYVAKIADFGLSR 190

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 76  DNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 124
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 125 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 168

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 714 GQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKIITIC 771
            +GRFG V+K  L +D   VAVK+  L+ K   +S+ SE E      ++H NL++ I   
Sbjct: 24  ARGRFGCVWKAQLMND--FVAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAAE 78
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                  V+   L+  + + GSL D+L  +        ++  +  ++A  ++  + YLH 
Sbjct: 79  KRGSNLEVEL-WLITAFHDKGSLTDYLKGNI-------ITWNELCHVAETMSRGLSYLHE 130
Query: 832 HC--------QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
                     +P + H D K  NVLL  D+ A + DFGLA            K P  + G
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFE------PGKPPGDTHG 184
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 185 QVGTRRYMAP 194

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 41/157 (26%), Positives = 84/157 (53%), Gaps = 17/157 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+ G V+ G   +    VAVK  +LKQ   S  +F++E   ++ ++H+ L+++  + 
Sbjct: 21  LGAGQAGEVWMGYY-NGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +           ++ EYMENGSL D+L   +      KL++ + +++A  +A  + ++  
Sbjct: 78  TQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE- 126
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             +   +H DL+ +N+L+   +   + DFGLA+ + +
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 32/190 (16%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVI------NLKQKGASKSFVSECEALRNIRHRNL 764
             IG+G FG V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++I +C+           +V E ++ G    +L     ++ V+ L     + +  D A+
Sbjct: 175 VRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            +EYL   C    +H DL   N L+    V  + DFG+++       + A    ++S G+
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR-------EEADGVXAASGGL 274
Query: 885 KGT-VGYVAP 893
           +   V + AP
Sbjct: 275 RQVPVKWTAP 284

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 25/189 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRNLIKII 768
           IG+G F TVYKG+  D E  V V    L+ +  +KS    F  E E L+ ++H N+++  
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
               ST  +G     LV E   +G+L+ +L     + +V K+ +++  +    +   +++
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLR--SWCRQILKGLQF 144
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           LH    PP++H DLK  N+ +        +GD GLA            K  S +  + GT
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------KRASFAKAVIGT 193
Query: 888 VGYVAPGKF 896
             + AP  +
Sbjct: 194 PEFXAPEXY 202

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 89  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 137
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL+++       +     +SS+G K  V + 
Sbjct: 138 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEETSSVGSKFPVRWS 188
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 189 PPE--VLMYSKFSSKS 202

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH 761
           +  S+F    ++GQG FG V K     D    A+K I   ++  S + +SE   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNH 61
Query: 762 RNLIKIITIC-SSTDF----EGVDFKALVF---EYMENGSLEDWLHQSN-DQVEVRKLSL 812
           + +++         +F      V  K+ +F   EY EN +L D +H  N +Q       L
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
            ++      +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK + +  LD
Sbjct: 122 FRQ------ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV-HRSLD 171
Query: 873 I----ASKTPSSSIGIKGTVG---YVA 892
           I    +   P SS  +   +G   YVA
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVA 198

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 24/160 (15%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVI------NLKQKGASKSFVSECEALRNIRHRNL 764
             IG+G FG V+ G L  D  +VAVK        +LK K     F+ E   L+   H N+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNI 174
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++I +C+           +V E ++ G    +L     ++ V+ L     + +  D A+
Sbjct: 175 VRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTL-----LQMVGDAAA 224
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +EYL   C    +H DL   N L+    V  + DFG+++
Sbjct: 225 GMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y         +VAVK +        +S +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
              C     +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           YLH       +H +L   NVLLD D +  +GDFGLAK +   H
Sbjct: 132 YLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 80  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 128
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL++++ +          +SS+G K  V + 
Sbjct: 129 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWS 179
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 180 PPE--VLMYSKFSSKS 193

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 73  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL++++ +          +SS+G K  V + 
Sbjct: 122 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWS 172
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 173 PPE--VLMYSKFSSKS 186

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 74  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL++++ +          +SS+G K  V + 
Sbjct: 123 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWS 173
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 174 PPE--VLMYSKFSSKS 187

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 89  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 137
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL++++ +          +SS+G K  V + 
Sbjct: 138 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWS 188
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 189 PPE--VLMYSKFSSKS 202

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 26/196 (13%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 69  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 117
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYV 891
                 +H DL   N L++   V  V DFGL++++ +          +SS+G K  V + 
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSKFPVRWS 168
Query: 892 APGKFFMLYTHIPSFS 907
            P    ++Y+   S S
Sbjct: 169 PPE--VLMYSKFSSKS 182

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 100 DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 148
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 149 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 192

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 78  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 126
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 170

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 81  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 129
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 130 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 173

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 72  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 121 VQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 164

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-----SFVSECEA 755
           S ATS +     IG G +GTVYK         VA+K + +   G        S V E   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 756 LRNIR---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSL 812
           LR +    H N+++++ +C+++  +      LVFE+++   L  +L    D+     L  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPA 119
Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++       +++LH +C   +VH DLKP N+L+       + DFGLA+  S
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS 171

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 89/199 (44%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVIN---LKQKGASKSFVSECEALR 757
           +  +    ++G+G FG V   IL  D++     AVKVI+   +KQK   +S + E + L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N+ K+        FE   +  LV E    G L D +      +  ++ S +    
Sbjct: 82  QLDHPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAAR 130
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S I Y H +    +VH DLKP N+LL+    D    + DFGL+          A
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE------A 181
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK     I   GT  Y+AP
Sbjct: 182 SKKXKDKI---GTAYYIAP 197

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLIKI 767
           +G+G FG V    Y         +VAVK +        +S +  E + LR + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
              C     +G     LV EY+  GSL D+L + +       + L Q +  A  +   + 
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMA 131
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           YLH       +H +L   NVLLD D +  +GDFGLAK +   H
Sbjct: 132 YLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH 171

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 85  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 133
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 177

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII- 768
           +G+G FG V        +  VA+K I+   LK+         E   L+ +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            I + TD        +V EY   G L D++      VE ++++  +       +  AIEY
Sbjct: 77  VITTPTDI------VMVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAIEY 123
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            H H    +VH DLKP N+LLD ++   + DFGL+  +++
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 45/218 (20%)
Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINL--- 740
           +Y + ++A  +F+            +IG G FG V  G L   G  ++ VA+K + +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 741 -KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLE 795
            KQ+   + F+ E   +    H N++ +         EGV  +     +V E+MENG+L+
Sbjct: 85  EKQR---RDFLCEASIMGQFDHPNVVHL---------EGVVTRGKPVMIVIEFMENGALD 132
Query: 796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA 855
            +L + + Q      ++IQ + +   +A+ + YL        VH DL   N+L++ ++V 
Sbjct: 133 AFLRKHDGQ-----FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVC 184
Query: 856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            V DFGL++ + +    + + T     G K  V + AP
Sbjct: 185 KVSDFGLSRVIEDDPEAVYTTT-----GGKIPVRWTAP 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 82/167 (49%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 117
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 26/179 (14%)
Query: 695 VSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSE 752
           VS A  + +   +     +G+G +G VYK I       VA+K I L  +++G   + + E
Sbjct: 24  VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE 83
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND-QVEVRKLS 811
              L+ ++HRN+I++ ++             L+FEY EN  L+ ++ ++ D  + V K  
Sbjct: 84  VSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF 137
Query: 812 LIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYD-----MVAHVGDFGLAK 864
           L Q +N        + + H   C    +H DLKP N+LL         V  +GDFGLA+
Sbjct: 138 LYQLIN-------GVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH 761
           +  S+F    ++GQG FG V K     D    A+K I   ++  S + +SE   L ++ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLNH 61
Query: 762 -------------RNLIKIITICSSTDFEGVDFKALVF---EYMENGSLEDWLHQSN-DQ 804
                        RN +K  T         V  K+ +F   EY EN +L D +H  N +Q
Sbjct: 62  QYVVRYYAAWLERRNFVKPXT--------AVKKKSTLFIQXEYCENRTLYDLIHSENLNQ 113
Query: 805 VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                  L ++      +  A+ Y+H      ++H +LKP N+ +D      +GDFGLAK
Sbjct: 114 QRDEYWRLFRQ------ILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAK 164
Query: 865 FLSNHHLDI----ASKTPSSSIGIK---GTVGYVA 892
            + +  LDI    +   P SS  +    GT  YVA
Sbjct: 165 NV-HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVA 198

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 XXKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSEC-EA 755
           +A   +   ++   ++IG+G    V + +        AVK++ +  +  S   + E  EA
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 756 LRNIRH--RNLI---KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
            R   H  R +     IIT+  S  +E   F  LVF+ M  G L D+L       E   L
Sbjct: 146 TRRETHILRQVAGHPHIITLIDS--YESSSFMFLVFDLMRKGELFDYL------TEKVAL 197
Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           S  +  +I   +  A+ +LH +    +VH DLKP N+LLD +M   + DFG +      H
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-----H 249
Query: 871 LDIASKTPSSSIGIKGTVGYVAP 893
           L+   K       + GT GY+AP
Sbjct: 250 LEPGEKLRE----LCGTPGYLAP 268

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 26/191 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINLKQKGASKSFVSECE---ALR 757
           +E     ++G G FGTV+KG+   +    ++ V +KVI  + K   +SF +  +   A+ 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIG 70
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           ++ H ++++++ +C  +  +      LV +Y+  GSL D + Q    +  + L     +N
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL-----LN 119
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL---SNHHLDIA 874
             + +A  + YL  H    MVH +L   NVLL       V DFG+A  L       L   
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 875 SKTPSSSIGIK 885
           +KTP   + ++
Sbjct: 177 AKTPIKWMALE 187

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINLKQKGASKSFVSECE---ALR 757
           +E     ++G G FGTV+KG+   +    ++ V +KVI  + K   +SF +  +   A+ 
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIG 88
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           ++ H ++++++ +C  +  +      LV +Y+  GSL D + Q    +  + L     +N
Sbjct: 89  SLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL-----LN 137
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL---SNHHLDIA 874
             + +A  + YL  H    MVH +L   NVLL       V DFG+A  L       L   
Sbjct: 138 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 875 SKTPSSSIGIKGTVGYVAPGKFFMLYTH 902
           +KTP   + ++           F  YTH
Sbjct: 195 AKTPIKWMALESI--------HFGKYTH 214

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 XXKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEAL-RNIR 760
           S+F    +IG+G FG V       +E+  AVKV+  K   +K   K  +SE   L +N++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H  L+ +        F+  D    V +Y+  G L   L +    +E R          A 
Sbjct: 98  HPFLVGL-----HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA------RFYAA 146
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
           ++ASA+ YLH      +V+ DLKP N+LLD      + DFGL K    H+        S+
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------ST 195
Query: 881 SIGIKGTVGYVAP 893
           +    GT  Y+AP
Sbjct: 196 TSTFCGTPEYLAP 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V  G     +  VA+K+I  K+   S+  F+ E + + N+ H  L+++  +C
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +    +   F  ++ EYM NG L ++L +   + + ++L     + +  DV  A+EYL  
Sbjct: 74  TK---QRPIF--IITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLE- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
                 +H DL   N L++   V  V DFGL++++
Sbjct: 123 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 79  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 127
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 128 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 171

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++  G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 12/190 (6%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDE---MVVAVKVINLKQKGAS--KSFVSECEALRNI 759
            +F+   M+G+G FG+V +  L  ++   + VAVK++      +S  + F+ E   ++  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 760 RHRNLIKIITICSSTDFEG-VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            H ++ K++ +   +  +G +    ++  +M++G L  +L  S        L L   +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN---HHLDIAS 875
            +D+A  +EYL        +H DL   N +L  DM   V DFGL++ + +   +    AS
Sbjct: 143 MVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 876 KTPSSSIGIK 885
           K P   + ++
Sbjct: 200 KLPVKWLALE 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 149 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 204 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 257
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 258 YYKKTTNGRLPVK----WMAPEALFDRVYTH 284

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IITLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 31/185 (16%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           IG+GR+G V+ G    ++  VAVKV    ++    S+  E E  + +  RH N++  I  
Sbjct: 45  IGKGRYGEVWMGKWRGEK--VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI-- 97
Query: 771 CSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             + D +G        L+ +Y ENGSL D+L  +        L     + +A    S + 
Sbjct: 98  --AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLC 148
Query: 828 YLHHHC-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSN-HHLDIASKTPSS 880
           +LH        +P + H DLK  N+L+  +    + D GLA KF+S+ + +DI    P++
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP---PNT 205
Query: 881 SIGIK 885
            +G K
Sbjct: 206 RVGTK 210

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   M VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   M VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IIHLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 174

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKG--ILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG  I   +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 167

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 77  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFG AK L
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++  G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 82  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 130
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQK---GASKSFVSECEALRNI 759
           +EF    ++  G FGTVYKG+     +++ + V +  L++     A+K  + E   + ++
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  + L     +N  
Sbjct: 75  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWC 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + +A  + YL       +VH DL   NVL+       + DFGLAK L
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 686 SPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVK---VINLKQ 742
            P + L P + Y  L+     F     IG+G+F  VY+     D + VA+K   + +L  
Sbjct: 17  QPQKALRPDMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 743 KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
             A    + E + L+ + H N+IK         F   +   +V E  + G L   +    
Sbjct: 73  AKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            Q  +     + +    + + SA+E++H      ++H D+KP+NV +    V  +GD GL
Sbjct: 128 KQKRLIPERTVWK--YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 182
Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGK 895
            +F S       SKT +++  + GT  Y++P +
Sbjct: 183 GRFFS-------SKT-TAAHSLVGTPYYMSPER 207

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 28/190 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           +G+GR+G V++G    +   VAVK+ + + +   KS+  E E    +  RH N++  I  
Sbjct: 45  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             ++         L+  Y E GSL D+L       ++  L  +  + I + +AS + +LH
Sbjct: 100 DMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHLH 151
Query: 831 -----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF--LSNHHLDIASKTPSSSIG 883
                   +P + H DLK  N+L+  +    + D GLA     S + LD+ +        
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV---- 207
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 208 --GTKRYMAP 215

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIK 766
           +GQG FG VY+G     I G+ E  VAVK +N       +  F++E   ++     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV---RKLSLIQRM-NIAIDV 822
           ++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A ++
Sbjct: 82  LLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 137 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 90  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 145 DLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLARDINN--ID 198
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 199 YYKKTTNGRLPVK----WMAPEALFDRVYTH 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 92  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 147 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 200
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 201 YYKKTTNGRLPVK----WMAPEALFDRVYTH 227

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 95  IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 150 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 203
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 204 YYKKTTNGRLPVK----WMAPEALFDRVYTH 230

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 20/186 (10%)
Query: 691 LFPMVSYA--ELSKATSEFSSSNMIGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQK 743
           +FP   Y   E   +  + +    +GQG FG VY+G     I G+ E  VAVK +N    
Sbjct: 1   VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 60
Query: 744 GASK-SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
              +  F++E   ++     ++++++ + S      V     V E M +G L+ +L    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLR 115
Query: 803 DQVE---VRKLSLIQRM-NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
            + E    R    +Q M  +A ++A  + YL+       VH DL   N ++ +D    +G
Sbjct: 116 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 172
Query: 859 DFGLAK 864
           DFG+ +
Sbjct: 173 DFGMTR 178

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/166 (30%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNL 764
           +G+G FG V    Y         +VAVK +   ++G      S    E E LR + H ++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K    C     +G     LV EY+  GSL D+L +         + L Q +  A  +  
Sbjct: 73  VKYKGCCED---QGEKSVQLVMEYVPLGSLRDYLPR-------HCVGLAQLLLFAQQICE 122
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            + YLH       +H  L   NVLLD D +  +GDFGLAK +   H
Sbjct: 123 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 165

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/166 (30%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 713 IGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNL 764
           +G+G FG V    Y         +VAVK +   ++G      S    E E LR + H ++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K    C     +G     LV EY+  GSL D+L +         + L Q +  A  +  
Sbjct: 74  VKYKGCCED---QGEKSVQLVMEYVPLGSLRDYLPR-------HCVGLAQLLLFAQQICE 123
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            + YLH       +H  L   NVLLD D +  +GDFGLAK +   H
Sbjct: 124 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH 166

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIK 766
           +GQG FG VY+G     I G+ E  VAVK +N       +  F++E   ++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE---VRKLSLIQRM-NIAIDV 822
           ++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A ++
Sbjct: 85  LLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 106 GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 154
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIK 766
           +GQG FG VY+G     I G+ E  VAVK +N       +  F++E   ++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE---VRKLSLIQRM-NIAIDV 822
           ++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A ++
Sbjct: 85  LLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIK 766
           +GQG FG VY+G     I G+ E  VAVK +N       +  F++E   ++     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE---VRKLSLIQRM-NIAIDV 822
           ++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A ++
Sbjct: 84  LLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 139 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 18/192 (9%)
Query: 689 EKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKG 744
           E  + M S  +             IG+G+FG V++GI    E   M VA+K   N     
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 745 ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ 804
             + F+ E   +R   H +++K+I + +           ++ E    G L  +L     Q
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL-----Q 482
Query: 805 VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           V    L L   +  A  +++A+ YL        VH D+   NVL+  +    +GDFGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 865 FLSNHHLDIASK 876
           ++ +     ASK
Sbjct: 540 YMEDSTYYKASK 551

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL-- 810
              ++     ++++++ + S      V     + E M  G L+ +L     ++E   +  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 811 --SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 44/212 (20%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F    +IG G FG V+K     D     ++ +    + A +    E +AL  + H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIV 68
Query: 766 KIITICSSTDF---------EGVDFKA---------------LVFEYMENGSLEDWLHQS 801
                    D+         E  D+                 +  E+ + G+LE W+ + 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 802 NDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
             +    KL  +  + +   +   ++Y+H      ++H DLKPSN+ L       +GDFG
Sbjct: 129 RGE----KLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           L   L N       +T S     KGT+ Y++P
Sbjct: 182 LVTSLKND----GKRTRS-----KGTLRYMSP 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL-- 810
              ++     ++++++ + S      V     + E M  G L+ +L     ++E   +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 811 --SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLK--QKGASKSFVSECEAL 756
           L +A  ++     IG+G +G V+K   L +    VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 757 RNIR---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           R++    H N++++  +C+ +  +      LVFE+++   L  +L    D+V    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTE 120
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              ++   +   +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 18/162 (11%)
Query: 713 IGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRNLIK 766
           +GQG FG VY+G     I G+ E  VAVK +N       +  F++E   ++     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE---VRKLSLIQRM-NIAIDV 822
           ++ + S      V     V E M +G L+ +L     + E    R    +Q M  +A ++
Sbjct: 85  LLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  + YL+       VH DL   N ++ +D    +GDFG+ +
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 83  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 131
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     +     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 81  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 129
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 180
Query: 869 HHLDIASKTPSSSIGIKG--TVGYVAPGKF----FMLYTHIPSF 906
              DI  +T     G KG   V +++P       F  Y+ + SF
Sbjct: 181 ---DI-XETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 28/190 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           +G+GR+G V++G    +   VAVK+ + + +   KS+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             ++         L+  Y E GSL D+L       ++  L  +  + I + +AS + +LH
Sbjct: 71  DMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 831 -----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF--LSNHHLDIASKTPSSSIG 883
                   +P + H DLK  N+L+  +    + D GLA     S + LD+ +        
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV---- 178
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 179 --GTKRYMAP 186

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 112
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 113 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 112
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 113 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 47/179 (26%), Positives = 87/179 (48%), Gaps = 18/179 (10%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 112
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG 
Sbjct: 113 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 87/190 (45%), Gaps = 28/190 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           +G+GR+G V++G    +   VAVK+ + + +   KS+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             ++         L+  Y E GSL D+L       ++  L  +  + I + +AS + +LH
Sbjct: 71  DMTSRHSSTQL-WLITHYHEMGSLYDYL-------QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 831 -----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF--LSNHHLDIASKTPSSSIG 883
                   +P + H DLK  N+L+  +    + D GLA     S + LD+ +        
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV---- 178
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 179 --GTKRYMAP 186

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLK--QKGASKSFVSECEAL 756
           L +A  ++     IG+G +G V+K   L +    VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 757 RNIR---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           R++    H N++++  +C+ +  +      LVFE+++   L  +L    D+V    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTE 120
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              ++   +   +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 18/192 (9%)
Query: 689 EKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKG 744
           E  + M S  +             IG+G+FG V++GI    E   M VA+K   N     
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS 433
Query: 745 ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ 804
             + F+ E   +R   H +++K+I + +           ++ E    G L  +L     Q
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFL-----Q 482
Query: 805 VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           V    L L   +  A  +++A+ YL        VH D+   NVL+       +GDFGL++
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 865 FLSNHHLDIASK 876
           ++ +     ASK
Sbjct: 540 YMEDSTYYKASK 551

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLK--QKGASKSFVSECEAL 756
           L +A  ++     IG+G +G V+K   L +    VA+K + ++  ++G   S + E   L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 757 RNIR---HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           R++    H N++++  +C+ +  +      LVFE+++   L  +L    D+V    +   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTE 120
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              ++   +   +++LH H    +VH DLKP N+L+       + DFGLA+  S
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 75  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 123
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   + VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 80  GVITENPV------WIIMELCTLGELRSFL-----QVRKYSLDLASLILYAYQLSTALAY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+  +    +GDFGL++++ +     ASK
Sbjct: 129 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 18/168 (10%)
Query: 713 IGQGRFGTVYKGILGDDE---MVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           IG+G+FG V++GI    E   M VA+K   N       + F+ E   +R   H +++K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            + +           ++ E    G L  +L     QV    L L   +  A  +++A+ Y
Sbjct: 78  GVITENPV------WIIMELCTLGELRSFL-----QVRKFSLDLASLILYAYQLSTALAY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           L        VH D+   NVL+       +GDFGL++++ +     ASK
Sbjct: 127 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S           ++ E M  G L+ +L     ++E    + 
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 33/177 (18%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAVK+I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 15  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLED------WLHQSNDQVEVRKLSLIQRMNIAIDV 822
            +  +   E   +  LV EY   G + D      W+ +   + + R+            +
Sbjct: 73  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------------I 115
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            SA++Y H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 116 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 169

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 41/158 (25%), Positives = 82/158 (51%), Gaps = 16/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   ++   VAVK   LK    S ++F+ E   ++ ++H  L+++  + 
Sbjct: 21  LGAGQFGEVWMGYY-NNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +  +        ++ EYM  GSL D+L       E  K+ L + ++ +  +A  + Y+  
Sbjct: 78  TREEP-----IYIITEYMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE- 127
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +NVL+   ++  + DFGLA+ + ++
Sbjct: 128 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 163

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++ EY   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
               T +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKNTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 696 SYAELSK---ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSF 749
           + AE+ K      +F     +G+G+FG VY      ++ ++A+KV+    L+++G     
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 62
Query: 750 VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK 809
             E E   ++RH N++++        F       L+ E+   G L   L +     E R 
Sbjct: 63  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 117
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            + ++      ++A A+ Y H   +  ++H D+KP N+L+ Y     + DFG
Sbjct: 118 ATFME------ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VR 808
              ++     ++++++ + S      V     + E M  G L+ +L     ++E    + 
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 30/187 (16%)
Query: 713 IGQGRFGTVYKGILGDDEMV---VAVKVINL---KQKGASKSFVSECEALRNIRHRNLIK 766
           +G G   TVY   L +D ++   VA+K I +   +++   K F  E      + H+N++ 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I +      E  D   LV EY+E  +L +++           LS+   +N    +   I
Sbjct: 76  MIDVD-----EEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGI 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           ++ H      +VH D+KP N+L+D +    + DFG+AK LS   L       + +  + G
Sbjct: 125 KHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------TQTNHVLG 174
Query: 887 TVGYVAP 893
           TV Y +P
Sbjct: 175 TVQYFSP 181

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVINL--KQKGASKSFVSECEALRNIRH 761
            ++     +G+G +G VYK    D +  +VA+K I L  + +G   + + E   L+ + H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++ +I +  S          LVFE+ME   L+  L ++         + +Q   I I 
Sbjct: 79  PNIVSLIDVIHSERC-----LTLVFEFMEK-DLKKVLDENK--------TGLQDSQIKIY 124
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +   +  + H  Q  ++H DLKP N+L++ D    + DFGLA+
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 59
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 60  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 113
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            ++  +++ + R     +   A+E+LH +    ++H D+K  N+LL  D    + DFG  
Sbjct: 114 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 164
Query: 864 KFLSNHHLDIASKTPSSSI--GIKGTVGYVAP 893
                     A  TP  S    + GT  ++AP
Sbjct: 165 ----------AQITPEQSKRSXMVGTPYWMAP 186

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVINL--KQKGASKSFVSECEALRNIRH 761
            ++     +G+G +G VYK    D +  +VA+K I L  + +G   + + E   L+ + H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++ +I +  S          LVFE+ME   L+  L ++         + +Q   I I 
Sbjct: 79  PNIVSLIDVIHSERC-----LTLVFEFMEK-DLKKVLDENK--------TGLQDSQIKIY 124
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +   +  + H  Q  ++H DLKP N+L++ D    + DFGLA+
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 44/176 (25%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL-- 810
              ++     ++++++ + S      V     + E M  G L+ +L     ++E   +  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 811 --SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             SL + + +A ++A  + YL+ +     VH DL   N  +  D    +GDFG+ +
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++  Y   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAVK+I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAVK+I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 696 SYAELSK---ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSF 749
           + AE+ K      +F     +G+G+FG VY      ++ ++A+KV+    L+++G     
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 750 VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK 809
             E E   ++RH N++++        F       L+ E+   G L   L +     E R 
Sbjct: 62  RREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            + ++      ++A A+ Y H   +  ++H D+KP N+L+ Y     + DFG
Sbjct: 117 ATFME------ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIIT 769
           + +G+G + TVYKG     + +VA+K I L+ ++GA  + + E   L++++H N++ +  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           I  +          LVFEY++   L+ +L    + + +  + L         +   + Y 
Sbjct: 68  IIHTEKS-----LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF-----LFQLLRGLAYC 116
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           H   +  ++H DLKP N+L++      + DFGLA+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/181 (22%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G+FG V+     +    VAVK +        ++F++E   ++ ++H  L+K+  + +
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 254 KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 301
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
            Q   +H DL+ +N+L+   +V  + DFGLA+ + ++         ++  G K  + + A
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 353
Query: 893 P 893
           P
Sbjct: 354 P 354

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 93/196 (47%), Gaps = 22/196 (11%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNI 759
           ++  ++ +  ++G+G +G V K    D   +VA+K    +   K   K  + E + L+ +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDW-LHQSNDQVEVRKLSLIQRMNI 818
           RH NL+ ++ +C            LVFE++++  L+D  L  +    +V +  L Q +N 
Sbjct: 82  RHENLVNLLEVCKKKKRW-----YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN- 135
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN----HHLDIA 874
                  I + H H    ++H D+KP N+L+    V  + DFG A+ L+     +  ++A
Sbjct: 136 ------GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 875 SKTPSSSIGIKGTVGY 890
           ++   +   + G V Y
Sbjct: 187 TRWYRAPELLVGDVKY 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEAL 756
           + +   +F   N++G+G F  VY+       + VA+K+I+ K   + G  +   +E +  
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
             ++H +++++        FE  ++  LV E   NG +  +L     +  V+  S  +  
Sbjct: 66  CQLKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEAR 115
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
           +    + + + YLH H    ++H DL  SN+LL  +M   + DFGLA  L   H      
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH------ 166
Query: 877 TPSSSIGIKGTVGYVAP 893
                  + GT  Y++P
Sbjct: 167 --EKHYTLCGTPNYISP 181

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 102/257 (39%), Gaps = 73/257 (28%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-ASKSFVSECEALRNI 759
           S+  ++F     +G+G FG V++     D+   A+K I L  +  A +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 760 RHRNLIKIITIC-------------------SSTDFE----------GVDFKAL------ 784
            H  +++                         STD+            V  + +      
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 785 ------------VFEYME-----NGSLEDWLHQSNDQVEVRKLSLIQR-----MNIAIDV 822
                       V+ Y++       +L+DW++        R+ SL  R     ++I I +
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN--------RRCSLEDREHGVCLHIFIQI 173
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP---- 878
           A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +     +    TP    
Sbjct: 174 AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 879 SSSIGIKGTVGYVAPGK 895
           ++  G  GT  Y++P +
Sbjct: 231 ATHXGQVGTKLYMSPEQ 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 709 SSNMIGQGRFGTVYKGILGD---DEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNL 764
           S  +IG+G FG VY G   D   + +  A+K ++ + +    ++F+ E   +R + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           + +I I      EG+    ++  YM +G L  ++        V+ L     ++  + VA 
Sbjct: 85  LALIGIMLPP--EGL--PHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVAR 135
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +EYL    +   VH DL   N +LD      V DFGLA+
Sbjct: 136 GMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 20/186 (10%)
Query: 691 LFPMVSYA--ELSKATSEFSSSNMIGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQK 743
           +FP   Y   E   +  + +    +GQG FG VY+G     I G+ E  VAVK +N    
Sbjct: 2   VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 61
Query: 744 GASK-SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
              +  F++E   ++     ++++++ + S      V     V E M +G L+ +L    
Sbjct: 62  LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLR 116
Query: 803 DQVE---VRKLSLIQRM-NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
            + E    R    +Q M  +A ++A  + YL+       VH +L   N ++ +D    +G
Sbjct: 117 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIG 173
Query: 859 DFGLAK 864
           DFG+ +
Sbjct: 174 DFGMTR 179

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 31/166 (18%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR----------HR 762
           +G+G +G V+K I      VVAVK I         +F +  +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ ++ +  + +   V    LVF+YME       LH     +    L  + +  +   +
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYMETD-----LHAV---IRANILEPVHKQYVVYQL 118
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
              I+YLH      ++H D+KPSN+LL+ +    V DFGL++   N
Sbjct: 119 IKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++    L+D++  S   +    L LI+  +   
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFLHQ-DLKDFMDAS--ALTGIPLPLIK--SYLF 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 713 IGQGRFGTVYK----GILGDD-EMVVAVKVINLKQKGASKSF---VSECEALRNI-RHRN 763
           +G+G FG V      GI  D  +  V V V  LK     K     VSE E ++ I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------DQVEVRKLSLI 813
           +I ++  C+    +G  +  ++  Y   G+L ++L              ++V   +++  
Sbjct: 103 IINLLGACTQ---DGPLY--VIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 814 QRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
             ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+ ++N  +D
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINN--ID 211
Query: 873 IASKTPSSSIGIKGTVGYVAPGKFF-MLYTH 902
              KT +  + +K    ++AP   F  +YTH
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFDRVYTH 238

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 42/158 (26%), Positives = 83/158 (52%), Gaps = 16/158 (10%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRNLIKIITIC 771
           +G G+FG V+ G   ++   VAVK   LK    S ++F+ E   ++ ++H  L+++  + 
Sbjct: 20  LGAGQFGEVWMGYY-NNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
             T  E +    ++ E+M  GSL D+L       E  K+ L + ++ +  +A  + Y+  
Sbjct: 77  --TKEEPI---YIITEFMAKGSLLDFLKSD----EGGKVLLPKLIDFSAQIAEGMAYIE- 126
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   +H DL+ +NVL+   ++  + DFGLA+ + ++
Sbjct: 127 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 162

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAVK+I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD     P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 41/204 (20%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +F    +IG G FG V+K     D     +K +    + A +    E +AL  + H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIV 67
Query: 766 KIITICSSTDFEGVDFKA----------------LVFEYMENGSLEDWLHQSNDQVEVRK 809
                  +  ++G D+                  +  E+ + G+LE W+ +   +    K
Sbjct: 68  HY-----NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           L  +  + +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL   L N 
Sbjct: 119 LDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 870 HLDIASKTPSSSIGIKGTVGYVAP 893
                S         KGT+ Y++P
Sbjct: 176 GKRXRS---------KGTLRYMSP 190

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 20/186 (10%)
Query: 691 LFPMVSYA--ELSKATSEFSSSNMIGQGRFGTVYKG-----ILGDDEMVVAVKVINLKQK 743
           +FP   Y   E   +  + +    +GQG FG VY+G     I G+ E  VAVK +N    
Sbjct: 1   VFPSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS 60
Query: 744 GASK-SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
              +  F++E   ++     ++++++ + S      V     V E M +G L+ +L    
Sbjct: 61  LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-----VMELMAHGDLKSYLRSLR 115
Query: 803 DQVE---VRKLSLIQRM-NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
            + E    R    +Q M  +A ++A  + YL+       VH +L   N ++ +D    +G
Sbjct: 116 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIG 172
Query: 859 DFGLAK 864
           DFG+ +
Sbjct: 173 DFGMTR 178

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 20/177 (11%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ-----SNDQVEV 807
              ++     ++++++ + S      V     + E M  G L+ +L       +N+ V +
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPAMANNPV-L 122
Query: 808 RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 37/157 (23%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G+FG V+     +    VAVK +      + ++F++E   ++ ++H  L+K+  + +
Sbjct: 23  LGAGQFGEVWMATY-NKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 81  KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 128
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            Q   +H DL+ +N+L+   +V  + DFGLA+ + ++
Sbjct: 129 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 164

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 21/176 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           S +     +G G  G V+  +  D +  VA+K I L    + K  + E + +R + H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 765 IKIITICSSTDFEGVDFKA---------LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           +K+  I   +  +  D            +V EYME   L + L Q     E  +L + Q 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQL 129
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHH 870
           +         ++Y+H      ++H DLKP+N+ ++  D+V  +GDFGLA+ +  H+
Sbjct: 130 LR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAV++I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSP 176

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 37/199 (18%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA---------SKSFVSECEALR 757
           +    ++G+G    V + I        AVK+I++   G+          ++ + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 758 NIR-HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
            +  H N+I++        +E   F  LVF+ M+ G L D+L +  +  + E RK+    
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            M   ++V  A+  L+      +VH DLKP N+LLD DM   + DFG +       LD  
Sbjct: 130 -MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS-----CQLDPG 177
Query: 875 SKTPSSSIGIKGTVGYVAP 893
            K  S    + GT  Y+AP
Sbjct: 178 EKLRS----VCGTPSYLAP 192

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +FS   +IG+G FG VY     D   + A+K ++ K+       + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETL-ALNERIML 243
Query: 766 KIIT-------ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            +++       +C S  F   D  + + + M  G L    H S   V     S       
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRFY 297
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 879 SSSIGIKGTVGYVAP 893
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +FS   +IG+G FG VY     D   + A+K ++ K     +  + + E L  +  R ++
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETL-ALNERIML 242
Query: 766 KIIT-------ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            +++       +C S  F   D  + + + M  G L    H S   V     S       
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRFY 296
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 346
Query: 879 SSSIGIKGTVGYVAP 893
            +S+   GT GY+AP
Sbjct: 347 HASV---GTHGYMAP 358

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +FS   +IG+G FG VY     D   + A+K ++ K+       + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETL-ALNERIML 243
Query: 766 KIIT-------ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            +++       +C S  F   D  + + + M  G L    H S   V     S       
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRFY 297
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 879 SSSIGIKGTVGYVAP 893
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 32/195 (16%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +FS   +IG+G FG VY     D   + A+K ++ K+       + + E L  +  R ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-----MKQGETL-ALNERIML 243
Query: 766 KIIT-------ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            +++       +C S  F   D  + + + M  G L    H S   V     S       
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEADMRFY 297
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++   +E++H+     +V+ DLKP+N+LLD      + D GLA        D + K P
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKP 347
Query: 879 SSSIGIKGTVGYVAP 893
            +S+   GT GY+AP
Sbjct: 348 HASV---GTHGYMAP 359

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++ +  L+D++  S   +    L LI+  +   
Sbjct: 63  HPNIVKLLDVIHTENK-----LYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLF 112
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++ +  L+D++  S   +    L LI+  +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEFL-SMDLKDFMDAS--ALTGIPLPLIK--SYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G +   L + +   E R  + I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----- 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 121 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 165
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 166 SRRXXLXGTLDYLPP 180

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 685 TSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LK 741
           +S  E L+   ++AE       ++   M+G+G FG V K      +   AVKVIN    K
Sbjct: 8   SSGRENLYFQGTFAE------RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQ 800
            K  S + + E E L+ + H N++K+  I   S+ F       +V E    G L D    
Sbjct: 62  NKDTS-TILREVELLKKLDHPNIMKLFEILEDSSSF------YIVGELYTGGELFD---- 110
Query: 801 SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHV 857
             + ++ ++ S      I   V S I Y+H H    +VH DLKP N+LL+    D    +
Sbjct: 111 --EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165
Query: 858 GDFGLA 863
            DFGL+
Sbjct: 166 IDFGLS 171

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 685 TSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LK 741
           +S  E L+   ++AE       ++   M+G+G FG V K      +   AVKVIN    K
Sbjct: 8   SSGRENLYFQGTFAE------RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLHQ 800
            K  S + + E E L+ + H N++K+  I   S+ F       +V E    G L D    
Sbjct: 62  NKDTS-TILREVELLKKLDHPNIMKLFEILEDSSSF------YIVGELYTGGELFD---- 110
Query: 801 SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHV 857
             + ++ ++ S      I   V S I Y+H H    +VH DLKP N+LL+    D    +
Sbjct: 111 --EIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165
Query: 858 GDFGLA 863
            DFGL+
Sbjct: 166 IDFGLS 171

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 21/187 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIK---- 766
           IG G +G   K     D  ++  K ++     +   +  VSE   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           II   ++T +       +V EY E G L   + +   + +      + R+   + +A   
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +        ++H DLKP+NV LD      +GDFGLA+ L NH  D A +         G
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKE-------FVG 178
Query: 887 TVGYVAP 893
           T  Y++P
Sbjct: 179 TPYYMSP 185

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 20/177 (11%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVY----KGILGDD-EMVVAVKVINLKQKGASK-SFVSE 752
           E   A  + + S  +GQG FG VY    KG++ D+ E  VA+K +N       +  F++E
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLH-----QSNDQVEV 807
              ++     ++++++ + S      V     + E M  G L+ +L       +N+ V +
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLV-----IMELMTRGDLKSYLRSLRPAMANNPV-L 132
Query: 808 RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              SL + + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 35/198 (17%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++           E++KLS       A
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 820 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
               ++A+A+ Y H      ++H D+KP N+LL       + DFG            +  
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW-----------SVH 183
Query: 877 TPSS-SIGIKGTVGYVAP 893
            PSS    + GT+ Y+ P
Sbjct: 184 APSSRRTTLCGTLDYLPP 201

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           S+     ++G+G FG   K    +   V+ +K +    +   ++F+ E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 765 IKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +K I         GV +K      + EY++ G+L   +   + Q         QR++ A 
Sbjct: 70  LKFI---------GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAK 115
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           D+AS + YLH      ++H DL   N L+  +    V DFGLA+ + +
Sbjct: 116 DIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 116
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 117 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SCHAPS 161
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 162 SRRTTLSGTLDYLPP 176

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAV++I+  Q  +S  +    E   ++ + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  LV EY   G + D+L       E    +  ++      + SA++Y
Sbjct: 80  EVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------IVSAVQY 128
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSP 176

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 35/191 (18%)
Query: 711 NMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIK 766
           +++G G F  V   IL +D   + +VA+K I  +  +G   S  +E   L  I+H N++ 
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     +E      L+ + +  G L D + +     E     LI        V  A+
Sbjct: 81  LDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI------FQVLDAV 129
Query: 827 EYLHHHCQPPMVHGDLKPSNVL---LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           +YLH      +VH DLKP N+L   LD D    + DFGL+K           + P S + 
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPGSVLS 176
Query: 884 IK-GTVGYVAP 893
              GT GYVAP
Sbjct: 177 TACGTPGYVAP 187

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 85/190 (44%), Gaps = 34/190 (17%)
Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
           M+G+G FG V K      +   AVKVIN    K K  S + + E E L+ + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 769 TICS-STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
            I   S+ F       +V E    G L D +      ++ ++ S      I   V S I 
Sbjct: 88  EILEDSSSF------YIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGIT 135
Query: 828 YLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIG 883
           Y+H H    +VH DLKP N+LL   + D    + DFGL+  F  N  +          I 
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRI- 184
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 185 --GTAYYIAP 192

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 23/167 (13%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++           E++KLS       A
Sbjct: 92  RHPNILRLYGY-----FHDATRVYLILEYAPLGTV---------YRELQKLSKFDEQRTA 137
Query: 820 I---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               ++A+A+ Y H      ++H D+KP N+LL       + DFG +
Sbjct: 138 TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS 181

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 GLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++       + +            I 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------IT 77
Query: 767 IITICSS---TDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L       E   L   Q   I 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 130
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 131 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 179

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 14/193 (7%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHR 762
           +S+F   +++G+G +G V          +VA+K I    K   +   + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N+I I  I     FE  +   ++ E M+       LH+    +  + LS           
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRV---ISTQMLSDDHIQYFIYQT 121
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS- 881
             A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D +  T   S 
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 882 -IGIKGTVGYVAP 893
            +    T  Y AP
Sbjct: 179 MVEFVATRWYRAP 191

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITI 770
           +G+GR+G V++G+   +   VAVK+ + + +   +S+  E E    +  RH N++  I  
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             ++         L+  Y E+GSL D+L +   +  +        + +A+  A  + +LH
Sbjct: 71  DMTSRNSSTQL-WLITHYHEHGSLYDFLQRQTLEPHLA-------LRLAVSAACGLAHLH 122
Query: 831 -----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS--NHHLDIASKTPSSSIG 883
                   +P + H D K  NVL+  ++   + D GLA   S  + +LDI +        
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV---- 178
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 179 --GTKRYMAP 186

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + + V +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K  + F     IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 3   DEEILEKLRIIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 59
Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +       +   D   +V EY+  GSL D + ++  
Sbjct: 60  PKKELIINEILVMRENKNPNIVNYL-----DSYLVGDELWVVMEYLAGGSLTDVVTETC- 113
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            ++  +++ + R     +   A+E+LH +    ++H ++K  N+LL  D    + DFG  
Sbjct: 114 -MDEGQIAAVCR-----ECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFC 164
Query: 864 KFLSNHHLDIASKTPSSSI--GIKGTVGYVAP 893
                     A  TP  S    + GT  ++AP
Sbjct: 165 ----------AQITPEQSKRSTMVGTPYWMAP 186

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY     + + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 116 -ELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 160
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 161 SRRAALCGTLDYLPP 175

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 72  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G +   L + +   E R  + I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----- 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 121 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 165
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 166 SRRTTLCGTLDYLPP 180

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++       + +            I 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-----------EIT 72
Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L       E   L   Q   I 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 125
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 126 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 63  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 112
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 63  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 112
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 62  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++       + +            I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-----------EIT 57
Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L       E   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 110
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++       + +            I 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ-----------EIT 57
Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L       E   L   Q   I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 110
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 111 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 159

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 62  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 61  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 110
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 65  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 114
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 63  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 112
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 113 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L +  D   +  + L    +   
Sbjct: 62  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLF 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 72  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 121
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VA+K+I+  Q   +  +    E   ++ + H N++K+ 
Sbjct: 20  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  L+ EY   G + D+L       E    S  ++      + SA++Y
Sbjct: 78  EVIET---EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F     LD    +P
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSP 174

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 66  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 14/169 (8%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRH 761
            S++     IGQG FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 762 RNLIKIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            N++ +I IC +        KA   LVF++ E+  L   L  SN  V   K +L +   +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLL--SNVLV---KFTLSEIKRV 130
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+  S
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 31/171 (18%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---VSECEALRNIRHRN 763
           FS    IG G FG VY      +  VVA+K ++   K +++ +   + E   L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            I+         + G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 116 TIQ---------YRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 157
Query: 820 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
                A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 35/190 (18%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA------SKSFVSECEALRNIRHRNLIK 766
           +G G +G V   +L  D++  A + I + +K +      S + + E   L+ + H N++K
Sbjct: 29  LGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +        FE      LV E    G L D      + +  +K S +    I   V S  
Sbjct: 86  LYEF-----FEDKRNYYLVMEVYRGGELFD------EIILRQKFSEVDAAVIMKQVLSGT 134
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
            YLH H    +VH DLKP N+LL+    D +  + DFGL+      H ++  K       
Sbjct: 135 TYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVGGKMKER--- 183
Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 184 -LGTAYYIAP 192

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 26/191 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVI--NLKQKGASKSFVSECEALRN 758
           +E     ++G G FGTVYKGI   D    ++ VA+KV+  N   K A+K  + E   +  
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAG 75
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           +    + +++ IC ++  +      LV + M  G L D + ++  ++  + L     +N 
Sbjct: 76  VGSPYVSRLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL-----LNW 124
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL----SNHHLDIA 874
            + +A  + YL       +VH DL   NVL+       + DFGLA+ L    + +H D  
Sbjct: 125 CMQIAKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD-G 180
Query: 875 SKTPSSSIGIK 885
            K P   + ++
Sbjct: 181 GKVPIKWMALE 191

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+  + IG+G FG VYKGI    + VVA+K+I+L++       + +            I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQ-----------EIT 69
Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K+    ++ EY+  GS  D L      +E   ++ I R    
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 123
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 124 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 171

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 16/190 (8%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHR 762
           +S+F   +++G+G +G V          +VA+K I    K   +   + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N+I I  I     FE  +   ++ E M+       LH+    +  + LS           
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRV---ISTQMLSDDHIQYFIYQT 121
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D +  T   S 
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS- 177
Query: 883 GIKGTVGYVA 892
              G   YVA
Sbjct: 178 ---GMTEYVA 184

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 37/199 (18%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA---------SKSFVSECEALR 757
           +    ++G+G    V + I        AVK+I++   G+          ++ + E + LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 758 NIR-HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
            +  H N+I++        +E   F  LVF+ M+ G L D+L +  +  + E RK+    
Sbjct: 79  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 129
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            M   ++V  A+  L+      +VH DLKP N+LLD DM   + DFG +       LD  
Sbjct: 130 -MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS-----CQLDPG 177
Query: 875 SKTPSSSIGIKGTVGYVAP 893
            K       + GT  Y+AP
Sbjct: 178 EKLRE----VCGTPSYLAP 192

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 37/199 (18%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA---------SKSFVSECEALR 757
           +    ++G+G    V + I        AVK+I++   G+          ++ + E + LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 758 NIR-HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
            +  H N+I++        +E   F  LVF+ M+ G L D+L +  +  + E RK+    
Sbjct: 66  KVSGHPNIIQL-----KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI---- 116
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            M   ++V  A+  L+      +VH DLKP N+LLD DM   + DFG +       LD  
Sbjct: 117 -MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS-----CQLDPG 164
Query: 875 SKTPSSSIGIKGTVGYVAP 893
            K       + GT  Y+AP
Sbjct: 165 EKLRE----VCGTPSYLAP 179

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VA+K+I+  Q   +  +    E   ++ + H N++K+ 
Sbjct: 23  IGKGNFAKVKLARHILTGRE--VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +   E   +  L+ EY   G + D+L       E    S  ++      + SA++Y
Sbjct: 81  EVIET---EKTLY--LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------IVSAVQY 129
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            H   Q  +VH DLK  N+LLD DM   + DFG + +F     LD     P
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAP 177

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE+++       L +  D   +  + L    +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEHVDQD-----LKKFMDASALTGIPLPLIKSYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 684 DTSPMEKLFPMVSYAELSK---ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI-- 738
           + +P E+L       E  K   A  +F     +G+G+FG VY       + ++A+KV+  
Sbjct: 1   ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 60
Query: 739 -NLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDW 797
             L++ G       E E   ++RH N++++        F       L+ EY   G++   
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRE 115
Query: 798 LHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV 857
           L + +   E R  + I       ++A+A+ Y H      ++H D+KP N+LL       +
Sbjct: 116 LQKLSKFDEQRTATYIT------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 166
Query: 858 GDFGLAKFLSNHHLDIASKTPSS-SIGIKGTVGYVAP 893
            DFG            +   PSS    + GT+ Y+ P
Sbjct: 167 ADFGW-----------SVHAPSSRRTTLCGTLDYLPP 192

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 163
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 164 SRRAALCGTLDYLPP 178

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 160
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 161 SRRAALCGTLDYLPP 175

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++   S++  L +  D   +  + L    +   
Sbjct: 62  HPNIVKLLDVIHTENK-----LYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLF 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++   S++  L +  D   +  + L    +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEFL---SMD--LKKFMDASALTGIPLPLIKSYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 707 FSSSNMIGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
           +     IG+G F  V   + +L   E  VAVK+I+  Q   +  +    E   ++ + H 
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGRE--VAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++K+  +  +   E   +  LV EY   G + D+L       E    +  ++      +
Sbjct: 75  NIVKLFEVIET---EKTLY--LVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------I 123
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
            SA++Y H   Q  +VH DLK  N+LLD DM   + DFG + +F   + LD    +P
Sbjct: 124 VSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSP 177

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 36/178 (20%)
Query: 713 IGQGRFGTVYK----GILGDDEM-VVAVKVINLKQKGAS---KSFVSECEALRNIRHRNL 764
           IG+G FG V++    G+L  +   +VAVK+  LK++ ++     F  E   +    + N+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDNPNI 112
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ---------SNDQVEVRK------ 809
           +K++ +C+           L+FEYM  G L ++L           S+  +  R       
Sbjct: 113 VKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 810 ---LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              LS  +++ IA  VA+ + YL        VH DL   N L+  +MV  + DFGL++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 69  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 118
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 119 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 95  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 141
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 142 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 191
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 192 ARANXFV-GTAQYVSP 206

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSEC---EALRNIRHRN 763
           +     +G G FG V + I  D    VA+K    +Q+ + K+    C   + ++ + H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 764 LIKIITICSS-TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           ++    +          D   L  EY E G L  +L+Q  +   +++  +     +  D+
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLSDI 130
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
           +SA+ YLH +    ++H DLKP N++L      ++  + D G AK L    L        
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-------- 179
Query: 880 SSIGIKGTVGYVAP 893
                 GT+ Y+AP
Sbjct: 180 -CTEFVGTLQYLAP 192

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 121 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 165
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 166 SRRTDLCGTLDYLPP 180

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 160
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 161 SRRTDLCGTLDYLPP 175

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 160
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 161 SRRTDLCGTLDYLPP 175

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 116
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 117 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 161
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 162 SRRTDLCGTLDYLPP 176

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 24/194 (12%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSEC---EALRNIRHRN 763
           +     +G G FG V + I  D    VA+K    +Q+ + K+    C   + ++ + H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 764 LIKIITICSS-TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           ++    +          D   L  EY E G L  +L+Q  +   +++  +     +  D+
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLSDI 131
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
           +SA+ YLH +    ++H DLKP N++L      ++  + D G AK L    L        
Sbjct: 132 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-------- 180
Query: 880 SSIGIKGTVGYVAP 893
                 GT+ Y+AP
Sbjct: 181 -CTEFVGTLQYLAP 193

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 117
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  + H   + +T  
Sbjct: 118 -ELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANFGWSVHAPSSRRTT- 167
Query: 880 SSIGIKGTVGYVAP 893
               + GT+ Y+ P
Sbjct: 168 ----LCGTLDYLPP 177

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL        G+  +A F  + H   + +T  
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLL-----GSAGELKIANFGWSVHAPSSRRTT- 168
Query: 880 SSIGIKGTVGYVAP 893
               + GT+ Y+ P
Sbjct: 169 ----LCGTLDYLPP 178

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIR 760
           +   F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N++K++ +  + +        LVFE++        L    D   +  + L    +   
Sbjct: 64  HPNIVKLLDVIHTENK-----LYLVFEFLHQD-----LKTFMDASALTGIPLPLIKSYLF 113
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            +   + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+   C   D      + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 97  PFFVKLY-FCFQDD------EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 143
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 144 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 193
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 194 ARANXFV-GTAQYVSP 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRN 758
           K   +F    ++G+G F TV            A+K++  +   K     +V+ E + +  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
           + H   +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +   
Sbjct: 64  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT--- 113
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                 ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       
Sbjct: 114 -----AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----- 160
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK   ++  + GT  YV+P
Sbjct: 161 SKQARANXFV-GTAQYVSP 178

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 119
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 120 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 164
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 165 SRRTTLCGTLDYLPP 179

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 163
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 164 SRRTTLCGTLDYLPP 178

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 114
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 115 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 159
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 160 SRRTTLCGTLDYLPP 174

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 121 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 165
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 166 SRRTTLCGTLDYLPP 180

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 163
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 164 SRRTTLCGTLDYLPP 178

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 120
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 121 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 165
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 166 SRRTTLCGTLDYLPP 180

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 160
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 161 SRRTTLCGTLDYLPP 175

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRN 758
           K   +F    ++G+G F TV            A+K++  +   K     +V+ E + +  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
           + H   +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +   
Sbjct: 66  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT--- 115
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                 ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       
Sbjct: 116 -----AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----- 162
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK   ++  + GT  YV+P
Sbjct: 163 SKQARANXFV-GTAQYVSP 180

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 117
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 118 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRN 758
           K   +F    ++G+G F TV            A+K++  +   K     +V+ E + +  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
           + H   +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +   
Sbjct: 67  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT--- 116
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                 ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       
Sbjct: 117 -----AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----- 163
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK   ++  + GT  YV+P
Sbjct: 164 SKQARANXFV-GTAQYVSP 181

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 116
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 117 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANXFV-GTAQYVSP 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 31/199 (15%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRN 758
           K   +F    ++G+G F TV            A+K++  +   K     +V+ E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQ 814
           + H   +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +   
Sbjct: 65  LDHPFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT--- 114
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                 ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       
Sbjct: 115 -----AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----- 161
Query: 875 SKTPSSSIGIKGTVGYVAP 893
           SK   ++  + GT  YV+P
Sbjct: 162 SKQARANXFV-GTAQYVSP 179

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 118
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 119 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
            ++A+A+ Y H      ++H D+KP N+LL       + DFG
Sbjct: 116 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 137 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 186
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 187 ARANAFV-GTAQYVSP 201

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 31/171 (18%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF---VSECEALRNIRHRN 763
           FS    IG G FG VY      +  VVA+K ++   K +++ +   + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            I+         + G   +     LV EY         L  ++D +EV K  L Q + IA
Sbjct: 77  TIQ---------YRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 118
Query: 820 IDVASAIE---YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
                A++   YLH H    M+H D+K  N+LL    +  +GDFG A  ++
Sbjct: 119 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANXFV-GTAQYVSP 203

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 35/199 (17%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA------SKSFVSECEALR 757
           +  +     +G G +G V   +L  D++  A + I + +K +      S + + E   L+
Sbjct: 3   SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 59
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
            + H N++K+        FE      LV E    G L D +      +  +K S +    
Sbjct: 60  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEI------ILRQKFSEVDAAV 108
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIA 874
           I   V S   YLH H    +VH DLKP N+LL+    D +  + DFGL+      H ++ 
Sbjct: 109 IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSA-----HFEVG 160
Query: 875 SKTPSSSIGIKGTVGYVAP 893
            K         GT  Y+AP
Sbjct: 161 GKMKERL----GTAYYIAP 175

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 137 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 186
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 187 ARANXFV-GTAQYVSP 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 139
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 140 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 189
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 190 ARANXFV-GTAQYVSP 204

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G+FG V+     +    VAVK +        ++F++E   ++ ++H  L+K+  + +
Sbjct: 190 LGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      ++ E+M  GSL D+L       E  K  L + ++ +  +A  + ++   
Sbjct: 248 KEPI------YIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFIE-- 295
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            Q   +H DL+ +N+L+   +V  + DFGLA+
Sbjct: 296 -QRNYIHRDLRAANILVSASLVCKIADFGLAR 326

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 135 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 137 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 186
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 187 ARANXFV-GTAQYVSP 201

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANXFV-GTAQYVSP 203

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 135
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 136 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 185
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 186 ARANXFV-GTAQYVSP 200

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANXFV-GTAQYVSP 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANXFV-GTAQYVSP 203

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 86/194 (44%), Gaps = 33/194 (17%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEM---VVAVKVINLKQ-KGASKSFVSECEALRNIRHR 762
           F     +G G F  V   +L +++    + AVK I  K  KG   S  +E   LR I+H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ +  I     +E  +   LV + +  G L D + +     E    +LI++      V
Sbjct: 81  NIVALEDI-----YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ------V 129
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             A+ YLH   +  +VH DLKP N+L    D +    + DFGL+K       D+ S    
Sbjct: 130 LDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG--DVMSTAC- 183
Query: 880 SSIGIKGTVGYVAP 893
                 GT GYVAP
Sbjct: 184 ------GTPGYVAP 191

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 44/173 (25%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 710 SNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLI 765
           + ++G+G FG VY+G+  +   +++ VAVK         +K  F+SE   ++N+ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+I I         +   ++ E    G L  +L ++ + ++V  L L      ++ +  A
Sbjct: 89  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKA 137
Query: 826 IEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           + YL   +C    VH D+   N+L+       +GDFGL++++ +     AS T
Sbjct: 138 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 44/173 (25%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 710 SNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLI 765
           + ++G+G FG VY+G+  +   +++ VAVK         +K  F+SE   ++N+ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+I I         +   ++ E    G L  +L ++ + ++V  L L      ++ +  A
Sbjct: 73  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKA 121
Query: 826 IEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           + YL   +C    VH D+   N+L+       +GDFGL++++ +     AS T
Sbjct: 122 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 170

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 44/173 (25%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 710 SNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRNLI 765
           + ++G+G FG VY+G+  +   +++ VAVK         +K  F+SE   ++N+ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+I I         +   ++ E    G L  +L ++ + ++V  L L      ++ +  A
Sbjct: 77  KLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY-----SLQICKA 125
Query: 826 IEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
           + YL   +C    VH D+   N+L+       +GDFGL++++ +     AS T
Sbjct: 126 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNL 764
           ++    +IG G    V        +  VA+K INL++ + +    + E +A+    H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI---D 821
           +   T      F   D   LV + +  GS+ D +     + E  K  ++    IA    +
Sbjct: 71  VSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILRE 124
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           V   +EYLH + Q   +H D+K  N+LL  D    + DFG++ FL+
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLA 167

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNL 764
           ++    +IG G    V        +  VA+K INL++ + +    + E +A+    H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI---D 821
           +   T      F   D   LV + +  GS+ D +     + E  K  ++    IA    +
Sbjct: 76  VSYYT-----SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILRE 129
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           V   +EYLH + Q   +H D+K  N+LL  D    + DFG++ FL+
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLA 172

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHR 762
           +   +++G G F  V   IL +D   + +VA+K I  K  +G   S  +E   L  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ +  I     +E      L+ + +  G L D + +     E     LI        V
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI------FQV 125
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVL---LDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             A++YLH      +VH DLKP N+L   LD D    + DFGL+K           + P 
Sbjct: 126 LDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPG 172
Query: 880 SSIGIK-GTVGYVAP 893
           S +    GT GYVAP
Sbjct: 173 SVLSTACGTPGYVAP 187

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRH 761
            S++     IGQG FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 762 RNLIKIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            N++ +I IC +        K    LVF++ E+  L   L  SN  V   K +L +   +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLV---KFTLSEIKRV 130
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+  S
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 113 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIK---- 766
           IG G +G   K     D  ++  K ++     +   +  VSE   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           II   ++T +       +V EY E G L   + +   + +      + R+   + +A   
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +        ++H DLKP+NV LD      +GDFGLA+ L NH    A           G
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAK-------AFVG 178
Query: 887 TVGYVAP 893
           T  Y++P
Sbjct: 179 TPYYMSP 185

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 93  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 139
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 140 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 189
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 190 ARANSFV-GTAQYVSP 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 29/195 (14%)
Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI 759
           A  +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH N++++        F       L+ EY   G++   L + +   E R  + I      
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----- 112
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
            ++A+A+ Y H      ++H D+KP N+LL       + DFG            +   PS
Sbjct: 113 -ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPS 157
Query: 880 S-SIGIKGTVGYVAP 893
           S    + GT+ Y+ P
Sbjct: 158 SRRTTLCGTLDYLPP 172

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 29/192 (15%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHR 762
           +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++++        F       L+ EY   G++   L + +   E R  + I       ++
Sbjct: 73  NILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT------EL 121
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS-S 881
           A+A+ Y H      ++H D+KP N+LL  +    + DFG            +   PSS  
Sbjct: 122 ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGW-----------SVHAPSSRR 167
Query: 882 IGIKGTVGYVAP 893
             + GT+ Y+ P
Sbjct: 168 TTLCGTLDYLPP 179

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHR 762
           +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++++        F       L+ EY   G++   L + +   E R  + I       ++
Sbjct: 73  NILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT------EL 121
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG 861
           A+A+ Y H      ++H D+KP N+LL  +    + DFG
Sbjct: 122 ANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 14/193 (7%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHR 762
           +S+F   +++G+G +G V          +VA+K I    K   +   + E + L++ +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N+I I  I     FE  +   ++ E M+       LH+    +  + LS           
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRV---ISTQMLSDDHIQYFIYQT 121
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS- 881
             A++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D +  T   S 
Sbjct: 122 LRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 882 -IGIKGTVGYVAP 893
                 T  Y AP
Sbjct: 179 MTEXVATRWYRAP 191

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 31/195 (15%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRHR 762
           +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 763 NLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMNI 818
             +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +       
Sbjct: 75  FFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------- 120
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
             ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK  
Sbjct: 121 -AEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQA 171
Query: 879 SSSIGIKGTVGYVAP 893
            ++  + GT  YV+P
Sbjct: 172 RANXFV-GTAQYVSP 185

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 139 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 190 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 89  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 135
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 136 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 185
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 186 ARANSFV-GTAQYVSP 200

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 21/187 (11%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIK---- 766
           IG G +G   K     D  ++  K ++     +   +  VSE   LR ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           II   ++T +       +V EY E G L   + +   + +      + R+   + +A   
Sbjct: 74  IIDRTNTTLY-------IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +        ++H DLKP+NV LD      +GDFGLA+ L NH    A           G
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-------FVG 178
Query: 887 TVGYVAP 893
           T  Y++P
Sbjct: 179 TPYYMSP 185

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRH 761
            S++     IGQG FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 762 RNLIKIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            N++ +I IC +        K    LVF++ E+  L   L  SN  V   K +L +   +
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLV---KFTLSEIKRV 130
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+  S
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 14/169 (8%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRH 761
            S++     IGQG FG V+K         VA+K + ++  ++G   + + E + L+ ++H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 762 RNLIKIITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            N++ +I IC +        K    LVF++ E+  L   L  SN  V   K +L +   +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLV---KFTLSEIKRV 129
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
              + + + Y+H +    ++H D+K +NVL+  D V  + DFGLA+  S
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L    D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEHVHQD-----LKTFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 90  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 140
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 115 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 165
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 166 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 22/157 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +GTV+K    +   +VA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 771 CSSTDFEGVDFK-ALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIE 827
             S      D K  LVFE+ +   L+ +    N  +  E+ K  L Q +         + 
Sbjct: 70  LHS------DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK-------GLG 115
Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F TV            A+K++  +   K     +V+ E + +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 92  PFFVKLY-------FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYT------ 138
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 139 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 188
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 189 ARANSFV-GTAQYVSP 203

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 116 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 166
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 167 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  VS      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 105 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 155
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 156 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 98  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 28/172 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F+    IG+G FG V+KGI    + VVA+K+I+L++       + +            I 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE-----------IT 73
Query: 767 IITICSS---TDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +++ C S   T + G   K     ++ EY+  GS  D L               Q   + 
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATML 126
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL 871
            ++   ++YLH   +   +H D+K +NVLL       + DFG+A  L++  +
Sbjct: 127 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 113 CI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 98  CI---------GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+  I L  + +G   + + E   L+ + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 65  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+  I L  + +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQD-----LKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 711 NMIGQGRFGTV---YKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           + +G+G FG+V       LGD+   +VAVK +        + F  E + L+ +    ++K
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +      + +    LV EY+ +G L D+L +   +++  +L L      +  +   +
Sbjct: 77  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 128
Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 129 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 711 NMIGQGRFGTV---YKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           + +G+G FG+V       LGD+   +VAVK +        + F  E + L+ +    ++K
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +      + +    LV EY+ +G L D+L +   +++  +L L      +  +   +
Sbjct: 76  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 127
Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 128 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 711 NMIGQGRFGTV---YKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           + +G+G FG+V       LGD+   +VAVK +        + F  E + L+ +    ++K
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +      + +    LV EY+ +G L D+L +   +++  +L L      +  +   +
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRLLLY-----SSQICKGM 140
Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 78
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 135
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 136 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 711 NMIGQGRFGTV----YKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           + +G+G FG+V    Y  +  +   +VAVK +        + F  E + L+ +    ++K
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 767 IITICSSTDFEGVDFKA------LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
                    + GV +        LV EY+ +G L D+L +   +++  +L L        
Sbjct: 73  ---------YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS----- 118
Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            +   +EYL    C    VH DL   N+L++ +    + DFGLAK L
Sbjct: 119 QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 113 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 164 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVS-ECEALRNIRH 761
            +F    ++G+G F T             A+K++  +   K     +V+ E + +  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 762 RNLIKIITICSSTDFEGVDFKALVF--EYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMN 817
              +K+        F   D + L F   Y +NG L  ++ +  S D+   R  +      
Sbjct: 90  PFFVKLY-------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT------ 136
Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKT 877
              ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       SK 
Sbjct: 137 --AEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-----SKQ 186
Query: 878 PSSSIGIKGTVGYVAP 893
             ++  + GT  YV+P
Sbjct: 187 ARANXFV-GTAQYVSP 201

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 99  CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 149
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 146
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 713 IGQGRFGTVY--KGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
           IG+G F  V   + IL   E  VAVK+I+  Q  +S  +    E    + + H N++K+ 
Sbjct: 22  IGKGNFAKVKLARHILTGKE--VAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVASAI 826
            +  +   E   +  LV EY   G + D+L  H    + E R             + SA+
Sbjct: 80  EVIET---EKTLY--LVXEYASGGEVFDYLVAHGRXKEKEARAKFR--------QIVSAV 126
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA-KFLSNHHLDIASKTP 878
           +Y H   Q  +VH DLK  N+LLD D    + DFG + +F   + LD     P
Sbjct: 127 QYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAP 176

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 172
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 113
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 170
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 213
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +      +  LS       A+ VA  +
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            YL        +H DL   N+LL    +  +GDFGL + L
Sbjct: 129 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 81
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 138
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 139 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 82
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 139
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 140 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 713 IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIK 766
           +G G FG VY+G    + +D   + V V  L +  + +    F+ E   +    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 767 IITICSSTDFEGVDFKAL----VFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAID 821
            I         GV  ++L    + E M  G L+ +L ++  +  +   L+++  +++A D
Sbjct: 125 CI---------GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 175
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAK 864
           +A   +YL  +     +H D+   N LL       VA +GDFG+A+
Sbjct: 176 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 90
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 147
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 148 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 96
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 153
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 154 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 168
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K   + Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K   + Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 85
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 142
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 143 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 105
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 162
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 168
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 22/196 (11%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRHR 762
            ++     IG+G +G V+K    D   +VA+K     +      K  + E   L+ ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           NL+ ++ +     F       LVFEY ++  L    H+ +         L++  +I    
Sbjct: 63  NLVNLLEV-----FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVK--SITWQT 111
Query: 823 ASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL---SNHHLD-IASKT 877
             A+ + H H+C    +H D+KP N+L+    V  + DFG A+ L   S+++ D +A++ 
Sbjct: 112 LQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW 167
Query: 878 PSSSIGIKGTVGYVAP 893
             S   + G   Y  P
Sbjct: 168 YRSPELLVGDTQYGPP 183

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 146
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 700 LSKATSE-FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI----NLKQKGASKSFVSECE 754
           L+K   E F     +G+G +G+VYK I  +   +VA+K +    +L++     S + +C+
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD 82
Query: 755 ALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
           +   +++            + F+  D   +V EY   GS+ D +   N  +   +++ I 
Sbjct: 83  SPHVVKY----------YGSYFKNTDL-WIVMEYCGAGSVSDIIRLRNKTLTEDEIATIL 131
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           +  +       +EYLH   +   +H D+K  N+LL+ +  A + DFG+A  L++
Sbjct: 132 QSTL-----KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 78/144 (54%), Gaps = 20/144 (13%)
Query: 713 IGQGRFGTVYKGI---LGD----DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +GQG F  ++KG+   +GD     E  V +KV++   +  S+SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
               +C   D E +    LV E+++ GSL+ +L ++ + +     +++ ++ +A  +A+A
Sbjct: 76  LNYGVCVCGD-ENI----LVQEFVKFGSLDTYLKKNKNCI-----NILWKLEVAKQLAAA 125
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLL 849
           + +L  +    ++HG++   N+LL
Sbjct: 126 MHFLEENT---LIHGNVCAKNILL 146

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHR 762
           +   +++G G F  V   IL +D   + +VA+K I  +  +G   S  +E   L  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ +  I     +E      L+ + +  G L D + +     E     LI        V
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI------FQV 125
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVL---LDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             A++YLH      +VH DLKP N+L   LD D    + DFGL+K           + P 
Sbjct: 126 LDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPG 172
Query: 880 SSIGIK-GTVGYVAP 893
           S +    GT GYVAP
Sbjct: 173 SVLSTACGTPGYVAP 187

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 35/195 (17%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHR 762
           +   +++G G F  V   IL +D   + +VA+K I  +  +G   S  +E   L  I+H 
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ +  I     +E      L+ + +  G L D + +     E     LI        V
Sbjct: 77  NIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI------FQV 125
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVL---LDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             A++YLH      +VH DLKP N+L   LD D    + DFGL+K           + P 
Sbjct: 126 LDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----------EDPG 172
Query: 880 SSIGIK-GTVGYVAP 893
           S +    GT GYVAP
Sbjct: 173 SVLSTACGTPGYVAP 187

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 38/230 (16%)
Query: 680 HKSVDTSPMEKLFPMVSYAELSKA-----------TSEFSSSNMIGQGRFGTVYKGILGD 728
           +   + SP+ +   ++ Y E +K              +F    +IG+G FG V    L +
Sbjct: 38  YDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN 97
Query: 729 DEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV 785
            + V A+K++N   + ++  +  F  E + L N       K IT      F+  +   LV
Sbjct: 98  ADKVFAMKILNKWEMLKRAETACFREERDVLVN----GDSKWITTLHYA-FQDDNNLYLV 152
Query: 786 FEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK 843
            +Y   G L   L +  D++  E+ +  L + M IAID    + Y         VH D+K
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLHY---------VHRDIK 202
Query: 844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           P N+L+D +    + DFG    L      +   T  SS+ + GT  Y++P
Sbjct: 203 PDNILMDMNGHIRLADFGSCLKL------MEDGTVQSSVAV-GTPDYISP 245

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 719 GTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG 778
           G ++KG    +++VV V  +       S+ F  EC  LR   H N++ ++  C S     
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--- 80
Query: 779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV 838
                L+  +M  GSL + LH+  + V    +   Q +  A+D+A  + +L H  +P + 
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFALDMARGMAFL-HTLEPLIP 135
Query: 839 HGDLKPSNVLLDYDMVAHV 857
              L   +V++D DM A +
Sbjct: 136 RHALNSRSVMIDEDMTARI 154

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKII 768
            +IG+GRFG VY G    +   VA+++I++++      K+F  E  A R  RH N++  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
             C S         A++    +  +L   +  +   ++V K        IA ++   + Y
Sbjct: 96  GACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR-----QIAQEIVKGMGY 145
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           LH      ++H DLK  NV  D   V  + DFGL
Sbjct: 146 LH---AKGILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEA 755
           A  ++ T ++     +G+G F  V + +        A K+IN K+  A   +    E   
Sbjct: 24  ATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
            R ++H N++++     S   EG  F  LVF+ +  G L +      D V     S    
Sbjct: 84  CRLLKHPNIVRLH---DSISEEG--FHYLVFDLVTGGELFE------DIVAREYYSEADA 132
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLD 872
            +    +  ++ ++H H    +VH DLKP N+LL          + DFGLA       ++
Sbjct: 133 SHCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-------IE 182
Query: 873 IASKTPSSSIGIKGTVGYVAP 893
           +  +   +  G  GT GY++P
Sbjct: 183 VQGEQ-QAWFGFAGTPGYLSP 202

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 12/162 (7%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K   + Q  A K+   E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKN--RELQIMRKLDHCNIVR 77
Query: 767 I-ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFL 866
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 27/186 (14%)
Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITI 770
            ++G G F  V+         + A+K I         S  +E   L+ I+H N++ +  I
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                +E      LV + +  G L D + +     E     +IQ+      V SA++YLH
Sbjct: 75  -----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------VLSAVKYLH 123
Query: 831 HHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
            +    +VH DLKP N+L    + +    + DFGL+K   N  +  A  TP         
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP--------- 171
Query: 888 VGYVAP 893
            GYVAP
Sbjct: 172 -GYVAP 176

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEA 755
           E+     +F    +IG+G FG V    + + E + A+K++N   + ++  +  F  E + 
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQ 814
           L N       + IT      F+  +   LV +Y   G L   L +  D++ E      I 
Sbjct: 128 LVN----GDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            M +AID   +I  LH+      VH D+KP NVLLD +    + DFG    +++      
Sbjct: 183 EMVLAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND------ 227
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T  SS+ + GT  Y++P
Sbjct: 228 DGTVQSSVAV-GTPDYISP 245

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 77/144 (53%), Gaps = 20/144 (13%)
Query: 713 IGQGRFGTVYKGI---LGD----DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +GQG F  ++KG+   +GD     E  V +KV++   +  S+SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
               +C    F G D   LV E+++ GSL+ +L ++ + +     +++ ++ +A  +A A
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNKNCI-----NILWKLEVAKQLAWA 125
Query: 826 IEYLHHHCQPPMVHGDLKPSNVLL 849
           + +L  +    ++HG++   N+LL
Sbjct: 126 MHFLEENT---LIHGNVCAKNILL 146

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEA 755
           E+     +F    +IG+G FG V    + + E + A+K++N   + ++  +  F  E + 
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQ 814
           L N       + IT      F+  +   LV +Y   G L   L +  D++ E      I 
Sbjct: 144 LVN----GDCQWITALHYA-FQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            M +AID   +I  LH+      VH D+KP NVLLD +    + DFG    +++      
Sbjct: 199 EMVLAID---SIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND------ 243
Query: 875 SKTPSSSIGIKGTVGYVAP 893
             T  SS+ + GT  Y++P
Sbjct: 244 DGTVQSSVAV-GTPDYISP 261

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 27/190 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G G FG V+        +   +K IN  + +   +   +E E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
               FE      +V E  E G L + +  +  Q   + LS      +   + +A+ Y H 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSA--QARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAH----VGDFGLAK-FLSNHHLDIASKTPSSSIGIKG 886
                +VH DLKP N+L   D   H    + DFGLA+ F S+ H          S    G
Sbjct: 143 Q---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEH----------STNAAG 188
Query: 887 TVGYVAPGKF 896
           T  Y+AP  F
Sbjct: 189 TALYMAPEVF 198

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 23/193 (11%)
Query: 678 STHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKV 737
           S H+S    P E++ P   Y +    T E      +G G FGTV KG     ++V  V V
Sbjct: 2   SLHESPYADP-EEIRPKEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQMKKVVKTVAV 57
Query: 738 INLKQKGASKSF----VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGS 793
             LK +    +     ++E   ++ + +  ++++I IC +  +       LV E  E G 
Sbjct: 58  KILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGP 111
Query: 794 LEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
           L  +L Q+    +   + L+ +      V+  ++YL    +   VH DL   NVLL    
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQ------VSMGMKYLE---ESNFVHRDLAARNVLLVTQH 162
Query: 854 VAHVGDFGLAKFL 866
            A + DFGL+K L
Sbjct: 163 YAKISDFGLSKAL 175

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 146
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 147 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 197
Query: 870 H 870
           H
Sbjct: 198 H 198

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 126
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 127 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 177
Query: 870 H 870
           H
Sbjct: 178 H 178

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 128
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 129 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 870 H 870
           H
Sbjct: 180 H 180

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNL 764
            +++ + IG+G +G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           I I  I  +   E +    +V + ME     L    H SND +                +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----------CYFLYQI 133
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH 178

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 75
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 131
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 132 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 870 H 870
           H
Sbjct: 183 H 183

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 17  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 76
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 132
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 133 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 183
Query: 870 H 870
           H
Sbjct: 184 H 184

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 8   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 67
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 123
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 124 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 174
Query: 870 H 870
           H
Sbjct: 175 H 175

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 78
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 134
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 135 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 185
Query: 870 H 870
           H
Sbjct: 186 H 186

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 126
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 127 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 870 H 870
           H
Sbjct: 178 H 178

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 24/166 (14%)
Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIK 766
           +G+ RFG VYKG L     G+    VA+K +  K +G   + F  E      ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLSLIQRM 816
           ++ + +          +++F Y  +G L ++L             +D+     L     +
Sbjct: 77  LLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           ++   +A+ +EYL  H    +VH DL   NVL+   +   + D GL
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGL 174

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 68
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 124
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 125 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 870 H 870
           H
Sbjct: 176 H 176

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 75
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 131
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 132 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 182
Query: 870 H 870
           H
Sbjct: 183 H 183

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 126
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 127 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 177
Query: 870 H 870
           H
Sbjct: 178 H 178

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 27/191 (14%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHR 762
           +F     +G+G+FG VY         +VA+KV+    ++++G       E E   ++ H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++++        F       L+ EY   G L   L +S    E R  ++++      ++
Sbjct: 84  NILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIME------EL 132
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           A A+ Y H      ++H D+KP N+LL       + DFG     S H   +  KT     
Sbjct: 133 ADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKT----- 180
Query: 883 GIKGTVGYVAP 893
            + GT+ Y+ P
Sbjct: 181 -MCGTLDYLPP 190

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 40/179 (22%)
Query: 705 SEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVK----------VINLKQKGASKSFVSEC 753
           +E +   +IG G FG VY+   +GD+  V A +          + N++Q         E 
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQ---------EA 57
Query: 754 EALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           +    ++H N+I +  +C            LV E+   G L       N  +  +++   
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPN-----LCLVMEFARGGPL-------NRVLSGKRIPPD 105
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDM---VAHVGDFGLAK 864
             +N A+ +A  + YLH     P++H DLK SN+L+     + D+   +  + DFGLA+
Sbjct: 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNL 764
            +++ + IG+G +G V       +++ VA+K I+  + +   +  + E + L   RH N+
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           I I  I  +   E +    +V + ME     L    H SND +                +
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI----------CYFLYQI 133
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H
Sbjct: 134 LRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH 178

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 22/165 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHR 762
            ++     IG+G +GTV+K    +   +VA+K + L    +G   S + E   L+ ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 763 NLIKIITICSSTDFEGVDFK-ALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIA 819
           N++++  +  S      D K  LVFE+ +   L+ +    N  +  E+ K  L Q     
Sbjct: 62  NIVRLHDVLHS------DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ----- 109
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             +   + + H      ++H DLKP N+L++ +    + +FGLA+
Sbjct: 110 --LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR 68
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 124
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 125 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 175
Query: 870 H 870
           H
Sbjct: 176 H 176

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 37/194 (19%)
Query: 700 LSKATSEFSSSNMI-----GQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KS 748
           L     EF   N++     G+G FG V K     L        V V  LK+  +    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 749 FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN------ 802
            +SE   L+ + H ++IK+   CS    +G     L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 803 ------------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
                       D  + R L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 851 YDMVAHVGDFGLAK 864
                 + DFGL++
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  VS      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 37/194 (19%)
Query: 700 LSKATSEFSSSNMI-----GQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KS 748
           L     EF   N++     G+G FG V K     L        V V  LK+  +    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 749 FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN------ 802
            +SE   L+ + H ++IK+   CS    +G     L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 803 ------------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
                       D  + R L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVA 184
Query: 851 YDMVAHVGDFGLAK 864
                 + DFGL++
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 37/194 (19%)
Query: 700 LSKATSEFSSSNMI-----GQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KS 748
           L     EF   N++     G+G FG V K     L        V V  LK+  +    + 
Sbjct: 13  LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 749 FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN------ 802
            +SE   L+ + H ++IK+   CS    +G     L+ EY + GSL  +L +S       
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQ---DGPLL--LIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 803 ------------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
                       D  + R L++   ++ A  ++  ++YL    +  +VH DL   N+L+ 
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVA 184
Query: 851 YDMVAHVGDFGLAK 864
                 + DFGL++
Sbjct: 185 EGRKMKISDFGLSR 198

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  VS      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  VS      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 128
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 129 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 179
Query: 870 H 870
           H
Sbjct: 180 H 180

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 26/146 (17%)
Query: 751 SECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
           +E   L+++ H N+IK+  +     FE   +  LV E+ E G L + +      +   K 
Sbjct: 95  NEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI------INRHKF 143
Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLS 867
                 NI   + S I YLH H    +VH D+KP N+LL+     +   + DFGL+ F S
Sbjct: 144 DECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 868 NHHLDIASKTPSSSIGIKGTVGYVAP 893
             +  +  +         GT  Y+AP
Sbjct: 201 KDY-KLRDRL--------GTAYYIAP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 83/191 (43%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  VS      E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 39/157 (24%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 713 IGQGRFGTVYKGI--LGDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G G FG+V +G+  +   ++ VA+KV+    +K  ++  + E + +  + +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +C +          LV E    G L  +L    +++ V  ++      +   V+  ++YL
Sbjct: 78  VCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 126
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
               +   VH DL   NVLL     A + DFGL+K L
Sbjct: 127 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHR 762
            ++     IG+G +G VYK      E   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAI 820
           N++K+  +  +          LVFE+++   L+  L      +E    K  L+Q +N   
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN--- 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                I Y H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 ----GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           F   + +G+G    VY+      +   A+KV  LK+    K   +E   L  + H N+IK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKV--LKKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     FE     +LV E +  G L D + +     E      +++      +  A+
Sbjct: 113 LKEI-----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAV 161
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
            YLH +    +VH DLKP N+L      D    + DFGL+K + +  L    KT      
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKT------ 209
Query: 884 IKGTVGYVAP 893
           + GT GY AP
Sbjct: 210 VCGTPGYCAP 219

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHR 762
            ++     IG+G +G VYK      E   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAI 820
           N++K+  +  +          LVFE+++   L+  L      +E    K  L+Q +N   
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN--- 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                I Y H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 ----GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           S + ++G GRFG V+K       + +A K+I  +     +   +E   +  + H NLI++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWL-HQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                   FE  +   LV EY++ G L D +  +S +  E+  +  +++      +   I
Sbjct: 152 YDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ------ICEGI 200
Query: 827 EYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAK 864
            ++H   Q  ++H DLKP N+L    D   +  + DFGLA+
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIK-IIDFGLAR 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA++ I+  + +   +  + 
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR 74
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 130
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 131 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181
Query: 870 H 870
           H
Sbjct: 182 H 182

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHR 762
            ++     IG+G +G VYK      E   A+K I L+++  G   + + E   L+ ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE--VRKLSLIQRMNIAI 820
           N++K+  +  +          LVFE+++   L+  L      +E    K  L+Q +N   
Sbjct: 61  NIVKLYDVIHTKKR-----LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN--- 111
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
                I Y H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 112 ----GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 79/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG--SLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    +V + ME     L    H SND +    
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI---- 128
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 129 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPD 179
Query: 870 H 870
           H
Sbjct: 180 H 180

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 22/183 (12%)
Query: 688 MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK 747
           +E++ P   Y +    T E      +G G FGTV KG     ++V  V V  LK +    
Sbjct: 3   LEEIRPKEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 59
Query: 748 SF----VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
           +     ++E   ++ + +  ++++I IC +  +       LV E  E G L  +L Q+  
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQNRH 113
Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
             +   + L+ +      V+  ++YL    +   VH DL   NVLL     A + DFGL+
Sbjct: 114 VKDKNIIELVHQ------VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 864 KFL 866
           K L
Sbjct: 165 KAL 167

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 17/144 (11%)
Query: 709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV-SECEALRNIR-HRNLIK 766
           +S ++G+G +  V   +   +    AVK+I  KQ G S+S V  E E L   + ++N+++
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIE-KQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I       FE      LVFE ++ GS+   + Q       R+ S + R     DVA+A+
Sbjct: 76  LIEF-----FEDDTRFYLVFEKLQGGSILAHI-QKQKHFNEREASRVVR-----DVAAAL 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLD 850
           ++LH      + H DLKP N+L +
Sbjct: 125 DFLH---TKGIAHRDLKPENILCE 145

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     LG ++ V+ V V  LK    +   ++ +SE +
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----DQVEVRK 809
            + ++ +H N++ ++  C+      V     + EY   G L ++L +      D+ + R 
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 810 LSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           L L   ++ +  VA  + +L   +C    +H D+   NVLL    VA +GDFGLA+ + N
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMN 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 142
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 95  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 142
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 143 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 177

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 73  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 120
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 121 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 155

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 75  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 122
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 123 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 161

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSF----VSECEALRNIRHRNLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +     ++E   ++ + +  ++++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 79  GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 126
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 127 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 161

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIK 766
           +G+ RFG VYKG L     G+    VA+K +  K +G   + F  E      ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLSLIQRM 816
           ++ + +          +++F Y  +G L ++L             +D+     L     +
Sbjct: 94  LLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           ++   +A+ +EYL  H    +VH DL   NVL+   +   + D GL +
Sbjct: 149 HLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 18/193 (9%)
Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
           ++R+  H S  T+ M +  P   +    +    +   ++IG G +G V +     ++ VV
Sbjct: 28  QQRKQHHSSKPTASMPR--PHSDW----QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 734 AVKVI--NLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN 791
           A+K I    +     K  + E   L  + H +++K++ I    D E  D   +V E  ++
Sbjct: 82  AIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS 141
Query: 792 GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY 851
               D+       V + +L +     +  ++   ++Y+H      ++H DLKP+N L++ 
Sbjct: 142 ----DFKKLFRTPVYLTELHI---KTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 852 DMVAHVGDFGLAK 864
           D    V DFGLA+
Sbjct: 192 DCSVKVCDFGLAR 204

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 19/187 (10%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ------KGASKSFVSECE 754
           +K   ++   +++G+G +G V K +L D E +    V  LK+           +   E +
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKV-KEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQ 58
Query: 755 ALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
            LR +RH+N+I+++ +  + + + +    +V EY   G     + +  D V  ++  + Q
Sbjct: 59  LLRRLRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCG-----MQEMLDSVPEKRFPVCQ 110
Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
                  +   +EYLH      +VH D+KP N+LL       +   G+A+ L     D  
Sbjct: 111 AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 875 SKTPSSS 881
            +T   S
Sbjct: 168 CRTSQGS 174

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI- 759
           S+ T+EF     IG G FG+V+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 62
Query: 760 ------RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI- 759
           S+ T+EF     IG G FG+V+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 3   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 58
Query: 760 ------RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 59  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 113
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 114 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI- 759
           S+ T+EF     IG G FG+V+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 760 ------RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 116 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI- 759
           S+ T+EF     IG G FG+V+K +   D  + A+K    + K      V E  ALR + 
Sbjct: 5   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK----RSKKPLAGSVDEQNALREVY 60
Query: 760 ------RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
                 +H ++++  +  +  D   +       EY   GSL D + ++   +   K + +
Sbjct: 61  AHAVLGQHSHVVRYFSAWAEDDHMLIQ-----NEYCNGGSLADAISENYRIMSYFKEAEL 115
Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           +  ++ + V   + Y+H      +VH D+KPSN+ +
Sbjct: 116 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFI 146

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 79/185 (42%), Gaps = 39/185 (21%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---------------------- 742
           ++++  + IG+G +G V      +D    A+KV++ K+                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 743 ----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL 798
               +G  +    E   L+ + H N++K++ +    D    D   +VFE +  G +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPV---- 125
Query: 799 HQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG 858
               +   ++ LS  Q      D+   IEYLH+     ++H D+KPSN+L+  D    + 
Sbjct: 126 ---MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179
Query: 859 DFGLA 863
           DFG++
Sbjct: 180 DFGVS 184

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  ++ A KVI+ K +   + ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              F   +   ++ E+   G+++  + +       R L+  Q   +      A+ YLH +
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               ++H DLK  N+L   D    + DFG++
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALR 757
           E+  S  +G G  G V           VA+K+I+         ++   + +  +E E L+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRM 816
            + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q +
Sbjct: 77  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDI 873
                   A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L  
Sbjct: 131 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 178
Query: 874 ASKTPSSSIGIKGTVGYVAP 893
             +T      + GT  Y+AP
Sbjct: 179 -MRT------LCGTPTYLAP 191

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALR 757
           E+  S  +G G  G V           VA+K+I+         ++   + +  +E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRM 816
            + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q +
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDI 873
                   A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L  
Sbjct: 125 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 874 ASKTPSSSIGIKGTVGYVAP 893
             +T      + GT  Y+AP
Sbjct: 173 -MRT------LCGTPTYLAP 185

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  ++ A KVI+ K +   + ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              F   +   ++ E+   G+++  + +       R L+  Q   +      A+ YLH +
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               ++H DLK  N+L   D    + DFG++
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALR 757
           E+  S  +G G  G V           VA+K+I+         ++   + +  +E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRM 816
            + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q +
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDI 873
                   A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L  
Sbjct: 125 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 874 ASKTPSSSIGIKGTVGYVAP 893
             +T      + GT  Y+AP
Sbjct: 173 -MRT------LCGTPTYLAP 185

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     LG ++ V+ V V  LK    +   ++ +SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----DQVEVRK 809
            + ++ +H N++ ++  C+      V     + EY   G L ++L +      D+ + R 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 810 LSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           L L   ++ +  VA  + +L   +C    +H D+   NVLL    VA +GDFGLA+ + N
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMN 212

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALR 757
           E+  S  +G G  G V           VA+K+I+         ++   + +  +E E L+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRM 816
            + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q +
Sbjct: 70  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDI 873
                   A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L  
Sbjct: 124 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 171
Query: 874 ASKTPSSSIGIKGTVGYVAP 893
             +T      + GT  Y+AP
Sbjct: 172 -MRT------LCGTPTYLAP 184

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  ++ A KVI+ K +   + ++ E + L +  H N++K++    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 102
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              F   +   ++ E+   G+++  + +       R L+  Q   +      A+ YLH +
Sbjct: 103 ---FYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 154
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               ++H DLK  N+L   D    + DFG++
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 84/200 (42%), Gaps = 37/200 (18%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALR 757
           E+  S  +G G  G V           VA+K+I+         ++   + +  +E E L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRM 816
            + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q +
Sbjct: 71  KLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDI 873
                   A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L  
Sbjct: 125 -------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 874 ASKTPSSSIGIKGTVGYVAP 893
                     + GT  Y+AP
Sbjct: 173 -------MRTLCGTPTYLAP 185

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 27/195 (13%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRH 761
           T E+     IG+G F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++++     S   EG  F  LVF+ +  G L + +       E      IQ++  A+ 
Sbjct: 63  SNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV- 116
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLDIASKTP 878
                  LH H Q  +VH DLKP N+LL          + DFGLA  +            
Sbjct: 117 -------LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 879 SSSIGIKGTVGYVAP 893
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           +F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V   + +        
Sbjct: 63  RHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YG 111
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 84  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 135
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL +D    + DFG    +S
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 87
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 88  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 139
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL +D    + DFG    +S
Sbjct: 140 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 171

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 92
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 93  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 144
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL +D    + DFG    +S
Sbjct: 145 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 176

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 94
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +    E       Q   + + V  A+  LH  
Sbjct: 95  -NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------QIAAVCLAVLQALSVLHAQ 146
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               ++H D+K  ++LL +D    + DFG    +S
Sbjct: 147 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 178

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV------SECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L Q     E    S I++      +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNV-LLDYDM-VAHVG--DFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N+ LLD ++ + H+   DFGLA     H ++   +  +   
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-----HEIEDGVEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           +F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N 
Sbjct: 9   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V   + +        
Sbjct: 66  RHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YG 114
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 115 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 156

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           +F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V   + +        
Sbjct: 63  RHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YG 111
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 16/181 (8%)
Query: 693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVS 751
           P +   ++      +++ + IG+G +G V       +++ VA+K I+  + +   +  + 
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 752 ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM--ENGSLEDWLHQSNDQVEVRK 809
           E + L   RH N+I I  I  +   E +    LV   M  +   L    H SND +    
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI---- 146
Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
                       +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     
Sbjct: 147 ------CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPD 197
Query: 870 H 870
           H
Sbjct: 198 H 198

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 37/201 (18%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEAL 756
            E+  S  +G G  G V           VA+++I+         ++   + +  +E E L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQR 815
           + + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLD 872
           +        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 263 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 311
Query: 873 IASKTPSSSIGIKGTVGYVAP 893
                      + GT  Y+AP
Sbjct: 312 --------MRTLCGTPTYLAP 324

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 16/167 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           ++    IG+G +G V        +  VA+K I+  + +   +  + E + L   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ--SNDQVEVRKLSLIQRMNIAIDVA 823
            I  I  ++  E +    +V + ME    +    Q  SND +                + 
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI----------CYFLYQIL 154
Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
             ++Y+H      ++H DLKPSN+L++      + DFGLA+     H
Sbjct: 155 RGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEH 198

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 29/197 (14%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNI 759
           +    +     +G+G F   Y+    D + V A KV+  ++  K   K  +S   A+   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI--- 95
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H++L     +     FE  DF  +V E     SL + LH+    V   +     R  I 
Sbjct: 96  -HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI- 152
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA---KFLSNHHLDIASK 876
                 ++YLH++    ++H DLK  N+ L+ DM   +GDFGLA   +F      D+   
Sbjct: 153 ----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-- 203
Query: 877 TPSSSIGIKGTVGYVAP 893
                    GT  Y+AP
Sbjct: 204 ---------GTPNYIAP 211

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MXGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MXGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           +F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V   + +        
Sbjct: 63  RHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YG 111
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           +F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N 
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V   + +        
Sbjct: 63  RHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----YG 111
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 112 AEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 214
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +   D   +V E++E G+L D +  +       +++  Q   + + V  A+  LH  
Sbjct: 215 -NSYLVGDELWVVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
               ++H D+K  ++LL +D    + DFG    +S  
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 37/201 (18%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEAL 756
            E+  S  +G G  G V           VA+++I+         ++   + +  +E E L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQR 815
           + + H  +IKI     + D+       +V E ME G L D +  +    E   KL   Q 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY------YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLD 872
           +        A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L 
Sbjct: 249 L-------LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 297
Query: 873 IASKTPSSSIGIKGTVGYVAP 893
                      + GT  Y+AP
Sbjct: 298 --------MRTLCGTPTYLAP 310

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 71
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 72  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 120
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 121 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DTTSVVKDSQV 173
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 174 ---GTVNYMPP 181

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 38/197 (19%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN- 763
            +F     +G G FG V+      +    A+KV+        K  V     L+ + H N 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVR---LKQVEHTND 55
Query: 764 ---LIKIIT----ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
              ++ I+T    I     F+      ++ +Y+E G L   L +S      R  + + + 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKF 110
Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
             A +V  A+EYLH      +++ DLKP N+LLD +    + DFG AK++          
Sbjct: 111 -YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV---------- 156
Query: 877 TPSSSIGIKGTVGYVAP 893
            P  +  + GT  Y+AP
Sbjct: 157 -PDVTYXLCGTPDYIAP 172

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V    +     +VAVK ++L+++   +   +E   +R+ +H N++++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
             D   V     V E++E G+L D +  +       +++  Q   + + V  A+  LH  
Sbjct: 142 VGDELWV-----VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
               ++H D+K  ++LL +D    + DFG    +S  
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 28/198 (14%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRN 758
           +K +  +     +G+G F  V + +     +  A K+IN K+  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLDIAS 875
              +  +I Y H +    +VH +LKP N+LL          + DFGLA         I  
Sbjct: 114 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 876 KTPSSSIGIKGTVGYVAP 893
               +  G  GT GY++P
Sbjct: 159 NDSEAWHGFAGTPGYLSP 176

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 28/198 (14%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRN 758
           +K +  +     +G+G F  V + +     +  A K+IN K+  A   +    E    R 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 61  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 112
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLDIAS 875
              +  +I Y H +    +VH +LKP N+LL          + DFGLA         I  
Sbjct: 113 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 157
Query: 876 KTPSSSIGIKGTVGYVAP 893
               +  G  GT GY++P
Sbjct: 158 NDSEAWHGFAGTPGYLSP 175

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 28/198 (14%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRN 758
           +K +  +     +G+G F  V + +     +  A K+IN K+  A   +    E    R 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 62  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 113
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLDIAS 875
              +  +I Y H +    +VH +LKP N+LL          + DFGLA         I  
Sbjct: 114 ---ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 158
Query: 876 KTPSSSIGIKGTVGYVAP 893
               +  G  GT GY++P
Sbjct: 159 NDSEAWHGFAGTPGYLSP 176

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 23/194 (11%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNI 759
           +    +     +G+G F   Y+    D + V A KV+  ++  K   K  +S   A+   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI--- 95
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H++L     +     FE  DF  +V E     SL + LH+    V   +     R  I 
Sbjct: 96  -HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI- 152
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
                 ++YLH++    ++H DLK  N+ L+ DM   +GDFGLA   +    D   K   
Sbjct: 153 ----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKK-- 200
Query: 880 SSIGIKGTVGYVAP 893
               + GT  Y+AP
Sbjct: 201 ---XLCGTPNYIAP 211

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 23/194 (11%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNI 759
           +    +     +G+G F   Y+    D + V A KV+  ++  K   K  +S   A+   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI--- 95
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H++L     +     FE  DF  +V E     SL + LH+    V   +     R  I 
Sbjct: 96  -HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI- 152
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
                 ++YLH++    ++H DLK  N+ L+ DM   +GDFGLA   +    D   K   
Sbjct: 153 ----QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKK-- 200
Query: 880 SSIGIKGTVGYVAP 893
               + GT  Y+AP
Sbjct: 201 ---TLCGTPNYIAP 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRN 758
           ++F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N
Sbjct: 10  NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 67  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 115
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 158

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           EF    ++G+G FG V   IL  ++      A+K++  +    K      ++E   L+N 
Sbjct: 9   EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V     S  +     
Sbjct: 66  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 114
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 115 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 68
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 69  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 117
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 118 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DTTSVVKDSQV 170
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 171 ---GTVNYMPP 178

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRN 758
           ++F    ++G+G FG V   IL  ++      A+K++  +    K      V+E   L+N
Sbjct: 5   NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            RH  L  +        F+  D    V EY   G L  + H S ++V   + +       
Sbjct: 62  TRHPFLTAL-----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF----Y 110
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             ++ SA+EYLH      +V+ D+K  N++LD D    + DFGL K
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 72  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 121
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 122 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 172
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 173 FKN----IFGTPEFVAP 185

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 72  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 121
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 122 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 172
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 173 FKN----IFGTPEFVAP 185

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 22/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS--ECEALRNIRHRNLIKIITI 770
           IG+G FG        +D     +K IN+ +  + +   S  E   L N++H N+++    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY--- 88
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                FE      +V +Y E G   D   + N Q  V      Q ++  + +  A++++H
Sbjct: 89  --RESFEENGSLYIVMDYCEGG---DLFKRINAQKGVL-FQEDQILDWFVQICLALKHVH 142
Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
                 ++H D+K  N+ L  D    +GDFG+A+ L N  +++A           GT  Y
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELAR-------ACIGTPYY 191
Query: 891 VAP 893
           ++P
Sbjct: 192 LSP 194

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 136
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DTTSVVKDSQV 189
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 190 ---GTVNYMPP 197

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           EF    ++G+G FG V   IL  ++      A+K++  +    K      ++E   L+N 
Sbjct: 10  EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V     S  +     
Sbjct: 67  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 115
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 116 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 35/196 (17%)
Query: 707 FSSSNMIGQGRFGT-VYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNI-RHRN 763
           F   +++G G  GT VY+G+   D   VAVK I  +      SF   E + LR    H N
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPE----CFSFADREVQLLRESDEHPN 79
Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN-DQVEVRKLSLIQRMNIAIDV 822
           +I+    C+  D +   F+ +  E +   +L++++ Q +   + +  ++L+Q+       
Sbjct: 80  VIRYF--CTEKDRQ---FQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQ------T 127
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDY-----DMVAHVGDFGLAKFLSNHHLDIASKT 877
            S + +LH      +VH DLKP N+L+        + A + DFGL K L+     +   +
Sbjct: 128 TSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA-----VGRHS 179
Query: 878 PSSSIGIKGTVGYVAP 893
            S   G+ GT G++AP
Sbjct: 180 FSRRSGVPGTEGWIAP 195

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           EF    ++G+G FG V   IL  ++      A+K++  +    K      ++E   L+N 
Sbjct: 149 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V     S  +     
Sbjct: 206 RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 254
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 255 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K          A K I  ++  +S+  VS      E   LR IRH N+I 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     FE      L+ E +  G L D+L +     E      +++      +   +
Sbjct: 80  LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------ILDGV 128
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAH----VGDFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N++L    V +    + DFG+A     H ++  ++  +   
Sbjct: 129 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 177
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 178 -IFGTPEFVAP 187

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           EF    ++G+G FG V   IL  ++      A+K++  +    K      ++E   L+N 
Sbjct: 11  EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V     S  +     
Sbjct: 68  RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 116
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 117 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 26/110 (23%), Positives = 54/110 (49%), Gaps = 14/110 (12%)
Query: 784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK 843
           +V EY++  +L D +H        R + +I       D   A+ + H   Q  ++H D+K
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSH---QNGIIHRDVK 160
Query: 844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           P+N+++       V DFG+A+ +++     +  + + +  + GT  Y++P
Sbjct: 161 PANIMISATNAVKVMDFGIARAIAD-----SGNSVTQTAAVIGTAQYLSP 205

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMV---VAVKVINLK---QKGASKSFVSECEALRNI 759
           EF    ++G+G FG V   IL  ++      A+K++  +    K      ++E   L+N 
Sbjct: 152 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           RH  L  +        F+  D    V EY   G L  + H S ++V     S  +     
Sbjct: 209 RHPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYG 257
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
            ++ SA++YLH   +  +V+ DLK  N++LD D    + DFGL K
Sbjct: 258 AEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 34/195 (17%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRH 761
           +     +G G +G V   +L  D++    + I + +K      ++   + E   L+ + H
Sbjct: 39  YQRVKKLGSGAYGEV---LLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++K+        FE      LV E  + G L D +      +   K + +    I   
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQ 144
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           V S + YLH H    +VH DLKP N+LL   + D +  + DFGL+    N       K  
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ------KKM 195
Query: 879 SSSIGIKGTVGYVAP 893
              +   GT  Y+AP
Sbjct: 196 KERL---GTAYYIAP 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K          A K I  ++  +S+  VS      E   LR IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     FE      L+ E +  G L D+L +     E      +++      +   +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------ILDGV 121
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAH----VGDFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N++L    V +    + DFG+A     H ++  ++  +   
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 170
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 171 -IFGTPEFVAP 180

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 67
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 68  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 116
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 117 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DTTSVVKDSQV 169
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 170 ---GTVNYMPP 177

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 164
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKDSQV 217
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 218 ---GTVNYMPP 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR----NLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +   E  A  N+  +     ++++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 437 GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 484
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 485 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR----NLIKII 768
           +G G FGTV KG     ++V  V V  LK +    +   E  A  N+  +     ++++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            IC +  +       LV E  E G L  +L Q+    +   + L+ +      V+  ++Y
Sbjct: 438 GICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKY 485
Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L    +   VH DL   NVLL     A + DFGL+K L
Sbjct: 486 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 520

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV----SECEALRNIRHR 762
           F     IG+G FG V      D + + A+K +N KQK   ++ V     E + ++ + H 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS-NDQVEVRKLSLIQRMNIAID 821
            L+ +        F+  +   +V + +  G L   L Q+ + + E  KL + +       
Sbjct: 76  FLVNLWY-----SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE------- 123
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +  A++YL +     ++H D+KP N+LLD     H+ DF +A  L            +  
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---------TQI 171
Query: 882 IGIKGTVGYVAPGKF 896
             + GT  Y+AP  F
Sbjct: 172 TTMAGTKPYMAPEMF 186

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 164
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DTTSVVKDSQV 217
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 218 ---GTVNYMPP 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSE 752
           E  +   EF    ++G G FG V       +    + + V V  LK+K  S   ++ +SE
Sbjct: 41  EFPRENLEFG--KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 98
Query: 753 CEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ-----SNDQVE 806
            + +  +  H N++ ++  C+ +   G  +  L+FEY   G L ++L       S D++E
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLS---GPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 807 V---RKLSLIQRMNI---------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV 854
               ++L   + +N+         A  VA  +E+L        VH DL   NVL+ +  V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 210
Query: 855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT----VGYVAPGKFF 897
             + DFGLA+       DI S    S+  ++G     V ++AP   F
Sbjct: 211 VKICDFGLAR-------DIMS---DSNYVVRGNARLPVKWMAPESLF 247

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MXGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MXGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MXGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 15/165 (9%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNIRHRN 763
           E+     IG G +G V           VA+K I         +K  + E + L++ +H N
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 764 LIKIITICSSTDFEGVDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           +I I  I   T   G +FK++  V + ME+  L   +H S        L+L         
Sbjct: 116 IIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQ------PLTLEHVRYFLYQ 167
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           +   ++Y+H      ++H DLKPSN+L++ +    +GDFG+A+ L
Sbjct: 168 LLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 209

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 15/165 (9%)
Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNIRHRN 763
           E+     IG G +G V           VA+K I         +K  + E + L++ +H N
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 764 LIKIITICSSTDFEGVDFKAL--VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           +I I  I   T   G +FK++  V + ME+  L   +H S        L+L         
Sbjct: 115 IIAIKDILRPTVPYG-EFKSVYVVLDLMES-DLHQIIHSSQ------PLTLEHVRYFLYQ 166
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           +   ++Y+H      ++H DLKPSN+L++ +    +GDFG+A+ L
Sbjct: 167 LLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           ++G+G +G VY G    +++ +A+K I  +    S+    E    ++++H+N+++ +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
               F    F  +  E +  GSL   L      ++  + ++         +   ++YLH 
Sbjct: 86  --GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI---GFYTKQILEGLKYLHD 140
Query: 832 HCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
           +    +VH D+K  NVL++ Y  V  + DFG +K L       A   P +     GT+ Y
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------AGINPCTET-FTGTLQY 189
Query: 891 VAP 893
           +AP
Sbjct: 190 MAP 192

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V           VAVK ++L+++   +   +E   +R+  H N++ +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMY---- 108
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
           S+   G D   +V E++E G+L D +  +    E       Q   + + V  A+ YLH+ 
Sbjct: 109 SSYLVG-DELWVVMEFLEGGALTDIVTHTRMNEE-------QIATVCLSVLRALSYLHNQ 160
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
               ++H D+K  ++LL  D    + DFG           ++ + P     + GT  ++A
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCA-------QVSKEVPKRKXLV-GTPYWMA 209
Query: 893 P 893
           P
Sbjct: 210 P 210

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 713 IGQGRFGTVYKGI--LGDDEMVVAVKVINL-KQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G G FG+V +G+  +   ++ VA+KV+    +K  ++  + E + +  + +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +C +          LV E    G L  +L    +++ V  ++      +   V+  ++YL
Sbjct: 404 VCQAEAL------MLVMEMAGGGPLHKFLVGKREEIPVSNVA-----ELLHQVSMGMKYL 452
Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
               +   VH +L   NVLL     A + DFGL+K L
Sbjct: 453 E---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 84/183 (45%), Gaps = 20/183 (10%)
Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           ++G+G +G VY G    +++ +A+K I  +    S+    E    ++++H+N+++ +   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           S        F  +  E +  GSL   L      ++  + ++         +   ++YLH 
Sbjct: 75  SEN-----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI---GFYTKQILEGLKYLHD 126
Query: 832 HCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
           +    +VH D+K  NVL++ Y  V  + DFG +K L       A   P +     GT+ Y
Sbjct: 127 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------AGINPCTET-FTGTLQY 175
Query: 891 VAP 893
           +AP
Sbjct: 176 MAP 178

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 29/197 (14%)
Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI--NLKQKGASKSFVSECEALRNI 759
           +    +     +G+G F   Y+    D + V A KV+  ++  K   K  +S   A+   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAI--- 79
Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H++L     +     FE  DF  +V E     SL + LH+    V   +     R  I 
Sbjct: 80  -HKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI- 136
Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA---KFLSNHHLDIASK 876
                 ++YLH++    ++H DLK  N+ L+ DM   +GDFGLA   +F      D+   
Sbjct: 137 ----QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-- 187
Query: 877 TPSSSIGIKGTVGYVAP 893
                    GT  Y+AP
Sbjct: 188 ---------GTPNYIAP 195

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 28/198 (14%)
Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRN 758
           +K +  +     +G+G F  V + +     +  A K+IN K+  A   +    E    R 
Sbjct: 25  TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 84
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N++++         +   F  LVF+ +  G L + +       E      IQ+   
Sbjct: 85  LQHPNIVRL-----HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--- 136
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVGDFGLAKFLSNHHLDIAS 875
              +  +I Y H +    +VH +LKP N+LL          + DFGLA         I  
Sbjct: 137 ---ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---------IEV 181
Query: 876 KTPSSSIGIKGTVGYVAP 893
               +  G  GT GY++P
Sbjct: 182 NDSEAWHGFAGTPGYLSP 199

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K          A K I  ++  +S+  VS      E   LR IRH N+I 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     FE      L+ E +  G L D+L +     E      +++      +   +
Sbjct: 94  LHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ------ILDGV 142
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAH----VGDFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N++L    V +    + DFG+A     H ++  ++  +   
Sbjct: 143 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA-----HKIEAGNEFKN--- 191
Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 192 -IFGTPEFVAP 201

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 20/159 (12%)
Query: 709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV-SECEALRNIR-HRNLIK 766
             +++G+G    V   I        AVK+I  KQ G  +S V  E E L   + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA+
Sbjct: 76  LIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASAL 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVG--DFGL 862
           ++LH+     + H DLKP N+L ++ + V+ V   DFGL
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGL 160

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 687 PMEKLFPMVSYAELSKATSE----FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ 742
           PM +  P     EL+K   E    + + + +G G +G+V         + VAVK ++   
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 61
Query: 743 KGA--SKSFVSECEALRNIRHRNLIKIITICS-STDFEGVDFKALVFEYMENGSLEDWLH 799
           +    +K    E   L++++H N+I ++ + + +   E  +   LV   M  G+      
Sbjct: 62  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GA------ 113
Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
             N+ V+ +KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + D
Sbjct: 114 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 170
Query: 860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           FGLA+            T     G   T  Y AP
Sbjct: 171 FGLAR-----------HTDDEMTGYVATRWYRAP 193

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 29/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVY--KGILGDD-EMVVAVKVI---NLKQKGASKSFVSECEALRN 758
           S+F    ++GQG FG V+  K I G D   + A+KV+    LK +   ++ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + H  ++K+        F+      L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNHPFIVKL-----HYAFQTEGKLYLILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K   +H         
Sbjct: 133 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------- 180
Query: 879 SSSIGIKGTVGYVAP 893
             +    GTV Y+AP
Sbjct: 181 KKAYSFCGTVEYMAP 195

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRH 761
           T E+     +G+G F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++++     S   EG  F  LVF+ +  G L + +       E      IQ++     
Sbjct: 63  PNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----- 112
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
               +E ++H     +VH DLKP N+LL          + DFGLA  +            
Sbjct: 113 ----LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 879 SSSIGIKGTVGYVAP 893
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPAFVAP 186

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 69
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 70  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 120
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 171
Query: 891 VAP 893
           VAP
Sbjct: 172 VAP 174

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 121
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 32/185 (17%)
Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     LG ++ V+ V V  LK    +   ++ +SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
            + ++ +H N++ ++  C+      V     + EY   G L ++L + +     R L   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKS-----RVLETD 151
Query: 814 QRMNIAIDVASAIEYLHHHCQPPM----------VHGDLKPSNVLLDYDMVAHVGDFGLA 863
               IA   AS  + LH   Q             +H D+   NVLL    VA +GDFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 864 KFLSN 868
           + + N
Sbjct: 212 RDIMN 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVY--KGILGDD-EMVVAVKVIN---LKQKGASKSFVSECEALRN 758
           S+F    ++GQG FG V+  K I G D   + A+KV+    LK +   ++ + E + L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 82
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + H  ++K+     +   EG  +  L+ +++  G L   L +     EV       +  +
Sbjct: 83  VNHPFIVKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 132
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K   +H         
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------- 180
Query: 879 SSSIGIKGTVGYVAP 893
             +    GTV Y+AP
Sbjct: 181 KKAYSFCGTVEYMAP 195

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 39/193 (20%)
Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     LG ++ V+ V V  LK    +   ++ +SE +
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN----------- 802
            + ++ +H N++ ++  C+      V     + EY   G L ++L +             
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 803 ------DQVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVA 855
                 D+ + R L L   ++ +  VA  + +L   +C    +H D+   NVLL    VA
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVA 197
Query: 856 HVGDFGLAKFLSN 868
            +GDFGLA+ + N
Sbjct: 198 KIGDFGLARDIMN 210

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 80/195 (41%), Gaps = 27/195 (13%)
Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRH 761
           T E+     +G+G F  V + +        A K+IN K+  A   +    E    R ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++++     S   EG  F  LVF+ +  G L + +       E      IQ++     
Sbjct: 63  PNIVRL---HDSISEEG--FHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI----- 112
Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
               +E ++H     +VH DLKP N+LL          + DFGLA  +            
Sbjct: 113 ----LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-------- 160
Query: 879 SSSIGIKGTVGYVAP 893
            +  G  GT GY++P
Sbjct: 161 QAWFGFAGTPGYLSP 175

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 705 SEFSSSNMIGQGRFGTVY--KGILGDD-EMVVAVKVIN---LKQKGASKSFVSECEALRN 758
           S+F    ++GQG FG V+  K I G D   + A+KV+    LK +   ++ + E + L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVE 83
Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + H  ++K+     +   EG  +  L+ +++  G L   L +     EV       +  +
Sbjct: 84  VNHPFIVKLHYAFQT---EGKLY--LILDFLRGGDLFTRLSK-----EVMFTEEDVKFYL 133
Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           A ++A A+++LH      +++ DLKP N+LLD +    + DFGL+K   +H         
Sbjct: 134 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------- 181
Query: 879 SSSIGIKGTVGYVAP 893
             +    GTV Y+AP
Sbjct: 182 KKAYSFCGTVEYMAP 196

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 115
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 116 DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 164
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D  S    S +
Sbjct: 165 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQM---QPDTTSVVKDSQV 217
Query: 883 GIKGTVGYVAP 893
              G V Y+ P
Sbjct: 218 ---GAVNYMPP 225

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 123
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY--- 70
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 71  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLHG 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 172
Query: 891 VAP 893
           VAP
Sbjct: 173 VAP 175

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 694 MVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFV 750
           +V   E+     +F    +IG+G F  V    +     V A+K++N   + ++G    F 
Sbjct: 50  VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109
Query: 751 SECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVR 808
            E + L N   R + ++        F+  ++  LV EY   G L   L +  +++  E+ 
Sbjct: 110 EERDVLVNGDRRWITQL-----HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA 164
Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           +  L + + +AID    + Y         VH D+KP N+LLD       G   LA F S 
Sbjct: 165 RFYLAE-IVMAIDSVHRLGY---------VHRDIKPDNILLD-----RCGHIRLADFGSC 209
Query: 869 HHLDIASKTPSSSIGIKGTVGYVAP 893
             L  A  T  S + + GT  Y++P
Sbjct: 210 LKLR-ADGTVRSLVAV-GTPDYLSP 232

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL 764
           +S    IG G    V++ +L + + + A+K +NL++       S+ +E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS- 87
Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLE--DWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            KII +    D+E  D    ++  ME G+++   WL +       + +   +R +   ++
Sbjct: 88  DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLKKK------KSIDPWERKSYWKNM 136
Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             A+  +H H    +VH DLKP+N L+  D +  + DFG+A  +     D       S +
Sbjct: 137 LEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQP---DXXXVVKDSQV 189
Query: 883 GIKGTVGYVAP 893
              GTV Y+ P
Sbjct: 190 ---GTVNYMPP 197

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 70/145 (48%), Gaps = 17/145 (11%)
Query: 709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV-SECEALRNIR-HRNLIK 766
             +++G+G    V   I        AVK+I  KQ G  +S V  E E L   + HRN+++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I      D        LVFE M  GS+   +H+     E+    ++Q      DVASA+
Sbjct: 76  LIEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASAL 124
Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDY 851
           ++LH+     + H DLKP N+L ++
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEH 146

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G  G V           VAVK+++L+++   +   +E   +R+ +H N++++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMY---- 108
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
            +   G +   L+ E+++ G+L D + Q        +L+  Q   +   V  A+ YLH  
Sbjct: 109 KSYLVGEELWVLM-EFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ 160
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
               ++H D+K  ++LL  D    + DFG    +S    D+  +       + GT  ++A
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK---DVPKRK-----XLVGTPYWMA 209
Query: 893 P 893
           P
Sbjct: 210 P 210

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 30/184 (16%)
Query: 706 EFSSSNM-----IGQGRFGTVYKGI---LGDDEMVVAVKVINLKQKGAS---KSFVSECE 754
           EF  +N+     +G G FG V +     LG ++ V+ V V  LK    +   ++ +SE +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 755 ALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV------ 807
            + ++ +H N++ ++  C+      V     + EY   G L ++L + +  +E       
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLV-----ITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 808 --RKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
               LS    ++ +  VA  + +L   +C    +H D+   NVLL    VA +GDFGLA+
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 865 FLSN 868
            + N
Sbjct: 213 DIMN 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 729 DEMVVAVKVINL---KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV 785
           D   VAVKV+     +       F  E +    + H  ++ +     +    G     +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIV 94
Query: 786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS 845
            EY++  +L D +H        R + +I       D   A+ + H +    ++H D+KP+
Sbjct: 95  MEYVDGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSHQNG---IIHRDVKPA 145
Query: 846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           N+++       V DFG+A+ +++     +  + + +  + GT  Y++P
Sbjct: 146 NIMISATNAVKVMDFGIARAIAD-----SGNSVTQTAAVIGTAQYLSP 188

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 33/197 (16%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIR 760
           + +   +G G+F  V K       +  A K I  ++  +S+  VS      E   L+ I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +     +E      L+ E +  G L D+L +     E      +++     
Sbjct: 73  HPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNV-LLDYDMVA---HVGDFGLAKFLSNHHLDIASK 876
            + + + YLH      + H DLKP N+ LLD ++      + DFGLA     H +D  ++
Sbjct: 123 -ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-----HKIDFGNE 173
Query: 877 TPSSSIGIKGTVGYVAP 893
             +    I GT  +VAP
Sbjct: 174 FKN----IFGTPEFVAP 186

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/168 (20%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 729 DEMVVAVKVINL---KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV 785
           D   VAVKV+     +       F  E +    + H  ++ +     +    G     +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIV 94
Query: 786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS 845
            EY++  +L D +H        R + +I       D   A+ + H +    ++H D+KP+
Sbjct: 95  MEYVDGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSHQNG---IIHRDVKPA 145
Query: 846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           N+++       V DFG+A+ +++     +  + + +  + GT  Y++P
Sbjct: 146 NIMISATNAVKVMDFGIARAIAD-----SGNSVTQTAAVIGTAQYLSP 188

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/164 (20%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 733 VAVKVINL---KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM 789
           VAVKV+     +       F  E +    + H  ++ +     +    G     +V EY+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAG-PLPYIVMEYV 98
Query: 790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           +  +L D +H        R + +I       D   A+ + H +    ++H D+KP+N+++
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
                  V DFG+A+ +++     +  + + +  + GT  Y++P
Sbjct: 150 SATNAVKVMDFGIARAIAD-----SGNSVTQTAAVIGTAQYLSP 188

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 15/153 (9%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG V++ +      V   K IN        +  +E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL----- 113
Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE      L+ E++  G L D +       E  K+S  + +N        ++++H H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI-----AAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVG--DFGLA 863
               +VH D+KP N++ +    + V   DFGLA
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/168 (21%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 729 DEMVVAVKVINL---KQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV 785
           D   VAVKV+     +       F  E +    + H  ++ +     +    G     +V
Sbjct: 36  DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIV 94
Query: 786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS 845
            EY++  +L D +H        R + +I       D   A+ + H +    ++H D+KP+
Sbjct: 95  MEYVDGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSHQNG---IIHRDVKPA 145
Query: 846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           N+L+       V DFG+A+ +++     +  +   +  + GT  Y++P
Sbjct: 146 NILISATNAVKVVDFGIARAIAD-----SGNSVXQTAAVIGTAQYLSP 188

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/110 (22%), Positives = 54/110 (49%), Gaps = 14/110 (12%)
Query: 784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK 843
           +V EY++  +L D +H        R + +I       D   A+ + H +    ++H D+K
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA------DACQALNFSHQNG---IIHRDVK 143
Query: 844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           P+N+++       V DFG+A+ +++     +  + + +  + GT  Y++P
Sbjct: 144 PANIMISATNAVKVMDFGIARAIAD-----SGNSVTQTAAVIGTAQYLSP 188

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 23/183 (12%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+     ++   E      + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY--- 71
Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                EG + + L  EY   G L D +       E        ++       + + YLH 
Sbjct: 72  -GHRREG-NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH- 122
Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK-FLSNHHLDIASKTPSSSIGIKGTVGY 890
                + H D+KP N+LLD      + DFGLA  F  N+   + +K       + GT+ Y
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-------MCGTLPY 173
Query: 891 VAP 893
           VAP
Sbjct: 174 VAP 176

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKIITI 770
           +G+G F  V + +        A K+IN K+  A   +    E    R ++H N++++   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL--- 86
Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             S   EG  +  L+F+ +  G L + +       E      IQ++  A+        LH
Sbjct: 87  HDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV--------LH 136
Query: 831 HHCQPPMVHGDLKPSNVLLDYDM---VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
            H Q  +VH DLKP N+LL   +      + DFGLA       +++  +   +  G  GT
Sbjct: 137 CH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-------IEVEGEQ-QAWFGFAGT 187
Query: 888 VGYVAP 893
            GY++P
Sbjct: 188 PGYLSP 193

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNIRHRNLI 765
           +++  +IG G FG V++  L + + V   KV+        K F + E + +R ++H N++
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVV 95
Query: 766 KIIT-ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
            +     S+ D +   F  LV EY+         H +  +  +  L +   M     +  
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM---YQLLR 152
Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFL 866
           ++ Y+H      + H D+KP N+LLD    V  + DFG AK L
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	914
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-157
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-94
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-69
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-62
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-90
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-79
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-82
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-73
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-61
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-51
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-71
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-67
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-52
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-62
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-56
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-50
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-49
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-48
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-47
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-22
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-43
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-41
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-40
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-10
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-30
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-13
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-38
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-30
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-18
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-29
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-28
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-21
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-19
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-12
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-29
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-28
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-20
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-25
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-18
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-26
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-26
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-23
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-23
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-04
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-21
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-14
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-22
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-07
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-19
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-21
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-08
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-07
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-14
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-05
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-15
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-04
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-08
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-04
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-05
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-14
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-04
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-04
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-06
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	3e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  480 bits (1237), Expect = e-157
 Identities = 161/577 (27%), Positives = 264/577 (45%), Gaps = 25/577 (4%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             L  L++SS      + P++G+ S L++++++ N   GD  + I     L+ L +S+N 
Sbjct: 200 VNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGN 195
           F G IP       +L +   + NK  G+IP  + G    L  L +  N+  G +P   G+
Sbjct: 259 FVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316

Query: 196 LSAIEVIRITENSLGGKIPT-TLGLLRRLVNLNVAENQFSGMFPRSICNIS-SVELIFLT 253
            S +E + ++ N+  G++P  TL  +R L  L+++ N+FSG  P S+ N+S S+  + L+
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376

Query: 254 ENRFSGIFPFDIL-LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI 312
            N FSG    ++       L++L +  N F G IP +LSN S L  L L  N   G +  
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436

Query: 313 DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS 372
              SL  L  L L  N L  G          L    +L+ L L  N   GE+P  ++N +
Sbjct: 437 SLGSLSKLRDLKLWLNML-EGEIPQ-----ELMYVKTLETLILDFNDLTGEIPSGLSNCT 490

Query: 373 LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF 432
             +  +S+  N+++G IP  I  L NL    L  N F G IP  + + ++L  L +  N 
Sbjct: 491 -NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549

Query: 433 LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN--KLTGDLPQQLL 490
             G IP+ +       S  + +N + G     + N         + N  +  G   +QL 
Sbjct: 550 FNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605

Query: 491 SITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
            ++T +   ++++ +  G       N  +++ LD+S N  SG IP  + +   L  L++ 
Sbjct: 606 RLSTRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664

Query: 551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG 610
            N   G IP     L+ +  L++SSN L G+IP+ +  L+ L  ++LS N   G +P  G
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724

Query: 611 VFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKPK 647
            F          N  LCG      LP C    +    
Sbjct: 725 QFETFPPAKFLNNPGLCG----YPLPRCDPSNADGYA 757

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  443 bits (1142), Expect = e-143
 Identities = 167/593 (28%), Positives = 266/593 (44%), Gaps = 48/593 (8%)

Query: 25  SPSFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNL 84
           S   S  Q+   +   L++ K  L D   +   W++  N C + GVTC  R  ++T ++L
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKNPCTFDGVTC--RDDKVTSIDL 57

Query: 85  SS---QRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI 141
           SS         +S  + +L+ L  + L+++   G +         L  L LS NS SG +
Sbjct: 58  SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116

Query: 142 PT--NLSRCSNLIHFCASNNKLEGQIPKEIG-NLLKLQRLSVDINYLTGQLPDSVGNLSA 198
            T  +L  CS L     S+N L+       G  L  L+ L +  N ++G           
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW----- 171

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
                                   L +L ++ N+ SG     +    ++E + ++ N FS
Sbjct: 172 ----------------VLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFS 213

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
              PF  L +   L+ L I GN   G    ++S  + L+LL++ SNQF G   I    LK
Sbjct: 214 TGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG--PIPPLPLK 269

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
           +L  L+L +N   TG    +   +    C +L  L LS N F G +P    + S  +  L
Sbjct: 270 SLQYLSLAENKF-TGE---IPDFLS-GACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESL 323

Query: 379 SVGRNQISGTIPPG-IRNLVNLITFTLEVNQFHGTIPDVISELK-NLQQLSVFNNFLRGG 436
           ++  N  SG +P   +  +  L    L  N+F G +P+ ++ L  +L  L + +N   G 
Sbjct: 324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383

Query: 437 IPSGLGN--LTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITT 494
           I   L       L  L L +N   G IP +L NC  L+    S+N L+G +P  L S++ 
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
           L   L L  N+L G +P ++  +K L  L +  N  +G IP  LS C +L ++ +S N  
Sbjct: 444 LR-DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502

Query: 555 YGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVP 607
            G IP     L+++  L +S+N+ SG IP  L +   L +L+L+ N F G +P
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  310 bits (796), Expect = 2e-94
 Identities = 103/634 (16%), Positives = 195/634 (30%), Gaps = 96/634 (15%)

Query: 37  DRLALLAIKSQLHDP--------SGVTSSWNNTMNFCQWT---GVTCGHRHQRLTELNLS 85
           D LAL  I   L+          +   ++WN       W    GV+    + R+T L+L 
Sbjct: 31  DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLE 89

Query: 86  SQRIGGVLSPYVGNLSFLRYINLADNGFRGD----IPQEIGNLFRLEKLALSNNSFSGTI 141
                G +   +G L+ L  + L  +G + +     P+ I      E+       +  T 
Sbjct: 90  GFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 142 PTNLSR--CSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAI 199
                R   S+LI  C +++  +  I K     LK  ++    N +T  +  +V  L+ +
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL 208

Query: 200 EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG 259
               +  +    +                              N                
Sbjct: 209 RQFYMGNSPFVAENICEAWENENSEYAQ-----QYKTEDLKWDN---------------- 247

Query: 260 IFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI------- 312
                    L +L  + +     +  +P  L     ++L+++  N+      +       
Sbjct: 248 ---------LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 313 -DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL 371
            D    + + ++ +  NNL T           L     L +L    NQ  G+LP +  + 
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVET-----SLQKMKKLGMLECLYNQLEGKLP-AFGSE 352

Query: 372 SLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDV--ISELKNLQQLSV 428
             K+  L++  NQI+  IP         +   +   N+    IP++     +  +  +  
Sbjct: 353 I-KLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDF 409

Query: 429 FNNFLRG-------GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKL 481
             N +          +         + S++L +N +             L       N L
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 482 TG-------DLPQQLLSITTLSLVLDLSNNLLNGSLP-LQVGNLKNLVMLDISSNQFSGV 533
           T        D  +   +   L+  +DL  N L       +   L  LV +D+S N FS  
Sbjct: 470 TEIPKNSLKDENENFKNTYLLT-SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK- 527

Query: 534 IPVTLSTCVSLEYLDI------SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLE 587
            P       +L+   I        N      P       S+  L + SN++     +   
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP 587

Query: 588 NLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLH 621
           N   +  L++  N     + +  V          
Sbjct: 588 N---ISVLDIKDNPNIS-IDLSYVCPYIEAGMYM 617

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  242 bits (619), Expect = 2e-69
 Identities = 63/478 (13%), Positives = 143/478 (29%), Gaps = 41/478 (8%)

Query: 78  RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF 137
            L +  ++S      +            I    N     + + +  L +L +  + N+ F
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF 218

Query: 138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLS 197
                       N         +       +  NL  L  + V       +LP  +  L 
Sbjct: 219 VAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273

Query: 198 AIEVIRITENSL--------GGKIPTTLGLLRRLVNLNVAENQF-SGMFPRSICNISSVE 248
            +++I +  N            +      +  ++  + +  N   +     S+  +  + 
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333

Query: 249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG 308
           ++    N+  G  P     +   L  L +  N       +       +E L    N+ K 
Sbjct: 334 MLECLYNQLEGKLP--AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391

Query: 309 KV-SIDFSSLKNLWLLNLEQNNLGTGTANDLD-FVIFLSNCSSLKVLSLSDNQFGGELPH 366
                D  S+  +  ++   N +G+    + D          ++  ++LS+NQ       
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451

Query: 367 SIANLSLKMIELSVGRNQISG-------TIPPGIRNLVNLITFTLEVNQFHGTIPDV-IS 418
             +  S  +  +++  N ++              +N   L +  L  N+      D   +
Sbjct: 452 LFSTGS-PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRAT 510

Query: 419 ELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG------SNSLQGNIPSSLGNCQNLI 472
            L  L  + +  N      P+   N + L    +        N      P  +  C +L 
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569

Query: 473 LFIASYNKLTGDLPQQLLSITTLSL-VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQ 529
                 N +   + +++      ++ VLD+ +N         V       M  +  ++
Sbjct: 570 QLQIGSNDIRK-VNEKITP----NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  221 bits (565), Expect = 4e-62
 Identities = 82/449 (18%), Positives = 152/449 (33%), Gaps = 52/449 (11%)

Query: 78  RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGD-------------------IP 118
           + T++   S  I   +S  V  L+ LR   + ++ F  +                     
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242

Query: 119 QEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL--------EGQIPKEIG 170
            +  NL  L  + + N      +PT L     +     + N+         + Q   +  
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302

Query: 171 NLLKLQRLSVDINYL-TGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVA 229
              K+Q + +  N L T  +  S+  +  + ++    N L GK+P   G   +L +LN+A
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLA 361

Query: 230 ENQFSGMFPRSIC-NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG---- 284
            NQ +   P + C     VE +    N+   I       ++  +  +    N        
Sbjct: 362 YNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420

Query: 285 ---SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV 341
               +  +     N+  ++L +NQ        FS+   L  +NL  N L     N L   
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480

Query: 342 IF-LSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIE-LSVGRNQISGTIPPGIRNLVNL 399
                N   L  + L  N+    L       +L  +  + +  N  S   P    N   L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538

Query: 400 ITFTLEV------NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG 453
             F +        N+     P+ I+   +L QL + +N +R  +   +     +  LD+ 
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIK 595

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLT 482
            N       S +       +++  Y+K  
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  289 bits (742), Expect = 1e-90
 Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 14/302 (4%)

Query: 344 LSNCSSL----KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT--IPPGIRNLV 397
           L N ++L          +  + G L  +      ++  L +    +     IP  + NL 
Sbjct: 18  LGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY-RVNNLDLSGLNLPKPYPIPSSLANLP 76

Query: 398 NLITFTL-EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNS 456
            L    +  +N   G IP  I++L  L  L + +  + G IP  L  +  L +LD   N+
Sbjct: 77  YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA 136

Query: 457 LQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGN 516
           L G +P S+ +  NL+      N+++G +P    S + L   + +S N L G +P    N
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196

Query: 517 LKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN 576
           L NL  +D+S N   G   V   +  + + + ++ NS    +       K++  L++ +N
Sbjct: 197 L-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254

Query: 577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLP 636
            + G +P+ L  L FL  LN+S+N   GE+P  G        +   N  LCG      LP
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLP 310

Query: 637 SC 638
           +C
Sbjct: 311 AC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  258 bits (661), Expect = 5e-79
 Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 13/305 (4%)

Query: 33  TNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQ--WTGVTCGHRHQ--RLTELNLSSQR 88
            N  D+ ALL IK  L +P+ + SSW  T + C   W GV C    Q  R+  L+LS   
Sbjct: 3   CNPQDKQALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61

Query: 89  IGGV--LSPYVGNLSFLRYINLAD-NGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNL 145
           +     +   + NL +L ++ +   N   G IP  I  L +L  L +++ + SG IP  L
Sbjct: 62  LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121

Query: 146 SRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA-IEVIRI 204
           S+   L+    S N L G +P  I +L  L  ++ D N ++G +PDS G+ S     + I
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181

Query: 205 TENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD 264
           + N L GKIP T   L  L  ++++ N   G       +  + + I L +N  +      
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239

Query: 265 ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLN 324
            +    NL  L +  N   G++P  L+    L  L++  N   G++     +L+   +  
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297

Query: 325 LEQNN 329
              N 
Sbjct: 298 YANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  200 bits (512), Expect = 4e-58
 Identities = 75/308 (24%), Positives = 120/308 (38%), Gaps = 41/308 (13%)

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMF--PRSICNISSVELIFLT-ENRFSGIFPF 263
            +  G +  T     R+ NL+++       +  P S+ N+  +  +++   N   G  P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLL 323
            I   L  L  L I   N  G+IPD LS    L  LD   N   G  ++  S        
Sbjct: 96  AIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--TLPPS-------- 144

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN 383
                               +S+  +L  ++   N+  G +P S  + S     +++ RN
Sbjct: 145 --------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184

Query: 384 QISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGN 443
           +++G IPP   NL NL    L  N   G    +    KN Q++ +  N L   +   +G 
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGL 242

Query: 444 LTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ--QLLSITTLSLVLDL 501
              L  LDL +N + G +P  L   + L     S+N L G++PQ   L      +     
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA--- 299

Query: 502 SNNLLNGS 509
           +N  L GS
Sbjct: 300 NNKCLCGS 307

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 47.9 bits (115), Expect = 7e-06
 Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 3/71 (4%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           L  L+L + RI G L   +  L FL  +N++ N   G+IPQ  GNL R +  A +NN   
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCL 304

Query: 139 GTIPTNLSRCS 149
              P  L  C+
Sbjct: 305 CGSP--LPACT 313

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  283 bits (726), Expect = 4e-84
 Identities = 120/574 (20%), Positives = 215/574 (37%), Gaps = 41/574 (7%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             LTEL+L S  I  + +        L  ++L+ NG           L  L++L LSNN 
Sbjct: 97  TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156

Query: 137 FSGTIPTNLS--RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
                   L     S+L     S+N+++   P     + +L  L ++   L   L + + 
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216

Query: 195 ---NLSAIEVIRITENSLGGKIPTTLGLLR--RLVNLNVAENQFSGMFPRSICNISSVEL 249
                ++I  + ++ + L     TT   L+   L  L+++ N  + +   S   +  +E 
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY 276

Query: 250 IFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI---------PDSLSNASNLELLD 300
            FL  N    +F    L  L N++ L +  +    SI           S      LE L+
Sbjct: 277 FFLEYNNIQHLFS-HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 301 LPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           +  N   G  S  F+ L NL  L+L  +     T  +  FV      S L +L+L+ N+ 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH--SPLHILNLTKNKI 393

Query: 361 GGELPHSIANLSLKMIELSVGRNQISGTIPPG-IRNLVNLITFTLEVNQFHGTIPDVISE 419
                 + + L   +  L +G N+I   +     R L N+    L  N++     +  + 
Sbjct: 394 SKIESDAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452

Query: 420 LKNLQQLSVFNNFLRG--GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
           + +LQ+L +    L+     PS    L  L  LDL +N++       L   + L +    
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512

Query: 478 YNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVT 537
           +N L                   L  +   G     +  L +L +L++ SN F  +    
Sbjct: 513 HNNLA-----------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555

Query: 538 LSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE-FLENLSFLEFLN 596
                 L+ +D+ +N+   +    F    S+K+LN+  N ++    + F      L  L+
Sbjct: 556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615

Query: 597 LSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGI 630
           + +N F+        F N    +     +L    
Sbjct: 616 MRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  277 bits (710), Expect = 8e-82
 Identities = 103/557 (18%), Positives = 192/557 (34%), Gaps = 46/557 (8%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           +T LNL+  ++  + +      S L  +++  N      P+    L  L+ L L +N  S
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                  + C+NL      +N ++            L  L +  N L+     +   L  
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 199 IEVIRITENSLGGKIPTTLGLL--RRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           ++ + ++ N +       L +     L  L ++ NQ     P     I  +  +FL   +
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206

Query: 257 FSGIFPFDI--LLNLPNLKKLGIGGNNFVGSIPDSLSN--ASNLELLDLPSNQFKGKVSI 312
                   +   L   +++ L +  +    +   +      +NL +LDL  N      + 
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266

Query: 313 DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS 372
            F+ L  L    LE NN+    ++       L    +++ L+L  +     +        
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSH------SLHGLFNVRYLNLKRSFTKQSISL------ 314

Query: 373 LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF 432
                       +        + L  L    +E N   G   ++ + L NL+ LS+ N+F
Sbjct: 315 ----------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSF 364

Query: 433 -----LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ 487
                L       L + + L  L+L  N +      +     +L +     N++  +L  
Sbjct: 365 TSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 488 QLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV--IPVTLSTCVSLE 545
           Q          + LS N            + +L  L +       V   P       +L 
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483

Query: 546 YLDISINSFYGVIPLSFRFLKSIKALNVSSNNLS--------GKIPEFLENLSFLEFLNL 597
            LD+S N+   +       L+ ++ L++  NNL+        G    FL+ LS L  LNL
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

Query: 598 SYNYFEGEVPVKGVFSN 614
             N F+       VF +
Sbjct: 544 ESNGFDEIPV--EVFKD 558

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  218 bits (558), Expect = 9e-61
 Identities = 91/448 (20%), Positives = 159/448 (35%), Gaps = 27/448 (6%)

Query: 175 LQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS 234
            +        LT Q+PD +   + I V+ +T N L            +L +L+V  N  S
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 235 GMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNAS 294
            + P     +  ++++ L  N  S +          NL +L +  N+      +      
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSD-KTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 295 NLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLS 354
           NL  LDL  N            L+NL  L L  N +    + +LD        SSLK L 
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI----FANSSLKKLE 177

Query: 355 LSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIR---NLVNLITFTLEVNQFHG 411
           LS NQ     P     +  ++  L +   Q+  ++   +       ++   +L  +Q   
Sbjct: 178 LSSNQIKEFSPGCFHAIG-RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 412 TIPDVISELK--NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQ 469
           T       LK  NL  L +  N L          L +L    L  N++Q     SL    
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 470 NLILFIASYNKLTGDLPQ-QLLSITTLSL-------VLDLSNNLLNGSLPLQVGNLKNLV 521
           N+       +     +    L  I   S         L++ +N + G        L NL 
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 522 MLDISSNQFSGVIPVTLS----TCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNN 577
            L +S++  S       +        L  L+++ N    +   +F +L  ++ L++  N 
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 578 LSGKIP-EFLENLSFLEFLNLSYNYFEG 604
           +  ++  +    L  +  + LSYN +  
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQ 444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  208 bits (531), Expect = 3e-57
 Identities = 81/395 (20%), Positives = 148/395 (37%), Gaps = 27/395 (6%)

Query: 242 CNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
           C +S  E+   +  + + + P D+     N+  L +  N        + +  S L  LD+
Sbjct: 2   CTVSH-EVADCSHLKLTQV-PDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56

Query: 302 PSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
             N            L  L +LNL+ N L +  ++        + C++L  L L  N   
Sbjct: 57  GFNTISKLEPELCQKLPMLKVLNLQHNEL-SQLSDKT-----FAFCTNLTELHLMSNSIQ 110

Query: 362 GELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK 421
               +        +I L +  N +S T       L NL    L  N+      + +    
Sbjct: 111 KIKNNPFVKQK-NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169

Query: 422 N--LQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG---NCQNLILFIA 476
           N  L++L + +N ++   P     + +L  L L +  L  ++   L       ++     
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229

Query: 477 SYNKLTGDLPQQLLSITTLSL-VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP 535
           S ++L+       L +   +L +LDLS N LN         L  L    +  N    +  
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289

Query: 536 VTLSTCVSLEYLD---------ISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFL 586
            +L    ++ YL+         IS+ S   +   SF++LK ++ LN+  N++ G      
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349

Query: 587 ENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLH 621
             L  L++L+LS ++          F +     LH
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  194 bits (494), Expect = 3e-52
 Identities = 88/470 (18%), Positives = 162/470 (34%), Gaps = 51/470 (10%)

Query: 73  GHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLAL 132
           G +   LT L+LS   +  V +     L  L Y  L  N  +      +  LF +  L L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 133 SNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
             +    +I               S   L          L  L+ L+++ N + G   + 
Sbjct: 304 KRSFTKQSI---------------SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348

Query: 193 VGNLSAIEVIRITENSLGGKIPTTLGL----LRRLVNLNVAENQFSGMFPRSICNISSVE 248
              L  ++ + ++ +    +  T           L  LN+ +N+ S +   +   +  +E
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408

Query: 249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG 308
           ++ L  N             L N+ ++ +  N ++    +S +   +L+ L L     K 
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 309 KVSID--FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
             S    F  L+NL +L+L  NN+     +       L     L++L L  N        
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDD------MLEGLEKLEILDLQHNNLA----- 517

Query: 367 SIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQL 426
                        + ++   G     ++ L +L    LE N F     +V  +L  L+ +
Sbjct: 518 ------------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565

Query: 427 SVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG-NCQNLILFIASYNKLTGDL 485
            +  N L     S   N   L SL+L  N +        G   +NL      +N      
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625

Query: 486 PQQLLSITTLSL----VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
                 +  ++     + +LS++ L  + P   G    + + D SS + S
Sbjct: 626 ESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG--FPVRLFDTSSCKDS 673

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.5 bits (238), Expect = 3e-20
 Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 9/150 (6%)

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
           S+ KLT  +P  L +  T   VL+L++N L             L  LD+  N  S + P 
Sbjct: 12  SHLKLT-QVPDDLPTNIT---VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE 67

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
                  L+ L++  N    +   +F F  ++  L++ SN++             L  L+
Sbjct: 68  LCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLD 127

Query: 597 LSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
           LS+N         G          + L  N
Sbjct: 128 LSHNGLSSTKL--GTQVQLENLQELLLSNN 155

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  277 bits (711), Expect = 1e-82
 Identities = 108/555 (19%), Positives = 205/555 (36%), Gaps = 41/555 (7%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              L+LS   +  + S    +   L+ ++L+    +        +L  L  L L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLS 197
                  S  S+L    A    L       IG+L  L+ L+V  N +   +LP+   NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 198 AIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
            +E + ++ N +     T L +L ++  LN++ +                    L+ N  
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD--------------------LSLNPM 189

Query: 258 SGIFPFDILLNLPNLKKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSI---D 313
           + I P         L KL +  N    ++    +   + LE+  L   +F+ + ++   D
Sbjct: 190 NFIQPG--AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 314 FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL 373
            S+L+ L  L +E+  L        D +   +  +++   SL           S  N   
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY-NFGW 306

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
           + +EL     +        +++L  L           G       +L +L+ L +  N L
Sbjct: 307 QHLELV--NCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGL 359

Query: 434 --RGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
             +G         T L  LDL  N +   + S+    + L      ++ L       +  
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI-PVTLSTCVSLEYLDIS 550
                + LD+S+     +       L +L +L ++ N F     P   +   +L +LD+S
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVP--V 608
                 + P +F  L S++ LN+S NN         + L+ L+ L+ S N+        +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

Query: 609 KGVFSNKTKISLHGN 623
           +   S+   ++L  N
Sbjct: 539 QHFPSSLAFLNLTQN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  252 bits (645), Expect = 2e-73
 Identities = 107/549 (19%), Positives = 188/549 (34%), Gaps = 36/549 (6%)

Query: 78  RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF 137
            L  L+LS   I  +      +LS L  + L  N  +         L  L+KL     + 
Sbjct: 53  ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112

Query: 138 SGTIPTNLSRCSNLIHFCASNNKLEG-QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
           +      +     L     ++N ++  ++P+   NL  L+ L +  N +       +  L
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 197 SAIEVIRIT----ENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSIC-NISSVELIF 251
             + ++ ++     N +    P     + RL  L +  N  S    ++    ++ +E+  
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231

Query: 252 LTENRFSGI-----FPFDILLNLPNLKKLGI---GGNNFVGSIPDSLSNASNLELLDLPS 303
           L    F        F    L  L NL          + ++  I D  +  +N+    L S
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291

Query: 304 NQFKGKVSIDF-SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSN----------CSSLKV 352
              +      +    ++L L+N +     T     L  + F SN            SL+ 
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEF 351

Query: 353 LSLSDNQ--FGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH 410
           L LS N   F G    S    +  +  L +  N +  T+      L  L     + +   
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTT-SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409

Query: 411 GTIP-DVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNI-PSSLGNC 468
                 V   L+NL  L + +   R         L+ L  L +  NS Q N  P      
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 469 QNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSN 528
           +NL     S  +L    P    S+++L  VL++S+N            L +L +LD S N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

Query: 529 QFSGVIPVTLSTCV-SLEYLDISINSFYGVIPLS--FRFLKSIKALNVSSNNLSGKIPEF 585
                    L     SL +L+++ N F          +++K  + L V    +    P  
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588

Query: 586 LENLSFLEF 594
            + +  L  
Sbjct: 589 KQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  219 bits (560), Expect = 1e-61
 Identities = 98/494 (19%), Positives = 162/494 (32%), Gaps = 38/494 (7%)

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
               +F   IP NL    +  +   S N L         +  +LQ L +    +      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF 251
           +  +LS +  + +T N +          L  L  L   E   + +    I ++ +++ + 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLEL----LDLPSNQFK 307
           +  N        +   NL NL+ L +  N         L     + L    LDL  N   
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 308 GKVSIDFSSLKNLWL--LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE-- 363
               I   + K + L  L L  N               +   + L+V  L   +F  E  
Sbjct: 191 F---IQPGAFKEIRLHKLTLRNNFDSLNVMKT-----CIQGLAGLEVHRLVLGEFRNEGN 242

Query: 364 LPHSIANLSLKMIELSVGRNQIS------GTIPPGIRNLVNLITFTLEVNQFHGTIPDVI 417
           L     +    +  L++   +++        I      L N+ +F+L             
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300

Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
           S     Q L + N          L +L +     L   S +G    S  +  +L     S
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLS 355

Query: 478 YNKLT--GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP 535
            N L+  G   Q     T+L   LDLS N +   +      L+ L  LD   +    +  
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 536 V-TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI-PEFLENLSFLE 593
                +  +L YLDIS           F  L S++ L ++ N+      P+    L  L 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 594 FLNLSYNYFEGEVP 607
           FL+LS    E   P
Sbjct: 474 FLDLSQCQLEQLSP 487

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.3 bits (248), Expect = 1e-21
 Identities = 33/150 (22%), Positives = 56/150 (37%), Gaps = 8/150 (5%)

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
                   +P  L   T     LDLS N L         +   L +LD+S  +   +   
Sbjct: 15  MELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
              +   L  L ++ N    +   +F  L S++ L     NL+      + +L  L+ LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 597 LSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
           +++N  +    +   FSN T    + L  N
Sbjct: 131 VAHNLIQS-FKLPEYFSNLTNLEHLDLSSN 159

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  260 bits (666), Expect = 3e-74
 Identities = 100/639 (15%), Positives = 188/639 (29%), Gaps = 79/639 (12%)

Query: 27  SFSAGQTNETDRLALLAIKSQLHDP--SGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNL 84
                     D  AL AI   L        + + NNT++   W               N 
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-------------FNK 306

Query: 85  SSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTN 144
                G      + N   +  ++LA  G +G +P  IG L  L+ L+   +S + +    
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 145 LSRCSNLIHFCASNNKLEGQIPKEIGNLL-KLQRLSVDINYLTGQLPDSVGNLSAIEVIR 203
                         +++     K   +   +L    +  + +       +  +     I 
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRIS 424

Query: 204 ITENSLGG------KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
           + +  +G        I   +  L +L  +  A + F+             E       + 
Sbjct: 425 LKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQ 479

Query: 258 SGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI----- 312
                     NL +L  + +     +  +PD L +   L+ L++  N+      +     
Sbjct: 480 YENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538

Query: 313 ----DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSI 368
               D  +   + +  +  NNL      +      L     L +L    N+       + 
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNL-----EEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591

Query: 369 ANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDV--ISELKNLQQ 425
                K+ +L +  NQI   IP         +       N+    IP++     +  +  
Sbjct: 592 GTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648

Query: 426 LSVFNNFLRG-----GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK 480
           +    N +                    ++ L  N +Q            +   I S N 
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 481 LTGDLPQQLLSITTLSL-------VLDLSNNLLNG-SLPLQVGNLKNLVMLDISSNQFSG 532
           +T  +P+  L     +         +DL  N L   S   +   L  L  +D+S N FS 
Sbjct: 709 MT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS 767

Query: 533 VIPVTLSTCVSLEYLDI------SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFL 586
             P        L+   I        N      P       S+  L + SN++  K+ E  
Sbjct: 768 -FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE-- 823

Query: 587 ENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK--ISLHGN 623
           +    L  L+++ N     + V  V          L  +
Sbjct: 824 KLTPQLYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  193 bits (492), Expect = 3e-51
 Identities = 67/431 (15%), Positives = 130/431 (30%), Gaps = 39/431 (9%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            +L  +  ++                    N        +      NL  L  + L N  
Sbjct: 448 TKLQIIYFANSPFTYD-----NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEG---------QIPKEIGNLLKLQRLSVDINYLTG 187
               +P  L     L     + N+            ++  +     K+Q   +  N L  
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562

Query: 188 QLPDSV--GNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSIC-NI 244
             P S     +  + ++    N +  +     G   +L +L +  NQ     P   C   
Sbjct: 563 -FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFT 618

Query: 245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPD-----SLSNASNLELL 299
             VE +  + N+   I       ++  +  +    N       +           N   +
Sbjct: 619 DQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678

Query: 300 DLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF-LSNCSSLKVLSLSDN 358
            L  N+ +   +  F++   +  + L  N + +   N L        N   L  + L  N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738

Query: 359 QFGGELPHSIANLSLKMIE-LSVGRNQISGTIPPGIRNLVNLITFTLE------VNQFHG 411
           +    L       +L  +  + V  N  S + P    N   L  F +        N+   
Sbjct: 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796

Query: 412 TIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
             P  I+   +L QL + +N +R  +   L    +L  LD+  N       +S+      
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853

Query: 472 ILFIASYNKLT 482
            +++  Y+K  
Sbjct: 854 GMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  119 bits (301), Expect = 9e-28
 Identities = 42/318 (13%), Positives = 104/318 (32%), Gaps = 35/318 (11%)

Query: 325 LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQ 384
           ++++ L T +     F +  +  +    + +   +    +    A  ++    L     +
Sbjct: 229 IKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIW-EALDGKNWR 287

Query: 385 ISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL 444
                     + +N   F  E++ +       +     +  LS+     +G +P  +G L
Sbjct: 288 YYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346

Query: 445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN 504
           T+L  L  G++S   +            +     +++     +  L       + DL  +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406

Query: 505 LLNG----------------------------SLPLQVGNLKNLVMLDISSNQFSGVIPV 536
            +N                              +   +  L  L ++  +++ F+     
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI- 465

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
                V  E  +      Y    LS+  LK +  + + +     ++P+FL +L  L+ LN
Sbjct: 466 ----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521

Query: 597 LSYNYFEGEVPVKGVFSN 614
           ++ N       +K  ++ 
Sbjct: 522 IACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.9 bits (228), Expect = 5e-19
 Identities = 32/202 (15%), Positives = 68/202 (33%), Gaps = 20/202 (9%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFR-------GDIPQEIGNLFR 126
           ++    + + LS   I    +      S +  I L++N                  N + 
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

Query: 127 LEKLALSNNSFSGTIPTNLSRC--SNLIHFCASNNKLEGQIPKEIGNLLKLQRLS----- 179
           L  + L  N  + ++  +        L +   S N      P +  N  +L+        
Sbjct: 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR 787

Query: 180 -VDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFP 238
             + N +  Q P  +    ++  ++I  N +  K+     L  +L  L++A+N    +  
Sbjct: 788 DAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE--KLTPQLYILDIADNPNISIDV 844

Query: 239 RSICNISSVELIFLTENRFSGI 260
            S+C      +  L  ++   I
Sbjct: 845 TSVCPYIEAGMYVLLYDKTQDI 866

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 11/118 (9%), Positives = 39/118 (33%), Gaps = 1/118 (0%)

Query: 523 LDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI 582
           LD  + ++           ++    +  ++ +     +       +  L+++     G++
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 583 PEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPS 640
           P+ +  L+ L+ L+   +       + G       +S     ++     ++ L     
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  247 bits (633), Expect = 1e-71
 Identities = 105/537 (19%), Positives = 184/537 (34%), Gaps = 21/537 (3%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              L  S   +  + +     L  L +++L              +  RL+ L L+ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
               T LS    L H       +       + N   L+ L +  N+++            
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 199 IEVIRITENSLGGKIPTTLGLLRRL--VNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           ++V+    N++       +  L++   ++LN+  N  +G+ P +  +     L F     
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSN--ASNLELLDLPSNQFKGKVSIDF 314
              IF       + +L        +     P         ++E ++L  + F    S  F
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLK 374
                L  L+L   +L    +        L   S+LK L LS N+F      S +N    
Sbjct: 275 HCFSGLQELDLTATHLSELPSG-------LVGLSTLKKLVLSANKFENLCQISASNFP-S 326

Query: 375 MIELSVGRNQISGTIPPG-IRNLVNLITFTLEVNQFH--GTIPDVISELKNLQQLSVFNN 431
           +  LS+  N     +  G + NL NL    L  +           +  L +LQ L++  N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386

Query: 432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIASYNKLTGDLPQQLL 490
                         +L  LDL    L+     S   N   L +   S++ L     Q   
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 491 SITTLSLVLDLSNNLLNGSLPLQVG---NLKNLVMLDISSNQFSGVIPVTLSTCVSLEYL 547
            +  L   L+L  N        +      L  L +L +S    S +     ++   + ++
Sbjct: 447 GLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505

Query: 548 DISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEG 604
           D+S N        +   LK I  LN++SN++S  +P  L  LS    +NL  N  + 
Sbjct: 506 DLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  234 bits (598), Expect = 6e-67
 Identities = 107/567 (18%), Positives = 198/567 (34%), Gaps = 30/567 (5%)

Query: 71  TCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKL 130
            C  +    T  N  +  +  +        +    +  + N            L  L  L
Sbjct: 7   KCIEKEVNKT-YNCENLGLNEIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62

Query: 131 ALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP 190
            L+                 L     + N L       +     L+ L      ++    
Sbjct: 63  DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122

Query: 191 DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELI 250
             + N   +E + +  N +            +L  L+   N    +    + ++     +
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182

Query: 251 FL--TENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNAS--NLELLDLPSNQF 306
            L    N  +GI P     +    + L  GG   +  I   L N++  +L L        
Sbjct: 183 SLNLNGNDIAGIEPG--AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240

Query: 307 KGKVSIDFSSLKNLWL--LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL 364
           +      F  L  + +  +NL+++     ++N           S L+ L L+      EL
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNT------FHCFSGLQELDLTATHL-SEL 293

Query: 365 PHSIANL-SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTI-PDVISELKN 422
           P  +  L +LK + LS   N+          N  +L   +++ N     +    +  L+N
Sbjct: 294 PSGLVGLSTLKKLVLS--ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351

Query: 423 LQQLSVFNNFLR--GGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK 480
           L++L + ++ +         L NL+ L SL+L  N        +   C  L L   ++ +
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411

Query: 481 LTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV---T 537
           L     Q       L  VL+LS++LL+ S       L  L  L++  N F         +
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471

Query: 538 LSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNL 597
           L T   LE L +S      +   +F  LK +  +++S N L+    E L +L  + +LNL
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530

Query: 598 SYNYFEGEVP-VKGVFSNKTKISLHGN 623
           + N+    +P +  + S +  I+L  N
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQN 557

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  224 bits (573), Expect = 2e-63
 Identities = 105/547 (19%), Positives = 182/547 (33%), Gaps = 27/547 (4%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALS 133
            R   LT L+L+  +I  +      +   L  + L  N         +     L+ L   
Sbjct: 54  SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113

Query: 134 NNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSV 193
               S      L     L      +N +      +     KL+ L    N +     + +
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 194 GNLSAIEVI--RITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI--CNISSVEL 249
            +L     +   +  N + G I           +LN    Q   +  + +    I S+ L
Sbjct: 174 SSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWL 232

Query: 250 IFLTENRFSGIFP--FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK 307
               +     I P  F+ L  + +++ + +  + F     ++    S L+ LDL +    
Sbjct: 233 GTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291

Query: 308 GKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL-PH 366
            ++      L  L  L L  N                SN  SL  LS+  N    EL   
Sbjct: 292 -ELPSGLVGLSTLKKLVLSANKFENLCQI------SASNFPSLTHLSIKGNTKRLELGTG 344

Query: 367 SIANLSLKMIELSVGRNQI--SGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ 424
            + NL   + EL +  + I  S      +RNL +L +  L  N+      +   E   L+
Sbjct: 345 CLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 425 QLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG 483
            L +    L+         NL  L  L+L  + L  +          L       N    
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 484 DLPQQLLSITTLS--LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTC 541
              Q+  S+ TL    +L LS   L+        +LK +  +D+S N+ +      LS  
Sbjct: 464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL 523

Query: 542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNY 601
             + YL+++ N    ++P     L   + +N+  N L         N+ FLE+   +   
Sbjct: 524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQK 578

Query: 602 FEGEVPV 608
            E     
Sbjct: 579 LEDTEDT 585

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  214 bits (546), Expect = 8e-60
 Identities = 91/518 (17%), Positives = 184/518 (35%), Gaps = 33/518 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
           + L  L      I  +    + N   L  + L  N        +     +L+ L   NN+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164

Query: 137 FSGTIPTNLSRCSNL--IHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
                  ++S       +    + N + G I     +    Q L+         +   + 
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLK 223

Query: 195 N--LSAIEVIRITENSLGGKIPTTLGLLRR--LVNLNVAENQFSGMFPRSICNISSVELI 250
           N  + ++ +    +       P     L    + ++N+ ++ F  +   +    S ++ +
Sbjct: 224 NSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283

Query: 251 FLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV 310
            LT    S +     L+ L  LKKL +  N F      S SN  +L  L +  N  + ++
Sbjct: 284 DLTATHLSELP--SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341

Query: 311 SID-FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA 369
                 +L+NL  L+L  +++ T    +L       N S L+ L+LS N+       +  
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSHLQSLNLSYNEPLSLKTEAFK 397

Query: 370 NL-SLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLS 427
               L++++L+    ++         +NL  L    L  +    +   +   L  LQ L+
Sbjct: 398 ECPQLELLDLA--FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455

Query: 428 VFNNFLRGGI---PSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD 484
           +  N    G     + L  L +L  L L    L      +  + + +     S+N+LT  
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 485 LPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVS- 543
             + L  +    + L+L++N ++  LP  +  L     +++  N           TC + 
Sbjct: 516 SIEALSHLK--GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC-------TCSNI 566

Query: 544 --LEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLS 579
             LE+   ++                ++ + +S   LS
Sbjct: 567 YFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 99.3 bits (248), Expect = 1e-21
 Identities = 39/231 (16%), Positives = 65/231 (28%), Gaps = 29/231 (12%)

Query: 412 TIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
            IP  +    + + L    N L     +    L  L  LDL    +      +  +   L
Sbjct: 26  EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 472 ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
                                      L L+ N L       +   K L  L       S
Sbjct: 84  D-------------------------TLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118

Query: 532 GVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSF 591
            +  + L    +LE L +  N    +        + +K L+  +N +     E + +L  
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178

Query: 592 LE--FLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPS 640
                LNL+ N   G  P     +    ++  G   L      L   +  S
Sbjct: 179 ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  235 bits (601), Expect = 3e-67
 Identities = 108/539 (20%), Positives = 195/539 (36%), Gaps = 34/539 (6%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              ++LS   +  + S    N S L++++L+         +    L  L  L L+ N   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLS 197
              P + S  ++L +  A   KL       IG L+ L++L+V  N++   +LP    NL+
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 198 AIEVIRITENSLGGKIPTTLGLLRRL----VNLNVAENQFSGMFPRSICNISSVELIFLT 253
            +  + ++ N +       L  LR      ++L+++ N    +  ++   I   EL  L 
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELT-LR 212

Query: 254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLE--------LLDLPSNQ 305
            N  S       L NL  L    +    F       +   S +E           L    
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272

Query: 306 FKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP 365
                 + F  L N+  ++L   ++          +  +      + LS+   Q      
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--------LEDVPKHFKWQSLSIIRCQLKQFPT 324

Query: 366 HSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK--NL 423
             +  L      L++  N+ S  I      L +L    L  N    +     S+L   +L
Sbjct: 325 LDLPFLK----SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIASYNKLT 482
           + L +  N     + +    L +L  LD   ++L+     S+  + + L+    SY    
Sbjct: 379 RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK 437

Query: 483 GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTC 541
            D     L +T+L+  L ++ N    +    V  N  NL  LD+S  Q   +      T 
Sbjct: 438 IDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL 496

Query: 542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
             L+ L++S N+   +    +  L S+  L+ S N +             L F NL+ N
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  192 bits (491), Expect = 2e-52
 Identities = 101/505 (20%), Positives = 181/505 (35%), Gaps = 43/505 (8%)

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
           G++   +    N+ + C  + KL  ++P +I +    + + +  N L      S  N S 
Sbjct: 2   GSLNPCIEVVPNITYQC-MDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           ++ + ++   +          L  L NL +  N      P S   ++S+E +   E + +
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVG-SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSL 317
            +     +  L  LKKL +  N      +P   SN +NL  +DL  N  +     D   L
Sbjct: 118 SL-ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 318 KNL----WLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP-HSIANLS 372
           +        L++  N +       +    F      L  L+L  N     +    + NL+
Sbjct: 177 RENPQVNLSLDMSLNPIDF-----IQDQAF--QGIKLHELTLRGNFNSSNIMKTCLQNLA 229

Query: 373 -LKMIELSVGR----NQISGTIPPGIRNLVNL--ITFTLEVNQFHGTIPDVISELKNLQQ 425
            L +  L +G       +    P  +  L ++    F L               L N+  
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289

Query: 426 LSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDL 485
           +S+    ++      +    K  SL +    L+      L   ++L L   + NK +   
Sbjct: 290 MSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTL---TMNKGSISF 344

Query: 486 PQQLLSITTLSL-VLDLSNNLLN--GSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCV 542
            +  L     SL  LDLS N L+  G          +L  LD+S N    ++        
Sbjct: 345 KKVALP----SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE 399

Query: 543 SLEYLDISINSFYGVIPLS-FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNY 601
            L++LD   ++   V   S F  L+ +  L++S  N           L+ L  L ++ N 
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459

Query: 602 FEGEVPVKGVFSNKTK---ISLHGN 623
           F+       VF+N T    + L   
Sbjct: 460 FKDNTL-SNVFANTTNLTFLDLSKC 483

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  213 bits (545), Expect = 2e-62
 Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 16/199 (8%)

Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECE 754
           S  EL  A+  FS+ N++G+G FG VYKG L D   +VAVK +  +  +G    F +E E
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-LVAVKRLKEERTQGGELQFQTEVE 79

Query: 755 ALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ 814
            +    HRNL+++   C          + LV+ YM NGS+   L +  +      L   +
Sbjct: 80  MISMAVHRNLLRLRGFCM----TP-TERLLVYPYMANGSVASCLRERPESQPP--LDWPK 132

Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
           R  IA+  A  + YLH HC P ++H D+K +N+LLD +  A VGDFGLAK +      + 
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV- 191

Query: 875 SKTPSSSIGIKGTVGYVAP 893
                 +  ++GT+G++AP
Sbjct: 192 ------TTAVRGTIGHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  197 bits (502), Expect = 1e-56
 Identities = 73/227 (32%), Positives = 111/227 (48%), Gaps = 27/227 (11%)

Query: 674 RKRRSTHKSVDTSPMEKLFPM----VSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDD 729
           +  ++T+   D      L P     V   +L +AT+ F    +IG G FG VYKG+L  D
Sbjct: 4   KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RD 62

Query: 730 EMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYM 789
              VA+K    +     + F +E E L   RH +L+ +I  C     E  +   L+++YM
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD----ER-NEMILIYKYM 117

Query: 790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           ENG+L+  L+ S+       +S  QR+ I I  A  + YLH      ++H D+K  N+LL
Sbjct: 118 ENGNLKRHLYGSDLPTM--SMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILL 172

Query: 850 DYDMVAHVGDFGLAKF---LSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           D + V  + DFG++K    L   HL         S  +KGT+GY+ P
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHL---------STVVKGTLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  180 bits (458), Expect = 1e-50
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 696 SYAELSKATSEFSS------SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--- 746
           S+ EL   T+ F         N +G+G FG VYKG +  +   VAVK +       +   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73

Query: 747 -KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
            + F  E + +   +H NL++++   S    +G D   LV+ YM NGSL D L   +   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS----DG-DDLCLVYVYMPNGSLLDRLSCLDGT- 127

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
               LS   R  IA   A+ I +LH +     +H D+K +N+LLD    A + DFGLA+ 
Sbjct: 128 --PPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 866 LSNHHLDIASKTPSSSIGIKGTVGYVAP 893
                 +  ++T  +S  I GT  Y+AP
Sbjct: 183 -----SEKFAQTVMTS-RIVGTTAYMAP 204

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (459), Expect = 1e-50
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 20/206 (9%)

Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE- 754
           + +E S          +IG+GR+G VYKG L +    VAVKV +   +   ++F++E   
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58

Query: 755 -ALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
             +  + H N+ + I        +G     LV EY  NGSL  +L              +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDWV 111

Query: 814 QRMNIAIDVASAIEYLH------HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
               +A  V   + YLH       H +P + H DL   NVL+  D    + DFGL+  L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 868 NHHLDIASKTPSSSIGIKGTVGYVAP 893
            + L    +  +++I   GT+ Y+AP
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAP 197

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  183 bits (466), Expect = 4e-50
 Identities = 113/509 (22%), Positives = 189/509 (37%), Gaps = 69/509 (13%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
            L+      L        + Q   +L ++  L              +   +NL     SN
Sbjct: 22  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           N+L    P  + NL KL  + ++ N +       + NL+ +  + +  N +       L 
Sbjct: 78  NQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDPLK 131

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
            L  L  L ++ N  S     ++  ++S++ +    N+ + + P     NL  L++L I 
Sbjct: 132 NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLA---NLTTLERLDIS 185

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL 338
            N    S    L+  +NLE L   +NQ           L NL  L+L  N L        
Sbjct: 186 SNKV--SDISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD------ 235

Query: 339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVN 398
             +  L++ ++L  L L++NQ     P  ++ L+ K+ EL +G NQIS   P  +  L  
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNISP--LAGLTA 288

Query: 399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ 458
           L    L  NQ     P  IS LKNL  L+++ N +     S + +LTKL  L   +N + 
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVS 344

Query: 459 GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLK 518
               SSL N  N+                           L   +N ++   PL   NL 
Sbjct: 345 D--VSSLANLTNIN-------------------------WLSAGHNQISDLTPL--ANLT 375

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
            +  L ++   ++   PV     VS+     ++     + P +     S    +++ N  
Sbjct: 376 RITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLP 433

Query: 579 SGKIPEFLENLSFLEFLNLSYNYFEGEVP 607
           S    E     S    +      F G V 
Sbjct: 434 S-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  180 bits (458), Expect = 4e-49
 Identities = 109/481 (22%), Positives = 188/481 (39%), Gaps = 45/481 (9%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
             +  L    +         +L  +  +     G +      +  L  L ++  SNN  +
Sbjct: 26  KMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLT 81

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
              P  L   + L+    +NN++    P  + NL  L  L++  N +T    D + NL+ 
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTN 135

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           +  + ++ N++     + L  L  L  L+   NQ + + P  + N++++E + ++ N+ S
Sbjct: 136 LNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVS 190

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
            I        L NL+ L    N      P  L   +NL+ L L  NQ K   +   +SL 
Sbjct: 191 DISVLA---KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLT 243

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
           NL  L+L  N +          +  LS  + L  L L  NQ     P  +A L+  +  L
Sbjct: 244 NLTDLDLANNQISN--------LAPLSGLTKLTELKLGANQISNISP--LAGLT-ALTNL 292

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
            +  NQ+    P  I NL NL   TL  N      P  +S L  LQ+L  +NN +     
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLV 498
           S L NLT +  L  G N +    P  L N   +     +    T        +++  + V
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 499 LDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVI 558
            +++  L+    P  + +  +    DI+ N  S    V+ +    +     +   F G +
Sbjct: 405 KNVTGALI---APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT-FSGTV 460

Query: 559 P 559
            
Sbjct: 461 T 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  177 bits (452), Expect = 2e-48
 Identities = 104/493 (21%), Positives = 190/493 (38%), Gaps = 48/493 (9%)

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
             +   +       +  +  +        +   +     +L ++  L  D   +     D
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--ID 62

Query: 192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF 251
            V  L+ +  I  + N L    P  L  L +LV++ +  NQ + + P  + N++++  + 
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
           L  N+ + I P     NL NL +L +  N    S   +LS  ++L+ L    NQ      
Sbjct: 119 LFNNQITDIDPLK---NLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTD--L 170

Query: 312 IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL 371
              ++L  L  L++  N +          +  L+  ++L+ L  ++NQ     P  +  L
Sbjct: 171 KPLANLTTLERLDISSNKVSD--------ISVLAKLTNLESLIATNNQISDITP--LGIL 220

Query: 372 SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN 431
           +  + ELS+  NQ+       + +L NL    L  NQ     P  +S L  L +L +  N
Sbjct: 221 T-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275

Query: 432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
            +     S L  LT L +L+L  N L+   P  + N +NL      +N ++   P  + S
Sbjct: 276 QISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISI 551
           +T L   L   NN ++    L   NL N+  L    NQ S + P  L+    +  L ++ 
Sbjct: 330 LTKLQ-RLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 384

Query: 552 NSFYGVIPLSFRFLKSIKALNVSSNNLSGKI-PEFLENLSFLEFLNLSYNYFEGEVPVKG 610
            ++         +  ++   N   N     I P  + +       ++++N       V  
Sbjct: 385 QAWTNAPV---NYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSY 441

Query: 611 VFSNKTKISLHGN 623
            FS    I     
Sbjct: 442 TFSQPVTIGKGTT 454

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  106 bits (267), Expect = 2e-24
 Identities = 66/317 (20%), Positives = 126/317 (39%), Gaps = 35/317 (11%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             L  L++SS ++  +    +  L+ L  +   +N      P  +G L  L++L+L+ N 
Sbjct: 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ 232

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
                   L+  +NL     +NN++    P  +  L KL  L +  N ++      +  L
Sbjct: 233 LKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGL 286

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           +A+  + + EN L    P  +  L+ L  L +  N  S + P  + +++ ++ +F   N+
Sbjct: 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS 316
            S +       NL N+  L  G N      P  L+N + +  L L    +    +   + 
Sbjct: 343 VSDVSSLA---NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT---NAPVNY 394

Query: 317 LKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL--- 373
             N+ + N  +N  G   A        +S+  S     ++ N     LP     +S    
Sbjct: 395 KANVSIPNTVKNVTGALIAP-----ATISDGGSYTEPDITWN-----LPSYTNEVSYTFS 444

Query: 374 KMIELSVGRNQISGTIP 390
           + + +  G    SGT+ 
Sbjct: 445 QPVTIGKGTTTFSGTVT 461

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  174 bits (444), Expect = 9e-49
 Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 24/205 (11%)

Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
               L   +       +  +GRFG V+K  L ++   VAVK+    Q   S     E  +
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFP-IQDKQSWQNEYEVYS 71

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           L  ++H N+++ I          VD   L+  + E GSL D+L           +S  + 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA-------NVVSWNEL 123

Query: 816 MNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            +IA  +A  + YLH          +P + H D+K  NVLL  ++ A + DFGLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE- 182

Query: 869 HHLDIASKTPSSSIGIKGTVGYVAP 893
                A K+   + G  GT  Y+AP
Sbjct: 183 -----AGKSAGDTHGQVGTRRYMAP 202

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  176 bits (449), Expect = 4e-47
 Identities = 106/530 (20%), Positives = 196/530 (36%), Gaps = 39/530 (7%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              L+LS   +  + S    +   L+ ++L+    +        +L  L  L L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLT-GQLPDSVGNLS 197
                  S  S+L    A    L       IG+L  L+ L+V  N +   +LP+   NL+
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 198 AIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
            +E + ++ N +     T L +L ++  LN++ +                    L+ N  
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD--------------------LSLNPM 189

Query: 258 SGIFPFDILLNLPNLKKLGIGGNNFVGSIPD-SLSNASNLELLDLPSNQFKGK---VSID 313
           + I P         L KL +  N    ++    +   + LE+  L   +F+ +      D
Sbjct: 190 NFIQPG--AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 314 FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL 373
            S+L+ L  L +E+  L        D +   +  +++   SL        +     N   
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-ERVKDFSYNFGW 306

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
           + +EL     +     P     L +L   T   N+      +V  +L +L+ L +  N L
Sbjct: 307 QHLELV--NCKFGQ-FPTL--KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGL 359

Query: 434 R--GGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
              G         T L  LDL  N +   + S+    + L      ++ L       +  
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI-PVTLSTCVSLEYLDIS 550
                + LD+S+     +       L +L +L ++ N F     P   +   +L +LD+S
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
                 + P +F  L S++ LN++SN L        + L+ L+ + L  N
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  158 bits (401), Expect = 6e-41
 Identities = 100/513 (19%), Positives = 171/513 (33%), Gaps = 43/513 (8%)

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
               +F   IP NL    +  +   S N L         +  +LQ L +    +      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF 251
           +  +LS +  + +T N +          L  L  L   E   + +    I ++ +++ + 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLEL----LDLPSNQFK 307
           +  N        +   NL NL+ L +  N         L     + L    LDL  N   
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 308 GKVSIDFSSLKNLWL--LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE-- 363
               I   + K + L  L L  N               +   + L+V  L   +F  E  
Sbjct: 191 ---FIQPGAFKEIRLHKLTLRNNFDSLNVMKT-----CIQGLAGLEVHRLVLGEFRNEGN 242

Query: 364 ----LPHSIANL-SLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVI 417
                  ++  L +L + E  +            +   L N+ +F+L        + D  
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF- 300

Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIA 476
           S     Q L + N          L +L +   L   SN          L + + L L   
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKR---LTFTSNKGGNAFSEVDLPSLEFLDL--- 354

Query: 477 SYNKLTG-DLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP 535
           S N L+      Q    TT    LDLS N +  ++      L+ L  LD   +    +  
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 536 V-TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI-PEFLENLSFLE 593
                +  +L YLDIS           F  L S++ L ++ N+      P+    L  L 
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 594 FLNLSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
           FL+LS    E ++     F++ +    +++  N
Sbjct: 474 FLDLSQCQLE-QLS-PTAFNSLSSLQVLNMASN 504

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  150 bits (381), Expect = 2e-38
 Identities = 94/496 (18%), Positives = 174/496 (35%), Gaps = 53/496 (10%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALS 133
                L+ L L+   I  +       LS L+ +   +          IG+L  L++L ++
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 134 NNSF-SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
           +N   S  +P   S  +NL H   S+NK++     ++  L ++  L++ ++         
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD--------- 183

Query: 193 VGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG-MFPRSICNISSVELIF 251
                      ++ N +   I        RL  L +  N  S  +    I  ++ +E+  
Sbjct: 184 -----------LSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231

Query: 252 LTENRFSGI-----FPFDILLNLPNLKKLGI---GGNNFVGSIPDSLSNASNLELLDLPS 303
           L    F        F    L  L NL          + ++  I D  +  +N+    L S
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291

Query: 304 NQFKGKVSIDF-SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG 362
              +      +    ++L L+N +     T                SLK L+ + N+ GG
Sbjct: 292 VTIERVKDFSYNFGWQHLELVNCKFGQFPTL------------KLKSLKRLTFTSNK-GG 338

Query: 363 ELPHSIANLSLKMIELSVGRNQIS--GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL 420
                +   SL+ ++LS  RN +S  G          +L    L  N    T+      L
Sbjct: 339 NAFSEVDLPSLEFLDLS--RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 395

Query: 421 KNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN 479
           + L+ L   ++ L+         +L  L  LD+     +           +L +   + N
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455

Query: 480 KLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTL 538
               +    + +       LDLS   L   L      +L +L +L+++SNQ   V     
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514

Query: 539 STCVSLEYLDISINSF 554
               SL+ + +  N +
Sbjct: 515 DRLTSLQKIWLHTNPW 530

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  180 bits (457), Expect = 6e-47
 Identities = 110/551 (19%), Positives = 199/551 (36%), Gaps = 55/551 (9%)

Query: 107 NLADNGFRG--DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQ 164
            +A   F     +PQ    L   E+L LS N       ++      L      +      
Sbjct: 7   RIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 165 IPKEI-GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKI--PTTLGLLR 221
           I KE   NL  L+ L +  + +    PD+   L  +  +R+    L   +        L+
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 222 RLVNLNVAENQFSGMFPR-SICNISSVELIFLTENRFSGIFPFDIL-LNLPNLKKLGIGG 279
            L  L++++NQ   ++   S   ++S++ I  + N+   +   ++  L    L    +  
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 280 NNFVGSIPDSLSNASN------LELLDLPSNQFKGKVSIDFSS------------LKNLW 321
           N+    +        N      LE+LD+  N +   ++ +FS+              ++ 
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 322 LLNLEQNNLGTGTANDLDFVIFLSNC-SSLKVLSLSDNQFGGELPHSIANL-SLKMIELS 379
                 +N+      D D   F     SS++ L LS              L  LK++ L+
Sbjct: 244 GAGFGFHNI-----KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298

Query: 380 VGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
              N+I+  I       L NL    L  N            L  +  + +  N +     
Sbjct: 299 --YNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLV 498
                L KL +LDL  N+L     +++    ++     S NKL   LP+  L+   + L 
Sbjct: 356 QTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHL- 408

Query: 499 LDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP-VTLSTCVSLEYLDISINSFYGV 557
               N L N  +   +  + +L +L ++ N+FS      T S   SLE L +  N     
Sbjct: 409 --SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466

Query: 558 IPLS-----FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVF 612
                    F  L  ++ L ++ N L+   P    +L+ L  L+L+ N     +    + 
Sbjct: 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP 525

Query: 613 SNKTKISLHGN 623
           +N   + +  N
Sbjct: 526 ANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  158 bits (400), Expect = 7e-40
 Identities = 108/542 (19%), Positives = 196/542 (36%), Gaps = 46/542 (8%)

Query: 77  QRLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNN 135
           ++L  L L SQ     +      NL  LR ++L  +      P     LF L +L L   
Sbjct: 48  EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107

Query: 136 SFSGTI--PTNLSRCSNLIHFCASNNKLEG-QIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
             S  +           L     S N++    +    G L  L+ +    N +       
Sbjct: 108 GLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167

Query: 193 VGNLSA--IEVIRITENSLGGKIPTT-LGLLRRLVNLNVAENQFSGMFPRSICNISSVEL 249
           +  L    +    +  NSL  ++       +    N+ +     SG       N  +V++
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDI 220

Query: 250 IFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSN--ASNLELLDLPSNQFK 307
                N  S       L+   ++   G G +N      ++ +    S++  LDL      
Sbjct: 221 TGNFSNAISKS-QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF 279

Query: 308 GKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHS 367
              S  F +LK+L +LNL  N +     N +    F     +L+VL+LS N  G     +
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKI-----NKIADEAF-YGLDNLQVLNLSYNLLGELYSSN 333

Query: 368 IANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQL 426
              L  K+  + + +N I+  I     + L  L T  L  N         I  + ++  +
Sbjct: 334 FYGLP-KVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDI 386

Query: 427 SVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-NIPSSLGNCQNLILFIASYNKLTGDL 485
            +  N L   +P           + L  N L+  +I   L    +L + I + N+ +   
Sbjct: 387 FLSGNKLV-TLPKINLTAN---LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCS 442

Query: 486 PQQLLSITTLSLVLDLSNNLLNGSLPLQV-----GNLKNLVMLDISSNQFSGVIPVTLST 540
             Q  S       L L  N+L  +   ++       L +L +L ++ N  + + P   S 
Sbjct: 443 GDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502

Query: 541 CVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
             +L  L ++ N    +         +++ L++S N L    P+   +LS    L++++N
Sbjct: 503 LTALRGLSLNSNRLTVLSHND--LPANLEILDISRNQLLAPNPDVFVSLS---VLDITHN 557

Query: 601 YF 602
            F
Sbjct: 558 KF 559

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  101 bits (254), Expect = 3e-22
 Identities = 75/348 (21%), Positives = 138/348 (39%), Gaps = 51/348 (14%)

Query: 73  GHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLAL 132
           G     +  L+LS   +  + S     L  L+ +NLA N       +    L  L+ L L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321

Query: 133 SNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
           S N       +N                           L K+  + +  N++      +
Sbjct: 322 SYNLLGELYSSNFY------------------------GLPKVAYIDLQKNHIAIIQDQT 357

Query: 193 VGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFL 252
              L  ++ + + +N+L     TT+  +  + ++ ++ N+   +   ++    +  LI L
Sbjct: 358 FKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHL 408

Query: 253 TENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSL-SNASNLELLDLPSNQFKGKVS 311
           +ENR   +     LL +P+L+ L +  N F     D   S   +LE L L  N  +    
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468

Query: 312 ID-----FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
            +     F  L +L +L L  N L     N L   +F S+ ++L+ LSL+ N+    L H
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYL-----NSLPPGVF-SHLTALRGLSLNSNRL-TVLSH 521

Query: 367 SIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIP 414
           +    +L+++++S  RNQ+     P +   V+L    +  N+F     
Sbjct: 522 NDLPANLEILDIS--RNQLL-APNPDV--FVSLSVLDITHNKFICECE 564

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  162 bits (411), Expect = 2e-44
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 21/218 (9%)

Query: 678 STHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKV 737
            +   + T+        +   ++     + +    IG G FGTV++      +  VAVK+
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKI 67

Query: 738 INLKQKGAS--KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLE 795
           +  +   A     F+ E   ++ +RH N++  +   +          ++V EY+  GSL 
Sbjct: 68  LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-----LSIVTEYLSRGSLY 122

Query: 796 DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA 855
             LH+S  +    +L   +R+++A DVA  + YLH+   PP+VH +LK  N+L+D     
Sbjct: 123 RLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178

Query: 856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            V DFGL++  ++        T  SS    GT  ++AP
Sbjct: 179 KVCDFGLSRLKAS--------TFLSSKSAAGTPEWMAP 208

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  159 bits (405), Expect = 4e-43
 Identities = 80/374 (21%), Positives = 142/374 (37%), Gaps = 39/374 (10%)

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
                 + IFP     +L    +  +   +    +        ++  L +   +     S
Sbjct: 7   TLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA---S 58

Query: 312 I-DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIAN 370
           I     L NL  LNL  N +          +  LSN   L  L +  N+       ++ N
Sbjct: 59  IQGIEYLTNLEYLNLNGNQITD--------ISPLSNLVKLTNLYIGTNKI--TDISALQN 108

Query: 371 LSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN 430
           L+  + EL +  + IS      + NL  + +  L  N    +    +S +  L  L+V  
Sbjct: 109 LT-NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTE 164

Query: 431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP-QQL 489
           + ++    + + NLT L SL L  N ++   P  L +  +L  F A  N++T   P   +
Sbjct: 165 SKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANM 220

Query: 490 LSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDI 549
             + +L     + NN +    PL   NL  L  L+I +NQ S +    +     L+ L++
Sbjct: 221 TRLNSL----KIGNNKITDLSPL--ANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNV 272

Query: 550 SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK 609
             N    +  L+   L  + +L +++N L  +  E +  L+ L  L LS N+     P+ 
Sbjct: 273 GSNQISDISVLNN--LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330

Query: 610 GVFSNKTKISLHGN 623
              S          
Sbjct: 331 S-LSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (390), Expect = 4e-41
 Identities = 71/404 (17%), Positives = 140/404 (34%), Gaps = 59/404 (14%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              L      I  +      +L+      L        +      L  + KL ++     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                 +   +NL +   + N++    P  + NL+KL  L +  N +T     ++ NL+ 
Sbjct: 57  -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           +  + + E+++    P  L  L ++ +LN+  N         + N++ +  + +TE++  
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
            + P     NL +L  L +  N      P  L++ ++L       NQ         +++ 
Sbjct: 169 DVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMT 221

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
            L  L +  N +          +  L+N S L  L +  NQ                   
Sbjct: 222 RLNSLKIGNNKITD--------LSPLANLSQLTWLEIGTNQI------------------ 255

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
                    +    +++L  L    +  NQ   +   V++ L  L  L + NN L     
Sbjct: 256 ---------SDINAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDM 304

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT 482
             +G LT L +L L  N +    P  L +   +     +   + 
Sbjct: 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  151 bits (385), Expect = 1e-40
 Identities = 73/368 (19%), Positives = 149/368 (40%), Gaps = 40/368 (10%)

Query: 215 TTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKK 274
                L   +   + +   +     +   + S+  + +   + + I   +    L NL+ 
Sbjct: 16  FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIE---YLTNLEY 70

Query: 275 LGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWLLNLEQNNLGTG 333
           L + GN      P  LSN   L  L + +N+      I    +L NL  L L ++N+   
Sbjct: 71  LNLNGNQITDISP--LSNLVKLTNLYIGTNKIT---DISALQNLTNLRELYLNEDNISD- 124

Query: 334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI 393
                  +  L+N + +  L+L  N         ++N++  +  L+V  +++    P  I
Sbjct: 125 -------ISPLANLTKMYSLNLGANHNLS-DLSPLSNMT-GLNYLTVTESKVKDVTP--I 173

Query: 394 RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG 453
            NL +L + +L  NQ     P  ++ L +L   + + N +     + + N+T+L SL +G
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIG 229

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP--QQLLSITTLSLVLDLSNNLLNGSLP 511
           +N +     S L N   L       N+++ D+   + L  +  L    ++ +N ++    
Sbjct: 230 NNKITD--LSPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKML----NVGSNQISDISV 282

Query: 512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL 571
           L   NL  L  L +++NQ        +    +L  L +S N    + PL+   L  + + 
Sbjct: 283 L--NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSA 338

Query: 572 NVSSNNLS 579
           + ++  + 
Sbjct: 339 DFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.3 bits (155), Expect = 1e-10
 Identities = 30/133 (22%), Positives = 58/133 (43%), Gaps = 8/133 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            RL  L + + +I  +    + NLS L ++ +  N         + +L +L+ L + +N 
Sbjct: 221 TRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQ 276

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
            S    + L+  S L     +NN+L  +  + IG L  L  L +  N++T   P  + +L
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL 332

Query: 197 SAIEVIRITENSL 209
           S ++        +
Sbjct: 333 SKMDSADFANQVI 345

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  158 bits (400), Expect = 1e-42
 Identities = 50/190 (26%), Positives = 88/190 (46%), Gaps = 24/190 (12%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE--ALRNIRHRNLIKII 768
             IG+GRFG V++G    +E  VAVK+ + +++   +S+  E E      +RH N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
              +  +        LV +Y E+GSL D+L++         +++   + +A+  AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAH 154

Query: 829 LH-----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           LH        +P + H DLK  N+L+  +    + D GLA    +           +   
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS----ATDTIDIAPNH 210

Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 211 RVGTKRYMAP 220

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  155 bits (395), Expect = 2e-42
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE--ALRNIRHRNLIKII 768
             +G+GR+G V++G    +   VAVK+ + + +   KS+  E E      +RH N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
               ++         L+  Y E GSL D+L           L  +  + I + +AS + +
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAH 120

Query: 829 LH-----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           LH        +P + H DLK  N+L+  +    + D GLA   S       ++    +  
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ----STNQLDVGNNP 176

Query: 884 IKGTVGYVAP 893
             GT  Y+AP
Sbjct: 177 RVGTKRYMAP 186

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  155 bits (393), Expect = 5e-42
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 26/190 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
            E     ++G+G FG V K      +  VA+K   ++ +   K+F+ E   L  + H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQ--IESESERKAFIVELRQLSRVNHPNI 63

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K+   C +          LV EY E GSL + LH +     +   +    M+  +  + 
Sbjct: 64  VKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQCSQ 113

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
            + YLH      ++H DLKP N+LL     V  + DFG A  +  H              
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----------MTN 162

Query: 884 IKGTVGYVAP 893
            KG+  ++AP
Sbjct: 163 NKGSAAWMAP 172

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  156 bits (395), Expect = 6e-42
 Identities = 48/190 (25%), Positives = 76/190 (40%), Gaps = 24/190 (12%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE--ALRNIRHRNLIKII 768
             IG+GR+G V+ G    ++  VAVKV    ++    S+  E E      +RH N++  I
Sbjct: 43  KQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFI 97

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                          L+ +Y ENGSL D+L           L     + +A    S + +
Sbjct: 98  AADIKGTGSWTQL-YLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCH 149

Query: 829 LH-----HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           LH        +P + H DLK  N+L+  +    + D GLA    +      ++       
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT----NEVDIPPNT 205

Query: 884 IKGTVGYVAP 893
             GT  Y+ P
Sbjct: 206 RVGTKRYMPP 215

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  153 bits (388), Expect = 1e-41
 Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 25/191 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA--SKSFVSECEALRNIRHR 762
            + +    + +   G ++KG    ++  + VKV+ ++      S+ F  EC  LR   H 
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++ ++  C S          L+  +M  GSL + LH+  +      +   Q +  A+D+
Sbjct: 68  NVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDM 120

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           A  + +LH   +P +    L   +V++D DM A +    +     +              
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP------------- 166

Query: 883 GIKGTVGYVAP 893
           G      +VAP
Sbjct: 167 GRMYAPAWVAP 177

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  152 bits (385), Expect = 3e-41
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 36/201 (17%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-------KSFVSECEALR 757
           +E      IG+G FG V+KG L  D+ VVA+K + L             + F  E   + 
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           N+ H N++K+  +  +          +V E++  G L   L           +    ++ 
Sbjct: 79  NLNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLR 126

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-----YDMVAHVGDFGLAKFLSNHHLD 872
           + +D+A  IEY+  +  PP+VH DL+  N+ L        + A V DFGL++   +    
Sbjct: 127 LMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---- 181

Query: 873 IASKTPSSSIGIKGTVGYVAP 893
                  S  G+ G   ++AP
Sbjct: 182 -------SVSGLLGNFQWMAP 195

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  155 bits (395), Expect = 6e-41
 Identities = 94/499 (18%), Positives = 177/499 (35%), Gaps = 93/499 (18%)

Query: 118 PQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQR 177
           P+ + N F L++    +++ +  +P       +   +  + ++ E   P   G   ++  
Sbjct: 5   PRNVSNTF-LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 178 LSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMF 237
             +                     + +    L   +P        L +L  + N  +   
Sbjct: 63  SRLRDCLDRQ-----------AHELELNNLGL-SSLPELPP---HLESLVASCNSLT-EL 106

Query: 238 PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLE 297
           P    ++ S+ +        S +         P L+ LG+  N     +P+ L N+S L+
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDL--------PPLLEYLGVSNNQLE-KLPE-LQNSSFLK 156

Query: 298 LLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSD 357
           ++D+ +N  K K+     SL+ +   N           N L+ +  L N   L  +   +
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFIAAGN-----------NQLEELPELQNLPFLTAIYADN 204

Query: 358 NQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVI 417
           N    +LP    +L      +  G N +     P ++NL  L T   + N    T+PD  
Sbjct: 205 NSL-KKLPDLPLSLE----SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPD-- 254

Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
               +L+ L+V +N+L   +P    +LT L   +   + L         N   L     S
Sbjct: 255 -LPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL----SELPPNLYYLNA---S 305

Query: 478 YNKLTGDLPQQLLSITTLSL----------------VLDLSNNLLNGSLPLQVGNLKNLV 521
            N++   L     S+  L++                 L  S N L   +P    NLK   
Sbjct: 306 SNEIR-SLCDLPPSLEELNVSNNKLIELPALPPRLERLIASFNHLA-EVPELPQNLKQ-- 361

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
            L +  N      P    +   L      +NS    +P      +++K L+V +N L  +
Sbjct: 362 -LHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVP---ELPQNLKQLHVETNPLR-E 410

Query: 582 IPEFLENLSFLEFLNLSYN 600
            P+  E+   +E L ++  
Sbjct: 411 FPDIPES---VEDLRMNSE 426

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  155 bits (395), Expect = 7e-41
 Identities = 93/521 (17%), Positives = 183/521 (35%), Gaps = 86/521 (16%)

Query: 93  LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLS------ 146
           ++P   + +FL+      +    ++P E  N+    +   + + +    P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 147 -------RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAI 199
                            +N  L   +P+   +   L+ L    N LT +LP+   +L ++
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116

Query: 200 EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG 259
            V      +L    P        L  L V+ NQ     P  + N S +++I +  N    
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK 167

Query: 260 IFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKN 319
           +         P+L+ +  G N     +P+ L N   L  +   +N  K K+     SL++
Sbjct: 168 LPDL-----PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLES 219

Query: 320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELS 379
           +   N           N L+ +  L N   L  +   +N     LP    +L      L+
Sbjct: 220 IVAGN-----------NILEELPELQNLPFLTTIYADNNLL-KTLPDLPPSLE----ALN 263

Query: 380 VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPS 439
           V  N ++  +P   ++L  L       +              NL  L+  +N +R  +  
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCD 314

Query: 440 GLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVL 499
              +L     L++ +N L   +P+     + LI    S+N L  ++P+   ++      L
Sbjct: 315 LPPSLE---ELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPELPQNLK----QL 362

Query: 500 DLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIP 559
            +  N L    P    ++++L M    ++  + V         +L+ L +  N      P
Sbjct: 363 HVEYNPLR-EFPDIPESVEDLRM----NSHLAEV----PELPQNLKQLHVETNPLR-EFP 412

Query: 560 LSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
                 +S++ L ++S  +        E    LE     ++
Sbjct: 413 DI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  145 bits (367), Expect = 3e-37
 Identities = 93/457 (20%), Positives = 152/457 (33%), Gaps = 72/457 (15%)

Query: 75  RHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSN 134
             ++  EL L++  +   L     +L     +  + N    ++P+   +L  L     + 
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 123

Query: 135 NSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
            + S   P        L +   SNN+LE ++P E+ N   L+ + VD N L  +LPD   
Sbjct: 124 KALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173

Query: 195 NLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTE 254
           +L   E I    N L  +    L  L  L  +    N    +         S+E I    
Sbjct: 174 SL---EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGN 224

Query: 255 NRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDF 314
           N    +     L NLP L  +    N    ++PD   +   L + D              
Sbjct: 225 NILEEL---PELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELP 276

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLK 374
            SL  L +     + L                  +L  L+ S N+    L     +L   
Sbjct: 277 QSLTFLDVSENIFSGLS-------------ELPPNLYYLNASSNEIR-SLCDLPPSLE-- 320

Query: 375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR 434
             EL+V  N++   +P     L  LI      N     + +V    +NL+QL V  N LR
Sbjct: 321 --ELNVSNNKLI-ELPALPPRLERLI---ASFNH----LAEVPELPQNLKQLHVEYNPLR 370

Query: 435 GGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITT 494
              P    ++      DL  NS    +P    N + L +     N L  + P    S+  
Sbjct: 371 E-FPDIPESVE-----DLRMNSHLAEVPELPQNLKQLHV---ETNPLR-EFPDIPESVE- 419

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
               L +++  +             L       +   
Sbjct: 420 ---DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  106 bits (267), Expect = 2e-24
 Identities = 49/339 (14%), Positives = 101/339 (29%), Gaps = 71/339 (20%)

Query: 267 LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE 326
           ++   L++     +N    +P    N  +        ++++          + + +  L 
Sbjct: 8   VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
                                     L L++      LP    +L      L    N ++
Sbjct: 67  DCL-----------------DRQAHELELNNLGLS-SLPELPPHLE----SLVASCNSLT 104

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTK 446
             +P   ++L +L+     +       P        L+ L V NN L   +P  L N + 
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LPE-LQNSSF 154

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
           L  +D+ +NSL+  +P    + + +       N+L                         
Sbjct: 155 LKIIDVDNNSLK-KLPDLPPSLEFIAA---GNNQLE------------------------ 186

Query: 507 NGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLK 566
              LP ++ NL  L  +   +N    +        +SLE +    N          + L 
Sbjct: 187 --ELP-ELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNIL--EELPELQNLP 237

Query: 567 SIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGE 605
            +  +   +N L   +P+   +L  L   +         
Sbjct: 238 FLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPEL 275

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  157 bits (399), Expect = 1e-40
 Identities = 102/512 (19%), Positives = 183/512 (35%), Gaps = 42/512 (8%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           +  L+LS  +I  +    +   + L+ + L  +           +L  LE L LS+N  S
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87

Query: 139 GTIPTNLSRCSNLIHFCASNNKL-EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSV-GNL 196
               +     S+L +     N      +     NL  LQ L +       ++       L
Sbjct: 88  SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           +++  + I   SL      +L  +R + +L +  ++ + +       +SSV  + L +  
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207

Query: 257 FSGIF--PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDF 314
            +     P  +      +KKL   G+         L++ S  ELL L             
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSV--------LTDESFNELLKLLRY---------I 250

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSN--CSSLKVLSLSDNQFGGELPHSIANLS 372
             L  +   +   N LG    ++ D V  L      +++ L +       +L    + L 
Sbjct: 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310

Query: 373 LKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTI---PDVISELKNLQQLSV 428
            K+  ++V  +++   +P    ++L +L    L  N                 +LQ L +
Sbjct: 311 -KVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368

Query: 429 FNNFLR--GGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP 486
             N LR        L  L  L SLD+  N+    +P S    + +     S   +   + 
Sbjct: 369 SQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVK 426

Query: 487 QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEY 546
             +        VLD+SNN L+ S  L    L  L  L IS N+   +   +L     L  
Sbjct: 427 TCIPQTLE---VLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASLFP--VLLV 477

Query: 547 LDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           + IS N    V    F  L S++ + + +N  
Sbjct: 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (368), Expect = 9e-37
 Identities = 84/513 (16%), Positives = 174/513 (33%), Gaps = 35/513 (6%)

Query: 107 NLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIP 166
           +     F   IP  +     ++ L LS N  +     +L  C+NL      ++++   I 
Sbjct: 11  DGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIE 66

Query: 167 KEI-GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLV 224
            +   +L  L+ L +  N+L+       G LS+++ + +  N      + +    L  L 
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126

Query: 225 NLNVA-ENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV 283
            L +     FS +       ++S+  + +             L ++ ++  L +  +   
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY-QSQSLKSIRDIHHLTLHLSESA 185

Query: 284 GSIPDSLSNASNLELLDLPSNQFKGKVSIDFS---SLKNLWLLNLEQNNLGTGTANDL-D 339
             +       S++  L+L                     +  L    + L   + N+L  
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS-------LKMIELSVGRNQISGTIPPG 392
            + ++   S ++    + N  G   P     +S       + +  L + +  +   +   
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305

Query: 393 IRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGI---PSGLGNLTKLGS 449
              L  +   T+E ++           LK+L+ L +  N +        +  G    L +
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365

Query: 450 LDLGSNSLQ--GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLN 507
           L L  N L+        L   +NL     S N     +P        +   L+LS+  + 
Sbjct: 366 LVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIR 423

Query: 508 GSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS 567
             +       + L +LD+S+N       + L     L+ L IS N    +   S      
Sbjct: 424 -VVKT--CIPQTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKTLPDAS--LFPV 474

Query: 568 IKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
           +  + +S N L        + L+ L+ + L  N
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (368), Expect = 9e-37
 Identities = 80/483 (16%), Positives = 157/483 (32%), Gaps = 50/483 (10%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRG-DIPQEIGNLFRLEKLALSNN 135
             L  L+LS   +  + S + G LS L+Y+NL  N ++   +     NL  L+ L + N 
Sbjct: 74  GSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133

Query: 136 SFSGTIPTN-LSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
                I     +  ++L         L     + + ++  +  L++ ++     L     
Sbjct: 134 ETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFAD 193

Query: 195 NLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTE 254
            LS++  + + + +L     + L +      +     + S +   S   +  +    L  
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253

Query: 255 NRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDF 314
           +            +           +               +  L +P       +S  +
Sbjct: 254 SEVE-------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLK 374
           S L+ +  + +E + +     +      F  +  SL+ L LS+N    E   +       
Sbjct: 307 SLLEKVKRITVENSKVFLVPCS------FSQHLKSLEFLDLSENLMVEEYLKN------- 353

Query: 375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH--GTIPDVISELKNLQQLSVFNNF 432
                                  +L T  L  N         +++  LKNL  L +  N 
Sbjct: 354 ---------------SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT 398

Query: 433 LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSI 492
               +P       K+  L+L S  ++  + +     Q L +   S N L       L  +
Sbjct: 399 FH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPRL 453

Query: 493 TTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISIN 552
                 L +S N L  +LP        L+++ IS NQ   V         SL+ + +  N
Sbjct: 454 QE----LYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

Query: 553 SFY 555
            + 
Sbjct: 508 PWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (367), Expect = 1e-36
 Identities = 90/494 (18%), Positives = 185/494 (37%), Gaps = 50/494 (10%)

Query: 157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTT 216
            +      IP  +     ++ L +  N +T      +   + ++V+ +  + +       
Sbjct: 13  RSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG 276
              L  L +L++++N  S +       +SS++ + L  N +  +    +  NL NL+ L 
Sbjct: 70  FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129

Query: 277 IGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTA 335
           IG       I     +  ++L  L++ +   +   S    S++++  L L  +       
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES----- 184

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN 395
             L  +      SS++ L L D         S   +      +     + S         
Sbjct: 185 AFLLEIFA-DILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242

Query: 396 LVNLITFTLEVNQ-------------FHGTIPDVISELK-----NLQQLSVFNNFLRGGI 437
           L+ L+ + LE+++             F+ +  DV+SEL       +++L +   +L   +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302

Query: 438 PSGLGNLTKLGSLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITT 494
            +    L K+  + + ++ +     +    L + + L L   S N +  +  +       
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDL---SENLMVEEYLKNSACKGA 359

Query: 495 LS--LVLDLSNNLLNGSLPLQVG---NLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDI 549
                 L LS N L  S+         LKNL  LDIS N F   +P +      + +L++
Sbjct: 360 WPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417

Query: 550 SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK 609
           S         +     ++++ L+VS+NNL      FL     L+ L +S N  +  +P  
Sbjct: 418 SSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDA 469

Query: 610 GVFSNKTKISLHGN 623
            +F     + +  N
Sbjct: 470 SLFPVLLVMKISRN 483

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  106 bits (266), Expect = 6e-24
 Identities = 62/411 (15%), Positives = 123/411 (29%), Gaps = 49/411 (11%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             L EL + +  +    S  + ++  + ++ L  +     +      L  +  L L + +
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
            +    + L              +      +    LLKL R  ++++ +           
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV----------- 256

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
              E    T N LG   P+   ++  L  +                   ++  + + +  
Sbjct: 257 ---EFDDCTLNGLGDFNPSESDVVSELGKVET----------------VTIRRLHIPQFY 297

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV---SID 313
                   +   L  +K++ +  +           +  +LE LDL  N    +    S  
Sbjct: 298 LFYDLS-TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

Query: 314 FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL 373
             +  +L  L L QN+L +                +L  L +S N F   +P S      
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEIL----LTLKNLTSLDISRNTF-HPMPDSCQWPE- 410

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
           KM  L++    I   +   I     L    +  N     +      L  LQ+L +  N L
Sbjct: 411 KMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNN----LDSFSLFLPRLQELYISRNKL 463

Query: 434 RGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD 484
           +  +P        L  + +  N L+           +L       N     
Sbjct: 464 K-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 94.8 bits (236), Expect = 3e-20
 Identities = 48/269 (17%), Positives = 101/269 (37%), Gaps = 17/269 (6%)

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE 405
           +C +  V       F   +P   + L+  M  L +  N+I+      +R   NL    L+
Sbjct: 3   SCDASGVCDGRSRSF-TSIP---SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-NIPSS 464
            ++ +    D    L +L+ L + +N L     S  G L+ L  L+L  N  Q   + S 
Sbjct: 59  SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 465 LGNCQNL-ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVML 523
             N  NL  L I +    +         +T+L+  L++    L       + +++++  L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN-ELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSG--- 580
            +  ++ + ++ +      S+ YL++   +            +    +   +   S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 581 -------KIPEFLENLSFLEFLNLSYNYF 602
                  K+  ++  LS +EF + + N  
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGL 266

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.4 bits (157), Expect = 1e-10
 Identities = 32/120 (26%), Positives = 57/120 (47%), Gaps = 4/120 (3%)

Query: 498 VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV 557
           V D  +     S+P   G    +  LD+S N+ + +    L  C +L+ L +  +    +
Sbjct: 9   VCDGRSRSFT-SIP--SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65

Query: 558 IPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK 617
              +F  L S++ L++S N+LS     +   LS L++LNL  N ++  + V  +F N T 
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (377), Expect = 5e-40
 Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 25/191 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
            + +    IG G FGTVYKG    D   VAVK++N+        ++F +E   LR  RH 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++  +   ++         A+V ++ E  SL   LH S       K  + + ++IA   
Sbjct: 81  NILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQT 129

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           A  ++YLH      ++H DLK +N+ L  D    +GDFGLA   S        +      
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL---- 182

Query: 883 GIKGTVGYVAP 893
              G++ ++AP
Sbjct: 183 --SGSILWMAP 191

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  146 bits (371), Expect = 2e-39
 Identities = 47/201 (23%), Positives = 79/201 (39%), Gaps = 36/201 (17%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK----QKGASKSFVSECEALRNIR 760
           +E +   +IG G FG VY+     DE  VAVK              ++   E +    ++
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I +  +C            LV E+   G L   L         +++     +N A+
Sbjct: 65  HPNIIALRGVCLKEPN-----LCLVMEFARGGPLNRVLSG-------KRIPPDILVNWAV 112

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH--------VGDFGLAKFLSNHHLD 872
            +A  + YLH     P++H DLK SN+L+   +           + DFGLA+        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---- 168

Query: 873 IASKTPSSSIGIKGTVGYVAP 893
                 ++ +   G   ++AP
Sbjct: 169 ------TTKMSAAGAYAWMAP 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  145 bits (369), Expect = 9e-39
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 22/191 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
            +     +IG+GRFG VY G    +   VA+++I++++      K+F  E  A R  RH 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++  +  C S         A++    +  +L   +  +        L + +   IA ++
Sbjct: 90  NVVLFMGACMSPPH-----LAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEI 139

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
              + YLH      ++H DLK  NV  D   V  + DFGL                    
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 883 GIKGTVGYVAP 893
              G + ++AP
Sbjct: 196 ---GWLCHLAP 203

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  144 bits (366), Expect = 3e-38
 Identities = 57/332 (17%), Positives = 107/332 (32%), Gaps = 26/332 (7%)

Query: 264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLL 323
               +    + L   G+  +    D LS        D        +     ++  N  + 
Sbjct: 6   HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIE 61

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN 383
                 L          ++  +       L L       + P     LS  +  +++   
Sbjct: 62  TRTGRAL-----KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAA 114

Query: 384 QISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGN 443
            +   +P  ++    L T TL  N     +P  I+ L  L++LS+        +P  L +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172

Query: 444 ---------LTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITT 494
                    L  L SL L    ++ ++P+S+ N QNL       + L+  L   +  +  
Sbjct: 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPK 230

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
           L   LDL       + P   G    L  L +        +P+ +     LE LD+     
Sbjct: 231 LE-ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289

Query: 555 YGVIPLSFRFLKSIKALNVSSNNLSGKIPEFL 586
              +P     L +   + V   +L  ++ +  
Sbjct: 290 LSRLPSLIAQLPANCIILV-PPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (346), Expect = 2e-35
 Identities = 53/353 (15%), Positives = 100/353 (28%), Gaps = 48/353 (13%)

Query: 187 GQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISS 246
           G       + S  E +    ++        L   +R  N +               N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 247 VELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
            ++   T                P    L +         PD     S+L+ + + +   
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
             ++         L  L L +N L    A+       +++ + L+ LS+       ELP 
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRALPAS-------IASLNRLRELSIRACPELTELPE 168

Query: 367 SIANLSLKMI--------ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVIS 418
            +A+               L +    I  ++P  I NL NL +  +  +     +   I 
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 419 ELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASY 478
            L  L++L +         P   G    L  L L   S    +P  +     L       
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE------ 280

Query: 479 NKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
                               LDL   +    LP  +  L    ++ +  +  +
Sbjct: 281 -------------------KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  127 bits (322), Expect = 2e-32
 Identities = 61/404 (15%), Positives = 111/404 (27%), Gaps = 86/404 (21%)

Query: 91  GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSN 150
           G    +  + S    +    +         +    R      +            +  +N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 151 LIHFCASNNKLEGQIPKEIGNL--LKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENS 208
                 +   L+      + +        L +    L  Q PD    LS ++ + I    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 209 LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLN 268
           L  ++P T+     L  L +A N      P SI +                         
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIAS------------------------- 148

Query: 269 LPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQN 328
           L  L++L I     +  +P+ L++                                    
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASG------------------------------- 177

Query: 329 NLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT 388
                               +L+ L L        LP SIANL   +  L +  + +S  
Sbjct: 178 --------------EHQGLVNLQSLRLEWTGIR-SLPASIANLQ-NLKSLKIRNSPLS-A 220

Query: 389 IPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN-NFLRGGIPSGLGNLTKL 447
           + P I +L  L    L         P +      L++L + + + L   +P  +  LT+L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQL 279

Query: 448 GSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
             LDL        +PS +       + +   +     L Q    
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA-QLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  120 bits (303), Expect = 6e-30
 Identities = 42/241 (17%), Positives = 94/241 (39%), Gaps = 17/241 (7%)

Query: 75  RHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSN 134
                  L L S  +          LS L+++ +   G   ++P  +     LE L L+ 
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 135 NSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN---------LLKLQRLSVDINYL 185
           N     +P +++  + L            ++P+ + +         L+ LQ L ++   +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 186 TGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNIS 245
              LP S+ NL  ++ ++I  + L   +   +  L +L  L++        +P      +
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253

Query: 246 SVELIFLTE-NRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN 304
            ++ + L + +    + P DI   L  L+KL + G   +  +P  ++      ++ +P +
Sbjct: 254 PLKRLILKDCSNLLTL-PLDI-HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

Query: 305 Q 305
            
Sbjct: 312 L 312

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  101 bits (254), Expect = 2e-23
 Identities = 48/319 (15%), Positives = 96/319 (30%), Gaps = 81/319 (25%)

Query: 283 VGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI 342
           +GS      ++S  E L    +          S  +  +  +  + +     AN  +  I
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSL-KMIELSVGRNQISGTIPPGIRNLVNLIT 401
                 +LK                + + +    + L +    +    P     L +L  
Sbjct: 61  ETRTGRALK-----------ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQH 108

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNI 461
            T++       +PD + +   L+ L++  N LR  +P+ + +L +L  L + +      +
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTEL 166

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
           P  L +                   Q L+++ +L     L    +  SLP  + NL+NL 
Sbjct: 167 PEPLASTDASGEH------------QGLVNLQSL----RLEWTGIR-SLPASIANLQNLK 209

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
            L I ++  S                                                  
Sbjct: 210 SLKIRNSPLS-------------------------------------------------A 220

Query: 582 IPEFLENLSFLEFLNLSYN 600
           +   + +L  LE L+L   
Sbjct: 221 LGPAIHHLPKLEELDLRGC 239

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 27/149 (18%), Positives = 52/149 (34%), Gaps = 4/149 (2%)

Query: 63  NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIG 122
                           L  L L    I   L   + NL  L+ + + ++     +   I 
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226

Query: 123 NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN-NKLEGQIPKEIGNLLKLQRLSVD 181
           +L +LE+L L   +     P      + L      + + L   +P +I  L +L++L + 
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLR 285

Query: 182 INYLTGQLPDSVGNLSAIEVIRITENSLG 210
                 +LP  +  L A  +I +  +   
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 22/114 (19%), Positives = 41/114 (35%), Gaps = 1/114 (0%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
           Q L  L + +  +   L P + +L  L  ++L       + P   G    L++L L + S
Sbjct: 206 QNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP 190
              T+P ++ R + L            ++P  I  L     + V  +       
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  143 bits (362), Expect = 7e-38
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 27/199 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           S+     ++G+G FG   K    +   V+ +K +    +   ++F+ E + +R + H N+
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 765 IKIITICSSTDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           +K         F GV +K      + EY++ G+L   +   +      +    QR++ A 
Sbjct: 70  LK---------FIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-----SQYPWSQRVSFAK 115

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD------IA 874
           D+AS + YLH      ++H DL   N L+  +    V DFGLA+ + +          + 
Sbjct: 116 DIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172

Query: 875 SKTPSSSIGIKGTVGYVAP 893
                    + G   ++AP
Sbjct: 173 KPDRKKRYTVVGNPYWMAP 191

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  139 bits (351), Expect = 5e-35
 Identities = 69/489 (14%), Positives = 147/489 (30%), Gaps = 72/489 (14%)

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ 176
           I +   N  R +   ++++S    + +      N+     S N L      ++    KL+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM 236
            L++  N L  +  D                         L  L  L  L++  N     
Sbjct: 62  LLNLSSNVLY-ETLD-------------------------LESLSTLRTLDLNNNYVQE- 94

Query: 237 FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL 296
                                        LL  P+++ L    NN    +    S     
Sbjct: 95  -----------------------------LLVGPSIETLHAANNNI-SRVS--CSRGQGK 122

Query: 297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS 356
           + + L +N+      +D      +  L+L+ N + T     ++F    ++  +L+ L+L 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-----VNFAELAASSDTLEHLNLQ 177

Query: 357 DNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV 416
            N    ++   +    LK ++LS   N+++  + P  ++   +   +L  N+    I   
Sbjct: 178 YNFI-YDVKGQVVFAKLKTLDLS--SNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 417 ISELKNLQQLSVFNNFLRGG-IPSGLGNLTKLGSLDLGSNS-LQGNIPSSLGNCQNLILF 474
           +   +NL+   +  N    G +        ++ ++   +   L G               
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

Query: 475 IASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI 534
                 L      +L+++      L          L  +  N      +D    Q+  VI
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 535 PVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEF 594
                   +   L+    +    +    R    +    +       ++    E  S L+ 
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG-TLQQAVGQIELQHATEEQSPLQL 411

Query: 595 LNLSYNYFE 603
           L      +E
Sbjct: 412 LRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  133 bits (337), Expect = 3e-33
 Identities = 64/500 (12%), Positives = 156/500 (31%), Gaps = 29/500 (5%)

Query: 98  GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS 157
            N +  +   + D+  +  +     + + +++L LS N  S     +L+  + L     S
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTL 217
           +N L      ++ +L  L+ L ++ NY+       +    +IE +    N++  ++    
Sbjct: 67  SNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--C 116

Query: 218 GLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGI 277
              +   N+ +A N+ + +        S V+ + L  N    +   ++  +   L+ L +
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 278 GGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTAND 337
             N     +   +   + L+ LDL SN+    +  +F S   +  ++L  N L       
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA- 232

Query: 338 LDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLV 397
                 L    +L+   L  N F         + + ++  ++  +  +            
Sbjct: 233 ------LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECT 284

Query: 398 NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG----GIPSGLGNLTKLGSLDLG 453
                                 L  L++        +G     +     N  +   +D  
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQ 513
               +  I       Q  I        L   +     +   L   L  +   +      +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

Query: 514 VGNLKNLVMLDISSNQFS-GVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN 572
                 L +L     ++    +        ++   D+  +    +   + R  K     +
Sbjct: 405 --EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEAD 462

Query: 573 VSSNNLSGKIPEFLENLSFL 592
           ++  + +  + E +     L
Sbjct: 463 LALASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  132 bits (334), Expect = 8e-33
 Identities = 60/458 (13%), Positives = 141/458 (30%), Gaps = 29/458 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            R     ++   +   L+    +   ++ ++L+ N        ++    +LE L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
              T+   L   S L     +NN +     +E+     ++ L    N ++ ++  S    
Sbjct: 70  LYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RG 119

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM-FPRSICNISSVELIFLTEN 255
              + I +  N +        G   R+  L++  N+   + F     +  ++E + L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFS 315
               +      +    LK L +  N     +     +A+ +  + L +N+    +     
Sbjct: 180 FIYDV---KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 316 SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKM 375
             +NL   +L  N    GT  D           + +V +++          +    ++  
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF-------FSKNQRVQTVAKQTVKKLTGQNEEECTV-P 286

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE----LKNLQQLSVFNN 431
                G         P    L+ L      +    G+  + +          +++     
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS 491
             R  I           +L+    +L   + +       L   +        +L      
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEE 405

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQ 529
            + L L+  +        +  Q      +   D+  ++
Sbjct: 406 QSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHK 443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  128 bits (324), Expect = 1e-31
 Identities = 55/343 (16%), Positives = 107/343 (31%), Gaps = 24/343 (6%)

Query: 264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLL 323
           +I  N    K   +  ++   ++     +A N++ LDL  N      + D +    L LL
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN 383
           NL  N L           + L + S+L+ L L++N         +      +  L    N
Sbjct: 64  NLSSNVLYE--------TLDLESLSTLRTLDLNNNYV-----QELLVGP-SIETLHAANN 109

Query: 384 QISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG-GIPSGLG 442
            IS  +              L  N+              +Q L +  N +          
Sbjct: 110 NIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166

Query: 443 NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLS 502
           +   L  L+L  N +  ++   +     L     S NKL   +  +  S   ++  + L 
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISLR 222

Query: 503 NNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSF 562
           NN L   +   +   +NL   D+  N F         +  +     ++  +   +   + 
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNE 280

Query: 563 RFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGE 605
                    +  +         F + L  L+    +    +G 
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGS 323

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  126 bits (317), Expect = 1e-30
 Identities = 57/320 (17%), Positives = 117/320 (36%), Gaps = 24/320 (7%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
           +I +   N +  ++  +  +  K  ++    S  N+  L+L  N L   +A D      L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD------L 54

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTL 404
           +  + L++L+LS N         + +LS  +  L +  N +       +    ++ T   
Sbjct: 55  APFTKLELLNLSSNVLYE--TLDLESLS-TLRTLDLNNNYVQ-----ELLVGPSIETLHA 106

Query: 405 EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-NIPS 463
             N     +    S  +  + + + NN +        G  +++  LDL  N +   N   
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVML 523
              +   L      YN +  D+    +    L   LDLS+N L   +  +  +   +  +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP 583
            + +N+   +I   L    +LE+ D+  N F+      F F K+ +   V+   +     
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTG 277

Query: 584 EFLENLSFLEFLNLSYNYFE 603
           +  E  +     +      E
Sbjct: 278 QNEEECTVPTLGHYGAYCCE 297

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 97.6 bits (243), Expect = 3e-21
 Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 17/214 (7%)

Query: 413 IPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLI 472
           I ++       +   V ++ L+  + S   +   +  LDL  N L     + L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 473 LFIASYNKLTGDLPQQLLSITTLS--LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF 530
           L   S N L      + L + +LS    LDL+NN +      ++    ++  L  ++N  
Sbjct: 62  LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111

Query: 531 SGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSG-KIPEFLENL 589
           S V           + + ++ N    +  L       ++ L++  N +      E   + 
Sbjct: 112 SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 590 SFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
             LE LNL YN+   +V  + VF+    + L  N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  129 bits (326), Expect = 5e-33
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 14/162 (8%)

Query: 711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
            ++G+G FG+V +G L       + VAVK   +K   +S+     F+SE   +++  H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           +I+++ +C     +G+    ++  +M+ G L  +L  S  +   + + L   +   +D+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 824 SAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             +EYL + +     +H DL   N +L  DM   V DFGL+K
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  130 bits (329), Expect = 3e-32
 Identities = 72/321 (22%), Positives = 128/321 (39%), Gaps = 16/321 (4%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
           ++P+ +   +   LLDL  N+ K     +F+S  +L  L L +N +              
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPG------AF 76

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFT 403
           +N  +L+ L L  N+           LS  + +L +  N+I   +   + ++L NL +  
Sbjct: 77  NNLFNLRTLGLRSNRLKLIPLGVFTGLS-NLTKLDISENKIV-ILLDYMFQDLYNLKSLE 134

Query: 404 LEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIP 462
           +  N          S L +L+QL++    L   IP+  L +L  L  L L   ++     
Sbjct: 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRD 193

Query: 463 SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLV 521
            S      L +   S+      +    L    L+  L +++  L  ++P     +L  L 
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYLR 251

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
            L++S N  S +    L   + L+ + +       V P +FR L  ++ LNVS N L+  
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL 311

Query: 582 IPEFLENLSFLEFLNLSYNYF 602
                 ++  LE L L  N  
Sbjct: 312 EESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  119 bits (300), Expect = 1e-28
 Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 12/312 (3%)

Query: 270 PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNN 329
              + L +G N       D  ++  +LE L+L  N         F++L NL  L L  N 
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 330 LGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTI 389
           L              +  S+L  L +S+N+    L +   +L   +  L VG N +   I
Sbjct: 92  LKLIPLG------VFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLV-YI 143

Query: 390 PPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLG 448
                  L +L   TLE         + +S L  L  L + +  +          L +L 
Sbjct: 144 SHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203

Query: 449 SLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG 508
            L++        +  +     NL     ++  LT  +P   +        L+LS N ++ 
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS- 261

Query: 509 SLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS 567
           ++   +   L  L  + +   Q + V P        L  L++S N    +    F  + +
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321

Query: 568 IKALNVSSNNLS 579
           ++ L + SN L+
Sbjct: 322 LETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  110 bits (277), Expect = 1e-25
 Identities = 61/312 (19%), Positives = 117/312 (37%), Gaps = 12/312 (3%)

Query: 101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK 160
           +  R ++L  N  +     E  +   LE+L L+ N  S   P   +   NL      +N+
Sbjct: 32  TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91

Query: 161 LEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGL 219
           L+  IP  +   L  L +L +  N +   L     +L  ++ + + +N L          
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           L  L  L + +   + +   ++ ++  + ++ L     + I        L  LK L I  
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI-RDYSFKRLYRLKVLEISH 209

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
             ++ ++  +     NL  L +          +    L  L  LNL  N + T   +   
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSM-- 267

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVN 398
               L     L+ + L   Q     P++   L+  +  L+V  NQ++ T+   +  ++ N
Sbjct: 268 ----LHELLRLQEIQLVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSVGN 321

Query: 399 LITFTLEVNQFH 410
           L T  L+ N   
Sbjct: 322 LETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  108 bits (272), Expect = 5e-25
 Identities = 67/333 (20%), Positives = 124/333 (37%), Gaps = 15/333 (4%)

Query: 104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEG 163
           R +      F   +P+ I        L L  N          +   +L     + N +  
Sbjct: 14  RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70

Query: 164 QIPKEIGNLLKLQRLSVDINYLTGQLPDSV-GNLSAIEVIRITENSLGGKIPTTLGLLRR 222
             P    NL  L+ L +  N L   +P  V   LS +  + I+EN +   +      L  
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF 282
           L +L V +N    +  R+   ++S+E + L +   + I P + L +L  L  L +   N 
Sbjct: 130 LKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI-PTEALSHLHGLIVLRLRHLNI 188

Query: 283 VGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI 342
                 S      L++L++    +   ++ +     NL  L++   NL       + ++ 
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-----TAVPYLA 243

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLIT 401
              +   L+ L+LS N         +  L  ++ E+ +   Q++  + P   R L  L  
Sbjct: 244 V-RHLVYLRFLNLSYNPISTIEGSMLHELL-RLQEIQLVGGQLA-VVEPYAFRGLNYLRV 300

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR 434
             +  NQ       V   + NL+ L + +N L 
Sbjct: 301 LNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 47/244 (19%), Positives = 86/244 (35%), Gaps = 18/244 (7%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTK 446
            +P GI          L  N+      D  +   +L++L +  N +   +  G   NL  
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFN 81

Query: 447 LGSLDLGSN---SLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSN 503
           L +L L SN    +   + + L N   L +   S NK+   L      +  L   L++ +
Sbjct: 82  LRTLGLRSNRLKLIPLGVFTGLSNLTKLDI---SENKIVILLDYMFQDLYNL-KSLEVGD 137

Query: 504 NLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSF 562
           N L   +  +    L +L  L +     + +    LS    L  L +   +   +   SF
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 563 RFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK---IS 619
           + L  +K L +S       +         L  L++++      VP      +      ++
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP-YLAVRHLVYLRFLN 254

Query: 620 LHGN 623
           L  N
Sbjct: 255 LSYN 258

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  132 bits (334), Expect = 3e-32
 Identities = 75/393 (19%), Positives = 130/393 (33%), Gaps = 56/393 (14%)

Query: 114 RGDIPQEIGNLFR--LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN 171
           R  + Q++          L +  +  + T+P  L   +++      +N L   +P     
Sbjct: 27  RAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPE 82

Query: 172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAEN 231
           L   + L V  N LT  LP     L  + +       L         L   L  L +  N
Sbjct: 83  L---RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGN 131

Query: 232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLS 291
           Q +   P     +     + +++N+ + +           L KL    N    S+P   S
Sbjct: 132 QLTS-LPVLPPGLQE---LSVSDNQLASLPA-----LPSELCKLWAYNNQLT-SLPMLPS 181

Query: 292 NASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK 351
               L+ L +  NQ    +    S L  LW  N   N L       L      +  S LK
Sbjct: 182 G---LQELSVSDNQLA-SLPTLPSELYKLWAYN---NRL-----TSLP-----ALPSGLK 224

Query: 352 VLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG 411
            L +S N+    LP   + L     EL V  N+++ ++P     L++L   ++  NQ   
Sbjct: 225 ELIVSGNRLT-SLPVLPSELK----ELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT- 274

Query: 412 TIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
            +P+ +  L +   +++  N L       L  +T                 S+    + L
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334

Query: 472 ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN 504
            L  A +  L      +        +     N 
Sbjct: 335 HLAAADW--LVPAREGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  130 bits (328), Expect = 1e-31
 Identities = 77/338 (22%), Positives = 129/338 (38%), Gaps = 56/338 (16%)

Query: 241 ICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLD 300
            C  +   ++ + E+  + + P  +     ++  L I  NN   S+P        L  L+
Sbjct: 36  ACLNNGNAVLNVGESGLTTL-PDCLP---AHITTLVIPDNNLT-SLPALPPE---LRTLE 87

Query: 301 LPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           +  NQ    + +    L  L + +    +L                 S L  L +  NQ 
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------------LPSGLCKLWIFGNQL 133

Query: 361 GGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL 420
              LP     L     ELSV  NQ++ ++P     L  L       NQ   ++P + S  
Sbjct: 134 T-SLPVLPPGLQ----ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS-- 181

Query: 421 KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK 480
             LQ+LSV +N L   +P+    L KL + +    SL    P+     + LI+   S N+
Sbjct: 182 -GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSL----PALPSGLKELIV---SGNR 232

Query: 481 LTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLST 540
           LT  LP     +  L     +S N L  SLP+    L +L    +  NQ +  +P +L  
Sbjct: 233 LT-SLPVLPSELKEL----MVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIH 282

Query: 541 CVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
             S   +++  N        + + L+ I +    S  +
Sbjct: 283 LSSETTVNLEGNPL---SERTLQALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  129 bits (326), Expect = 3e-31
 Identities = 71/345 (20%), Positives = 121/345 (35%), Gaps = 53/345 (15%)

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
           L      LNV E+  +   P  +     +  + + +N  +      +    P L+ L + 
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-----SLPALPPELRTLEVS 89

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL 338
           GN    S+P        L +   P            +    L  L +  N L +      
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS------ 135

Query: 339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVN 398
                      L+ LS+SDNQ    LP   + L     +L    NQ++ ++P     L  
Sbjct: 136 ----LPVLPPGLQELSVSDNQLA-SLPALPSELC----KLWAYNNQLT-SLPMLPSGLQE 185

Query: 399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ 458
           L   ++  NQ   ++P + S    L +L  +NN L   +P+    L     L +  N L 
Sbjct: 186 L---SVSDNQLA-SLPTLPS---ELYKLWAYNNRLTS-LPALPSGLK---ELIVSGNRLT 234

Query: 459 GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLK 518
            ++P      + L++   S N+LT  LP     + +L     +  N L   LP  + +L 
Sbjct: 235 -SLPVLPSELKELMV---SGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLS 284

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR 563
           +   +++  N  S      L    S       I  F      + R
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  121 bits (305), Expect = 1e-28
 Identities = 64/290 (22%), Positives = 106/290 (36%), Gaps = 51/290 (17%)

Query: 311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIAN 370
            +         +LN+ ++ L       L   +     + +  L + DN     LP     
Sbjct: 33  KMRACLNNGNAVLNVGESGL-----TTLPDCLP----AHITTLVIPDNNLT-SLPALPPE 82

Query: 371 LSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN 430
           L      L V  NQ++ ++P     L+ L  F+  +      +P + S    L +L +F 
Sbjct: 83  LR----TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH----LPALPS---GLCKLWIFG 130

Query: 431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLL 490
           N L   +P     L     L +  N L  ++P+       L       N+LT  LP    
Sbjct: 131 NQLTS-LPVLPPGLQ---ELSVSDNQLA-SLPALPSELCKLWA---YNNQLT-SLPMLPS 181

Query: 491 SITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
            +  L     +S+N L  SLP     L  L      +N+ +  +P   S    L+ L +S
Sbjct: 182 GLQEL----SVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPS---GLKELIVS 229

Query: 551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
            N     +P+       +K L VS N L+  +P     L     L++  N
Sbjct: 230 GNRL-TSLPVL---PSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRN 271

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  120 bits (302), Expect = 3e-28
 Identities = 72/384 (18%), Positives = 120/384 (31%), Gaps = 104/384 (27%)

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
             +         + L   +P  +     +  L +  N LT  LP     L          
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL---------- 83

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDIL 266
                              L V+ NQ +   P     +  + +          +      
Sbjct: 84  -----------------RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------ 119

Query: 267 LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE 326
                L KL I GN    S+P        L+ L +  NQ    +    S L  LW  N  
Sbjct: 120 --PSGLCKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWAYN-- 170

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
            N L +               S L+ LS+SDNQ    LP   + L     +L    N+++
Sbjct: 171 -NQLTS----------LPMLPSGLQELSVSDNQLA-SLPTLPSELY----KLWAYNNRLT 214

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTK 446
                                    ++P   +    L++L V  N L   +P     L +
Sbjct: 215 -------------------------SLP---ALPSGLKELIVSGNRLTS-LPVLPSELKE 245

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
           L    +  N L  ++P       +L +     N+LT  LP+ L+ +++ +  ++L  N L
Sbjct: 246 L---MVSGNRLT-SLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSET-TVNLEGNPL 296

Query: 507 NGSLPLQVGNLKNLVMLDISSNQF 530
           +    LQ   L+ +      S   
Sbjct: 297 S-ERTLQ--ALREITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 93.0 bits (231), Expect = 1e-19
 Identities = 44/205 (21%), Positives = 74/205 (36%), Gaps = 29/205 (14%)

Query: 398 NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSL 457
                 +  +    T+PD +    ++  L + +N L   +P+    L    +L++  N L
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPELR---TLEVSGNQL 93

Query: 458 QGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNL 517
             ++P        L +F      L   LP  L         L +  N L  SLP+    L
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK-------LWIFGNQLT-SLPVLPPGL 143

Query: 518 KNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNN 577
           + L    +S NQ +  +P   S    L   +  + S    +P+    L+    L+VS N 
Sbjct: 144 QEL---SVSDNQLA-SLPALPSELCKLWAYNNQLTS----LPMLPSGLQE---LSVSDNQ 192

Query: 578 LSGKIPEFLENLSFLEFLNLSYNYF 602
           L+  +P     L  L   N      
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLTSL 216

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 17/105 (16%), Positives = 35/105 (33%), Gaps = 8/105 (7%)

Query: 499 LDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVI 558
            + S         ++        +L++  +  +  +P  L     +  L I  N+    +
Sbjct: 21  AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSL 76

Query: 559 PLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE 603
           P     L++   L VS N L+  +P     L  L   +    +  
Sbjct: 77  PALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  128 bits (323), Expect = 5e-32
 Identities = 68/368 (18%), Positives = 138/368 (37%), Gaps = 29/368 (7%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           I + L       ++++        F      +++ +++    +    + P  +L +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSFRQV 71

Query: 273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT 332
           + L +           + + A  ++ L +  N  +      F ++  L +L LE+N+L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-- 129

Query: 333 GTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL-SLKMIELSVGRNQISGTIPP 391
              + L   IF  N   L  LS+S+N        +     SL+ ++LS   N+++  +  
Sbjct: 130 ---SSLPRGIF-HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS--SNRLT-HVDL 182

Query: 392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
               + +L    +  N         ++    +++L   +N +   +   +    +L  L 
Sbjct: 183 S--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP 511
           L  N+L     + L N   L+    SYN+L   +             L +SNN L  +L 
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 288

Query: 512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL 571
           L    +  L +LD+S N     +         LE L +  NS    + L      ++K L
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI---VTLKLSTHHTLKNL 344

Query: 572 NVSSNNLS 579
            +S N+  
Sbjct: 345 TLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (315), Expect = 6e-31
 Identities = 81/389 (20%), Positives = 145/389 (37%), Gaps = 37/389 (9%)

Query: 242 CNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
           C    V +   T++ + G       + L N K +    +         L +   +ELL+L
Sbjct: 21  CVFYDVHIDMQTQDVYFGFED----ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76

Query: 302 PSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
              Q +   +  F+    +  L +  N +       L   +F  N   L VL L  N   
Sbjct: 77  NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-----LPPHVF-QNVPLLTVLVLERNDLS 130

Query: 362 GELPHSI-ANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISE 419
             LP  I  N   K+  LS+  N +   I     +   +L    L  N+    +    S 
Sbjct: 131 -SLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDL--SL 184

Query: 420 LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN 479
           + +L   +V  N L     S L     +  LD   NS+   +   +     L +    +N
Sbjct: 185 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHN 236

Query: 480 KLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTL 538
            LT D    LL+   L   +DLS N L   +       ++ L  L IS+N+    + +  
Sbjct: 237 NLT-DTAW-LLNYPGLV-EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291

Query: 539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLS 598
               +L+ LD+S N     +  +      ++ L +  N++   +   L     L+ L LS
Sbjct: 292 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLS 347

Query: 599 YNYFEGEVPVKGVFSNKTKISLHGNVKLC 627
           +N ++    ++ +F N  + ++    + C
Sbjct: 348 HNDWD-CNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  120 bits (302), Expect = 3e-29
 Identities = 67/392 (17%), Positives = 134/392 (34%), Gaps = 53/392 (13%)

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKL 175
           I   +        + +   +            +N       N+ +  ++P  +  +  ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           + L+++   +                  I   +              +  L +  N    
Sbjct: 72  ELLNLNDLQIE----------------EIDTYAFAY--------AHTIQKLYMGFNAIRY 107

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN 295
           + P    N+  + ++ L  N  S + P  I  N P L  L +  NN      D+    ++
Sbjct: 108 LPPHVFQNVPLLTVLVLERNDLSSL-PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166

Query: 296 LELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL 355
           L+ L L SN+      +D S + +L+  N+  N L T           L+   +++ L  
Sbjct: 167 LQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLLST-----------LAIPIAVEELDA 212

Query: 356 SDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD 415
           S N     +     N+ L +++L    N +  T    + N   L+   L  N+    +  
Sbjct: 213 SHNSI-NVVRGP-VNVELTILKLQ--HNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYH 266

Query: 416 VISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFI 475
              +++ L++L + NN L   +      +  L  LDL  N L  ++  +      L    
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324

Query: 476 ASYNKLTGDLPQQLLSITTLSLVLDLSNNLLN 507
             +N +   L        TL   L LS+N  +
Sbjct: 325 LDHNSIV-TLKLSTHH--TLK-NLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  116 bits (293), Expect = 4e-28
 Identities = 64/319 (20%), Positives = 124/319 (38%), Gaps = 28/319 (8%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
            I  +L        + +           +  +L N  ++  + + +    A        L
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA------LL 65

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANL-SLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
            +   +++L+L+D Q      ++ A   +++ + +    N I   +PP + +N+  L   
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG--FNAIR-YLPPHVFQNVPLLTVL 122

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNI 461
            LE N        +      L  LS+ NN L   I        T L +L L SN L    
Sbjct: 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVD 181

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
            S + +  +  +   SYN L+       L+I      LD S+N +N    ++      L 
Sbjct: 182 LSLIPSLFHANV---SYNLLS------TLAIPIAVEELDASHNSINV---VRGPVNVELT 229

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
           +L +  N  +      L     L  +D+S N    ++   F  ++ ++ L +S+N L   
Sbjct: 230 ILKLQHNNLTD-TA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286

Query: 582 IPEFLENLSFLEFLNLSYN 600
           +  + + +  L+ L+LS+N
Sbjct: 287 LNLYGQPIPTLKVLDLSHN 305

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (287), Expect = 2e-27
 Identities = 60/385 (15%), Positives = 127/385 (32%), Gaps = 56/385 (14%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNSF 137
             ++++  Q            L+  + +   ++  R  +P  +  +  ++E L L++   
Sbjct: 23  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81

Query: 138 SGTIPTN-LSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGN 195
              I T   +    +       N +   +P  +  N+  L  L ++ N L+  LP     
Sbjct: 82  E-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP----- 133

Query: 196 LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN 255
                                     +L  L+++ N    +   +    +S++ + L+ N
Sbjct: 134 ------------------RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFS 315
           R + +        +P+L    +  N        +L+    +E LD   N       +   
Sbjct: 176 RLTHV-DLS---LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN---VVRGP 223

Query: 316 SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKM 375
               L +L L+ NNL             L N   L  + LS N+    + H    +  ++
Sbjct: 224 VNVELTILKLQHNNLTDTAW--------LLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RL 274

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
             L +  N++   +    + +  L    L  N     +     +   L+ L + +N +  
Sbjct: 275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 331

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGN 460
            +   L     L +L L  N    N
Sbjct: 332 TLK--LSTHHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 23/285 (8%)

Query: 345 SNCSSLKVLS-LSDNQFGGELPHSIANLSLKMIE-LSVGRNQISGTIPPGI-RNLVNLIT 401
           SN     V   +  +    ++     +++L   + ++   + +   +P  +  +   +  
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 73

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNI 461
             L   Q         +    +Q+L +  N +R   P    N+  L  L L  N L    
Sbjct: 74  LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 133

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
                N   L     S N L   +       TT    L LS+N L     + +  + +L 
Sbjct: 134 RGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLF 189

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
             ++S N  S     TL+  +++E LD S NS   V       L     L +  NNL+  
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-D 240

Query: 582 IPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
                 N   L  ++LSYN  E ++     F    +   + +  N
Sbjct: 241 TAWL-LNYPGLVEVDLSYNELE-KIM-YHPFVKMQRLERLYISNN 282

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 48/237 (20%), Positives = 84/237 (35%), Gaps = 13/237 (5%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKL 447
            I   ++         +++             L N + ++  N+ +R    + L +  ++
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 448 GSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLN 507
             L+L    ++     +      +      +N +   LP  +     L  VL L  N L+
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 508 GSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLK 566
            SLP  +  N   L  L +S+N    +   T     SL+ L +S N       +    + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIP 186

Query: 567 SIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
           S+   NVS N LS      L     +E L+ S+N     V    V    T + L  N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 236

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.7 bits (101), Expect = 5e-04
 Identities = 22/86 (25%), Positives = 39/86 (45%), Gaps = 5/86 (5%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
           QRL  L +S+ R+   L+ Y   +  L+ ++L+ N     + +      RLE L L +NS
Sbjct: 272 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLE 162
              T+  +      L +   S+N  +
Sbjct: 330 IV-TLKLST--HHTLKNLTLSHNDWD 352

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  124 bits (313), Expect = 3e-31
 Identities = 57/317 (17%), Positives = 117/317 (36%), Gaps = 24/317 (7%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
           +I +   N +  ++  +  +  K  ++    S  N+  L+L  N L   +A D      L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAAD------L 54

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTL 404
           +  + L++L+LS N    E    + +LS  +  L +  N +   +        ++ T   
Sbjct: 55  APFTKLELLNLSSNVL-YETL-DLESLS-TLRTLDLNNNYVQ-ELLV----GPSIETLHA 106

Query: 405 EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-NIPS 463
             N     +    S  +  + + + NN +        G  +++  LDL  N +   N   
Sbjct: 107 ANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVML 523
              +   L      YN +  D+    +    L   LDLS+N L   +  +  +   +  +
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP 583
            + +N+   +I   L    +LE+ D+  N F+      F F K+ +   V+   +     
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTG 277

Query: 584 EFLENLSFLEFLNLSYN 600
           +  E  +     +    
Sbjct: 278 QNEEECTVPTLGHYGAY 294

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  114 bits (287), Expect = 7e-28
 Identities = 60/351 (17%), Positives = 116/351 (33%), Gaps = 49/351 (13%)

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ 176
           I +   N  R +   ++++S    + +      N+     S N L      ++    KL+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM 236
            L++  N L  +  D + +LS +  + +  N +       L +   +  L+ A N     
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN---- 110

Query: 237 FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL 296
                  IS V                         K + +  N             S +
Sbjct: 111 -------ISRVS-----------------CSRGQGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 297 ELLDLPSNQFKG-KVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL 355
           + LDL  N+      +   +S   L  LNL+ N +      D+   +  +    LK L L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-----YDVKGQVVFAK---LKTLDL 198

Query: 356 SDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD 415
           S N+    +     + +  +  +S+  N++   I   +R   NL  F L  N FH     
Sbjct: 199 SSNKL-AFMGPEFQSAA-GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTL 254

Query: 416 VISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG 466
                KN +  +V    ++  +         + +L         ++P+   
Sbjct: 255 RDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (282), Expect = 3e-27
 Identities = 55/294 (18%), Positives = 102/294 (34%), Gaps = 18/294 (6%)

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE 405
           N +  K+  ++D+     L     +    + EL +  N +S      +     L    L 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSL 465
            N  +    D +  L  L+ L + NN++       L     + +L   +N++     S  
Sbjct: 67  SNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRG 119

Query: 466 GNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG-SLPLQVGNLKNLVMLD 524
              +N+ L   + NK+T  L        +    LDL  N ++  +      +   L  L+
Sbjct: 120 QGKKNIYL---ANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE 584
           +  N    V          L+ LD+S N     +   F+    +  +++ +N L   I +
Sbjct: 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 585 FLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN-VKLCGGIDELHLPS 637
            L     LE  +L  N F           N+   ++    VK   G +E     
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  104 bits (262), Expect = 1e-24
 Identities = 46/262 (17%), Positives = 102/262 (38%), Gaps = 20/262 (7%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
           N +  +   + D+  +  +     + + +++L LS N  S     +L+  + L     S+
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           N L  +   ++ +L  L+ L ++ NY+       +    +IE +    N++  ++     
Sbjct: 68  NVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVS--CS 117

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
             +   N+ +A N+ + +        S V+ + L  N    +   ++  +   L+ L + 
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL 338
            N     +   +   + L+ LDL SN+    +  +F S   +  ++L  N L        
Sbjct: 178 YNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKA-- 232

Query: 339 DFVIFLSNCSSLKVLSLSDNQF 360
                L    +L+   L  N F
Sbjct: 233 -----LRFSQNLEHFDLRGNGF 249

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  102 bits (257), Expect = 6e-24
 Identities = 49/324 (15%), Positives = 106/324 (32%), Gaps = 24/324 (7%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            R     ++   +   L+    +   ++ ++L+ N        ++    +LE L LS+N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
                  +L   S L     +NN ++     E+     ++ L    N ++ ++  S    
Sbjct: 70  LY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RG 119

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM-FPRSICNISSVELIFLTEN 255
              + I +  N +        G   R+  L++  N+   + F     +  ++E + L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFS 315
               +      +    LK L +  N     +     +A+ +  + L +N+    +     
Sbjct: 180 FIYDV---KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234

Query: 316 SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKM 375
             +NL   +L  N    GT  D           + +V +++      +L           
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDF-------FSKNQRVQTVAKQTV-KKLTGQNEEECTVP 286

Query: 376 IELSVGRNQISGTIPPGIRNLVNL 399
                G         P    L+ L
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIAL 310

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 17/214 (7%)

Query: 413 IPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLI 472
           I ++       +   V ++ L+  + S   +   +  LDL  N L     + L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 473 LFIASYNKLTGDLPQQLLSITTLS--LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF 530
           L   S N L      + L + +LS    LDL+NN +      ++    ++  L  ++N  
Sbjct: 62  LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111

Query: 531 SGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSG-KIPEFLENL 589
           S V           + + ++ N    +  L       ++ L++  N +      E   + 
Sbjct: 112 SRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 590 SFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
             LE LNL YN+   +V  + VF+    + L  N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (310), Expect = 6e-31
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 15/163 (9%)

Query: 711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
            M+G+G FG+V +  L       + VAVK+  LK    + S    F+ E   ++   H +
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 764 LIKIITICSSTDFEGVDFKAL-VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           + K++ +   +  +G     + +  +M++G L  +L  S        L L   +   +D+
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A  +EYL   +     +H DL   N +L  DM   V DFGL++
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  121 bits (306), Expect = 3e-30
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 21/165 (12%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKG--ASKSFVSECEALRNIRHRNLIK 766
           +G+G FG+V          +   +VAVK   L+  G    + F  E + L+ +    ++K
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
              +      + +    LV EY+ +G L D+L +   +++  +L     +  +  +   +
Sbjct: 89  YRGVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGM 140

Query: 827 EYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           EYL    C    VH DL   N+L++ +    + DFGLAK L    
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  120 bits (304), Expect = 4e-30
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 23/171 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLK---QKGASKSFVSECEALR 757
           +EF    ++G G FGTVYKG+        ++ VA+K   L+      A+K  + E   + 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72

Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           ++ + ++ +++ IC ++         L+ + M  G L D++ +  D +  + L     +N
Sbjct: 73  SVDNPHVCRLLGICLTSTV------QLITQLMPFGCLLDYVREHKDNIGSQYL-----LN 121

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             + +A  + YL       +VH DL   NVL+       + DFGLAK L  
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  120 bits (302), Expect = 6e-30
 Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 22/166 (13%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKS---FVSECEALRNIRHRNLI 765
           +G+G FG V          +    VAVK   LK +           E E LRN+ H N++
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K   IC+     G+    L+ E++ +GSL+++L   N      K++L Q++  A+ +   
Sbjct: 87  KYKGICTEDGGNGI---KLIMEFLPSGSLKEYL-PKNKN----KINLKQQLKYAVQICKG 138

Query: 826 IEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           ++YL         VH DL   NVL++ +    +GDFGL K +    
Sbjct: 139 MDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  119 bits (301), Expect = 6e-30
 Identities = 49/207 (23%), Positives = 80/207 (38%), Gaps = 23/207 (11%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR 760
            +  S+F    ++GQG FG V K     D    A+K I    +    + +SE   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60

Query: 761 HRNLIKIITICSSTDFEGVDFKA--------LVFEYMENGSLEDWLHQSNDQVEVRKLSL 812
           H+ +++                A        +  EY ENG+L D +H  N          
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQR 115

Query: 813 IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD 872
            +   +   +  A+ Y+H      ++H DLKP N+ +D      +GDFGLAK +      
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 873 IASKTPSSSIGIK------GTVGYVAP 893
           +   + +            GT  YVA 
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVAT 199

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  121 bits (305), Expect = 1e-29
 Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 38/224 (16%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
               + +  P   +  L+    +      IG+G FG V+ G L  D  +VAVK      +
Sbjct: 96  SGVVLHRAVPKDKW-VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---E 149

Query: 744 GASKS----FVSECEALRNIRHRNLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDW 797
                    F+ E   L+   H N++++I +C+     +       +V E ++ G    +
Sbjct: 150 TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY-------IVMELVQGGDFLTF 202

Query: 798 LHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV 857
           L ++       +L +   + +  D A+ +EYL        +H DL   N L+    V  +
Sbjct: 203 L-RTEG----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKI 254

Query: 858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP-----GKF 896
            DFG+++  ++     A+      + +K T    AP     G++
Sbjct: 255 SDFGMSREEADG--VYAASGGLRQVPVKWT----APEALNYGRY 292

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  118 bits (299), Expect = 1e-29
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V          +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L Q + +    ++  I+ +     +   +EY
Sbjct: 78  GVCYSAGRRNL---KLIMEYLPYGSLRDYL-QKHKE----RIDHIKLLQYTSQICKGMEY 129

Query: 829 LH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L         +H DL   N+L++ +    +GDFGL K L
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL 164

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  118 bits (298), Expect = 1e-29
 Identities = 46/171 (26%), Positives = 69/171 (40%), Gaps = 20/171 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVIN---LKQKGASKSFVSECEALRN 758
            +      +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ +
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + HRNLI++  +  +          +V E    GSL D L +           L      
Sbjct: 78  LDHRNLIRLYGVVLTPPM------KMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 126

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           A+ VA  + YL        +H DL   N+LL    +  +GDFGL + L  +
Sbjct: 127 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (299), Expect = 2e-29
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 17/159 (10%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKII 768
           +G+G FG+V          +   VVAVK +    +   + F  E E L++++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +C S     +    L+ EY+  GSL D+L +  ++++  KL     +     +   +EY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEY 160

Query: 829 LH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           L         +H DL   N+L++ +    +GDFGL K L
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVL 195

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (298), Expect = 3e-29
 Identities = 51/166 (30%), Positives = 72/166 (43%), Gaps = 24/166 (14%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKS---FVSECEALRNIRHRNLI 765
           +G+G FG V              +VAVK   LK     +    +  E + LR + H ++I
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K    C       +    LV EY+  GSL D+L +         + L Q +  A  +   
Sbjct: 97  KYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEG 146

Query: 826 IEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           + YLH  H     +H DL   NVLLD D +  +GDFGLAK +   H
Sbjct: 147 MAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  117 bits (296), Expect = 3e-29
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 33/219 (15%)

Query: 691 LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGAS- 746
           L   V    +        S  +IG+G FG VY G       + +  A+K ++   +    
Sbjct: 7   LLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEM 63

Query: 747 ---KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              ++F+ E   +R + H N++ +I I      EG+    ++  YM +G L  ++     
Sbjct: 64  QQVEAFLREGLLMRGLNHPNVLALIGIM--LPPEGLPH--VLLPYMCHGDLLQFIRSPQ- 118

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
               R  ++   ++  + VA  +EYL         VH DL   N +LD      V DFGL
Sbjct: 119 ----RNPTVKDLISFGLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGL 170

Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAP-----GKF 896
           A+ + +       +   + + +K T    A       +F
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWT----ALESLQTYRF 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  122 bits (307), Expect = 5e-29
 Identities = 60/367 (16%), Positives = 125/367 (34%), Gaps = 27/367 (7%)

Query: 165 IPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV 224
           I   +        + +D+             L+  +++    +++       L   R++ 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 225 NLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG 284
            LN+ + Q   +   +     +++ +++  N    + P  +  N+P L  L +  N+   
Sbjct: 79  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYL-PPHVFQNVPLLTVLVLERNDLSS 137

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
                  N   L  L + +N  +      F +  +L  L L  N L       +D  +  
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSLI- 191

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTL 404
               SL   ++S N        ++A   + + EL    N I+  +   +   V L    L
Sbjct: 192 ---PSLFHANVSYNLL-----STLAIP-IAVEELDASHNSIN-VVRGPV--NVELTILKL 239

Query: 405 EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSS 464
           + N    T    +     L ++ +  N L   +      + +L  L + +N L   +   
Sbjct: 240 QHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 296

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD 524
                 L +   S+N L   + +       L   L L +N +     L++     L  L 
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLE-NLYLDHNSIV---TLKLSTHHTLKNLT 351

Query: 525 ISSNQFS 531
           +S N + 
Sbjct: 352 LSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  119 bits (299), Expect = 5e-28
 Identities = 77/403 (19%), Positives = 133/403 (33%), Gaps = 35/403 (8%)

Query: 189 LPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVE 248
           +  ++        + I   +           L     +    +    +    + +   VE
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG 308
           L+ L + +   I           ++KL +G N      P    N   L +L L  N    
Sbjct: 79  LLNLNDLQIEEI-DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 309 KVSID---FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP 365
             S+    F +   L  L++  NNL       ++   F    +SL+ L LS N+      
Sbjct: 137 --SLPRGIFHNTPKLTTLSMSNNNL-----ERIEDDTF-QATTSLQNLQLSSNRLTHVDL 188

Query: 366 HSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQ 425
             I +L       +V  N +S      +   + +       N  +  +   +     L  
Sbjct: 189 SLIPSLF----HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 236

Query: 426 LSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDL 485
           L + +N L     + L N   L  +DL  N L+  +       Q L     S N+L   L
Sbjct: 237 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293

Query: 486 PQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLE 545
                 I TL  VLDLS+N L   +         L  L +  N    +   T     +L+
Sbjct: 294 NLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH---TLK 348

Query: 546 YLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLEN 588
            L +S N +      +    +++    V   +   KI   LE+
Sbjct: 349 NLTLSHNDWDCNSLRA--LFRNVARPAVDDADQHCKIDYQLEH 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  118 bits (297), Expect = 9e-28
 Identities = 81/500 (16%), Positives = 159/500 (31%), Gaps = 61/500 (12%)

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKL 175
           I   +        + +   +            +N       N+ +  ++P  +  +  ++
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           + L+++   +                  I   +              +  L +  N    
Sbjct: 78  ELLNLNDLQIE----------------EIDTYAFAY--------AHTIQKLYMGFNAIRY 113

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN 295
           + P    N+  + ++ L  N  S + P  I  N P L  L +  NN      D+    ++
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLSSL-PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172

Query: 296 LELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL 355
           L+ L L SN+      +D S + +L+  N+  N L T           L+   +++ L  
Sbjct: 173 LQNLQLSSNRLT---HVDLSLIPSLFHANVSYNLLST-----------LAIPIAVEELDA 218

Query: 356 SDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD 415
           S N     +     N+ L +++L    N +  T    + N   L+   L  N+    +  
Sbjct: 219 SHNSI-NVVRGP-VNVELTILKLQ--HNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYH 272

Query: 416 VISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFI 475
              +++ L++L + NN L   +      +  L  LDL  N L  ++  +      L    
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330

Query: 476 ASYNKLTGDLPQQLLSITTLSLVLDLSNN-LLNGSLPLQVGNLKNLVMLDISSNQFSGVI 534
             +N +   L        TL   L LS+N     SL     N+    + D   +      
Sbjct: 331 LDHNSIV-TLKLSTHH--TLK-NLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQ 386

Query: 535 PVTLSTCVSLEY-------LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLE 587
                 C   +          I++ S    +  +     +   +N   +       +   
Sbjct: 387 LEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGV 446

Query: 588 NLSFLEFLNLSYNYFEGEVP 607
            L   E L    N    EV 
Sbjct: 447 PLQGNEQLEAEVNELRAEVQ 466

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  115 bits (290), Expect = 6e-27
 Identities = 73/530 (13%), Positives = 164/530 (30%), Gaps = 77/530 (14%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNSF 137
             ++++  Q            L+  + +   ++  R  +P  +  +  ++E L L++   
Sbjct: 29  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 87

Query: 138 SGTIPTN-LSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGN 195
              I T   +    +       N +   +P  +  N+  L  L ++ N L+  LP     
Sbjct: 88  E-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP----- 139

Query: 196 LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN 255
                                     +L  L+++ N    +   +    +S++ + L+ N
Sbjct: 140 ------------------RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFS 315
           R + +        +P+L    +  N        +L+    +E LD   N       +   
Sbjct: 182 RLTHV-DLS---LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN---VVRGP 229

Query: 316 SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKM 375
               L +L L+ NNL             L N   L  + LS N+    + H    +  ++
Sbjct: 230 VNVELTILKLQHNNLTDTAW--------LLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RL 280

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
             L +  N++   +    + +  L    L  N     +     +   L+ L + +N +  
Sbjct: 281 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV- 337

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL 495
            +   L     L +L L  N            C +L     +  +   D   Q   I   
Sbjct: 338 TLK--LSTHHTLKNLTLSHNDWD---------CNSLRALFRNVARPAVDDADQHCKIDYQ 386

Query: 496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY 555
                                  + ++  I+       +      C + + ++   +  +
Sbjct: 387 LEHGLCCKESDK--------PYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSH 438

Query: 556 GVIPLSFRFLKSIKALNVSSNNLSGKI----PEFLENLSFLEFLNLSYNY 601
            +       L+  + L    N L  ++     E ++    L+ L+   + 
Sbjct: 439 YITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  113 bits (283), Expect = 5e-26
 Identities = 64/319 (20%), Positives = 124/319 (38%), Gaps = 28/319 (8%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
            I  +L        + +           +  +L N  ++  + + +    A        L
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA------LL 71

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANL-SLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
            +   +++L+L+D Q      ++ A   +++ + +    N I   +PP + +N+  L   
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG--FNAIR-YLPPHVFQNVPLLTVL 128

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNI 461
            LE N        +      L  LS+ NN L   I        T L +L L SN L    
Sbjct: 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLTHVD 187

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
            S + +  +  +   SYN L+       L+I      LD S+N +N    ++      L 
Sbjct: 188 LSLIPSLFHANV---SYNLLS------TLAIPIAVEELDASHNSINV---VRGPVNVELT 235

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
           +L +  N  +      L     L  +D+S N    ++   F  ++ ++ L +S+N L   
Sbjct: 236 ILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292

Query: 582 IPEFLENLSFLEFLNLSYN 600
           +  + + +  L+ L+LS+N
Sbjct: 293 LNLYGQPIPTLKVLDLSHN 311

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 96.1 bits (239), Expect = 1e-20
 Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 23/285 (8%)

Query: 345 SNCSSLKVLS-LSDNQFGGELPHSIANLSLKMIE-LSVGRNQISGTIPPGI-RNLVNLIT 401
           SN     V   +  +    ++     +++L   + ++   + +   +P  +  +   +  
Sbjct: 21  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 79

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNI 461
             L   Q         +    +Q+L +  N +R   P    N+  L  L L  N L    
Sbjct: 80  LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP 139

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
                N   L     S N L   +       TT    L LS+N L     + +  + +L 
Sbjct: 140 RGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLF 195

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
             ++S N  S     TL+  +++E LD S NS   V       L     L +  NNL+  
Sbjct: 196 HANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-D 246

Query: 582 IPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
                 N   L  ++LSYN  E ++     F    +   + +  N
Sbjct: 247 TAWL-LNYPGLVEVDLSYNELE-KIM-YHPFVKMQRLERLYISNN 288

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.8 bits (194), Expect = 3e-15
 Identities = 68/491 (13%), Positives = 148/491 (30%), Gaps = 70/491 (14%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            +LT L++S+  +  +        + L+ + L+ N     +   +  +  L    +S N 
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 203

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
                 + L+    +    AS+N +   +   +   ++L  L +  N LT      + N 
Sbjct: 204 L-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNY 253

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
             +  + ++ N L   +      ++RL  L ++ N+           + ++ L       
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-----------LVALNLYG----- 297

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS 316
                       +P LK L +  N+ +  +  +      LE L L  N      ++  S+
Sbjct: 298 ----------QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLST 343

Query: 317 LKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG----------ELPH 366
              L  L L  N+      +         N +   V     +              E   
Sbjct: 344 HHTLKNLTLSHNDW-----DCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDK 398

Query: 367 SIANLSLKMIELS-----VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK 421
              +  L+ I L+     V R Q   +    I ++ +L  +  +         + +    
Sbjct: 399 PYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEV 458

Query: 422 NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKL 481
           N  +L      L          L  L +    +          L    + +         
Sbjct: 459 N--ELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLN-----KVF 511

Query: 482 TGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTC 541
           T    +Q   +         ++     +  L+  N+     LD    + + +   T    
Sbjct: 512 THLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKR 571

Query: 542 VSLEYLDISIN 552
             ++ L+   N
Sbjct: 572 QKVKQLEAKKN 582

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.1 bits (174), Expect = 9e-13
 Identities = 41/236 (17%), Positives = 80/236 (33%), Gaps = 29/236 (12%)

Query: 412 TIPDVISELKNLQQLSVFNN----FLRGGIPSGL--GNLTKLGSLDLGSNSLQGNIPSSL 465
             P+      NLQ   VF +         +  G     L     +   +++++    + L
Sbjct: 12  RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71

Query: 466 GNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLD 524
            + + + L   +  ++  ++     +       L +  N +   LP  V  N+  L +L 
Sbjct: 72  DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 129

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP- 583
           +  N  S +          L  L +S N+   +   +F+   S++ L +SSN L+  +  
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL 188

Query: 584 ----------------EFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
                             L     +E L+ S+N     V    V    T + L  N
Sbjct: 189 SLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 242

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 50/328 (15%), Positives = 106/328 (32%), Gaps = 22/328 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
           QRL  L +S+ R+   L+ Y   +  L+ ++L+ N     + +      RLE L L +NS
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 335

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
              T+   LS    L +   S+N  +    + +     + R +VD      ++   + + 
Sbjct: 336 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHG 390

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM-----FPRSICNISSVELIF 251
                 + ++     ++   + L   +  +  A+ + S              I+    + 
Sbjct: 391 L---CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVP 447

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
           L  N        ++   +  L    I     +  +   +   +NL    LP +       
Sbjct: 448 LQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID--TNLRRYRLPKDGLAR--- 502

Query: 312 IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL 371
              S   N    +L++                 +     + L   +     +L +  A  
Sbjct: 503 --SSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQ 560

Query: 372 SLKMIELSVGRNQISGTIPPGIRNLVNL 399
           +    E S+ R ++        RN    
Sbjct: 561 AELRQETSLKRQKVKQLEAKKNRNPDTR 588

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (294), Expect = 5e-29
 Identities = 42/169 (24%), Positives = 89/169 (52%), Gaps = 23/169 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
           ++ +  + +G G++G VY+G+     + VAVK +    +     + F+ E   ++ I+H 
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           NL++++ +C+     +       ++ E+M  G+L D+L + N Q    ++S +  + +A 
Sbjct: 70  NLVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMAT 118

Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            ++SA+EYL   +     +H DL   N L+  + +  V DFGL++ ++ 
Sbjct: 119 QISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG 163

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (305), Expect = 5e-29
 Identities = 90/483 (18%), Positives = 171/483 (35%), Gaps = 32/483 (6%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
            T LN+S   I  + +  + +LS LR + ++ N  +            LE L LS+N   
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEG-QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLS 197
                      NL H   S N  +   I KE GN+ +L+ L +   +L       + +L+
Sbjct: 83  KISCHPTV---NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 198 AIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
             +V+ +   + G K       L+     ++     +      I ++S   +  L  +  
Sbjct: 140 ISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197

Query: 258 SGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSL 317
             +   +      ++            +   +    SNL L ++ +        +     
Sbjct: 198 KCVLEDNKCSYFLSIL-----------AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 318 KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIE 377
             +W  ++    L  G  +  DF    ++  +L +  +  + FG      I  +   M  
Sbjct: 247 TTVWYFSISNVKL-QGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNI 304

Query: 378 LSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR--G 435
            +   +            +   +      N    T+ +    L  L+ L +  N L+   
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS 364

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGNIP----SSLGNCQNLILFIASYNKLTGDLPQQLLS 491
            I      +  L  LD+  NS+  +      S   +  +L +   S N LT  + + L  
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM---SSNILTDTIFRCLPP 421

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISI 551
                 VLDL +N +  S+P QV  L+ L  L+++SNQ   V         SL+ + +  
Sbjct: 422 RIK---VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477

Query: 552 NSF 554
           N +
Sbjct: 478 NPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  116 bits (293), Expect = 2e-27
 Identities = 91/468 (19%), Positives = 183/468 (39%), Gaps = 26/468 (5%)

Query: 127 LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLT 186
              L +S N  S    +++   S L     S+N+++           +L+ L +  N L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 187 GQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNIS 245
             +         ++ + ++ N+     I    G + +L  L ++           I +++
Sbjct: 83  K-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 246 SVELIFLTENRFSGIFPFDIL--LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPS 303
             +++ +    +      + L   N  +L  +      F   +  S+   +NLEL ++  
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 304 NQFKGKVSIDFSSL----KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
                K S   S L     N  L NL  NN+ T T N    ++ L   +++   S+S+ +
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET-TWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 360 FGGELPH---SIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPD 415
             G+L       +  SLK + +    + + G     I     N+      V+        
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 416 VISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ-----GNIPSSLGNCQN 470
             S++     L   NN L   +    G+LT+L +L L  N L+       + + + + Q 
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378

Query: 471 LILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF 530
           L +   S N ++ D  +   S T   L L++S+N+L  ++   +     + +LD+ SN+ 
Sbjct: 379 LDI---SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433

Query: 531 SGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
              IP  +    +L+ L+++ N    V    F  L S++ + + +N  
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  111 bits (278), Expect = 1e-25
 Identities = 94/490 (19%), Positives = 181/490 (36%), Gaps = 42/490 (8%)

Query: 157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTT 216
           S N L   +PK++    K   L++  NY++      + +LS + ++ I+ N +     + 
Sbjct: 8   SKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISV 64

Query: 217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG 276
               + L  L+++ N+   +   S     +++ + L+ N F  +       N+  LK LG
Sbjct: 65  FKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121

Query: 277 IGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTAN 336
           +   +   S    +++ +  ++L +    +      D   L++    +L          +
Sbjct: 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFH 179

Query: 337 DLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS-----LKMIELSVGRNQISGTIPP 391
            +  V      ++L++ ++       +  + ++ L+      K+  L++   + +     
Sbjct: 180 FILDVSVK-TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238

Query: 392 GIRNLVNLIT--------FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGN 443
            I  LV   T          L+            + LK L    V ++            
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 444 LTKLGSLDLGSNSLQG---NIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLD 500
            + +   +   +  +      PS +    +L     S N LT  + +    +T L   L 
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF---SNNLLTDTVFENCGHLTELE-TLI 354

Query: 501 LSNNLLNGSLPLQVG---NLKNLVMLDISSNQFSGVIP-VTLSTCVSLEYLDISINSFYG 556
           L  N L   L         +K+L  LDIS N  S        S   SL  L++S N    
Sbjct: 355 LQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413

Query: 557 VIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKT 616
            I         IK L++ SN +   IP+ +  L  L+ LN++ N  +  VP  G+F   T
Sbjct: 414 TIF--RCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP-DGIFDRLT 468

Query: 617 K---ISLHGN 623
               I LH N
Sbjct: 469 SLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.3 bits (224), Expect = 5e-19
 Identities = 70/398 (17%), Positives = 135/398 (33%), Gaps = 26/398 (6%)

Query: 79  LTELNLSSQRIGGV-LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLE-KLALSNNS 136
           L  L+LS      + +    GN+S L+++ L+           I +L   +  L L    
Sbjct: 92  LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 137 FSGTIPTNLSRC--SNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG 194
                P  L      +L     +N +    +   +  +  L+  ++       +    + 
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

Query: 195 NLSAIEVIRITENSLGGKIPTT---------LGLLRRLVNLNVAENQFSGMFPRSICNIS 245
            L+ ++      N     I TT         L     +   +++  +  G       + S
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 246 SVELIFLTENRFS----GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDL 301
              L  L+ ++      G     I     N+       +          S  S    LD 
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331

Query: 302 PSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG 361
            +N     V  +   L  L  L L+ N L   +          +   SL+ L +S N   
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT----TQMKSLQQLDISQNSVS 387

Query: 362 GELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK 421
            +      + +  ++ L++  N ++ TI   +     +    L  N+   +IP  + +L+
Sbjct: 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLE 444

Query: 422 NLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQ 458
            LQ+L+V +N L+  +P G    LT L  + L +N   
Sbjct: 445 ALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 42/164 (25%), Positives = 68/164 (41%), Gaps = 8/164 (4%)

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
           S N L   +P+ L   TT   +L++S N ++      + +L  L +L IS N+   +   
Sbjct: 8   SKNGLI-HVPKDLSQKTT---ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL-SGKIPEFLENLSFLEFL 595
                  LEYLD+S N       +S     ++K L++S N   +  I +   N+S L+FL
Sbjct: 64  VFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120

Query: 596 NLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCP 639
            LS  + E    +     N +K+ L          D   L    
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 33/179 (18%), Positives = 71/179 (39%), Gaps = 8/179 (4%)

Query: 59  NNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIP 118
           N T++  +   + C  +      L+ S+  +   +    G+L+ L  + L  N  + ++ 
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364

Query: 119 QEIG---NLFRLEKLALSNNSFSGTIPTNL-SRCSNLIHFCASNNKLEGQIPKEIGNLLK 174
           +       +  L++L +S NS S        S   +L+    S+N L   I + +    +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422

Query: 175 LQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQF 233
           ++ L +  N +   +P  V  L A++ + +  N L          L  L  + +  N +
Sbjct: 423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  121 bits (305), Expect = 7e-29
 Identities = 55/297 (18%), Positives = 101/297 (34%), Gaps = 40/297 (13%)

Query: 262 PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNA-SNLELLDLPSNQFKGKVS-IDFSSLKN 319
           P +   +L           N +        +A    E   LP       VS +    +  
Sbjct: 6   PINNNFSLSQNSF-----YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELS 379
              L L + NL +     L   +       + VL ++ N     LP   A+L      L 
Sbjct: 61  FSELQLNRLNLSS-----LPDNLP----PQITVLEITQNALI-SLPELPASLE----YLD 106

Query: 380 VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPS 439
              N++S T+P    +L +L    ++ NQ    +P++ +    L+ ++  NN L   +P 
Sbjct: 107 ACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPE 157

Query: 440 GLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG--DLPQQLLSITTLSL 497
              +L  L    + +N L   +P    + + L +   S N L     +P +        +
Sbjct: 158 LPTSLEVL---SVRNNQLTF-LPELPESLEALDV---STNLLESLPAVPVRNHHSEETEI 210

Query: 498 VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
                 N +   +P  + +L     + +  N  S  I  +LS   +          F
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  109 bits (273), Expect = 8e-25
 Identities = 60/299 (20%), Positives = 102/299 (34%), Gaps = 37/299 (12%)

Query: 310 VSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA 369
           +SI      N  L      N  +GT  D       S     +  +L       E    + 
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADY-----FSAWDKWEKQALPGENRN-EAVSLLK 54

Query: 370 NLSLKMI-ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSV 428
              +    EL + R  +S ++P  +     +    +  N    ++P+      +L+ L  
Sbjct: 55  ECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPE---LPASLEYLDA 107

Query: 429 FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ 488
            +N L   +P    +L  L   D+ +N L   +P      + +       N+LT  LP+ 
Sbjct: 108 CDNRLST-LPELPASLKHL---DVDNNQLT-MLPELPALLEYINA---DNNQLT-MLPEL 158

Query: 489 LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLE--- 545
             S+  L     + NN L   LP    +L+ L   D+S+N     +P         E   
Sbjct: 159 PTSLEVL----SVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETE 209

Query: 546 -YLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE 603
            +     N     IP +   L     + +  N LS +I E L   +     +    YF 
Sbjct: 210 IFFRCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 88.9 bits (220), Expect = 2e-18
 Identities = 44/254 (17%), Positives = 83/254 (32%), Gaps = 46/254 (18%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
            + +EL L+   +   L   +     +  + +  N     +P+   +L   E L   +N 
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPASL---EYLDACDNR 111

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
            S T+P   +   +L      NN+L   +P+    L   + ++ D N LT  LP+   +L
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSL 162

Query: 197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
              EV+ +  N L   +P     L  L   +V+ N      P         E        
Sbjct: 163 ---EVLSVRNNQLT-FLPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEET------ 208

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS 316
                  +I               N +  IP+++ +      + L  N    ++    S 
Sbjct: 209 -------EIFFRC---------RENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252

Query: 317 LKNLWLLNLEQNNL 330
                  +  +   
Sbjct: 253 QTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 18/124 (14%), Positives = 37/124 (29%), Gaps = 8/124 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLR----YINLADNGFRGDIPQEIGNLFRLEKLAL 132
           + L  L++S+  +   L               +    +N     IP+ I +L     + L
Sbjct: 180 ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237

Query: 133 SNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
            +N  S  I  +LS+ +    +            ++  N L          +        
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSD 295

Query: 193 VGNL 196
           V  +
Sbjct: 296 VSQI 299

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (303), Expect = 7e-29
 Identities = 47/186 (25%), Positives = 94/186 (50%), Gaps = 22/186 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRN 763
           ++ +  + +G G++G VY+G+     + VAVK   LK+       F+ E   ++ I+H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 277

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           L++++ +C+     +       ++ E+M  G+L D+L + N Q    ++S +  + +A  
Sbjct: 278 LVQLLGVCTREPPFY-------IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQ 326

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           ++SA+EYL        +H +L   N L+  + +  V DFGL++ ++    D  +    + 
Sbjct: 327 ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAK 380

Query: 882 IGIKGT 887
             IK T
Sbjct: 381 FPIKWT 386

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  117 bits (295), Expect = 8e-29
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 23/171 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKS---FVSECEALR 757
           +E     ++G G FGTV+KG+        ++ V +KV  ++ K   +S         A+ 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIG 70

Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           ++ H ++++++ +C  +         LV +Y+  GSL D + Q    +  + L     +N
Sbjct: 71  SLDHAHIVRLLGLCPGSSL------QLVTQYLPLGSLLDHVRQHRGALGPQLL-----LN 119

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             + +A  + YL  H    MVH +L   NVLL       V DFG+A  L  
Sbjct: 120 WGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  116 bits (293), Expect = 1e-28
 Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 23/171 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLK---QKGASKSFVSECEALR 757
           +EF    ++G G FGTVYKG+        ++ VA+K   L+      A+K  + E   + 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMA 72

Query: 758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           ++ + ++ +++ IC ++         L+ + M  G L D++ +  D +  + L     +N
Sbjct: 73  SVDNPHVCRLLGICLTSTV------QLITQLMPFGCLLDYVREHKDNIGSQYL-----LN 121

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             + +A  + YL       +VH DL   NVL+       + DFGLAK L  
Sbjct: 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  115 bits (290), Expect = 2e-28
 Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 711 NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
            +IG+G FG VY G L      ++  AVK +N   +         F++E   +++  H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++ ++ IC     EG     +V  YM++G L +++            ++   +   + VA
Sbjct: 88  VLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVA 138

Query: 824 SAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
             ++YL         VH DL   N +LD      V DFGLA+ +
Sbjct: 139 KGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM 178

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (289), Expect = 2e-28
 Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 18/201 (8%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK-SFVSECEALRNIRHRN 763
           ++F     +G+G FG V++     D+   A+K I L  +  ++   + E +AL  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 764 LIK----IITICSSTDFEGVDFKALVF---EYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
           +++     +   ++   +    K  ++   +     +L+DW++      E  +      +
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC---L 121

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN----HHLD 872
           +I + +A A+E+LH      ++H DLKPSN+    D V  VGDFGL   +        + 
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 873 IASKTPSSSIGIKGTVGYVAP 893
                 +   G  GT  Y++P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  114 bits (288), Expect = 3e-28
 Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 27/185 (14%)

Query: 695 VSYAELSKATSEFSSSN------MIGQGRFGTVYKGIL--GDDEMVVAVKVI--NLKQKG 744
           ++  E+                  +G G FGTV KG          VAVK++        
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 745 ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ 804
                ++E   ++ + +  ++++I IC +   E      LV E  E G L  +L Q+   
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEA---ESW---MLVMEMAELGPLNKYLQQN--- 111

Query: 805 VEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
              R +     + +   V+  ++YL   +     VH DL   NVLL     A + DFGL+
Sbjct: 112 ---RHVKDKNIIELVHQVSMGMKYLEESNF----VHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 864 KFLSN 868
           K L  
Sbjct: 165 KALRA 169

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  113 bits (286), Expect = 4e-28
 Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 38/215 (17%)

Query: 693 PMVSYAELSKATSEFSSS-----NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK 747
            + +  E  ++    +         IG+G FG V  G    ++  VAVK   +K    ++
Sbjct: 4   SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQ 59

Query: 748 SFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV 807
           +F++E   +  +RH NL++++ +      E      +V EYM  GSL D+L         
Sbjct: 60  AFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--- 112

Query: 808 RKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
             L     +  ++DV  A+EYL  ++     VH DL   NVL+  D VA V DFGL K  
Sbjct: 113 -VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK-- 165

Query: 867 SNHHLDIASKTPSSSIGIKGTVGYVAP-----GKF 896
                + +S   +  + +K T    AP      KF
Sbjct: 166 -----EASSTQDTGKLPVKWT----APEALREKKF 191

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  116 bits (292), Expect = 4e-28
 Identities = 47/232 (20%), Positives = 92/232 (39%), Gaps = 26/232 (11%)

Query: 643 SRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSK 702
              P +  +  +  +  S    +    + +             +P  +L   V +  +  
Sbjct: 29  RGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP--ELVQAVQHVVIGP 86

Query: 703 ATSEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEA 755
           ++     + +IG+G FG VY G L      ++  AVK +N   +         F++E   
Sbjct: 87  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGII 143

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           +++  H N++ ++ IC     EG     +V  YM++G L +++            ++   
Sbjct: 144 MKDFSHPNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHN-----PTVKDL 194

Query: 816 MNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           +   + VA  +++L         VH DL   N +LD      V DFGLA+ +
Sbjct: 195 IGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDM 242

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (296), Expect = 4e-28
 Identities = 75/464 (16%), Positives = 143/464 (30%), Gaps = 59/464 (12%)

Query: 127 LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLT 186
                 +      T   +  + + L      N+ +       I  L  L +L    N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 187 GQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISS 246
             L   +   + +  +    N L   +   +  L +L  LN   N+ + +    +     
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPL 128

Query: 247 VELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
           +  +    N  + I     + +   L +L    N  +  +   ++  + L  LD   N+ 
Sbjct: 129 LTYLNCARNTLTEI----DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
                +D S  K L  LN + NN+       LD     +    L  L  S N+   E+  
Sbjct: 183 T---ELDVSQNKLLNRLNCDTNNI-----TKLDL----NQNIQLTFLDCSSNKL-TEID- 228

Query: 367 SIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQL 426
            +  L+ ++       N ++  +      L  L T           I   ++    L   
Sbjct: 229 -VTPLT-QLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280

Query: 427 SVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP 486
                     +   + + T+L  LD  +  +   +   L     L+    +  +LT +L 
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334

Query: 487 -QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVT-----LST 540
                 + +    L   N  +       VG +  L     +  Q   +   T     L+ 
Sbjct: 335 VSHNTKLKS----LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388

Query: 541 CVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE 584
            VS + LD   N     I      +       ++  NLS   P 
Sbjct: 389 AVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (291), Expect = 2e-27
 Identities = 83/461 (18%), Positives = 155/461 (33%), Gaps = 55/461 (11%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
                 ++  +    +     L+ L  ++  ++    D+   I  L  L KL  ++N+ +
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                +LS+ +NL +    +NKL   +   +  L KL  L+ D N LT      V     
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           +  +    N+L  +I   +    +L  L+   N+        +   + +  +  + N+ +
Sbjct: 129 LTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
            +     +     L +L    NN    +   L+    L  LD  SN+      ID + L 
Sbjct: 184 EL----DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT---EIDVTPLT 233

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
            L   +   N L      +LD     S  S L  L         E+  +  N  L   + 
Sbjct: 234 QLTYFDCSVNPL-----TELDV----STLSKLTTLHCIQTDL-LEIDLT-HNTQLIYFQA 282

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
                         + +   L     +       +   +S+   L  L + N  L   + 
Sbjct: 283 ----EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD 334

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT----GDLPQQLLSITT 494
             + + TKL SL   +  +Q +   S+G    L     +  +        L    L+I  
Sbjct: 335 --VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAV 390

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP 535
              +LD   N +N  +    G + +     I+    S   P
Sbjct: 391 SPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (289), Expect = 3e-27
 Identities = 75/421 (17%), Positives = 144/421 (34%), Gaps = 65/421 (15%)

Query: 223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF 282
             +   A  +       S   ++++  +    +  + +   +    L  L KL    NN 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE---KLTGLTKLICTSNNI 76

Query: 283 VGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI 342
             ++   LS  +NL  L   SN+     ++D + L  L  LN + N L           +
Sbjct: 77  T-TLD--LSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLTK---------L 121

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSL----KMIELSVGRNQISGTIPPGIRNLVN 398
            +S    L  L+ + N         +  + +    ++ EL    N+        +     
Sbjct: 122 DVSQNPLLTYLNCARNT--------LTEIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQ 171

Query: 399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ 458
           L T     N+    +   +S+ K L +L+   N +   +   L    +L  LD  SN L 
Sbjct: 172 LTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT 225

Query: 459 GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLV------LDLSNNL------- 505
             I   +     L  F  S N LT      L  +TTL  +      +DL++N        
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA 282

Query: 506 --LNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR 563
                   L V +   L +LD  +   +    + LS    L YL ++         L   
Sbjct: 283 EGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE---LDVS 336

Query: 564 FLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
               +K+L+  + ++       +  +  L     +       +P + + +N   I++  +
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPD 393

Query: 624 V 624
           +
Sbjct: 394 L 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (263), Expect = 6e-24
 Identities = 66/436 (15%), Positives = 128/436 (29%), Gaps = 58/436 (13%)

Query: 149 SNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENS 208
            N     A+  +++         L  L  L    + +T      +  L+ +  +  T N+
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNN 75

Query: 209 LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLN 268
           +   +   L     L  L    N+ + +    +  ++ +  +    N+ + +     +  
Sbjct: 76  I-TTLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL----DVSQ 125

Query: 269 LPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQN 328
            P L  L    N     I   +S+ + L  LD   N+      +D +    L  L+   N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFN 180

Query: 329 NLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL----KMIELSVGRNQ 384
            +           + +S    L  L+   N         I  L L    ++  L    N+
Sbjct: 181 KITE---------LDVSQNKLLNRLNCDTNN--------ITKLDLNQNIQLTFLDCSSNK 223

Query: 385 ISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL 444
           ++  I   +  L  L  F   VN     +   +S L  L  L      L   I   L + 
Sbjct: 224 LT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHN 274

Query: 445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN 504
           T+L                 + +   L L       +T     Q   +      L L+N 
Sbjct: 275 TQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVY----LYLNNT 328

Query: 505 LLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRF 564
            L   L +   +   L  L   +          +    +L     +      +   +   
Sbjct: 329 ELT-ELDV--SHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTN 383

Query: 565 LKSIKALNVSSNNLSG 580
                A++    +  G
Sbjct: 384 NSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 60/399 (15%), Positives = 132/399 (33%), Gaps = 55/399 (13%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           LT L   S ++  +    V  L+ L Y+N   N        ++     L  L  + N+ +
Sbjct: 87  LTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT 140

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                ++S  + L       NK   ++   +    +L  L    N +T      V     
Sbjct: 141 ---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKL 192

Query: 199 IEVIRITENSLGGKIPTTLGL--LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR 256
           +  +    N++     T L L    +L  L+ + N+ + +    +  ++ +     + N 
Sbjct: 193 LNRLNCDTNNI-----TKLDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNP 244

Query: 257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS 316
            + +     +  L  L  L     + +      +    N +L+   +   +    +D + 
Sbjct: 245 LTEL----DVSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTH 295

Query: 317 LKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMI 376
              L+LL+ +   +           + LS    L  L L++ +   EL   +++ + K+ 
Sbjct: 296 NTQLYLLDCQAAGITE---------LDLSQNPKLVYLYLNNTEL-TELD--VSHNT-KLK 342

Query: 377 ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK-----NLQQLSVFNN 431
            LS     I       +  +  L        Q      + ++        +   L  F N
Sbjct: 343 SLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGN 400

Query: 432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN 470
            +   I  G G +    +  +   +L  + P+      +
Sbjct: 401 PM--NIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  117 bits (295), Expect = 5e-28
 Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
            E      IG+G FG V  G    ++  VAVK   +K    +++F++E   +  +RH NL
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQAFLAEASVMTQLRHSNL 248

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++++ +      E      +V EYM  GSL D+L           L     +  ++DV  
Sbjct: 249 VQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCE 300

Query: 825 AIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           A+EYL  ++     VH DL   NVL+  D VA V DFGL K
Sbjct: 301 AMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  113 bits (284), Expect = 9e-28
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 26/162 (16%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHRNLI 765
           IG+G+FG V++GI     +  + VA+K         S    + F+ E   +R   H +++
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+I + +           ++ E    G L  +L Q         L L   +  A  +++A
Sbjct: 80  KLIGVITENPV------WIIMELCTLGELRSFL-QVRK----YSLDLASLILYAYQLSTA 128

Query: 826 IEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + YL         VH D+   NVL+  +    +GDFGL++++
Sbjct: 129 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYM 166

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  113 bits (284), Expect = 1e-27
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKI 767
           +G G FG+V +G+      ++ VA+KV  LK   +K  ++  + E + +  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           I +C +          LV E    G L  +L          ++ +     +   V+  ++
Sbjct: 76  IGVCQAEAL------MLVMEMAGGGPLHKFL-VGKR----EEIPVSNVAELLHQVSMGMK 124

Query: 828 YL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           YL   +     VH DL   NVLL     A + DFGL+K L  
Sbjct: 125 YLEEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGA 162

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  113 bits (286), Expect = 1e-27
 Identities = 47/165 (28%), Positives = 87/165 (52%), Gaps = 24/165 (14%)

Query: 713 IGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHRNL 764
           IG G FG VYKG+L    G  E+ VA+K +     G +      F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           I++  +   + ++ +    ++ EYMENG+L+ +L + + +      S++Q + +   +A+
Sbjct: 109 IRLEGVI--SKYKPM---MIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAA 158

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            ++YL +      VH DL   N+L++ ++V  V DFGL++ L + 
Sbjct: 159 GMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  113 bits (286), Expect = 1e-27
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 23/161 (14%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNIRHRNLI 765
           IG G  G V  G L   G  ++ VA+K +     G +    + F+SE   +    H N+I
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           ++  +   T         +V EYMENGSL+ +L   + Q      +++Q + +   V + 
Sbjct: 114 RLEGVV--TRGRLA---MIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAG 163

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + YL        VH DL   NVL+D ++V  V DFGL++ L
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (285), Expect = 1e-27
 Identities = 39/168 (23%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +GQG FG VY+G+       + E  VA+K +N   + AS      F++E   ++     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL----HQSNDQVEVRKLSLIQRMN 817
           +++++ + S             ++ E M  G L+ +L        +   +   SL + + 
Sbjct: 90  VVRLLGVVSQGQPTL-------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 818 IAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +A ++A  + YL+ +      VH DL   N ++  D    +GDFG+ +
Sbjct: 143 MAGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (282), Expect = 2e-27
 Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 26/162 (16%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRNLI 765
           +G+G FG VY+G+      +++ VAVK      K  +      F+SE   ++N+ H +++
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           K+I I             ++ E    G L  +L + N       L ++  +  ++ +  A
Sbjct: 77  KLIGIIEEEPT------WIIMELYPYGELGHYL-ERNK----NSLKVLTLVLYSLQICKA 125

Query: 826 IEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           + YL   +C    VH D+   N+L+       +GDFGL++++
Sbjct: 126 MAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI 163

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  111 bits (280), Expect = 2e-27
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 25/167 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
            E +    +G G+FG V  G     +  VAVK+I    +G+     F  E + +  + H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHP 63

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
            L+K   +CS     +       +V EY+ NG L ++L +S+     + L   Q + +  
Sbjct: 64  KLVKFYGVCSKEYPIY-------IVTEYISNGCLLNYL-RSHG----KGLEPSQLLEMCY 111

Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           DV   + +L  H      +H DL   N L+D D+   V DFG+ +++
Sbjct: 112 DVCEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (280), Expect = 3e-27
 Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 25/167 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
            + +    +G G+FG V  G     +  VA+K+I    +G+     F+ E + + N+ H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHE 79

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
            L+++  +C+     F       ++ EYM NG L ++L +        +    Q + +  
Sbjct: 80  KLVQLYGVCTKQRPIF-------IITEYMANGCLLNYL-REMR----HRFQTQQLLEMCK 127

Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           DV  A+EYL         +H DL   N L++   V  V DFGL++++
Sbjct: 128 DVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  111 bits (279), Expect = 4e-27
 Identities = 39/165 (23%), Positives = 83/165 (50%), Gaps = 21/165 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
                   +G G+FG V+ G   +    VAVK +    +G+    +F++E   ++ ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            L+++  + +           ++ EYMENGSL D+L   +      KL++ + +++A  +
Sbjct: 69  RLVRLYAVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQI 118

Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
           A  + ++   +     +H DL+ +N+L+   +   + DFGLA+ +
Sbjct: 119 AEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLI 159

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  110 bits (278), Expect = 4e-27
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 21/165 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
           SE +    IG G+FG V+ G    ++  VA+K I    +GA   + F+ E E +  + H 
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 63

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            L+++  +C   +   +    LV E+ME+G L D+L ++         +    + + +DV
Sbjct: 64  KLVQLYGVC--LEQAPI---CLVTEFMEHGCLSDYL-RTQRG----LFAAETLLGMCLDV 113

Query: 823 ASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
              + YL         +H DL   N L+  + V  V DFG+ +F+
Sbjct: 114 CEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFV 154

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  110 bits (278), Expect = 6e-27
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 31/204 (15%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR 760
            +   +F    +IG G FG V+K     D     +K +    + A      E +AL  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLD 62

Query: 761 HRNLIKIITICSSTDFEGVDFKA-----------LVFEYMENGSLEDWLHQSNDQVEVRK 809
           H N++         D++                 +  E+ + G+LE W+ +   +    K
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118

Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           L  +  + +   +   ++Y+H      +++ DLKPSN+ L       +GDFGL   L N 
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN- 174

Query: 870 HLDIASKTPSSSIGIKGTVGYVAP 893
             D            KGT+ Y++P
Sbjct: 175 --DGKRTR------SKGTLRYMSP 190

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  112 bits (282), Expect = 7e-27
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 33/196 (16%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS---FVSECEALRNIRHRNLIK 766
           +G G FG V  G L      E+ VA+K   LK     K    F+ E   +    H N+I+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +   T  + V    +V EYMENGSL+ +L + + Q      ++IQ + +   +AS +
Sbjct: 111 LEGVV--TKSKPV---MIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGM 160

Query: 827 EYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +YL         VH DL   N+L++ ++V  V DFGL + L +   + A  T    I I+
Sbjct: 161 KYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKIPIR 215

Query: 886 GTVGYVAP-----GKF 896
            T    +P      KF
Sbjct: 216 WT----SPEAIAYRKF 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  111 bits (279), Expect = 1e-26
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 30/168 (17%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G G FG VY+G +         + VAVK +    +  S+     F+ E   +    H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQS-NDQVEVRKLSLIQRMNIAI 820
           +++ I +   +   F       ++ E M  G L+ +L ++     +   L+++  +++A 
Sbjct: 95  IVRCIGVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAK 864
           D+A   +YL  +H     +H D+   N LL       VA +GDFG+A+
Sbjct: 148 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  113 bits (284), Expect = 1e-26
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
                   +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 241

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  + S           +V EYM  GSL D+L     +     L L Q +++A  +AS
Sbjct: 242 VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIAS 291

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            + Y+        VH DL+ +N+L+  ++V  V DFGLA+ + ++ 
Sbjct: 292 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  112 bits (283), Expect = 1e-26
 Identities = 80/396 (20%), Positives = 145/396 (36%), Gaps = 49/396 (12%)

Query: 240 SICNI-SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIP-DSLSNASNLE 297
            +  + + V  + L+ N  + +        L +L+ L +        I  ++    S+L 
Sbjct: 24  QVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 298 LLDLPSNQFKGKVSID---FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLS 354
           +L L  NQF     ++   F+ L NL +L L Q NL       L    F    +SL++L 
Sbjct: 83  ILKLDYNQFL---QLETGAFNGLANLEVLTLTQCNL---DGAVLSGNFF-KPLTSLEMLV 135

Query: 355 LSDNQFGGELPHSI-ANL-SLKMIELSVGRNQISGTIPPGI-----------RNLVNLIT 401
           L DN      P S   N+    +++L+   N++  +I                 L ++  
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLT--FNKVK-SICEEDLLNFQGKHFTLLRLSSITL 192

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG---GIPSGLGNLTKLGSLDLGSN--- 455
             +              +  ++  L +  N  +             TK+ SL L ++   
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 456 --SLQGNIPSSLGNCQNLILFIA-------SYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
             S          N     L  +       S +K+   L + + S  T    L L+ N +
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311

Query: 507 NGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFL 565
           N  +       L +L+ L++S N    +          LE LD+S N    +   SF  L
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGL 370

Query: 566 KSIKALNVSSNNLSGKIPE-FLENLSFLEFLNLSYN 600
            ++K L + +N L   +P+   + L+ L+ + L  N
Sbjct: 371 PNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  111 bits (279), Expect = 5e-26
 Identities = 68/396 (17%), Positives = 137/396 (34%), Gaps = 46/396 (11%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           +P  +        ++++ N  + +   S   +  ++ + + +     +   +    L +L
Sbjct: 28  LPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID--FSSLKNLWLLNLEQNNL 330
             L +  N F+     + +  +NLE+L L      G V     F  L +L +L L  NN+
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQ--------FGGELPHSIANLSLKMIEL-SVG 381
                  +    F  N     VL L+ N+                   L L  I L  + 
Sbjct: 142 KK-----IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196

Query: 382 RNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL 441
              +            ++ T  L  N F  ++     +     ++          + S  
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256

Query: 442 GN---------------LTKLGSLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNKLTG 483
           G+                + + + DL  + +     ++ S   + + L L   + N++  
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL---AQNEIN- 312

Query: 484 DLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCV 542
            +        T  L L+LS N L GS+  ++  NL  L +LD+S N    +   +     
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP 371

Query: 543 SLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           +L+ L +  N    V    F  L S++ + + +N  
Sbjct: 372 NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  102 bits (255), Expect = 7e-23
 Identities = 72/376 (19%), Positives = 128/376 (34%), Gaps = 32/376 (8%)

Query: 127 LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYL 185
           +  + LS NS +    T+ SR  +L             I       L  L  L +D N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 186 TGQLPDSV-GNLSAIEVIRITENSLGGKI--PTTLGLLRRLVNLNVAENQFSGMFPRSI- 241
             QL       L+ +EV+ +T+ +L G +        L  L  L + +N    + P S  
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 242 CNISSVELIFLTENRFSGIFP--FDIL-------LNLPNLKKLGIGGNNFVGSIPDSLSN 292
            N+    ++ LT N+   I               L L ++    +           +   
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 293 ASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF--LSNC--- 347
            +++  LDL  N FK  ++  F        +     +      +      F    N    
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270

Query: 348 ----SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
               S +K   LS ++    L    ++ +  + +L++ +N+I+  I       L +L+  
Sbjct: 271 GLEASGVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSN---SLQ 458
            L  N        +   L  L+ L +  N +R  +       L  L  L L +N   S+ 
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVP 387

Query: 459 GNIPSSLGNCQNLILF 474
             I   L + Q + L 
Sbjct: 388 DGIFDRLTSLQKIWLH 403

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.3 bits (232), Expect = 4e-20
 Identities = 72/394 (18%), Positives = 131/394 (33%), Gaps = 45/394 (11%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLA 131
            R Q L  L +  Q  G V+       LS L  + L  N F   +       L  LE L 
Sbjct: 51  SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLT 109

Query: 132 LSNNSF-SGTIPTNL-SRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQ 188
           L+  +     +  N     ++L      +N ++   P     N+ +   L +  N +   
Sbjct: 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-- 167

Query: 189 LPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVN--LNVAENQFSGMFPRSICNISS 246
                          I E  L         LLR       ++ E         +    +S
Sbjct: 168 --------------SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213

Query: 247 VELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
           +  + L+ N F           +   K   +  +N                  D  +  F
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN----FKDPDNFTF 269

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
           KG           +   +L ++ +       L   +F S+ + L+ L+L+ N+      +
Sbjct: 270 KGL------EASGVKTCDLSKSKIFA-----LLKSVF-SHFTDLEQLTLAQNEINKIDDN 317

Query: 367 SIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQ 425
           +   L+  +++L++ +N +  +I   +  NL  L    L  N            L NL++
Sbjct: 318 AFWGLT-HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375

Query: 426 LSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQ 458
           L++  N L+  +P G    LT L  + L +N   
Sbjct: 376 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 74.0 bits (182), Expect = 8e-14
 Identities = 45/295 (15%), Positives = 92/295 (31%), Gaps = 45/295 (15%)

Query: 366 HSIANLSLKMIELSVGRNQISGTIPPG-IRNLVNLITFTLEVNQFHGTIP-DVISELKNL 423
           H +  L   +  + +  N I+  +       L +L    +E       I  +    L +L
Sbjct: 23  HQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 424 QQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNI--PSSLGNCQNLILFIASYNK 480
             L +  N     + +G    L  L  L L   +L G +   +      +L + +   N 
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 481 LT----GDLPQQLLSITTLSLVLDLSNNLLN----------GSLPLQVGNLKNLVMLDIS 526
           +           +         LDL+ N +                 +  L ++ + D++
Sbjct: 141 IKKIQPASFFLNMRRFHV----LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196

Query: 527 SNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL--------NVSSNNL 578
                           S+  LD+S N F   +   F    +   +            ++ 
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256

Query: 579 SGKIPEFLENLSF-------LEFLNLSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
                +  +N +F       ++  +LS +     +  K VFS+ T    ++L  N
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFTDLEQLTLAQN 309

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 2e-26
 Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 17/165 (10%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHRN 763
                   +G G+FG V+     +    VAVK   +K    S   F++E   ++ ++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDK 244

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           L+K+  + +           ++ E+M  GSL D+L          K  L + ++ +  +A
Sbjct: 245 LVKLHAVVTKEPI------YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIA 294

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             + ++        +H DL+ +N+L+   +V  + DFGLA+ + +
Sbjct: 295 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  109 bits (274), Expect = 2e-26
 Identities = 36/172 (20%), Positives = 78/172 (45%), Gaps = 34/172 (19%)

Query: 713 IGQGRFGTVYKGIL-------GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
           +GQG F  ++KG+           E  V +KV++   +  S+SF      +  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 766 KIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
               +C   D          LV E+++ GSL+ +L + N       ++++ ++ +A  +A
Sbjct: 76  LNYGVCVCGDENI-------LVQEFVKFGSLDTYL-KKNK----NCINILWKLEVAKQLA 123

Query: 824 SAIEYL-HHHCQPPMVHGDLKPSNVLLDYD--------MVAHVGDFGLAKFL 866
           +A+ +L  +      +HG++   N+LL  +            + D G++  +
Sbjct: 124 AAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  109 bits (274), Expect = 2e-26
 Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 37/173 (21%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G+G FG V+           D+M+VAVK +    K  + +    F  E E L N++H +
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHEH 78

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLS 811
           ++K   +C   D          +VFEYM++G L  +L               +    +L 
Sbjct: 79  IVKFYGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 812 LIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
           L Q ++IA  +AS + YL   H     VH DL   N L+  +++  +GDFG++
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMS 180

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  108 bits (273), Expect = 3e-26
 Identities = 43/173 (24%), Positives = 71/173 (41%), Gaps = 36/173 (20%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G+ RFG VYKG L     G+    VA+K   LK   A       F  E      ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT--LK-DKAEGPLREEFRHEAMLRARLQHPN 73

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLS 811
           ++ ++ + +             ++F Y  +G L ++L             +D+     L 
Sbjct: 74  VVCLLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 812 LIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
               +++   +A+ +EYL  HH     VH DL   NVL+   +   + D GL 
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF 175

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  109 bits (275), Expect = 3e-26
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKI 767
           +G+G FG V+           D+M+VAVK +    + A + F  E E L  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 768 ITICSSTD--FEGVDFKALVFEYMENGSLEDWL---------HQSNDQVEVRKLSLIQRM 816
             +C+             +VFEYM +G L  +L             + V    L L Q +
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 817 NIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            +A  VA+ + YL   H     VH DL   N L+   +V  +GDFG++
Sbjct: 162 AVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMS 205

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  108 bits (271), Expect = 5e-26
 Identities = 46/186 (24%), Positives = 82/186 (44%), Gaps = 25/186 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKIITI 770
           IG+G F TVYKG+  +  + VA   +  ++   S  + F  E E L+ ++H N+++    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 771 CSSTDFEGVDFKALVF--EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
             ST       K +V   E M +G+L+ +L         + + +    +    +   +++
Sbjct: 94  WESTVKGK---KCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQF 144

Query: 829 LHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           LH    PP++H DLK  N+ +        +GD GLA           +K       + GT
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKA------VIGT 193

Query: 888 VGYVAP 893
             ++AP
Sbjct: 194 PEFMAP 199

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (272), Expect = 5e-26
 Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 9/183 (4%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G+G F  V       D    A+K I   ++   +    E +  R   H N+++++    
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94

Query: 773 STDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                G   +A L+  + + G+L + + +   + +   L+  Q + + + +   +E +H 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERL--KDKGNFLTEDQILWLLLGICRGLEAIH- 151

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA-SKTPSSSIGIKGTVGY 890
                  H DLKP+N+LL  +    + D G       H      + T       + T+ Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 891 VAP 893
            AP
Sbjct: 210 RAP 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (275), Expect = 5e-26
 Identities = 42/168 (25%), Positives = 78/168 (46%), Gaps = 30/168 (17%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G G FG VY+G +         + VAVK +    +  S+     F+ E   +    H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQS-NDQVEVRKLSLIQRMNIAI 820
           +++ I +   +   F       ++ E M  G L+ +L ++     +   L+++  +++A 
Sbjct: 136 IVRCIGVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 821 DVASAIEYL-HHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAK 864
           D+A   +YL  +H     +H D+   N LL       VA +GDFG+A+
Sbjct: 189 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  108 bits (273), Expect = 5e-26
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 34/174 (19%)

Query: 711 NMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-RHRN 763
           ++IG+G FG V K  +      M  A+K   +K + ASK     F  E E L  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MK-EYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQS----------NDQVEVRKLS 811
           +I ++  C      +       L  EY  +G+L D+L +S                  LS
Sbjct: 88  IINLLGACEHRGYLY-------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 812 LIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             Q ++ A DVA  ++YL         +H DL   N+L+  + VA + DFGL++
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  112 bits (281), Expect = 7e-26
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 15/166 (9%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
                   +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 324

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  + S           +V EYM  GSL D+L     +     L L Q +++A  +AS
Sbjct: 325 VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIAS 374

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            + Y+        VH DL+ +N+L+  ++V  V DFGLA+ + ++ 
Sbjct: 375 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (269), Expect = 7e-26
 Identities = 48/186 (25%), Positives = 74/186 (39%), Gaps = 17/186 (9%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNLIKIIT 769
            IG G +G   K     D  ++  K ++      +  +  VSE   LR ++H N   I+ 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                         +V EY E G L   + +     E + L     + +   +  A++  
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLDEEFVLRVMTQLTLALKEC 127

Query: 830 H--HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           H        ++H DLKP+NV LD      +GDFGLA+ L NH    A           GT
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-------FVGT 179

Query: 888 VGYVAP 893
             Y++P
Sbjct: 180 PYYMSP 185

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (279), Expect = 2e-25
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKI 767
           +G G FG+V +G+      ++ VA+KV  LK   +K  ++  + E + +  + +  ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           I +C +          LV E    G L  +L          ++ +     +   V+  ++
Sbjct: 402 IGVCQAEAL------MLVMEMAGGGPLHKFL-VGKR----EEIPVSNVAELLHQVSMGMK 450

Query: 828 YL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
           YL   +     VH +L   NVLL     A + DFGL+K L  
Sbjct: 451 YLEEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  107 bits (269), Expect = 2e-25
 Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 44/182 (24%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           +G+G FG V K              VAVK+  LK + AS S     +SE   L+ + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL------------------HQSND 803
           +IK+   CS             L+ EY + GSL  +L                    S D
Sbjct: 88  VIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
             + R L++   ++ A  ++  ++YL         VH DL   N+L+       + DFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGL 196

Query: 863 AK 864
           ++
Sbjct: 197 SR 198

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  111 bits (279), Expect = 2e-25
 Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 54/244 (22%)

Query: 661 CLLLSSCLTIVYARKRRSTHKSVDTSPM-------------EKLFPMVSYAELSKATSEF 707
           C L++        R ++   +++ + P                +     YAE+      +
Sbjct: 318 CRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY 377

Query: 708 SSSN---------------MIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQKGASKS- 748
           +  +                IG+G+FG V++GI     +  M VA+K    K    S S 
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT--CKN-CTSDSV 434

Query: 749 ---FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
              F+ E   +R   H +++K+I + +           ++ E    G L  +L       
Sbjct: 435 REKFLQEALTMRQFDHPHIVKLIGVITENPV------WIIMELCTLGELRSFLQVRKFS- 487

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
               L L   +  A  +++A+ YL         VH D+   NVL+  +    +GDFGL++
Sbjct: 488 ----LDLASLILYAYQLSTALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSR 539

Query: 865 FLSN 868
           ++ +
Sbjct: 540 YMED 543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  106 bits (267), Expect = 2e-25
 Identities = 42/173 (24%), Positives = 75/173 (43%), Gaps = 32/173 (18%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-RHR 762
           +G+G FG V +              VAVK++    +GA+ S     +SE + L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLSL 812
           N++ ++  C+           ++ E+ + G+L  +L            + + +    L+L
Sbjct: 92  NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 813 IQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
              +  +  VA  +E+L    C    +H DL   N+LL    V  + DFGLA+
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 4e-25
 Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 27/187 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNL--IK 766
             IG G    V++  L + + + A+K +NL++       S+ +E   L  ++  +   I+
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +             +  +V E   N  L  WL       + + +   +R +   ++  A+
Sbjct: 93  LYDY-----EITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAV 140

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
             +H H    +VH DLKP+N L+   M+  + DFG+A  +      +   +        G
Sbjct: 141 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 190

Query: 887 TVGYVAP 893
           TV Y+ P
Sbjct: 191 TVNYMPP 197

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (265), Expect = 4e-25
 Identities = 43/187 (22%), Positives = 78/187 (41%), Gaps = 23/187 (12%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITI 770
           ++GQG    V++G       + A+KV N           + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
               +      K L+ E+   GSL   L + +       L   + + +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 831 HHCQPPMVHGDLKPSNVLL----DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +    +VH ++KP N++     D   V  + DFG A+ L +        +      + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVS------LYG 177

Query: 887 TVGYVAP 893
           T  Y+ P
Sbjct: 178 TEEYLHP 184

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  105 bits (265), Expect = 7e-25
 Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 27/187 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL--IK 766
             IG G    V++  L + + + A+K +NL++       S+ +E   L  ++  +   I+
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +             +  +V E   N  L  WL +       + +   +R +   ++  A+
Sbjct: 74  LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAV 121

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
             +H H    +VH DLKP+N L+   M+  + DFG+A  +      +   +        G
Sbjct: 122 HTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QVG 171

Query: 887 TVGYVAP 893
           TV Y+ P
Sbjct: 172 TVNYMPP 178

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (266), Expect = 1e-24
 Identities = 40/187 (21%), Positives = 77/187 (41%), Gaps = 27/187 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHRNL--IK 766
             IG G    V++  L + + + A+K +NL++       S+ +E   L  ++  +   I+
Sbjct: 62  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +             +  +V E   N  L  WL +       + +   +R +   ++  A+
Sbjct: 121 LYDY-----EITDQYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAV 168

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
             +H H    +VH DLKP+N L+  D +  + DFG+A  +      +   +        G
Sbjct: 169 HTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS------QVG 218

Query: 887 TVGYVAP 893
            V Y+ P
Sbjct: 219 AVNYMPP 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  105 bits (264), Expect = 1e-24
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 39/177 (22%)

Query: 713 IGQGRFGTVYKGIL-------GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-R 760
           +G+G FG V              + + VAVK++      A++      VSE E ++ I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99

Query: 761 HRNLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVR 808
           H+N+I ++  C+     +       ++ EY   G+L ++L              ++V   
Sbjct: 100 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 809 KLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +++    ++    +A  +EYL    C    +H DL   NVL+  + V  + DFGLA+
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  105 bits (264), Expect = 1e-24
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 44/182 (24%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNIRHRN 763
           IG+G FG V++         +   +VAVK+  LK + AS      F  E   +    + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LK-EEASADMQADFQREAALMAEFDNPN 111

Query: 764 LIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQS------------------ND 803
           ++K++ +C+             L+FEYM  G L ++L                       
Sbjct: 112 IVKLLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
                 LS  +++ IA  VA+ + YL         VH DL   N L+  +MV  + DFGL
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGL 220

Query: 863 AK 864
           ++
Sbjct: 221 SR 222

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  106 bits (266), Expect = 1e-24
 Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 44/218 (20%)

Query: 677 RSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSN-----MIGQGRFGTVYKGIL----- 726
           R T +   T+    L  +  Y        EF          +G+G FG V          
Sbjct: 48  RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK 107

Query: 727 --GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-RHRNLIKIITICSSTD--FE 777
               + + VAVK+  LK   A++      VSE E ++ I +H+N+I ++  C+     + 
Sbjct: 108 DKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY- 163

Query: 778 GVDFKALVFEYMENGSLEDWL----------HQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                 ++ EY   G+L ++L              ++V   +++    ++    +A  +E
Sbjct: 164 ------VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217

Query: 828 YL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           YL    C    +H DL   NVL+  + V  + DFGLA+
Sbjct: 218 YLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  105 bits (263), Expect = 1e-24
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 35/172 (20%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-RHR 762
           +G G FG V +         D  + VAVK+  LK   A        +SE + + ++ +H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL--------HQSNDQVEVRKLSL 812
           N++ ++  C+             ++ EY   G L ++L              +     S 
Sbjct: 111 NIVNLLGACTHGGPVL-------VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 813 IQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
              ++ +  VA  + +L   +C    +H D+   NVLL    VA +GDFGLA
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA 211

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  103 bits (260), Expect = 2e-24
 Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 39/176 (22%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-RHR 762
           +G G FG V +         D  M VAVK++      A  +     +SE + L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL------------HQSNDQVEVR 808
           N++ ++  C+             ++ EY   G L ++L              +  + +  
Sbjct: 88  NIVNLLGACTIGGPTL-------VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 809 KLSLIQRMNIAIDVASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            L L   ++ +  VA  + +L   +C    +H DL   N+LL +  +  + DFGLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  104 bits (261), Expect = 2e-24
 Identities = 37/189 (19%), Positives = 78/189 (41%), Gaps = 11/189 (5%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKII-- 768
           ++ +G F  VY+          A+K +   ++  +++ + E   ++ +  H N+++    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
                 + +    + L+   +  G L ++L +   +     LS    + I      A+++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQH 151

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS----IGI 884
           +H   +PP++H DLK  N+LL       + DFG A  +S++     S    +     I  
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 885 KGTVGYVAP 893
             T  Y  P
Sbjct: 211 NTTPMYRTP 219

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (262), Expect = 2e-24
 Identities = 27/247 (10%), Positives = 59/247 (23%), Gaps = 40/247 (16%)

Query: 672 YARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEM 731
             ++  +  ++V  +   +       + LS+   +      +  G    V+     +   
Sbjct: 29  ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88

Query: 732 VVAVKVINLKQKGAS---KSFVSECEALRNIRHRNLI---------------------KI 767
             A+KV  +  + +    +       A   +   +                         
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR-KLSLIQRMNIAIDVASAI 826
             +    D   V    L+        LE      +     R    ++    +   +    
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
             L       +VHG   P N+ +  D    +GD                K  +       
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----------KVGTRGPASSV 253

Query: 887 TVGYVAP 893
            V Y   
Sbjct: 254 PVTYAPR 260

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  104 bits (261), Expect = 3e-24
 Identities = 44/208 (21%), Positives = 84/208 (40%), Gaps = 30/208 (14%)

Query: 696 SYAELSKATSEFSSSNM--------IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS- 746
             + +   T      +M        IG+G FG        +D     +K IN+ +  +  
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 747 -KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
            +    E   L N++H N+++         FE      +V +Y E G L   ++      
Sbjct: 67  REESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKG-- 119

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
                   Q ++  + +  A++++H      ++H D+K  N+ L  D    +GDFG+A+ 
Sbjct: 120 --VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

Query: 866 LSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           L N  +++A +         GT  Y++P
Sbjct: 175 L-NSTVELA-RA------CIGTPYYLSP 194

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  104 bits (260), Expect = 7e-24
 Identities = 43/187 (22%), Positives = 79/187 (42%), Gaps = 23/187 (12%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           ++GQG    V++G       + A+KV N +         + E E L+ + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
               +      K L+ E+   GSL   L + +       L   + + +  DV   + +L 
Sbjct: 76  ---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 831 HHCQPPMVHGDLKPSNVLL----DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +    +VH ++KP N++     D   V  + DFG A+ L +        +      + G
Sbjct: 130 ENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVS------LYG 177

Query: 887 TVGYVAP 893
           T  Y+ P
Sbjct: 178 TEEYLHP 184

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  102 bits (257), Expect = 9e-24
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 44/181 (24%)

Query: 713 IGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGAS----KSFVSECEALRNI-RHR 762
           +G G FG V              + VAVK+  LK + A     ++ +SE + +  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109

Query: 763 NLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL-----------------HQSND 803
           N++ ++  C+ +   +       L+FEY   G L ++L                  +  +
Sbjct: 110 NIVNLLGACTLSGPIY-------LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
           + ++  L+    +  A  VA  +E+L    C    VH DL   NVL+ +  V  + DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGL 218

Query: 863 A 863
           A
Sbjct: 219 A 219

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  102 bits (257), Expect = 1e-23
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 39/177 (22%)

Query: 713 IGQGRFGTVYKGIL-------GDDEMVVAVKVINLKQKGASKS----FVSECEALRNI-R 760
           +G+G FG V             +    VAVK++      A++      +SE E ++ I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 761 HRNLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWL----------HQSNDQVEVR 808
           H+N+I ++  C+     +       ++ EY   G+L ++L            +       
Sbjct: 134 HKNIINLLGACTQDGPLY-------VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 809 KLSLIQRMNIAIDVASAIEYL-HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           +LS    ++ A  VA  +EYL    C    +H DL   NVL+  D V  + DFGLA+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  105 bits (264), Expect = 2e-23
 Identities = 44/189 (23%), Positives = 75/189 (39%), Gaps = 36/189 (19%)

Query: 712 MIGQGRFGTVYKGILGDDEMV----VAVKVINLKQKG---ASKSFVSECEALRNIRHRNL 764
            I  G  G +Y   L  D  V    V +K   L   G   A    ++E + L  + H ++
Sbjct: 87  CIAHGGLGWIY---LALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++I      TD  G     +V EY+   SL+            +KL + + +   +++  
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILP 193

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A+ YLH      +V+ DLKP N++L  + +  + D G    +               +  
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYLY- 238

Query: 885 KGTVGYVAP 893
            GT G+ AP
Sbjct: 239 -GTPGFQAP 246

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 3e-23
 Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 27/223 (12%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
           + RR + +   +  ++      S  E S     F   + +G G +G V+K    +D  + 
Sbjct: 27  QPRRVSFRGEASETLQSPGYDPSRPE-SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLY 85

Query: 734 AVKVINLKQKGAS--KSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYME 790
           AVK      +G       ++E  +   + +H   +++     +  +E      L  E   
Sbjct: 86  AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE---QA--WEEGGILYLQTELCG 140

Query: 791 NGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
             SL+              L   Q      D   A+ +LH      +VH D+KP+N+ L 
Sbjct: 141 -PSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLG 191

Query: 851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
                 +GDFGL   L          T  +    +G   Y+AP
Sbjct: 192 PRGRCKLGDFGLLVELG---------TAGAGEVQEGDPRYMAP 225

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 3e-23
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
            +G+G F   ++    D + V A K++    L +    +    E    R++ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                  FE  DF  +V E     SL +     ++  + E R   L Q       +    
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ-------IVLGC 128

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           +YLH +    ++H DLK  N+ L+ D+   +GDFGLA  +   +     K       + G
Sbjct: 129 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LCG 177

Query: 887 TVGYVAP 893
           T  Y+AP
Sbjct: 178 TPNYIAP 184

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  104 bits (260), Expect = 4e-23
 Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 26/190 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKII-T 769
            +G G FG V + I  D    VA+K    +      + +  E + ++ + H N++     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV---EVRKLSLIQRMNIAIDVASAI 826
                     D   L  EY E G L  +L+Q  +     E    +L+       D++SA+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSAL 134

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
            YLH +    ++H DLKP N++L      ++  + D G AK L    L            
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTE------ 182

Query: 884 IKGTVGYVAP 893
             GT+ Y+AP
Sbjct: 183 FVGTLQYLAP 192

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  102 bits (255), Expect = 4e-23
 Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 31/195 (15%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRN 763
            F   +++G G  GT+    + D+  V AVK I  +    A +    E + LR    H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           +I+    C+    +   F+ +  E     +L++++ Q +          ++ + +     
Sbjct: 80  VIRYF--CT---EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTT 128

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           S + +LH      +VH DLKP N+L+        + A + DFGL K L+         + 
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG-----RHSF 180

Query: 879 SSSIGIKGTVGYVAP 893
           S   G+ GT G++AP
Sbjct: 181 SRRSGVPGTEGWIAP 195

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (251), Expect = 5e-23
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 29/187 (15%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
            +G+G F   ++    D + V A K++    L +    +    E    R++ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                  FE  DF  +V E     SL +     ++  + E R   L Q       +    
Sbjct: 108 GF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ-------IVLGC 154

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           +YLH +    ++H DLK  N+ L+ D+   +GDFGLA  +   +     K       + G
Sbjct: 155 QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV------LCG 203

Query: 887 TVGYVAP 893
           T  Y+AP
Sbjct: 204 TPNYIAP 210

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  100 bits (250), Expect = 5e-23
 Identities = 51/294 (17%), Positives = 98/294 (33%), Gaps = 25/294 (8%)

Query: 245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN 304
               L+ L  N  S +   D    L +L  L +  N        + S    L+ L +  N
Sbjct: 54  PDTTLLDLQNNDISEL-RKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112

Query: 305 QFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL 364
                  I  +   +L  L +  N +              S   ++  + +  N      
Sbjct: 113 HLV---EIPPNLPSSLVELRIHDNRIRKVPKGVF------SGLRNMNCIEMGGNPLENSG 163

Query: 365 PHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ 424
               A   LK+  L +   +++  IP  +     L    L+ N+      + +     L 
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLY 220

Query: 425 QLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT- 482
           +L + +N +R  I +G L  L  L  L L +N L   +P+ L + + L +     N +T 
Sbjct: 221 RLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278

Query: 483 ---GDLPQQLLSITTLSL-VLDLSNNLLNGSLPLQVG---NLKNLVMLDISSNQ 529
               D       +       + L NN +     +Q      + + + +   + +
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 55/279 (19%), Positives = 100/279 (35%), Gaps = 26/279 (9%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEV 406
               +L L +N            L   +  L +  N+IS  I       L  L    +  
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQ-HLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQ-GNIPSS 464
           N     IP  +    +L +L + +N +R  +P G    L  +  +++G N L+       
Sbjct: 112 NHLV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSL-VLDLSNNLLNGSLPLQV-GNLKNLVM 522
             +   L     S  KLT  +P+ L      +L  L L +N +  ++ L+       L  
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDLPE----TLNELHLDHNKIQ-AIELEDLLRYSKLYR 221

Query: 523 LDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI 582
           L +  NQ   +   +LS   +L  L +  N     +P     LK ++ + + +NN++ K+
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KV 279

Query: 583 PE-------FLENLSFLEFLNLSYNYFEGEVPVKGVFSN 614
                    F    ++   ++L  N           F  
Sbjct: 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 61/289 (21%), Positives = 100/289 (34%), Gaps = 23/289 (7%)

Query: 345 SNCS-SLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPG-IRNLVNLITF 402
             C   L+V+  SD      +P     +S     L +  N IS  +     + L +L   
Sbjct: 29  FGCHCHLRVVQCSDLGLK-AVP---KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYAL 83

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP 462
            L  N+         S L+ LQ+L +  N L   IP  L   + L  L +  N ++    
Sbjct: 84  VLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPK 140

Query: 463 SSLGNCQNLILFIASYNKLTGD-LPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLV 521
                 +N+       N L              L+  L +S   L G   +     + L 
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN-YLRISEAKLTG---IPKDLPETLN 196

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
            L +  N+   +    L     L  L +  N    +   S  FL +++ L++ +N LS +
Sbjct: 197 ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255

Query: 582 IPEFLENLSFLEFLNLSYNYFE-------GEVPVKGVFSNKTKISLHGN 623
           +P  L +L  L+ + L  N            V      +    ISL  N
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN 304

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 68/308 (22%), Positives = 111/308 (36%), Gaps = 46/308 (14%)

Query: 64  FCQWTGVTCGHRH---------QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFR 114
            C    V C                T L+L +  I  +       L  L  + L +N   
Sbjct: 32  HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 115 GDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLL 173
               +    L +L+KL +S N     IP NL    +L+     +N++  ++PK +   L 
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGLR 147

Query: 174 KLQRLSVDINYLT-GQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQ 232
            +  + +  N L          +   +  +RI+E  L   IP    L   L  L++  N+
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK 204

Query: 233 FSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPD-SLS 291
                      I ++                + LL    L +LG+G N  +  I + SLS
Sbjct: 205 -----------IQAI--------------ELEDLLRYSKLYRLGLGHNQ-IRMIENGSLS 238

Query: 292 NASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK 351
               L  L L +N+   +V      LK L ++ L  NN+     ND   V F    +   
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297

Query: 352 VLSLSDNQ 359
            +SL +N 
Sbjct: 298 GISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 68/319 (21%), Positives = 118/319 (36%), Gaps = 33/319 (10%)

Query: 102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL 161
            LR +  +D G +  +P+EI        L L NN  S     +     +L      NNK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 162 EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR 221
                K    L KLQ+L +  N+L  ++P ++   S++  +RI +N +          LR
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 222 RLVNLNVAENQF-SGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGN 280
            +  + +  N   +  F     +   +  + ++E + +GI P D+      L +L +  N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKDLP---ETLNELHLDHN 203

Query: 281 NFVGSIPD-SLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
               +I    L   S L  L L  NQ +   +   S L  L  L+L+ N L    A    
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAG--- 259

Query: 340 FVIFLSNCSSLKVLSLSDNQ--------FGGELPHSIANLSLKMIELSVGRNQIS-GTIP 390
               L +   L+V+ L  N         F   +   +       I L    N +    + 
Sbjct: 260 ----LPDLKLLQVVYLHTNNITKVGVNDFCP-VGFGVKRAYYNGISLF--NNPVPYWEVQ 312

Query: 391 PGI-RNLVNLITFTLEVNQ 408
           P   R + + +       +
Sbjct: 313 PATFRCVTDRLAIQFGNYK 331

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (255), Expect = 6e-23
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 14/257 (5%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEV 406
           +    +  +      E+P     +      L++  N I   I     R+L +L    L  
Sbjct: 54  NQFSKVVCTRRGLS-EVP---QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGR 108

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPS-S 464
           N          + L +L  L +F+N+L   IPSG    L+KL  L L +N ++ +IPS +
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166

Query: 465 LGNCQNL-ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVML 523
                +L  L +    KL   + +           L+L    +   +P  +  L  L  L
Sbjct: 167 FNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP 583
           ++S N F  + P +     SL+ L +  +    +   +F  L S+  LN++ NNLS    
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283

Query: 584 EFLENLSFLEFLNLSYN 600
           +    L +L  L+L +N
Sbjct: 284 DLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 53/252 (21%), Positives = 94/252 (37%), Gaps = 23/252 (9%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           +P   G+      LN+ EN    +   +  ++  +E++ L  N    I        L +L
Sbjct: 69  VPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQI-EVGAFNGLASL 125

Query: 273 KKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQN 328
             L +  N  +  IP  +    S L  L L +N  +   SI    F+ + +L  L+L + 
Sbjct: 126 NTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGEL 181

Query: 329 NLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT 388
                 +             +LK L+L       ++P+    + L+ +E+S   N     
Sbjct: 182 KKLEYISEGA-----FEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMS--GNHFP-E 232

Query: 389 IPPG-IRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTK 446
           I PG    L +L    +  +Q      +    L +L +L++ +N L   +P      L  
Sbjct: 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRY 291

Query: 447 LGSLDLGSNSLQ 458
           L  L L  N   
Sbjct: 292 LVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 90.6 bits (225), Expect = 4e-19
 Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 11/235 (4%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEV 406
           S+ + L+L +N        +  +L   +  L +GRN I   I  G    L +L T  L  
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGS-NSLQGNIPSS 464
           N            L  L++L + NN +   IPS     +  L  LDLG    L+     +
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGA 191

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVML 523
                NL         +  D+P  L  +  L   L++S N     +       L +L  L
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLE-ELEMSGNHFP-EIRPGSFHGLSSLKKL 247

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
            + ++Q S +         SL  L+++ N+   +    F  L+ +  L++  N  
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 8/231 (3%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTN-LSRCSNLIHFCASNNKL 161
            RY+NL +N  +        +L  LE L L  NS    I     +  ++L      +N L
Sbjct: 77  TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWL 135

Query: 162 EGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE-NSLGGKIPTTLGL 219
              IP      L KL+ L +  N +      +   + ++  + + E   L          
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           L  L  LN+       M   ++  +  +E + ++ N F  I        L +LKKL +  
Sbjct: 195 LFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEI-RPGSFHGLSSLKKLWVMN 251

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL 330
           +       ++    ++L  L+L  N         F+ L+ L  L+L  N  
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 27/133 (20%), Positives = 41/133 (30%), Gaps = 26/133 (19%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             L  LNL    I  +  P +  L  L  + ++ N F    P     L  L+KL + N+ 
Sbjct: 196 FNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253

Query: 137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL 196
            S  I  N                           L  L  L++  N L+    D    L
Sbjct: 254 VS-LIERNA-----------------------FDGLASLVELNLAHNNLSSLPHDLFTPL 289

Query: 197 SAIEVIRITENSL 209
             +  + +  N  
Sbjct: 290 RYLVELHLHHNPW 302

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 55/209 (26%), Positives = 85/209 (40%), Gaps = 41/209 (19%)

Query: 701 SKATSEFSS----SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---------KGASK 747
           S +T  F        ++G+G    V + I        AVK+I++           +   +
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 748 SFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE 806
           + + E + LR +  H N+I++        +E   F  LVF+ M+ G L D+L       E
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TE 117

Query: 807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
              LS  +   I   +   I  LH      +VH DLKP N+LLD DM   + DFG +  L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 867 SNHHL--DIASKTPSSSIGIKGTVGYVAP 893
                  ++            GT  Y+AP
Sbjct: 175 DPGEKLREVC-----------GTPSYLAP 192

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 21/185 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKII 768
            IG+G+F  VY+     D + VA+K + +     +K     + E + L+ + H N   +I
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---VI 95

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
              +S  F   +   +V E  + G L   +     Q  +     +      + + SA+E+
Sbjct: 96  KYYAS--FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV--WKYFVQLCSALEH 151

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           +H      ++H D+KP+NV +    V  +GD GL +F S+     A  +      + GT 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAA-HS------LVGTP 200

Query: 889 GYVAP 893
            Y++P
Sbjct: 201 YYMSP 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.8 bits (247), Expect = 8e-23
 Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 29/185 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G F  V+         + A+K I         S  +E   L+ I+H N++ +  I  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              +E      LV + +  G L D +      +E    +      +   V SA++YLH +
Sbjct: 75  ---YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 833 CQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL-DIASKTPSSSIGIKGTV 888
               +VH DLKP N+L    + +    + DFGL+K   N  +               GT 
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC-----------GTP 171

Query: 889 GYVAP 893
           GYVAP
Sbjct: 172 GYVAP 176

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 64/292 (21%), Positives = 106/292 (36%), Gaps = 30/292 (10%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLS-LKMIELSVGRNQISGTIPPGI-RNLVNLITFTLE 405
               +L L +N+          NL  L  + L    N+IS  I PG    LV L    L 
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI--NNKIS-KISPGAFAPLVKLERLYLS 108

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNI--P 462
            NQ    +P+ +   K LQ+L V  N +   +       L ++  ++LG+N L+ +    
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIEN 164

Query: 463 SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSL-VLDLSNNLLNGSLPLQV-GNLKNL 520
            +    + L     +   +T  +PQ L      SL  L L  N +   +       L NL
Sbjct: 165 GAFQGMKKLSYIRIADTNIT-TIPQGLPP----SLTELHLDGNKIT-KVDAASLKGLNNL 218

Query: 521 VMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSG 580
             L +S N  S V   +L+    L  L ++ N     +P      K I+ + + +NN+S 
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

Query: 581 ------KIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK---ISLHGN 623
                   P +    +    ++L  N  +        F        + L   
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 28/292 (9%)

Query: 345 SNCS-SLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
             C   L+V+  SD     ++P    +L      L +  N+I+  I  G  +NL NL T 
Sbjct: 27  FRCQCHLRVVQCSDLGLE-KVP---KDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTL 81

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSN---SLQG 459
            L  N+     P   + L  L++L +  N L+  +P  +     L  L +  N    ++ 
Sbjct: 82  ILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRK 138

Query: 460 NIPSSLGNCQNLILFIASYNKLT-GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLK 518
           ++ + L     + L     N L    +             + +++  +     +  G   
Sbjct: 139 SVFNGLNQMIVVEL---GTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPP 192

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           +L  L +  N+ + V   +L    +L  L +S NS   V   S      ++ L++++N L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 579 SGKIPEFLENLSFLEFLNLSYNYFE----GEVPVKGVFSNKTK---ISLHGN 623
             K+P  L +  +++ + L  N        +    G  + K     +SL  N
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 65/307 (21%), Positives = 112/307 (36%), Gaps = 45/307 (14%)

Query: 65  CQWTGVTCGHRH---------QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRG 115
           C    V C                  L+L + +I  +      NL  L  + L +N    
Sbjct: 31  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90

Query: 116 DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLK 174
             P     L +LE+L LS N     +P  + +   L       N++  ++ K +   L +
Sbjct: 91  ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGLNQ 146

Query: 175 LQRLSVDINYLT-GQLPDSV-GNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQ 232
           +  + +  N L    + +     +  +  IRI + ++   IP   GL   L  L++  N+
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203

Query: 233 FSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSN 292
                      I+ V                  L  L NL KLG+  N+       SL+N
Sbjct: 204 -----------ITKV--------------DAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238

Query: 293 ASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKV 352
             +L  L L +N+   KV    +  K + ++ L  NN+    +ND     + +  +S   
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297

Query: 353 LSLSDNQ 359
           +SL  N 
Sbjct: 298 VSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 58/318 (18%), Positives = 113/318 (35%), Gaps = 47/318 (14%)

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
           +C   +  C S+  LE ++PK++        L +  N +T        NL  +  + +  
Sbjct: 30  QCHLRVVQC-SDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFS----GMFPRSICNISSVELIFLTENRFSGIFP 262
           N +    P     L +L  L +++NQ       M         +++ + + EN  + +  
Sbjct: 86  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPK-------TLQELRVHENEITKVRK 138

Query: 263 FDILLNLPNLKKLGIGGNNFVGSI--PDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNL 320
             +   L  +  + +G N    S     +      L  + +         +I      +L
Sbjct: 139 -SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSL 194

Query: 321 WLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSV 380
             L+L+ N +    A  L         ++L  L LS N        S+AN    + EL +
Sbjct: 195 TELHLDGNKITKVDAASL------KGLNNLAKLGLSFNSISAVDNGSLANTP-HLRELHL 247

Query: 381 GRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG 440
             N++   +P G+ +   +    L  N         IS + +       N+F   G  + 
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNN--------ISAIGS-------NDFCPPGYNTK 291

Query: 441 LGNLTKLGSLDLGSNSLQ 458
             + + +    L SN +Q
Sbjct: 292 KASYSGV---SLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 63/358 (17%), Positives = 125/358 (34%), Gaps = 64/358 (17%)

Query: 102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL 161
            LR +  +D G    +P+++        L L NN  +     +     NL      NNK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 162 EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR 221
               P     L+KL+RL +  N L  +LP+ +     ++ +R+ EN +     +    L 
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145

Query: 222 RLVNLNVAENQFSGMF--PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           +++ + +  N          +   +  +  I + +   + I P  +    P+L +L + G
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP---PSLTELHLDG 201

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
           N        SL   +NL  L L  N      +   ++  +L  L+L  N L         
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG--- 258

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNL 399
               L++   ++V+ L +N                                         
Sbjct: 259 ----LADHKYIQVVYLHNNN---------------------------------------- 274

Query: 400 ITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR-GGIPSGL-GNLTKLGSLDLGSN 455
           I+  +  N F    P   ++  +   +S+F+N ++   I       +    ++ LG+ 
Sbjct: 275 IS-AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 22/184 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           ++G+G +G VY G    +++ +A+K I  +    S+    E    ++++H+N+++ +   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 772 SSTDFEGVDFKALVF-EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
           S            +F E +  GSL   L      ++  +   I        +   ++YLH
Sbjct: 89  SENG------FIKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLKYLH 139

Query: 831 HHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
            +    +VH D+K  NVL++ Y  V  + DFG +K L+     I   T +      GT+ 
Sbjct: 140 DNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA----GINPCTET----FTGTLQ 188

Query: 890 YVAP 893
           Y+AP
Sbjct: 189 YMAP 192

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.5 bits (248), Expect = 4e-22
 Identities = 43/202 (21%), Positives = 73/202 (36%), Gaps = 32/202 (15%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALR-NIRHRNLI 765
             S  ++G G  GTV          V AVK +           + E + L  +  H N+I
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPV-AVKRML---IDFCDIALMEIKLLTESDDHPNVI 72

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE-VRKLSLIQRMNIAIDVAS 824
           +              F  +  E     +L+D +   N   E ++       +++   +AS
Sbjct: 73  RYYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLD-------------YDMVAHVGDFGLAKFLSNHHL 871
            + +LH      ++H DLKP N+L+               ++   + DFGL K L +   
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 872 DIASKTPSSSIGIKGTVGYVAP 893
              +          GT G+ AP
Sbjct: 184 SFRTNLN----NPSGTSGWRAP 201

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 99.1 bits (247), Expect = 5e-22
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 10/236 (4%)

Query: 369 ANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLS 427
             +S     L++  NQI   I     ++L +L    L  N          + L NL  L 
Sbjct: 60  DGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE 118

Query: 428 VFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPSSL-GNCQNL-ILFIASYNKLTGD 484
           +F+N L   IP+G    L+KL  L L +N ++ +IPS       +L  L +    +L+  
Sbjct: 119 LFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYI 176

Query: 485 LPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSL 544
                  ++ L   L+L+   L   +P  +  L  L  LD+S N  S + P +    + L
Sbjct: 177 SEGAFEGLSNLR-YLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233

Query: 545 EYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
           + L +  +    +   +F  L+S+  +N++ NNL+    +    L  LE ++L +N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 96.4 bits (240), Expect = 4e-21
 Identities = 56/251 (22%), Positives = 104/251 (41%), Gaps = 21/251 (8%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           +P   G+      LN+ ENQ   +   S  ++  +E++ L+ N    I        L NL
Sbjct: 58  VPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTI-EIGAFNGLANL 114

Query: 273 KKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQN 328
             L +  N  + +IP  +    S L+ L L +N  +   SI    F+ + +L  L+L + 
Sbjct: 115 NTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGEL 170

Query: 329 NLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT 388
              +  +            S+L+ L+L+      E+P+ +  L  K+ EL +  N +S  
Sbjct: 171 KRLSYISEGA-----FEGLSNLRYLNLAMCNLR-EIPN-LTPLI-KLDELDLSGNHLS-A 221

Query: 389 IPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKL 447
           I PG  + L++L    +  +Q      +    L++L ++++ +N L          L  L
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281

Query: 448 GSLDLGSNSLQ 458
             + L  N   
Sbjct: 282 ERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.9 bits (218), Expect = 2e-18
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 17/238 (7%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEV 406
           ++ ++L+L +NQ      +S  +L   +  L + RN I  TI  G    L NL T  L  
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSN----SLQGNI 461
           N+           L  L++L + NN +   IPS     +  L  LDLG       +    
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 462 PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNL 520
              L N + L L   +   L  ++P  L  +  L   LDLS N L+ ++       L +L
Sbjct: 181 FEGLSNLRYLNL---AMCNLR-EIPN-LTPLIKLD-ELDLSGNHLS-AIRPGSFQGLMHL 233

Query: 521 VMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
             L +  +Q   +         SL  ++++ N+   +    F  L  ++ +++  N  
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 75.2 bits (185), Expect = 3e-14
 Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 23/262 (8%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLE 162
              +       R ++P  I        L L  N        +     +L     S N + 
Sbjct: 45  FSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 163 GQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPT-TLGLL 220
             I       L  L  L +  N LT     +   LS ++ + +  N +   IP+     +
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRI 159

Query: 221 RRLVNLNVAE-NQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
             L  L++ E  + S +   +   +S++  + L       I        L  L +L + G
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLT---PLIKLDELDLSG 216

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQNNLGTGTAN 336
           N+     P S     +L+ L +  +Q +    I+   F +L++L  +NL  NNL     +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQ---VIERNAFDNLQSLVEINLAHNNLTLLPHD 273

Query: 337 DLDFVIFLSNCSSLKVLSLSDN 358
                   +    L+ + L  N
Sbjct: 274 ------LFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 36/135 (26%), Positives = 57/135 (42%), Gaps = 5/135 (3%)

Query: 77  QRLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNN 135
             L  L+L   +    +S      LS LRY+NLA    R +IP  +  L +L++L LS N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217

Query: 136 SFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKE-IGNLLKLQRLSVDINYLTGQLPDSVG 194
             S   P +     +L       ++++  I +    NL  L  +++  N LT    D   
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276

Query: 195 NLSAIEVIRITENSL 209
            L  +E I +  N  
Sbjct: 277 PLHHLERIHLHHNPW 291

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.9 bits (244), Expect = 5e-22
 Identities = 57/236 (24%), Positives = 91/236 (38%), Gaps = 40/236 (16%)

Query: 673 ARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSS----SNMIGQGRFGTVYKGILGD 728
           A+K          +   +            A  EF       ++IG+G    V + +   
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 729 DEMVVAVKVINLKQKGASKSFV--------SECEALRNIR-HRNLIKIITICSSTDFEGV 779
                AVK++ +  +  S   +         E   LR +  H ++I +I       +E  
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESS 172

Query: 780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH 839
            F  LVF+ M  G L D+L       E   LS  +  +I   +  A+ +LH +    +VH
Sbjct: 173 SFMFLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223

Query: 840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGIKGTVGYVAP 893
            DLKP N+LLD +M   + DFG +  L       ++            GT GY+AP
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-----------GTPGYLAP 268

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 7e-22
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 21/187 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV-SECEALRNIR-HRNLIKIIT 769
           ++G+G    V   I        AVK+I  KQ G  +S V  E E L   + HRN++++I 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                 FE  D   LVFE M  GS+   +H+     E  + S++ +     DVASA+++L
Sbjct: 79  F-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-LEASVVVQ-----DVASALDFL 127

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           H+     + H DLKP N+L    +      + DF L   +  +       TP       G
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183

Query: 887 TVGYVAP 893
           +  Y+AP
Sbjct: 184 SAEYMAP 190

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 99.6 bits (248), Expect = 9e-22
 Identities = 78/463 (16%), Positives = 173/463 (37%), Gaps = 20/463 (4%)

Query: 127 LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYL 185
            + L+LS NS S     ++S  S L     S+N++   +   +      L+ L V  N L
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112

Query: 186 TGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNI 244
              +      ++++  + ++ N      +    G L +L  L ++  +F  +    + ++
Sbjct: 113 QN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169

Query: 245 SSVELIFLTENRFSGIFPFDIL--LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
               ++    +        + L   N   L  +    + F   +  S++   +L+L ++ 
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229

Query: 303 SNQFKGKVSIDFS--SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
            N    +  + F     +   LLN+   ++ T     +    F      ++ L++ +   
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP-RPVEYLNIYNLTI 288

Query: 361 GGEL---PHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDV 416
              +     + +  +LK + +   +NQ+       +      +    L ++         
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348

Query: 417 ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ--GNIPSSLGNCQNLILF 474
                +   L+   N     +  G   L +L +L L  N L+    +     N  +L   
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408

Query: 475 IASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI 534
             S N L      +  +     LVL+LS+N+L GS+   +     + +LD+ +N+    I
Sbjct: 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SI 465

Query: 535 PVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNN 577
           P  ++   +L+ L+++ N    V    F  L S++ + +  N 
Sbjct: 466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 96.5 bits (240), Expect = 7e-21
 Identities = 82/503 (16%), Positives = 150/503 (29%), Gaps = 88/503 (17%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALS 133
                L  L LS  RI  +          L Y++++ N  +  I      +  L  L LS
Sbjct: 73  SFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLS 129

Query: 134 NNSFSGTIPTN--LSRCSNLIHFCASNNKLEGQIPKEIGNL-LKLQRLSVDINYLTGQLP 190
            N F   +P        + L     S  K        + +L L    L +   ++ G   
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188

Query: 191 DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELI 250
           +S+   +   V+ +  +            +  L +L ++  + +    + +    S    
Sbjct: 189 ESLQIPN-TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTR 247

Query: 251 FLTENRFS---------GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN-----L 296
             T    +                      ++ L I        I       S      L
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307

Query: 297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS 356
            +  + +  F       +S    + +  L  ++           ++   + SS   L+ +
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI------HMVCPPSPSSFTFLNFT 361

Query: 357 DNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV 416
                                     N  + ++  G   L  L T  L+ N        V
Sbjct: 362 Q-------------------------NVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKV 395

Query: 417 ISELKNLQQLSVFNNFLRGGIPSGL-----GNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
               KN+  L   +  L   + S            +  L+L SN L G++          
Sbjct: 396 ALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC------- 447

Query: 472 ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
                        LP ++        VLDL NN +  S+P  V +L+ L  L+++SNQ  
Sbjct: 448 -------------LPPKV-------KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486

Query: 532 GVIPVTLSTCVSLEYLDISINSF 554
            V         SL+Y+ +  N +
Sbjct: 487 SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 91.5 bits (227), Expect = 3e-19
 Identities = 58/358 (16%), Positives = 111/358 (31%), Gaps = 23/358 (6%)

Query: 268 NLPNLKKLGIGGNNFVGSIPDSL-SNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE 326
            L  L+ L +  N    S+   +     +LE LD+  N+ +   +I    + +L  L+L 
Sbjct: 74  FLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ---NISCCPMASLRHLDLS 129

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
            N+      + L       N + L  L LS  +F       +A+L L  I L +    I 
Sbjct: 130 FNDF-----DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK 184

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTK 446
           G        + N     L  +        V   +  L  L + N  L       L     
Sbjct: 185 G-GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS 243

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLV-LDLSNNL 505
             +      ++      +   C   +                   +  L++  L ++  +
Sbjct: 244 ELTRGPTLLNVTLQHIETTWKCSVKLF-----------QFFWPRPVEYLNIYNLTITERI 292

Query: 506 LNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFL 565
                      LK+L++  + +  F        S    +    +SI+    +  +     
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP 352

Query: 566 KSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
            S   LN + N  +  + +    L  L+ L L  N  +    V  +  N + +     
Sbjct: 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 91.5 bits (227), Expect = 3e-19
 Identities = 86/485 (17%), Positives = 166/485 (34%), Gaps = 55/485 (11%)

Query: 157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSV-GNLSAIEVIRITENSLGGKIPT 215
           S N +      +I  L +L+ L +  N +   L   V      +E + ++ N L   I  
Sbjct: 60  SQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC 117

Query: 216 TLGLLRRLVNLNVAENQFSGM-FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKK 274
               +  L +L+++ N F  +   +   N++ +  + L+  +F  +     + +L     
Sbjct: 118 --CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCI 174

Query: 275 LGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGT 334
           L    +  +           N  +L L  +           S+  L  L L    L    
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234

Query: 335 ANDLD-FVIFLSNCSSLKVLSLSDNQFGGELPHSIANL-------SLKMIELSVGRNQIS 386
              L  F+  L+   +L  ++L   +   +    +           L +  L++      
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN---FLRGGIPSGLGN 443
                    L +L+   ++   F  +   + S    +    +  +   F+    P    +
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354

Query: 444 LTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSN 503
            T    L+   N    ++       + L   I   N L         +   ++L+     
Sbjct: 355 FT---FLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK--------NFFKVALMTK--- 400

Query: 504 NLLNGSLPLQVGNLKNLVMLDISSNQF-SGVIPVTLSTCVSLEYLDISINSFYGVIPLSF 562
                       N+ +L  LD+S N   S     T +   S+  L++S N         F
Sbjct: 401 ------------NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT---GSVF 445

Query: 563 RFL-KSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK---I 618
           R L   +K L++ +N +   IP+ + +L  L+ LN++ N  +  VP  GVF   T    I
Sbjct: 446 RCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDRLTSLQYI 502

Query: 619 SLHGN 623
            LH N
Sbjct: 503 WLHDN 507

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 37/200 (18%), Positives = 75/200 (37%), Gaps = 38/200 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-----------------ECEA 755
           + QG+F  +       D    A+K          + F                   E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKLSLI 813
           + +I++   +    I         D   +++EYMEN S+  +       D+     + + 
Sbjct: 97  ITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDI 873
               I   V ++  Y+H+     + H D+KPSN+L+D +    + DFG ++++ +  +  
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI-- 207

Query: 874 ASKTPSSSIGIKGTVGYVAP 893
             K        +GT  ++ P
Sbjct: 208 --KG------SRGTYEFMPP 219

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 61/264 (23%), Positives = 111/264 (42%), Gaps = 16/264 (6%)

Query: 345 SNCS-SLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
           S CS S   +  +       +P  I   S   +EL    N++  ++P G+   L  L   
Sbjct: 3   SRCSCSGTEIRCNSKGLT-SVPTGI-PSSATRLELE--SNKLQ-SLPHGVFDKLTQLTKL 57

Query: 403 TLEVNQ--FHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGN 460
           +L  N   F G          +L+ L +  N +   + S    L +L  LD   ++L+  
Sbjct: 58  SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 116

Query: 461 IPSSL-GNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLK 518
              S+  + +NLI    S+          + +  +   VL ++ N    +    +   L+
Sbjct: 117 SEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           NL  LD+S  Q   + P   ++  SL+ L++S N+F+ +    ++ L S++ L+ S N++
Sbjct: 176 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235

Query: 579 SGKIPE--FLENLSFLEFLNLSYN 600
                +       S L FLNL+ N
Sbjct: 236 M-TSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 56/254 (22%), Positives = 93/254 (36%), Gaps = 20/254 (7%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
           S+P  +   S+   L+L SN+ +      F  L  L  L+L  N L              
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSD---- 74

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFT 403
              +SLK L LS N     +  +   L  ++  L    + +       +  +L NLI   
Sbjct: 75  FGTTSLKYLDLSFNGVI-TMSSNFLGLE-QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132

Query: 404 LEVNQFHGTIPDVISELKNLQQLSV-FNNFLRGGIPSGLGNLTKLGSLDLGSN---SLQG 459
           +           + + L +L+ L +  N+F    +P     L  L  LDL       L  
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192

Query: 460 NIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV--GNL 517
              +SL + Q L +   S+N            + +L  VLD S N +  +   Q      
Sbjct: 193 TAFNSLSSLQVLNM---SHNNFFSLDTFPYKCLNSLQ-VLDYSLNHIM-TSKKQELQHFP 247

Query: 518 KNLVMLDISSNQFS 531
            +L  L+++ N F+
Sbjct: 248 SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 82.8 bits (205), Expect = 3e-17
 Identities = 58/269 (21%), Positives = 101/269 (37%), Gaps = 18/269 (6%)

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
            CS     C ++  L   +P  I       RL ++ N L          L+ +  + ++ 
Sbjct: 6   SCSGTEIRC-NSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61

Query: 207 NSLGGK--IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD 264
           N L  K     +      L  L+++ N    M   +   +  +E +    +    +  F 
Sbjct: 62  NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFS 120

Query: 265 ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWLL 323
           + L+L NL  L I   +   +     +  S+LE+L +  N F+     D F+ L+NL  L
Sbjct: 121 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN 383
           +L Q  L   +    +      + SSL+VL++S N F          L+  +  L    N
Sbjct: 181 DLSQCQLEQLSPTAFN------SLSSLQVLNMSHNNFFSLDTFPYKCLN-SLQVLDYSLN 233

Query: 384 QISGTIPPGI-RNLV-NLITFTLEVNQFH 410
            I  T      ++   +L    L  N F 
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 55/260 (21%), Positives = 99/260 (38%), Gaps = 31/260 (11%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNN--SFSGTIPTNLSRCSNLIHFCASNNK 160
              + L  N  +         L +L KL+LS+N  SF G    +    ++L +   S N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 161 LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLL 220
           +   +      L +L+ L    + L  Q+ +                       +    L
Sbjct: 90  VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE----------------------FSVFLSL 125

Query: 221 RRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGN 280
           R L+ L+++       F      +SS+E++ +  N F   F  DI   L NL  L +   
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185

Query: 281 NFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDF 340
                 P + ++ S+L++L++  N F    +  +  L +L +L+   N++ T        
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-----SKK 240

Query: 341 VIFLSNCSSLKVLSLSDNQF 360
                  SSL  L+L+ N F
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 35/192 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--------LKQKGASKSFVSECEALRNIRHRNL 764
           +G G  G V           VA+K+I+         ++   + +  +E E L+ + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           IKI     + D+       +V E ME G L D +      V  ++L           +  
Sbjct: 78  IKIKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLL 125

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L    +T    
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRT---- 175

Query: 882 IGIKGTVGYVAP 893
             + GT  Y+AP
Sbjct: 176 --LCGTPTYLAP 185

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 54/193 (27%), Positives = 82/193 (42%), Gaps = 37/193 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS---------ECEALRNIRHRN 763
           +G G  G V           VA+++I+ K+K A  S            E E L+ + H  
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           +IKI     + D+       +V E ME G L D +      V  ++L           + 
Sbjct: 202 IIKIKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQML 249

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            A++YLH +    ++H DLKP NVLL   + D +  + DFG +K L    L    +T   
Sbjct: 250 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRT--- 300

Query: 881 SIGIKGTVGYVAP 893
              + GT  Y+AP
Sbjct: 301 ---LCGTPTYLAP 310

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.9 bits (238), Expect = 4e-21
 Identities = 37/246 (15%), Positives = 71/246 (28%), Gaps = 37/246 (15%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
             + +    V TS      P    +EL +         ++GQ       +    +     
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106

Query: 734 AVKVINLKQKGAS---KSFVSECEALRNIR----------------------HRNLIKII 768
            V V    ++  S   K    E   LR +R                           K+I
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK-LSLIQRMNIAIDVASAIE 827
            +        V  +  ++  M+  +L+ +           K L    R+ + + V   + 
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
            LHH+    +VH  L+P +++LD      +  F             ++ +P         
Sbjct: 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGASAVSPIGR--GFAP 275

Query: 888 VGYVAP 893
               A 
Sbjct: 276 PETTAE 281

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 94.7 bits (235), Expect = 7e-21
 Identities = 34/211 (16%), Positives = 67/211 (31%), Gaps = 31/211 (14%)

Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQKGASKSFVSEC 753
           E    +      +++G+G F  VY+   GD     ++    +KV                
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 754 EALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           E L+       +K  +          +   LV E    G+L + ++   +  E + +   
Sbjct: 119 ERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPE-KVMPQG 172

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG-----------DFGL 862
             ++ A+ +   IE +H      ++HGD+KP N +L    +               D G 
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           +  +                    T G+   
Sbjct: 230 SIDMKLFPKGTIFTA------KCETSGFQCV 254

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 92.6 bits (231), Expect = 7e-21
 Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 22/157 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G F  VY+       + VA+K+I+   + + G  +   +E +    ++H +++++  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVASAI 826
                 FE  ++  LV E   NG +  +L        + E R    + ++       + +
Sbjct: 79  Y-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQI------ITGM 125

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            YLH H    ++H DL  SN+LL  +M   + DFGLA
Sbjct: 126 LYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.6 bits (231), Expect = 7e-21
 Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 34/189 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G F  V + +     +  A K+IN  +K +++       E    R ++H N++++  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                  +   F  LVF+ +  G L + +      V     S     +    +  +I Y 
Sbjct: 73  S-----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYC 121

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGI 884
           H +    +VH +LKP N+LL          + DFGLA  +++       A          
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------- 168

Query: 885 KGTVGYVAP 893
            GT GY++P
Sbjct: 169 -GTPGYLSP 176

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 94.7 bits (235), Expect = 8e-21
 Identities = 33/245 (13%), Positives = 70/245 (28%), Gaps = 40/245 (16%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
             + +    V TS      P    +EL +         ++GQ       +    +     
Sbjct: 42  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101

Query: 734 AVKVINLKQKGAS----------------KSFVSECEALRNIRHRNLIKIITICSS---- 773
            V V    ++  S                +   ++ +A  ++R      ++         
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161

Query: 774 ---TDFEGVDFKALVFEYM-ENGSLEDWLHQSNDQVEVRK-LSLIQRMNIAIDVASAIEY 828
               D   +   +  F Y     +L+ +           K L    R+ + + V   +  
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           LHH+    +VH  L+P +++LD      +  F          +               + 
Sbjct: 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------------SSVSR 266

Query: 889 GYVAP 893
           G+  P
Sbjct: 267 GFEPP 271

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 55/189 (29%), Positives = 80/189 (42%), Gaps = 34/189 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V K      +   AVKVIN K    +K   + + E E L+ + H N++K+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           I      E      +V E    G L D +      ++ ++ S      I   V S I Y+
Sbjct: 89  I-----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYM 137

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGI 884
           H H    +VH DLKP N+LL   + D    + DFGL+     +    D            
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---------- 184

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 185 -GTAYYIAP 192

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 51/292 (17%), Positives = 84/292 (28%), Gaps = 32/292 (10%)

Query: 322 LLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL--SLKMIELS 379
             +LE       T  DL     +    SLK L++   +    +      +     + EL+
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101

Query: 380 VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE------LKNLQQLSVFNNFL 433
           +   +++GT PP +          L +        D             L+ LS+     
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 434 RGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSIT 493
                  +     L +LDL  N   G        C                 P +  ++ 
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALC-----------------PLKFPTLQ 204

Query: 494 TLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTL-STCVSLEYLDISIN 552
            L+L  +      +G           L  LD+S N                L  L++S  
Sbjct: 205 VLAL-RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263

Query: 553 SFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEG 604
               V          +  L++S N L    P   E L  +  L+L  N F  
Sbjct: 264 GLKQVPKGLPA---KLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 41/279 (14%), Positives = 82/279 (29%), Gaps = 27/279 (9%)

Query: 98  GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSR---CSNLIHF 154
           G  S    +   D         +I     L++L +        I     R    S L   
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 155 CASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQ-LPDSVGNLS-----AIEVIRITENS 208
              N ++ G  P  +          +++  ++       +  L       ++V+ I +  
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 209 LGGKIPTTLGLLRRLVNLNVAENQFSGM--FPRSIC--NISSVELIFLTENRFSGIF--P 262
                   + +   L  L++++N   G      ++C     +++++ L            
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 263 FDILLNLPNLKKLGIGGNNFVGSIPDSL-SNASNLELLDLPSNQFKGKVSIDFSSLKNLW 321
             +      L+ L +  N+   +         S L  L+L     K    +       L 
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---QVPKGLPAKLS 277

Query: 322 LLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           +L+L  N         LD          +  LSL  N F
Sbjct: 278 VLDLSYNR--------LDRNPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.8 bits (194), Expect = 7e-16
 Identities = 65/294 (22%), Positives = 103/294 (35%), Gaps = 38/294 (12%)

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPG---IRNLVNL 399
                 SL+ L    +        +    SL +  L+V   +I   I  G   +  +  L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 400 ITFTLEVNQFHGTIPDVISEL--KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSL 457
              TLE  +  GT P  + E    +L  L++ N        + L  L +     L   S+
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW-ATRDAWLAELQQWLKPGLKVLSI 156

Query: 458 QGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL----- 512
                              +         +Q+     LS  LDLS+N   G   L     
Sbjct: 157 -------------------AQAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGLISALC 196

Query: 513 --QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIP-LSFRFLKSIK 569
             +   L+ L + +      SGV     +  V L+ LD+S NS        S  +   + 
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256

Query: 570 ALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
           +LN+S   L  ++P+ L   + L  L+LSYN  +   P          +SL GN
Sbjct: 257 SLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGN 306

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 54/280 (19%), Positives = 88/280 (31%), Gaps = 25/280 (8%)

Query: 170 GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR-----RLV 224
           G  L+     VD     GQ  D + +LS   + R+T  +         G LR      L 
Sbjct: 42  GRSLEYLLKRVDTEADLGQFTDIIKSLS---LKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 225 NLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNL-----PNLKKLGIGG 279
            L +   + +G  P  +   +  +L  L     S       L  L     P LK L I  
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFS----SLKNLWLLNLEQNNLGTGTA 335
            + +    + +     L  LDL  N   G+  +  +        L +L L    +     
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM---ET 215

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN 395
                    +    L+ L LS N           +   ++  L++    +   +P G+  
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272

Query: 396 LVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
              L    L  N+     P    EL  +  LS+  N    
Sbjct: 273 PAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 33/216 (15%), Positives = 68/216 (31%), Gaps = 28/216 (12%)

Query: 75  RHQRLTELNLSSQRIGGVLSPYVGNLSF----LRYINLADNGFRGDIPQEIGNLFRLEKL 130
               L  LNL +       +       +    L+ +++A         +++     L  L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178

Query: 131 ALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP 190
            LS+N   G      + C                 P +   L  L   +  +   +G   
Sbjct: 179 DLSDNPELGERGLISALC-----------------PLKFPTLQVLALRNAGMETPSGVCS 221

Query: 191 DSVGNLSAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFSGMFPRSICNISSVEL 249
                   ++ + ++ NSL       +     +L +LN++      +        + + +
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---GLPAKLSV 278

Query: 250 IFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS 285
           + L+ NR            LP +  L + GN F+ S
Sbjct: 279 LDLSYNRLDRN---PSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 35/185 (18%), Positives = 62/185 (33%), Gaps = 13/185 (7%)

Query: 59  NNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIP 118
            +      W           L  L+++           V     L  ++L+DN   G+  
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 119 QEI----GNLFRLEKLALSNN---SFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN 171
                       L+ LAL N    + SG      +    L     S+N L         +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 172 LL-KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE 230
              +L  L++    L  Q+P   G  + + V+ ++ N L    P+    L ++ NL++  
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKG 305

Query: 231 NQFSG 235
           N F  
Sbjct: 306 NPFLD 310

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 92.9 bits (231), Expect = 2e-20
 Identities = 53/222 (23%), Positives = 80/222 (36%), Gaps = 27/222 (12%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
           R    T  +      EKL P+    E  +     +    +G+G FG V++          
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDY--EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86

Query: 734 AVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF-EYMENG 792
           AVK + L+        V E  A   +    ++ +                 +F E +E G
Sbjct: 87  AVKKVRLE-----VFRVEELVACAGLSSPRIVPLY------GAVREGPWVNIFMELLEGG 135

Query: 793 SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD 852
           SL   + Q         L   + +         +EYLH      ++HGD+K  NVLL  D
Sbjct: 136 SLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186

Query: 853 -MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
              A + DFG A  L    L  +  T      I GT  ++AP
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTETHMAP 225

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 27/187 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
           +G G FG V+        +   +K IN  + +   +   +E E L+++ H N+IKI  + 
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
               FE      +V E  E G L + +  +  + +   LS      +   + +A+ Y H 
Sbjct: 89  ----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142

Query: 832 HCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGIKG 886
                +VH DLKP N+L           + DFGLA+   +     + A           G
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----------G 188

Query: 887 TVGYVAP 893
           T  Y+AP
Sbjct: 189 TALYMAP 195

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 55/299 (18%), Positives = 107/299 (35%), Gaps = 33/299 (11%)

Query: 243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
            +++   I   ++  +         +L  +  L   G   V +I   +   +NL  L+L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTG-VTTIE-GVQYLNNLIGLELK 71

Query: 303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG 362
            NQ    ++    +L  +  L L  N L          V  ++   S+K L L+  Q   
Sbjct: 72  DNQIT-DLA-PLKNLTKITELELSGNPLKN--------VSAIAGLQSIKTLDLTSTQI-- 119

Query: 363 ELPHSIANLSL--KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL 420
                +  L+    +  L +  NQI+      +  L NL   ++   Q     P  ++ L
Sbjct: 120 ---TDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANL 172

Query: 421 KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK 480
             L  L   +N +     S L +L  L  + L +N +     S L N  NL +   +   
Sbjct: 173 SKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQT 228

Query: 481 LTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLS 539
           +T        ++   ++V   S   +    P  + +       +++ N  S +  V+ +
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNLTSFINNVSYT 284

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 90.1 bits (224), Expect = 9e-20
 Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 28/292 (9%)

Query: 290 LSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSS 349
               +N   +    +     V+   + L  +  L+     + T        +  +   ++
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--------IEGVQYLNN 64

Query: 350 LKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQF 409
           L  L L DNQ     P  + NL+ K+ EL +  N +       I  L ++ T  L   Q 
Sbjct: 65  LIGLELKDNQITDLAP--LKNLT-KITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQI 119

Query: 410 HGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQ 469
               P  ++ L NLQ L +  N +     S L  LT L  L +G+  +  ++ + L N  
Sbjct: 120 TDVTP--LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS-DL-TPLANLS 173

Query: 470 NLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQ 529
            L    A  NK++ D+   L S+  L   + L NN ++   PL   N  NL ++ +++  
Sbjct: 174 KLTTLKADDNKIS-DISP-LASLPNLI-EVHLKNNQISDVSPL--ANTSNLFIVTLTNQT 228

Query: 530 FSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
            +       +  V    +     +   + P +     +  + N++ N  S  
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 74/329 (22%), Positives = 132/329 (40%), Gaps = 34/329 (10%)

Query: 255 NRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID- 313
              + IFP      L N  K+  G +N   ++    ++   +  L           +I+ 
Sbjct: 7   TAINVIFP---DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT---TIEG 58

Query: 314 FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL 373
              L NL  L L+ N +          +  L N + +  L LS N    +   +IA L  
Sbjct: 59  VQYLNNLIGLELKDNQITD--------LAPLKNLTKITELELSGNPL--KNVSAIAGLQ- 107

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
            +  L +   QI+   P  +  L NL    L++NQ     P  ++ L NLQ LS+ N  +
Sbjct: 108 SIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV 163

Query: 434 RGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSIT 493
                + L NL+KL +L    N +  +I S L +  NLI      N+++ D+   L + +
Sbjct: 164 SD--LTPLANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVS-PLANTS 217

Query: 494 TLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINS 553
            L  ++ L+N  +         NL       +     + + P T+S   +    +++ N 
Sbjct: 218 NLF-IVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNL 274

Query: 554 FYGVIPLSFRFLKSIKALNVSSNNLSGKI 582
              +  +S+ F +S+   N +    SG +
Sbjct: 275 TSFINNVSYTFNQSVTFKNTTV-PFSGTV 302

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 40/205 (19%), Positives = 77/205 (37%), Gaps = 32/205 (15%)

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP--QQLLSITTLS 496
                L     +  G +++      +  +   +    A    +T  +   Q L ++  L 
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLE 69

Query: 497 L------------------VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTL 538
           L                   L+LS N L     +    L+++  LD++S Q + V P  L
Sbjct: 70  LKDNQITDLAPLKNLTKITELELSGNPLKNVSAI--AGLQSIKTLDLTSTQITDVTP--L 125

Query: 539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLS 598
           +   +L+ L + +N    + PL+   L +++ L++ +  +S  +   L NLS L  L   
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKAD 181

Query: 599 YNYFEGEVPVKGVFSNKTKISLHGN 623
            N      P+     N  ++ L  N
Sbjct: 182 DNKISDISPLAS-LPNLIEVHLKNN 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 56/261 (21%), Positives = 106/261 (40%), Gaps = 49/261 (18%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
            L+    I    +     + Q   +L  +  L+      + TI   +   +NLI     +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           N++    P  + NL K+  L +  N L         N+SA                  + 
Sbjct: 73  NQITDLAP--LKNLTKITELELSGNPLK--------NVSA------------------IA 104

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
            L+ +  L++   Q + + P  +  +S++++++L  N+ + I P      L NL+ L IG
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIG 159

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL 338
               V  +   L+N S L  L    N+    +S   +SL NL  ++L+ N +        
Sbjct: 160 NAQ-VSDL-TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISD------ 209

Query: 339 DFVIFLSNCSSLKVLSLSDNQ 359
             V  L+N S+L +++L++  
Sbjct: 210 --VSPLANTSNLFIVTLTNQT 228

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 50/245 (20%), Positives = 98/245 (40%), Gaps = 19/245 (7%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           L  L L   +I  +    + NL+ +  + L+ N  + ++   I  L  ++ L L++   +
Sbjct: 65  LIGLELKDNQITDL--APLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT 120

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
               T L+  SNL       N++    P  +  L  LQ LS+    ++      + NLS 
Sbjct: 121 DV--TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LTPLANLSK 174

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           +  ++  +N +   I   L  L  L+ +++  NQ S + P  + N S++ ++ LT    +
Sbjct: 175 LTTLKADDNKI-SDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQ--FKGKVSIDFSS 316
                 +  N   +    + G +     P ++S+       +L  N   F   VS  F+ 
Sbjct: 231 NQ---PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287

Query: 317 LKNLW 321
                
Sbjct: 288 SVTFK 292

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 55/291 (18%), Positives = 97/291 (33%), Gaps = 33/291 (11%)

Query: 270 PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLE 326
             +K L +  N         L    NL+ L L SN      +I+   FSSL +L  L+L 
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN---TIEEDSFSSLGSLEHLDLS 108

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
            N L       L    F    SSL  L+L  N +      S+ +   K+  L VG     
Sbjct: 109 YNYLSN-----LSSSWF-KPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162

Query: 387 GTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNL 444
             I       L  L    ++ +      P  +  ++N+  L +        +        
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVT 221

Query: 445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN 504
           + +  L+L    L                    +++L+      L+   T    + +++ 
Sbjct: 222 SSVECLELRDTDLDTF----------------HFSELSTGETNSLIKKFTFRN-VKITDE 264

Query: 505 LLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY 555
            L   +   +  +  L+ L+ S NQ   V         SL+ + +  N + 
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 56/284 (19%), Positives = 115/284 (40%), Gaps = 12/284 (4%)

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
            S+ S + +IP+ L+    +     SNN++      ++   + LQ L +  N +     D
Sbjct: 38  GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED 94

Query: 192 SVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI-CNISSVELI 250
           S  +L ++E + ++ N L     +    L  L  LN+  N +  +   S+  +++ ++++
Sbjct: 95  SFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154

Query: 251 FLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV 310
            +                L  L++L I  ++     P SL +  N+  L L   Q    +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214

Query: 311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF--LSNCSSLKVLSLSDNQFGGELPHSI 368
            I      ++  L L   +L T   ++L       L    + + + ++D     ++   +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLL 273

Query: 369 ANL-SLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFH 410
             +  L  +E S  RNQ+  ++P GI   L +L    L  N + 
Sbjct: 274 NQISGLLELEFS--RNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 43/288 (14%), Positives = 93/288 (32%), Gaps = 41/288 (14%)

Query: 347 CSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLE 405
           C    +   S       +P   + L+  +  L +  N+I+  I     +  VNL    L 
Sbjct: 30  CDRNGICKGSSGSLN-SIP---SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLT 84

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSLQGNIPSS 464
            N  +    D  S L +L+ L +  N+L   + S     L+ L  L+L  N  +    +S
Sbjct: 85  SNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETS 143

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVML 523
           L                          +T L ++   + +     +  +    L  L  L
Sbjct: 144 L-----------------------FSHLTKLQILRVGNMDTF-TKIQRKDFAGLTFLEEL 179

Query: 524 DISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP 583
           +I ++      P +L +  ++ +L + +     ++ +      S++ L +   +L     
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239

Query: 584 EFLENLSF--------LEFLNLSYNYFEGEVPVKGVFSNKTKISLHGN 623
             L                + ++       + +    S   ++    N
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 16/264 (6%)

Query: 79  LTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNS 136
           +  L+LS+ RI   +S         L+ + L  NG    I ++   +L  LE L LS N 
Sbjct: 54  VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 137 FSGTIPTNL-SRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSV- 193
            S  + ++     S+L       N  +      +  +L KLQ L V       ++     
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 194 GNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT 253
             L+ +E + I  + L    P +L  ++ + +L +   Q   +    +   SSVE + L 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 254 ENRFSGI-------FPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
           +                + L+     + + I   +    +   L+  S L  L+   NQ 
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNL 330
           K      F  L +L  + L  N  
Sbjct: 290 KSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 30/208 (14%), Positives = 68/208 (32%), Gaps = 22/208 (10%)

Query: 78  RLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNN 135
            LT LNL       +    +  +L+ L+ + + +      I ++    L  LE+L +  +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184

Query: 136 SFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSVG 194
                 P +L    N+ H      +    + +        ++ L +    L         
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT------- 236

Query: 195 NLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTE 254
                       + L      +L       N+ + +        + +  IS +  +  + 
Sbjct: 237 ---------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286

Query: 255 NRFSGIFPFDILLNLPNLKKLGIGGNNF 282
           N+   + P  I   L +L+K+ +  N +
Sbjct: 287 NQLKSV-PDGIFDRLTSLQKIWLHTNPW 313

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 48/186 (25%), Positives = 66/186 (35%), Gaps = 30/186 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G +G V   +     +  A K I          F  E E ++++ H N+I++     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE      LV E    G L + +      V  R         I  DV SA+ Y H  
Sbjct: 75  ---FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 833 CQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGIKGT 887
               + H DLKP N L      D    + DFGLA       +                GT
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV-----------GT 171

Query: 888 VGYVAP 893
             YV+P
Sbjct: 172 PYYVSP 177

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.4 bits (227), Expect = 6e-20
 Identities = 45/222 (20%), Positives = 76/222 (34%), Gaps = 53/222 (23%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ-----KGASKSFVSECEALRNIRHRNLIKI 767
           IGQG +G V   I      + A+K++N  +         +   +E   ++ + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM----------- 816
             +     +E   +  LV E    G L D L+   D    +    + +            
Sbjct: 94  YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 817 -----------------------NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
                                  NI   + SA+ YLH+     + H D+KP N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 854 VAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
              +   DFGL+K     +               GT  +VAP
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMT----TKAGTPYFVAP 243

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.9 bits (226), Expect = 9e-20
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 41/225 (18%)

Query: 680 HKSVDTSPMEKLFPMVSYAELSKATSEFS-----SSNMIGQGRFGTVYKGILGDDEMVVA 734
           H    +S +E LF               +     S  ++G G  G V +          A
Sbjct: 4   HHHHHSSGLEVLF-----QGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA 58

Query: 735 VKVINLKQKGASKSFVSECEAL-RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGS 793
           +K++      A +    E +   +     +++ I+ +  +          ++ E ME G 
Sbjct: 59  LKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGE 112

Query: 794 LEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-- 849
           L   + +  DQ   E R+ + I R     D+ +AI++LH H    + H D+KP N+L   
Sbjct: 113 LFSRIQERGDQAFTE-REAAEIMR-----DIGTAIQFLHSHN---IAHRDVKPENLLYTS 163

Query: 850 -DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            + D V  + DFG AK  + + L    +TP        T  YVAP
Sbjct: 164 KEKDAVLKLTDFGFAKETTQNAL----QTPC------YTPYYVAP 198

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 90.7 bits (225), Expect = 9e-20
 Identities = 47/250 (18%), Positives = 85/250 (34%), Gaps = 63/250 (25%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNI 759
           S+  ++F     +G+G FG V++     D+   A+K I L  +  + +  + E +AL  +
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 760 R----------------------------------------------------HRNLIKI 767
                                                                       
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
            T+          +  +  +     +L+DW+++     +         ++I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC---LHIFIQIAEAVE 178

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK-- 885
           +LH      ++H DLKPSN+    D V  VGDFGL   +     +    TP  +      
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235

Query: 886 --GTVGYVAP 893
             GT  Y++P
Sbjct: 236 QVGTKLYMSP 245

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.8 bits (226), Expect = 9e-20
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 699 ELSKATSEFSS----SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE 754
           +L + + +F+        IG G +    + I     M  AVK+I+  ++  ++    E E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67

Query: 755 AL-RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
            L R  +H N+I +  +     ++   +  +V E M+ G L D + +     E R+ S +
Sbjct: 68  ILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAV 121

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-----DYDMVAHVGDFGLAKFLSN 868
                   +   +EYLH      +VH DLKPSN+L      + + +  + DFG AK L  
Sbjct: 122 LF-----TITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR-ICDFGFAKQLRA 172

Query: 869 HHLDIASKTPSSSIGIKGTVGYVAP 893
              +    TP        T  +VAP
Sbjct: 173 E--NGLLMTPC------YTANFVAP 189

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 27/186 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKI 767
             +G+G+FG VY       + ++A+KV+    L++ G       E E   ++RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
                   F       L+ EY   G++   L       ++ K    +      ++A+A+ 
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALS 123

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           Y H      ++H D+KP N+LL       + DFG +    +               + GT
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----D------LCGT 170

Query: 888 VGYVAP 893
           + Y+ P
Sbjct: 171 LDYLPP 176

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 43/193 (22%), Positives = 78/193 (40%), Gaps = 34/193 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           IG+G F  V + I  +     AVK+++   K  S   +S      E      ++H ++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV---RKLSLIQRMNIAIDVA 823
           ++       +       +VFE+M+   L   + +  D   V      S   R      + 
Sbjct: 91  LLET-----YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-----QIL 140

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            A+ Y H +    ++H D+KP  VLL   +      +G FG+A  L         ++   
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--------GESGLV 189

Query: 881 SIGIKGTVGYVAP 893
           + G  GT  ++AP
Sbjct: 190 AGGRVGTPHFMAP 202

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 1e-19
 Identities = 64/334 (19%), Positives = 129/334 (38%), Gaps = 45/334 (13%)

Query: 314 FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL 373
             +       NL++ ++           +  +  +S+  +  +++        S+  +  
Sbjct: 17  DDAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDI-----KSVQGIQY 63

Query: 374 --KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV--ISELKNLQQLSVF 429
              + +L +  N+++  I P + NL NL    L+ N+    I D+  + +LK L+ LS+ 
Sbjct: 64  LPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENK----IKDLSSLKDLKKLKSLSLE 117

Query: 430 NNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQL 489
           +N +     +GL +L +L SL LG+N +     + L     L       N+++ D+   L
Sbjct: 118 HNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-L 171

Query: 490 LSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDI 549
             +T L   L LS N ++    L    LKNL +L++ S +         S  V    +  
Sbjct: 172 AGLTKLQ-NLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228

Query: 550 SINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK 609
           +  S      +S          +    N+   +PEF   +SF+ +  ++          K
Sbjct: 229 TDGSLVTPEIISDDG-------DYEKPNVKWHLPEFTNEVSFIFYQPVTIG------KAK 275

Query: 610 GVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGS 643
             F  +    L     +   +D   + +    G+
Sbjct: 276 ARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGT 309

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.1 bits (189), Expect = 1e-14
 Identities = 52/289 (17%), Positives = 111/289 (38%), Gaps = 27/289 (9%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           + E    S  I   + P     +     NL        + Q    L  ++++  +N+   
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
            ++   +    N+     + NKL   I K + NL  L  L +D N +   L  S+ +L  
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
           ++ + +  N +       L  L +L +L +  N+ + +    +  ++ ++ + L +N+ S
Sbjct: 111 LKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 166

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
            I P      L  L+ L +  N+ +  +  +L+   NL++L+L S +   K     S+L 
Sbjct: 167 DIVPLA---GLTKLQNLYLSKNH-ISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHS 367
               +     +L T           +S+    +  ++  +        S
Sbjct: 222 VPNTVKNTDGSLVT--------PEIISDDGDYEKPNVKWHLPEFTNEVS 262

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 43/189 (22%), Positives = 77/189 (40%), Gaps = 34/189 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G+G F  V + +     +  A K+IN  +K +++       E    R ++H N++++  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                  +   F  LVF+ +  G L + +      V     S     +    +  +I Y 
Sbjct: 96  S-----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYC 144

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGI 884
           H +    +VH +LKP N+LL          + DFGLA  +++       A          
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------- 191

Query: 885 KGTVGYVAP 893
            GT GY++P
Sbjct: 192 -GTPGYLSP 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 54/215 (25%), Positives = 79/215 (36%), Gaps = 6/215 (2%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKL 447
            +P GI          L  N+            +NL  L + +N L     +    L  L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 448 GSLDLGSNSLQGNIPSS-LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
             LDL  N+   ++  +       L         L  +L   L         L L +N L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 507 NGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFL 565
             +LP     +L NL  L +  N+ S V         SL+ L +  N    V P +FR L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 566 KSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
             +  L + +NNLS    E L  L  L++L L+ N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 49/252 (19%), Positives = 81/252 (32%), Gaps = 45/252 (17%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           +P   G+      + +  N+ S +   S     ++ +++L  N  + I        L  L
Sbjct: 26  VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI-DAAAFTGLALL 82

Query: 273 KKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQN 328
           ++L +  N  + S+   +      L  L L     +    +    F  L  L  L L+ N
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDN 139

Query: 329 NLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT 388
            L       L    F  +  +L  L L  N+                            +
Sbjct: 140 AL-----QALPDDTF-RDLGNLTHLFLHGNRIS--------------------------S 167

Query: 389 IPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTK 446
           +P    R L +L    L  N+     P    +L  L  L +F N L   +P+  L  L  
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRA 226

Query: 447 LGSLDLGSNSLQ 458
           L  L L  N   
Sbjct: 227 LQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 42/236 (17%), Positives = 78/236 (33%), Gaps = 35/236 (14%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEV 406
           ++ + + L  N+       S       +  L +  N ++  I       L  L    L  
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89

Query: 407 NQFHGTIP-DVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPS- 463
           N    ++       L  L  L +    L+  +  G    L  L  L L  N+LQ  +P  
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDD 147

Query: 464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVM 522
           +  +  NL                           L L  N ++ S+P +    L +L  
Sbjct: 148 TFRDLGNL-------------------------THLFLHGNRIS-SVPERAFRGLHSLDR 181

Query: 523 LDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           L +  N+ + V P        L  L +  N+   +   +   L++++ L ++ N  
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 43/229 (18%), Positives = 81/229 (35%), Gaps = 11/229 (4%)

Query: 133 SNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS 192
                   +P  +   +         N++             L  L +  N L      +
Sbjct: 19  PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 193 VGNLSAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF 251
              L+ +E + +++N+    +   T   L RL  L++       + P     +++++ ++
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS 311
           L +N    + P D   +L NL  L + GN        +     +L+ L L  N+      
Sbjct: 136 LQDNALQAL-PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 312 IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
             F  L  L  L L  NNL       L      +   +L+ L L+DN +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSA-----LPTEAL-APLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 42/208 (20%), Positives = 76/208 (36%), Gaps = 6/208 (2%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              + L   RI  V +        L  + L  N            L  LE+L LS+N+  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 139 GTIPTN-LSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSV-GN 195
            ++          L         L+ ++   +   L  LQ L +  N L   LPD    +
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151

Query: 196 LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN 255
           L  +  + +  N +          L  L  L + +N+ + + P +  ++  +  ++L  N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFV 283
             S + P + L  L  L+ L +  N +V
Sbjct: 212 NLSAL-PTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 47.7 bits (114), Expect = 8e-06
 Identities = 30/136 (22%), Positives = 56/136 (41%), Gaps = 6/136 (4%)

Query: 77  QRLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSN 134
            RL  L+L    +   L P +   L+ L+Y+ L DN  +  +P +   +L  L  L L  
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162

Query: 135 NSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSV 193
           N  S           +L       N++   +      +L +L  L +  N L+    +++
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221

Query: 194 GNLSAIEVIRITENSL 209
             L A++ +R+ +N  
Sbjct: 222 APLRALQYLRLNDNPW 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 28/192 (14%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLI 765
             S + ++G GRFG V+K       + +A K+I  +     +   +E   +  + H NLI
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           ++        FE  +   LV EY++ G L D +   +  +      L  +      +   
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ-----ICEG 199

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           I ++H      ++H DLKP N+L    D   +  + DFGLA+             P   +
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIK-IIDFGLARRYK----------PREKL 245

Query: 883 GIK-GTVGYVAP 893
            +  GT  ++AP
Sbjct: 246 KVNFGTPEFLAP 257

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 34/189 (17%)

Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVINLKQKGAS-----KSFVSECEALRNIRHRNL 764
           +G G   TVY     IL      VA+K   +           K F  E      + H+N 
Sbjct: 19  LGGGGMSTVYLAEDTILNIK---VAIKA--IFIPPREKEETLKRFEREVHNSSQLSHQN- 72

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
             I+++    + +   +  LV EY+E  +L +++           LS+   +N    +  
Sbjct: 73  --IVSMIDVDEEDDCYY--LVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILD 122

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            I++ H      +VH D+KP N+L+D +    + DFG+AK LS       S T ++   +
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-----TSLTQTNH--V 172

Query: 885 KGTVGYVAP 893
            GTV Y +P
Sbjct: 173 LGTVQYFSP 181

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.8 bits (226), Expect = 3e-19
 Identities = 39/187 (20%), Positives = 70/187 (37%), Gaps = 29/187 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G F  V + +        A  +IN K+      +    E    R ++H N++++   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                        L+F+ +  G L + +      V     S     +    +  A+ + H
Sbjct: 79  -----ISEEGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127

Query: 831 HHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI-GIKG 886
                 +VH +LKP N+LL          + DFGLA  +         +    +  G  G
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV---------EGEQQAWFGFAG 175

Query: 887 TVGYVAP 893
           T GY++P
Sbjct: 176 TPGYLSP 182

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 41/184 (22%), Positives = 79/184 (42%), Gaps = 27/184 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G+FG VY      ++ ++A+KV+    L+++G       E E   ++RH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                 F       L+ E+   G L   L       +  +    +      ++A A+ Y 
Sbjct: 82  Y-----FHDRKRIYLMLEFAPRGELYKEL------QKHGRFDEQRSATFMEELADALHYC 130

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H      ++H D+KP N+L+ Y     + DFG +    +       +T      + GT+ 
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RT------MCGTLD 177

Query: 890 YVAP 893
           Y+ P
Sbjct: 178 YLPP 181

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 42/215 (19%), Positives = 85/215 (39%), Gaps = 44/215 (20%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRN 758
           S+ T+EF     IG G FG+V+K +   D  + A+K       G+   ++ + E  A   
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 759 I-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN 817
           + +H ++++  +      +   D   +  EY   GSL D + ++   +   K + +   +
Sbjct: 67  LGQHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL--KD 119

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV-------------------G 858
           + + V   + Y+H      +VH D+KPSN+ +    + +                    G
Sbjct: 120 LLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           D G    +S+  +             +G   ++A 
Sbjct: 177 DLGHVTRISSPQV------------EEGDSRFLAN 199

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 41/168 (24%), Positives = 80/168 (47%), Gaps = 14/168 (8%)

Query: 703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRH 761
           ++S+F     +G G + TVYKG+     + VA+K + L  + G   + + E   ++ ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 762 RNLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            N++++  +  + +          LVFE+M+N  L+ ++         R L L       
Sbjct: 63  ENIVRLYDVIHTENKLT-------LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
             +   + + H +    ++H DLKP N+L++      +GDFGLA+   
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.8 bits (223), Expect = 4e-19
 Identities = 40/183 (21%), Positives = 71/183 (38%), Gaps = 24/183 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG V++ +      V   K IN        +  +E   +  + H  LI +     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE      L+ E++  G L D +   + ++   ++    R          ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-----QACEGLKHMHEH 168

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
               +VH D+KP N++ +    + V   DFGLA  L+   +    K          T  +
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKV------TTATAEF 216

Query: 891 VAP 893
            AP
Sbjct: 217 AAP 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 39/190 (20%), Positives = 78/190 (41%), Gaps = 34/190 (17%)

Query: 712 MIGQGRFGTVYKG---ILGDDEMVVAVKVINLKQKGAS-KSFVS----ECEALRNIRHRN 763
           ++G+G  G VY+    +       VA+K+  + +  +S   F +    E      ++  +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERI---VALKL--MSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
              ++ I    + +G  +  +    +    L   L +         L+  + + I   + 
Sbjct: 96  ---VVPIHDFGEIDGQLY--VDMRLINGVDLAAMLRRQ------GPLAPPRAVAIVRQIG 144

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
           SA++  H        H D+KP N+L+  D  A++ DFG+A   ++  L     T   +  
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGN-- 194

Query: 884 IKGTVGYVAP 893
             GT+ Y+AP
Sbjct: 195 TVGTLYYMAP 204

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.7 bits (225), Expect = 6e-19
 Identities = 41/223 (18%), Positives = 79/223 (35%), Gaps = 26/223 (11%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
               S + +      ++ +P     +       +     +G G FG V++          
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185

Query: 734 AVKVINLKQKGASKSFV-SECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG 792
           A K +      + K  V  E + +  +RH  L+ +        FE  +   +++E+M  G
Sbjct: 186 AAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGG 239

Query: 793 SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD 852
            L + +   ++++   +     R      V   + ++H +     VH DLKP N++    
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMR-----QVCKGLCHMHEN---NYVHLDLKPENIMFTTK 291

Query: 853 MVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
               +   DFGL   L       + K         GT  + AP
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ---SVKV------TTGTAEFAAP 325

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.4 bits (217), Expect = 7e-19
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 16/185 (8%)

Query: 688 MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK 747
           M +    + +   S    ++    +IG G    V        +  VA+K INL++   S 
Sbjct: 1   MSEDSSALPW---SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM 57

Query: 748 SFVS-ECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE 806
             +  E +A+    H N++      S   F   D   LV + +  GS+ D +     + E
Sbjct: 58  DELLKEIQAMSQCHHPNIVSY--YTS---FVVKDELWLVMKLLSGGSVLDIIKHIVAKGE 112

Query: 807 VRKLSLIQRMNIAI---DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            +   L +   IA    +V   +EYLH + Q   +H D+K  N+LL  D    + DFG++
Sbjct: 113 HKSGVLDEST-IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168

Query: 864 KFLSN 868
            FL+ 
Sbjct: 169 AFLAT 173

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.8 bits (223), Expect = 7e-19
 Identities = 53/187 (28%), Positives = 79/187 (42%), Gaps = 29/187 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G+G FG V            AVKVI+   +KQK   +S + E + L+ + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                 FE   +  LV E    G L D +      +  ++ S +    I   V S I Y+
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGELFDEI------ISRKRFSEVDAARIIRQVLSGITYM 142

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           H +    +VH DLKP N+LL     D    + DFGL+            +         G
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---------EASKKMKDKIG 190

Query: 887 TVGYVAP 893
           T  Y+AP
Sbjct: 191 TAYYIAP 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 33/187 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITIC 771
           +G+G F    K +        AVK+I+ + +  ++    E  AL+    H N++K+  + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV- 74

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
               F       LV E +  G L + + +     E  + S I R      + SA+ ++H 
Sbjct: 75  ----FHDQLHTFLVMELLNGGELFERIKKKKHFSE-TEASYIMR-----KLVSAVSHMHD 124

Query: 832 HCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFL--SNHHLDIASKTPSSSIGIKG 886
                +VH DLKP N+L    + ++   + DFG A+     N  L    KTP        
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL----KTPC------F 171

Query: 887 TVGYVAP 893
           T+ Y AP
Sbjct: 172 TLHYAAP 178

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 38/190 (20%), Positives = 80/190 (42%), Gaps = 28/190 (14%)

Query: 712 MIGQGRFGTVYKG---ILGDDEMVVAVKVINLKQKGAS-KSFVS----ECEALRNIRHRN 763
           ++G G    V+         D   VAVKV  L+   A   SF      E +    + H  
Sbjct: 19  ILGFGGMSEVHLARDLRDHRD---VAVKV--LRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++ +       +        +V EY++  +L D +H          ++  + + +  D  
Sbjct: 74  IVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADAC 126

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
            A+ + H +    ++H D+KP+N+++       V DFG+A+ +++     +  + + +  
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD-----SGNSVTQTAA 178

Query: 884 IKGTVGYVAP 893
           + GT  Y++P
Sbjct: 179 VIGTAQYLSP 188

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 88.2 bits (219), Expect = 3e-18
 Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 30/189 (15%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKII 768
            M+G+G FG V K      +   AVKVIN        + + + E E L+ + H N++K+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            I      E      +V E    G L D +      ++ ++ S      I   V S I Y
Sbjct: 88  EI-----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITY 136

Query: 829 LHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI-GI 884
           +H H    +VH DLKP N+LL   + D    + DFGL+               ++ +   
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----------QNTKMKDR 183

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 184 IGTAYYIAP 192

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 28/195 (14%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRH 761
           +  +     +G G +G V         +  A+K+I        ++   + E   L+ + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++K+        FE      LV E  + G L D +      +   K + +    I   
Sbjct: 96  PNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQ 144

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           V S + YLH H    +VH DLKP N+LL   + D +  + DFGL+            +  
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---------ENQ 192

Query: 879 SSSIGIKGTVGYVAP 893
                  GT  Y+AP
Sbjct: 193 KKMKERLGTAYYIAP 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 49/193 (25%), Positives = 73/193 (37%), Gaps = 37/193 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV------SECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAH-----VGDFGLAKFLSNHHLDIASKTPSSS 881
            YLH      + H DLKP N++L  D         + DFGLA  +               
Sbjct: 129 NYLHTKK---IAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIE----------DGVE 174

Query: 882 I-GIKGTVGYVAP 893
              I GT  +VAP
Sbjct: 175 FKNIFGTPEFVAP 187

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 86.8 bits (215), Expect = 4e-18
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 17/188 (9%)

Query: 687 PMEKLFPMVSYAELSKATSEFSSSNM-IGQGRFGTVYKGILGD--DEMVVAVKVINLKQK 743
            M+  F +   +E  +    F      +G+G +G VYK    D  D+   A+K I  +  
Sbjct: 2   KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGT 59

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN--GSLEDWLHQS 801
           G S S   E   LR ++H N+I +  +  S     V    L+F+Y E+    +  +   S
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKV---WLLFDYAEHDLWHIIKFHRAS 116

Query: 802 NDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH----V 857
               +  +L      ++   +   I YLH +    ++H DLKP+N+L+  +        +
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173

Query: 858 GDFGLAKF 865
            D G A+ 
Sbjct: 174 ADMGFARL 181

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.1 bits (214), Expect = 4e-18
 Identities = 45/185 (24%), Positives = 86/185 (46%), Gaps = 19/185 (10%)

Query: 688 MEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GA 745
           M K +  V      +  S++     IGQG FG V+K         VA+K + ++ +  G 
Sbjct: 1   MAKQYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

Query: 746 SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA---LVFEYMEN--GSLEDWLHQ 800
             + + E + L+ ++H N++ +I IC +        K    LVF++ E+    L   +  
Sbjct: 60  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119

Query: 801 SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF 860
                E++++ +   +       + + Y+H +    ++H D+K +NVL+  D V  + DF
Sbjct: 120 KFTLSEIKRV-MQMLL-------NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168

Query: 861 GLAKF 865
           GLA+ 
Sbjct: 169 GLARA 173

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.9 bits (213), Expect = 5e-18
 Identities = 49/193 (25%), Positives = 73/193 (37%), Gaps = 37/193 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV------SECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  +Q  AS+  V       E   LR + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L       +   LS  +  +    +   +
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAH-----VGDFGLAKFLSNHHLDIASKTPSSS 881
            YLH      + H DLKP N++L  D         + DFGLA  +               
Sbjct: 129 NYLHTKK---IAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIE----------DGVE 174

Query: 882 I-GIKGTVGYVAP 893
              I GT  +VAP
Sbjct: 175 FKNIFGTPEFVAP 187

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 35/184 (19%), Positives = 74/184 (40%), Gaps = 27/184 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G+G FG V++ +    +     K +   +         E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES-- 69

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE ++   ++FE++    + + ++ S  ++  R++           V  A+++LH H
Sbjct: 70  ---FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-----QVCEALQFLHSH 121

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIK-GTVG 889
               + H D++P N++      + +   +FG A+ L           P  +  +      
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----------KPGDNFRLLFTAPE 168

Query: 890 YVAP 893
           Y AP
Sbjct: 169 YYAP 172

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNL 764
            +   + +G+G + TVYKG     + +VA+K I L+ + GA  + + E   L++++H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 765 IKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIA 819
           + +  I  +            LVFEY++   L+ +L       +   V+   L Q +   
Sbjct: 63  VTLHDIIHTEKSLT-------LVFEYLDK-DLKQYLDDCGNIINMHNVKLF-LFQLL--- 110

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
                 + Y H      ++H DLKP N+L++      + DFGLA+  S
Sbjct: 111 ----RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 48/187 (25%), Positives = 75/187 (40%), Gaps = 33/187 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           IG+G F  V           VA+K+I+   L      K F  E   ++ + H N++K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 770 ICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           +  +    +       L+ EY   G + D+L      V   ++   +  +    + SA++
Sbjct: 82  VIETEKTLY-------LIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQ 128

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL-AKFLSNHHLDIASKTPSSSIGIKG 886
           Y H      +VH DLK  N+LLD DM   + DFG   +F     LD     P        
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP------- 178

Query: 887 TVGYVAP 893
              Y AP
Sbjct: 179 ---YAAP 182

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 26/189 (13%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K   +++    IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLH 799
              +  ++E   +R  ++ N++          +           +V EY+  GSL D + 
Sbjct: 59  PKKELIINEILVMRENKNPNIVN---------YLDSYLVGDELWVVMEYLAGGSLTDVVT 109

Query: 800 QSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD 859
           +         +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + D
Sbjct: 110 E-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159

Query: 860 FGLAKFLSN 868
           FG    ++ 
Sbjct: 160 FGFCAQITP 168

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 51/186 (27%), Positives = 75/186 (40%), Gaps = 32/186 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G+G    VY+      +   A+KV+        K   +E   L  + H N+IK+  I  
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI-- 116

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE     +LV E +  G L D +      VE    S     +    +  A+ YLH +
Sbjct: 117 ---FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHEN 167

Query: 833 CQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSSSIGIKGT 887
               +VH DLKP N+L      D    + DFGL+K + +  L   +            GT
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----------GT 213

Query: 888 VGYVAP 893
            GY AP
Sbjct: 214 PGYCAP 219

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.5 bits (210), Expect = 7e-18
 Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 22/176 (12%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINL-KQKGASKSF-------VSE 752
           S ATS +     IG G +GTVYK         VA+K + +    G            V+ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 753 CEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMEN---GSLEDWLHQSNDQVEVRK 809
              L    H N+++++ +C+++  +      LVFE+++      L+           ++ 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124

Query: 810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
           L + Q +         +++LH +C   +VH DLKP N+L+       + DFGLA+ 
Sbjct: 125 L-MRQFL-------RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 43/187 (22%), Positives = 73/187 (39%), Gaps = 31/187 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNIRHRNLIKIIT-I 770
           +G+G +G V   +    E  VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKL--SLIQRMNIAIDVASAI 826
                        L  EY   G L D +       + + ++    L+          + +
Sbjct: 75  REGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGV 118

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            YLH      + H D+KP N+LLD      + DFGLA     ++ +             G
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------G 169

Query: 887 TVGYVAP 893
           T+ YVAP
Sbjct: 170 TLPYVAP 176

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.8 bits (208), Expect = 7e-18
 Identities = 50/192 (26%), Positives = 74/192 (38%), Gaps = 35/192 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS------ECEALRNIRHRNLIK 766
           +G G+F  V K          A K I  ++  +S+  VS      E   LR IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  I     FE      L+ E +  G L D+L       E   L+  +       +   +
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGV 121

Query: 827 EYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
            YLH      + H DLKP N++L      +    + DFG+A  +             +  
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----------AGNEF 168

Query: 883 -GIKGTVGYVAP 893
             I GT  +VAP
Sbjct: 169 KNIFGTPEFVAP 180

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.2 bits (209), Expect = 8e-18
 Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 27/188 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVS-ECEALRNIRHRNLIK-- 766
           +G+G +G V + +  +     AVK++    L++    ++ V  E + LR +RH+N+I+  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 767 -IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++               +V EY   G  E  +    D V  ++  + Q       +   
Sbjct: 73  DVLYNEEKQKM------YMVMEYCVCGMQE--ML---DSVPEKRFPVCQAHGYFCQLIDG 121

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +EYLH      +VH D+KP N+LL       +   G+A+ L     D   +T        
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ------ 172

Query: 886 GTVGYVAP 893
           G+  +  P
Sbjct: 173 GSPAFQPP 180

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.1 bits (211), Expect = 9e-18
 Identities = 47/188 (25%), Positives = 72/188 (38%), Gaps = 36/188 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC- 771
           IG G FG          + +VAVK I  +     ++   E    R++RH N+++   +  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKL--SLIQRMNIAIDVASAIE 827
           + T        A++ EY   G L + +       + E R     L+          S + 
Sbjct: 87  TPTHL------AIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVS 130

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAH--VGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           Y H      + H DLK  N LLD        + DFG +K    H        P S++   
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------PKSTV--- 178

Query: 886 GTVGYVAP 893
           GT  Y+AP
Sbjct: 179 GTPAYIAP 186

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 37/193 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV------SECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  ++  +S+  V       E   L+ I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L       E   L+  +       + + +
Sbjct: 79  LHEV-----YENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGV 127

Query: 827 EYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGDFGLAKFLSNHHL--DIASKTPSS 880
            YLH      + H DLKP N++L           + DFGLA  +   +   +I       
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF------ 178

Query: 881 SIGIKGTVGYVAP 893
                GT  +VAP
Sbjct: 179 -----GTPEFVAP 186

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 85.5 bits (212), Expect = 2e-17
 Identities = 51/197 (25%), Positives = 79/197 (40%), Gaps = 39/197 (19%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ-------------KGASKSFVSECEALRNI 759
           +G G +G V      +     A+KVI   Q             +   +   +E   L+++
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H N+IK+  +     FE   +  LV E+ E G L + +      +   K       NI 
Sbjct: 104 DHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI------INRHKFDECDAANIM 152

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASK 876
             + S I YLH H    +VH D+KP N+LL   +  +   + DFGL+ F S         
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK------DY 203

Query: 877 TPSSSIGIKGTVGYVAP 893
                +   GT  Y+AP
Sbjct: 204 KLRDRL---GTAYYIAP 217

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 58/187 (31%), Positives = 86/187 (45%), Gaps = 32/187 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNLIKII 768
           +G G FG V  G        VAVK++N +QK  S   V     E + L+  RH ++IK+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 769 T-ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
             I + TDF       +V EY+  G L D++       +  ++  ++   +   + SA++
Sbjct: 78  QVISTPTDF------FMVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVD 125

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL-AKFLSNHHLDIASKTPSSSIGIKG 886
           Y H H    +VH DLKP NVLLD  M A + DFGL         L  +  +P+       
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN------- 175

Query: 887 TVGYVAP 893
              Y AP
Sbjct: 176 ---YAAP 179

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 43/186 (23%), Positives = 75/186 (40%), Gaps = 29/186 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-ECEALRNIRHRNLIKIITIC 771
           +G+G +G V   +    E  VAVK++++K+       +  E    + + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKL--SLIQRMNIAIDVASAIE 827
              + +      L  EY   G L D +       + + ++    L+          + + 
Sbjct: 75  REGNIQ-----YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGVV 119

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
           YLH      + H D+KP N+LLD      + DFGLA     ++ +             GT
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------GT 170

Query: 888 VGYVAP 893
           + YVAP
Sbjct: 171 LPYVAP 176

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 39/199 (19%), Positives = 75/199 (37%), Gaps = 26/199 (13%)

Query: 674 RKRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVV 733
                +           L  +V   +         S   IG+G  G V           V
Sbjct: 17  NLYFQSGVVTHEQFKAALRMVVDQGDPRL---LLDSYVKIGEGSTGIVCLAREKHSGRQV 73

Query: 734 AVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYM 789
           AVK+++L+++   +   +E   +R+ +H N+++                     ++ E++
Sbjct: 74  AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEELWVLMEFL 124

Query: 790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL 849
           + G+L D + Q        +L+  Q   +   V  A+ YLH      ++H D+K  ++LL
Sbjct: 125 QGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174

Query: 850 DYDMVAHVGDFGLAKFLSN 868
             D    + DFG    +S 
Sbjct: 175 TLDGRVKLSDFGFCAQISK 193

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 37/199 (18%)

Query: 676 RRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAV 735
               H S     +     M  Y +L K          +G+G +G VYK        +VA+
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEK----------VGEGTYGVVYKAKDSQGR-IVAL 50

Query: 736 KVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTD--FEGVDFKALVFEYMEN 791
           K I L  +  G   + + E   L+ + H N++ +I +  S            LVFE+ME 
Sbjct: 51  KRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT-------LVFEFMEK 103

Query: 792 GSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848
             L+  L ++       +++   L Q +         + + H H    ++H DLKP N+L
Sbjct: 104 -DLKKVLDENKTGLQDSQIKIY-LYQLL-------RGVAHCHQHR---ILHRDLKPQNLL 151

Query: 849 LDYDMVAHVGDFGLAKFLS 867
           ++ D    + DFGLA+   
Sbjct: 152 INSDGALKLADFGLARAFG 170

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 34/169 (20%), Positives = 69/169 (40%), Gaps = 21/169 (12%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN 763
              +     +G G FG VYK    +   + A KVI  K +   + ++ E E L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           ++K           G  +      ++ E+   G+++  + + +  +   ++ ++ R    
Sbjct: 78  IVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR---- 124

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             +  A+ +LH      ++H DLK  NVL+  +    + DFG++     
Sbjct: 125 -QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.0 bits (205), Expect = 4e-17
 Identities = 45/246 (18%), Positives = 85/246 (34%), Gaps = 14/246 (5%)

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
           IP+   L R  + L     +   +   +      +E I +++N    +   D+  NLP L
Sbjct: 24  IPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 273 KKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLG 331
            ++ I   N +  I  ++  N  NL+ L + +   K    +         LL+++ N   
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 332 TGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPP 391
                +     F+       +L L+ N        +     L  + LS   N +   +P 
Sbjct: 142 HTIERNS----FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS-DNNNLE-ELPN 195

Query: 392 GI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSL 450
            +       +   +   + H      +  LK L+  S +N      +P+ L  L  L   
Sbjct: 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LPT-LEKLVALMEA 251

Query: 451 DLGSNS 456
            L   S
Sbjct: 252 SLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 38/217 (17%), Positives = 74/217 (34%), Gaps = 7/217 (3%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTK 446
            IP  +    N I     + +         S   +L+++ +  N +   I +    NL K
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 447 LGSLDL-GSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNL 505
           L  + +  +N+L    P +  N  NL   + S   +   LP      +   ++LD+ +N+
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139

Query: 506 LNGSLPLQV--GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR 563
              ++      G     V+L ++ N    +     +     E      N+   +    F 
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 564 FLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
                  L++S   +       LENL  L   +    
Sbjct: 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 236

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 45/232 (19%), Positives = 66/232 (28%), Gaps = 19/232 (8%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP----TNLSRCSNLIHFCASN 158
              +       R            LEK+ +S N     I     +NL +   +       
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI--EKA 89

Query: 159 NKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLPDSV-GNLSAIEVIRITENSLGGKIPTT 216
           N L   I  E   NL  LQ L +    +   LPD    +     ++ I +N     I   
Sbjct: 90  NNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147

Query: 217 L--GLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKK 274
              GL    V L + +N    +   +       EL     N    + P D+         
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL-PNDVFHGASGPVI 206

Query: 275 LGIGGNNFVGSIPD-SLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNL 325
           L I       S+P   L N   L      +     K       L  L   +L
Sbjct: 207 LDISRTRIH-SLPSYGLENLKKLRARSTYNL----KKLPTLEKLVALMEASL 253

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 44/202 (21%), Positives = 81/202 (40%), Gaps = 33/202 (16%)

Query: 675 KRRSTHKSVDTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVA 734
               T ++    P             + +   +     +G+G +G VYK I       VA
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPS---ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA 63

Query: 735 VKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTD--FEGVDFKALVFEYME 790
           +K I L+ +  G   + + E   L+ ++HRN+I++ ++               L+FEY E
Sbjct: 64  IKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH-------LIFEYAE 116

Query: 791 NGSLEDWLHQSN--DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848
           N  L+ ++ ++       ++   L Q       + + + + H       +H DLKP N+L
Sbjct: 117 N-DLKKYMDKNPDVSMRVIKSF-LYQ-------LINGVNFCHSRR---CLHRDLKPQNLL 164

Query: 849 LDYDMVAHVG-----DFGLAKF 865
           L     +        DFGLA+ 
Sbjct: 165 LSVSDASETPVLKIGDFGLARA 186

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 47/194 (24%), Positives = 73/194 (37%), Gaps = 40/194 (20%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS---------ECEALRNIRHRN 763
           +G G FG V+  +  +    V VK I  K+K     ++          E   L  + H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGS-LEDWL--HQSNDQVEVRKLSLIQRMNIAI 820
           +IK++ I     FE   F  LV E   +G  L  ++  H   D+     +   Q      
Sbjct: 91  IIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI-FRQ------ 138

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL-AKFLSNHHLDIASKTPS 879
            + SA+ YL       ++H D+K  N+++  D    + DFG  A                
Sbjct: 139 -LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---- 190

Query: 880 SSIGIKGTVGYVAP 893
                 GT+ Y AP
Sbjct: 191 ------GTIEYCAP 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 26/162 (16%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKII 768
             IG+G +GTV+K    +   +VA+K + L     G   S + E   L+ ++H+N++++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 769 TICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVA 823
            +  S            LVFE+ +   L+ +    N   D   V+   L Q +       
Sbjct: 68  DVLHSDKKLT-------LVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF-LFQLL------- 111

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
             + + H      ++H DLKP N+L++ +    + +FGLA+ 
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA 150

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 81.8 bits (203), Expect = 5e-17
 Identities = 39/161 (24%), Positives = 72/161 (44%), Gaps = 25/161 (15%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKII 768
             IG+G +G VYK        VVA+K I L  +  G   + + E   L+ + H N++K++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68

Query: 769 TICSSTD--FEGVDFKALVFEYMEN---GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
            +  + +  +       LVFE++       ++           ++   L Q +       
Sbjct: 69  DVIHTENKLY-------LVFEFLHQDLKKFMDASALTGIPLPLIKSY-LFQLL------- 113

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
             + + H H    ++H DLKP N+L++ +    + DFGLA+
Sbjct: 114 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 21/158 (13%), Positives = 46/158 (29%), Gaps = 27/158 (17%)

Query: 713 IGQGRFGTVYKGILGDDEM---VVAVKVINLKQKGASKS---FVSECEALRNIRHRNLIK 766
            G       ++ +   D      VA+  ++ +           +S    L  I    + +
Sbjct: 39  HGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 767 IITICSSTDF-EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           ++      D         +V E++  GSL++              S +  +     +A+A
Sbjct: 96  VL------DVVHTRAGGLVVAEWIRGGSLQEVAD--------TSPSPVGAIRAMQSLAAA 141

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
            +  H      +      PS V +  D    +      
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 8e-17
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 22/160 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           +G+G +G V K    D   +VA+K        K   K  + E + L+ +RH NL+ ++ +
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVASAIE 827
           C     +   +  LVFE++++ ++ D L       D   V+K  L Q +N        I 
Sbjct: 93  CKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKY-LFQIIN-------GIG 138

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + H H    ++H D+KP N+L+    V  + DFG A+ L+
Sbjct: 139 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 53/210 (25%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN----LKQKGASKSFVS----------------- 751
           IG+G +G V      +D    A+KV++    ++Q G  +                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 752 -----ECEALRNIRHRNLIKIIT-ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV 805
                E   L+ + H N++K++  +    +    D   +VFE +  G + +         
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNE----DHLYMVFELVNQGPVME-------VP 129

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
            ++ LS  Q      D+   IEYLH+     ++H D+KPSN+L+  D    + DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 866 L--SNHHLDIASKTPSSSIGIKGTVGYVAP 893
              S+  L     TP+          ++AP
Sbjct: 187 FKGSDALLSNTVGTPA----------FMAP 206

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 42/188 (22%), Positives = 82/188 (43%), Gaps = 23/188 (12%)

Query: 685 TSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG 744
             P  +L  +   +   +    F     +G+G +G+VYK I  +   +VA+K + ++   
Sbjct: 9   NPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD- 67

Query: 745 ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQ 800
             +  + E   ++     +++K         + G  FK     +V EY   GS+ D +  
Sbjct: 68  -LQEIIKEISIMQQCDSPHVVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117

Query: 801 SNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF 860
            N  +   +++ I +          +EYLH       +H D+K  N+LL+ +  A + DF
Sbjct: 118 RNKTLTEDEIATILQ-----STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADF 169

Query: 861 GLAKFLSN 868
           G+A  L++
Sbjct: 170 GVAGQLTD 177

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 17/180 (9%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
           ++P  L    +  +L L  N               L  LNL++  L     +        
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG------- 74

Query: 345 SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFT 403
                L  L LS NQ    LP     L   +  L V  N+++ ++P G  R L  L    
Sbjct: 75  -TLPVLGTLDLSHNQL-QSLPLLGQTLP-ALTVLDVSFNRLT-SLPLGALRGLGELQELY 130

Query: 404 LEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSLQGNIP 462
           L+ N+     P +++    L++LS+ NN L   +P+GL   L  L +L L  NSL   IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 41/189 (21%), Positives = 70/189 (37%), Gaps = 16/189 (8%)

Query: 245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN 304
               ++ L+EN          L+    L +L +     +  +         L  LDL  N
Sbjct: 31  KDTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAE-LTKLQ-VDGTLPVLGTLDLSHN 87

Query: 305 QFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL 364
           Q +  + +   +L  L +L++  N L +     L           L+ L L  N+    L
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR------GLGELQELYLKGNELK-TL 139

Query: 365 PHSI-ANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKN 422
           P  +      K+ +LS+  N ++  +P G+   L NL T  L+ N  + TIP        
Sbjct: 140 PPGLLTPTP-KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196

Query: 423 LQQLSVFNN 431
           L    +  N
Sbjct: 197 LPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 52/191 (27%), Positives = 76/191 (39%), Gaps = 14/191 (7%)

Query: 437 IPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP--QQLLSITT 494
           +P  L        L L  N L     ++L     L        +LT  L     L  + T
Sbjct: 25  LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGT 81

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
               LDLS+N L  SLPL    L  L +LD+S N+ + +    L     L+ L +  N  
Sbjct: 82  ----LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136

Query: 555 YGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSN 614
             + P        ++ L++++NNL+      L  L  L+ L L  N     +P KG F +
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFGS 194

Query: 615 K--TKISLHGN 623
                  LHGN
Sbjct: 195 HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 46/229 (20%), Positives = 74/229 (32%), Gaps = 38/229 (16%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
             E+N   + +  +             ++L++N         +    RL +L L     +
Sbjct: 12  HLEVNCDKRNLTALPP---DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSV-GNLS 197
             +         L     S+N+L+  +P     L  L  L V  N LT  LP      L 
Sbjct: 69  -KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLG 124

Query: 198 AIEVIRITENSLGGKIPTTL--GLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN 255
            ++ + +  N L      TL  GLL     L                     E + L  N
Sbjct: 125 ELQELYLKGNEL-----KTLPPGLLTPTPKL---------------------EKLSLANN 158

Query: 256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN 304
             + + P  +L  L NL  L +  N+   +IP     +  L    L  N
Sbjct: 159 NLTEL-PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 43/151 (28%), Positives = 63/151 (41%), Gaps = 14/151 (9%)

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
               LT  LP  L   TT   +L LS NLL       +     L  L++   + +  + V
Sbjct: 18  DKRNLT-ALPPDLPKDTT---ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV 72

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE-FLENLSFLEFL 595
              T   L  LD+S N     +PL  + L ++  L+VS N L+  +P   L  L  L+ L
Sbjct: 73  -DGTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL 129

Query: 596 NLSYNYFEGEVPVKGVF---SNKTKISLHGN 623
            L  N  +  +P  G+        K+SL  N
Sbjct: 130 YLKGNELK-TLPP-GLLTPTPKLEKLSLANN 158

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 45/170 (26%), Positives = 70/170 (41%), Gaps = 24/170 (14%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKS-FVSECEALRNIRHR 762
              F+    IG+G FG V+KGI    + VVA+K+I+L++          E   L      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 763 NLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
            + K         + G   K     ++ EY+  GS  D L           L   Q   I
Sbjct: 81  YVTK---------YYGSYLKDTKLWIIMEYLGGGSALDLLEP-------GPLDETQIATI 124

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             ++   ++YLH       +H D+K +NVLL       + DFG+A  L++
Sbjct: 125 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 16/170 (9%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHR 762
              F    ++G G +G VYKG       + A+KV+++      +    E   L+    HR
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHR 81

Query: 763 NLIKIITICSSTDFEGVDFKA-LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI- 820
           N+          +  G+D +  LV E+   GS+ D +  +        L       IA  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEW---IAYI 134

Query: 821 --DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
             ++   + +LH H    ++H D+K  NVLL  +    + DFG++  L  
Sbjct: 135 CREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 20/173 (11%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQK--GASKSFVSECEALR 757
            +A  ++     IG+G +G V+K   L +    VA+K + ++    G   S + E   LR
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 758 NIR---HRNLIKIITICSSTDFEGVDFKALVFEYMEN---GSLEDWLHQSNDQVEVRKLS 811
           ++    H N++++  +C+ +  +      LVFE+++      L+           ++ + 
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 125

Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + Q +         +++LH H    +VH DLKP N+L+       + DFGLA+
Sbjct: 126 MFQLL-------RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 59/192 (30%), Positives = 86/192 (44%), Gaps = 42/192 (21%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNLIKII 768
           +G G FG V  G        VAVK++N +QK  S   V     E + L+  RH ++IK+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 769 TICSSTD--FEGVDFKALVFEYMENGSLEDWL--HQSNDQVEVRKL--SLIQRMNIAIDV 822
            + S+    F       +V EY+  G L D++  +   D+ E R+L   ++         
Sbjct: 83  QVISTPSDIF-------MVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL--------- 126

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL-AKFLSNHHLDIASKTPSSS 881
            S ++Y H H    +VH DLKP NVLLD  M A + DFGL         L  +  +P+  
Sbjct: 127 -SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-- 180

Query: 882 IGIKGTVGYVAP 893
                   Y AP
Sbjct: 181 --------YAAP 184

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 33/221 (14%), Positives = 68/221 (30%), Gaps = 46/221 (20%)

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL- 373
           S+ K      L Q++    T   ++         SL  ++L++          +  +   
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMN---------SLTYITLANINV-----TDLTGIEYA 65

Query: 374 -KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF 432
             + +L++     +   P  I  L NL    +            +S L +L  L + ++ 
Sbjct: 66  HNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123

Query: 433 LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSI 492
               I + +  L K+ S+DL  N    +I   L     L                     
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK-------------------- 162

Query: 493 TTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV 533
                 L++  + ++    ++  +   L  L   S    G 
Sbjct: 163 -----SLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 35/183 (19%), Positives = 65/183 (35%), Gaps = 14/183 (7%)

Query: 443 NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLP--QQLLSITTLSLVLD 500
                 +  LG +S      + + +   + L   +   +T DL   +   +I  L     
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITL---ANINVT-DLTGIEYAHNIKDL----T 72

Query: 501 LSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPL 560
           ++N       P+    L NL  L I     +      LS   SL  LDIS ++    I  
Sbjct: 73  INNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 561 SFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISL 620
               L  + ++++S N     I   L+ L  L+ LN+ ++       ++  F    ++  
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIED-FPKLNQLYA 188

Query: 621 HGN 623
              
Sbjct: 189 FSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 31/172 (18%), Positives = 63/172 (36%), Gaps = 15/172 (8%)

Query: 216 TLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKL 275
           T   +  L  + +A    + +    I    +++ + +     +   P      L NL++L
Sbjct: 39  TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPIS---GLSNLERL 93

Query: 276 GIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTA 335
            I G +       +LS  ++L LLD+  +     +    ++L  +  ++L  N   T   
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT--- 150

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISG 387
            D+     L     LK L++  +         I +   K+ +L      I G
Sbjct: 151 -DIM---PLKTLPELKSLNIQFDGVHDYRG--IEDFP-KLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 23/157 (14%), Positives = 56/157 (35%), Gaps = 7/157 (4%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           LT + L++  +  +    +     ++ + + +     +    I  L  LE+L +     +
Sbjct: 46  LTYITLANINVTDL--TGIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVT 101

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                NLS  ++L     S++  +  I  +I  L K+  + +  N     +   +  L  
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPE 160

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           ++ + I  + +       +    +L  L        G
Sbjct: 161 LKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 27/161 (16%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKII 768
             IG+G +G VYK      E   A+K I L+++  G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 769 TICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVA 823
            +  +            LVFE+++   L+  L       + V  +   L+Q +       
Sbjct: 67  DVIHTKKRLV-------LVFEHLDQ-DLKKLLDVCEGGLESVTAKSF-LLQLL------- 110

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK 864
           + I Y H      ++H DLKP N+L++ +    + DFGLA+
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 45/187 (24%), Positives = 78/187 (41%), Gaps = 30/187 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITIC 771
           +G G  G V +      +   A+K++      A +    E E      +  ++++I+ + 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIEYL 829
               + G     +V E ++ G L   +    DQ   E R+ S I +      +  AI+YL
Sbjct: 125 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMK-----SIGEAIQYL 177

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           H      + H D+KP N+L      + +  + DFG AK  ++H+   +  TP        
Sbjct: 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPC------Y 225

Query: 887 TVGYVAP 893
           T  YVAP
Sbjct: 226 TPYYVAP 232

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 29/177 (16%)

Query: 699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-----EC 753
           ++      +   + +G+G+F TVYK    +   +VA+K I L  +  +K  ++     E 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 754 EALRNIRHRNLIKIITICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVR 808
           + L+ + H N+I ++                 LVF++ME   LE  +  ++       ++
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNIS-------LVFDFMET-DLEVIIKDNSLVLTPSHIK 115

Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
              ++            +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK 
Sbjct: 116 AY-MLM-------TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +G V+K    D   +VA+K     +      K  + E   L+ ++H NL+ ++ +
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 771 CSSTD--FEGVDFKALVFEYMENGSLEDWLHQSN---DQVEVRKLSLIQRMNIAIDVASA 825
                          LVFEY ++ ++   L +      +  V+ +   Q          A
Sbjct: 71  FRRKRRLH-------LVFEYCDH-TVLHELDRYQRGVPEHLVKSI-TWQ-------TLQA 114

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS 867
           + + H H     +H D+KP N+L+    V  + DFG A+ L+
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 40/190 (21%), Positives = 73/190 (38%), Gaps = 33/190 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR-NLIKIIT 769
           +G+G+F  V + I        A K +  +++G       + E   L   +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIE 827
           +     +E      L+ EY   G +         ++  E   + LI+       +   + 
Sbjct: 97  V-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK------QILEGVY 145

Query: 828 YLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI-G 883
           YLH +    +VH DLKP N+LL          + DFG+++ +            +  +  
Sbjct: 146 YLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG----------HACELRE 192

Query: 884 IKGTVGYVAP 893
           I GT  Y+AP
Sbjct: 193 IMGTPEYLAP 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.8 bits (197), Expect = 7e-16
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 16/168 (9%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN 763
              ++ + +IG G FG VY+  L D   +VA+K +   ++  ++    E + +R + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 764 LIKII-TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK--LSLIQRMNIAI 820
           ++++     SS + +   +  LV +Y+     E  +++        K  L +I       
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFLS 867
            +  ++ Y+H      + H D+KP N+LLD D  V  + DFG AK L 
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 45/199 (22%), Positives = 75/199 (37%), Gaps = 30/199 (15%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
             S M       +     K    F    M GQG FGTV  G      M VA+K +    +
Sbjct: 2   PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD--FKALVFEYMENGSLEDWLHQS 801
             ++  +   + L  + H N++++ +   +         +  +V EY+     +  LH+ 
Sbjct: 62  FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRC 115

Query: 802 NDQVEVRKLSL-----------IQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD 850
                 R+++            + R         +I  LH      + H D+KP NVL++
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIR---------SIGCLHLPSV-NVCHRDIKPHNVLVN 165

Query: 851 Y-DMVAHVGDFGLAKFLSN 868
             D    + DFG AK LS 
Sbjct: 166 EADGTLKLCDFGSAKKLSP 184

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 79.2 bits (195), Expect = 1e-15
 Identities = 37/169 (21%), Positives = 62/169 (36%), Gaps = 32/169 (18%)

Query: 713 IGQGR--FGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNLIK 766
           IG+G     TV           V V+ INL+    S   V+    E    +   H N++ 
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMN---IAI--- 820
                +   F   +   +V  +M  GS +D +              +  MN   IA    
Sbjct: 91  Y--RAT---FIADNELWVVTSFMAYGSAKDLI----------CTHFMDGMNELAIAYILQ 135

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            V  A++Y+HH      VH  +K S++L+  D   ++        + +H
Sbjct: 136 GVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 40/194 (20%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-------ECEALRNIRHR--N 763
           +G G FG+VY GI   D + VA+K +  K + +    +        E   L+ +      
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMEN-GSLEDWL--HQSNDQVEVRKLSLIQRMNIAI 820
           +I+++       FE  D   L+ E  E    L D++    +  +   R     Q      
Sbjct: 110 VIRLLDW-----FERPDSFVLILERPEPVQDLFDFITERGALQEELARSF-FWQ------ 157

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHHLDIASKTPS 879
            V  A+ + H+     ++H D+K  N+L+D +     + DFG    L +           
Sbjct: 158 -VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---- 209

Query: 880 SSIGIKGTVGYVAP 893
                 GT  Y  P
Sbjct: 210 ------GTRVYSPP 217

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 43/194 (22%), Positives = 82/194 (42%), Gaps = 32/194 (16%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEALRNIRHRN 763
            +F   + +G G  G V+K       +V+A K+I+L+ K A     + E + L       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 764 LIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           ++          F G  +      +  E+M+ GSL+  L +        ++       ++
Sbjct: 93  IVG---------FYGAFYSDGEISICMEHMDGGSLDQVLKK------AGRIPEQILGKVS 137

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
           I V   + YL    +  ++H D+KPSN+L++      + DFG++  L +    +A  +  
Sbjct: 138 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMA-NS-- 189

Query: 880 SSIGIKGTVGYVAP 893
                 GT  Y++P
Sbjct: 190 ----FVGTRSYMSP 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 48/197 (24%), Positives = 75/197 (38%), Gaps = 42/197 (21%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS-------ECEALRNIR---- 760
           ++G+G FGTV+ G    D + VA+KVI  + +    S +S       E   L  +     
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGS-LEDWL--HQSNDQVEVRKLSLIQRMN 817
           H  +I+++       FE  +   LV E       L D++       +   R     Q   
Sbjct: 97  HPGVIRLLDW-----FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF-FGQ--- 147

Query: 818 IAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFLSNHHLDIASK 876
               V +AI++ H      +VH D+K  N+L+D     A + DFG    L +        
Sbjct: 148 ----VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199

Query: 877 TPSSSIGIKGTVGYVAP 893
                    GT  Y  P
Sbjct: 200 ---------GTRVYSPP 207

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 59/286 (20%), Positives = 109/286 (38%), Gaps = 24/286 (8%)

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN 395
             +  +      +     +L        +      L+  + ++    + I  ++  GI+ 
Sbjct: 12  TPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELN-SIDQIIANNSDIK-SV-QGIQY 66

Query: 396 LVNLITFTLEVNQFHGTIPDV--ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG 453
           L N+    L  N+    + D+  ++ LKNL  L +  N ++    S L +L KL SL L 
Sbjct: 67  LPNVTKLFLNGNK----LTDIKPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLE 120

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQ 513
            N +  +I + L +   L       NK+T D+   L  +T L   L L +N ++  +PL 
Sbjct: 121 HNGIS-DI-NGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLD-TLSLEDNQISDIVPLA 175

Query: 514 VGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNV 573
              L  L  L +S N  S +    L+   +L+ L++               L     +  
Sbjct: 176 --GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231

Query: 574 SSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKIS 619
           +  +L    PE + +    E  N+ ++  E    V  +F     I 
Sbjct: 232 TDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 275

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 55/271 (20%), Positives = 110/271 (40%), Gaps = 34/271 (12%)

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL- 373
            +       NL++ ++           +  +  +S+  +  +++        S+  +   
Sbjct: 21  DAFAETIKDNLKKKSVTD--------AVTQNELNSIDQIIANNSDI-----KSVQGIQYL 67

Query: 374 -KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV--ISELKNLQQLSVFN 430
             + +L +  N+++  I P + NL NL    L+ N+    + D+  + +LK L+ LS+ +
Sbjct: 68  PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENK----VKDLSSLKDLKKLKSLSLEH 121

Query: 431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLL 490
           N +     +GL +L +L SL LG+N +  +I + L     L       N+++ D+   L 
Sbjct: 122 NGIS--DINGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVP-LA 175

Query: 491 SITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
            +T L   L LS N ++    L    LKNL +L++ S +         S  V    +  +
Sbjct: 176 GLTKLQ-NLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232

Query: 551 INSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
             S      +S       +  NV  +     
Sbjct: 233 DGSLVTPEIIS--DDGDYEKPNVKWHLPEFT 261

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 30/241 (12%)

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
               +  N+ +   +         ++S++ I    +    +        LPN+ KL + G
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLNG 77

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWLLNLEQNNLGTGTANDL 338
           N  +  I   L+N  NL  L L  N+ K    +     LK L  L+LE N +     +D+
Sbjct: 78  NK-LTDIKP-LANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGI-----SDI 127

Query: 339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVN 398
           +    L +   L+ L L +N+        ++ L+ K+  LS+  NQIS  I P +  L  
Sbjct: 128 NG---LVHLPQLESLYLGNNKI--TDITVLSRLT-KLDTLSLEDNQIS-DIVP-LAGLTK 179

Query: 399 LITFTLEVNQFHGTIPDV--ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNS 456
           L    L  N     I D+  ++ LKNL  L +F+        +   NL    ++     S
Sbjct: 180 LQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 457 L 457
           L
Sbjct: 236 L 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 56/301 (18%), Positives = 100/301 (33%), Gaps = 42/301 (13%)

Query: 241 ICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLD 300
               +      L +   +     +    L ++ ++    ++ + S+   +    N+  L 
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLF 74

Query: 301 LPSNQFKGKVSI-DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
           L  N+      I   ++LKNL  L L++N +          +  L +   LK LSL  N 
Sbjct: 75  LNGNKLT---DIKPLANLKNLGWLFLDENKVKD--------LSSLKDLKKLKSLSLEHNG 123

Query: 360 FGGELPHSIANLSL--KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVI 417
                   I  L    ++  L +G N+I  T    +  L  L T +LE NQ   +    +
Sbjct: 124 I-----SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI--SDIVPL 174

Query: 418 SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS 477
           + L  LQ L +  N +       L  L  L  L+L S        +   N         +
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 232

Query: 478 YNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNL----KNLVMLDISSNQFSGV 533
              L         +   +S   D     +   LP     +       V +  +  +F G 
Sbjct: 233 DGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGR 284

Query: 534 I 534
           +
Sbjct: 285 V 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 48/293 (16%), Positives = 101/293 (34%), Gaps = 54/293 (18%)

Query: 143 TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVI 202
            +    +  I        +   +      L  + ++  + + +         ++  I+  
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--------SVQGIQ-- 65

Query: 203 RITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFP 262
                            L  +  L +  N+ + + P  + N+ ++  +FL EN+   +  
Sbjct: 66  ----------------YLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSS 107

Query: 263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWL 322
                +L  LK L +  N    S  + L +   LE L L +N+    ++   S L  L  
Sbjct: 108 LK---DLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDT 160

Query: 323 LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS--LKMIELSV 380
           L+LE N +     +D+     L+  + L+ L LS N         +  L+    +  L +
Sbjct: 161 LSLEDNQI-----SDIV---PLAGLTKLQNLYLSKNHI-----SDLRALAGLKNLDVLEL 207

Query: 381 GRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
              +          NLV   T            P++IS+  + ++ +V  +  
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLP 258

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 45/232 (19%), Positives = 96/232 (41%), Gaps = 17/232 (7%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
             +     NL        + Q    L  ++++  +N+    ++   +    N+     + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           NKL   I K + NL  L  L +D N +   L  S+ +L  ++ + +  N +       L 
Sbjct: 78  NKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLV 131

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
            L +L +L +  N+ + +    +  ++ ++ + L +N+ S I P      L  L+ L + 
Sbjct: 132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLS 186

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL 330
            N+ +  +  +L+   NL++L+L S +   K     S+L     +     +L
Sbjct: 187 KNH-ISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 20/211 (9%)

Query: 383 NQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLG 442
             I+   P     L N +   L        +     EL  +Q  +  N+ ++    +G+ 
Sbjct: 7   TPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ--SLAGMQ 60

Query: 443 NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSL-VLDL 501
             T L  L L  N +  ++ S L +   L     + N+L       L  I +  L  L L
Sbjct: 61  FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFL 113

Query: 502 SNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLS 561
            NN L  +  L   +LKNL +L I +N+   ++   L     LE LD+  N       L+
Sbjct: 114 DNNELRDTDSLI--HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGGLT 169

Query: 562 FRFLKSIKALNVSSNNLSGKIPEFLENLSFL 592
              LK +  ++++      +  ++   L   
Sbjct: 170 R--LKKVNWIDLTGQKCVNEPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 43/286 (15%), Positives = 91/286 (31%), Gaps = 47/286 (16%)

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN 395
             ++ V      ++    +L            + +L                      + 
Sbjct: 7   TPINQVFPDPGLANAVKQNLGKQS--------VTDLV-------------------SQKE 39

Query: 396 LVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSN 455
           L  +  F  + +         +    NL++L + +N +     S L +LTKL  L +  N
Sbjct: 40  LSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRN 95

Query: 456 SLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVG 515
            L+            L L     N+L       L+ +  L  +L + NN L   + L   
Sbjct: 96  RLKNLNGIPSACLSRLFL---DNNELRD--TDSLIHLKNLE-ILSIRNNKLKSIVMLG-- 147

Query: 516 NLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS 575
            L  L +LD+  N+ +      L+    + ++D++       +    ++   +   N + 
Sbjct: 148 FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK---CVNEPVKYQPELYITN-TV 201

Query: 576 NNLSGKI--PEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKIS 619
            +  G+   P ++ N        + +        V   FS    + 
Sbjct: 202 KDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVG 247

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 39/246 (15%), Positives = 77/246 (31%), Gaps = 29/246 (11%)

Query: 217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG 276
              L   V  N+ +   + +       +S V+      +    +          NLK+L 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQ---FFTNLKELH 69

Query: 277 IGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTAN 336
           +  N  +  +   L + + LE L +  N+ K   +++      L  L L+ N L      
Sbjct: 70  LSHNQ-ISDL-SPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRD---- 120

Query: 337 DLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS--LKMIELSVGRNQISGTIPPGIR 394
                  L +  +L++LS+ +N+       SI  L    K+  L +  N+I+      + 
Sbjct: 121 ----TDSLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEIT-NTGG-LT 169

Query: 395 NLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS 454
            L  +    L   +          EL     +   +       P  + N        +  
Sbjct: 170 RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLW 227

Query: 455 NSLQGN 460
                 
Sbjct: 228 ELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 49/294 (16%), Positives = 101/294 (34%), Gaps = 56/294 (19%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
            L+     NL        + Q+   L  ++     N++   ++   +   +NL     S+
Sbjct: 17  GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           N++   +   + +L KL+ LSV+ N L         NL+ I                   
Sbjct: 73  NQIS-DL-SPLKDLTKLEELSVNRNRLK--------NLNGIP------------------ 104

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
               L  L +  N+       S+ ++ ++E++ +  N+   I        L  L+ L + 
Sbjct: 105 -SACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVMLG---FLSKLEVLDLH 158

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL 338
           GN  + +    L+    +  +DL   +    V+        L++ N  ++  G   +   
Sbjct: 159 GNE-ITNT-GGLTRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISP-- 211

Query: 339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL---KMIELSVGRNQISGTI 389
               ++SN  S     +        LP     +S    + I +        GT+
Sbjct: 212 ---YYISNGGSYVDGCVLWE-----LPVYTDEVSYKFSEYINVGETEAIFDGTV 257

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 17/100 (17%), Positives = 42/100 (42%), Gaps = 8/100 (8%)

Query: 501 LSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPL 560
                +N   P     L N V  ++     + ++         ++  +   ++   +  +
Sbjct: 4   QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGM 59

Query: 561 SFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
            F    ++K L++S N +S  +   L++L+ LE L+++ N
Sbjct: 60  QF--FTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRN 95

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 35/188 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVS----ECEALRNIRHRNLIKII 768
           +G+G FG V        +  VA+K I+ +Q             E   L+ +RH ++IK+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 769 TICSSTD--FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
            + ++            +V EY   G L D++      VE ++++  +       +  AI
Sbjct: 76  DVITTPTDIV-------MVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAI 121

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL-AKFLSNHHLDIASKTPSSSIGIK 885
           EY H H    +VH DLKP N+LLD ++   + DFGL       + L  +  +P+      
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN------ 172

Query: 886 GTVGYVAP 893
               Y AP
Sbjct: 173 ----YAAP 176

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 76.9 bits (190), Expect = 8e-15
 Identities = 76/450 (16%), Positives = 143/450 (31%), Gaps = 88/450 (19%)

Query: 199 IEVIRITENSLGGK-IPTTLGLLRRLVNLNVAENQFSGMFPRSICNI----SSVELIFLT 253
           I+ + I    L        L LL++   + + +   +    + I +      ++  + L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 254 ENRF--SGIFPFDILLNLPN--LKKLGIGGNNF----VGSIPDSLSNASNLELLDLPSNQ 305
            N     G+      L  P+  ++KL +          G +  +L     L+ L L  N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 306 FKGKVSIDFSSL-----KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
                              L  L LE  +L   +   L  V  L      K L++S+N  
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNNDI 182

Query: 361 GGE----LPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV 416
                  L   + +   ++  L +    ++       R+L                   +
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCG-----------------I 222

Query: 417 ISELKNLQQLSVFNNFLRGG-----IPSGLGNLTKLGSLDLGSNSLQ----GNIPSSLGN 467
           ++   +L++L++ +N L         P  L   ++L +L +    +     G++   L  
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282

Query: 468 CQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISS 527
            ++L     + N+L GD                L   LL     L+         L + S
Sbjct: 283 KESLKELSLAGNEL-GD-----------EGARLLCETLLEPGCQLES--------LWVKS 322

Query: 528 NQFSGV----IPVTLSTCVSLEYLDISINSF--YGVIPLSFRFLKS----IKALNVSSNN 577
             F+          L+    L  L IS N     GV  L  + L      ++ L ++  +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC-QGLGQPGSVLRVLWLADCD 381

Query: 578 LSGK----IPEFLENLSFLEFLNLSYNYFE 603
           +S      +   L     L  L+LS N   
Sbjct: 382 VSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.0 bits (172), Expect = 1e-12
 Identities = 59/343 (17%), Positives = 111/343 (32%), Gaps = 77/343 (22%)

Query: 294 SNLELLDLPSNQFKGK-VSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKV 352
            +++ LD+   +      +     L+   ++ L+   L      D+     L    +L  
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60

Query: 353 LSLSDNQFGGE----LPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQ 408
           L+L  N+ G      +   +   S K+ +LS+    ++G    G   L            
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA---GCGVLS----------- 106

Query: 409 FHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL--------TKLGSLDLGSNSLQGN 460
                   +  L  LQ+L + +N L     +GL  L         +L  L L   SL   
Sbjct: 107 ------STLRTLPTLQELHLSDNLLG---DAGLQLLCEGLLDPQCRLEKLQLEYCSL--- 154

Query: 461 IPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGS-----LPLQVG 515
             S+   C+ L   + +                     L +SNN +N +           
Sbjct: 155 --SAAS-CEPLASVLRAKPDFK---------------ELTVSNNDINEAGVRVLCQGLKD 196

Query: 516 NLKNLVMLDISSNQFS----GVIPVTLSTCVSLEYLDISINSF--YGVIPLSFRFLK--- 566
           +   L  L + S   +      +   +++  SL  L +  N     G+  L    L    
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 567 SIKALNVSSNNLSGK----IPEFLENLSFLEFLNLSYNYFEGE 605
            ++ L +    ++ K    +   L     L+ L+L+ N    E
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.8 bits (161), Expect = 3e-11
 Identities = 83/481 (17%), Positives = 147/481 (30%), Gaps = 97/481 (20%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFR-LEKLALSNNSFSGT----IPTNLSRCSNLIHFCAS 157
           ++ +++           E+  L +  + + L +   +      I + L     L      
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK----I 213
           +N+L       +   L+                        I+ + +    L G     +
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCK-------------------IQKLSLQNCCLTGAGCGVL 105

Query: 214 PTTLGLLRRLVNLNVAENQFSGMFPRSICNI-----SSVELIFLTENRFS---GIFPFDI 265
            +TL  L  L  L++++N       + +C         +E + L     S         +
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165

Query: 266 LLNLPNLKKLGIGGNNF----VGSIPDSL-SNASNLELLDLPSNQFKGKVSIDFSSL--- 317
           L   P+ K+L +  N+     V  +   L  +   LE L L S         D   +   
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225

Query: 318 -KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA-----NL 371
             +L  L L  N LG     +L   +   +   L+ L + +     +    +        
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSR-LRTLWIWECGITAKGCGDLCRVLRAKE 284

Query: 372 SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNN 431
           SLK  ELS+  N++      G R L   +                +     L+ L V + 
Sbjct: 285 SLK--ELSLAGNELGDE---GARLLCETL----------------LEPGCQLESLWVKSC 323

Query: 432 FLRG----GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG------NC--QNLILFIASYN 479
                      S L     L  L + +N L+      L           + L L   +  
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL---ADC 380

Query: 480 KLT----GDLPQQLLSITTLSLVLDLSNNLLN--GSLPLQVG---NLKNLVMLDISSNQF 530
            ++      L   LL+  +L   LDLSNN L   G L L          L  L +    +
Sbjct: 381 DVSDSSCSSLAATLLANHSLR-ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439

Query: 531 S 531
           S
Sbjct: 440 S 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.7 bits (153), Expect = 3e-10
 Identities = 56/344 (16%), Positives = 105/344 (30%), Gaps = 73/344 (21%)

Query: 74  HRHQRLTELNLSSQRIG----GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFR--- 126
               ++ +L+L +  +     GVLS  +  L  L+ ++L+DN       Q +        
Sbjct: 82  TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141

Query: 127 --LEKLALSNNSFSGT----IPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK-----L 175
             LEKL L   S S      + + L    +      SNN +     + +   LK     L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           + L ++   +T    D+  +L  I                 +     L  L +  N+   
Sbjct: 202 EALKLESCGVT---SDNCRDLCGI-----------------VASKASLRELALGSNKLGD 241

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF----VGSIPDSLS 291
           +    +C                      +L     L+ L I          G +   L 
Sbjct: 242 VGMAELCPG--------------------LLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 292 NASNLELLDLPSNQFKGKVSIDFSSL-----KNLWLLNLEQNNLGTGTANDLDFVIFLSN 346
              +L+ L L  N+   + +             L  L ++  +      +    V  L+ 
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV--LAQ 339

Query: 347 CSSLKVLSLSDNQFGGE----LPHSIANLSLKMIELSVGRNQIS 386
              L  L +S+N+        L   +      +  L +    +S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 58.0 bits (141), Expect = 7e-09
 Identities = 50/329 (15%), Positives = 101/329 (30%), Gaps = 48/329 (14%)

Query: 74  HRHQRLTELNLSSQRIG----GVLSPYVGNLSFLRYINLADNGFRGDIPQEIG-----NL 124
               RL +L L    +       L+  +      + + +++N       + +      + 
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198

Query: 125 FRLEKLALSNNSFS----GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK-----L 175
            +LE L L +   +      +   ++  ++L      +NKL      E+   L      L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258

Query: 176 QRLSVDINYLTGQ----LPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAEN 231
           + L +    +T +    L   +    +++ + +  N LG +    L          +   
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL 318

Query: 232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF----VGSIP 287
                     C+ ++      +           +L     L +L I  N      V  + 
Sbjct: 319 WVKS------CSFTAACCSHFSS----------VLAQNRFLLELQISNNRLEDAGVRELC 362

Query: 288 DSL-SNASNLELLDLPSNQFKGKVSIDFSSL----KNLWLLNLEQNNLGTGTANDLDFVI 342
             L    S L +L L             ++      +L  L+L  N LG      L   +
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANL 371
               C  L+ L L D  +  E+   +  L
Sbjct: 423 RQPGCL-LEQLVLYDIYWSEEMEDRLQAL 450

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 45/277 (16%), Positives = 85/277 (30%), Gaps = 53/277 (19%)

Query: 74  HRHQRLTELNLSSQRIG----GVLSPYVGNLSFLRYINLADN-----GFRGDIPQEIGNL 124
               +L  L L S  +       L   V + + LR + L  N     G     P  +   
Sbjct: 196 DSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS 255

Query: 125 FRLEKLALSNNSFS----GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK-----L 175
            RL  L +     +    G +   L    +L     + N+L  +  + +   L      L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 176 QRLSVDINYLTGQ----LPDSVGNLSAIEVIRITENSLGGKIPTTLG-----LLRRLVNL 226
           + L V     T          +     +  ++I+ N L       L          L  L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 227 NVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF---- 282
            +A+   S     S  ++++                   LL   +L++L +  N      
Sbjct: 376 WLADCDVS---DSSCSSLAAT------------------LLANHSLRELDLSNNCLGDAG 414

Query: 283 VGSIPDSL-SNASNLELLDLPSNQFKGKVSIDFSSLK 318
           +  + +S+      LE L L    +  ++     +L+
Sbjct: 415 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 25/167 (14%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS---KSFVSECEALRNIR 760
              FS    IG G FG VY      +  VVA+K ++   K ++   +  + E   L+ +R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 761 HRNLIKIITICSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRM 816
           H N I+         + G   +     LV EY   GS  D L      ++  +++ +   
Sbjct: 113 HPNTIQ---------YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH- 161

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
                    + YLH H    M+H D+K  N+LL    +  +GDFG A
Sbjct: 162 ----GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 31/226 (13%)

Query: 389 IPPGIRNLV---NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNL 444
           +P   +NL    N +   L    F             LQ L +    ++  I  G   +L
Sbjct: 26  LPFSTKNLDLSFNPLR-HLGSYSFFS--------FPELQVLDLSRCEIQT-IEDGAYQSL 75

Query: 445 TKLGSLDLGSN---SLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDL 501
           + L +L L  N   SL     S L + Q L+        L   L    +        L++
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVA---VETNLA-SLENFPIGHLKTLKELNV 131

Query: 502 SNNLLNGSLPLQVG---NLKNLVMLDISSNQFSGVIPVTLSTCVSLEY----LDISINSF 554
           ++NL+  S  L      NL NL  LD+SSN+   +    L     +      LD+S+N  
Sbjct: 132 AHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 555 YGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
             + P +F+ ++ +K L + +N L        + L+ L+ + L  N
Sbjct: 190 NFIQPGAFKEIR-LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 20/227 (8%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFL 344
            IPD+L    + + LDL  N  +   S  F S   L +L+L +  + T     ++   + 
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-----IEDGAY- 72

Query: 345 SNCSSLKVLSLSDNQFGGELPHSI-ANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
            + S L  L L+ N     L     + LS  + +L      ++ ++      +L  L   
Sbjct: 73  QSLSHLSTLILTGNPI-QSLALGAFSGLS-SLQKLVAVETNLA-SLENFPIGHLKTLKEL 129

Query: 403 TLEVNQFHG-TIPDVISELKNLQQLSVFNNFLR---GGIPSGLGNLTKLG-SLDLGSNSL 457
            +  N      +P+  S L NL+ L + +N ++         L  +  L  SLDL  N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 458 QGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN 504
              I         L       N+L   +P  +    T    + L  N
Sbjct: 190 N-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 10/143 (6%)

Query: 460 NIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLK 518
           N+P S    +NL L   S+N L         S   L  VLDLS   +  ++      +L 
Sbjct: 25  NLPFST---KNLDL---SFNPLRHLGSYSFFSFPELQ-VLDLSRCEIQ-TIEDGAYQSLS 76

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
           +L  L ++ N    +     S   SL+ L     +   +       LK++K LNV+ N +
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 579 -SGKIPEFLENLSFLEFLNLSYN 600
            S K+PE+  NL+ LE L+LS N
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSN 159

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 17/224 (7%)

Query: 141 IPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSV-GNLSAI 199
           IP NL    +  +   S N L         +  +LQ L +    +   + D    +LS +
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 200 EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG 259
             + +T N +          L  L  L   E   + +    I ++ +++ + +  N    
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 260 IFPFDILLNLPNLKKLGIGGNNFVGSIP----DSLSNASNLEL-LDLPSNQFKGKVSIDF 314
               +   NL NL+ L +  N    SI       L     L L LDL  N         F
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 315 SSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
             +  L  L L+ N L +      D        +SL+ + L  N
Sbjct: 198 KEI-RLKELALDTNQLKSVPDGIFD------RLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 48/256 (18%), Positives = 75/256 (29%), Gaps = 57/256 (22%)

Query: 79  LTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNS 136
              L+LS   +   L  Y   +   L+ ++L+    +  I      +L  L  L L+ N 
Sbjct: 30  TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 137 FSGTIPTNL-SRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGN 195
              ++     S  S+L    A    L       IG+L  L+ L+V  N +          
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ--------- 137

Query: 196 LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN 255
                                      L NL                     E + L+ N
Sbjct: 138 ----------------SFKLP-EYFSNLTNL---------------------EHLDLSSN 159

Query: 256 RFSGIFPFDILLNLPNLKKLGIG---GNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI 312
           +   I     L  L  +  L +      N +  I         L+ L L +NQ K     
Sbjct: 160 KIQSI-YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDG 218

Query: 313 DFSSLKNLWLLNLEQN 328
            F  L +L  + L  N
Sbjct: 219 IFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 41.1 bits (97), Expect = 8e-04
 Identities = 30/136 (22%), Positives = 54/136 (39%), Gaps = 8/136 (5%)

Query: 78  RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNS 136
            L +L      +  + +  +G+L  L+ +N+A N  +     E   NL  LE L LS+N 
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 137 FSGTIPTN-LSRCSNLIHFCA----SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD 191
              +I    L     +         S N +   I       ++L+ L++D N L      
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDG 218

Query: 192 SVGNLSAIEVIRITEN 207
               L++++ I +  N
Sbjct: 219 IFDRLTSLQKIWLHTN 234

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 49/204 (24%), Positives = 82/204 (40%), Gaps = 47/204 (23%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV----SECEALRNIR 760
            +F    ++G+G F TV            A+K++  K+    ++ V     E + +  + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLD 88

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI-- 818
           H   +K+    +   F+  +       Y +NG L               L  I+++    
Sbjct: 89  HPFFVKLY--FT---FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGSFD 128

Query: 819 -------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNH 869
                    ++ SA+EYLH      ++H DLKP N+LL+ DM  H+   DFG AK LS  
Sbjct: 129 ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPE 183

Query: 870 HLDIASKTPSSSIGIKGTVGYVAP 893
                + +        GT  YV+P
Sbjct: 184 SKQARANS------FVGTAQYVSP 201

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 76.3 bits (187), Expect = 2e-14
 Identities = 40/264 (15%), Positives = 85/264 (32%), Gaps = 28/264 (10%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLE 162
           L   +L D   +             ++  L  +        + +    L     S  K  
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST 362

Query: 163 GQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRR 222
             +  E+ +  +LQ L  +  +    +   +  + A++ +   + +L          L+ 
Sbjct: 363 -VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETL-----QYFSTLKA 413

Query: 223 LVNLNVAENQFSGM-----FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGI 277
           +  +  A                    + V ++ L     + +     L  L  +  L +
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL---CHLEQLLLVTHLDL 470

Query: 278 GGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWLLNLEQNNLGTGTAN 336
             N    ++P +L+    LE+L    N  +   ++D  ++L  L  L L  N L      
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCNNRL-----Q 521

Query: 337 DLDFVIFLSNCSSLKVLSLSDNQF 360
               +  L +C  L +L+L  N  
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.9 bits (165), Expect = 9e-12
 Identities = 37/234 (15%), Positives = 75/234 (32%), Gaps = 22/234 (9%)

Query: 301 LPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           +           D ++ + L+   L         +        L +C  L+ L   +   
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQS-------ELESCKELQELEPENKWC 384

Query: 361 GGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL 420
              +   +  L      L   +  +         + +         ++F      +  E 
Sbjct: 385 LLTIILLMRALD----PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY 440

Query: 421 KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK 480
            +++ L + +  L   +   L  L  +  LDL  N L+  +P +L   + L +  AS N 
Sbjct: 441 ADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497

Query: 481 LTGDLPQQLLSITTLSL--VLDLSNNLLNG-SLPLQVGNLKNLVMLDISSNQFS 531
           L       +  +  L     L L NN L   +    + +   LV+L++  N   
Sbjct: 498 LE-----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.0 bits (155), Expect = 1e-10
 Identities = 38/242 (15%), Positives = 73/242 (30%), Gaps = 22/242 (9%)

Query: 243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
           + S  E + L +              L   +            +   L +   L+ L+  
Sbjct: 325 SDSQKECVLLKDRPECWCRDSATDEQLFRCEL----SVEKSTVLQSELESCKELQELEPE 380

Query: 303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG 362
           +      + +   +L  L               + L  V  +       + S    +   
Sbjct: 381 NKWCLLTIILLMRALDPLLYEKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSV 435

Query: 363 ELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKN 422
                          L +    +  T+   +  L+ +    L  N+    +P  ++ L+ 
Sbjct: 436 LKMEYADVR-----VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRC 487

Query: 423 LQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPS--SLGNCQNLILFIASYNK 480
           L+ L   +N L      G+ NL +L  L L +N LQ    +   L +C  L+L     N 
Sbjct: 488 LEVLQASDNALE--NVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNS 544

Query: 481 LT 482
           L 
Sbjct: 545 LC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 34/243 (13%), Positives = 84/243 (34%), Gaps = 12/243 (4%)

Query: 383 NQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLG 442
           +Q+       I    +     + +           +  + L +  +        + S L 
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV-LQSELE 369

Query: 443 NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLS 502
           +  +L  L+  +      I   +     L+    +    +     + +     + + DL 
Sbjct: 370 SCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---LKAVDPMRAAYLDDLR 426

Query: 503 NNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSF 562
           +  L  +  +      ++ +L ++    + +    L   + + +LD+S N     +P + 
Sbjct: 427 SKFLLEN-SVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRL-RALPPAL 482

Query: 563 RFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNK--TKISL 620
             L+ ++ L  S N L   +   + NL  L+ L L  N  +    ++ + S      ++L
Sbjct: 483 AALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNL 540

Query: 621 HGN 623
            GN
Sbjct: 541 QGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.3 bits (109), Expect = 4e-05
 Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 7/101 (6%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS 136
             +T L+LS  R+   L P +  L  L  +  +DN    ++   + NL RL++L L NN 
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 519

Query: 137 FSGTIPT--NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL 175
                     L  C  L+      N L  Q       L ++
Sbjct: 520 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 38/187 (20%), Positives = 67/187 (35%), Gaps = 32/187 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECEAL-RNIRHRNLIKIITI 770
           +G G  G V+K        V+AVK +         K  + + + + ++     +++    
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88

Query: 771 CSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                  G         +  E M     E    +    +  R L       + + +  A+
Sbjct: 89  -----CFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKAL 137

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            YL       ++H D+KPSN+LLD      + DFG++  L +       K    S    G
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DKAKDRSA---G 186

Query: 887 TVGYVAP 893
              Y+AP
Sbjct: 187 CAAYMAP 193

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 27/168 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV--------SECEALRNIRHRNL 764
           IG G FG +Y     +     A  V+ ++ +     F         ++ + ++    R  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 765 IKIITI-----CSSTDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNI 818
           +  + I        T+F+G  ++ +V E +  G  L+  +   N             + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQN-----GTFKKSTVLQL 156

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--VAHVGDFGLAK 864
            I +   +EY+H +     VHGD+K +N+LL Y      ++ D+GL+ 
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 42/187 (22%), Positives = 79/187 (42%), Gaps = 29/187 (15%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECE-ALRNIRHRNLIKIITI 770
           +G+G +G V K        ++AVK I         K  + + + ++R +     +     
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70

Query: 771 CSSTDFEGVDFK----ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                F G  F+     +  E M + SL+ +  Q  D+ +     ++ +  IA+ +  A+
Sbjct: 71  -----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           E+LH      ++H D+KPSNVL++      + DFG++ +L +                 G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDA---G 171

Query: 887 TVGYVAP 893
              Y+AP
Sbjct: 172 CKPYMAP 178

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 39/187 (20%), Positives = 76/187 (40%), Gaps = 28/187 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS-KSFVSECE-ALRNIRHRNLIKIITI 770
           IG+G +G+V K +      ++AVK I         K  + + +  +R+     +++    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85

Query: 771 CSSTDFEGVDFKA----LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
                F G  F+     +  E M + S + +       ++   +       I +    A+
Sbjct: 86  -----FYGALFREGDCWICMELM-STSFDKFYKYVYSVLD-DVIPEEILGKITLATVKAL 138

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            +L  + +  ++H D+KPSN+LLD      + DFG++  L +      S   +      G
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDA---G 187

Query: 887 TVGYVAP 893
              Y+AP
Sbjct: 188 CRPYMAP 194

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 73.5 bits (181), Expect = 8e-14
 Identities = 42/172 (24%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN 763
              +++  +IG G FG V++  L + +  VA+K +   ++  ++    E + +R ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPN 93

Query: 764 LIKII-TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI-- 820
           ++ +     S+ D +   F  LV EY+     E  +++++      K    Q M + +  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLK----QTMPMLLIK 144

Query: 821 ----DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLAKFLS 867
                +  ++ Y+H      + H D+KP N+LLD    V  + DFG AK L 
Sbjct: 145 LYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 73.7 bits (181), Expect = 9e-14
 Identities = 42/197 (21%), Positives = 77/197 (39%), Gaps = 22/197 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINL--KQKGASKSFVSECEALRNIRHRNLIKIITI 770
           IG G +G V +     ++ VVA+K I    +     K  + E   L  + H +++K++ I
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120

Query: 771 CSSTDFEGVDFKA--LVFEYMENGSLEDWLHQ---SNDQVEVRKLSLIQRMNIAIDVASA 825
               D E   F    +V E  ++    D   +   +        L+ +    +  ++   
Sbjct: 121 VIPKDVE--KFDELYVVLEIADS----D-FKKLFRTPV-----YLTELHIKTLLYNLLVG 168

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           ++Y+H      ++H DLKP+N L++ D    V DFGLA+ +       +    S      
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 886 GTVGYVAPGKFFMLYTH 902
             V +          T 
Sbjct: 226 NLVTFPHTKNLKRQLTG 242

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 30/171 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMV-----VAVKV-----------INLKQKGASKSFVSECEAL 756
           IGQG FG +Y   +   E V       VKV           +   Q+ A    + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 757 RNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQR 815
           R +++  + K        D  G  ++ ++ +    G  L+     +      ++ S    
Sbjct: 103 RKLKYLGVPKYWG-SGLHDKNGKSYRFMIMDRF--GSDLQKIYEANA-----KRFSRKTV 154

Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--VAHVGDFGLAK 864
           + +++ +   +EY+H H     VHGD+K SN+LL+Y      ++ D+GLA 
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 50/190 (26%), Positives = 77/190 (40%), Gaps = 17/190 (8%)

Query: 271 NLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQ 327
           + KKL +  N        +    + L LL L  N+ +   ++    F  LKNL  L +  
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ---TLPAGIFKELKNLETLWVTD 94

Query: 328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSI-ANLSLKMIELSVGRNQIS 386
           N L           +F     +L  L L  NQ    LP  +  +L+ K+  LS+G N++ 
Sbjct: 95  NKLQALPIG-----VF-DQLVNLAELRLDRNQLK-SLPPRVFDSLT-KLTYLSLGYNELQ 146

Query: 387 GTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLT 445
            ++P G+   L +L    L  NQ          +L  L+ L + NN L+        +L 
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205

Query: 446 KLGSLDLGSN 455
           KL  L L  N
Sbjct: 206 KLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 48/218 (22%), Positives = 76/218 (34%), Gaps = 37/218 (16%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTK 446
            IP  I    +     L+ N+           L  L+ L + +N L+  +P+G+   L  
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86

Query: 447 LGSLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSN 503
           L +L +  N LQ     +   L N   L L     N+L                      
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAELRL---DRNQLK--------------------- 122

Query: 504 NLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSF 562
                SLP +V  +L  L  L +  N+   +         SL+ L +  N    V   +F
Sbjct: 123 -----SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAF 177

Query: 563 RFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
             L  +K L + +N L        ++L  L+ L L  N
Sbjct: 178 DKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 40/236 (16%), Positives = 76/236 (32%), Gaps = 20/236 (8%)

Query: 347 CSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLE 405
           C   +   ++           I +L      L +    +  TIP     NL N+    + 
Sbjct: 10  CHQEEDFRVTCKDI-----QRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 406 VNQFHGTIP-DVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIP- 462
           ++     +       L  +  + + N      I    L  L  L  L + +  L+   P 
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD 122

Query: 463 -SSLGNCQNLILFIASYNKLTGDLPQQLLS-ITTLSLVLDLSNNLLNGSLPLQVGNLKNL 520
            + + +     +   + N     +P      +   +L L L NN    S+     N   L
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKL 181

Query: 521 VMLDISSNQFSGVIP----VTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN 572
             + ++ N++  VI       + +      LD+S  S   +       LK + A N
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYS--GPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 44/261 (16%), Positives = 82/261 (31%), Gaps = 42/261 (16%)

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
            C     F  +   ++ +IP         Q L +   +L      +  NL  I  I ++ 
Sbjct: 9   ECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDIL 266
           +    ++ +       L  +                       I +   R       D L
Sbjct: 65  DVTLQQLES--HSFYNLSKV---------------------THIEIRNTRNLTYIDPDAL 101

Query: 267 LNLPNLKKLGIGGNNFVGSIPD--SLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWL- 322
             LP LK LGI         PD   + +     +L++  N +   + ++ F  L N  L 
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 323 LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP-HSIANLSLKMIELSVG 381
           L L  N   +             N + L  + L+ N++   +   +   +      L V 
Sbjct: 161 LKLYNNGFTSVQGYAF-------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213

Query: 382 RNQISGTIPPGI-RNLVNLIT 401
           +  ++  +P     +L  LI 
Sbjct: 214 QTSVT-ALPSKGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 43/256 (16%), Positives = 72/256 (28%), Gaps = 57/256 (22%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLALSNNSF 137
              L L    +  + S    NL  +  I ++ +     +      NL ++  + + N   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPD--SVGN 195
              I  +                        +  L  L+ L +    L    PD   V +
Sbjct: 93  LTYIDPDA-----------------------LKELPLLKFLGIFNTGLK-MFPDLTKVYS 128

Query: 196 LSAIEVIRITENSLGGKIPTTL--GLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT 253
                ++ IT+N     IP     GL    + L +  N             +SV+     
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG-----------FTSVQ----- 172

Query: 254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIP-DSLSNA-SNLELLDLPSNQFKGKVS 311
                  F      N   L  + +  N ++  I  D+     S   LLD+         S
Sbjct: 173 ----GYAF------NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPS 222

Query: 312 IDFSSLKNLWLLNLEQ 327
                LK L   N   
Sbjct: 223 KGLEHLKELIARNTWT 238

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 34/175 (19%), Positives = 69/175 (39%), Gaps = 24/175 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR--------HRN 763
            +G G F TV+      +   VA+K++   +     +   E + L+ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMG 84

Query: 764 LIKIITICSSTDFEGVDFK--ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
              I+ +    + +G +     +VFE +   +L   + +       R + LI    I+  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQ 139

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH------VGDFGLAKFLSNHH 870
           +   ++Y+H  C   ++H D+KP NVL++            + D G A +   H+
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 21/158 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITIC 771
           +G G  G V +      +   A+K++      A +    E E      +  ++++I+ + 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--EVRKLSLIQRMNIAIDVASAIEYL 829
               + G     +V E ++ G L   +    DQ   E R+ S I +      +  AI+YL
Sbjct: 81  -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMK-----SIGEAIQYL 133

Query: 830 HHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDFGLAK 864
           H      + H D+KP N+L      + +  + DFG AK
Sbjct: 134 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 71.4 bits (175), Expect = 6e-13
 Identities = 50/216 (23%), Positives = 82/216 (37%), Gaps = 33/216 (15%)

Query: 686 SPMEKLFPMVSYAELSKATSE-FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LK 741
           S     F    + E    T   F    ++G+G FG V    +     + A K +    +K
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223

Query: 742 QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQS 801
           ++      ++E + L  +  R    ++++  +  +E  D   LV   M  G L+  ++  
Sbjct: 224 KRKGEAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMNGGDLKFHIYHM 278

Query: 802 NDQV--EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV-- 857
                 E R          A ++   +E LH      +V+ DLKP N+LLD     H+  
Sbjct: 279 GQAGFPEARA-----VFYAA-EICCGLEDLHRER---IVYRDLKPENILLDDH--GHIRI 327

Query: 858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
            D GLA         +            GTVGY+AP
Sbjct: 328 SDLGLAV-------HVPEGQTIKGRV--GTVGYMAP 354

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 27/194 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            +F    +IG+G F  V    +     V A+K++N   + ++G    F  E + L N   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
           R + ++    +   F+  ++  LV EY   G L   L +  +++         R  +A +
Sbjct: 121 RWITQLH--FA---FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLA-E 170

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPS 879
           +  AI+ +H       VH D+KP N+LLD     H+   DFG    L      + S    
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKL-RADGTVRSLVAV 224

Query: 880 SSIGIKGTVGYVAP 893
                 GT  Y++P
Sbjct: 225 ------GTPDYLSP 232

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 55/237 (23%), Positives = 92/237 (38%), Gaps = 26/237 (10%)

Query: 663 LLSSCLTIVYARKRRSTHKSVDTSPMEKLFPMVSYAELSKATSE-FSSSNMIGQGRFGTV 721
           L    L  V A   ++  +    S     F    + E      + F    ++G+G FG V
Sbjct: 142 LFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEV 201

Query: 722 YKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG 778
           +   +     + A K +N   LK++   +  + E + L  +  R ++ +    +   FE 
Sbjct: 202 FACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA--YA---FET 256

Query: 779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV 838
                LV   M  G +    H  N   +       + +     + S +E+LH      ++
Sbjct: 257 KTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---II 311

Query: 839 HGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           + DLKP NVLLD D   +V   D GLA           +KT   +    GT G++AP
Sbjct: 312 YRDLKPENVLLDDD--GNVRISDLGLAV----ELKAGQTKTKGYA----GTPGFMAP 358

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 33/199 (16%), Positives = 69/199 (34%), Gaps = 35/199 (17%)

Query: 713 IGQGRFGTVYKGI--------LGDDEMVVAVKV----------INLKQKGASKSFVSECE 754
             +   G +Y+           G  +   ++K+           N  Q+ A    V++ +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 755 ALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLI 813
            L +     +   +        +   ++ LV   +  G SL+  L  S        LS  
Sbjct: 110 KLYSTPLLAIPTCM---GFGVHQD-KYRFLVLPSL--GRSLQSALDVSPK----HVLSER 159

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--VAHVGDFGLAKFLSNHHL 871
             + +A  +  A+E+LH +     VHG++   N+ +D +      +  +G A        
Sbjct: 160 SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

Query: 872 DIASKTPSSSIGIKGTVGY 890
            +A     S    +G + +
Sbjct: 217 HVAYV-EGSRSPHEGDLEF 234

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 70.3 bits (172), Expect = 2e-12
 Identities = 65/267 (24%), Positives = 105/267 (39%), Gaps = 30/267 (11%)

Query: 634 HLPSCPSKGSRKPKITLLKVLIPVVVSCLLLSSCLTIVYARKRRSTHKSVDTSPMEKLFP 693
            L +C    S+     +   L+   V   L    +  +    R    +    S     F 
Sbjct: 116 ELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175

Query: 694 MVSYAELSKATSE--FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKS 748
                EL+   +   FS   +IG+G FG VY     D   + A+K ++   +K K     
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235

Query: 749 FVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVR 808
            ++E   L  +   +   I+ +  +  F   D  + + + M  G L   L Q     E  
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293

Query: 809 KLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFL 866
                 R   A ++   +E++H+     +V+ DLKP+N+LLD     HV   D GLA   
Sbjct: 294 -----MRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEH--GHVRISDLGLAC-- 340

Query: 867 SNHHLDIASKTPSSSIGIKGTVGYVAP 893
                D + K P +S+   GT GY+AP
Sbjct: 341 -----DFSKKKPHASV---GTHGYMAP 359

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 53/305 (17%), Positives = 108/305 (35%), Gaps = 51/305 (16%)

Query: 264 DILLNLPNLKKLGIGGNNF----VGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK- 318
            +LL   ++K++ + GN         + +++++  +LE+ +               +L+ 
Sbjct: 26  AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL 85

Query: 319 ---------NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA 369
                     L  + L  N  G      L  + FLS  + L+ L L +N  G   P + A
Sbjct: 86  LLQALLKCPKLHTVRLSDNAFGPTAQEPL--IDFLSKHTPLEHLYLHNNGLG---PQAGA 140

Query: 370 NLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG----TIPDVISELKNLQQ 425
            ++  + EL+V +   +            L +     N+                + L  
Sbjct: 141 KIARALQELAVNKKAKNAP---------PLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191

Query: 426 LSVFNNFLR-----GGIPSGLGNLTKLGSLDLGSNSL--QG--NIPSSLGNCQNLILFIA 476
           + +  N +R       +  GL    +L  LDL  N+    G   +  +L +  NL     
Sbjct: 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251

Query: 477 SYNKLTGD----LPQQLLSITTLSL-VLDLSNNLLN--GSLPLQ---VGNLKNLVMLDIS 526
           +   L+      +      +  + L  L L  N +       L+      + +L+ L+++
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311

Query: 527 SNQFS 531
            N+FS
Sbjct: 312 GNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 61/325 (18%), Positives = 106/325 (32%), Gaps = 63/325 (19%)

Query: 323 LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIA-----NLSLKMIE 377
            +L+ + + T     +     L    S+K + LS N  G E    ++        L++ E
Sbjct: 9   KSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 66

Query: 378 LS-VGRNQISGTIPPGIRNLV-------NLITFTLEVNQFHGT----IPDVISELKNLQQ 425
            S +   ++   IP  +R L+        L T  L  N F  T    + D +S+   L+ 
Sbjct: 67  FSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 126

Query: 426 LSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD- 484
           L + NN            L       +     +  +     N   L   I   N+L    
Sbjct: 127 LYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175

Query: 485 ---LPQQLLSITTLSLVLDLSNN---------LLNGSLPLQVGNLKNLVMLDISSNQFS- 531
                +   S   L   + +  N         LL   L       + L +LD+  N F+ 
Sbjct: 176 MKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLLLEGL----AYCQELKVLDLQDNTFTH 230

Query: 532 -GVIPV--TLSTCVSLEYLDISINSF--YGVIP----LSFRFLKSIKALNVSSNNLSGK- 581
            G   +   L +  +L  L ++       G        S      ++ L +  N +    
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290

Query: 582 ---IPEFL-ENLSFLEFLNLSYNYF 602
              +   + E +  L FL L+ N F
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 47/343 (13%), Positives = 89/343 (25%), Gaps = 67/343 (19%)

Query: 79  LTELNLSSQRIGGV----LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFR----LEKL 130
           +   +L    I       +   +     ++ I L+ N    +  + +         LE  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 131 ALSNNSFS----------GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLK----LQ 176
             S+                +   L +C  L     S+N       + + + L     L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM 236
            L +  N            L      +I        +         L ++    N+    
Sbjct: 126 HLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174

Query: 237 FPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF-----VGSIPDSLS 291
             +                            +   L  + +  N          + + L+
Sbjct: 175 SMKEWA---------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213

Query: 292 NASNLELLDLPSNQFKGKVSIDFS----SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC 347
               L++LDL  N F    S   +    S  NL  L L    L    A  +         
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273

Query: 348 SSLKVLSLSDNQFGGE----LPHSIANLSLKMIELSVGRNQIS 386
             L+ L L  N+   +    L   I      ++ L +  N+ S
Sbjct: 274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS 356
           E LDL S          F  L  L  LNL+ N L T +A      +F  + + L  L L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG-----VF-DDLTELGTLGLA 91

Query: 357 DNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPD 415
           +NQ    LP  + +   ++ +L +G NQ+  ++P G+   L  L    L  NQ   +IP 
Sbjct: 92  NNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148

Query: 416 -VISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSN 455
               +L NLQ LS+  N L+  +P G    L KL ++ L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 43/159 (27%), Positives = 62/159 (38%), Gaps = 11/159 (6%)

Query: 377 ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGG 436
           +L +    ++       R L  L    L+ NQ       V  +L  L  L + NN L   
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 437 IPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLGNCQNLILFIASYNKLTGDLPQQLLS 491
           +P G+  +LT+L  L LG N L+  +PS     L   + L L   + N+L   +P     
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL---NTNQLQ-SIPAGAFD 152

Query: 492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF 530
             T    L LS N L          L  L  + +  NQF
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 9/157 (5%)

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNK 480
           ++L + +  L     +    LTKL  L+L  N LQ     +   L     L L   + N+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL---ANNQ 94

Query: 481 LTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLS 539
           L   LP  +    T    L L  N L  SLP  V   L  L  L +++NQ   +      
Sbjct: 95  LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152

Query: 540 TCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN 576
              +L+ L +S N    V   +F  L  ++ + +  N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 46/215 (21%), Positives = 74/215 (34%), Gaps = 55/215 (25%)

Query: 388 TIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTK 446
           ++P GI    +     L+              L  L  L++  N L+  + +G+  +LT+
Sbjct: 28  SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL 506
           LG+L L +N L                       L   +   L  +  L     L  N L
Sbjct: 85  LGTLGLANNQLA---------------------SLPLGVFDHLTQLDKL----YLGGNQL 119

Query: 507 NGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFL 565
             SLP  V   L  L  L +++NQ    IP                    G     F  L
Sbjct: 120 K-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA-------------------GA----FDKL 154

Query: 566 KSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
            +++ L++S+N L        + L  L+ + L  N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 43/189 (22%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
            IG+G FG V      D + + A+K +N     ++   ++   E + ++ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQ----SNDQVEVRKLSLIQRMNIAIDVAS 824
              S   F+  +   +V + +  G L   L Q      + V         ++ I  ++  
Sbjct: 82  --YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---------KLFIC-ELVM 126

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A++YL +     ++H D+KP N+LLD     H+ DF +A         +  +T  +++  
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA-------MLPRETQITTMA- 175

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 176 -GTKPYMAP 183

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 46/201 (22%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR----------HR 762
           +G+G +G V+K I      VVAVK I         +F +  +A R  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ---SNDQVEVRKLSLI-QRMNI 818
           N++ ++ +  + +   V    LVF+YME     D LH    +N    V K  ++ Q +  
Sbjct: 70  NIVNLLNVLRADNDRDV---YLVFDYME----TD-LHAVIRANILEPVHKQYVVYQLIK- 120

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
                  I+YLH      ++H D+KPSN+LL+ +    V DFGL++   N      +   
Sbjct: 121 ------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 879 SSSIGIKGTV-------GYVA 892
           S +   +           YVA
Sbjct: 172 SINENTENFDDDQPILTDYVA 192

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 36/163 (22%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKII-TI 770
           +G+G++  V++ I   +   V VK++   +K   K    E + L N+R   N+I +   +
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS------ 824
                        LVFE++ N    D   Q           L Q +    D+        
Sbjct: 101 KDPVSRTPA----LVFEHVNN---TD-FKQ-----------LYQTLTDY-DIRFYMYEIL 140

Query: 825 -AIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKF 865
            A++Y H      ++H D+KP NV++D++     + D+GLA+F
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 40/202 (19%), Positives = 78/202 (38%), Gaps = 45/202 (22%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            ++    +IG+G FG V          V A+K+++   + ++  S  F  E + +     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             ++++    +   F+   +  +V EYM  G L               ++L+   ++   
Sbjct: 129 PWVVQLF--YA---FQDDRYLYMVMEYMPGGDL---------------VNLMSNYDVPEK 168

Query: 822 VA--------SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHL 871
            A         A++ +H       +H D+KP N+LLD     H+   DFG    ++   +
Sbjct: 169 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGM 223

Query: 872 DIASKTPSSSIGIKGTVGYVAP 893
                T        GT  Y++P
Sbjct: 224 V-RCDTAV------GTPDYISP 238

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 28/187 (14%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHRNLIKIITIC 771
           +G+G +G V          +VA+K I    K   +   + E + L++ +H N+I I  I 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78

Query: 772 SSTDFEGVDFKA--LVFEYMENGSLEDWLHQ---SNDQVEVRKLSLI-QRMNIAIDVASA 825
               FE  +F    ++ E M+     D LH+   +    +      I Q +        A
Sbjct: 79  RPDSFE--NFNEVYIIQELMQ----TD-LHRVISTQMLSDDHIQYFIYQTLR-------A 124

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           ++ LH      ++H DLKPSN+L++ +    V DFGLA+ +     D +  T   S    
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG--- 178

Query: 886 GTVGYVA 892
             V +VA
Sbjct: 179 -MVEFVA 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 44/202 (21%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA---------LRNIRHRN 763
           IG+G +G VY     + E  VA+K +       ++ F    +          L  ++   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSDY 86

Query: 764 LIKIITICSSTDFEGVDFKA--LVFEYMENGSLEDWLHQ---SNDQVEVRKLSLIQRMNI 818
           +I++  +    D     F    +V E  +     D L +   +        L+      I
Sbjct: 87  IIRLYDLIIPDDLL--KFDELYIVLEIAD----SD-LKKLFKTPI-----FLTEEHIKTI 134

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
             ++     ++H   +  ++H DLKP+N LL+ D    V DFGLA+ +++          
Sbjct: 135 LYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 879 SSSIGIKGTV--------GYVA 892
             +                +V 
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVV 213

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 41/181 (22%), Positives = 64/181 (35%), Gaps = 18/181 (9%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKG-KVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF 343
           ++P SL   S   LLDL  N     +     + L NL  L L  N+L       +    F
Sbjct: 32  NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-----ISSEAF 84

Query: 344 LSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITF 402
                +L+ L LS N          ++L   +  L +  N I   +      ++  L   
Sbjct: 85  -VPVPNLRYLDLSSNHLHTLDEFLFSDLQ-ALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141

Query: 403 TLEVNQFHGTIPDVI---SELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG 459
            L  NQ      ++I   ++L  L  L + +N L+    + L  L       L    L  
Sbjct: 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL---YLHN 198

Query: 460 N 460
           N
Sbjct: 199 N 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 45/188 (23%), Positives = 71/188 (37%), Gaps = 23/188 (12%)

Query: 449 SLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNL 505
            L      L     ++PS       L L   S+N L+    +   +  T    L LS+N 
Sbjct: 22  ILSCSKQQLPNVPQSLPSYT---ALLDL---SHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 506 LNGSLPLQV-GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRF 564
           LN  +  +    + NL  LD+SSN    +     S   +LE L +  N    V   +F  
Sbjct: 76  LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 565 LKSIKALNVSSNNLSGKIPE----FLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTK--- 617
           +  ++ L +S N +S + P         L  L  L+LS N  + ++P             
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTDLQKLPAWVK 191

Query: 618 --ISLHGN 623
             + LH N
Sbjct: 192 NGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 31/162 (19%), Positives = 59/162 (36%), Gaps = 10/162 (6%)

Query: 175 LQRLSVDINYLTGQLPDSV-GNLSAIEVIRITENSLGGKIPT-TLGLLRRLVNLNVAENQ 232
              L +  N L+    +     L+ +  + ++ N L   I +     +  L  L+++ N 
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99

Query: 233 FSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIP----D 288
              +      ++ ++E++ L  N    +   +   ++  L+KL +  N      P     
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIVVV-DRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157

Query: 289 SLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE-QNN 329
             +    L LLDL SN+ K     D   L       L   NN
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 34/145 (23%), Positives = 54/145 (37%), Gaps = 13/145 (8%)

Query: 74  HRHQRLTELNLSSQRIGGVLSPYV-GNLSFLRYINLADNGFRGDIPQEI-GNLFRLEKLA 131
            R   L  L LS   +   +S      +  LRY++L+ N     + + +  +L  LE L 
Sbjct: 61  TRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLL 118

Query: 132 LSNNSFSGTIPTN-LSRCSNLIHFCASNNKLEGQIPKEI----GNLLKLQRLSVDINYLT 186
           L NN     +  N     + L     S N++  + P E+      L KL  L +  N L 
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

Query: 187 GQLPDSVGNLSAI--EVIRITENSL 209
                 +  L A     + +  N L
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPL 201

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 48/222 (21%)

Query: 688 MEKLFPMVSYAELSKAT-SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQK 743
           +E   P  S  +  +    +F    +IG+G FG V    L + + V A+K++N   + ++
Sbjct: 56  LEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR 115

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
             +  F  E + L N   + +  +    +   F+  +   LV +Y   G L         
Sbjct: 116 AETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLVMDYYVGGDL--------- 161

Query: 804 QVEVRKLSLIQRMNIAID----------VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
                 L+L+ +    +           +  AI+ +H       VH D+KP N+L+D + 
Sbjct: 162 ------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN- 211

Query: 854 VAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             H+   DFG    L      + S          GT  Y++P
Sbjct: 212 -GHIRLADFGSCLKLMEDG-TVQSSVAV------GTPDYISP 245

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.0 bits (160), Expect = 4e-11
 Identities = 91/626 (14%), Positives = 193/626 (30%), Gaps = 191/626 (30%)

Query: 237 FPRSICNISSVELIFLTENRFSGI-FPFDILLNLPN--LKKLGIGGNNFVGSIPDS---- 289
            P+SI +   ++ I ++++  SG    F  LL+     ++K       FV  +       
Sbjct: 41  MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK-------FVEEVLRINYKF 93

Query: 290 LSNASNLELLDLPS----------------NQ-F-KGKVSI--DFSSLKNLWLLNLEQNN 329
           L +    E    PS                NQ F K  VS    +  L+   LL L    
Sbjct: 94  LMSPIKTEQRQ-PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ-ALLELRPAK 151

Query: 330 -------LGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGR 382
                  LG+G              + + +      +   ++   I         L++  
Sbjct: 152 NVLIDGVLGSGK-------------TWVALDVCLSYKVQCKMDFKI-------FWLNLKN 191

Query: 383 NQISGTIPPGIRNLVNLITFTLEVNQFHG-TIP----DVISELKNLQQLSVFNNFLRGGI 437
                T+   ++ L+  I         H   I      + +EL+ L +   + N L   +
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL--V 249

Query: 438 PSGLGNLTKLGSLDLGS------------NSLQGN---------IPSSLGNCQNLILFIA 476
              + N     + +L              + L               +L   +   L + 
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
             +    DLP+++L+     L + ++ ++ +G       N K+     ++ ++ + +I  
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSI-IAESIRDG--LATWDNWKH-----VNCDKLTTIIES 361

Query: 537 TLSTCVSLE----YLDISINSF-YGV-IPLSFRFLKSIKALNVSSNNLSGKIPEF----L 586
           +L+     E    +  +S+  F     IP           L++   ++           L
Sbjct: 362 SLNVLEPAEYRKMFDRLSV--FPPSAHIP--------TILLSLIWFDVIKSDVMVVVNKL 411

Query: 587 ENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRKP 646
              S +E               K     ++ IS+            ++L     K   + 
Sbjct: 412 HKYSLVE---------------KQ--PKESTISIPS----------IYL---ELKVKLEN 441

Query: 647 KITLLKVLIP--VVVSCLLLSSCLT----------IVYARKRRSTH-KSVDTSPMEKLFP 693
           +  L + ++    +         +           I +       H K+++      LF 
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-------HLKNIEHPERMTLFR 494

Query: 694 MVSYAEL-----------SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ 742
           MV + +            +   +  S  N + Q +F   YK  + D++      V  +  
Sbjct: 495 MV-FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDNDPKYERLVNAILD 550

Query: 743 KGASKSFVSECEA-LRNIRHRNLIKI 767
                 F+ + E  L   ++ +L++I
Sbjct: 551 ------FLPKIEENLICSKYTDLLRI 570

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 1e-07
 Identities = 98/609 (16%), Positives = 176/609 (28%), Gaps = 205/609 (33%)

Query: 43  AIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSF 102
            IK++   PS +T  +    +   +         Q   + N+S  +    L   +  L  
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRL-YNDN------QVFAKYNVSRLQPYLKLRQALLELRP 149

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEK--LA---LSNNSFSGTIPT-----NLSRCSNLI 152
            + + +  +G  G      G      K  +A     +      +       NL  C    
Sbjct: 150 AKNVLI--DGVLG-----SG------KTWVALDVCLSYKVQCKMDFKIFWLNLKNC---- 192

Query: 153 HFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK 212
                        P+ +  L  LQ+L   I+       D   N      I++  +S+  +
Sbjct: 193 -----------NSPETV--LEMLQKLLYQIDPNWTSRSDHSSN------IKLRIHSIQAE 233

Query: 213 IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNL 272
                  LRRL+         S  +           L+              +L      
Sbjct: 234 -------LRRLL--------KSKPYENC--------LL--------------VL------ 250

Query: 273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV-------SI-DFSSLKNLWLLN 324
                           ++ NA      +        K+        + DF S      ++
Sbjct: 251 ---------------LNVQNAKAWNAFN-----LSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 325 LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH---SIANLSLKMI--ELS 379
           L+ +++           +       LK L         +LP    +     L +I   + 
Sbjct: 291 LDHHSMTLTPDEVKS--LL------LKYLDCRP----QDLPREVLTTNPRRLSIIAESIR 338

Query: 380 VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNL-QQLSVFNNFLRGGIP 438
            G              L  +I  +L V +     P    E + +  +LSVF       IP
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLE-----PA---EYRKMFDRLSVFPPSAH--IP 388

Query: 439 SGL-----GNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSIT 493
           + L      ++ K   + +  N L      SL   Q       S   +  +L  +L +  
Sbjct: 389 TILLSLIWFDVIKSDVMVV-VNKLHK---YSLVEKQPK-ESTISIPSIYLELKVKLENEY 443

Query: 494 TL-SLVLDLSNNL----LNGSLPLQVGN---------LKNLVMLDISSNQFSGVIPVTLS 539
            L   ++D  N       +  +P  +           LKN+   +     F  V      
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPE-RMTLFRMV------ 496

Query: 540 TCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN-NLSGKIPEFLENLSFLE-FLNL 597
                 +LD             FRFL+  K  + S+  N SG I   L+ L F + ++  
Sbjct: 497 ------FLD-------------FRFLEQ-KIRHDSTAWNASGSILNTLQQLKFYKPYICD 536

Query: 598 SYNYFEGEV 606
           +   +E  V
Sbjct: 537 NDPKYERLV 545

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 27/192 (14%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-SKSFVSECEALRNIRHR 762
              +++ + IG+G +G V       +++ VA+K I+  +     +  + E + L   RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 763 NLIKIITICSSTDFEGVDFKA--LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           N+I I  I  +   E    K   +V + ME     D L++    ++ + LS         
Sbjct: 86  NIIGINDIIRAPTIE--QMKDVYIVQDLME----TD-LYKL---LKTQHLSNDHICYFLY 135

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +   ++Y+H      ++H DLKPSN+LL+      + DFGLA+     H      T   
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT--- 189

Query: 881 SIGIKGTVGYVA 892
                    YVA
Sbjct: 190 --------EYVA 193

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 45/160 (28%), Positives = 64/160 (40%), Gaps = 26/160 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG G FG +  G        VA+K+     K  +     E         + L     I  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFY-----KQLGSGDGIPQ 69

Query: 773 STDF--EGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
              F   G  + A+V E +  G SLED     +     R  SL   + IAI + S +EY+
Sbjct: 70  VYYFGPCG-KYNAMVLELL--GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYV 121

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDM-----VAHVGDFGLAK 864
           H      +++ D+KP N L+         V H+ DF LAK
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 34/201 (16%), Positives = 70/201 (34%), Gaps = 48/201 (23%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN 763
           + ++S    +G G FG V +    +     A+K +    +  ++    E + ++ + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 764 LIKIITICSSTDFEGVDFKA---------------------------------LVFEYME 790
           +IK++    +T  E                                       ++ EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 791 NGSLEDWLHQSNDQVEVRK--LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL 848
               +  LH+           + +         +  A+ ++H      + H D+KP N+L
Sbjct: 122 ----DT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLL 173

Query: 849 LD-YDMVAHVGDFGLAKFLSN 868
           ++  D    + DFG AK L  
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIP 194

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 24/185 (12%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G+G FG V            A+K++    +  K      ++E   L+N RH  L  + 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
              S   F+  D    V EY   G L   L +     E R      R   A ++ SA++Y
Sbjct: 215 --YS---FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGA-EIVSALDY 263

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
           LH      +V+ DLK  N++LD D    + DFGL K        I       +    GT 
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFC--GTP 313

Query: 889 GYVAP 893
            Y+AP
Sbjct: 314 EYLAP 318

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 43/190 (22%), Positives = 78/190 (41%), Gaps = 32/190 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITI-- 770
           +G G  G V+  +  D +  VA+K I L    + K  + E + +R + H N++K+  I  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 771 -----CSSTDFEGVDFKA--LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
                 +       +  +  +V EYME     D L      +E   L           + 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMET----D-LANV---LEQGPLLEEHARLFMYQLL 130

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
             ++Y+H      ++H DLKP+N+ ++  D+V  +GDFGLA+ +  H+      +     
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS----- 182

Query: 883 GIKGTVGYVA 892
                   + 
Sbjct: 183 ------EGLV 186

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 17/146 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-----HRNLIK 766
            +G G F TV+       +  VA+KV+   +     + + E   L+++R       N   
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 767 IITICSSTDFEGVDFK--ALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           ++ +       GV+     +VFE +  G  L  W+ +SN     + L L     I   V 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY----QGLPLPCVKKIIQQVL 156

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL 849
             ++YLH  C+  ++H D+KP N+LL
Sbjct: 157 QGLDYLHTKCR--IIHTDIKPENILL 180

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 35/167 (20%), Positives = 54/167 (32%), Gaps = 31/167 (18%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIR---------H 761
           I  G +G V  G+  +   V A+K +   +                R +R         H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 762 RNLIKIITICSSTDFEGVDFKA--LVFEYMENGSLEDWLHQ---SNDQVEVRKLSLIQRM 816
            N++ +  I    +          LV E M      D L Q            +S     
Sbjct: 89  PNILGLRDIFVHFEEP--AMHKLYLVTELMRT----D-LAQVIHDQRI----VISPQHIQ 137

Query: 817 NIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
                +   +  LH   +  +VH DL P N+LL  +    + DF LA
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 36/164 (21%), Positives = 71/164 (43%), Gaps = 16/164 (9%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR---NLIKII 768
           +IG+G FG V K         VA+K++  +++   ++   E   L ++R +   N + +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNVI 162

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +  F       + FE +   +L + + ++      +  SL      A  +   ++ 
Sbjct: 163 HMLENFTFRN--HICMTFELLSM-NLYELIKKNKF----QGFSLPLVRKFAHSILQCLDA 215

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAH--VGDFGLAKFLSNHH 870
           LH +    ++H DLKP N+LL     +   V DFG + +     
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 35/180 (19%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA-------- 755
              + +   IG G  G V        +  VA+K +       S+ F ++  A        
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113

Query: 756 -LRNIRHRNLIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
            ++ + H+N+I ++ +     +  +F+ V    LV E M+     + L Q    V   +L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDV---YLVMELMDA----N-LCQ----VIQMEL 161

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              +   +   +   I++LH      ++H DLKPSN+++  D    + DFGLA+      
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 26/160 (16%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G FG +++G    +   VA+K    +    +     E         + L     I +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTY-----KLLAGCTGIPN 70

Query: 773 STDF--EGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
              F  EG     LV + +  G SLED L         RK S+      A  + + ++ +
Sbjct: 71  VYYFGQEG-LHNVLVIDLL--GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSI 122

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDM-----VAHVGDFGLAK 864
           H      +V+ D+KP N L+         + +V DFG+ K
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 35/179 (19%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA-------- 755
              + S   +G G +G+V   I       VA+K +       S+ F SE  A        
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75

Query: 756 -LRNIRHRNLIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
            L++++H N+I ++ +     S  +F       LV  +M+     D L +        K 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDF---YLVMPFMQ----TD-LQKIMGL----KF 123

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           S  +   +   +   ++Y+H      +VH DLKP N+ ++ D    + DFGLA+     
Sbjct: 124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 35/181 (19%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA-------- 755
              + +   IG G  G V        E  VA+K +       S+ F ++  A        
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELV 76

Query: 756 -LRNIRHRNLIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
            ++ + H+N+I ++ +     S  +F+ V    +V E M+     + L Q    V   +L
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDV---YIVMELMD----AN-LCQ----VIQMEL 124

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              +   +   +   I++LH      ++H DLKPSN+++  D    + DFGLA+      
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

Query: 871 L 871
           +
Sbjct: 182 M 182

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 34/179 (18%)

Query: 704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA-------- 755
              + + + +G G +G+V         + VAVK +       S+ F S   A        
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAKRTYRELR 80

Query: 756 -LRNIRHRNLIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
            L++++H N+I ++ +     S  +F  V    LV   M      D L+     V+ +KL
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDV---YLVTHLMG----AD-LNNI---VKCQKL 129

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
           +      +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+  ++ 
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 20/156 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG G FG +Y G        VA+K+  +K K        E +  + ++    I  I  C 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 773 STDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
           +      D+  +V E +  G SLED  +  +     RK SL   + +A  + S IEY+H 
Sbjct: 75  AEG----DYNVMVMELL--GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS 123

Query: 832 HCQPPMVHGDLKPSNVLLDYDM---VAHVGDFGLAK 864
                 +H D+KP N L+       + ++ DFGLAK
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 60.7 bits (146), Expect = 7e-10
 Identities = 38/240 (15%), Positives = 69/240 (28%), Gaps = 65/240 (27%)

Query: 687 PMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVI-------- 738
           P     P        K          IG+G FG V++ I   D   VA+K+I        
Sbjct: 12  PFSHCLPTEKLQRCEK----------IGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLV 59

Query: 739 NLKQKGASKSFVSECEALRNI---------RHRNLIKIITIC------------------ 771
           N   +   +  + E    + +         R    I + ++                   
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 772 -------SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
                     DF   D   +V E+   G   + +         +  SL    +I   + +
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTA 172

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK--FLSNHHLDIASKTPSSSI 882
           ++       +    H DL   NVLL    +  +      K   + +  L ++    + S 
Sbjct: 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSR 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 34/170 (20%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA---------LRNIRHRN 763
           +G G +G V   + G     VA+K +        + F SE  A         L+++RH N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMRHEN 85

Query: 764 LIKIITI----CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
           +I ++ +     +  DF       LV  +M      D L +    ++  KL   +   + 
Sbjct: 86  VIGLLDVFTPDETLDDFTDF---YLVMPFMG----TD-LGKL---MKHEKLGEDRIQFLV 134

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
             +   + Y+H      ++H DLKP N+ ++ D    + DFGLA+   + 
Sbjct: 135 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 30/193 (15%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV----SECEALRNIR 760
            +F     +G G FG V      +     A+K+++ KQK      +    +E   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
              L+K+    S   F+      +V EY+  G +  + H       + + S       A 
Sbjct: 100 FPFLVKLE--FS---FKDNSNLYMVMEYVAGGEM--FSHLRR----IGRFSEPHARFYAA 148

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSS 880
            +    EYLH      +++ DLKP N+L+D      V DFG AK        +  +T + 
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWT- 197

Query: 881 SIGIKGTVGYVAP 893
              + GT   +AP
Sbjct: 198 ---LCGTPEALAP 207

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 49/201 (24%), Positives = 85/201 (42%), Gaps = 21/201 (10%)

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
              V     + +  ++++ +   ++  K    I    L N+  L L  N L   +A    
Sbjct: 28  KKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLHDISALK-- 82

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN-LVN 398
                   ++L  L L+ NQ    LP+ + +    + EL +  NQ+  ++P G+ + L N
Sbjct: 83  ------ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN 134

Query: 399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSL 457
           L    L  NQ       V  +L NL +L +  N L+  +P G+   LT+L  L L  N L
Sbjct: 135 LTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQL 193

Query: 458 QGNIPS----SLGNCQNLILF 474
           + ++P      L + Q + L 
Sbjct: 194 K-SVPDGVFDRLTSLQYIWLH 213

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 29/191 (15%)

Query: 299 LDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
            +L        V+   + L ++  +    +++ +                +++ L+L  N
Sbjct: 24  ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--------YLPNVRYLALGGN 73

Query: 359 QFGGELP--HSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPD 415
           +   ++     + NL+     L +  NQ+  ++P G+   L NL    L  NQ       
Sbjct: 74  KLH-DISALKELTNLT----YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDG 127

Query: 416 VISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLGNCQN 470
           V  +L NL  L++ +N L+  +P G+   LT L  LDL  N LQ ++P      L   ++
Sbjct: 128 VFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKD 185

Query: 471 LILFIASYNKL 481
           L L     N+L
Sbjct: 186 LRL---YQNQL 193

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 19/152 (12%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT---GTANDLDFV 341
            IP +L     +  + L  N  K      FS  K L  ++L  N +          L   
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGL--- 79

Query: 342 IFLSNCSSLKVLSLSDNQFGGELPHSI-ANLSLKMIELSVGRNQISGTIPPGI-RNLVNL 399
                  SL  L L  N+   ELP S+   L   +  L +  N+I+  +     ++L NL
Sbjct: 80  ------RSLNSLVLYGNKI-TELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNL 130

Query: 400 ITFTLEVNQFHGTIPDVISELKNLQQLSVFNN 431
              +L  N+         S L+ +Q + +  N
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 17/150 (11%)

Query: 412 TIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGNIPS----SLG 466
            IP  + E   + ++ +  N ++  IP G      KL  +DL +N +   +       L 
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 467 NCQNLILFIASYNKLTGDLPQQLL-SITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLD 524
           +  +L+L     NK+T +LP+ L   + +L L L L+ N +N  L +    +L NL +L 
Sbjct: 81  SLNSLVL---YGNKIT-ELPKSLFEGLFSLQL-LLLNANKIN-CLRVDAFQDLHNLNLLS 134

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
           +  N+   +   T S   +++ + ++ N F
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 57.9 bits (141), Expect = 4e-09
 Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 41/175 (23%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFV----SECEALRNIR 760
            +F     +G G FG V+      +    A+KV+  K+       V     E   L  + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVT 64

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI-- 818
           H  +I++    +   F+      ++ +Y+E G L                SL+++     
Sbjct: 65  HPFIIRMW--GT---FQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFP 104

Query: 819 -------AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAK 864
                  A +V  A+EYLH      +++ DLKP N+LLD +   H+   DFG AK
Sbjct: 105 NPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK 154

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 20/156 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG G FG +Y G        VA+K+ N+K K      + E +  R ++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 773 STDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                  D+  LV + +  G SLED  +  +     RKLSL   + +A  + + +E++H 
Sbjct: 73  VEG----DYNVLVMDLL--GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS 121

Query: 832 HCQPPMVHGDLKPSNVLLDYDMVAH---VGDFGLAK 864
                 +H D+KP N L+     A+   + DFGLAK
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 31/188 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G+G FG V            A+K++    +  K      V+E   L+N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI-AIDVASAIE 827
              +   F+  D    V EY   G L   L +       R  +  +R      ++ SA+E
Sbjct: 72  --YA---FQTHDRLCFVMEYANGGELFFHLSRE------RVFTE-ERARFYGAEIVSALE 119

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           YLH      +V+ D+K  N++LD D   H+   DFGL K        I+      +    
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK------EGISDGATMKTFC-- 166

Query: 886 GTVGYVAP 893
           GT  Y+AP
Sbjct: 167 GTPEYLAP 174

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 56.0 bits (136), Expect = 2e-08
 Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 35/191 (18%)

Query: 712 MIGQGRFGTVY---KGILGDDEMVVAVKVINLKQKGASKSFV---SECEALRNIRHRNLI 765
           ++GQG FG V+   K    D   + A+KV+  K     +  V    E + L  + H  ++
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ-RMNIAIDVAS 824
           K+    +   F+      L+ +++  G L   L +          +    +  +A ++A 
Sbjct: 90  KLH--YA---FQTEGKLYLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLA-ELAL 137

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSI 882
           A+++LH      +++ DLKP N+LLD +   H+   DFGL+K        I  +  + S 
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK------ESIDHEKKAYSF 186

Query: 883 GIKGTVGYVAP 893
              GTV Y+AP
Sbjct: 187 C--GTVEYMAP 195

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 25/139 (17%), Positives = 56/139 (40%), Gaps = 18/139 (12%)

Query: 323 LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP----HSIANLSLKMIEL 378
           L L  N      A  +           L+ ++ S+N+   ++        + ++    E+
Sbjct: 37  LRLNNNEFTVLEATGI-----FKKLPQLRKINFSNNKIT-DIEEGAFEGASGVN----EI 86

Query: 379 SVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGI 437
            +  N++   +   + + L +L T  L  N+      D    L +++ LS+++N +   +
Sbjct: 87  LLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TV 144

Query: 438 PSG-LGNLTKLGSLDLGSN 455
             G    L  L +L+L +N
Sbjct: 145 APGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 17/140 (12%)

Query: 245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPD-SLSNASNLELLDLPS 303
                + L  N F+ +    I   LP L+K+    NN +  I + +   AS +  + L S
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFEGASGVNEILLTS 90

Query: 304 NQFKGKVSIDFSSLKNLWLLNLEQNNLGT---GTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           N+ +      F  L++L  L L  N +      +   L         SS+++LSL DNQ 
Sbjct: 91  NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL---------SSVRLLSLYDNQI 141

Query: 361 GGELPHSI-ANL-SLKMIEL 378
              +       L SL  + L
Sbjct: 142 -TTVAPGAFDTLHSLSTLNL 160

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 30/150 (20%), Positives = 62/150 (41%), Gaps = 16/150 (10%)

Query: 412 TIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLG 466
            IP+ I +     +L + NN       +G+   L +L  ++  +N +  +I         
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 467 NCQNLILFIASYNKLTGDLPQQLL-SITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLD 524
               ++L   + N+L  ++  ++   + +L   L L +N +   +       L ++ +L 
Sbjct: 82  GVNEILL---TSNRLE-NVQHKMFKGLESLKT-LMLRSNRIT-CVGNDSFIGLSSVRLLS 135

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSF 554
           +  NQ + V P    T  SL  L++  N F
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 30/142 (21%), Positives = 52/142 (36%), Gaps = 8/142 (5%)

Query: 460 NIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLK 518
           +IP        L L   + N+ T      +         ++ SNN +   +         
Sbjct: 29  HIPQYT---AELRL---NNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNL 578
            +  + ++SN+   V         SL+ L +  N    V   SF  L S++ L++  N +
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141

Query: 579 SGKIPEFLENLSFLEFLNLSYN 600
           +   P   + L  L  LNL  N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 9/113 (7%)

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           L +L  +N + N+ + +   +    S V  I LT NR   +    +   L +LK L +  
Sbjct: 56  LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV-QHKMFKGLESLKTLMLRS 114

Query: 280 NNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSID---FSSLKNLWLLNLEQN 328
           N     +  DS    S++ LL L  NQ     ++    F +L +L  LNL  N
Sbjct: 115 NRIT-CVGNDSFIGLSSVRLLSLYDNQIT---TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 28/158 (17%), Positives = 62/158 (39%), Gaps = 20/158 (12%)

Query: 65  CQWTGVTCGHRHQRLT-----------ELNLSSQRIGGVLSPYV-GNLSFLRYINLADNG 112
           C+ T V C ++  +L            EL L++     + +  +   L  LR IN ++N 
Sbjct: 11  CEGTTVDCSNQ--KLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK 68

Query: 113 FRGDIPQEI-GNLFRLEKLALSNNSFSGTIPTNL-SRCSNLIHFCASNNKLEGQIPKEI- 169
              DI +        + ++ L++N     +   +     +L      +N++   +  +  
Sbjct: 69  IT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF 125

Query: 170 GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN 207
             L  ++ LS+  N +T   P +   L ++  + +  N
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 14/165 (8%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR---NLIKI 767
           ++IG+G FG V K     ++  VA+K+I  K+   +++ + E   L  +          I
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-EVRLLELMNKHDTEMKYYI 118

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           + +     F       LVFE +   +L D L  +N     R +SL      A  + +A+ 
Sbjct: 119 VHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTN----FRGVSLNLTRKFAQQMCTALL 171

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAH--VGDFGLAKFLSNHH 870
           +L    +  ++H DLKP N+LL     +   + DFG +  L    
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 40/140 (28%), Positives = 59/140 (42%), Gaps = 12/140 (8%)

Query: 294 SNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF--LSNCSSLK 351
           +N ++L L  NQ        F SL NL  L L  N LG          +F  L+    L 
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-----VFDSLTQ---LT 91

Query: 352 VLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG 411
           VL L  NQ    LP ++ +  + + EL +  N+++  +P GI  L +L    L+ NQ   
Sbjct: 92  VLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149

Query: 412 TIPDVISELKNLQQLSVFNN 431
                   L +L    +F N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 33/126 (26%), Positives = 48/126 (38%), Gaps = 8/126 (6%)

Query: 377 ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGG 436
            L +  NQI+   P    +L+NL    L  NQ       V   L  L  L +  N L   
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 437 IPSGL-GNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ----QLLS 491
           +PS +   L  L  L +  N L   +P  +    +L       N+L   +P     +L S
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSS 160

Query: 492 ITTLSL 497
           +T   L
Sbjct: 161 LTHAYL 166

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 32/114 (28%), Positives = 45/114 (39%), Gaps = 10/114 (8%)

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ---GNIPSSLGNCQNLILFIASYNK 480
           Q L + +N +    P    +L  L  L LGSN L      +  SL     L L     N+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDL---GTNQ 99

Query: 481 LTGDLPQQLL-SITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV 533
           LT  LP  +   +  L   L +  N L   LP  +  L +L  L +  NQ   +
Sbjct: 100 LTV-LPSAVFDRLVHLKE-LFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI 150

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 42/187 (22%), Positives = 73/187 (39%), Gaps = 28/187 (14%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G+G FG V        + + AVK++    + Q    +  + E   L        +  +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
             C  T     D    V EY+  G L   + Q      V +      +  A ++A  + +
Sbjct: 408 HSCFQTM----DRLYFVMEYVNGGDLMYHIQQ------VGRFKEPHAVFYAAEIAIGLFF 457

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           L       +++ DLK  NV+LD +   H+   DFG+ K       +I     + +    G
Sbjct: 458 LQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVTTKTFC--G 504

Query: 887 TVGYVAP 893
           T  Y+AP
Sbjct: 505 TPDYIAP 511

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 54.5 bits (132), Expect = 7e-08
 Identities = 43/192 (22%), Positives = 83/192 (43%), Gaps = 35/192 (18%)

Query: 712 MIGQGRFGTVY---KGILGDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHRNL 764
           ++G+G +G V+   K    +   + A+KV+     ++    +    +E   L  ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ-RMNIAIDVA 823
           + +I   +   F+      L+ EY+  G L   L +                  +A +++
Sbjct: 84  VDLI--YA---FQTGGKLYLILEYLSGGELFMQLERE------GIFMEDTACFYLA-EIS 131

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSS 881
            A+ +LH      +++ DLKP N++L++    HV   DFGL K        I   T + +
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK------ESIHDGTVTHT 180

Query: 882 IGIKGTVGYVAP 893
               GT+ Y+AP
Sbjct: 181 FC--GTIEYMAP 190

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 34/180 (18%), Positives = 63/180 (35%), Gaps = 35/180 (19%)

Query: 706 EFSSSN-----MIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQKGAS----KSFVS 751
           EF          +G+G FG V +              VAVK++    +GA+    ++ +S
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMS 74

Query: 752 ECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKL 810
           E + L +I  H N++ ++  C  T   G     ++ E+ + G+L  +L    ++    K 
Sbjct: 75  ELKILIHIGHHLNVVNLLGAC--TKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKT 130

Query: 811 SLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
              +                       +  DLK     +     +    F   K LS+  
Sbjct: 131 KGARFRQ-------------GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 7/116 (6%)

Query: 243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
             S V+ + L  +R +      +      L+ L       + SI + L   + L+ L+L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSIAN-LPKLNKLKKLELS 72

Query: 303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
            N+  G + +      NL  LNL  N +      DL  +  L    +LK L L + 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 30/122 (24%), Positives = 49/122 (40%), Gaps = 16/122 (13%)

Query: 313 DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS 372
             S +K L L N  ++N G                  L+ LS  +         SIANL 
Sbjct: 15  TPSDVKELVLDNS-RSNEGKLEGL-------TDEFEELEFLSTINVGL-----TSIANLP 61

Query: 373 L--KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG-TIPDVISELKNLQQLSVF 429
              K+ +L +  N++SG +        NL    L  N+    +  + + +L+NL+ L +F
Sbjct: 62  KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121

Query: 430 NN 431
           N 
Sbjct: 122 NC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 26/110 (23%), Positives = 40/110 (36%), Gaps = 6/110 (5%)

Query: 516 NLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS 575
           ++K LV+ +  SN   G +         LE+L         +  L    L  +K L +S 
Sbjct: 18  DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSIANLPK--LNKLKKLELSD 73

Query: 576 NNLSGKIPEFLENLSFLEFLNLSYNYFE--GEVPVKGVFSNKTKISLHGN 623
           N +SG +    E    L  LNLS N  +    +       N   + L   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 5/103 (4%)

Query: 79  LTELNLSSQRIG-GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF 137
           + EL L + R   G L         L +++  + G    I   +  L +L+KL LS+N  
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRV 76

Query: 138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV 180
           SG +     +C NL H   S NK++      I  L KL+ L  
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKS 117

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 39/182 (21%), Positives = 75/182 (41%), Gaps = 34/182 (18%)

Query: 712 MIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR---NLIKI 767
            +G+G FG V + +     +  VA+K+I    K    + + E   L+ I+ +   N    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLC 84

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           + +    +F G     + FE +   +  ++L ++N     +   L    ++A  +  A+ 
Sbjct: 85  VLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNF----QPYPLPHVRHMAYQLCHALR 137

Query: 828 YLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVG----------------DFGLAKFLSN 868
           +LH +    + H DLKP N+L    +++ + +                  DFG A F   
Sbjct: 138 FLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194

Query: 869 HH 870
           HH
Sbjct: 195 HH 196

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)

Query: 351 KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQF 409
             L L  NQF   +P  ++N    +  + +  N+IS T+      N+  L+T  L  N+ 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYK-HLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL 90

Query: 410 HGTIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSN 455
               P     LK+L+ LS+  N +   +P G   +L+ L  L +G+N
Sbjct: 91  RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 51.8 bits (125), Expect = 5e-07
 Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 30/188 (15%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEAL-RNIRHRNLIKI 767
           M+G+G FG V+           A+K +    +      +  + E   L     H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
              C+   F+  +    V EY+  G L   +          K  L +    A ++   ++
Sbjct: 84  F--CT---FQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQ 132

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +LH      +V+ DLK  N+LLD D   H+   DFG+ K       ++     +++    
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK------ENMLGDAKTNTFC-- 179

Query: 886 GTVGYVAP 893
           GT  Y+AP
Sbjct: 180 GTPDYIAP 187

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 51.9 bits (125), Expect = 5e-07
 Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 39/195 (20%)

Query: 712 MIGQGRFGTVY---KGILGDDEMVVAVKVINLKQKGASKSFVSEC-EALRNIRHRNLIK- 766
           ++G G +G V+   K    D   + A+KV+  K     K+  +E     R +    L   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV----LEHI 115

Query: 767 -----IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ-RMNIAI 820
                ++T+  +  F+      L+ +Y+  G L   L Q        + +  + ++ +  
Sbjct: 116 RQSPFLVTLHYA--FQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVG- 166

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTP 878
           ++  A+E+LH      +++ D+K  N+LLD +   HV   DFGL+K       + A    
Sbjct: 167 EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAY-D- 219

Query: 879 SSSIGIKGTVGYVAP 893
                  GT+ Y+AP
Sbjct: 220 -----FCGTIEYMAP 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 51.5 bits (124), Expect = 6e-07
 Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 32/189 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEAL-RNIRHRNLIKI 767
           +IG+G FG V       +E+  AVKV+    + +K   K  +SE   L +N++H  L+ +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ-RMNIAIDVASAI 826
               S   F+  D    V +Y+  G L   L +       R     + R   A ++ASA+
Sbjct: 105 H--FS---FQTADKLYFVLDYINGGELFYHLQRE------RCFLEPRARFYAA-EIASAL 152

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGI 884
            YLH      +V+ DLKP N+LLD     H+   DFGL K       +I   + +S+   
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK------ENIEHNSTTSTFC- 200

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 201 -GTPEYLAP 208

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 52.2 bits (125), Expect = 6e-07
 Identities = 57/355 (16%), Positives = 108/355 (30%), Gaps = 38/355 (10%)

Query: 265 ILLNLPNLKKLGIGGNNFVGSIPDS-----LSNASNLELLDLPSNQFKGKVSIDFSSLKN 319
                 +L  L I  +     +  S     ++   NL+ L L       K++        
Sbjct: 179 FPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236

Query: 320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLS-LKMIEL 378
           L  L                  + LS C  L+ LS   +     LP   +  S L  + L
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
           S      S  +   +     L    +        +  + S  K+L++L VF       + 
Sbjct: 297 S-YATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP--SEPFVM 353

Query: 439 SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD----LPQQLLSITT 494
                LT+ G + +               C  L   +    ++T      + +   ++T 
Sbjct: 354 EPNVALTEQGLVSVSM------------GCPKLESVLYFCRQMTNAALITIARNRPNMTR 401

Query: 495 LSLVL-------DLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYL 547
             L +        L+   L+      V + K+L  L +S      V     +    +E L
Sbjct: 402 FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEML 461

Query: 548 DISI--NSFYGVIPLSFRFLKSIKALNVSSNNLSGK-IPEFLENLSFLEFLNLSY 599
            ++   +S  G+  +      S++ L +       K +      L  +  L +S 
Sbjct: 462 SVAFAGDSDLGMHHVL-SGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 41/291 (14%), Positives = 84/291 (28%), Gaps = 45/291 (15%)

Query: 322 LLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVG 381
           +    +  +  G    +     +     ++ + L             A+ +L        
Sbjct: 40  IERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKP-------HFADFNLVPDGWGGY 92

Query: 382 RNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD-----VISELKNLQQLSVFN--NFLR 434
                  +      L  +    L+       + D     +    KN + L + +   F  
Sbjct: 93  VYPWIEAMSSSYTWLEEI---RLK----RMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145

Query: 435 GGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITT 494
            G+ +       L  LDL  + +       L +                  P    S+ +
Sbjct: 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSH-----------------FPDTYTSLVS 188

Query: 495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS---- 550
           L++   L++ +   +L   V    NL  L ++       +   L     LE L       
Sbjct: 189 LNIS-CLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247

Query: 551 --INSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSY 599
                 Y  + ++    K ++ L+   + +   +P      S L  LNLSY
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSY 298

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 7/128 (5%)

Query: 498 VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV 557
           ++ L+  L+  +      N      LD+   +   VI    +T    + +D S N    +
Sbjct: 1   MVKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57

Query: 558 IPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE--GEVPVKGVFSNK 615
                  L+ +K L V++N +        + L  L  L L+ N     G++       + 
Sbjct: 58  DGFPL--LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115

Query: 616 TKISLHGN 623
           T + +  N
Sbjct: 116 TYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 21/116 (18%), Positives = 41/116 (35%), Gaps = 9/116 (7%)

Query: 243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
           N      + L   +   I   ++   L     +    +N +  + D       L+ L + 
Sbjct: 17  NAVRDRELDLRGYKIPVIE--NLGATLDQFDAIDFS-DNEIRKL-DGFPLLRRLKTLLVN 72

Query: 303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
           +N+          +L +L  L L  N+L      +L  +  L++  SL  L +  N
Sbjct: 73  NNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 24/103 (23%), Positives = 39/103 (37%), Gaps = 5/103 (4%)

Query: 78  RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF 137
           R  EL+L   +I  V+      L     I+ +DN  R  +      L RL+ L ++NN  
Sbjct: 20  RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRI 76

Query: 138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV 180
                       +L     +NN L      ++  L  L+ L+ 
Sbjct: 77  CRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTY 117

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 11/95 (11%)

Query: 266 LLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLKNLWLLN 324
             N    ++L + G   +  I +  +     + +D   N+ +    +D F  L+ L  L 
Sbjct: 15  YTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLL 70

Query: 325 LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
           +  N +                   L  L L++N 
Sbjct: 71  VNNNRICRIGEG------LDQALPDLTELILTNNS 99

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 3/110 (2%)

Query: 171 NLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE 230
           N ++ + L +    +   + +    L   + I  ++N +  K+     LLRRL  L V  
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73

Query: 231 NQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGN 280
           N+   +       +  +  + LT N    +   D L +L +L  L I  N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 18/121 (14%)

Query: 470 NLILFIASYNKLTG----DLPQQLLS-ITTLSL------VLDLSNNLLNGSLPLQVGNLK 518
            LI   A Y         DL    +  I  L         +D S+N +          L+
Sbjct: 7   ELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLR 64

Query: 519 NLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS---INSFYGVIPLSFRFLKSIKALNVSS 575
            L  L +++N+   +          L  L ++   +     + PL    LKS+  L +  
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL--ASLKSLTYLCILR 122

Query: 576 N 576
           N
Sbjct: 123 N 123

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 25/107 (23%), Positives = 47/107 (43%), Gaps = 4/107 (3%)

Query: 351 KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQF 409
             L L+DN+ G      +      +++L + RNQ++  I P       ++    L  N+ 
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 410 HGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSN 455
                 +   L  L+ L++++N +   +  G   +L  L SL+L SN
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 23/104 (22%), Positives = 46/104 (44%), Gaps = 8/104 (7%)

Query: 377 ELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
           EL +  N++      G+   L +L+   L+ NQ  G  P+      ++Q+L +  N ++ 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 436 GIPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLGNCQNLILF 474
            I + +   L +L +L+L  N +   +       L +  +L L 
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLA 134

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.9 bits (121), Expect = 9e-07
 Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 2/101 (1%)

Query: 503 NNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIP-VTLSTCVSLEYLDISINSFYGVIPLS 561
                      +   +NL  L I + Q    +    L     L  L I  +    V P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 562 FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF 602
           F F   +  LN+S N L     + ++ LS L+ L LS N  
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.9 bits (108), Expect = 4e-05
 Identities = 21/96 (21%), Positives = 33/96 (34%), Gaps = 7/96 (7%)

Query: 285 SIPDSLSNASNLELLDLPSNQFKGKV-SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIF 343
                L  A NL  L + + Q    +   D   L  L  L + ++ L     +       
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF----- 76

Query: 344 LSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELS 379
                 L  L+LS N        ++  LSL+ + LS
Sbjct: 77  -HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLS 111

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.5 bits (107), Expect = 6e-05
 Identities = 17/93 (18%), Positives = 30/93 (32%), Gaps = 1/93 (1%)

Query: 238 PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLE 297
              +    ++  +++   +         L  L  L+ L I  +      PD+      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 298 LLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNL 330
            L+L  N  +         L +L  L L  N L
Sbjct: 84  RLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 26/116 (22%), Positives = 45/116 (38%), Gaps = 7/116 (6%)

Query: 243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLP 302
             ++V  + L   + +      +     NL+ L +     + S+  +L     L+ L+L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG-LISV-SNLPKLPKLKKLELS 79

Query: 303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
            N+  G + +    L NL  LNL  N L      D+  +  L     LK L L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 29/143 (20%), Positives = 57/143 (39%), Gaps = 18/143 (12%)

Query: 293 ASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKV 352
           +S    +D+         +   ++++ L L N + N+               +   +L+ 
Sbjct: 2   SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEG--------LTAEFVNLEF 53

Query: 353 LSLSDNQFGGELPHSIANLSL--KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH 410
           LSL +         S++NL    K+ +L +  N+I G +      L NL    L  N+  
Sbjct: 54  LSLINVGL-----ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL- 107

Query: 411 GTIPDV--ISELKNLQQLSVFNN 431
             I  +  + +L+ L+ L +FN 
Sbjct: 108 KDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 25/115 (21%), Positives = 42/115 (36%), Gaps = 5/115 (4%)

Query: 512 LQVGNLKNLVMLDISSNQFS-GVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKA 570
           L+      +  L + + + + G I    +  V+LE+L +       V  L    L  +K 
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK--LPKLKK 75

Query: 571 LNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE--GEVPVKGVFSNKTKISLHGN 623
           L +S N + G +    E L  L  LNLS N  +    +           + L   
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 5/103 (4%)

Query: 77  QRLTELNLSSQRIG-GVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNN 135
             + EL L + +   G +         L +++L + G    +   +  L +L+KL LS N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSEN 81

Query: 136 SFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL 178
              G +     +  NL H   S NKL+      +  L KL+ L
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECL 122

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 59/417 (14%), Positives = 126/417 (30%), Gaps = 51/417 (12%)

Query: 220 LRRLVNLNVAENQFSGMFPRSICNI--SSVELIFLTENRFSGIFPFDILLNLPNLKKLGI 277
              L  LN    +F+ + P+ +  I  +   L+ +    F  +          NL++   
Sbjct: 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCG 250

Query: 278 GGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID--FSSLKNLWLLNLEQNNLGTGTA 335
           G  N    +P+   N      L      + G   +   F     +  L+L    L T   
Sbjct: 251 GSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETE-- 308

Query: 336 NDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN 395
              D    +  C +L+VL    N  G      +A    ++  L + R    G    G+ +
Sbjct: 309 ---DHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIER----GADEQGMED 360

Query: 396 LVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR----GGIPSGLGNLTKLGSLD 451
              L++           +  +    + L+ ++V+ + +       I + L NL     + 
Sbjct: 361 EEGLVS--------QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP 511
           L       ++P   G     +  +                +   +        L +  L 
Sbjct: 413 LDREERITDLPLDNG-----VRSLLIG----------CKKLRRFAF-YLRQGGLTDLGLS 456

Query: 512 LQVGNLKNLVMLDISSNQFS--GVIPVTLSTCVSLEYLDISINSF--YGVIPLSFRFLKS 567
                  N+  + +     S  G++      C +L+ L++    F    +     + L S
Sbjct: 457 YIGQYSPNVRWMLLGYVGESDEGLMEF-SRGCPNLQKLEMRGCCFSERAIAAAVTK-LPS 514

Query: 568 IKALNVSSNNLSGKIPEFLE---NLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLH 621
           ++ L V     S    + ++       +E +         +        +   I  +
Sbjct: 515 LRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHILAY 571

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 58/449 (12%), Positives = 121/449 (26%), Gaps = 64/449 (14%)

Query: 239 RSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNA----- 293
           R    I S     +T        P  +    PNL+ L + G            N      
Sbjct: 42  RRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVT 101

Query: 294 ----------SNLELLDLPSNQF--KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV 341
                       L+ +              +  +   +L  L L++ +  T        +
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT----TDGLL 157

Query: 342 IFLSNCSSLKVLSLSDNQF---GGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLV- 397
             +++C  +K L + ++ F    G+  H +A  +  +  L+    + +   P  +  +  
Sbjct: 158 SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217

Query: 398 ---NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDL-- 452
              +L++  +  +     +        NL++    +     G+P    NL     L    
Sbjct: 218 NCRSLVSVKVG-DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276

Query: 453 GSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL 512
            S      +P        +      Y  L  +    L+       VL+  N + +  L +
Sbjct: 277 LSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 513 QVGNLKNLVMLDISSNQFSGVIPVTLST------------CVSLEYLDISINSF--YGVI 558
                K L  L I        +                  C  LEY+ + ++      + 
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLE 396

Query: 559 PLS--------FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG 610
            +         FR +   +   ++   L   +   L     L                  
Sbjct: 397 SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--------- 447

Query: 611 VFSNKTKISLHGNVKLCGGIDELHLPSCP 639
                T + L    +    +  + L    
Sbjct: 448 --GGLTDLGLSYIGQYSPNVRWMLLGYVG 474

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 50/345 (14%), Positives = 87/345 (25%), Gaps = 43/345 (12%)

Query: 78  RLTELNLSSQRIGGV----LSPYVGNLSFLRYINLADNGFRGD--IPQEIGNLFRLEKLA 131
            L  LN        +    L     N   L  + + D          +   NL      +
Sbjct: 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGS 252

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV-DINYLTGQLP 190
           L+ +        NL     L     S       +P       ++++L +      T    
Sbjct: 253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHC 311

Query: 191 DSVGNLSAIEVIR----ITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISS 246
             +     +EV+     I +  L           ++L  L +               +S 
Sbjct: 312 TLIQKCPNLEVLETRNVIGDRGLE----VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQ 367

Query: 247 VELIFLTEN------------RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDS----- 289
             LI L +               +      I   L NL    +   +    I D      
Sbjct: 368 RGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG 427

Query: 290 ----LSNASNLELLDLPSNQFKGKVSIDFSSLKNL--WLLNLEQNNLGTGTANDLDFVIF 343
               L     L        Q      +    L  +  +  N+    LG    +D   + F
Sbjct: 428 VRSLLIGCKKLRRFAFYLRQGG----LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEF 483

Query: 344 LSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT 388
              C +L+ L +    F      +       +  L V   + S T
Sbjct: 484 SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 41/222 (18%)

Query: 686 SPMEKLFPMVSYAELSKATSEFSSSN-----MIGQGRFGTVYKGILGDDEMVVAVKVINL 740
           S +E+    ++  E  KA+S     +     +IG+G +  V    L   + + A++V+  
Sbjct: 28  SGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK- 86

Query: 741 KQKGASKSFVSECEALRNIRHRNLIK------IITICSSTDFEGVDFKALVFEYMENGSL 794
           K+       +   +  +++      +      ++ + S   F+       V EY+  G L
Sbjct: 87  KELVNDDEDIDWVQTEKHV----FEQASNHPFLVGLHSC--FQTESRLFFVIEYVNGGDL 140

Query: 795 EDWLHQSNDQVEVRKLSLIQ-RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM 853
              + +       RKL     R   A +++ A+ YLH      +++ DLK  NVLLD + 
Sbjct: 141 MFHMQRQ------RKLPEEHARFYSA-EISLALNYLHER---GIIYRDLKLDNVLLDSE- 189

Query: 854 VAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             H+   D+G+ K        +     +S+    GT  Y+AP
Sbjct: 190 -GHIKLTDYGMCK------EGLRPGDTTSTFC--GTPNYIAP 222

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 17/140 (12%)

Query: 297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT---GTANDLDFVIFLSNCSSLKVL 353
             LDL +N  K   +  F  L +L  L L  N L +   G  N L         +SL  L
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL---------TSLTYL 81

Query: 354 SLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGT 412
           +LS NQ    LP+ + +   ++ EL++  NQ+  ++P G+   L  L    L  NQ   +
Sbjct: 82  NLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-S 138

Query: 413 IPD-VISELKNLQQLSVFNN 431
           +PD V   L +LQ + + +N
Sbjct: 139 VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 10/110 (9%)

Query: 377 ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGG 436
            L +  N +          L +L    L  N+       V ++L +L  L++  N L+  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 437 IPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLGNCQNLILFIASYNKL 481
           +P+G+   LT+L  L L +N LQ ++P      L   ++L L     N+L
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRL---YQNQL 136

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 25/146 (17%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR-----NLIK 766
            +G G FG V      D++   AVKV+   +K    + + E + L+ I++      N++K
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-EADILKKIQNDDINNNNIVK 100

Query: 767 IITICSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
                         +     L+FE +   SL + +   N+      +  I+     I++ 
Sbjct: 101 Y--------HGKFMYYDHMCLIFEPLGP-SLYEII-TRNNYNGF-HIEDIKL--YCIEIL 147

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLL 849
            A+ YL       + H DLKP N+LL
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILL 170

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 43/191 (22%), Positives = 79/191 (41%), Gaps = 36/191 (18%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK----- 766
           +IG+G +  V    L   + + A+KV+  K+       +   +  +++      +     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----FEQASNHP 70

Query: 767 -IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQ-RMNIAIDVAS 824
            ++ + S   F+       V EY+  G L   + +       RKL     R   A +++ 
Sbjct: 71  FLVGLHSC--FQTESRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSA-EISL 121

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSI 882
           A+ YLH      +++ DLK  NVLLD +   H+   D+G+ K        +     +S+ 
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------EGLRPGDTTSTF 170

Query: 883 GIKGTVGYVAP 893
              GT  Y+AP
Sbjct: 171 C--GTPNYIAP 179

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 34/182 (18%)

Query: 712 MIGQGRFGTVYKGI-LGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR---NLIKI 767
            +G+G FG V + I        VAVK++    +    +   E + L ++      +  + 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-EIQVLEHLNTTDPNSTFRC 79

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           + +    +  G     +VFE +   S  D++ + N  +   +L  I++  +A  +  ++ 
Sbjct: 80  VQMLEWFEHHG--HICIVFELLGL-STYDFI-KENGFLPF-RLDHIRK--MAYQICKSVN 132

Query: 828 YLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVG----------------DFGLAKFLSN 868
           +LH +    + H DLKP N+L    DY    +                  DFG A +   
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 869 HH 870
           HH
Sbjct: 190 HH 191

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 49.1 bits (118), Expect = 3e-06
 Identities = 40/192 (20%), Positives = 76/192 (39%), Gaps = 38/192 (19%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVI---NLKQKGASKSFVSECEALRNI-----RHRN 763
           ++G+G FG V        + + AVK++    + Q    +  + E    + +     +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE----KRVLALPGKPPF 82

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           L ++        F+ +D    V EY+  G L   + Q        +      +  A ++A
Sbjct: 83  LTQLH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIA 131

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSS 881
             + +L       +++ DLK  NV+LD +   H+   DFG+ K       +I     + +
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVTTKT 180

Query: 882 IGIKGTVGYVAP 893
               GT  Y+AP
Sbjct: 181 FC--GTPDYIAP 190

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 4e-06
 Identities = 30/200 (15%), Positives = 64/200 (32%), Gaps = 49/200 (24%)

Query: 415 DVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILF 474
           D+   L  +  L+         +  G      L SL++ S  L  ++   +         
Sbjct: 163 DLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS------ 216

Query: 475 IASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP-----LQVGNLKNLVMLDISSNQ 529
                    DLP    ++  L L + + +   +G +             NL  L I   +
Sbjct: 217 ---------DLP----NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263

Query: 530 FSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK----IPEF 585
              V+                              L  ++ +++S+  L+ +    + + 
Sbjct: 264 EQNVVVEMFLES---------------------DILPQLETMDISAGVLTDEGARLLLDH 302

Query: 586 LENLSFLEFLNLSYNYFEGE 605
           ++ +  L+F+N+ YNY   E
Sbjct: 303 VDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 9e-06
 Identities = 28/189 (14%), Positives = 63/189 (33%), Gaps = 27/189 (14%)

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF----- 306
             E   S I   D+   L  +  L         ++        NL+ L++ S        
Sbjct: 151 FEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVV 210

Query: 307 KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH 366
           +  +  D  +L+ L L    ++    G  N    +       +LK L + D +    +  
Sbjct: 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270

Query: 367 SIANLSL--KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ 424
                 +  ++  + +    ++     G R L+                 D + ++K+L+
Sbjct: 271 MFLESDILPQLETMDISAGVLTDE---GARLLL-----------------DHVDKIKHLK 310

Query: 425 QLSVFNNFL 433
            +++  N+L
Sbjct: 311 FINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 3e-05
 Identities = 35/182 (19%), Positives = 63/182 (34%), Gaps = 18/182 (9%)

Query: 211 GKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILL-NL 269
             +   L  +  L NL +       +  +   N+ S+E+I             DIL  +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIIS---GGLPDSVVEDILGSDL 218

Query: 270 PNLKKL-------GIGGNNFVGSIPDSLSNAS--NLELLDLPSNQFKGKVSIDFSS---L 317
           PNL+KL         G +  +       S     NL+ L +   + +  V   F     L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 318 KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIE 377
             L  +++    L    A  L  +  +     LK +++  N    E+   +       I+
Sbjct: 279 PQLETMDISAGVLTDEGARLL--LDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKID 336

Query: 378 LS 379
           +S
Sbjct: 337 VS 338

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 48.4 bits (116), Expect = 6e-06
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 32/189 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-----RHRNLIK 766
           ++G+G FG V    + +   + AVKV+  K        V      + I      H  L +
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +   C    F+  D    V E++  G L   + +S      R+    +    A ++ SA+
Sbjct: 89  LF--CC---FQTPDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEIISAL 137

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGI 884
            +LH      +++ DLK  NVLLD++   H    DFG+ K        I +   +++   
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK------EGICNGVTTATFC- 185

Query: 885 KGTVGYVAP 893
            GT  Y+AP
Sbjct: 186 -GTPDYIAP 193

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 21/114 (18%), Positives = 44/114 (38%), Gaps = 6/114 (5%)

Query: 487 QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEY 546
           + +++     + L      +   +   +  LK    L +S+N    +    LS   +L  
Sbjct: 18  KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRI 74

Query: 547 LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN 600
           L +  N    +  L      +++ L +S N ++  +   +E L  L  L +S N
Sbjct: 75  LSLGRNLIKKIENLDA-VADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNN 125

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 42/196 (21%), Positives = 63/196 (32%), Gaps = 47/196 (23%)

Query: 242 CNISSVELIFLTENRFSGIFPFDILL-NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLD 300
              +  E + L       I   D  L  L   K L +  NN    I  SLS   NL +L 
Sbjct: 20  VVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILS 76

Query: 301 LPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
           L  N  K K+    +    L  L +  N +       L     +    +L+VL +S+N+ 
Sbjct: 77  LGRNLIK-KIENLDAVADTLEELWISYNQI-----ASLSG---IEKLVNLRVLYMSNNK- 126

Query: 361 GGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPD----- 415
                  I N      E+              +  L  L    L  N  +    +     
Sbjct: 127 -------ITNWG----EIDK------------LAALDKLEDLLLAGNPLYNDYKENNATS 163

Query: 416 -----VISELKNLQQL 426
                V+  L NL++L
Sbjct: 164 EYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 15/142 (10%)

Query: 415 DVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL-IL 473
            V +E + ++   +     +  + + L  L     L L +N+++  I SSL   +NL IL
Sbjct: 20  VVATEAEKVELHGMIPPIEK--MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRIL 75

Query: 474 FIASYNKLT--GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS 531
            +   N +    +L     ++      L +S N +     ++   L NL +L +S+N+ +
Sbjct: 76  SL-GRNLIKKIENLDAVADTLEE----LWISYNQIASLSGIE--KLVNLRVLYMSNNKIT 128

Query: 532 GVIPV-TLSTCVSLEYLDISIN 552
               +  L+    LE L ++ N
Sbjct: 129 NWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 33/148 (22%), Positives = 53/148 (35%), Gaps = 35/148 (23%)

Query: 344 LSNCSSLKVLSLSDNQFGGELPHSIANLS-LKMI-ELSVGRNQISGTIPPGIRNLVNLIT 401
           LS   + K L+LS N         I++LS ++ +  LS+GRN I       I NL  +  
Sbjct: 44  LSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIKK-----IENLDAV-- 91

Query: 402 FTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQG-N 460
                                L++L +  N +     SG+  L  L  L + +N +    
Sbjct: 92  ------------------ADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWG 131

Query: 461 IPSSLGNCQNLILFIASYNKLTGDLPQQ 488
               L     L   + + N L  D  + 
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 7/102 (6%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
              L LS+  I  + S  +  +  LR ++L  N  +  I         LE+L +S N  +
Sbjct: 50  CKHLALSTNNIEKISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA 106

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV 180
            ++ + + +  NL     SNNK+      EI  L  L +L  
Sbjct: 107 -SL-SGIEKLVNLRVLYMSNNKITN--WGEIDKLAALDKLED 144

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 19/70 (27%), Positives = 35/70 (50%), Gaps = 3/70 (4%)

Query: 534 IPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLE 593
           +  TLST  + ++L +S N+   +  LS   +++++ L++  N +  KI         LE
Sbjct: 40  MDATLSTLKACKHLALSTNNIEKISSLSG--MENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 594 FLNLSYNYFE 603
            L +SYN   
Sbjct: 97  ELWISYNQIA 106

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 9/103 (8%)

Query: 378 LSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGG 436
           L +  N++  ++P G+   L  L   +L  NQ       V  +L  L  L +  N L+  
Sbjct: 33  LELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 437 IPSGL-GNLTKLGSLDLGSNSLQGNIPS----SLGNCQNLILF 474
           +P+G+   LT+L  L L +N L+ ++P      L + Q + L 
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLH 132

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 48/299 (16%), Positives = 87/299 (29%), Gaps = 62/299 (20%)

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIA----NLSLKMIELSVGRNQISGTIPPGIRNLVN 398
           F S    +  L LS N         +     N    +  L++  N +          LV 
Sbjct: 17  FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG---FKNSDELVQ 73

Query: 399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG----GIPSGL-GNLTKLGSLDLG 453
           +    L                 N+  L++  NFL       +   L      +  LDLG
Sbjct: 74  I----LAAIP------------ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117

Query: 454 SNSLQGNIPSSLG------NCQNLILFIASYNKLTGD----LPQQLLSITTLSLVLDLSN 503
            N       S               L +   N L       L Q L +I      L+L  
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNL-RGNDLGIKSSDELIQILAAIPANVNSLNLRG 176

Query: 504 NLLNG------SLPLQVGNLKNLVMLDISSNQF--SGVIPVT---LSTCVSLEYLDISIN 552
           N L        +  L      ++  LD+S+N         +     S    +  L++ +N
Sbjct: 177 NNLASKNCAELAKFLASIP-ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235

Query: 553 SFYGV----IPLSFRFLKSIKALNVSSNNLSGK-------IPEFLENLSFLEFLNLSYN 600
             +G     + L    LK ++ + +  + +          +     N+  +  ++ +  
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGK 294

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 56/337 (16%), Positives = 107/337 (31%), Gaps = 80/337 (23%)

Query: 145 LSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRI 204
            S    +     S N L      E+                           +++  + +
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFA-------------------NTPASVTSLNL 58

Query: 205 TENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFD 264
           + NSLG K    L  +   +  NV     SG        +S      L +          
Sbjct: 59  SGNSLGFKNSDELVQILAAIPANVTSLNLSG------NFLSYKSSDELVK---------- 102

Query: 265 ILLNLPN--LKKLGIGGNNF----VGSIPDSL-SNASNLELLDLPSNQFKGKVSIDFSSL 317
             L      +  L +G N+F          +  +  +++  L+L  N    K S +   +
Sbjct: 103 -TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161

Query: 318 -----KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE----LPHSI 368
                 N+  LNL  NNL +    +L      S  +S+  L LS N  G +    L +  
Sbjct: 162 LAAIPANVNSLNLRGNNLASKNCAEL-AKFLASIPASVTSLDLSANLLGLKSYAELAYIF 220

Query: 369 ANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSV 428
           +++   ++ L++  N + G     + NL  L                    LK+LQ + +
Sbjct: 221 SSIPNHVVSLNLCLNCLHGP---SLENLKLL-----------------KDSLKHLQTVYL 260

Query: 429 FNNFLRG-------GIPSGLGNLTKLGSLDLGSNSLQ 458
             + ++         + +   N+ K+  +D     + 
Sbjct: 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	914
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.98
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.98
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.98
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.98
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.98
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.98
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.98
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.98
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.98
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.98
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.98
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3bhy_A	283	Death-associated protein kinase 3; death associate	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.86
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.61
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.61
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.6
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.56
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.55
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.32
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.28
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.27
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.01
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.96
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.96
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.86
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.86
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.54
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.54
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.53
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.45
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.32
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.95
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.95
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.49
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.46
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.42
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.37
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.22
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.18
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.15
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.88
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.78
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.65
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.57
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.38
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.32
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.97
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.98
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.53
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	86.25

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.6e-87  Score=820.19  Aligned_cols=609  Identities=29%  Similarity=0.452  Sum_probs=412.6

Q ss_pred             cccCCCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCccceeecCCCCceEEEecCCCCCccc---cC---------
Q 042766           27 SFSAGQTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGV---LS---------   94 (914)
Q Consensus        27 ~~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~---------   94 (914)
                      .++++++.++|++|||+||+++.||. .+++|+.++|||.|.||+|+  +++|++|||+++++.|.   ++         
T Consensus         3 ~~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            3 QASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             -----CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             cCccccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            34556678999999999999999888 89999988899999999998  68999999999999886   44         


Q ss_pred             --------------CCCCCCCCCCEEEcCCCCCcccCCc--ccCCCCCCCeeecCCCCCCCcCCCCc-cccCCcchhccC
Q 042766           95 --------------PYVGNLSFLRYINLADNGFRGDIPQ--EIGNLFRLEKLALSNNSFSGTIPTNL-SRCSNLIHFCAS  157 (914)
Q Consensus        95 --------------~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~Ls  157 (914)
                                    +.++.+++|++|||++|.++|.+|.  .++++++|++|||++|.+++.+|..+ +++++|++|||+
T Consensus        80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls  159 (768)
T 3rgz_A           80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS  159 (768)
T ss_dssp             CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred             cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence                          5788889999999999999998888  88899999999999888888777665 455555555555


Q ss_pred             CCcccCCCChh---c----------------------cccccccccccccccccCcCCcccccccccceeecccCCCCCC
Q 042766          158 NNKLEGQIPKE---I----------------------GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK  212 (914)
Q Consensus       158 ~N~l~~~~p~~---~----------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  212 (914)
                      +|++++..|..   +                      +.+++|++|+|++|++++.+|. ++++++|++|+|++|.+++.
T Consensus       160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~  238 (768)
T 3rgz_A          160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD  238 (768)
T ss_dssp             SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred             CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence            55544333322   1                      2334444444444444444443 44444444444444444444


Q ss_pred             CCccchhhhc----------------------ccccccccccccCCCCCccccc-cccceeeccCCcccCcccccccccC
Q 042766          213 IPTTLGLLRR----------------------LVNLNVAENQFSGMFPRSICNI-SSVELIFLTENRFSGIFPFDILLNL  269 (914)
Q Consensus       213 ~p~~~~~l~~----------------------L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~l  269 (914)
                      +|..++.+++                      |++|+|++|++++.+|..+... ++|++|+|++|++++.+|.. +.++
T Consensus       239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~-~~~l  317 (768)
T 3rgz_A          239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF-FGSC  317 (768)
T ss_dssp             HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGG-GGGC
T ss_pred             ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchH-HhcC
Confidence            4444443333                      3333344444444555555553 66777777777776665543 3466


Q ss_pred             cccceeeccCccCCCCCCCc-cccccccccccccCccCCccccccccccc-cccceeccCCcCCCCCCCCc---------
Q 042766          270 PNLKKLGIGGNNFVGSIPDS-LSNASNLELLDLPSNQFKGKVSIDFSSLK-NLWLLNLEQNNLGTGTANDL---------  338 (914)
Q Consensus       270 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~---------  338 (914)
                      ++|++|+|++|++++.+|.. +..+++|++|+|++|++++.+|..+..++ +|++|++++|.+++.....+         
T Consensus       318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~  397 (768)
T 3rgz_A          318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ  397 (768)
T ss_dssp             TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred             CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence            66777777777666666654 66666666666666666666666666665 66666666666543211000         


Q ss_pred             -----------chhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccC
Q 042766          339 -----------DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVN  407 (914)
Q Consensus       339 -----------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  407 (914)
                                 .+|..+.++++|++|+|++|++++.+|..+..+. +|+.|++++|++++.+|..|..+++|++|+|++|
T Consensus       398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  476 (768)
T 3rgz_A          398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN  476 (768)
T ss_dssp             EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHHHcCCCCceEEEecCC
Confidence                       1334455555555555555555555555555544 4555555555555555555555555555555555


Q ss_pred             cccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCch
Q 042766          408 QFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ  487 (914)
Q Consensus       408 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  487 (914)
                      ++++.+|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|+++|.+|..++++++|+.|++++|+++|.+|.
T Consensus       477 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~  556 (768)
T 3rgz_A          477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA  556 (768)
T ss_dssp             CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCG
T ss_pred             cccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCCh
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             hhhcccchh---------------------------------------------hhhcccCCccCCCcccccccccccee
Q 042766          488 QLLSITTLS---------------------------------------------LVLDLSNNLLNGSLPLQVGNLKNLVM  522 (914)
Q Consensus       488 ~~~~~~~l~---------------------------------------------~~L~Ls~N~l~~~~p~~~~~l~~L~~  522 (914)
                      .++....+.                                             ..++++.|.+.|.+|..++.+++|+.
T Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~  636 (768)
T 3rgz_A          557 AMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF  636 (768)
T ss_dssp             GGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCE
T ss_pred             HHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccE
Confidence            444322110                                             11233335555555666677889999


Q ss_pred             ecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCcc
Q 042766          523 LDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF  602 (914)
Q Consensus       523 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  602 (914)
                      ||||+|+++|.+|.+|+.+++|+.|+|++|+++|.+|.+|+.+++|+.|||++|+++|.+|..+..+++|++||||+|++
T Consensus       637 LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l  716 (768)
T 3rgz_A          637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNL  716 (768)
T ss_dssp             EECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEE
T ss_pred             EECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcCCCCCccCccCCCCCCCCccCCCCCCCCCCCCCC
Q 042766          603 EGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSCPSKGSRK  645 (914)
Q Consensus       603 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~l~~~~c~~~~s~~  645 (914)
                      +|.||..+++.++...++.||+++||.  ++  +.|+......
T Consensus       717 ~g~iP~~~~~~~~~~~~~~gN~~Lcg~--~l--~~C~~~~~~~  755 (768)
T 3rgz_A          717 SGPIPEMGQFETFPPAKFLNNPGLCGY--PL--PRCDPSNADG  755 (768)
T ss_dssp             EEECCSSSSGGGSCGGGGCSCTEEEST--TS--CCCCSCC---
T ss_pred             cccCCCchhhccCCHHHhcCCchhcCC--CC--cCCCCCccCC
Confidence            999999999999999999999999997  34  3787555443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.5e-68  Score=655.17  Aligned_cols=521  Identities=35%  Similarity=0.521  Sum_probs=435.9

Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCC--CccccCCcchhccCCCcccCCCChhc-cccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT--NLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKL  175 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L  175 (914)
                      +|++|+.++++.|++. .+|..++++++|++|||++|.++|.+|.  .++++++|++|||++|.+++.+|..+ .++++|
T Consensus        75 ~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L  153 (768)
T 3rgz_A           75 SLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL  153 (768)
T ss_dssp             TCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTC
T ss_pred             ccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCC
Confidence            3556666666666655 4668999999999999999999999998  99999999999999999999998876 789999


Q ss_pred             cccccccccccCcCCcc-------------------------cccccccceeecccCCCCCCCCccchhhhccccccccc
Q 042766          176 QRLSVDINYLTGQLPDS-------------------------VGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE  230 (914)
Q Consensus       176 ~~L~L~~N~l~~~~p~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  230 (914)
                      ++|+|++|++++..|..                         +.++++|++|+|++|.+++.+|. ++++++|++|+|++
T Consensus       154 ~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~  232 (768)
T 3rgz_A          154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG  232 (768)
T ss_dssp             SEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCS
T ss_pred             CEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcC
Confidence            99999999988766544                         25678899999999999998888 99999999999999


Q ss_pred             ccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccc-cccccccccCccCCcc
Q 042766          231 NQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNA-SNLELLDLPSNQFKGK  309 (914)
Q Consensus       231 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~  309 (914)
                      |++++.+|..|.++++|++|++++|.+++.+|..   .+++|++|+|++|++++.+|..+... ++|++|+|++|++++.
T Consensus       233 n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            9999999999999999999999999998877753   67888888888888888888877765 8888888888888888


Q ss_pred             ccccccccccccceeccCCcCCCCCCCCcchhh-cccCCCCCcEEeccccccCCCcCchhhccc----------------
Q 042766          310 VSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI-FLSNCSSLKVLSLSDNQFGGELPHSIANLS----------------  372 (914)
Q Consensus       310 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----------------  372 (914)
                      +|..|..+++|++|++++|.+++.      +|. .+..+++|++|+|++|++++.+|..+..+.                
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~------ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~  383 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGE------LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP  383 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEE------CCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEE
T ss_pred             cchHHhcCCCccEEECCCCcccCc------CCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCC
Confidence            888888888888888888877632      222 256666666666666666666666555443                


Q ss_pred             ----------cccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCcccc
Q 042766          373 ----------LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLG  442 (914)
Q Consensus       373 ----------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  442 (914)
                                .+|++|++++|++++.+|..|+++++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+|..+.
T Consensus       384 ~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~  463 (768)
T 3rgz_A          384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM  463 (768)
T ss_dssp             CCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             cChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHc
Confidence                      2467777777777777888888888888888888888888888888888888888888888888888888


Q ss_pred             CCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcccccccccccee
Q 042766          443 NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVM  522 (914)
Q Consensus       443 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~  522 (914)
                      .+++|++|+|++|++++.+|..+.++++|+.|++++|++++.+|.++..++.+ ++|+|++|+++|.+|..++++++|++
T Consensus       464 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~  542 (768)
T 3rgz_A          464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL-AILKLSNNSFSGNIPAELGDCRSLIW  542 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGGCTTCCE
T ss_pred             CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCC-CEEECCCCcccCcCCHHHcCCCCCCE
Confidence            88888888888888888888888888899999999999988888888888887 78899999998888888999999999


Q ss_pred             ecccCCccccccCccc----------------------------------------------------------------
Q 042766          523 LDISSNQFSGVIPVTL----------------------------------------------------------------  538 (914)
Q Consensus       523 L~Ls~N~l~~~~p~~~----------------------------------------------------------------  538 (914)
                      |||++|+++|.+|..+                                                                
T Consensus       543 L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g  622 (768)
T 3rgz_A          543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG  622 (768)
T ss_dssp             EECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEE
T ss_pred             EECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecc
Confidence            9999988887777543                                                                


Q ss_pred             ------cccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-Cc
Q 042766          539 ------STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GV  611 (914)
Q Consensus       539 ------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~  611 (914)
                            +.+++|++|||++|+++|.+|.+|+.++.|+.|||++|+++|.+|+.++++++|+.||||+|+++|.+|.. ..
T Consensus       623 ~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~  702 (768)
T 3rgz_A          623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA  702 (768)
T ss_dssp             ECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGG
T ss_pred             cCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhC
Confidence                  33567889999999999999999999999999999999999999999999999999999999999999865 55


Q ss_pred             CCCCCccCccCCCCCCCCccC
Q 042766          612 FSNKTKISLHGNVKLCGGIDE  632 (914)
Q Consensus       612 ~~~~~~~~~~~n~~lc~~~~~  632 (914)
                      +..+..+++++| .+.|.+|.
T Consensus       703 l~~L~~L~ls~N-~l~g~iP~  722 (768)
T 3rgz_A          703 LTMLTEIDLSNN-NLSGPIPE  722 (768)
T ss_dssp             CCCCSEEECCSS-EEEEECCS
T ss_pred             CCCCCEEECcCC-cccccCCC
Confidence            677888888888 45666543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.5e-63  Score=601.13  Aligned_cols=549  Identities=21%  Similarity=0.198  Sum_probs=471.5

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      .+++.|+|++|.+++..+..++++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            57999999999999877778999999999999999999999999999999999999999999555557999999999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccch--hhhccccccccccccc
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG--LLRRLVNLNVAENQFS  234 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~  234 (914)
                      ++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.+++..|..++  .+++|++|++++|+++
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~  184 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK  184 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence            99999987788999999999999999999999999999999999999999999988887765  4589999999999999


Q ss_pred             CCCCCcccccc---------------------------ccceeeccCCcccCcccccccccCcc--cceeeccCccCCCC
Q 042766          235 GMFPRSICNIS---------------------------SVELIFLTENRFSGIFPFDILLNLPN--LKKLGIGGNNFVGS  285 (914)
Q Consensus       235 ~~~p~~~~~l~---------------------------~L~~L~L~~N~l~~~~p~~~~~~l~~--L~~L~Ls~N~l~~~  285 (914)
                      +..|..|..+.                           +|+.|++++|.+++..|.. +.+++.  |++|+|++|++++.
T Consensus       185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~-~~~l~~~~L~~L~Ls~n~l~~~  263 (680)
T 1ziw_A          185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT-FLGLKWTNLTMLDLSYNNLNVV  263 (680)
T ss_dssp             CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT-TGGGGGSCCCEEECTTSCCCEE
T ss_pred             ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH-hhccCcCCCCEEECCCCCcCcc
Confidence            99888877654                           5667777777777665543 345544  88899999988888


Q ss_pred             CCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhh----cccCCCCCcEEeccccccC
Q 042766          286 IPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI----FLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       286 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~----~l~~l~~L~~L~Ls~N~l~  361 (914)
                      .|..|..+++|++|+|++|++++..+..|.++++|++|++++|....... ...+|.    .+..+++|++|++++|+++
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~-~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS-LASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             CcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc-cccccccChhhcccCCCCCEEECCCCccC
Confidence            88888888889999999998888888888888889988888775442100 000121    4678899999999999999


Q ss_pred             CCcCchhhccccccEEEEeecccccc--cCCccccCC--CCCcEEEcccCcccccCChhhhcccCCceeeeccccccccc
Q 042766          362 GELPHSIANLSLKMIELSVGRNQISG--TIPPGIRNL--VNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGI  437 (914)
Q Consensus       362 ~~~p~~~~~~~~~L~~L~L~~N~l~~--~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  437 (914)
                      +..|..+..+. +|++|++++|.+..  ..+..|..+  ++|+.|++++|++++..|..|..+++|++|+|++|.+++.+
T Consensus       343 ~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  421 (680)
T 1ziw_A          343 GIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL  421 (680)
T ss_dssp             CCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEEC
T ss_pred             CCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcccc
Confidence            87777777776 69999999987543  333445544  58999999999999999999999999999999999998876


Q ss_pred             C-ccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccC--CCCchhhhcccchhhhhcccCCccCCCccccc
Q 042766          438 P-SGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT--GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV  514 (914)
Q Consensus       438 p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~  514 (914)
                      | ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.++  +.+|..+..+..+ ++|++++|++++..|..|
T Consensus       422 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~  500 (680)
T 1ziw_A          422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL-TILDLSNNNIANINDDML  500 (680)
T ss_dssp             CSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC-CEEECCSSCCCCCCTTTT
T ss_pred             CcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC-CEEECCCCCCCcCChhhh
Confidence            6 67899999999999999999889999999999999999999987  6788889888888 899999999998888889


Q ss_pred             cccccceeecccCCccccccC--------ccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccc
Q 042766          515 GNLKNLVMLDISSNQFSGVIP--------VTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFL  586 (914)
Q Consensus       515 ~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  586 (914)
                      .++++|++|+|++|++++..+        ..|.++++|++|+|++|+++...+..|..+++|+.|+|++|+|++..+..|
T Consensus       501 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~  580 (680)
T 1ziw_A          501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF  580 (680)
T ss_dssp             TTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             ccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHh
Confidence            999999999999999987633        237889999999999999997666789999999999999999998888888


Q ss_pred             cccCCCCeEeCCCCccccccCCC-C-cCCCCCccCccCCCCCCCC
Q 042766          587 ENLSFLEFLNLSYNYFEGEVPVK-G-VFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       587 ~~l~~L~~L~ls~N~l~~~~p~~-~-~~~~~~~~~~~~n~~lc~~  629 (914)
                      ..+++|+.|+|++|++++..|.. . .+.++..+.+.+||+.|..
T Consensus       581 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c  625 (680)
T 1ziw_A          581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC  625 (680)
T ss_dssp             TTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCC
T ss_pred             CCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCC
Confidence            99999999999999999876643 2 4678888999999999964

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1e-60  Score=580.39  Aligned_cols=524  Identities=21%  Similarity=0.228  Sum_probs=466.3

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      .+++.|+|++|.+.+..|..++++++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            46899999999999888888999999999999999999655557999999999999999999777789999999999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccc--cccccceeecccCCCCCCCCccchhh--------------
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVG--NLSAIEVIRITENSLGGKIPTTLGLL--------------  220 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l--------------  220 (914)
                      ++|++++..|..++++++|++|+|++|.+++..|..++  .+++|+.|++++|.+++..|..|+.+              
T Consensus       129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~  208 (680)
T 1ziw_A          129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG  208 (680)
T ss_dssp             CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCH
T ss_pred             CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccC
Confidence            99999999899999999999999999999987777665  45899999999999999888887765              


Q ss_pred             -------------hcccccccccccccCCCCCccccccc--cceeeccCCcccCcccccccccCcccceeeccCccCCCC
Q 042766          221 -------------RRLVNLNVAENQFSGMFPRSICNISS--VELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS  285 (914)
Q Consensus       221 -------------~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~  285 (914)
                                   ++|+.|++++|++++..|..|.+++.  |+.|++++|++++..| ..+..+++|++|+|++|++.+.
T Consensus       209 ~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN-DSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSCCBSEE
T ss_pred             hhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc-ccccCcccccEeeCCCCccCcc
Confidence                         45778888999999999999998876  9999999999997655 4566999999999999999999


Q ss_pred             CCCccccccccccccccCccCCc---------cccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecc
Q 042766          286 IPDSLSNASNLELLDLPSNQFKG---------KVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS  356 (914)
Q Consensus       286 ~p~~~~~l~~L~~L~Ls~N~l~~---------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls  356 (914)
                      .|..|.++++|++|++++|...+         +....|..+++|++|++++|.+++.      .+..+.++++|++|+++
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~------~~~~~~~l~~L~~L~Ls  361 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI------KSNMFTGLINLKYLSLS  361 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC------CTTTTTTCTTCCEEECT
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC------ChhHhccccCCcEEECC
Confidence            99999999999999999986553         2233788999999999999999987      34467899999999999


Q ss_pred             ccccCCC-cCc-hhhccc-cccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCC-hhhhcccCCceeeecccc
Q 042766          357 DNQFGGE-LPH-SIANLS-LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIP-DVISELKNLQQLSVFNNF  432 (914)
Q Consensus       357 ~N~l~~~-~p~-~~~~~~-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~  432 (914)
                      +|.+... ++. .+..+. .+++.|++++|++++..|.+|..+++|++|+|++|++++.+| ..|.++++|++|++++|+
T Consensus       362 ~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~  441 (680)
T 1ziw_A          362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK  441 (680)
T ss_dssp             TCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCS
T ss_pred             CCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCC
Confidence            9986533 232 232222 369999999999999999999999999999999999997665 789999999999999999


Q ss_pred             cccccCccccCCCCCCeEEeeCCcCC--CCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCc
Q 042766          433 LRGGIPSGLGNLTKLGSLDLGSNSLQ--GNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSL  510 (914)
Q Consensus       433 l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~  510 (914)
                      +.+..+..|..+++|+.|++++|.++  +.+|..|.++++|+.|++++|++++..|..+..+..+ ++|++++|++++..
T Consensus       442 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~  520 (680)
T 1ziw_A          442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLW  520 (680)
T ss_dssp             EEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGG
T ss_pred             cceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccc
Confidence            99999999999999999999999997  5789999999999999999999997666678888888 89999999998643


Q ss_pred             c--------ccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCcccccc
Q 042766          511 P--------LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI  582 (914)
Q Consensus       511 p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  582 (914)
                      +        ..|.++++|++|+|++|+++.+++..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..
T Consensus       521 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~  600 (680)
T 1ziw_A          521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE  600 (680)
T ss_dssp             STTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred             hhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccC
Confidence            2        24789999999999999999777778999999999999999999988888999999999999999999998


Q ss_pred             Ccccc-ccCCCCeEeCCCCccccccCC
Q 042766          583 PEFLE-NLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       583 p~~~~-~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      |..+. .+++|+.|++++|+|.|.|+.
T Consensus       601 ~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          601 KKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             HHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             hhHhcccccccCEEEccCCCcccCCcc
Confidence            88887 789999999999999999986

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.2e-60  Score=572.01  Aligned_cols=518  Identities=20%  Similarity=0.165  Sum_probs=417.6

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      ..++.|||++|.+++..|..++++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  112 (606)
T 3t6q_A           33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF  112 (606)
T ss_dssp             TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred             CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence            35778888888887766777888888888888888888777777888888888888888887777778888888888888


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccc--cccccccccc
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV--NLNVAENQFS  234 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~Ls~N~l~  234 (914)
                      ++|++++..|..++++++|++|+|++|++++..+..+..+++|++|++++|.+++..|..|+.+++|+  .|++++|+++
T Consensus       113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~  192 (606)
T 3t6q_A          113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA  192 (606)
T ss_dssp             TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred             cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence            88888766567777888888888888888764433444478888888888888877777788888877  7788888888


Q ss_pred             CCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCC-----CCCCCcccccc--ccccccccCccCC
Q 042766          235 GMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV-----GSIPDSLSNAS--NLELLDLPSNQFK  307 (914)
Q Consensus       235 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~--~L~~L~Ls~N~l~  307 (914)
                      +..|..|.. .+|+.|++++|..   ++ ..+..+.++....+..+.+.     ...+..|..+.  +|+.|++++|+++
T Consensus       193 ~~~~~~~~~-~~L~~L~l~~~~~---~~-~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~  267 (606)
T 3t6q_A          193 GIEPGAFDS-AVFQSLNFGGTQN---LL-VIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF  267 (606)
T ss_dssp             EECTTTTTT-CEEEEEECTTCSC---HH-HHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCS
T ss_pred             ccChhHhhh-ccccccccCCchh---HH-HHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccC
Confidence            776666554 5778888877752   11 12223443333333222222     12233444443  7889999999999


Q ss_pred             ccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccc
Q 042766          308 GKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISG  387 (914)
Q Consensus       308 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~  387 (914)
                      +..+..|..+++|++|++++|.++.+       |..+.++++|++|++++|++++..|..+..++ +|++|++++|.+.+
T Consensus       268 ~~~~~~~~~l~~L~~L~l~~n~l~~l-------p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~  339 (606)
T 3t6q_A          268 NISSNTFHCFSGLQELDLTATHLSEL-------PSGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRL  339 (606)
T ss_dssp             SCCTTTTTTCTTCSEEECTTSCCSCC-------CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCC
T ss_pred             ccCHHHhccccCCCEEeccCCccCCC-------ChhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCccc
Confidence            88888899999999999999988854       44577888999999999999877777777776 69999999998887


Q ss_pred             cCCc-cccCCCCCcEEEcccCcccccC--ChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCC-
Q 042766          388 TIPP-GIRNLVNLITFTLEVNQFHGTI--PDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPS-  463 (914)
Q Consensus       388 ~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-  463 (914)
                      .+|. .+..+++|++|++++|++++..  +..+..+++|++|++++|.+.+..|..|..+++|++|++++|++++..|. 
T Consensus       340 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  419 (606)
T 3t6q_A          340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS  419 (606)
T ss_dssp             BCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC
T ss_pred             ccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch
Confidence            6665 4889999999999999998776  77888999999999999999988888899999999999999999877654 


Q ss_pred             ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCC---ccccccccccceeecccCCccccccCccccc
Q 042766          464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGS---LPLQVGNLKNLVMLDISSNQFSGVIPVTLST  540 (914)
Q Consensus       464 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  540 (914)
                      .+.++++|+.|++++|.+++..|..+..++.+ ++|++++|++++.   .+..+..+++|++|+|++|++++.+|..|+.
T Consensus       420 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  498 (606)
T 3t6q_A          420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS  498 (606)
T ss_dssp             TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTT
T ss_pred             hhhCcccCCEEECCCCccCCcCHHHHhCCCCC-CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhcc
Confidence            48889999999999999988888888888887 7899999998863   3367899999999999999999999999999


Q ss_pred             cccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          541 CVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       541 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      +++|++|+|++|++++.+|..|..++.| .|+|++|++++.+|..+..+++|+.|++++|++.|.|+..
T Consensus       499 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             CTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             ccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence            9999999999999999999999999999 9999999999999999999999999999999999999854

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-61  Score=580.81  Aligned_cols=502  Identities=22%  Similarity=0.276  Sum_probs=377.1

Q ss_pred             CCCHhHHHHHHHHHHhcCCC-CC-------CCCCCCCCCCCCCc---cceeecCCCCceEEEecCCCCCccccCCCCCCC
Q 042766           32 QTNETDRLALLAIKSQLHDP-SG-------VTSSWNNTMNFCQW---TGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNL  100 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~~~-~~-------~~~~w~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l  100 (914)
                      +....|+.||.+||+++.++ ..       ...+|+.+.|||.|   .||+|+.. ++|+.|+|+++++.|.+|+++++|
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L  104 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQL  104 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGC
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcC
Confidence            44667999999999998643 22       23489988999999   99999765 899999999999999999999999


Q ss_pred             CCCCEEEcCCCCC------cc------cCCcccCCCCCCCeeecCCCCCCCcCCCCccc-cCCcchhccCCCcccCCCCh
Q 042766          101 SFLRYINLADNGF------RG------DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSR-CSNLIHFCASNNKLEGQIPK  167 (914)
Q Consensus       101 ~~L~~L~L~~n~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~p~  167 (914)
                      ++|++|+|++|.+      .|      .+|...  +..|+ +++++|.+.+.+|..++. +..+..+++....+..    
T Consensus       105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----  177 (636)
T 4eco_A          105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----  177 (636)
T ss_dssp             TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----
T ss_pred             ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----
Confidence            9999999999977      33      455544  55677 888888888888877763 4456666666544431    


Q ss_pred             hccccccccccccc--cccccCcCCcccccccccceeecccCCCCCC-----------------CCccch--hhhccccc
Q 042766          168 EIGNLLKLQRLSVD--INYLTGQLPDSVGNLSAIEVIRITENSLGGK-----------------IPTTLG--LLRRLVNL  226 (914)
Q Consensus       168 ~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L  226 (914)
                        .....++.+++.  .|+++| +|.+|+++++|++|+|++|.+++.                 +|..++  ++++|++|
T Consensus       178 --~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L  254 (636)
T 4eco_A          178 --SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV  254 (636)
T ss_dssp             --CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred             --ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence              122344444443  688888 888899999999999999998885                 888888  99999999


Q ss_pred             ccccccccCCCCCccccccccceeeccCCc-ccC-cccccccccC------cccceeeccCccCCCCCCC--cccccccc
Q 042766          227 NVAENQFSGMFPRSICNISSVELIFLTENR-FSG-IFPFDILLNL------PNLKKLGIGGNNFVGSIPD--SLSNASNL  296 (914)
Q Consensus       227 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L  296 (914)
                      +|++|++.+.+|..|+++++|++|++++|+ ++| .+|..+. ++      ++|++|+|++|+++ .+|.  .++++++|
T Consensus       255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~-~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L  332 (636)
T 4eco_A          255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ-ALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL  332 (636)
T ss_dssp             EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHH-HHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred             EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHH-hhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence            999999999999999999999999999998 888 7786654 44      89999999999999 7888  89999999


Q ss_pred             ccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCC-CcEEeccccccCCCcCchhhccc-cc
Q 042766          297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSS-LKVLSLSDNQFGGELPHSIANLS-LK  374 (914)
Q Consensus       297 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~~~-~~  374 (914)
                      ++|+|++|+++|.+| .|..+++|++|++++|.++.       +|..+..+++ |++|++++|+++ .+|..+.... .+
T Consensus       333 ~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~-------lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~  403 (636)
T 4eco_A          333 GMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-------IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV  403 (636)
T ss_dssp             CEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEE-------CCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSC
T ss_pred             CEEeCcCCcCccchh-hhCCCCCCCEEECCCCcccc-------ccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCc
Confidence            999999999998888 89999999999999999884       4555788888 999999999998 7887766553 26


Q ss_pred             cEEEEeecccccccCCcccc-------CCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCcc-ccCCC-
Q 042766          375 MIELSVGRNQISGTIPPGIR-------NLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLT-  445 (914)
Q Consensus       375 L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~-  445 (914)
                      |+.|++++|++++.+|..|.       .+.+|++|+|++|++++..+..+..+++|++|+|++|+++ .+|.. +.... 
T Consensus       404 L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~  482 (636)
T 4eco_A          404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENE  482 (636)
T ss_dssp             EEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTE
T ss_pred             cCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccc
Confidence            88888888888888888887       7778888888888888655556667888888888888888 44543 33222 


Q ss_pred             ------CCCeEEeeCCcCCCCCCCccC--CCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcccccccc
Q 042766          446 ------KLGSLDLGSNSLQGNIPSSLG--NCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNL  517 (914)
Q Consensus       446 ------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l  517 (914)
                            +|++|+|++|+++ .+|..+.  .+++|+.|++++|+++                         + +|..+.++
T Consensus       483 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~-------------------------~-ip~~~~~l  535 (636)
T 4eco_A          483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS-------------------------K-FPTQPLNS  535 (636)
T ss_dssp             ECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCS-------------------------S-CCCGGGGC
T ss_pred             cccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCC-------------------------C-cChhhhcC
Confidence                  6777777777776 4555554  5555555555555444                         3 34445555


Q ss_pred             ccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeC
Q 042766          518 KNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNL  597 (914)
Q Consensus       518 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  597 (914)
                      ++|+.|+|++|+                  ++++|++.+.+|..|..+++|++|+|++|++ +.+|..+.  ++|+.|||
T Consensus       536 ~~L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~L  594 (636)
T 4eco_A          536 STLKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDI  594 (636)
T ss_dssp             SSCCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEEC
T ss_pred             CCCCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEEC
Confidence            666666665544                  3345556666666666666666666666666 35555544  56666666


Q ss_pred             CCCcccc
Q 042766          598 SYNYFEG  604 (914)
Q Consensus       598 s~N~l~~  604 (914)
                      ++|++.+
T Consensus       595 s~N~l~~  601 (636)
T 4eco_A          595 KDNPNIS  601 (636)
T ss_dssp             CSCTTCE
T ss_pred             cCCCCcc
Confidence            6666553

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.4e-59  Score=562.75  Aligned_cols=515  Identities=21%  Similarity=0.228  Sum_probs=455.8

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      .+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            57899999999998887888999999999999999999888889999999999999999999888999999999999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhccc----ccccccc
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV----NLNVAEN  231 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N  231 (914)
                      ++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|++++|.+++..|..|+.+++|+    +|++++|
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n  191 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN  191 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence            9999997777889999999999999999986 6799999999999999999999998899999998876    7999999


Q ss_pred             cccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCC------CCCcccccc--ccccccc-c
Q 042766          232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS------IPDSLSNAS--NLELLDL-P  302 (914)
Q Consensus       232 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~------~p~~~~~l~--~L~~L~L-s  302 (914)
                      ++++..+..+... +|+.|++++|.+++......+.++++|+.+++..+.+.+.      .+..+..+.  +++.+++ .
T Consensus       192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  270 (606)
T 3vq2_A          192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY  270 (606)
T ss_dssp             CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred             CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence            9997777666655 8999999999998655556667899999988876655431      122222222  4666777 7


Q ss_pred             CccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeec
Q 042766          303 SNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGR  382 (914)
Q Consensus       303 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~  382 (914)
                      .|.+++..|. |..+++|+.|++++|.+...+        .+..+++|+.|++++|++ +.+|. + .+. +|+.|++++
T Consensus       271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--------~l~~~~~L~~L~l~~n~l-~~lp~-~-~l~-~L~~L~l~~  337 (606)
T 3vq2_A          271 TNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--------DVPKHFKWQSLSIIRCQL-KQFPT-L-DLP-FLKSLTLTM  337 (606)
T ss_dssp             CTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--------CCCTTCCCSEEEEESCCC-SSCCC-C-CCS-SCCEEEEES
T ss_pred             cccccccccc-cccCCCCCEEEecCccchhhh--------hccccccCCEEEcccccC-ccccc-C-CCC-ccceeeccC
Confidence            8889988887 999999999999999997763        467889999999999999 58884 4 444 799999999


Q ss_pred             ccccccCCccccCCCCCcEEEcccCccccc--CChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCC
Q 042766          383 NQISGTIPPGIRNLVNLITFTLEVNQFHGT--IPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGN  460 (914)
Q Consensus       383 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  460 (914)
                      |...+..  .+..+++|++|++++|++++.  .|..+..+++|++|++++|.+++ +|..|..+++|+.|++++|++++.
T Consensus       338 n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~  414 (606)
T 3vq2_A          338 NKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRV  414 (606)
T ss_dssp             CSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEEST
T ss_pred             CcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCc
Confidence            9766544  678999999999999999977  48999999999999999999995 668899999999999999999988


Q ss_pred             CC-CccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCC-CccccccccccceeecccCCccccccCccc
Q 042766          461 IP-SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG-SLPLQVGNLKNLVMLDISSNQFSGVIPVTL  538 (914)
Q Consensus       461 ~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  538 (914)
                      .| ..+.++++|+.|++++|++++..|..+..+..+ ++|++++|.+++ .+|..|+.+++|+.|+|++|++++.+|..|
T Consensus       415 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  493 (606)
T 3vq2_A          415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF  493 (606)
T ss_dssp             TTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             cChhhhhccccCCEEECcCCCCCccchhhhcCCCCC-CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence            88 789999999999999999999999999999888 899999999998 478999999999999999999999999999


Q ss_pred             cccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccC-CCCeEeCCCCccccccCCCC
Q 042766          539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLS-FLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       539 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~  610 (914)
                      +.+++|++|+|++|++++.+|..|..+++|++|+|++|+|+ .+|..+..++ +|++|++++|++.|.++..+
T Consensus       494 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             TTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             cccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            99999999999999999999999999999999999999999 6777798887 59999999999999999753

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-59  Score=579.75  Aligned_cols=522  Identities=20%  Similarity=0.179  Sum_probs=455.2

Q ss_pred             CCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccC-CcccCCCCCCCeeecCCCCCCCcCCC
Q 042766           65 CQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDI-PQEIGNLFRLEKLALSNNSFSGTIPT  143 (914)
Q Consensus        65 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~  143 (914)
                      |.|..|-+  ...+++.|||++|.+++..+..+.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            57888877  4578999999999999988999999999999999999877777 78899999999999999999988899


Q ss_pred             CccccCCcchhccCCCcccCCCChh--ccccccccccccccccccCcCC-cccccccccceeecccCCCCCCCCccchhh
Q 042766          144 NLSRCSNLIHFCASNNKLEGQIPKE--IGNLLKLQRLSVDINYLTGQLP-DSVGNLSAIEVIRITENSLGGKIPTTLGLL  220 (914)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  220 (914)
                      .|+++++|++|+|++|.+++.+|..  |+++++|++|+|++|++++..| ..|+++++|++|+|++|.+++..|..++.+
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            9999999999999999999877775  9999999999999999998765 579999999999999999999999999988


Q ss_pred             --hcccccccccccccCCCCCccccccc------cceeeccCCcccCcccccccccC--cccceeeccC---------cc
Q 042766          221 --RRLVNLNVAENQFSGMFPRSICNISS------VELIFLTENRFSGIFPFDILLNL--PNLKKLGIGG---------NN  281 (914)
Q Consensus       221 --~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~~l--~~L~~L~Ls~---------N~  281 (914)
                        ++|+.|+|++|.+.+..|..+..+.+      |+.|++++|.+++..|..+...+  ++++.|.++.         |+
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              89999999999999999888877766      99999999999988776655332  5677888773         34


Q ss_pred             CCCCCCCccccc--cccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccc
Q 042766          282 FVGSIPDSLSNA--SNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ  359 (914)
Q Consensus       282 l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  359 (914)
                      +.+..+..|..+  ++|+.|+|++|.+++..+..|..+++|+.|+|++|++++.      .+..+.++++|++|+|++|+
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~------~~~~~~~l~~L~~L~Ls~N~  325 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKI------ADEAFYGLDNLQVLNLSYNL  325 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEE------CTTTTTTCSSCCEEEEESCC
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCC------ChHHhcCCCCCCEEECCCCC
Confidence            444445556655  7899999999999999999999999999999999999877      34457899999999999999


Q ss_pred             cCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCc
Q 042766          360 FGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPS  439 (914)
Q Consensus       360 l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  439 (914)
                      +++..|..+..++ +|+.|++++|++.+..+..|.++++|++|+|++|.+++...     +++|+.|++++|+++ .+|.
T Consensus       326 l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~-----~~~L~~L~l~~N~l~-~l~~  398 (844)
T 3j0a_A          326 LGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHF-----IPSIPDIFLSGNKLV-TLPK  398 (844)
T ss_dssp             CSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSS-----CCSCSEEEEESCCCC-CCCC
T ss_pred             CCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccC-----CCCcchhccCCCCcc-cccc
Confidence            9988888888877 79999999999999888999999999999999999985432     789999999999998 5554


Q ss_pred             cccCCCCCCeEEeeCCcCCCCC-CCccCCCCCccccccCCCccCCCCchh-hhcccchhhhhcccCCccC-----CCccc
Q 042766          440 GLGNLTKLGSLDLGSNSLQGNI-PSSLGNCQNLILFIASYNKLTGDLPQQ-LLSITTLSLVLDLSNNLLN-----GSLPL  512 (914)
Q Consensus       440 ~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~-----~~~p~  512 (914)
                      .   ..+++.|++++|++++.. +..+.++++|+.|++++|++++..+.. +..+..+ +.|+|++|.++     +..|.
T Consensus       399 ~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L-~~L~Ls~N~l~~~~~~~~~~~  474 (844)
T 3j0a_A          399 I---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL-EQLFLGENMLQLAWETELCWD  474 (844)
T ss_dssp             C---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC-CBCEEESCCCSSSCCSCCCSS
T ss_pred             c---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc-ccccCCCCccccccccccchh
Confidence            3   467999999999998642 234568999999999999998655443 3334555 89999999997     45567


Q ss_pred             cccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCC
Q 042766          513 QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFL  592 (914)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  592 (914)
                      .|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|+|++.+|..+.  ++|+.|||++|+|++.+|+.+.   +|
T Consensus       475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L  549 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SL  549 (844)
T ss_dssp             CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SC
T ss_pred             hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---Cc
Confidence            789999999999999999999999999999999999999999998888776  8999999999999999998764   68


Q ss_pred             CeEeCCCCccccccCCCC
Q 042766          593 EFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       593 ~~L~ls~N~l~~~~p~~~  610 (914)
                      +.|++++|++.|.|+..+
T Consensus       550 ~~l~l~~Np~~C~c~~~~  567 (844)
T 3j0a_A          550 SVLDITHNKFICECELST  567 (844)
T ss_dssp             CEEEEEEECCCCSSSCCS
T ss_pred             CEEEecCCCcccccccHH
Confidence            999999999999998653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2e-59  Score=561.37  Aligned_cols=529  Identities=19%  Similarity=0.200  Sum_probs=460.8

Q ss_pred             ecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCccc
Q 042766           83 NLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLE  162 (914)
Q Consensus        83 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  162 (914)
                      +..+.+++ .+|..+..  .+++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus        18 ~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~   94 (606)
T 3t6q_A           18 NCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI   94 (606)
T ss_dssp             ECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCS
T ss_pred             ECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccc
Confidence            34444553 45655543  7899999999999888999999999999999999999888999999999999999999999


Q ss_pred             CCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccc
Q 042766          163 GQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSIC  242 (914)
Q Consensus       163 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  242 (914)
                      +..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++..+..+..+++|++|++++|++++..|..|.
T Consensus        95 ~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  174 (606)
T 3t6q_A           95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS  174 (606)
T ss_dssp             EECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHH
T ss_pred             ccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhh
Confidence            88899999999999999999999987788899999999999999999975544555599999999999999998899999


Q ss_pred             cccccc--eeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccC-----Ccccccccc
Q 042766          243 NISSVE--LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQF-----KGKVSIDFS  315 (914)
Q Consensus       243 ~l~~L~--~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-----~~~~~~~~~  315 (914)
                      .+++|+  .|++++|.+++..|. .+ ...+|++|++++|.   .++..+..+.++....+..+.+     ..+.+..|.
T Consensus       175 ~l~~L~~l~L~l~~n~l~~~~~~-~~-~~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~  249 (606)
T 3t6q_A          175 SLQQATNLSLNLNGNDIAGIEPG-AF-DSAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE  249 (606)
T ss_dssp             TTTTCCSEEEECTTCCCCEECTT-TT-TTCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred             hhcccceeEEecCCCccCccChh-Hh-hhccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhc
Confidence            999999  899999999987654 44 55789999999997   3445555555444433333222     233445555


Q ss_pred             ccc--cccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccc
Q 042766          316 SLK--NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI  393 (914)
Q Consensus       316 ~l~--~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~  393 (914)
                      ++.  +|+.|++++|.++..+      +..+..+++|++|++++|+++ .+|..+..+. +|++|++++|.+++..|..+
T Consensus       250 ~l~~~~L~~L~l~~n~l~~~~------~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~-~L~~L~l~~n~l~~~~~~~~  321 (606)
T 3t6q_A          250 GLCEMSVESINLQKHYFFNIS------SNTFHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQISA  321 (606)
T ss_dssp             GGGGSEEEEEECTTCCCSSCC------TTTTTTCTTCSEEECTTSCCS-CCCSSCCSCT-TCCEEECTTCCCSBGGGGCG
T ss_pred             hhhcCceeEEEeecCccCccC------HHHhccccCCCEEeccCCccC-CCChhhcccc-cCCEEECccCCcCcCchhhh
Confidence            555  7999999999999874      345789999999999999999 8898888776 79999999999999999999


Q ss_pred             cCCCCCcEEEcccCcccccCCh-hhhcccCCceeeeccccccccc--CccccCCCCCCeEEeeCCcCCCCCCCccCCCCC
Q 042766          394 RNLVNLITFTLEVNQFHGTIPD-VISELKNLQQLSVFNNFLRGGI--PSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN  470 (914)
Q Consensus       394 ~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  470 (914)
                      ..+++|++|++++|++.+.+|. .+..+++|++|++++|.+++..  |..+..+++|++|++++|++++..|..|.++++
T Consensus       322 ~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  401 (606)
T 3t6q_A          322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ  401 (606)
T ss_dssp             GGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTT
T ss_pred             hccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCcc
Confidence            9999999999999999976655 5999999999999999999776  788999999999999999999999999999999


Q ss_pred             ccccccCCCccCCCCchh-hhcccchhhhhcccCCccCCCccccccccccceeecccCCccccc---cCccccccccccE
Q 042766          471 LILFIASYNKLTGDLPQQ-LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV---IPVTLSTCVSLEY  546 (914)
Q Consensus       471 L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~  546 (914)
                      |+.|++++|++++..|.. +..+..+ ++|++++|.+++..|..++.+++|++|+|++|++++.   .+..+..+++|++
T Consensus       402 L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~  480 (606)
T 3t6q_A          402 LELLDLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI  480 (606)
T ss_dssp             CSEEECTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCE
T ss_pred             CCeEECCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccE
Confidence            999999999999887765 6677777 8999999999999999999999999999999999873   3367999999999


Q ss_pred             EEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-CcCCCCCccCccCCCC
Q 042766          547 LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVFSNKTKISLHGNVK  625 (914)
Q Consensus       547 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~  625 (914)
                      |+|++|++++.+|.+|..+++|++|+|++|++++.+|+.+..++.| .|++++|++++.+|.. ..+..+..+.+.+||+
T Consensus       481 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  559 (606)
T 3t6q_A          481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL  559 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCE
T ss_pred             EECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCc
Confidence            9999999999999999999999999999999999999999999999 9999999999877753 4567788899999999


Q ss_pred             CCCC
Q 042766          626 LCGG  629 (914)
Q Consensus       626 lc~~  629 (914)
                      .|..
T Consensus       560 ~c~c  563 (606)
T 3t6q_A          560 DCTC  563 (606)
T ss_dssp             ECSG
T ss_pred             cccC
Confidence            8843

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.1e-59  Score=569.29  Aligned_cols=507  Identities=19%  Similarity=0.204  Sum_probs=360.2

Q ss_pred             CCCCCHhHHHHHHHHHHhcCCCCCCCCCCCCCC-----CC--CCc------------cceeecCCCCceEEEecCCCCCc
Q 042766           30 AGQTNETDRLALLAIKSQLHDPSGVTSSWNNTM-----NF--CQW------------TGVTCGHRHQRLTELNLSSQRIG   90 (914)
Q Consensus        30 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~   90 (914)
                      ++++..+|+.||++||+++.+|     +|+.+.     +|  |.|            .||+|+. +++|+.|+|+++++.
T Consensus       263 ~~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~  336 (876)
T 4ecn_A          263 ETAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK  336 (876)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred             ccccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence            3345678999999999999776     786543     55  999            9999976 689999999999999


Q ss_pred             cccCCCCCCCCCCCEEEc-CCCCCcccCCcccCCCC-CCCe--------------eec-CCCCCC-----------CcCC
Q 042766           91 GVLSPYVGNLSFLRYINL-ADNGFRGDIPQEIGNLF-RLEK--------------LAL-SNNSFS-----------GTIP  142 (914)
Q Consensus        91 ~~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~~~~l~-~L~~--------------L~L-s~N~l~-----------~~~p  142 (914)
                      |.+|+++++|++|++|+| ++|.++|..|....... .+..              ++. ....++           ...+
T Consensus       337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            999999999999999999 89999988654322110 0000              000 000000           0111


Q ss_pred             CCccccCCcchhccCC--CcccCCCChhccccccccccccccccccC-----------------cCCcccc--cccccce
Q 042766          143 TNLSRCSNLIHFCASN--NKLEGQIPKEIGNLLKLQRLSVDINYLTG-----------------QLPDSVG--NLSAIEV  201 (914)
Q Consensus       143 ~~l~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~  201 (914)
                      ........++.+.+..  |++++ +|..|+++++|++|+|++|+++|                 .+|+.++  ++++|++
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~  495 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD  495 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence            1222333445555544  66766 67777777777777777777776                 3777776  8888888


Q ss_pred             eecccCCCCCCCCccchhhhccccccccccc-ccC-CCCCcccccc-------ccceeeccCCcccCcccc-cccccCcc
Q 042766          202 IRITENSLGGKIPTTLGLLRRLVNLNVAENQ-FSG-MFPRSICNIS-------SVELIFLTENRFSGIFPF-DILLNLPN  271 (914)
Q Consensus       202 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~-~~~~~l~~  271 (914)
                      |+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..+++++       +|++|+|++|+++ .+|. ..+.++++
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~  574 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK  574 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence            8888888877888888888888888888887 777 6777666655       8888888888887 5665 24557888


Q ss_pred             cceeeccCccCCCCCCCccccccccccccccCccCCcccccccccccc-ccceeccCCcCCCCCCCCcchhhcccCCC--
Q 042766          272 LKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKN-LWLLNLEQNNLGTGTANDLDFVIFLSNCS--  348 (914)
Q Consensus       272 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~l~~l~--  348 (914)
                      |++|+|++|+++ .+| .|+.+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.++.+       |..+..++  
T Consensus       575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~l-------p~~~~~~~~~  644 (876)
T 4ecn_A          575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYI-------PNIFNAKSVY  644 (876)
T ss_dssp             CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSC-------CSCCCTTCSS
T ss_pred             CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcC-------chhhhccccC
Confidence            888888888887 677 7888888888888888888 66667888887 88888888887754       33344444  


Q ss_pred             CCcEEeccccccCCCcCchh---hcc-ccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhc-----
Q 042766          349 SLKVLSLSDNQFGGELPHSI---ANL-SLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE-----  419 (914)
Q Consensus       349 ~L~~L~Ls~N~l~~~~p~~~---~~~-~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----  419 (914)
                      +|+.|+|++|++++.+|...   ..+ ..+|+.|++++|+++...+..+..+++|+.|+|++|+++...+..+..     
T Consensus       645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l  724 (876)
T 4ecn_A          645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY  724 (876)
T ss_dssp             CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCC
T ss_pred             CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccc
Confidence            48888888888887665432   111 126888999999988443344568899999999999998433333332     


Q ss_pred             --ccCCceeeecccccccccCcccc--CCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccch
Q 042766          420 --LKNLQQLSVFNNFLRGGIPSGLG--NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL  495 (914)
Q Consensus       420 --l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  495 (914)
                        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|+.|++++|+               
T Consensus       725 ~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~---------------  787 (876)
T 4ecn_A          725 KNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR---------------  787 (876)
T ss_dssp             TTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB---------------
T ss_pred             cccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC---------------
Confidence              338999999999999 7888887  89999999999999997 78888899999888888776               


Q ss_pred             hhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccC
Q 042766          496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS  575 (914)
Q Consensus       496 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  575 (914)
                          ++++|++.+.+|..|.++++|+.|+|++|++ +.+|..+.  ++|+.|||++|++....+..|.....+..+.|++
T Consensus       788 ----~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~  860 (876)
T 4ecn_A          788 ----DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLY  860 (876)
T ss_dssp             ----CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEEC
T ss_pred             ----CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecC
Confidence                4556666666666666677777777777776 45555544  4666666666666555555554444444444444


Q ss_pred             Ccc
Q 042766          576 NNL  578 (914)
Q Consensus       576 N~l  578 (914)
                      |++
T Consensus       861 n~~  863 (876)
T 4ecn_A          861 DKT  863 (876)
T ss_dssp             CTT
T ss_pred             CCc
Confidence            443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=563.88  Aligned_cols=523  Identities=19%  Similarity=0.172  Sum_probs=456.0

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcC-CCCccccCCcchhccCCC
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI-PTNLSRCSNLIHFCASNN  159 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N  159 (914)
                      ..|.++++++. +|.   -.++|++|||++|.+++..|..|+++++|++|||++|.+.+.+ |..|+++++|++|+|++|
T Consensus         8 ~~dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            34556777764 555   4589999999999999999999999999999999999877777 788999999999999999


Q ss_pred             cccCCCChhccccccccccccccccccCcCCcc--cccccccceeecccCCCCCCCC-ccchhhhcccccccccccccCC
Q 042766          160 KLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDS--VGNLSAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFSGM  236 (914)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~  236 (914)
                      ++++..|+.|+++++|++|+|++|.+++.+|..  |+++++|++|+|++|.+++..| ..|+++++|++|+|++|++++.
T Consensus        84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~  163 (844)
T 3j0a_A           84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV  163 (844)
T ss_dssp             CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred             cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence            999889999999999999999999999877765  9999999999999999998765 5899999999999999999999


Q ss_pred             CCCccccc--cccceeeccCCcccCcccccccccCc------ccceeeccCccCCCCCCCccccc---ccccccccc---
Q 042766          237 FPRSICNI--SSVELIFLTENRFSGIFPFDILLNLP------NLKKLGIGGNNFVGSIPDSLSNA---SNLELLDLP---  302 (914)
Q Consensus       237 ~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~~l~------~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls---  302 (914)
                      .|..+..+  ++|+.|+++.|.+.+..|..+. .++      +|++|+|++|++++..|..+...   ++++.|+++   
T Consensus       164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~-~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWG-KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCC-SSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             CHHHcccccCCccceEECCCCccccccccchh-hcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            99999988  8999999999999988776543 444      49999999999998888877654   567777776   


Q ss_pred             ------CccCCcccccccccc--ccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccc
Q 042766          303 ------SNQFKGKVSIDFSSL--KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLK  374 (914)
Q Consensus       303 ------~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  374 (914)
                            .|.+.+.....|.++  ++|+.|++++|.+...      .+..+..+++|+.|+|++|++++..|..+..+. +
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~------~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~  315 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL------NSRVFETLKDLKVLNLAYNKINKIADEAFYGLD-N  315 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEE------CSCCSSSCCCCCEEEEESCCCCEECTTTTTTCS-S
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCccccc------ChhhhhcCCCCCEEECCCCcCCCCChHHhcCCC-C
Confidence                  455566666677776  7899999999999876      345678999999999999999988888888776 7


Q ss_pred             cEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeC
Q 042766          375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS  454 (914)
Q Consensus       375 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  454 (914)
                      |++|++++|++++..|..|.++++|++|+|++|++.+..+..|..+++|++|+|++|.+++. +    .+++|+.|++++
T Consensus       316 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l~~  390 (844)
T 3j0a_A          316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFLSG  390 (844)
T ss_dssp             CCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEEES
T ss_pred             CCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhccCC
Confidence            99999999999999999999999999999999999998888999999999999999999853 2    378999999999


Q ss_pred             CcCCCCCCCccCCCCCccccccCCCccCCCC-chhhhcccchhhhhcccCCccCCCccc-cccccccceeecccCCccc-
Q 042766          455 NSLQGNIPSSLGNCQNLILFIASYNKLTGDL-PQQLLSITTLSLVLDLSNNLLNGSLPL-QVGNLKNLVMLDISSNQFS-  531 (914)
Q Consensus       455 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-  531 (914)
                      |+++ .+|..   ..+++.+++++|++++.- +..+..++.+ +.|+|++|++++..+. .+..+++|+.|+|++|.++ 
T Consensus       391 N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~  465 (844)
T 3j0a_A          391 NKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL  465 (844)
T ss_dssp             CCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSS
T ss_pred             CCcc-ccccc---ccccceeecccCccccCchhhhhhcCCcc-ceeeCCCCcccccccccccccCCccccccCCCCcccc
Confidence            9998 55654   467889999999998532 2334467777 8999999999976543 4567899999999999997 


Q ss_pred             ----cccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccC
Q 042766          532 ----GVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVP  607 (914)
Q Consensus       532 ----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  607 (914)
                          +..|..|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|||++|++++.+|
T Consensus       466 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~  543 (844)
T 3j0a_A          466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNP  543 (844)
T ss_dssp             SCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCS
T ss_pred             ccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCCh
Confidence                45567789999999999999999999999999999999999999999988887776  899999999999999988


Q ss_pred             CCCcCCCCCccCccCCCCCCCC
Q 042766          608 VKGVFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       608 ~~~~~~~~~~~~~~~n~~lc~~  629 (914)
                      ..  +..+..+++.+||+.|..
T Consensus       544 ~~--~~~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          544 DV--FVSLSVLDITHNKFICEC  563 (844)
T ss_dssp             CC--CSSCCEEEEEEECCCCSS
T ss_pred             hH--hCCcCEEEecCCCccccc
Confidence            54  668888999999999953

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.2e-57  Score=545.84  Aligned_cols=526  Identities=19%  Similarity=0.179  Sum_probs=458.6

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK  160 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  160 (914)
                      .++.++++++ .+|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus        15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            4566677775 4666554  889999999999998888899999999999999999998889999999999999999999


Q ss_pred             ccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCCCC
Q 042766          161 LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPR  239 (914)
Q Consensus       161 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  239 (914)
                      +++..|..|+++++|++|+|++|++++..|..++++++|++|++++|.+++ .+|..|+++++|++|+|++|++++..|.
T Consensus        92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~  171 (606)
T 3vq2_A           92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN  171 (606)
T ss_dssp             CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred             ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence            998889999999999999999999998887899999999999999999986 6799999999999999999999999999


Q ss_pred             ccccccccc----eeeccCCcccCcccccccccCcccceeeccCccCC-CCCCCccccccccccccccCccCCcc-----
Q 042766          240 SICNISSVE----LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV-GSIPDSLSNASNLELLDLPSNQFKGK-----  309 (914)
Q Consensus       240 ~~~~l~~L~----~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~-----  309 (914)
                      .|..+.+|+    +|++++|.+++. |...+.. .+|++|++++|.+. +..|..+.++++|+.+++..+.+.+.     
T Consensus       172 ~~~~l~~L~~~l~~L~l~~n~l~~~-~~~~~~~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~  249 (606)
T 3vq2_A          172 DLQFLRENPQVNLSLDMSLNPIDFI-QDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI  249 (606)
T ss_dssp             TTHHHHHCTTCCCEEECTTCCCCEE-CTTTTTT-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSC
T ss_pred             hhhhhhccccccceeeccCCCccee-CcccccC-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccc
Confidence            999988876    799999999865 5455544 49999999999987 46778899999999999877665432     


Q ss_pred             -ccccccccc--cccceec-cCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccc
Q 042766          310 -VSIDFSSLK--NLWLLNL-EQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQI  385 (914)
Q Consensus       310 -~~~~~~~l~--~L~~L~L-~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l  385 (914)
                       .+..+.++.  +++.+++ ..|.+.+.      .|. +..+++|+.|++++|.+. .+| .+..+. +|+.|++++|.+
T Consensus       250 ~~~~~~~~l~~l~l~~l~l~~~~~~~~~------~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~-~L~~L~l~~n~l  319 (606)
T 3vq2_A          250 FEPSIMEGLCDVTIDEFRLTYTNDFSDD------IVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHF-KWQSLSIIRCQL  319 (606)
T ss_dssp             CCGGGGTTGGGSEEEEEEECCCTTCCGG------GGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTC-CCSEEEEESCCC
T ss_pred             cChHHhhhhhhccHhheecccccccccc------ccc-cccCCCCCEEEecCccch-hhh-hccccc-cCCEEEcccccC
Confidence             233333333  3445555 55666554      444 788999999999999997 567 666655 799999999999


Q ss_pred             cccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccc--cCccccCCCCCCeEEeeCCcCCCCCCC
Q 042766          386 SGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGG--IPSGLGNLTKLGSLDLGSNSLQGNIPS  463 (914)
Q Consensus       386 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~  463 (914)
                       +.+| .+ .+++|++|++++|+..+..  .+..+++|++|++++|.+++.  +|..+..+++|++|+|++|.+++ +|.
T Consensus       320 -~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~  393 (606)
T 3vq2_A          320 -KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSA  393 (606)
T ss_dssp             -SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECC
T ss_pred             -cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chh
Confidence             6788 55 9999999999999766544  577999999999999999976  48889999999999999999985 678


Q ss_pred             ccCCCCCccccccCCCccCCCCc-hhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcccc-ccCcccccc
Q 042766          464 SLGNCQNLILFIASYNKLTGDLP-QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSG-VIPVTLSTC  541 (914)
Q Consensus       464 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l  541 (914)
                      .+.++++|+.|++++|++++..| ..+..+..+ ++|++++|.+.+..|..++++++|++|+|++|++++ .+|..|+.+
T Consensus       394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  472 (606)
T 3vq2_A          394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT  472 (606)
T ss_dssp             CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred             hccCCCCCCeeECCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence            99999999999999999998887 577778887 899999999999999999999999999999999998 589999999


Q ss_pred             ccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-CcCC-CCCccC
Q 042766          542 VSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVFS-NKTKIS  619 (914)
Q Consensus       542 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~-~~~~~~  619 (914)
                      ++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..+++|+.||+++|+++. +|.. ..+. ++..+.
T Consensus       473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~  551 (606)
T 3vq2_A          473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFN  551 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEE
T ss_pred             CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEE
Confidence            999999999999999999999999999999999999999999999999999999999999994 5543 3443 578889


Q ss_pred             ccCCCCCCCC
Q 042766          620 LHGNVKLCGG  629 (914)
Q Consensus       620 ~~~n~~lc~~  629 (914)
                      +.+|++.|..
T Consensus       552 l~~N~~~c~c  561 (606)
T 3vq2_A          552 LTNNSVACIC  561 (606)
T ss_dssp             CCSCCCCCSS
T ss_pred             ccCCCcccCC
Confidence            9999999854

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=9.5e-55  Score=514.51  Aligned_cols=494  Identities=17%  Similarity=0.163  Sum_probs=381.9

Q ss_pred             CCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCC
Q 042766           64 FCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT  143 (914)
Q Consensus        64 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  143 (914)
                      .|.|.|| |+.          ++++++ .+|+.+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++..|.
T Consensus         3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999998 854          345554 4666654  7999999999999998899999999999999999999988889


Q ss_pred             CccccCCcchhccCCCcccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCC-ccchhhh
Q 042766          144 NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIP-TTLGLLR  221 (914)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~  221 (914)
                      .|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ ..|..++++++|++|++++|.+.+.+| ..|++++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  148 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence            99999999999999999998888889999999999999999997 467889999999999999999554554 6899999


Q ss_pred             cccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCC--C-Ccccccccccc
Q 042766          222 RLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI--P-DSLSNASNLEL  298 (914)
Q Consensus       222 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~  298 (914)
                      +|++|++++|++++..|..+..+++|++|+++.|.+. .+|...+..+++|++|++++|++++..  | .....+++|+.
T Consensus       149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~  227 (549)
T 2z81_A          149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK  227 (549)
T ss_dssp             EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCE
T ss_pred             ccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccc
Confidence            9999999999999999999999999999999999986 456666667999999999999999752  2 23456789999


Q ss_pred             ccccCccCCccccc----cccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcC----chhhc
Q 042766          299 LDLPSNQFKGKVSI----DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP----HSIAN  370 (914)
Q Consensus       299 L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p----~~~~~  370 (914)
                      |++++|++++..+.    .+..+++|+.+++++|.+.+...-.......+..+++|+.|+++++.+.....    ..+..
T Consensus       228 L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~  307 (549)
T 2z81_A          228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS  307 (549)
T ss_dssp             EEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHH
T ss_pred             eeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhh
Confidence            99999999876543    34667889999999998877533211122335677888888888887653110    01112


Q ss_pred             cccccEEEEeecccccccCCccc-cCCCCCcEEEcccCcccccCChh---hhcccCCceeeecccccccccC--ccccCC
Q 042766          371 LSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDV---ISELKNLQQLSVFNNFLRGGIP--SGLGNL  444 (914)
Q Consensus       371 ~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~---~~~l~~L~~L~L~~N~l~~~~p--~~~~~l  444 (914)
                      ...+++.|++++|++. .+|..+ .++++|++|+|++|++++.+|..   +..+++|++|+|++|++++..+  ..+..+
T Consensus       308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l  386 (549)
T 2z81_A          308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL  386 (549)
T ss_dssp             HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred             hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence            2235666666666665 344443 45666666666666666555332   5556666666666666664322  345666


Q ss_pred             CCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeec
Q 042766          445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD  524 (914)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  524 (914)
                      ++|++|+|++|+++ .+|..+..+++|+.|++++|+++ .                         +|..+  .++|++||
T Consensus       387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~-------------------------l~~~~--~~~L~~L~  437 (549)
T 2z81_A          387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-V-------------------------VKTCI--PQTLEVLD  437 (549)
T ss_dssp             TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-C-------------------------CCTTS--CTTCSEEE
T ss_pred             CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-c-------------------------ccchh--cCCceEEE
Confidence            66666666666666 45656666666666666666554 1                         22222  14789999


Q ss_pred             ccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCcccc
Q 042766          525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       525 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  604 (914)
                      |++|++++.+    ..+++|++|+|++|+++ .+|. ...+++|++|||++|++++.+|..+..+++|+.|++++|++.|
T Consensus       438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            9999998753    57889999999999998 5665 5679999999999999999999999999999999999999999


Q ss_pred             ccCC
Q 042766          605 EVPV  608 (914)
Q Consensus       605 ~~p~  608 (914)
                      .||.
T Consensus       512 ~~~~  515 (549)
T 2z81_A          512 SCPR  515 (549)
T ss_dssp             CHHH
T ss_pred             CCcc
Confidence            9984

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-53  Score=502.03  Aligned_cols=494  Identities=20%  Similarity=0.207  Sum_probs=384.2

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      .+++.|||++|.+++..+..+.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+.+++|++|++
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            46888899998888777778888999999999999888777788888899999999999888777788888999999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhcc----cccccccc
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRL----VNLNVAEN  231 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N  231 (914)
                      ++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|.+++..|..++.+++|    +.|++++|
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n  187 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  187 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence            9998886555578888899999999998886 468888888999999999998888888888888888    78889999


Q ss_pred             cccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCC------CCCCCcccccc--ccccccccC
Q 042766          232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV------GSIPDSLSNAS--NLELLDLPS  303 (914)
Q Consensus       232 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~------~~~p~~~~~l~--~L~~L~Ls~  303 (914)
                      .+++..|..|... +|+.|++++|......-...+.++++++.+.+..+.+.      ......+..++  .++.+++++
T Consensus       188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  266 (570)
T 2z63_A          188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  266 (570)
T ss_dssp             CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred             CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence            8888888777766 78888888886543322334456777776665543332      12222333333  356677777


Q ss_pred             c-cCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeec
Q 042766          304 N-QFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGR  382 (914)
Q Consensus       304 N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~  382 (914)
                      | .+.+..+..|..+++|++|++++|.++.+       |..+..+ +|+.|++++|.+. .+|..  .+ .+|+.|++++
T Consensus       267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l-------~~~~~~~-~L~~L~l~~n~~~-~l~~~--~l-~~L~~L~l~~  334 (570)
T 2z63_A          267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-------KDFSYNF-GWQHLELVNCKFG-QFPTL--KL-KSLKRLTFTS  334 (570)
T ss_dssp             TTEEESCSTTTTGGGTTCSEEEEESCEECSC-------CBCCSCC-CCSEEEEESCBCS-SCCBC--BC-SSCCEEEEES
T ss_pred             chhhhhhchhhhcCcCcccEEEecCccchhh-------hhhhccC-CccEEeeccCccc-ccCcc--cc-cccCEEeCcC
Confidence            7 67777777788888888888888877653       3345566 7888888888877 55552  22 3577777777


Q ss_pred             ccccccCCccccCCCCCcEEEcccCcccccC--ChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCC
Q 042766          383 NQISGTIPPGIRNLVNLITFTLEVNQFHGTI--PDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGN  460 (914)
Q Consensus       383 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  460 (914)
                      |.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+++.
T Consensus       335 n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~  411 (570)
T 2z63_A          335 NKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQM  411 (570)
T ss_dssp             CBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESC
T ss_pred             Ccccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccc
Confidence            777766554  66777788888877777554  66777777777777777777754443 77777777777777777765


Q ss_pred             CC-CccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccc-cccCccc
Q 042766          461 IP-SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS-GVIPVTL  538 (914)
Q Consensus       461 ~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~  538 (914)
                      .| ..+.++++|+.|++++|+                         +.+..|..|.++++|++|+|++|+++ +.+|..+
T Consensus       412 ~~~~~~~~l~~L~~L~l~~n~-------------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~  466 (570)
T 2z63_A          412 SEFSVFLSLRNLIYLDISHTH-------------------------TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF  466 (570)
T ss_dssp             TTSCTTTTCTTCCEEECTTSC-------------------------CEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred             cchhhhhcCCCCCEEeCcCCc-------------------------ccccchhhhhcCCcCcEEECcCCcCccccchhhh
Confidence            54 456666666555555554                         44456677888999999999999998 6789999


Q ss_pred             cccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCCc
Q 042766          539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGV  611 (914)
Q Consensus       539 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~  611 (914)
                      ..+++|++|+|++|++++..|..|..+++|++|++++|++++.+|..+..+++|+.|++++|+++|.||..+.
T Consensus       467 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~  539 (570)
T 2z63_A          467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  539 (570)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHH
T ss_pred             hcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHH
Confidence            9999999999999999999999999999999999999999999899999999999999999999999997643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=8.3e-51  Score=489.62  Aligned_cols=516  Identities=21%  Similarity=0.210  Sum_probs=421.4

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      ..++.|||++|.+++..+.+|.++++|++|||++|+|++..|.+|++|++|++|+|++|+|++..|..|.++++|++|+|
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            36788999998888766677888999999999999888777778888999999999999888666667888899999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhccc----ccccccc
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV----NLNVAEN  231 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N  231 (914)
                      ++|++++..+..|+++++|++|+|++|++++ ..|..++.+++|++|+|++|++++..|..|..+.+++    .++++.|
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence            9998887666778888899999999998875 4677888888899999999988888888888887765    4678888


Q ss_pred             cccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc------CCCCCCCccccccccccccccCcc
Q 042766          232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN------FVGSIPDSLSNASNLELLDLPSNQ  305 (914)
Q Consensus       232 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~~L~~L~Ls~N~  305 (914)
                      .++...+..+. ...++.+++++|..+..++...+..++.++...+..+.      +....+..+..+..+...++..+.
T Consensus       212 ~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          212 PMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             cccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            88865555444 44667788888877655555666677777776665443      333344556667777777776665


Q ss_pred             CCcc---ccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeec
Q 042766          306 FKGK---VSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGR  382 (914)
Q Consensus       306 l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~  382 (914)
                      ....   ....+..+.+++.+++.+|.+....        .+....+|+.|++++|.+.+..+..+    ..++.+++..
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~  358 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--------DFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTS  358 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--------GGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEES
T ss_pred             hcccccchhhhhhhhccccccccccccccccc--------ccccchhhhhhhcccccccCcCcccc----hhhhhccccc
Confidence            4432   3345677788999999998876542        24567889999999999985544332    2578899999


Q ss_pred             ccccccCCccccCCCCCcEEEcccCccc--ccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCC
Q 042766          383 NQISGTIPPGIRNLVNLITFTLEVNQFH--GTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGN  460 (914)
Q Consensus       383 N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  460 (914)
                      |.+....  .+..+++|+.|++++|.+.  +..+..+..+.+|+.|+++.|.+.+ .+..+..+++|+.++++.|.....
T Consensus       359 n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~  435 (635)
T 4g8a_A          359 NKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM  435 (635)
T ss_dssp             CCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEEST
T ss_pred             ccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccc
Confidence            9876543  4567899999999999986  4567788899999999999999884 566788999999999999887655


Q ss_pred             C-CCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCcc-CCCccccccccccceeecccCCccccccCccc
Q 042766          461 I-PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLL-NGSLPLQVGNLKNLVMLDISSNQFSGVIPVTL  538 (914)
Q Consensus       461 ~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  538 (914)
                      . +..+.++++++.++++.|.+.+..|..+..+..+ +.|++++|.+ .+..|..|..+++|++|||++|+|++++|.+|
T Consensus       436 ~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f  514 (635)
T 4g8a_A          436 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF  514 (635)
T ss_dssp             TSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred             ccccccccccccccccccccccccccccccccchhh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHH
Confidence            4 4568899999999999999998888777777777 8999999975 45678899999999999999999999999999


Q ss_pred             cccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCcccccc-CCCCeEeCCCCccccccCCC
Q 042766          539 STCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENL-SFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       539 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~  609 (914)
                      +++++|++|+|++|+|++.+|..|..+++|++|||++|+|++.+|+.+..+ ++|++|+|++|+|.|+|...
T Consensus       515 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~  586 (635)
T 4g8a_A          515 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ  586 (635)
T ss_dssp             TTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred             cCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence            999999999999999999999999999999999999999999999999988 68999999999999999854

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.5e-52  Score=499.89  Aligned_cols=516  Identities=19%  Similarity=0.263  Sum_probs=316.2

Q ss_pred             CCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCC----CCCccce--eecCCC-CceEEEecCCCCCccccCCCCCCCCCCC
Q 042766           32 QTNETDRLALLAIKSQLHDPSGVTSSWNNTMN----FCQWTGV--TCGHRH-QRLTELNLSSQRIGGVLSPYVGNLSFLR  104 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~----~c~w~gv--~C~~~~-~~v~~l~l~~~~l~~~~~~~l~~l~~L~  104 (914)
                      ...+.+...-.++++-...-.+  ..|....+    .|.|..-  .|.|.. ..|+.   ...             .+++
T Consensus        23 ~~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C---~~~-------------~~V~   84 (636)
T 4eco_A           23 SRTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL---NSN-------------GRVT   84 (636)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTCCTTEEE---CTT-------------CCEE
T ss_pred             hhhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccCCCCeEE---cCC-------------CCEE
Confidence            3456666777777766543333  47874332    3479632  355511 12331   000             3688


Q ss_pred             EEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccccc
Q 042766          105 YINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINY  184 (914)
Q Consensus       105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (914)
                      .|+|++|+++|.+|+++++|++|++|||++|.+.. .+..++...           +...+|...  +.+|+ ++++.|.
T Consensus        85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~~~-----------~~~~~~~~~--~~~l~-l~l~~~~  149 (636)
T 4eco_A           85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-NERLFGPKG-----------ISANMSDEQ--KQKMR-MHYQKTF  149 (636)
T ss_dssp             EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGG-TCCSBSTTS-----------BCTTCCHHH--HHHHH-THHHHHH
T ss_pred             EEEecCcccCCcCChHHhcCccceEEECcCCcccc-CCccccccc-----------cccCchHHH--HHHHH-hhHHHhh
Confidence            99999999999999999999999999999998731 111111000           011344444  45566 6777777


Q ss_pred             ccCcCCccccc-ccccceeecccCCCCCCCCccchhhhcccccccc--cccccCCCCCccccccccceeeccCCcccCc-
Q 042766          185 LTGQLPDSVGN-LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVA--ENQFSGMFPRSICNISSVELIFLTENRFSGI-  260 (914)
Q Consensus       185 l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-  260 (914)
                      +.+.+|..+.. +..+..+++....+..      .....++.+.+.  .|+++| +|..|+++++|++|+|++|++++. 
T Consensus       150 l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~  222 (636)
T 4eco_A          150 VDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN  222 (636)
T ss_dssp             TCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGG
T ss_pred             hccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccc
Confidence            76666665542 3344444544433321      111233333333  467776 677777777777777777777763 


Q ss_pred             ----------------cccccc-ccCcccceeeccCccCCCCCCCccccccccccccccCcc-CCc-ccccccccc----
Q 042766          261 ----------------FPFDIL-LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQ-FKG-KVSIDFSSL----  317 (914)
Q Consensus       261 ----------------~p~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l----  317 (914)
                                      +|..+. .++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+..+    
T Consensus       223 ~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~  302 (636)
T 4eco_A          223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP  302 (636)
T ss_dssp             BSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSG
T ss_pred             ccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccc
Confidence                            554331 266777777777777777777777777777777777776 776 666665554    


Q ss_pred             --ccccceeccCCcCCCCCCCCcchhh--cccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccc
Q 042766          318 --KNLWLLNLEQNNLGTGTANDLDFVI--FLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI  393 (914)
Q Consensus       318 --~~L~~L~L~~N~l~~~~~~~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~  393 (914)
                        ++|++|++++|+++.       +|.  .++++++|++|+|++|+++|.+|                          .|
T Consensus       303 ~l~~L~~L~L~~n~l~~-------ip~~~~l~~l~~L~~L~L~~N~l~g~ip--------------------------~~  349 (636)
T 4eco_A          303 VGEKIQIIYIGYNNLKT-------FPVETSLQKMKKLGMLECLYNQLEGKLP--------------------------AF  349 (636)
T ss_dssp             GGGTCCEEECCSSCCSS-------CCCHHHHTTCTTCCEEECCSCCCEEECC--------------------------CC
T ss_pred             cCCCCCEEECCCCcCCc-------cCchhhhccCCCCCEEeCcCCcCccchh--------------------------hh
Confidence              555555555555552       233  34555555555555555554444                          44


Q ss_pred             cCCCCCcEEEcccCcccccCChhhhcccC-CceeeecccccccccCccccCCC--CCCeEEeeCCcCCCCCCCccC----
Q 042766          394 RNLVNLITFTLEVNQFHGTIPDVISELKN-LQQLSVFNNFLRGGIPSGLGNLT--KLGSLDLGSNSLQGNIPSSLG----  466 (914)
Q Consensus       394 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~----  466 (914)
                      +.+++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++  +|++|+|++|++++.+|..+.    
T Consensus       350 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~  427 (636)
T 4eco_A          350 GSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP  427 (636)
T ss_dssp             EEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCS
T ss_pred             CCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccc
Confidence            44444444444444444 34444444444 444444444444 3444443332  444555555555444444444    


Q ss_pred             ---CCCCccccccCCCccCCCCchhhhc-ccchhhhhcccCCccCCCcccc-c-------cccccceeecccCCcccccc
Q 042766          467 ---NCQNLILFIASYNKLTGDLPQQLLS-ITTLSLVLDLSNNLLNGSLPLQ-V-------GNLKNLVMLDISSNQFSGVI  534 (914)
Q Consensus       467 ---~l~~L~~L~l~~N~l~~~~p~~~~~-~~~l~~~L~Ls~N~l~~~~p~~-~-------~~l~~L~~L~Ls~N~l~~~~  534 (914)
                         .+++|+.|++++|+++ .+|..++. ++.+ ++|+|++|+++ .+|.. +       .++++|+.|+|++|+++ .+
T Consensus       428 ~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l  503 (636)
T 4eco_A          428 TPFKGINVSSINLSNNQIS-KFPKELFSTGSPL-SSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KL  503 (636)
T ss_dssp             SCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCC-SEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BC
T ss_pred             ccccCCCCCEEECcCCccC-cCCHHHHccCCCC-CEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-cc
Confidence               4444555555555554 34443332 3333 45555555555 33322 2       23448888999999888 56


Q ss_pred             Ccccc--ccccccEEEeecccccccCCcchhccCCCCEEEc------cCCccccccCccccccCCCCeEeCCCCcccccc
Q 042766          535 PVTLS--TCVSLEYLDISINSFYGVIPLSFRFLKSIKALNV------SSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEV  606 (914)
Q Consensus       535 p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  606 (914)
                      |..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|++ +.+
T Consensus       504 p~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~i  581 (636)
T 4eco_A          504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKV  581 (636)
T ss_dssp             CGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC
T ss_pred             ChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Ccc
Confidence            77776  88899999999999887 7888888999999988      57889999999999999999999999999 788


Q ss_pred             CCCCcCCCCCccCccCCCCCCCC
Q 042766          607 PVKGVFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       607 p~~~~~~~~~~~~~~~n~~lc~~  629 (914)
                      |.. ....+..+.+++|+..|-.
T Consensus       582 p~~-~~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          582 NEK-ITPNISVLDIKDNPNISID  603 (636)
T ss_dssp             CSC-CCTTCCEEECCSCTTCEEE
T ss_pred             CHh-HhCcCCEEECcCCCCcccc
Confidence            876 3478889999999888754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=486.65  Aligned_cols=504  Identities=20%  Similarity=0.201  Sum_probs=358.7

Q ss_pred             ecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCccc
Q 042766           83 NLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLE  162 (914)
Q Consensus        83 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  162 (914)
                      +.++.+++ .+|..+.  +++++|+|++|++++..|..|.++++|++|||++|++++..|..|+++++|++|+|++|+++
T Consensus        13 ~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~   89 (570)
T 2z63_A           13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ   89 (570)
T ss_dssp             ECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             EeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC
Confidence            33444443 3555443  57899999999999888888999999999999999999777788999999999999999998


Q ss_pred             CCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCCCCcc
Q 042766          163 GQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSI  241 (914)
Q Consensus       163 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  241 (914)
                      +..|..|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..+
T Consensus        90 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~  169 (570)
T 2z63_A           90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  169 (570)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGG
T ss_pred             ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHc
Confidence            7777889999999999999999986666678999999999999999886 468889999999999999999988878888


Q ss_pred             cccccc----ceeeccCCcccCcccccccccCcccceeeccCccCCC-CCCCccccccccccccccCccCC------ccc
Q 042766          242 CNISSV----ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG-SIPDSLSNASNLELLDLPSNQFK------GKV  310 (914)
Q Consensus       242 ~~l~~L----~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~------~~~  310 (914)
                      ..+++|    +.|++++|.+++..| ..+.. .+|++|++++|.... .+|..+..+++++.+++..+.+.      ...
T Consensus       170 ~~l~~L~~~~~~L~l~~n~l~~~~~-~~~~~-~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  247 (570)
T 2z63_A          170 RVLHQMPLLNLSLDLSLNPMNFIQP-GAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  247 (570)
T ss_dssp             HHHHTCTTCCCEEECTTCCCCEECT-TTTTT-CEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECC
T ss_pred             cchhccchhhhhcccCCCCceecCH-HHhcc-CcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcc
Confidence            888888    788888888876544 34433 378888888774331 23444555666665555433222      122


Q ss_pred             cccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecccc-ccCCCcCchhhccccccEEEEeecccccccC
Q 042766          311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN-QFGGELPHSIANLSLKMIELSVGRNQISGTI  389 (914)
Q Consensus       311 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~  389 (914)
                      ...|.+++++                            .++.+++++| .+.+.+|..+..+. +++.|++++|.++ .+
T Consensus       248 ~~~~~~l~~l----------------------------~l~~l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l  297 (570)
T 2z63_A          248 KSALEGLCNL----------------------------TIEEFRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RV  297 (570)
T ss_dssp             TTTTGGGGGS----------------------------EEEEEEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SC
T ss_pred             hhhhcccccc----------------------------chhhhhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hh
Confidence            2222222221                            2344444444 44444444444443 3555555555554 34


Q ss_pred             CccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCC--CCccCC
Q 042766          390 PPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNI--PSSLGN  467 (914)
Q Consensus       390 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~  467 (914)
                      |..+..+ +|++|++++|++. .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  |..+.+
T Consensus       298 ~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~  371 (570)
T 2z63_A          298 KDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFG  371 (570)
T ss_dssp             CBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHT
T ss_pred             hhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccc
Confidence            4445555 5555555555555 3332  2455555555555555544333  44555555555555555332  444555


Q ss_pred             CCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcc-ccccccccceeecccCCccccccCccccccccccE
Q 042766          468 CQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP-LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEY  546 (914)
Q Consensus       468 l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  546 (914)
                      +++|+.|++++|++++ +|..+..+..+ +.|++++|.+.+..| ..+.++++|++|++++|++++.+|..|.++++|++
T Consensus       372 ~~~L~~L~l~~n~l~~-~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  449 (570)
T 2z63_A          372 TTSLKYLDLSFNGVIT-MSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  449 (570)
T ss_dssp             CSCCCEEECCSCSEEE-EEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             cCccCEEECCCCcccc-ccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcE
Confidence            5555555555555553 23334444444 566666666665555 46788999999999999999999999999999999


Q ss_pred             EEeeccccc-ccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-CcCCCCCccCccCCC
Q 042766          547 LDISINSFY-GVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVFSNKTKISLHGNV  624 (914)
Q Consensus       547 L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~  624 (914)
                      |+|++|.++ +.+|..|..+++|++|++++|++++..|..+..+++|++|++++|++++.+|.. ..+..+..+.+.+|+
T Consensus       450 L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~  529 (570)
T 2z63_A          450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP  529 (570)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCc
Confidence            999999998 689999999999999999999999999999999999999999999999877653 456788889999998


Q ss_pred             CCCCC
Q 042766          625 KLCGG  629 (914)
Q Consensus       625 ~lc~~  629 (914)
                      ..|..
T Consensus       530 ~~~~~  534 (570)
T 2z63_A          530 WDCSC  534 (570)
T ss_dssp             BCCCT
T ss_pred             ccCCC
Confidence            87753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.6e-51  Score=500.00  Aligned_cols=466  Identities=19%  Similarity=0.219  Sum_probs=347.7

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCeeec-CCCCCCCcCCCCcccc----CCcchhccC------------CCcccC
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLAL-SNNSFSGTIPTNLSRC----SNLIHFCAS------------NNKLEG  163 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~l~~l----~~L~~L~Ls------------~N~l~~  163 (914)
                      .+++.|+|++|+++|.+|++|++|++|++||| ++|.++|..|-.....    +..+...+.            ...+++
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 9999988755332111    110000000            001110


Q ss_pred             -----------CCChhcccccccccccccc--ccccCcCCcccccccccceeecccCCCCC-----------------CC
Q 042766          164 -----------QIPKEIGNLLKLQRLSVDI--NYLTGQLPDSVGNLSAIEVIRITENSLGG-----------------KI  213 (914)
Q Consensus       164 -----------~~p~~~~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~  213 (914)
                                 ..+........++.+.+..  |+++| +|..|+++++|++|+|++|.+++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                       1111112334566666665  99998 89999999999999999999998                 38


Q ss_pred             Cccch--hhhcccccccccccccCCCCCccccccccceeeccCCc-ccC-ccccccc------ccCcccceeeccCccCC
Q 042766          214 PTTLG--LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR-FSG-IFPFDIL------LNLPNLKKLGIGGNNFV  283 (914)
Q Consensus       214 p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~------~~l~~L~~L~Ls~N~l~  283 (914)
                      |..++  ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+ ++| .+|..+.      ..+++|++|+|++|+++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            99987  99999999999999999999999999999999999998 998 7786543      24459999999999999


Q ss_pred             CCCCC--ccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCC-CcEEecccccc
Q 042766          284 GSIPD--SLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSS-LKVLSLSDNQF  360 (914)
Q Consensus       284 ~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~-L~~L~Ls~N~l  360 (914)
                       .+|.  .|+++++|+.|+|++|+++ .+| .|..+++|+.|+|++|.++.       +|..+..+++ |+.|+|++|++
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~~-------lp~~l~~l~~~L~~L~Ls~N~L  631 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-------IPEDFCAFTDQVEGLGFSHNKL  631 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCSC-------CCTTSCEECTTCCEEECCSSCC
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcccc-------chHHHhhccccCCEEECcCCCC
Confidence             8898  9999999999999999999 666 89999999999999999985       4556788998 99999999999


Q ss_pred             CCCcCchhhccc-cccEEEEeecccccccCCccc---c--CCCCCcEEEcccCcccccCChhhhcccCCceeeecccccc
Q 042766          361 GGELPHSIANLS-LKMIELSVGRNQISGTIPPGI---R--NLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLR  434 (914)
Q Consensus       361 ~~~~p~~~~~~~-~~L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  434 (914)
                      + .+|..+.... .+|+.|++++|++.+.+|...   .  .+.+|+.|+|++|+++...+..+..+++|+.|+|++|+|+
T Consensus       632 ~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~  710 (876)
T 4ecn_A          632 K-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT  710 (876)
T ss_dssp             C-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS
T ss_pred             C-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC
Confidence            9 8888776654 248999999999988766432   2  3347888888888888443344557888888888888888


Q ss_pred             cccCccccCC--------CCCCeEEeeCCcCCCCCCCccC--CCCCccccccCCCccCCCCchhhhcccchhhhhcccCC
Q 042766          435 GGIPSGLGNL--------TKLGSLDLGSNSLQGNIPSSLG--NCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN  504 (914)
Q Consensus       435 ~~~p~~~~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N  504 (914)
                       .+|..+...        ++|+.|+|++|+|+ .+|..+.  .+++|+.|++++|++++ +|..+..+..+ +.|+|++|
T Consensus       711 -~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L-~~L~Ls~N  786 (876)
T 4ecn_A          711 -SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQL-KAFGIRHQ  786 (876)
T ss_dssp             -CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTC-CEEECCCC
T ss_pred             -ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCC-CEEECCCC
Confidence             555543322        27777777777777 5666665  66666666666666653 44444433333 33444333


Q ss_pred             ccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCc
Q 042766          505 LLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE  584 (914)
Q Consensus       505 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  584 (914)
                      +                  ++++|++.+.+|..|..+++|+.|+|++|++ +.+|..+.  ++|+.|||++|++....+.
T Consensus       787 ~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~  845 (876)
T 4ecn_A          787 R------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVT  845 (876)
T ss_dssp             B------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred             C------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChH
Confidence            3                  3344777777777777777777777777777 56666654  5777777777777766666


Q ss_pred             cccccCCCCeEeCCCCccc
Q 042766          585 FLENLSFLEFLNLSYNYFE  603 (914)
Q Consensus       585 ~~~~l~~L~~L~ls~N~l~  603 (914)
                      .+.....+..+.|++|++.
T Consensus       846 ~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          846 SVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             GGHHHHHTTCCEEECCTTS
T ss_pred             HccccccchheeecCCCcc
Confidence            6665555666666666654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-51  Score=481.20  Aligned_cols=458  Identities=19%  Similarity=0.225  Sum_probs=339.2

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      ++||+++|+++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            57888888888 6777666  78888888888888666677788888888888888888777777888888888888888


Q ss_pred             cccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCCCCcccccccc--ceeeccCCcc--c
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV--ELIFLTENRF--S  258 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~  258 (914)
                      +++ .+|..  .+++|++|+|++|.+++ .+|..|+++++|++|++++|++++   ..+..+++|  ++|++++|.+  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            877 55655  67777777777777776 466777777777777777777764   345555555  6666666666  4


Q ss_pred             CcccccccccCc-ccceeeccCccCCCCCCC-ccccccccccccccCcc-------CCccccccccccccccceeccCCc
Q 042766          259 GIFPFDILLNLP-NLKKLGIGGNNFVGSIPD-SLSNASNLELLDLPSNQ-------FKGKVSIDFSSLKNLWLLNLEQNN  329 (914)
Q Consensus       259 ~~~p~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~~~~~~~~~~l~~L~~L~L~~N~  329 (914)
                      +..|..+ ..+. +...+++++|++.+.+++ .+..+++|+.|++++|+       +.+.++                  
T Consensus       154 ~~~~~~l-~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~------------------  214 (520)
T 2z7x_B          154 KEDPEGL-QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA------------------  214 (520)
T ss_dssp             SCCTTTT-TTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH------------------
T ss_pred             ccccccc-cccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh------------------
Confidence            4444322 1222 222344555554443332 34445555555555554       222222                  


Q ss_pred             CCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhcc--ccccEEEEeecccccccCCccc-----cCCCCCcEE
Q 042766          330 LGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL--SLKMIELSVGRNQISGTIPPGI-----RNLVNLITF  402 (914)
Q Consensus       330 l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~--~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L  402 (914)
                                   .++.+++|+.|++++|.+++..+..+...  ..+|++|++++|+++|.+|..+     .++++|+.+
T Consensus       215 -------------~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l  281 (520)
T 2z7x_B          215 -------------KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH  281 (520)
T ss_dssp             -------------GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEE
T ss_pred             -------------hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEec
Confidence                         34556666666666666654332222210  1257788888888888888877     889999999


Q ss_pred             EcccCcccccCC-hhhhcc---cCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCC
Q 042766          403 TLEVNQFHGTIP-DVISEL---KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASY  478 (914)
Q Consensus       403 ~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  478 (914)
                      ++++|.+  .+| ..+..+   .+|+.|++++|.+.+..  .+..+++|++|+|++|++++.+|..++++++|+.|++++
T Consensus       282 ~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  357 (520)
T 2z7x_B          282 QVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM  357 (520)
T ss_dssp             EEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCS
T ss_pred             cccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccC
Confidence            9999998  445 666666   67999999999887432  126788999999999999988999999999999999999


Q ss_pred             CccCC--CCchhhhcccchhhhhcccCCccCCCccc-cccccccceeecccCCccccccCccccccccccEEEeeccccc
Q 042766          479 NKLTG--DLPQQLLSITTLSLVLDLSNNLLNGSLPL-QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY  555 (914)
Q Consensus       479 N~l~~--~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  555 (914)
                      |++++  .+|..+..++.+ ++|++++|.+++.+|. .+..+++|+.|+|++|++++.+|..+.  ++|++|+|++|+++
T Consensus       358 N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~  434 (520)
T 2z7x_B          358 NQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK  434 (520)
T ss_dssp             SCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred             CccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence            99986  566778888888 8999999999985665 488899999999999999988887765  79999999999998


Q ss_pred             ccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCC
Q 042766          556 GVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       556 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                       .+|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+++|.|+..+
T Consensus       435 -~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  488 (520)
T 2z7x_B          435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  488 (520)
T ss_dssp             -CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHH
T ss_pred             -ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchH
Confidence             788888899999999999999995444459999999999999999999988543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.4e-50  Score=478.91  Aligned_cols=483  Identities=20%  Similarity=0.231  Sum_probs=327.4

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      ...|+++|+++ .+|..+.  ++|++|||++|++++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|++|
T Consensus         8 ~~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n   84 (549)
T 2z81_A            8 GVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN   84 (549)
T ss_dssp             SEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             ceEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCC
Confidence            34677778887 6776654  67888888888888767777777888888888888777666677777777777777777


Q ss_pred             cccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCC-CCccccccccceeeccCCcccCcc
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMF-PRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                      ++++..|..|+++++|++|+|++|.+++ ..|..++++++|++|++++|++.+.+ +..|.++++|++|++++|++++  
T Consensus        85 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~--  162 (549)
T 2z81_A           85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN--  162 (549)
T ss_dssp             CCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE--
T ss_pred             ccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccc--
Confidence            7776666667777777777777777765 24556666666666666666533233 2445555555555555555554  


Q ss_pred             cccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchh
Q 042766          262 PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV  341 (914)
Q Consensus       262 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  341 (914)
                                             ..|..+..+++|++|++++|.+....+..+..+++|++|++++|++++......   
T Consensus       163 -----------------------~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~---  216 (549)
T 2z81_A          163 -----------------------YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL---  216 (549)
T ss_dssp             -----------------------ECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCC---
T ss_pred             -----------------------cChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccccccccc---
Confidence                                   444444444444444444444443322223334455555555555444321110   


Q ss_pred             hcccCCCCCcEEeccccccCCCcCchhhcc---ccccEEEEeecccccccC------CccccCCCCCcEEEcccCcccc-
Q 042766          342 IFLSNCSSLKVLSLSDNQFGGELPHSIANL---SLKMIELSVGRNQISGTI------PPGIRNLVNLITFTLEVNQFHG-  411 (914)
Q Consensus       342 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~~~L~~L~L~~N~l~~~~------p~~~~~l~~L~~L~L~~N~l~~-  411 (914)
                      .....+++|+.|++++|.+++..+..+...   ..+++.+++++|.+.+..      ...+..+.+|+.|++.++.+.. 
T Consensus       217 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~  296 (549)
T 2z81_A          217 PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF  296 (549)
T ss_dssp             SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCG
T ss_pred             chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchh
Confidence            012234555555555555554333332211   124556666666555421      2345667778888888777653 


Q ss_pred             ----cCChhhhcccCCceeeecccccccccCccc-cCCCCCCeEEeeCCcCCCCCC---CccCCCCCccccccCCCccCC
Q 042766          412 ----TIPDVISELKNLQQLSVFNNFLRGGIPSGL-GNLTKLGSLDLGSNSLQGNIP---SSLGNCQNLILFIASYNKLTG  483 (914)
Q Consensus       412 ----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~  483 (914)
                          ..+..+...++|+.|++++|.+. .+|..+ ..+++|++|+|++|++++.+|   ..++.+++|+.|++++|++++
T Consensus       297 ~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  375 (549)
T 2z81_A          297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS  375 (549)
T ss_dssp             GGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCC
T ss_pred             hhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccc
Confidence                23444556678888888888887 566655 578888888888888887653   447788888888888888874


Q ss_pred             CCc--hhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcc
Q 042766          484 DLP--QQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLS  561 (914)
Q Consensus       484 ~~p--~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  561 (914)
                      ..+  ..+..+..+ ++|++++|+++ .+|..+..+++|++|+|++|++++. |..+  .++|++|+|++|++++.+   
T Consensus       376 ~~~~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~---  447 (549)
T 2z81_A          376 MQKTGEILLTLKNL-TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS---  447 (549)
T ss_dssp             HHHHHHHGGGCTTC-CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC---
T ss_pred             cccchhhhhcCCCC-CEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc---
Confidence            322  346667777 78999999998 6788899999999999999999854 4433  268999999999999754   


Q ss_pred             hhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-CcCCCCCccCccCCCCCCCC
Q 042766          562 FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       562 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~  629 (914)
                       ..+++|++|+|++|+|+ .+|+ ...+++|++|||++|++++.+|.. ..+..+..+.+.+|++.|..
T Consensus       448 -~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  513 (549)
T 2z81_A          448 -LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  513 (549)
T ss_dssp             -CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred             -ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence             57899999999999999 6676 467999999999999999987763 56778889999999988753

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=7e-51  Score=477.86  Aligned_cols=456  Identities=16%  Similarity=0.184  Sum_probs=368.8

Q ss_pred             EEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCC
Q 042766           80 TELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNN  159 (914)
Q Consensus        80 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  159 (914)
                      +.||+++++++ .+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|||++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            46899999998 5787776  89999999999999888889999999999999999999888999999999999999999


Q ss_pred             cccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhcc--cccccccccc--c
Q 042766          160 KLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRL--VNLNVAENQF--S  234 (914)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~  234 (914)
                      +++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++   ..++.+++|  ++|++++|++  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            999 67776  89999999999999997 578999999999999999999986   567888888  9999999999  8


Q ss_pred             CCCCCcccccc-ccceeeccCCcccCcccccccccCcccceeeccCcc-------CCCCCCCccccccccccccccCccC
Q 042766          235 GMFPRSICNIS-SVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN-------FVGSIPDSLSNASNLELLDLPSNQF  306 (914)
Q Consensus       235 ~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l  306 (914)
                      +..|..+..+. +...+++++|++.+.++...+.++++|+.|++++|.       +.+.+| .++.+++|+.|++++|.+
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l  232 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET  232 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence            88899988877 455678999999998888888899999999999998       776666 789999999999999998


Q ss_pred             Ccccccccc---ccccccceeccCCcCCCCCCCCcchhhcc-----cCCCCCcEEeccccccCCCcC-chhhccc--ccc
Q 042766          307 KGKVSIDFS---SLKNLWLLNLEQNNLGTGTANDLDFVIFL-----SNCSSLKVLSLSDNQFGGELP-HSIANLS--LKM  375 (914)
Q Consensus       307 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~--~~L  375 (914)
                      ++..+..+.   ..++|++|++++|++++.      +|..+     ..+++|+.+++++|.+  .+| ..+..+.  .++
T Consensus       233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~------~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L  304 (520)
T 2z7x_B          233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQ------LDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNI  304 (520)
T ss_dssp             EHHHHHHHHHHHHTSSCSEEEEEEEEEESC------CCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCC
T ss_pred             CHHHHHHHHHHhhhCcccEEEeecccccCc------cccchhhcccccCceeEeccccccce--ecchhhhhcccccCce
Confidence            865433221   235788888888888743      33344     7788888888888888  456 4444431  247


Q ss_pred             EEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccccccc--ccCccccCCCCCCeEEee
Q 042766          376 IELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG--GIPSGLGNLTKLGSLDLG  453 (914)
Q Consensus       376 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls  453 (914)
                      +.|++++|.+.+..  .+..+++|++|++++|++++.+|..+..+++|++|+|++|++++  .+|..+..+++|++|+|+
T Consensus       305 ~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls  382 (520)
T 2z7x_B          305 KNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS  382 (520)
T ss_dssp             SEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECC
T ss_pred             eEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECC
Confidence            88888888776432  12577778888888888887777778888888888888888876  455667778888888888


Q ss_pred             CCcCCCCCCC-ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcccc
Q 042766          454 SNSLQGNIPS-SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSG  532 (914)
Q Consensus       454 ~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  532 (914)
                      +|++++.+|. .+..+++|+.|++++|++++                         ..|..+.  ++|+.|||++|+++ 
T Consensus       383 ~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~l~--~~L~~L~Ls~N~l~-  434 (520)
T 2z7x_B          383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTD-------------------------TIFRCLP--PRIKVLDLHSNKIK-  434 (520)
T ss_dssp             SSCCBCCGGGCSCCCCTTCCEEECCSSCCCG-------------------------GGGGSCC--TTCCEEECCSSCCC-
T ss_pred             CCcCCcccccchhccCccCCEEECcCCCCCc-------------------------chhhhhc--ccCCEEECCCCccc-
Confidence            8888764554 36666777666666666653                         3333332  57889999999998 


Q ss_pred             ccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccC
Q 042766          533 VIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP  583 (914)
Q Consensus       533 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  583 (914)
                      .+|..+..+++|++|+|++|++++..+..|..+++|++|++++|++++..+
T Consensus       435 ~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            677777789999999999999985444458899999999999999987544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1.5e-48  Score=469.88  Aligned_cols=529  Identities=18%  Similarity=0.157  Sum_probs=431.4

Q ss_pred             ecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCccc
Q 042766           83 NLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLE  162 (914)
Q Consensus        83 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  162 (914)
                      +-++.+|+ .+|+.+-  +.+++|||++|+|++..|.+|.++++|++|||++|+|++..|.+|.++++|++|+|++|+++
T Consensus        37 ~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~  113 (635)
T 4g8a_A           37 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ  113 (635)
T ss_dssp             ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence            33444554 4565442  47899999999999877889999999999999999999777788999999999999999999


Q ss_pred             CCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCCCCcc
Q 042766          163 GQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSI  241 (914)
Q Consensus       163 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  241 (914)
                      +..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|++++..|..|
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  193 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  193 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence            7777789999999999999999998777889999999999999999986 468899999999999999999999999988


Q ss_pred             ccccccc----eeeccCCcccCcccccccccCcccceeeccCccCCC-CCCCccccccccccccccCcc------CCccc
Q 042766          242 CNISSVE----LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG-SIPDSLSNASNLELLDLPSNQ------FKGKV  310 (914)
Q Consensus       242 ~~l~~L~----~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~------l~~~~  310 (914)
                      ..+.+++    .++++.|.++...+ ..+ ....++.+++++|.... ..+..+..++.++..++..+.      +....
T Consensus       194 ~~L~~l~~~~~~~~ls~n~l~~i~~-~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~  271 (635)
T 4g8a_A          194 RVLHQMPLLNLSLDLSLNPMNFIQP-GAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD  271 (635)
T ss_dssp             HHHHTCTTCCCEEECTTCCCCEECT-TTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             cchhhhhhhhhhhhcccCcccccCc-ccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence            8877654    58899999986543 444 45567889999987653 233456667777776665443      33344


Q ss_pred             cccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCC
Q 042766          311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP  390 (914)
Q Consensus       311 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p  390 (914)
                      ...+..+..+...++..+........   .+..+..+.+++.+++.+|.+....+  +... ..++.|++.+|.+.+..+
T Consensus       272 ~~~~~~~~~l~~~~l~~~~~~~~~~~---~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~~-~~L~~L~l~~~~~~~~~~  345 (635)
T 4g8a_A          272 KSALEGLCNLTIEEFRLAYLDYYLDG---IIDLFNCLTNVSSFSLVSVTIERVKD--FSYN-FGWQHLELVNCKFGQFPT  345 (635)
T ss_dssp             TTTTGGGGGSEEEEEEEECCCSCEEE---CTTTTGGGTTCSEEEEESCEEEECGG--GGSC-CCCSEEEEESCEESSCCC
T ss_pred             ccccccccchhhhhhhhhhhcccccc---hhhhhhhhcccccccccccccccccc--cccc-hhhhhhhcccccccCcCc
Confidence            45566677777777666554332111   22345677889999999998874332  2222 368999999999987655


Q ss_pred             ccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccccccc--ccCccccCCCCCCeEEeeCCcCCCCCCCccCCC
Q 042766          391 PGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG--GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNC  468 (914)
Q Consensus       391 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  468 (914)
                      .   .+..|+.++++.|.+....+  ...+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+. ..+..+..+
T Consensus       346 ~---~l~~L~~l~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l  419 (635)
T 4g8a_A          346 L---KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGL  419 (635)
T ss_dssp             C---BCTTCCEEEEESCCSCCBCC--CCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTC
T ss_pred             c---cchhhhhcccccccCCCCcc--cccccccccchhhccccccccccccchhhhhhhhhhhccccccc-ccccccccc
Confidence            4   46778999999999875443  4578999999999999864  45667788999999999999987 456678899


Q ss_pred             CCccccccCCCccCCCCchh-hhcccchhhhhcccCCccCCCccccccccccceeecccCCcc-ccccCccccccccccE
Q 042766          469 QNLILFIASYNKLTGDLPQQ-LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF-SGVIPVTLSTCVSLEY  546 (914)
Q Consensus       469 ~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~  546 (914)
                      ++|+.++++.|+.....+.. +..+..+ +.+++++|.+.+..|..+..++.|+.|+|++|++ .+.+|..|..+++|++
T Consensus       420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l-~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~  498 (635)
T 4g8a_A          420 EQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  498 (635)
T ss_dssp             TTCCEEECTTSEEESTTSSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             ccccchhhhhcccccccccccccccccc-ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence            99999999999887766654 4445555 8999999999999999999999999999999985 4568899999999999


Q ss_pred             EEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC-CcC-CCCCccCccCCC
Q 042766          547 LDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK-GVF-SNKTKISLHGNV  624 (914)
Q Consensus       547 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~-~~~~~~~~~~n~  624 (914)
                      |||++|+|++.+|.+|.++++|++|+|++|+|++..|..|.++++|++|||++|++++.+|.. ..+ .++..+.+.+||
T Consensus       499 L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np  578 (635)
T 4g8a_A          499 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND  578 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCC
T ss_pred             EECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCC
Confidence            999999999999999999999999999999999999999999999999999999999988864 223 578889999999


Q ss_pred             CCCCC
Q 042766          625 KLCGG  629 (914)
Q Consensus       625 ~lc~~  629 (914)
                      +.|..
T Consensus       579 ~~C~C  583 (635)
T 4g8a_A          579 FACTC  583 (635)
T ss_dssp             BCCSG
T ss_pred             CcccC
Confidence            99953

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.7e-48  Score=457.09  Aligned_cols=462  Identities=19%  Similarity=0.217  Sum_probs=339.6

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      ..+++|+++|+++ .+|..+.  ++|++|||++|++++..|..|+++++|++|+|++|++++..|++|+++++|++|+|+
T Consensus        32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            3488999999998 4787665  789999999999987777788888888888888888887778888888888888888


Q ss_pred             cccccCcCCcccccccccceeecccCCCCC-CCCccchhhhcccccccccccccCCCCCcccccccc--ceeeccCCcc-
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGG-KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV--ELIFLTENRF-  257 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l-  257 (914)
                      +|+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++.   .+..+++|  ++|++++|.+ 
T Consensus       109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred             CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence            88888 56665  78888888888888876 3467777788888888888777642   34444444  6666666666 


Q ss_pred             -cCcccccccccCcccceeeccCccCCCCCCCcccccc--ccccccccCccCCcccc-ccccccccccceeccCCcCCCC
Q 042766          258 -SGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNAS--NLELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       258 -~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                       ++..|                         ..+..+.  .+ .+++++|.+.+.++ ..+..+++|+.|++++|.....
T Consensus       183 ~~~~~~-------------------------~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  236 (562)
T 3a79_B          183 IKGGET-------------------------ESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ  236 (562)
T ss_dssp             CCSSSC-------------------------CEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH
T ss_pred             ccccCc-------------------------ccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccc
Confidence             44444                         3333322  12 23444444443222 2334455555555555431100


Q ss_pred             CCCCcchhhcccCCCCCcEEeccccccCCCc----CchhhccccccEEEEeecccccccCCccc-----cCCCCCcEEEc
Q 042766          334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGEL----PHSIANLSLKMIELSVGRNQISGTIPPGI-----RNLVNLITFTL  404 (914)
Q Consensus       334 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~~~~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L  404 (914)
                      .  -...+..+..+++|+.|+++++.+.+..    +..+.  ..+|++|++++|+++|.+|..+     ..+++|+.+++
T Consensus       237 ~--l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~--~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~  312 (562)
T 3a79_B          237 R--LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW--PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV  312 (562)
T ss_dssp             H--HHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHT--TSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEE
T ss_pred             h--HHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhh--cccccEEEEeccEeeccccchhhhcccccchheehhhc
Confidence            0  0001223556667777777766665321    22211  1268888888888888888877     78888888888


Q ss_pred             ccCcccccCC-hhhhcc---cCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCc
Q 042766          405 EVNQFHGTIP-DVISEL---KNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNK  480 (914)
Q Consensus       405 ~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  480 (914)
                      +.|.+  .+| ..+..+   .+|++|++++|.+....  ....+++|++|+|++|++++.+|..++++++|+.|++++|+
T Consensus       313 ~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  388 (562)
T 3a79_B          313 KNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG  388 (562)
T ss_dssp             EECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSC
T ss_pred             cccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCC
Confidence            88887  445 444443   67999999999886432  12678999999999999998899999999999999999999


Q ss_pred             cCC--CCchhhhcccchhhhhcccCCccCCCccc-cccccccceeecccCCccccccCccccccccccEEEeeccccccc
Q 042766          481 LTG--DLPQQLLSITTLSLVLDLSNNLLNGSLPL-QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV  557 (914)
Q Consensus       481 l~~--~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  557 (914)
                      +++  .+|..+..+..+ ++|++++|++++.+|. .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+++ .
T Consensus       389 l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~  464 (562)
T 3a79_B          389 LKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-S  464 (562)
T ss_dssp             CCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-C
T ss_pred             cCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-c
Confidence            985  334567777877 8999999999985554 588899999999999999988877665  79999999999998 6


Q ss_pred             CCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCC
Q 042766          558 IPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       558 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      +|..+..+++|++|+|++|+|++..+..+..+++|+.|++++|+|+|+||..+
T Consensus       465 ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~  517 (562)
T 3a79_B          465 IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR  517 (562)
T ss_dssp             CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHH
T ss_pred             cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHH
Confidence            77777799999999999999995444449999999999999999999998654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.6e-47  Score=451.38  Aligned_cols=456  Identities=18%  Similarity=0.179  Sum_probs=334.2

Q ss_pred             EEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCC
Q 042766           80 TELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNN  159 (914)
Q Consensus        80 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  159 (914)
                      +.+|++++++++ +|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|||++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            689999999986 777664  89999999999999888889999999999999999999888999999999999999999


Q ss_pred             cccCCCChhccccccccccccccccccC-cCCcccccccccceeecccCCCCCCCCccchhhhcc--cccccccccc--c
Q 042766          160 KLEGQIPKEIGNLLKLQRLSVDINYLTG-QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRL--VNLNVAENQF--S  234 (914)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~  234 (914)
                      +++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++   ..+..+++|  ++|++++|++  +
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~  184 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIK  184 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeeccccccc
Confidence            999 67776  89999999999999997 457899999999999999999986   356666666  9999999999  8


Q ss_pred             CCCCCcccccc-ccceeeccCCcccCcccccccccCcccceeeccCcc-----CCCCCCCccccccccccccccCccCCc
Q 042766          235 GMFPRSICNIS-SVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN-----FVGSIPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       235 ~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-----l~~~~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                      +..|..|..+. +.-.++++.|.+.+.++...+.++++|+.|++++|+     +.+ .+..+..+++|+.|+|+++.+++
T Consensus       185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~  263 (562)
T 3a79_B          185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTW  263 (562)
T ss_dssp             SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECH
T ss_pred             ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcH
Confidence            88999888865 222568899999988888778889999999999985     221 12346667778888887777664


Q ss_pred             ccccc---ccccccccceeccCCcCCCCCCCCcchhhcc-----cCCCCCcEEeccccccCCCcC-chhhcc--ccccEE
Q 042766          309 KVSID---FSSLKNLWLLNLEQNNLGTGTANDLDFVIFL-----SNCSSLKVLSLSDNQFGGELP-HSIANL--SLKMIE  377 (914)
Q Consensus       309 ~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~~--~~~L~~  377 (914)
                      .....   ....++|++|++++|.+++.      +|..+     ..++.|+.++++.|.+  .+| ..+..+  ..+++.
T Consensus       264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~------ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~  335 (562)
T 3a79_B          264 KCSVKLFQFFWPRPVEYLNIYNLTITER------IDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKM  335 (562)
T ss_dssp             HHHHHHHHHHTTSSEEEEEEEEEEECSC------CCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred             HHHHHHHHhhhcccccEEEEeccEeecc------ccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceE
Confidence            32111   11223677777777777633      22222     5556666666666665  344 222222  124666


Q ss_pred             EEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccccccc--ccCccccCCCCCCeEEeeCC
Q 042766          378 LSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG--GIPSGLGNLTKLGSLDLGSN  455 (914)
Q Consensus       378 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N  455 (914)
                      |++++|.+....  ....+++|++|++++|++++.+|..+..+++|++|+|++|++++  .+|..|.++++|++|+|++|
T Consensus       336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N  413 (562)
T 3a79_B          336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN  413 (562)
T ss_dssp             EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTS
T ss_pred             EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCC
Confidence            677766664322  12456666666666666666666666666666666666666664  22345666666666666666


Q ss_pred             cCCCCCCC-ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcccccc
Q 042766          456 SLQGNIPS-SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI  534 (914)
Q Consensus       456 ~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  534 (914)
                      ++++.+|. .+..+++|+.|++++|+++                         +..|..+.  ++|++|+|++|+++ .+
T Consensus       414 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~l~--~~L~~L~L~~N~l~-~i  465 (562)
T 3a79_B          414 SLNSHAYDRTCAWAESILVLNLSSNMLT-------------------------GSVFRCLP--PKVKVLDLHNNRIM-SI  465 (562)
T ss_dssp             CCBSCCSSCCCCCCTTCCEEECCSSCCC-------------------------GGGGSSCC--TTCSEEECCSSCCC-CC
T ss_pred             cCCCccChhhhcCcccCCEEECCCCCCC-------------------------cchhhhhc--CcCCEEECCCCcCc-cc
Confidence            66653333 3555566655555555554                         34443333  57899999999998 56


Q ss_pred             CccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccC
Q 042766          535 PVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP  583 (914)
Q Consensus       535 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  583 (914)
                      |..+..+++|++|+|++|++++..+..|..+++|+.|++++|++.+..|
T Consensus       466 p~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          466 PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             ChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            6666689999999999999985444448899999999999999987654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.6e-46  Score=409.56  Aligned_cols=293  Identities=29%  Similarity=0.469  Sum_probs=276.7

Q ss_pred             CCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC--ccceeecCCC--CceEEEecCCCCCcc--ccCCCCCCCCCCCE
Q 042766           32 QTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQ--WTGVTCGHRH--QRLTELNLSSQRIGG--VLSPYVGNLSFLRY  105 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~  105 (914)
                      .|.++|++||++||+++.||. .+.+|..+.|||.  |.||+|+..+  ++|+.|+|+++.+.|  .+|+.++++++|++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~   80 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence            478999999999999998776 7889988889998  9999998655  899999999999999  89999999999999


Q ss_pred             EEcCC-CCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccccc
Q 042766          106 INLAD-NGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINY  184 (914)
Q Consensus       106 L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (914)
                      |+|++ |.+++.+|..|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|+
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  160 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence            99995 99999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCccccccc-ccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccc
Q 042766          185 LTGQLPDSVGNLS-AIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPF  263 (914)
Q Consensus       185 l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  263 (914)
                      ++|.+|..++.++ +|++|++++|++++.+|..++.++ |++|+|++|++++..|..|..+++|++|+|++|++++.+|.
T Consensus       161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  239 (313)
T 1ogq_A          161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK  239 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred             ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc
Confidence            9999999999998 999999999999999999999997 99999999999999999999999999999999999987765


Q ss_pred             cccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCc
Q 042766          264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNN  329 (914)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  329 (914)
                        +..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|.. ..+++|+.|++++|.
T Consensus       240 --~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          240 --VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             --CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             --ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence              558899999999999999999999999999999999999999888876 888999999999887

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.6e-44  Score=413.48  Aligned_cols=401  Identities=22%  Similarity=0.288  Sum_probs=182.3

Q ss_pred             CCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeec
Q 042766          125 FRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRI  204 (914)
Q Consensus       125 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  204 (914)
                      ++|++|++++|.+ |.+|.+++++++|++|++++|+++|.+|..++++++|+.++++.+..           .++++|++
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~l   78 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELEL   78 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEEC
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEEe
Confidence            4455555555555 45555555555555555555555555555555555554444444331           23444455


Q ss_pred             ccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCC
Q 042766          205 TENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVG  284 (914)
Q Consensus       205 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~  284 (914)
                      ++|.+++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++. |.    ..++|++|++++|++++
T Consensus        79 ~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~----~~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           79 NNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SD----LPPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             TTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CS----CCTTCCEEECCSSCCSS
T ss_pred             cCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cC----CCCCCCEEECcCCCCCC
Confidence            5554443 2221   1345555555555554 3322   24455555555555432 11    11455555555555553


Q ss_pred             CCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCc
Q 042766          285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL  364 (914)
Q Consensus       285 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  364 (914)
                       +| .|+++++|++|++++|+++++ |..   .++|++|++++|++++.+        .++++++|++|++++|++++ +
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~l~--------~~~~l~~L~~L~l~~N~l~~-l  210 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEELP--------ELQNLPFLTAIYADNNSLKK-L  210 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSCC--------CCTTCTTCCEEECCSSCCSS-C
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCcCc--------cccCCCCCCEEECCCCcCCc-C
Confidence             44 355555555555555555542 222   135555555555555431        14555566666666666553 3


Q ss_pred             CchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCC
Q 042766          365 PHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL  444 (914)
Q Consensus       365 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  444 (914)
                      |...    .+|++|++++|+++ .+| .|+.+++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .
T Consensus       211 ~~~~----~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~  276 (454)
T 1jl5_A          211 PDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---P  276 (454)
T ss_dssp             CCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---C
T ss_pred             CCCc----CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---c
Confidence            3221    24566666666665 344 36666666666666666664 3322   3566666666666664 3432   2


Q ss_pred             CCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeec
Q 042766          445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD  524 (914)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  524 (914)
                      ++|+.|++++|++++ +|..   .++|+.|++++|++++ ++    ....-+++|++++|++++ +|..   +++|++|+
T Consensus       277 ~~L~~L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~  343 (454)
T 1jl5_A          277 QSLTFLDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLI  343 (454)
T ss_dssp             TTCCEEECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred             CcCCEEECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEE
Confidence            566666666666664 2211   1456666666666653 22    111112566666666664 4433   35667777


Q ss_pred             ccCCccccccCccccccccccEEEeecccccc--cCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCcc
Q 042766          525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYG--VIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF  602 (914)
Q Consensus       525 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  602 (914)
                      +++|++++ +|.   .+++|++|+|++|++++  .+|.++..+        +.|++.+.+|..   +++|+.||+++|++
T Consensus       344 L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l  408 (454)
T 1jl5_A          344 ASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPL  408 (454)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC-------------------------
T ss_pred             CCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcC
Confidence            77777764 343   35667777777777766  555554432        335555555543   35667777777777


Q ss_pred             cc--ccC
Q 042766          603 EG--EVP  607 (914)
Q Consensus       603 ~~--~~p  607 (914)
                      +|  .+|
T Consensus       409 ~~~~~iP  415 (454)
T 1jl5_A          409 REFPDIP  415 (454)
T ss_dssp             -------
T ss_pred             Cccccch
Confidence            66  555

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=7.5e-44  Score=407.84  Aligned_cols=428  Identities=21%  Similarity=0.249  Sum_probs=205.6

Q ss_pred             CCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccc
Q 042766           94 SPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLL  173 (914)
Q Consensus        94 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  173 (914)
                      .|.-...++|++|++++|.+ |.+|.+++++++|++|++++|+++|.+|.+++++++|+.++++.|..           .
T Consensus         4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~   71 (454)
T 1jl5_A            4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------R   71 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------H
T ss_pred             cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------c
Confidence            34444568899999999999 79999999999999999999999999999999988886555554432           3


Q ss_pred             cccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeecc
Q 042766          174 KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT  253 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  253 (914)
                      +|++|++++|.+++ +|..   .++|++|++++|.+++ +|..   +++|++|++++|++++. |..   .++|++|+++
T Consensus        72 ~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~  139 (454)
T 1jl5_A           72 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS  139 (454)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred             CCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECc
Confidence            45555555555553 3331   2455555666665554 4432   24555566666655532 211   1455666666


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCC
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      +|++++ +| + +.++++|++|++++|++++ +|..+   ++|++|++++|++++. | .|.++++|++|++++|.++++
T Consensus       140 ~n~l~~-lp-~-~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~l  210 (454)
T 1jl5_A          140 NNQLEK-LP-E-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKKL  210 (454)
T ss_dssp             SSCCSS-CC-C-CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSC
T ss_pred             CCCCCC-Cc-c-cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCcC
Confidence            666654 34 2 4455666666666666553 34332   3566666666666552 2 355666666666666665543


Q ss_pred             CCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccC
Q 042766          334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTI  413 (914)
Q Consensus       334 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  413 (914)
                      +..          .++|++|++++|+++ .+|. +..+. +|++|++++|++++ +|..   +++|++|++++|++++ +
T Consensus       211 ~~~----------~~~L~~L~l~~n~l~-~lp~-~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l  272 (454)
T 1jl5_A          211 PDL----------PLSLESIVAGNNILE-ELPE-LQNLP-FLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-L  272 (454)
T ss_dssp             CCC----------CTTCCEEECCSSCCS-SCCC-CTTCT-TCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-C
T ss_pred             CCC----------cCcccEEECcCCcCC-cccc-cCCCC-CCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-c
Confidence            211          135666666666665 4553 44433 46666666666654 3322   2566666666666664 3


Q ss_pred             ChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhccc
Q 042766          414 PDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSIT  493 (914)
Q Consensus       414 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~  493 (914)
                      |..   .++|++|++++|++++. |..   .++|+.|++++|++++ ++..   .++|+.|++++|++++ +|..+   .
T Consensus       273 ~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~~---~  337 (454)
T 1jl5_A          273 PEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPALP---P  337 (454)
T ss_dssp             CCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCCC---T
T ss_pred             Ccc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-ccccC---C
Confidence            332   35666677777666652 211   1466677777776664 2211   1366677777777764 55432   3


Q ss_pred             chhhhhcccCCccCCCccccccccccceeecccCCcccc--ccCccccccccccEEEeecccccccCCcchhccCCCCEE
Q 042766          494 TLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSG--VIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKAL  571 (914)
Q Consensus       494 ~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  571 (914)
                      .+ ++|++++|+++ .+|.   .+++|++|+|++|++++  .+|.++..        |+.|.+.+.+|..   +++|+.|
T Consensus       338 ~L-~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L  401 (454)
T 1jl5_A          338 RL-ERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQL  401 (454)
T ss_dssp             TC-CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC------------------
T ss_pred             cC-CEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEE
Confidence            33 67788888887 4555   46889999999999998  66766543        4568888888864   5789999


Q ss_pred             EccCCcccc--ccCccccccCCCCeEeCCCCccccccCCC
Q 042766          572 NVSSNNLSG--KIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       572 ~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      |+++|++++  .+|.+      ++.|.+.+|.+.+.+|..
T Consensus       402 ~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~  435 (454)
T 1jl5_A          402 HVETNPLREFPDIPES------VEDLRMNSERVVDPYEFA  435 (454)
T ss_dssp             ----------------------------------------
T ss_pred             ECCCCcCCccccchhh------HhheeCcCcccCCccccC
Confidence            999999997  66654      566778999998877654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.4e-43  Score=408.69  Aligned_cols=374  Identities=19%  Similarity=0.227  Sum_probs=262.7

Q ss_pred             eecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc
Q 042766          202 IRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN  281 (914)
Q Consensus       202 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~  281 (914)
                      ++.+++.++ .+|. +  .++|++|+|++|++++..|..|.++++|++|+|++|.+.+.++...+.++++|++|+|++|+
T Consensus        15 ~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~   90 (455)
T 3v47_A           15 AICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ   90 (455)
T ss_dssp             EECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCT
T ss_pred             cCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCc
Confidence            444444444 3333 1  14555666666666555555666666666666666666555555555566666666666666


Q ss_pred             CCCCCCCccccccccccccccCccCCcccccc--ccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccc
Q 042766          282 FVGSIPDSLSNASNLELLDLPSNQFKGKVSID--FSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ  359 (914)
Q Consensus       282 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~  359 (914)
                      +++..|..|.++++|++|+|++|++++..+..  |..+++|++|+|++|.+++....     ..+.++++|++|++++|+
T Consensus        91 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~~l~~L~~L~L~~n~  165 (455)
T 3v47_A           91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA-----SFFLNMRRFHVLDLTFNK  165 (455)
T ss_dssp             TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC-----GGGGGCTTCCEEECTTCC
T ss_pred             cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc-----cccCCCCcccEEeCCCCc
Confidence            66666666666777777777777766543333  66667777777777766655211     125666777777777777


Q ss_pred             cCCCcCchhhccc-cccEEEEeecccccccCCcc--------ccCCCCCcEEEcccCcccccCChhhhcc---cCCceee
Q 042766          360 FGGELPHSIANLS-LKMIELSVGRNQISGTIPPG--------IRNLVNLITFTLEVNQFHGTIPDVISEL---KNLQQLS  427 (914)
Q Consensus       360 l~~~~p~~~~~~~-~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~  427 (914)
                      +++..|..+..+. .+++.|++++|.+.+..+..        +..+++|++|++++|++++..|..+...   ++|+.|+
T Consensus       166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~  245 (455)
T 3v47_A          166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI  245 (455)
T ss_dssp             BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred             ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence            7766666665542 35777777777777655443        3356788888999988888888877765   7888888


Q ss_pred             eccccccccc----------CccccC--CCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccch
Q 042766          428 VFNNFLRGGI----------PSGLGN--LTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL  495 (914)
Q Consensus       428 L~~N~l~~~~----------p~~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l  495 (914)
                      +++|.+.+..          +..+..  .++|+.|++++|++++.+|..++.+++|+                       
T Consensus       246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~-----------------------  302 (455)
T 3v47_A          246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE-----------------------  302 (455)
T ss_dssp             CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCC-----------------------
T ss_pred             eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCC-----------------------
Confidence            8888665421          111221  13555666666666555555555555554                       


Q ss_pred             hhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccC
Q 042766          496 SLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS  575 (914)
Q Consensus       496 ~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  575 (914)
                        +|++++|++++..|..|+++++|++|+|++|++++.+|..|+.+++|++|+|++|++++..|.+|..+++|++|+|++
T Consensus       303 --~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  380 (455)
T 3v47_A          303 --QLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDT  380 (455)
T ss_dssp             --EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             --EEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCC
Confidence              455555555556677888899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          576 NNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      |++++..+..+..+++|+.|++++|+++|.||..
T Consensus       381 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          381 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            9999888888899999999999999999999964

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.6e-43  Score=406.29  Aligned_cols=368  Identities=17%  Similarity=0.219  Sum_probs=306.2

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcC-CCCccccCCcchhccCCCcccCCCChhccccccccccc
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI-PTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLS  179 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  179 (914)
                      ++|++|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            67889999999998888888889999999999999887666 45688899999999999998887888888899999999


Q ss_pred             cccccccCcCCcc--cccccccceeecccCCCCCCCCcc-chhhhcccccccccccccCCCCCccccc--cccceeeccC
Q 042766          180 VDINYLTGQLPDS--VGNLSAIEVIRITENSLGGKIPTT-LGLLRRLVNLNVAENQFSGMFPRSICNI--SSVELIFLTE  254 (914)
Q Consensus       180 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~  254 (914)
                      |++|++++..|..  |+++++|++|+|++|.+++..|.. ++++++|++|++++|++++..|..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            9999988755544  888889999999999998887776 7888999999999999988888888776  6888999999


Q ss_pred             CcccCcccccc-------cccCcccceeeccCccCCCCCCCccccc---cccccccccCccCCcccccccccccccccee
Q 042766          255 NRFSGIFPFDI-------LLNLPNLKKLGIGGNNFVGSIPDSLSNA---SNLELLDLPSNQFKGKVSIDFSSLKNLWLLN  324 (914)
Q Consensus       255 N~l~~~~p~~~-------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  324 (914)
                      |.+.+..+..+       +..+++|++|+|++|++.+..|..+...   ++|+.|++++|.+.+...             
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~-------------  256 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-------------  256 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-------------
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-------------
Confidence            98886543321       2256789999999999988888777665   889999999998764321             


Q ss_pred             ccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEc
Q 042766          325 LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTL  404 (914)
Q Consensus       325 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  404 (914)
                       ..+.+.......+    .-...++|+.|++++|++++..|..+..+. +|++|++++|++++..|..|.++++|++|+|
T Consensus       257 -~~~~~~~~~~~~~----~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  330 (455)
T 3v47_A          257 -GHTNFKDPDNFTF----KGLEASGVKTCDLSKSKIFALLKSVFSHFT-DLEQLTLAQNEINKIDDNAFWGLTHLLKLNL  330 (455)
T ss_dssp             -TCCSSCCCCTTTT----GGGTTSCCCEEECCSSCCCEECTTTTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             -chhhhccCccccc----ccccccCceEEEecCccccccchhhcccCC-CCCEEECCCCcccccChhHhcCcccCCEEEC
Confidence             1222222211110    011346899999999999988888887776 6999999999999999999999999999999


Q ss_pred             ccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCC
Q 042766          405 EVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD  484 (914)
Q Consensus       405 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  484 (914)
                      ++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|++++.
T Consensus       331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  410 (455)
T 3v47_A          331 SQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  410 (455)
T ss_dssp             CSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence            99999998899999999999999999999998899999999999999999999987778889999999999999999988


Q ss_pred             Cch
Q 042766          485 LPQ  487 (914)
Q Consensus       485 ~p~  487 (914)
                      .|.
T Consensus       411 ~~~  413 (455)
T 3v47_A          411 CPR  413 (455)
T ss_dssp             TTT
T ss_pred             CCc
Confidence            873

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.6e-43  Score=377.73  Aligned_cols=189  Identities=23%  Similarity=0.374  Sum_probs=166.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   +....+.+.+|++++++++|||||++++++     +..+.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            5799999999999999999999999999999999743   344567899999999999999999999995     44558


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+|||||+||+|.+++.+.      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus       107 ~yivmEy~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            99999999999999999865      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +|+.+.....      .......+||+.|||||++.    +.++||||+||++|||
T Consensus       178 la~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyem  227 (311)
T 4aw0_A          178 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL  227 (311)
T ss_dssp             TCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred             CceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHH
Confidence            9997653221      11223568999999999995    5899999999999998

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-43  Score=382.45  Aligned_cols=187  Identities=23%  Similarity=0.346  Sum_probs=166.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++..     .+..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            469999999999999999999999999999999987766667789999999999999999999999644     458999


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      |||||+||+|.+++.+       ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       149 vmEy~~gg~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EECCCTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence            9999999999999875       3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      .+....        ......+||+.|||||++    ++.++||||+||++|||.
T Consensus       219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml  264 (346)
T 4fih_A          219 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV  264 (346)
T ss_dssp             ECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             ecCCCC--------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence            764321        122346899999999999    468999999999999983

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-43  Score=382.25  Aligned_cols=190  Identities=21%  Similarity=0.317  Sum_probs=160.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++...  ....+.+.+|++++++++|||||++++++.     ..+..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence            58999999999999999999999999999999997543  234568999999999999999999999954     34589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+|||||+||+|.+++...+.    ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence            999999999999999976532    4678999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.+....        ......+||+.|||||++.    +.++||||+||++|||.
T Consensus       172 a~~~~~~~--------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml  219 (350)
T 4b9d_A          172 ARVLNSTV--------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC  219 (350)
T ss_dssp             ESCCCHHH--------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeecCCc--------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence            98764321        1122468999999999994    58999999999999983

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.1e-41  Score=390.36  Aligned_cols=363  Identities=18%  Similarity=0.194  Sum_probs=272.6

Q ss_pred             ccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccc
Q 042766           92 VLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN  171 (914)
Q Consensus        92 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  171 (914)
                      ..+..++++++|++|++++|.+++ +| .++.+++|++|+|++|++++ +|  ++.+++|++|++++|++++. |  +++
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCC
Confidence            334456677778888888888875 35 57778888888888888875 34  77788888888888888753 3  777


Q ss_pred             cccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceee
Q 042766          172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIF  251 (914)
Q Consensus       172 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  251 (914)
                      +++|++|++++|++++ +|  ++.+++|++|++++|++++. |  ++.+++|++|++++|+..+.+  .+..+++|++|+
T Consensus       105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            8888888888888875 34  77788888888888888763 3  777788888888888655554  477788888888


Q ss_pred             ccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCC
Q 042766          252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLG  331 (914)
Q Consensus       252 L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  331 (914)
                      +++|++++. |   +..+++|++|++++|++++.   .++.+++|++|+|++|+++++ |  +..+++|++|++++|+++
T Consensus       177 ls~n~l~~l-~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~  246 (457)
T 3bz5_A          177 CSFNKITEL-D---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLT  246 (457)
T ss_dssp             CCSSCCCCC-C---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS
T ss_pred             CCCCcccee-c---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCC
Confidence            888888763 4   45778888888888888864   377888888888888888874 3  778888888888888887


Q ss_pred             CCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccc
Q 042766          332 TGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG  411 (914)
Q Consensus       332 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  411 (914)
                      +.+         +..+++|+.|+++.|++               +.|++++|.+.+.+|  ++.+++|+.|++++|++.+
T Consensus       247 ~~~---------~~~l~~L~~L~l~~n~L---------------~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~  300 (457)
T 3bz5_A          247 ELD---------VSTLSKLTTLHCIQTDL---------------LEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLY  300 (457)
T ss_dssp             CCC---------CTTCTTCCEEECTTCCC---------------SCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCC
T ss_pred             CcC---------HHHCCCCCEEeccCCCC---------------CEEECCCCccCCccc--ccccccCCEEECCCCcccc
Confidence            753         34677888888887754               356777888777776  4678889999999998877


Q ss_pred             cCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhc
Q 042766          412 TIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLS  491 (914)
Q Consensus       412 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  491 (914)
                      .+|.   ..++|+.|++++|             ++|++|+|++|++++. +  ++++++|+.|++++|++++ +      
T Consensus       301 ~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-l------  354 (457)
T 3bz5_A          301 LLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-F------  354 (457)
T ss_dssp             EEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-C------
T ss_pred             eecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC-c------
Confidence            7774   3466777766655             6788999999999874 3  8888899999999888885 2      


Q ss_pred             ccchhhhhcccCCccCCCccccccccccceeecccCCccccccCcccc
Q 042766          492 ITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLS  539 (914)
Q Consensus       492 ~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  539 (914)
                       ..+ ..|++++|.++|.     +.+..|..+++++|+++|.+|..+.
T Consensus       355 -~~L-~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          355 -SSV-GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             -TTG-GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred             -ccc-ccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence             223 5677888888765     3556777888888888888876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=384.84  Aligned_cols=187  Identities=23%  Similarity=0.346  Sum_probs=167.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++..     .+..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            569999999999999999999999999999999987766667789999999999999999999999654     458999


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      |||||+||+|.++++.       ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||+|+
T Consensus       226 VmEy~~gG~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEECCTTEEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence            9999999999999964       3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      .+....        ......+||+.|||||++    ++.++||||+||++|||+
T Consensus       296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml  341 (423)
T 4fie_A          296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV  341 (423)
T ss_dssp             ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence            764321        122356899999999999    469999999999999983

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-42  Score=372.31  Aligned_cols=196  Identities=25%  Similarity=0.421  Sum_probs=163.5

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......++|.+|++++++++|||||+++|+|...     
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence            57888999999999999999975     35789999999766656678899999999999999999999997543     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCC-------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          780 DFKALVFEYMENGSLEDWLHQSND-------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                      +..++|||||++|+|.++++..+.       ......+++.++++|+.||+.||+|||++   +||||||||+|||++.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            478999999999999999976431       11235799999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++||+|||+|+.........      ......||+.|||||++.    +.++|||||||++|||+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell  224 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF  224 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEE------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCcee------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            999999999998764432111      112356999999999995    59999999999999984

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.9e-42  Score=364.14  Aligned_cols=190  Identities=25%  Similarity=0.409  Sum_probs=160.7

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|+||+||+|+++.+++.||+|++....  ....+++.+|++++++++|||||++++++.... ......++
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            366678999999999999999999999999997443  334567999999999999999999999875421 23456899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFGla  863 (914)
                      |||||+||+|.+++++.      ..+++..+..|+.||+.||+|||++ .++||||||||+|||++. +|.+||+|||+|
T Consensus       107 vmEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            99999999999999865      4689999999999999999999998 123999999999999984 799999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      +.....          .....+||+.|||||++.   +.++||||+||++|||.
T Consensus       180 ~~~~~~----------~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyell  223 (290)
T 3fpq_A          180 TLKRAS----------FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMA  223 (290)
T ss_dssp             GGCCTT----------SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHH
T ss_pred             EeCCCC----------ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence            854221          123468999999999995   58999999999999973

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=372.87  Aligned_cols=196  Identities=26%  Similarity=0.430  Sum_probs=158.4

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|...++||+|+||+||+|+++     .+++.||||+++.......++|.+|++++++++|||||+++|+|...     
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence            46788899999999999999975     36789999999766666678899999999999999999999997543     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCc---------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQ---------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ...++|||||++|+|.++++..+..         ....++++.++++|+.||+.||+|||++   +||||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            4789999999999999999865321         1224699999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++++||+|||+|+........      ......+||+.|||||++.    +.++|||||||++|||+
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell  254 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYY------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF  254 (329)
T ss_dssp             TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcc------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHH
Confidence            9999999999999876432211      1122457999999999994    58999999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.8e-42  Score=366.84  Aligned_cols=204  Identities=23%  Similarity=0.396  Sum_probs=156.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC------
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDF------  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  776 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++.... ...+.+.+|++++++++|||||++++++...+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            3579999999999999999999999999999999975443 345688999999999999999999998754331      


Q ss_pred             -CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          777 -EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       777 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                       ....+.|+|||||++|+|.+++.....   ....++..++.|+.||+.||+|||++   +||||||||+|||++.++.+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT---IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS---GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC---CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence             123357999999999999999986542   13356677889999999999999999   99999999999999999999


Q ss_pred             EEeccccccccccccccccc----CCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          856 HVGDFGLAKFLSNHHLDIAS----KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~----~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+|||+|+.+.........    .........+||+.|||||++.    +.++||||+||++|||
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyel  223 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL  223 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHH
Confidence            99999999987543221110    1112234568999999999994    5899999999999998

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-42  Score=367.96  Aligned_cols=188  Identities=30%  Similarity=0.462  Sum_probs=155.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .+++++.+.||+|+||+||+|++++   .||||+++...  ....++|.+|++++++++|||||+++|+|..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            3577888999999999999999763   48999987443  2345689999999999999999999998642      24


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++|||||+||+|.+++...+     ..+++.++++|+.|||.||+|||++   +||||||||+|||+++++++||+|||
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             EEEEEEcCCCCCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence            689999999999999997653     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +|+........      ......+||+.|||||++.       +.++|||||||++|||+
T Consensus       178 la~~~~~~~~~------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell  231 (307)
T 3omv_A          178 LATVKSRWSGS------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM  231 (307)
T ss_dssp             SCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CceecccCCcc------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH
Confidence            99875432211      1123468999999999984       46899999999999984

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4e-42  Score=371.56  Aligned_cols=188  Identities=26%  Similarity=0.290  Sum_probs=158.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ...|+..++||+|+||+||+|+++.+|+.||||+++.+..     ..+|++++++++|||||++++++..     .+..|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-----GPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3568888999999999999999999999999999975432     2469999999999999999999644     45899


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFGl  862 (914)
                      +|||||+||+|.+++++.      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+| ++||+|||+
T Consensus       127 ivmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl  197 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH  197 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred             EEEeccCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence            999999999999999865      3689999999999999999999999   999999999999999998 699999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+.+.......   ........+||+.|||||++.    +.++||||+||++|||
T Consensus       198 a~~~~~~~~~~---~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyem  249 (336)
T 4g3f_A          198 ALCLQPDGLGK---SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM  249 (336)
T ss_dssp             CEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             CeEccCCCccc---ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHH
Confidence            99765432111   111223468999999999995    5889999999999998

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.5e-42  Score=359.60  Aligned_cols=186  Identities=28%  Similarity=0.386  Sum_probs=150.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...   ....+++.+|++++++++|||||++++++.     ..+
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence            368999999999999999999999999999999997442   334568999999999999999999999954     445


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..|+||||+ +|+|.+++.+.      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+||
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF  156 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF  156 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred             EEEEEEeCC-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence            899999999 67999999765      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      |+|+...+..         .....+||+.|||||++.     +.++||||+||++|||
T Consensus       157 Gla~~~~~~~---------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~l  205 (275)
T 3hyh_A          157 GLSNIMTDGN---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM  205 (275)
T ss_dssp             SCC------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHH
T ss_pred             CCCeecCCCC---------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHH
Confidence            9998654321         122468999999999994     3689999999999997

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-41  Score=365.29  Aligned_cols=196  Identities=22%  Similarity=0.346  Sum_probs=162.2

Q ss_pred             hcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      +++++.+.||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|...    
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~----  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD----  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence            45677889999999999999974     356899999997443 33457899999999999999999999997543    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                       +..++|||||++|+|.+++......          .....+++.++++|+.|||.||+|||++   +||||||||+|||
T Consensus       102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL  177 (308)
T 4gt4_A          102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL  177 (308)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence             3679999999999999999754311          1235689999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          849 LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++++++||+|||+|+........      ......+||+.|||||++.    +.++|||||||+++|||
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~  241 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYY------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF  241 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCB------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ECCCCCEEECCcccceeccCCCce------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence            999999999999999876443211      1122457999999999994    59999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.8e-42  Score=366.50  Aligned_cols=188  Identities=24%  Similarity=0.308  Sum_probs=155.7

Q ss_pred             hcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|++.+.||+|+||+||+|++.   .+++.||||+++...  .....++.+|++++++++|||||++++++..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            58999999999999999999984   467899999997432  2234578899999999999999999999543     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..|+|||||+||+|.+++.+.      ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+|
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  169 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD  169 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence            5899999999999999999865      4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+...+..        ......+||+.|||||++.    +.++||||+||++|||.
T Consensus       170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml  220 (304)
T 3ubd_A          170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML  220 (304)
T ss_dssp             SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred             cccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHH
Confidence            99998654321        1123468999999999994    58999999999999983

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.8e-40  Score=378.53  Aligned_cols=364  Identities=20%  Similarity=0.203  Sum_probs=222.8

Q ss_pred             CCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCcc
Q 042766          137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTT  216 (914)
Q Consensus       137 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  216 (914)
                      ..+..+..++++++|++|++++|.+++ +| .++.+++|++|+|++|++++. |  ++.+++|++|++++|.+++. |  
T Consensus        30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--  101 (457)
T 3bz5_A           30 MQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--  101 (457)
T ss_dssp             CCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred             cCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--
Confidence            333444455666666666666666664 24 456666666666666666642 3  55666666666666666543 2  


Q ss_pred             chhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccc
Q 042766          217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL  296 (914)
Q Consensus       217 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  296 (914)
                      ++.+++|++|++++|++++. |  +..+++|++|++++|++++. +   +.++++|++|++++|+..+.+  .+..+++|
T Consensus       102 ~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L  172 (457)
T 3bz5_A          102 VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D---VSHNTQLTELDCHLNKKITKL--DVTPQTQL  172 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C---CTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred             cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c---cccCCcCCEEECCCCCccccc--ccccCCcC
Confidence            55566666666666666542 2  55555555555555555543 2   234555555555555433333  24455555


Q ss_pred             ccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccE
Q 042766          297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMI  376 (914)
Q Consensus       297 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~  376 (914)
                      ++|++++|++++..   +..+++|+.|++++|++++.         .++.+++|++|++++|                  
T Consensus       173 ~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~~~---------~l~~l~~L~~L~Ls~N------------------  222 (457)
T 3bz5_A          173 TTLDCSFNKITELD---VSQNKLLNRLNCDTNNITKL---------DLNQNIQLTFLDCSSN------------------  222 (457)
T ss_dssp             CEEECCSSCCCCCC---CTTCTTCCEEECCSSCCSCC---------CCTTCTTCSEEECCSS------------------
T ss_pred             CEEECCCCccceec---cccCCCCCEEECcCCcCCee---------ccccCCCCCEEECcCC------------------
Confidence            55555555555421   44455555555555555443         0233444444444444                  


Q ss_pred             EEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCc
Q 042766          377 ELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNS  456 (914)
Q Consensus       377 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  456 (914)
                             ++++ +|  +..+++|++|++++|++++..   +..+++|+.|++++|              +|+.|++++|.
T Consensus       223 -------~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~  275 (457)
T 3bz5_A          223 -------KLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNT  275 (457)
T ss_dssp             -------CCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCT
T ss_pred             -------cccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCc
Confidence                   4443 23  455666666666666666543   334556666666554              34566777777


Q ss_pred             CCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCc
Q 042766          457 LQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV  536 (914)
Q Consensus       457 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  536 (914)
                      +.+.+|  ++.+++|+.|++++|.+.+.+|....   .+ +.|+++             ++++|++|+|++|+|++. + 
T Consensus       276 ~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~---~L-~~L~l~-------------~~~~L~~L~L~~N~l~~l-~-  334 (457)
T 3bz5_A          276 QLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAA---GI-TELDLS-------------QNPKLVYLYLNNTELTEL-D-  334 (457)
T ss_dssp             TCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTC---CC-SCCCCT-------------TCTTCCEEECTTCCCSCC-C-
T ss_pred             cCCccc--ccccccCCEEECCCCcccceeccCCC---cc-eEechh-------------hcccCCEEECCCCccccc-c-
Confidence            666665  45677777777777777766664322   22 334444             346899999999999985 3 


Q ss_pred             cccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       537 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                       ++.+++|+.|++++|++++        ++.|+.|++++|+++|.     ..+..|+.+++++|+++|.+|..
T Consensus       335 -l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          335 -VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             -CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             -cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence             8899999999999999986        24667778999999986     34566888999999999999965

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=380.99  Aligned_cols=348  Identities=22%  Similarity=0.236  Sum_probs=271.8

Q ss_pred             ceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccC
Q 042766          248 ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQ  327 (914)
Q Consensus       248 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  327 (914)
                      +.++.+++.++. +|..+.   +++++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~~-ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFVA-VPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCSS-CCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-CCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            578888888874 565443   5889999999999988888999999999999999999988888999999999999999


Q ss_pred             CcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccC
Q 042766          328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVN  407 (914)
Q Consensus       328 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  407 (914)
                      |.++.++.      ..|.++++|++|+|++|++++..|..+..+. +|++|++++|.+++..+..|.++++|++|+|++|
T Consensus        90 n~l~~~~~------~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  162 (477)
T 2id5_A           90 NRLKLIPL------GVFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC  162 (477)
T ss_dssp             SCCCSCCT------TSSTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred             CcCCccCc------ccccCCCCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCC
Confidence            99887643      3467788888888888888766666665554 5666777777666666666666666666666666


Q ss_pred             cccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCch
Q 042766          408 QFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ  487 (914)
Q Consensus       408 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  487 (914)
                      ++++..+..|..+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|                
T Consensus       163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L----------------  226 (477)
T 2id5_A          163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL----------------  226 (477)
T ss_dssp             CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC----------------
T ss_pred             cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc----------------
Confidence            6666555566666666666666666666555566666666666666666555554443333333                


Q ss_pred             hhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCC
Q 042766          488 QLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS  567 (914)
Q Consensus       488 ~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  567 (914)
                               +.|++++|++++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..|.+|..+++
T Consensus       227 ---------~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  297 (477)
T 2id5_A          227 ---------TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY  297 (477)
T ss_dssp             ---------SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred             ---------cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence                     45666666666444467888999999999999999998999999999999999999999999999999999


Q ss_pred             CCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCCcc
Q 042766          568 IKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGID  631 (914)
Q Consensus       568 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~  631 (914)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.++..+.+.......+.++...|..+.
T Consensus       298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            9999999999998888889999999999999999999998777666555567778888887643

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.8e-39  Score=372.10  Aligned_cols=343  Identities=28%  Similarity=0.398  Sum_probs=227.2

Q ss_pred             ceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccC
Q 042766           78 RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS  157 (914)
Q Consensus        78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  157 (914)
                      +++.|++.++++.. +| .+..+++|++|+|++|.+++. |. ++++++|++|+|++|++++..|  ++++++|++|+++
T Consensus        47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  120 (466)
T 1o6v_A           47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF  120 (466)
T ss_dssp             TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence            57778888877754 43 477788888888888888754 33 7888888888888888875444  7888888888888


Q ss_pred             CCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCC
Q 042766          158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMF  237 (914)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  237 (914)
                      +|++++. |. +..+++|++|++++|.+++ +| .++.+++|++|+++ |.+.+..+  ++++++|++|++++|++++. 
T Consensus       121 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-  192 (466)
T 1o6v_A          121 NNQITDI-DP-LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI-  192 (466)
T ss_dssp             SSCCCCC-GG-GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC-
T ss_pred             CCCCCCC-hH-HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC-
Confidence            8888754 33 7778888888888888774 33 37777888888875 44543322  77777777777777777653 


Q ss_pred             CCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccccccccc
Q 042766          238 PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSL  317 (914)
Q Consensus       238 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  317 (914)
                       ..+..+++|++|++++|.+++..|   +..+++|++|++++|++++.  ..+..+++|++|++++|++++..+  +..+
T Consensus       193 -~~l~~l~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l  264 (466)
T 1o6v_A          193 -SVLAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL  264 (466)
T ss_dssp             -GGGGGCTTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred             -hhhccCCCCCEEEecCCccccccc---ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence             246677777777777777776544   34567777777777777643  346666777777777777766554  6666


Q ss_pred             ccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCC
Q 042766          318 KNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLV  397 (914)
Q Consensus       318 ~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~  397 (914)
                      ++|++|++++|.+++.      .+  +..+++|+.|+|++|++++.                         .+  +..++
T Consensus       265 ~~L~~L~l~~n~l~~~------~~--~~~l~~L~~L~L~~n~l~~~-------------------------~~--~~~l~  309 (466)
T 1o6v_A          265 TKLTELKLGANQISNI------SP--LAGLTALTNLELNENQLEDI-------------------------SP--ISNLK  309 (466)
T ss_dssp             TTCSEEECCSSCCCCC------GG--GTTCTTCSEEECCSSCCSCC-------------------------GG--GGGCT
T ss_pred             CCCCEEECCCCccCcc------cc--ccCCCccCeEEcCCCcccCc-------------------------hh--hcCCC
Confidence            6666666666666553      11  45566666666666665532                         22  44555


Q ss_pred             CCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccC
Q 042766          398 NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS  477 (914)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  477 (914)
                      +|+.|+|++|++++..|  +..+++|++|++++|.+++.  ..+.++++|+.|++++|++++..|  +..+++|+.|+++
T Consensus       310 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~  383 (466)
T 1o6v_A          310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN  383 (466)
T ss_dssp             TCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEecc
Confidence            66666666666665544  55666666666666666643  345666666666666666665555  5666666666666


Q ss_pred             CCccCC
Q 042766          478 YNKLTG  483 (914)
Q Consensus       478 ~N~l~~  483 (914)
                      +|.+++
T Consensus       384 ~n~~~~  389 (466)
T 1o6v_A          384 DQAWTN  389 (466)
T ss_dssp             CEEEEC
T ss_pred             CCcccC
Confidence            666663

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-40  Score=358.54  Aligned_cols=195  Identities=26%  Similarity=0.322  Sum_probs=154.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++.... ....+..|+..+.+++|||||+++++|.... ......++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence            4678889999999999999998  478999999864322 1223344555667889999999999986543 12236799


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH-----CQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~-----~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      |||||++|+|.++++..       .+++.++.+++.|++.||+|||++     +.++||||||||+|||++.++++||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            99999999999999753       589999999999999999999976     246899999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.........    .......+||+.|||||++.          +.++|||||||++|||+
T Consensus       152 FGla~~~~~~~~~~----~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~  212 (303)
T 3hmm_A          152 LGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  212 (303)
T ss_dssp             CTTCEEEETTTTEE----SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCccccCCCCce----eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence            99998764322110    11122467999999999983          46899999999999973

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=8.3e-39  Score=369.25  Aligned_cols=344  Identities=26%  Similarity=0.385  Sum_probs=164.0

Q ss_pred             ccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeec
Q 042766          173 LKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFL  252 (914)
Q Consensus       173 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  252 (914)
                      ++|+.|++++|.++ .+|. +..+++|++|+|++|.+++..|  ++++++|++|++++|++++..|  +.++++|++|++
T Consensus        46 ~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L  119 (466)
T 1o6v_A           46 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL  119 (466)
T ss_dssp             HTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             ccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence            33444444444443 2222 3334444444444444443222  4444444444444444443322  444444444444


Q ss_pred             cCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCC
Q 042766          253 TENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT  332 (914)
Q Consensus       253 ~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  332 (914)
                      ++|.+++..+   +.++++|++|++++|.+.+. + .+..+++|++|+++ |.+.+..+  +..+++|++|++++|.++.
T Consensus       120 ~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~  191 (466)
T 1o6v_A          120 FNNQITDIDP---LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD  191 (466)
T ss_dssp             CSSCCCCCGG---GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCChH---HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence            4444443211   23444444444444444421 1 24444444444443 23332222  4444444444444444433


Q ss_pred             CCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccccc
Q 042766          333 GTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGT  412 (914)
Q Consensus       333 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  412 (914)
                      .        ..+..+++|++|++++|++++..|  +..+. +|+.|++++|++++.  +.+..+++|++|++++|++++.
T Consensus       192 ~--------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~  258 (466)
T 1o6v_A          192 I--------SVLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL  258 (466)
T ss_dssp             C--------GGGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred             C--------hhhccCCCCCEEEecCCccccccc--ccccC-CCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccc
Confidence            2        113444555555555555443322  11111 344444444444332  2345555566666666655544


Q ss_pred             CChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcc
Q 042766          413 IPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSI  492 (914)
Q Consensus       413 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~  492 (914)
                      .|  +..+++|++|++++|.+++..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|+++          
T Consensus       259 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~----------  322 (466)
T 1o6v_A          259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS----------  322 (466)
T ss_dssp             GG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCS----------
T ss_pred             hh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCC----------
Confidence            33  5555556666666665554332  5555556666666665554332  445555555554444444          


Q ss_pred             cchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEE
Q 042766          493 TTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALN  572 (914)
Q Consensus       493 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  572 (914)
                                     +..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+|  +..+++|+.|+
T Consensus       323 ---------------~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  381 (466)
T 1o6v_A          323 ---------------DISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  381 (466)
T ss_dssp             ---------------CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEE
T ss_pred             ---------------Cchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEe
Confidence                           3333  44556666666666666654  345666666666666666666555  56666666666


Q ss_pred             ccCCcccc
Q 042766          573 VSSNNLSG  580 (914)
Q Consensus       573 Ls~N~l~~  580 (914)
                      +++|++++
T Consensus       382 l~~n~~~~  389 (466)
T 1o6v_A          382 LNDQAWTN  389 (466)
T ss_dssp             CCCEEEEC
T ss_pred             ccCCcccC
Confidence            66666665

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-40  Score=361.47  Aligned_cols=205  Identities=21%  Similarity=0.327  Sum_probs=167.8

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCC-CCcceEEe
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQK-GASKSFVSECEALRNIRH-RNLIKIIT  769 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~  769 (914)
                      .+++....++|++.+.||+|+||+||+|++..     +++.||||+++.... ...+++.+|++++++++| ||||+++|
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            34444556789999999999999999999854     347899999974432 345679999999999976 89999999


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH  839 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivH  839 (914)
                      +|...    ....++|||||++|+|.++++..+..          .....+++.+++.|+.|||.||+|||++   +|||
T Consensus       136 ~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH  208 (353)
T 4ase_A          136 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  208 (353)
T ss_dssp             EECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence            97543    24679999999999999999764321          1124589999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       840 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||||+|||+++++++||+|||+|+.+......      ......+||+.|||||++.    +.++|||||||++||||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~  281 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  281 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCc------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHH
Confidence            999999999999999999999999876432211      1223467999999999995    59999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=362.32  Aligned_cols=196  Identities=25%  Similarity=0.349  Sum_probs=164.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecC-CCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSST-DFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|+++|++++|||||++++++... .+.....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999999999999999996443  23346788999999999999999999987543 2445567


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+|||||+ |+|.+++...      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+|.+||+|||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeCCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence            899999996 6899999765      4699999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+......    ........+||+.|||||++.     +.++||||+||++|||+
T Consensus       204 la~~~~~~~~~----~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          204 MARGLCTSPAE----HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             TCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             eeeecccCccc----cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            99876432211    111233578999999999974     57899999999999983

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=361.44  Aligned_cols=349  Identities=19%  Similarity=0.177  Sum_probs=299.3

Q ss_pred             cccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccC
Q 042766          224 VNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPS  303 (914)
Q Consensus       224 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  303 (914)
                      +.++.++++++ .+|..+.  ++++.|+|++|++++..| ..+.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~   89 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS   89 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence            56888999998 5666554  689999999999997654 5567999999999999999998899999999999999999


Q ss_pred             ccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecc
Q 042766          304 NQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN  383 (914)
Q Consensus       304 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N  383 (914)
                      |+++++.+..|.++++|++|+|++|.++..      .+..+.++++|+.|+|++|++++..|..+..+. +|+.|++++|
T Consensus        90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n  162 (477)
T 2id5_A           90 NRLKLIPLGVFTGLSNLTKLDISENKIVIL------LDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN-SLEQLTLEKC  162 (477)
T ss_dssp             SCCCSCCTTSSTTCTTCCEEECTTSCCCEE------CTTTTTTCTTCCEEEECCTTCCEECTTSSTTCT-TCCEEEEESC
T ss_pred             CcCCccCcccccCCCCCCEEECCCCccccC------ChhHccccccCCEEECCCCccceeChhhccCCC-CCCEEECCCC
Confidence            999998888999999999999999999876      344678999999999999999988788888776 7999999999


Q ss_pred             cccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCC
Q 042766          384 QISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPS  463 (914)
Q Consensus       384 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  463 (914)
                      ++++..+..|.++++|+.|+|++|++.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|+|++|++++..+.
T Consensus       163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  242 (477)
T 2id5_A          163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL  242 (477)
T ss_dssp             CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH
T ss_pred             cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH
Confidence            99988888899999999999999999999999999999999999999998888888877778999999999999965556


Q ss_pred             ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCcccccccc
Q 042766          464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVS  543 (914)
Q Consensus       464 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  543 (914)
                      .+.++++|+.|++++|+++                         +..+..|.++++|+.|+|++|++++..|..|..+++
T Consensus       243 ~~~~l~~L~~L~Ls~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  297 (477)
T 2id5_A          243 AVRHLVYLRFLNLSYNPIS-------------------------TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNY  297 (477)
T ss_dssp             HHTTCTTCCEEECCSSCCC-------------------------EECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTT
T ss_pred             HhcCccccCeeECCCCcCC-------------------------ccChhhccccccCCEEECCCCccceECHHHhcCccc
Confidence            7888888877777776665                         344456778889999999999999988999999999


Q ss_pred             ccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          544 LEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       544 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      |++|+|++|++++..+..|..+++|+.|+|++|.+.+.-+. ..-...+..+++.++...|..|..
T Consensus       298 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          298 LRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             CCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             CCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCchH
Confidence            99999999999988888889999999999999999864332 112233455667788888777753

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-37  Score=350.34  Aligned_cols=349  Identities=16%  Similarity=0.150  Sum_probs=204.3

Q ss_pred             CCCCCCCCCCCC-ccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecC
Q 042766           55 TSSWNNTMNFCQ-WTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALS  133 (914)
Q Consensus        55 ~~~w~~~~~~c~-w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  133 (914)
                      +++|..+.+||. |.+..|.....++     ............-..++++++|++++|.++...+..+.++++|++|+|+
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~   77 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN   77 (390)
T ss_dssp             ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred             cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence            468987778875 4444442111111     2111112222333456788888888888884444446788888888888


Q ss_pred             CCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCC
Q 042766          134 NNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKI  213 (914)
Q Consensus       134 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  213 (914)
                      +|++++..|..++.+++|++|+|++|++++..|..|+++++|++|+|++|+++...+..|+++++|++|++++|.+++..
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  157 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  157 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence            88888666678888888888888888888777777788888888888888877444444577777777777777777666


Q ss_pred             CccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccc
Q 042766          214 PTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNA  293 (914)
Q Consensus       214 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  293 (914)
                      |..|+.+++|++|++++|++++.   .+..+++|+.|++++|.+++.                              ...
T Consensus       158 ~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~------------------------------~~~  204 (390)
T 3o6n_A          158 DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL------------------------------AIP  204 (390)
T ss_dssp             TTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE------------------------------ECC
T ss_pred             hhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc------------------------------CCC
Confidence            66666777777777777766643   234445555555555555431                              112


Q ss_pred             cccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhcccc
Q 042766          294 SNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL  373 (914)
Q Consensus       294 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  373 (914)
                      ++|+.|++++|+++.....   ..++|+.|++++|.++..        .++..+++|++|+|++|++++..|..+..+. 
T Consensus       205 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-  272 (390)
T 3o6n_A          205 IAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-  272 (390)
T ss_dssp             SSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCEEESGGGTTCS-
T ss_pred             CcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--------HHHcCCCCccEEECCCCcCCCcChhHccccc-
Confidence            3455555555555433221   124555566666655543        1345666666666666666644444444433 


Q ss_pred             ccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEee
Q 042766          374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG  453 (914)
Q Consensus       374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  453 (914)
                      +|++|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|.+++. |  +..+++|+.|+++
T Consensus       273 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~  347 (390)
T 3o6n_A          273 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLS  347 (390)
T ss_dssp             SCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECC
T ss_pred             cCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcC
Confidence            34444444444443 2334455566666666666666 3444455666666666666666532 2  4455556666666


Q ss_pred             CCcCC
Q 042766          454 SNSLQ  458 (914)
Q Consensus       454 ~N~l~  458 (914)
                      +|+++
T Consensus       348 ~N~~~  352 (390)
T 3o6n_A          348 HNDWD  352 (390)
T ss_dssp             SSCEE
T ss_pred             CCCcc
Confidence            66554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.8e-38  Score=366.00  Aligned_cols=186  Identities=25%  Similarity=0.322  Sum_probs=159.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHH---HHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSE---CEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.++||+|+||+||+|+++.+|+.||||+++...   ........+|   +.+++.++|||||++++++     +
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~  262 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H  262 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----E
Confidence            468999999999999999999999999999999996432   2223334444   5667778999999999984     4


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      ..+..|+|||||+||+|.+++.+.      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.+|++||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence            456899999999999999999865      4689999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      +|||+|+.+....          ....+||+.|||||++.     +.++|+||+||++|||
T Consensus       334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEm  384 (689)
T 3v5w_A          334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL  384 (689)
T ss_dssp             CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHH
T ss_pred             cccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999998764321          22468999999999983     4789999999999998

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.3e-37  Score=366.76  Aligned_cols=348  Identities=16%  Similarity=0.155  Sum_probs=202.1

Q ss_pred             CCCCCCCCCCCCCCC----ccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCC
Q 042766           52 SGVTSSWNNTMNFCQ----WTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRL  127 (914)
Q Consensus        52 ~~~~~~w~~~~~~c~----w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  127 (914)
                      ...+++|.++.+||.    |.++.|+.      .++-.....  .....-..+++++.|++++|.+++..+..++++++|
T Consensus         6 ~~~l~~~~~~~~C~~~~~~~~c~~~~~------~i~~~~~~~--~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L   77 (597)
T 3oja_B            6 RYNVKPRQPEYKCIDSNLQYDCVFYDV------HIDMQTQDV--YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV   77 (597)
T ss_dssp             -----CCCSEECCCCC--CCSEEECSC------EECSSCCCC--EESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred             cccccCCCCCCcCcccCcCceeEecCc------eeccccccc--ccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence            345678998878874    77666641      112111111  112222356788888888888886555567888888


Q ss_pred             CeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccC
Q 042766          128 EKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN  207 (914)
Q Consensus       128 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  207 (914)
                      ++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|
T Consensus        78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            88888888888777778888888888888888888777777788888888888888887555555677777777777777


Q ss_pred             CCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCC
Q 042766          208 SLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIP  287 (914)
Q Consensus       208 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p  287 (914)
                      .+++..|..|+.+++|++|+|++|++++..   +..+++|+.|++++|.+++.                           
T Consensus       158 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l---------------------------  207 (597)
T 3oja_B          158 NLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL---------------------------  207 (597)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE---------------------------
T ss_pred             cCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc---------------------------
Confidence            777777777777777777777777776532   34445555555555555432                           


Q ss_pred             CccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCch
Q 042766          288 DSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHS  367 (914)
Q Consensus       288 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~  367 (914)
                         ...++|+.|++++|.++...+..+   ++|+.|+|++|.+++.        .++..+++|+.|+|++|.+++..|..
T Consensus       208 ---~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~--------~~l~~l~~L~~L~Ls~N~l~~~~~~~  273 (597)
T 3oja_B          208 ---AIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT--------AWLLNYPGLVEVDLSYNELEKIMYHP  273 (597)
T ss_dssp             ---ECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC--------GGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred             ---cCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC--------hhhccCCCCCEEECCCCccCCCCHHH
Confidence               122344455555555443332221   3555566666655542        23556666677766666666444444


Q ss_pred             hhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCC
Q 042766          368 IANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKL  447 (914)
Q Consensus       368 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  447 (914)
                      +..+. +|+.|+|++|.+++ +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|.+++. |  +..+++|
T Consensus       274 ~~~l~-~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L  347 (597)
T 3oja_B          274 FVKMQ-RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTL  347 (597)
T ss_dssp             GTTCS-SCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCC
T ss_pred             hcCcc-CCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCC
Confidence            33332 23333333333332 2333344445555555555554 2333444444444444444444422 1  3333444


Q ss_pred             CeEEeeCCcC
Q 042766          448 GSLDLGSNSL  457 (914)
Q Consensus       448 ~~L~Ls~N~l  457 (914)
                      +.|+|++|.+
T Consensus       348 ~~L~l~~N~~  357 (597)
T 3oja_B          348 KNLTLSHNDW  357 (597)
T ss_dssp             SEEECCSSCE
T ss_pred             CEEEeeCCCC
Confidence            4444444443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.6e-38  Score=346.89  Aligned_cols=193  Identities=22%  Similarity=0.296  Sum_probs=157.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|++.+.||+|+||+||+|+++   .+++.||||++...  ....++.+|+++++.+ +|||||++++++.     .
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----K   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----E
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----E
Confidence            4567999999999999999999874   46889999998543  3446788999999998 6999999999854     4


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEE
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHV  857 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki  857 (914)
                      .++.++||||++||+|.+++.         .+++.++..++.|++.||+|||++   +||||||||+|||++.+ +.+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             CCEEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence            458999999999999999984         478899999999999999999999   99999999999999877 89999


Q ss_pred             ecccccccccccccccc--------------------cCCCCccccccCcccccccchhh-----hhhcccCcccccccc
Q 042766          858 GDFGLAKFLSNHHLDIA--------------------SKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVH  912 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~--------------------~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~  912 (914)
                      +|||+|+...+......                    ..........+||+.|||||++.     +.++||||+||++||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            99999986543221100                    00011223468999999999984     478899999999999


Q ss_pred             cC
Q 042766          913 HF  914 (914)
Q Consensus       913 ~f  914 (914)
                      |+
T Consensus       240 ll  241 (361)
T 4f9c_A          240 LL  241 (361)
T ss_dssp             HH
T ss_pred             HH
Confidence            73

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=2e-37  Score=339.75  Aligned_cols=280  Identities=16%  Similarity=0.218  Sum_probs=171.9

Q ss_pred             CCCHhHHHHHHHHHHhcC-CCCCCCCCC----CCCCCCCCccceeecC--------CCCceEEEecCCCCCccccCCCCC
Q 042766           32 QTNETDRLALLAIKSQLH-DPSGVTSSW----NNTMNFCQWTGVTCGH--------RHQRLTELNLSSQRIGGVLSPYVG   98 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~-~~~~~~~~w----~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~l~   98 (914)
                      .+..+|++||++||+++. |+.+.+.+|    ..+.++|.|.||+|+.        ...+|+.|+|+++.++ .+|+.++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~  101 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF  101 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence            346789999999999995 787778899    4567899999999952        2356667777776665 5666666


Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..++..      
T Consensus       102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------  173 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------  173 (328)
T ss_dssp             GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------
T ss_pred             hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------
Confidence            6666666666666666 66666666666666666666666 566666666666666666666666666555430      


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCccc
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS  258 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  258 (914)
                               .++..|+++++|++|+|++|.++ .+|..++.+++|++|+|++|++++ +|..+..+++|++|+|++|++.
T Consensus       174 ---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~  242 (328)
T 4fcg_A          174 ---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTAL  242 (328)
T ss_dssp             ---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTC
T ss_pred             ---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcch
Confidence                     00011223555555555555555 445555555555555555555553 3334555555555555555555


Q ss_pred             CcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCC
Q 042766          259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT  332 (914)
Q Consensus       259 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  332 (914)
                      +.+|.. +.++++|++|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus       243 ~~~p~~-~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          243 RNYPPI-FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ  315 (328)
T ss_dssp             CBCCCC-TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred             hhhHHH-hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence            554432 2355555555555555555566666666666666666666666666666666666666666555443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.9e-37  Score=359.39  Aligned_cols=188  Identities=21%  Similarity=0.300  Sum_probs=166.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|++++|||||++++++     +.....+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            36899999999999999999999999999999999766655667899999999999999999999995     4455899


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC--CcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD--MVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~--~~~ki~DFG  861 (914)
                      +|||||+||+|.+++....     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||
T Consensus       231 iv~E~~~gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             EEEeecCCCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence            9999999999999997543     3688999999999999999999999   99999999999999854  899999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      +|+.+....         .....+||+.|||||++.    +.++||||+||++|||
T Consensus       303 ~a~~~~~~~---------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyem  349 (573)
T 3uto_A          303 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL  349 (573)
T ss_dssp             SCEECCTTS---------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHH
T ss_pred             ceeEccCCC---------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            998764321         123468999999999994    5899999999999997

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=4.3e-36  Score=357.19  Aligned_cols=343  Identities=20%  Similarity=0.207  Sum_probs=246.3

Q ss_pred             ccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccce
Q 042766          244 ISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLL  323 (914)
Q Consensus       244 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  323 (914)
                      +.+++.|++++|.+.. +|..++.++++|++|+|++|.+++..|..|+.+++|++|+|++|.|++.+|..|.++++|++|
T Consensus        50 l~~l~~l~l~~~~l~~-lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCCC-cCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            5566777777777653 455556667777777777777776666677777777777777777776666666666666666


Q ss_pred             eccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEE
Q 042766          324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFT  403 (914)
Q Consensus       324 ~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  403 (914)
                      +|++|.++.++.      ..|+++++|++|+|++|.++                         +..|..|+++++|++|+
T Consensus       129 ~L~~n~l~~l~~------~~~~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~  177 (597)
T 3oja_B          129 VLERNDLSSLPR------GIFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQ  177 (597)
T ss_dssp             ECCSSCCCCCCT------TTTTTCTTCCEEECCSSCCC-------------------------BCCTTTTTTCTTCCEEE
T ss_pred             EeeCCCCCCCCH------HHhccCCCCCEEEeeCCcCC-------------------------CCChhhhhcCCcCcEEE
Confidence            666666665422      22345555555555555554                         45555666667777777


Q ss_pred             cccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCC
Q 042766          404 LEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG  483 (914)
Q Consensus       404 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  483 (914)
                      |++|++++..   +..+++|+.|++++|.+++     +....+|+.|++++|.++...+. +  .++|+.|++++|.+++
T Consensus       178 L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~  246 (597)
T 3oja_B          178 LSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD  246 (597)
T ss_dssp             CTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC
T ss_pred             CcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC
Confidence            7777776542   4456677777777777664     23345677777777777643322 2  2567777777777775


Q ss_pred             CCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchh
Q 042766          484 DLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFR  563 (914)
Q Consensus       484 ~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  563 (914)
                        +..+..++.+ +.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+.
T Consensus       247 --~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~  321 (597)
T 3oja_B          247 --TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP  321 (597)
T ss_dssp             --CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred             --ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccc
Confidence              3556666666 788888888888889999999999999999999997 4677788999999999999998 5788899


Q ss_pred             ccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCCccCCCCCCC
Q 042766          564 FLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELHLPSC  638 (914)
Q Consensus       564 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~l~~~~c  638 (914)
                      .+++|+.|+|++|++++..   +..++.|+.|++++|+|+|.++. ..+..+....+.++...|+.........|
T Consensus       322 ~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~~~~~~~c  392 (597)
T 3oja_B          322 QFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDYQLEHGLC  392 (597)
T ss_dssp             HHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTCEEETTEE
T ss_pred             cCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcchhccCCcc
Confidence            9999999999999998653   66788999999999999998654 34566666778889999987444333334

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=5.1e-36  Score=326.55  Aligned_cols=254  Identities=27%  Similarity=0.442  Sum_probs=217.4

Q ss_pred             ccEEEEeecccccc--cCCccccCCCCCcEEEccc-CcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeE
Q 042766          374 KMIELSVGRNQISG--TIPPGIRNLVNLITFTLEV-NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSL  450 (914)
Q Consensus       374 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  450 (914)
                      +++.|++++|.+++  .+|..|.++++|++|+|++ |++.+.+|..|..+++|++|+|++|.+++.+|..|.++++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            46677777777776  6777777777788888874 77777777777778888888888888877777777778888888


Q ss_pred             EeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcc
Q 042766          451 DLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF  530 (914)
Q Consensus       451 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  530 (914)
                      +|++|++++.+|..+.++++|+.|++++|+++|.+|..+..+...+++|++++|++++.+|..+..++ |++|+|++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            88888887777777777888888888888887777877777773337888888888888888898887 99999999999


Q ss_pred             ccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCC
Q 042766          531 SGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      ++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            999999999999999999999999988776 8899999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCccCccCCCCCCCC
Q 042766          611 VFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       611 ~~~~~~~~~~~~n~~lc~~  629 (914)
                      .+..+..+.+.+|+++||.
T Consensus       289 ~l~~L~~l~l~~N~~lc~~  307 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             TGGGSCGGGTCSSSEEEST
T ss_pred             cccccChHHhcCCCCccCC
Confidence            8889999999999999997

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-35  Score=335.12  Aligned_cols=335  Identities=19%  Similarity=0.209  Sum_probs=237.5

Q ss_pred             cccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccc
Q 042766          243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWL  322 (914)
Q Consensus       243 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  322 (914)
                      .+.+++.|++++|.++. +|...+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++
T Consensus        43 ~l~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GGCCCSEEEEESCEESE-ECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCceEEEecCCchhh-CChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            35667777777777663 45555666777777777777777666667777777777777777777666666666666666


Q ss_pred             eeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEE
Q 042766          323 LNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITF  402 (914)
Q Consensus       323 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  402 (914)
                      |++++|.++.++..      .+.++++|++|++++|+++                         +..|..|.++++|++|
T Consensus       122 L~L~~n~l~~l~~~------~~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L  170 (390)
T 3o6n_A          122 LVLERNDLSSLPRG------IFHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNL  170 (390)
T ss_dssp             EECCSSCCCCCCTT------TTTTCTTCCEEECCSSCCC-------------------------BCCTTTTSSCTTCCEE
T ss_pred             EECCCCccCcCCHH------HhcCCCCCcEEECCCCccC-------------------------ccChhhccCCCCCCEE
Confidence            66666666654222      2345555555555555554                         4445556666666666


Q ss_pred             EcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccC
Q 042766          403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT  482 (914)
Q Consensus       403 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  482 (914)
                      ++++|++++..   +..+++|+.|++++|.+++.     ...++|+.|++++|.++.. |...  .++|+.|++++|+++
T Consensus       171 ~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          171 QLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLT  239 (390)
T ss_dssp             ECCSSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCC
T ss_pred             ECCCCcCCccc---cccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCc
Confidence            66666666442   45566677777777766532     2335677777777777643 3222  356777777777776


Q ss_pred             CCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcch
Q 042766          483 GDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSF  562 (914)
Q Consensus       483 ~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  562 (914)
                      +.  ..+..++.+ ++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+|..+
T Consensus       240 ~~--~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~  314 (390)
T 3o6n_A          240 DT--AWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQ  314 (390)
T ss_dssp             CC--GGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGH
T ss_pred             cc--HHHcCCCCc-cEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccc
Confidence            43  355566666 778888888888888899999999999999999996 4667788999999999999998 567778


Q ss_pred             hccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCC
Q 042766          563 RFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       563 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  629 (914)
                      ..+++|+.|+|++|+++.. |  +..+++|+.|++++|+++|.+.. ..+..+....+.+++..|..
T Consensus       315 ~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          315 PQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             HHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCT
T ss_pred             cccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceecc
Confidence            9999999999999999865 3  67788999999999999997653 34555666667778777865

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.6e-34  Score=320.37  Aligned_cols=305  Identities=24%  Similarity=0.335  Sum_probs=162.1

Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .+++|++|++++|.++ .+| .+..+++|++|+|++|++++ +|. +..+++|++|++++|++++ + +.+..+++|++|
T Consensus        42 ~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~~L  115 (347)
T 4fmz_A           42 ELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLREL  115 (347)
T ss_dssp             HHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCSEE
T ss_pred             hcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCCEE
Confidence            4556666666666666 344 36666677777777776663 333 6666666666666666653 3 246666666666


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCccc
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS  258 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  258 (914)
                      ++++|.+++. |. +..+++|++|++++|.....++ .+..+++|++|++++|.+.+..+  +..+++|+.|++++|.++
T Consensus       116 ~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (347)
T 4fmz_A          116 YLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE  190 (347)
T ss_dssp             ECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred             ECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence            6666666632 32 5566666666666664443332 25556666666666666554332  555555555555555555


Q ss_pred             CcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCc
Q 042766          259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL  338 (914)
Q Consensus       259 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  338 (914)
                      +..+   +..+++|++|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|++|++++|.++..     
T Consensus       191 ~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-----  258 (347)
T 4fmz_A          191 DISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-----  258 (347)
T ss_dssp             CCGG---GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-----
T ss_pred             cccc---ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-----
Confidence            4322   3345555555555555553322  4555555555555555554333  44444444444444444432     


Q ss_pred             chhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhh
Q 042766          339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVIS  418 (914)
Q Consensus       339 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  418 (914)
                         ..+..+++|++|++++|+++                         +.  +.+..+++|++|++++|++++..|..+.
T Consensus       259 ---~~~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          259 ---NAVKDLTKLKMLNVGSNQIS-------------------------DI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             ---GGGTTCTTCCEEECCSSCCC-------------------------CC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             ---hhHhcCCCcCEEEccCCccC-------------------------CC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence               11333444444444444433                         11  2244455555555555555555555555


Q ss_pred             cccCCceeeecccccccccCccccCCCCCCeEEeeCCcCC
Q 042766          419 ELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ  458 (914)
Q Consensus       419 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  458 (914)
                      .+++|++|++++|.+++..|  +..+++|++|++++|.|+
T Consensus       309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            55555555555555554433  455555555555555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7.5e-34  Score=314.87  Aligned_cols=308  Identities=25%  Similarity=0.366  Sum_probs=207.8

Q ss_pred             ccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccccccccccc
Q 042766          240 SICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKN  319 (914)
Q Consensus       240 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  319 (914)
                      .+..+++|+.|++++|.+... |.  +..+++|++|++++|++++..+  +..+++|++|+|++|++++.  ..|..+++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~~-~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~  111 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVASI-QG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN  111 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCCC-TT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred             cchhcccccEEEEeCCccccc-hh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence            345677888888888888753 32  4577888888888888875433  77888888888888888764  25777888


Q ss_pred             ccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCC
Q 042766          320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNL  399 (914)
Q Consensus       320 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L  399 (914)
                      |++|++++|.++..+       . +..+++|+.|++++|.....++. +..+. +|++|++++|.+.+..+  +..+++|
T Consensus       112 L~~L~l~~n~i~~~~-------~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~-~L~~L~l~~~~~~~~~~--~~~l~~L  179 (347)
T 4fmz_A          112 LRELYLNEDNISDIS-------P-LANLTKMYSLNLGANHNLSDLSP-LSNMT-GLNYLTVTESKVKDVTP--IANLTDL  179 (347)
T ss_dssp             CSEEECTTSCCCCCG-------G-GTTCTTCCEEECTTCTTCCCCGG-GTTCT-TCCEEECCSSCCCCCGG--GGGCTTC
T ss_pred             CCEEECcCCcccCch-------h-hccCCceeEEECCCCCCcccccc-hhhCC-CCcEEEecCCCcCCchh--hccCCCC
Confidence            888888888776641       1 56777777777777755433332 33333 45555555555554332  4555555


Q ss_pred             cEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCC
Q 042766          400 ITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN  479 (914)
Q Consensus       400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  479 (914)
                      ++|++++|++.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|+       
T Consensus       180 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~-------  246 (347)
T 4fmz_A          180 YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT-------  246 (347)
T ss_dssp             SEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCC-------
T ss_pred             CEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCC-------
Confidence            555555555553322  4555555555555555553322  4455555555555555553222  44444444       


Q ss_pred             ccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCC
Q 042766          480 KLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIP  559 (914)
Q Consensus       480 ~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  559 (914)
                                        +|++++|.+++.  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++++..|
T Consensus       247 ------------------~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~  304 (347)
T 4fmz_A          247 ------------------WLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDM  304 (347)
T ss_dssp             ------------------EEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGH
T ss_pred             ------------------EEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcCh
Confidence                              455555555432  3567788999999999999875  468899999999999999999999


Q ss_pred             cchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccc
Q 042766          560 LSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFE  603 (914)
Q Consensus       560 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  603 (914)
                      ..|..+++|+.|++++|++++..|  +..+++|++|++++|+++
T Consensus       305 ~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             hHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            999999999999999999998766  888999999999999875

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.4e-34  Score=315.36  Aligned_cols=293  Identities=22%  Similarity=0.255  Sum_probs=173.9

Q ss_pred             CCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccc
Q 042766          103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI  182 (914)
Q Consensus       103 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  182 (914)
                      ++.+++++++++ .+|..+.  ++|++|+|++|++++..|..++++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            344444444444 3444332  3455555555555544444455555555555555555544455555555555555555


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc--CCCCCccccccccceeeccCCcccCc
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS--GMFPRSICNISSVELIFLTENRFSGI  260 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~  260 (914)
                      |+++ .+|..+.  ++|++|++++|.+++..+..|+.+++|++|++++|+++  +..|..+..+ +|++|++++|++++ 
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            5555 3443333  45555555555555444445555666666666666654  3455556655 66666666666664 


Q ss_pred             ccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcch
Q 042766          261 FPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDF  340 (914)
Q Consensus       261 ~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  340 (914)
                      +|..++   ++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|++++|+++.+       
T Consensus       187 l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-------  256 (332)
T 2ft3_A          187 IPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-------  256 (332)
T ss_dssp             CCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBC-------
T ss_pred             cCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeec-------
Confidence            343332   5777778888887777777788888888888888888877777777777888888887777643       


Q ss_pred             hhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccc--ccCChhhh
Q 042766          341 VIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH--GTIPDVIS  418 (914)
Q Consensus       341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~  418 (914)
                      |..+..+++|++|++++|++++..+..+.....                   -....+|+.|++++|.+.  +..|..|.
T Consensus       257 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~-------------------~~~~~~l~~L~l~~N~~~~~~~~~~~~~  317 (332)
T 2ft3_A          257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF-------------------GVKRAYYNGISLFNNPVPYWEVQPATFR  317 (332)
T ss_dssp             CTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC-------------------CSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred             ChhhhcCccCCEEECCCCCCCccChhHcccccc-------------------ccccccccceEeecCcccccccCccccc
Confidence            334667777777777777777443333332210                   011345777777777776  56667777


Q ss_pred             cccCCceeeecccc
Q 042766          419 ELKNLQQLSVFNNF  432 (914)
Q Consensus       419 ~l~~L~~L~L~~N~  432 (914)
                      .+++|+.+++++|+
T Consensus       318 ~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          318 CVTDRLAIQFGNYK  331 (332)
T ss_dssp             TBCCSTTEEC----
T ss_pred             ccchhhhhhccccc
Confidence            77888888877764

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.3e-33  Score=310.62  Aligned_cols=288  Identities=21%  Similarity=0.276  Sum_probs=181.1

Q ss_pred             CCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecc
Q 042766          126 RLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRIT  205 (914)
Q Consensus       126 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  205 (914)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            6899999999988 7887764  688889999998887777788888888888888888887778888888888888888


Q ss_pred             cCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccC-cccccccccCcccceeeccCccCCC
Q 042766          206 ENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG-IFPFDILLNLPNLKKLGIGGNNFVG  284 (914)
Q Consensus       206 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~l~~L~~L~Ls~N~l~~  284 (914)
                      +|.++ .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++. ..+...+..+ +|++|++++|++++
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~  186 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG  186 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence            88888 4555544  678888888888876666667777777777777777752 1222333344 66666666666664


Q ss_pred             CCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCc
Q 042766          285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL  364 (914)
Q Consensus       285 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  364 (914)
                       +|..+.  ++|++|+|++|++++..+..|..+++|++|++++|.++...      +..+..+++|++|+|++|+++   
T Consensus       187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~---  254 (332)
T 2ft3_A          187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE------NGSLSFLPTLRELHLDNNKLS---  254 (332)
T ss_dssp             -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCC------TTGGGGCTTCCEEECCSSCCC---
T ss_pred             -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCC------hhHhhCCCCCCEEECCCCcCe---
Confidence             444433  56666666666666655555555555555555555555431      112334444444444444433   


Q ss_pred             CchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcc------cCCceeeecccccc--cc
Q 042766          365 PHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL------KNLQQLSVFNNFLR--GG  436 (914)
Q Consensus       365 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~  436 (914)
                                             .+|..+..+++|++|++++|++++..+..|...      .+|+.|++++|.+.  +.
T Consensus       255 -----------------------~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~  311 (332)
T 2ft3_A          255 -----------------------RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV  311 (332)
T ss_dssp             -----------------------BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGS
T ss_pred             -----------------------ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccccc
Confidence                                   233444455555555555555555444444332      34455555555544  33


Q ss_pred             cCccccCCCCCCeEEeeCC
Q 042766          437 IPSGLGNLTKLGSLDLGSN  455 (914)
Q Consensus       437 ~p~~~~~l~~L~~L~Ls~N  455 (914)
                      .|.+|..+++|+.++|++|
T Consensus       312 ~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          312 QPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             CGGGGTTBCCSTTEEC---
T ss_pred             Ccccccccchhhhhhcccc
Confidence            4444445555555555444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-34  Score=327.93  Aligned_cols=197  Identities=22%  Similarity=0.273  Sum_probs=167.6

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      .++....++|++.++||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.. 
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-  145 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-  145 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            34445568999999999999999999999999999999999642   22333458899999999999999999998644 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                          ....++||||++||+|.+++.+..     ..+++..+..++.|++.||+|||+.   +||||||||+|||++.++.
T Consensus       146 ----~~~~~lV~Ey~~gg~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          146 ----DNNLYLVMDYYVGGDLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             ----SSEEEEEECCCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             ----CCEEEEEEecCCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCC
Confidence                457899999999999999998643     4689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.......       ......+||+.|||||++.         +.++|+||+||++|||+
T Consensus       214 vkL~DFGla~~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell  275 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML  275 (437)
T ss_dssp             EEECCCTTCEECCTTSC-------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH
T ss_pred             EEEcchhhhhhcccCCC-------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH
Confidence            99999999986543221       1122357999999999985         46899999999999973

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.3e-33  Score=308.54  Aligned_cols=291  Identities=19%  Similarity=0.193  Sum_probs=170.9

Q ss_pred             EecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcc
Q 042766           82 LNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL  161 (914)
Q Consensus        82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  161 (914)
                      +++++++++ .+|..+.  +.|++|+|++|++++..+..|+++++|++|+|++|++++..|..++.+++|++|+|++|++
T Consensus        36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  112 (330)
T 1xku_A           36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL  112 (330)
T ss_dssp             EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence            344444443 3444432  5677777777777766666777777777777777777766677777777777777777777


Q ss_pred             cCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCC--CCCccchhhhcccccccccccccCCCCC
Q 042766          162 EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGG--KIPTTLGLLRRLVNLNVAENQFSGMFPR  239 (914)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  239 (914)
                      + .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++.  ..+..+..+++|++|++++|+++     
T Consensus       113 ~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-----  184 (330)
T 1xku_A          113 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-----  184 (330)
T ss_dssp             S-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-----
T ss_pred             C-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-----
Confidence            6 4555443  566666666666665555556666666666666666542  44444555555555555555544     


Q ss_pred             ccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccccccccccc
Q 042766          240 SICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKN  319 (914)
Q Consensus       240 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  319 (914)
                                         . +|...+   ++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++
T Consensus       185 -------------------~-l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  241 (330)
T 1xku_A          185 -------------------T-IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH  241 (330)
T ss_dssp             -------------------S-CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTT
T ss_pred             -------------------c-CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCC
Confidence                               2 232221   45666666666666555566666666666666666666665556666666


Q ss_pred             ccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCC
Q 042766          320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNL  399 (914)
Q Consensus       320 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L  399 (914)
                      |++|+|++|.++.+       |..+..+++|++|++++|++++..+..+....                   ......+|
T Consensus       242 L~~L~L~~N~l~~l-------p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~-------------------~~~~~~~l  295 (330)
T 1xku_A          242 LRELHLNNNKLVKV-------PGGLADHKYIQVVYLHNNNISAIGSNDFCPPG-------------------YNTKKASY  295 (330)
T ss_dssp             CCEEECCSSCCSSC-------CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS-------------------CCTTSCCC
T ss_pred             CCEEECCCCcCccC-------ChhhccCCCcCEEECCCCcCCccChhhcCCcc-------------------cccccccc
Confidence            66666666666533       33355666666666666666643333332211                   00123456


Q ss_pred             cEEEcccCcccc--cCChhhhcccCCceeeecccc
Q 042766          400 ITFTLEVNQFHG--TIPDVISELKNLQQLSVFNNF  432 (914)
Q Consensus       400 ~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~  432 (914)
                      +.|++++|.+..  ..|..|..+.+++.++|++|+
T Consensus       296 ~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cceEeecCcccccccCccccccccceeEEEecccC
Confidence            666666666642  455666677777777777664

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.1e-34  Score=308.57  Aligned_cols=188  Identities=24%  Similarity=0.356  Sum_probs=166.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|+..+.||+|+||+||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...     +..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            45799999999999999999999999999999999877666678899999999999999999999996543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++...       .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|
T Consensus        94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            999999999999999753       588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......||+.|+|||++.    +.++||||+||++|||+
T Consensus       164 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  210 (297)
T 3fxz_A          164 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI  210 (297)
T ss_dssp             EECCSTTC--------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHH
T ss_pred             eecCCccc--------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            86543221        122457999999999984    58999999999999873

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4e-34  Score=314.12  Aligned_cols=189  Identities=25%  Similarity=0.294  Sum_probs=164.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|++++++++||||+++++++..     .+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-----~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-----CC
Confidence            46899999999999999999999999999999999743   23455678999999999999999999998543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence            889999999999999999754      4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  199 (337)
T 1o6l_A          150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  199 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred             cchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh
Confidence            9998532211        1123468999999999984    58999999999999973

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-34  Score=325.24  Aligned_cols=195  Identities=19%  Similarity=0.260  Sum_probs=166.2

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      .++....++|++.+.||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|+++++.++||||+++++++.. 
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-  140 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  140 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence            34445567899999999999999999999999999999999642   23344568899999999999999999999643 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                          ....++||||++||+|.+++...       .+++..+..++.|++.||+|||++   +|+||||||+|||++.+|+
T Consensus       141 ----~~~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          141 ----DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             ----SSEEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             ----CCEEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence                45899999999999999998753       588999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh--------hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.......       ......+||+.|||||++.        +.++|+||+||++|||+
T Consensus       207 ikL~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell  267 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  267 (410)
T ss_dssp             EEECCCTTCEECCTTSE-------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred             EEEeccceeEeeccCCc-------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence            99999999986543221       1122468999999999984        36899999999999973

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=325.53  Aligned_cols=198  Identities=23%  Similarity=0.286  Sum_probs=168.2

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeec
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSS  773 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  773 (914)
                      .++.....++|++.+.||+|+||+||+|+++.+++.||||+++...   ....+.+.+|+.++.+++||||+++++++..
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444456689999999999999999999999999999999996432   2334568899999999999999999998543


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                           ....++||||++||+|.+++.+.+     ..+++..+..++.||+.||+|||++   +||||||||+|||++.++
T Consensus       133 -----~~~~~lVmE~~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g  199 (412)
T 2vd5_A          133 -----ENYLYLVMEYYVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCG  199 (412)
T ss_dssp             -----SSEEEEEECCCCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             -----CCEEEEEEcCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCC
Confidence                 458999999999999999997643     3689999999999999999999999   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh-----------hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di~s~g~~~~~~f  914 (914)
                      ++||+|||+|+.......       ......+||+.|||||++.           +.++|+||+||++|||+
T Consensus       200 ~vkL~DFGla~~~~~~~~-------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell  264 (412)
T 2vd5_A          200 HIRLADFGSCLKLRADGT-------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF  264 (412)
T ss_dssp             CEEECCCTTCEECCTTSC-------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred             CEEEeechhheeccCCCc-------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence            999999999987543211       1122458999999999985           47899999999999973

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.6e-34  Score=312.79  Aligned_cols=189  Identities=23%  Similarity=0.327  Sum_probs=164.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++..     ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----EK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CC
Confidence            3468999999999999999999999999999999997543  2345678899999999999999999999643     44


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred             EEEEEEECCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence            789999999999999999765      3688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         .....+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       159 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  208 (328)
T 3fe3_A          159 GFSNEFTVGG---------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV  208 (328)
T ss_dssp             TCCGGGSSSC---------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH
T ss_pred             cCceecCCCC---------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH
Confidence            9998654321         123457999999999995     37899999999999873

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=317.52  Aligned_cols=190  Identities=23%  Similarity=0.296  Sum_probs=160.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|.++++.+ +||||+++++++.     .
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----T   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----C
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----e
Confidence            357899999999999999999999999999999999743   233456788999999988 6999999999954     3


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||++||+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++++||+
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEc
Confidence            45799999999999999999765      4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       167 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  218 (353)
T 3txo_A          167 DFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML  218 (353)
T ss_dssp             CCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHH
T ss_pred             cccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHH
Confidence            999998533211        1223468999999999984    58999999999999973

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-34  Score=308.72  Aligned_cols=198  Identities=22%  Similarity=0.373  Sum_probs=166.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|...+.||+|+||+||+|++..+++.||+|++...+....+.+.+|++++++++||||+++++++...     ...+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence            36899999999999999999999999999999998765666678899999999999999999999997543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.++++...     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence            9999999999999998643     4689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccc------CCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIAS------KTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~------~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +...........      ..........||+.|+|||++.    +.++||||+||++|||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  216 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII  216 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence            876543221100      0111122467999999999995    58899999999999873

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.5e-34  Score=318.13  Aligned_cols=189  Identities=21%  Similarity=0.275  Sum_probs=162.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...   ....+.+.+|..+++++ +||||+++++++.     ..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----EC
Confidence            468999999999999999999999999999999997542   33345688999999887 8999999999854     34


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||++||+|.+++.+.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence            5899999999999999999764      4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       197 FGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell  247 (396)
T 4dc2_A          197 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM  247 (396)
T ss_dssp             CTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             cceeeecccCC--------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence            99998532211        1223468999999999995    58999999999999973

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.7e-33  Score=304.86  Aligned_cols=289  Identities=21%  Similarity=0.298  Sum_probs=163.7

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      +++.++++++.++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            5778888888877 5666554  577788888888776555567777777777777777776666667777777777777


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccC-c
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSG-I  260 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~  260 (914)
                      +|+++ .+|..+.  ++|++|++++|.++                        +..+..|.++++|++|++++|.++. .
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~  161 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEIT------------------------KVRKSVFNGLNQMIVVELGTNPLKSSG  161 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCC------------------------BBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCccc------------------------ccCHhHhcCCccccEEECCCCcCCccC
Confidence            77666 4444332  34444444444444                        4334444444455555555554432 0


Q ss_pred             ccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcch
Q 042766          261 FPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDF  340 (914)
Q Consensus       261 ~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  340 (914)
                      .....+.++++|++|++++|+++. +|..+.  ++|++|+|++|++++..+..|..+++|++|++++|.+++..      
T Consensus       162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~------  232 (330)
T 1xku_A          162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD------  232 (330)
T ss_dssp             BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC------
T ss_pred             cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC------
Confidence            122334567778888888888773 455443  67777777777777766666666666666666666655432      


Q ss_pred             hhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcc
Q 042766          341 VIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISEL  420 (914)
Q Consensus       341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  420 (914)
                      +..+..+++|++|+|++|+++                          .+|..+..+++|++|++++|++++..+..|...
T Consensus       233 ~~~~~~l~~L~~L~L~~N~l~--------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~  286 (330)
T 1xku_A          233 NGSLANTPHLRELHLNNNKLV--------------------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP  286 (330)
T ss_dssp             TTTGGGSTTCCEEECCSSCCS--------------------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred             hhhccCCCCCCEEECCCCcCc--------------------------cCChhhccCCCcCEEECCCCcCCccChhhcCCc
Confidence            112344444444444444443                          233344445555555555555554444444322


Q ss_pred             ------cCCceeeeccccccc--ccCccccCCCCCCeEEeeCC
Q 042766          421 ------KNLQQLSVFNNFLRG--GIPSGLGNLTKLGSLDLGSN  455 (914)
Q Consensus       421 ------~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N  455 (914)
                            +.|+.|++++|.+..  ..|..|..+..++.++|++|
T Consensus       287 ~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC---
T ss_pred             ccccccccccceEeecCcccccccCccccccccceeEEEeccc
Confidence                  344444444444431  22334444444444444444

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=5.6e-37  Score=354.02  Aligned_cols=385  Identities=16%  Similarity=0.134  Sum_probs=196.8

Q ss_pred             ccceeecccCCCCCCCCc-cchhhhcccccccccccccC----CCCCccccccccceeeccCCcccCcccccccccCc--
Q 042766          198 AIEVIRITENSLGGKIPT-TLGLLRRLVNLNVAENQFSG----MFPRSICNISSVELIFLTENRFSGIFPFDILLNLP--  270 (914)
Q Consensus       198 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~--  270 (914)
                      +|++|+|++|+++..... .+..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..++..++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            344444444444322211 14445555555555555442    22344555556666666666655433333333444  


Q ss_pred             --ccceeeccCccCCC----CCCCccccccccccccccCccCCcccccccc-----ccccccceeccCCcCCCCCCCCcc
Q 042766          271 --NLKKLGIGGNNFVG----SIPDSLSNASNLELLDLPSNQFKGKVSIDFS-----SLKNLWLLNLEQNNLGTGTANDLD  339 (914)
Q Consensus       271 --~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~  339 (914)
                        +|++|+|++|+++.    .+|..+..+++|++|+|++|++++..+..+.     ..++|++|++++|.++.....  .
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--~  161 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE--P  161 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--H
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--H
Confidence              57777777777663    3466677777777777777777654443332     244677777777766543211  1


Q ss_pred             hhhcccCCCCCcEEeccccccCCCcCchhhcc----ccccEEEEeeccccccc----CCccccCCCCCcEEEcccCcccc
Q 042766          340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANL----SLKMIELSVGRNQISGT----IPPGIRNLVNLITFTLEVNQFHG  411 (914)
Q Consensus       340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  411 (914)
                      ++..+..+++|++|+|++|.+++..+..+...    ..+|++|++++|.+++.    ++..+..+++|++|++++|++++
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  241 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  241 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence            34445566777777777777654333333221    11344444444444432    23334444444444444444432


Q ss_pred             cCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCC----CCCccCCCCCccccccCCCccCCCCch
Q 042766          412 TIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGN----IPSSLGNCQNLILFIASYNKLTGDLPQ  487 (914)
Q Consensus       412 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~  487 (914)
                      .....+.                   +..+..+++|++|+|++|++++.    ++..+.++++|+.|++++|.+++..+.
T Consensus       242 ~~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          242 VGMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            2111110                   11112344444444444444432    333344444444444444444322222


Q ss_pred             hhhcc-----cchhhhhcccCCccCCC----ccccccccccceeecccCCccccccCccccc-----cccccEEEeeccc
Q 042766          488 QLLSI-----TTLSLVLDLSNNLLNGS----LPLQVGNLKNLVMLDISSNQFSGVIPVTLST-----CVSLEYLDISINS  553 (914)
Q Consensus       488 ~~~~~-----~~l~~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~  553 (914)
                      .+...     ..+ +.|++++|.+++.    ++..+..+++|++|||++|++++..+..+..     .++|++|+|++|.
T Consensus       303 ~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          303 LLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             HHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             HHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            22111     122 3444444444432    3445556677777777777777655554443     5677777777777


Q ss_pred             ccc----cCCcchhccCCCCEEEccCCccccccCcccc-----ccCCCCeEeCCCCcccc
Q 042766          554 FYG----VIPLSFRFLKSIKALNVSSNNLSGKIPEFLE-----NLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       554 l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~ls~N~l~~  604 (914)
                      +++    .+|..+..+++|++|++++|++++.....+.     ....|+.|++.+|.+..
T Consensus       382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence            775    6677777777777777777777654222221     12346666666666554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.4e-34  Score=316.17  Aligned_cols=188  Identities=23%  Similarity=0.355  Sum_probs=164.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|++++++++||||+++++++..     ..
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-----EE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence            36899999999999999999999999999999999643   23455788999999999999999999998643     44


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence            789999999999999999864      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         .....+||+.|||||++.       +.++|+||+||++|||+
T Consensus       160 G~a~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell  211 (384)
T 4fr4_A          160 NIAAMLPRET---------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL  211 (384)
T ss_dssp             TTCEECCTTC---------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH
T ss_pred             ceeeeccCCC---------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH
Confidence            9998654321         123467999999999983       57899999999999873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.4e-34  Score=312.02  Aligned_cols=192  Identities=22%  Similarity=0.319  Sum_probs=163.8

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      ....++|++.+.||+|+||.||+|+++.+++.||||+++...   ....+.+.+|.++++.+ +||||+++++++..   
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---   89 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---   89 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe---
Confidence            345678999999999999999999999999999999997432   34456788999999887 89999999998543   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                        ....++||||++||+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.+|.+|
T Consensus        90 --~~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           90 --KENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence              45799999999999999999764      3689999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+|+......        ......+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       159 L~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  212 (345)
T 1xjd_A          159 IADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML  212 (345)
T ss_dssp             ECCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             EeEChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHh
Confidence            99999998543211        1123468999999999984    58899999999999873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-33  Score=308.60  Aligned_cols=186  Identities=25%  Similarity=0.334  Sum_probs=163.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|+.+++.++||||+++++++..     ..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence            46899999999999999999999999999999999743   23445678899999999999999999998543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.+|.+||+||
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence            789999999999999999764      3688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           ....+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  197 (318)
T 1fot_A          151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML  197 (318)
T ss_dssp             SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred             CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHH
Confidence            999865321           12357999999999985    58899999999999873

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=2.5e-37  Score=357.02  Aligned_cols=362  Identities=16%  Similarity=0.134  Sum_probs=202.5

Q ss_pred             ceEEEecCCCCCccccCCC-CCCCCCCCEEEcCCCCCcc----cCCcccCCCCCCCeeecCCCCCCCcCCCCcc-ccC--
Q 042766           78 RLTELNLSSQRIGGVLSPY-VGNLSFLRYINLADNGFRG----DIPQEIGNLFRLEKLALSNNSFSGTIPTNLS-RCS--  149 (914)
Q Consensus        78 ~v~~l~l~~~~l~~~~~~~-l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~--  149 (914)
                      +++.|||+++.++...... +..+++|++|+|++|++++    .+|..+..+++|++|||++|.+++..+..+. .++  
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~   83 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   83 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence            4556666666554332222 4455556666666665553    2344455555566666655555433222222 122  


Q ss_pred             --CcchhccCCCcccC----CCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcc
Q 042766          150 --NLIHFCASNNKLEG----QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRL  223 (914)
Q Consensus       150 --~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  223 (914)
                        +|++|+|++|+++.    .+|..+..+++|++|+|++|.+++..+..+...                   .+...++|
T Consensus        84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-------------------l~~~~~~L  144 (461)
T 1z7x_W           84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG-------------------LLDPQCRL  144 (461)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH-------------------HTSTTCCC
T ss_pred             CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH-------------------HhcCCCcc
Confidence              35555555555542    234444455555555555555443222222110                   00012245


Q ss_pred             cccccccccccCCC----CCccccccccceeeccCCcccCcccccccc----cCcccceeeccCccCCCC----CCCccc
Q 042766          224 VNLNVAENQFSGMF----PRSICNISSVELIFLTENRFSGIFPFDILL----NLPNLKKLGIGGNNFVGS----IPDSLS  291 (914)
Q Consensus       224 ~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~----~l~~L~~L~Ls~N~l~~~----~p~~~~  291 (914)
                      ++|+|++|++++..    +..+..+++|++|++++|.+++..+..+..    ..++|++|+|++|++++.    ++..+.
T Consensus       145 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~  224 (461)
T 1z7x_W          145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA  224 (461)
T ss_dssp             CEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH
T ss_pred             eEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHH
Confidence            55555555554322    334444555666666666554332222211    244677777777776643    455666


Q ss_pred             cccccccccccCccCCccc-----cccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCc
Q 042766          292 NASNLELLDLPSNQFKGKV-----SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH  366 (914)
Q Consensus       292 ~l~~L~~L~Ls~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~  366 (914)
                      .+++|++|+|++|++++..     +..+..+++|++|++++|.++.....  .++..+..+++|++|+|++|.+++..+.
T Consensus       225 ~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG--DLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--HHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             hCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--HHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            6777777777777776533     22333567777777777776543111  1344556677888888888877654443


Q ss_pred             hhhcc----ccccEEEEeeccccccc----CCccccCCCCCcEEEcccCcccccCChhhhc-----ccCCceeeeccccc
Q 042766          367 SIANL----SLKMIELSVGRNQISGT----IPPGIRNLVNLITFTLEVNQFHGTIPDVISE-----LKNLQQLSVFNNFL  433 (914)
Q Consensus       367 ~~~~~----~~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l  433 (914)
                      .+...    ..+|++|++++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|++|+|++|.+
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            44332    23577777777777654    4556667778888888888877665555543     56788888888888


Q ss_pred             cc----ccCccccCCCCCCeEEeeCCcCCCC
Q 042766          434 RG----GIPSGLGNLTKLGSLDLGSNSLQGN  460 (914)
Q Consensus       434 ~~----~~p~~~~~l~~L~~L~Ls~N~l~~~  460 (914)
                      ++    .+|..+..+++|++|+|++|++++.
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~  413 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGDA  413 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence            75    6677777778888888888887643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-33  Score=325.68  Aligned_cols=200  Identities=23%  Similarity=0.336  Sum_probs=155.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  +....+++.+|++++++++||||+++++++.....+.....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6899999999999999999999999999999999643  23345688999999999999999999999876665666789


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+||||+ +++|.+++...      ..+++..+..++.||+.||+|||+.   +||||||||+|||++.++.+||+|||+
T Consensus       133 ~lv~e~~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEecc-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            9999998 57999999754      4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccccccccc-------------------CCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIAS-------------------KTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~-------------------~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      |+...........                   .........+||+.|||||++     ++.++||||+||++|||+
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            9876432211000                   000123456899999999986     358999999999999974

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-33  Score=305.69  Aligned_cols=199  Identities=23%  Similarity=0.319  Sum_probs=170.4

Q ss_pred             CccCHHHHHHHhhc----------ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCC
Q 042766          693 PMVSYAELSKATSE----------FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR  762 (914)
Q Consensus       693 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  762 (914)
                      +.++.+++..++..          |+..+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            44666777666643          67778999999999999999989999999999877666678899999999999999


Q ss_pred             CcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 042766          763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDL  842 (914)
Q Consensus       763 niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDl  842 (914)
                      ||+++++++...     ...++||||+++++|.+++..       ..+++.++..++.|++.||+|||+.   +|+||||
T Consensus       103 niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  167 (321)
T 2c30_A          103 NVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI  167 (321)
T ss_dssp             TBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             CcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence            999999997543     478999999999999999864       3589999999999999999999999   9999999


Q ss_pred             CCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          843 KPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       843 kp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+||+++.++.+||+|||+++.......        ......||+.|+|||++.    +.++|+||+||+++||+
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  235 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDVP--------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV  235 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSSC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCcc--------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999986543211        122457999999999994    57899999999999873

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-33  Score=310.39  Aligned_cols=189  Identities=21%  Similarity=0.280  Sum_probs=162.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|+++.+++.||+|+++...   ....+.+.+|+.+++++ +||||+++++++..     .
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~   82 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E   82 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence            358999999999999999999999999999999997543   22345688999999988 89999999998543     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++++||+|
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence            5889999999999999999764      3689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......        ......+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  204 (345)
T 3a8x_A          154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM  204 (345)
T ss_dssp             GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             ccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH
Confidence            99998532211        1223468999999999985    58899999999999873

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.8e-33  Score=307.05  Aligned_cols=206  Identities=24%  Similarity=0.388  Sum_probs=164.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-----
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-----  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  776 (914)
                      ..++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|++++++++||||+++++++.....     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3568999999999999999999999999999999997543 3455789999999999999999999998754321     


Q ss_pred             -----------------------------------------------CCCceEeEEEecccCCCHHHHHhccCCcccccC
Q 042766          777 -----------------------------------------------EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK  809 (914)
Q Consensus       777 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~  809 (914)
                                                                     ....+.++||||+++|+|.+++.....   ...
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~  160 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LED  160 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS---GGG
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC---ccc
Confidence                                                           112247999999999999999987543   234


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccccccc----CCCCcccccc
Q 042766          810 LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS----KTPSSSIGIK  885 (914)
Q Consensus       810 ~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~----~~~~~~~~~~  885 (914)
                      .++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+...........    ..........
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV  237 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence            57778899999999999999999   9999999999999999999999999999876543211100    0011223457


Q ss_pred             Ccccccccchhh----hhhcccCcccccccccC
Q 042766          886 GTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       886 GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+.|+|||++.    +.++|+||+||+++||+
T Consensus       238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (332)
T 3qd2_B          238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL  270 (332)
T ss_dssp             -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCcCccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence            999999999985    58999999999999873

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.6e-33  Score=310.57  Aligned_cols=188  Identities=25%  Similarity=0.320  Sum_probs=163.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG------ASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++..    
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----   86 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN----   86 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence            45799999999999999999999999999999999754321      34688999999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----  853 (914)
                       ....++||||++||+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++    
T Consensus        87 -~~~~~lv~e~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           87 -RTDVVLILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence             45789999999999999999754      4689999999999999999999999   999999999999998877    


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++......         .....+||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll  212 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  212 (361)
T ss_dssp             CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH
Confidence            79999999998764321         112357999999999984    57899999999999873

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-33  Score=311.03  Aligned_cols=190  Identities=21%  Similarity=0.260  Sum_probs=163.8

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|++.+.||+|+||.||+|+++.+++.||||+++..   .....+.+.+|..+++.+ +||+|+++++++.     .
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence            457899999999999999999999999999999999743   234556788999999988 7999999999854     3


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      .+..++||||++||+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence            45899999999999999999764      3689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  215 (353)
T 2i0e_A          164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML  215 (353)
T ss_dssp             CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred             eCCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHH
Confidence            999998532211        1223468999999999984    58999999999999973

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-33  Score=309.84  Aligned_cols=186  Identities=22%  Similarity=0.270  Sum_probs=163.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|+..+.||+|+||.||+|++..+++.||+|+++..   .....+.+.+|++++++++||||+++++++..     ..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence            36899999999999999999999999999999999643   23445688899999999999999999998543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence            789999999999999999764      3589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           ....+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  232 (350)
T 1rdq_E          186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA  232 (350)
T ss_dssp             TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHh
Confidence            999865321           12357999999999984    58999999999999873

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=6.1e-33  Score=303.38  Aligned_cols=188  Identities=19%  Similarity=0.275  Sum_probs=163.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+++++.++||||+++++++..     ....+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEE
Confidence            46899999999999999999999999999999998643 3345678899999999999999999999644     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC--CCcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY--DMVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~--~~~~ki~DFG  861 (914)
                      +||||+++|+|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||
T Consensus        78 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            9999999999999997643     4689999999999999999999999   9999999999999987  7899999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       150 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  197 (321)
T 1tki_A          150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL  197 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred             CCeECCCCC---------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence            998764321         122457999999999984    58999999999999873

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.98  E-value=3.9e-33  Score=301.30  Aligned_cols=189  Identities=27%  Similarity=0.396  Sum_probs=158.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++..     .+.
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~   85 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DDC   85 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SSE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CCe
Confidence            579999999999999999999999999999999864432   234678999999999999999999999543     457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEEEEeCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence            89999999999999999764      3689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......       .......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       157 ~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll  206 (294)
T 4eqm_A          157 IAKALSETSL-------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML  206 (294)
T ss_dssp             SSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred             Cccccccccc-------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence            9986543221       1122357999999999995    47899999999999873

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.98  E-value=3.6e-33  Score=305.61  Aligned_cols=191  Identities=23%  Similarity=0.325  Sum_probs=161.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++..     ....
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence            3689999999999999999999999999999999975432 334678899999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence            9999999999999988654      3689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+......      ......+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       152 a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  202 (323)
T 3tki_A          152 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML  202 (323)
T ss_dssp             CEECEETTEE------CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred             cceeccCCcc------cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH
Confidence            9865432211      1112457999999999984     46899999999999873

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.98  E-value=6.7e-33  Score=309.27  Aligned_cols=197  Identities=24%  Similarity=0.415  Sum_probs=162.7

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-------CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-------DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++|++.+.||+|+||.||+|++.       .++..||||+++... ....+.+.+|+++++++ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            368999999999999999999874       356789999997543 23456789999999999 89999999999643 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                          .+..++||||+++|+|.+++...+..          .....+++.+++.++.||+.||+|||++   +|+||||||
T Consensus       159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          159 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             ----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence                34689999999999999999865321          1124588999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||++.++.+||+|||+|+........      .......||+.|||||++.    +.++|||||||++|||+
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell  299 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF  299 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999866432211      1122346889999999984    58899999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.98  E-value=3.1e-33  Score=311.14  Aligned_cols=189  Identities=30%  Similarity=0.387  Sum_probs=153.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHH-HHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEA-LRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...   ....+.+.+|..+ ++.++||||+++++++..     .
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-----~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----A  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----S
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----C
Confidence            368999999999999999999999999999999997543   2234556677776 577899999999998543     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||++||+|.+++.+.      ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|++||+|
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence            5899999999999999999764      3688899999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       183 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  233 (373)
T 2r5t_A          183 FGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML  233 (373)
T ss_dssp             CCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence            99998533211        1223468999999999984    58899999999999973

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.98  E-value=5.8e-33  Score=316.53  Aligned_cols=201  Identities=22%  Similarity=0.305  Sum_probs=164.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+++.+|++++++++||||+++++++....+.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            36899999999999999999999999999999999643  2334568899999999999999999999987655545567


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ |+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG  174 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG  174 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEecCC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence            899999996 5999999764      4689999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccc--------------CCCCccccccCcccccccchh-----hhhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIAS--------------KTPSSSIGIKGTVGYVAPGKF-----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~--------------~~~~~~~~~~GT~~y~APE~~-----~~~~~Di~s~g~~~~~~f  914 (914)
                      +|+...........              .........+||+.|+|||++     ++.++||||+||++|||+
T Consensus       175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            99876543211000              000122456899999999987     468999999999999873

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.98  E-value=9.3e-33  Score=314.19  Aligned_cols=190  Identities=22%  Similarity=0.283  Sum_probs=162.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++.....  ...+.+.+|++++++++||||+++++++..     .
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~   82 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----E   82 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----S
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----C
Confidence            345789999999999999999999999999999999975432  334678999999999999999999999643     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec---CCCcEE
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAH  856 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~---~~~~~k  856 (914)
                      +..++||||++||+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++   .++.+|
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vk  153 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVK  153 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEE
Confidence            5889999999999999998765      4689999999999999999999999   999999999999998   467899


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+|||+|+......        ......+||+.|||||++.    +.++||||+||++|+|
T Consensus       154 L~DFG~a~~~~~~~--------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel  206 (444)
T 3soa_A          154 LADFGLAIEVEGEQ--------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL  206 (444)
T ss_dssp             ECCCSSCBCCCTTC--------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred             EccCceeEEecCCC--------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHH
Confidence            99999998654321        1122467999999999984    5899999999999987

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.98  E-value=1.3e-32  Score=301.55  Aligned_cols=188  Identities=23%  Similarity=0.313  Sum_probs=162.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....      ...+.+.+|++++++++||||+++++++..    
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   85 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN----   85 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            3579999999999999999999999999999999975432      135789999999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----  853 (914)
                       ....++||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        86 -~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~  155 (326)
T 2y0a_A           86 -KTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  155 (326)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred             -CCEEEEEEEcCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence             34789999999999999999754      4689999999999999999999999   999999999999999887    


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+|+......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       156 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  211 (326)
T 2y0a_A          156 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  211 (326)
T ss_dssp             CEEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence            89999999998754221         112357999999999985    47899999999999873

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=6.4e-33  Score=307.33  Aligned_cols=193  Identities=21%  Similarity=0.293  Sum_probs=162.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++...     ....+.+.+|++++++++||||+++++++..     
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-----   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence            357999999999999999999999999999999996421     2245789999999999999999999999654     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc---E
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV---A  855 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~---~  855 (914)
                      .+..++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.   +
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence            3478999999999999988764321  123589999999999999999999999   9999999999999987654   9


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+++.......        .....+||+.|+|||++.    +.++||||+||++|+|+
T Consensus       173 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  227 (351)
T 3c0i_A          173 KLGGFGVAIQLGESGL--------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL  227 (351)
T ss_dssp             EECCCTTCEECCTTSC--------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             EEecCcceeEecCCCe--------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH
Confidence            9999999987643221        112357999999999984    58899999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=8.1e-33  Score=302.23  Aligned_cols=194  Identities=24%  Similarity=0.422  Sum_probs=150.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++.     ..+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence            468999999999999999999999999999999997543 334578899999999999999999999954     34578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ |+|.+++...........+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999997 59999987543222234689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......        .......||+.|+|||++.     +.++||||+||++|||+
T Consensus       155 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  203 (317)
T 2pmi_A          155 ARAFGIPV--------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI  203 (317)
T ss_dssp             CEETTSCC--------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ceecCCCc--------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            98654221        1112357999999999984     47899999999999873

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.98  E-value=7.9e-33  Score=307.52  Aligned_cols=189  Identities=23%  Similarity=0.350  Sum_probs=162.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.....  ...+.+.+|++++++++||||+++++++..     ..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            35689999999999999999999999999999999975432  334678899999999999999999999643     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~ki  857 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+||+++.+   +.+||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            789999999999999998754      3689999999999999999999999   99999999999999865   45999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+......         .....+||+.|+|||++.    +.++||||+||++|+|+
T Consensus       173 ~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  224 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL  224 (362)
T ss_dssp             CCCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             eecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            9999998654321         112357999999999984    57999999999999873

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.98  E-value=7e-33  Score=321.11  Aligned_cols=190  Identities=23%  Similarity=0.349  Sum_probs=164.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|+..+.||+|+||.||+|+++.+++.||||++...   .......+.+|++++++++||||+++++++..     .+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----CC
Confidence            46799999999999999999999999999999999643   23445678899999999999999999998543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++...+.    ..+++..+..++.||+.||+|||++   +||||||||+|||++.+|.+||+||
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence            89999999999999999976532    4589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         .....+||+.|||||++.    +.++|+||+||++|||+
T Consensus       331 Gla~~~~~~~---------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl  379 (576)
T 2acx_A          331 GLAVHVPEGQ---------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI  379 (576)
T ss_dssp             TTCEECCTTC---------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH
T ss_pred             ccceecccCc---------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH
Confidence            9998654321         112357999999999984    58899999999999973

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=3.5e-33  Score=301.99  Aligned_cols=195  Identities=25%  Similarity=0.404  Sum_probs=161.0

Q ss_pred             hhcccccCcccCCccEEEEEEE----ECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGI----LGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|+    +..+++.||||++........+.+.+|++++++++||||+++++++...+   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            3689999999999999999999    45688999999997665556678999999999999999999999875322   2


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...+     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  157 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  157 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence            35789999999999999998653     4589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........     ........||+.|+|||++.    +.++||||+||+++||+
T Consensus       158 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  211 (295)
T 3ugc_A          158 FGLTKVLPQDKEF-----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF  211 (295)
T ss_dssp             CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcccccccCCcce-----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHH
Confidence            9999876432211     11122345888999999985    58999999999999873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.98  E-value=6.8e-33  Score=303.80  Aligned_cols=193  Identities=27%  Similarity=0.441  Sum_probs=159.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC---cEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|++..+   +..||||+++.. .....+.+.+|++++++++||||+++++++.     ..
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            35789999999999999999999754   456999999754 2334568999999999999999999999964     34


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D  194 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD  194 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence            47899999999999999997543     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........     ........||+.|+|||++.    +.++||||+||++|||+
T Consensus       195 fg~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  248 (325)
T 3kul_A          195 FGLSRVLEDDPDA-----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL  248 (325)
T ss_dssp             CSSCEECC----C-----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccccccCccc-----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            9999876543211     11122345788999999995    48999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.98  E-value=1.5e-32  Score=296.55  Aligned_cols=188  Identities=23%  Similarity=0.394  Sum_probs=160.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            57999999999999999999999999999999997543  2334688899999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++ ++.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCC-CHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999975 6666665432     4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+......        .......||+.|+|||++.     +.++||||+||++++|+
T Consensus       148 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  196 (292)
T 3o0g_A          148 ARAFGIPV--------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA  196 (292)
T ss_dssp             CEECCSCC--------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred             ceecCCcc--------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHH
Confidence            98654221        1122357999999999984     57899999999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.98  E-value=7.5e-33  Score=303.63  Aligned_cols=187  Identities=25%  Similarity=0.373  Sum_probs=161.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+++++.++||||+++++++..     ..
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-----PT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence            36899999999999999999999999999999999643   23344688999999999999999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +|+|.+++...      ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EEEEEEECC-CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence            789999999 78999988754      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......         .....+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       153 G~s~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  202 (336)
T 3h4j_B          153 GLSNIMTDGN---------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML  202 (336)
T ss_dssp             SCTBTTTTSB---------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH
T ss_pred             ccceeccCCc---------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHH
Confidence            9998654321         112357999999999984     47899999999999873

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=1e-32  Score=308.46  Aligned_cols=189  Identities=21%  Similarity=0.296  Sum_probs=163.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..........+.+|++++++++||||+++++++..     ....+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence            3579999999999999999999999999999999976554455688999999999999999999999643     45789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC--CCcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY--DMVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~--~~~~ki~DFG  861 (914)
                      +||||+++|+|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.  ++.+||+|||
T Consensus       125 lv~E~~~gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence            9999999999999997543     4689999999999999999999999   9999999999999974  4789999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+......         ......||+.|+|||++.    +.++||||+||++|||+
T Consensus       197 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  244 (387)
T 1kob_A          197 LATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL  244 (387)
T ss_dssp             TCEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred             cceecCCCc---------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence            998754321         112347999999999994    58999999999999873

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=8.4e-33  Score=299.43  Aligned_cols=190  Identities=24%  Similarity=0.364  Sum_probs=157.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--------------------------cchHHHHHHHHHHH
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--------------------------GASKSFVSECEALR  757 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  757 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999999999999999964321                          12356889999999


Q ss_pred             hcCCCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042766          758 NIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPM  837 (914)
Q Consensus       758 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~i  837 (914)
                      +++||||+++++++...   .....++||||+++++|.+++..       ..+++.++..++.|++.||+|||++   +|
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i  158 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHYQ---KI  158 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            99999999999997542   23578999999999999876432       4689999999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccc
Q 042766          838 VHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTN  910 (914)
Q Consensus       838 vHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~  910 (914)
                      +||||||+||+++.++.+||+|||+++.......        ......||+.|+|||++.       +.++|+||+||++
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCccccccccc--------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence            9999999999999999999999999987543211        112357999999999984       4678999999999


Q ss_pred             cccC
Q 042766          911 VHHF  914 (914)
Q Consensus       911 ~~~f  914 (914)
                      |+|+
T Consensus       231 ~~l~  234 (298)
T 2zv2_A          231 YCFV  234 (298)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=4.6e-33  Score=304.93  Aligned_cols=199  Identities=34%  Similarity=0.550  Sum_probs=167.6

Q ss_pred             HHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       699 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++....++|+..+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++.     .
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  106 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----E  106 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----C
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C
Confidence            33446679999999999999999999975 68899999987666666788999999999999999999999954     3


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      .+..++||||+++|+|.+++.....  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence            4478999999999999999875432  124689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++.......      ........||+.|+|||++.    +.++||||+||++|||+
T Consensus       182 Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell  235 (321)
T 2qkw_B          182 DFGISKKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL  235 (321)
T ss_dssp             CCTTCEECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH
T ss_pred             ecccccccccccc------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH
Confidence            9999986432211      11122356999999999984    58899999999999873

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.97  E-value=3.1e-32  Score=296.53  Aligned_cols=195  Identities=27%  Similarity=0.429  Sum_probs=162.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-----CcchHHHHHHHHHHHhcC---CCCcceEEeEeecC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-----KGASKSFVSECEALRNIR---HRNLIKIITICSST  774 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  774 (914)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4578999999999999999999999999999999997432     223457788888887775   99999999998765


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                      ........++||||++ |+|.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            5444446899999996 699999986542    3489999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+......         ......||+.|+|||++.    +.++||||+||++|+|+
T Consensus       159 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~  213 (308)
T 3g33_A          159 VKLADFGLARIYSYQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF  213 (308)
T ss_dssp             EEECSCSCTTTSTTCC---------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT
T ss_pred             EEEeeCccccccCCCc---------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH
Confidence            9999999998653221         123457999999999994    58899999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=1e-32  Score=302.92  Aligned_cols=207  Identities=34%  Similarity=0.598  Sum_probs=173.6

Q ss_pred             CccCHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEe
Q 042766          693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITIC  771 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~  771 (914)
                      ..++..++....++|+..+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45788899999999999999999999999999865 68899999997543 22334789999999999999999999996


Q ss_pred             ecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC
Q 042766          772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY  851 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~  851 (914)
                      ..     ....++||||+++|+|.+++.....  ....+++..+..++.|++.||+|||+++.++|+||||||+||+++.
T Consensus        97 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           97 MT-----PTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             CC-----SSCCEEEEECCTTCBHHHHHHCCST--TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             ec-----CCceEEEEEeccCCCHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            54     3467899999999999999986542  2245899999999999999999999987778999999999999999


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+||+|||+|+.......       .......||+.|+|||++.    +.++||||+||++|+|+
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  229 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI  229 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH
T ss_pred             CCCEEeccCccccccCcccc-------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH
Confidence            99999999999987643221       1122356999999999984    58999999999999873

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=6.5e-33  Score=302.21  Aligned_cols=196  Identities=19%  Similarity=0.341  Sum_probs=157.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++....   .....+.+|++++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            3579999999999999999999999999999999975432   23457889999999999999999999875433 1223


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             ccEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence            458999999999999999754      3689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.+......     ........||+.|+|||++.    +.++||||+||++|+|+
T Consensus       161 g~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll  213 (311)
T 3ork_A          161 GIARAIADSGNS-----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL  213 (311)
T ss_dssp             SCC-----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cCcccccccccc-----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence            999876432211     11222457999999999985    47899999999999873

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.1e-32  Score=302.45  Aligned_cols=189  Identities=20%  Similarity=0.276  Sum_probs=152.8

Q ss_pred             hhcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ----KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++.   .+++.||+|+++...    ......+.+|++++++++||||+++++++..   
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT---   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence            468999999999999999999985   688999999997432    2334567899999999999999999999644   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                        .+..++||||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           93 --GGKLYLILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             --SSCEEEEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             --CCEEEEEEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence              34789999999999999999764      3588899999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+++......        ......+||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       162 l~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  215 (327)
T 3a62_A          162 LTDFGLCKESIHDG--------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML  215 (327)
T ss_dssp             ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred             EEeCCcccccccCC--------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHH
Confidence            99999997543211        1122457999999999984    58899999999999874

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.1e-32  Score=302.47  Aligned_cols=287  Identities=16%  Similarity=0.185  Sum_probs=234.0

Q ss_pred             CCCCCCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCC
Q 042766           58 WNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF  137 (914)
Q Consensus        58 w~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  137 (914)
                      |.....+|.|.|+ |+.          ++++++ .+|..+.  ++|++|+|++|++++..+..++++++|++|+|++|++
T Consensus        23 ~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   88 (353)
T 2z80_A           23 SNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI   88 (353)
T ss_dssp             ----CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             CCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCcc
Confidence            5445678999988 753          455554 4566554  5899999999999977777899999999999999999


Q ss_pred             CCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCC-cccccccccceeecccC-CCCCCCCc
Q 042766          138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP-DSVGNLSAIEVIRITEN-SLGGKIPT  215 (914)
Q Consensus       138 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~  215 (914)
                      ++..|..++++++|++|+|++|++++..+..|+++++|++|+|++|++++..+ ..+.++++|++|++++| .+++..|.
T Consensus        89 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  168 (353)
T 2z80_A           89 NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK  168 (353)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT
T ss_pred             CccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHH
Confidence            98888899999999999999999996555569999999999999999995433 47999999999999999 57777788


Q ss_pred             cchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccc---c
Q 042766          216 TLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLS---N  292 (914)
Q Consensus       216 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~  292 (914)
                      .|+++++|++|++++|++++..|..|..+++|++|++++|.++ .+|...+..+++|++|+|++|++++..+..+.   .
T Consensus       169 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~  247 (353)
T 2z80_A          169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET  247 (353)
T ss_dssp             TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred             HccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccccc
Confidence            9999999999999999999999999999999999999999996 45666666799999999999999976655443   3


Q ss_pred             ccccccccccCccCCc----cccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcC
Q 042766          293 ASNLELLDLPSNQFKG----KVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELP  365 (914)
Q Consensus       293 l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p  365 (914)
                      .+.++.++|++|.+++    .+|..+..+++|++|++++|+++.++..      .+..+++|++|+|++|++.+..|
T Consensus       248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~------~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG------IFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHH------HHhcCCCCCEEEeeCCCccCcCC
Confidence            5667777888887765    3456677888888888888888765332      24677888888888888876554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=1.7e-32  Score=317.37  Aligned_cols=193  Identities=22%  Similarity=0.329  Sum_probs=165.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|...+.||+|+||+||+|+++.+++.||+|++....   ....+.+.+|++++++++||||+++++++..     ..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence            367999999999999999999999999999999996432   3345678999999999999999999998543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++||+|.+++.....  ....+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+||
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDE--DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSST--TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhc--ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence            78999999999999999976431  124689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+.....        .....+||+.|||||++.    +.++|+||+||++|||+
T Consensus       334 Gla~~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell  383 (543)
T 3c4z_A          334 GLAVELKAGQT--------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI  383 (543)
T ss_dssp             TTCEECCTTCC--------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             ceeeeccCCCc--------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH
Confidence            99987543211        122358999999999994    58899999999999973

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=3e-32  Score=298.17  Aligned_cols=192  Identities=25%  Similarity=0.370  Sum_probs=163.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++....   ....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence            57999999999999999999999999999999997433 334577889999999999999999999875432   34679


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee----cCCCcEEEec
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGD  859 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl----~~~~~~ki~D  859 (914)
                      +||||+++++|.+++.....   ...+++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        86 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence            99999999999999986531   23489999999999999999999999   99999999999999    7788899999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......         ......||+.|+|||++.            +.++||||+||+++||+
T Consensus       160 fg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~  217 (319)
T 4euu_A          160 FGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA  217 (319)
T ss_dssp             CTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred             CCCceecCCCC---------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence            99998764321         112357999999999875            36899999999999873

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=2.7e-32  Score=307.28  Aligned_cols=198  Identities=18%  Similarity=0.157  Sum_probs=165.7

Q ss_pred             hhcccccCcccCC--ccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQG--RFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|  +||.||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++..     .
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----D   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-----C
Confidence            4689999999999  99999999999999999999997543  2334678899999999999999999999654     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++.....    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d  171 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG  171 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence            478999999999999999976532    4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ||.+........... ..........||+.|+|||++.      +.++||||+||++|||+
T Consensus       172 fg~~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~  231 (389)
T 3gni_B          172 LRSNLSMISHGQRQR-VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA  231 (389)
T ss_dssp             GGGCEECEETTEECS-CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred             cccceeecccccccc-ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence            999876543221111 1111223357999999999984      47899999999999873

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=1.9e-32  Score=301.30  Aligned_cols=193  Identities=22%  Similarity=0.319  Sum_probs=162.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++++ +||||+++++++..     ....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~   81 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNA   81 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccE
Confidence            579999999999999999999999999999999864432  34688999999999 99999999998654     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc-----EEEe
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV-----AHVG  858 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~ki~  858 (914)
                      +||||+ +++|.+++...+     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.     +||+
T Consensus        82 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EEEEeC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            999999 999999998643     4789999999999999999999999   9999999999999998887     9999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+....... ...........||+.|+|||++.    +.++|+|||||++|||+
T Consensus       153 DFg~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell  211 (330)
T 2izr_A          153 DFALAKEYIDPETKK-HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL  211 (330)
T ss_dssp             CCTTCEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             EcccceeeecCCCCc-cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh
Confidence            999998765432111 11111233568999999999995    57999999999999873

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.9e-32  Score=305.63  Aligned_cols=186  Identities=24%  Similarity=0.327  Sum_probs=155.2

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +...+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++..     ....++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----KNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEEEE
Confidence            3346789999999999999999999999999986655566789999999999999999999999654     34789999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee--cCCCcEEEecccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL--DYDMVAHVGDFGLAK  864 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl--~~~~~~ki~DFGla~  864 (914)
                      ||+++|+|.+++....     ..+++.++..++.|++.||+|||+.   +|+||||||+|||+  +.++.+||+|||+++
T Consensus       166 E~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          166 EYVDGGELFDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             ECCTTCEEHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             eCCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            9999999999887543     4689999999999999999999999   99999999999999  567899999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+....         ......||+.|+|||++.    +.++|+||+||+++||+
T Consensus       238 ~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  282 (373)
T 2x4f_A          238 RYKPRE---------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL  282 (373)
T ss_dssp             ECCTTC---------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCcc---------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence            764321         112346999999999984    47899999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.6e-32  Score=300.52  Aligned_cols=194  Identities=27%  Similarity=0.347  Sum_probs=160.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++... .......+|+.++++++||||+++++++.... ......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            468999999999999999999986  7899999996433 23445677999999999999999999976543 1234579


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCcEecCCCCCCeeecCCCcEE
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH-------CQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~-------~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      +||||+++|+|.++++..       .+++..++.++.|++.||+|||+.       +.++|+||||||+||+++.++.+|
T Consensus        99 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            999999999999999753       589999999999999999999975       134899999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhhh---------hhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM---------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~---------~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+|+.......      ........||+.|+|||++.+         .++|||||||++|||+
T Consensus       172 L~DFg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~  232 (322)
T 3soc_A          172 IADFGLALKFEAGKS------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA  232 (322)
T ss_dssp             ECCCTTCEEECTTSC------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EccCCcccccccccC------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence            999999987654321      111223579999999999753         5779999999999873

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=7.9e-33  Score=309.78  Aligned_cols=192  Identities=23%  Similarity=0.382  Sum_probs=161.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||||+++... ....+++.+|++++++++||||+++++++..     ....
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CCCc
Confidence            358899999999999999999999899999999986432 2233578899999999999999999999643     3467


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...+     ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence            99999999999999997543     4688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+...+......      .....+|+.|+|||++.    +.++|||||||+++||+
T Consensus       260 s~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~  309 (377)
T 3cbl_A          260 SREEADGVYAAS------GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF  309 (377)
T ss_dssp             CEECTTSEEECC------SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ceecCCCceeec------CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence            986543221110      11224678899999985    58999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=3.5e-32  Score=294.98  Aligned_cols=191  Identities=26%  Similarity=0.383  Sum_probs=157.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++  +++.||||++...   ..+.+.+|.+++..  ++||||+++++++.... .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence            46899999999999999999998  5889999998643   34566677777766  79999999999875432 33456


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCCeeecCCC
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH--------HHCQPPMVHGDLKPSNVLLDYDM  853 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH--------~~~~~~ivHrDlkp~NILl~~~~  853 (914)
                      .++||||+++|+|.++++.       ..+++..++.++.|++.|++|||        +.   +|+||||||+||+++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred             eEEehhhccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence            8999999999999999964       35899999999999999999999        76   999999999999999999


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhhh----------hhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM----------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~----------~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+|+..........    .......||+.|+|||++.+          .++||||+||+++||+
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~  217 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLD----VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA  217 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEE----CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CEEEeeCCCeeeccccccccc----ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence            999999999986544321110    11123479999999999853          5899999999999873

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=2.3e-32  Score=297.23  Aligned_cols=195  Identities=28%  Similarity=0.418  Sum_probs=154.3

Q ss_pred             HHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       699 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ++.....+|++.+.||+|+||+||+|++  +++.||||++.....  ...+.+.+|++++++++||||+++++++..   
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  105 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ---  105 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE---
Confidence            3334457899999999999999999988  478899999865432  334678999999999999999999999643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeecCCCc
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~~~~~  854 (914)
                        ....++||||+++|+|.+++.....   ...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.
T Consensus       106 --~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          106 --PPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred             --CCceEEEEecCCCCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence              3468999999999999999986431   23589999999999999999999998   7  999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+++......        .......||+.|+|||++.    +.++||||+||++|+|+
T Consensus       178 ~kL~Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  233 (309)
T 3p86_A          178 VKVCDFGLSRLKASTF--------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA  233 (309)
T ss_dssp             EEECCCC-------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             EEECCCCCCccccccc--------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence            9999999998543221        1122457999999999995    47999999999999873

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=9.7e-33  Score=316.33  Aligned_cols=189  Identities=25%  Similarity=0.289  Sum_probs=153.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++..   .......+.+|++++++++||||+++++++...     +
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----D  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----T
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----C
Confidence            46899999999999999999999999999999999743   333446778999999999999999999996543     4


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ..++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred             EEEEEEeeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence            789999999999999999764      468999999999999999999998 7   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       293 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  343 (446)
T 4ejn_A          293 FGLCKEGIKDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM  343 (446)
T ss_dssp             CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCceeccCCC--------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh
Confidence            99998543221        1122467999999999995    58999999999999873

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=1.2e-32  Score=307.34  Aligned_cols=194  Identities=15%  Similarity=0.182  Sum_probs=159.1

Q ss_pred             HhhcccccCcccCCccEEEEEEE-----ECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC---CCCcceEEeEeecC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGI-----LGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR---HRNLIKIITICSST  774 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  774 (914)
                      ..++|.+.+.||+|+||+||+|+     +..+++.||||+++..   ....+.+|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34689999999999999999994     5667889999998643   4467888888888887   99999999996543


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---  851 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---  851 (914)
                           +..++||||+++|+|.+++...+.. ....+++.+++.|+.|++.||+|||++   +||||||||+|||++.   
T Consensus       140 -----~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          140 -----NGSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             -----SCEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred             -----CCcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence                 3679999999999999999753211 125699999999999999999999999   9999999999999998   


Q ss_pred             --------CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          852 --------DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       852 --------~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                              ++.+||+|||+|+.+.....      .......+||+.|||||++.    +.++||||+||++|||+
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  279 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML  279 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred             CccccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence                    89999999999976542111      11223467999999999994    58999999999999873

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=2.9e-32  Score=303.07  Aligned_cols=187  Identities=24%  Similarity=0.294  Sum_probs=153.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++||||+++++++..     ....+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEEE
Confidence            468999999999999999999999999999999997433 334678899999999999999999999654     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc--EEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV--AHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~--~ki~DFG  861 (914)
                      +||||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.  +||+|||
T Consensus        93 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             EEEEeCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence            999999999999999754      3689999999999999999999999   9999999999999987765  9999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+......         ......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       164 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  212 (361)
T 3uc3_A          164 YSKSSVLHS---------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML  212 (361)
T ss_dssp             CC------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccC---------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH
Confidence            997432211         112357999999999985     34589999999999873

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=1.5e-32  Score=305.85  Aligned_cols=207  Identities=21%  Similarity=0.328  Sum_probs=167.9

Q ss_pred             cCHHHHHHHhhcccccCcccCCccEEEEEEE-----ECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceE
Q 042766          695 VSYAELSKATSEFSSSNMIGQGRFGTVYKGI-----LGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKI  767 (914)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l  767 (914)
                      +...++....++|++.+.||+|+||.||+|+     ...+++.||||+++... ....+.+.+|+++++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3445555667899999999999999999999     55677999999997543 23346799999999999 79999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcc------------------------------------------
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV------------------------------------------  805 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------  805 (914)
                      ++++...    ....++||||+++|+|.+++.......                                          
T Consensus        92 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           92 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             EEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            9997543    245789999999999999998653210                                          


Q ss_pred             ------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccc
Q 042766          806 ------------------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLS  867 (914)
Q Consensus       806 ------------------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~  867 (914)
                                        ....+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                              012289999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          868 NHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       868 ~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .....      .......||+.|||||++.    +.++||||+||++|||+
T Consensus       245 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  289 (359)
T 3vhe_A          245 KDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  289 (359)
T ss_dssp             SCTTC------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccccc------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHH
Confidence            32211      1122456899999999984    58999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=6e-32  Score=295.39  Aligned_cols=195  Identities=24%  Similarity=0.303  Sum_probs=157.5

Q ss_pred             hccccc-CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSS-NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +.|++. +.||+|+||.||+|++..+++.||||+++.......+.+.+|+++++++ +||||+++++++..     .+..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCEE
Confidence            467774 7899999999999999989999999999866666678899999999985 79999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc---EEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV---AHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~---~ki~D  859 (914)
                      ++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.   +||+|
T Consensus        87 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             EEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence            9999999999999999764      3688999999999999999999999   9999999999999998775   99999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........... ........+||+.|+|||++.         +.++||||+||++|||+
T Consensus       158 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~  220 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL  220 (316)
T ss_dssp             TTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred             ccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence            9999865432111000 111122456999999999874         47899999999999873

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=3.6e-32  Score=296.19  Aligned_cols=188  Identities=27%  Similarity=0.411  Sum_probs=157.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||+||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.     ....
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCE
Confidence            468999999999999999999996 58899999996443  233467889999999999999999999954     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++ ++.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEcCCCC-CHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence            8999999974 8888887643     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+......        .......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       165 ~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  214 (311)
T 3niz_A          165 LARAFGIPV--------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI  214 (311)
T ss_dssp             TCEETTSCC--------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             CceecCCCc--------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHH
Confidence            998654221        1122357899999999984     47899999999999873

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=4.6e-32  Score=289.01  Aligned_cols=189  Identities=29%  Similarity=0.470  Sum_probs=161.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ...+++.+|++++++++||||+++++++..     ....+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCceE
Confidence            368999999999999999999997 46779999997433 345789999999999999999999999643     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....     ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        82 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEEeCCCCcHHHHHHhcC-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence            9999999999999997643     4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       154 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll  201 (269)
T 4hcu_A          154 RFVLDDQYT-------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF  201 (269)
T ss_dssp             GGBCCHHHH-------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccc-------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHh
Confidence            866443211       112345788999999995    58999999999999873

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=7e-32  Score=288.87  Aligned_cols=189  Identities=25%  Similarity=0.258  Sum_probs=165.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++..     ....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   81 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDI   81 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeE
Confidence            34689999999999999999999999999999999986666667889999999999999999999999653     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~D  859 (914)
                      ++||||+++++|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||++   +.++.+||+|
T Consensus        82 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            9999999999999998764      4689999999999999999999999   99999999999999   7889999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++......         ......||+.|+|||++.   +.++|+||+||++++|+
T Consensus       153 fg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~  201 (277)
T 3f3z_A          153 FGLAARFKPGK---------MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLL  201 (277)
T ss_dssp             CTTCEECCTTS---------CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHH
T ss_pred             cccceeccCcc---------chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHH
Confidence            99998654321         112356999999999985   58999999999999873

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=2.9e-32  Score=312.69  Aligned_cols=190  Identities=23%  Similarity=0.287  Sum_probs=156.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  .....+++.+|+++++.++||||+++++++.... .+...
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46899999999999999999999999999999999743  3344568889999999999999999999976443 23445


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++ ++.+.+.        ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence            78999999975 5777664        2478899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         .....+||+.|+|||++.    +.++||||+||++|||+
T Consensus       209 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  257 (464)
T 3ttj_A          209 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  257 (464)
T ss_dssp             CCC-----CC---------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             EeeeecCCCc---------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence            9998654321         122467999999999995    48999999999999873

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.4e-32  Score=306.41  Aligned_cols=197  Identities=23%  Similarity=0.391  Sum_probs=160.1

Q ss_pred             hhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||+||+|++     ..+++.||||+++.. .......+.+|+.++++++||||+++++++..    
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            35799999999999999999995     456789999998643 23344578899999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCc-ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC---
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQ-VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM---  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~---  853 (914)
                       ....++||||+++|+|.+++...+.. .....+++.+++.++.|++.||+|||++   +|+||||||+|||++.++   
T Consensus       146 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          146 -SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence             34679999999999999999865321 1224689999999999999999999999   999999999999999555   


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+|+........      .......||+.|||||++.    +.++|||||||+++||+
T Consensus       222 ~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell  280 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF  280 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSC------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eEEECCCcccccccccccc------ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            5999999999865432211      1122356899999999984    58999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=3.5e-32  Score=306.14  Aligned_cols=199  Identities=24%  Similarity=0.357  Sum_probs=154.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEG  778 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  778 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||||++...  .....+++.+|+.+++++. ||||+++++++...   .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence            3457899999999999999999999999999999998533  2334567889999999997 99999999997542   2


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||++ ++|.+++..       ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCEEEEEecccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence            346899999997 599999875       3588899999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccc-------------cCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIA-------------SKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~-------------~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+........             ..........+||+.|+|||++.     +.++||||+||+++||+
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            9999987643111000             00111223468999999999984     47899999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=4.9e-32  Score=298.85  Aligned_cols=199  Identities=29%  Similarity=0.451  Sum_probs=157.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHH--HHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA--LRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++  +++.||||++....   ...+..|.++  ++.++||||+++++++.....++...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999987  57899999996432   2344445554  44589999999998766555556667


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEecCCCCCCeeecCCCcE
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC------QPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~------~~~ivHrDlkp~NILl~~~~~~  855 (914)
                      .++||||+++|+|.+++...       ..++..+..++.|++.||+|||+.+      .++|+||||||+|||++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            89999999999999999754       3588899999999999999999863      3389999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhhh-----------hhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-----------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----------~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+|+.+...................||+.|+|||++.+           .++|||||||++|||+
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell  229 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF  229 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence            9999999987654322111111222334579999999999853           6899999999999873

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=3.2e-32  Score=311.72  Aligned_cols=188  Identities=28%  Similarity=0.391  Sum_probs=163.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|.+.+.||+|+||.||+|++..+|+.||||+++...   ....+.+.+|+++++.++||||+++++++..     ..
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-----~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-----PS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence            357999999999999999999999999999999996432   2345688999999999999999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence            789999999999999999754      3689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         .....+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       161 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  210 (476)
T 2y94_A          161 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL  210 (476)
T ss_dssp             SSCEECCTTC---------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred             cchhhccccc---------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHh
Confidence            9998754321         112357999999999985     47899999999999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=1.9e-32  Score=295.22  Aligned_cols=186  Identities=22%  Similarity=0.383  Sum_probs=161.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc-------EEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE-------MVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++..++       ..||+|+++.......+.+.+|++++++++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            358999999999999999999987655       5799999976666677889999999999999999999999654   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc--
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV--  854 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~--  854 (914)
                        .+..++||||+++|+|.+++...+     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.  
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  153 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK  153 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence              346789999999999999998653     3589999999999999999999999   9999999999999998887  


Q ss_pred             ------EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 ------AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ------~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                            +||+|||+++.....            ....||+.|+|||++.     +.++||||+||+++||+
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  212 (289)
T 4fvq_A          154 TGNPPFIKLSDPGISITVLPK------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC  212 (289)
T ss_dssp             GTBCCEEEECCCCSCTTTSCH------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred             ccccceeeeccCcccccccCc------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence                  999999999754321            1245899999999884     47899999999999873

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=3.8e-32  Score=300.70  Aligned_cols=186  Identities=26%  Similarity=0.337  Sum_probs=146.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++..     ....+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~  124 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PTEIS  124 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-----CCeEE
Confidence            467999999999999999999999999999999997432  34678899999999999999999999654     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEecc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDF  860 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~DF  860 (914)
                      +||||+++|+|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+||
T Consensus       125 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df  195 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEK------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF  195 (349)
T ss_dssp             EEECCCCSCBHHHHHTTC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence            999999999999999764      3589999999999999999999999   9999999999999975   889999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......         ......||+.|+|||++.    +.++||||+||++|||+
T Consensus       196 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  244 (349)
T 2w4o_A          196 GLSKIVEHQV---------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL  244 (349)
T ss_dssp             C-------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccCccc---------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence            9998654321         112357999999999985    57999999999999873

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=6.6e-32  Score=297.46  Aligned_cols=186  Identities=26%  Similarity=0.325  Sum_probs=157.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCce
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++....    ...+|++++.++ +||||+++++++.     ....
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~   90 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKY   90 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCE
Confidence            45689999999999999999999999999999999975433    235688888888 7999999999954     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC----CcEEE
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD----MVAHV  857 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~----~~~ki  857 (914)
                      .++||||++||+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+||++..+    +.+||
T Consensus        91 ~~lv~E~~~gg~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           91 VYVVTELMKGGELLDKILRQ------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EEEEECCCCSCBHHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEEEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence            89999999999999999765      3689999999999999999999999   99999999999998543    35999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+.......        .....+||+.|+|||++.    +.++|+||+||++|||+
T Consensus       162 ~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  214 (342)
T 2qr7_A          162 CDFGFAKQLRAENG--------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML  214 (342)
T ss_dssp             CCCTTCEECBCTTC--------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EECCCcccCcCCCC--------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh
Confidence            99999986543211        122357999999999984    58999999999999873

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.9e-32  Score=305.82  Aligned_cols=191  Identities=26%  Similarity=0.469  Sum_probs=150.1

Q ss_pred             hcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||.||+|++.   .++..||||+++... ....+++.+|++++++++||||+++++++..     ..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-----SK  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence            57999999999999999999986   467789999997543 3345689999999999999999999999643     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...+     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  191 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDF  191 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             ceEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcC
Confidence            6899999999999999997653     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+++........     ........+|+.|+|||++.    +.++|||||||+++|+
T Consensus       192 g~a~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~el  243 (373)
T 2qol_A          192 GLGRVLEDDPEA-----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV  243 (373)
T ss_dssp             ---------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccCCcc-----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHH
Confidence            999876532211     01112234678999999995    5889999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=5.1e-32  Score=299.27  Aligned_cols=184  Identities=28%  Similarity=0.376  Sum_probs=158.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +.|+..+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|++++++++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            468999999999999999999999999999999975432   2235788999999999999999999996543     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ |++.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEecCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence            899999997 68888886433     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +++.....            ....||+.|+|||++.       +.++|||||||+++||+
T Consensus       200 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell  247 (348)
T 1u5q_A          200 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  247 (348)
T ss_dssp             TCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred             CceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence            99765321            1357999999999983       47899999999999873

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=6.1e-32  Score=294.39  Aligned_cols=187  Identities=22%  Similarity=0.236  Sum_probs=155.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|+..+.||+|+||+||+|++..+++.||||++.....  .......+|+..+.++ +||||+++++++..     ..
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CC
Confidence            3689999999999999999999999999999999864332  2334555666666555 89999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +++|.+++...+     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             EEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            789999999 779999887653     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---hhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~  913 (914)
                      |+|+......         ......||+.|+|||++.   +.++||||+||+++||
T Consensus       202 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el  248 (311)
T 3p1a_A          202 GLLVELGTAG---------AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEV  248 (311)
T ss_dssp             TTCEECC---------------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHH
T ss_pred             eeeeecccCC---------CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHH
Confidence            9998654321         112346999999999985   5899999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=3.3e-32  Score=299.42  Aligned_cols=190  Identities=24%  Similarity=0.351  Sum_probs=162.8

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--------cchHHHHHHHHHHHhcCCCCcceEEeEeec
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--------GASKSFVSECEALRNIRHRNLIKIITICSS  773 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  773 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++....        ...+.+.+|++++++++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            345789999999999999999999999999999999975431        123467789999999999999999999643


Q ss_pred             CCCCCCceEeEEEecccCC-CHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          774 TDFEGVDFKALVFEYMENG-SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                           ....++||||+.+| +|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||+++.+
T Consensus       101 -----~~~~~lv~e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  166 (335)
T 3dls_A          101 -----QGFFQLVMEKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED  166 (335)
T ss_dssp             -----SSEEEEEEECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             -----CCEEEEEEEeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence                 44789999999776 999999765      3689999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+++......         ......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       167 ~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  224 (335)
T 3dls_A          167 FTIKLIDFGSAAYLERGK---------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV  224 (335)
T ss_dssp             SCEEECCCTTCEECCTTC---------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH
T ss_pred             CcEEEeecccceECCCCC---------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH
Confidence            999999999998754321         122357999999999984     56789999999999873

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=6.1e-32  Score=323.43  Aligned_cols=190  Identities=22%  Similarity=0.276  Sum_probs=164.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|.++++.+ +||+|++++++     ++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence            456899999999999999999999999999999999743   234557788999999988 69999999998     455


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      .+..|+||||++||+|.+++...      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.++++||+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence            56899999999999999999865      3689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+......        ......+||+.|||||++.    +.++|+||+||++|||+
T Consensus       485 DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell  536 (674)
T 3pfq_A          485 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML  536 (674)
T ss_dssp             CCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH
T ss_pred             ecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH
Confidence            999998543211        1223468999999999994    68999999999999984

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=2.9e-32  Score=293.68  Aligned_cols=187  Identities=25%  Similarity=0.408  Sum_probs=156.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||.||+|++ .+++.||+|+++...  ....+.+.+|++++++++||||+++++++..     .+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4789999999999999999999 578899999996443  2334788899999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++ +|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        76 ~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           76 VLVFEHLDQ-DLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             EEEEECCSE-EHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             EEEEEecCC-CHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999975 9999987643     4688999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+......        .......||+.|+|||++.     +.++|+||+||++|||+
T Consensus       147 ~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  195 (288)
T 1ob3_A          147 ARAFGIPV--------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV  195 (288)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             ccccCccc--------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHH
Confidence            98654211        1112346899999999984     57899999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=1.3e-31  Score=285.24  Aligned_cols=189  Identities=28%  Similarity=0.467  Sum_probs=161.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. ++..||+|+++... ...+++.+|++++++++||||+++++++.     .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceE
Confidence            468999999999999999999887 56789999996443 34567899999999999999999999964     334689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++...+     ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence            9999999999999997643     4689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  199 (268)
T 3sxs_A          152 RYVLDDQYV-------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF  199 (268)
T ss_dssp             EECCTTCEE-------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHH
T ss_pred             eecchhhhh-------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHH
Confidence            876443211       122345788999999985    48999999999999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=4.9e-32  Score=297.37  Aligned_cols=190  Identities=25%  Similarity=0.421  Sum_probs=153.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEE----EEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMV----VAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|+..+.||+|+||.||+|++..+++.    ||+|.++.. .....+.+.+|++++++++||||++++++|...     
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence            5799999999999999999999877665    577777533 234557899999999999999999999997642     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                       ..++||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CeEEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence             3678999999999999998654     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+........      .......||+.|+|||++.    +.++|||||||+++||+
T Consensus       161 fg~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  213 (327)
T 3poz_A          161 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  213 (327)
T ss_dssp             TTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcceeEccCCccc------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHH
Confidence            9999876433211      1122346789999999985    58999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=5.1e-32  Score=301.98  Aligned_cols=201  Identities=18%  Similarity=0.291  Sum_probs=159.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCC-----cEEEEEEEeeccCCc-----------chHHHHHHHHHHHhcCCCCcce
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDD-----EMVVAVKVINLKQKG-----------ASKSFVSECEALRNIRHRNLIK  766 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~  766 (914)
                      ..++|++.+.||+|+||.||+|++..+     ++.||||++......           ....+.+|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345899999999999999999999764     578999998644311           1123445666777888999999


Q ss_pred             EEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 042766          767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSN  846 (914)
Q Consensus       767 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~N  846 (914)
                      +++++.... .+..+.++||||+ +++|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+|
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            999976532 2335689999999 999999997643     4689999999999999999999999   99999999999


Q ss_pred             eeec--CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          847 VLLD--YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       847 ILl~--~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||++  .++.+||+|||+|+.+......... .........||+.|||||++.    +.++|||||||++|||+
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  255 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL  255 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence            9999  8899999999999877543321111 111223457999999999995    48999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=8.1e-32  Score=295.10  Aligned_cols=185  Identities=22%  Similarity=0.293  Sum_probs=142.4

Q ss_pred             hccccc---CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSS---NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~---~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.   +.||+|+||.||+|++..+++.||||++...   ....+.+|+++++++. ||||+++++++..     ..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~   79 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QL   79 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CC
Confidence            345543   7899999999999999999999999998633   3467789999999997 9999999999643     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC---cEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM---VAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~---~~ki  857 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++   .+||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKKK------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEE
T ss_pred             EEEEEEEccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEE
Confidence            789999999999999999865      4689999999999999999999999   999999999999998766   8999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+.......        .....+||+.|+|||++.    +.++||||+||++|+|+
T Consensus       151 ~Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  203 (325)
T 3kn6_A          151 IDFGFARLKPPDNQ--------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML  203 (325)
T ss_dssp             CCCTTCEECCC------------------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             eccccceecCCCCC--------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence            99999986543211        112357899999999984    58899999999999873

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=1.3e-32  Score=301.39  Aligned_cols=285  Identities=15%  Similarity=0.218  Sum_probs=233.2

Q ss_pred             HHhcCCCCCCCCCCCC--CCCCCCccceeecCCCCceEEEecCCCCCccc----cCCCC--CCCCCCCEEEcCCCCCccc
Q 042766           45 KSQLHDPSGVTSSWNN--TMNFCQWTGVTCGHRHQRLTELNLSSQRIGGV----LSPYV--GNLSFLRYINLADNGFRGD  116 (914)
Q Consensus        45 k~~~~~~~~~~~~w~~--~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~----~~~~l--~~l~~L~~L~L~~n~l~~~  116 (914)
                      |..+.|+..++.+|+.  ..|+|.|.++.|.......     .-+...|.    ++..+  ...+.+++|+|++|+++ .
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~-----~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~   95 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNP-----QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q   95 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCT-----TSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-S
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhcccccccc-----cccccCCcchhhhHHHHhcccccceeEEEccCCCch-h
Confidence            3445566667788974  3489999999884221100     00111111    11111  23477889999999998 8


Q ss_pred             CCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccc
Q 042766          117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL  196 (914)
Q Consensus       117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  196 (914)
                      +|..++++++|++|+|++|+++ .+|..++++++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..++..
T Consensus        96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~  173 (328)
T 4fcg_A           96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST  173 (328)
T ss_dssp             CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred             cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence            8888888999999999999998 88888899999999999999888 788888888888888888888888888766541


Q ss_pred             cccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceee
Q 042766          197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG  276 (914)
Q Consensus       197 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~  276 (914)
                                     ..+..|+++++|++|+|++|+++ .+|..+.++++|++|+|++|++++. |.. +..+++|++|+
T Consensus       174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l-~~~-l~~l~~L~~L~  235 (328)
T 4fcg_A          174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPA-IHHLPKLEELD  235 (328)
T ss_dssp             ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCC-CGG-GGGCTTCCEEE
T ss_pred             ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcC-chh-hccCCCCCEEE
Confidence                           23345778999999999999999 7899999999999999999999974 544 56899999999


Q ss_pred             ccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecc
Q 042766          277 IGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS  356 (914)
Q Consensus       277 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls  356 (914)
                      |++|++.+.+|..+..+++|++|+|++|++.+.+|..|..+++|++|+|++|++.+.      +|..+.++++|+.+++.
T Consensus       236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~------iP~~l~~L~~L~~l~l~  309 (328)
T 4fcg_A          236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR------LPSLIAQLPANCIILVP  309 (328)
T ss_dssp             CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC------CCGGGGGSCTTCEEECC
T ss_pred             CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh------ccHHHhhccCceEEeCC
Confidence            999999999999999999999999999999999999999999999999999998876      78889999999999999


Q ss_pred             ccccC
Q 042766          357 DNQFG  361 (914)
Q Consensus       357 ~N~l~  361 (914)
                      .|.+.
T Consensus       310 ~~~~~  314 (328)
T 4fcg_A          310 PHLQA  314 (328)
T ss_dssp             GGGSC
T ss_pred             HHHHH
Confidence            88776

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=5.5e-32  Score=313.51  Aligned_cols=191  Identities=24%  Similarity=0.488  Sum_probs=164.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+|++.+.||+|+||.||+|++..++..||||+++... ...+.+.+|++++++++||||++++++|...     ...+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEE
Confidence            357899999999999999999999889999999996443 3467899999999999999999999996543     3679


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++.....    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       293 lv~E~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence            99999999999999986432    4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......+|+.|+|||++.    +.++|||||||+++||+
T Consensus       366 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~  413 (495)
T 1opk_A          366 RLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA  413 (495)
T ss_dssp             ECCTTCCEE-------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             eeccCCcee-------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHH
Confidence            876432211       112345788999999985    58999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=9.3e-32  Score=303.20  Aligned_cols=192  Identities=25%  Similarity=0.370  Sum_probs=163.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|.+.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++....   ....+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence            57999999999999999999999999999999997433 334577889999999999999999999875432   34679


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee----cCCCcEEEec
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DYDMVAHVGD  859 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl----~~~~~~ki~D  859 (914)
                      +||||+++|+|.+++.....   ...+++.+++.++.|++.||+|||++   +|+||||||+||++    +.++.+||+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             EEEecCCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEec
Confidence            99999999999999976431   13489999999999999999999999   99999999999999    7778899999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......         ......||+.|+|||++.            +.++||||+||++|||+
T Consensus       160 FG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~  217 (396)
T 4eut_A          160 FGAARELEDDE---------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA  217 (396)
T ss_dssp             GGGCEECCCGG---------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCceEccCCC---------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH
Confidence            99998764322         112357999999999874            47899999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1e-31  Score=294.94  Aligned_cols=194  Identities=23%  Similarity=0.347  Sum_probs=165.5

Q ss_pred             hcccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++...   ...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence            5899999999999999999994    568899999999766655667899999999999999999999987532   345


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...+     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence            7899999999999999997643     3689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.........     .......||+.|+|||++.    +.++||||+||++++|+
T Consensus       172 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  224 (327)
T 3lxl_A          172 GLAKLLPLDKDYY-----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF  224 (327)
T ss_dssp             GGCEECCTTCSEE-----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ccceecccCCccc-----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHH
Confidence            9998764322111     1112346899999999985    58999999999999873

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=1.4e-31  Score=287.51  Aligned_cols=190  Identities=26%  Similarity=0.460  Sum_probs=159.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||.||+|++. ++..||+|+++... ...+++.+|++++++++||||+++++++..     ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----CCCe
Confidence            3468999999999999999999987 67789999997443 345789999999999999999999999643     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++....     ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccc
Confidence            99999999999999997643     4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++........       ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       167 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~  215 (283)
T 3gen_A          167 SRYVLDDEYT-------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY  215 (283)
T ss_dssp             GGGBCCHHHH-------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             cccccccccc-------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            9876443211       112345788999999985    58999999999999873

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=6.6e-32  Score=304.21  Aligned_cols=188  Identities=21%  Similarity=0.301  Sum_probs=151.5

Q ss_pred             hccccc-CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHH-hcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSS-NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALR-NIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|.+. +.||+|+||+||+|++..+++.||||+++.     ...+.+|++++. ..+||||+++++++... +.+....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence            466665 789999999999999999999999999852     246778999874 45899999999986532 2234578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~D  859 (914)
                      ++||||++||+|.+++.....    ..+++.++..|+.||+.||+|||+.   +|+||||||+|||++.   ++.+||+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeCCCCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence            999999999999999986532    4689999999999999999999999   9999999999999997   78999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......         .....+||+.|||||++.    +.++||||+||++|||+
T Consensus       208 FG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  257 (400)
T 1nxk_A          208 FGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL  257 (400)
T ss_dssp             CTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred             cccccccCCCC---------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence            99998654221         112457999999999983    58999999999999873

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=4.9e-32  Score=301.88  Aligned_cols=197  Identities=27%  Similarity=0.346  Sum_probs=166.6

Q ss_pred             CccCHHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-----CCCcceE
Q 042766          693 PMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-----HRNLIKI  767 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  767 (914)
                      ..+++.+.....++|++.+.||+|+||.||+|++..+++.||||+++. .....+.+.+|++++++++     ||||+++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            344555555667899999999999999999999999999999999863 2334567788999999996     9999999


Q ss_pred             EeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 042766          768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV  847 (914)
Q Consensus       768 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NI  847 (914)
                      ++++...     +..++||||+ +++|.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||
T Consensus       102 ~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  168 (360)
T 3llt_A          102 HGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENI  168 (360)
T ss_dssp             EEEEEET-----TEEEEEECCC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccE
Confidence            9996543     4789999999 9999999986532    3589999999999999999999999   999999999999


Q ss_pred             eecC-------------------------CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----h
Q 042766          848 LLDY-------------------------DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----M  898 (914)
Q Consensus       848 Ll~~-------------------------~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~  898 (914)
                      |++.                         ++.+||+|||+|+.....           .....||+.|+|||++.    +
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~  237 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----------HGSIINTRQYRAPEVILNLGWD  237 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------CCSCCSCGGGCCHHHHTTCCCC
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------CcCccCcccccCcHHHcCCCCC
Confidence            9975                         789999999999864321           11357999999999985    5


Q ss_pred             hhcccCcccccccccC
Q 042766          899 LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       899 ~~~Di~s~g~~~~~~f  914 (914)
                      .++||||+||++|+|+
T Consensus       238 ~~~DiwslG~il~ell  253 (360)
T 3llt_A          238 VSSDMWSFGCVLAELY  253 (360)
T ss_dssp             TTHHHHHHHHHHHHHH
T ss_pred             CccchHHHHHHHHHHH
Confidence            8999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=2.3e-31  Score=289.47  Aligned_cols=204  Identities=33%  Similarity=0.495  Sum_probs=170.9

Q ss_pred             cCccCHHHHHHHhhccccc------CcccCCccEEEEEEEECCCcEEEEEEEeecc----CCcchHHHHHHHHHHHhcCC
Q 042766          692 FPMVSYAELSKATSEFSSS------NMIGQGRFGTVYKGILGDDEMVVAVKVINLK----QKGASKSFVSECEALRNIRH  761 (914)
Q Consensus       692 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  761 (914)
                      ...+++.++..++.+|...      +.||+|+||.||+|++  +++.||||++...    .....+.+.+|++++++++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4567889999999998877      8999999999999987  4678999998643    23345789999999999999


Q ss_pred             CCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       762 ~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                      |||+++++++..     .+..++||||+++++|.+++....   ....+++..++.++.|++.||+|||++   +|+|||
T Consensus        90 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~d  158 (307)
T 2nru_A           90 ENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRD  158 (307)
T ss_dssp             TTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             CCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCC
Confidence            999999999643     346899999999999999997542   124689999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          842 LKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       842 lkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      |||+||+++.++.+||+|||+++........      .......||+.|+|||++.   +.++|+||+||++++|+
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~  228 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEII  228 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHH
Confidence            9999999999999999999999865432111      1122357999999999985   47999999999999873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=1.3e-31  Score=293.36  Aligned_cols=188  Identities=25%  Similarity=0.322  Sum_probs=162.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc------chHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG------ASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+.+.+|++++++++||||+++++++..    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----   86 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN----   86 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            46799999999999999999999999999999999754321      35689999999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----  853 (914)
                       ....++||||+++++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           87 -RTDVVLILELVSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             -SSEEEEEECCCCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence             34789999999999999999764      3578999999999999999999999   999999999999999888    


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       157 ~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  212 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  212 (321)
T ss_dssp             CEEECCCTTCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CEEEccCccceecCccc---------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH
Confidence            79999999998654321         112356999999999985    47899999999999873

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=4.2e-32  Score=297.64  Aligned_cols=202  Identities=23%  Similarity=0.402  Sum_probs=148.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcE---EEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEM---VVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      ..++|++.+.||+|+||.||+|++..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34689999999999999999999876664   8999999754  344567899999999999999999999997654321


Q ss_pred             C-CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          778 G-VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       778 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      + ....++||||+++|+|.+++...........+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence            1 112489999999999999997543222223689999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |+|||+|+........      .......||+.|+|||++.    +.++||||+||++|||
T Consensus       178 l~Dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (323)
T 3qup_A          178 VADFGLSRKIYSGDYY------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI  232 (323)
T ss_dssp             ECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             Eeeccccccccccccc------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHH
Confidence            9999999876432211      1122345788999999985    5899999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=1.5e-31  Score=290.19  Aligned_cols=194  Identities=26%  Similarity=0.404  Sum_probs=160.9

Q ss_pred             hcccccCcccCCccEEEEEEE----ECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGI----LGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|+..+.||+|+||.||+|+    +..+++.||+|+++... ....+.+.+|++++++++||||+++++++....   .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence            468999999999999999999    45688999999997443 344578999999999999999999999976432   3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            45789999999999999996543     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.........     .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       170 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  223 (302)
T 4e5w_A          170 FGLTKAIETDKEYY-----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL  223 (302)
T ss_dssp             CTTCEECCTTCCEE-----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ccccccccCCCcce-----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH
Confidence            99998765432110     1122356899999999985    47899999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=1.3e-31  Score=288.28  Aligned_cols=184  Identities=27%  Similarity=0.445  Sum_probs=157.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcc-------hHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGA-------SKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.......       .+.+.+|++++++++||||+++++++...   
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   95 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---   95 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence            68999999999999999999999999999999996443221       26789999999999999999999986432   


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeecCCCc-
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDYDMV-  854 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~~~~~-  854 (914)
                          .++||||+++|+|.+++....     ..+++..++.++.|++.|++|||++   +  |+||||||+||+++.++. 
T Consensus        96 ----~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~  163 (287)
T 4f0f_A           96 ----PRMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN  163 (287)
T ss_dssp             ----TEEEEECCTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred             ----CeEEEEecCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence                269999999999999887653     4689999999999999999999998   7  999999999999988776 


Q ss_pred             ----EEEecccccccccccccccccCCCCccccccCcccccccchh------hhhhcccCcccccccccC
Q 042766          855 ----AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF------FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ----~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~------~~~~~Di~s~g~~~~~~f  914 (914)
                          +||+|||+|+.....           .....||+.|+|||++      ++.++|+||+||++|+|+
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          164 APVCAKVADFGLSQQSVHS-----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             CSCCEEECCCTTCBCCSSC-----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred             CceeEEeCCCCcccccccc-----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence                999999999743221           1235799999999998      257899999999999873

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=1.7e-31  Score=296.41  Aligned_cols=198  Identities=25%  Similarity=0.383  Sum_probs=163.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC---CC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF---EG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  778 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ......+.+|++++++++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999999999999999986443  3335678899999999999999999999765431   11


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||+++ ++.+.+....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence            3468999999975 8888776543     4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+......    .........||+.|+|||++.     +.++||||+||++|+|+
T Consensus       167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  223 (351)
T 3mi9_A          167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  223 (351)
T ss_dssp             CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccc----cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence            99999876532211    112223467999999999884     57899999999999873

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=5.8e-32  Score=296.62  Aligned_cols=190  Identities=26%  Similarity=0.395  Sum_probs=156.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEE----EEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMV----VAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|++.+.||+|+||.||+|++..+++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++..      
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence            5789999999999999999999877765    7777775332 3334567889999999999999999998632      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...+     ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D  158 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD  158 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred             CccEEEEEeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence            35789999999999999997643     4688889999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+........      .......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       159 fg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~  211 (325)
T 3kex_A          159 FGVADLLPPDDKQ------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM  211 (325)
T ss_dssp             CSGGGGSCCCTTC------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCcccccCccccc------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHH
Confidence            9999876543211      1122356888999999995    58999999999999863

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1e-31  Score=291.98  Aligned_cols=254  Identities=19%  Similarity=0.239  Sum_probs=193.8

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCC--Cc
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS--GT  140 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~  140 (914)
                      ..|.|.+|.|+..            +++ .+|..+.  ++|++|+|++|+++...+..|+++++|++|+|++|+++  +.
T Consensus         5 C~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~   69 (306)
T 2z66_A            5 CSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC   69 (306)
T ss_dssp             CEEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred             CeeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence            4488999988642            232 3444332  68899999999998444445789999999999999987  33


Q ss_pred             CCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCC-cccccccccceeecccCCCCCCCCccchh
Q 042766          141 IPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP-DSVGNLSAIEVIRITENSLGGKIPTTLGL  219 (914)
Q Consensus       141 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  219 (914)
                      +|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..|..
T Consensus        70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  148 (306)
T 2z66_A           70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  148 (306)
T ss_dssp             EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred             cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence            4667778889999999999888 577778888889999999988886554 57888888888888888888888888888


Q ss_pred             hhcccccccccccccC-CCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccccc
Q 042766          220 LRRLVNLNVAENQFSG-MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLEL  298 (914)
Q Consensus       220 l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  298 (914)
                      +++|++|++++|++++ ..|..+..+++|++|++++|++++..| ..+..+++|++|+|++|++++..+..+..+++|++
T Consensus       149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  227 (306)
T 2z66_A          149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP-TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  227 (306)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred             CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCH-HHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence            8888888888888876 567778888888888888888876544 34457777888888888777666667777777777


Q ss_pred             ccccCccCCccccccccccc-cccceeccCCcCCCC
Q 042766          299 LDLPSNQFKGKVSIDFSSLK-NLWLLNLEQNNLGTG  333 (914)
Q Consensus       299 L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~  333 (914)
                      |||++|++++..+..+..++ +|++|+|++|.++..
T Consensus       228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             eECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            77777777777777777663 677777777776553

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=8.6e-32  Score=297.77  Aligned_cols=198  Identities=23%  Similarity=0.407  Sum_probs=163.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++... ....+.+.+|++++++++||||+++++++..   
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc---
Confidence            4578999999999999999999996     456899999997543 2335678999999999999999999999643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQV------------------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV  838 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~iv  838 (914)
                        ....++||||+++|+|.+++.......                  ....+++.+++.++.|++.||+|||++   +|+
T Consensus       122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence              346899999999999999998643110                  125689999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          839 HGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       839 HrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||||||+||+++.++.+||+|||+++........      .......||+.|+|||++.    +.++|+||+||++|||+
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccc------cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence            9999999999999999999999999866432211      1122356899999999985    58999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5.9e-32  Score=299.35  Aligned_cols=204  Identities=23%  Similarity=0.269  Sum_probs=162.3

Q ss_pred             HHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-----CCcchHHHHHHHHHHHhcCCCCcceEEeEeec
Q 042766          699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-----QKGASKSFVSECEALRNIRHRNLIKIITICSS  773 (914)
Q Consensus       699 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  773 (914)
                      ++....++|++.+.||+|+||.||+|++..+++.||+|++...     .....+.+.+|++++++++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3455677899999999999999999999999999999999643     23455789999999999999999999999644


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCc----------------------------------ccccCCCHHHHHHHH
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------------------------------VEVRKLSLIQRMNIA  819 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~~~~~~~~~i~  819 (914)
                           ....++||||+++|+|.+++......                                  .....+++..+..++
T Consensus       100 -----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  174 (345)
T 3hko_A          100 -----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIM  174 (345)
T ss_dssp             -----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHH
T ss_pred             -----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHH
Confidence                 34789999999999999998631100                                  001234567788999


Q ss_pred             HHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC--cEEEecccccccccccccccccCCCCccccccCcccccccchhh
Q 042766          820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF  897 (914)
Q Consensus       820 ~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~--~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~  897 (914)
                      .|++.||+|||+.   +|+||||||+||+++.++  .+||+|||+|+.+......    .........||+.|+|||++.
T Consensus       175 ~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          175 RQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG----EYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCcc----ccccccccCCCccccCchhhc
Confidence            9999999999999   999999999999998776  8999999999865432111    111123457999999999984


Q ss_pred             ------hhhcccCcccccccccC
Q 042766          898 ------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       898 ------~~~~Di~s~g~~~~~~f  914 (914)
                            +.++||||+||+++||+
T Consensus       248 ~~~~~~~~~~DiwslG~il~el~  270 (345)
T 3hko_A          248 TTNESYGPKCDAWSAGVLLHLLL  270 (345)
T ss_dssp             CSSSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHH
Confidence                  36999999999999873

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=2.4e-31  Score=286.38  Aligned_cols=190  Identities=22%  Similarity=0.338  Sum_probs=160.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...  ......+.+|+..+.++ +||||+++++++...     
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----
Confidence            4578999999999999999999999999999999997542  33456788999999999 999999999996543     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-------
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-------  852 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-------  852 (914)
                      +..++||||+++++|.+++.....  ....+++.++..++.|++.||+|||++   +|+||||||+||+++.+       
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~  158 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS  158 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence            478999999999999999975421  114589999999999999999999999   99999999999999844       


Q ss_pred             ------------CcEEEecccccccccccccccccCCCCccccccCcccccccchhhh-----hhcccCcccccccccC
Q 042766          853 ------------MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-----LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ------------~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-----~~~Di~s~g~~~~~~f  914 (914)
                                  ..+||+|||.++......            ...||+.|+|||++.+     .++||||+||++++|+
T Consensus       159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA  225 (289)
T ss_dssp             -----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT
T ss_pred             cccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh
Confidence                        479999999998654211            2359999999999853     6899999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=3.1e-31  Score=295.33  Aligned_cols=193  Identities=26%  Similarity=0.388  Sum_probs=164.8

Q ss_pred             HHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--------chHHHHHHHHHHHhc-CCCCcceEEe
Q 042766          699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--------ASKSFVSECEALRNI-RHRNLIKIIT  769 (914)
Q Consensus       699 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~  769 (914)
                      ......++|++.+.||+|+||.||+|++..+|+.||||+++.....        ..+.+.+|+++++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            3345567899999999999999999999989999999999754321        135678999999999 7999999999


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      ++..     ....++||||+++++|.+++...      ..+++..+..++.|++.||.|||+.   +|+||||||+||++
T Consensus       168 ~~~~-----~~~~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~  233 (365)
T 2y7j_A          168 SYES-----SSFMFLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILL  233 (365)
T ss_dssp             EEEB-----SSEEEEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEee-----CCEEEEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            8644     34789999999999999999754      4689999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+||+|||+++.+....         ......||+.|+|||++.          +.++||||+||++|+|+
T Consensus       234 ~~~~~ikl~DfG~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell  299 (365)
T 2y7j_A          234 DDNMQIRLSDFGFSCHLEPGE---------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL  299 (365)
T ss_dssp             CTTCCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEecCcccccCCCc---------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH
Confidence            999999999999998654321         112357999999999985          35899999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=1.5e-31  Score=287.45  Aligned_cols=191  Identities=26%  Similarity=0.344  Sum_probs=159.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeEE
Confidence            57999999999999999999999999999999997543 3456789999999999999999999999643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEecc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDF  860 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~DF  860 (914)
                      +||||+++|+|.+++.....  ....+++..+..++.|++.||+|||++   +|+||||||+||++   +.++.+||+||
T Consensus        97 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEeCCCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            99999999999998864321  124689999999999999999999999   99999999999999   45688999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         ......||+.|+|||++.   +.++|+||+||++++|+
T Consensus       172 g~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll  219 (285)
T 3is5_A          172 GLAELFKSDE---------HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLL  219 (285)
T ss_dssp             CCCCC-------------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHH
T ss_pred             ecceecCCcc---------cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHH
Confidence            9998654321         112357999999999985   58999999999999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=2.1e-31  Score=297.08  Aligned_cols=195  Identities=25%  Similarity=0.329  Sum_probs=165.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..+|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.....+.....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            358999999999999999999999999999999997433 2334678999999999999999999999876665555678


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ |+|.+++..       ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus       106 ~iv~e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEcccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            99999996 599999865       3588999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+........     .......+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       175 a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  226 (364)
T 3qyz_A          175 ARVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML  226 (364)
T ss_dssp             CEECCGGGCB-----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHH
T ss_pred             eEecCCCCCc-----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHH
Confidence            9876532211     11122457999999999873     57899999999999873

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.5e-31  Score=286.55  Aligned_cols=190  Identities=25%  Similarity=0.429  Sum_probs=148.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++..     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence            468999999999999999999998899999999996432   2345788999999999999999999999644     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++....     ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  156 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADF  156 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEee
Confidence            7899999999999999998643     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.......        ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       157 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  206 (278)
T 3cok_A          157 GLATQLKMPHE--------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL  206 (278)
T ss_dssp             TTCEECC------------------------------------CTHHHHHHHHHHHHH
T ss_pred             cceeeccCCCC--------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence            99986542211        112357999999999984    47999999999999873

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=6.4e-32  Score=296.73  Aligned_cols=192  Identities=25%  Similarity=0.420  Sum_probs=153.3

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .....++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|++++++++||||+++++++..    
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----  104 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----
Confidence            3455678999999999999999999999999999999996443  2234577899999999999999999999654    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-----CC
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-----YD  852 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-----~~  852 (914)
                       ....++||||++ |+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++     .+
T Consensus       105 -~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  173 (329)
T 3gbz_A          105 -NHRLHLIFEYAE-NDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASET  173 (329)
T ss_dssp             -TTEEEEEEECCS-EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----C
T ss_pred             -CCEEEEEEecCC-CCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCcc
Confidence             347899999997 5999999765      3588999999999999999999999   999999999999994     45


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+|+......        .......||+.|+|||++.     +.++||||+||++|||+
T Consensus       174 ~~~kl~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  232 (329)
T 3gbz_A          174 PVLKIGDFGLARAFGIPI--------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML  232 (329)
T ss_dssp             CEEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ceEEECcCCCccccCCcc--------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            569999999998654321        1122356899999999984     57899999999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.7e-31  Score=293.89  Aligned_cols=198  Identities=24%  Similarity=0.408  Sum_probs=160.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ..++|++.+.||+|+||.||+|++     ..+++.||||+++.. .....+.+.+|+++++++ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            457899999999999999999997     346789999999743 234457899999999999 89999999999643  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcc-----------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQV-----------------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV  838 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~iv  838 (914)
                         .+..++||||+++|+|.+++.......                 ....+++..++.++.|++.||+|||++   +|+
T Consensus       121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence               346899999999999999998653210                 113478999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          839 HGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       839 HrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||||||+||+++.++.+||+|||+++.......      ........||+.|+|||++.    +.++||||+||++++|+
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCcc------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            999999999999999999999999986543221      11122356889999999984    58899999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.9e-32  Score=299.43  Aligned_cols=189  Identities=23%  Similarity=0.349  Sum_probs=154.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  780 (914)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ....+++.+|++++++++||||+++++++.... .....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            357999999999999999999999999999999985432  233567889999999999999999999976442 12224


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +++|.+++..       ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence            569999999 8899999875       3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           ....+||+.|+|||++.     +.++|+||+||+++||+
T Consensus       173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  220 (367)
T 1cm8_A          173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI  220 (367)
T ss_dssp             TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence            999864321           12357999999999984     47899999999999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.8e-31  Score=291.27  Aligned_cols=197  Identities=23%  Similarity=0.364  Sum_probs=162.6

Q ss_pred             hhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|.+.+.||+|+||.||+|++     +.+++.||||+++... ....+.+.+|++++++++||||+++++++..    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----   97 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ----   97 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec----
Confidence            46899999999999999999998     3456899999997443 2344678999999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQV------------------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH  839 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivH  839 (914)
                       .+..++||||+++|+|.+++.......                  ....+++.+++.++.|++.||+|||++   +|+|
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence             346899999999999999998653210                  123488999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       840 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||||+||+++.++.+||+|||+++.........      ......||+.|+|||++.    +.++||||+||++|||+
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  246 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV  246 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccce------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999998664322111      112346889999999985    58999999999999873

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=4.4e-34  Score=340.79  Aligned_cols=459  Identities=16%  Similarity=0.114  Sum_probs=246.6

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCC---cccCCcccC------------CCCCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGF---RGDIPQEIG------------NLFRL  127 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~~~------------~l~~L  127 (914)
                      -|++|.++.+.. ..   .+.+.. .+...++..+..+++|++|+|+++..   .+.+|..++            ++++|
T Consensus        40 vck~W~~~~~~~-~~---~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L  114 (592)
T 3ogk_B           40 VCRRWFKIDSET-RE---HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL  114 (592)
T ss_dssp             SCHHHHHHHHHH-CC---EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HhHHHHHhhhcc-cc---EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence            455899885422 11   223332 22233344466788899999987532   245555444            57778


Q ss_pred             CeeecCCCCCCCcCCCCcccc--CCcchhccCCCc-ccC-CCChhccccccccccccccccccCc----CCccccccccc
Q 042766          128 EKLALSNNSFSGTIPTNLSRC--SNLIHFCASNNK-LEG-QIPKEIGNLLKLQRLSVDINYLTGQ----LPDSVGNLSAI  199 (914)
Q Consensus       128 ~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~Ls~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L  199 (914)
                      ++|+|++|.+++..+..++..  .+|++|+|++|. ++. .++....++++|++|+|++|.+++.    ++..+.++++|
T Consensus       115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L  194 (592)
T 3ogk_B          115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL  194 (592)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred             CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence            888888887776666666553  347777777765 211 1222233567777777777777655    33344566777


Q ss_pred             ceeecccCCCCC----CCCccchhhhcccccccccccccCCCCCccccccccceeeccCCccc---CcccccccccCccc
Q 042766          200 EVIRITENSLGG----KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS---GIFPFDILLNLPNL  272 (914)
Q Consensus       200 ~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~~l~~L  272 (914)
                      +.|++++|.+++    .++..+.++++|++|++++|.+.+ +|..+..+++|+.|+++.+...   +..+ ..+..+++|
T Consensus       195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~~l~~~~~L  272 (592)
T 3ogk_B          195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKY-MNLVFPRKL  272 (592)
T ss_dssp             CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSS-SCCCCCTTC
T ss_pred             cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHH-HHhhccccc
Confidence            777777777652    233344556667777777666664 4555666666666666542221   0111 112244555


Q ss_pred             ceeeccCccCCCCCCCccccccccccccccCccCCcccc-ccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCc
Q 042766          273 KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK  351 (914)
Q Consensus       273 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~  351 (914)
                      +.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+...     .++.....+++|+
T Consensus       273 ~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~-----~l~~~~~~~~~L~  345 (592)
T 3ogk_B          273 CRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDR-----GLEVLAQYCKQLK  345 (592)
T ss_dssp             CEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH-----HHHHHHHHCTTCC
T ss_pred             cccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHH-----HHHHHHHhCCCCC
Confidence            55555554222 344455555555555555555443222 123444555555554 222111     0222223344444


Q ss_pred             EEeccc---cccCCCcCchhhccccccEEEEeeccccccc-CCccccCCCCCcEEEcccCcccccCChhhhc-ccCCcee
Q 042766          352 VLSLSD---NQFGGELPHSIANLSLKMIELSVGRNQISGT-IPPGIRNLVNLITFTLEVNQFHGTIPDVISE-LKNLQQL  426 (914)
Q Consensus       352 ~L~Ls~---N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L  426 (914)
                      +|+|++   +.....                 ..|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|
T Consensus       346 ~L~L~~g~~~~~~~~-----------------~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L  408 (592)
T 3ogk_B          346 RLRIERGADEQGMED-----------------EEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF  408 (592)
T ss_dssp             EEEEECCCCSSTTSS-----------------TTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEE
T ss_pred             EEEeecCcccccccc-----------------ccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEE
Confidence            444441   000000                 02333322 1122344667777777777776665555554 6777777


Q ss_pred             eec----ccccccc-----cCccccCCCCCCeEEeeCC--cCCCCCCCccC-CCCCccccccCCCccCCCCchhhhcccc
Q 042766          427 SVF----NNFLRGG-----IPSGLGNLTKLGSLDLGSN--SLQGNIPSSLG-NCQNLILFIASYNKLTGDLPQQLLSITT  494 (914)
Q Consensus       427 ~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~~  494 (914)
                      +++    .|.+++.     ++..+.++++|++|+|+++  .+++..+..+. .+++|+.|++++|++++.          
T Consensus       409 ~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~----------  478 (592)
T 3ogk_B          409 RLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE----------  478 (592)
T ss_dssp             EEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHH----------
T ss_pred             EEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHH----------
Confidence            775    5566642     2333556777777777643  35544333333 266677777666665521          


Q ss_pred             hhhhhcccCCccCCCccccccccccceeecccCCccccc-cCccccccccccEEEeecccccccCCcch-hccCCCCEEE
Q 042766          495 LSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV-IPVTLSTCVSLEYLDISINSFYGVIPLSF-RFLKSIKALN  572 (914)
Q Consensus       495 l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~  572 (914)
                                    .++..+.++++|++|+|++|++++. ++..+..+++|++|+|++|++++.--..+ ..++.+....
T Consensus       479 --------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~  544 (592)
T 3ogk_B          479 --------------GLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIEL  544 (592)
T ss_dssp             --------------HHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEE
T ss_pred             --------------HHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEE
Confidence                          1122334566777777877777654 33334567778888888888765433333 2456665555


Q ss_pred             ccCC
Q 042766          573 VSSN  576 (914)
Q Consensus       573 Ls~N  576 (914)
                      +..+
T Consensus       545 ~~~~  548 (592)
T 3ogk_B          545 IPSR  548 (592)
T ss_dssp             ECCC
T ss_pred             ecCc
Confidence            5443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=2e-31  Score=290.51  Aligned_cols=188  Identities=23%  Similarity=0.347  Sum_probs=156.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....  ...+.+.+|++++++++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            579999999999999999999999999999999864432  234678899999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++...      ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        78 ~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEeCCCchHHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            9999999999999988754      3589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.......        ......||+.|+|||++.     +.++|+||+||++++|+
T Consensus       149 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  197 (311)
T 4agu_A          149 ARLLTGPSD--------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL  197 (311)
T ss_dssp             CEECC--------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             chhccCccc--------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence            987543211        112357999999999984     47899999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=1.1e-31  Score=288.08  Aligned_cols=189  Identities=22%  Similarity=0.384  Sum_probs=149.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|++..+   +..||+|+++... ....+.+.+|+.++++++||||+++++++..      
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc------
Confidence            46899999999999999999998643   5679999986433 2345678999999999999999999998632      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++|+|.+++...+     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CccEEEEecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECc
Confidence            34689999999999999997643     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++........       ......||+.|+|||++.    +.++|+||+||++|||
T Consensus       160 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el  210 (281)
T 1mp8_A          160 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI  210 (281)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred             cccccccCccccc-------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHH
Confidence            9999876432211       112345788999999985    4789999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=9.3e-32  Score=305.10  Aligned_cols=189  Identities=25%  Similarity=0.346  Sum_probs=153.4

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------CcchHHHHHHHHHHHhcCCCCcceEEeEeec
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------KGASKSFVSECEALRNIRHRNLIKIITICSS  773 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  773 (914)
                      ...++|.+.+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34578999999999999999999999999999999997432        1122357899999999999999999998532


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-  852 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-  852 (914)
                            ...++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+ 
T Consensus       212 ------~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          212 ------EDYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             ------SEEEEEEECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred             ------CceEEEEEcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence                  2468999999999999988754      4689999999999999999999999   99999999999999754 


Q ss_pred             --CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          853 --MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 --~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                        +.+||+|||+|+......         .....+||+.|||||++.       +.++|+||+||++|+|+
T Consensus       277 ~~~~~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll  338 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  338 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred             CcceEEEeecccceecCCCc---------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence              459999999998754321         112357999999999973       47999999999999873

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=2.9e-31  Score=292.28  Aligned_cols=189  Identities=21%  Similarity=0.329  Sum_probs=163.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.++++++||||+++++++..     .+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CC
Confidence            368999999999999999999999999999999997442   2345678899999999999999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecCCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence            789999999999999998754      4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.......        ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       186 g~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  235 (335)
T 2owb_A          186 GLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL  235 (335)
T ss_dssp             TTCEECCSTTC--------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH
T ss_pred             cCceecccCcc--------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            99986542211        122357999999999995    47899999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=3.1e-31  Score=287.02  Aligned_cols=194  Identities=19%  Similarity=0.281  Sum_probs=162.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|+++++++ +|++++++++++..     ....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Ccee
Confidence            357999999999999999999999999999999986432  335678999999999 79999999998643     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc-----EEE
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV-----AHV  857 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~ki  857 (914)
                      ++||||+ +++|.+++...+     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.     +||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             EEEEEec-CCCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            9999999 999999998653     4689999999999999999999999   9999999999999987776     999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+......... ...........||+.|+|||++.    +.++||||+||++|||+
T Consensus       153 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  212 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQ-HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL  212 (298)
T ss_dssp             CCCTTCEESBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             EECccccccccccccc-cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence            9999998765432211 11112234567999999999985    58999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1e-31  Score=298.21  Aligned_cols=190  Identities=21%  Similarity=0.270  Sum_probs=160.9

Q ss_pred             hhcccccCcccCCccEEEEEEEEC---CCcEEEEEEEeeccC----CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG---DDEMVVAVKVINLKQ----KGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      .++|++.+.||+|+||.||+|++.   .+++.||||+++...    ....+.+.+|+++++++ +||||+++++++..  
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            368999999999999999999984   578999999986432    23345677899999999 69999999998644  


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                         ....++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus       131 ---~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  198 (355)
T 1vzo_A          131 ---ETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV  198 (355)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             ---CceEEEEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence               34789999999999999999764      3688999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+++.+.....       ......+||+.|+|||++.      +.++|||||||++|||+
T Consensus       199 kl~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell  256 (355)
T 1vzo_A          199 VLTDFGLSKEFVADET-------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL  256 (355)
T ss_dssp             EESCSSEEEECCGGGG-------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred             EEeeCCCCeecccCCC-------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence            9999999986543221       1122457999999999985      36899999999999873

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.5e-32  Score=297.58  Aligned_cols=191  Identities=28%  Similarity=0.444  Sum_probs=155.0

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++....     ...+.+.+|++++++++||||+++++++..   
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH---   83 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence            345789999999999999999999998999999999964321     123578899999999999999999999643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                        ....++||||+++ +|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+|
T Consensus        84 --~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           84 --KSNISLVFDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             --TTCCEEEEECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             --CCceEEEEEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEE
Confidence              3478999999976 8999887643     4578888999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+|+.+....        .......||+.|+|||++.     +.++||||+||++|||+
T Consensus       153 l~Dfg~a~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  207 (346)
T 1ua2_A          153 LADFGLAKSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL  207 (346)
T ss_dssp             ECCCGGGSTTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred             EEecccceeccCCc--------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH
Confidence            99999998654321        1122357999999999984     47899999999999873

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.8e-31  Score=306.16  Aligned_cols=189  Identities=22%  Similarity=0.442  Sum_probs=160.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. ++..||||+++... ...+.+.+|++++++++||||+++++++..      ...+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~~  258 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY  258 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCE
T ss_pred             hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------CccE
Confidence            467899999999999999999996 46789999997543 456789999999999999999999998642      3578


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++...+    ...+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       259 lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             EEEeecCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            9999999999999997542    24688899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.........       .....+|+.|+|||++.    +.++|||||||+++||+
T Consensus       332 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~  379 (454)
T 1qcf_A          332 RVIEDNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV  379 (454)
T ss_dssp             GGBCCHHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eEcCCCceec-------cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHH
Confidence            8764322111       11245788999999985    58999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=2.4e-31  Score=308.74  Aligned_cols=188  Identities=24%  Similarity=0.349  Sum_probs=158.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++...  ......+.+|++++++++||||+++++++..     ...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence            457999999999999999999999999999999997543  3345788999999999999999999999644     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEEEe
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAHVG  858 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~ki~  858 (914)
                      .++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++..   +.+||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence            89999999999999988754      4689999999999999999999999   99999999999999764   569999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+......         .....+||+.|+|||++.   +.++||||+||++|+|+
T Consensus       182 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll  231 (494)
T 3lij_A          182 DFGLSAVFENQK---------KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILL  231 (494)
T ss_dssp             CCTTCEECBTTB---------CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHH
T ss_pred             ECCCCeECCCCc---------cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHH
Confidence            999998764321         122357999999999984   58999999999999873

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=3.5e-31  Score=286.13  Aligned_cols=189  Identities=21%  Similarity=0.329  Sum_probs=163.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++..     .+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence            368999999999999999999999999999999997542   2345678899999999999999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence            789999999999999998754      4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.......        ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       160 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  209 (294)
T 2rku_A          160 GLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL  209 (294)
T ss_dssp             TTCEECCSTTC--------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH
T ss_pred             cCceecccCcc--------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH
Confidence            99986542211        122357999999999985    47999999999999873

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=1.6e-31  Score=291.59  Aligned_cols=208  Identities=24%  Similarity=0.411  Sum_probs=157.1

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEee
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICS  772 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  772 (914)
                      .++....++|.+.+.||+|+||.||+|++..   +++.||+|+++...  ....+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3334456789999999999999999998754   56789999997543  233467899999999999999999999987


Q ss_pred             cCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                      ..........++||||+++|+|.+++...........+++.+++.++.|++.||.|||++   +|+||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence            654333345699999999999999986443222335789999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+++........      .......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  243 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYY------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA  243 (313)
T ss_dssp             SCEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred             CcEEEeecCcceeccccccc------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence            99999999999866432211      1112346889999999995    57899999999999873

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=1.9e-31  Score=286.61  Aligned_cols=192  Identities=23%  Similarity=0.421  Sum_probs=162.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC------
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF------  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  776 (914)
                      ...+|+..+.||+|+||.||+|++..+++.||+|+++...    +.+.+|++++++++||||+++++++....+      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4468999999999999999999999899999999997443    356789999999999999999998754211      


Q ss_pred             -----CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC
Q 042766          777 -----EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY  851 (914)
Q Consensus       777 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~  851 (914)
                           ......++||||+++|+|.+++....    ...+++..++.++.|++.|+.|||++   +|+||||||+||+++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                 12345799999999999999997542    24689999999999999999999999   9999999999999999


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+||+|||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  215 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG---------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL  215 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS---------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCEEECcchhheeccccc---------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence            9999999999998764321         112346999999999985    57899999999999873

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=2.6e-31  Score=307.97  Aligned_cols=189  Identities=28%  Similarity=0.360  Sum_probs=162.0

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..++|++.+.||+|+||+||+|++..+++.||||++...  .......+.+|++++++++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   94 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS   94 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CC
Confidence            346899999999999999999999999999999999643  23456788999999999999999999999644     44


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec---CCCcEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~---~~~~~ki  857 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.|++.||.|||++   +|+||||||+||+++   .++.+||
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  165 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI  165 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEEcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence            789999999999999988754      4689999999999999999999999   999999999999995   4568999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+......         .....+||+.|+|||++.   +.++||||+||++|+|+
T Consensus       166 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll  216 (486)
T 3mwu_A          166 IDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILL  216 (486)
T ss_dssp             CSCSCTTTBCCC-------------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHH
T ss_pred             EECCcCeECCCCC---------ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHH
Confidence            9999998654321         112357999999999995   48899999999999873

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=2.2e-31  Score=288.80  Aligned_cols=203  Identities=24%  Similarity=0.321  Sum_probs=159.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-------
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTD-------  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  775 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++||||+++++++....       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            356899999999999999999999989999999999643 334567899999999999999999999875421       


Q ss_pred             -CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          776 -FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       776 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                       .+.....++||||+++|+|.+++....     ..+++.+++.++.|++.|++|||++   +|+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence             123457899999999999999998643     4678889999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccccccccccc------ccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDI------ASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~------~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+++.........      ............||+.|+|||++.     +.++|+||+||++|+|+
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  225 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI  225 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence            9999999998654321000      000011223457999999999984     47899999999999873

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=5.4e-32  Score=291.53  Aligned_cols=192  Identities=24%  Similarity=0.489  Sum_probs=165.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++..     ....
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCE
Confidence            457899999999999999999999989999999999643 3456789999999999999999999999643     3468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++.....    ..+++..++.++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             EEEEEcCCCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcc
Confidence            999999999999999986432    4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.......       .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  206 (288)
T 3kfa_A          158 SRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA  206 (288)
T ss_dssp             GGTSCSSSS-------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeccCCcc-------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHH
Confidence            986543221       1222356788999999985    57999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1.7e-31  Score=286.15  Aligned_cols=188  Identities=23%  Similarity=0.380  Sum_probs=160.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      +.++|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++..     .
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----A   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----C
Confidence            3468999999999999999999999999999999986432   2345678999999999999999999999643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++...      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence            4789999999999999999764      3688999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||++......          ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       153 fg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  201 (279)
T 3fdn_A          153 FGWSVHAPSS----------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL  201 (279)
T ss_dssp             CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccccccCCcc----------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHH
Confidence            9998654321          112357999999999985    47899999999999873

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.5e-31  Score=297.11  Aligned_cols=197  Identities=25%  Similarity=0.389  Sum_probs=162.4

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-------CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-------DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++|.+.+.||+|+||.||+|++.       ..+..||||+++... ....+++.+|+++++++ +||||+++++++.. 
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence            368999999999999999999974       344689999997543 23346789999999999 89999999999643 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                          .+..++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus       147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence                34689999999999999999865321          1124589999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+++.++.+||+|||+|+........      .......||+.|+|||++.    +.++||||+||++++|+
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell  287 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  287 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTT------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceEEEcCCCcEEEcccCccccccccccc------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence            9999999999999999999866432211      1122346899999999985    57999999999999873

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9e-32  Score=299.95  Aligned_cols=194  Identities=25%  Similarity=0.445  Sum_probs=150.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCC---cEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..|+..+.||+|+||.||+|++..+   +..||||.++.. .....+++.+|+.++++++||||++++++|..    ..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCC
Confidence            3577788999999999999997432   357899998643 33455789999999999999999999998743    234


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DF  236 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  236 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CeEEEEECCCCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeec
Confidence            6789999999999999997653     4578889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.........    ........||+.|+|||++.    +.++|||||||++|||+
T Consensus       237 G~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ell  290 (373)
T 3c1x_A          237 GLARDMYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM  290 (373)
T ss_dssp             -------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccc----ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            9998664332111    11223456889999999985    58999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=3.7e-31  Score=303.13  Aligned_cols=185  Identities=31%  Similarity=0.417  Sum_probs=157.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++...  ..+.+.+|++++++++||||+++++++...    ....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            467899999999999999999985  6789999996433  557899999999999999999999997543    23689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++...+.    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus       264 iv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            99999999999999986532    3478899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......           ....+|+.|+|||++.    +.++|||||||+++||+
T Consensus       337 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~  380 (450)
T 1k9a_A          337 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY  380 (450)
T ss_dssp             EECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccc-----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            8542110           1235789999999994    58999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=4.2e-31  Score=283.92  Aligned_cols=188  Identities=23%  Similarity=0.356  Sum_probs=161.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++..     ...
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence            468999999999999999999999999999999997543  2334678899999999999999999999643     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc---EEEe
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV---AHVG  858 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~---~ki~  858 (914)
                      .++||||+++++|.+++...      ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.   +||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            89999999999999988754      4689999999999999999999999   9999999999999987655   9999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       151 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  201 (284)
T 3kk8_A          151 DFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL  201 (284)
T ss_dssp             CCTTCEECCSSC---------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             eceeeEEcccCc---------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence            999997654321         112357999999999985    47899999999999873

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=3.8e-31  Score=282.97  Aligned_cols=192  Identities=22%  Similarity=0.317  Sum_probs=164.3

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++..     ...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI   79 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCE
Confidence            4578999999999999999999999899999999997543 3445788999999999999999999999654     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  150 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG  150 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEEEEecCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence            89999999999999988653      4688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      .++........      .......||+.|+|||++.     +.++|+||+||++++|+
T Consensus       151 ~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  202 (276)
T 2yex_A          151 LATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML  202 (276)
T ss_dssp             TCEECEETTEE------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHH
T ss_pred             CccccCCCcch------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHH
Confidence            99865432111      1112357999999999984     46899999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=4.6e-31  Score=284.54  Aligned_cols=190  Identities=24%  Similarity=0.377  Sum_probs=162.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..|.+.+.||+|+||.||+|++..++..||+|++....  ....+.+.+|++++++++||||+++++++.... ......
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            35788889999999999999999999999999997443  334567899999999999999999999875432 334578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeec-CCCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLD-YDMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~ki~D  859 (914)
                      ++||||+++|+|.+++...      ..+++..+..++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|
T Consensus       105 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEEEecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEee
Confidence            9999999999999999764      4688999999999999999999998   7  99999999999998 789999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.....          ......||+.|+|||++.   +.++|+||+||++++|+
T Consensus       176 fg~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~  223 (290)
T 1t4h_A          176 LGLATLKRAS----------FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMA  223 (290)
T ss_dssp             TTGGGGCCTT----------SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCccccccc----------ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHH
Confidence            9999754321          112356999999999985   58999999999999873

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=7.1e-32  Score=295.69  Aligned_cols=188  Identities=24%  Similarity=0.398  Sum_probs=153.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|++++++++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            579999999999999999999999999999999964432 222345679999999999999999999654     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++ |+|.+++...+     ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+|
T Consensus        77 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEecccc-cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence            9999997 59999987653     4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        .......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       148 ~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  195 (324)
T 3mtl_A          148 RAKSIPT--------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA  195 (324)
T ss_dssp             ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccCCc--------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            8643221        1122357899999999984     47899999999999873

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=3.5e-31  Score=286.66  Aligned_cols=194  Identities=25%  Similarity=0.437  Sum_probs=158.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..+|++.+.||+|+||.||+|++..+   ...||+|.+.... ....+.+.+|++++++++||||+++++++..    ..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence            35788899999999999999997543   3468999986433 3345678999999999999999999998643    23


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence            46789999999999999997643     4678999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+|+........    .........||+.|+|||++.    +.++|+||+||++++|
T Consensus       172 fg~a~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  225 (298)
T 3f66_A          172 FGLARDMYDKEYY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL  225 (298)
T ss_dssp             CGGGCCCSCGGGC----BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccchh----ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHH
Confidence            9999876543221    111223457899999999995    4889999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.7e-31  Score=289.56  Aligned_cols=195  Identities=25%  Similarity=0.414  Sum_probs=163.6

Q ss_pred             hhcccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++....   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence            35789999999999999999994    5678999999997666666678999999999999999999999865322   2


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++...+     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence            35789999999999999998653     3589999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++..........     ......||+.|+|||++.    +.++||||+||+++||+
T Consensus       189 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  242 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYK-----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF  242 (326)
T ss_dssp             CTTCEECCSSCSEEE-----CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             Ccchhhccccccccc-----cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHH
Confidence            999987653221100     112345888999999985    58999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=3.2e-31  Score=289.18  Aligned_cols=197  Identities=24%  Similarity=0.389  Sum_probs=162.8

Q ss_pred             hhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQK-GASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++     ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++..   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence            46899999999999999999985     45788999999975432 3457889999999999 99999999999643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                        .+..++||||+++|+|.+++......            .....+++.+++.++.|++.||+|||++   +|+||||||
T Consensus        99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence              34679999999999999999865321            1123589999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+++.++.+||+|||+++........      .......||+.|+|||++.    +.++||||+||++++|+
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  241 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF  241 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceEEEcCCCCEEEccccccccccccccc------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence            9999999999999999999876432211      1112346889999999984    58899999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=2.7e-31  Score=307.97  Aligned_cols=188  Identities=27%  Similarity=0.369  Sum_probs=163.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++..     ..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence            458999999999999999999999999999999996442   3456789999999999999999999999644     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEE
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHV  857 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki  857 (914)
                      ..++||||+++|+|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||++   +.++.+||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence            889999999999999998765      3688999999999999999999999   99999999999999   46789999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+|+.+....         .....+||+.|+|||++.   +.++||||+||++|+|+
T Consensus       171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll  221 (484)
T 3nyv_A          171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILL  221 (484)
T ss_dssp             CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHH
T ss_pred             EeeeeeEEccccc---------ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHH
Confidence            9999998654321         122457999999999985   58899999999999873

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.97  E-value=4.4e-31  Score=293.34  Aligned_cols=200  Identities=25%  Similarity=0.359  Sum_probs=164.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++....++.....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            368999999999999999999999999999999996433 2334678899999999999999999999876666666788


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||++ ++|.+++..       ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        90 ~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            99999996 699999875       3588999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccc--cCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIA--SKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~--~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+..........  ...........||+.|+|||++.     +.++|+||+||++++|+
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  217 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF  217 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH
Confidence            987654321111  01111123457999999999874     47899999999999873

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=5.2e-31  Score=306.79  Aligned_cols=189  Identities=26%  Similarity=0.360  Sum_probs=160.4

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-------------cchHHHHHHHHHHHhcCCCCcceEEe
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-------------GASKSFVSECEALRNIRHRNLIKIIT  769 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  769 (914)
                      ..++|.+.+.||+|+||+||+|+++.+++.||||++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34689999999999999999999999999999999974321             33567899999999999999999999


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      ++..     ....++||||+++|+|.+++...      ..+++..+..++.|++.||+|||++   +|+||||||+||++
T Consensus       114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          114 VFED-----KKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL  179 (504)
T ss_dssp             EEEC-----SSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             EEEc-----CCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence            9643     45789999999999999998754      4689999999999999999999999   99999999999999


Q ss_pred             cCCC---cEEEecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          850 DYDM---VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~---~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      +.++   .+||+|||+|+......         .....+||+.|+|||++.   +.++||||+||++|+|+
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll  241 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILL  241 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHH
Confidence            8776   69999999998764321         122357999999999985   58999999999999873

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.97  E-value=7.6e-31  Score=281.77  Aligned_cols=188  Identities=24%  Similarity=0.323  Sum_probs=160.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++....      ...+.+.+|++++++++||||+++++++..    
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   79 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----   79 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence            3579999999999999999999999999999999975421      235789999999999999999999999654    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----  853 (914)
                       ....++||||+++++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++    
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~  149 (283)
T 3bhy_A           80 -KTDVVLILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP  149 (283)
T ss_dssp             -SSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred             -CCeEEEEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence             34789999999999999999754      4689999999999999999999999   999999999999999877    


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       150 ~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  205 (283)
T 3bhy_A          150 RIKLIDFGIAHKIEAGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  205 (283)
T ss_dssp             CEEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ceEEEecccceeccCCC---------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH
Confidence            89999999998654321         112346999999999985    47899999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=292.96  Aligned_cols=198  Identities=18%  Similarity=0.296  Sum_probs=157.3

Q ss_pred             hcccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccCCc-----------chHHHHHHHHHHHhcCCCCcceEEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQKG-----------ASKSFVSECEALRNIRHRNLIKIITI  770 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~  770 (914)
                      ++|++.+.||+|+||.||+|++..   ++..||||++......           ..+.+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            689999999999999999999987   7889999998754321           12356788899999999999999999


Q ss_pred             eecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       771 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      +... ++.....++||||+ +++|.+++...      ..+++.+++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG  185 (345)
T ss_dssp             EEEE-SSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             cccc-cCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence            7653 23456889999999 99999998754      3689999999999999999999999   999999999999999


Q ss_pred             CCC--cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDM--VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~--~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++  .+||+|||+|+.+....... ...........||+.|+|||++.    +.++|||||||++|||+
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell  254 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHK-QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL  254 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCC-CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCcEEEEeCCCceecccccccc-cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence            887  99999999998765432111 11111223567999999999985    58999999999999873

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=2e-31  Score=289.23  Aligned_cols=190  Identities=22%  Similarity=0.322  Sum_probs=159.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++...     ...+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEE
Confidence            36899999999999999999999999999999999766666678899999999999999999999996543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....     ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        93 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             EEEEeCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence            9999999999999987543     4689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      ........        ......||+.|+|||++.         +.++|+||+||++++|+
T Consensus       165 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  216 (302)
T 2j7t_A          165 AKNLKTLQ--------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA  216 (302)
T ss_dssp             HHHHHHHH--------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH
T ss_pred             cccccccc--------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh
Confidence            64322110        112346999999999983         46899999999999873

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=4.6e-31  Score=296.40  Aligned_cols=187  Identities=22%  Similarity=0.368  Sum_probs=154.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcC--CCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIR--HRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~  780 (914)
                      .+|++.+.||+|+||.||+|++.. ++.||||++....  ....+.+.+|++++++++  ||||+++++++...     +
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----Q  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----C
Confidence            469999999999999999999875 8899999997543  234568899999999997  59999999986543     4


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||| +.+++|.+++...      ..+++.++..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             EEEEEEe-cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence            7899999 5588999999865      3678889999999999999999999   999999999999995 589999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---------------hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------------~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+......      ......+||+.|||||++.               +.++||||+||++|||+
T Consensus       199 G~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell  261 (390)
T 2zmd_A          199 GIANQMQPDTTS------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  261 (390)
T ss_dssp             SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred             CccccccCCCcc------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence            999876432211      1112357999999999974               46899999999999873

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=3.1e-31  Score=288.04  Aligned_cols=187  Identities=26%  Similarity=0.334  Sum_probs=159.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++..     ....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence            4689999999999999999999999999999999986554455678999999999999999999999643     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEecc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDF  860 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~DF  860 (914)
                      +||||+++++|.+++...      ..+++.++..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+||
T Consensus        83 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEcCCCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence            999999999999998754      3688999999999999999999999   99999999999999   77899999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.....          ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       154 g~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  201 (304)
T 2jam_A          154 GLSKMEQNG----------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL  201 (304)
T ss_dssp             STTCCCCCB----------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred             CcceecCCC----------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence            999754321          112346999999999984    57999999999999873

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=1.5e-31  Score=292.34  Aligned_cols=205  Identities=20%  Similarity=0.233  Sum_probs=165.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence            468999999999999999999999899999999997666666678999999999999999999999875321 2334789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++.....  ....+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       107 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKD--KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EEEEeCCCCcHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            99999999999999876321  125689999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccccccccc-cCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIA-SKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~-~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +.......... ...........||+.|+|||++.       +.++||||+||++++|+
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  240 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM  240 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence            76532111000 00000112346899999999984       57999999999999873

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.2e-31  Score=294.34  Aligned_cols=281  Identities=19%  Similarity=0.237  Sum_probs=140.7

Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .++.....++++|+++ .+|..+.  ++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|+++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            3344445666666666 5565444  366666666666664444455556666666665555554444455555555555


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCC-CccccccccceeeccCCc-
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFP-RSICNISSVELIFLTENR-  256 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~-  256 (914)
                      +|++|++++..+..|+++++|++|+|++|+++                        +..+ ..|.++++|++|++++|+ 
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~------------------------~l~~~~~~~~l~~L~~L~l~~n~~  161 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK------------------------TLGETSLFSHLTKLQILRVGNMDT  161 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS------------------------SSCSSCSCTTCTTCCEEEEEESSS
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc------------------------ccCchhhhccCCCCcEEECCCCcc
Confidence            55555555332233444444444444444444                        2222 234444444444444442 


Q ss_pred             ccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCC
Q 042766          257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTAN  336 (914)
Q Consensus       257 l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  336 (914)
                      ++ .++...+.++++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|++|++++|.+++..  
T Consensus       162 ~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~--  238 (353)
T 2z80_A          162 FT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH--  238 (353)
T ss_dssp             CC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCC--
T ss_pred             cc-ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccc--
Confidence            22 222223334445555555555555444555555555555555555554433333333444444444444444332  


Q ss_pred             CcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccc----c
Q 042766          337 DLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG----T  412 (914)
Q Consensus       337 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~----~  412 (914)
                                                  +..+..                      ......++.++|++|.+++    .
T Consensus       239 ----------------------------~~~l~~----------------------~~~~~~l~~l~L~~~~l~~~~l~~  268 (353)
T 2z80_A          239 ----------------------------FSELST----------------------GETNSLIKKFTFRNVKITDESLFQ  268 (353)
T ss_dssp             ----------------------------CC----------------------------CCCCCCEEEEESCBCCHHHHHH
T ss_pred             ----------------------------cccccc----------------------ccccchhhccccccccccCcchhh
Confidence                                        111110                      0112223344444444432    3


Q ss_pred             CChhhhcccCCceeeecccccccccCcc-ccCCCCCCeEEeeCCcCCCC
Q 042766          413 IPDVISELKNLQQLSVFNNFLRGGIPSG-LGNLTKLGSLDLGSNSLQGN  460 (914)
Q Consensus       413 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~  460 (914)
                      +|..+..+++|++|+|++|+++. +|.. |.++++|++|+|++|.+++.
T Consensus       269 l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          269 VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             HHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             hHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccCc
Confidence            55666777777777777777773 4433 56777777777777777653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.2e-31  Score=290.71  Aligned_cols=190  Identities=25%  Similarity=0.421  Sum_probs=153.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEE----EEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVV----AVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .+|++.+.||+|+||.||+|++..+++.|    |+|.+... .....+.+.+|++++++++||||+++++++...     
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----   89 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   89 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence            57999999999999999999998777654    66666432 344567899999999999999999999997542     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                       ..++||||+++|+|.+++....     ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        90 -~~~~v~~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D  160 (327)
T 3lzb_A           90 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             -SEEEEECCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CceEEEEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence             3678999999999999998654     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+........      .......||+.|+|||++.    +.++||||+||++|||+
T Consensus       161 fG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell  213 (327)
T 3lzb_A          161 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  213 (327)
T ss_dssp             TTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcceeEccCcccc------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHH
Confidence            9999876432211      1122345788999999985    58999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=4.5e-31  Score=296.38  Aligned_cols=194  Identities=21%  Similarity=0.280  Sum_probs=156.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-----
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-----  776 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  776 (914)
                      ...++|++.+.||+|+||+||+|++..+++.||||++......    ..+|+++++.++||||+++++++.....     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4457899999999999999999999999999999998644322    2379999999999999999999754321     


Q ss_pred             ----------------------------CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHH
Q 042766          777 ----------------------------EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY  828 (914)
Q Consensus       777 ----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~  828 (914)
                                                  ....+.++||||++ |+|.+.+.....  ....+++..+..++.|++.||+|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHH
Confidence                                        23345889999997 588887764211  12578999999999999999999


Q ss_pred             HHhCCCCCcEecCCCCCCeeec-CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcc
Q 042766          829 LHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTH  902 (914)
Q Consensus       829 LH~~~~~~ivHrDlkp~NILl~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~D  902 (914)
                      ||++   +|+||||||+||+++ .++.+||+|||+|+......         ......||+.|+|||++.     +.++|
T Consensus       157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------PSVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------CCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------CCcCcccCCCccCHHHhcCCCCCCcchh
Confidence            9999   999999999999998 68999999999998654322         112357899999999874     47899


Q ss_pred             cCcccccccccC
Q 042766          903 IPSFSCTNVHHF  914 (914)
Q Consensus       903 i~s~g~~~~~~f  914 (914)
                      |||+||++|||+
T Consensus       225 iwslG~il~ell  236 (383)
T 3eb0_A          225 LWSIGCVFGELI  236 (383)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHH
Confidence            999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.9e-31  Score=287.03  Aligned_cols=191  Identities=20%  Similarity=0.299  Sum_probs=156.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.....   ...+.+.+|++++++++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            35789999999999999999999999999999999964432   234678999999999999999999999654     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++++|.+++...      ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             CeEEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEec
Confidence            4789999999999999999764      3689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.......       .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       178 fg~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  229 (309)
T 2h34_A          178 FGIASATTDEKL-------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL  229 (309)
T ss_dssp             CCC-----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH
T ss_pred             CccCcccccccc-------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH
Confidence            999986543221       1112356999999999984    57899999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=5.7e-31  Score=282.91  Aligned_cols=187  Identities=21%  Similarity=0.382  Sum_probs=162.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...   .....+.+.+|++++++++||||+++++++..     ..
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence            36899999999999999999999999999999999643   23345688999999999999999999999653     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...      ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence            789999999999999999764      3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |++.......          .....||+.|+|||++.    +.++|+||+||++++|+
T Consensus       159 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  206 (284)
T 2vgo_A          159 GWSVHAPSLR----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL  206 (284)
T ss_dssp             TTCEECSSSC----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred             cccccCcccc----------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH
Confidence            9987543211          12357999999999985    47899999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=6.4e-31  Score=289.52  Aligned_cols=198  Identities=24%  Similarity=0.416  Sum_probs=160.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-------CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeec
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-------DDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSS  773 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  773 (914)
                      ..++|++.+.||+|+||.||+|++.       .+++.||||+++... ....+.+.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999985       356789999997443 23456789999999999 89999999999643


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLK  843 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlk  843 (914)
                           .+..++||||+++|+|.+++......          .....+++.+++.++.|++.||+|||++   +|+|||||
T Consensus       113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk  184 (334)
T 2pvf_A          113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLA  184 (334)
T ss_dssp             -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCc
Confidence                 34789999999999999999865321          0123589999999999999999999999   99999999


Q ss_pred             CCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          844 PSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       844 p~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+||+++.++.+||+|||+++........      .......||+.|+|||++.    +.++||||+||+++||+
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  253 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF  253 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSE------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             cceEEEcCCCCEEEccccccccccccccc------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH
Confidence            99999999999999999999866432211      1112346889999999985    48899999999999873

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=5.5e-31  Score=291.07  Aligned_cols=188  Identities=23%  Similarity=0.363  Sum_probs=154.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCC--CCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRH--RNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~  779 (914)
                      ..+|++.+.||+|+||.||+|++. +++.||||++.....  ...+.+.+|++++++++|  |||+++++++..     .
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-----~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----D   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----C
Confidence            357999999999999999999985 688999999975432  234678999999999987  999999999654     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++|||| .+++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++ ++.+||+|
T Consensus        82 ~~~~lv~e~-~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           82 QYIYMVMEC-GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             CEEEEEEeC-CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence            478999995 588999999865      4688999999999999999999999   999999999999997 67899999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh---------------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+........      ......+||+.|+|||++.               +.++||||+||++|||+
T Consensus       151 FG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell  214 (343)
T 3dbq_A          151 FGIANQMQPDTTS------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  214 (343)
T ss_dssp             CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH
T ss_pred             cccccccCccccc------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH
Confidence            9999876432211      1122457999999999984               36899999999999873

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=7.4e-31  Score=279.25  Aligned_cols=189  Identities=28%  Similarity=0.458  Sum_probs=161.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++..     .+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeE
Confidence            368999999999999999999997 567899999975433 44789999999999999999999999643     34689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        80 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             EEEeCCCCCcHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence            9999999999999997653     4688999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  199 (267)
T 3t9t_A          152 RFVLDDQYT-------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF  199 (267)
T ss_dssp             GGBCCHHHH-------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccc-------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHh
Confidence            865432211       112346888999999985    47899999999999873

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.6e-31  Score=291.71  Aligned_cols=201  Identities=23%  Similarity=0.325  Sum_probs=163.1

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.....
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            334445678999999999999999999999899999999997543 3457889999999999 79999999999765322


Q ss_pred             C-CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          777 E-GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       777 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                      . .....++||||+++|+|.+++....    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence            1 1357899999999999999998643    24688999999999999999999999   99999999999999999999


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+++......        .......||+.|+|||++.         +.++|+||+||++++|+
T Consensus       169 kl~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  228 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA  228 (326)
T ss_dssp             EECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred             EEeeCcCceecCcCc--------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence            999999998653211        1112357999999999984         47899999999999873

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=4.4e-31  Score=299.63  Aligned_cols=191  Identities=24%  Similarity=0.375  Sum_probs=154.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  783 (914)
                      .+|+..+.||+|+||+||+|++..+++.||||++.....    ...+|++++++++||||+++++++..... ....+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            478999999999999999999999999999999864322    23479999999999999999998754321 2334577


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-CcEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~~ki~DFGl  862 (914)
                      +||||+++ ++.+.+....  .....+++..+..++.||+.||+|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus       130 lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eehhcccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence            99999975 6776665321  1125789999999999999999999999   99999999999999965 6789999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.+....         ......||+.|+|||++.     +.++||||+||++|||+
T Consensus       204 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  251 (420)
T 1j1b_A          204 AKQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL  251 (420)
T ss_dssp             CEECCTTC---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             hhhcccCC---------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH
Confidence            98654321         112357999999999984     47899999999999974

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=4e-31  Score=281.84  Aligned_cols=186  Identities=22%  Similarity=0.341  Sum_probs=158.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++...  ....+.+.+|++++++++||||+++++++....   ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence            358999999999999999999985  7889999997543  234467999999999999999999999975432   246


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeecCCCcEEEec
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      .++||||+++|+|.+++.....    ..+++.+++.++.|++.|++|||++   +  |+||||||+||+++.++.++|+|
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             eEeeecccCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence            7899999999999999986532    3689999999999999999999998   7  99999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhhh-------hhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM-------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~-------~~~Di~s~g~~~~~~f  914 (914)
                      ||++.....             ....||+.|+|||++.+       .++||||+||+++||+
T Consensus       157 ~~~~~~~~~-------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  205 (271)
T 3kmu_A          157 ADVKFSFQS-------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV  205 (271)
T ss_dssp             GGSCCTTSC-------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             ccceeeecc-------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence            998764321             12468999999999953       2699999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=5.3e-31  Score=289.78  Aligned_cols=189  Identities=24%  Similarity=0.381  Sum_probs=157.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++......  ..+.+.+|++++++++||||+++++++..     ...
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----KKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----CCE
Confidence            36899999999999999999999999999999998644332  34567899999999999999999999654     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++++++.++....      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCcchHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence            89999999999999887644      3589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.......        ......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       170 ~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  219 (331)
T 4aaa_A          170 FARTLAAPGE--------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF  219 (331)
T ss_dssp             TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             CceeecCCcc--------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH
Confidence            9986543211        112346999999999984     47899999999999873

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.97  E-value=8.1e-33  Score=301.30  Aligned_cols=246  Identities=17%  Similarity=0.192  Sum_probs=141.0

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCC-CCcCCCCcc-------ccCCcchhccCCCcccCCCChhc--c
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSF-SGTIPTNLS-------RCSNLIHFCASNNKLEGQIPKEI--G  170 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~--~  170 (914)
                      ++|++|++++|.+  .+|..+...  |++|+|++|++ .+.+|..+.       ++++|++|+|++|++++.+|..+  +
T Consensus        43 ~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~  118 (312)
T 1wwl_A           43 RSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA  118 (312)
T ss_dssp             EECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred             CCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence            3455555555555  455444433  55555555555 233444443       45555555555555555555544  5


Q ss_pred             ccccccccccccccccCcCCcccccc-----cccceeecccCCCCCCCCccchhhhcccccccccccccCC--CCCcc--
Q 042766          171 NLLKLQRLSVDINYLTGQLPDSVGNL-----SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM--FPRSI--  241 (914)
Q Consensus       171 ~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--  241 (914)
                      .+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+.+++|++|+|++|++.+.  .|..+  
T Consensus       119 ~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  197 (312)
T 1wwl_A          119 TGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP  197 (312)
T ss_dssp             CSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred             cCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence            555555555555555544 5555555     5566666666666655555666666666666666665443  22222  


Q ss_pred             ccccccceeeccCCcccC--cccccccccCcccceeeccCccCCCCCC-CccccccccccccccCccCCccccccccccc
Q 042766          242 CNISSVELIFLTENRFSG--IFPFDILLNLPNLKKLGIGGNNFVGSIP-DSLSNASNLELLDLPSNQFKGKVSIDFSSLK  318 (914)
Q Consensus       242 ~~l~~L~~L~L~~N~l~~--~~p~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  318 (914)
                      ..+++|++|+|++|++++  .++..++.++++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+.  +
T Consensus       198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~  274 (312)
T 1wwl_A          198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--A  274 (312)
T ss_dssp             TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--S
T ss_pred             ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--C
Confidence            566666666666666653  2333444566677777777777766554 34555667777777777776 3344443  6


Q ss_pred             cccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCC
Q 042766          319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGG  362 (914)
Q Consensus       319 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  362 (914)
                      +|++|+|++|+|++.+       . +..+++|++|+|++|++++
T Consensus       275 ~L~~L~Ls~N~l~~~p-------~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          275 KLSVLDLSYNRLDRNP-------S-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             EEEEEECCSSCCCSCC-------C-TTTSCEEEEEECTTCTTTC
T ss_pred             CceEEECCCCCCCCCh-------h-HhhCCCCCEEeccCCCCCC
Confidence            6777777777766541       1 4566777777777777664

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=1.2e-30  Score=283.27  Aligned_cols=187  Identities=27%  Similarity=0.370  Sum_probs=163.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      +.|+..+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++...     ...+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence            56899999999999999999999999999999997554 34557899999999999999999999996543     4789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++..       ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        97 lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             EEEECCTTEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence            99999999999999864       3588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......        ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       167 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  213 (303)
T 3a7i_A          167 GQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA  213 (303)
T ss_dssp             EECBTTBC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             eecCcccc--------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHc
Confidence            87643221        112357999999999984    47899999999999873

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=6.9e-31  Score=293.45  Aligned_cols=190  Identities=23%  Similarity=0.280  Sum_probs=152.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.... .+...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999999999999999997432  233467889999999999999999999976432 23334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++ |+|.+++.        ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       104 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEcCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence            7899999997 47888875        2478889999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......         ......||+.|+|||++.    +.++||||+||++|+|+
T Consensus       172 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  220 (371)
T 2xrw_A          172 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  220 (371)
T ss_dssp             CC-------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             eccccccccc---------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence            9998653211         112357999999999985    58899999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=9.4e-31  Score=283.31  Aligned_cols=189  Identities=27%  Similarity=0.348  Sum_probs=162.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---------cchHHHHHHHHHHHhcC-CCCcceEEeEee
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---------GASKSFVSECEALRNIR-HRNLIKIITICS  772 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  772 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++....         ...+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            45689999999999999999999999999999999975431         22357889999999996 999999999964


Q ss_pred             cCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       773 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                      .     ....++||||+++++|.+++...      ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        95 ~-----~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           95 T-----NTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD  160 (298)
T ss_dssp             C-----SSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred             c-----CCeEEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence            3     45789999999999999999754      4689999999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+++......         ......||+.|+|||++.          +.++|+||+||++++|+
T Consensus       161 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~  223 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL  223 (298)
T ss_dssp             CCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             CcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH
Confidence            999999999998654321         112357999999999985          36899999999999873

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=5.8e-31  Score=293.40  Aligned_cols=199  Identities=23%  Similarity=0.288  Sum_probs=160.4

Q ss_pred             HHHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-----------chHHHHHHHHHHHhcCCCCcc
Q 042766          697 YAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-----------ASKSFVSECEALRNIRHRNLI  765 (914)
Q Consensus       697 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv  765 (914)
                      .+++....++|++.+.||+|+||.||+|++.. ++.||||++......           ..+.+.+|++++++++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            56677788999999999999999999999864 889999998643211           126889999999999999999


Q ss_pred             eEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       766 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                      ++++++...........++||||++ |++.+++...+     ..+++..+..++.|++.||+|||++   +|+||||||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999986654445557899999997 68988887543     4689999999999999999999999   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.++.+||+|||+|+......         ......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  228 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADA---------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF  228 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             HEEEcCCCCEEEEecCccccccccc---------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence            9999999999999999997543221         122357999999999874     47899999999999873

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=1.8e-31  Score=297.00  Aligned_cols=189  Identities=23%  Similarity=0.353  Sum_probs=144.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecC-CCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSST-DFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~~  780 (914)
                      .++|+..+.||+|+||.||+|++..+++.||||++....  ....+++.+|++++++++||||+++++++... ..+...
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            368999999999999999999999999999999986432  23456788999999999999999999997543 122334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +++|.+++..       ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCEEEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             eEEEEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence            679999999 7899998864       3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           .....||+.|+|||++.     +.++||||+||+++||+
T Consensus       177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  224 (367)
T 2fst_X          177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  224 (367)
T ss_dssp             -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH
T ss_pred             ccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH
Confidence            999864321           12357999999999984     47899999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=4.5e-31  Score=283.28  Aligned_cols=189  Identities=21%  Similarity=0.415  Sum_probs=156.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|.+.+.||+|+||.||+|++..   ++..||+|+++... ....+.+.+|++++++++||||+++++++..      
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence            4689999999999999999998643   45679999987543 3345788999999999999999999998642      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++++|.+++...+     ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  156 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGD  156 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECC
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCc
Confidence            23589999999999999997643     4688999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++........       ......||+.|+|||++.    +.++|+||+||++++|
T Consensus       157 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  207 (281)
T 3cc6_A          157 FGLSRYIEDEDYY-------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI  207 (281)
T ss_dssp             CCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCccccccccc-------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHH
Confidence            9999866432211       112345789999999985    4789999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.5e-31  Score=293.07  Aligned_cols=203  Identities=22%  Similarity=0.376  Sum_probs=164.6

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEe
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITIC  771 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~  771 (914)
                      +++....++|++.+.||+|+||.||+|++.     .+++.||||++..... .....+.+|++++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344455678999999999999999999886     3578899999964432 3345788999999999999999999996


Q ss_pred             ecCCCCCCceEeEEEecccCCCHHHHHhccCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCe
Q 042766          772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQ----VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNV  847 (914)
Q Consensus       772 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NI  847 (914)
                      ..     ....++||||+++|+|.+++...+..    .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        98 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI  169 (322)
T 1p4o_A           98 SQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  169 (322)
T ss_dssp             CS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred             cc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence            43     34679999999999999999753211    0113568899999999999999999999   999999999999


Q ss_pred             eecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          848 LLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       848 Ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.++.+||+|||+++.........      ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  234 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA  234 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHH
Confidence            99999999999999998654322111      112346789999999985    48899999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=282.02  Aligned_cols=190  Identities=25%  Similarity=0.362  Sum_probs=158.4

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      +|.....||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...     +..++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEE
Confidence            344556999999999999999999999999999866666678899999999999999999999996543     478999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-CCcEEEecccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAK  864 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-~~~~ki~DFGla~  864 (914)
                      |||+++++|.+++.....   ...+++..+..++.|++.||+|||++   +|+||||||+||+++. ++.+||+|||+++
T Consensus        98 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWG---PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EECCSEEEHHHHHHHTTC---CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEeCCCCCHHHHHHhhcc---CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            999999999999976431   23567888999999999999999999   9999999999999987 8999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      .......        ......||+.|+|||++.      +.++|+||+||++++|+
T Consensus       172 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  219 (295)
T 2clq_A          172 RLAGINP--------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA  219 (295)
T ss_dssp             ESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCC--------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH
Confidence            6543211        112357999999999984      36899999999999873

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=9.1e-31  Score=284.58  Aligned_cols=250  Identities=21%  Similarity=0.276  Sum_probs=209.0

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccC--CCChhccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEG--QIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~  181 (914)
                      +.+++++++++ .+|..+.  ++|++|+|++|+++...+..++++++|++|+|++|+++.  ..|..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            57889999998 7887664  689999999999994444457999999999999999983  347788889999999999


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCC-ccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGI  260 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  260 (914)
                      +|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|++++..|..|..+++|++|++++|.+++.
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  165 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN  165 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence            99998 577789999999999999999987665 6789999999999999999988888899999999999999999873


Q ss_pred             ccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcch
Q 042766          261 FPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDF  340 (914)
Q Consensus       261 ~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  340 (914)
                      .....+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++.      .
T Consensus       166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------~  239 (306)
T 2z66_A          166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS------K  239 (306)
T ss_dssp             EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC------S
T ss_pred             cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc------C
Confidence            3334556888999999999999888788888889999999999999888777888888888888888888776      3


Q ss_pred             hhcccCC-CCCcEEeccccccCCC
Q 042766          341 VIFLSNC-SSLKVLSLSDNQFGGE  363 (914)
Q Consensus       341 ~~~l~~l-~~L~~L~Ls~N~l~~~  363 (914)
                      +..+..+ ++|++|+|++|.+++.
T Consensus       240 ~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          240 KQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             SSSCCCCCTTCCEEECTTCCEECS
T ss_pred             HHHHHhhhccCCEEEccCCCeecc
Confidence            3345666 3788888888888754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=3e-31  Score=295.46  Aligned_cols=188  Identities=22%  Similarity=0.342  Sum_probs=161.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence            357999999999999999999999999999999997543 33456889999999999999999999996543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++...      ..+++..+..++.|++.|++|||+.+  +|+||||||+||+++.++.+||+|||+
T Consensus       107 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~  178 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV  178 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             EEEEECCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCC
Confidence            9999999999999999764      36889999999999999999999831  799999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......          .....||+.|+|||++.    +.++||||+||++|+|+
T Consensus       179 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  224 (360)
T 3eqc_A          179 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA  224 (360)
T ss_dssp             CHHHHHHC--------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH
T ss_pred             Cccccccc----------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence            97653211          11357999999999985    57899999999999873

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=5.6e-31  Score=288.44  Aligned_cols=188  Identities=26%  Similarity=0.336  Sum_probs=156.8

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------CcchHHHHHHHHHHHhcCCCCcceEEeEeecC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------KGASKSFVSECEALRNIRHRNLIKIITICSST  774 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  774 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....        ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3468999999999999999999999999999999986432        12234588999999999999999999986432


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                            ..++||||+++++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.
T Consensus        88 ------~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  152 (322)
T 2ycf_A           88 ------DYYIVLELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE  152 (322)
T ss_dssp             ------SEEEEEECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred             ------ceEEEEecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence                  378999999999999998754      4688999999999999999999999   9999999999999987654


Q ss_pred             ---EEEecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          855 ---AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ---~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                         +||+|||+++......         ......||+.|+|||++.       +.++||||+||++|+|+
T Consensus       153 ~~~~kl~Dfg~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          153 DCLIKITDFGHSKILGETS---------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             SCCEEECCCTTCEECCCCH---------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             CCeEEEccCccceeccccc---------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence               9999999998654321         112356999999999973       47899999999999873

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=5.6e-32  Score=303.11  Aligned_cols=195  Identities=14%  Similarity=0.149  Sum_probs=151.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHH---HHHhcCCCCcceEE-------eE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECE---ALRNIRHRNLIKII-------TI  770 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  770 (914)
                      .++|++.+.||+|+||+||+|++..+++.||||++...   .....+.+.+|++   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999999889999999999743   3345578899994   55566899999998       44


Q ss_pred             eecCC-------CCCCc-----eEeEEEecccCCCHHHHHhccCCccc-ccCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042766          771 CSSTD-------FEGVD-----FKALVFEYMENGSLEDWLHQSNDQVE-VRKLSLIQRMNIAIDVASAIEYLHHHCQPPM  837 (914)
Q Consensus       771 ~~~~~-------~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~i  837 (914)
                      +....       ++...     ..++||||+ +|+|.+++...+...+ ...+++..++.|+.|++.||+|||++   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            33221       00111     268999999 6899999986421111 12344578889999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhhh---------------hhcc
Q 042766          838 VHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM---------------LYTH  902 (914)
Q Consensus       838 vHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~---------------~~~D  902 (914)
                      +||||||+|||++.++.+||+|||+|+....           .....+| +.|+|||++.+               .++|
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence            9999999999999999999999999985322           1123568 99999999854               4899


Q ss_pred             cCcccccccccC
Q 042766          903 IPSFSCTNVHHF  914 (914)
Q Consensus       903 i~s~g~~~~~~f  914 (914)
                      ||||||++|||+
T Consensus       296 vwSlG~il~ell  307 (377)
T 3byv_A          296 AWALGLVIYWIW  307 (377)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            999999999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=7.7e-32  Score=297.16  Aligned_cols=181  Identities=19%  Similarity=0.216  Sum_probs=149.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--------CcchHHHHHHHHHHHhcC---------CCCcce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--------KGASKSFVSECEALRNIR---------HRNLIK  766 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  766 (914)
                      .++|++.+.||+|+||+||+|++  +++.||||+++...        ....+.+.+|++++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  57999999997543        223378899999999886         888888


Q ss_pred             EEeEeecCC-------------------------CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHH
Q 042766          767 IITICSSTD-------------------------FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID  821 (914)
Q Consensus       767 l~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~  821 (914)
                      +.+++....                         +......++||||+++|++.+.+.+       ..+++.++..++.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQ  169 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHH
Confidence            877653211                         1124678999999999977666643       35789999999999


Q ss_pred             HHHHHHHHH-hCCCCCcEecCCCCCCeeecCCC--------------------cEEEecccccccccccccccccCCCCc
Q 042766          822 VASAIEYLH-HHCQPPMVHGDLKPSNVLLDYDM--------------------VAHVGDFGLAKFLSNHHLDIASKTPSS  880 (914)
Q Consensus       822 i~~gl~~LH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~~  880 (914)
                      |+.||+||| ++   +|+||||||+|||++.++                    .+||+|||+|+...+.           
T Consensus       170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------  235 (336)
T 2vuw_A          170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------  235 (336)
T ss_dssp             HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred             HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence            999999999 88   999999999999999887                    9999999999865421           


Q ss_pred             cccccCcccccccchhh---hhhcccCccccc
Q 042766          881 SIGIKGTVGYVAPGKFF---MLYTHIPSFSCT  909 (914)
Q Consensus       881 ~~~~~GT~~y~APE~~~---~~~~Di~s~g~~  909 (914)
                        ..+||+.|||||++.   +.++||||++++
T Consensus       236 --~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~  265 (336)
T 2vuw_A          236 --IVVFCDVSMDEDLFTGDGDYQFDIYRLMKK  265 (336)
T ss_dssp             --EEECCCCTTCSGGGCCCSSHHHHHHHHHHH
T ss_pred             --cEEEeecccChhhhcCCCccceehhhhhCC
Confidence              247999999999995   478999999887

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=1.1e-30  Score=279.53  Aligned_cols=188  Identities=28%  Similarity=0.394  Sum_probs=155.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|++++++++||||+++++++..     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence            36899999999999999999999989999999999643   23345688999999999999999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++...      ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             eEEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence            789999999999999999764      3588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......         ......||+.|+|||++.     +.++|+||+||++++|+
T Consensus       156 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~  205 (276)
T 2h6d_A          156 GLSNMMSDGE---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL  205 (276)
T ss_dssp             CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCCc---------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH
Confidence            9998654321         112346999999999984     47899999999999873

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=5.7e-31  Score=288.92  Aligned_cols=201  Identities=18%  Similarity=0.270  Sum_probs=165.1

Q ss_pred             CccCHHHHHHHhhccccc-CcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcC-CCCcceEE
Q 042766          693 PMVSYAELSKATSEFSSS-NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIR-HRNLIKII  768 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~  768 (914)
                      +.+.++......++|.+. +.||+|+||.||+|++..+++.||+|+++...  ......+.+|+.++++++ ||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            344455556666778877 89999999999999999999999999997443  334578899999999995 69999999


Q ss_pred             eEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                      +++..     ....++||||+++|+|.+++....    ...+++.+++.++.|++.||+|||++   +|+||||||+||+
T Consensus        96 ~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl  163 (327)
T 3lm5_A           96 EVYEN-----TSEIILILEYAAGGEIFSLCLPEL----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNIL  163 (327)
T ss_dssp             EEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             EEEEe-----CCeEEEEEEecCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEE
Confidence            99643     447899999999999999986532    25689999999999999999999999   9999999999999


Q ss_pred             ecC---CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          849 LDY---DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~~---~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.   ++.+||+|||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll  227 (327)
T 3lm5_A          164 LSSIYPLGDIKIVDFGMSRKIGHAC---------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL  227 (327)
T ss_dssp             ESCBTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             EecCCCCCcEEEeeCccccccCCcc---------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence            998   7899999999998654321         112357999999999985    47999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=1.3e-30  Score=279.45  Aligned_cols=189  Identities=23%  Similarity=0.474  Sum_probs=160.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++. ++..||+|+++... ...+.+.+|++++++++||||+++++++..      +..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CCcE
Confidence            468999999999999999999986 56789999986443 346789999999999999999999998642      2468


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....    ...+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        84 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            9999999999999997532    13689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......||+.|+|||++.    +.++|+||+||+++||+
T Consensus       157 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  204 (279)
T 1qpc_A          157 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV  204 (279)
T ss_dssp             EECSSSCEE-------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             ccccCcccc-------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHH
Confidence            876543211       112345788999999985    47899999999999873

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=4.4e-31  Score=288.43  Aligned_cols=206  Identities=21%  Similarity=0.332  Sum_probs=166.2

Q ss_pred             CHHHHHHHhhcccccCcccCCccEEEEEEEE-----CCCcEEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCCcceEE
Q 042766          696 SYAELSKATSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQK-GASKSFVSECEALRNI-RHRNLIKII  768 (914)
Q Consensus       696 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  768 (914)
                      .........++|++.+.||+|+||.||+|++     ..+++.||||+++.... ...+.+.+|+++++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344445567899999999999999999985     35779999999975432 2346789999999999 699999999


Q ss_pred             eEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcc----------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042766          769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV----------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV  838 (914)
Q Consensus       769 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~iv  838 (914)
                      +++...    ....++||||+++|+|.+++.......          ....+++.+++.++.|++.||+|||++   +|+
T Consensus        98 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~  170 (316)
T 2xir_A           98 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  170 (316)
T ss_dssp             EEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence            997533    245789999999999999998654210          012378999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          839 HGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       839 HrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||||||+||+++.++.+||+|||+++.......      ........||+.|+|||++.    +.++||||+||++++|+
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  244 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  244 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCcc------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence            999999999999999999999999986543211      11122356899999999985    48999999999999873

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=1.8e-30  Score=285.54  Aligned_cols=183  Identities=22%  Similarity=0.336  Sum_probs=158.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||+++.   ...+.+.+|++++++++ ||||+++++++....   ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence            689999999999999999999999999999999863   33578899999999997 999999999976422   34679


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFGl  862 (914)
                      +||||+++++|.+++.         .+++.++..++.|++.||+|||++   +|+||||||+||+++.++ .+||+|||+
T Consensus       110 lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~  177 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  177 (330)
T ss_dssp             EEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence            9999999999999874         377889999999999999999999   999999999999999777 899999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+......         ......||+.|+|||++.     +.++||||+||++++|+
T Consensus       178 a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  225 (330)
T 3nsz_A          178 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI  225 (330)
T ss_dssp             CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             ceEcCCCC---------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence            98654321         112347999999999984     47899999999999873

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=285.50  Aligned_cols=194  Identities=25%  Similarity=0.375  Sum_probs=156.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC---------
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTD---------  775 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  775 (914)
                      ++|++.+.||+|+||.||+|++..+++.||+|++...+....+.+.+|++++++++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57999999999999999999999999999999998666666678999999999999999999999874321         


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CCCc
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMV  854 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~~~  854 (914)
                      +......++||||++ |+|.+++..       ..+++..+..++.|++.||+|||++   +|+||||||+||+++ .++.
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence            233457899999997 699999864       3588899999999999999999999   999999999999997 5679


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+++........     ........||+.|+|||++.     +.++|+||+||+++||+
T Consensus       160 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  219 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSH-----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  219 (320)
T ss_dssp             EEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEccCccccccCCCccc-----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence            999999999876432111     11122356899999999874     47899999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.9e-31  Score=283.87  Aligned_cols=193  Identities=24%  Similarity=0.397  Sum_probs=159.2

Q ss_pred             cccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .|...+.||+|+||.||+|++..+   +..||+|++..... ...+.+.+|++++++++||||+++++++....    ..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence            566778999999999999997543   44799999864332 34568899999999999999999999975332    34


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg  169 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG  169 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred             cEEEEecccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence            589999999999999997643     4678899999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+........    .........||+.|+|||.+.    +.++|+||+||++|+|+
T Consensus       170 ~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  222 (298)
T 3pls_A          170 LARDILDREYY----SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL  222 (298)
T ss_dssp             SSCTTTTGGGG----CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcccccCCccc----ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence            99866543211    111223457899999999985    58899999999999873

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=5.2e-31  Score=302.07  Aligned_cols=189  Identities=27%  Similarity=0.475  Sum_probs=155.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|+..+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++..      ...+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            3578899999999999999999975 4679999997543 345789999999999999999999998643      3478


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++....    ...+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       255 iv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEehhhcCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence            9999999999999997532    24588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......||+.|+|||++.    +.++|||||||+++||+
T Consensus       328 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~  375 (452)
T 1fmk_A          328 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT  375 (452)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eecCCCcee-------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHH
Confidence            876432211       112345788999999985    58999999999999874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=1e-30  Score=282.63  Aligned_cols=196  Identities=24%  Similarity=0.346  Sum_probs=158.6

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++++++|++++..++++..    .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence            4468999999999999999999999999999999875433  23457889999999999988887777643    23578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~D  859 (914)
                      ++||||+ +++|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||++   +.++.+||+|
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             EEEEEcc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence            9999999 999999997543     4689999999999999999999999   99999999999999   7889999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.......... ..........||+.|+|||++.    +.++||||+||++|+|+
T Consensus       152 fg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  209 (296)
T 4hgt_A          152 FGLAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  209 (296)
T ss_dssp             CTTCEECBCTTTCCB-CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CccceeccCcccCcc-CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence            999987654322111 1111223467999999999985    47899999999999873

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=3.1e-31  Score=284.20  Aligned_cols=195  Identities=25%  Similarity=0.368  Sum_probs=162.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            468999999999999999999999999999999997543  23456789999999999999999999986432   2357


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEecCCCCCCeeecCCCcEE
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP-----MVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~k  856 (914)
                      .++||||+++++|.+++.....  ....+++..++.++.|++.||+|||+.   +     |+||||||+||+++.++.+|
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence            8999999999999999975421  124589999999999999999999998   7     99999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+++......        .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       157 l~dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  210 (279)
T 2w5a_A          157 LGDFGLARILNHDT--------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC  210 (279)
T ss_dssp             ECCCCHHHHC---C--------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred             EecCchheeecccc--------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence            99999998654321        0112356999999999985    58899999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=8.1e-31  Score=289.05  Aligned_cols=204  Identities=20%  Similarity=0.223  Sum_probs=151.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCC---CCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDF---EGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~---~~~  779 (914)
                      ..+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.....   ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            358999999999999999999999999999999997666556678899999999996 9999999999753221   344


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCeeecCCCcEEE
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPP--MVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~--ivHrDlkp~NILl~~~~~~ki  857 (914)
                      ...++||||++ |+|.+++....   ....+++.+++.++.|++.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            56899999995 79999887522   124689999999999999999999998   7  999999999999999999999


Q ss_pred             eccccccccccccccccc----CCCCccccccCcccccccchh-------hhhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIAS----KTPSSSIGIKGTVGYVAPGKF-------FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~----~~~~~~~~~~GT~~y~APE~~-------~~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++...........    ..........||+.|+|||++       ++.++||||+||++|+|+
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~  247 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC  247 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence            999999876542211000    000112245699999999998       247999999999999873

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=4.5e-31  Score=290.71  Aligned_cols=200  Identities=22%  Similarity=0.352  Sum_probs=162.9

Q ss_pred             HHHhhcccccCcccCCccEEEEEEEECCCc-----EEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCCcceEEeEeec
Q 042766          701 SKATSEFSSSNMIGQGRFGTVYKGILGDDE-----MVVAVKVINLKQK-GASKSFVSECEALRNI-RHRNLIKIITICSS  773 (914)
Q Consensus       701 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  773 (914)
                      ....++|+..+.||+|+||.||+|++..++     +.||+|+++.... ...+.+.+|+++++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344578999999999999999999997655     3799999975432 3456789999999999 89999999999643


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcc--------cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQV--------EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                           .+..++||||+++|+|.+++.......        ....+++..++.++.|++.||+|||++   +|+||||||+
T Consensus       122 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  193 (333)
T 2i1m_A          122 -----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR  193 (333)
T ss_dssp             -----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             -----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccc
Confidence                 346899999999999999997542100        123578999999999999999999999   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++.++.+||+|||+++........      .......||+.|+|||++.    +.++||||+||+++||+
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~  260 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNY------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF  260 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTS------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             eEEECCCCeEEECccccccccccccce------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHH
Confidence            999999999999999999865432211      1112346789999999984    58999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=6.1e-31  Score=289.37  Aligned_cols=191  Identities=28%  Similarity=0.479  Sum_probs=152.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCC----cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|+..+.||+|+||.||+|++..+    +..||||+++... ......+.+|++++++++||||+++++++..     .
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-----Y  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-----C
Confidence            4678889999999999999998644    3569999997443 2334578999999999999999999999643     4


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|+|.+++....     ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  190 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  190 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence            47899999999999999997643     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ||+++........     ........||+.|+|||++.    +.++|+||+||+++||
T Consensus       191 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  243 (333)
T 1mqb_A          191 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV  243 (333)
T ss_dssp             CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred             CCcchhhcccccc-----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence            9999876532211     11112345788999999985    5789999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=283.78  Aligned_cols=189  Identities=24%  Similarity=0.354  Sum_probs=158.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++....  ..+.+.+|++++++++||||+++++++...     ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence            4568999999999999999999999999999999996533  457789999999999999999999996543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++++|.+++....     ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEeecCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            99999999999999987432     4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.......        ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       172 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  219 (314)
T 3com_A          172 AGQLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA  219 (314)
T ss_dssp             CEECBTTBS--------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH
T ss_pred             chhhhhhcc--------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHH
Confidence            986543211        122357999999999984    57899999999999873

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1e-30  Score=278.89  Aligned_cols=187  Identities=25%  Similarity=0.396  Sum_probs=147.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|+..+.||+|+||.||+|++.  ++.||||+++...    ....+.+.+|++++++++||||+++++++..     .
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence            357999999999999999999985  7889999986432    2334688999999999999999999999643     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC--------
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY--------  851 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~--------  851 (914)
                      ...++||||+++++|.+++..       ..+++.++..++.|++.|++|||++...+|+||||||+||+++.        
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             CceEEEEEcCCCCCHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            468999999999999999864       36889999999999999999999992122999999999999986        


Q ss_pred             CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       852 ~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++.+||+|||+++......          .....||+.|+|||++.    +.++|+||+||++++|+
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~  208 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT----------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL  208 (271)
T ss_dssp             SCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             CcceEEccCCccccccccc----------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            6789999999998654321          11346999999999985    57899999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=1.6e-30  Score=281.25  Aligned_cols=195  Identities=25%  Similarity=0.349  Sum_probs=161.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  ..+.+.+|++++++++|++++..++++..    .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            468999999999999999999999999999999986443  33568899999999999988777766543    235789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEecc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGDF  860 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~DF  860 (914)
                      +||||+ +++|.+++....     ..+++.++..++.|++.||+|||++   +|+||||||+||++   +.++.+||+||
T Consensus        82 lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df  152 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF  152 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEec-CCCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence            999999 999999997543     4689999999999999999999999   99999999999999   48889999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......... ...........||+.|+|||++.    +.++||||+||+++||+
T Consensus       153 g~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  209 (296)
T 3uzp_A          153 GLAKKYRDARTHQ-HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  209 (296)
T ss_dssp             TTCEECBCTTTCC-BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCccccccccccc-ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence            9998765432211 01111223567999999999985    47999999999999873

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=1.3e-30  Score=296.34  Aligned_cols=186  Identities=22%  Similarity=0.306  Sum_probs=158.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc------CCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI------RHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  777 (914)
                      ..+|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+++++.+      +|+||+++++++...   
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~---  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR---  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence            35799999999999999999999999999999999632 23446778899988887      577999999986543   


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc--E
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV--A  855 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~--~  855 (914)
                        ...++||||++ ++|.+++.....    ..+++..+..++.||+.||+|||++   +||||||||+|||++.++.  +
T Consensus       172 --~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          172 --NHICMTFELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             --TEEEEEECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred             --CeEEEEEeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence              47899999995 699999986542    4589999999999999999999999   9999999999999999987  9


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+|+.....           ....+||+.|||||++.    +.++||||+||++|||+
T Consensus       242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  293 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL  293 (429)
T ss_dssp             EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH
T ss_pred             EEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHH
Confidence            99999999754321           12357999999999985    58999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=1.5e-30  Score=282.65  Aligned_cols=194  Identities=22%  Similarity=0.365  Sum_probs=160.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC----CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...    ....+.+.+|++++++++||||+++++++..   +..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            468999999999999999999999999999999996432    3445789999999999999999999998743   223


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||++++ +.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeec
Confidence            4689999999876 7777765432    5689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........      .......||+.|+|||++.      +.++|+||+||++++|+
T Consensus       153 fg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  207 (305)
T 2wtk_C          153 LGVAEALHPFAAD------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT  207 (305)
T ss_dssp             CTTCEECCTTCSS------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH
T ss_pred             cccccccCccccc------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH
Confidence            9999865432111      1122356999999999985      46899999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.3e-30  Score=283.45  Aligned_cols=186  Identities=28%  Similarity=0.426  Sum_probs=150.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++.  ++.||||++..  ....+.+.+|++++++++||||+++++++..       ..+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~   75 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC   75 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence            357899999999999999999985  67899999853  3455789999999999999999999998532       358


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc-EEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV-AHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~-~ki~DFGl  862 (914)
                      +||||+++|+|.+++.....   ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+
T Consensus        76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             EEEEcCCCCCHHHHHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            99999999999999986532   235788899999999999999999932228999999999999998886 79999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ++......           ....||+.|+|||++.    +.++|||||||+++||+
T Consensus       153 ~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  197 (307)
T 2eva_A          153 ACDIQTHM-----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI  197 (307)
T ss_dssp             -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccc-----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH
Confidence            97543211           1246999999999985    47999999999999873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.2e-30  Score=278.80  Aligned_cols=191  Identities=23%  Similarity=0.389  Sum_probs=158.6

Q ss_pred             hcccccC-cccCCccEEEEEEEEC--CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSN-MIGQGRFGTVYKGILG--DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|.+.+ .||+|+||.||+|++.  .++..||||+++... ....+.+.+|++++++++||||+++++++..      +
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence            4666666 9999999999999864  467889999997543 3345688999999999999999999999732      2


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++....     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df  154 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  154 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence            4799999999999999997543     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.........     .......||+.|+|||++.    +.++|+||+||+++||+
T Consensus       155 g~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  207 (287)
T 1u59_A          155 GLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  207 (287)
T ss_dssp             TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             cceeeeccCccee-----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            9998764322111     1112345789999999985    58999999999999873

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.9e-30  Score=286.28  Aligned_cols=196  Identities=26%  Similarity=0.348  Sum_probs=154.9

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc--CCCCcceEEeEeecCCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI--RHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~~  779 (914)
                      ...++|++.+.||+|+||.||+|++.  ++.||||++...   ....+.+|.+++...  +||||+++++++.... ...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence            34578999999999999999999985  789999998533   234455666666554  8999999999976542 122


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCCeeecCCCc
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC-----QPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~-----~~~ivHrDlkp~NILl~~~~~  854 (914)
                      ...++||||+++|+|.++++..       .+++.+++.++.|++.||+|||+++     .++|+||||||+||+++.++.
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence            4789999999999999999653       5889999999999999999999752     348999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhhh----h------hcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM----L------YTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~----~------~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.+........    .......||+.|+|||++.+    .      ++|||||||++|||+
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~  246 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA  246 (337)
T ss_dssp             EEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCceeecccccccc----CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH
Confidence            99999999986643321111    11123579999999999853    2      489999999999873

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=6.5e-31  Score=283.20  Aligned_cols=188  Identities=29%  Similarity=0.460  Sum_probs=148.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..   .||+|+++...  ....+.+.+|++++++++||||+++++++..      ..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------Cc
Confidence            4689999999999999999998753   49999997543  2334678999999999999999999997432      24


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++++|.+++....     ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             cEEEEEecCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            689999999999999997543     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +++........      .......||+.|+|||++.       +.++||||+||++++|+
T Consensus       166 ~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  219 (289)
T 3og7_A          166 LATEKSRWSGS------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM  219 (289)
T ss_dssp             ------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH
T ss_pred             ecccccccccc------ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH
Confidence            99865432111      1122357999999999984       36899999999999873

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.8e-30  Score=304.04  Aligned_cols=292  Identities=21%  Similarity=0.271  Sum_probs=163.2

Q ss_pred             CCCCCCCCCCCCCCccceee------cCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCC
Q 042766           53 GVTSSWNNTMNFCQWTGVTC------GHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFR  126 (914)
Q Consensus        53 ~~~~~w~~~~~~c~w~gv~C------~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  126 (914)
                      ...++|..+.+||.|.|..|      ......++.|++++++++ .+|..+.  ++|++|+|++|.++ .+|.   .+++
T Consensus        10 ~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~   82 (622)
T 3g06_A           10 AVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE   82 (622)
T ss_dssp             CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred             HHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence            34567877778999977532      111234667777777775 5566554  67777777777776 4554   4566


Q ss_pred             CCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeeccc
Q 042766          127 LEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE  206 (914)
Q Consensus       127 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  206 (914)
                      |++|+|++|+|+ .+|.   .+++|++|+|++|++++ +|.   .+++|++|++++|++++ +|..   +++|++|+|++
T Consensus        83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~  150 (622)
T 3g06_A           83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSD  150 (622)
T ss_dssp             CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred             CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcC
Confidence            777777777776 4554   55666666666666663 333   34556666666666552 3432   24455555555


Q ss_pred             CCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCC
Q 042766          207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI  286 (914)
Q Consensus       207 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~  286 (914)
                      |.+++ +|.                           .+.+|+.|++++|.+++ +|    ..+++|++|+|++|+|++ +
T Consensus       151 N~l~~-l~~---------------------------~~~~L~~L~L~~N~l~~-l~----~~~~~L~~L~Ls~N~l~~-l  196 (622)
T 3g06_A          151 NQLAS-LPA---------------------------LPSELCKLWAYNNQLTS-LP----MLPSGLQELSVSDNQLAS-L  196 (622)
T ss_dssp             SCCSC-CCC---------------------------CCTTCCEEECCSSCCSC-CC----CCCTTCCEEECCSSCCSC-C
T ss_pred             CcCCC-cCC---------------------------ccCCCCEEECCCCCCCC-Cc----ccCCCCcEEECCCCCCCC-C
Confidence            55542 222                           12345555555555553 23    234566666666666653 3


Q ss_pred             CCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCc
Q 042766          287 PDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH  366 (914)
Q Consensus       287 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~  366 (914)
                      |..   +++|+.|++++|+|+.+..    .+++|++|+|++|+|+.++          ..+++|+.|+|++|+|+ .+|.
T Consensus       197 ~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~lp----------~~l~~L~~L~Ls~N~L~-~lp~  258 (622)
T 3g06_A          197 PTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSLP----------VLPSELKELMVSGNRLT-SLPM  258 (622)
T ss_dssp             CCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCCC----------CCCTTCCEEECCSSCCS-CCCC
T ss_pred             CCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcCC----------CCCCcCcEEECCCCCCC-cCCc
Confidence            332   3556666666666664332    1355666666666665542          23355666666666665 2332


Q ss_pred             hhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCC
Q 042766          367 SIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL  444 (914)
Q Consensus       367 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  444 (914)
                                                  .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++..|..+..+
T Consensus       259 ----------------------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          259 ----------------------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             ----------------------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             ----------------------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence                                        2344555555555555 445555555555555555555555555544433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=6.9e-31  Score=293.64  Aligned_cols=191  Identities=11%  Similarity=0.029  Sum_probs=142.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhc--CCCCcceEE-------eEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNI--RHRNLIKII-------TIC  771 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  771 (914)
                      ..+|+..+.||+|+||.||+|++..+++.||||++.....   ...+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            3468999999999999999999999999999999986543   2345677885554444  699988755       332


Q ss_pred             ecCCCC------------CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHH------HHHHHHHHHHHHHHHhCC
Q 042766          772 SSTDFE------------GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR------MNIAIDVASAIEYLHHHC  833 (914)
Q Consensus       772 ~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~------~~i~~~i~~gl~~LH~~~  833 (914)
                      ......            .....++||||++ |+|.+++...+     ..+++..+      ..++.|++.||+|||++ 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSK-  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence            211100            0134799999998 89999998642     23344445      67789999999999999 


Q ss_pred             CCCcEecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCccc
Q 042766          834 QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFS  907 (914)
Q Consensus       834 ~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g  907 (914)
                        +|+||||||+|||++.++.+||+|||+|+......           ....||+.|||||++.      +.++||||+|
T Consensus       214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  280 (371)
T 3q60_A          214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----------PASSVPVTYAPREFLNASTATFTHALNAWQLG  280 (371)
T ss_dssp             --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred             --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----------cCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence              99999999999999999999999999998653211           1245779999999984      4899999999


Q ss_pred             ccccccC
Q 042766          908 CTNVHHF  914 (914)
Q Consensus       908 ~~~~~~f  914 (914)
                      |++|||+
T Consensus       281 ~il~ell  287 (371)
T 3q60_A          281 LSIYRVW  287 (371)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=2.4e-30  Score=279.13  Aligned_cols=191  Identities=26%  Similarity=0.384  Sum_probs=157.1

Q ss_pred             hhcccccC-cccCCccEEEEEEEE--CCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          704 TSEFSSSN-MIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       704 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      .++|.+.+ .||+|+||.||+|++  ..+++.||||+++...  ....+.+.+|++++++++||||+++++++..     
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-----
Confidence            45788888 999999999999954  5678999999997543  2335689999999999999999999999722     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                       +..++||||+++++|.+++...      ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             -CCcEEEEEeCCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence             3578999999999999999764      3588999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++.........     .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       160 Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  214 (291)
T 1xbb_A          160 DFGLSKALRADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  214 (291)
T ss_dssp             CCTTCEECCTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cCCcceeeccCCCcc-----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence            999998764322111     1112235789999999995    47899999999999873

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=1.5e-30  Score=283.53  Aligned_cols=193  Identities=24%  Similarity=0.407  Sum_probs=152.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|++++++++||||+++++++...     +
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----N  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----C
Confidence            457999999999999999999999899999999997532   23456788999999999999999999997543     4


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++++|.+++.....  ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cEEEEEecCCCCCHHHHHHHhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEec
Confidence            78999999999999999875321  124688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.......        ......||+.|+|||++.    +.++|+|||||++++|+
T Consensus       181 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~  230 (310)
T 2wqm_A          181 GLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA  230 (310)
T ss_dssp             --------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeeecCCCc--------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence            99986543211        112356999999999984    58999999999999873

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=9.9e-31  Score=305.77  Aligned_cols=189  Identities=27%  Similarity=0.475  Sum_probs=160.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++..      ...+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            4578899999999999999999975 4679999997543 345789999999999999999999998643      3478


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++....    ...+++.+++.++.||+.||+|||++   +||||||||+|||++.++.+||+|||++
T Consensus       338 lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             EeeehhcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            9999999999999997532    14588999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +........       ......+|..|||||++.    +.++|||||||+++||+
T Consensus       411 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~  458 (535)
T 2h8h_A          411 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT  458 (535)
T ss_dssp             TTCCCHHHH-------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             eecCCCcee-------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence            876532211       111345788999999984    58999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.6e-30  Score=292.66  Aligned_cols=190  Identities=23%  Similarity=0.338  Sum_probs=151.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  783 (914)
                      .+|+..+.||+|+||+||+|++..+++ ||+|++......    ..+|+++++.++||||+++++++..... ....+.+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999999999987766 888877533222    2369999999999999999999765432 3344578


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CCCcEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~~~~ki~DFGl  862 (914)
                      +||||++++ +.+.+....  .....+++..+..++.|++.||+|||++   +|+||||||+|||++ .++.+||+|||+
T Consensus       115 lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeeccCcc-HHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            999999764 444333211  0125689999999999999999999999   999999999999999 789999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+......         ......||+.|+|||++.     +.++||||+||++|||+
T Consensus       189 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  236 (394)
T 4e7w_A          189 AKILIAGE---------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM  236 (394)
T ss_dssp             CEECCTTC---------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             cccccCCC---------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence            98754321         112357999999999984     47899999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.5e-30  Score=308.61  Aligned_cols=190  Identities=22%  Similarity=0.385  Sum_probs=153.9

Q ss_pred             cccccC-cccCCccEEEEEEEEC--CCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          706 EFSSSN-MIGQGRFGTVYKGILG--DDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       706 ~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++.+.+ .||+|+||.||+|+++  .++..||||+++... ....+.+.+|++++++++|||||+++++|..      +.
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EA  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SS
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CC
Confidence            344444 7999999999999875  456789999997543 3456789999999999999999999999753      24


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...+     ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             eEEEEEeCCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence            799999999999999997543     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.........     .......+|+.|||||++.    +.++|||||||+++||+
T Consensus       482 la~~~~~~~~~~-----~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  533 (613)
T 2ozo_A          482 LSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  533 (613)
T ss_dssp             TTTTCC-------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             CcccccCCCcee-----eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            998764322110     1112234678999999995    58999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=9.9e-31  Score=295.92  Aligned_cols=196  Identities=24%  Similarity=0.313  Sum_probs=144.7

Q ss_pred             hcccc-cCcccCCccEEEEEEEEC--CCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSS-SNMIGQGRFGTVYKGILG--DDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +.|++ .++||+|+||.||+|+++  .+++.||||++...  ...+.+.+|++++++++||||+++++++...   ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCe
Confidence            45665 558999999999999976  46789999998633  3346788999999999999999999997532   2457


Q ss_pred             EeEEEecccCCCHHHHHhccCCc---ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee----cCCCc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQ---VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL----DYDMV  854 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl----~~~~~  854 (914)
                      .++||||++ |+|.+++...+..   .....+++..+..++.||+.||+|||++   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            899999996 5888887643210   1123589999999999999999999999   99999999999999    67789


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.+.....     ........+||+.|+|||++.     +.++||||+||++|||+
T Consensus       171 ~kl~Dfg~a~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  230 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLK-----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL  230 (405)
T ss_dssp             EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH
T ss_pred             EEEEECCCceecCCCCc-----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH
Confidence            99999999987643211     111223467999999999984     47899999999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.5e-30  Score=285.73  Aligned_cols=193  Identities=26%  Similarity=0.404  Sum_probs=157.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEE--EEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVV--AVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||.||+|++..++..+  |+|.++.. .....+.+.+|+++++++ +||||+++++++..     .+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----CC
Confidence            57999999999999999999998888755  99988643 233456789999999999 89999999999654     34


Q ss_pred             eEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ..++||||+++|+|.+++...+..          .....+++.+++.++.|++.||+|||++   +|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence            789999999999999999765310          0124689999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++.+||+|||+++......         ......+|+.|+|||++.    +.++|+||+||+++||+
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  235 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  235 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEcccCcCccccccc---------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence            99999999999997432211         112245789999999985    58999999999999873

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=2e-30  Score=283.35  Aligned_cols=191  Identities=28%  Similarity=0.403  Sum_probs=158.1

Q ss_pred             cccccCcccCCccEEEEEEEE----CCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          706 EFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .|++.+.||+|+||.||+|.+    ..+++.||||+++... ....+.+.+|++++++++||||+++++++....   ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~  108 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---AA  108 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---TT
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---Cc
Confidence            348999999999999988765    3478999999997543 234567899999999999999999999976432   35


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...       .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Df  178 (318)
T 3lxp_A          109 SLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDF  178 (318)
T ss_dssp             EEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCG
T ss_pred             eEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCc
Confidence            789999999999999999753       488999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+++.........     .......||+.|+|||++.    +.++||||+||++++|+
T Consensus       179 g~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll  231 (318)
T 3lxp_A          179 GLAKAVPEGHEYY-----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL  231 (318)
T ss_dssp             GGCEECCTTCSEE-----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccc-----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            9998765422110     1122346899999999995    47899999999999873

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.96  E-value=7e-31  Score=291.42  Aligned_cols=192  Identities=15%  Similarity=0.213  Sum_probs=157.2

Q ss_pred             hcccccCcccCCccEEEEEEEECC--------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcce----------
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD--------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK----------  766 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  766 (914)
                      ++|++.+.||+|+||.||+|++..        .++.||+|++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            689999999999999999999987        3789999998643     46789999999999999998          


Q ss_pred             -----EEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecC
Q 042766          767 -----IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGD  841 (914)
Q Consensus       767 -----l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrD  841 (914)
                           +++++..    .....++||||+ +++|.+++....    ...+++.+++.++.|++.||+|||++   +|+|||
T Consensus       117 ~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D  184 (352)
T 2jii_A          117 LAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGN  184 (352)
T ss_dssp             CSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred             cCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence                 4555432    235789999999 999999998652    25789999999999999999999999   999999


Q ss_pred             CCCCCeeecCCC--cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          842 LKPSNVLLDYDM--VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       842 lkp~NILl~~~~--~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+||+++.++  .+||+|||+|+.+........ ..........||+.|+|||++.    +.++|||||||++|||+
T Consensus       185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA-YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC-CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCceEEEecCcceeeccCCCcccc-ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence            999999999998  999999999987654322111 1111223457999999999985    48999999999999873

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.7e-32  Score=325.33  Aligned_cols=429  Identities=15%  Similarity=0.093  Sum_probs=233.3

Q ss_pred             cCCcccCCCCCCCeeecCCCCC---CCcCCCCcc------------ccCCcchhccCCCcccCCCChhcccc--cccccc
Q 042766          116 DIPQEIGNLFRLEKLALSNNSF---SGTIPTNLS------------RCSNLIHFCASNNKLEGQIPKEIGNL--LKLQRL  178 (914)
Q Consensus       116 ~~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~l~------------~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L  178 (914)
                      .++..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..++..  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            3344556788899999987532   244554444            45566666666665554444444442  236666


Q ss_pred             cccccc-ccC-cCCcccccccccceeecccCCCCCC----CCccchhhhcccccccccccccC----CCCCccccccccc
Q 042766          179 SVDINY-LTG-QLPDSVGNLSAIEVIRITENSLGGK----IPTTLGLLRRLVNLNVAENQFSG----MFPRSICNISSVE  248 (914)
Q Consensus       179 ~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~  248 (914)
                      +|++|. ++. .++....++++|++|+|++|.+++.    ++..+..+++|++|++++|.+++    .++..+.      
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~------  217 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR------  217 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH------
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh------
Confidence            665554 110 1112223445555555555554433    22223344445555555554441    1222233      


Q ss_pred             eeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCC---ccccccccccccccceec
Q 042766          249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK---GKVSIDFSSLKNLWLLNL  325 (914)
Q Consensus       249 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L  325 (914)
                                         ++++|++|+|++|.+.+ +|..+..+++|+.|+++++...   +..+..+..+++|+.|++
T Consensus       218 -------------------~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l  277 (592)
T 3ogk_B          218 -------------------NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL  277 (592)
T ss_dssp             -------------------HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEE
T ss_pred             -------------------hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCc
Confidence                               34444444444444442 3344444444444444432211   112223344445555555


Q ss_pred             cCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcc
Q 042766          326 EQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE  405 (914)
Q Consensus       326 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  405 (914)
                      +++....       +|..+..+++|++|+|++|.+++.....+....++|+.|+++++...+.++..+..+++|++|+|+
T Consensus       278 ~~~~~~~-------l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~  350 (592)
T 3ogk_B          278 SYMGPNE-------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE  350 (592)
T ss_dssp             TTCCTTT-------GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred             cccchhH-------HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence            4432111       333444555555555555554432222211222245555555222222233334566778888887


Q ss_pred             -----------cCccccc-CChhhhcccCCceeeecccccccccCccccC-CCCCCeEEee----CCcCCCC-----CCC
Q 042766          406 -----------VNQFHGT-IPDVISELKNLQQLSVFNNFLRGGIPSGLGN-LTKLGSLDLG----SNSLQGN-----IPS  463 (914)
Q Consensus       406 -----------~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~  463 (914)
                                 .|.+++. ++..+..+++|++|+++.|.+++..+..++. +++|+.|+|+    .|.+++.     ++.
T Consensus       351 ~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~  430 (592)
T 3ogk_B          351 RGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS  430 (592)
T ss_dssp             CCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHH
T ss_pred             cCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHH
Confidence                       3566543 2333456788888888778877766666654 7778888886    5666643     222


Q ss_pred             ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcccccc-ccccceeecccCCcccc-ccCcccccc
Q 042766          464 SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVG-NLKNLVMLDISSNQFSG-VIPVTLSTC  541 (914)
Q Consensus       464 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l  541 (914)
                      .+.++++|+.|+++++.                       +.+++..+..++ .+++|++|+|++|++++ .++..+.++
T Consensus       431 ~~~~~~~L~~L~L~~~~-----------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  487 (592)
T 3ogk_B          431 LLIGCKKLRRFAFYLRQ-----------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGC  487 (592)
T ss_dssp             HHHHCTTCCEEEEECCG-----------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCC
T ss_pred             HHHhCCCCCEEEEecCC-----------------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcC
Confidence            34456666666665322                       112222222332 37889999999999987 345556789


Q ss_pred             ccccEEEeeccccccc-CCcchhccCCCCEEEccCCccccccCccc-cccCCCCeEeCCCC
Q 042766          542 VSLEYLDISINSFYGV-IPLSFRFLKSIKALNVSSNNLSGKIPEFL-ENLSFLEFLNLSYN  600 (914)
Q Consensus       542 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N  600 (914)
                      ++|++|+|++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus       488 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             TTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             cccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            9999999999998765 34445689999999999999987644444 35666666655554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=3.1e-30  Score=287.26  Aligned_cols=201  Identities=24%  Similarity=0.282  Sum_probs=151.7

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-  776 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  776 (914)
                      .......++|++.+.||+|+||.||+|++..+++.||||++... ........+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            44566778999999999999999999999999999999998643 3334567788899999999999999999865332 


Q ss_pred             -CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCcEecCCCCCCeeecC-C
Q 042766          777 -EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH--HHCQPPMVHGDLKPSNVLLDY-D  852 (914)
Q Consensus       777 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH--~~~~~~ivHrDlkp~NILl~~-~  852 (914)
                       ....+.++||||+++ ++.+.+.....  ....+++..+..++.|++.|+.|||  +.   +|+||||||+||+++. +
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence             223357899999976 55554432110  1246888999999999999999999  77   9999999999999997 8


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+|+......         ......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell  226 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSE---------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM  226 (360)
T ss_dssp             TEEEECCCTTCBCCCTTS---------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCC---------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999998664321         112357999999999983     57899999999999873

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=1.1e-30  Score=286.73  Aligned_cols=197  Identities=23%  Similarity=0.383  Sum_probs=155.7

Q ss_pred             hhcccccCcccCCccEEEEEEE-----ECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGI-----LGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||.||+|+     ...+++.||||++.... .....++.+|+.++++++||||+++++++..    
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ----  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence            4689999999999999999999     44567899999996432 3345678999999999999999999999643    


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CC
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQV-EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DM  853 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~  853 (914)
                       ....++||||+++|+|.+++....... ....+++.+++.++.|++.||.|||++   +|+||||||+||+++.   +.
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence             346799999999999999998654211 124589999999999999999999999   9999999999999984   44


Q ss_pred             cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          854 VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       854 ~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+||+|||+++........      .......||+.|+|||++.    +.++||||+||++++|+
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell  239 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF  239 (327)
T ss_dssp             CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eEEECcccccccccccccc------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence            6999999999865332211      1122356899999999984    58999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=1.5e-30  Score=309.20  Aligned_cols=184  Identities=27%  Similarity=0.394  Sum_probs=151.0

Q ss_pred             CcccCCccEEEEEEEE--CCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGIL--GDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      +.||+|+||.||+|.+  ..+++.||||+++...  ....+++.+|++++++++|||||++++++..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999965  4567899999997542  3345789999999999999999999999742      2468999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++..|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+
T Consensus       449 E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             ECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             EccCCCCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            999999999999754      4688999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ......     ........||+.|+|||++.    +.++|||||||++|||+
T Consensus       520 ~~~~~~-----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell  566 (635)
T 4fl3_A          520 RADENY-----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  566 (635)
T ss_dssp             TC------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccCccc-----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence            543211     11122345789999999995    58999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=4.9e-31  Score=286.22  Aligned_cols=202  Identities=24%  Similarity=0.313  Sum_probs=144.4

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...     +
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~   86 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D   86 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence            34568999999999999999999998889999999986443 33456788999999999999999999996543     3


Q ss_pred             eEeEEEecccCCCHHHHHhccCC--cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          781 FKALVFEYMENGSLEDWLHQSND--QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ..++||||+++++|.+++.....  ......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence            68999999999999999874210  01124689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++........   ..........||+.|+|||++.     +.++|+||+||++++|+
T Consensus       164 dfg~~~~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  221 (303)
T 2vwi_A          164 DFGVSAFLATGGDI---TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA  221 (303)
T ss_dssp             CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred             eccchheeccCCCc---cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence            99999865432110   0111122457999999999984     47899999999999873

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.96  E-value=3.4e-30  Score=282.72  Aligned_cols=195  Identities=25%  Similarity=0.440  Sum_probs=161.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-CCcEEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-DDEMVVAVKVINLKQ--KGASKSFVSECEALRNI---RHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~  776 (914)
                      ..++|++.+.||+|+||.||+|++. .+++.||+|+++...  ......+.+|+++++++   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 678999999997433  22334677888887776   89999999999764333


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                      +.....++||||++ |+|.+++.....    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence            34567899999997 699999976532    3589999999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+++......         ......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       161 l~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  213 (326)
T 1blx_A          161 LADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF  213 (326)
T ss_dssp             ECSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             EecCcccccccCCC---------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence            99999998654321         112357999999999984    58899999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=7.2e-30  Score=282.21  Aligned_cols=195  Identities=26%  Similarity=0.350  Sum_probs=160.3

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHh--cCCCCcceEEeEeecCCCC
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRN--IRHRNLIKIITICSSTDFE  777 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~  777 (914)
                      .....++|++.+.||+|+||.||+|++  +++.||||++...   ..+.+.+|+++++.  ++||||+++++++.... .
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~  110 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-G  110 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence            344567899999999999999999998  4889999998533   34677889999887  78999999999976543 1


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCCeee
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH--------HHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH--------~~~~~~ivHrDlkp~NILl  849 (914)
                      .....++||||+++|+|.+++...       .+++.+++.++.|++.|++|||        +.   +|+||||||+||++
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             ccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            123689999999999999999753       5889999999999999999999        66   99999999999999


Q ss_pred             cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhhh----------hhcccCcccccccccC
Q 042766          850 DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM----------LYTHIPSFSCTNVHHF  914 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~----------~~~Di~s~g~~~~~~f  914 (914)
                      +.++.+||+|||+++..........    .......||+.|+|||++.+          .++|||||||++|||+
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~  251 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA  251 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEE----ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEECCCceeccccccccc----cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence            9999999999999986543221100    01123579999999999854          5899999999999873

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2e-29  Score=289.57  Aligned_cols=246  Identities=20%  Similarity=0.221  Sum_probs=141.9

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            44455555554 4444333  35555555555555444555555555555555555555444455555555555555555


Q ss_pred             cccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccc-ccccCCCCCccccccccceeeccCCcccCccc
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE-NQFSGMFPRSICNISSVELIFLTENRFSGIFP  262 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  262 (914)
                      ++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|++++. |
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~  212 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P  212 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence            55544444455555555555555555544444555555555555555 333333334555666666666666666543 2


Q ss_pred             ccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhh
Q 042766          263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVI  342 (914)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  342 (914)
                      .  +..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|+++..+.      .
T Consensus       213 ~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------~  284 (452)
T 3zyi_A          213 N--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH------D  284 (452)
T ss_dssp             C--CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT------T
T ss_pred             c--ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccCh------H
Confidence            1  3356666677777776666666667777777777777777776666666666777777777776665532      2


Q ss_pred             cccCCCCCcEEeccccccC
Q 042766          343 FLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       343 ~l~~l~~L~~L~Ls~N~l~  361 (914)
                      .+..+++|+.|+|++|.+.
T Consensus       285 ~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          285 LFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             SSTTCTTCCEEECCSSCEE
T ss_pred             HhccccCCCEEEccCCCcC
Confidence            3455666666666666654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.7e-30  Score=278.32  Aligned_cols=185  Identities=31%  Similarity=0.414  Sum_probs=151.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|++.  ++.||||+++..  ...+.+.+|++++++++||||+++++++..    .....+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceE
Confidence            468999999999999999999984  789999998643  355789999999999999999999998643    234678


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++++|.+++....    ...+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEecCCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence            9999999999999997542    13478899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +......           ....+|+.|+|||++.    +.++|+||+||++++|+
T Consensus       165 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  208 (278)
T 1byg_A          165 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY  208 (278)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccc-----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHH
Confidence            7543211           1235789999999985    58999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=6.4e-30  Score=293.20  Aligned_cols=194  Identities=24%  Similarity=0.349  Sum_probs=157.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc-ceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL-IKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++.++|++. ..+..++.     .....
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~-----~~~~~   78 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV-----EGDYN   78 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE-----ETTEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe-----eCCEE
Confidence            3689999999999999999999999999999998864432  3457899999999987554 44444432     23478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee---cCCCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL---DYDMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl---~~~~~~ki~D  859 (914)
                      ++||||+ +++|.+++....     ..+++.+++.|+.||+.||+|||++   +||||||||+|||+   +.++.+||+|
T Consensus        79 ~lvme~~-g~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEEECC-CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence            9999999 999999997543     4689999999999999999999999   99999999999999   6889999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.+....... ...........||+.|+|||++.    +.++|||||||++|||+
T Consensus       150 FGla~~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell  207 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQ-HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL  207 (483)
T ss_dssp             CTTCEECBCTTTCC-BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCcceeccCCcccc-ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence            99998765432111 11112223568999999999995    57899999999999874

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=5.3e-32  Score=294.88  Aligned_cols=250  Identities=19%  Similarity=0.186  Sum_probs=187.5

Q ss_pred             cCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcc-cCCCChhcc-------ccccccccccccccccCcCCcc
Q 042766          121 IGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL-EGQIPKEIG-------NLLKLQRLSVDINYLTGQLPDS  192 (914)
Q Consensus       121 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~  192 (914)
                      ++..++|++|++++|.+  .+|..+...  |++|+|++|++ .+.+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45667788888888888  677766655  88888888888 456777665       6788888888888888888877


Q ss_pred             c--ccccccceeecccCCCCCCCCccchhh-----hcccccccccccccCCCCCccccccccceeeccCCcccCcc--cc
Q 042766          193 V--GNLSAIEVIRITENSLGGKIPTTLGLL-----RRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF--PF  263 (914)
Q Consensus       193 ~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~  263 (914)
                      +  +.+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|..+++|++|+|++|++.+.+  |.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            5  7888888888888888876 7778877     78888888888888877788888888888888888876642  22


Q ss_pred             c-ccccCcccceeeccCccCCCC---CCCccccccccccccccCccCCcccc-ccccccccccceeccCCcCCCCCCCCc
Q 042766          264 D-ILLNLPNLKKLGIGGNNFVGS---IPDSLSNASNLELLDLPSNQFKGKVS-IDFSSLKNLWLLNLEQNNLGTGTANDL  338 (914)
Q Consensus       264 ~-~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~  338 (914)
                      . .+.++++|++|+|++|++++.   ....+..+++|++|+|++|+|++.+| ..+..+++|++|+|++|.|+.++.   
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~---  270 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---  270 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCS---
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhh---
Confidence            2 235778888888888888731   12334567788888888888887764 456667888888888888875432   


Q ss_pred             chhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccc
Q 042766          339 DFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISG  387 (914)
Q Consensus       339 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~  387 (914)
                          .+.  ++|++|+|++|++++. |. +..+. +|++|++++|.+++
T Consensus       271 ----~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~-~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          271 ----GLP--AKLSVLDLSYNRLDRN-PS-PDELP-QVGNLSLKGNPFLD  310 (312)
T ss_dssp             ----SCC--SEEEEEECCSSCCCSC-CC-TTTSC-EEEEEECTTCTTTC
T ss_pred             ----hcc--CCceEEECCCCCCCCC-hh-HhhCC-CCCEEeccCCCCCC
Confidence                233  6788888888888855 55 55554 68888888888775

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.4e-29  Score=287.60  Aligned_cols=252  Identities=21%  Similarity=0.228  Sum_probs=182.0

Q ss_pred             cEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecc
Q 042766          351 KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN  430 (914)
Q Consensus       351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  430 (914)
                      ..++.+++.++ .+|..+.   .+++.|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        57 ~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             cEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            34444444444 3443332   2455566666666665666666666666666666666666666666666666666666


Q ss_pred             cccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchh-hhcccchhhhhcccCCccCCC
Q 042766          431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ-LLSITTLSLVLDLSNNLLNGS  509 (914)
Q Consensus       431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~  509 (914)
                      |+|++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++|+..+.+|.. +..+..+ ++|+|++|++++.
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~~~  211 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL-KYLNLGMCNIKDM  211 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTC-CEEECTTSCCSSC
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCC-CEEECCCCccccc
Confidence            6666555555666666666666666666555556666666666666664333344443 3444444 6667777777643


Q ss_pred             ccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCcccccc
Q 042766          510 LPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENL  589 (914)
Q Consensus       510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  589 (914)
                       | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..++.+..+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence             3 47788999999999999999999999999999999999999999999999999999999999999998888899999


Q ss_pred             CCCCeEeCCCCccccccCCC
Q 042766          590 SFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       590 ~~L~~L~ls~N~l~~~~p~~  609 (914)
                      ++|+.|+|++|+|.|+|...
T Consensus       290 ~~L~~L~L~~Np~~CdC~~~  309 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCDIL  309 (452)
T ss_dssp             TTCCEEECCSSCEECSTTTH
T ss_pred             cCCCEEEccCCCcCCCCCch
Confidence            99999999999999998865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=2.3e-30  Score=286.91  Aligned_cols=187  Identities=22%  Similarity=0.346  Sum_probs=159.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---ch--------------HHHHHHHHHHHhcCCCCcce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---AS--------------KSFVSECEALRNIRHRNLIK  766 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~--------------~~~~~E~~~l~~l~h~niv~  766 (914)
                      .++|++.+.||+|+||.||+|++  +++.||||++......   ..              +.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  7899999999743211   11              78999999999999999999


Q ss_pred             EEeEeecCCCCCCceEeEEEecccCCCHHHH------HhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEe
Q 042766          767 IITICSSTDFEGVDFKALVFEYMENGSLEDW------LHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVH  839 (914)
Q Consensus       767 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivH  839 (914)
                      +++++..     .+..++||||+++|+|.++      +....    ...+++..+..++.|++.|++|||+ .   +|+|
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H  175 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH  175 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence            9999654     3478999999999999998      44321    2578999999999999999999999 8   9999


Q ss_pred             cCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhhh------hhcccCccccccccc
Q 042766          840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM------LYTHIPSFSCTNVHH  913 (914)
Q Consensus       840 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~------~~~Di~s~g~~~~~~  913 (914)
                      |||||+||+++.++.+||+|||.++.....          ......||+.|+|||++.+      .++|+||+||+++||
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999999999865432          1123569999999999853      389999999999987


Q ss_pred             C
Q 042766          914 F  914 (914)
Q Consensus       914 f  914 (914)
                      +
T Consensus       246 ~  246 (348)
T 2pml_X          246 F  246 (348)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=285.95  Aligned_cols=253  Identities=21%  Similarity=0.217  Sum_probs=191.5

Q ss_pred             cEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecc
Q 042766          351 KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN  430 (914)
Q Consensus       351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  430 (914)
                      +.++.+++.++ .+|..+.   .+++.|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        46 ~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            44555555555 4554433   2456666666666666666677777777777777777766666677777777777777


Q ss_pred             cccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCch-hhhcccchhhhhcccCCccCCC
Q 042766          431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ-QLLSITTLSLVLDLSNNLLNGS  509 (914)
Q Consensus       431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~l~~~L~Ls~N~l~~~  509 (914)
                      |+|++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++|+..+.+|. .+..+..+ ++|+|++|.++ .
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L-~~L~L~~n~l~-~  199 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL-RYLNLAMCNLR-E  199 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC-CEEECTTSCCS-S
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc-CeecCCCCcCc-c
Confidence            777755555666777777777777777666666667777777777776444334444 34445555 67777777777 3


Q ss_pred             ccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCcccccc
Q 042766          510 LPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENL  589 (914)
Q Consensus       510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  589 (914)
                      +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..+..+..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            44 47889999999999999999999999999999999999999999999999999999999999999999888899999


Q ss_pred             CCCCeEeCCCCccccccCCCC
Q 042766          590 SFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       590 ~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      ++|+.|+|++|+|.|+|...+
T Consensus       279 ~~L~~L~L~~Np~~CdC~l~~  299 (440)
T 3zyj_A          279 HHLERIHLHHNPWNCNCDILW  299 (440)
T ss_dssp             TTCCEEECCSSCEECSSTTHH
T ss_pred             cCCCEEEcCCCCccCCCCchH
Confidence            999999999999999987653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=3.6e-30  Score=290.78  Aligned_cols=191  Identities=23%  Similarity=0.347  Sum_probs=158.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC--------CCCcceEEeEeecCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR--------HRNLIKIITICSSTD  775 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~~  775 (914)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999999999999999999633 334567889999999985        788999999865321


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC--
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM--  853 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~--  853 (914)
                       ......++||||+ ++++.+++.....    ..+++.+++.++.||+.||+|||+++  +|+||||||+|||++.++  
T Consensus       115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          115 -VNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             -TTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred             -CCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence             1345789999999 6677776654421    46899999999999999999999853  799999999999999775  


Q ss_pred             -----------------------------------------------cEEEecccccccccccccccccCCCCccccccC
Q 042766          854 -----------------------------------------------VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG  886 (914)
Q Consensus       854 -----------------------------------------------~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~G  886 (914)
                                                                     .+||+|||+|+.....           ....+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----------~~~~~g  255 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----------FTEDIQ  255 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------SCSCCS
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------CccCCC
Confidence                                                           7999999999865321           113479


Q ss_pred             cccccccchhh----hhhcccCcccccccccC
Q 042766          887 TVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       887 T~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.|||||++.    +.++||||+||++|||+
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell  287 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELA  287 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence            99999999995    58899999999999873

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=4.2e-30  Score=277.12  Aligned_cols=191  Identities=27%  Similarity=0.374  Sum_probs=149.8

Q ss_pred             hcccccCcccCCccEEEEEEEECC-C--cEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD-D--EMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||.||+|++.. +  +..||||+++..   .....+.+.+|++++++++||||+++++++...    
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----   93 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   93 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence            589999999999999999998642 2  347999998644   233457889999999999999999999986432    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                        ..++||||+++++|.+++....     ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+
T Consensus        94 --~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~  163 (291)
T 1u46_A           94 --PMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  163 (291)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             --CceeeEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEc
Confidence              2689999999999999997643     4688999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++.........     .......||+.|+|||++.    +.++|+||+||++++|+
T Consensus       164 Dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  218 (291)
T 1u46_A          164 DFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  218 (291)
T ss_dssp             CCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccch-----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence            999998764322110     1112346888999999995    47899999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=4.6e-30  Score=286.78  Aligned_cols=188  Identities=23%  Similarity=0.321  Sum_probs=155.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~  780 (914)
                      .++|...+.||+|+||.||+|++..+++.||||++....  ....+.+.+|++++++++||||+++++++..... ....
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            358999999999999999999999999999999997433  2234688899999999999999999999764431 1112


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||++ ++|.+++.        ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             eEEEEEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence            3489999996 68888774        3488999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           .....||+.|+|||++.     +.++|+||+||++++|+
T Consensus       189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  236 (371)
T 4exu_A          189 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  236 (371)
T ss_dssp             TCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             CcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH
Confidence            999854321           12357899999999874     57899999999999873

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=4e-30  Score=277.18  Aligned_cols=191  Identities=21%  Similarity=0.276  Sum_probs=146.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-c-chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-G-ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++.... . ..+.+.+|...++.++||||+++++++..     .+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence            4689999999999999999999999999999999964422 1 22334455556888899999999999654     346


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ |+|.+++.....  ....+++..+..++.|++.|++|||+++  +|+||||||+||+++.++.+||+|||
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVID--KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG  155 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred             EEEEEehhc-cchHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence            899999997 588887764211  1257899999999999999999999842  89999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh--------hhhhcccCccccccccc
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF--------FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~--------~~~~~Di~s~g~~~~~~  913 (914)
                      +|+......         ......||+.|+|||++        ++.++|+||+||++++|
T Consensus       156 ~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l  206 (290)
T 3fme_A          156 ISGYLVDDV---------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL  206 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHH
T ss_pred             Ccccccccc---------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHH
Confidence            998654321         11224699999999996        25799999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.96  E-value=1.1e-29  Score=273.21  Aligned_cols=190  Identities=27%  Similarity=0.349  Sum_probs=162.1

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  ....+.+.+|++++++++||||+++++++..     .
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----S   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----C
Confidence            34568999999999999999999999899999999997442  3456789999999999999999999999654     3


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC---CcEE
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD---MVAH  856 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~---~~~k  856 (914)
                      ...++||||+++++|.+++...      ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.+   +.+|
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k  164 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK  164 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CeEEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence            4789999999999999988754      3688999999999999999999999   99999999999999764   4799


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      |+|||+++......         ......||+.|+|||++.   +.++|+||+||++++|+
T Consensus       165 L~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~  216 (287)
T 2wei_A          165 IIDFGLSTCFQQNT---------KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILL  216 (287)
T ss_dssp             ECSTTGGGTBCCCS---------SCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHH
T ss_pred             EeccCcceeecCCC---------ccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHH
Confidence            99999998654321         112346899999999985   47899999999999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=5.1e-30  Score=280.42  Aligned_cols=188  Identities=22%  Similarity=0.291  Sum_probs=159.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc------chHHHHHHHHHHHhcC--CCCcceEEeEeecC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG------ASKSFVSECEALRNIR--HRNLIKIITICSST  774 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  774 (914)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++.....      ..+.+.+|++++++++  ||||+++++++.. 
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-  119 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-  119 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence            456899999999999999999999999999999999754321      2346678999999996  5999999999654 


Q ss_pred             CCCCCceEeEEEecccC-CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CC
Q 042766          775 DFEGVDFKALVFEYMEN-GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YD  852 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~  852 (914)
                          .+..++||||+.+ ++|.+++...      ..+++..+..++.|++.||+|||+.   +|+||||||+||+++ .+
T Consensus       120 ----~~~~~lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          120 ----PDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             ----SSEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred             ----CCcEEEEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence                3478999999976 8999999764      4688999999999999999999999   999999999999999 78


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +.+||+|||+++......          .....||+.|+|||++.     +.++|||||||+++||+
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  243 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV  243 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEeeCcccccccccc----------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH
Confidence            999999999998764321          12346999999999985     47789999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=6.5e-30  Score=282.00  Aligned_cols=186  Identities=22%  Similarity=0.353  Sum_probs=157.0

Q ss_pred             hhcccccCcccCCccEEEEEEEE-CCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC------cceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGIL-GDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN------LIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|++ ..+++.||||+++.. ....+.+.+|++++++++|++      ++++++++..   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~---   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH---   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE---
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc---
Confidence            35899999999999999999998 568899999998633 234567889999999987654      9999998643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-----
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-----  851 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-----  851 (914)
                        .+..++||||+ +++|.+++...+.    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.     
T Consensus        89 --~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           89 --HGHICIVFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred             --CCcEEEEEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence              34889999999 8899999976532    4688999999999999999999999   9999999999999987     


Q ss_pred             --------------CCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          852 --------------DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       852 --------------~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                                    ++.+||+|||+++.....           .....||+.|+|||++.    +.++||||+||++|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  227 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY  227 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHH
Confidence                          668999999999864321           12357999999999985    5899999999999987


Q ss_pred             C
Q 042766          914 F  914 (914)
Q Consensus       914 f  914 (914)
                      +
T Consensus       228 ~  228 (339)
T 1z57_A          228 Y  228 (339)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.5e-30  Score=280.79  Aligned_cols=191  Identities=25%  Similarity=0.300  Sum_probs=154.3

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhc----CCCCcceEEe
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNI----RHRNLIKIIT  769 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  769 (914)
                      .....++|++.+.||+|+||.||+|++..+++.||||+++....      .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            34456789999999999999999999998999999999964432      1233566799999998    8999999999


Q ss_pred             EeecCCCCCCceEeEEEec-ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCee
Q 042766          770 ICSSTDFEGVDFKALVFEY-MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVL  848 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NIL  848 (914)
                      ++.     ..+..++|||| +++++|.+++...      ..+++..++.++.|++.||+|||++   +|+||||||+||+
T Consensus       106 ~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  171 (312)
T 2iwi_A          106 WFE-----TQEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENIL  171 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEE
T ss_pred             EEe-----cCCeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEE
Confidence            853     33467899999 7899999999764      3689999999999999999999999   9999999999999


Q ss_pred             ec-CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          849 LD-YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       849 l~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      ++ .++.+||+|||+++......          .....||+.|+|||++.     +.++|+||+||++++|+
T Consensus       172 ~~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  233 (312)
T 2iwi_A          172 IDLRRGCAKLIDFGSGALLHDEP----------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV  233 (312)
T ss_dssp             EETTTTEEEECCCSSCEECCSSC----------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCeEEEEEcchhhhcccCc----------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence            99 88999999999998764321          12356999999999985     35899999999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=5.1e-30  Score=309.08  Aligned_cols=185  Identities=23%  Similarity=0.330  Sum_probs=156.0

Q ss_pred             hcccccCcccCCccEEEEEEEECC-CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD-DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|++++++++||||+++++++......+....
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999975 78999999986432 2344678899999999999999999999876543333346


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      |+||||++|++|.+++..        .+++.+++.|+.||+.||.|||++   +||||||||+|||++.+ .+||+|||+
T Consensus       160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence            999999999999987652        589999999999999999999999   99999999999999886 899999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh---hhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~  913 (914)
                      ++.....            ....||+.|||||++.   +.++|||||||++++|
T Consensus       228 a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l  269 (681)
T 2pzi_A          228 VSRINSF------------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAAL  269 (681)
T ss_dssp             CEETTCC------------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHH
T ss_pred             chhcccC------------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHH
Confidence            9865321            2357999999999986   4789999999999986

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=8.4e-29  Score=283.34  Aligned_cols=242  Identities=20%  Similarity=0.202  Sum_probs=143.8

Q ss_pred             CCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCC
Q 042766           85 SSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQ  164 (914)
Q Consensus        85 ~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  164 (914)
                      .+.+++ .+|..+.  +.+++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++.
T Consensus        51 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~  127 (440)
T 3zyj_A           51 VRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI  127 (440)
T ss_dssp             CSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSC
T ss_pred             CCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCee
Confidence            334443 3454443  5667777777777766666777777777777777777655556666666666666666666644


Q ss_pred             CChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccc
Q 042766          165 IPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNI  244 (914)
Q Consensus       165 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  244 (914)
                      .+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+                       .+....+..|.++
T Consensus       128 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~-----------------------~l~~i~~~~~~~l  184 (440)
T 3zyj_A          128 PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK-----------------------RLSYISEGAFEGL  184 (440)
T ss_dssp             CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT-----------------------TCCEECTTTTTTC
T ss_pred             CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC-----------------------CcceeCcchhhcc
Confidence            44456666666666666666664444455555555555555532                       2222222344444


Q ss_pred             cccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccccccccccccccee
Q 042766          245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLN  324 (914)
Q Consensus       245 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  324 (914)
                      ++|++|+|++|+++.. |.  +..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+
T Consensus       185 ~~L~~L~L~~n~l~~~-~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  261 (440)
T 3zyj_A          185 SNLRYLNLAMCNLREI-PN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN  261 (440)
T ss_dssp             SSCCEEECTTSCCSSC-CC--CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEE
T ss_pred             cccCeecCCCCcCccc-cc--cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEE
Confidence            4455555555544422 21  33556666666666666666666666666666777777766666666666666666666


Q ss_pred             ccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          325 LEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       325 L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      |++|+++..+.      ..+..+++|+.|+|++|.+.
T Consensus       262 L~~N~l~~~~~------~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          262 LAHNNLTLLPH------DLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTSCCCCCCT------TTTSSCTTCCEEECCSSCEE
T ss_pred             CCCCCCCccCh------hHhccccCCCEEEcCCCCcc
Confidence            66666665532      23456666666666666654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=1.4e-29  Score=278.86  Aligned_cols=188  Identities=23%  Similarity=0.321  Sum_probs=139.0

Q ss_pred             hhcccccC-cccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSN-MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|.+.+ .||+|+||.||+|+++.+++.||||++...     ....+|+. .++.++||||+++++++.... .....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            45788854 699999999999999999999999998532     22233333 456779999999999875422 22446


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEe
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVG  858 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~  858 (914)
                      .++||||+++|+|.+++.....    ..+++.+++.++.|++.||+|||++   +|+||||||+||+++.   ++.+||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence            8999999999999999986532    4689999999999999999999999   9999999999999986   4569999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++......          .....||+.|+|||++    ++.++||||+||++|+|+
T Consensus       174 Dfg~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  223 (336)
T 3fhr_A          174 DFGFAKETTQNA----------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL  223 (336)
T ss_dssp             CCTTCEEC--------------------------------CHHHHHHHHHHHHHHHHHHH
T ss_pred             ccccceeccccc----------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH
Confidence            999998654221          1235689999999998    468999999999999873

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.9e-29  Score=269.63  Aligned_cols=250  Identities=24%  Similarity=0.214  Sum_probs=186.9

Q ss_pred             cEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecc
Q 042766          351 KVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFN  430 (914)
Q Consensus       351 ~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  430 (914)
                      +.++.+++.++ .+|..+   ..++++|++++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            67788888887 566543   33677788888887777777777777778888877777777777777777777777777


Q ss_pred             cc-cccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCC
Q 042766          431 NF-LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGS  509 (914)
Q Consensus       431 N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~  509 (914)
                      |. +++..|..|..+++|++|+|++|++++..|..+.++++|+.|++++|+++                         +.
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~  144 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-------------------------AL  144 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------------------CC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-------------------------cc
Confidence            76 66555677777777777777777777766777777777766666666554                         34


Q ss_pred             ccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCcccccc
Q 042766          510 LPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENL  589 (914)
Q Consensus       510 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  589 (914)
                      .+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|+.|++++|++++..+..+..+
T Consensus       145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  224 (285)
T 1ozn_A          145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL  224 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred             CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence            44556777888888888888887777778888888888888888888888888888888888888888887777778888


Q ss_pred             CCCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCC
Q 042766          590 SFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGG  629 (914)
Q Consensus       590 ~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~  629 (914)
                      ++|+.|++++|++.|.++..+....+.......+...|..
T Consensus       225 ~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~  264 (285)
T 1ozn_A          225 RALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSL  264 (285)
T ss_dssp             TTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEE
T ss_pred             cccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCC
Confidence            8888888888888888776543333333444555555554

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.96  E-value=1.4e-29  Score=302.16  Aligned_cols=190  Identities=23%  Similarity=0.381  Sum_probs=157.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC---CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ..++|++.+.||+|+||.||+|++..   .+..||||+++... ....+.+.+|+.++++++||||+++++++..     
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence            34689999999999999999999864   35689999986433 2334688999999999999999999998632     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                       +..++||||+++|+|.+++...+     ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence             24789999999999999997643     4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      |||+|+........       ......||+.|||||++.    +.++|||||||+++||
T Consensus       534 DFG~a~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el  585 (656)
T 2j0j_A          534 DFGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI  585 (656)
T ss_dssp             CCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             ecCCCeecCCCcce-------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence            99999876432211       112345789999999985    5889999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=7.5e-30  Score=283.31  Aligned_cols=187  Identities=24%  Similarity=0.325  Sum_probs=154.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  781 (914)
                      ++|...+.||+|+||.||+|++..+++.||||++....  ....+.+.+|+.++++++||||+++++++..... .....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57999999999999999999999999999999996432  2234678899999999999999999999754321 11123


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++ ++|.+++.        ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       104 ~~lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             EEEEecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence            589999997 58887764        3488999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +++.....           .....||+.|+|||++.     +.++|+||+||++++|+
T Consensus       172 ~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  218 (353)
T 3coi_A          172 LARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML  218 (353)
T ss_dssp             CTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH
T ss_pred             cccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH
Confidence            99864321           12357899999999874     47899999999999873

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=1.9e-29  Score=283.05  Aligned_cols=189  Identities=25%  Similarity=0.317  Sum_probs=156.5

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CC-----CcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HR-----NLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  776 (914)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.++ |+     +|+++++++...  
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence            457899999999999999999999999999999999632 233467788999998885 55     389999886543  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec--CCCc
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--YDMV  854 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~--~~~~  854 (914)
                         ...++||||++ |+|.+++.....    ..+++..+..++.|++.||.|||++ ..+||||||||+|||++  .++.
T Consensus       129 ---~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          129 ---NHLCLVFEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             ---TEEEEEEECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred             ---CceEEEEecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence               47899999996 599999986532    4589999999999999999999952 23899999999999995  4788


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+.....           .....||+.|+|||++.    +.++||||+||++|||+
T Consensus       200 ~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  252 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH  252 (382)
T ss_dssp             EEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             EEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999865321           12357999999999995    58999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=4.2e-30  Score=281.08  Aligned_cols=193  Identities=23%  Similarity=0.351  Sum_probs=154.4

Q ss_pred             HHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       702 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ...++|++.+.||+|+||.||+|++..   .||+|+++...  ....+.+.+|+.++++++||||+++++++...     
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence            345789999999999999999999864   38999987442  23345678899999999999999999997543     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++++|.+++...+     ..+++.+++.++.|++.|++|||++   +|+||||||+||+++ ++.+||+|
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECC
T ss_pred             CceEEEeecccCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEee
Confidence            36899999999999999997643     4688899999999999999999999   999999999999998 67999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh-------------hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+++........   ..........||+.|+|||++.             +.++||||+||+++||+
T Consensus       173 fg~~~~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~  237 (319)
T 2y4i_B          173 FGLFSISGVLQAG---RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH  237 (319)
T ss_dssp             CSCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCcccccccccc---ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence            9998765322111   1111222456999999999984             57899999999999873

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=2.5e-29  Score=279.22  Aligned_cols=186  Identities=22%  Similarity=0.346  Sum_probs=155.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc-EEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC------cceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE-MVVAVKVINLKQKGASKSFVSECEALRNIRHRN------LIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||+||+|++..++ +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~---   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE---
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee---
Confidence            368999999999999999999997666 79999998632 234567889999999997766      8888887543   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee-------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL-------  849 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl-------  849 (914)
                        ....++||||+ ++++.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||++       
T Consensus        94 --~~~~~lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           94 --HGHMCIAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             --TTEEEEEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred             --CCeEEEEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence              34789999999 6778777765432    4689999999999999999999999   99999999999999       


Q ss_pred             ------------cCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          850 ------------DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       850 ------------~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                                  +.++.+||+|||+++.....           .....||+.|+|||++.    +.++|+||+||++|||
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccccccccccCCCcEEEeecCcccccccc-----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence                        56789999999999864321           12357999999999984    5889999999999987


Q ss_pred             C
Q 042766          914 F  914 (914)
Q Consensus       914 f  914 (914)
                      +
T Consensus       233 ~  233 (355)
T 2eu9_A          233 Y  233 (355)
T ss_dssp             H
T ss_pred             H
Confidence            4

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=1.8e-29  Score=282.57  Aligned_cols=190  Identities=21%  Similarity=0.334  Sum_probs=158.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-----------CCCcceEEeEeec
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-----------HRNLIKIITICSS  773 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  773 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||++.. +....+.+.+|++++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            589999999999999999999999999999999863 2234567889999999886           8999999998764


Q ss_pred             CCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec---
Q 042766          774 TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---  850 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~---  850 (914)
                      .. ......++||||+ +++|.+++.....    ..+++..+..++.|++.||+|||+++  +|+||||||+||+++   
T Consensus        98 ~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           98 KG-PNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EE-TTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             cC-CCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            32 2233689999999 8999999986432    45899999999999999999999853  899999999999995   


Q ss_pred             ---CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 ---YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ---~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                         ..+.+||+|||+|+.....           .....||+.|+|||++.    +.++||||+||++|||+
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  229 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH-----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI  229 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCcCcceEEEcccccccccCCC-----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH
Confidence               3448999999999865421           11347999999999995    57899999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=3.2e-29  Score=275.09  Aligned_cols=193  Identities=20%  Similarity=0.272  Sum_probs=141.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-cchHHHHHHHH-HHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-GASKSFVSECE-ALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|+..+.||+|+||.||+|++..+++.||||+++.... ....++.+|+. +++.++||||+++++++...     +.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----Cc
Confidence            3689999999999999999999999999999999975432 23345666666 67778999999999996543     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++ +|.+++..... .....+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             eEEEEeecCC-ChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence            8999999975 88887763110 01246899999999999999999999852  79999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchh--------hhhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF--------FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~--------~~~~~Di~s~g~~~~~~f  914 (914)
                      +++......         ......||+.|+|||++        ++.++||||+||++++|+
T Consensus       172 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~  223 (327)
T 3aln_A          172 ISGQLVDSI---------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA  223 (327)
T ss_dssp             SSCC---------------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred             Cceeccccc---------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence            998654321         11124699999999998        247899999999999873

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=6.1e-29  Score=271.11  Aligned_cols=192  Identities=22%  Similarity=0.352  Sum_probs=153.9

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcC--CCCcceEEeEeecCC
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIR--HRNLIKIITICSSTD  775 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  775 (914)
                      +....++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++  ||||+++++++... 
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-
Confidence            3344568999999999999999999986 58889999997543  234568899999999997  59999999996543 


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcE
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVA  855 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~  855 (914)
                          ...++||| +.+++|.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+||++++ +.+
T Consensus       101 ----~~~~lv~e-~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~  165 (313)
T 3cek_A          101 ----QYIYMVME-CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GML  165 (313)
T ss_dssp             ----SEEEEEEC-CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEE
T ss_pred             ----CEEEEEEe-cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeE
Confidence                47899999 5588999999865      3688999999999999999999999   9999999999999964 899


Q ss_pred             EEecccccccccccccccccCCCCccccccCcccccccchhh---------------hhhcccCcccccccccC
Q 042766          856 HVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       856 ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------------~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|||+++........      .......||+.|+|||++.               +.++||||+||++++|+
T Consensus       166 kL~Dfg~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~  233 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTS------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  233 (313)
T ss_dssp             EECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred             EEeeccccccccCcccc------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence            99999999866432211      1112356999999999974               35899999999999873

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=1.4e-29  Score=296.07  Aligned_cols=196  Identities=24%  Similarity=0.366  Sum_probs=161.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~~  781 (914)
                      .++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|++++++++||||+++++++.... +...+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999999989999999998643 2334567899999999999999999999865421 223456


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc---EEEe
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV---AHVG  858 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~---~ki~  858 (914)
                      .++||||+++|+|.+++.....   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~---~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC---TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            7999999999999999986532   13578889999999999999999999   9999999999999997764   9999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+++......         ......||+.|+|||++.    +.++|+||+||++|+|+
T Consensus       167 DFG~a~~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLl  217 (676)
T 3qa8_A          167 DLGYAKELDQGE---------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI  217 (676)
T ss_dssp             SCCCCCBTTSCC---------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHH
T ss_pred             cccccccccccc---------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHH
Confidence            999998654321         112357999999999984    58999999999999873

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=1.5e-28  Score=264.13  Aligned_cols=253  Identities=17%  Similarity=0.113  Sum_probs=216.5

Q ss_pred             cceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCc
Q 042766          321 WLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLI  400 (914)
Q Consensus       321 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~  400 (914)
                      ++++.+++.++.++..         -.++|++|+|++|++++..+..+..+. +|++|++++|.+++..|..|.++++|+
T Consensus        14 ~~~~c~~~~l~~ip~~---------~~~~l~~L~l~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~   83 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVG---------IPAASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLE   83 (285)
T ss_dssp             CEEECCSSCCSSCCTT---------CCTTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             eEEEcCcCCcccCCcC---------CCCCceEEEeeCCcCCccCHHHcccCC-CCCEEECCCCccceeCHhhcCCccCCC
Confidence            6789999999887543         246899999999999976666777766 799999999999999999999999999


Q ss_pred             EEEcccCc-ccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCC
Q 042766          401 TFTLEVNQ-FHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN  479 (914)
Q Consensus       401 ~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  479 (914)
                      +|++++|+ +....|..|..+++|++|++++|.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|++++|
T Consensus        84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  163 (285)
T 1ozn_A           84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (285)
T ss_dssp             EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence            99999997 88777999999999999999999999888999999999999999999999888788999999888877777


Q ss_pred             ccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCC
Q 042766          480 KLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIP  559 (914)
Q Consensus       480 ~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  559 (914)
                      ++++                         ..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+
T Consensus       164 ~l~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  218 (285)
T 1ozn_A          164 RISS-------------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT  218 (285)
T ss_dssp             CCCE-------------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred             cccc-------------------------cCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCH
Confidence            7652                         233457778899999999999999889999999999999999999998887


Q ss_pred             cchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          560 LSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       560 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      ..|..+++|+.|++++|++.+..+.. .-+..++.+..+.|.+.|..|..
T Consensus       219 ~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          219 EALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred             HHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence            88999999999999999998654432 22234566678889999988864

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.1e-29  Score=277.11  Aligned_cols=265  Identities=20%  Similarity=0.196  Sum_probs=173.4

Q ss_pred             chhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccc
Q 042766          152 IHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAEN  231 (914)
Q Consensus       152 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  231 (914)
                      +.++++.+.+...++..+..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|  +..+++|++|+|++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN   90 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence            334555555543333344455666666666666666555666666667777777776665443  666777777777777


Q ss_pred             cccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCcccc
Q 042766          232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVS  311 (914)
Q Consensus       232 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  311 (914)
                      ++++..     ..++|++|++++|++++..+.    .+++|++|+|++|++++..|..+..+++|++|+|++|++++..+
T Consensus        91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~----~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (317)
T 3o53_A           91 YVQELL-----VGPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (317)
T ss_dssp             EEEEEE-----ECTTCCEEECCSSCCSEEEEC----CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred             cccccc-----CCCCcCEEECCCCccCCcCcc----ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence            776432     236777888888877765332    35778888888888887777788888888888888888887777


Q ss_pred             cccc-ccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCC
Q 042766          312 IDFS-SLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIP  390 (914)
Q Consensus       312 ~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p  390 (914)
                      ..+. .+++|++|+|++|.++..+.        ...+++|++|+|++|+++ .+|..+..+. +|+.|++++|+|++ +|
T Consensus       162 ~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~-~L~~L~L~~N~l~~-l~  230 (317)
T 3o53_A          162 AELAASSDTLEHLNLQYNFIYDVKG--------QVVFAKLKTLDLSSNKLA-FMGPEFQSAA-GVTWISLRNNKLVL-IE  230 (317)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEEEC--------CCCCTTCCEEECCSSCCC-EECGGGGGGT-TCSEEECTTSCCCE-EC
T ss_pred             HHHhhccCcCCEEECCCCcCccccc--------ccccccCCEEECCCCcCC-cchhhhcccC-cccEEECcCCcccc-hh
Confidence            6663 67888888888888776522        234677778888877777 3444454443 46666666666663 45


Q ss_pred             ccccCCCCCcEEEcccCccc-ccCChhhhcccCCceeeecc-cccccccC
Q 042766          391 PGIRNLVNLITFTLEVNQFH-GTIPDVISELKNLQQLSVFN-NFLRGGIP  438 (914)
Q Consensus       391 ~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~-N~l~~~~p  438 (914)
                      ..+..+++|+.|++++|++. +.+|.++..+++|+.|++++ +.++|..|
T Consensus       231 ~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             hHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            55666666666666666666 55566666666666666663 33444433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=2.5e-29  Score=286.43  Aligned_cols=192  Identities=24%  Similarity=0.272  Sum_probs=141.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      .|...+.||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+++++++ +||||+++++++..     ....++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~l   86 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYI   86 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEE
Confidence            455678899999999986544 47889999998643   345678999999886 89999999998543     457899


Q ss_pred             EEecccCCCHHHHHhccCCcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-----------
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEV-RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-----------  852 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-----------  852 (914)
                      ||||++ |+|.+++......... ...++..++.++.||+.||+|||++   +|+||||||+|||++.+           
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence            999995 6999999865421111 1123335678999999999999999   99999999999999754           


Q ss_pred             --CcEEEecccccccccccccccccCCCCccccccCcccccccchhh-----------hhhcccCcccccccccC
Q 042766          853 --MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 --~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----------~~~~Di~s~g~~~~~~f  914 (914)
                        +.+||+|||+|+.........    .......+||+.|||||++.           +.++||||+||++|||+
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell  233 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL  233 (434)
T ss_dssp             CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence              489999999998765432110    01122457999999999883           47899999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=4e-29  Score=283.90  Aligned_cols=187  Identities=26%  Similarity=0.340  Sum_probs=143.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..+|...+.||+|+||+||... ..+++.||||++.....   ..+.+|+++++++ +||||+++++++..     ....
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~~   93 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-----RQFQ   93 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-----CCEE
Confidence            3468899999999999865433 34678999999864332   2356899999999 79999999998643     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-----CCcEEE
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-----DMVAHV  857 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~ki  857 (914)
                      ++||||++ |+|.+++....     ....+.+++.++.||+.||+|||++   +|+||||||+||+++.     ...+||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             EEEEECCC-CCHHHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence            99999996 69999998654     2344445678999999999999999   9999999999999953     236889


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~  913 (914)
                      +|||+|+........     .......+||+.|||||++.       +.++||||+||+++||
T Consensus       165 ~DFG~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~el  222 (432)
T 3p23_A          165 SDFGLCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV  222 (432)
T ss_dssp             CCTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHH
T ss_pred             ecccceeeccCCCcc-----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHH
Confidence            999999876432211     11223467999999999985       2479999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=8.9e-29  Score=270.42  Aligned_cols=188  Identities=19%  Similarity=0.268  Sum_probs=141.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc-c-hHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG-A-SKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|+..+.||+|+||.||+|++..+++.||||++...... . .+.+.++..+++.++||||+++++++...     +.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----Cc
Confidence            46899999999999999999999989999999999754322 2 23344555578888999999999996543     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      .++||||+ ++.+..+.....     ..+++..+..++.|++.||+|||+ .   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEecc-CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence            89999999 556666654322     468999999999999999999998 5   8999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      |+++......         ......||+.|+|||++.         +.++||||+||++++|+
T Consensus       170 g~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~  223 (318)
T 2dyl_A          170 GISGRLVDDK---------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA  223 (318)
T ss_dssp             TTC-----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH
T ss_pred             CCchhccCCc---------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH
Confidence            9997654321         112346999999999983         36899999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=4.9e-29  Score=291.77  Aligned_cols=177  Identities=15%  Similarity=0.027  Sum_probs=126.7

Q ss_pred             cccCCccEEEEEEEECCCcEEEEEEEeeccC----------CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQ----------KGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       712 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ..+.|+.|.+..++....|+.||||++....          +...+++.+|+++|+++ .|+||++++++     +++..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECC
Confidence            4567777777777776778899999997432          12235799999999999 69999999999     45556


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..||||||++|++|.+++.+.+      +++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+||
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence            8999999999999999998653      45543   5889999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhhh---hhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFM---LYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~---~~~Di~s~g~~~~~~  913 (914)
                      |+|+......        ......+||++|||||++.+   .++|+||+|++.+++
T Consensus       384 GlAr~~~~~~--------~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l  431 (569)
T 4azs_A          384 GSIVTTPQDC--------SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNL  431 (569)
T ss_dssp             TTEESCC-----------CCSHHHHHHHHHHHHHHC-----------------CCC
T ss_pred             ccCeeCCCCC--------ccccCceechhhccHHHhCCCCCCcccccccccchhhh
Confidence            9998764322        12234689999999999965   689999999998775

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=1.8e-27  Score=280.28  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=177.1

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      .+++|++++|+++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+++ .+|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence            4788888888888 7777665  67888888888887 5665   4566666666666665 3443   34555555555


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                      +|++++ +|.                           .+++|+.|++++|++++ +|..   +++|++|+|++|++++. 
T Consensus       110 ~N~l~~-l~~---------------------------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-  156 (622)
T 3g06_A          110 SNPLTH-LPA---------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-  156 (622)
T ss_dssp             SCCCCC-CCC---------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-
T ss_pred             CCcCCC-CCC---------------------------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-
Confidence            555542 222                           23445555555555553 3322   25677777777777643 


Q ss_pred             cccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchh
Q 042766          262 PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV  341 (914)
Q Consensus       262 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  341 (914)
                      |.    .+++|+.|++++|++++ +|   ..+++|+.|+|++|+|+++.+    .+++|+.|++++|.++.++.      
T Consensus       157 ~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~~------  218 (622)
T 3g06_A          157 PA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT----LPSELYKLWAYNNRLTSLPA------  218 (622)
T ss_dssp             CC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCCC------
T ss_pred             CC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC----ccchhhEEECcCCcccccCC------
Confidence            32    34667777777777774 44   345667777777777765332    12455555555555554321      


Q ss_pred             hcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhccc
Q 042766          342 IFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK  421 (914)
Q Consensus       342 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  421 (914)
                          .+++                         |+.|++++|+|++ +|   ..+++|++|+|++|+|+. +|.   .++
T Consensus       219 ----~~~~-------------------------L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~  261 (622)
T 3g06_A          219 ----LPSG-------------------------LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPS  261 (622)
T ss_dssp             ----CCTT-------------------------CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCT
T ss_pred             ----CCCC-------------------------CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccc
Confidence                1233                         5555555555554 33   345789999999999995 454   678


Q ss_pred             CCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCC
Q 042766          422 NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQ  469 (914)
Q Consensus       422 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  469 (914)
                      +|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++.+|..+..++
T Consensus       262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            9999999999999 7788999999999999999999998888776655

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.7e-29  Score=275.69  Aligned_cols=258  Identities=18%  Similarity=0.164  Sum_probs=165.5

Q ss_pred             cccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeecc
Q 042766          174 KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT  253 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  253 (914)
                      +++.++++.+.+...++..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|  +..+++|++|+++
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            45666777777765555556667778888888888877777777778888888888887776554  7777777777777


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCC
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      +|++++..      ..++|++|++++|++++..+..   +++|++|+|++|++++..+..|..+++|++|++++|.++..
T Consensus        89 ~n~l~~l~------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  159 (317)
T 3o53_A           89 NNYVQELL------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV  159 (317)
T ss_dssp             SSEEEEEE------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE
T ss_pred             CCcccccc------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc
Confidence            77776432      2367777777777776554433   45677777777777766666666666666666666666543


Q ss_pred             CCCCcchhhcc-cCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccccc
Q 042766          334 TANDLDFVIFL-SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGT  412 (914)
Q Consensus       334 ~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  412 (914)
                            .+..+ ..+++|++|+|++|+++                         +..  ....+++|++|+|++|++++.
T Consensus       160 ------~~~~~~~~l~~L~~L~L~~N~l~-------------------------~~~--~~~~l~~L~~L~Ls~N~l~~l  206 (317)
T 3o53_A          160 ------NFAELAASSDTLEHLNLQYNFIY-------------------------DVK--GQVVFAKLKTLDLSSNKLAFM  206 (317)
T ss_dssp             ------EGGGGGGGTTTCCEEECTTSCCC-------------------------EEE--CCCCCTTCCEEECCSSCCCEE
T ss_pred             ------cHHHHhhccCcCCEEECCCCcCc-------------------------ccc--cccccccCCEEECCCCcCCcc
Confidence                  11222 34555555555555554                         221  112356677777777777644


Q ss_pred             CChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCC-CCCCCccCCCCCccccccC
Q 042766          413 IPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ-GNIPSSLGNCQNLILFIAS  477 (914)
Q Consensus       413 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~  477 (914)
                      . ..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.++++
T Consensus       207 ~-~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          207 G-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             C-GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             h-hhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            3 33666777777777777776 35556666677777777777766 5555556666666555555

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=4.4e-28  Score=260.11  Aligned_cols=163  Identities=13%  Similarity=0.087  Sum_probs=141.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||.||+|++..+++.||||+++....   ...+.+.+|+.++++++||||+++++++..     .+.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----RAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----CCc
Confidence            579999999999999999999999999999999975432   233688999999999999999999999654     347


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+||||++|++|.++++..        ....++.+++.|++.||+|||++   +|+||||||+||+++.++.+||+++ 
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~-  173 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP-  173 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC-
T ss_pred             EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec-
Confidence            89999999999999998532        34557889999999999999999   9999999999999999999998743 


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhhhhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~Di~s~g~~~~~~f  914 (914)
                                                 +|++|   .+.++||||+||++|||+
T Consensus       174 ---------------------------~~~~~---~~~~~Di~slG~il~ell  196 (286)
T 3uqc_A          174 ---------------------------ATMPD---ANPQDDIRGIGASLYALL  196 (286)
T ss_dssp             ---------------------------CCCTT---CCHHHHHHHHHHHHHHHH
T ss_pred             ---------------------------cccCC---CCchhHHHHHHHHHHHHH
Confidence                                       34444   578899999999999874

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=2.9e-27  Score=251.79  Aligned_cols=216  Identities=19%  Similarity=0.260  Sum_probs=138.1

Q ss_pred             CCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcC
Q 042766           62 MNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI  141 (914)
Q Consensus        62 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  141 (914)
                      .++|.|.|+.|+.. ..++.+++++++++. +|..+.  +.|++|+|++|++++..+..|+++++|++|+|++|++++..
T Consensus         2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCSCN-NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBEEE-TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCEeC-CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            48999999998643 235678888888764 555443  56778888888887655567777888888888888777444


Q ss_pred             CCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhh
Q 042766          142 PTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR  221 (914)
Q Consensus       142 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  221 (914)
                      +..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..+..|+.++
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  157 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT  157 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence            44456777777777777777755555666677777777777777666566666666666666666666655555566666


Q ss_pred             cccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccC
Q 042766          222 RLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF  282 (914)
Q Consensus       222 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l  282 (914)
                      +|++|+|++|++++..+..|..+++|++|+|++|++++ +|...+..+++|++|+|++|.+
T Consensus       158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~  217 (270)
T 2o6q_A          158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQENPW  217 (270)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCB
T ss_pred             ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc-CCHHHhccccCCCEEEecCCCe
Confidence            66666666666665544455555555555555555543 2223333444444444444444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.95  E-value=2.1e-28  Score=276.92  Aligned_cols=195  Identities=15%  Similarity=0.165  Sum_probs=145.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCC-CCcceE---------EeE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRH-RNLIKI---------ITI  770 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l---------~~~  770 (914)
                      ...|...+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|+.+++.++| ++....         ...
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3468888999999999999999999999999999874332   335789999999999987 321111         111


Q ss_pred             eec------------CCCCCCceEeEEEecccCCCHHHHHhccCC-cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 042766          771 CSS------------TDFEGVDFKALVFEYMENGSLEDWLHQSND-QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPM  837 (914)
Q Consensus       771 ~~~------------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~i  837 (914)
                      +..            .........+++|+++ +++|.+++..... ......+++..++.++.|++.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            110            0000012356777766 6899998852110 00124577889999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh--------------hhhccc
Q 042766          838 VHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF--------------MLYTHI  903 (914)
Q Consensus       838 vHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~--------------~~~~Di  903 (914)
                      |||||||+|||++.++.+||+|||+|+.....           ....+| +.|||||++.              +.++||
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            99999999999999999999999999865432           123568 9999999993              359999


Q ss_pred             CcccccccccC
Q 042766          904 PSFSCTNVHHF  914 (914)
Q Consensus       904 ~s~g~~~~~~f  914 (914)
                      |||||++|||+
T Consensus       301 wSlGvil~ell  311 (413)
T 3dzo_A          301 WTLGLAIYWIW  311 (413)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999873

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2.9e-28  Score=281.41  Aligned_cols=240  Identities=16%  Similarity=0.160  Sum_probs=188.3

Q ss_pred             CCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccc
Q 042766           97 VGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ  176 (914)
Q Consensus        97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  176 (914)
                      ....++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|  ++.+++|++|+|++|.+++..     ..++|+
T Consensus        30 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~  102 (487)
T 3oja_A           30 RQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIE  102 (487)
T ss_dssp             STTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCC
T ss_pred             cccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcC
Confidence            3445589999999999998878889999999999999999987666  888999999999999988432     337899


Q ss_pred             ccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccc-cccccceeeccCC
Q 042766          177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSIC-NISSVELIFLTEN  255 (914)
Q Consensus       177 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N  255 (914)
                      +|+|++|.+++..+.   .+++|+.|+|++|.+++..|..|+.+++|++|+|++|++++..|..+. .+++|++|+|++|
T Consensus       103 ~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N  179 (487)
T 3oja_A          103 TLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN  179 (487)
T ss_dssp             EEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred             EEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCC
Confidence            999999998876554   357788889999988888888888888888888888888887787776 6888888888888


Q ss_pred             cccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCC
Q 042766          256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTA  335 (914)
Q Consensus       256 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  335 (914)
                      .+++. |..  ..+++|++|+|++|+|++. |..+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.+...  
T Consensus       180 ~l~~~-~~~--~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~--  252 (487)
T 3oja_A          180 FIYDV-KGQ--VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG--  252 (487)
T ss_dssp             CCCEE-ECC--CCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH--
T ss_pred             ccccc-ccc--ccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc--
Confidence            88865 322  2578888888888888864 4447788888888888888886 455677777888888888877621  


Q ss_pred             CCcchhhcccCCCCCcEEecc
Q 042766          336 NDLDFVIFLSNCSSLKVLSLS  356 (914)
Q Consensus       336 ~~~~~~~~l~~l~~L~~L~Ls  356 (914)
                         ..|.++..++.|+.++++
T Consensus       253 ---~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          253 ---TLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ---HHHHHHTTCHHHHHHHHH
T ss_pred             ---chHHHHHhCCCCcEEecc
Confidence               155566667777776665

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=2.1e-28  Score=282.59  Aligned_cols=215  Identities=20%  Similarity=0.174  Sum_probs=137.5

Q ss_pred             cEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeC
Q 042766          375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS  454 (914)
Q Consensus       375 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  454 (914)
                      |+.|+|++|.+++..|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|++..+     .++|++|+|++
T Consensus        36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~  108 (487)
T 3oja_A           36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAAN  108 (487)
T ss_dssp             CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCS
T ss_pred             ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECcC
Confidence            4444444444444444555555555555555555555444  5555566666666665553222     25566666666


Q ss_pred             CcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCcccccc-ccccceeecccCCccccc
Q 042766          455 NSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVG-NLKNLVMLDISSNQFSGV  533 (914)
Q Consensus       455 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~  533 (914)
                      |.|++..+..   +++|+.|++++|.+++..|..+..+..+ +.|+|++|.+++..|..+. .+++|+.|+|++|.|++.
T Consensus       109 N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          109 NNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            6665544432   3455566666666665555555555555 5666666666666666665 677888888888888876


Q ss_pred             cCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCcccc
Q 042766          534 IPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       534 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  604 (914)
                      .+  +..+++|+.|+|++|.+++.+| .|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.|
T Consensus       185 ~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c  251 (487)
T 3oja_A          185 KG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (487)
T ss_dssp             EC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred             cc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence            33  3357888888888888886554 47788888888888888885 66777788888888888888874

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=7.4e-31  Score=313.00  Aligned_cols=460  Identities=11%  Similarity=0.082  Sum_probs=268.3

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcc---cCCcc------------cCCCCCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRG---DIPQE------------IGNLFRL  127 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~---~~p~~------------~~~l~~L  127 (914)
                      -|++|.++..    .....+++...... .....+..+++|++|+|+++....   ..|..            ...+++|
T Consensus        33 vck~W~~~~~----~~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           33 VCKSWYEIER----WCRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             SCHHHHHHHH----HHCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHHhhh----hhceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            3557887722    12245566544321 112235677889999999875321   22222            2357789


Q ss_pred             CeeecCCCCCCCcCCCCcc-ccCCcchhccCCC-cccCC-CChhccccccccccccccccccCcCCcccc----cccccc
Q 042766          128 EKLALSNNSFSGTIPTNLS-RCSNLIHFCASNN-KLEGQ-IPKEIGNLLKLQRLSVDINYLTGQLPDSVG----NLSAIE  200 (914)
Q Consensus       128 ~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~  200 (914)
                      ++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            9999999998877777776 6889999999988 55532 444555788999999999998876555443    566899


Q ss_pred             eeecccCCCCCCCCccc----hhhhcccccccccc-cccCCCCCccccccccceeeccCC-------cccCccccccccc
Q 042766          201 VIRITENSLGGKIPTTL----GLLRRLVNLNVAEN-QFSGMFPRSICNISSVELIFLTEN-------RFSGIFPFDILLN  268 (914)
Q Consensus       201 ~L~L~~N~l~~~~p~~~----~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N-------~l~~~~p~~~~~~  268 (914)
                      .|++++|. ....+..+    ..+++|++|+|++| .+.+ +|..+..+++|+.|+++.+       .+.+. +. .+.+
T Consensus       188 ~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l-~~-~l~~  263 (594)
T 2p1m_B          188 SLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGL-SV-ALSG  263 (594)
T ss_dssp             EEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHH-HH-HHHT
T ss_pred             EEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHH-HH-HHhc
Confidence            99999887 21112223    34588888888888 4444 6777778888888885443       34332 22 2346


Q ss_pred             Cccccee-eccCccCCCCCCCccccccccccccccCccCCccccc-cccccccccceeccCCcCCCCCCCCcchhhcccC
Q 042766          269 LPNLKKL-GIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSI-DFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSN  346 (914)
Q Consensus       269 l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~  346 (914)
                      +++|+.| .+.+... +.+|..+..+++|++|+|++|.+++.... .+..+++|++|++++| ++..     .++.....
T Consensus       264 ~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~-----~l~~l~~~  336 (594)
T 2p1m_B          264 CKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA-----GLEVLAST  336 (594)
T ss_dssp             CTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH-----HHHHHHHH
T ss_pred             CCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH-----HHHHHHHh
Confidence            7777777 3443322 23444445667777777777776543222 2345666777777665 3211     12222334


Q ss_pred             CCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccc-cCCCCCcEEEcccCcccccCChhhh-cccCCc
Q 042766          347 CSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGI-RNLVNLITFTLEVNQFHGTIPDVIS-ELKNLQ  424 (914)
Q Consensus       347 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~  424 (914)
                      +++|+.|+++++.-.|                ..+.+.+++.....+ .++++|+.|+++.|++++.....+. .+++|+
T Consensus       337 ~~~L~~L~L~~~~~~g----------------~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~  400 (594)
T 2p1m_B          337 CKDLRELRVFPSEPFV----------------MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMT  400 (594)
T ss_dssp             CTTCCEEEEECSCTTC----------------SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCC
T ss_pred             CCCCCEEEEecCcccc----------------cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcc
Confidence            6666666663321000                001122222111112 2356666666666666655444443 466777


Q ss_pred             eeeec--c----cccccc-----cCccccCCCCCCeEEeeCCcCCCCCCCccCC-CCCccccccCCCccCCCCchhhhcc
Q 042766          425 QLSVF--N----NFLRGG-----IPSGLGNLTKLGSLDLGSNSLQGNIPSSLGN-CQNLILFIASYNKLTGDLPQQLLSI  492 (914)
Q Consensus       425 ~L~L~--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~~  492 (914)
                      .|+|+  +    |.+++.     ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..    
T Consensus       401 ~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~----  475 (594)
T 2p1m_B          401 RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH----  475 (594)
T ss_dssp             EEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH----
T ss_pred             eeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH----
Confidence            77776  3    444421     112245567777777765 555444444443 666666666666654211110    


Q ss_pred             cchhhhhcccCCccCCCccccccccccceeecccCCccccccCc-cccccccccEEEeecccccccCCcch-hccCCCCE
Q 042766          493 TTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV-TLSTCVSLEYLDISINSFYGVIPLSF-RFLKSIKA  570 (914)
Q Consensus       493 ~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~  570 (914)
                                          ...++++|+.|+|++|++++..+. ....+++|++|++++|+++......+ ..++.|+.
T Consensus       476 --------------------l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i  535 (594)
T 2p1m_B          476 --------------------VLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNV  535 (594)
T ss_dssp             --------------------HHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEE
T ss_pred             --------------------HHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEE
Confidence                                113466788888888887654443 33457888888888888754433444 45677777


Q ss_pred             EEccCCccc
Q 042766          571 LNVSSNNLS  579 (914)
Q Consensus       571 L~Ls~N~l~  579 (914)
                      ..+..+.-.
T Consensus       536 ~~~~~~~~~  544 (594)
T 2p1m_B          536 EVIDERGAP  544 (594)
T ss_dssp             EEECSSSCG
T ss_pred             EEecCCCcc
Confidence            666665443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=2.6e-30  Score=308.26  Aligned_cols=451  Identities=16%  Similarity=0.135  Sum_probs=249.5

Q ss_pred             CEEEcCCCCCcccCC-cccCCCCCCCeeecCCCCCCC---cCCCCccccCCcchhccCCCcccCCCChhccccccccccc
Q 042766          104 RYINLADNGFRGDIP-QEIGNLFRLEKLALSNNSFSG---TIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLS  179 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  179 (914)
                      +.+++++...  ..| ..+..+++|++|+|+++....   ..|..++.            .....++.....+++|++|+
T Consensus        46 ~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~------------~~~~~l~~l~~~~~~L~~L~  111 (594)
T 2p1m_B           46 RKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGG------------YVYPWIEAMSSSYTWLEEIR  111 (594)
T ss_dssp             CEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCC------------BCHHHHHHHHHHCTTCCEEE
T ss_pred             eEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccc------------hhhHHHHHHHHhCCCCCeEE
Confidence            4566655432  223 345677889999998875321   12222100            00000111122344555555


Q ss_pred             cccccccCcCCcccc-cccccceeecccC-CCCCC-CCccchhhhcccccccccccccCCCCCccc----cccccceeec
Q 042766          180 VDINYLTGQLPDSVG-NLSAIEVIRITEN-SLGGK-IPTTLGLLRRLVNLNVAENQFSGMFPRSIC----NISSVELIFL  252 (914)
Q Consensus       180 L~~N~l~~~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~L  252 (914)
                      |++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|+.|++
T Consensus       112 L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l  191 (594)
T 2p1m_B          112 LKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI  191 (594)
T ss_dssp             EESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEEC
T ss_pred             eeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEe
Confidence            555554444443333 3455555555555 33211 223333555555555555555543333222    4446666666


Q ss_pred             cCCc--ccCcccccccccCcccceeeccCc-cCCCCCCCccccccccccccccC-------ccCCccccccccccccccc
Q 042766          253 TENR--FSGIFPFDILLNLPNLKKLGIGGN-NFVGSIPDSLSNASNLELLDLPS-------NQFKGKVSIDFSSLKNLWL  322 (914)
Q Consensus       253 ~~N~--l~~~~p~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-------N~l~~~~~~~~~~l~~L~~  322 (914)
                      ++|.  ++......+..++++|++|+|++| .+.+ +|..+..+++|+.|+++.       |.+.+.. ..+.++++|+.
T Consensus       192 ~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~-~~l~~~~~L~~  269 (594)
T 2p1m_B          192 SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLS-VALSGCKELRC  269 (594)
T ss_dssp             TTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHH-HHHHTCTTCCE
T ss_pred             cccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHH-HHHhcCCCccc
Confidence            6664  211111122234567777777766 3332 555566666777776433       3344332 35666777777


Q ss_pred             e-eccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeeccccccc-CCccccCCCCCc
Q 042766          323 L-NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT-IPPGIRNLVNLI  400 (914)
Q Consensus       323 L-~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~~L~  400 (914)
                      | .+.+....       .++..+..+++|+.|+|++|.+++.....+....++|+.|++++| +... ++.....+++|+
T Consensus       270 Ls~~~~~~~~-------~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~  341 (594)
T 2p1m_B          270 LSGFWDAVPA-------YLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR  341 (594)
T ss_dssp             EECCBTCCGG-------GGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred             ccCCcccchh-------hHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence            6 33322111       133344567778888888877654333332222346777777766 3322 222233567788


Q ss_pred             EEEc---------ccCcccccCChhhh-cccCCceeeecccccccccCcccc-CCCCCCeEEee--C----CcCCCCC--
Q 042766          401 TFTL---------EVNQFHGTIPDVIS-ELKNLQQLSVFNNFLRGGIPSGLG-NLTKLGSLDLG--S----NSLQGNI--  461 (914)
Q Consensus       401 ~L~L---------~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~--  461 (914)
                      +|++         +.|.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+  +    |.+++..  
T Consensus       342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~  421 (594)
T 2p1m_B          342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD  421 (594)
T ss_dssp             EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred             EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence            8877         33455543333333 477888888877877765555554 47788888888  3    4444211  


Q ss_pred             ---CCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccc-cccceeecccCCccccccCcc
Q 042766          462 ---PSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGN-LKNLVMLDISSNQFSGVIPVT  537 (914)
Q Consensus       462 ---p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~  537 (914)
                         +..+.++++|+.|++                         ++ .+++..+..++. +++|+.|+|++|.+++..+..
T Consensus       422 ~~~~~l~~~~~~L~~L~L-------------------------~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~  475 (594)
T 2p1m_B          422 IGFGAIVEHCKDLRRLSL-------------------------SG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHH  475 (594)
T ss_dssp             HHHHHHHHHCTTCCEEEC-------------------------CS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHH
T ss_pred             hHHHHHHhhCCCccEEee-------------------------cC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHH
Confidence               111334445555544                         33 333333334443 788999999999998766666


Q ss_pred             c-cccccccEEEeecccccccCCc-chhccCCCCEEEccCCccccccCccc-cccCCCCeEeCCCCcccc
Q 042766          538 L-STCVSLEYLDISINSFYGVIPL-SFRFLKSIKALNVSSNNLSGKIPEFL-ENLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       538 ~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~  604 (914)
                      + .++++|++|+|++|.+++.... ....+++|+.|++++|+++......+ ..++.|+...+..+.-..
T Consensus       476 l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~  545 (594)
T 2p1m_B          476 VLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD  545 (594)
T ss_dssp             HHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred             HHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence            5 6799999999999999765544 34468999999999999965544555 567788777777665443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.8e-26  Score=246.52  Aligned_cols=228  Identities=19%  Similarity=0.220  Sum_probs=181.8

Q ss_pred             EeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccc
Q 042766          353 LSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF  432 (914)
Q Consensus       353 L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  432 (914)
                      .+.++..+. .+|..+.   .++++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            344444454 4555432   357777777777777777788888888888888888887777788888888888888888


Q ss_pred             cccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccc
Q 042766          433 LRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPL  512 (914)
Q Consensus       433 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~  512 (914)
                      +++..+..|.++++|++|++++|++++..+..++++++|+.|++++|++++.                        .+|.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~------------------------~l~~  143 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF------------------------KLPE  143 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC------------------------CCCG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee------------------------cCch
Confidence            8877777888888888888888888876666777777777777776666521                        2466


Q ss_pred             cccccccceeecccCCccccccCcccccccccc----EEEeecccccccCCcchhccCCCCEEEccCCccccccCccccc
Q 042766          513 QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLE----YLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLEN  588 (914)
Q Consensus       513 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  588 (914)
                      .|+++++|++|+|++|++++..+..+..+.+|+    .|++++|.+++..+..+.. .+|+.|+|++|++++..+..+..
T Consensus       144 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~  222 (276)
T 2z62_A          144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDR  222 (276)
T ss_dssp             GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTT
T ss_pred             hhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcc
Confidence            788888999999999999988888888888887    8999999999777766654 48999999999999887788899


Q ss_pred             cCCCCeEeCCCCccccccCCC
Q 042766          589 LSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       589 l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      +++|+.|++++|+++|.+|..
T Consensus       223 l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          223 LTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCSCCEEECCSSCBCCCTTTT
T ss_pred             cccccEEEccCCcccccCCch
Confidence            999999999999999999854

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=4.8e-27  Score=254.24  Aligned_cols=171  Identities=20%  Similarity=0.332  Sum_probs=144.3

Q ss_pred             hccccc-CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHH-HhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSS-NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL-RNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|.+. +.||+|+||.||+|++..+++.||+|+++.     ...+.+|++++ +..+||||+++++++... .......
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            567776 789999999999999999999999999852     35677899988 566899999999986542 1234578


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~D  859 (914)
                      ++||||+++|+|.+++.....    ..+++.++..++.|++.||+|||++   +|+||||||+||+++.   ++.+||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence            999999999999999986532    4689999999999999999999999   9999999999999998   78999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhhhhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+....                          .-++.++|+||+||++|||+
T Consensus       164 fg~a~~~~~--------------------------~~~~~~~DiwslG~il~el~  192 (299)
T 3m2w_A          164 FGFAKETTG--------------------------EKYDKSCDMWSLGVIMYILL  192 (299)
T ss_dssp             CTTCEECTT--------------------------CGGGGHHHHHHHHHHHHHHH
T ss_pred             ccccccccc--------------------------ccCCchhhHHHHHHHHHHHH
Confidence            999975321                          11356799999999999873

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=5.2e-26  Score=243.00  Aligned_cols=211  Identities=16%  Similarity=0.170  Sum_probs=141.1

Q ss_pred             cCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccc
Q 042766           93 LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNL  172 (914)
Q Consensus        93 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l  172 (914)
                      +|..+.  +.|++|+|++|++++..+..++++++|++|+|++|++++..+..+.++++|++|+|++|++++..|..|.++
T Consensus        22 ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (276)
T 2z62_A           22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL   99 (276)
T ss_dssp             CCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred             cCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCC
Confidence            454443  468888888888887777788888888888888888886666678888888888888888887777778888


Q ss_pred             ccccccccccccccCcCCcccccccccceeecccCCCCCC-CCccchhhhcccccccccccccCCCCCccccccccc---
Q 042766          173 LKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK-IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVE---  248 (914)
Q Consensus       173 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---  248 (914)
                      ++|++|++++|.+++..+..++++++|++|++++|.+++. +|..|+.+++|++|+|++|++++..+..|..+.+|+   
T Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~  179 (276)
T 2z62_A          100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN  179 (276)
T ss_dssp             TTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCC
T ss_pred             ccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccc
Confidence            8888888888888766666677777888888888877753 477777777777777777777766666666555555   


Q ss_pred             -eeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCC
Q 042766          249 -LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK  307 (914)
Q Consensus       249 -~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  307 (914)
                       .|++++|.+++. |...+ ...+|++|+|++|++++..+..|..+++|+.|+|++|+++
T Consensus       180 l~L~ls~n~l~~~-~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  237 (276)
T 2z62_A          180 LSLDLSLNPMNFI-QPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  237 (276)
T ss_dssp             EEEECCSSCCCEE-CTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBC
T ss_pred             eeeecCCCccccc-Ccccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCccc
Confidence             455555555432 22222 2224444444444444333333444444444444444443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=5.5e-25  Score=234.13  Aligned_cols=206  Identities=20%  Similarity=0.214  Sum_probs=154.3

Q ss_pred             cEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeC
Q 042766          375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS  454 (914)
Q Consensus       375 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  454 (914)
                      .+.+++++|+++. +|..+.  ++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus        18 ~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~   94 (270)
T 2o6q_A           18 KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD   94 (270)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred             CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence            4566666666663 444332  4566666666666655555666666666666666666654444556666666666666


Q ss_pred             CcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcccccc
Q 042766          455 NSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI  534 (914)
Q Consensus       455 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  534 (914)
                      |++++..+..|.++++|+.|++                         ++|++++..|..|+.+++|++|+|++|++++..
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~l-------------------------~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  149 (270)
T 2o6q_A           95 NKLQALPIGVFDQLVNLAELRL-------------------------DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP  149 (270)
T ss_dssp             SCCCCCCTTTTTTCSSCCEEEC-------------------------CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CcCCcCCHhHcccccCCCEEEC-------------------------CCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence            6666555555555555555554                         445555555667788999999999999999888


Q ss_pred             CccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCC
Q 042766          535 PVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       535 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      +..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+|.|.++.
T Consensus       150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            88899999999999999999988888899999999999999999988888899999999999999999998873

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.92  E-value=3e-25  Score=233.42  Aligned_cols=192  Identities=18%  Similarity=0.208  Sum_probs=157.2

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP  142 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  142 (914)
                      +||.|.|++|..   ..+.+++++++++ .+|..+.  +.|++|+|++|++++..|..|+++++|++|+|++|++++..|
T Consensus         3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            689999999953   2356889998886 4666554  688999999999998888888999999999999999988777


Q ss_pred             CCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhc
Q 042766          143 TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRR  222 (914)
Q Consensus       143 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  222 (914)
                      ..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  156 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN  156 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence            78888899999999999988777777888888888888888888666667788888888888888888777777888888


Q ss_pred             ccccccccccccCCCCCccccccccceeeccCCcccCc
Q 042766          223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGI  260 (914)
Q Consensus       223 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  260 (914)
                      |++|+|++|++++..+..|..+++|++|+|++|.+++.
T Consensus       157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            88888888888877777777788888888888877654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=7e-25  Score=235.39  Aligned_cols=207  Identities=22%  Similarity=0.195  Sum_probs=141.7

Q ss_pred             cCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccc
Q 042766          394 RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLIL  473 (914)
Q Consensus       394 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  473 (914)
                      +++++++++++++|+++.+ |..+.  ++++.|+|++|.+++..|..|.++++|++|+|++|.|++..+.  +.+++|+.
T Consensus         7 ~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~   81 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGT   81 (290)
T ss_dssp             ECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCE
T ss_pred             cccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCE
Confidence            3444455555555555422 22221  3455555555555544444455555555555555555432221  44455555


Q ss_pred             cccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeeccc
Q 042766          474 FIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINS  553 (914)
Q Consensus       474 L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  553 (914)
                      |++++|+++ .+|..+..+..+ ++|++++|+|++..|..|.++++|++|+|++|++++.++..|..+++|+.|+|++|+
T Consensus        82 L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           82 LDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            555555554 444444444444 566666666666666788899999999999999998888889999999999999999


Q ss_pred             ccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCC
Q 042766          554 FYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       554 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+..|+.++|++|+|.|.+..
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~  213 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence            99888888899999999999999998 6788888888999999999999987753

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=5.7e-25  Score=236.09  Aligned_cols=203  Identities=22%  Similarity=0.251  Sum_probs=115.8

Q ss_pred             CCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccc
Q 042766           97 VGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ  176 (914)
Q Consensus        97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  176 (914)
                      +.++++++++++++|+++ .+|..+.  +++++|+|++|++++..|..+..+++|++|+|++|++++. |.. +.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCC
Confidence            445566666666666666 4555443  4666666666666655556666666666666666666532 222 4556666


Q ss_pred             ccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCc
Q 042766          177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR  256 (914)
Q Consensus       177 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  256 (914)
                      +|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            6666666665 455555566666666666666665555556666666666666666655555555555555555555555


Q ss_pred             ccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCC
Q 042766          257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK  307 (914)
Q Consensus       257 l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  307 (914)
                      +++ +|...+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       160 l~~-l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          160 LTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CSC-CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCc-cCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            553 33344445555555555555555 34444444455555555555443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=7.8e-25  Score=233.15  Aligned_cols=212  Identities=17%  Similarity=0.208  Sum_probs=141.2

Q ss_pred             CCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccc
Q 042766           97 VGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ  176 (914)
Q Consensus        97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  176 (914)
                      +..+++|++|++++|.++ .++ .++.+++|++|+|++|.+++ + +.++.+++|++|+|++|++++..|..|+.+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  112 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK  112 (272)
T ss_dssp             HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence            345566666666666665 233 46666677777777776664 2 3566667777777777777655555666677777


Q ss_pred             ccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCc
Q 042766          177 RLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENR  256 (914)
Q Consensus       177 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  256 (914)
                      +|+|++|++++..|..|+++++|++|++++|.+++..|..|+.+++|++|++++|++++..+..|..+++|++|++++|+
T Consensus       113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            77777777776656666677777777777777776666666677777777777777776666666777777777777777


Q ss_pred             ccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccc
Q 042766          257 FSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNL  320 (914)
Q Consensus       257 l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  320 (914)
                      +++..| ..+..+++|++|+|++|.+.+.       +++|+.|+++.|+++|.+|..++.+...
T Consensus       193 l~~~~~-~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          193 LKSVPD-GVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             CSCCCT-TTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             CCccCH-HHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCCC
Confidence            775433 4455677777777777766643       3457777777777777777776665543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=6.8e-25  Score=233.61  Aligned_cols=207  Identities=18%  Similarity=0.248  Sum_probs=153.2

Q ss_pred             ceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccC
Q 042766           78 RLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCAS  157 (914)
Q Consensus        78 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  157 (914)
                      .++.|+++++.+..  .+.+..+++|++|+|++|.+++ + +.++++++|++|+|++|++++..|..++.+++|++|+|+
T Consensus        42 ~L~~L~l~~~~i~~--~~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  117 (272)
T 3rfs_A           42 SIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV  117 (272)
T ss_dssp             TCCEEECTTSCCCC--CTTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             ceeeeeeCCCCccc--ccccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECC
Confidence            56777777777643  2347777778888888887775 2 367777788888888887776666667777888888888


Q ss_pred             CCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCC
Q 042766          158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMF  237 (914)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  237 (914)
                      +|++++..|..|+.+++|++|+|++|++++..|..++.+++|++|++++|++++..|..|+.+++|++|+|++|++++..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (272)
T 3rfs_A          118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVP  197 (272)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccC
Confidence            88877666666777778888888888777666666777778888888888877776777777778888888888887777


Q ss_pred             CCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccc
Q 042766          238 PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL  296 (914)
Q Consensus       238 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  296 (914)
                      |..|..+++|++|++++|.+.+        .+++|+.|+++.|+++|.+|.+++.+...
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~l~~~~n~~~g~ip~~~~~~~~~  248 (272)
T 3rfs_A          198 DGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVAPD  248 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCC--------CTTTTHHHHHHHHHTGGGBBCTTSCBCGG
T ss_pred             HHHHhCCcCCCEEEccCCCccc--------cCcHHHHHHHHHHhCCCcccCcccccCCC
Confidence            7777777788888888877764        34567777777788877777777765543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1.4e-26  Score=257.52  Aligned_cols=274  Identities=18%  Similarity=0.184  Sum_probs=146.5

Q ss_pred             EEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC----CCccccC-CcchhccCCCcccCCCChhcccc-----cc
Q 042766          105 YINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP----TNLSRCS-NLIHFCASNNKLEGQIPKEIGNL-----LK  174 (914)
Q Consensus       105 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~  174 (914)
                      +++|+.|+++|.+|..+...++|++|||++|.+++..+    ..+..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            45677777777777766666667777777777775444    4555666 67777777777766556655554     66


Q ss_pred             ccccccccccccCcCCcccccc-----cccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcccc-ccccc
Q 042766          175 LQRLSVDINYLTGQLPDSVGNL-----SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICN-ISSVE  248 (914)
Q Consensus       175 L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~  248 (914)
                      |++|+|++|++++..+..+...     ++|++|+|++|.+++..+..+...                    +.. .++|+
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~--------------------l~~~~~~L~  141 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA--------------------FSNLPASIT  141 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH--------------------HTTSCTTCC
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH--------------------HHhCCCcee
Confidence            6666666666665544433332     455555555555554444333221                    111 12444


Q ss_pred             eeeccCCcccCccccc---ccccCc-ccceeeccCccCCCCCCCcccc----c-cccccccccCccCCccc----ccccc
Q 042766          249 LIFLTENRFSGIFPFD---ILLNLP-NLKKLGIGGNNFVGSIPDSLSN----A-SNLELLDLPSNQFKGKV----SIDFS  315 (914)
Q Consensus       249 ~L~L~~N~l~~~~p~~---~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~~----~~~~~  315 (914)
                      +|+|++|.+++..+..   .+..++ +|++|+|++|++++..+..+..    . ++|++|||++|+|++..    +..+.
T Consensus       142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~  221 (362)
T 3goz_A          142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS  221 (362)
T ss_dssp             EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence            4444444444221111   111222 5555666666555444433332    2 46666666666665422    22333


Q ss_pred             c-cccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCcccc
Q 042766          316 S-LKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIR  394 (914)
Q Consensus       316 ~-l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~  394 (914)
                      . .++|++|+|++|.++..+...  +...+..+++|+.|+|++|.+.+..+..+.                  .++..+.
T Consensus       222 ~~~~~L~~L~Ls~N~l~~~~~~~--l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~------------------~l~~~~~  281 (362)
T 3goz_A          222 SIPNHVVSLNLCLNCLHGPSLEN--LKLLKDSLKHLQTVYLDYDIVKNMSKEQCK------------------ALGAAFP  281 (362)
T ss_dssp             HSCTTCCEEECCSSCCCCCCHHH--HHHTTTTTTTCSEEEEEHHHHTTCCHHHHH------------------HHHTTST
T ss_pred             cCCCCceEEECcCCCCCcHHHHH--HHHHHhcCCCccEEEeccCCccccCHHHHH------------------HHHHHhc
Confidence            3 235666666666655542211  123345556666666666665533222222                  1234556


Q ss_pred             CCCCCcEEEcccCcccccCChhhh
Q 042766          395 NLVNLITFTLEVNQFHGTIPDVIS  418 (914)
Q Consensus       395 ~l~~L~~L~L~~N~l~~~~p~~~~  418 (914)
                      .+++|+.||+++|++....+..+.
T Consensus       282 ~l~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          282 NIQKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             TCCEEEEECTTSCBCCGGGCHHHH
T ss_pred             cCCceEEEecCCCcCCCcchHHHH
Confidence            677777788888877766554443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=5.7e-27  Score=260.75  Aligned_cols=270  Identities=16%  Similarity=0.151  Sum_probs=183.8

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCC----cccCCCC-CCCeeecCCCCCCCcCCCCcccc-----CC
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIP----QEIGNLF-RLEKLALSNNSFSGTIPTNLSRC-----SN  150 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~  150 (914)
                      .++|+.++++|.+|..+...++|++|+|++|.+++..+    ..+.+++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            36788999999998888888889999999999997766    6788898 89999999999998878888876     99


Q ss_pred             cchhccCCCcccCCCChhcccc-----ccccccccccccccCcCCccccc-----ccccceeecccCCCCCCCCccc---
Q 042766          151 LIHFCASNNKLEGQIPKEIGNL-----LKLQRLSVDINYLTGQLPDSVGN-----LSAIEVIRITENSLGGKIPTTL---  217 (914)
Q Consensus       151 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~---  217 (914)
                      |++|+|++|++++..+..++..     ++|++|+|++|++++..+..+..     .++|++|+|++|.++...+..+   
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            9999999999998877766554     89999999999999776655543     2689999999999986444433   


Q ss_pred             -hhhh-cccccccccccccCCCCCccccc-----cccceeeccCCcccCc----ccccccccCcccceeeccCccCCCCC
Q 042766          218 -GLLR-RLVNLNVAENQFSGMFPRSICNI-----SSVELIFLTENRFSGI----FPFDILLNLPNLKKLGIGGNNFVGSI  286 (914)
Q Consensus       218 -~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~~~~  286 (914)
                       ..++ +|++|+|++|++++..+..+...     ++|++|+|++|.+++.    ++..+....++|++|+|++|.+++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence             3443 78888888888876655444332     4666666666666542    12222211235555555555554332


Q ss_pred             CCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCc-chhhcccCCCCCcEEeccccccCCCcC
Q 042766          287 PDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL-DFVIFLSNCSSLKVLSLSDNQFGGELP  365 (914)
Q Consensus       287 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~p  365 (914)
                      +..+                    ...+..+++|++|+|++|.+...+.... .++..+..+++|+.||+++|++....+
T Consensus       242 ~~~l--------------------~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          242 LENL--------------------KLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HHHH--------------------HHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHHH--------------------HHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence            2110                    0223344455555555555433322110 122345567778888888888776555


Q ss_pred             chhhc
Q 042766          366 HSIAN  370 (914)
Q Consensus       366 ~~~~~  370 (914)
                      ..+..
T Consensus       302 ~~~~~  306 (362)
T 3goz_A          302 IPISN  306 (362)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=3.7e-25  Score=257.52  Aligned_cols=174  Identities=16%  Similarity=0.140  Sum_probs=125.7

Q ss_pred             cccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc--------chHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG--------ASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       708 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ...+.||+|+||.||+|+.  .++.+|+|+...+...        ..+++.+|++++++++||||+++..++...     
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----
Confidence            4467899999999999955  4667888886533211        134589999999999999999554444322     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||++|++|.+++..              +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred             CccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence            245899999999999999864              457899999999999999   9999999999999998  999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCcccc
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSC  908 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~  908 (914)
                      ||+|+......... ..........+||+.|||||++.      +..+|+|+...
T Consensus       473 FGla~~~~~~~~~~-~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl  526 (540)
T 3en9_A          473 FGLGKISNLDEDKA-VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL  526 (540)
T ss_dssp             CTTCEECCCHHHHH-HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred             CccCEECCCccccc-cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence            99999765422100 00000112468999999999994      46778887543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=7.7e-25  Score=228.54  Aligned_cols=181  Identities=16%  Similarity=0.177  Sum_probs=101.7

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCC-CCCcCCCCccccCCcchhccCC-CcccCCCChhccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS-FSGTIPTNLSRCSNLIHFCASN-NKLEGQIPKEIGNLLKLQRLS  179 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  179 (914)
                      .|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            67777777777776656677777777777777775 6644444666666666666666 666644445566666666666


Q ss_pred             cccccccCcCCcccccccccc---eeecccC-CCCCCCCccchhhhcccccccccccccCCCCCccccccccc-eeeccC
Q 042766          180 VDINYLTGQLPDSVGNLSAIE---VIRITEN-SLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVE-LIFLTE  254 (914)
Q Consensus       180 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~  254 (914)
                      +++|++++ +|. |+.+++|+   +|++++| .++                        +..+..|.++++|+ +|++++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~------------------------~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT------------------------SIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC------------------------EECTTTTTTTBSSEEEEECCS
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchh------------------------hcCcccccchhcceeEEEcCC
Confidence            66666653 444 44444444   4444444 444                        33333444444444 444444


Q ss_pred             CcccCcccccccccCcccceeeccCcc-CCCCCCCccccc-cccccccccCccCCccc
Q 042766          255 NRFSGIFPFDILLNLPNLKKLGIGGNN-FVGSIPDSLSNA-SNLELLDLPSNQFKGKV  310 (914)
Q Consensus       255 N~l~~~~p~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~  310 (914)
                      |+++ .+|...+.. ++|++|+|++|+ +++..+..|..+ ++|+.|+|++|+|++.+
T Consensus       166 n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~  221 (239)
T 2xwt_C          166 NGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP  221 (239)
T ss_dssp             CCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred             CCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC
Confidence            4444 233333322 455555555552 544444445555 55555555555555433

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=8.5e-25  Score=237.71  Aligned_cols=201  Identities=15%  Similarity=0.142  Sum_probs=107.6

Q ss_pred             CcchhccCCCcccCCCChhc--cccccccccccccccccCcCC----cccccccccceeecccCCCCCCCCccchhhhcc
Q 042766          150 NLIHFCASNNKLEGQIPKEI--GNLLKLQRLSVDINYLTGQLP----DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRL  223 (914)
Q Consensus       150 ~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  223 (914)
                      +|++|++++|++++..|..+  +.+++|++|+|++|.+++..|    ..+..+++|++|+|++|.+++..|..|+.+++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            34444444444444444443  444444444444444443333    122344455555555555554444555555555


Q ss_pred             cccccccccccCC---C-CCccccccccceeeccCCcccCc--ccccccccCcccceeeccCccCCCCCCCccccc---c
Q 042766          224 VNLNVAENQFSGM---F-PRSICNISSVELIFLTENRFSGI--FPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNA---S  294 (914)
Q Consensus       224 ~~L~Ls~N~l~~~---~-p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~  294 (914)
                      ++|+|++|++.+.   . +..+..+++|++|+|++|+++..  .+..++.++++|++|+|++|++++..|..+..+   +
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~  251 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS  251 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence            5555555554321   1 12234555666666666666421  111234456677777777777766666666555   4


Q ss_pred             ccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          295 NLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       295 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      +|++|+|++|+|+.+ |..+.  ++|++|+|++|+|++.+.        +..+++|+.|+|++|+++
T Consensus       252 ~L~~L~Ls~N~l~~l-p~~~~--~~L~~L~Ls~N~l~~~~~--------~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          252 ALNSLNLSFAGLEQV-PKGLP--AKLRVLDLSSNRLNRAPQ--------PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             TCCCEECCSSCCCSC-CSCCC--SCCSCEECCSCCCCSCCC--------TTSCCCCSCEECSSTTTS
T ss_pred             cCCEEECCCCCCCch-hhhhc--CCCCEEECCCCcCCCCch--------hhhCCCccEEECcCCCCC
Confidence            777777777777733 44342  577777777777765421        345677777777777775

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=1.7e-26  Score=254.42  Aligned_cols=268  Identities=15%  Similarity=0.195  Sum_probs=162.5

Q ss_pred             CCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCC--CCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCC
Q 042766           62 MNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNL--SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSG  139 (914)
Q Consensus        62 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  139 (914)
                      .-|..|.++.|+.  ..++.+|++++.+.   +..++.+  +.+++|++++|.+++..|. +.++++|++|+|++|.+++
T Consensus        34 ~vc~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           34 GVCKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SSCHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            3566899998853  34678888887665   3445555  7788888888888766554 5567788888888887775


Q ss_pred             c-CCCCccccCCcchhccCCCcccCCCChhccccccccccccccc-cccCc-CCcccccccccceeecccC-CCCCC-CC
Q 042766          140 T-IPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN-YLTGQ-LPDSVGNLSAIEVIRITEN-SLGGK-IP  214 (914)
Q Consensus       140 ~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p  214 (914)
                      . +|..+..+++|++|+|++|++++..|..++.+++|++|+|++| .+++. +|..+.++++|++|++++| .+++. ++
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~  187 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ  187 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHH
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHH
Confidence            5 6666777777777777777777666777777777777777777 56542 5555666666777777766 66543 45


Q ss_pred             ccchhhh-ccccccccccc--cc-CCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc-CCCCCCCc
Q 042766          215 TTLGLLR-RLVNLNVAENQ--FS-GMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN-FVGSIPDS  289 (914)
Q Consensus       215 ~~~~~l~-~L~~L~Ls~N~--l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~-l~~~~p~~  289 (914)
                      ..+..++ +|++|++++|.  ++ +.+|..+.                         ++++|++|+|++|. +++..+..
T Consensus       188 ~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~-------------------------~~~~L~~L~l~~~~~l~~~~~~~  242 (336)
T 2ast_B          188 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVR-------------------------RCPNLVHLDLSDSVMLKNDCFQE  242 (336)
T ss_dssp             HHHHHSCTTCCEEECCSCGGGSCHHHHHHHHH-------------------------HCTTCSEEECTTCTTCCGGGGGG
T ss_pred             HHHHhcccCCCEEEeCCCcccCCHHHHHHHHh-------------------------hCCCCCEEeCCCCCcCCHHHHHH
Confidence            5555666 66666666663  32 22333334                         44555555555555 44444445


Q ss_pred             cccccccccccccCcc-CCccccccccccccccceeccCCcCCCCCCCCcchhhcccCC-CCCcEEeccccccCCCcCch
Q 042766          290 LSNASNLELLDLPSNQ-FKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC-SSLKVLSLSDNQFGGELPHS  367 (914)
Q Consensus       290 ~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~  367 (914)
                      +..+++|++|+|++|. +.......+..+++|+.|++++| ++.   ..      +..+ .+|+.|+++.|++++..|..
T Consensus       243 l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~------~~~l~~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          243 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GT------LQLLKEALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TC------HHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred             HhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HH------HHHHHhhCcceEEecccCccccCCc
Confidence            5555555555555553 22111124555566666666665 222   11      1111 22445556777777666666


Q ss_pred             hhc
Q 042766          368 IAN  370 (914)
Q Consensus       368 ~~~  370 (914)
                      +..
T Consensus       313 ~~~  315 (336)
T 2ast_B          313 IGN  315 (336)
T ss_dssp             CSS
T ss_pred             ccc
Confidence            554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=1.3e-24  Score=236.25  Aligned_cols=225  Identities=16%  Similarity=0.132  Sum_probs=187.3

Q ss_pred             CCCCEEEcCCCCCcccC-Cc--ccCCCCCCCeeecCCCCCCCcCCCCc--cccCCcchhccCCCcccCCCC----hhccc
Q 042766          101 SFLRYINLADNGFRGDI-PQ--EIGNLFRLEKLALSNNSFSGTIPTNL--SRCSNLIHFCASNNKLEGQIP----KEIGN  171 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~-p~--~~~~l~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~~~~  171 (914)
                      ..++.|.+.++.++... ..  .+..+++|++|+|++|++++.+|..+  +.+++|++|+|++|++++..|    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            35788999998886421 11  12235679999999999999999998  999999999999999998666    45567


Q ss_pred             cccccccccccccccCcCCcccccccccceeecccCCCCCC--C--CccchhhhcccccccccccccCCCCC----cccc
Q 042766          172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGK--I--PTTLGLLRRLVNLNVAENQFSGMFPR----SICN  243 (914)
Q Consensus       172 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~  243 (914)
                      +++|++|+|++|++++..|..|+++++|++|+|++|++.+.  +  +..++.+++|++|+|++|+++. +|.    .+.+
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence            89999999999999988889999999999999999998752  2  2345789999999999999973 233    3578


Q ss_pred             ccccceeeccCCcccCcccccccccC---cccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccc
Q 042766          244 ISSVELIFLTENRFSGIFPFDILLNL---PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNL  320 (914)
Q Consensus       244 l~~L~~L~L~~N~l~~~~p~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  320 (914)
                      +++|++|+|++|++++..|..+. .+   ++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~-~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L  296 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAP-RCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEV  296 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCS-SCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCC
T ss_pred             CCCCCEEECCCCCCCccchhhHH-hccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCc
Confidence            89999999999999988775554 33   79999999999999 6787775  8999999999999976 32 6888999


Q ss_pred             cceeccCCcCCC
Q 042766          321 WLLNLEQNNLGT  332 (914)
Q Consensus       321 ~~L~L~~N~l~~  332 (914)
                      +.|+|++|.++.
T Consensus       297 ~~L~L~~N~l~~  308 (310)
T 4glp_A          297 DNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECSSTTTSC
T ss_pred             cEEECcCCCCCC
Confidence            999999999875

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=8.9e-24  Score=220.44  Aligned_cols=200  Identities=17%  Similarity=0.193  Sum_probs=152.6

Q ss_pred             ccEEEEeecccccccCCccccCCCCCcEEEcccCc-ccccCChhhhcccCCceeeecc-cccccccCccccCCCCCCeEE
Q 042766          374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQ-FHGTIPDVISELKNLQQLSVFN-NFLRGGIPSGLGNLTKLGSLD  451 (914)
Q Consensus       374 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  451 (914)
                      ++++|++++|++++..+..|.++++|++|++++|+ ++++.+..|.++++|++|++++ |.+++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            67788888888887777788888888888888886 7777777788888888888887 888876667788888888888


Q ss_pred             eeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCC-ccCCCccccccccccce-eecccCCc
Q 042766          452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNN-LLNGSLPLQVGNLKNLV-MLDISSNQ  529 (914)
Q Consensus       452 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~  529 (914)
                      +++|++++ +|. +..+++|+.|                      ++|++++| .+++..+..|.++++|+ .|++++|+
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L----------------------~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~  167 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIF----------------------FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG  167 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSE----------------------EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCC
T ss_pred             CCCCCCcc-ccc-cccccccccc----------------------cEEECCCCcchhhcCcccccchhcceeEEEcCCCC
Confidence            88888875 554 6666655410                      24555555 55545556688888899 99999999


Q ss_pred             cccccCccccccccccEEEeeccc-ccccCCcchhcc-CCCCEEEccCCccccccCccccccCCCCeEeCCCCc
Q 042766          530 FSGVIPVTLSTCVSLEYLDISINS-FYGVIPLSFRFL-KSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNY  601 (914)
Q Consensus       530 l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~  601 (914)
                      ++.+.+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++.
T Consensus       168 l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          168 FTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             CCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             CcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            98555555555 889999999995 887778888888 8999999999999854443   56778888888763

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=2e-26  Score=258.87  Aligned_cols=249  Identities=19%  Similarity=0.222  Sum_probs=115.0

Q ss_pred             CCCCCCCCCCCEEEcCCCCCccc----CCcccCCCCCCCeeecCCC---CCCCcCCCCc-------cccCCcchhccCCC
Q 042766           94 SPYVGNLSFLRYINLADNGFRGD----IPQEIGNLFRLEKLALSNN---SFSGTIPTNL-------SRCSNLIHFCASNN  159 (914)
Q Consensus        94 ~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~Ls~N  159 (914)
                      +..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|   ++++.+|..+       ..+++|++|+|++|
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n  104 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  104 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence            34455556666666666666544    2333556666666666663   3334444433       34455555555555


Q ss_pred             cccC----CCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhh---------hccccc
Q 042766          160 KLEG----QIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLL---------RRLVNL  226 (914)
Q Consensus       160 ~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l---------~~L~~L  226 (914)
                      ++++    .+|..+..+++|++|+|++|.+++..+..+..                    .+..+         ++|++|
T Consensus       105 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~l~~l~~~~~~~~~~~L~~L  164 (386)
T 2ca6_A          105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------ALQELAVNKKAKNAPPLRSI  164 (386)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------HHHHHHHHHHHHTCCCCCEE
T ss_pred             cCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------HHHHHhhhhhcccCCCCcEE
Confidence            5543    23444444444555555544443222222211                    11112         444444


Q ss_pred             cccccccc-CCCC---CccccccccceeeccCCcccCc----ccccccccCcccceeeccCccCC----CCCCCcccccc
Q 042766          227 NVAENQFS-GMFP---RSICNISSVELIFLTENRFSGI----FPFDILLNLPNLKKLGIGGNNFV----GSIPDSLSNAS  294 (914)
Q Consensus       227 ~Ls~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~  294 (914)
                      +|++|+++ +.+|   ..+..+++|++|+|++|+++..    +....+..+++|++|+|++|.++    +.+|..+..++
T Consensus       165 ~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~  244 (386)
T 2ca6_A          165 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  244 (386)
T ss_dssp             ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             ECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCC
Confidence            44444443 2222   2333444455555555544411    01112234455555555555553    33445555555


Q ss_pred             ccccccccCccCCcc----ccccc--cccccccceeccCCcCCCCCCCCcchhhcc-cCCCCCcEEeccccccCCCc
Q 042766          295 NLELLDLPSNQFKGK----VSIDF--SSLKNLWLLNLEQNNLGTGTANDLDFVIFL-SNCSSLKVLSLSDNQFGGEL  364 (914)
Q Consensus       295 ~L~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~  364 (914)
                      +|++|+|++|+|++.    ++..+  +.+++|++|+|++|.++.....  .+|..+ .++++|++|+|++|++++..
T Consensus       245 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~--~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR--TLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHH--HHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHH--HHHHHHHhcCCCceEEEccCCcCCcch
Confidence            555555555555543    22333  2255555555555555431000  023333 34566666666666665444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.89  E-value=2.2e-24  Score=250.71  Aligned_cols=205  Identities=25%  Similarity=0.351  Sum_probs=138.5

Q ss_pred             CCCCCCCCCC-----Cccce-eecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCe
Q 042766           56 SSWNNTMNFC-----QWTGV-TCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEK  129 (914)
Q Consensus        56 ~~w~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  129 (914)
                      .+|..+.++|     .|.|+ .|..  .+++.|+|++|++++ +|+.+.  ++|++|+|++|+|+ .+|   +.+++|++
T Consensus        34 ~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~  104 (571)
T 3cvr_A           34 DKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY  104 (571)
T ss_dssp             HHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred             HHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence            4565556677     79999 7853  468889999999877 777664  78999999999988 677   45788899


Q ss_pred             eecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCC
Q 042766          130 LALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSL  209 (914)
Q Consensus       130 L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  209 (914)
                      |+|++|+|++ +|. +..  +|++|+|++|++++ +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|.|
T Consensus       105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L  172 (571)
T 3cvr_A          105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL  172 (571)
T ss_dssp             EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred             EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence            9999998885 777 655  88888888888886 666   56788888888888875 555   466777777777777


Q ss_pred             CCCCCccchhhhcccccccccccccCCCCCcccccccc-------ceeeccCCcccCcccccccccCcccceeeccCccC
Q 042766          210 GGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV-------ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF  282 (914)
Q Consensus       210 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l  282 (914)
                      ++ +|. |.  ++|++|+|++|+|+ .+|. |..  +|       +.|+|++|+|+. +|..++ .+++|++|+|++|.+
T Consensus       173 ~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~-~l~~L~~L~L~~N~l  242 (571)
T 3cvr_A          173 TF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENIL-SLDPTCTIILEDNPL  242 (571)
T ss_dssp             SC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGG-GSCTTEEEECCSSSC
T ss_pred             CC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHh-cCCCCCEEEeeCCcC
Confidence            75 555 55  67777777777777 4444 433  44       444444444442 333333 244444444444444


Q ss_pred             CCCCCCccc
Q 042766          283 VGSIPDSLS  291 (914)
Q Consensus       283 ~~~~p~~~~  291 (914)
                      ++.+|..+.
T Consensus       243 ~~~~p~~l~  251 (571)
T 3cvr_A          243 SSRIRESLS  251 (571)
T ss_dssp             CHHHHHHHH
T ss_pred             CCcCHHHHH
Confidence            444444333

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=3.2e-25  Score=244.23  Aligned_cols=257  Identities=17%  Similarity=0.202  Sum_probs=176.3

Q ss_pred             CCCEEEcCCCCCcccCCcccCCC--CCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCC-CChhcccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNL--FRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQ-IPKEIGNLLKLQRL  178 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L  178 (914)
                      .++.+++++|.+.   |..+..+  ++++.|++++|.+++..|. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            3678888887776   4455666  7788888888887755444 55677777777777777654 66666667777777


Q ss_pred             ccccccccCcCCcccccccccceeecccC-CCCCC-CCccchhhhcccccccccccccCCCCCccccccccceeeccCC-
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITEN-SLGGK-IPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN-  255 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-  255 (914)
                      +|++|.+++..|..++.+++|++|+|++| .+++. +|..+..                        +++|++|++++| 
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~------------------------~~~L~~L~l~~~~  179 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS------------------------CSRLDELNLSWCF  179 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHH------------------------CTTCCEEECCCCT
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhc------------------------CCCCCEEcCCCCC
Confidence            77777666666666666666666666666 44431 3333444                        445555555555 


Q ss_pred             cccCcccccccccCc-ccceeeccCc--cCC-CCCCCccccccccccccccCcc-CCccccccccccccccceeccCCcC
Q 042766          256 RFSGIFPFDILLNLP-NLKKLGIGGN--NFV-GSIPDSLSNASNLELLDLPSNQ-FKGKVSIDFSSLKNLWLLNLEQNNL  330 (914)
Q Consensus       256 ~l~~~~p~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l  330 (914)
                      .+++......+..++ +|++|+|++|  .++ +.+|..+..+++|++|+|++|. +++..+..+..+++|++|++++|. 
T Consensus       180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~-  258 (336)
T 2ast_B          180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY-  258 (336)
T ss_dssp             TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT-
T ss_pred             CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC-
Confidence            444321123344677 7888888887  444 3566778889999999999999 887888899999999999999996 


Q ss_pred             CCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccC
Q 042766          331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRN  395 (914)
Q Consensus       331 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~  395 (914)
                       .....   ....+..+++|+.|++++| ++.   ..+..+...+..|+++.|++++..|..++.
T Consensus       259 -~~~~~---~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          259 -DIIPE---TLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             -TCCGG---GGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             -CCCHH---HHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence             22111   2235788999999999999 432   233444334777889999999999988775

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=3.5e-25  Score=248.82  Aligned_cols=247  Identities=21%  Similarity=0.249  Sum_probs=168.4

Q ss_pred             hhhcccCCCCCcEEeccccccCCCcCch----hhccccccEEEEeecc---cccccCCccc-------cCCCCCcEEEcc
Q 042766          340 FVIFLSNCSSLKVLSLSDNQFGGELPHS----IANLSLKMIELSVGRN---QISGTIPPGI-------RNLVNLITFTLE  405 (914)
Q Consensus       340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~----~~~~~~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~  405 (914)
                      ++..+..+++|+.|+|++|++++..+..    +..+. +|+.|+|++|   ++++.+|..+       ..+++|++|+|+
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~-~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCT-TCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCC-CccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            3445677788888888888887554433    33333 5777777764   4444455444       566677777777


Q ss_pred             cCcccc----cCChhhhcccCCceeeecccccccccCcccc----CC---------CCCCeEEeeCCcCC-CCCC---Cc
Q 042766          406 VNQFHG----TIPDVISELKNLQQLSVFNNFLRGGIPSGLG----NL---------TKLGSLDLGSNSLQ-GNIP---SS  464 (914)
Q Consensus       406 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~  464 (914)
                      +|++++    .+|..+..+++|++|+|++|.+++..+..+.    .+         ++|++|+|++|+++ +.+|   ..
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  182 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT  182 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence            777765    3556666667777777777776544333333    22         66666666666665 2333   24


Q ss_pred             cCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccc----cccCccccc
Q 042766          465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFS----GVIPVTLST  540 (914)
Q Consensus       465 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~  540 (914)
                      +..+++|+.|++++|+++.   ..+.                 ...|..+..+++|+.|+|++|+++    +.+|..+..
T Consensus       183 l~~~~~L~~L~L~~n~l~~---~g~~-----------------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          183 FQSHRLLHTVKMVQNGIRP---EGIE-----------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             HHHCTTCCEEECCSSCCCH---HHHH-----------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             HHhCCCcCEEECcCCCCCH---hHHH-----------------HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            4455555555555555431   0000                 023446778899999999999996    677888999


Q ss_pred             cccccEEEeeccccccc----CCcchhc--cCCCCEEEccCCcccc----ccCccc-cccCCCCeEeCCCCccccccC
Q 042766          541 CVSLEYLDISINSFYGV----IPLSFRF--LKSIKALNVSSNNLSG----KIPEFL-ENLSFLEFLNLSYNYFEGEVP  607 (914)
Q Consensus       541 l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~ls~N~l~~~~p  607 (914)
                      +++|++|+|++|.+++.    +|..+..  +++|+.|+|++|++++    .+|..+ .++++|++|++++|++++..|
T Consensus       243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            99999999999999876    5666644  8999999999999998    488877 668999999999999986654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=3e-23  Score=229.41  Aligned_cols=203  Identities=15%  Similarity=0.098  Sum_probs=115.0

Q ss_pred             CCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCC-
Q 042766           65 CQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT-  143 (914)
Q Consensus        65 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-  143 (914)
                      |+|..|.|+.            ++++ .+|..+  .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. 
T Consensus         9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~   73 (350)
T 4ay9_X            9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   73 (350)
T ss_dssp             EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred             eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence            6777777753            3343 345544  25678888888888744445678888888888888887666654 


Q ss_pred             CccccCCcch-hccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeeccc-CCCCCCCCccchhhh
Q 042766          144 NLSRCSNLIH-FCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE-NSLGGKIPTTLGLLR  221 (914)
Q Consensus       144 ~l~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~  221 (914)
                      .|.++++|++ ++++.|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |.+....+.+|..+.
T Consensus        74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~  153 (350)
T 4ay9_X           74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  153 (350)
T ss_dssp             SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence            4566666554 55556777655566677777777777777777655555555555666666644 345444444444443


Q ss_pred             -cccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCC
Q 042766          222 -RLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV  283 (914)
Q Consensus       222 -~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~  283 (914)
                       .++.|+|++|+|+.+.+..| ...+|+.|++++|+..+.+|.+.|.++++|++|+|++|+|+
T Consensus       154 ~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          154 FESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             SSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             hhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence             35555555555553222222 23344444444322222334444444444444444444444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=3.7e-23  Score=228.69  Aligned_cols=240  Identities=19%  Similarity=0.170  Sum_probs=192.4

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCCh-hccccccccc-cccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPK-EIGNLLKLQR-LSVD  181 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~-L~L~  181 (914)
                      +.++.++++++ .+|..+.  +++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. +|.++++|++ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            56788999999 8888773  6899999999999944445789999999999999998776664 6888988775 6677


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccc-ccccCCCCCcccccc-ccceeeccCCcccC
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE-NQFSGMFPRSICNIS-SVELIFLTENRFSG  259 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  259 (914)
                      .|++++..|+.|.++++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+.
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~  168 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  168 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence            8999988888999999999999999999977777777888888899865 577766677777765 68889999999985


Q ss_pred             cccccccccCcccceeeccC-ccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCc
Q 042766          260 IFPFDILLNLPNLKKLGIGG-NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDL  338 (914)
Q Consensus       260 ~~p~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  338 (914)
                       +|...| ..++|++|++++ |.++.+.++.|..+++|++|||++|+|+.+++..|.++++|+.+++  ++++..+    
T Consensus       169 -i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP----  240 (350)
T 4ay9_X          169 -IHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP----  240 (350)
T ss_dssp             -ECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCC----
T ss_pred             -CChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCC----
Confidence             565666 567899999975 6676555567899999999999999999888877887777777665  3444432    


Q ss_pred             chhhcccCCCCCcEEecccc
Q 042766          339 DFVIFLSNCSSLKVLSLSDN  358 (914)
Q Consensus       339 ~~~~~l~~l~~L~~L~Ls~N  358 (914)
                          .+.++++|+.++++++
T Consensus       241 ----~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          241 ----TLEKLVALMEASLTYP  256 (350)
T ss_dssp             ----CTTTCCSCCEEECSCH
T ss_pred             ----CchhCcChhhCcCCCC
Confidence                2567888888888765

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=3.5e-23  Score=224.37  Aligned_cols=194  Identities=24%  Similarity=0.369  Sum_probs=126.5

Q ss_pred             CCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccc
Q 042766           98 GNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQR  177 (914)
Q Consensus        98 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  177 (914)
                      ..+++|++|++++|+++ .+| .+..+++|++|+|++|++++. |. +..+++|++|+|++|++++ +| .+..+++|++
T Consensus        38 ~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~  111 (308)
T 1h6u_A           38 ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKT  111 (308)
T ss_dssp             HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCE
T ss_pred             HHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCE
Confidence            34667777777777776 355 577777777777777777743 33 7777777777777777764 33 5677777777


Q ss_pred             cccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcc
Q 042766          178 LSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF  257 (914)
Q Consensus       178 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  257 (914)
                      |+|++|++++ +|. +..+++|++|++++|.+++..+  ++.+++|++|+|++|++++..+  +..+++|+.|++++|++
T Consensus       112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            7777777764 332 6677777777777777765433  6666777777777777665433  66666666666666666


Q ss_pred             cCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCc
Q 042766          258 SGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       258 ~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                      ++..+   +..+++|++|+|++|++++..  .+..+++|+.|+|++|++++
T Consensus       186 ~~~~~---l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          186 SDISP---LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG---GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             CcChh---hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            65432   345666666666666666443  25566666666666666654

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=1.1e-22  Score=213.80  Aligned_cols=182  Identities=19%  Similarity=0.176  Sum_probs=146.3

Q ss_pred             CCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccC
Q 042766          398 NLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIAS  477 (914)
Q Consensus       398 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  477 (914)
                      +.++++++++.++. +|..+.  ++++.|+|++|.+++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+++
T Consensus        15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            46678888888873 444332  577888888888887777777888888888888888877777777777777666666


Q ss_pred             CCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeeccccccc
Q 042766          478 YNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV  557 (914)
Q Consensus       478 ~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  557 (914)
                      +|+++                         +..+..|..+++|++|+|++|++++.++..|..+++|++|+|++|++++.
T Consensus        92 ~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  146 (251)
T 3m19_A           92 NNQLA-------------------------SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI  146 (251)
T ss_dssp             TSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCccc-------------------------ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence            66554                         34455677888999999999999988887888999999999999999988


Q ss_pred             CCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccC
Q 042766          558 IPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVP  607 (914)
Q Consensus       558 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  607 (914)
                      .+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+|.+.
T Consensus       147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred             CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence            88889999999999999999998888889999999999999999998743

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=3.2e-23  Score=224.67  Aligned_cols=205  Identities=22%  Similarity=0.333  Sum_probs=113.4

Q ss_pred             cCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccC
Q 042766          108 LADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTG  187 (914)
Q Consensus       108 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  187 (914)
                      +..+.+++.++  +..+++|++|++++|.++ .+| .+..+++|++|+|++|++++. +. +..+++|++|+|++|++++
T Consensus        26 l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~   99 (308)
T 1h6u_A           26 AGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN   99 (308)
T ss_dssp             TTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC
T ss_pred             hCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC
Confidence            34444443322  345667777777777776 344 566677777777777777643 33 6666667777777666664


Q ss_pred             cCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccc
Q 042766          188 QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILL  267 (914)
Q Consensus       188 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  267 (914)
                       +| .+..+++|++|++++|.+++. |. +..+++|++|++++|++++..+  +..+++|                    
T Consensus       100 -~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L--------------------  153 (308)
T 1h6u_A          100 -VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNL--------------------  153 (308)
T ss_dssp             -CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTC--------------------
T ss_pred             -ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCc--------------------
Confidence             22 456666666666666666542 22 5555555555555555554322  4444444                    


Q ss_pred             cCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCC
Q 042766          268 NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC  347 (914)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  347 (914)
                           ++|+|++|++++..+  +..+++|+.|+|++|++++..+  +..+++|++|++++|++++.+        .+..+
T Consensus       154 -----~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--------~l~~l  216 (308)
T 1h6u_A          154 -----QYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--------PLANT  216 (308)
T ss_dssp             -----CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--------GGTTC
T ss_pred             -----cEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--------cccCC
Confidence                 444555554443222  4455555555555555554433  455555555555555555431        14556


Q ss_pred             CCCcEEeccccccC
Q 042766          348 SSLKVLSLSDNQFG  361 (914)
Q Consensus       348 ~~L~~L~Ls~N~l~  361 (914)
                      ++|+.|+|++|+++
T Consensus       217 ~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          217 SNLFIVTLTNQTIT  230 (308)
T ss_dssp             TTCCEEEEEEEEEE
T ss_pred             CCCCEEEccCCeee
Confidence            66666666666665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=3.4e-23  Score=220.73  Aligned_cols=151  Identities=17%  Similarity=0.170  Sum_probs=119.5

Q ss_pred             HHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------------------cchHHHHHHHHHHHhcC
Q 042766          699 ELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------------------GASKSFVSECEALRNIR  760 (914)
Q Consensus       699 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  760 (914)
                      .+......|++.+.||+|+||.||+|++ .+++.||+|+++....                  .....+.+|++++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3344455677789999999999999999 7899999999964321                  12456899999999999


Q ss_pred             CCCcceEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 042766          761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHG  840 (914)
Q Consensus       761 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHr  840 (914)
                      |   +++.+++..      +..++||||++||+|.+ +...            +...++.|++.|++|||+.   +|+||
T Consensus       163 ~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiHr  217 (282)
T 1zar_A          163 G---LAVPKVYAW------EGNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVHG  217 (282)
T ss_dssp             T---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             C---CCcCeEEec------cceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEeC
Confidence            5   444444321      24589999999999988 4321            2346999999999999999   99999


Q ss_pred             CCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh
Q 042766          841 DLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF  897 (914)
Q Consensus       841 Dlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~  897 (914)
                      ||||+|||++ ++.+||+|||+|+.                     +..|+|||++.
T Consensus       218 Dlkp~NILl~-~~~vkl~DFG~a~~---------------------~~~~~a~e~l~  252 (282)
T 1zar_A          218 DLSQYNVLVS-EEGIWIIDFPQSVE---------------------VGEEGWREILE  252 (282)
T ss_dssp             CCSTTSEEEE-TTEEEECCCTTCEE---------------------TTSTTHHHHHH
T ss_pred             CCCHHHEEEE-CCcEEEEECCCCeE---------------------CCCCCHHHHHH
Confidence            9999999999 99999999999863                     34688999984

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=3e-22  Score=204.04  Aligned_cols=186  Identities=19%  Similarity=0.247  Sum_probs=110.0

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP  142 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  142 (914)
                      ..|.|.+|.|+..            +++ .+|..+  .++|++|++++|++++..+..++++++|++|+|++|++++..+
T Consensus         5 C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~   69 (208)
T 2o6s_A            5 CSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN   69 (208)
T ss_dssp             CEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred             CEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence            4589999999642            222 233332  3467777777777775555566777777777777777774444


Q ss_pred             CCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhc
Q 042766          143 TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRR  222 (914)
Q Consensus       143 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  222 (914)
                      ..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++.                        .+..|..+++
T Consensus        70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------------------~~~~~~~l~~  125 (208)
T 2o6s_A           70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSL------------------------PDGVFDKLTQ  125 (208)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC------------------------CTTTTTTCTT
T ss_pred             hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCccc------------------------CHhHhccCCc
Confidence            4456666666666666666644444445555555555555555543                        3334444455


Q ss_pred             ccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccc
Q 042766          223 LVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN  295 (914)
Q Consensus       223 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  295 (914)
                      |++|+|++|++++..+..|..+++|++|++++|.+.+        .+++|++|+++.|+++|.+|..++.++.
T Consensus       126 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          126 LKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC--------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC--------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CCEEECCCCccceeCHHHhccCCCccEEEecCCCeec--------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            5555555555554444445555556666666665543        3456667777777777777776665544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=3.9e-22  Score=203.17  Aligned_cols=185  Identities=18%  Similarity=0.191  Sum_probs=155.7

Q ss_pred             CCCCCCCCCCCCCCccceeecC--CCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCee
Q 042766           53 GVTSSWNNTMNFCQWTGVTCGH--RHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKL  130 (914)
Q Consensus        53 ~~~~~w~~~~~~c~w~gv~C~~--~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  130 (914)
                      ....+|. +.+ |...|.+.-.  ...+++.|+|++|.+++..+..++.+++|++|+|++|++++..+..+.++++|++|
T Consensus         4 ~C~C~~~-~v~-c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L   81 (208)
T 2o6s_A            4 RCSCSGT-TVE-CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL   81 (208)
T ss_dssp             TCEEETT-EEE-CCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCEECCC-EEE-ecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence            3345675 333 5555543321  23478999999999987666678999999999999999997666778999999999


Q ss_pred             ecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCC
Q 042766          131 ALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLG  210 (914)
Q Consensus       131 ~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  210 (914)
                      +|++|++++..+..++.+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|.+.
T Consensus        82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  161 (208)
T 2o6s_A           82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  161 (208)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence            99999999766677899999999999999999777778999999999999999999777777999999999999999887


Q ss_pred             CCCCccchhhhcccccccccccccCCCCCccccccc
Q 042766          211 GKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISS  246 (914)
Q Consensus       211 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  246 (914)
                      +.       +++|++|+++.|+++|.+|..++.+..
T Consensus       162 ~~-------~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          162 CT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CC-------TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             cC-------CCCHHHHHHHHHhCCceeeccCccccC
Confidence            54       457999999999999999998887654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=5.5e-22  Score=230.56  Aligned_cols=189  Identities=22%  Similarity=0.312  Sum_probs=154.4

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      +|++|+|++|++++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +++  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999996 887764  78999999999999 788   557999999999999996 777 766  89999999


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                      +|++++ +|.   .+++|++|+|++|.+++ +|.   .+++|++|+|++|+|++ +|. |.  ++|++|+|++|+|+ .+
T Consensus       129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            999996 666   67899999999999986 665   57889999999999987 566 65  88999999999988 45


Q ss_pred             cccccccCccc-------ceeeccCccCCCCCCCccccccccccccccCccCCcccccccccccc
Q 042766          262 PFDILLNLPNL-------KKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKN  319 (914)
Q Consensus       262 p~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  319 (914)
                      |. +. .  +|       ++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..|..++.
T Consensus       196 p~-~~-~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          196 PA-VP-V--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             CC-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             hh-HH-H--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            54 32 2  66       88888888888 57777777888888888888888887777665543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.86  E-value=5.5e-23  Score=248.08  Aligned_cols=218  Identities=20%  Similarity=0.225  Sum_probs=93.8

Q ss_pred             CCHhHHHHHHHHHHhcC-CCCCCCCCCC-CCCCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCC
Q 042766           33 TNETDRLALLAIKSQLH-DPSGVTSSWN-NTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLAD  110 (914)
Q Consensus        33 ~~~~~~~aLl~~k~~~~-~~~~~~~~w~-~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~  110 (914)
                      ..+.++++|+++..... +....-..|. ..+..+.|.+++++.  .+++.|+|.++.+... +..+     |+.++|+.
T Consensus       129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~  200 (727)
T 4b8c_D          129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQAL-----LQHKKLSQ  200 (727)
T ss_dssp             ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred             ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhhH-----hhcCccCc
Confidence            46778999999998875 2223334564 334567899998853  6789999998887653 3332     34444554


Q ss_pred             CCCcc---------cCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          111 NGFRG---------DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       111 n~l~~---------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      |.|.+         ..|..+..++.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|+++++|++|+|+
T Consensus       201 ~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls  278 (727)
T 4b8c_D          201 YSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLS  278 (727)
T ss_dssp             ---------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECT
T ss_pred             ccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCc
Confidence            44442         34555666666666666666666 56666666666666666666666 566666666666666666


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcccccccc-ceeeccCCcccCc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV-ELIFLTENRFSGI  260 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~  260 (914)
                      +|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+... ..|+|++|.+++.
T Consensus       279 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~  356 (727)
T 4b8c_D          279 HNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP  356 (727)
T ss_dssp             TSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             CCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence            66666 55666666666666666666665 455556666666666666666655555554433221 2244555555544


Q ss_pred             cc
Q 042766          261 FP  262 (914)
Q Consensus       261 ~p  262 (914)
                      +|
T Consensus       357 ~p  358 (727)
T 4b8c_D          357 LP  358 (727)
T ss_dssp             CC
T ss_pred             Cc
Confidence            33

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=6.4e-21  Score=197.05  Aligned_cols=163  Identities=19%  Similarity=0.221  Sum_probs=114.5

Q ss_pred             CCCCCCCCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCC
Q 042766           57 SWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNS  136 (914)
Q Consensus        57 ~w~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~  136 (914)
                      -|..+.+.|+|++|.|+..            ++ +.+|..+.  ++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        11 ~~~~~~~~Cs~~~v~c~~~------------~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~   75 (229)
T 3e6j_A           11 AACPSQCSCSGTTVDCRSK------------RH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ   75 (229)
T ss_dssp             CCCCTTCEEETTEEECTTS------------CC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccCCCCCEEeCCEeEccCC------------Cc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence            3555778999999999642            22 23454443  778888888888887778888888888888888888


Q ss_pred             CCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCcc
Q 042766          137 FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTT  216 (914)
Q Consensus       137 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  216 (914)
                      |++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..
T Consensus        76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~  154 (229)
T 3e6j_A           76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGA  154 (229)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTT
T ss_pred             CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHH
Confidence            87444455677777777777777777655556677777777777777777 56666666666666666666666555555


Q ss_pred             chhhhcccccccccccccC
Q 042766          217 LGLLRRLVNLNVAENQFSG  235 (914)
Q Consensus       217 ~~~l~~L~~L~Ls~N~l~~  235 (914)
                      |..+++|+.|+|++|.+.+
T Consensus       155 ~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          155 FDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             TTTCTTCCEEECTTSCBCT
T ss_pred             HhCCCCCCEEEeeCCCccC
Confidence            6666666666666666554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.84  E-value=1.3e-23  Score=245.81  Aligned_cols=207  Identities=19%  Similarity=0.167  Sum_probs=146.9

Q ss_pred             CCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc-------------ccCCCChhccccccccccc-cccccccC
Q 042766          122 GNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK-------------LEGQIPKEIGNLLKLQRLS-VDINYLTG  187 (914)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~  187 (914)
                      ..+++|+.|+|++|+++ .+|.+++++++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            67888999999999997 889999999999999997775             5667788888888999888 7777543 


Q ss_pred             cCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccc
Q 042766          188 QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILL  267 (914)
Q Consensus       188 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  267 (914)
                                .|+.+.+++|.++...+      ..|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|.. +.
T Consensus       424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~-~~  483 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA-LA  483 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG-GG
T ss_pred             ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh-hh
Confidence                      45556666666553221      236777777777775 454 777777777777777777 45543 34


Q ss_pred             cCcccceeeccCccCCCCCCCccccccccccccccCccCCccc-cccccccccccceeccCCcCCCCCCCCcchhhcccC
Q 042766          268 NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV-SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSN  346 (914)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~  346 (914)
                      ++++|++|+|++|+|++ +| .++.+++|++|+|++|+|++.. |..|..+++|+.|+|++|.+++.+..   ....+..
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~---~~~l~~~  558 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI---QERLAEM  558 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC---TTHHHHH
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH---HHHHHHH
Confidence            77777777777777775 45 6777777777777777777766 77777777777777777777765432   1122345


Q ss_pred             CCCCcEEec
Q 042766          347 CSSLKVLSL  355 (914)
Q Consensus       347 l~~L~~L~L  355 (914)
                      +++|+.|++
T Consensus       559 lp~L~~L~l  567 (567)
T 1dce_A          559 LPSVSSILT  567 (567)
T ss_dssp             CTTCSEEEC
T ss_pred             CcccCccCC
Confidence            777777764

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=4.4e-21  Score=196.86  Aligned_cols=159  Identities=20%  Similarity=0.133  Sum_probs=129.1

Q ss_pred             ceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCC-CccCCCCCccccccCCCccCCCCchhhhcccchhhhhccc
Q 042766          424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP-SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLS  502 (914)
Q Consensus       424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls  502 (914)
                      +.+++++|.++ .+|..+.  ..+++|+|++|+|++..| ..|.++++|+.|++++|                       
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N-----------------------   67 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-----------------------   67 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSS-----------------------
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCC-----------------------
Confidence            46777777776 3555443  345677777777775543 34566666655555554                       


Q ss_pred             CCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCcccccc
Q 042766          503 NNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKI  582 (914)
Q Consensus       503 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  582 (914)
                        +|++..+..|.++++|++|+|++|++++.+|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..
T Consensus        68 --~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (220)
T 2v70_A           68 --KITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA  145 (220)
T ss_dssp             --CCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred             --cCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence              444455667889999999999999999998889999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCeEeCCCCccccccCCCC
Q 042766          583 PEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       583 p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      |..|..+++|+.|+|++|+|+|.++..+
T Consensus       146 ~~~~~~l~~L~~L~L~~N~l~c~c~l~~  173 (220)
T 2v70_A          146 PGAFDTLHSLSTLNLLANPFNCNCYLAW  173 (220)
T ss_dssp             TTTTTTCTTCCEEECCSCCEECSGGGHH
T ss_pred             HHHhcCCCCCCEEEecCcCCcCCCchHH
Confidence            9999999999999999999999998654

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=1.9e-20  Score=220.29  Aligned_cols=196  Identities=21%  Similarity=0.331  Sum_probs=109.7

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      ..++++.+.+...++  +..|++|+.|+|++|.++ .+| .+..+++|+.|+|++|++++..|  +..+++|++|+|++|
T Consensus        24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N   97 (605)
T 1m9s_A           24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN   97 (605)
T ss_dssp             HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             HHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence            334444444443322  344555556666666555 333 35555666666666666554332  555666666666666


Q ss_pred             cccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccc
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPF  263 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  263 (914)
                      .+++ +| .+..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|.+++..| 
T Consensus        98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-  170 (605)
T 1m9s_A           98 KIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  170 (605)
T ss_dssp             CCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred             CCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence            6653 22 455666666666666666542  2355666666666666666643  455666666666666666665544 


Q ss_pred             cccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccc
Q 042766          264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSS  316 (914)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  316 (914)
                        +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++.+...+..
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~  219 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSN  219 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred             --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence              44566666666666666643  24666666666666666666544433333

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=2.6e-22  Score=234.66  Aligned_cols=206  Identities=19%  Similarity=0.213  Sum_probs=166.7

Q ss_pred             cccCCcchhccCCCcccCCCChhcccccccccccccccc-------------ccCcCCcccccccccceee-cccCCCCC
Q 042766          146 SRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINY-------------LTGQLPDSVGNLSAIEVIR-ITENSLGG  211 (914)
Q Consensus       146 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~  211 (914)
                      ..+++|+.|+|++|+++ .+|+.++++++|++|++++|.             +.+..|..++++++|+.|+ ++.|.   
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~---  421 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAY---  421 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHH---
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcc---
Confidence            67889999999999998 889999999999999998876             5566677777777887777 55553   


Q ss_pred             CCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccc
Q 042766          212 KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLS  291 (914)
Q Consensus       212 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  291 (914)
                              +..|..+.+++|.++...+.      .|+.|+|++|.|++ +|.  +.++++|++|+|++|+|+ .+|..|+
T Consensus       422 --------~~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~  483 (567)
T 1dce_A          422 --------LDDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALA  483 (567)
T ss_dssp             --------HHHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred             --------cchhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhh
Confidence                    34677777888887754332      48899999999997 464  678999999999999999 7899999


Q ss_pred             cccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCch--hh
Q 042766          292 NASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHS--IA  369 (914)
Q Consensus       292 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~  369 (914)
                      .+++|+.|+|++|+|+++ | .|..+++|++|+|++|+|++..     .|..+..+++|+.|+|++|++++..|..  +.
T Consensus       484 ~l~~L~~L~Ls~N~l~~l-p-~l~~l~~L~~L~Ls~N~l~~~~-----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~  556 (567)
T 1dce_A          484 ALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSA-----AIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA  556 (567)
T ss_dssp             GCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSS-----TTGGGGGCTTCCEEECTTSGGGGSSSCTTHHH
T ss_pred             cCCCCCEEECCCCCCCCC-c-ccCCCCCCcEEECCCCCCCCCC-----CcHHHhcCCCCCEEEecCCcCCCCccHHHHHH
Confidence            999999999999999984 5 7999999999999999998862     1667889999999999999999665532  22


Q ss_pred             ccccccEEEEe
Q 042766          370 NLSLKMIELSV  380 (914)
Q Consensus       370 ~~~~~L~~L~L  380 (914)
                      ...++|+.|++
T Consensus       557 ~~lp~L~~L~l  567 (567)
T 1dce_A          557 EMLPSVSSILT  567 (567)
T ss_dssp             HHCTTCSEEEC
T ss_pred             HHCcccCccCC
Confidence            32346777754

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=7.7e-21  Score=195.08  Aligned_cols=159  Identities=18%  Similarity=0.202  Sum_probs=133.9

Q ss_pred             ceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccC
Q 042766          424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSN  503 (914)
Q Consensus       424 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~  503 (914)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|++++|+++                     
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~---------------------   69 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS---------------------   69 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC---------------------
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC---------------------
Confidence            56788888887 4565554  67888888888888766667777777766666555554                     


Q ss_pred             CccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccC
Q 042766          504 NLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIP  583 (914)
Q Consensus       504 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  583 (914)
                          +..|..|.++++|++|+|++|+|+++++..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+
T Consensus        70 ----~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  145 (220)
T 2v9t_B           70 ----ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK  145 (220)
T ss_dssp             ----EECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             ----CcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence                4557788889999999999999998877888999999999999999999999999999999999999999999888


Q ss_pred             ccccccCCCCeEeCCCCccccccCCCC
Q 042766          584 EFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       584 ~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      ..+..+++|+.|+|++|+|.|.++..+
T Consensus       146 ~~~~~l~~L~~L~L~~N~~~c~c~l~~  172 (220)
T 2v9t_B          146 GTFSPLRAIQTMHLAQNPFICDCHLKW  172 (220)
T ss_dssp             TTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             HHHhCCCCCCEEEeCCCCcCCCCccHH
Confidence            899999999999999999999887654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=1.5e-20  Score=201.75  Aligned_cols=171  Identities=22%  Similarity=0.363  Sum_probs=78.7

Q ss_pred             CCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766           99 NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus        99 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .+++|++|++++|.++. +| .+..+++|++|+|++|++++..|  ++.+++|++|+|++|++++ +| .          
T Consensus        44 ~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~----------  107 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-S----------  107 (291)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-G----------
T ss_pred             hcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-h----------
Confidence            34445555555555542 22 24444555555555555543222  4444444444444444442 11 2          


Q ss_pred             ccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCccc
Q 042766          179 SVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS  258 (914)
Q Consensus       179 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  258 (914)
                                    +..+++|++|+|++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|+++
T Consensus       108 --------------l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~  169 (291)
T 1h6t_A          108 --------------LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  169 (291)
T ss_dssp             --------------GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             --------------hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence                          44444444444444444432  2344444444444444444432  23444445555555555554


Q ss_pred             CcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCc
Q 042766          259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       259 ~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                      +..|   +..+++|++|+|++|++++. | .+..+++|+.|++++|+++.
T Consensus       170 ~~~~---l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          170 DIVP---LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCGG---GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             cchh---hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            4322   33455555555555555532 2 25555555555555555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=4.6e-20  Score=189.26  Aligned_cols=151  Identities=22%  Similarity=0.279  Sum_probs=84.2

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCC-cccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCC
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIP-QEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNN  159 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N  159 (914)
                      .++++++.++. +|..+.  ..+++|+|++|++++..| ..|.++++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus        15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N   91 (220)
T 2v70_A           15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN   91 (220)
T ss_dssp             EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence            44555566543 454443  234666777776665544 33566666666666666666555555666666666666666


Q ss_pred             cccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          160 KLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      ++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+.
T Consensus        92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            666555555555555555555555555555555555555555555555555444444444444444444444444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=6.9e-20  Score=187.97  Aligned_cols=146  Identities=20%  Similarity=0.264  Sum_probs=91.5

Q ss_pred             CCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCC
Q 042766           86 SQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQI  165 (914)
Q Consensus        86 ~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  165 (914)
                      +++++ .+|..+.  +.|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus        20 ~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~   96 (220)
T 2v9t_B           20 GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELP   96 (220)
T ss_dssp             TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCC
T ss_pred             CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccC
Confidence            34443 3454443  56777777777777666667777777777777777777666777777777777777777776444


Q ss_pred             ChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          166 PKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       166 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      +..|..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+.
T Consensus        97 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             HhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            444566666666666666666555555655666666666555555554445555555555555555544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=5.8e-20  Score=197.23  Aligned_cols=168  Identities=18%  Similarity=0.298  Sum_probs=130.9

Q ss_pred             CceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhcc
Q 042766           77 QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA  156 (914)
Q Consensus        77 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  156 (914)
                      .+++.|+++++.+...  +.+..+++|++|+|++|++++..|  ++++++|++|+|++|++++ +| .++.+++|++|+|
T Consensus        46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L  119 (291)
T 1h6t_A           46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL  119 (291)
T ss_dssp             HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred             CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence            3588999999998654  458999999999999999996544  9999999999999999985 44 4999999999999


Q ss_pred             CCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCC
Q 042766          157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGM  236 (914)
Q Consensus       157 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  236 (914)
                      ++|++++.  +.+..+++|++|++++|++++.  ..++.+++|++|++++|.+++..|  +..+++|++|+|++|++++.
T Consensus       120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l  193 (291)
T 1h6t_A          120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL  193 (291)
T ss_dssp             TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC
T ss_pred             CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC
Confidence            99999853  5688888888888888888854  567777777777777777775544  66677777777777777643


Q ss_pred             CCCccccccccceeeccCCccc
Q 042766          237 FPRSICNISSVELIFLTENRFS  258 (914)
Q Consensus       237 ~p~~~~~l~~L~~L~L~~N~l~  258 (914)
                       | .+..+++|+.|++++|+++
T Consensus       194 -~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          194 -R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             -G-GGTTCTTCSEEEEEEEEEE
T ss_pred             -h-hhccCCCCCEEECcCCccc
Confidence             2 2555555555555555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=3.1e-20  Score=206.12  Aligned_cols=181  Identities=22%  Similarity=0.115  Sum_probs=149.4

Q ss_pred             cEEEcccCcccccCChhhhcccCCceeeecccccccccCcccc-CCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCC
Q 042766          400 ITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLG-NLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASY  478 (914)
Q Consensus       400 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  478 (914)
                      +.+++++|+++. +|..+  .+.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|+.|++++
T Consensus        21 ~~l~c~~~~l~~-iP~~~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSC--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccC--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            578999999884 55443  24588899999999987777777 889999999999999877778888888887777776


Q ss_pred             CccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccC
Q 042766          479 NKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVI  558 (914)
Q Consensus       479 N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  558 (914)
                      |+++                         +..+..|.++++|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++..
T Consensus        98 N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~  152 (361)
T 2xot_A           98 NHLH-------------------------TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP  152 (361)
T ss_dssp             SCCC-------------------------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred             CcCC-------------------------cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence            6665                         234556788899999999999999988999999999999999999999766


Q ss_pred             Ccch---hccCCCCEEEccCCccccccCccccccCC--CCeEeCCCCccccccCC
Q 042766          559 PLSF---RFLKSIKALNVSSNNLSGKIPEFLENLSF--LEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       559 p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~ls~N~l~~~~p~  608 (914)
                      +..|   ..+++|+.|||++|+|++..+..+..++.  ++.|+|++|+|.|++..
T Consensus       153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l  207 (361)
T 2xot_A          153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL  207 (361)
T ss_dssp             GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred             HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence            6666   67999999999999999877788888887  48899999999998764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=5.3e-20  Score=204.20  Aligned_cols=126  Identities=17%  Similarity=0.175  Sum_probs=67.5

Q ss_pred             EecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccC-CCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc
Q 042766           82 LNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIG-NLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK  160 (914)
Q Consensus        82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  160 (914)
                      +++++++|+. +|..+.  +.+++|+|++|+|++..+..+. ++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus        23 l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~   99 (361)
T 2xot_A           23 LSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH   99 (361)
T ss_dssp             EECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence            4455555543 444332  2356666666666655555555 66666666666666664444555555555555555555


Q ss_pred             ccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCC
Q 042766          161 LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLG  210 (914)
Q Consensus       161 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  210 (914)
                      +++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+++
T Consensus       100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A          100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            55444444555555555555555555444444444444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1e-19  Score=213.96  Aligned_cols=195  Identities=26%  Similarity=0.331  Sum_probs=116.7

Q ss_pred             hhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccccc
Q 042766          219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLEL  298 (914)
Q Consensus       219 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  298 (914)
                      .+..+..++++.+.+....+  +..+.+|+.|++++|.+... |  .+..+++|+.|+|++|+|.+..|  +..+++|+.
T Consensus        19 ~l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~   91 (605)
T 1m9s_A           19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGW   91 (605)
T ss_dssp             HHHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCE
T ss_pred             HHHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCE
Confidence            45667777777777765433  45666677777777766643 2  13456666666666666665433  666666666


Q ss_pred             ccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEE
Q 042766          299 LDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL  378 (914)
Q Consensus       299 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L  378 (914)
                      |+|++|+|++..  .+..+++|+.|+|++|.+..+        ..+..+++|+.|+|++|+++                 
T Consensus        92 L~Ls~N~l~~l~--~l~~l~~L~~L~Ls~N~l~~l--------~~l~~l~~L~~L~Ls~N~l~-----------------  144 (605)
T 1m9s_A           92 LFLDENKIKDLS--SLKDLKKLKSLSLEHNGISDI--------NGLVHLPQLESLYLGNNKIT-----------------  144 (605)
T ss_dssp             EECCSSCCCCCT--TSTTCTTCCEEECTTSCCCCC--------GGGGGCTTCSEEECCSSCCC-----------------
T ss_pred             EECcCCCCCCCh--hhccCCCCCEEEecCCCCCCC--------ccccCCCccCEEECCCCccC-----------------
Confidence            666666665432  455555555555555555442        12344455555555555444                 


Q ss_pred             EeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCC
Q 042766          379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ  458 (914)
Q Consensus       379 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  458 (914)
                              +.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.
T Consensus       145 --------~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          145 --------DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             --------CC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             --------Cc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence                    22  345566677777777777766555  66677777777777777653  24666777777777777776


Q ss_pred             CCC
Q 042766          459 GNI  461 (914)
Q Consensus       459 ~~~  461 (914)
                      +..
T Consensus       211 ~~p  213 (605)
T 1m9s_A          211 NKP  213 (605)
T ss_dssp             CCC
T ss_pred             CCc
Confidence            543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=3.8e-19  Score=183.71  Aligned_cols=154  Identities=19%  Similarity=0.218  Sum_probs=130.4

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            46788888888 7887665  78999999999999888889999999999999999998665667888999999999999


Q ss_pred             cccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcc
Q 042766          184 YLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       184 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                      ++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+....
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            999777777888999999999999988 77888888888888888888888777777888888888888888776543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=4.4e-20  Score=222.71  Aligned_cols=192  Identities=19%  Similarity=0.174  Sum_probs=113.4

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCe-----eecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccc
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEK-----LALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL  175 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~-----L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  175 (914)
                      +.++.|+|.+|.+.. +|..+.....|..     ++++.|.+. ..|..+..+++|+.|+|++|++. .+|..+..+++|
T Consensus       173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L  249 (727)
T 4b8c_D          173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFL  249 (727)
T ss_dssp             ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSC
T ss_pred             CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCC
Confidence            567899999999985 4444322222222     233334444 45777888888999999999888 788888888889


Q ss_pred             cccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCC
Q 042766          176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTEN  255 (914)
Q Consensus       176 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  255 (914)
                      ++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+++++|++|+|++|
T Consensus       250 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N  326 (727)
T 4b8c_D          250 TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN  326 (727)
T ss_dssp             SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTS
T ss_pred             CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCC
Confidence            99999999888 88888888889999999999888 77888888888999999988887 66777888888888888888


Q ss_pred             cccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCc
Q 042766          256 RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN  304 (914)
Q Consensus       256 ~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  304 (914)
                      .|++.+|..+......+..|+|++|.+++.+|..      |+.|++++|
T Consensus       327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence            8888777554322223345778888888777763      456667766

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.2e-19  Score=187.71  Aligned_cols=138  Identities=20%  Similarity=0.168  Sum_probs=107.1

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEE--EEEEEeeccCCc------------------------chHHHHHHHHHHHhc
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMV--VAVKVINLKQKG------------------------ASKSFVSECEALRNI  759 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  759 (914)
                      -|++.+.||+|+||.||+|++..+|+.  ||||+++.....                        ....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367788999999999999999667888  999997533111                        013688999999999


Q ss_pred             CCCCc--ceEEeEeecCCCCCCceEeEEEecccC-C----CHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHH-h
Q 042766          760 RHRNL--IKIITICSSTDFEGVDFKALVFEYMEN-G----SLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH-H  831 (914)
Q Consensus       760 ~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH-~  831 (914)
                      .|+++  +..+++         ...++||||+.+ |    +|.++...         .++.++..++.|++.|+.||| +
T Consensus       128 ~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          128 KEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH
Confidence            88864  344432         235799999942 3    77776432         123356789999999999999 8


Q ss_pred             CCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          832 HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       832 ~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      .   +|+||||||+|||++.  .++|+|||+|...
T Consensus       190 ~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 A---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             S---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            8   9999999999999988  9999999999754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=2.1e-19  Score=180.22  Aligned_cols=136  Identities=27%  Similarity=0.332  Sum_probs=112.2

Q ss_pred             hhhcccCCccCCCccc-cccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccC
Q 042766          497 LVLDLSNNLLNGSLPL-QVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS  575 (914)
Q Consensus       497 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  575 (914)
                      ++|++++|++++..+. .|+.+++|++|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        32 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  111 (192)
T 1w8a_A           32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD  111 (192)
T ss_dssp             SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCS
T ss_pred             CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC
Confidence            4566666666655553 488899999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCccccccCCCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCCCccC
Q 042766          576 NNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDE  632 (914)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~  632 (914)
                      |+|++.+|..+..+++|++|+|++|+|+|.++..+....+....+.++...|+.++.
T Consensus       112 N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~  168 (192)
T 1w8a_A          112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK  168 (192)
T ss_dssp             SCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSSTT
T ss_pred             CcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCChH
Confidence            999999999999999999999999999999986543332333345566667766443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=3e-19  Score=188.55  Aligned_cols=163  Identities=24%  Similarity=0.319  Sum_probs=86.8

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK  160 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  160 (914)
                      .++++++.+....  .+..+++|++|++++|+++ .+| .++.+++|++|+|++|++++..|  ++.+++|++|+|++|+
T Consensus        23 ~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~   96 (263)
T 1xeu_A           23 KQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR   96 (263)
T ss_dssp             HHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred             HHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc
Confidence            3444555444322  3455566666666666665 344 45566666666666666653322  5566666666666666


Q ss_pred             ccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCc
Q 042766          161 LEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRS  240 (914)
Q Consensus       161 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  240 (914)
                      +++ +|... . ++|++|+|++|++++ +| .++.+++|++|+|++|++++. | .++.+++|++|+|++|++++.  ..
T Consensus        97 l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~  167 (263)
T 1xeu_A           97 LKN-LNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GG  167 (263)
T ss_dssp             CSC-CTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TT
T ss_pred             cCC-cCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HH
Confidence            653 33222 2 556666666665553 22 355555555555555555533 2 455555555555555555543  34


Q ss_pred             cccccccceeeccCCccc
Q 042766          241 ICNISSVELIFLTENRFS  258 (914)
Q Consensus       241 ~~~l~~L~~L~L~~N~l~  258 (914)
                      +..+++|+.|++++|.++
T Consensus       168 l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          168 LTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             STTCCCCCEEEEEEEEEE
T ss_pred             hccCCCCCEEeCCCCccc
Confidence            555555555555555554

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.76  E-value=2.1e-19  Score=189.76  Aligned_cols=151  Identities=18%  Similarity=0.344  Sum_probs=62.9

Q ss_pred             ccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccc
Q 042766          145 LSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLV  224 (914)
Q Consensus       145 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  224 (914)
                      +..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..|  +.++++|++|+|++|++++ +|....  ++|+
T Consensus        37 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~  109 (263)
T 1xeu_A           37 QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLS  109 (263)
T ss_dssp             HHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCC
T ss_pred             hhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--Cccc
Confidence            333344444444444333 222 33334444444444444442222  3444444444444444432 111111  4444


Q ss_pred             ccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCc
Q 042766          225 NLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN  304 (914)
Q Consensus       225 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  304 (914)
                      +|+|++|++++.  ..+..+++|+.|+|++|++++. |  .+..+++|++|+|++|++++.  ..+..+++|+.|++++|
T Consensus       110 ~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~--~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N  182 (263)
T 1xeu_A          110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V--MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQ  182 (263)
T ss_dssp             EEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G--GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEE
T ss_pred             EEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h--HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCC
Confidence            444444444432  1244444444444444444432 1  233445555555555555433  34445555555555555


Q ss_pred             cCCcc
Q 042766          305 QFKGK  309 (914)
Q Consensus       305 ~l~~~  309 (914)
                      ++++.
T Consensus       183 ~~~~~  187 (263)
T 1xeu_A          183 KCVNE  187 (263)
T ss_dssp             EEECC
T ss_pred             cccCC
Confidence            55433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=4.1e-19  Score=178.98  Aligned_cols=105  Identities=18%  Similarity=0.249  Sum_probs=45.3

Q ss_pred             CCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccc
Q 042766          100 LSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLS  179 (914)
Q Consensus       100 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  179 (914)
                      +++|++|++++|.++ .+| .+..+++|++|++++|.++  .++.+..+++|++|++++|++++..|..++.+++|++|+
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            344444445444444 333 3444444555555444332  112344444444444444444433344444444444444


Q ss_pred             cccccccCcCCcccccccccceeecccCC
Q 042766          180 VDINYLTGQLPDSVGNLSAIEVIRITENS  208 (914)
Q Consensus       180 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  208 (914)
                      |++|++++..|..++.+++|++|++++|.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            44444443333344444444444444443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=1.1e-18  Score=175.96  Aligned_cols=154  Identities=18%  Similarity=0.232  Sum_probs=84.0

Q ss_pred             CCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccce
Q 042766          122 GNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEV  201 (914)
Q Consensus       122 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  201 (914)
                      +.+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45566666777666666 455 4666666666666666443  2235555556666666666655555555555555555


Q ss_pred             eecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc
Q 042766          202 IRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN  281 (914)
Q Consensus       202 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~  281 (914)
                      |++++|.+++..|..++.+++|++|++++|++                       ++. +|  .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~-----------------------i~~-~~--~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGA-----------------------ITD-IM--PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTB-----------------------CCC-CG--GGGGCSSCCEEECTTBC
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCC-----------------------ccc-cH--hhcCCCCCCEEECCCCC
Confidence            55555555544445555555555555555541                       322 22  23355556666666665


Q ss_pred             CCCCCCCccccccccccccccCccCC
Q 042766          282 FVGSIPDSLSNASNLELLDLPSNQFK  307 (914)
Q Consensus       282 l~~~~p~~~~~l~~L~~L~Ls~N~l~  307 (914)
                      +++ ++ .+..+++|++|++++|+|.
T Consensus       171 i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          171 VHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             CcC-hH-HhccCCCCCEEEeeCcccC
Confidence            553 22 5556666666666666654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=2.3e-18  Score=188.45  Aligned_cols=101  Identities=12%  Similarity=0.034  Sum_probs=74.6

Q ss_pred             cccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCc-eeeecccccccccCccccCCCCCCeEE
Q 042766          373 LKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ-QLSVFNNFLRGGIPSGLGNLTKLGSLD  451 (914)
Q Consensus       373 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~  451 (914)
                      .+|+.+++++|+++.+.+.+|.++.+|+.++|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.++
T Consensus       226 ~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          226 PNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             TTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            36777777777777777777777777777777776 6666677777777777 777777 66656667777777777777


Q ss_pred             eeCCcCCCCCCCccCCCCCccccc
Q 042766          452 LGSNSLQGNIPSSLGNCQNLILFI  475 (914)
Q Consensus       452 Ls~N~l~~~~p~~~~~l~~L~~L~  475 (914)
                      +++|+++...+.+|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            777777766666777777777664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=3.6e-18  Score=171.13  Aligned_cols=129  Identities=20%  Similarity=0.350  Sum_probs=81.7

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCC-CccccCCcchhccCCCcccCCCChhcccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT-NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI  182 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  182 (914)
                      +++++++|+++ .+|..+..  +|++|+|++|++++..|. .++.+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            67788888875 67766544  777777777777744443 366677777777777777666666666666666666666


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccC
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG  235 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  235 (914)
                      |++++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|.+++
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            66665555555556666666665555555555555555555555555555543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=9.4e-18  Score=168.07  Aligned_cols=113  Identities=26%  Similarity=0.318  Sum_probs=99.1

Q ss_pred             hhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCC
Q 042766          497 LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN  576 (914)
Q Consensus       497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  576 (914)
                      ++|++++|.|+ .+|..|.++++|+.|+|++|+|+++.+.+|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        34 ~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N  112 (193)
T 2wfh_A           34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN  112 (193)
T ss_dssp             CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCC
Confidence            44555566655 56677888899999999999999988889999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccCCCCeEeCCCCccccccCCCC
Q 042766          577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      +|++..+..|..+++|+.|+|++|+|.|.+...+
T Consensus       113 ~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~  146 (193)
T 2wfh_A          113 DISVVPEGAFNDLSALSHLAIGANPLYCDCNMQW  146 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             CCCeeChhhhhcCccccEEEeCCCCeecCCcCHH
Confidence            9998777789999999999999999999887553

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.71  E-value=8.1e-18  Score=184.13  Aligned_cols=287  Identities=10%  Similarity=0.057  Sum_probs=175.3

Q ss_pred             cCCcchhccCCCcccCCCChhccc-ccccccccccccccc--CcCCcccccccccceeecccCCCCCCCCccchh-----
Q 042766          148 CSNLIHFCASNNKLEGQIPKEIGN-LLKLQRLSVDINYLT--GQLPDSVGNLSAIEVIRITENSLGGKIPTTLGL-----  219 (914)
Q Consensus       148 l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----  219 (914)
                      +.+++.|.++++ +.+.--..+.. +++|++|||++|+++  ...+..+   +.+..+.+..|.+   .+.+|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccccc
Confidence            566777777643 21111112333 566777777777776  2222222   2234444444422   2344555     


Q ss_pred             ---hhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCcc----CCCCCCCcccc
Q 042766          220 ---LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNN----FVGSIPDSLSN  292 (914)
Q Consensus       220 ---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~----l~~~~p~~~~~  292 (914)
                         +++|+.|+|.+ .++.+.+.+|.++++|+.+++++|.++ .++...|.++.++..+.+..+.    .....+.+|.+
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence               67777777776 666555666777777777777777665 3444555566666655555422    12223344545


Q ss_pred             ccccc-cccccCccC-CccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhc
Q 042766          293 ASNLE-LLDLPSNQF-KGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIAN  370 (914)
Q Consensus       293 l~~L~-~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  370 (914)
                      +.+|+ .+++....- .......-....++..+.+.++-. ..     ++......+++|+.|+|++|+++ .+|...+.
T Consensus       175 ~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~-~~-----~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~  247 (329)
T 3sb4_A          175 GEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLD-NA-----DFKLIRDYMPNLVSLDISKTNAT-TIPDFTFA  247 (329)
T ss_dssp             SCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCC-HH-----HHHHHHHHCTTCCEEECTTBCCC-EECTTTTT
T ss_pred             ccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeec-HH-----HHHHHHHhcCCCeEEECCCCCcc-eecHhhhh
Confidence            55554 333332210 000000111234444555544311 10     01111234789999999999998 56655444


Q ss_pred             cccccEEEEeecccccccCCccccCCCCCc-EEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCe
Q 042766          371 LSLKMIELSVGRNQISGTIPPGIRNLVNLI-TFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGS  449 (914)
Q Consensus       371 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  449 (914)
                      ...+|+.+++.+| ++.+.+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|++++|.++...+.+|.++++|+.
T Consensus       248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~  325 (329)
T 3sb4_A          248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL  325 (329)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred             CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence            4447999999998 8888889999999999 999998 888788899999999999999999999888889999999999


Q ss_pred             EEe
Q 042766          450 LDL  452 (914)
Q Consensus       450 L~L  452 (914)
                      ++.
T Consensus       326 ly~  328 (329)
T 3sb4_A          326 IYK  328 (329)
T ss_dssp             EEC
T ss_pred             hcc
Confidence            873

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=2.7e-17  Score=161.02  Aligned_cols=133  Identities=19%  Similarity=0.211  Sum_probs=87.6

Q ss_pred             CCCCCEEEcCCCCCc-ccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766          100 LSFLRYINLADNGFR-GDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus       100 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            356777777777776 66777677777777777777777643  566677777777777777776566666667777777


Q ss_pred             ccccccccCcC-CcccccccccceeecccCCCCCCCC---ccchhhhccccccccccccc
Q 042766          179 SVDINYLTGQL-PDSVGNLSAIEVIRITENSLGGKIP---TTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       179 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      +|++|++++.. +..+..+++|++|++++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            77777776432 2556666666666666666664433   35556666666666666655

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.68  E-value=2.8e-17  Score=157.34  Aligned_cols=128  Identities=16%  Similarity=0.187  Sum_probs=98.3

Q ss_pred             CCCCCEEEcCCCCCc-ccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccc
Q 042766          100 LSFLRYINLADNGFR-GDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRL  178 (914)
Q Consensus       100 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  178 (914)
                      .++|++|++++|.++ +.+|..++.+++|++|+|++|.+++.  ..++.+++|++|+|++|++++.+|..++.+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            367888888888887 77888888888888888888888754  677888888888888888887677777778888888


Q ss_pred             ccccccccCc-CCcccccccccceeecccCCCCCCCC---ccchhhhcccccccc
Q 042766          179 SVDINYLTGQ-LPDSVGNLSAIEVIRITENSLGGKIP---TTLGLLRRLVNLNVA  229 (914)
Q Consensus       179 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls  229 (914)
                      ++++|++++. .|..++.+++|++|++++|.+++..+   ..++.+++|++|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            8888888753 34667777777777777777775554   466777777777765

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=8.9e-17  Score=157.32  Aligned_cols=83  Identities=20%  Similarity=0.272  Sum_probs=33.1

Q ss_pred             CCcchhccCCCccc-CCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccc
Q 042766          149 SNLIHFCASNNKLE-GQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLN  227 (914)
Q Consensus       149 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  227 (914)
                      ++|++|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|++|+|++|.+++.+|..++.+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            33444444444443 33344444444444444444444322  3333344444444444444333333333333333333


Q ss_pred             cccccc
Q 042766          228 VAENQF  233 (914)
Q Consensus       228 Ls~N~l  233 (914)
                      |++|++
T Consensus       102 Ls~N~l  107 (168)
T 2ell_A          102 LSGNKL  107 (168)
T ss_dssp             CBSSSC
T ss_pred             ccCCcc
Confidence            333333

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=1.8e-16  Score=158.66  Aligned_cols=108  Identities=27%  Similarity=0.324  Sum_probs=52.0

Q ss_pred             CCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccc
Q 042766          101 SFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV  180 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  180 (914)
                      +.|++|+|++|.++ .+|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            34555555555555 44555555555555555555555444444555555555555555554444444444444444444


Q ss_pred             ccccccCcCCcccccccccceeecccCCC
Q 042766          181 DINYLTGQLPDSVGNLSAIEVIRITENSL  209 (914)
Q Consensus       181 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  209 (914)
                      ++|++++..+..|..+++|+.|+|++|.+
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            44444433333344444444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=4.9e-17  Score=155.66  Aligned_cols=128  Identities=15%  Similarity=0.161  Sum_probs=86.1

Q ss_pred             CCCCCeeecCCCCCC-CcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCccccccccccee
Q 042766          124 LFRLEKLALSNNSFS-GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVI  202 (914)
Q Consensus       124 l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  202 (914)
                      .++|++|++++|.++ +.+|..+..+++|++|++++|++++.  ..++.+++|++|+|++|.+++.+|..++.+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            357888888888887 77787778888888888888888754  667777777777777777776666666667777777


Q ss_pred             ecccCCCCCC-CCccchhhhcccccccccccccCCCC---Cccccccccceeecc
Q 042766          203 RITENSLGGK-IPTTLGLLRRLVNLNVAENQFSGMFP---RSICNISSVELIFLT  253 (914)
Q Consensus       203 ~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~  253 (914)
                      ++++|.+++. .|..++.+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            7777776642 23556666666666666666664433   244444555544443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=3.4e-16  Score=154.55  Aligned_cols=112  Identities=21%  Similarity=0.227  Sum_probs=98.9

Q ss_pred             hhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCC
Q 042766          497 LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN  576 (914)
Q Consensus       497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  576 (914)
                      +.|++++|++++..+..|..+++|++|+|++|++++.++..|..+++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        31 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  110 (177)
T 2o6r_A           31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN  110 (177)
T ss_dssp             SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC
Confidence            45666666666666667788999999999999999888888899999999999999999888888999999999999999


Q ss_pred             ccccccCccccccCCCCeEeCCCCccccccCC
Q 042766          577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      ++++..+..+..+++|++|++++|+++|.+|.
T Consensus       111 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A          111 QLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            99987777789999999999999999998873

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=6e-16  Score=152.79  Aligned_cols=136  Identities=19%  Similarity=0.232  Sum_probs=96.8

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP  142 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  142 (914)
                      ..|.|.+|.|+.            ++++ .+|..+  .+.|++|++++|++++..+..++++++|++|+|++|++++..+
T Consensus         5 C~C~~~~l~~~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~   69 (177)
T 2o6r_A            5 CSCSGTEIRCNS------------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD   69 (177)
T ss_dssp             CEEETTEEECCS------------SCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred             CEeCCCEEEecC------------CCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence            447888888853            2332 234333  3678888888888886666667888888888888888885555


Q ss_pred             CCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCC
Q 042766          143 TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKI  213 (914)
Q Consensus       143 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  213 (914)
                      ..++.+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+.+..
T Consensus        70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            56778888888888888887666666777777777777777777555555667777777777777776543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=3.3e-16  Score=170.52  Aligned_cols=136  Identities=14%  Similarity=0.177  Sum_probs=98.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--------------cchH--------HHHHHHHHHHhcCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--------------GASK--------SFVSECEALRNIRHR  762 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~  762 (914)
                      .=|++.+.||+|++|.||+|++. +|+.||||+++....              ....        ...+|...+.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34889999999999999999986 688999999853210              0011        123566666666544


Q ss_pred             Ccc--eEEeEeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 042766          763 NLI--KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHG  840 (914)
Q Consensus       763 niv--~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHr  840 (914)
                      ++.  ..+++         ...++||||++|+++.++...            .....++.|++.++.|||++   +||||
T Consensus       174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHr  229 (397)
T 4gyi_A          174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHG  229 (397)
T ss_dssp             TCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCC
Confidence            432  22221         123699999999888654321            12356789999999999999   99999


Q ss_pred             CCCCCCeeecCCC----------cEEEeccccccc
Q 042766          841 DLKPSNVLLDYDM----------VAHVGDFGLAKF  865 (914)
Q Consensus       841 Dlkp~NILl~~~~----------~~ki~DFGla~~  865 (914)
                      ||||.|||+++++          .+.|+||+-+-.
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999998876          389999997754

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.61  E-value=5.5e-15  Score=165.16  Aligned_cols=253  Identities=10%  Similarity=0.119  Sum_probs=150.4

Q ss_pred             CcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccC
Q 042766          190 PDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNL  269 (914)
Q Consensus       190 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l  269 (914)
                      +.+|.++ +|+.+.+.+| ++..-..+|.+ .+|+.+.+.+ .++.+.+.+|.++.+|+.+++++|+++. +|...|. .
T Consensus       129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~-I~~~aF~-~  202 (401)
T 4fdw_A          129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK-LPASTFV-Y  202 (401)
T ss_dssp             TTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE-ECTTTTT-T
T ss_pred             HhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE-echhhEe-e
Confidence            3445443 4555555544 44344445555 3455555553 4444445555566666666666555552 3444443 3


Q ss_pred             cccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCC
Q 042766          270 PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSS  349 (914)
Q Consensus       270 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~  349 (914)
                      .+|+.+.|..+ ++.+-..+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .|.++.++..      .|.++++
T Consensus       203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~------aF~~c~~  272 (401)
T 4fdw_A          203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASR------AFYYCPE  272 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTT------TTTTCTT
T ss_pred             cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChh------HhhCCCC
Confidence            55666665533 44444555556666666666543 44455555555 55555555 2334433222      3445555


Q ss_pred             CcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeec
Q 042766          350 LKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVF  429 (914)
Q Consensus       350 L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  429 (914)
                      |+.+++.+|.+.                    .+.+..+.+.+|.+|.+|+.++|. |.++.+...+|.++++|+.++|.
T Consensus       273 L~~l~l~~~~~~--------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          273 LAEVTTYGSTFN--------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             CCEEEEESSCCC--------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred             CCEEEeCCcccc--------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence            555555555433                    011123556788888889999888 45777777888888889999886


Q ss_pred             ccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCC-CccccccCCCcc
Q 042766          430 NNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQ-NLILFIASYNKL  481 (914)
Q Consensus       430 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l  481 (914)
                      +| ++.+-+.+|.++ +|+.+++++|.+....+..|.+++ ++..+++..+.+
T Consensus       332 ~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          332 AN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             cc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            55 665667788888 899999998888766677777774 566666655543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.61  E-value=1.7e-17  Score=167.25  Aligned_cols=111  Identities=18%  Similarity=0.342  Sum_probs=48.0

Q ss_pred             hccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcccccccc
Q 042766          168 EIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV  247 (914)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  247 (914)
                      .++.+++|++|+|++|++++ +| .+.++++|++|++++|.++ .+|..+..+++|++|+|++|++++ +| .+..+++|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L  117 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence            44444444444444444443 33 4444444444444444444 344444444444444444444443 22 34444444


Q ss_pred             ceeeccCCcccCcccccccccCcccceeeccCccCC
Q 042766          248 ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV  283 (914)
Q Consensus       248 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~  283 (914)
                      ++|++++|++++..+...+..+++|++|++++|.+.
T Consensus       118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~  153 (198)
T 1ds9_A          118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred             CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence            444444444443211122234444444444444443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.60  E-value=1.2e-17  Score=168.36  Aligned_cols=154  Identities=21%  Similarity=0.297  Sum_probs=97.7

Q ss_pred             CCCCCCeeecCCCCCCCcCCC------CccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccc
Q 042766          123 NLFRLEKLALSNNSFSGTIPT------NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL  196 (914)
Q Consensus       123 ~l~~L~~L~Ls~N~l~~~~p~------~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  196 (914)
                      ....++.++++.+.++|.+|.      .++.+++|++|+|++|++++ +| .+..+++|++|+|++|.++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            344555555555555555554      56666666666666666664 55 6666667777777777766 566666666


Q ss_pred             cccceeecccCCCCCCCCccchhhhcccccccccccccCCCC-CccccccccceeeccCCcccCcccc---------ccc
Q 042766          197 SAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFP-RSICNISSVELIFLTENRFSGIFPF---------DIL  266 (914)
Q Consensus       197 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~---------~~~  266 (914)
                      ++|++|+|++|++++ +| .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|.         ..+
T Consensus        93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  170 (198)
T 1ds9_A           93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred             CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence            777777777777764 34 56777777777777777774332 4677777788888888877665443         234


Q ss_pred             ccCcccceeeccCccCC
Q 042766          267 LNLPNLKKLGIGGNNFV  283 (914)
Q Consensus       267 ~~l~~L~~L~Ls~N~l~  283 (914)
                      ..+++|++||  +|.++
T Consensus       171 ~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          171 KRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHCSSCSEEC--CGGGT
T ss_pred             HhCCCcEEEC--CcccC
Confidence            4566666654  44443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=1e-14  Score=162.91  Aligned_cols=256  Identities=13%  Similarity=0.109  Sum_probs=144.9

Q ss_pred             CCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCc
Q 042766          285 SIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL  364 (914)
Q Consensus       285 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  364 (914)
                      +-+.+|.+. +|+.++|..| ++.+...+|.+ .+|+.+.+.. .++.++..      .|.+|++|+.++|++|+++ .+
T Consensus       127 I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~------aF~~c~~L~~l~l~~n~l~-~I  195 (401)
T 4fdw_A          127 IPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKED------IFYYCYNLKKADLSKTKIT-KL  195 (401)
T ss_dssp             ECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSS------TTTTCTTCCEEECTTSCCS-EE
T ss_pred             ehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHH------HhhCcccCCeeecCCCcce-Ee
Confidence            334445543 4555665544 55555555555 3466666653 44443222      3556666666666666665 33


Q ss_pred             CchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCC
Q 042766          365 PHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNL  444 (914)
Q Consensus       365 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  444 (914)
                      |...+.. .+|+.+.+.. .++.+...+|.++.+|+.+++..| ++.+...+|.+ .+|+.+.+ .|.++...+.+|.++
T Consensus       196 ~~~aF~~-~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c  270 (401)
T 4fdw_A          196 PASTFVY-AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYC  270 (401)
T ss_dssp             CTTTTTT-CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTC
T ss_pred             chhhEee-cccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCC
Confidence            3332222 2344555542 244445556666666666666543 34344444544 45555555 233333334445555


Q ss_pred             CCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeec
Q 042766          445 TKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD  524 (914)
Q Consensus       445 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  524 (914)
                      ++|+.+++.+|.+.                        .                    +.+..+.+.+|.++++|+.++
T Consensus       271 ~~L~~l~l~~~~~~------------------------~--------------------~~~~~I~~~aF~~c~~L~~l~  306 (401)
T 4fdw_A          271 PELAEVTTYGSTFN------------------------D--------------------DPEAMIHPYCLEGCPKLARFE  306 (401)
T ss_dssp             TTCCEEEEESSCCC------------------------C--------------------CTTCEECTTTTTTCTTCCEEC
T ss_pred             CCCCEEEeCCcccc------------------------C--------------------CcccEECHHHhhCCccCCeEE
Confidence            55555555444432                        0                    011113345677777788888


Q ss_pred             ccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccC-CCCeEeCCCCccc
Q 042766          525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLS-FLEFLNLSYNYFE  603 (914)
Q Consensus       525 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~  603 (914)
                      |. |.++.+...+|.+|++|+.++|..| ++...+.+|.++ +|+.+++++|.+....+..|.+++ .++.|++..|.+.
T Consensus       307 l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          307 IP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             eC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            87 4476666777888888888888554 666667788887 888888888887776677777774 6777777776544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=1.6e-15  Score=149.49  Aligned_cols=132  Identities=16%  Similarity=0.171  Sum_probs=81.9

Q ss_pred             CCCCCCCCEEEcCCCCCcccCCcccCCCC-CCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccc
Q 042766           97 VGNLSFLRYINLADNGFRGDIPQEIGNLF-RLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL  175 (914)
Q Consensus        97 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  175 (914)
                      +.+++.|++|++++|+++ .+|. +..+. +|++|+|++|++++.  ..++.+++|++|+|++|++++..|..++.+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            455667777777777777 4443 44444 777777777777743  566677777777777777764433444666677


Q ss_pred             cccccccccccCcCCc--ccccccccceeecccCCCCCCCCcc----chhhhccccccccccccc
Q 042766          176 QRLSVDINYLTGQLPD--SVGNLSAIEVIRITENSLGGKIPTT----LGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       176 ~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~  234 (914)
                      ++|+|++|+++ .+|.  .++.+++|++|++++|.++ .+|..    ++.+++|++||+++|.+.
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            77777777665 4444  5666666666666666665 33442    555555666665555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.56  E-value=9e-14  Score=155.94  Aligned_cols=326  Identities=10%  Similarity=0.071  Sum_probs=152.2

Q ss_pred             hccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcccccccc
Q 042766          168 EIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSV  247 (914)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  247 (914)
                      +|.++.+|+.+.|..+ ++..-..+|.++++|+.+++.++ ++..-..+|.++.+|+.+.+..+ +......+|.+...+
T Consensus        66 AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~  142 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK  142 (394)
T ss_dssp             TTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred             HhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence            3334444444444322 33222334444444554444432 33233344555555555444432 222333444444333


Q ss_pred             ceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccC
Q 042766          248 ELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQ  327 (914)
Q Consensus       248 ~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  327 (914)
                      +........   .+....|.++++|+.+.+..+. .......|.++++|+.+++..| ++.+...+|.++..|+.+.+..
T Consensus       143 ~~~~~~~~~---~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~  217 (394)
T 4fs7_A          143 EITIPEGVT---VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN  217 (394)
T ss_dssp             EEECCTTCC---EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred             ccccCcccc---ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence            222222211   1223444555556666555432 2233445556666666666554 4444455555555555555443


Q ss_pred             CcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccC
Q 042766          328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVN  407 (914)
Q Consensus       328 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  407 (914)
                      +.....        .......+                         ++.+.+.. .++.+...+|.++.+|+.+.+..+
T Consensus       218 ~~~~i~--------~~~~~~~~-------------------------l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          218 SLYYLG--------DFALSKTG-------------------------VKNIIIPD-SFTELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             TCCEEC--------TTTTTTCC-------------------------CCEEEECT-TCCEECSSTTTTCSSCCEEEECCT
T ss_pred             CceEee--------hhhcccCC-------------------------CceEEECC-CceecccccccccccceeEEcCCC
Confidence            322110        00111223                         33333322 122234456666777777777665


Q ss_pred             cccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCch
Q 042766          408 QFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ  487 (914)
Q Consensus       408 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  487 (914)
                      ... +....|..+..++.+....+.+.   ...|..+.+|+.+.+.++ ++..-..+|.+|++|+.+++..+ ++     
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-----  332 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-----  332 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-----
T ss_pred             cce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-----
Confidence            443 55556666666666666554332   234566666666666543 44344455656665555543211 11     


Q ss_pred             hhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCC
Q 042766          488 QLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS  567 (914)
Q Consensus       488 ~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  567 (914)
                                          .+-..+|.++++|+.+++..| ++.+...+|.+|++|+.+++..+ ++ .+..+|.+.++
T Consensus       333 --------------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~  389 (394)
T 4fs7_A          333 --------------------EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTK  389 (394)
T ss_dssp             --------------------EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCE
T ss_pred             --------------------EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCC
Confidence                                122345556666666666555 55455556666666666666544 21 22344554444


Q ss_pred             CC
Q 042766          568 IK  569 (914)
Q Consensus       568 L~  569 (914)
                      |+
T Consensus       390 L~  391 (394)
T 4fs7_A          390 FK  391 (394)
T ss_dssp             EE
T ss_pred             Cc
Confidence            44

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.55  E-value=6.3e-15  Score=144.19  Aligned_cols=109  Identities=21%  Similarity=0.230  Sum_probs=97.1

Q ss_pred             hhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCC
Q 042766          497 LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN  576 (914)
Q Consensus       497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  576 (914)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            46778888887 4665553  78999999999999999999999999999999999999888888999999999999999


Q ss_pred             ccccccCccccccCCCCeEeCCCCccccccCC
Q 042766          577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      +|++..+..|..+++|+.|+|++|+|+|.++.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence            99988888899999999999999999998873

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=2.3e-15  Score=148.45  Aligned_cols=133  Identities=19%  Similarity=0.196  Sum_probs=86.7

Q ss_pred             ccCCCCCCCeeecCCCCCCCcCCCCccccC-CcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccc
Q 042766          120 EIGNLFRLEKLALSNNSFSGTIPTNLSRCS-NLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA  198 (914)
Q Consensus       120 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  198 (914)
                      .+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|++++.  +.|+.+++|++|+|++|++++..|..++.+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            4566778888888888887 4543 55444 788888888877753  56677777777777777777544444567777


Q ss_pred             cceeecccCCCCCCCCc--cchhhhcccccccccccccCCCCCc----cccccccceeeccCCccc
Q 042766          199 IEVIRITENSLGGKIPT--TLGLLRRLVNLNVAENQFSGMFPRS----ICNISSVELIFLTENRFS  258 (914)
Q Consensus       199 L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~  258 (914)
                      |++|+|++|.++ .+|.  .++.+++|++|++++|.++. +|..    +..+++|++|+++.|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            777777777775 3444  56666666666666666663 3432    555555555555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.52  E-value=2.9e-13  Score=151.74  Aligned_cols=329  Identities=10%  Similarity=0.041  Sum_probs=182.9

Q ss_pred             CCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccc
Q 042766           94 SPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLL  173 (914)
Q Consensus        94 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  173 (914)
                      ..++.++++|+.+.|.+ .++..-..+|.++++|+.++|.++ ++..-...|..+++|+.+.+..+ +...-..+|.+..
T Consensus        64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~  140 (394)
T 4fs7_A           64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD  140 (394)
T ss_dssp             TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred             HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence            34566777788888764 365333456777788888888654 44233456677777777666544 3323334555544


Q ss_pred             cccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeecc
Q 042766          174 KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLT  253 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  253 (914)
                      .++.........  .-...|.++++|+.+.+.++. ......+|.++.+|+.+++..| ++.+....|.++..|+.+.+.
T Consensus       141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~  216 (394)
T 4fs7_A          141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFP  216 (394)
T ss_dssp             CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCC
T ss_pred             ccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecC
Confidence            333322222221  223456666777777665443 3244456666666666666655 333445556666666666555


Q ss_pred             CCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCC
Q 042766          254 ENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTG  333 (914)
Q Consensus       254 ~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  333 (914)
                      .+...  +... +....+|+.+.+..+ ++..-...|.++.+|+.+.+..+..+ +....|.....++.+....+.+...
T Consensus       217 ~~~~~--i~~~-~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~  291 (394)
T 4fs7_A          217 NSLYY--LGDF-ALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEK  291 (394)
T ss_dssp             TTCCE--ECTT-TTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTT
T ss_pred             CCceE--eehh-hcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccc
Confidence            44332  1111 113345555554432 22223344455555555555444322 3344444444444444433322111


Q ss_pred             CCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccC
Q 042766          334 TANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTI  413 (914)
Q Consensus       334 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  413 (914)
                               .+..+.                         +|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+.
T Consensus       292 ---------~F~~~~-------------------------~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~  335 (394)
T 4fs7_A          292 ---------TFYGCS-------------------------SLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIG  335 (394)
T ss_dssp             ---------TTTTCT-------------------------TCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred             ---------cccccc-------------------------cccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence                     123333                         3444444432 44455677888888888888644 66666


Q ss_pred             ChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccc
Q 042766          414 PDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLIL  473 (914)
Q Consensus       414 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  473 (914)
                      ..+|.++.+|+.+++..| ++..-..+|.++++|+.+++..+ ++ .+..+|.++++|+.
T Consensus       336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~  392 (394)
T 4fs7_A          336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW  392 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred             HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence            778888888888888776 66566677888888888888755 33 33456777777664

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=1.7e-14  Score=141.63  Aligned_cols=108  Identities=21%  Similarity=0.256  Sum_probs=95.4

Q ss_pred             hhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCC
Q 042766          497 LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN  576 (914)
Q Consensus       497 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  576 (914)
                      ..+++++|+++ .+|..+.  ++|++|+|++|+|++.+|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            46778888876 5666554  78999999999999998999999999999999999999888888899999999999999


Q ss_pred             ccccccCccccccCCCCeEeCCCCccccccC
Q 042766          577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVP  607 (914)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p  607 (914)
                      +|++..+..|..+++|+.|+|++|+|.+.++
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            9998777779999999999999999998876

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=8.2e-14  Score=136.71  Aligned_cols=103  Identities=16%  Similarity=0.170  Sum_probs=48.5

Q ss_pred             EEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCc
Q 042766           81 ELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK  160 (914)
Q Consensus        81 ~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  160 (914)
                      .+++++++++ .+|..+.  +.|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            4556666552 3444432  455555555555555445555555555555555555553222233444444444444444


Q ss_pred             ccCCCChhcccccccccccccccccc
Q 042766          161 LEGQIPKEIGNLLKLQRLSVDINYLT  186 (914)
Q Consensus       161 l~~~~p~~~~~l~~L~~L~L~~N~l~  186 (914)
                      |++..+..|..+++|++|+|++|.+.
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcc
Confidence            44332223444444444444444433

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=9e-14  Score=135.93  Aligned_cols=102  Identities=18%  Similarity=0.205  Sum_probs=49.7

Q ss_pred             EecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcc
Q 042766           82 LNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL  161 (914)
Q Consensus        82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  161 (914)
                      +++++++++. +|..+.  +.|++|+|++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus        14 l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l   90 (170)
T 3g39_A           14 VDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL   90 (170)
T ss_dssp             EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence            4444455532 443332  4555555555555555455555555555555555555533333344555555555555555


Q ss_pred             cCCCChhcccccccccccccccccc
Q 042766          162 EGQIPKEIGNLLKLQRLSVDINYLT  186 (914)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~  186 (914)
                      ++..+..|..+++|++|+|++|.++
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           91 KSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            4333334444444444444444444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.36  E-value=6.6e-13  Score=146.25  Aligned_cols=109  Identities=26%  Similarity=0.231  Sum_probs=97.8

Q ss_pred             hhcccCC-ccCCCccccccccccceeecccC-CccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccC
Q 042766          498 VLDLSNN-LLNGSLPLQVGNLKNLVMLDISS-NQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSS  575 (914)
Q Consensus       498 ~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  575 (914)
                      .++++++ .|+ .+|. +..+++|+.|+|++ |+|++++|..|+++++|+.|+|++|+|++.+|..|..|++|+.|||++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4577777 787 4677 99999999999996 999999889999999999999999999999999999999999999999


Q ss_pred             CccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          576 NNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       576 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      |+|++..+..+..++ |+.|+|++|+|.|.++..
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~  122 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALR  122 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGH
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccH
Confidence            999988777787777 999999999999988754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.32  E-value=1.9e-12  Score=142.46  Aligned_cols=108  Identities=19%  Similarity=0.189  Sum_probs=77.7

Q ss_pred             CCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCC-CCCcccCCcccCCCCCCCeeecCCCCCCCcCCC
Q 042766           65 CQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLAD-NGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPT  143 (914)
Q Consensus        65 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  143 (914)
                      |.|.+|.|+..           |+|++ +|+ +..+++|++|+|++ |.|++..|..|++|++|++|+|++|+|++..|.
T Consensus         8 C~~~~v~~~~~-----------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~   74 (347)
T 2ifg_A            8 HGSSGLRCTRD-----------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD   74 (347)
T ss_dssp             SSSSCEECCSS-----------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred             ccCCEEEcCCC-----------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence            88888877431           14543 666 88888888888885 888877777788888888888888888877777


Q ss_pred             CccccCCcchhccCCCcccCCCChhcccccccccccccccccc
Q 042766          144 NLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLT  186 (914)
Q Consensus       144 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  186 (914)
                      .|+++++|++|||++|+|++..+..|..++ |++|+|++|.+.
T Consensus        75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            777777777777777777754444454444 666666666665

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=4.8e-14  Score=155.99  Aligned_cols=66  Identities=17%  Similarity=0.149  Sum_probs=31.2

Q ss_pred             ccccceeecccCCcccccc----CccccccccccEEEeeccccccc----CCcchhccCCCCEEEccCCccccc
Q 042766          516 NLKNLVMLDISSNQFSGVI----PVTLSTCVSLEYLDISINSFYGV----IPLSFRFLKSIKALNVSSNNLSGK  581 (914)
Q Consensus       516 ~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  581 (914)
                      ..++|++|||++|+|++..    +..+...++|+.|+|++|.|+..    +...+...++|++|||++|.|+..
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            3445555555555554321    23344445555555555555432    222233345555555555555443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.28  E-value=5.4e-11  Score=133.24  Aligned_cols=85  Identities=8%  Similarity=0.141  Sum_probs=41.1

Q ss_pred             hhccccc-cccccccccccccCcCCcccccccccceeecccCC---CCCCCCccchhhhcccccccccccccCCCCCccc
Q 042766          167 KEIGNLL-KLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENS---LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSIC  242 (914)
Q Consensus       167 ~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  242 (914)
                      .+|.+.. .|+.+.+..+ ++..-..+|.++++|+.+.++.|.   ++..-..+|.++.+|+.+.+..+ ++.+...+|.
T Consensus        57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence            3555543 4666666433 443444556666666666665543   33333444555555555544433 2223333444


Q ss_pred             cccccceeecc
Q 042766          243 NISSVELIFLT  253 (914)
Q Consensus       243 ~l~~L~~L~L~  253 (914)
                      .+.+|+.+.+.
T Consensus       135 ~c~~L~~i~lp  145 (394)
T 4gt6_A          135 HCEELDTVTIP  145 (394)
T ss_dssp             TCTTCCEEECC
T ss_pred             hhccccccccc
Confidence            44444444443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.27  E-value=1.6e-10  Score=129.30  Aligned_cols=294  Identities=13%  Similarity=0.120  Sum_probs=140.5

Q ss_pred             cccccCcccceeeccCcc---CCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcch
Q 042766          264 DILLNLPNLKKLGIGGNN---FVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDF  340 (914)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  340 (914)
                      ..|.++++|+.+.++.|.   ++.+-..+|.++.+|+.+.+..+ ++.+...+|..+.+|+.+.+..+ +..+..     
T Consensus        81 ~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~-----  153 (394)
T 4gt6_A           81 NAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVAD-----  153 (394)
T ss_dssp             TTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECT-----
T ss_pred             HHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecc-----
Confidence            334444444444444432   33233345555555555555433 44444555556666666555432 222211     


Q ss_pred             hhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhc-
Q 042766          341 VIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE-  419 (914)
Q Consensus       341 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-  419 (914)
                       ..+.++.+|+.+.+..+ ++ .+....+... .|+.+.+..+- ......+|.++.+++......+.........+.. 
T Consensus       154 -~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~~-~l~~i~ip~~~-~~i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~  228 (394)
T 4gt6_A          154 -GMFSYCYSLHTVTLPDS-VT-AIEERAFTGT-ALTQIHIPAKV-TRIGTNAFSECFALSTITSDSESYPAIDNVLYEKS  228 (394)
T ss_dssp             -TTTTTCTTCCEEECCTT-CC-EECTTTTTTC-CCSEEEECTTC-CEECTTTTTTCTTCCEEEECCSSSCBSSSCEEEEC
T ss_pred             -cceecccccccccccce-ee-Eecccccccc-ceeEEEECCcc-cccccchhhhccccceecccccccccccceeeccc
Confidence             12455556666665543 22 2222222222 35555554432 2345566777777777766655543211111111 


Q ss_pred             ------------ccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCch
Q 042766          420 ------------LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQ  487 (914)
Q Consensus       420 ------------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  487 (914)
                                  ...+..+.+. +.++..-..+|.+++.|+.+.+.++..+ ....+|.+++.|+.+.+.          
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~----------  296 (394)
T 4gt6_A          229 ANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS----------  296 (394)
T ss_dssp             TTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC----------
T ss_pred             ccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC----------
Confidence                        1112222221 1122223344555555555555443322 333445555555444332          


Q ss_pred             hhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCC
Q 042766          488 QLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS  567 (914)
Q Consensus       488 ~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  567 (914)
                                      +.++.+...+|.++.+|+.++|..+ ++.+...+|.+|.+|+.+.|..+ ++..-..+|.++++
T Consensus       297 ----------------~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          297 ----------------SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             ----------------TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             ----------------CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence                            1222233456677777777777654 55555667777777777777544 55555667777777


Q ss_pred             CCEEEccCCccccccCccccccCCCCeEeCCCCcc
Q 042766          568 IKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYF  602 (914)
Q Consensus       568 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l  602 (914)
                      |+.+++.+|....   ..+.....|+.+.+..|.+
T Consensus       359 L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          359 LNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             CCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            7777777765432   3455566677766665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.23  E-value=2.4e-13  Score=150.36  Aligned_cols=161  Identities=17%  Similarity=0.149  Sum_probs=112.1

Q ss_pred             ccCCceeeecccccccccCccccCC-----CCCCeEEeeCCcCCCCCCCcc-CCCCCccccccCCCccCCCCchhhhccc
Q 042766          420 LKNLQQLSVFNNFLRGGIPSGLGNL-----TKLGSLDLGSNSLQGNIPSSL-GNCQNLILFIASYNKLTGDLPQQLLSIT  493 (914)
Q Consensus       420 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~~~  493 (914)
                      +++|+.|+|++|.++......+...     ++|+.|+|++|.++......+ ..+++|+.|++++|.++           
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~-----------  139 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLG-----------  139 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCC-----------
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCC-----------
Confidence            4678888888888875444443332     578888888887764322222 23445566666666554           


Q ss_pred             chhhhhcccCCccCCCccccc-----cccccceeecccCCccccc----cCccccccccccEEEeeccccccc----CCc
Q 042766          494 TLSLVLDLSNNLLNGSLPLQV-----GNLKNLVMLDISSNQFSGV----IPVTLSTCVSLEYLDISINSFYGV----IPL  560 (914)
Q Consensus       494 ~l~~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~  560 (914)
                                    ......+     ...++|+.|+|++|.|+..    ++..+..+++|++|||++|.|++.    ++.
T Consensus       140 --------------~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~  205 (372)
T 3un9_A          140 --------------PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA  205 (372)
T ss_dssp             --------------HHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred             --------------HHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence                          2211222     2346899999999999753    344557789999999999999753    356


Q ss_pred             chhccCCCCEEEccCCccccc----cCccccccCCCCeEeCCCCccccc
Q 042766          561 SFRFLKSIKALNVSSNNLSGK----IPEFLENLSFLEFLNLSYNYFEGE  605 (914)
Q Consensus       561 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~  605 (914)
                      .+...++|++|+|++|.|+..    ++..+...+.|++|||++|+++..
T Consensus       206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence            677889999999999999854    445566678999999999998753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=3.8e-11  Score=126.45  Aligned_cols=148  Identities=16%  Similarity=0.141  Sum_probs=112.3

Q ss_pred             HHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCC
Q 042766          700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEG  778 (914)
Q Consensus       700 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  778 (914)
                      +......|+.....+.|+.+.||++...  +..+++|+...........+.+|+++++.+. +..+.++++++..     
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----   81 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----   81 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----
Confidence            3445567888888898999999998754  5689999986432233456889999999985 6678888888543     


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC--------------------------
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH--------------------------  832 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~--------------------------  832 (914)
                      .+..|+||||++|.++.+.....           .....++.+++++++.||+.                          
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYEDE-----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCTT-----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             CCceEEEEEecCCeehhhccCCc-----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence            34789999999999998763211           12246788999999999981                          


Q ss_pred             ------------------------------CCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          833 ------------------------------CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       833 ------------------------------~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                                                    ..+.++|+|++|.||+++.++.+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                          013589999999999998766677999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.01  E-value=3e-10  Score=119.34  Aligned_cols=138  Identities=14%  Similarity=0.093  Sum_probs=96.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC--cceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN--LIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~  782 (914)
                      ..+.+....+.|..+.||++.. .+|..+++|+....   ....+.+|+++++.+.+.+  +.+++++...     .+..
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~   90 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRD   90 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCC
Confidence            3455444444666799999965 35677999987533   2356788999999986544  4567776432     2357


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC-----------------------------  833 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~-----------------------------  833 (914)
                      ++||||++|.++.  ...         .+   ...++.++++.++.+|+..                             
T Consensus        91 ~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             EEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             EEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence            9999999998884  211         11   1246677778888888641                             


Q ss_pred             --------------------------CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          834 --------------------------QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       834 --------------------------~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                                                .+.++|+|++|.||+++.++.++|+|||.|..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      12399999999999998877778999999864

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.96  E-value=1.4e-12  Score=135.46  Aligned_cols=79  Identities=16%  Similarity=0.244  Sum_probs=42.1

Q ss_pred             ccccccccccccccccC--cCCcccccccccceeecccCCCCCCCCccchhhh--cccccccccccccCCCCC-------
Q 042766          171 NLLKLQRLSVDINYLTG--QLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR--RLVNLNVAENQFSGMFPR-------  239 (914)
Q Consensus       171 ~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-------  239 (914)
                      ++++|++|+|++|+|++  .+|..+..+++|+.|+|++|.|++.  ..+..+.  +|++|+|++|.+++.+|.       
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~  245 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA  245 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence            34555555555555554  3344455555555555555555543  2233333  566666666666654442       


Q ss_pred             ccccccccceee
Q 042766          240 SICNISSVELIF  251 (914)
Q Consensus       240 ~~~~l~~L~~L~  251 (914)
                      .+..+++|+.||
T Consensus       246 il~~~P~L~~LD  257 (267)
T 3rw6_A          246 IRERFPKLLRLD  257 (267)
T ss_dssp             HHHHCTTCCEES
T ss_pred             HHHHCcccCeEC
Confidence            245566666654

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.96  E-value=1.6e-08  Score=112.43  Aligned_cols=165  Identities=13%  Similarity=0.132  Sum_probs=84.8

Q ss_pred             cCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccc
Q 042766          394 RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLIL  473 (914)
Q Consensus       394 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  473 (914)
                      ....++..+.+..+. .......+....+|+.+.+..+ +......+|.++..|+.+.+..+ ++..-..+|.++.+|+.
T Consensus       191 ~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~  267 (379)
T 4h09_A          191 PAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT  267 (379)
T ss_dssp             CTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred             cccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence            334444444443322 2234445555566666665443 23234445556666666666544 43334445555555554


Q ss_pred             cccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeeccc
Q 042766          474 FIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINS  553 (914)
Q Consensus       474 L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  553 (914)
                      +.+..+ +                         ......+|.++++|+.+++.++.++.+...+|.++.+|+.++|..+ 
T Consensus       268 i~l~~~-i-------------------------~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-  320 (379)
T 4h09_A          268 LNFYAK-V-------------------------KTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-  320 (379)
T ss_dssp             EEECCC-C-------------------------SEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-
T ss_pred             cccccc-c-------------------------eeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-
Confidence            433211 1                         1122234556666666666666666555666666666666666543 


Q ss_pred             ccccCCcchhccCCCCEEEccCCccccccCcccccc
Q 042766          554 FYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENL  589 (914)
Q Consensus       554 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  589 (914)
                      ++..-..+|.++.+|+.+.+..+ ++.+-..+|.+.
T Consensus       321 l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          321 LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            44444556666666666666543 443444455443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=7.7e-11  Score=129.04  Aligned_cols=104  Identities=14%  Similarity=0.181  Sum_probs=65.9

Q ss_pred             CCCceEEEecCCCCCcc-c-------cCCCCCCCCCCCEEEcCCCCCc---------ccCCcccCCCCCCCeeecCCCCC
Q 042766           75 RHQRLTELNLSSQRIGG-V-------LSPYVGNLSFLRYINLADNGFR---------GDIPQEIGNLFRLEKLALSNNSF  137 (914)
Q Consensus        75 ~~~~v~~l~l~~~~l~~-~-------~~~~l~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l  137 (914)
                      ...+|+.|.+...++.| .       +..++..+++|+.|.+.++...         +.++..+..+++|+.|+|++|.-
T Consensus       105 ~~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~  184 (362)
T 2ra8_A          105 KLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNN  184 (362)
T ss_dssp             TGGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBT
T ss_pred             CchhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCC
Confidence            34578888888766553 1       2344567889999988775432         22444556778888888887731


Q ss_pred             CCcCCCCccccCCcchhccCCCcccCCCChhcc--ccccccccccc
Q 042766          138 SGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIG--NLLKLQRLSVD  181 (914)
Q Consensus       138 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~  181 (914)
                      . .+|. + .+++|++|+|+.|.+.......++  .+++|++|+|+
T Consensus       185 l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          185 L-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             C-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred             c-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence            1 2333 3 377888888877776543333443  56777777775

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=1.6e-10  Score=126.44  Aligned_cols=111  Identities=15%  Similarity=0.165  Sum_probs=55.5

Q ss_pred             CCCCEEEcCCCCCcc-c-------CCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccc
Q 042766          101 SFLRYINLADNGFRG-D-------IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNL  172 (914)
Q Consensus       101 ~~L~~L~L~~n~l~~-~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l  172 (914)
                      +.++.|.+....+.| .       +..++.++++|+.|.+.++....              .+++... .+.++..+..+
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~--------------~~is~~~-~~~L~~ll~~~  171 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEE--------------QEISWIE-QVDLSPVLDAM  171 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTT--------------CCGGGCB-CCBCHHHHHTC
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhh--------------ccccccc-ccCHHHHHhcC
Confidence            456777777665543 1       12334566777777776543210              0000000 11233445566


Q ss_pred             ccccccccccccccCcCCcccccccccceeecccCCCCCCCCccch--hhhcccccccc
Q 042766          173 LKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG--LLRRLVNLNVA  229 (914)
Q Consensus       173 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls  229 (914)
                      ++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......+.  .+++|+.|+|+
T Consensus       172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred             CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence            67777777666211 2222 2 256677777766665432222232  45666666664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.86  E-value=3.7e-09  Score=116.62  Aligned_cols=145  Identities=15%  Similarity=0.219  Sum_probs=104.6

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEee--ccC-CcchHHHHHHHHHHHhcC--CCCcceEEeEeecCCCCCCceEe
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVIN--LKQ-KGASKSFVSECEALRNIR--HRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..+.++.|.++.||+++..  +..+++|+..  ... ......+.+|+++++.+.  +..+.+++.++....  ..+..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence            3567899999999998875  3567888765  322 122357788999999997  455788888865432  123568


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC------------------------------  833 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~------------------------------  833 (914)
                      +||||++|..+.+..        ...++..++..++.+++++|+.||+..                              
T Consensus       118 ~vme~v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             EEEECCCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            999999997774311        124667788889999999999999731                              


Q ss_pred             -------------------------CCCcEecCCCCCCeeecCCCc--EEEeccccccc
Q 042766          834 -------------------------QPPMVHGDLKPSNVLLDYDMV--AHVGDFGLAKF  865 (914)
Q Consensus       834 -------------------------~~~ivHrDlkp~NILl~~~~~--~ki~DFGla~~  865 (914)
                                               .+.++|+|++|.||+++.++.  +.|+||+.|..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     247999999999999997753  68999999874

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.86  E-value=4.6e-08  Score=108.68  Aligned_cols=147  Identities=14%  Similarity=0.106  Sum_probs=80.9

Q ss_pred             CCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCC
Q 042766          389 IPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNC  468 (914)
Q Consensus       389 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  468 (914)
                      ...++..+.+|+.+.+..+ +..+....|.++..|+.+.+..+ ++..-..+|.++.+|+.+.+..+ +......+|.+|
T Consensus       209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c  285 (379)
T 4h09_A          209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC  285 (379)
T ss_dssp             CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred             eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence            3445555666666666543 33344555666666666666554 44344555666666666666543 443444566666


Q ss_pred             CCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEE
Q 042766          469 QNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLD  548 (914)
Q Consensus       469 ~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  548 (914)
                      ++|+.+.+..+.++                         .+-..+|.++.+|+.++|..+ ++.+...+|.++++|+.+.
T Consensus       286 ~~L~~i~l~~~~i~-------------------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~  339 (379)
T 4h09_A          286 SNLTKVVMDNSAIE-------------------------TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS  339 (379)
T ss_dssp             TTCCEEEECCTTCC-------------------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred             cccccccccccccc-------------------------eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence            66666555444433                         122334555666666666543 4444555666666666666


Q ss_pred             eecccccccCCcchhcc
Q 042766          549 ISINSFYGVIPLSFRFL  565 (914)
Q Consensus       549 Ls~N~l~~~~p~~~~~l  565 (914)
                      +..+ ++.+-..+|.+.
T Consensus       340 ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          340 YPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             CCTT-CCEECTTTTTTS
T ss_pred             ECCc-cCEEchhHhhCC
Confidence            6543 444445555544

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.54  E-value=1.3e-07  Score=101.60  Aligned_cols=139  Identities=19%  Similarity=0.252  Sum_probs=98.4

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCC--cceEEeEeecCCCCCCceEeEEE
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRN--LIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      .+.++.|....||++.     ..+++|+....  .....+.+|+++++.+. +..  +.+.+..+...  ......|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence            4568999999999864     34788886422  34567899999998883 333  44555443221  1112458899


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH----------------------------------  832 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~----------------------------------  832 (914)
                      ||++|.++.+...        ..++..++..++.++++.++.||+.                                  
T Consensus        96 ~~i~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             ECCCCEECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cccCCeECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            9999988865332        2456677778888888888888861                                  


Q ss_pred             ---------------------CCCCcEecCCCCCCeeecC--CCcEEEeccccccc
Q 042766          833 ---------------------CQPPMVHGDLKPSNVLLDY--DMVAHVGDFGLAKF  865 (914)
Q Consensus       833 ---------------------~~~~ivHrDlkp~NILl~~--~~~~ki~DFGla~~  865 (914)
                                           ..+.++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                                 1246899999999999998  45688999999864

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.53  E-value=9.9e-09  Score=106.41  Aligned_cols=92  Identities=18%  Similarity=0.250  Sum_probs=57.3

Q ss_pred             ccccccccc--ccccccccc---CcCCcccccccccceeecccCCCCC--CCCccchhhhcccccccccccccCCCCCcc
Q 042766          169 IGNLLKLQR--LSVDINYLT---GQLPDSVGNLSAIEVIRITENSLGG--KIPTTLGLLRRLVNLNVAENQFSGMFPRSI  241 (914)
Q Consensus       169 ~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  241 (914)
                      |...+.|+.  ++++.|+..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            444455555  556666332   2222223567788888888888887  4556777888888888888888754  233


Q ss_pred             cccc--ccceeeccCCcccCccc
Q 042766          242 CNIS--SVELIFLTENRFSGIFP  262 (914)
Q Consensus       242 ~~l~--~L~~L~L~~N~l~~~~p  262 (914)
                      ..+.  +|+.|+|++|.+.+.+|
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhcccCCcceEEccCCcCccccC
Confidence            3333  66666666666665443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.45  E-value=5e-09  Score=103.47  Aligned_cols=94  Identities=14%  Similarity=0.135  Sum_probs=52.0

Q ss_pred             cCCCCCCCCCCCEEEcCCC-CCcc----cCCcccCCCCCCCeeecCCCCCCCc----CCCCccccCCcchhccCCCcccC
Q 042766           93 LSPYVGNLSFLRYINLADN-GFRG----DIPQEIGNLFRLEKLALSNNSFSGT----IPTNLSRCSNLIHFCASNNKLEG  163 (914)
Q Consensus        93 ~~~~l~~l~~L~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~  163 (914)
                      +...+...+.|++|+|++| .+..    .+...+...++|++|+|++|+|...    +...+...++|++|+|++|.++.
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3344556677777777777 7753    2344556667777777777777532    22333444556666666666553


Q ss_pred             C----CChhcccccccccccc--cccccc
Q 042766          164 Q----IPKEIGNLLKLQRLSV--DINYLT  186 (914)
Q Consensus       164 ~----~p~~~~~l~~L~~L~L--~~N~l~  186 (914)
                      .    +...+...++|++|+|  ++|.++
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            2    2233333444555555  445444

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.32  E-value=2.5e-06  Score=91.46  Aligned_cols=137  Identities=16%  Similarity=0.163  Sum_probs=90.8

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCC---CcceEEeEeecCCCCCCceEeEEE
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR---NLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      .+.++.|....||+.     +..+++|+..  .......+.+|+++++.+.+.   .+.+.+.++..    ..+..++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEE
Confidence            346788888999987     3457888752  223456789999999999752   35666666531    124568999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH----------------------------------  832 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~----------------------------------  832 (914)
                      ||++|.++.+...        ..++..+...++.++++.++.||+.                                  
T Consensus        93 e~i~G~~l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           93 RKVQGQILGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             ECCCSEECHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             eccCCeECchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            9999988866321        1123333444444444444444432                                  


Q ss_pred             -----------------------CCCCcEecCCCCCCeeecC---CCc-EEEeccccccc
Q 042766          833 -----------------------CQPPMVHGDLKPSNVLLDY---DMV-AHVGDFGLAKF  865 (914)
Q Consensus       833 -----------------------~~~~ivHrDlkp~NILl~~---~~~-~ki~DFGla~~  865 (914)
                                             ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                   2346799999999999987   455 58999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=3.5e-06  Score=88.58  Aligned_cols=136  Identities=18%  Similarity=0.115  Sum_probs=97.0

Q ss_pred             cccCCccE-EEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEeEEEecc
Q 042766          712 MIGQGRFG-TVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKALVFEYM  789 (914)
Q Consensus       712 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  789 (914)
                      .+..|..| .||+......+..+++|+-..   .....+.+|+..++.+. +--+.++++++...     +..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence            34455554 699988776777888998642   23457888999998884 33466777775433     4679999999


Q ss_pred             cCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 042766          790 ENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC------------------------------------  833 (914)
Q Consensus       790 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~------------------------------------  833 (914)
                      +|.++.+......          .....++.+++..++-||+..                                    
T Consensus       103 ~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          103 PGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             CCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            9988887654321          122345667777777777521                                    


Q ss_pred             -------------------CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          834 -------------------QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       834 -------------------~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                                         .+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               12489999999999999887778999998864

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.29  E-value=3.6e-08  Score=97.27  Aligned_cols=95  Identities=18%  Similarity=0.278  Sum_probs=60.4

Q ss_pred             cCCcccCCCCCCCeeecCCC-CCCCc----CCCCccccCCcchhccCCCcccCC----CChhcccccccccccccccccc
Q 042766          116 DIPQEIGNLFRLEKLALSNN-SFSGT----IPTNLSRCSNLIHFCASNNKLEGQ----IPKEIGNLLKLQRLSVDINYLT  186 (914)
Q Consensus       116 ~~p~~~~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  186 (914)
                      .+...+...+.|++|+|++| .+...    +...+...++|++|+|++|++...    +...+...++|++|+|++|.|+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34455677889999999998 88632    334455667788888888887632    2233444466777777777776


Q ss_pred             Cc----CCcccccccccceeec--ccCCCC
Q 042766          187 GQ----LPDSVGNLSAIEVIRI--TENSLG  210 (914)
Q Consensus       187 ~~----~p~~~~~l~~L~~L~L--~~N~l~  210 (914)
                      ..    +...+...++|++|+|  ++|.++
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            42    3344455555666666  556555

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.95  E-value=1.2e-05  Score=88.25  Aligned_cols=84  Identities=11%  Similarity=0.065  Sum_probs=55.1

Q ss_pred             cCcc-cCCccEEEEEEEEC---C---CcEEEEEEEeeccC---CcchHHHHHHHHHHHhcC-C--CCcceEEeEeecCCC
Q 042766          710 SNMI-GQGRFGTVYKGILG---D---DEMVVAVKVINLKQ---KGASKSFVSECEALRNIR-H--RNLIKIITICSSTDF  776 (914)
Q Consensus       710 ~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~  776 (914)
                      .+.| +.|....+|+....   +   ++..+++|+.....   ......+.+|+++++.+. +  -.+.++++++.....
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998753   1   15678889765322   111256788999988884 2  356778877543321


Q ss_pred             CCCceEeEEEecccCCCHH
Q 042766          777 EGVDFKALVFEYMENGSLE  795 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~  795 (914)
                        .+..++||||++|..+.
T Consensus       105 --~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 --LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             --TSSCEEEEECCCCBCCC
T ss_pred             --cCCceEEEEecCCCChh
Confidence              13457899999986653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.95  E-value=1.6e-05  Score=88.57  Aligned_cols=76  Identities=16%  Similarity=0.101  Sum_probs=49.4

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-------cchHHHHHHHHHHHhcCC--C-CcceEEeEeecCCCCCC
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-------GASKSFVSECEALRNIRH--R-NLIKIITICSSTDFEGV  779 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~  779 (914)
                      .+.+|.|.++.||+++...+++.|+||.......       ...+++..|+++++.+..  | .+.+++.+.  .     
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~-----  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C-----
Confidence            4578999999999998765667899998653211       233567889999988742  3 344565442  1     


Q ss_pred             ceEeEEEecccCC
Q 042766          780 DFKALVFEYMENG  792 (914)
Q Consensus       780 ~~~~lv~e~~~~g  792 (914)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            1347999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.49  E-value=0.00033  Score=76.05  Aligned_cols=149  Identities=17%  Similarity=0.156  Sum_probs=79.0

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCC--CCcceEEeEeecCC-CCCCceEeEEEe
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH--RNLIKIITICSSTD-FEGVDFKALVFE  787 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~~~~lv~e  787 (914)
                      +.++.|..+.||++... ++ .+++|+...    .......|+++++.+..  -.+.+++....... .+..+..++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET-TE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC-CC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34666778899998874 33 488998864    12344456666665531  12333332100000 012346789999


Q ss_pred             cccCCCHH-----------HH---Hhcc-CCc--c-c----ccCCCHHHH------------------------------
Q 042766          788 YMENGSLE-----------DW---LHQS-NDQ--V-E----VRKLSLIQR------------------------------  815 (914)
Q Consensus       788 ~~~~gsL~-----------~~---l~~~-~~~--~-~----~~~~~~~~~------------------------------  815 (914)
                      |++|.++.           +.   ++.. ...  . .    .....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986532           11   1110 000  0 0    001122110                              


Q ss_pred             -HHHHHHHHHHHHHHHh----------CCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          816 -MNIAIDVASAIEYLHH----------HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       816 -~~i~~~i~~gl~~LH~----------~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                       ..+..++..+++++++          ...+.++|+|+++.||+++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             1111223445666653          0235899999999999998888999999998853

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.46  E-value=4.2e-05  Score=73.31  Aligned_cols=84  Identities=14%  Similarity=0.044  Sum_probs=56.2

Q ss_pred             ccceeecccCCccccccCccccccccccEEEeeccc-ccccCCcchhcc----CCCCEEEccCCc-cccccCccccccCC
Q 042766          518 KNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINS-FYGVIPLSFRFL----KSIKALNVSSNN-LSGKIPEFLENLSF  591 (914)
Q Consensus       518 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~  591 (914)
                      ..|+.||||++.++..--..+.++++|+.|+|+++. ++..--..+..+    ++|++|+|+++. ++..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            357778888877766555566777888888888874 554333344443    368888888764 66544455667788


Q ss_pred             CCeEeCCCCc
Q 042766          592 LEFLNLSYNY  601 (914)
Q Consensus       592 L~~L~ls~N~  601 (914)
                      |++|+|++.+
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888887664

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.42  E-value=1.6e-05  Score=76.30  Aligned_cols=82  Identities=4%  Similarity=0.056  Sum_probs=35.0

Q ss_pred             CCCeeecCCCCCCCcCCCCccccCCcchhccCCCc-ccCCCChhcccc----cccccccccccc-ccCcCCccccccccc
Q 042766          126 RLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNK-LEGQIPKEIGNL----LKLQRLSVDINY-LTGQLPDSVGNLSAI  199 (914)
Q Consensus       126 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L  199 (914)
                      +|++||||++.++..--..+..+++|++|+|++|. ++..--..++.+    ++|++|+|++|. +|..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34444444444443222233444444444444442 332111223322    245566665553 443222234445555


Q ss_pred             ceeecccC
Q 042766          200 EVIRITEN  207 (914)
Q Consensus       200 ~~L~L~~N  207 (914)
                      +.|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.37  E-value=0.0008  Score=71.56  Aligned_cols=150  Identities=17%  Similarity=0.198  Sum_probs=92.7

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC---CCCcceEEeEeecCCCCCCceEeEEE
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR---HRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      .+.|+.|....+|+...  ++..+++|+....   ....+..|++.++.+.   ...+.++++++..     .+..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence            45789999999999875  3567888987532   3567889999998884   3567788877543     24689999


Q ss_pred             ecccCCCHH--------HH---HhccCC--ccc--------------ccCCCHHHHH---HHHH----------------
Q 042766          787 EYMENGSLE--------DW---LHQSND--QVE--------------VRKLSLIQRM---NIAI----------------  820 (914)
Q Consensus       787 e~~~~gsL~--------~~---l~~~~~--~~~--------------~~~~~~~~~~---~i~~----------------  820 (914)
                      ||++|..+.        +.   ++....  ...              .-.-+|....   ++..                
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            999987541        11   222111  000              0012444321   1111                


Q ss_pred             HHHHHH-HHHHh-CCCCCcEecCCCCCCeeecCCCcEEEecccccccccccccc
Q 042766          821 DVASAI-EYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLD  872 (914)
Q Consensus       821 ~i~~gl-~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~  872 (914)
                      +++..+ ..|.. ...|.+||+|+.+.|++++.++ +.|.||+ + .+.+...+
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~-~-~~g~~~~D  241 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA-C-YWGDRECD  241 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC-C-EEECTHHH
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc-c-ccCChHHH
Confidence            111111 23321 2257899999999999999887 8899984 3 35544433

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.001  Score=70.24  Aligned_cols=78  Identities=15%  Similarity=0.161  Sum_probs=56.5

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCC---CCcceEEeEeecCCCCCCceE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH---RNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~~~  782 (914)
                      +....+.+|.|..+.||+.+.. +|+.|.+|+...........+..|++.|+.+..   -.+.+++++.         ..
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~   85 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR   85 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence            3455677899999999999886 677899998764444445678899999998842   2345665541         23


Q ss_pred             eEEEecccCCC
Q 042766          783 ALVFEYMENGS  793 (914)
Q Consensus       783 ~lv~e~~~~gs  793 (914)
                      ++||||++++.
T Consensus        86 ~lv~e~l~~~~   96 (288)
T 3f7w_A           86 TLAMEWVDERP   96 (288)
T ss_dssp             EEEEECCCCCC
T ss_pred             eEEEEeecccC
Confidence            68999998764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.22  E-value=0.00036  Score=63.73  Aligned_cols=62  Identities=21%  Similarity=0.311  Sum_probs=46.0

Q ss_pred             EEEeeccccc-ccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          546 YLDISINSFY-GVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       546 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      .++.+++.++ ..+|..+  -++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.|++...
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~   74 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLV   74 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGH
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccH
Confidence            5677777775 2444332  246888888888888777778888888999999999998877653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.18  E-value=0.00095  Score=70.96  Aligned_cols=72  Identities=10%  Similarity=0.104  Sum_probs=43.9

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc-ceEEeEeecCCCCCCceEeEEEe
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL-IKIITICSSTDFEGVDFKALVFE  787 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e  787 (914)
                      ..+.|+.|....+|++      ..+++|+....... .....+|+.+++.+....+ .+++++..       +..++|+|
T Consensus        22 ~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~-------~~~~~v~e   87 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP-------ATGVMVTR   87 (301)
T ss_dssp             SCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT-------TTCCEEEE
T ss_pred             ceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC-------CCCEEEEe
Confidence            3677889999999998      24788887533211 1223568888877743233 45655421       12368999


Q ss_pred             cc-cCCCH
Q 042766          788 YM-ENGSL  794 (914)
Q Consensus       788 ~~-~~gsL  794 (914)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66444

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.15  E-value=0.00076  Score=75.52  Aligned_cols=31  Identities=26%  Similarity=0.478  Sum_probs=27.4

Q ss_pred             CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          834 QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       834 ~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      .+.++|+|++|.||+++.++ ++++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            34899999999999998876 99999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.88  E-value=0.0041  Score=66.66  Aligned_cols=169  Identities=14%  Similarity=0.100  Sum_probs=88.9

Q ss_pred             CccCHHHHHHHhhcccc-----cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC--cc
Q 042766          693 PMVSYAELSKATSEFSS-----SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN--LI  765 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  765 (914)
                      ..++.+++......|..     .+.|+.|....+|+....+ + .+++|+....  ...+.+..|+++++.+....  +.
T Consensus         5 ~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            5 TDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            34555666666666654     2456778888999988643 3 5788988542  12345667888887774222  23


Q ss_pred             eEEeEeecCC-CCCCceEeEEEecccCCCHH-----H------H---HhccC-Ccccc--cCC---CHHHHHH-------
Q 042766          766 KIITICSSTD-FEGVDFKALVFEYMENGSLE-----D------W---LHQSN-DQVEV--RKL---SLIQRMN-------  817 (914)
Q Consensus       766 ~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~~-~~~~~--~~~---~~~~~~~-------  817 (914)
                      +++....... .+..+..+++|+|++|..+.     .      .   ++... .....  ...   .|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            3332100000 00123568999999986431     1      0   11110 00000  000   1111000       


Q ss_pred             -----HHHHHHHHHHHHHhC----CCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          818 -----IAIDVASAIEYLHHH----CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       818 -----i~~~i~~gl~~LH~~----~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                           +...+...++++++.    ..++++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 001234445555532    234799999999999999876668999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.78  E-value=0.0085  Score=64.31  Aligned_cols=167  Identities=15%  Similarity=0.132  Sum_probs=88.3

Q ss_pred             CccCHHHHHHHhhcccc-----cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC--cc
Q 042766          693 PMVSYAELSKATSEFSS-----SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN--LI  765 (914)
Q Consensus       693 ~~~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  765 (914)
                      ...+.+.+......|..     ...++ |....||++... +|+.+++|+..... .....+..|..+++.+....  ++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            34455556555555533     23466 777899987654 45578899885332 23456778888888774222  34


Q ss_pred             eEEeEeecCC-CCCCceEeEEEecccCCCHH-----HH---------Hhcc---CCcccccCCCHHHH----HH------
Q 042766          766 KIITICSSTD-FEGVDFKALVFEYMENGSLE-----DW---------LHQS---NDQVEVRKLSLIQR----MN------  817 (914)
Q Consensus       766 ~l~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~~---------l~~~---~~~~~~~~~~~~~~----~~------  817 (914)
                      +++.. .... .+..+..++||||++|..+.     .+         ++..   .........++...    ..      
T Consensus        86 ~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  164 (328)
T 1zyl_A           86 APVAF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT  164 (328)
T ss_dssp             CCCCB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred             ceeec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence            44432 1100 01134567899999875421     11         1110   00000011111110    00      


Q ss_pred             ---------HHHHHHHHHHHHHhC----CCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          818 ---------IAIDVASAIEYLHHH----CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       818 ---------i~~~i~~gl~~LH~~----~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                               +...+...++.+.+.    ..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     011111222333221    234689999999999998 5 899999988763

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.68  E-value=0.00027  Score=69.00  Aligned_cols=15  Identities=33%  Similarity=0.496  Sum_probs=6.8

Q ss_pred             CCCCcEEeccccccC
Q 042766          347 CSSLKVLSLSDNQFG  361 (914)
Q Consensus       347 l~~L~~L~Ls~N~l~  361 (914)
                      -+.|+.|+|++|.|.
T Consensus        97 N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           97 SPSLRVLNVESNFLT  111 (197)
T ss_dssp             CSSCCEEECCSSBCC
T ss_pred             CCccCeEecCCCcCC
Confidence            344444444444443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.65  E-value=0.0035  Score=70.12  Aligned_cols=73  Identities=19%  Similarity=0.231  Sum_probs=48.8

Q ss_pred             cCcccCCccEEEEEEEECC-------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc-ceEEeEeecCCCCCCce
Q 042766          710 SNMIGQGRFGTVYKGILGD-------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL-IKIITICSSTDFEGVDF  781 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~  781 (914)
                      .+.|+.|....||++....       ++..|++|+....  ...+.+.+|..+++.+...++ .++++.+     .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence            3567888889999998753       2467889987321  122556689999988853333 5666652     11   


Q ss_pred             EeEEEecccCCC
Q 042766          782 KALVFEYMENGS  793 (914)
Q Consensus       782 ~~lv~e~~~~gs  793 (914)
                       .+||||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             37999998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.61  E-value=0.0043  Score=67.80  Aligned_cols=144  Identities=13%  Similarity=0.167  Sum_probs=81.6

Q ss_pred             CcccCCccEEEEEEEECC-------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC-cceEEeEeecCCCCCCceE
Q 042766          711 NMIGQGRFGTVYKGILGD-------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN-LIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  782 (914)
                      +.+..|-...+|++....       +++.|++|+.... ........+|.++++.+.... ..++++++     ++    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            456678788899988742       3467888986322 223456678999998884222 35666653     21    


Q ss_pred             eEEEecccCCCHHH--------------HH---hccCCcccccCCC--HHHHHHHHHHHHH-------------------
Q 042766          783 ALVFEYMENGSLED--------------WL---HQSNDQVEVRKLS--LIQRMNIAIDVAS-------------------  824 (914)
Q Consensus       783 ~lv~e~~~~gsL~~--------------~l---~~~~~~~~~~~~~--~~~~~~i~~~i~~-------------------  824 (914)
                      .+||||++|.++..              .+   +....... ....  +.+..++..++..                   
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~-~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFT-KEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSC-CSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCC-CCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence            28999999855421              11   11110001 1111  3344444443321                   


Q ss_pred             HHHHHHh----C-CCCCcEecCCCCCCeeecCC----CcEEEeccccccc
Q 042766          825 AIEYLHH----H-CQPPMVHGDLKPSNVLLDYD----MVAHVGDFGLAKF  865 (914)
Q Consensus       825 gl~~LH~----~-~~~~ivHrDlkp~NILl~~~----~~~ki~DFGla~~  865 (914)
                      .+.++.+    . ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2333322    1 23478999999999999876    7899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.57  E-value=0.011  Score=66.51  Aligned_cols=75  Identities=15%  Similarity=0.095  Sum_probs=47.9

Q ss_pred             cCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc-ceEEeEeecCCCCCCceEeEEEec
Q 042766          710 SNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL-IKIITICSSTDFEGVDFKALVFEY  788 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~  788 (914)
                      .+.|+.|-...+|++...+++..|++|+........ -...+|..+++.+...++ .++++++     .+    ..||||
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            356788888999999886545788899874322111 122579999998865554 5666653     11    259999


Q ss_pred             ccCCCH
Q 042766          789 MENGSL  794 (914)
Q Consensus       789 ~~~gsL  794 (914)
                      ++|.++
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.55  E-value=0.0023  Score=58.34  Aligned_cols=56  Identities=14%  Similarity=0.274  Sum_probs=36.1

Q ss_pred             eecccCCccc-cccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccc
Q 042766          522 MLDISSNQFS-GVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLS  579 (914)
Q Consensus       522 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  579 (914)
                      .+|.+++.++ ..+|..+.  .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5566666665 23343322  35677777777777666677777777777777777765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.38  E-value=0.023  Score=61.09  Aligned_cols=32  Identities=31%  Similarity=0.295  Sum_probs=27.8

Q ss_pred             CCCcEecCCCCCCeeecCC----CcEEEeccccccc
Q 042766          834 QPPMVHGDLKPSNVLLDYD----MVAHVGDFGLAKF  865 (914)
Q Consensus       834 ~~~ivHrDlkp~NILl~~~----~~~ki~DFGla~~  865 (914)
                      .+.++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999875    6899999998864

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.32  E-value=0.00053  Score=66.97  Aligned_cols=89  Identities=13%  Similarity=0.167  Sum_probs=52.2

Q ss_pred             ccCCCCCcEEEcccCcccc----cCChhhhcccCCceeeeccccccccc----CccccCCCCCCeEEeeCCcC---CC--
Q 042766          393 IRNLVNLITFTLEVNQFHG----TIPDVISELKNLQQLSVFNNFLRGGI----PSGLGNLTKLGSLDLGSNSL---QG--  459 (914)
Q Consensus       393 ~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l---~~--  459 (914)
                      +..-+.|+.|+|++|+|..    .+...+..-+.|++|+|++|.|.+.-    -.++..-+.|+.|+|++|..   ..  
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g  145 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV  145 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence            3444567777777777763    23344555677888888888776432    23344556688888876532   21  


Q ss_pred             --CCCCccCCCCCccccccCCCcc
Q 042766          460 --NIPSSLGNCQNLILFIASYNKL  481 (914)
Q Consensus       460 --~~p~~~~~l~~L~~L~l~~N~l  481 (914)
                        .+...+..-+.|+.|+++.|..
T Consensus       146 ~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          146 EMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHHHhCCCcCeEeccCCCc
Confidence              1233444556666666666554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.11  E-value=0.0081  Score=65.73  Aligned_cols=73  Identities=11%  Similarity=0.156  Sum_probs=43.1

Q ss_pred             CcccCCccEEEEEEEECCC--------cEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC-cceEEeEeecCCCCCCce
Q 042766          711 NMIGQGRFGTVYKGILGDD--------EMVVAVKVINLKQKGASKSFVSECEALRNIRHRN-LIKIITICSSTDFEGVDF  781 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~  781 (914)
                      +.++.|....+|++...+.        +..+++|+...... .......|.++++.+...+ +.++++..     .    
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4677788889999987531        25788888643221 1112467888888875333 34666542     1    


Q ss_pred             EeEEEecccCCC
Q 042766          782 KALVFEYMENGS  793 (914)
Q Consensus       782 ~~lv~e~~~~gs  793 (914)
                      .++||||++|.+
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            257999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.97  E-value=0.023  Score=61.18  Aligned_cols=31  Identities=19%  Similarity=0.288  Sum_probs=27.9

Q ss_pred             CCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          835 PPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       835 ~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.98  E-value=0.11  Score=57.44  Aligned_cols=73  Identities=11%  Similarity=0.109  Sum_probs=46.5

Q ss_pred             CcccCCccEEEEEEEECCC-------cEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC-cceEEeEeecCCCCCCceE
Q 042766          711 NMIGQGRFGTVYKGILGDD-------EMVVAVKVINLKQKGASKSFVSECEALRNIRHRN-LIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  782 (914)
                      +.+..|-...+|++.....       +..|++|+...... ......+|.++++.+...+ ..++++.+     .    .
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF-----P----E  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----T
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----C
Confidence            4567788889999987521       46788888643221 1123357888888875323 34555532     1    2


Q ss_pred             eEEEecccCCC
Q 042766          783 ALVFEYMENGS  793 (914)
Q Consensus       783 ~lv~e~~~~gs  793 (914)
                      +.||||++|.+
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            68999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.53  E-value=1.2  Score=48.94  Aligned_cols=30  Identities=23%  Similarity=0.371  Sum_probs=25.2

Q ss_pred             CcEecCCCCCCeee------cCCCcEEEeccccccc
Q 042766          836 PMVHGDLKPSNVLL------DYDMVAHVGDFGLAKF  865 (914)
Q Consensus       836 ~ivHrDlkp~NILl------~~~~~~ki~DFGla~~  865 (914)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4457899999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=86.25  E-value=0.35  Score=47.37  Aligned_cols=93  Identities=17%  Similarity=0.089  Sum_probs=60.1

Q ss_pred             CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccccccccc
Q 042766          792 GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHL  871 (914)
Q Consensus       792 gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~  871 (914)
                      -+|.+++...+     .++++.++|.++.|.+.++.-+-.+..+  ..+=+-|..|++..+|.|...+ +.+.       
T Consensus        33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-------
Confidence            37999998765     6899999999999999998776221111  1222346889999999987753 2111       


Q ss_pred             ccccCCCCccccccCcccccccchhh---hhhcccCcccccccc
Q 042766          872 DIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVH  912 (914)
Q Consensus       872 ~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~  912 (914)
                                   .....+.|||...   ..+.-|+|+|.++|.
T Consensus        98 -------------~~~~~~~~pe~~~~~~te~~~IysLG~tLY~  128 (229)
T 2yle_A           98 -------------AGEPPPVAGKLGYSQCMETEVIESLGIIIYK  128 (229)
T ss_dssp             ----------------------CCSSSSSCHHHHHHHHHHHHHH
T ss_pred             -------------ccccCCCChhhccccchHHHHHHHHHHHHHH
Confidence                         0122466888875   577889999998874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	914
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-38
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-37
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-37
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-35
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-35
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-34
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-33
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-33
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-33
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-32
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-30
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-29
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.004
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-28
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-27
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-26
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-24
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-24
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-21
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-44
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 25/191 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS--KSFVSECEALRNIRHR 762
            + +    IG G FGTVYKG    D   VAVK++N+        ++F +E   LR  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
           N++  +   ++         A+V ++ E  SL   LH         K  +I+ ++IA   
Sbjct: 65  NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQT 113

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
           A  ++YLH      ++H DLK +N+ L  D+   +GDFGLA   S        +      
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ----- 165

Query: 883 GIKGTVGYVAP 893
            + G++ ++AP
Sbjct: 166 -LSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  154 bits (391), Expect = 2e-42
 Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 29/211 (13%)

Query: 696 SYAELSKATSEFSSS---------NMIGQGRFGTVYKGIL---GDDEMVVAVKVINLKQ- 742
           ++ + ++A  EF+            +IG G FG V  G L   G  E+ VA+K +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 743 KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN 802
           +   + F+SE   +    H N+I +  + + +         ++ E+MENGSL+ +L Q++
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQND 122

Query: 803 DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL 862
                 + ++IQ + +   +A+ ++YL        VH DL   N+L++ ++V  V DFGL
Sbjct: 123 -----GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           ++FL +   D +  T +S++G K  + + AP
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAP 202

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-39
 Identities = 39/195 (20%), Positives = 79/195 (40%), Gaps = 24/195 (12%)

Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK-QKGASKSFVSECEALRN 758
           +     +F   + +G G  G V+K       +V+A K+I+L+ +       + E + L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
                ++       S         ++  E+M+ GSL+  L ++       ++       +
Sbjct: 61  CNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
           +I V   + YL       ++H D+KPSN+L++      + DFG++  L +   +      
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN------ 161

Query: 879 SSSIGIKGTVGYVAP 893
                  GT  Y++P
Sbjct: 162 ----SFVGTRSYMSP 172

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 48/203 (23%), Positives = 87/203 (42%), Gaps = 24/203 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G F TVYKG+  +  + VA   +  ++  K   + F  E E L+ ++H N+++    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             ST  +G     LV E M +G+L+ +L +       + + +    +    +   +++LH
Sbjct: 77  WESTV-KGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLH 129

Query: 831 HHCQPPMVHGDLKPSNVLL-DYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
               PP++H DLK  N+ +        +GD GLA                    + GT  
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----------AVIGTPE 178

Query: 890 YVAPGKFFMLYTH---IPSFSCT 909
           ++AP  +   Y     + +F   
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMC 201

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-39
 Identities = 42/189 (22%), Positives = 90/189 (47%), Gaps = 22/189 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
                   +G G+FG V+ G   +    VAVK +  +   +  +F++E   ++ ++H+ L
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  + +           ++ EYMENGSL D+L   +      KL++ + +++A  +A 
Sbjct: 71  VRLYAVVTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAE 120

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            + ++        +H DL+ +N+L+   +   + DFGLA+ + ++          +  G 
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-------AREGA 170

Query: 885 KGTVGYVAP 893
           K  + + AP
Sbjct: 171 KFPIKWTAP 179

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 22/184 (11%)

Query: 713 IGQGRFGTVYKGIL--GDDEMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIIT 769
           +G G FG+V +G+      ++ VA+KV+    +K  ++  + E + +  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           +C +          LV E    G L  +L          ++ +     +   V+  ++YL
Sbjct: 77  VCQAEAL------MLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYL 125

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
                   VH DL   NVLL     A + DFGL+K L            ++    K  + 
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-----DSYYTARSAGKWPLK 177

Query: 890 YVAP 893
           + AP
Sbjct: 178 WYAP 181

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 48/198 (24%), Positives = 99/198 (50%), Gaps = 20/198 (10%)

Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEA 755
           +Y +     ++ +  + +G G++G VY+G+     + VAVK +  +     + F+ E   
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAV 66

Query: 756 LRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQR 815
           ++ I+H NL++++ +C+           ++ E+M  G+L D+L + N Q    ++S +  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPP-----FYIITEFMTYGNLLDYLRECNRQ----EVSAVVL 117

Query: 816 MNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIAS 875
           + +A  ++SA+EYL        +H DL   N L+  + +  V DFGL++ ++        
Sbjct: 118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------ 168

Query: 876 KTPSSSIGIKGTVGYVAP 893
            T ++  G K  + + AP
Sbjct: 169 -TYTAHAGAKFPIKWTAP 185

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-38
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+GRFG V++G    +E  VAVK+ +  ++  S    +E      +RH N++  I   +
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
             +        LV +Y E+GSL D+L++         +++   + +A+  AS + +LH  
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHME 119

Query: 833 C-----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
                 +P + H DLK  N+L+  +    + D GLA    +           +     GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT----DTIDIAPNHRVGT 175

Query: 888 VGYVAP 893
             Y+AP
Sbjct: 176 KRYMAP 181

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 21/181 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG VYK    +  ++ A KVI+ K +   + ++ E + L +  H N++K++    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                  +   ++ E+   G+++  + +       R L+  Q   +      A+ YLH +
Sbjct: 80  YE-----NNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN 129

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVA 892
               ++H DLK  N+L   D    + DFG++   +                  GT  ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--------QRRDSFIGTPYWMA 178

Query: 893 P 893
           P
Sbjct: 179 P 179

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 47/197 (23%), Positives = 82/197 (41%), Gaps = 18/197 (9%)

Query: 701 SKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRN 758
           S+A  ++     IG G +G   K     D  ++  K ++     +   +  VSE   LR 
Sbjct: 1   SRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           ++H N+++            +    +V EY E G L   + +     E + L     + +
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRV 114

Query: 819 AIDVASAIEYLHHH--CQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASK 876
              +  A++  H        ++H DLKP+NV LD      +GDFGLA+ L++        
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-------- 166

Query: 877 TPSSSIGIKGTVGYVAP 893
             S +    GT  Y++P
Sbjct: 167 DTSFAKAFVGTPYYMSP 183

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (351), Expect = 6e-37
 Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 29/190 (15%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRN 763
           FS    IG G FG VY      +  VVA+K ++   K      +  + E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
            I+                 LV EY    + +            + L  ++   +     
Sbjct: 77  TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGAL 125

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIG 883
             + YLH H    M+H D+K  N+LL    +  +GDFG A  +            + +  
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------APANS 170

Query: 884 IKGTVGYVAP 893
             GT  ++AP
Sbjct: 171 FVGTPYWMAP 180

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 22/189 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
                   +GQG FG V+ G   +    VA+K +      + ++F+ E + ++ +RH  L
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  + S           +V EYM  GSL D+L     +         Q +++A  +AS
Sbjct: 75  VQLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIAS 124

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            + Y+        VH DL+ +N+L+  ++V  V DFGLA+ +            ++  G 
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-------DNEYTARQGA 174

Query: 885 KGTVGYVAP 893
           K  + + AP
Sbjct: 175 KFPIKWTAP 183

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-36
 Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 24/187 (12%)

Query: 711 NMIGQGRFGTVYKGILGDDEM--VVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIK 766
             +G G FGTV KG     ++   VAVK++  +          ++E   ++ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +I IC +  +       LV E  E G L  +L Q+      R +     + +   V+  +
Sbjct: 73  MIGICEAESW------MLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGM 120

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           +YL        VH DL   NVLL     A + DFGL+K L             +    K 
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172

Query: 887 TVGYVAP 893
            V + AP
Sbjct: 173 PVKWYAP 179

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 9e-36
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 22/189 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
            + +    +G G+FG V  G     +  VA+K+I  +   +   F+ E + + N+ H  L
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  +C+           ++ EYM NG L ++L +        +    Q + +  DV  
Sbjct: 62  VQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCE 111

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A+EYL        +H DL   N L++   V  V DFGL++++ +          +SS+G 
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGS 161

Query: 885 KGTVGYVAP 893
           K  V +  P
Sbjct: 162 KFPVRWSPP 170

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 9e-36
 Identities = 42/189 (22%), Positives = 75/189 (39%), Gaps = 21/189 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNL 764
           ++     +G+G +G V   +    E  VAVK++++K+     ++   E    + + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K        +      + L  EY   G L D +           +           + +
Sbjct: 66  VKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMA 114

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
            + YLH      + H D+KP N+LLD      + DFGLA     ++ +           +
Sbjct: 115 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------M 165

Query: 885 KGTVGYVAP 893
            GT+ YVAP
Sbjct: 166 CGTLPYVAP 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (337), Expect = 1e-35
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 26/189 (13%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
            E      IG+G FG V  G        VAVK I  K    +++F++E   +  +RH NL
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 62

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           ++++ +             +V EYM  GSL D+L      V    L     +  ++DV  
Sbjct: 63  VQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCE 114

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
           A+EYL  +     VH DL   NVL+  D VA V DFGL K  S           S+    
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTG 160

Query: 885 KGTVGYVAP 893
           K  V + AP
Sbjct: 161 KLPVKWTAP 169

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 3e-35
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 26/209 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL 764
           SE +    IG G+FG V+ G   + +  VA+K I  +   + + F+ E E +  + H  L
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +++  +C            LVFE+ME+G L D+L                 + + +DV  
Sbjct: 63  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGI 884
               + +  +  ++H DL   N L+  + V  V DFG+ +F+ +          +SS G 
Sbjct: 113 G---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGT 162

Query: 885 KGTVGYVAP----GKFFMLYTHIPSFSCT 909
           K  V + +P       +   + + SF   
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVL 191

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-35
 Identities = 41/192 (21%), Positives = 78/192 (40%), Gaps = 27/192 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            +F     +G+G+FG VY       + ++A+KV+    L++ G       E E   ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
            N++++                L+ EY   G++   L +      + K    +      +
Sbjct: 66  PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQK------LSKFDEQRTATYITE 114

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +A+A+ Y H      ++H D+KP N+LL       + DFG +    +             
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-------- 163

Query: 882 IGIKGTVGYVAP 893
             + GT+ Y+ P
Sbjct: 164 --LCGTLDYLPP 173

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-34
 Identities = 45/233 (19%), Positives = 87/233 (37%), Gaps = 42/233 (18%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDE-----MVVAVKVINLK-QKGASKSFVSECEALRN 758
                  ++G G FG V              + VAVK++  K      ++ +SE + +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 759 I-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV------------ 805
           +  H N++ ++  C+ +         L+FEY   G L ++L    ++             
Sbjct: 97  LGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 806 -----EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF 860
                ++  L+    +  A  VA  +E+L        VH DL   NVL+ +  V  + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDF 208

Query: 861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP----GKFFMLYTHIPSFSCT 909
           GLA+ + +                +  V ++AP       + + + + S+   
Sbjct: 209 GLARDIMSD------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 684 DTSPMEKLFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK 743
           D   +EKL  +VS  +  K   +++    IGQG  GTVY  +       VA++ +NL+Q+
Sbjct: 2   DEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 744 GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSND 803
              +  ++E   +R  ++ N++  +           D   +V EY+  GSL D + +   
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE--- 110

Query: 804 QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA 863
                 +   Q   +  +   A+E+LH +    ++H D+K  N+LL  D    + DFG  
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163

Query: 864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
             ++           S    + GT  ++AP
Sbjct: 164 AQITPEQ--------SKRSTMVGTPYWMAP 185

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 23/194 (11%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI 759
           S  +   +IG G FG VYKG+L    G  E+ VA+K +     +     F+ E   +   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            H N+I++  + S           ++ EYMENG+L+ +L + +      + S++Q + + 
Sbjct: 67  SHHNIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKD-----GEFSVLQLVGML 116

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
             +A+ +    +      VH DL   N+L++ ++V  V DFGL++ L +       +   
Sbjct: 117 RGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD-----PEATY 168

Query: 880 SSIGIKGTVGYVAP 893
           ++ G K  + + AP
Sbjct: 169 TTSGGKIPIRWTAP 182

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 5e-34
 Identities = 49/187 (26%), Positives = 74/187 (39%), Gaps = 25/187 (13%)

Query: 713 IGQGRFGTVYKGIL---GDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIK 766
           +G G FG V +G         + VAVK +    L Q  A   F+ E  A+ ++ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +  +   +      +V E    GSL D L +           L      A+ VA  +
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGM 124

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
            YL        +H DL   N+LL    +  +GDFGL + L  +      +        K 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----HRKV 176

Query: 887 TVGYVAP 893
              + AP
Sbjct: 177 PFAWCAP 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 8e-34
 Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 38/217 (17%)

Query: 691 LFPMVSYAELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASK 747
           ++P++ +       ++    ++IG+G FG V K  +  D + +   +  +K+   K   +
Sbjct: 3   IYPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55

Query: 748 SFVSECEALRNI-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSN---- 802
            F  E E L  +  H N+I ++  C     E   +  L  EY  +G+L D+L +S     
Sbjct: 56  DFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110

Query: 803 ------DQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH 856
                        LS  Q ++ A DVA     + +  Q   +H DL   N+L+  + VA 
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARG---MDYLSQKQFIHRDLAARNILVGENYVAK 167

Query: 857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           + DFGL++    +               +  V ++A 
Sbjct: 168 IADFGLSRGQEVYV---------KKTMGRLPVRWMAI 195

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-33
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 20/188 (10%)

Query: 710 SNMIGQGRFGTVYKGILGDD---EMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLI 765
           + +IG+G FG VY G L D+   ++  AVK +N +   G    F++E   +++  H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++ IC  ++        +V  YM++G L +++       E    ++   +   + VA  
Sbjct: 92  SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
              +        VH DL   N +LD      V DFGLA+ + +   D    +  +  G K
Sbjct: 143 ---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD----SVHNKTGAK 195

Query: 886 GTVGYVAP 893
             V ++A 
Sbjct: 196 LPVKWMAL 203

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 45/222 (20%), Positives = 83/222 (37%), Gaps = 38/222 (17%)

Query: 696 SYAELSKATSEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLK-QKGASKSF 749
               L    +       IG+G FG V++         +   +VAVK++  +        F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 750 VSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEV-- 807
             E   +    + N++K++ +C+           L+FEYM  G L ++L   +       
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 808 ----------------RKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY 851
                             LS  +++ IA  VA+ + YL        VH DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 852 DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           +MV  + DFGL++ + +      +    +       + ++ P
Sbjct: 176 NMVVKIADFGLSRNIYS------ADYYKADGNDAIPIRWMPP 211

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  129 bits (326), Expect = 2e-33
 Identities = 43/203 (21%), Positives = 75/203 (36%), Gaps = 28/203 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG V++          A K +    +   ++   E + +  +RH  L+ +     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-- 91

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE  +   +++E+M  G L + +   +      K+S  + +     V   + ++H +
Sbjct: 92  ---FEDDNEMVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
                VH DLKP N++        +   DFGL   L             S     GT  +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---------SVKVTTGTAEF 191

Query: 891 VAP----GKFFMLYTHIPSFSCT 909
            AP    GK    YT + S    
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVL 214

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-33
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 25/194 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDD----EMVVAVKVINL-KQKGASKSFVSECEALRNI 759
           +EF    ++G G FGTVYKG+   +    ++ VA+K +       A+K  + E   + ++
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
            + ++ +++ IC ++  +      L+ + M  G L D++ +  D +  +       +N  
Sbjct: 69  DNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQ-----YLLNWC 117

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPS 879
           + +A  + YL       +VH DL   NVL+       + DFGLAK L         +   
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA------EEKEY 168

Query: 880 SSIGIKGTVGYVAP 893
            + G K  + ++A 
Sbjct: 169 HAEGGKVPIKWMAL 182

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 9e-33
 Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 33/208 (15%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQK-GASKSFVSECEALRN 758
           +  S    +G G FG V +         D  M VAVK++         ++ +SE + L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 759 I-RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQV------------ 805
           +  H N++ ++  C+           ++ EY   G L ++L +  D              
Sbjct: 83  LGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 806 EVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF 865
           +   L L   ++ +  VA  + +L        +H DL   N+LL +  +  + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 866 LSNHHLDIASKTPSSSIGIKGTVGYVAP 893
           + N                +  V ++AP
Sbjct: 195 IKN------DSNYVVKGNARLPVKWMAP 216

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-32
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 23/195 (11%)

Query: 702 KATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRN 758
           K   +F    ++G+G F TV            A+K++    + ++        E + +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNI 818
           + H   +K+       +            Y +NG L  ++ +      +           
Sbjct: 65  LDHPFFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRK------IGSFDETCTRFY 113

Query: 819 AIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
             ++ SA+EYLH      ++H DLKP N+LL+ DM   + DFG AK LS       + + 
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 169

Query: 879 SSSIGIKGTVGYVAP 893
                  GT  YV+P
Sbjct: 170 -----FVGTAQYVSP 179

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-32
 Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 712 MIGQGRFGTVYKGIL---GDDEMVVAVKVI-NLKQKGASKSFVSECEALRNIRHRNLIKI 767
            IG+G+FG V++GI     +  + VA+K   N       + F+ E   +R   H +++K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 768 ITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           I + +       +   ++ E    G L  +L           L L   +  A  +++A  
Sbjct: 74  IGVITE------NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTA-- 120

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
            L +      VH D+   NVL+  +    +GDFGL++++ +        T   +   K  
Sbjct: 121 -LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASKGKLP 172

Query: 888 VGYVAP----GKFFMLYTHIPSFSCT 909
           + ++AP     + F   + +  F   
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVC 198

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  124 bits (313), Expect = 1e-31
 Identities = 39/183 (21%), Positives = 69/183 (37%), Gaps = 24/183 (13%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G FG V++ +      V   K IN        +  +E   +  + H  LI +     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      L+ E++  G L D +   +      K+S  + +N        ++++H H
Sbjct: 97  DK-----YEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGY 890
               +VH D+KP N++ +    + V   DFGLA  L+   +               T  +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---------VKVTTATAEF 194

Query: 891 VAP 893
            AP
Sbjct: 195 AAP 197

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 6e-31
 Identities = 40/199 (20%), Positives = 82/199 (41%), Gaps = 24/199 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRN 758
            + + S  +GQG FG VY+G+       + E  VA+K +N          F++E   ++ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE----VRKLSLIQ 814
               ++++++ + S           ++ E M  G L+ +L      +     +   SL +
Sbjct: 80  FNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 815 RMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
            + +A ++A  + YL+ +     VH DL   N ++  D    +GDFG+ + +        
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 875 SKTPSSSIGIKGTVGYVAP 893
                        V +++P
Sbjct: 192 GGK------GLLPVRWMSP 204

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  120 bits (302), Expect = 7e-31
 Identities = 35/185 (18%), Positives = 77/185 (41%), Gaps = 18/185 (9%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHRNLIKII 768
           ++G G    V+          VAVKV+     +       F  E +    + H  ++ + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
               +    G     +V EY++  +L D +H          ++  + + +  D   A+ +
Sbjct: 74  DTGEAETPAG-PLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEVIADACQALNF 126

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
            H +    ++H D+KP+N+++       V DFG+A+ +++        + + +  + GT 
Sbjct: 127 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NSVTQTAAVIGTA 178

Query: 889 GYVAP 893
            Y++P
Sbjct: 179 QYLSP 183

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-30
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 12/166 (7%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIK 766
           ++ + +IG G FG VY+  L D   +VA+K +   +    +    E + +R + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 767 IITIC-SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
           +     SS + +   +  LV +Y+         H S  +   + L +I        +  +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK---QTLPVIYVKLYMYQLFRS 134

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHH 870
           + Y+H      + H D+KP N+LLD D  V  + DFG AK L    
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  122 bits (306), Expect = 2e-30
 Identities = 39/179 (21%), Positives = 68/179 (37%), Gaps = 20/179 (11%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK------QKGASKSFVSECEALRNI 759
           +FS   +IG+G FG VY     D   + A+K ++ K       +  + +       +   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 760 RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIA 819
               ++ +        F   D  + + + M  G L   L Q     E            A
Sbjct: 65  DCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113

Query: 820 IDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTP 878
            ++   +E++H+     +V+ DLKP+N+LLD      + D GLA   S      +  T 
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-30
 Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 17/184 (9%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVIN-LKQKGASKSFVSECEALRNIRHRNLIKIIT 769
           + IG+G +G V       +++ VA+K I+  + +   +  + E + L   RH N+I I  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           I  +   E +    LV   M    L   L         + LS          +   ++Y+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-------QHLSNDHICYFLYQILRGLKYI 125

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H      ++H DLKPSN+LL+      + DFGLA+     H      T         T  
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----YVATRW 177

Query: 890 YVAP 893
           Y AP
Sbjct: 178 YRAP 181

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 11/307 (3%)

Query: 34  NETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQ--WTGVTC--GHRHQRLTELNLSSQRI 89
           N  D+ ALL IK  L +P+   SSW  T + C   W GV C    +  R+  L+LS   +
Sbjct: 4   NPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 90  GGV--LSPYVGNLSFLRYINLADN-GFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLS 146
                +   + NL +L ++ +       G IP  I  L +L  L +++ + SG IP  LS
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 147 RCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITE 206
           +   L+    S N L G +P  I +L  L  ++ D N ++G +PDS G+ S +       
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDIL 266
            +              L  ++++ N   G       +  + + I L +N  +       L
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242

Query: 267 LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE 326
               N   L    N   G++P  L+    L  L++  N   G++     +L+   +    
Sbjct: 243 SKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299

Query: 327 QNNLGTG 333
            N    G
Sbjct: 300 NNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 86.7 bits (213), Expect = 5e-19
 Identities = 65/270 (24%), Positives = 107/270 (39%), Gaps = 9/270 (3%)

Query: 372 SLKMIELSVGRNQISG--TIPPGIRNLVNLITFTLEVN-QFHGTIPDVISELKNLQQLSV 428
           + ++  L +    +     IP  + NL  L    +       G IP  I++L  L  L +
Sbjct: 49  TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108

Query: 429 FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ 488
            +  + G IP  L  +  L +LD   N+L G +P S+ +  NL+      N+++G +P  
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

Query: 489 LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLD 548
             S + L   + +S N L G +P    NL    +    S          L          
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQKI 226

Query: 549 ISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV 608
               +            K++  L++ +N + G +P+ L  L FL  LN+S+N   GE+P 
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 609 KGVFSNKTKISLHGNVKLCGGIDELHLPSC 638
            G        +   N  LCG      LP+C
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS----PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.8 bits (125), Expect = 8e-08
 Identities = 21/109 (19%), Positives = 36/109 (33%), Gaps = 1/109 (0%)

Query: 58  WNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDI 117
           + +          +      + T+    ++         VG    L  ++L +N   G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260

Query: 118 PQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIP 166
           PQ +  L  L  L +S N+  G IP              +NNK     P
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.9 bits (120), Expect = 3e-07
 Identities = 21/69 (30%), Positives = 31/69 (44%), Gaps = 3/69 (4%)

Query: 148 CSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN 207
             NL      NN++ G +P+ +  L  L  L+V  N L G++P   GNL   +V     N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

Query: 208 SL--GGKIP 214
               G  +P
Sbjct: 302 KCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 2/141 (1%)

Query: 439 SGLGNLTKLGSLDLGSNSLQGN--IPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLS 496
                  ++ +LDL   +L     IPSSL N   L                  ++  T  
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 497 LVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYG 556
             L +++  ++G++P  +  +K LV LD S N  SG +P ++S+  +L  +    N   G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 557 VIPLSFRFLKSIKALNVSSNN 577
            IP S+     +      S N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  115 bits (288), Expect = 5e-29
 Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 24/170 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---------KGASKSFVSECEALRNIR- 760
            ++G+G    V + I        AVK+I++           +   ++ + E + LR +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
           H N+I++        +E   F  LVF+ M+ G L D+L +         LS  +   I  
Sbjct: 69  HPNIIQLK-----DTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMR 117

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            +   I  LH      +VH DLKP N+LLD DM   + DFG +  L    
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (290), Expect = 5e-29
 Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 21/184 (11%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIIT 769
           +++G G F  V        + +VA+K I  K  +G   S  +E   L  I+H N++ +  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
           I  S          L+ + +  G L D + +          +      +   V  A++YL
Sbjct: 75  IYESGGH-----LYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVG 889
           H                  LD D    + DFGL+K      +              GT G
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---------LSTACGTPG 174

Query: 890 YVAP 893
           YVAP
Sbjct: 175 YVAP 178

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 7e-29
 Identities = 32/160 (20%), Positives = 70/160 (43%), Gaps = 16/160 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G+G FG V++ +    +     K + +K          E   L   RHRN++ +     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES-- 69

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
              FE ++   ++FE++    + + ++ S       +L+  + ++    V  A+++LH H
Sbjct: 70  ---FESMEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHV--GDFGLAKFLSNHH 870
               + H D++P N++      + +   +FG A+ L    
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (288), Expect = 8e-29
 Identities = 47/205 (22%), Positives = 75/205 (36%), Gaps = 23/205 (11%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITIC 771
            IG G FG +Y G        VA+K+  +K K        E +  + ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
            +      D+  +V E +     + +   S      RK SL   + +A  + S IEY+H 
Sbjct: 72  GAEG----DYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHS 121

Query: 832 HCQPPMVHGDLKPSNVL---LDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTV 888
                 +H D+KP N L        + ++ DFGLAK   +           +   + GT 
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177

Query: 889 GYVAP----GKFFMLYTHIPSFSCT 909
            Y +     G        + S    
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYV 202

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 6e-28
 Identities = 44/186 (23%), Positives = 85/186 (45%), Gaps = 18/186 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITI 770
           IGQG FG V+K         VA+K + ++  ++G   + + E + L+ ++H N++ +I I
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 771 CSSTDFEGVDFKA---LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           C +        K    LVF++ E+       +       + K +L +   +   + +   
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSEIKRVMQMLLNG-- 129

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
            L++  +  ++H D+K +NVL+  D V  + DFGLA+  S       ++  +       T
Sbjct: 130 -LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN----RVVT 184

Query: 888 VGYVAP 893
           + Y  P
Sbjct: 185 LWYRPP 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 7e-28
 Identities = 42/186 (22%), Positives = 74/186 (39%), Gaps = 26/186 (13%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEAL-RNIRHRNLIKIITI 770
           ++G G  G V +      +   A+K++    K        E E   R  +  ++++I+ +
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
                + G     +V E ++ G L   +    DQ      +  +   I   +  AI+YLH
Sbjct: 74  Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128

Query: 831 HHCQPPMVHGDLKPSNVLLD---YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
                 + H D+KP N+L      + +  + DFG AK  ++H+         S      T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYT 176

Query: 888 VGYVAP 893
             YVAP
Sbjct: 177 PYYVAP 182

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 42/220 (19%), Positives = 77/220 (35%), Gaps = 28/220 (12%)

Query: 705 SEFSSSNMIGQGRFGTVYKGIL-----GDDEMVVAVKVINLKQ-KGASKSFVSECEALRN 758
                   +G+G FG V +              VAVK++         ++ +SE + L +
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 759 IRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRK--------- 809
           I H   +  +        +      ++ E+ + G+L  +L    ++    K         
Sbjct: 73  IGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 810 -LSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSN 868
            L+L   +  +  VA  +E+L        +H DL   N+LL    V  + DFGLA+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 869 HHLDIASKTPSSSIGIKGTVGYVAPGKFFMLYTHIPSFSC 908
                           +  + ++AP   F     I S   
Sbjct: 187 ------DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 4e-27
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 27/188 (14%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK-----QKGASKSFVSECEALRNIRHRNLI 765
           + +G+G+F TVYK    +   +VA+K I L      + G +++ + E + L+ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
            ++              +LVF++ME          S        L+        +     
Sbjct: 64  GLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQG 112

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIK 885
           +EYLH H    ++H DLKP+N+LLD + V  + DFGLAK   + +         +     
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--------RAYTHQV 161

Query: 886 GTVGYVAP 893
            T  Y AP
Sbjct: 162 VTRWYRAP 169

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-27
 Identities = 43/200 (21%), Positives = 79/200 (39%), Gaps = 33/200 (16%)

Query: 713 IGQGRFGTVYKGIL-------GDDEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRN 763
           +G+G FG V             +    VAVK++     +      +SE E ++ I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQ----------SNDQVEVRKLSLI 813
           +I ++  C+           ++ EY   G+L ++L            +       +LS  
Sbjct: 81  IINLLGACTQDGP-----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDI 873
             ++ A  VA     + +      +H DL   NVL+  D V  + DFGLA+ + +     
Sbjct: 136 DLVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----- 187

Query: 874 ASKTPSSSIGIKGTVGYVAP 893
                  +   +  V ++AP
Sbjct: 188 -IDYYKKTTNGRLPVKWMAP 206

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 9e-27
 Identities = 45/200 (22%), Positives = 87/200 (43%), Gaps = 23/200 (11%)

Query: 700 LSKATSEFSSSNMIGQGRFGTVYKGI-LGDDEMVVAVKVINLK--QKGASKSFVSECEAL 756
           L +A  ++     IG+G +G V+K   L +    VA+K + ++  ++G   S + E   L
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 757 RNI---RHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLI 813
           R++    H N++++  +C+ +  +      LVFE+++                   +   
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTE 116

Query: 814 QRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDI 873
              ++   +   +++LH H    +VH DLKP N+L+       + DFGLA+  S      
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--- 170

Query: 874 ASKTPSSSIGIKGTVGYVAP 893
                 +   +  T+ Y AP
Sbjct: 171 ------ALTSVVVTLWYRAP 184

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-26
 Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 26/192 (13%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEAL-RNIRH 761
           +F    M+G+G FG V+           A+K +    +      +  + E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             L  +     + +         V EY+  G L   +          K  L +    A +
Sbjct: 63  PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAE 111

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
           +   +++LH      +V+ DLK  N+LLD D    + DFG+ K              + +
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AKT 160

Query: 882 IGIKGTVGYVAP 893
               GT  Y+AP
Sbjct: 161 NTFCGTPDYIAP 172

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-26
 Identities = 39/179 (21%), Positives = 76/179 (42%), Gaps = 18/179 (10%)

Query: 699 ELSKATSEFSSS----NMIGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSE 752
           E++K   E  +       +G G +G V   + G     VA+K +    + +  +K    E
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67

Query: 753 CEALRNIRHRNLIKIITICSSTD-FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLS 811
              L+++RH N+I ++ + +  +  +      LV  +M  G+    L +        KL 
Sbjct: 68  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH------EKLG 119

Query: 812 LIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
             +   +   +   + Y+H      ++H DLKP N+ ++ D    + DFGLA+   +  
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (269), Expect = 4e-26
 Identities = 38/192 (19%), Positives = 69/192 (35%), Gaps = 28/192 (14%)

Query: 705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRH 761
            +F     +G G FG V+      +    A+KV+    + +    +    E   L  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 762 RNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAID 821
             +I++                ++ +Y+E G L   L +S              +     
Sbjct: 64  PFIIRMWGTFQDAQQ-----IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----- 113

Query: 822 VASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSS 881
                  L +     +++ DLKP N+LLD +    + DFG AK++ +             
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT--------- 160

Query: 882 IGIKGTVGYVAP 893
             + GT  Y+AP
Sbjct: 161 --LCGTPDYIAP 170

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (259), Expect = 4e-25
 Identities = 32/186 (17%), Positives = 62/186 (33%), Gaps = 21/186 (11%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           IG+G FG +++G    +   VA+K    +    +     E    + +     I  +    
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 773 STDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHH 832
                      LV + +     +            RK S+      A  + + ++ +H  
Sbjct: 71  QEG----LHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 833 CQPPMVHGDLKPSNVLLDYDMVAHVG-----DFGLAKFLSNHHLDIASKTPSSSIGIKGT 887
               +V+ D+KP N L+      +       DFG+ KF  +               + GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGT 176

Query: 888 VGYVAP 893
             Y++ 
Sbjct: 177 ARYMSI 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 9e-25
 Identities = 43/191 (22%), Positives = 71/191 (37%), Gaps = 25/191 (13%)

Query: 706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVIN---LKQKGASKSFVSECEALRNIRHR 762
           +F    ++G+G FG V            A+K++    +  K      V+E   L+N RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 763 NLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDV 822
            L  +     + D         V EY   G L   L +          +  +      ++
Sbjct: 66  FLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRER------VFTEERARFYGAEI 114

Query: 823 ASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
            SA   L +     +V+ D+K  N++LD D    + DFGL K   +          ++  
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMK 163

Query: 883 GIKGTVGYVAP 893
              GT  Y+AP
Sbjct: 164 TFCGTPEYLAP 174

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-24
 Identities = 36/160 (22%), Positives = 73/160 (45%), Gaps = 16/160 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITI 770
           IG+G +GTV+K    +   +VA+K + L    +G   S + E   L+ ++H+N++++  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 771 CSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLH 830
             S          LVFE+ +    + +   + D       S + ++         ++ L 
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL---------LKGLG 115

Query: 831 HHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
                 ++H DLKP N+L++ +    + +FGLA+      
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 42/191 (21%), Positives = 74/191 (38%), Gaps = 33/191 (17%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGAS------KSFVSECEALRNIRHRNLIK 766
           +G G+F  V K       +  A K I  ++  +S      +    E   L+ I+H N+I 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 767 IITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAI 826
           +  +     +E      L+ E +  G L D+L +     E      ++++         +
Sbjct: 78  LHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123

Query: 827 EYLHHHCQPPMVHGDLKPSNVLLDYDMVA----HVGDFGLAKFLSNHHLDIASKTPSSSI 882
             +++     + H DLKP N++L    V      + DFGLA  +            +   
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------FGNEFK 174

Query: 883 GIKGTVGYVAP 893
            I GT  +VAP
Sbjct: 175 NIFGTPEFVAP 185

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 3e-24
 Identities = 37/191 (19%), Positives = 63/191 (32%), Gaps = 32/191 (16%)

Query: 712 MIGQGRFGTVYKGILGDDEMVVAVKVINLK------QKGASKSFVSECEALRNIR--HRN 763
           ++G G FG+VY GI   D + VA+K +         +         E   L+ +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 764 LIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVA 823
           +I+++           D   L+ E  E                   L      +    V 
Sbjct: 71  VIRLLDWFERP-----DSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVL 120

Query: 824 SAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHHLDIASKTPSSSI 882
            A+ + H+     ++H D+K  N+L+D +     + DFG    L +              
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---------- 167

Query: 883 GIKGTVGYVAP 893
              GT  Y  P
Sbjct: 168 DFDGTRVYSPP 178

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (252), Expect = 6e-24
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 20/160 (12%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITIC 771
           +G+G++  V++ I   +   V VK++   +K   K    E + L N+R   N+I +  I 
Sbjct: 43  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99

Query: 772 SSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH 831
                      ALVFE++ N   +            + L+         ++  A++Y H 
Sbjct: 100 KDPVSRTP---ALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 832 HCQPPMVHGDLKPSNVLLDYD-MVAHVGDFGLAKFLSNHH 870
                ++H D+KP NV++D++     + D+GLA+F     
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  100 bits (249), Expect = 7e-24
 Identities = 38/161 (23%), Positives = 71/161 (44%), Gaps = 17/161 (10%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKII 768
             IG+G +G VYK      E   A+K I L++  +G   + + E   L+ ++H N++K+ 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 769 TICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEY 828
            +  +          LVFE+++    +              L  +   +  + + + I Y
Sbjct: 67  DVIHTKKR-----LVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAY 115

Query: 829 LHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNH 869
            H      ++H DLKP N+L++ +    + DFGLA+     
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  100 bits (250), Expect = 2e-23
 Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 17/161 (10%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASK---SFVSECEALRNIRHRNLIKIIT 769
           +G G FG V      +     A+K+++ ++    K     ++E   L+ +    L+K+  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
                         +V EY+  G +   L +        + S       A  +    EYL
Sbjct: 109 SFKDNSN-----LYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYL 157

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           H      +++ DLKP N+L+D      V DFG AK +    
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 2e-23
 Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 15/166 (9%)

Query: 707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNL 764
           F     IG+G +G VYK        VVA+K I L    +G   + + E   L+ + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 765 IKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVAS 824
           +K++ +  + +        LVFE++        L +  D   +  + L    +    +  
Sbjct: 64  VKLLDVIHTENK-----LYLVFEFLHQ-----DLKKFMDASALTGIPLPLIKSYLFQLLQ 113

Query: 825 AIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            + + H H    ++H DLKP N+L++ +    + DFGLA+      
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 6e-23
 Identities = 37/184 (20%), Positives = 76/184 (41%), Gaps = 16/184 (8%)

Query: 693 PMVSYAELSKATSEFSSS----NMIGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGAS 746
           P     EL+K   E        + +G G +G+V         + VAVK ++   +    +
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 747 KSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVE 806
           K    E   L++++H N+I ++ + +            +  ++    L + +        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------ 115

Query: 807 VRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL 866
            +KL+      +   +   ++Y+H      ++H DLKPSN+ ++ D    + DFGLA+  
Sbjct: 116 -QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171

Query: 867 SNHH 870
            +  
Sbjct: 172 DDEM 175

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 7e-23
 Identities = 34/161 (21%), Positives = 67/161 (41%), Gaps = 15/161 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVIN--LKQKGASKSFVSECEALRNIRHRNLIKIITI 770
           IG G  G V        +  VA+K ++   + +  +K    E   ++ + H+N+I ++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 771 CSSTD-FEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYL 829
            +     E      LV E M+    +    + + +         +   +   +   I++L
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135

Query: 830 HHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
           H      ++H DLKPSN+++  D    + DFGLA+      
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.8 bits (237), Expect = 1e-21
 Identities = 74/387 (19%), Positives = 128/387 (33%), Gaps = 30/387 (7%)

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           L   +   + +   +    ++  ++  V  +        GI   D +  L NL ++    
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL---GIKSIDGVEYLNNLTQINFSN 75

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
           N      P  L N + L  + + +NQ      +   +      L   Q        N  +
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIA------NLSLKMIELSVGRNQISGTIPPGI 393
                 + +++  +S        +             L+       +  +    +    +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 394 RNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG 453
             L NL +     NQ     P  I    NL +LS+  N L+      L +LT L  LDL 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 454 SNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQ 513
           +N +    P  L     L       N+++   P   L+  T         N         
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL-----ELNENQLEDISP 302

Query: 514 VGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNV 573
           + NLKNL  L +  N  S + P  +S+   L+ L  + N        S   L +I  L+ 
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 574 SSNNLSGKIPEFLENLSFLEFLNLSYN 600
             N +S   P  L NL+ +  L L+  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 5e-20
 Identities = 80/393 (20%), Positives = 129/393 (32%), Gaps = 41/393 (10%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
            L+      L        + Q   +L ++  L              +   +NL     SN
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLT------------GQLPDSVGNLSAIEVIRITE 206
           N+L    P  + NL KL  + ++ N +             G    +        +  +T 
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 207 NSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDIL 266
            +       T+  +  L  L   +    G     +  ++++  +   +   + +    +L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 267 LNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE 326
             L NL+ L    N      P      +NL+ L L  NQ K   +   +SL NL  L+L 
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLA 249

Query: 327 QNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQIS 386
            N +          +  LS  + L  L L  NQ     P +       +       N+  
Sbjct: 250 NNQISN--------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLE-----LNENQ 296

Query: 387 GTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTK 446
                 I NL NL   TL  N      P  +S L  LQ+L   NN +     S L NLT 
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTN 352

Query: 447 LGSLDLGSNSLQGNIPSSLGNCQNLILFIASYN 479
           +  L  G N +    P  L N   +     +  
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 83.1 bits (204), Expect = 2e-17
 Identities = 78/386 (20%), Positives = 142/386 (36%), Gaps = 26/386 (6%)

Query: 171 NLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE 230
            L +  +  +    +T  +  +  +L  +  ++     +  K    +  L  L  +N + 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75

Query: 231 NQFSGMFP----RSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSI 286
           NQ + + P      + +I             + +     L    N         N     
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 287 PDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSN 346
              LS+ +  ++  L       ++S          L NL        ++N +  +  L+ 
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 347 CSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEV 406
            ++L+ L  ++NQ     P  I      + ELS+  NQ+       + +L NL    L  
Sbjct: 196 LTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG 466
           NQ     P  +S L  L +L +  N +    P  L  LT L +L+L  N L+   P S  
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS-- 304

Query: 467 NCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDIS 526
           N +NL      +N ++   P  + S+T L   L  +NN ++      + NL N+  L   
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAG 359

Query: 527 SNQFSGVIPVTLSTCVSLEYLDISIN 552
            NQ S + P  L+    +  L ++  
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 82.7 bits (203), Expect = 3e-17
 Identities = 70/362 (19%), Positives = 140/362 (38%), Gaps = 26/362 (7%)

Query: 268 NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQ 327
           +L  +  L       + SI D +   +NL  ++  +NQ          +L  L  + +  
Sbjct: 42  DLDQVTTLQADRLG-IKSI-DGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNN 97

Query: 328 NNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPH------SIANLSLKMIELSVG 381
           N +   T       +      + ++  +   +    L        +I+++S      S+ 
Sbjct: 98  NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157

Query: 382 RNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL 441
           +      +              L+++    +   V+++L NL+ L   NN +    P G 
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG- 216

Query: 442 GNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDL 501
             LT L  L L  N L+     +L +  NL     + N+++   P   L+  T    L L
Sbjct: 217 -ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLT---ELKL 270

Query: 502 SNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLS 561
             N ++   PL    L  L  L+++ NQ   + P++     +L YL +  N+   + P+S
Sbjct: 271 GANQISNISPLA--GLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISPVS 326

Query: 562 FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLH 621
              L  ++ L  ++N +S      L NL+ + +L+  +N      P+    +  T++ L+
Sbjct: 327 S--LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN-LTRITQLGLN 381

Query: 622 GN 623
             
Sbjct: 382 DQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 73.1 bits (178), Expect = 3e-14
 Identities = 47/209 (22%), Positives = 86/209 (41%), Gaps = 17/209 (8%)

Query: 96  YVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFC 155
            +  L+ L  +   +N      P  I     L++L+L+ N         L+  +NL    
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 156 ASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPT 215
            +NN++    P  +  L KL  L +  N ++   P  +  L+A+  + + EN L    P 
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPI 303

Query: 216 TLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKL 275
           +   L+ L  L +  N  S + P  + +++ ++ +F   N+ S +       NL N+  L
Sbjct: 304 SN--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLA---NLTNINWL 356

Query: 276 GIGGNNFVGSIPDSLSNASNLELLDLPSN 304
             G N      P  L+N + +  L L   
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 70.8 bits (172), Expect = 2e-13
 Identities = 44/229 (19%), Positives = 92/229 (40%), Gaps = 17/229 (7%)

Query: 52  SGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADN 111
           + +T+     ++  + + ++   +   L  L  ++ +I  +       L+ L  ++L  N
Sbjct: 172 ANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGN 229

Query: 112 GFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN 171
             +      + +L  L  L L+NN  S   P  LS  + L       N++    P  +  
Sbjct: 230 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAG 283

Query: 172 LLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAEN 231
           L  L  L ++ N    +    + NL  +  + +  N++    P  +  L +L  L  A N
Sbjct: 284 LTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANN 339

Query: 232 QFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGN 280
           + S     S+ N++++  +    N+ S + P     NL  + +LG+   
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.0 bits (157), Expect = 1e-11
 Identities = 73/386 (18%), Positives = 128/386 (33%), Gaps = 61/386 (15%)

Query: 286 IPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLS 345
             D+    +      L        VS   + L  +  L  ++  +       +D    + 
Sbjct: 16  FTDT--ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI-----KSIDG---VE 63

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANL-SLKMIELSVGRNQISGTIPPGIRNLVNLITFTL 404
             ++L  ++ S+NQ     P  + NL  L  I ++  +      +          +    
Sbjct: 64  YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 121

Query: 405 EVNQFHGTIP-------------DVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLD 451
             +                      IS L  L  L   +   +      L NLT L  LD
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181

Query: 452 LGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLP 511
           + SN +      +     NL   IA+ N+++   P  +L+       L L+ N L     
Sbjct: 182 ISSNKVSDISVLA--KLTNLESLIATNNQISDITPLGILTNLD---ELSLNGNQLKD--I 234

Query: 512 LQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPL----------- 560
             + +L NL  LD+++NQ S + P  LS    L  L +  N    + PL           
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292

Query: 561 ---------SFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKGV 611
                        LK++  L +  NN+S   P  + +L+ L+ L  + N     V     
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLAN 349

Query: 612 FSNKTKISLHGNVKLCGGIDELHLPS 637
            +N   +S   N ++       +L  
Sbjct: 350 LTNINWLSAGHN-QISDLTPLANLTR 374

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.5 bits (135), Expect = 7e-09
 Identities = 32/163 (19%), Positives = 61/163 (37%), Gaps = 10/163 (6%)

Query: 1   MPNISISISCLAILIRCFSLFLINSPSFSAGQTNETDRLALLAIKSQ----LHDPSGVTS 56
             N    I  LA L     L L N+   +    +   +L  L + +     +   +G+T+
Sbjct: 227 NGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTA 286

Query: 57  SWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGD 116
             N  +N  Q   ++     + LT L L    I  +    V +L+ L+ +  A+N     
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNKVSD- 343

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNN 159
               + NL  +  L+  +N  S   P  L+  + +     ++ 
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.004
 Identities = 22/109 (20%), Positives = 41/109 (37%), Gaps = 13/109 (11%)

Query: 452 LGSNSLQGNIPSS----LGNCQNLILFIASYNKLTGDLPQ-QLLSITTLSLVLDLSNNLL 506
           LGS ++  + P +           +  +     +T  + Q  L  +TTL          +
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTL----QADRLGI 56

Query: 507 NGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFY 555
             S+   V  L NL  ++ S+NQ + + P  L     L  + ++ N   
Sbjct: 57  K-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 101

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 3e-21
 Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 20/169 (11%)

Query: 713 IGQGRFGTVYKG---ILGDDEMVVAVKVIN----LKQKGASKSFVSECEALRNIRHRNLI 765
           +G G +G V+        D   + A+KV+     +++   ++   +E + L +IR    +
Sbjct: 32  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 766 KIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASA 825
             +       F+      L+ +Y+  G L   L Q     E           + I V   
Sbjct: 92  VTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTE---------HEVQIYVGEI 138

Query: 826 IEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIA 874
           +  L H  +  +++ D+K  N+LLD +    + DFGL+K       + A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 187

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.4 bits (228), Expect = 1e-20
 Identities = 42/207 (20%), Positives = 79/207 (38%), Gaps = 19/207 (9%)

Query: 713 IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICS 772
           +G G F TV+      +   VA+K++    K  +++   E + L+ +   +  K  ++ +
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 773 S-----TDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIE 827
           +      D         V   M    L + L     + E R + LI    I+  +   ++
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 828 YLHHHCQPPMVHGDLKPSNVLLDY-DMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKG 886
           Y+H  C   ++H D+KP NVL++  D   ++    +A   +      A            
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN------ACWYDEHYTNSIQ 191

Query: 887 TVGYVAP----GKFFMLYTHIPSFSCT 909
           T  Y +P    G  +     I S +C 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACL 218

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 2e-19
 Identities = 25/170 (14%), Positives = 53/170 (31%), Gaps = 29/170 (17%)

Query: 711 NMIGQGRFGTVYKGILGDDEMVVAVKVINL----------KQKGASKSFVSECEALRNIR 760
            ++G+G+   V+            VK   +          K+      F           
Sbjct: 6   KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 761 HRNLIKIITICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAI 820
            R L K+  +     +   +  A++ E ++   L     ++ D+             +  
Sbjct: 65  FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110

Query: 821 DVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHH 870
            +   +   +H     +VHGDL   NVL+  +    + DF  +  +    
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.5 bits (210), Expect = 1e-18
 Identities = 59/304 (19%), Positives = 103/304 (33%), Gaps = 39/304 (12%)

Query: 65  CQWTGVTCGHRH---------QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRG 115
           C    V C                  L+L + +I  +      NL  L  + L +N    
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 116 DIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL 175
             P     L +LE+L LS N               L        K+   +   +  ++ +
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 176 QRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           + L  +    +G    +   +  +  IRI + ++   IP   GL   L  L++  N+ + 
Sbjct: 130 E-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITK 185

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN 295
           +   S+                           L NL KLG+  N+       SL+N  +
Sbjct: 186 VDAASLK-------------------------GLNNLAKLGLSFNSISAVDNGSLANTPH 220

Query: 296 LELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL 355
           L  L   +N    KV    +  K + ++ L  NN+    +ND     + +  +S   +SL
Sbjct: 221 LRELH-LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

Query: 356 SDNQ 359
             N 
Sbjct: 280 FSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.8 bits (203), Expect = 1e-17
 Identities = 49/262 (18%), Positives = 100/262 (38%), Gaps = 13/262 (4%)

Query: 369 ANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSV 428
            +L      L +  N+I+       +NL NL T  L  N+     P   + L  L++L +
Sbjct: 27  KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86

Query: 429 FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ 488
             N L+         L +L   +     ++ ++ + L     + L   +  K +G     
Sbjct: 87  SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGA 145

Query: 489 LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLD 548
              +  LS +  +++  +     +  G   +L  L +  N+ + V   +L    +L  L 
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201

Query: 549 ISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEG---- 604
           +S NS   V   S      ++ L++++N L  K+P  L +  +++ + L  N        
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 260

Query: 605 ---EVPVKGVFSNKTKISLHGN 623
                      ++ + +SL  N
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.0 bits (188), Expect = 9e-16
 Identities = 58/299 (19%), Positives = 99/299 (33%), Gaps = 35/299 (11%)

Query: 270 PNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNN 329
           P+   L +  N           N  NL  L L +N+        F+ L  L  L L +N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 330 LGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKM-IELSVGRNQISGT 388
           L           +      +L+ L + +N+           L+  + +EL     + SG 
Sbjct: 91  LKE---------LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 389 IPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLG 448
                + +  L    +       TIP  +    +L +L +  N +     + L  L  L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 449 SLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG 508
            L L  NS+      SL N  +L     + NKL    P  L     +  V+ L NN ++ 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQ-VVYLHNNNISA 256

Query: 509 ------SLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLS 561
                   P       +   + + SN               ++Y +I  ++F  V   +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNP--------------VQYWEIQPSTFRCVYVRA 301

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 71.6 bits (174), Expect = 6e-14
 Identities = 58/336 (17%), Positives = 103/336 (30%), Gaps = 70/336 (20%)

Query: 245 SSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN 304
               L+ L  N+ + I       NL NL  L +  N      P + +    LE L L  N
Sbjct: 31  PDTALLDLQNNKITEIKD-GDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 305 QFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGEL 364
           Q K        +L+ L +   E   +     N L+ +I +   ++               
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN--------------- 134

Query: 365 PHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQ 424
                              + SG      + +  L    +       TIP  +    +L 
Sbjct: 135 -----------------PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT 174

Query: 425 QLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGD 484
           +L +  N +     + L  L  L  L L  NS+      SL N  +L     + NKL   
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234

Query: 485 LPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV------IPVTL 538
                                     P  + + K + ++ + +N  S +       P   
Sbjct: 235 --------------------------PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 268

Query: 539 STCVSLEYLDISIN--SFYGVIPLSFRFLKSIKALN 572
           +   S   + +  N   ++ + P +FR +    A+ 
Sbjct: 269 TKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (203), Expect = 6e-18
 Identities = 42/257 (16%), Positives = 81/257 (31%), Gaps = 5/257 (1%)

Query: 348 SSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVN 407
           ++ + + L  N+       S        I                    +       +  
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 408 QFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGN 467
           Q     P     L  L  L +    L+   P     L  L  L L  N+LQ     +  +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 468 CQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISS 527
             NL       N+++    +    + +L  +  L  N +    P    +L  L+ L + +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 528 NQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLE 587
           N  S +    L+   +L+YL ++ N +             ++    SS+ +   +P+ L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 588 NLSFLEFLNLSYNYFEG 604
                    L+ N  +G
Sbjct: 270 GRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.8 bits (169), Expect = 2e-13
 Identities = 51/272 (18%), Positives = 91/272 (33%), Gaps = 15/272 (5%)

Query: 117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQ 176
           +P  I      +++ L  N  S     +   C NL      +N L          L  L+
Sbjct: 26  VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 177 RLSVDINYLTGQL-PDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSG 235
           +L +  N     + P +   L  +  + +    L    P     L  L  L + +N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASN 295
           +   +  ++ ++  +FL  NR S + P      L +L +L +  N      P +  +   
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSV-PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 296 LELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL 355
           L  L L +N      +   + L+ L  L L  N        D       +    L+    
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW----VCDCRARPLWAW---LQKFRG 255

Query: 356 SDNQFGGELPHSIANLSLKMIELSVGRNQISG 387
           S ++    LP  +A   L      +  N + G
Sbjct: 256 SSSEVPCSLPQRLAGRDL----KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.2 bits (157), Expect = 6e-12
 Identities = 48/261 (18%), Positives = 81/261 (31%), Gaps = 11/261 (4%)

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFS 258
            + I +  N +      +    R L  L +  N  + +   +   ++ +E + L++N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 259 GIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK 318
                     L  L  L +         P      + L+ L L  N  +      F  L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
           NL  L L  N + +                SL  L L  N+     PH+  +L   M   
Sbjct: 154 NLTHLFLHGNRISSVPERAFR------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL- 206

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIP 438
            +  N +S      +  L  L    L  N +             LQ+    ++ +   +P
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP 265

Query: 439 SGLGNLTKLGSLDLGSNSLQG 459
             L          L +N LQG
Sbjct: 266 QRLAGRD---LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (143), Expect = 3e-10
 Identities = 58/290 (20%), Positives = 93/290 (32%), Gaps = 38/290 (13%)

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE 405
           +C    + ++        +P +   + L         N+IS       R   NL    L 
Sbjct: 17  SCPQQGLQAVPVG-----IPAASQRIFLH-------GNRISHVPAASFRACRNLTILWLH 64

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGI-PSGLGNLTKLGSLDLGSNSLQGNIPSS 464
            N          + L  L+QL + +N     + P+    L +L +L L    LQ   P  
Sbjct: 65  SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124

Query: 465 LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLD 524
                 L       N L                                  +L NL  L 
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTF-------------------------RDLGNLTHLF 159

Query: 525 ISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPE 584
           +  N+ S V         SL+ L +  N    V P +FR L  +  L + +NNLS    E
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219

Query: 585 FLENLSFLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCGGIDELH 634
            L  L  L++L L+ N +  +   + +++   K     +   C     L 
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 8e-09
 Identities = 40/210 (19%), Positives = 68/210 (32%), Gaps = 8/210 (3%)

Query: 97  VGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCA 156
           V  ++    +N         +P ++        L LS N         L   + L     
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 157 SNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTT 216
              +L          +L    LS +       LP     L A+ V+ ++ N L       
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQ---SLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLG 276
           L  L  L  L +  N+   + P  +     +E + L  N  + +    +L  L NL  L 
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPA-GLLNGLENLDTLL 178

Query: 277 IGGNNFVGSIPDSLSNASNLELLDLPSNQF 306
           +  N+   +IP     +  L    L  N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 38/219 (17%), Positives = 67/219 (30%), Gaps = 15/219 (6%)

Query: 240 SICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELL 299
            +  ++S   +   +   + + P D+     +   L +  N        +L   + L  L
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 300 DLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQ 359
           +L   +           L  L  L+L  N L +                S   L+     
Sbjct: 61  NLDRAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT----- 113

Query: 360 FGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISE 419
               LP        ++ EL +  N++    P  +     L   +L  N        +++ 
Sbjct: 114 ---SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170

Query: 420 LKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQ 458
           L+NL  L +  N L   IP G      L    L  N   
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 46/211 (21%), Positives = 75/211 (35%), Gaps = 7/211 (3%)

Query: 417 ISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIA 476
           +S++ +  +++     L   +P  L   T    L L  N L     ++L     L     
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPV 536
              +LT       L      L     ++    SLPL    L  L +LD+S N+ + +   
Sbjct: 63  DRAELTKLQVDGTLP----VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 537 TLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
            L     L+ L +  N    + P        ++ L++++NNL+      L  L  L+ L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 597 LSYNYFEGEVPVKGVFSNKTKISLHGNVKLC 627
           L  N                   LHGN  LC
Sbjct: 179 LQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 39/179 (21%), Positives = 59/179 (32%), Gaps = 4/179 (2%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
            T L+LS   +       +   + L  +NL  +       Q  G L  L  L LS+N   
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNL--DRAELTKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 139 GTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSA 198
                       L     S N+L       +  L +LQ L +  N L    P  +     
Sbjct: 91  SLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 199 IEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRF 257
           +E + +  N+L       L  L  L  L + EN      P+       +   FL  N +
Sbjct: 150 LEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 5e-08
 Identities = 43/252 (17%), Positives = 80/252 (31%), Gaps = 17/252 (6%)

Query: 79  LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFS 138
           LT  NL     G +LS  V      R        F      E  + FR++ + LSN+   
Sbjct: 7   LTGKNLHPDVTGRLLSQGVIAFRCPR-------SFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 139 G-TIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLP------- 190
             T+   LS+CS L +      +L   I   +     L RL++       +         
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 191 -DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVEL 249
              +  L+       TE  +   +      + +L      +N         +    ++  
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 250 IFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFV-GSIPDSLSNASNLELLDLPSNQFKG 308
           + L+++       F     L  L+ L +     +       L     L+ L +      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 309 KVSIDFSSLKNL 320
            + +   +L +L
Sbjct: 240 TLQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 40/278 (14%), Positives = 92/278 (33%), Gaps = 20/278 (7%)

Query: 299 LDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDN 358
           LDL        V+    S   +      ++ +    A          +   ++ + LS++
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHF-------SPFRVQHMDLSNS 56

Query: 359 QFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNL--ITFTLEVNQFHGTIPDV 416
                  H I +   K+  LS+   ++S  I   +    NL  +  +         +  +
Sbjct: 57  VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116

Query: 417 ISELKNLQQLSV------FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQN 470
           +S    L +L++          ++  +      +T+L       N  + ++ + +  C N
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176

Query: 471 LILFIASYNKLTGDLPQQLLSITTLSLVLDLSN-NLLNGSLPLQVGNLKNLVMLDISSNQ 529
           L+    S + +  +   Q          L LS    +     L++G +  L  L +    
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236

Query: 530 FSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKS 567
             G + +         +L I+ + F  +   +    K+
Sbjct: 237 PDGTLQLLKEAL---PHLQINCSHFTTIARPTIGNKKN 271

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 3e-06
 Identities = 34/242 (14%), Positives = 67/242 (27%), Gaps = 4/242 (1%)

Query: 236 MFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF-VGSIPDSLSNAS 294
           + P     + S  +I     R     P     +   ++ + +  +   V ++   LS  S
Sbjct: 12  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 71

Query: 295 NLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE--QNNLGTGTANDLDFVIFLSNCSSLKV 352
            L+ L L   +    +    +   NL  LNL              L     L   +    
Sbjct: 72  KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131

Query: 353 LSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGT 412
              ++      + H    ++   +       Q S       R    +     +       
Sbjct: 132 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 191

Query: 413 IPDVISELKNLQQLSVFN-NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
                 +L  LQ LS+     +       LG +  L +L +      G +        +L
Sbjct: 192 CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 251

Query: 472 IL 473
            +
Sbjct: 252 QI 253

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 1e-05
 Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 4/101 (3%)

Query: 449 SLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG 508
           +LDL   +L  ++   L +   +                +  S   +   +DLSN+++  
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQGVIAFRCP--RSFMDQPLAEHFSPFRVQ-HMDLSNSVIEV 60

Query: 509 -SLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLD 548
            +L   +     L  L +   + S  I  TL+   +L  L+
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.7 bits (118), Expect = 7e-08
 Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 6/109 (5%)

Query: 498 VLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGV 557
           VL L++  L  ++   +  L  +  LD+S N+   + P  L+    LE L  S N+   V
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 558 IPLSFRFLKSIKALNVSSNNL-SGKIPEFLENLSFLEFLNLSYNYFEGE 605
                  L  ++ L + +N L      + L +   L  LNL  N    E
Sbjct: 59  DG--VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.7 bits (105), Expect = 4e-06
 Identities = 28/128 (21%), Positives = 46/128 (35%), Gaps = 10/128 (7%)

Query: 424 QQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTG 483
           + L + +  L   +   L  L  +  LDL  N L+   P+ L   + L +  AS N L  
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57

Query: 484 DLPQQLLSITTLSLVLDLSNNLLNG-SLPLQVGNLKNLVMLDISSNQFS---GVIPVTLS 539
                 L        L L NN L   +    + +   LV+L++  N      G+      
Sbjct: 58  VDGVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 540 TCVSLEYL 547
              S+  +
Sbjct: 115 MLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 7/124 (5%)

Query: 450 LDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGS 509
           L L    L   +   L     +     S+N+L    P    ++  L  +  L  +     
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56

Query: 510 LPLQVGNLKNLVMLDISSNQFSGVIPV-TLSTCVSLEYLDISINSFYGVIPLSFRFLKSI 568
               V NL  L  L + +N+      +  L +C  L  L++  NS      +  R  + +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 569 KALN 572
            +++
Sbjct: 117 PSVS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 19/107 (17%), Positives = 44/107 (41%), Gaps = 6/107 (5%)

Query: 82  LNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI 141
           L+L+ + +  +   ++  L  + +++L+ N  R   P  +  L  LE L    +  +   
Sbjct: 3   LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNALEN 57

Query: 142 PTNLSRCSNLIHFCASNNKLEG-QIPKEIGNLLKLQRLSVDINYLTG 187
              ++    L      NN+L+     + + +  +L  L++  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 41/217 (18%), Positives = 70/217 (32%), Gaps = 21/217 (9%)

Query: 395 NLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS 454
            L N I      +    T+    ++L  +  LS F   +      G+  L  L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 455 NSLQGNIPSS------LGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG 508
           N +    P                L   S       +    L+ T ++ V  L+      
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 509 SLPLQVGNLKNLVMLDI-------SSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLS 561
            L L +  + N+  L         S           L+    L  L    N    + PL+
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192

Query: 562 FRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLS 598
              L ++  +++ +N +S   P  L N S L  + L+
Sbjct: 193 S--LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 3e-07
 Identities = 36/221 (16%), Positives = 74/221 (33%), Gaps = 24/221 (10%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
            L+    I    +     + Q   +L  +  L+      +      +   +NLI     +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           N++    P +    +    LS +       +       +         +       + L 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 219 LLRRLVNLNVAENQFSGMFPR--------------SICNISSVELIFLTENRFSGIFPFD 264
           +L   +N     +  +G+                  + N+S +  +   +N+ S I P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192

Query: 265 ILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQ 305
              +LPNL ++ +  N      P  L+N SNL ++ L +NQ
Sbjct: 193 ---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 36/220 (16%), Positives = 68/220 (30%), Gaps = 20/220 (9%)

Query: 260 IFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSID-FSSLK 318
           IFP      L N  K+  G +N   ++  + ++   +  L           +I+    L 
Sbjct: 12  IFP---DPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---TIEGVQYLN 63

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIEL 378
           NL  L L+ N +           I     S   + ++S       +       +      
Sbjct: 64  NLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 379 SVGRNQISGTIPPGIRNLVNLITFTLEVNQFHG-------TIPDVISELKNLQQLSVFNN 431
            +        +   +  + N+       N  +        +    ++ L  L  L   +N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 432 FLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL 471
            +    P  L +L  L  + L +N +    P  L N  NL
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 39/244 (15%), Positives = 79/244 (32%), Gaps = 29/244 (11%)

Query: 286 IPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLS 345
            PD     +N   +    +     V+   + L  +  L+     +       ++    + 
Sbjct: 13  FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEG---VQ 60

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLE 405
             ++L  L L DNQ     P        ++         +S          ++L +  + 
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120

Query: 406 VNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSL 465
                  + ++     +L Q++  +                     L   + Q +  + L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQ-----------YLSIGNAQVSDLTPL 169

Query: 466 GNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDI 525
            N   L    A  NK++   P  L S+  L   + L NN ++   PL   N  NL ++ +
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNLI-EVHLKNNQISDVSPL--ANTSNLFIVTL 224

Query: 526 SSNQ 529
            +NQ
Sbjct: 225 -TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 38/233 (16%), Positives = 78/233 (33%), Gaps = 26/233 (11%)

Query: 220 LRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG 279
           L   + +   ++  +    ++  ++  +  +       + I   + +  L NL  L +  
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI---EGVQYLNNLIGLELKD 72

Query: 280 NNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD 339
           N         L+   NL  +           ++   +           +   T       
Sbjct: 73  NQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT------- 120

Query: 340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNL 399
            V  L+  S+L+VL L  NQ       +I+ L+       +       +    + NL  L
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQI-----TNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175

Query: 400 ITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDL 452
            T   + N+     P  ++ L NL ++ + NN +    P  L N + L  + L
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 33/229 (14%), Positives = 71/229 (31%), Gaps = 22/229 (9%)

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSL--KMIELSVG 381
            L          +++   +  ++   +  LS            +I  +     +I L + 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGV-----TTIEGVQYLNNLIGLELK 71

Query: 382 RNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGL 441
            NQI+   P      +  +  +    +    I  + S        +   +       S L
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 442 GNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDL 501
             L                I +         L   S           L +++ L+ +   
Sbjct: 132 QVL----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL-KA 180

Query: 502 SNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
            +N ++   PL   +L NL+ + + +NQ S V P  L+   +L  + ++
Sbjct: 181 DDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 31/214 (14%), Positives = 65/214 (30%), Gaps = 21/214 (9%)

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
             I+++ G++ ++ T+     +L  + T +        TI   +  L NL  L + +N +
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75

Query: 434 RGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSIT 493
               P           L          I          +      +         L  + 
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135

Query: 494 TLSLVLDLSNNLL-------------NGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLST 540
                +   + L                S    + NL  L  L    N+ S + P  L++
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 541 CVSLEYLDISINSFYGVIPLSFRFLKSIKALNVS 574
             +L  + +  N    V PL+     ++  + ++
Sbjct: 194 LPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 8e-07
 Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 9/91 (9%)

Query: 407 NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG 466
           N     I  +     +L++L+V NN L   +P+    L +L       N L   +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLA-EVPELPQ 324

Query: 467 NCQNLILFIASYNKLTGDLPQQLLSITTLSL 497
           N + L +    YN L    P    S+  L +
Sbjct: 325 NLKQLHV---EYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 19/92 (20%), Positives = 37/92 (40%), Gaps = 10/92 (10%)

Query: 429 FNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQ 488
           + N     I S       L  L++ +N L   +P+     + LI    S+N L  ++P+ 
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIA---SFNHLA-EVPEL 322

Query: 489 LLSITTLSLVLDLSNNLLNGSLPLQVGNLKNL 520
             ++      L +  N L    P    ++++L
Sbjct: 323 PQNLKQ----LHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 4e-06
 Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 9/96 (9%)

Query: 501 LSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPL 560
              N  +  +        +L  L++S+N+    +P        LE L  S N     +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHL-AEVP- 320

Query: 561 SFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLN 596
                +++K L+V  N L  + P+  E++  L   +
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 7e-06
 Identities = 20/88 (22%), Positives = 36/88 (40%), Gaps = 10/88 (11%)

Query: 337 DLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNL 396
             +         SL+ L++S+N+   ELP     L      L    N ++  +P   +NL
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE----RLIASFNHLA-EVPELPQNL 326

Query: 397 VNLITFTLEVNQFHGTIPDVISELKNLQ 424
             L    +E N      PD+   +++L+
Sbjct: 327 KQL---HVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 3e-05
 Identities = 18/128 (14%), Positives = 32/128 (25%), Gaps = 9/128 (7%)

Query: 49  HDPSGVTSSWNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINL 108
            D                            L             +         L  +N+
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291

Query: 109 ADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKE 168
           ++N    ++P     L   E+L  S N  +  +P       NL       N L  + P  
Sbjct: 292 SNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFPDI 342

Query: 169 IGNLLKLQ 176
             ++  L+
Sbjct: 343 PESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 20/74 (27%), Positives = 31/74 (41%), Gaps = 9/74 (12%)

Query: 374 KMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFL 433
            + EL+V  N++   +P     L  LI      N     +P+     +NL+QL V  N L
Sbjct: 285 SLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPE---LPQNLKQLHVEYNPL 336

Query: 434 RGGIPSGLGNLTKL 447
           R   P    ++  L
Sbjct: 337 R-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.001
 Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 16/82 (19%)

Query: 294 SNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVL 353
            +LE L++ +N+      +  +    L  L    N+L                  +LK L
Sbjct: 284 PSLEELNVSNNKLI---ELP-ALPPRLERLIASFNHLAE----------VPELPQNLKQL 329

Query: 354 SLSDNQFGG--ELPHSIANLSL 373
            +  N      ++P S+ +L +
Sbjct: 330 HVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 8/76 (10%)

Query: 255 NRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDF 314
              S      +    P+L++L +  N  +  +P        LE L    N       +  
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA---EVP- 320

Query: 315 SSLKNLWLLNLEQNNL 330
              +NL  L++E N L
Sbjct: 321 ELPQNLKQLHVEYNPL 336

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 19/95 (20%), Positives = 28/95 (29%), Gaps = 5/95 (5%)

Query: 290 LSNASNLELLDLPSNQFKGKVSIDFSS----LKNLWLLNLEQNNLGTGTANDLDFVIFLS 345
               S L +L L             ++      +L  L+L  N LG      L       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423

Query: 346 NCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSV 380
               L+ L L D  +  E+   +  L      L V
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 9/97 (9%)

Query: 58  WNNTMNFCQWTGVTCGHRHQRLTELNLSSQRIGGV----LSPYVGNLSFLRYINLADNGF 113
                   +      G     L  L L+   +       L+  +     LR ++L++N  
Sbjct: 350 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 409

Query: 114 RGDIPQEIGNLFR-----LEKLALSNNSFSGTIPTNL 145
                 ++    R     LE+L L +  +S  +   L
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 9/96 (9%)

Query: 110 DNGFRGDIPQEIGNLFRLEKLALSNNSFSGT----IPTNLSRCSNLIHFCASNNKLEGQI 165
           D G R            L  L L++   S +    +   L    +L     SNN L    
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 166 PKEIGNLLK-----LQRLSVDINYLTGQLPDSVGNL 196
             ++   ++     L++L +   Y + ++ D +  L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 9e-05
 Identities = 12/69 (17%), Positives = 20/69 (28%), Gaps = 5/69 (7%)

Query: 542 VSLEYLDISINSFYGV-IPLSFRFLKSIKALNVSSNNLSGK----IPEFLENLSFLEFLN 596
           + ++ LDI                L+  + + +    L+      I   L     L  LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 597 LSYNYFEGE 605
           L  N     
Sbjct: 62  LRSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 9e-05
 Identities = 14/94 (14%), Positives = 28/94 (29%), Gaps = 10/94 (10%)

Query: 519 NLVMLDISSNQFSGV-IPVTLSTCVSLEYLDISINSF----YGVIPLSFRFLKSIKALNV 573
           ++  LDI   + S       L      + + +            I  + R   ++  LN+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 574 SSNNLSGKIPEFL-----ENLSFLEFLNLSYNYF 602
            SN L       +          ++ L+L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 14/79 (17%), Positives = 26/79 (32%), Gaps = 9/79 (11%)

Query: 538 LSTCVSLEYLDISINSF----YGVIPLSFRFLKSIKALNVSSNNLSGKIPEFL-----EN 588
                 L  L ++           +  +     S++ L++S+N L       L     + 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 589 LSFLEFLNLSYNYFEGEVP 607
              LE L L   Y+  E+ 
Sbjct: 425 GCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 9/91 (9%), Positives = 27/91 (29%), Gaps = 5/91 (5%)

Query: 103 LRYINLADNGFR-GDIPQEIGNLFRLEKLALSNNSFSG----TIPTNLSRCSNLIHFCAS 157
           ++ +++           + +  L + + + L +   +      I + L     L      
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 158 NNKLEGQIPKEIGNLLKLQRLSVDINYLTGQ 188
           +N+L       +   L+     +    L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 11/83 (13%), Positives = 24/83 (28%), Gaps = 4/83 (4%)

Query: 252 LTENRFSGIFPFDILLNLPNLKKLGIGGNNF----VGSIPDSLSNASNLELLDLPSNQFK 307
           +     S     ++L  L   + + +            I  +L     L  L+L SN+  
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 308 GKVSIDFSSLKNLWLLNLEQNNL 330
                            +++ +L
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)

Query: 343 FLSNCSSLKVLSLSDNQFGGELPHSIANL---SLKMIELSVGRNQISGTIPPGI-----R 394
                S L+VL L+D         S+A     +  + EL +  N +       +     +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 395 NLVNLITFTLEVNQFHGTIPDVISEL-KNLQQLSVF 429
               L    L    +   + D +  L K+   L V 
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 7/88 (7%)

Query: 79  LTELNLSSQRIGGV-LSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFR----LEKLALS 133
           +  L++  + +     +  +  L   + + L D G      ++I +  R    L +L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 134 NNSFSGTIPTNLSRCSNLIHFCASNNKL 161
           +N         +     L        KL
Sbjct: 64  SNELGDVGVHCV--LQGLQTPSCKIQKL 89

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 16/83 (19%), Positives = 29/83 (34%), Gaps = 9/83 (10%)

Query: 516 NLKNLVMLDISSNQFSGV----IPVTLSTCVSLEYLDISINSFYGVIPLSF-----RFLK 566
               L +L ++    S      +  TL    SL  LD+S N       L       +   
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 567 SIKALNVSSNNLSGKIPEFLENL 589
            ++ L +     S ++ + L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 17/95 (17%), Positives = 31/95 (32%), Gaps = 6/95 (6%)

Query: 271 NLKKLGIGGNNFVGS-IPDSLSNASNLELLDLPSNQFKGKVSIDFSS----LKNLWLLNL 325
           +++ L I       +   + L      +++ L           D SS       L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 326 EQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQF 360
             N LG    + +      +    ++ LSL +   
Sbjct: 63  RSNELGDVGVHCV-LQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 12/77 (15%), Positives = 28/77 (36%), Gaps = 5/77 (6%)

Query: 397 VNLITFTLEVNQF-HGTIPDVISELKNLQQLSVFNNFLRG----GIPSGLGNLTKLGSLD 451
           +++ +  ++  +       +++  L+  Q + + +  L       I S L     L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 452 LGSNSLQGNIPSSLGNC 468
           L SN L       +   
Sbjct: 62  LRSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 11/87 (12%), Positives = 25/87 (28%), Gaps = 5/87 (5%)

Query: 499 LDLS-NNLLNGSLPLQVGNLKNLVMLDISSNQFSGV----IPVTLSTCVSLEYLDISINS 553
           LD+    L +      +  L+   ++ +     +      I   L    +L  L++  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 554 FYGVIPLSFRFLKSIKALNVSSNNLSG 580
              V            +  +   +L  
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 5e-04
 Identities = 11/90 (12%), Positives = 32/90 (35%), Gaps = 8/90 (8%)

Query: 319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANL---SLKM 375
           ++  L+++   L      D  +   L      +V+ L D          I++    +  +
Sbjct: 3   DIQSLDIQCEELS-----DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 376 IELSVGRNQISGTIPPGIRNLVNLITFTLE 405
            EL++  N++       +   +   +  ++
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 6e-04
 Identities = 12/83 (14%), Positives = 28/83 (33%), Gaps = 9/83 (10%)

Query: 477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNG----SLPLQVGNLKNLVMLDISSNQFSG 532
              +L+     +LL +     V+ L +  L       +   +     L  L++ SN+   
Sbjct: 10  QCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69

Query: 533 VIPVTL-----STCVSLEYLDIS 550
           V    +     +    ++ L + 
Sbjct: 70  VGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 16/85 (18%), Positives = 23/85 (27%), Gaps = 9/85 (10%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFR----LEKLALSNNSFSGTIPTNLSR-----CS 149
             S LR + LAD          +         L +L LSNN         L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 150 NLIHFCASNNKLEGQIPKEIGNLLK 174
            L      +     ++   +  L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 17/94 (18%), Positives = 32/94 (34%), Gaps = 9/94 (9%)

Query: 443 NLTKLGSLDLGSNSLQGN----IPSSLGNCQNLILFIASYNKLTGDLPQQLLSI----TT 494
             + L  L L    +  +    + ++L    +L     S N L      QL+        
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 495 LSLVLDLSNNLLNGSLPLQVGNL-KNLVMLDISS 527
           L   L L +   +  +  ++  L K+   L + S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 18/91 (19%), Positives = 33/91 (36%), Gaps = 15/91 (16%)

Query: 498 VLDLSNNLLNG----SLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCV-----SLEYLD 548
           VL L++  ++     SL   +    +L  LD+S+N       + L   V      LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 549 ISINSFYGVIPLSFRFLKSIKALNVSSNNLS 579
           +    +   +         ++AL     +L 
Sbjct: 433 LYDIYWSEEME------DRLQALEKDKPSLR 457

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 31/188 (16%), Positives = 70/188 (37%), Gaps = 11/188 (5%)

Query: 345 SNCS-SLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIR-NLVNLITF 402
           + C      +  +      E+P    ++ L   EL +  N++      G+   L +L+  
Sbjct: 4   AMCHCEGTTVDCTGRGLK-EIP---RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKL 59

Query: 403 TLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIP 462
            L+ NQ  G  P+      ++Q+L +  N ++         L +L +L+L  N +   +P
Sbjct: 60  ELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119

Query: 463 SSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVM 522
            S  +  +L     + N    +      +         L+        P     ++++ +
Sbjct: 120 GSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAP---SKVRDVQI 174

Query: 523 LDISSNQF 530
            D+  ++F
Sbjct: 175 KDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.6 bits (101), Expect = 3e-05
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 9/177 (5%)

Query: 132 LSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEI-GNLLKLQRLSVDINYLTGQLP 190
            +       IP ++    +      ++N+L       + G L  L +L +  N LTG  P
Sbjct: 15  CTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71

Query: 191 DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELI 250
           ++    S I+ +++ EN +          L +L  LN+ +NQ S + P S  +++S+  +
Sbjct: 72  NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131

Query: 251 FLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK 307
            L  N F+              K L   G       P  + +   +++ DLP ++FK
Sbjct: 132 NLASNPFNCNCHLAWFAEWLRKKSLN--GGAARCGAPSKVRD---VQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 28/171 (16%), Positives = 53/171 (30%), Gaps = 35/171 (20%)

Query: 65  CQWTGVTCGHRH---------QRLTELNLSSQRIGGVL-SPYVGNLSFLRYIN------- 107
           C+ T V C  R             TEL L+   +G +      G L  L  +        
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 108 -----------------LADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSN 150
                            L +N  +    +    L +L+ L L +N  S  +P +    ++
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 151 LIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEV 201
           L     ++N               L++ S++        P  V ++   ++
Sbjct: 128 LTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDL 177

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 35/204 (17%), Positives = 65/204 (31%), Gaps = 17/204 (8%)

Query: 395 NLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS 454
                I   L+       +    +EL ++ Q+   N+ ++     G+  L  +  L L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 455 NSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV 514
           N L    P  L N +NL       NK+      + L       +     + +NG + L  
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 515 GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVS 574
                L    I+       +    +  +    +   +             L  ++ L +S
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP---------LAGLTKLQNLYLS 186

Query: 575 SNNLSGKIPEFLENLSFLEFLNLS 598
            N++S      L  L  L+ L L 
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 8e-05
 Identities = 31/207 (14%), Positives = 66/207 (31%), Gaps = 18/207 (8%)

Query: 99  NLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN 158
             +     NL        + Q    L  ++++  +N+         +    N+     + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLG 218
           NKL    P        L  L         +      +         + +     I    G
Sbjct: 78  NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129

Query: 219 LLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIG 278
           L+      ++            +  ++ ++ + L +N+ S I P      L  L+ L + 
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLS 186

Query: 279 GNNFVGSIPDSLSNASNLELLDLPSNQ 305
            N+   S   +L+   NL++L+L  +Q
Sbjct: 187 KNHI--SDLRALAGLKNLDVLEL-FSQ 210

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 5e-05
 Identities = 46/333 (13%), Positives = 89/333 (26%), Gaps = 33/333 (9%)

Query: 323 LNLEQNNLGTGTANDLD-FVIFLSNCSSLKVLSLSDNQFGGELPHSIA-----NLSLKMI 376
            +L+ + +   T  D       L    S+K + LS N  G E    ++        L++ 
Sbjct: 8   KSLKLDAI---TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 377 ELS-VGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG 435
           E S +   ++   IP  +R L+  +    +++    +        +      +  +    
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 436 GIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTL 495
            +      L       +     +  +     N   L   I   N+L     ++       
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 496 SLVLDLSNN-----------------LLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTL 538
             +L                      L        +    N      SS     +     
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244

Query: 539 STCVSLEYLDISINSFYGVI-PLSFRFLKSIKALNVSSNNLSGKIPEFL-----ENLSFL 592
              + L    +S      V+   S      ++ L +  N +       L     E +  L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304

Query: 593 EFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVK 625
            FL L+ N F  E  V             G + 
Sbjct: 305 LFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 5e-04
 Identities = 38/312 (12%), Positives = 81/312 (25%), Gaps = 27/312 (8%)

Query: 77  QRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGD----IPQEIGNLFRLEKLAL 132
           + L    ++++    V +  +     ++ I L+ N    +    + + I +   LE    
Sbjct: 8   KSLKLDAITTEDEKSVFAV-LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 133 SNNS---FSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQL 189
           S+         IP  L      +  C   + +            +     +  +     L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 190 PDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVEL 249
                 L      +I        +         L ++    N+      +          
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 250 IFLTENRFSGIFPFDILLNLPNL------------KKLGIGGNNFVGSIPDSLSNASNLE 297
           +  T          + + +L                +     +    ++  +L +  NL 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 298 LLDLPSNQFKGKVS------IDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLK 351
            L L       + +              L  L L+ N +       L  VI       L 
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID-EKMPDLL 305

Query: 352 VLSLSDNQFGGE 363
            L L+ N+F  E
Sbjct: 306 FLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 9e-04
 Identities = 40/349 (11%), Positives = 100/349 (28%), Gaps = 41/349 (11%)

Query: 103 LRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSG----TIPTNLSRCSNLIHFCASN 158
           L+   +     +  +   +     ++++ LS N+        +  N++   +L     S+
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 159 N---KLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPT 215
               +++ +IP+ +  LL+       ++ +               +  +++++    +  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 216 TLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKL 275
               L       +A         +   N   +  I    NR       +      + + L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 276 GIGGNNFVGSIPDSLSNASNLELLDLPS------------NQFKGKVSIDFSSLKNLWLL 323
                   G  P+ + +     L                 +     ++I   S  NL  L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRN 383
            L    L    A  +           L+ L L  N+   +   ++  +  +         
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE--------- 299

Query: 384 QISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNF 432
                       + +L+   L  N+F     DV+ E++ +         
Sbjct: 300 -----------KMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGEL 336

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 0.001
 Identities = 41/309 (13%), Positives = 97/309 (31%), Gaps = 25/309 (8%)

Query: 246 SVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNF----VGSIPDSLSNASNLELLDL 301
           S++L  +T      +F   +LL   ++K++ + GN         + +++++  +LE+ + 
Sbjct: 9   SLKLDAITTEDEKSVF--AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 302 PSNQFKGKVSIDFSSLKNLW-----LLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS 356
                         +L+ L         L    L             +   S    L   
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 357 DNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDV 416
                G  P + A ++  + EL+V +   +      I    N +                
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 417 ISELKNLQQLSVFNNFLRGGIPSGLGNLTKL----GSLDLGSNSLQGNIPSSLGNCQNLI 472
           +     + Q  +    +   +  GL    +L       +  ++     +  +L +  NL 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 473 LFIASYNKLTGDLPQQLLSITTLS-----LVLDLSNNLLNGSLPLQV-----GNLKNLVM 522
               +   L+      ++   +         L L  N +       +       + +L+ 
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 523 LDISSNQFS 531
           L+++ N+FS
Sbjct: 307 LELNGNRFS 315

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 32/246 (13%), Positives = 61/246 (24%), Gaps = 22/246 (8%)

Query: 65  CQWTGVTCGHRHQRLTEL--NLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIG 122
           C      C  +  ++TE+  +L                     +       R        
Sbjct: 8   CSNRVFLC--QESKVTEIPSDLPRN---------------AIELRFVLTKLRVIQKGAFS 50

Query: 123 NLFRLEKLALSNNSFSGTIPTNLSRCSNLIH--FCASNNKLEGQIPKEIGNLLKLQRLSV 180
               LEK+ +S N     I  ++      +H       N L    P+   NL  LQ L +
Sbjct: 51  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 110

Query: 181 DINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRS 240
               +         +     ++ I +N     I     +     ++ +  N+       +
Sbjct: 111 SNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 170

Query: 241 ICNISSVELIFLTEN-RFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELL 299
                +        +       P D+         L I            L N   L   
Sbjct: 171 CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230

Query: 300 DLPSNQ 305
              + +
Sbjct: 231 STYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 12/77 (15%), Positives = 23/77 (29%)

Query: 522 MLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGK 581
           +L ++ N    +     +     E      N+   +    F        L++S   +   
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216

Query: 582 IPEFLENLSFLEFLNLS 598
               LENL  L   +  
Sbjct: 217 PSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 7/36 (19%), Positives = 10/36 (27%)

Query: 515 GNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDIS 550
                 V+LDIS  +   +    L     L      
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	914
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.76
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.49
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.43
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.31
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.57
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.56
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.59
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.46
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.34
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.28
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.34
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.96
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.37

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=2.7e-45  Score=398.02  Aligned_cols=293  Identities=28%  Similarity=0.457  Sum_probs=269.6

Q ss_pred             CCCHhHHHHHHHHHHhcCCCCCCCCCCCCCCCCCC--ccceeecCCC--CceEEEecCCCCCcc--ccCCCCCCCCCCCE
Q 042766           32 QTNETDRLALLAIKSQLHDPSGVTSSWNNTMNFCQ--WTGVTCGHRH--QRLTELNLSSQRIGG--VLSPYVGNLSFLRY  105 (914)
Q Consensus        32 ~~~~~~~~aLl~~k~~~~~~~~~~~~w~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~~  105 (914)
                      .|.|+|++||++||+++.||. .+++|..++|||.  |.||+|+..+  +||++|||+++++.|  .+|+.+++|++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence            488999999999999998775 6789998899994  9999998754  489999999999988  58899999999999


Q ss_pred             EEcCC-CCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccccccc
Q 042766          106 INLAD-NGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINY  184 (914)
Q Consensus       106 L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (914)
                      |+|++ |+++|.+|.+|++|++|++|||++|++++..|..+..+.+|+++++++|++.+.+|..++++++|+++++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99997 89999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCccccccccc-ceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccc
Q 042766          185 LTGQLPDSVGNLSAI-EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPF  263 (914)
Q Consensus       185 l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  263 (914)
                      ++|.+|+.+..+..+ +.+++++|++++..|..++.+..+ .+++++|.+.+.+|..+..+++++.+++++|.+++.+|.
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~  239 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK  239 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            999999999998886 889999999999999999887655 699999999999999999999999999999999987653


Q ss_pred             cccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCc
Q 042766          264 DILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNN  329 (914)
Q Consensus       264 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  329 (914)
                        +..+++|++|+|++|+++|.+|+.|+++++|++|||++|+|+|.+|. +.++++|+.+++++|+
T Consensus       240 --~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         240 --VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             --CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             --cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence              45789999999999999999999999999999999999999988874 6788888888888886

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-42  Score=359.83  Aligned_cols=191  Identities=23%  Similarity=0.323  Sum_probs=163.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++..     .+..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            468999999999999999999999999999999997543 2344678999999999999999999999654     4588


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++...      ..+++.++..++.|+++||+|||++   +||||||||+|||++.++.+||+|||+
T Consensus        79 ~ivmEy~~gg~L~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence            9999999999999998654      4689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+........      ......+||+.|||||++.     +.++||||+||++|||+
T Consensus       150 a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml  200 (271)
T d1nvra_         150 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML  200 (271)
T ss_dssp             CEECEETTEE------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred             heeeccCCcc------ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH
Confidence            9876543211      1123468999999999984     47799999999999973

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=358.92  Aligned_cols=187  Identities=24%  Similarity=0.351  Sum_probs=166.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++..     .+..|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            479999999999999999999999999999999987766667889999999999999999999999654     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||++||+|.+++.+       ..+++.++..++.||+.||+|||++   +||||||||+|||++.++++||+|||+|+
T Consensus        95 vmEy~~gg~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEECCTTCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            9999999999998764       3589999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .+.....        .....+||+.|||||++.    +.++||||+||++|+|+
T Consensus       165 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyeml  210 (293)
T d1yhwa1         165 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI  210 (293)
T ss_dssp             ECCSTTC--------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHH
T ss_pred             eeccccc--------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHh
Confidence            7643221        123457999999999994    58999999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-41  Score=351.83  Aligned_cols=186  Identities=22%  Similarity=0.379  Sum_probs=164.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++...   +....+.+.+|++++++++|||||++++++..     .+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence            5799999999999999999999999999999999643   34456788999999999999999999999653     457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...      ..+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             EEEEEeecCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence            89999999999999999764      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+......          ....+||+.|||||++.    +.++||||+||++|||+
T Consensus       152 ~a~~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell  198 (263)
T d2j4za1         152 WSVHAPSSR----------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL  198 (263)
T ss_dssp             SCSCCCCCC----------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             eeeecCCCc----------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence            998654321          22457999999999995    58999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-41  Score=357.63  Aligned_cols=189  Identities=22%  Similarity=0.341  Sum_probs=166.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      +.|++.+.||+|+||+||+|+++.+++.||||+++.......+.+.+|++++++++|||||++++++..     .+..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            468999999999999999999999999999999987766677889999999999999999999999654     347899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      |||||++|+|.+++.+.+     ..+++.++..++.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+
T Consensus        87 vmEy~~~g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence            999999999999986543     4689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh---------hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---------~~~~Di~s~g~~~~~~f  914 (914)
                      .......        .....+||+.|||||++.         +.++||||+||++|||+
T Consensus       159 ~~~~~~~--------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml  209 (288)
T d2jfla1         159 KNTRTIQ--------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA  209 (288)
T ss_dssp             ECHHHHH--------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH
T ss_pred             ccCCCcc--------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh
Confidence            6543211        112357999999999982         57899999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-41  Score=354.48  Aligned_cols=190  Identities=23%  Similarity=0.372  Sum_probs=163.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   +....+.+.+|++++++++|||||++++++.     ..+.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            5799999999999999999999999999999999743   2445578999999999999999999999954     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+||||++||+|.+++...      ..+++.++..++.|++.||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEccCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence            89999999999999998765      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+......      ......+||+.|||||++.    +.++||||+||++|||+
T Consensus       154 ~a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell  204 (288)
T d1uu3a_         154 TAKVLSPESKQ------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV  204 (288)
T ss_dssp             TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cceecccCCcc------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence            99876532211      1222457999999999995    58999999999999973

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=353.39  Aligned_cols=197  Identities=24%  Similarity=0.355  Sum_probs=154.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...  +...+.+.+|++++++++|||||++++++...   .....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            58999999999999999999999999999999997543  23346789999999999999999999987532   23467


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC--QPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~--~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      |+|||||++|+|.+++.+...  ....+++..++.++.|++.||+|||++.  ..+||||||||+|||++.++.+||+||
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF  158 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  158 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred             EEEEecCCCCcHHHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence            999999999999999875321  2257999999999999999999999861  124999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+.....        .....+||+.|||||++.    +.++||||+||++|||+
T Consensus       159 G~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~  208 (269)
T d2java1         159 GLARILNHDTS--------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC  208 (269)
T ss_dssp             HHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeecccCCC--------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh
Confidence            99987643211        122467999999999994    58999999999999973

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-41  Score=363.15  Aligned_cols=187  Identities=23%  Similarity=0.350  Sum_probs=163.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++... ....+++.+|++++++++|||||++++++..     ....
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-----SSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEE
Confidence            468999999999999999999999999999999997543 3445688999999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      ++||||++||+|.+++.+.      ..+++..+..++.|++.||+|||+ +   +|+||||||+|||++.+|++||+|||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG  150 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG  150 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence            9999999999999999765      368999999999999999999996 5   89999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+.+..          ....+||+.|||||++.    +.++||||+||++|||+
T Consensus       151 la~~~~~~~----------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell  197 (322)
T d1s9ja_         151 VSGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA  197 (322)
T ss_dssp             CCHHHHHHT----------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred             CccccCCCc----------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence            998754321          12368999999999995    58999999999999984

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-41  Score=354.87  Aligned_cols=192  Identities=24%  Similarity=0.489  Sum_probs=166.1

Q ss_pred             HhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ..++|++.+.||+|+||+||+|+++.+++.||||+++.. ....+++.+|++++++++|||||+++++|..     .+..
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee-----CCee
Confidence            346899999999999999999999999999999998643 3456789999999999999999999999643     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+++|+|.+++.....    ..+++..+..|+.||++||+|||++   +||||||||+|||++.++.+||+|||+
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~  161 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGL  161 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred             EEEeecccCcchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccc
Confidence            999999999999999976432    5789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.......       .......||+.|||||++.    +.++|||||||++|||+
T Consensus       162 a~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell  210 (287)
T d1opja_         162 SRLMTGDTY-------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA  210 (287)
T ss_dssp             TTTCCSSSS-------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             eeecCCCCc-------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHH
Confidence            987643221       1222456899999999985    58999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-40  Score=344.66  Aligned_cols=190  Identities=25%  Similarity=0.411  Sum_probs=160.6

Q ss_pred             ccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          707 FSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       707 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      |+..+.||+|+||+||+|++..+++.||+|++....  ....+.+.+|++++++++|||||++++++.... .+....++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            356678999999999999999999999999997543  334567899999999999999999999875432 33457899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec-CCCcEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD-YDMVAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~-~~~~~ki~DFGla  863 (914)
                      ||||+++|+|.+++.+.      ..+++.++..++.||++||+|||++ .++||||||||+|||++ +++.+||+|||+|
T Consensus        90 vmE~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEeCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            99999999999999764      4689999999999999999999998 12399999999999996 5789999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh---hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF---MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~---~~~~Di~s~g~~~~~~f  914 (914)
                      +.....          .....+||+.|||||++.   +.++||||+||++|||+
T Consensus       163 ~~~~~~----------~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~  206 (270)
T d1t4ha_         163 TLKRAS----------FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMA  206 (270)
T ss_dssp             GGCCTT----------SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHH
T ss_pred             eeccCC----------ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHH
Confidence            854321          122467999999999995   58999999999999983

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=348.70  Aligned_cols=188  Identities=29%  Similarity=0.477  Sum_probs=156.3

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||+||+|++++   .||||+++..  +....+.|.+|++++++++|||||++++++..      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            4679999999999999999998753   4999999744  34456789999999999999999999998643      24


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|+|.+++...+     ..+++.++..|+.||++||+|||++   +||||||||+|||++.++.+||+|||
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG  149 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG  149 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred             EEEEEecCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence            689999999999999997653     4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +|+........      .......||+.|||||++.       +.++|||||||++|||+
T Consensus       150 la~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~  203 (276)
T d1uwha_         150 LATVKSRWSGS------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM  203 (276)
T ss_dssp             CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeeccccCCc------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence            99876432211      1123467999999999984       57889999999999984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-40  Score=352.32  Aligned_cols=184  Identities=26%  Similarity=0.338  Sum_probs=160.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      +.|+..+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|++++++++|||||++++++...     +.
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~   89 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT   89 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence            459999999999999999999999999999999975443   2335788999999999999999999996543     47


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++|||||++|++..++...      ..+++.++..++.||+.||.|||++   +||||||||+|||++.++.+||+|||
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG  160 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG  160 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             EEEEEEecCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence            89999999999998776544      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-------hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-------MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-------~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.....            ...+||+.|||||++.       +.++||||+||++|||+
T Consensus       161 ~a~~~~~~------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~  208 (309)
T d1u5ra_         161 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA  208 (309)
T ss_dssp             TCBSSSSB------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             cccccCCC------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH
Confidence            99864321            2357999999999983       46899999999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=353.32  Aligned_cols=188  Identities=25%  Similarity=0.304  Sum_probs=165.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|++++++++||||+++++++.     ..+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----ccc
Confidence            36899999999999999999999999999999999743   3445678899999999999999999999954     445


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..|+|||||+||+|.+++...      ..+++..+..++.|++.||+|||++   +||||||||+|||++.+|.+||+||
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccceeccCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence            899999999999999999865      4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchh----hhhhcccCccccccccc
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHH  913 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~  913 (914)
                      |+|+......        ......+||+.|||||++    ++.++|+||+||++|||
T Consensus       150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyem  198 (337)
T d1o6la_         150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM  198 (337)
T ss_dssp             TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHH
T ss_pred             ccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHH
Confidence            9998653321        122346899999999999    46999999999999997

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=343.37  Aligned_cols=189  Identities=23%  Similarity=0.474  Sum_probs=161.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.+.+|++++++++|||||+++|++..      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            368999999999999999999987 5788999999643 3455789999999999999999999998643      2468


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++....    ...+++.++++|+.||++||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        84 iv~Ey~~~g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence            9999999999999876542    24689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +...+....       ......||+.|||||++.    +.++|||||||++|||+
T Consensus       157 ~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ell  204 (272)
T d1qpca_         157 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV  204 (272)
T ss_dssp             EECSSSCEE-------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             EEccCCccc-------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHH
Confidence            976543211       122357999999999985    48899999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-39  Score=354.58  Aligned_cols=189  Identities=21%  Similarity=0.297  Sum_probs=165.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++|||||++++++..     .+..+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            3589999999999999999999999999999999976655566789999999999999999999999644     45899


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC--CCcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY--DMVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~--~~~~ki~DFG  861 (914)
                      +|||||+||+|.+++....     ..+++.++..|+.||+.||+|||++   +||||||||+|||++.  ++.+||+|||
T Consensus       100 ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG  171 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG  171 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence            9999999999999996543     4689999999999999999999999   9999999999999964  5789999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+....         ......||+.|||||++.    +.++||||+||++|||+
T Consensus       172 ~a~~~~~~~---------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell  219 (350)
T d1koaa2         172 LTAHLDPKQ---------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL  219 (350)
T ss_dssp             TCEECCTTS---------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred             hheeccccc---------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence            998764321         223467999999999995    48999999999999984

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=342.40  Aligned_cols=188  Identities=29%  Similarity=0.478  Sum_probs=153.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|+..+.||+|+||+||+|++. +++.||||+++.. ....+++.+|++++++++|||||+++|+|...     +..++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l   77 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL   77 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence            57899999999999999999997 5678999999743 34557899999999999999999999997543     36799


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|+|.+++....     ..+++..+..|+.|++.||+|+|++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        78 v~E~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             EEECCTTCBHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             EEEecCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence            999999999999987653     4688999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......       .......||+.|||||++.    +.++|||||||++|||+
T Consensus       150 ~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~  196 (263)
T d1sm2a_         150 FVLDDQY-------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF  196 (263)
T ss_dssp             ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             eccCCCc-------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHH
Confidence            7654321       1122357999999999985    58899999999999974

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-39  Score=348.98  Aligned_cols=194  Identities=28%  Similarity=0.462  Sum_probs=149.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE---EEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM---VVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||+||+|+++.+++   .||||.+.... ....++|.+|++++++++|||||+++|+|...     +
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence            456677899999999999999976554   68999886432 33456899999999999999999999997443     4


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++|||||++|+|.+++....     ..+++.++..++.||++||+|||++   +||||||||+|||++.++++||+||
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF  172 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF  172 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEEecCCCcceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence            6899999999999999987653     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+......   ..........||+.|||||++.    +.++|||||||++|||+
T Consensus       173 Gla~~~~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~  227 (299)
T d1jpaa_         173 GLSRFLEDDTSD---PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM  227 (299)
T ss_dssp             --------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccceEccCCCCc---ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHH
Confidence            999876543211   1111223456899999999985    58899999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-39  Score=348.33  Aligned_cols=185  Identities=25%  Similarity=0.337  Sum_probs=164.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+.++++++|||||++++++.     ..+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            6799999999999999999999999999999999743   3445678999999999999999999999954     3458


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||++||++.+++...      ..+++..+..++.||+.|++|||++   +||||||||+|||++.+|.+||+|||
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eeeEeeecCCcccccccccc------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence            99999999999999998765      4678888999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+...+.           ....+||+.|||||++.    +.++||||+||++|||+
T Consensus       150 ~a~~~~~~-----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml  195 (316)
T d1fota_         150 FAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML  195 (316)
T ss_dssp             SCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred             cceEeccc-----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHH
Confidence            99875432           12367999999999994    58999999999999973

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-39  Score=348.98  Aligned_cols=188  Identities=26%  Similarity=0.336  Sum_probs=148.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.     ..+..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            356999999999999999999999999999999997543 233457889999999999999999999954     44589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec---CCCcEEEec
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD---YDMVAHVGD  859 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~---~~~~~ki~D  859 (914)
                      |+|||||+||+|.+++...      ..+++.++..++.||+.||+|||++   +||||||||+||++.   .++.+||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeccCCCcHHHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence            9999999999999999764      4689999999999999999999999   999999999999995   578999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+......         .....+||+.|||||++.    +.++||||+||++|||+
T Consensus       154 FG~a~~~~~~~---------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell  203 (307)
T d1a06a_         154 FGLSKMEDPGS---------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL  203 (307)
T ss_dssp             C---------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             cceeEEccCCC---------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence            99998654321         122457999999999994    68999999999999973

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-39  Score=352.18  Aligned_cols=188  Identities=21%  Similarity=0.300  Sum_probs=165.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++|||||++++++.     ..+..|+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            57999999999999999999999999999999997665555678899999999999999999999954     4458899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec--CCCcEEEecccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD--YDMVAHVGDFGL  862 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~--~~~~~ki~DFGl  862 (914)
                      |||||+||+|.+++...+     ..+++.++..|+.||+.||+|||++   +||||||||+|||++  .++.+||+|||+
T Consensus       104 vmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         104 ILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEcCCCChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeeccc
Confidence            999999999999886543     4689999999999999999999999   999999999999998  578999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.+....         ......||+.|||||++.    +.++||||+||++|||+
T Consensus       176 a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  222 (352)
T d1koba_         176 ATKLNPDE---------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL  222 (352)
T ss_dssp             CEECCTTS---------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred             ceecCCCC---------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence            98764322         123457999999999994    68999999999999973

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-39  Score=340.44  Aligned_cols=191  Identities=23%  Similarity=0.386  Sum_probs=159.7

Q ss_pred             hcccccCc-ccCCccEEEEEEEECC--CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNM-IGQGRFGTVYKGILGD--DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|.+.+. ||+|+||+||+|+++.  ++..||||+++... ....++|.+|++++++++|||||+++|+|...      
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence            45667774 9999999999998753  45689999997443 33457899999999999999999999987432      


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+++|+|.+++...+     ..+++.++.+++.||+.||+|||++   +||||||||+||+++.++.+||+||
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence            4789999999999999986543     4689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.+.......     .......||+.|||||++.    +.++|||||||++|||+
T Consensus       154 Gla~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~l  206 (285)
T d1u59a_         154 GLSKALGADDSYY-----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL  206 (285)
T ss_dssp             TTCEECTTCSCEE-----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             hhhhccccccccc-----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHH
Confidence            9999765432111     1122456999999999995    58999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=339.78  Aligned_cols=187  Identities=24%  Similarity=0.311  Sum_probs=163.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC------CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ------KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++...      ....+.+.+|++++++++|||||++++++.     .
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            57999999999999999999999999999999996432      123578999999999999999999999954     4


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC----c
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM----V  854 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~----~  854 (914)
                      ....++|||||++|+|.+++...      ..+++.++..++.|++.||+|||++   +||||||||+||+++.++    .
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred             CCEEEEEEEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence            45899999999999999999764      4689999999999999999999999   999999999999998876    5


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|++|||+|+......         ......||+.|||||++.    +.++||||+||++|||+
T Consensus       156 vkl~DfG~a~~~~~~~---------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell  210 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL  210 (293)
T ss_dssp             EEECCCTTCEECTTSC---------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             eEecchhhhhhcCCCc---------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH
Confidence            9999999998764321         122457999999999984    58999999999999973

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-38  Score=330.13  Aligned_cols=188  Identities=26%  Similarity=0.468  Sum_probs=163.4

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|+..+.||+|+||+||+|+++ +++.||||+++... ...+++.+|++++++++||||++++|+|..     .+..++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~i   76 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceEE
Confidence            68999999999999999999996 77899999997543 345789999999999999999999999753     346899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAK  864 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~  864 (914)
                      ||||+++|++.+++....     ..+++..+++++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus        77 v~Ey~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             EEECCTTEEHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             EEEccCCCcHHHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence            999999999999976543     5688999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          865 FLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       865 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ...+...       .......||+.|||||++.    +.++|||||||+++||+
T Consensus       149 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~  195 (258)
T d1k2pa_         149 YVLDDEY-------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY  195 (258)
T ss_dssp             BCSSSSC-------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eccCCCc-------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHH
Confidence            7654321       1223457999999999995    58999999999999974

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-39  Score=339.63  Aligned_cols=192  Identities=27%  Similarity=0.472  Sum_probs=154.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCc----EEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDE----MVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|+..++||+|+||+||+|+++.++    ..||||+++... ....++|.+|++++++++|||||+++|++...     
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence            57888999999999999999986544    579999996443 23345789999999999999999999997543     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      ...++||||+++|++.+++....     ..+++.++.+++.|++.|++|||++   +|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D  153 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD  153 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred             CceEEEEEecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence            46899999999999999887653     4789999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.+......     ........||+.|||||++.    +.++|||||||+++||+
T Consensus       154 FGla~~~~~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~  207 (283)
T d1mqba_         154 FGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM  207 (283)
T ss_dssp             CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred             cchhhcccCCCcc-----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHH
Confidence            9999876543211     11223456999999999984    58999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.5e-39  Score=348.55  Aligned_cols=185  Identities=22%  Similarity=0.273  Sum_probs=164.0

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   +....+.+.+|++++++++|||||++++++.     ....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence            5899999999999999999999999999999999643   2345578899999999999999999999854     3457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .++||||+++|++.+++.+.      ..+++.++..++.||+.||.|||++   +||||||||+|||++.+|.+||+|||
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence            89999999999999999765      3689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+...           ....+||+.|||||++.    +.++||||+||++|||+
T Consensus       187 ~a~~~~~~-----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml  232 (350)
T d1rdqe_         187 FAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA  232 (350)
T ss_dssp             TCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             eeeecccc-----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence            99876432           12357999999999994    58899999999999983

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=336.78  Aligned_cols=184  Identities=27%  Similarity=0.396  Sum_probs=153.0

Q ss_pred             CcccCCccEEEEEEEEC--CCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEEE
Q 042766          711 NMIGQGRFGTVYKGILG--DDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALVF  786 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  786 (914)
                      ++||+|+||+||+|+++  .+++.||||+++..  +....+++.+|++++++++|||||+++|+|...      ..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence            46999999999999874  45688999999643  233456899999999999999999999997432      368999


Q ss_pred             ecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccccccc
Q 042766          787 EYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       787 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~~  866 (914)
                      ||+++|+|.+++...      ..+++.++++|+.||+.||+|||++   +||||||||+|||++.++.+||+|||+|+.+
T Consensus        87 E~~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          87 EMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             ECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence            999999999999765      4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          867 SNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       867 ~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .......     .......||+.|||||++.    +.++|||||||++|||+
T Consensus       158 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell  204 (277)
T d1xbba_         158 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF  204 (277)
T ss_dssp             CTTCSEE-----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             ccccccc-----ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence            5332111     1122457999999999994    58999999999999974

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=343.39  Aligned_cols=197  Identities=24%  Similarity=0.401  Sum_probs=159.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCc-----EEEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDE-----MVVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||+||+|++..++     ..||||++... .......+.+|+.+++++ +|||||++++++..   
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee---
Confidence            368999999999999999999986443     47999998643 344557899999999998 89999999999644   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc-----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ-----------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVH  839 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivH  839 (914)
                        .+..++|||||++|+|.++++..+..                 .....+++.+++.|+.||++||+|||++   +|||
T Consensus       113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence              34789999999999999999765321                 1123589999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          840 GDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       840 rDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||||+||+++.++++||+|||+|+........      .......||+.|||||++.    +.++|||||||++|||+
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml  260 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  260 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCce------eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence            999999999999999999999999875432211      1122456899999999985    58999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.9e-38  Score=330.85  Aligned_cols=186  Identities=28%  Similarity=0.366  Sum_probs=162.8

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCc---------chHHHHHHHHHHHhcC-CCCcceEEeEeecC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKG---------ASKSFVSECEALRNIR-HRNLIKIITICSST  774 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  774 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++.....         ..+++.+|++++++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            6899999999999999999999999999999999754321         2246889999999997 999999999954  


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCc
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMV  854 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~  854 (914)
                         ..+..|+|||||++|+|.++++..      ..+++.++..++.||++||+|||++   +||||||||+||+++.++.
T Consensus        81 ---~~~~~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          81 ---TNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             ---cCcceEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence               445899999999999999999764      4689999999999999999999999   9999999999999999999


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCccccccccc
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~  913 (914)
                      +||+|||+|+.+....         .....+||+.|+|||++.          +.++||||+||++|||
T Consensus       149 ~kl~DFG~a~~~~~~~---------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         149 IKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             EEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             eEEccchheeEccCCC---------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence            9999999998764321         122457999999999995          3579999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-38  Score=345.57  Aligned_cols=186  Identities=25%  Similarity=0.325  Sum_probs=158.1

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC---CcchHHHHHH---HHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ---KGASKSFVSE---CEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....   ......+.+|   +++++.++|||||++++++.     .
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            68999999999999999999999999999999996332   2223334444   66777788999999999854     3


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      .+..|+||||++||+|.+++.+.      ..+++.++..++.||+.||+|||++   +||||||||+|||++.+|.+||+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEe
Confidence            45899999999999999999765      4678999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+....          ....+||+.|||||++.     +.++||||+||++|||+
T Consensus       150 DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml  200 (364)
T d1omwa3         150 DLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL  200 (364)
T ss_dssp             CCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             eeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH
Confidence            999998654321          12357999999999983     47899999999999983

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-38  Score=336.75  Aligned_cols=188  Identities=23%  Similarity=0.335  Sum_probs=161.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc---CCcchHHHHHHHHHHH-hcCCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK---QKGASKSFVSECEALR-NIRHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.++. .++|||||++++++..     .+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence            5799999999999999999999999999999999743   2344566777777765 6899999999999543     45


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..|+||||+++|+|.+++...      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEEeecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence            899999999999999999765      4688999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+......        .......||+.|||||++.    +.++||||+||++|||+
T Consensus       148 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml  197 (320)
T d1xjda_         148 GMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML  197 (320)
T ss_dssp             TTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred             chhhhccccc--------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH
Confidence            9998654321        1222457999999999994    58999999999999983

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-38  Score=332.72  Aligned_cols=189  Identities=27%  Similarity=0.478  Sum_probs=156.2

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|+++++ +.||||+++.. ....+.|.+|+.++++++|||||+++++|..      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            36899999999999999999999855 56999999644 3455789999999999999999999998642      2468


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|++.+++....    ...+++.++..|+.||+.||+|||++   +|+||||||+|||++.++++||+|||+|
T Consensus        88 lv~Ey~~~g~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEEecCCCchhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence            9999999999999887542    24689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.......       .......||+.|||||++.    +.++|||||||++|||+
T Consensus       161 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~  208 (285)
T d1fmka3         161 RLIEDNEY-------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT  208 (285)
T ss_dssp             C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             hhccCCCc-------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHH
Confidence            87643221       1122357999999999995    58999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.3e-38  Score=331.52  Aligned_cols=195  Identities=18%  Similarity=0.327  Sum_probs=158.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC---cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK---GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....   ...+.+.+|++++++++|||||++++++...+ .....
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCce
Confidence            579999999999999999999999999999999975432   33457899999999999999999999876543 22345


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+||||++||+|.+++...      ..+++.++..++.||++||+|||++   +||||||||+|||++.++.++++|||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~  156 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG  156 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred             EEEEEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence            89999999999999988765      4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++.......     ........+||+.|||||++.    +.++||||+||++|||.
T Consensus       157 ~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell  208 (277)
T d1o6ya_         157 IARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL  208 (277)
T ss_dssp             TCEECC---------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             hhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence            9876543221     112233568999999999994    58999999999999973

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=336.05  Aligned_cols=188  Identities=19%  Similarity=0.270  Sum_probs=162.8

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||+||+|+++.+++.||||+++... .....+.+|++++++++|||||++++++.     ..+..|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            367999999999999999999999999999999997543 33457889999999999999999999954     445899


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC--CcEEEeccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD--MVAHVGDFG  861 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~--~~~ki~DFG  861 (914)
                      +|||||+||+|.+++...+     ..+++.++..|+.||+.||+|||+.   +|+||||||+|||++.+  +.+||+|||
T Consensus        78 lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence            9999999999999997653     3689999999999999999999999   99999999999999854  589999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......         ......||+.|||||...    +.++||||+||++|+|+
T Consensus       150 ~~~~~~~~~---------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll  197 (321)
T d1tkia_         150 QARQLKPGD---------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL  197 (321)
T ss_dssp             TCEECCTTC---------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred             hhhccccCC---------cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence            998654321         123457999999999984    58999999999999973

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=336.00  Aligned_cols=190  Identities=25%  Similarity=0.421  Sum_probs=156.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE----EEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM----VVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      ++|++.+.||+|+||+||+|++..+|+    .||+|+++.. .....+++.+|++++++++|||||+++|+|...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            479999999999999999999987765    5888887633 344567899999999999999999999998643     


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                       ..+++|||+++|+|.+++....     ..+++..+.+++.||+.||+|||++   +||||||||+|||++.++.+||+|
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred             -CeeEEEEeccCCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence             3578899999999999887654     5789999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+........      .......||+.|||||++.    +.++|||||||+++||+
T Consensus       155 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~  207 (317)
T d1xkka_         155 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM  207 (317)
T ss_dssp             CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccceeccccccc------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHH
Confidence            9999876543211      1122356999999999984    58999999999999873

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=336.51  Aligned_cols=189  Identities=21%  Similarity=0.320  Sum_probs=159.1

Q ss_pred             hhcccccC-cccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSN-MIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+ .||+|+||+||+|++..+++.||||+++.     .+.+.+|++++.++ +|||||++++++... ......
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            35788764 69999999999999999999999999852     35678899987655 899999999986432 123457


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEe
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVG  858 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~  858 (914)
                      .|+|||||+||+|.+++.+.+.    ..+++.++..|+.||+.||+|||++   +|+||||||+|||++.   ++.+||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence            8999999999999999986532    4689999999999999999999999   9999999999999985   5679999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+......         .....+||+.|||||++    ++.++||||+||++|+|.
T Consensus       157 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll  207 (335)
T d2ozaa1         157 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL  207 (335)
T ss_dssp             CCTTCEECCCCC---------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred             ccceeeeccCCC---------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence            999998764322         12235799999999998    468999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-38  Score=335.45  Aligned_cols=184  Identities=28%  Similarity=0.411  Sum_probs=152.8

Q ss_pred             ccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC-----cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          709 SSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK-----GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       709 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ..++||+|+||+||+|+++.+++.||||+++....     ...+.+.+|++++++++|||||++++++.     ..+..+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            35789999999999999999999999999964432     12357899999999999999999999954     345789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||++++++..+....      ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|
T Consensus        77 ivmE~~~~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             EEEECCSEEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ehhhhhcchHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence            999999888777665433      4678889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......        ......+||+.|||||++.     +.++||||+||++|||+
T Consensus       148 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  195 (299)
T d1ua2a_         148 KSFGSPN--------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL  195 (299)
T ss_dssp             STTTSCC--------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH
T ss_pred             cccCCCc--------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHH
Confidence            8654322        1122357999999999983     58899999999999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-37  Score=330.85  Aligned_cols=199  Identities=22%  Similarity=0.347  Sum_probs=153.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhc-CCCCcceEEeEeecCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQ-KGASKSFVSECEALRNI-RHRNLIKIITICSSTD  775 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  775 (914)
                      ..++|++.+.||+|+||+||+|++..     +++.||||+++... ....+.+.+|++++.++ +|+||+.+++++... 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            34689999999999999999999743     45789999986433 33456788888888887 688999999987433 


Q ss_pred             CCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 042766          776 FEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPS  845 (914)
Q Consensus       776 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~  845 (914)
                         ....++|||||++|+|.++++..+..          .....+++.++..++.||++||+|||++   +||||||||+
T Consensus        90 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          90 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             ---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence               34679999999999999999754321          1124589999999999999999999999   9999999999


Q ss_pred             CeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          846 NVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       846 NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||++.++++||+|||+|+........      .......||+.|||||++.    +.++|||||||++|||+
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell  230 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  230 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTS------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeECCCCcEEEccCcchhhccccccc------cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence            999999999999999999865432211      1223457999999999994    58999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-37  Score=331.10  Aligned_cols=198  Identities=23%  Similarity=0.405  Sum_probs=162.7

Q ss_pred             HhhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQK-GASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ..++|++.+.||+|+||+||+|+++     .+++.||||+++.... ...+++.+|++++++++||||++++++|...  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence            3568999999999999999999975     3568999999975433 2356799999999999999999999997543  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc------------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ------------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMV  838 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~iv  838 (914)
                         ...++||||+++|+|.+++......                  .....+++.++..|+.|++.||+|||++   +||
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence               4688999999999999999753211                  1123589999999999999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          839 HGDLKPSNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       839 HrDlkp~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||||||+|||++.++.+||+|||+|+...+.....      ......||+.|||||++.    +.++|||||||++|||+
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell  236 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  236 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCcccc------ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence            99999999999999999999999998765432211      122457999999999995    58999999999999974

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-37  Score=325.68  Aligned_cols=190  Identities=22%  Similarity=0.387  Sum_probs=150.6

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC---cEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD---EMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGV  779 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  779 (914)
                      .++|++.+.||+|+||+||+|++..+   +..||||.++... ....+.+.+|++++++++|||||++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35899999999999999999998644   4678999886433 3345679999999999999999999998632      


Q ss_pred             ceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEec
Q 042766          780 DFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGD  859 (914)
Q Consensus       780 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~D  859 (914)
                      +..++||||+++|++.+++....     ..+++.++..++.||++||+|||++   +||||||||+||+++.++.+||+|
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred             CeEEEEEEeccCCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence            35789999999999999887543     4689999999999999999999999   999999999999999999999999


Q ss_pred             ccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          860 FGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       860 FGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ||+|+.......       .......||+.|||||++.    +.++|||||||++|||+
T Consensus       152 fG~a~~~~~~~~-------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l  203 (273)
T d1mp8a_         152 FGLSRYMEDSTY-------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL  203 (273)
T ss_dssp             --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred             chhheeccCCcc-------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence            999987643221       1122356899999999995    58999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=322.52  Aligned_cols=185  Identities=31%  Similarity=0.413  Sum_probs=152.4

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      .++|++.+.||+|+||.||+|+++  |+.||||+++.  ....+++.+|++++++++||||++++|+|...    .+..+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~   77 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY   77 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEE
Confidence            357889999999999999999985  67899999953  34557899999999999999999999987432    24579


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      +||||+++|+|.+++...+    ...+++..+++|+.||+.|++|||+.   +|+||||||+||+++.++.+|++|||++
T Consensus        78 lv~ey~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          78 IVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             EEECCCTTEEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEeccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence            9999999999999997542    24689999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +.....           .....||+.|||||++.    +.++|||||||++||||
T Consensus       151 ~~~~~~-----------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~  194 (262)
T d1byga_         151 KEASST-----------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY  194 (262)
T ss_dssp             ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eecCCC-----------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHH
Confidence            864321           11246899999999995    58999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-37  Score=328.83  Aligned_cols=189  Identities=25%  Similarity=0.426  Sum_probs=157.7

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  +...+++.+|++++++++|||||++++++..     ....
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            58999999999999999999999999999999996443  2345789999999999999999999999644     4589


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+.+ ++.+++....    ...+++.++..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             eEEEeecCC-chhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence            999999965 5555443322    14689999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+......        .......||+.|+|||++.     +.++||||+||++|+|+
T Consensus       149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~  197 (298)
T d1gz8a_         149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV  197 (298)
T ss_dssp             HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccccchhhhHHh
Confidence            98654321        1122357999999999873     58899999999999873

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=325.35  Aligned_cols=192  Identities=26%  Similarity=0.360  Sum_probs=153.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHH--HHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSE--CEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      .+|...+.||+|+||.||+|++  +|+.||||+++...   .+.+.+|  +..+++++|||||+++++|.... ......
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence            4678889999999999999997  57899999986432   2344444  44556789999999999987543 233468


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCCeeecCCCcEEE
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC-----QPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      ++|||||++|+|.+++++.       .+++.++++++.|++.|++|+|+..     .++||||||||+|||++.++.+||
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            9999999999999999753       5889999999999999999999731     349999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchhh----------hhhcccCccccccccc
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----------~~~~Di~s~g~~~~~~  913 (914)
                      +|||+++.........    ........||+.|||||++.          +.++|||||||+++||
T Consensus       150 ~DFGl~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el  211 (303)
T d1vjya_         150 ADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             CCCTTCEEEETTTTEE----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             EecCccccccCCCcce----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence            9999998765432111    11222467999999999973          4689999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-37  Score=323.27  Aligned_cols=186  Identities=22%  Similarity=0.298  Sum_probs=157.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------cchHHHHHHHHHHHhcC--CCCcceEEeEeecCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------GASKSFVSECEALRNIR--HRNLIKIITICSSTDF  776 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  776 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++....      ....++.+|++++++++  |||||++++++.    
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~----   79 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE----   79 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence            579999999999999999999999999999999974321      12234678999999996  899999999954    


Q ss_pred             CCCceEeEEEecccC-CCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC-Cc
Q 042766          777 EGVDFKALVFEYMEN-GSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD-MV  854 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~-~~  854 (914)
                       ..+..++||||+++ +++.+++...      ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.
T Consensus        80 -~~~~~~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          80 -RPDSFVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             -CSSEEEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred             -eCCeEEEEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence             34588999999976 6888888654      4689999999999999999999999   99999999999999855 79


Q ss_pred             EEEecccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          855 AHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       855 ~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+|||+|+......          .....||+.|||||++.     +.++||||+||++|||+
T Consensus       150 vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell  204 (273)
T d1xwsa_         150 LKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV  204 (273)
T ss_dssp             EEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred             EEECccccceeccccc----------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence            9999999998653221          12357999999999984     46789999999999973

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=320.16  Aligned_cols=191  Identities=27%  Similarity=0.374  Sum_probs=150.9

Q ss_pred             hcccccCcccCCccEEEEEEEECC---CcEEEEEEEeecc---CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGD---DEMVVAVKVINLK---QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEG  778 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  778 (914)
                      ++|++.+.||+|+||+||+|++..   ....||||+++..   .....++|.+|++++++++|||||+++|++...    
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~----   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP----   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence            579999999999999999998742   2357999998643   233456899999999999999999999997432    


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                        ..++||||+++|++.+++....     ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+||+
T Consensus        84 --~~~lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          84 --PMKMVTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred             --chheeeeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence              4589999999999999887543     4689999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.........     .......||+.|||||++.    +.++|||||||++|||+
T Consensus       154 DfGl~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml  208 (273)
T d1u46a_         154 DFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF  208 (273)
T ss_dssp             CCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred             cchhhhhcccCCCcc-----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence            999999764432111     1122356889999999995    58899999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=324.99  Aligned_cols=194  Identities=23%  Similarity=0.403  Sum_probs=161.0

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC-cEEEEEEEeeccC--CcchHHHHHHHHHHHhc---CCCCcceEEeEeecCCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD-EMVVAVKVINLKQ--KGASKSFVSECEALRNI---RHRNLIKIITICSSTDFE  777 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~  777 (914)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+++++.+   +||||+++++++.....+
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999654 7889999997432  33344677888887766   799999999998765555


Q ss_pred             CCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEE
Q 042766          778 GVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHV  857 (914)
Q Consensus       778 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki  857 (914)
                      .....+++|||++++.+........     ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence            6668899999998877665544332     5688999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccccccccccccCCCCccccccCcccccccchh----hhhhcccCcccccccccC
Q 042766          858 GDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKF----FMLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       858 ~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~----~~~~~Di~s~g~~~~~~f  914 (914)
                      +|||+++......         ......||+.|||||++    ++.++||||+||++|||+
T Consensus       158 ~dfg~~~~~~~~~---------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell  209 (305)
T d1blxa_         158 ADFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF  209 (305)
T ss_dssp             CSCCSCCCCCGGG---------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             cchhhhhhhcccc---------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH
Confidence            9999998654321         12245799999999999    469999999999999974

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-36  Score=321.67  Aligned_cols=189  Identities=26%  Similarity=0.480  Sum_probs=158.1

Q ss_pred             cCcccCCccEEEEEEEECCC---cEEEEEEEeecc-CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeEE
Q 042766          710 SNMIGQGRFGTVYKGILGDD---EMVVAVKVINLK-QKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKALV  785 (914)
Q Consensus       710 ~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  785 (914)
                      .++||+|+||+||+|++..+   ...||||+++.. +....++|.+|++++++++||||++++|+|...+    ...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence            47899999999999998654   346999999643 3445578999999999999999999999975432    468999


Q ss_pred             EecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          786 FEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       786 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      ||||++|+|.+++....     ...++..+++++.|+++|+.|+|+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus       108 ~E~~~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~  179 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  179 (311)
T ss_dssp             EECCTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred             EEEeecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence            99999999999987654     4677888999999999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          866 LSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       866 ~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      ........    ........||+.|+|||.+.    +.++|||||||+++||+
T Consensus       180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~  228 (311)
T d1r0pa_         180 MYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM  228 (311)
T ss_dssp             TTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccc----ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHH
Confidence            65433211    11223457999999999985    58999999999999974

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-36  Score=323.51  Aligned_cols=193  Identities=26%  Similarity=0.407  Sum_probs=158.2

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcE--EEEEEEeecc-CCcchHHHHHHHHHHHhc-CCCCcceEEeEeecCCCCCCc
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEM--VVAVKVINLK-QKGASKSFVSECEALRNI-RHRNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  780 (914)
                      ++|++.+.||+|+||+||+|+++.++.  .||||+++.. .....+++.+|+++++++ +|||||+++|+|...     +
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----G   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----T
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----C
Confidence            578899999999999999999987776  4777877533 334556899999999998 799999999997643     4


Q ss_pred             eEeEEEecccCCCHHHHHhccCC----------cccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeec
Q 042766          781 FKALVFEYMENGSLEDWLHQSND----------QVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLD  850 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~  850 (914)
                      ..++||||+++|+|.++++....          ......+++.++++++.||+.|+.|+|++   +||||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            78999999999999999975421          01235789999999999999999999999   999999999999999


Q ss_pred             CCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          851 YDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       851 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      .++.+||+|||+|+......         ......||+.|+|||.+.    +.++|||||||+++||+
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell  220 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV  220 (309)
T ss_dssp             GGGCEEECCTTCEESSCEEC---------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred             CCCceEEccccccccccccc---------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHH
Confidence            99999999999998654321         112346999999999995    48899999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=325.47  Aligned_cols=194  Identities=25%  Similarity=0.320  Sum_probs=160.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++... ....+++.+|+++|++++||||+++++++....+......+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            57999999999999999999999999999999997443 33456889999999999999999999998766655554555


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLA  863 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla  863 (914)
                      ++| |+.+|+|.+++..       ..+++.++..++.|++.||+|||++   +||||||||+|||++.++.+||+|||+|
T Consensus        88 l~~-~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a  156 (345)
T d1pmea_          88 LVT-HLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA  156 (345)
T ss_dssp             EEE-ECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEE-eecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence            554 5668999999964       3589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +........     .......+||+.|+|||++.     +.++||||+||++|+|+
T Consensus       157 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml  207 (345)
T d1pmea_         157 RVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML  207 (345)
T ss_dssp             EECCGGGCB-----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH
T ss_pred             eeccCCCcc-----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh
Confidence            876543221     11223467999999999983     57899999999999973

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=319.59  Aligned_cols=197  Identities=24%  Similarity=0.385  Sum_probs=164.3

Q ss_pred             hhcccccCcccCCccEEEEEEEEC-----CCcEEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCCcceEEeEeecCCC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILG-----DDEMVVAVKVINLKQK-GASKSFVSECEALRNI-RHRNLIKIITICSSTDF  776 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  776 (914)
                      .++|++.+.||+|+||.||+|+++     .+++.||||+++.... .....+.+|+.+++++ +|||||+++++|...  
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG--   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence            368999999999999999999863     5678999999975433 3445789999999999 699999999997543  


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ------------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                         ...++|||||++|+|.+++......            .....+++..+..++.||++|++|||++   +||||||||
T Consensus       100 ---~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_         100 ---GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ---CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence               4689999999999999999765321            1224689999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +||+++.++.+|++|||.++........      ......+||+.|||||++.    +.++|||||||+++|||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell  241 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF  241 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence            9999999999999999999876532211      1223468999999999995    59999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=320.45  Aligned_cols=198  Identities=24%  Similarity=0.351  Sum_probs=158.9

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeecc--CCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC---CC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLK--QKGASKSFVSECEALRNIRHRNLIKIITICSSTDF---EG  778 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  778 (914)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .+...+++.+|++++++++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999999999999999998644  33455788999999999999999999998765331   22


Q ss_pred             CceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEe
Q 042766          779 VDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVG  858 (914)
Q Consensus       779 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~  858 (914)
                      ....++||||++++.+..+....      ..+++.++..++.|++.||+|||++   +||||||||+|||++.++.+||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence            34689999999877665544332      4688899999999999999999999   99999999999999999999999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+.......    .......+||+.|+|||++.     +.++||||+||++|||+
T Consensus       160 dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~  216 (318)
T d3blha1         160 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  216 (318)
T ss_dssp             CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             ecceeeecccccccc----cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence            999998765432211    11223457999999999984     58999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=316.52  Aligned_cols=197  Identities=25%  Similarity=0.377  Sum_probs=158.5

Q ss_pred             hhcccccCcccCCccEEEEEEEECCC-------cEEEEEEEeeccCC-cchHHHHHHHHHHHhc-CCCCcceEEeEeecC
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDD-------EMVVAVKVINLKQK-GASKSFVSECEALRNI-RHRNLIKIITICSST  774 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  774 (914)
                      .++|++.+.||+|+||.||+|++..+       +..||||+++.... .....+.+|+..+.++ +|||||+++++|.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            36899999999999999999997544       35799999975433 3446788999999888 89999999999754 


Q ss_pred             CCCCCceEeEEEecccCCCHHHHHhccCCc----------ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCC
Q 042766          775 DFEGVDFKALVFEYMENGSLEDWLHQSNDQ----------VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKP  844 (914)
Q Consensus       775 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp  844 (914)
                          .+..++||||+++|+|.+++...+..          .....+++.++++++.|++.||+|||++   +||||||||
T Consensus        91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence                34689999999999999999765321          1235689999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          845 SNVLLDYDMVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       845 ~NILl~~~~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|||++.++.+||+|||+++........      .......||+.|||||++.    +.++|||||||++|||+
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell  231 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF  231 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTT------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeecCCCCeEeccchhhccccccccc------cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhc
Confidence            9999999999999999999876543211      1223467999999999995    58999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-36  Score=322.17  Aligned_cols=198  Identities=22%  Similarity=0.380  Sum_probs=162.9

Q ss_pred             HhhcccccCcccCCccEEEEEEEECC-----CcEEEEEEEeeccC-CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC
Q 042766          703 ATSEFSSSNMIGQGRFGTVYKGILGD-----DEMVVAVKVINLKQ-KGASKSFVSECEALRNIRHRNLIKIITICSSTDF  776 (914)
Q Consensus       703 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  776 (914)
                      ..++|+..+.||+|+||+||+|+++.     +++.||||+++... ......+.+|++++++++|||||+++++|..   
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ---   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec---
Confidence            34789999999999999999999852     35789999997433 2334578999999999999999999999643   


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCc----ccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCC
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQ----VEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYD  852 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~  852 (914)
                        ....++||||+++|+|.+++...+..    .....+++.++.+++.|+++||.|||++   +|+||||||+|||++.+
T Consensus        95 --~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          95 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             --CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence              33679999999999999998753211    1123578899999999999999999999   99999999999999999


Q ss_pred             CcEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          853 MVAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       853 ~~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++||+|||+|+........      .......||+.|||||.+.    +.++|+|||||+++||+
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~  229 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYY------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA  229 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCE------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ceEEEeecccceeccCCcce------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHH
Confidence            99999999999876543221      1122356999999999986    47999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-35  Score=323.03  Aligned_cols=190  Identities=25%  Similarity=0.376  Sum_probs=154.6

Q ss_pred             cccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCceEeE
Q 042766          706 EFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDFKAL  784 (914)
Q Consensus       706 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l  784 (914)
                      +|+..++||+|+||+||+|++..+++.||||+++.....    ..+|++++++++||||+++++++..... +...+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999999999999999999754322    2479999999999999999999765432 34456899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEeccccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGLA  863 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFGla  863 (914)
                      |||||+++....+.....   ....+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+|
T Consensus        97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence            999997654333332111   125799999999999999999999999   999999999999999875 8999999999


Q ss_pred             ccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          864 KFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       864 ~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +......         .....+||+.|+|||.+.     +.++||||+||++|||+
T Consensus       171 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~  217 (350)
T d1q5ka_         171 KQLVRGE---------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL  217 (350)
T ss_dssp             EECCTTS---------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             hhccCCc---------ccccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence            8764322         122357999999999873     58999999999999973

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-35  Score=311.50  Aligned_cols=193  Identities=19%  Similarity=0.289  Sum_probs=160.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCC-CCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRH-RNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ..+.+.+|++.++.++| +||+.+++++..     ....+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccE
Confidence            57999999999999999999999999999999986432  23457789999999975 899999988543     34789


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC-----CCcEEEe
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY-----DMVAHVG  858 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~ki~  858 (914)
                      +||||+ +++|.+++...+     ..+++.++..++.|++.||+|||++   +||||||||+|||++.     ++.+||+
T Consensus        78 ~vme~~-~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEEEec-CCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence            999999 789999987654     4689999999999999999999999   9999999999999974     5789999


Q ss_pred             cccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          859 DFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       859 DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      |||+|+.+.+...... .........+||+.|||||++.    +.++|||||||++|||+
T Consensus       149 DFG~a~~~~~~~~~~~-~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell  207 (293)
T d1csna_         149 DFGMVKFYRDPVTKQH-IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL  207 (293)
T ss_dssp             CCTTCEESBCTTTCCB-CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccceeEEcccCccccc-eeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH
Confidence            9999998764332111 1122234568999999999995    58899999999999973

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-35  Score=315.75  Aligned_cols=187  Identities=24%  Similarity=0.357  Sum_probs=156.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|+..+.||+|+||+||+|+++ +++.||||+++...  ....+++.+|+.++++++|||||++++++..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            57999999999999999999996 77899999996542  3345789999999999999999999999654     3478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+.++.+..+....      ..+++.++..++.||+.||+|||+.   +||||||||+|||++.++.+|++|||.
T Consensus        76 ~i~~e~~~~~~~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             EEEEECCSEEHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEeehhhhHHHHHhhc------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence            9999999876666665543      4699999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |........        ......||+.|+|||.+.     +.++||||+||+++||+
T Consensus       147 a~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~  195 (286)
T d1ob3a_         147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV  195 (286)
T ss_dssp             HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             ceecccCcc--------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHH
Confidence            987543211        122356999999999984     58999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-35  Score=320.82  Aligned_cols=189  Identities=23%  Similarity=0.349  Sum_probs=155.7

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCC-CCCCc
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTD-FEGVD  780 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~  780 (914)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++...  ....+.+.+|+++|++++|||||++++++...+ .....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            358999999999999999999999999999999997432  233567899999999999999999999976543 22334


Q ss_pred             eEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecc
Q 042766          781 FKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDF  860 (914)
Q Consensus       781 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DF  860 (914)
                      ..++||||+ +.++..+.+.       ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+|++||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df  165 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  165 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence            579999999 6688887754       3689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          861 GLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       861 Gla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+|+.....           .....||+.|||||++.     +.++||||+||++|+|+
T Consensus       166 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  213 (346)
T d1cm8a_         166 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI  213 (346)
T ss_dssp             TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH
T ss_pred             cceeccCCc-----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH
Confidence            999865321           12357999999999984     47999999999999873

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-34  Score=315.04  Aligned_cols=182  Identities=22%  Similarity=0.338  Sum_probs=156.3

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCCCCCceEe
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDFEGVDFKA  783 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  783 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..   ..+++.+|++++++++ ||||+++++++...   .....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence            5899999999999999999999999999999998632   3567899999999995 99999999986532   234689


Q ss_pred             EEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCC-cEEEecccc
Q 042766          784 LVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDM-VAHVGDFGL  862 (914)
Q Consensus       784 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~-~~ki~DFGl  862 (914)
                      +||||+++++|.++.         ..+++.++..++.||+.||+|||++   +||||||||+|||++.++ .+||+|||+
T Consensus       109 ~v~e~~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEECCCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EEEeecCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence            999999999987653         3588999999999999999999999   999999999999998765 699999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCccccccccc
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~  913 (914)
                      |+......         .....+||+.|+|||.+.     +.++||||+||+++||
T Consensus       177 a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~  223 (328)
T d3bqca1         177 AEFYHPGQ---------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM  223 (328)
T ss_dssp             CEECCTTC---------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             ceeccCCC---------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHh
Confidence            98764321         122457999999999984     5788999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-34  Score=309.97  Aligned_cols=194  Identities=25%  Similarity=0.360  Sum_probs=156.9

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceEeE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFKAL  784 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  784 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||++.....  .+++.+|++++++++|++++..++.+..    ..+..++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence            469999999999999999999999999999999875432  3457899999999998877666655532    2357899


Q ss_pred             EEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecC---CCcEEEeccc
Q 042766          785 VFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDY---DMVAHVGDFG  861 (914)
Q Consensus       785 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~---~~~~ki~DFG  861 (914)
                      ||||+ ++++.+.+....     ..+++..+..++.|++.||+|||++   +||||||||+|||++.   +..+|++|||
T Consensus        81 vme~~-~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             EEECC-CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EEEEc-CCchhhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence            99999 567777765443     4789999999999999999999999   9999999999999864   4579999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +|+.+.+...... ..........||+.|||||++.    +.++|||||||++|||+
T Consensus       152 ~a~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~  207 (299)
T d1ckia_         152 LAKKYRDARTHQH-IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN  207 (299)
T ss_dssp             SCEECBCTTTCCB-CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeccccccccc-eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence            9998765332211 1122234568999999999984    58999999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-35  Score=314.99  Aligned_cols=188  Identities=22%  Similarity=0.286  Sum_probs=160.4

Q ss_pred             hcccccCcccCCccEEEEEEEE---CCCcEEEEEEEeecc----CCcchHHHHHHHHHHHhcCC-CCcceEEeEeecCCC
Q 042766          705 SEFSSSNMIGQGRFGTVYKGIL---GDDEMVVAVKVINLK----QKGASKSFVSECEALRNIRH-RNLIKIITICSSTDF  776 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  776 (914)
                      ++|++.+.||+|+||+||+|++   +.+|+.||||+++..    +....+.+.+|++++++++| |||+++++++.    
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~----   99 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----   99 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence            6799999999999999999997   447899999998643    22345678899999999977 79999999854    


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEE
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAH  856 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~k  856 (914)
                       .....++||||+++|+|.+++...      ..+++..+..++.|++.|++|+|++   +||||||||+||+++.++.+|
T Consensus       100 -~~~~~~~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk  169 (322)
T d1vzoa_         100 -TETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV  169 (322)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             -cCCceeeeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence             345889999999999999999765      3577889999999999999999999   999999999999999999999


Q ss_pred             EecccccccccccccccccCCCCccccccCcccccccchhh------hhhcccCccccccccc
Q 042766          857 VGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF------MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       857 i~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~------~~~~Di~s~g~~~~~~  913 (914)
                      |+|||+|+.+......       ......||+.|+|||.+.      +.++||||+||++|||
T Consensus       170 L~DFG~a~~~~~~~~~-------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyel  225 (322)
T d1vzoa_         170 LTDFGLSKEFVADETE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL  225 (322)
T ss_dssp             ESCSSEEEECCGGGGG-------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred             Eeeccchhhhcccccc-------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHH
Confidence            9999999876543221       122457999999999984      4689999999999998

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-34  Score=306.57  Aligned_cols=188  Identities=22%  Similarity=0.352  Sum_probs=162.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCceE
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  782 (914)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+++.+|+.++++++||||+++++++...     ...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence            47999999999999999999999999999999997543  33457889999999999999999999996543     478


Q ss_pred             eEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEecccc
Q 042766          783 ALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFGL  862 (914)
Q Consensus       783 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFGl  862 (914)
                      ++||||+.++++..++...      ..+++..+..++.|++.||+|||++   +||||||||+|||++.++.+||+|||.
T Consensus        77 ~iv~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEeeeccccccccccccc------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence            9999999999998887655      4678899999999999999999999   999999999999999999999999999


Q ss_pred             cccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          863 AKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       863 a~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      |+.......        ......+++.|+|||++.     +.++||||+||+++||.
T Consensus       148 a~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell  196 (292)
T d1unla_         148 ARAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA  196 (292)
T ss_dssp             CEECCSCCS--------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred             hhcccCCCc--------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh
Confidence            987643221        122346889999999984     58899999999999974

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-33  Score=305.38  Aligned_cols=260  Identities=27%  Similarity=0.454  Sum_probs=229.1

Q ss_pred             ccEEEEeecccccc--cCCccccCCCCCcEEEccc-CcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeE
Q 042766          374 KMIELSVGRNQISG--TIPPGIRNLVNLITFTLEV-NQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSL  450 (914)
Q Consensus       374 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  450 (914)
                      +++.|+|++|.++|  .+|+.++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..|..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46677777777766  4778888888888888886 78888888888888888888888888888888888888888888


Q ss_pred             EeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcc
Q 042766          451 DLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQF  530 (914)
Q Consensus       451 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  530 (914)
                      ++++|++.+.+|..+.+++.|+.+++++|.++|.+|..+..+..+.+.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            8888888888888888888888888888888888888888888877788999999999999888887655 699999999


Q ss_pred             ccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCCCC
Q 042766          531 SGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVKG  610 (914)
Q Consensus       531 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~  610 (914)
                      .+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|+|+|.+|+.+.++++|++|||++|+|+|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999998766 68899999999999999999999999999999999999999999999888


Q ss_pred             cCCCCCccCccCCCCCCCCccCCCCCCCC
Q 042766          611 VFSNKTKISLHGNVKLCGGIDELHLPSCP  639 (914)
Q Consensus       611 ~~~~~~~~~~~~n~~lc~~~~~l~~~~c~  639 (914)
                      .++.+..+++.||+.+||.  |+  |.|.
T Consensus       289 ~L~~L~~l~l~~N~~l~g~--pl--p~c~  313 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGS--PL--PACT  313 (313)
T ss_dssp             TGGGSCGGGTCSSSEEEST--TS--SCCC
T ss_pred             cCCCCCHHHhCCCccccCC--CC--CCCC
Confidence            8889999999999999997  33  5673

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-34  Score=314.95  Aligned_cols=190  Identities=21%  Similarity=0.314  Sum_probs=157.1

Q ss_pred             hhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC--cchHHHHHHHHHHHhcCCCCcceEEeEeecCCCCCCce
Q 042766          704 TSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK--GASKSFVSECEALRNIRHRNLIKIITICSSTDFEGVDF  781 (914)
Q Consensus       704 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  781 (914)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+++.+|++++++++|||||++++++..........
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4579999999999999999999999999999999975432  33457889999999999999999999876443222234


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .+++|+|+.+|+|.+++..       ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg  166 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  166 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred             eEEEEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence            4566777889999999864       3589999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh-----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF-----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~-----~~~~Di~s~g~~~~~~f  914 (914)
                      +|......           .....||+.|+|||++.     +.++||||+||++|+|+
T Consensus       167 ~a~~~~~~-----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll  213 (348)
T d2gfsa1         167 LARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  213 (348)
T ss_dssp             ---CCTGG-----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred             hhcccCcc-----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence            99764321           12357999999999974     58899999999999873

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.3e-33  Score=309.88  Aligned_cols=189  Identities=23%  Similarity=0.277  Sum_probs=150.5

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccC--CcchHHHHHHHHHHHhcCCCCcceEEeEeecCCC-CCCce
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQ--KGASKSFVSECEALRNIRHRNLIKIITICSSTDF-EGVDF  781 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~~~  781 (914)
                      ++|++.++||+|+||+||+|+++.+|+.||||+++...  ....+++.+|+.++++++|||||++++++..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999999999999999997443  3334578899999999999999999999764432 34568


Q ss_pred             EeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeeecCCCcEEEeccc
Q 042766          782 KALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLLDYDMVAHVGDFG  861 (914)
Q Consensus       782 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl~~~~~~ki~DFG  861 (914)
                      .|+||||+.++ +.+.+.        ..+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eEEEEeccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            99999999765 444443        3578999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccccccccCCCCccccccCcccccccchhh----hhhcccCcccccccccC
Q 042766          862 LAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHHF  914 (914)
Q Consensus       862 la~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~f  914 (914)
                      +++......         .....+||+.|+|||++.    +.++||||+||++++|+
T Consensus       165 ~~~~~~~~~---------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell  212 (355)
T d2b1pa1         165 LARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  212 (355)
T ss_dssp             C------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             hhhcccccc---------ccccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence            988654321         223457999999999995    58999999999999873

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.9e-29  Score=280.83  Aligned_cols=192  Identities=31%  Similarity=0.402  Sum_probs=123.4

Q ss_pred             cccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCc
Q 042766          392 GIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNL  471 (914)
Q Consensus       392 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  471 (914)
                      .+..+++++.+++++|.+++..|  +...++|++|++++|.+++ + ..+..+++|+.|++++|++++..+  +..+++|
T Consensus       192 ~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L  265 (384)
T d2omza2         192 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKL  265 (384)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred             ccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccC
Confidence            34445555555555555554433  3344555555555555553 1 234555555555555555554322  4455555


Q ss_pred             cccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeec
Q 042766          472 ILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISI  551 (914)
Q Consensus       472 ~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  551 (914)
                      +.+++++|++++..|  +..+..+ +.+++++|.+++.  ..+..+++++.|++++|++++..|  +..+++|++|+|++
T Consensus       266 ~~L~l~~~~l~~~~~--~~~~~~l-~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~  338 (384)
T d2omza2         266 TELKLGANQISNISP--LAGLTAL-TNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN  338 (384)
T ss_dssp             SEEECCSSCCCCCGG--GTTCTTC-SEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred             CEeeccCcccCCCCc--ccccccc-ccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCC
Confidence            555555555553221  3333333 4566666666642  346777888899999999987643  78889999999999


Q ss_pred             ccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCC
Q 042766          552 NSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYN  600 (914)
Q Consensus       552 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N  600 (914)
                      |++++ ++ .+.++++|++|++++|+|++.+|  +.++++|+.|+|++|
T Consensus       339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            98875 33 68889999999999999987665  788899999999887

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=4.7e-29  Score=277.54  Aligned_cols=166  Identities=26%  Similarity=0.352  Sum_probs=97.0

Q ss_pred             CCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCcccccc
Q 042766          397 VNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIA  476 (914)
Q Consensus       397 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l  476 (914)
                      ++|++|++++|+++..  ..+..+++|+.|++++|.+++..+  +..+++|++|++++|++++..  .+.+++.++.+++
T Consensus       219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~  292 (384)
T d2omza2         219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL  292 (384)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccc
Confidence            3344444444444321  123444444444444444443221  334444444444444444322  1334444444444


Q ss_pred             CCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccccCccccccccccEEEeecccccc
Q 042766          477 SYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYG  556 (914)
Q Consensus       477 ~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  556 (914)
                      +.|++++ + ..+..+..+ +.|++++|++++..  .+..+++|++|++++|++++. + .++++++|++|+|++|++++
T Consensus       293 ~~n~l~~-~-~~~~~~~~l-~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         293 NENQLED-I-SPISNLKNL-TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             CSSCCSC-C-GGGGGCTTC-SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCB
T ss_pred             ccccccc-c-cccchhccc-CeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCC
Confidence            4444442 1 123333333 45666666666543  367788999999999999853 3 68899999999999999998


Q ss_pred             cCCcchhccCCCCEEEccCCc
Q 042766          557 VIPLSFRFLKSIKALNVSSNN  577 (914)
Q Consensus       557 ~~p~~~~~l~~L~~L~Ls~N~  577 (914)
                      .+|  +.++++|+.|+|++|.
T Consensus       366 l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         366 LTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CGG--GTTCTTCSEEECCCEE
T ss_pred             Chh--hccCCCCCEeeCCCCc
Confidence            765  8899999999999883

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=7.1e-29  Score=273.72  Aligned_cols=187  Identities=20%  Similarity=0.286  Sum_probs=147.6

Q ss_pred             hcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-----------CCCcceEEeEeec
Q 042766          705 SEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-----------HRNLIKIITICSS  773 (914)
Q Consensus       705 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  773 (914)
                      ++|++.++||+|+||+||+|++..+|+.||||+++.. ....+.+.+|++++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999999999999999999643 233467788999988875           5789999888643


Q ss_pred             CCCCCCceEeEEEecccCCCHH-HHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecC
Q 042766          774 TDFEGVDFKALVFEYMENGSLE-DWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDY  851 (914)
Q Consensus       774 ~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~  851 (914)
                      .   .....+++|+++..+... .......    ...+++..+..++.|++.|++|||+ .   +|+||||||+|||++.
T Consensus        92 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~  161 (362)
T d1q8ya_          92 K---GPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI  161 (362)
T ss_dssp             E---ETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred             c---cccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence            2   234566677766554433 3222221    2578889999999999999999998 5   8999999999999986


Q ss_pred             CC------cEEEecccccccccccccccccCCCCccccccCcccccccchhh----hhhcccCccccccccc
Q 042766          852 DM------VAHVGDFGLAKFLSNHHLDIASKTPSSSIGIKGTVGYVAPGKFF----MLYTHIPSFSCTNVHH  913 (914)
Q Consensus       852 ~~------~~ki~DFGla~~~~~~~~~~~~~~~~~~~~~~GT~~y~APE~~~----~~~~Di~s~g~~~~~~  913 (914)
                      ++      .+|++|||.|+......           ...+||+.|+|||++.    +.++|+||+||++++|
T Consensus       162 ~~~~~~~~~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  222 (362)
T d1q8ya_         162 VDSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL  222 (362)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHH
T ss_pred             cCcccccceeeEeeccccccccccc-----------ccccccccccChhhccccCCCccccccchHHHHHHH
Confidence            65      49999999998653211           2357999999999985    5899999999999876

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=4.1e-27  Score=252.97  Aligned_cols=276  Identities=22%  Similarity=0.274  Sum_probs=223.7

Q ss_pred             CCCCccceeecCCCCceEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC
Q 042766           63 NFCQWTGVTCGHRHQRLTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP  142 (914)
Q Consensus        63 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  142 (914)
                      +-|.|.+|.|+.            ++|+ .+|+.+.  +.+++|+|++|+|+...+.+|.++++|++|++++|.++...|
T Consensus         8 c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~   72 (305)
T d1xkua_           8 CQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP   72 (305)
T ss_dssp             CEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred             CEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccch
Confidence            447899999964            3343 4566553  679999999999995555689999999999999999997778


Q ss_pred             CCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCC--CCCCccchhh
Q 042766          143 TNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLG--GKIPTTLGLL  220 (914)
Q Consensus       143 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l  220 (914)
                      ..|.++++|++|++++|+++ .+|..+.  ..|+.|++++|.+.+..+..+.....+..++...|...  ...+..+..+
T Consensus        73 ~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l  149 (305)
T d1xkua_          73 GAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM  149 (305)
T ss_dssp             TTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred             hhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccc
Confidence            88999999999999999998 5665443  57889999999998766666777888888888887544  4456678888


Q ss_pred             hcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccccccc
Q 042766          221 RRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLD  300 (914)
Q Consensus       221 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  300 (914)
                      ++|+++++++|.++. +|..+  +++|+.|++++|..++..+ ..+.+++.+++|++++|++.+..+..+.++++|++|+
T Consensus       150 ~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~-~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~  225 (305)
T d1xkua_         150 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDA-ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  225 (305)
T ss_dssp             TTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECT-GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             cccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCCh-hHhhccccccccccccccccccccccccccccceeee
Confidence            999999999999884 45443  5788999999999887655 4456888999999999999988888899999999999


Q ss_pred             ccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccC
Q 042766          301 LPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFG  361 (914)
Q Consensus       301 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  361 (914)
                      |++|+|+.+ |..|..+++|++|+|++|+|+.++...+..+..+..+.+|+.|+|++|.++
T Consensus       226 L~~N~L~~l-p~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~  285 (305)
T d1xkua_         226 LNNNKLVKV-PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  285 (305)
T ss_dssp             CCSSCCSSC-CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             ccccccccc-ccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence            999999855 668888999999999999999887766655556677788888888888875

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.5e-26  Score=248.59  Aligned_cols=286  Identities=20%  Similarity=0.263  Sum_probs=214.4

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      .++.+|-++++++ .+|..+.  +++++|||++|+|+...+.+|.++++|++|++++|.++...|.+|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            5678899999999 8888775  689999999999994444579999999999999999997778899999999999999


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc--CCCCCccccccccceeeccCCcccC
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS--GMFPRSICNISSVELIFLTENRFSG  259 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~  259 (914)
                      +|+++ .+|..+  ...++.|++++|.+.+..+..+.....+..++...|...  ...+..+..+++|+.+++++|.++.
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence            99999 566543  357888999999999777777777888888888887543  3456678888888888888888874


Q ss_pred             cccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcc
Q 042766          260 IFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLD  339 (914)
Q Consensus       260 ~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  339 (914)
                       +|..   .+++|++|++++|.+.+..+..|..++.+++|++++|++++..+..|.++++|++|+|++|.|+.+      
T Consensus       165 -l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l------  234 (305)
T d1xkua_         165 -IPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV------  234 (305)
T ss_dssp             -CCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC------
T ss_pred             -cCcc---cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccc------
Confidence             3433   356788888888888877788888888888888888888888787888888888888888877764      


Q ss_pred             hhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccc--ccCChhh
Q 042766          340 FVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH--GTIPDVI  417 (914)
Q Consensus       340 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~  417 (914)
                       |..+..+++|++|+|++|+|+ .++...+.                  .+..+..+.+|+.|+|++|.+.  ...|.+|
T Consensus       235 -p~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~------------------~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f  294 (305)
T d1xkua_         235 -PGGLADHKYIQVVYLHNNNIS-AIGSNDFC------------------PPGYNTKKASYSGVSLFSNPVQYWEIQPSTF  294 (305)
T ss_dssp             -CTTTTTCSSCCEEECCSSCCC-CCCTTSSS------------------CSSCCTTSCCCSEEECCSSSSCGGGSCGGGG
T ss_pred             -ccccccccCCCEEECCCCccC-ccChhhcc------------------CcchhcccCCCCEEECCCCcCccCcCCHhHh
Confidence             234667777777777777776 33322111                  1223344556666777776654  3344444


Q ss_pred             hcccCC
Q 042766          418 SELKNL  423 (914)
Q Consensus       418 ~~l~~L  423 (914)
                      .-+...
T Consensus       295 ~~~~~~  300 (305)
T d1xkua_         295 RCVYVR  300 (305)
T ss_dssp             TTCCCG
T ss_pred             cccccC
Confidence            444333

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.9e-26  Score=244.77  Aligned_cols=248  Identities=25%  Similarity=0.233  Sum_probs=170.9

Q ss_pred             EEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeec-c
Q 042766          352 VLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVF-N  430 (914)
Q Consensus       352 ~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~  430 (914)
                      .++.++++++ .+|..+.   ..+++|+|++|+|++..+.+|.++++|++|++++|++....+..+..++.++.++.. .
T Consensus        15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            3456666666 5565432   345666666666665555566666666666666666666656556666666665543 3


Q ss_pred             cccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCc
Q 042766          431 NFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSL  510 (914)
Q Consensus       431 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~  510 (914)
                      |.++...|..|.++++|++|++++|.+....+..+..+++|+.                         +++++|+|++..
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~-------------------------l~l~~N~l~~i~  145 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY-------------------------LYLQDNALQALP  145 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE-------------------------EECCSSCCCCCC
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccch-------------------------hhhccccccccC
Confidence            4455444555666666666666666655444445555555544                         555555555555


Q ss_pred             cccccccccceeecccCCccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccC
Q 042766          511 PLQVGNLKNLVMLDISSNQFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLS  590 (914)
Q Consensus       511 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  590 (914)
                      +..|..+++|+.|++++|+++++.+.+|.++++|+++++++|++++..|..|..+++|++||+++|++++..|..|.+++
T Consensus       146 ~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~  225 (284)
T d1ozna_         146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             hhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccccc
Confidence            66777888899999999999988888999999999999999999998899999999999999999999988888999999


Q ss_pred             CCCeEeCCCCccccccCCCCcCCCCCccCccCCCCCCC
Q 042766          591 FLEFLNLSYNYFEGEVPVKGVFSNKTKISLHGNVKLCG  628 (914)
Q Consensus       591 ~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~  628 (914)
                      +|++|++++|+|.|+++..+....+.......+...|.
T Consensus       226 ~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~  263 (284)
T d1ozna_         226 ALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS  263 (284)
T ss_dssp             TCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred             ccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence            99999999999999888654332233333333444453

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.9e-26  Score=242.43  Aligned_cols=224  Identities=20%  Similarity=0.261  Sum_probs=148.8

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhcccccccccccc-cc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSV-DI  182 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L-~~  182 (914)
                      ..++.++++++ .+|..+.  +.+++|+|++|+|++..+.+|.++++|++||+++|++.+..+..+..+..++.++. ..
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            34677788888 7787664  46788888888888555567888888888888888888766667777777777765 35


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCccc
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFP  262 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  262 (914)
                      |.++...|.+|+++++|++|++++|.+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|++++. |
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l-~  169 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV-P  169 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE-C
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc-c
Confidence            566655566777777777777777777666666666677777777777777766566666666666666666666543 3


Q ss_pred             ccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCC
Q 042766          263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLG  331 (914)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  331 (914)
                      ...+.++++|+++++++|++++..|..|.++++|++||+++|++++..+..|..+++|++|++++|.+.
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence            344445666666666666666555566666666666666666665555555555555555555555443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=3.5e-24  Score=224.61  Aligned_cols=202  Identities=22%  Similarity=0.257  Sum_probs=158.3

Q ss_pred             cEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeC
Q 042766          375 MIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGS  454 (914)
Q Consensus       375 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  454 (914)
                      +.+++.+++.++. +|..+.  +++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++
T Consensus        12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~   86 (266)
T d1p9ag_          12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSH   86 (266)
T ss_dssp             CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCS
T ss_pred             CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccc
Confidence            4556777777774 565443  467777777777777666777777777777777777774 33 346677777777777


Q ss_pred             CcCCCCCCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCcccccc
Q 042766          455 NSLQGNIPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGVI  534 (914)
Q Consensus       455 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  534 (914)
                      |++++ .+..+.++++|+.|++++|.+                         .+..+..+..+.+++.|++++|.++...
T Consensus        87 N~l~~-~~~~~~~l~~L~~L~l~~~~~-------------------------~~~~~~~~~~l~~l~~L~l~~n~l~~l~  140 (266)
T d1p9ag_          87 NQLQS-LPLLGQTLPALTVLDVSFNRL-------------------------TSLPLGALRGLGELQELYLKGNELKTLP  140 (266)
T ss_dssp             SCCSS-CCCCTTTCTTCCEEECCSSCC-------------------------CCCCSSTTTTCTTCCEEECTTSCCCCCC
T ss_pred             ccccc-ccccccccccccccccccccc-------------------------ceeeccccccccccccccccccccceec
Confidence            77763 455666666666555555554                         4455566778889999999999999888


Q ss_pred             CccccccccccEEEeecccccccCCcchhccCCCCEEEccCCccccccCccccccCCCCeEeCCCCccccccCC
Q 042766          535 PVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSNNLSGKIPEFLENLSFLEFLNLSYNYFEGEVPV  608 (914)
Q Consensus       535 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~  608 (914)
                      +..+..+++|+.|++++|++++..+..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|+|.|+|..
T Consensus       141 ~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~  213 (266)
T d1p9ag_         141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (266)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             cccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcch
Confidence            888999999999999999999999999999999999999999999 7888888899999999999999988764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=9.3e-24  Score=221.34  Aligned_cols=147  Identities=20%  Similarity=0.217  Sum_probs=68.8

Q ss_pred             EecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcc
Q 042766           82 LNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL  161 (914)
Q Consensus        82 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  161 (914)
                      +|.++++|+. +|+.+.  +.+++|+|++|.|++..+..|.++++|++|+|++|+|+ .+|. ++.+++|++|+|++|++
T Consensus        15 v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l   89 (266)
T d1p9ag_          15 VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQL   89 (266)
T ss_dssp             EECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCC
T ss_pred             EEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccccccc
Confidence            4555555542 454442  34566666666665444445566666666666666655 3332 34455555555555555


Q ss_pred             cCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccccccc
Q 042766          162 EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      + .+|..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+++
T Consensus        90 ~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             c-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            4 23334444444444444444444333333344444444444444443333333333333333333333333

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=4.9e-21  Score=209.20  Aligned_cols=305  Identities=23%  Similarity=0.268  Sum_probs=149.4

Q ss_pred             eEEEecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCC
Q 042766           79 LTELNLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASN  158 (914)
Q Consensus        79 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~  158 (914)
                      +++|||++++++ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++.-   .++|++|++++
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~  107 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN  107 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence            455666666654 24432   345556666666665 455433   34555555555554 22211   12345555555


Q ss_pred             CcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCC
Q 042766          159 NKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFP  238 (914)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  238 (914)
                      |.++ .+|. ++.+++|++|++++|.++. .|.                        ..   ..+..+.+..+...  .+
T Consensus       108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~------------------------~~---~~l~~l~~~~~~~~--~~  155 (353)
T d1jl5a_         108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPD------------------------LP---PSLEFIAAGNNQLE--EL  155 (353)
T ss_dssp             SCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCC------------------------CC---TTCCEEECCSSCCS--SC
T ss_pred             cccc-cccc-hhhhccceeeccccccccc-ccc------------------------cc---ccccchhhcccccc--cc
Confidence            5544 3332 3444445555554444442 222                        11   22333333333322  12


Q ss_pred             CccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccc
Q 042766          239 RSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLK  318 (914)
Q Consensus       239 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  318 (914)
                      ..+..++.++.+++++|.+.....     .....+.+..+++.+. .+| .+..++.|+.+++++|......    ....
T Consensus       156 ~~l~~l~~l~~L~l~~n~~~~~~~-----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~~~----~~~~  224 (353)
T d1jl5a_         156 PELQNLPFLTAIYADNNSLKKLPD-----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP----DLPP  224 (353)
T ss_dssp             CCCTTCTTCCEEECCSSCCSSCCC-----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC----SCCT
T ss_pred             ccccccccceeccccccccccccc-----cccccccccccccccc-ccc-cccccccccccccccccccccc----cccc
Confidence            334445555555555555442211     1122334444444443 222 2445666666666666554322    1234


Q ss_pred             cccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCC
Q 042766          319 NLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVN  398 (914)
Q Consensus       319 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~  398 (914)
                      ++..+.+.+|.+....          .....+...++..|.+.+     +..+.......++..|.+.+.    ...+++
T Consensus       225 ~l~~~~~~~~~~~~~~----------~~~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~~----~~~~~~  285 (353)
T d1jl5a_         225 SLEALNVRDNYLTDLP----------ELPQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRSL----CDLPPS  285 (353)
T ss_dssp             TCCEEECCSSCCSCCC----------CCCTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSEE----CCCCTT
T ss_pred             cccccccccccccccc----------cccccccccccccccccc-----cccccchhcccccccCccccc----cccCCC
Confidence            4555566666554431          123445555665555442     111222334455555555432    233567


Q ss_pred             CcEEEcccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccC
Q 042766          399 LITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLG  466 (914)
Q Consensus       399 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  466 (914)
                      |++|+|++|+++ .+|.   .+++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|....
T Consensus       286 L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~~  344 (353)
T d1jl5a_         286 LEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPE  344 (353)
T ss_dssp             CCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCCT
T ss_pred             CCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcccc
Confidence            777788777777 3443   2567777777777777 45532   356777777777776 4555433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=2.3e-22  Score=199.15  Aligned_cols=132  Identities=19%  Similarity=0.216  Sum_probs=103.9

Q ss_pred             cccCcccCCccEEEEEEEECCCcEEEEEEEeeccCC------------------cchHHHHHHHHHHHhcCCCCcceEEe
Q 042766          708 SSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQK------------------GASKSFVSECEALRNIRHRNLIKIIT  769 (914)
Q Consensus       708 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  769 (914)
                      .+.+.||+|+||+||+|++. +|+.||||+++....                  .......+|+..+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            46789999999999999986 688999998753210                  01134567889999999999999876


Q ss_pred             EeecCCCCCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCeee
Q 042766          770 ICSSTDFEGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHCQPPMVHGDLKPSNVLL  849 (914)
Q Consensus       770 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~~~~ivHrDlkp~NILl  849 (914)
                      +.         ..++||||++++...+             ++...+..++.|++.|++|||++   +|+||||||+|||+
T Consensus        82 ~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv  136 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  136 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             ec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheee
Confidence            52         1368999998754432             33334567899999999999999   99999999999999


Q ss_pred             cCCCcEEEecccccccc
Q 042766          850 DYDMVAHVGDFGLAKFL  866 (914)
Q Consensus       850 ~~~~~~ki~DFGla~~~  866 (914)
                      +++ .++++|||+|+..
T Consensus       137 ~~~-~~~liDFG~a~~~  152 (191)
T d1zara2         137 SEE-GIWIIDFPQSVEV  152 (191)
T ss_dssp             ETT-EEEECCCTTCEET
T ss_pred             eCC-CEEEEECCCcccC
Confidence            966 4899999999754

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=3.1e-20  Score=202.67  Aligned_cols=299  Identities=26%  Similarity=0.300  Sum_probs=168.0

Q ss_pred             CCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccc
Q 042766          102 FLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVD  181 (914)
Q Consensus       102 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  181 (914)
                      ++++|||++|+++ .+|+.   .++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .                 
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~-----------------   92 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-A-----------------   92 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-C-----------------
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-h-----------------
Confidence            4677888888777 56753   356777777777777 566543   34555555555554 1                 


Q ss_pred             cccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcc
Q 042766          182 INYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIF  261 (914)
Q Consensus       182 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  261 (914)
                             +++.   .+.|++|++++|.++ .+|. ++.+++|++|++++|.+... |..   ...+..+.+..+..... 
T Consensus        93 -------l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~~-  155 (353)
T d1jl5a_          93 -------LSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEEL-  155 (353)
T ss_dssp             -------CCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSSC-
T ss_pred             -------hhhh---ccccccccccccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccccc-
Confidence                   2211   024666777777666 3443 46677777788877777633 322   34555666666655432 


Q ss_pred             cccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchh
Q 042766          262 PFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFV  341 (914)
Q Consensus       262 p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  341 (914)
                        ..+..++.++.|++++|.+.. .+...   ...+.+..+++.+...  ..+..++.|+.+++++|.....+       
T Consensus       156 --~~l~~l~~l~~L~l~~n~~~~-~~~~~---~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~~~-------  220 (353)
T d1jl5a_         156 --PELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKTLP-------  220 (353)
T ss_dssp             --CCCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSSCC-------
T ss_pred             --ccccccccceecccccccccc-ccccc---cccccccccccccccc--ccccccccccccccccccccccc-------
Confidence              223467788888888887763 23222   2344556666655522  23566777888888877765542       


Q ss_pred             hcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhccc
Q 042766          342 IFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELK  421 (914)
Q Consensus       342 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  421 (914)
                         ....++..+.+.+|++.. .+..    ...+...++..+.+.+...    -.......++..|.+.+..    ..++
T Consensus       221 ---~~~~~l~~~~~~~~~~~~-~~~~----~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~~----~~~~  284 (353)
T d1jl5a_         221 ---DLPPSLEALNVRDNYLTD-LPEL----PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSLC----DLPP  284 (353)
T ss_dssp             ---SCCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEEC----CCCT
T ss_pred             ---cccccccccccccccccc-cccc----ccccccccccccccccccc----ccchhcccccccCcccccc----ccCC
Confidence               234566777777777652 2222    1234445555554432210    0123445556655555322    2245


Q ss_pred             CCceeeecccccccccCccccCCCCCCeEEeeCCcCCCCCCCccCCCCCccccccCCCccC
Q 042766          422 NLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLGSNSLQGNIPSSLGNCQNLILFIASYNKLT  482 (914)
Q Consensus       422 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  482 (914)
                      +|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|++++|+++
T Consensus       285 ~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         285 SLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             TCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS
T ss_pred             CCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC
Confidence            6667777777666 34532   356666667666666 34432   234555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3.2e-22  Score=226.96  Aligned_cols=390  Identities=17%  Similarity=0.175  Sum_probs=183.2

Q ss_pred             cccccccccccccCc-CCcccccccccceeecccCCCCC----CCCccchhhhcccccccccccccCCCCCccccccccc
Q 042766          174 KLQRLSVDINYLTGQ-LPDSVGNLSAIEVIRITENSLGG----KIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVE  248 (914)
Q Consensus       174 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  248 (914)
                      +|++||++.|++++. +.+.+..++++++|+|++|.++.    .+...+..+++|++|||++|+|+...-..        
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~--------   74 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC--------   74 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH--------
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHH--------
Confidence            566677777776642 12334455666666666665541    12233344445555555555443100000        


Q ss_pred             eeeccCCcccCcccccccccCcccceeeccCccCCCC----CCCccccccccccccccCccCCccccccccc-----ccc
Q 042766          249 LIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGS----IPDSLSNASNLELLDLPSNQFKGKVSIDFSS-----LKN  319 (914)
Q Consensus       249 ~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~  319 (914)
                                  +...+.....+|++|+|++|+++..    ++..+..+++|++|+|++|+|+......+..     ...
T Consensus        75 ------------l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~  142 (460)
T d1z7xw1          75 ------------VLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR  142 (460)
T ss_dssp             ------------HHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCC
T ss_pred             ------------HHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccc
Confidence                        0011111223455566665555422    2344555666666666666665332211110     011


Q ss_pred             ccceeccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCC----cCchhhccccccEEEEeeccccccc----CCc
Q 042766          320 LWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGE----LPHSIANLSLKMIELSVGRNQISGT----IPP  391 (914)
Q Consensus       320 L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~~~~~L~~L~L~~N~l~~~----~p~  391 (914)
                      ..........+.....  ......+.....++.++++.+.+...    ....+.........+++..+.+...    ...
T Consensus       143 ~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~  220 (460)
T d1z7xw1         143 LEKLQLEYCSLSAASC--EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  220 (460)
T ss_dssp             CCEEECTTSCCBGGGH--HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             cccccccccccchhhh--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccc
Confidence            1112222221111000  00111234455666777766654311    0111111122334455544443311    111


Q ss_pred             cccCCCCCcEEEcccCccccc-----CChhhhcccCCceeeeccccccccc----CccccCCCCCCeEEeeCCcCCCCCC
Q 042766          392 GIRNLVNLITFTLEVNQFHGT-----IPDVISELKNLQQLSVFNNFLRGGI----PSGLGNLTKLGSLDLGSNSLQGNIP  462 (914)
Q Consensus       392 ~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p  462 (914)
                      .+.....++.+++++|++...     .+..+.....++.+++++|.+....    ...+...+.++.+++++|.++....
T Consensus       221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~  300 (460)
T d1z7xw1         221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA  300 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred             cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            233445566666666655321     1222233455666666666554321    1223445566666666666542111


Q ss_pred             Ccc-----CCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccccceeecccCCccccc----
Q 042766          463 SSL-----GNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLKNLVMLDISSNQFSGV----  533 (914)
Q Consensus       463 ~~~-----~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----  533 (914)
                      ..+     .....|+.+++++|.++......                     +...+...++|++|||++|++++.    
T Consensus       301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~---------------------l~~~~~~~~~L~~L~Ls~N~i~~~g~~~  359 (460)
T d1z7xw1         301 RLLCETLLEPGCQLESLWVKSCSFTAACCSH---------------------FSSVLAQNRFLLELQISNNRLEDAGVRE  359 (460)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCBGGGHHH---------------------HHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred             chhhccccccccccccccccccchhhhhhhh---------------------cccccccccchhhhheeeecccCcccch
Confidence            111     11233444444444443111000                     111223445788888888888653    


Q ss_pred             cCcccc-ccccccEEEeeccccccc----CCcchhccCCCCEEEccCCccccccCccc----c-ccCCCCeEeCCCCccc
Q 042766          534 IPVTLS-TCVSLEYLDISINSFYGV----IPLSFRFLKSIKALNVSSNNLSGKIPEFL----E-NLSFLEFLNLSYNYFE  603 (914)
Q Consensus       534 ~p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~ls~N~l~  603 (914)
                      ++..+. ..+.|++|+|++|.|+..    ++..+...++|++|||++|+|+......+    . +...|+.|++++|.+.
T Consensus       360 l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         360 LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             hhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            222332 356688888888888643    44456667888888888888875433332    2 3346888888888887


Q ss_pred             ccc
Q 042766          604 GEV  606 (914)
Q Consensus       604 ~~~  606 (914)
                      .+.
T Consensus       440 ~~~  442 (460)
T d1z7xw1         440 EEM  442 (460)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=1.3e-19  Score=186.71  Aligned_cols=208  Identities=17%  Similarity=0.101  Sum_probs=109.4

Q ss_pred             ccCCCCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCC-CCccccCCcchhccC-CCcccCCCChhc
Q 042766           92 VLSPYVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIP-TNLSRCSNLIHFCAS-NNKLEGQIPKEI  169 (914)
Q Consensus        92 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~Ls-~N~l~~~~p~~~  169 (914)
                      .+|+.+.  +++++|+|++|.++...+..|.++++|++|+|++|.+...+| ..|..+++++++++. .|++....+..|
T Consensus        22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~   99 (242)
T d1xwdc1          22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF   99 (242)
T ss_dssp             SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred             CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence            3454432  466777777777774444457777777777777777665443 345666666666654 345555555556


Q ss_pred             cccccccccccccccccCcCC-cccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccc
Q 042766          170 GNLLKLQRLSVDINYLTGQLP-DSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVE  248 (914)
Q Consensus       170 ~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  248 (914)
                      .++++|++|++++|+++...+ ..+..+..+..+..+++.+....+..|.+++                       ..++
T Consensus       100 ~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~-----------------------~~l~  156 (242)
T d1xwdc1         100 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS-----------------------FESV  156 (242)
T ss_dssp             ECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB-----------------------SSCE
T ss_pred             cccccccccccchhhhccccccccccccccccccccccccccccccccccccc-----------------------ccce
Confidence            666666666666666553221 1223334444444444444433333333332                       1344


Q ss_pred             eeeccCCcccCcccccccccCccccee-eccCccCCCCCCCccccccccccccccCccCCccccccccccccccceecc
Q 042766          249 LIFLTENRFSGIFPFDILLNLPNLKKL-GIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLE  326 (914)
Q Consensus       249 ~L~L~~N~l~~~~p~~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  326 (914)
                      .|++++|+++. ++...+ ..++++++ ++++|+++...+..|.++++|++|||++|+|+.+++..|.++++|+.+++.
T Consensus       157 ~L~l~~n~l~~-i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         157 ILWLNKNGIQE-IHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EEECCSSCCCE-ECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             eeecccccccc-cccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            44555555542 222333 23333332 345555554334455666666666666666665555556666666555543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.8e-19  Score=184.16  Aligned_cols=106  Identities=23%  Similarity=0.368  Sum_probs=61.6

Q ss_pred             ceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccC
Q 042766          200 EVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGG  279 (914)
Q Consensus       200 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~  279 (914)
                      +.++.+++.++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|.+...+|...|.++++++++.+..
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            45555555555 4444332  35666666666666554555666666666666666665555555555666666666543


Q ss_pred             -ccCCCCCCCccccccccccccccCccCCc
Q 042766          280 -NNFVGSIPDSLSNASNLELLDLPSNQFKG  308 (914)
Q Consensus       280 -N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  308 (914)
                       |++....+..|.++++|++|++++|++..
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             cccccccccccccccccccccccchhhhcc
Confidence             45555555556666666666666666553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=2.2e-22  Score=228.36  Aligned_cols=173  Identities=21%  Similarity=0.086  Sum_probs=108.1

Q ss_pred             ccCCCCCcEEEcccCccccc----CChhhhcccCCceeeecccccccccCccc-----cCCCCCCeEEeeCCcCCCCCCC
Q 042766          393 IRNLVNLITFTLEVNQFHGT----IPDVISELKNLQQLSVFNNFLRGGIPSGL-----GNLTKLGSLDLGSNSLQGNIPS  463 (914)
Q Consensus       393 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p~  463 (914)
                      +.....++.+++++|.+...    ....+...+.++.+++++|.+++.....+     .....|+.+++++|.++.....
T Consensus       251 ~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~  330 (460)
T d1z7xw1         251 LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS  330 (460)
T ss_dssp             TSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhh
Confidence            34456677788888777633    22345567788888888888764322222     2345788888888887754322


Q ss_pred             ----ccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccc-cccccceeecccCCccccc----c
Q 042766          464 ----SLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQV-GNLKNLVMLDISSNQFSGV----I  534 (914)
Q Consensus       464 ----~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~----~  534 (914)
                          .+...++|+.|++++|++++.   ++.                  .++..+ ...+.|++|+|++|+|+..    +
T Consensus       331 ~l~~~~~~~~~L~~L~Ls~N~i~~~---g~~------------------~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l  389 (460)
T d1z7xw1         331 HFSSVLAQNRFLLELQISNNRLEDA---GVR------------------ELCQGLGQPGSVLRVLWLADCDVSDSSCSSL  389 (460)
T ss_dssp             HHHHHHHHCSSCCEEECCSSBCHHH---HHH------------------HHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred             hcccccccccchhhhheeeecccCc---ccc------------------hhhhhhhcccCCCCEEECCCCCCChHHHHHH
Confidence                233445677777777666421   010                  011122 1345688889999888753    3


Q ss_pred             CccccccccccEEEeecccccccCCcchh-----ccCCCCEEEccCCccccccCccc
Q 042766          535 PVTLSTCVSLEYLDISINSFYGVIPLSFR-----FLKSIKALNVSSNNLSGKIPEFL  586 (914)
Q Consensus       535 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~  586 (914)
                      +..+..+++|++|||++|+|+......|.     +...|+.|++++|.+....+..+
T Consensus       390 ~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l  446 (460)
T d1z7xw1         390 AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  446 (460)
T ss_dssp             HHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             HHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence            44566778899999999988754433332     33479999999999886655544

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=2e-19  Score=177.85  Aligned_cols=172  Identities=22%  Similarity=0.349  Sum_probs=87.0

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcC-CCCccccCCcchhccCCCcccCCCChhcccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTI-PTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDI  182 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  182 (914)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++.+ +..|+++++|++|+|++|++.+..+..+..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            45666666666 5665543  45666666666665433 33344555555555555555544444444444444444444


Q ss_pred             ccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCccc
Q 042766          183 NYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFP  262 (914)
Q Consensus       183 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  262 (914)
                      |+|                        ++..|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+....+
T Consensus        88 N~l------------------------~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          88 NKI------------------------KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCC------------------------CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             ccc------------------------cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            444                        44444445555555555555555555445555555555555555555543322


Q ss_pred             ccccccCcccceeeccCccCCCCCCCccccccccccccccCccCC
Q 042766          263 FDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFK  307 (914)
Q Consensus       263 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  307 (914)
                      ...+  ...++.+.+..|.++...|..   +..++.+||+.|.++
T Consensus       144 ~~~~--~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         144 LAWF--AEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK  183 (192)
T ss_dssp             GHHH--HHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred             hHHH--hhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence            2211  123444455555555444433   234455566666554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=2.7e-19  Score=182.18  Aligned_cols=77  Identities=30%  Similarity=0.400  Sum_probs=37.6

Q ss_pred             cCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCC
Q 042766          268 NLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNC  347 (914)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l  347 (914)
                      +.++|++|++++|.+.+.  ..++++++|++|||++|+++++.+  |+++++|++|+|++|+++.++        .++++
T Consensus       149 ~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~--------~l~~l  216 (227)
T d1h6ua2         149 GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--------PLANT  216 (227)
T ss_dssp             GCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--------GGTTC
T ss_pred             cccccccccccccccccc--hhhcccccceecccCCCccCCChh--hcCCCCCCEEECcCCcCCCCc--------ccccC
Confidence            344455555555544422  124455555555555555554322  455555555555555554431        14455


Q ss_pred             CCCcEEecc
Q 042766          348 SSLKVLSLS  356 (914)
Q Consensus       348 ~~L~~L~Ls  356 (914)
                      ++|++|+++
T Consensus       217 ~~L~~L~ls  225 (227)
T d1h6ua2         217 SNLFIVTLT  225 (227)
T ss_dssp             TTCCEEEEE
T ss_pred             CCCCEEEee
Confidence            566666554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=4.1e-19  Score=175.61  Aligned_cols=169  Identities=17%  Similarity=0.206  Sum_probs=138.2

Q ss_pred             ecCCCCCccccCCCCCCCCCCCEEEcCCCCCcccC-CcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcc
Q 042766           83 NLSSQRIGGVLSPYVGNLSFLRYINLADNGFRGDI-PQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKL  161 (914)
Q Consensus        83 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  161 (914)
                      +.++++|+ .+|+.+.  +++++|+|++|.|++.+ +..|+++++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus        14 ~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l   90 (192)
T d1w8aa_          14 DCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence            34455665 4676653  68999999999998755 56689999999999999999988999999999999999999999


Q ss_pred             cCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCcc
Q 042766          162 EGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSI  241 (914)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  241 (914)
                      ++..|.+|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+.... ....-...++.+.+..|.++...|..+
T Consensus        91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~p~~l  169 (192)
T d1w8aa_          91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGAPSKV  169 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCSSTTT
T ss_pred             cccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCCChhh
Confidence            9888889999999999999999999888899999999999999999998443 323334457778888888877666544


Q ss_pred             ccccccceeeccCCccc
Q 042766          242 CNISSVELIFLTENRFS  258 (914)
Q Consensus       242 ~~l~~L~~L~L~~N~l~  258 (914)
                         ..++.++|+.|.+.
T Consensus       170 ---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         170 ---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             ---TTSBGGGSCTTTCC
T ss_pred             ---cCCEeeecCHhhCc
Confidence               34556667776664

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.7e-18  Score=174.67  Aligned_cols=208  Identities=24%  Similarity=0.345  Sum_probs=95.7

Q ss_pred             ccccceeecccCCCCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCccccee
Q 042766          196 LSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKL  275 (914)
Q Consensus       196 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L  275 (914)
                      +.++..++++.+++++.+  .+..+.+|+.|++.+|.|+..  +.+..+++|++|++++|++++..|   +.++++|+++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l   90 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc---cccccccccc
Confidence            334444555555555432  345555666666666655532  235555555555555555554322   2344455555


Q ss_pred             eccCccCCCCCCCccccccccccccccCccCCccccccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEec
Q 042766          276 GIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSL  355 (914)
Q Consensus       276 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L  355 (914)
                      ++++|.++. + ..+..+++|+.+++++|...+..+                                +...+.++.+.+
T Consensus        91 ~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~--------------------------------~~~~~~~~~l~~  136 (227)
T d1h6ua2          91 ELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDVTP--------------------------------LAGLSNLQVLYL  136 (227)
T ss_dssp             ECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCCGG--------------------------------GTTCTTCCEEEC
T ss_pred             ccccccccc-c-ccccccccccccccccccccccch--------------------------------hccccchhhhhc
Confidence            555554442 1 123444444444444444332211                                223334444444


Q ss_pred             cccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCcccccCChhhhcccCCceeeeccccccc
Q 042766          356 SDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFHGTIPDVISELKNLQQLSVFNNFLRG  435 (914)
Q Consensus       356 s~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  435 (914)
                      +.+.+....+  +.... +++.|++++|.+.+.  ..++++++|++|+|++|++++. + .+..+++|++|+|++|++++
T Consensus       137 ~~~~~~~~~~--~~~~~-~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         137 DLNQITNISP--LAGLT-NLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             CSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             hhhhhchhhh--hcccc-ccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCC
Confidence            4444332111  11111 233344444433321  1245555666666666665542 2 25555666666666666554


Q ss_pred             ccCccccCCCCCCeEEee
Q 042766          436 GIPSGLGNLTKLGSLDLG  453 (914)
Q Consensus       436 ~~p~~~~~l~~L~~L~Ls  453 (914)
                      ..|  +.++++|++|+++
T Consensus       210 i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         210 VSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CGG--GTTCTTCCEEEEE
T ss_pred             Ccc--cccCCCCCEEEee
Confidence            322  5555666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=7.3e-18  Score=168.98  Aligned_cols=164  Identities=29%  Similarity=0.378  Sum_probs=82.6

Q ss_pred             ccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccccccccccccccce
Q 042766          244 ISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWLL  323 (914)
Q Consensus       244 l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  323 (914)
                      +.+|+.|++++|.+++..+   +..+++|++|+|++|+|++..  .++.+++|++|++++|+|+++.  .+..+++|+.|
T Consensus        45 L~~L~~L~l~~~~i~~l~~---l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L  117 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSL  117 (210)
T ss_dssp             HHTCCEEECTTSCCCCCTT---GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEE
T ss_pred             hcCccEEECcCCCCCCchh---HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--ccccccccccc
Confidence            3444444555554443211   234555555555555555322  2445555555555555555432  24555555555


Q ss_pred             eccCCcCCCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEE
Q 042766          324 NLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFT  403 (914)
Q Consensus       324 ~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  403 (914)
                      ++++|.+...        ..+..+++++.+++++|.+++                           +..+..+++|++++
T Consensus       118 ~l~~~~~~~~--------~~l~~l~~l~~l~~~~n~l~~---------------------------~~~~~~l~~L~~l~  162 (210)
T d1h6ta2         118 SLEHNGISDI--------NGLVHLPQLESLYLGNNKITD---------------------------ITVLSRLTKLDTLS  162 (210)
T ss_dssp             ECTTSCCCCC--------GGGGGCTTCCEEECCSSCCCC---------------------------CGGGGGCTTCSEEE
T ss_pred             cccccccccc--------ccccccccccccccccccccc---------------------------cccccccccccccc
Confidence            5555554332        123444555555555554431                           12233455566666


Q ss_pred             cccCcccccCChhhhcccCCceeeecccccccccCccccCCCCCCeEEee
Q 042766          404 LEVNQFHGTIPDVISELKNLQQLSVFNNFLRGGIPSGLGNLTKLGSLDLG  453 (914)
Q Consensus       404 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  453 (914)
                      +++|++++..+  +.++++|++|+|++|+|+. +| .|.++++|++|+|+
T Consensus       163 l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         163 LEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             ccccccccccc--ccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            66666654322  5566666666666666653 33 35666666666665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=3.8e-18  Score=171.06  Aligned_cols=183  Identities=22%  Similarity=0.299  Sum_probs=97.8

Q ss_pred             cchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhhccccccccc
Q 042766          151 LIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLRRLVNLNVAE  230 (914)
Q Consensus       151 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  230 (914)
                      ....+++.+.+++.++.  ..+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..  .++.+++|++|++++
T Consensus        26 ~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~   99 (210)
T d1h6ta2          26 TIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDE   99 (210)
T ss_dssp             HHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred             HHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccc
Confidence            33444555555443332  234555555666655553 22 2455556666666666555422  245555666666666


Q ss_pred             ccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCccCCccc
Q 042766          231 NQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSNQFKGKV  310 (914)
Q Consensus       231 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  310 (914)
                      |++++ +| .+.++++|+.|++++|.+... +  .+..+++++.+++++|.+++  +..+..+++|+++++++|+++++.
T Consensus       100 n~i~~-l~-~l~~l~~L~~L~l~~~~~~~~-~--~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~  172 (210)
T d1h6ta2         100 NKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N--GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV  172 (210)
T ss_dssp             SCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G--GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG
T ss_pred             ccccc-cc-ccccccccccccccccccccc-c--cccccccccccccccccccc--cccccccccccccccccccccccc
Confidence            66553 22 355566666666666655432 1  23355666666666666653  234555666666666666666543


Q ss_pred             cccccccccccceeccCCcCCCCCCCCcchhhcccCCCCCcEEecc
Q 042766          311 SIDFSSLKNLWLLNLEQNNLGTGTANDLDFVIFLSNCSSLKVLSLS  356 (914)
Q Consensus       311 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls  356 (914)
                      +  +.++++|++|+|++|+|+.+       + .+.++++|++|+|+
T Consensus       173 ~--l~~l~~L~~L~Ls~N~i~~l-------~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         173 P--LAGLTKLQNLYLSKNHISDL-------R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             G--GTTCTTCCEEECCSSCCCBC-------G-GGTTCTTCSEEEEE
T ss_pred             c--ccCCCCCCEEECCCCCCCCC-------h-hhcCCCCCCEEEcc
Confidence            2  55666666666666666543       1 24556666666664

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=4.3e-18  Score=169.16  Aligned_cols=107  Identities=27%  Similarity=0.414  Sum_probs=46.3

Q ss_pred             chhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCcccccccc
Q 042766          217 LGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNL  296 (914)
Q Consensus       217 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  296 (914)
                      ++++++|++|++++|.+... + .+.++++|+.|++++|.+....   .+..+++|+.|++++|++.. + +.+..+++|
T Consensus        80 l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~~---~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L  152 (199)
T d2omxa2          80 LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDID---PLKNLTNLNRLELSSNTISD-I-SALSGLTSL  152 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTC
T ss_pred             ccCCcccccccccccccccc-c-cccccccccccccccccccccc---ccchhhhhHHhhhhhhhhcc-c-ccccccccc
Confidence            33344444444444443321 1 2334444444444444443321   12244445555555554442 1 234445555


Q ss_pred             ccccccCccCCccccccccccccccceeccCCcCCC
Q 042766          297 ELLDLPSNQFKGKVSIDFSSLKNLWLLNLEQNNLGT  332 (914)
Q Consensus       297 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  332 (914)
                      +.|++++|++++..  .|.++++|++|++++|+++.
T Consensus       153 ~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         153 QQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             SEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence            55555555554432  24455555555555555543

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=7.2e-18  Score=167.51  Aligned_cols=177  Identities=24%  Similarity=0.342  Sum_probs=91.0

Q ss_pred             eeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCC
Q 042766          129 KLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENS  208 (914)
Q Consensus       129 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  208 (914)
                      .++++.+++++.++  ...+.++++|++++|.++ .+ +.+..+++|++|+|++|++++..|  ++++++|++|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Cc-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            34455555554332  234555556666666555 22 235555556666666665553322  5555566666666655


Q ss_pred             CCCCCCccchhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCC
Q 042766          209 LGGKIPTTLGLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPD  288 (914)
Q Consensus       209 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~  288 (914)
                      +.. +| .++++++|+.|++++|.+...  ..+..+++|+.|++++|++... +  .+..+++|++|++++|++++..  
T Consensus        96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~--~l~~~~~L~~L~l~~n~l~~l~--  166 (199)
T d2omxa2          96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI-S--ALSGLTSLQQLNFSSNQVTDLK--  166 (199)
T ss_dssp             CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G--GGTTCTTCSEEECCSSCCCCCG--
T ss_pred             ccc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc-c--cccccccccccccccccccCCc--
Confidence            542 22 255555566666665555432  2345555566666666655432 1  1335555666666666555321  


Q ss_pred             ccccccccccccccCccCCccccccccccccccc
Q 042766          289 SLSNASNLELLDLPSNQFKGKVSIDFSSLKNLWL  322 (914)
Q Consensus       289 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  322 (914)
                      .++++++|++|++++|+|+++.  .++++++|++
T Consensus       167 ~l~~l~~L~~L~ls~N~i~~i~--~l~~L~~L~~  198 (199)
T d2omxa2         167 PLANLTTLERLDISSNKVSDIS--VLAKLTNLES  198 (199)
T ss_dssp             GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCSE
T ss_pred             cccCCCCCCEEECCCCCCCCCc--cccCCCCCCc
Confidence            2555556666666666555432  2444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=2.1e-16  Score=166.16  Aligned_cols=159  Identities=15%  Similarity=0.167  Sum_probs=76.6

Q ss_pred             cccccccccccccccccCcCCcccccccccceeecccC-CCCCC-CCccchhhhcccccccccc-cccC-CCCCcccc-c
Q 042766          170 GNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN-SLGGK-IPTTLGLLRRLVNLNVAEN-QFSG-MFPRSICN-I  244 (914)
Q Consensus       170 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~-~~p~~~~~-l  244 (914)
                      ..+++|++|+|+++.+++..+..++.+++|++|+++++ .++.. +...+.++++|++|+++++ .++. .++..+.. .
T Consensus        68 ~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~  147 (284)
T d2astb2          68 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS  147 (284)
T ss_dssp             TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred             HhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccc
Confidence            33444444444444444333344444444444444442 22211 1111233445555555543 2221 01111111 2


Q ss_pred             cccceeeccCC--cccCcccccccccCcccceeeccCc-cCCCCCCCccccccccccccccCc-cCCccccccccccccc
Q 042766          245 SSVELIFLTEN--RFSGIFPFDILLNLPNLKKLGIGGN-NFVGSIPDSLSNASNLELLDLPSN-QFKGKVSIDFSSLKNL  320 (914)
Q Consensus       245 ~~L~~L~L~~N--~l~~~~p~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L  320 (914)
                      ++|+.|+++++  .++...-..+..++++|++|+|++| .+++.....+..+++|++|+|+++ .+++.....++++++|
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L  227 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL  227 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence            45556666543  2322211223345677777777765 455555566667777777777773 5665555556666677


Q ss_pred             cceeccCC
Q 042766          321 WLLNLEQN  328 (914)
Q Consensus       321 ~~L~L~~N  328 (914)
                      +.|+++++
T Consensus       228 ~~L~l~~~  235 (284)
T d2astb2         228 KTLQVFGI  235 (284)
T ss_dssp             CEEECTTS
T ss_pred             CEEeeeCC
Confidence            77776655

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=3.6e-15  Score=134.71  Aligned_cols=102  Identities=25%  Similarity=0.338  Sum_probs=51.6

Q ss_pred             CEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccc
Q 042766          104 RYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDIN  183 (914)
Q Consensus       104 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (914)
                      |+|||++|+++ .+| .++++++|++||+++|+|+ .+|+.++.+++|++|++++|++++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            35555555555 333 2555555555555555555 445555555555555555555552 22 2455555555555555


Q ss_pred             cccCcC-CcccccccccceeecccCCCC
Q 042766          184 YLTGQL-PDSVGNLSAIEVIRITENSLG  210 (914)
Q Consensus       184 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~  210 (914)
                      +++... ...++.+++|++|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            554221 123444444555555554443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.3e-15  Score=143.20  Aligned_cols=127  Identities=17%  Similarity=0.132  Sum_probs=83.1

Q ss_pred             CCCCCCCCCEEEcCCCCCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccc
Q 042766           96 YVGNLSFLRYINLADNGFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKL  175 (914)
Q Consensus        96 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  175 (914)
                      .+.+...+++|||++|+|+ .+|..+..+++|++||||+|+++ .++ .+..+++|++|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3556667788888888887 55666667788888888888887 453 46777777777777777774444445567777


Q ss_pred             cccccccccccCcCC--cccccccccceeecccCCCCCCCCc----cchhhhcccccc
Q 042766          176 QRLSVDINYLTGQLP--DSVGNLSAIEVIRITENSLGGKIPT----TLGLLRRLVNLN  227 (914)
Q Consensus       176 ~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~  227 (914)
                      ++|+|++|+++. ++  ..+..+++|++|++++|.++. .|.    .+..+++|++||
T Consensus        90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            777777777763 22  345566666666666666652 222    344555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=4.8e-15  Score=133.92  Aligned_cols=103  Identities=24%  Similarity=0.309  Sum_probs=78.2

Q ss_pred             CeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccC
Q 042766          128 EKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITEN  207 (914)
Q Consensus       128 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  207 (914)
                      |+|||++|+++ .+| .+.++++|++||+++|+++ .+|+.++.+++|++|++++|++++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57889999987 555 4888888888888888887 677778888888888888888874 44 4777888888888888


Q ss_pred             CCCCCC-CccchhhhcccccccccccccC
Q 042766          208 SLGGKI-PTTLGLLRRLVNLNVAENQFSG  235 (914)
Q Consensus       208 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~  235 (914)
                      +++... ...++.+++|++|++++|.++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            877433 2456667777777777777663

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=5.3e-15  Score=140.62  Aligned_cols=18  Identities=22%  Similarity=0.272  Sum_probs=7.7

Q ss_pred             cccccccccccccCccCC
Q 042766          290 LSNASNLELLDLPSNQFK  307 (914)
Q Consensus       290 ~~~l~~L~~L~Ls~N~l~  307 (914)
                      +..+++|++|++++|.++
T Consensus       108 l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_         108 LASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             GGGCTTCCEEECCSSGGG
T ss_pred             cccccccchhhcCCCccc
Confidence            333444444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.49  E-value=2.1e-15  Score=158.32  Aligned_cols=185  Identities=20%  Similarity=0.185  Sum_probs=100.5

Q ss_pred             cccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCccccccccccccccCc-cCCccc-cccccccccc
Q 042766          243 NISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDSLSNASNLELLDLPSN-QFKGKV-SIDFSSLKNL  320 (914)
Q Consensus       243 ~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~-~~~~~~l~~L  320 (914)
                      ...+|++||++++.++......++..+++|++|+|++|.+.+..+..++.+++|++|+|+++ .++... ...+.++++|
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence            44567777777776654444455666777777777777776655666666777777777774 454221 1122345666


Q ss_pred             cceeccCC-cCCCCCCCCcchhhcc-cCCCCCcEEeccccccCCCcCchhhccccccEEEEeeccccccc-CCccccCCC
Q 042766          321 WLLNLEQN-NLGTGTANDLDFVIFL-SNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGT-IPPGIRNLV  397 (914)
Q Consensus       321 ~~L~L~~N-~l~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~-~p~~~~~l~  397 (914)
                      ++|+++++ .++...     ....+ ...++|+.|++++..-                       .++.. +...+.+++
T Consensus       124 ~~L~ls~c~~~~~~~-----~~~~~~~~~~~L~~L~l~~~~~-----------------------~i~~~~l~~l~~~~~  175 (284)
T d2astb2         124 DELNLSWCFDFTEKH-----VQVAVAHVSETITQLNLSGYRK-----------------------NLQKSDLSTLVRRCP  175 (284)
T ss_dssp             CEEECCCCTTCCHHH-----HHHHHHHSCTTCCEEECCSCGG-----------------------GSCHHHHHHHHHHCT
T ss_pred             ccccccccccccccc-----chhhhcccccccchhhhccccc-----------------------ccccccccccccccc
Confidence            66666653 222110     11111 1234555555554311                       11111 111223456


Q ss_pred             CCcEEEcccC-cccccCChhhhcccCCceeeeccc-ccccccCccccCCCCCCeEEeeCC
Q 042766          398 NLITFTLEVN-QFHGTIPDVISELKNLQQLSVFNN-FLRGGIPSGLGNLTKLGSLDLGSN  455 (914)
Q Consensus       398 ~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N  455 (914)
                      +|++|++++| .+++.....+..+++|++|+|++| .+++.....++++++|+.|+++++
T Consensus       176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            6666666654 355555555666666666666663 455554555666666777776665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=8.9e-16  Score=166.42  Aligned_cols=142  Identities=18%  Similarity=0.207  Sum_probs=85.7

Q ss_pred             CCCCCCeEEeeCCcCCCC----CCCccCCCCCccccccCCCccCCCCchhhhcccchhhhhcccCCccCCCccccccccc
Q 042766          443 NLTKLGSLDLGSNSLQGN----IPSSLGNCQNLILFIASYNKLTGDLPQQLLSITTLSLVLDLSNNLLNGSLPLQVGNLK  518 (914)
Q Consensus       443 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~p~~~~~l~  518 (914)
                      ..+.|+.+++++|+++..    +...+..++.|+.|++++|+++.   ..+..                 .+...+...+
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~---~g~~~-----------------~l~~~l~~~~  215 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP---EGIEH-----------------LLLEGLAYCQ  215 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH---HHHHH-----------------HHHTTGGGCT
T ss_pred             cCcccceeecccccccccccccccchhhhhhhhcccccccccccc---ccccc-----------------chhhhhcchh
Confidence            345677777777766522    22233445556666666665541   11000                 1122345567


Q ss_pred             cceeecccCCccccc----cCccccccccccEEEeecccccccCCcch----hc--cCCCCEEEccCCccccc----cCc
Q 042766          519 NLVMLDISSNQFSGV----IPVTLSTCVSLEYLDISINSFYGVIPLSF----RF--LKSIKALNVSSNNLSGK----IPE  584 (914)
Q Consensus       519 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~----~p~  584 (914)
                      +|+.|+|++|+++..    +...+..+++|++|+|++|.|++.-...+    ..  .+.|++||+++|+|+..    +..
T Consensus       216 ~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~  295 (344)
T d2ca6a1         216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT  295 (344)
T ss_dssp             TCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHH
T ss_pred             hhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHH
Confidence            788888888887543    33456677888888888888765433333    22  35788889988888643    233


Q ss_pred             ccc-ccCCCCeEeCCCCcccc
Q 042766          585 FLE-NLSFLEFLNLSYNYFEG  604 (914)
Q Consensus       585 ~~~-~l~~L~~L~ls~N~l~~  604 (914)
                      .+. +.+.|++|+|++|++..
T Consensus       296 ~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         296 VIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHccCCCCCEEECCCCcCCC
Confidence            342 56788899999998864

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.43  E-value=3.7e-15  Score=161.45  Aligned_cols=193  Identities=18%  Similarity=0.266  Sum_probs=100.6

Q ss_pred             cCcccceeeccCccCCCC----CCCccccccccccccccCccCCccccccc-------------cccccccceeccCCcC
Q 042766          268 NLPNLKKLGIGGNNFVGS----IPDSLSNASNLELLDLPSNQFKGKVSIDF-------------SSLKNLWLLNLEQNNL  330 (914)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l  330 (914)
                      ..++|++|+|++|.+...    +...+...++|++|++++|.+.......+             ...+.|+.+++++|.+
T Consensus        91 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1          91 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred             hCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccc
Confidence            445666666666665532    12233345666666666666542211111             1233445555555544


Q ss_pred             CCCCCCCcchhhcccCCCCCcEEeccccccCCCcCchhhccccccEEEEeecccccccCCccccCCCCCcEEEcccCccc
Q 042766          331 GTGTANDLDFVIFLSNCSSLKVLSLSDNQFGGELPHSIANLSLKMIELSVGRNQISGTIPPGIRNLVNLITFTLEVNQFH  410 (914)
Q Consensus       331 ~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  410 (914)
                      +.....  .+...+...+.|+.|+|++|+++..   .+                 ...+...+..+++|+.|+|++|.++
T Consensus       171 ~~~~~~--~l~~~l~~~~~L~~L~L~~n~i~~~---g~-----------------~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         171 ENGSMK--EWAKTFQSHRLLHTVKMVQNGIRPE---GI-----------------EHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             TGGGHH--HHHHHHHHCTTCCEEECCSSCCCHH---HH-----------------HHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             cccccc--cccchhhhhhhhccccccccccccc---cc-----------------ccchhhhhcchhhhccccccccccc
Confidence            322111  0222233444555555555544311   00                 0012334566677777777777765


Q ss_pred             cc----CChhhhcccCCceeeecccccccccCccc----c--CCCCCCeEEeeCCcCCCC----CCCccC-CCCCccccc
Q 042766          411 GT----IPDVISELKNLQQLSVFNNFLRGGIPSGL----G--NLTKLGSLDLGSNSLQGN----IPSSLG-NCQNLILFI  475 (914)
Q Consensus       411 ~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~  475 (914)
                      ..    +...+...++|++|+|++|.|++.-...+    .  ....|++||+++|+|+..    +...+. ++++|+.|+
T Consensus       229 ~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~  308 (344)
T d2ca6a1         229 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE  308 (344)
T ss_dssp             HHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEE
T ss_pred             ccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEE
Confidence            32    33445667777777777777765422222    2  235677888888877532    223332 466778888


Q ss_pred             cCCCccC
Q 042766          476 ASYNKLT  482 (914)
Q Consensus       476 l~~N~l~  482 (914)
                      +++|++.
T Consensus       309 l~~N~~~  315 (344)
T d2ca6a1         309 LNGNRFS  315 (344)
T ss_dssp             CTTSBSC
T ss_pred             CCCCcCC
Confidence            8888876

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.40  E-value=2.8e-15  Score=147.81  Aligned_cols=113  Identities=23%  Similarity=0.284  Sum_probs=59.1

Q ss_pred             CCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccc
Q 042766          117 IPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNL  196 (914)
Q Consensus       117 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  196 (914)
                      +|.++..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.++ .+|..+..+++|++|++++|+++. ++ .+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccc
Confidence            4445666666666666666665 343 3556666666666666665 444444444556666666665552 22 24445


Q ss_pred             cccceeecccCCCCCCCC-ccchhhhccccccccccccc
Q 042766          197 SAIEVIRITENSLGGKIP-TTLGLLRRLVNLNVAENQFS  234 (914)
Q Consensus       197 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  234 (914)
                      ++|++|++++|+++.... ..+..+++|++|+|++|.+.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            555555555555542211 23444445555555555444

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=6.2e-15  Score=145.28  Aligned_cols=88  Identities=20%  Similarity=0.296  Sum_probs=38.3

Q ss_pred             CCCccccCCcchhccCCCcccCCCChhccccccccccccccccccCcCCcccccccccceeecccCCCCCCCCccchhhh
Q 042766          142 PTNLSRCSNLIHFCASNNKLEGQIPKEIGNLLKLQRLSVDINYLTGQLPDSVGNLSAIEVIRITENSLGGKIPTTLGLLR  221 (914)
Q Consensus       142 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  221 (914)
                      |.+++.+++|++|+|++|+++ .++ .+..+++|++|+|++|+++ .+|..+..+++|++|++++|+++..  ..+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence            334444555555555555554 232 2444445555555555444 3333333333444444444444421  1233444


Q ss_pred             ccccccccccccc
Q 042766          222 RLVNLNVAENQFS  234 (914)
Q Consensus       222 ~L~~L~Ls~N~l~  234 (914)
                      +|++|+|++|+++
T Consensus       116 ~L~~L~L~~N~i~  128 (198)
T d1m9la_         116 NLRVLYMSNNKIT  128 (198)
T ss_dssp             HSSEEEESEEECC
T ss_pred             cccccccccchhc
Confidence            4444444444443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=7.5e-13  Score=124.57  Aligned_cols=110  Identities=22%  Similarity=0.149  Sum_probs=93.6

Q ss_pred             hhcccCCccCCCccccccccccceeecccCC-ccccccCccccccccccEEEeecccccccCCcchhccCCCCEEEccCC
Q 042766          498 VLDLSNNLLNGSLPLQVGNLKNLVMLDISSN-QFSGVIPVTLSTCVSLEYLDISINSFYGVIPLSFRFLKSIKALNVSSN  576 (914)
Q Consensus       498 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  576 (914)
                      .++.+++.+. ..|..+..+++|+.|++++| .++.+.+.+|.++++|+.|+|++|+|+++.|.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            4566666665 45777888899999999876 599888889999999999999999999999999999999999999999


Q ss_pred             ccccccCccccccCCCCeEeCCCCccccccCCC
Q 042766          577 NLSGKIPEFLENLSFLEFLNLSYNYFEGEVPVK  609 (914)
Q Consensus       577 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~  609 (914)
                      +|+...+..+..+ +|+.|+|++|+|.|.+-..
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~  122 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLHCSCALR  122 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGH
T ss_pred             CCcccChhhhccc-cccccccCCCcccCCchHH
Confidence            9996666666655 6999999999999877543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=2.7e-12  Score=120.66  Aligned_cols=92  Identities=17%  Similarity=0.119  Sum_probs=51.3

Q ss_pred             cCCCCCCCCCCCEEEcCCC-CCcccCCcccCCCCCCCeeecCCCCCCCcCCCCccccCCcchhccCCCcccCCCChhccc
Q 042766           93 LSPYVGNLSFLRYINLADN-GFRGDIPQEIGNLFRLEKLALSNNSFSGTIPTNLSRCSNLIHFCASNNKLEGQIPKEIGN  171 (914)
Q Consensus        93 ~~~~l~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~  171 (914)
                      .|..+..+++|++|++++| .++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|.....
T Consensus        23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~  101 (156)
T d2ifga3          23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ  101 (156)
T ss_dssp             TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTC
T ss_pred             CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhc
Confidence            3455566666777777554 366444455666666666666666666444555566666666666666665 33332222


Q ss_pred             cccccccccccccc
Q 042766          172 LLKLQRLSVDINYL  185 (914)
Q Consensus       172 l~~L~~L~L~~N~l  185 (914)
                      ..+|++|+|++|.+
T Consensus       102 ~~~l~~L~L~~Np~  115 (156)
T d2ifga3         102 GLSLQELVLSGNPL  115 (156)
T ss_dssp             SCCCCEEECCSSCC
T ss_pred             cccccccccCCCcc
Confidence            22455555555544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=4.4e-09  Score=99.00  Aligned_cols=59  Identities=22%  Similarity=0.202  Sum_probs=25.3

Q ss_pred             hhhhcccccccccccccCCCCCccccccccceeeccCCcccCcccc------cccccCcccceee
Q 042766          218 GLLRRLVNLNVAENQFSGMFPRSICNISSVELIFLTENRFSGIFPF------DILLNLPNLKKLG  276 (914)
Q Consensus       218 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------~~~~~l~~L~~L~  276 (914)
                      ..+++|+.|+|++|+|+...+-.+....+|+.|++++|.+......      .++..+|+|++||
T Consensus        88 ~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          88 QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             HHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             hhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            3344444444444444432221222223444455555544432221      2344567777664

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=5.1e-09  Score=98.55  Aligned_cols=84  Identities=18%  Similarity=0.249  Sum_probs=46.7

Q ss_pred             cchhhhcccccccccccccCCC--CCccccccccceeeccCCcccCcccccccccCcccceeeccCccCCCCCCCc----
Q 042766          216 TLGLLRRLVNLNVAENQFSGMF--PRSICNISSVELIFLTENRFSGIFPFDILLNLPNLKKLGIGGNNFVGSIPDS----  289 (914)
Q Consensus       216 ~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~Ls~N~l~~~~p~~----  289 (914)
                      .+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.++..-+.... ...+|+.|+|++|.+.......    
T Consensus        60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l-~~~~L~~L~L~~Npl~~~~~~~~~y~  138 (162)
T d1koha1          60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI-KGLKLEELWLDGNSLSDTFRDQSTYI  138 (162)
T ss_dssp             HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHH-TTCCCSSCCCTTSTTSSSSSSHHHHH
T ss_pred             HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhh-hccccceeecCCCCcCcCcccchhHH
Confidence            3344555666666666665432  34455666777777777776654332222 3445677777777666443321    


Q ss_pred             ---ccccccccccc
Q 042766          290 ---LSNASNLELLD  300 (914)
Q Consensus       290 ---~~~l~~L~~L~  300 (914)
                         +..+++|+.||
T Consensus       139 ~~i~~~~P~L~~LD  152 (162)
T d1koha1         139 SAIRERFPKLLRLD  152 (162)
T ss_dssp             HHHHTTSTTCCEET
T ss_pred             HHHHHHCCCCCEEC
Confidence               44566666665

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=1.4e-06  Score=88.71  Aligned_cols=150  Identities=17%  Similarity=0.153  Sum_probs=101.3

Q ss_pred             HHHHHHhhcccccCcccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcC-CCCcceEEeEeecCCC
Q 042766          698 AELSKATSEFSSSNMIGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIR-HRNLIKIITICSSTDF  776 (914)
Q Consensus       698 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  776 (914)
                      .++....+.|+..+..+.++.+.||+...  ++..+++|+...........+.+|+..++.+. +--+.+++.+..    
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----   80 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----   80 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----
Confidence            34555566777666655455578998764  45567788876554444556788999888774 333566666633    


Q ss_pred             CCCceEeEEEecccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------
Q 042766          777 EGVDFKALVFEYMENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHHHC-----------------------  833 (914)
Q Consensus       777 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~~~-----------------------  833 (914)
                       ..+..++||++++|.++.+.....        .   ....++.++++.++.||+..                       
T Consensus        81 -~~~~~~lv~~~l~G~~~~~~~~~~--------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (263)
T d1j7la_          81 -HDGWSNLLMSEADGVLCSEEYEDE--------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN  148 (263)
T ss_dssp             -ETTEEEEEEECCSSEEHHHHTTTC--------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred             -cCCceEEEEEeccccccccccccc--------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence             234778999999998887654321        1   12234566666677777521                       


Q ss_pred             ---------------------------------CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          834 ---------------------------------QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       834 ---------------------------------~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                                                       .+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                             12479999999999999877777999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.59  E-value=9.9e-05  Score=79.11  Aligned_cols=76  Identities=14%  Similarity=0.107  Sum_probs=49.1

Q ss_pred             CcccCCccEEEEEEEECCCcEEEEEEEeecc----C---CcchHHHHHHHHHHHhcC-C--CCcceEEeEeecCCCCCCc
Q 042766          711 NMIGQGRFGTVYKGILGDDEMVVAVKVINLK----Q---KGASKSFVSECEALRNIR-H--RNLIKIITICSSTDFEGVD  780 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~  780 (914)
                      +.||.|....||++....+++.|+||.....    .   .....+...|++.++.+. +  ..+.+++.+..       +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-------~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-------E  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------T
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC-------C
Confidence            4689999999999998777888999976431    1   123345667888887763 2  34666766522       1


Q ss_pred             eEeEEEecccCCC
Q 042766          781 FKALVFEYMENGS  793 (914)
Q Consensus       781 ~~~lv~e~~~~gs  793 (914)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3468999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.46  E-value=0.00022  Score=71.34  Aligned_cols=131  Identities=15%  Similarity=0.111  Sum_probs=81.1

Q ss_pred             cccCCcc-EEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCC--CcceEEeEeecCCCCCCceEeEEEec
Q 042766          712 MIGQGRF-GTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHR--NLIKIITICSSTDFEGVDFKALVFEY  788 (914)
Q Consensus       712 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e~  788 (914)
                      .+..|.. +.||+.... ++..+++|......   ...+..|++.++.+...  .+.++++++..     .+..++||||
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEe
Confidence            3445543 679998764 56667888764332   33567888888877433  35667766433     2467899999


Q ss_pred             ccCCCHHHHHhccCCcccccCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 042766          789 MENGSLEDWLHQSNDQVEVRKLSLIQRMNIAIDVASAIEYLHH-------------------------------------  831 (914)
Q Consensus       789 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~i~~~i~~gl~~LH~-------------------------------------  831 (914)
                      ++|.++.+.           ....   ...+.++.+.++-||+                                     
T Consensus        88 i~G~~~~~~-----------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          88 VPGQDLLSS-----------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             CSSEETTTS-----------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             eeccccccc-----------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            988654321           0010   0112233333333332                                     


Q ss_pred             --------------CC----CCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          832 --------------HC----QPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       832 --------------~~----~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                                    ..    .+.++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                          11    12489999999999999887778999998864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.34  E-value=2e-05  Score=73.56  Aligned_cols=14  Identities=7%  Similarity=0.237  Sum_probs=6.6

Q ss_pred             CCCCcEEEcccCcc
Q 042766          396 LVNLITFTLEVNQF  409 (914)
Q Consensus       396 l~~L~~L~L~~N~l  409 (914)
                      .++|++|+|++|++
T Consensus        99 n~sL~~L~l~~n~~  112 (167)
T d1pgva_          99 TQSIVEFKADNQRQ  112 (167)
T ss_dssp             TCCCSEEECCCCSS
T ss_pred             CCcCCEEECCCCcC
Confidence            34455555554443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.28  E-value=1.4e-05  Score=74.69  Aligned_cols=64  Identities=17%  Similarity=0.224  Sum_probs=31.1

Q ss_pred             CCCCCCEEEcCCC-CCccc----CCcccCCCCCCCeeecCCCCCCCcCCCC----ccccCCcchhccCCCccc
Q 042766           99 NLSFLRYINLADN-GFRGD----IPQEIGNLFRLEKLALSNNSFSGTIPTN----LSRCSNLIHFCASNNKLE  162 (914)
Q Consensus        99 ~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l~  162 (914)
                      +.+.|++|+|+++ .++..    +-..+...+.|++|+|++|.+...-...    +...+.|++|+|++|.++
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            3456667777653 34421    2233455566666666666665222111    223344444444444443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.44  E-value=0.00012  Score=67.92  Aligned_cols=65  Identities=12%  Similarity=0.106  Sum_probs=35.5

Q ss_pred             CCCCCCCEEEcCC-CCCccc----CCcccCCCCCCCeeecCCCCCCCc----CCCCccccCCcchhccCCCccc
Q 042766           98 GNLSFLRYINLAD-NGFRGD----IPQEIGNLFRLEKLALSNNSFSGT----IPTNLSRCSNLIHFCASNNKLE  162 (914)
Q Consensus        98 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~  162 (914)
                      .+.+.|++|+|++ +.++..    +-..+...++|++|+|++|.++..    +-..+...++++.+++++|.+.
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence            3456677777766 445421    223445666777777777766532    1122334555666666665554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.34  E-value=0.0043  Score=63.99  Aligned_cols=72  Identities=14%  Similarity=0.104  Sum_probs=44.4

Q ss_pred             EEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc--ceEEeEeecCCCCCCceEeEEEecccCC
Q 042766          719 GTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL--IKIITICSSTDFEGVDFKALVFEYMENG  792 (914)
Q Consensus       719 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~g  792 (914)
                      -.||+++.. +|+.|++|+.+... ...+++..|...+..+....+  +..........++.....+.++++++|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            379998875 67789999986432 244677889988888753322  2222111111223345678899999763

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.96  E-value=0.0004  Score=64.27  Aligned_cols=90  Identities=20%  Similarity=0.232  Sum_probs=41.2

Q ss_pred             cCcccceeeccCccCCCC----CCCccccccccccccccCccCCccc----cccccccccccceec--cCCcCCCCCCCC
Q 042766          268 NLPNLKKLGIGGNNFVGS----IPDSLSNASNLELLDLPSNQFKGKV----SIDFSSLKNLWLLNL--EQNNLGTGTAND  337 (914)
Q Consensus       268 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L--~~N~l~~~~~~~  337 (914)
                      ..++|++|+|++|.+...    +-..+...++++.+++++|.+....    ...+...++|+.++|  ++|.+...... 
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~-  122 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEM-  122 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHH-
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHH-
Confidence            344455555555544321    1122334455666666666654322    123344455554333  34444332111 


Q ss_pred             cchhhcccCCCCCcEEeccccc
Q 042766          338 LDFVIFLSNCSSLKVLSLSDNQ  359 (914)
Q Consensus       338 ~~~~~~l~~l~~L~~L~Ls~N~  359 (914)
                       .+...+...++|+.|+++.+.
T Consensus       123 -~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         123 -EIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             -HHHHHHHHCSSCCEEECCCSS
T ss_pred             -HHHHHHHhCCCcCEEeCcCCC
Confidence             123334556666666666554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.25  E-value=0.043  Score=57.80  Aligned_cols=72  Identities=18%  Similarity=0.197  Sum_probs=47.9

Q ss_pred             CcccCCccEEEEEEEECC-------CcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCC-cceEEeEeecCCCCCCceE
Q 042766          711 NMIGQGRFGTVYKGILGD-------DEMVVAVKVINLKQKGASKSFVSECEALRNIRHRN-LIKIITICSSTDFEGVDFK  782 (914)
Q Consensus       711 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  782 (914)
                      +.|+.|-.=.+|++....       ..+.|.+++.. .. .......+|..+++.+.-.+ ..++++++.         -
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------~  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS---------G  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------T
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------C
Confidence            567878888999998753       23567777764 22 23345668999988885334 457777631         1


Q ss_pred             eEEEecccCCC
Q 042766          783 ALVFEYMENGS  793 (914)
Q Consensus       783 ~lv~e~~~~gs  793 (914)
                      .+||||++|.+
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             ceEEEEecccc
Confidence            57999998754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.37  E-value=0.11  Score=52.68  Aligned_cols=167  Identities=11%  Similarity=0.026  Sum_probs=81.5

Q ss_pred             cCHHHHHHHhhcccccCc-----ccCCccEEEEEEEECCCcEEEEEEEeeccCCcchHHHHHHHHHHHhcCCCCc--ceE
Q 042766          695 VSYAELSKATSEFSSSNM-----IGQGRFGTVYKGILGDDEMVVAVKVINLKQKGASKSFVSECEALRNIRHRNL--IKI  767 (914)
Q Consensus       695 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l  767 (914)
                      ++.+++....++|...+.     |..|---+.|+.+..+ | .+++|+....  ...+.+..|++++..+...++  ...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence            456777777788876543     3455556789988753 3 4889988532  223455667777777643222  111


Q ss_pred             EeEeecCC-CCCCceEeEEEecccCCCHH-----H------H---Hh----ccCCccccc-----------------CCC
Q 042766          768 ITICSSTD-FEGVDFKALVFEYMENGSLE-----D------W---LH----QSNDQVEVR-----------------KLS  811 (914)
Q Consensus       768 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~-----~------~---l~----~~~~~~~~~-----------------~~~  811 (914)
                      ........ .........++.+.++....     .      .   ++    .........                 ...
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            11000000 00122345566666653211     0      0   00    000000000                 000


Q ss_pred             HHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCeeecCCCcEEEeccccccc
Q 042766          812 LIQRMNIAIDVASAIEYLHH-HCQPPMVHGDLKPSNVLLDYDMVAHVGDFGLAKF  865 (914)
Q Consensus       812 ~~~~~~i~~~i~~gl~~LH~-~~~~~ivHrDlkp~NILl~~~~~~ki~DFGla~~  865 (914)
                      .......+..+...+.-.+. ....++||+|+.++||+++.+...-|+||+.|..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            00011111122222222221 1234899999999999999988778999998863